archetype #,Feature Name,P value (Mann-Whitney),Median Difference,Mean Difference,Significant after Benjamini-Hochberg correction?,Is first bin maximal?
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,3.3713e-09,1.3349,1.271,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,3.3713e-09,1.2134,1.0942,1,1
1,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,2.457e-10,1.1211,1.0503,1,1
1,GO BLEB ASSEMBLY,2.559e-11,1.0785,1.1365,1,1
1,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,4.7449e-12,0.96188,0.98102,1,1
1,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,9.5677e-09,0.95468,0.8148,1,1
1,GO RESPONSE TO INTERFERON ALPHA,1.736e-11,0.94538,0.97677,1,1
1,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,6.8695e-12,0.8783,0.8845,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,5.6451e-10,0.87087,0.88074,1,1
1,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.5688e-10,0.8707,0.78237,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,4.4148e-09,0.86697,0.74559,1,1
1,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,9.3752e-12,0.85385,0.89275,1,1
1,GO T HELPER 2 CELL DIFFERENTIATION,4.5526e-11,0.83357,0.76238,1,1
1,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,2.7614e-08,0.80729,0.79581,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,8.5043e-10,0.80044,0.75803,1,1
1,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,3.2685e-12,0.79442,0.80224,1,1
1,GO T HELPER 1 CELL DIFFERENTIATION,1.1099e-11,0.78394,0.74405,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,4.1403e-10,0.77658,0.71191,1,1
1,GO NEGATIVE REGULATION OF CELL KILLING,1.6407e-09,0.77043,0.70829,1,1
1,GO RESPONSE TO INTERFERON BETA,1.069e-09,0.7641,0.79339,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,6.0205e-08,0.74199,0.64528,1,1
1,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,3.3697e-11,0.73729,0.78075,1,1
1,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,1.6514e-08,0.73395,0.73454,1,1
1,GO NEGATIVE REGULATION OF HIPPO SIGNALING,1.069e-09,0.72006,0.67822,1,1
1,GO INFLAMMATORY RESPONSE TO WOUNDING,1.2682e-10,0.7199,0.72638,1,1
1,GO MEMBRANE RAFT ORGANIZATION,8.2903e-10,0.71729,0.71575,1,1
1,GO HEMIDESMOSOME ASSEMBLY,1.0791e-07,0.71097,0.76554,1,1
1,GO HYALURONAN CATABOLIC PROCESS,1.3291e-12,0.7102,0.78712,1,1
1,GO T CELL MEDIATED CYTOTOXICITY,2.3853e-09,0.7071,0.62093,1,1
1,GO RESPONSE TO TYPE I INTERFERON,2.1064e-09,0.70279,0.66287,1,1
1,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,2.65e-07,0.70084,0.63266,1,1
1,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,8.9558e-11,0.69835,0.68489,1,1
1,GO TOLERANCE INDUCTION,4.1815e-08,0.69693,0.59693,1,1
1,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,1.3039e-08,0.69617,0.61955,1,1
1,GO FIBRINOLYSIS,6.8406e-11,0.69142,0.66769,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,3.4553e-09,0.68817,0.60587,1,1
1,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.9514e-07,0.68406,0.61618,1,1
1,GO CHEMOKINE BIOSYNTHETIC PROCESS,4.4749e-10,0.67427,0.65866,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.6717e-09,0.67121,0.55812,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,7.3803e-06,0.66496,0.59197,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,3.1098e-10,0.66384,0.63874,1,1
1,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.2058e-07,0.65907,0.53248,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,4.9624e-10,0.65585,0.5903,1,1
1,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,1.484e-09,0.65527,0.65545,1,1
1,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.8389e-10,0.65456,0.59803,1,1
1,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,2.559e-11,0.65415,0.70424,1,1
1,GO NEUTROPHIL HOMEOSTASIS,5.5078e-11,0.64981,0.68395,1,1
1,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.1595e-09,0.64945,0.57524,1,1
1,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,2.65e-07,0.64239,0.56291,1,1
1,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,2.0546e-09,0.63922,0.73344,1,1
1,GO DETECTION OF BIOTIC STIMULUS,1.0964e-09,0.63769,0.57516,1,1
1,GO CYTOLYSIS,5.3617e-10,0.63425,0.55242,1,1
1,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,4.3774e-08,0.63403,0.61507,1,1
1,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,3.5427e-10,0.63372,0.58034,1,1
1,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.3024e-10,0.63083,0.61528,1,1
1,GO REGULATION OF METANEPHROS DEVELOPMENT,4.2042e-09,0.62964,0.63034,1,1
1,GO OLIGOSACCHARIDE CATABOLIC PROCESS,4.5922e-10,0.62528,0.60953,1,1
1,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.9805e-09,0.62356,0.73852,1,1
1,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,3.094e-05,0.62121,0.50405,1,1
1,GO GLYCOLIPID CATABOLIC PROCESS,1.3419e-09,0.61823,0.577,1,1
1,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,6.757e-10,0.61671,0.55631,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,1.9465e-08,0.61583,0.60672,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,5.9432e-10,0.61352,0.54801,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,2.1064e-09,0.60722,0.59458,1,1
1,GO RESPONSE TO INTERLEUKIN 18,1.3878e-06,0.60675,0.5973,1,1
1,GO T HELPER 1 TYPE IMMUNE RESPONSE,5.6594e-11,0.60601,0.54883,1,1
1,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,7.8286e-11,0.60549,0.62457,1,1
1,GO ELASTIC FIBER ASSEMBLY,2.0879e-07,0.60307,0.68482,1,1
1,GO LEUKOCYTE AGGREGATION,2.2775e-07,0.60051,0.53643,1,1
1,GO T CELL EXTRAVASATION,9.1793e-10,0.5992,0.60639,1,1
1,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.4893e-11,0.59818,0.62956,1,1
1,GO RESPONSE TO INTERFERON GAMMA,1.2348e-10,0.59261,0.55645,1,1
1,GO SKIN MORPHOGENESIS,2.9602e-08,0.59022,0.63515,1,1
1,GO MUCUS SECRETION,3.7356e-07,0.59007,0.56595,1,1
1,GO ENDODERMAL CELL DIFFERENTIATION,8.4871e-11,0.58697,0.58321,1,1
1,GO DETECTION OF OTHER ORGANISM,3.5794e-07,0.58671,0.5282,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,9.9705e-11,0.58656,0.53856,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.3933e-10,0.58542,0.54701,1,1
1,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,9.8716e-08,0.58244,0.55055,1,1
1,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,5.8698e-06,0.58243,0.43067,1,1
1,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,7.6205e-11,0.58198,0.60463,1,1
1,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,2.9805e-09,0.57967,0.54397,1,1
1,GO ZYMOGEN INHIBITION,7.2202e-11,0.57815,0.62498,1,1
1,GO NEGATIVE REGULATION OF VIRAL PROCESS,1.1706e-10,0.57782,0.55407,1,1
1,GO DENDRITIC CELL APOPTOTIC PROCESS,4.719e-07,0.57762,0.55051,1,1
1,GO CHRONIC INFLAMMATORY RESPONSE,1.1398e-10,0.57076,0.564,1,1
1,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,3.6567e-07,0.56913,0.52078,1,1
1,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,6.2175e-05,0.56687,0.57596,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,3.0295e-08,0.56675,0.52541,1,1
1,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,3.3228e-08,0.56552,0.48873,1,1
1,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,2.5893e-10,0.56365,0.55699,1,1
1,GO GLYCOPROTEIN CATABOLIC PROCESS,1.2441e-09,0.56182,0.52561,1,1
1,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,3.9941e-08,0.56129,0.51935,1,1
1,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,5.7923e-10,0.56085,0.6488,1,1
1,GO ZYMOGEN ACTIVATION,1.6514e-08,0.55839,0.51032,1,1
1,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,1.7687e-09,0.55686,0.51962,1,1
1,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,2.9514e-07,0.55196,0.53669,1,1
1,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,5.2359e-09,0.55179,0.63381,1,1
1,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.3737e-10,0.54967,0.59158,1,1
1,GO PLASMINOGEN ACTIVATION,4.9069e-08,0.54878,0.50771,1,1
1,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,5.6451e-10,0.54741,0.46478,1,1
1,GO IMMUNOLOGICAL SYNAPSE FORMATION,6.1583e-08,0.54554,0.52273,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.7319e-10,0.54169,0.4804,1,1
1,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,7.4177e-11,0.54131,0.568,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,7.0279e-11,0.54006,0.50068,1,1
1,GO NEGATIVE REGULATION OF COAGULATION,3.8118e-09,0.53796,0.51208,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,6.4341e-05,0.53746,0.42682,1,1
1,GO EPIBOLY,1.0804e-10,0.535,0.56937,1,1
1,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,5.4982e-08,0.53483,0.5211,1,1
1,GO REGULATION OF MONOCYTE DIFFERENTIATION,1.3671e-08,0.53438,0.60896,1,1
1,GO RESPONSE TO MURAMYL DIPEPTIDE,9.1996e-11,0.53355,0.5407,1,1
1,GO ETHANOL OXIDATION,0.0012005,0.53318,0.36495,1,1
1,GO INTERLEUKIN 1 PRODUCTION,9.4157e-10,0.53216,0.46804,1,1
1,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,2.4586e-08,0.53213,0.5344,1,1
1,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,8.9047e-09,0.53129,0.54945,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,4.9069e-08,0.53095,0.46309,1,1
1,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,7.0017e-09,0.53066,0.55927,1,1
1,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.5386e-08,0.5305,0.54091,1,1
1,GO DNA DEAMINATION,2.1338e-07,0.52855,0.50641,1,1
1,GO TYPE 2 IMMUNE RESPONSE,5.7923e-10,0.52853,0.53722,1,1
1,GO COLLAGEN BIOSYNTHETIC PROCESS,3.192e-10,0.52591,0.58909,1,1
1,GO IMMUNE RESPONSE TO TUMOR CELL,2.5066e-09,0.52567,0.50528,1,1
1,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.8262e-08,0.52247,0.41666,1,1
1,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,9.4157e-10,0.5222,0.47046,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.4586e-08,0.52194,0.45152,1,1
1,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,2.4305e-07,0.52123,0.44349,1,1
1,GO REGULATION OF TOLERANCE INDUCTION,2.5868e-06,0.52077,0.42104,1,1
1,GO REGULATION OF T CELL APOPTOTIC PROCESS,5.2253e-10,0.52047,0.43834,1,1
1,GO REGULATION OF MACROPHAGE DIFFERENTIATION,2.7e-09,0.52014,0.49319,1,1
1,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,7.1726e-09,0.51904,0.47492,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,2.9078e-09,0.51857,0.43215,1,1
1,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,6.0205e-08,0.51718,0.48916,1,1
1,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,2.9602e-08,0.51713,0.45683,1,1
1,GO GERMINAL CENTER FORMATION,4.2444e-07,0.51667,0.45957,1,1
1,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,3.2859e-07,0.51488,0.5221,1,1
1,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.3082e-09,0.5141,0.48551,1,1
1,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,8.1414e-12,0.51324,0.5268,1,1
1,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,5.8856e-08,0.51305,0.46697,1,1
1,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,1.6782e-07,0.51068,0.48807,1,1
1,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0020092,0.51007,0.31711,1,1
1,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,2.8369e-09,0.50857,0.56119,1,1
1,GO REGULATION OF FIBRINOLYSIS,1.7721e-08,0.50829,0.4908,1,1
1,GO ENDODERM FORMATION,1.3024e-10,0.50804,0.52441,1,1
1,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,2.6981e-08,0.50737,0.45194,1,1
1,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,2.5359e-06,0.50552,0.52723,1,1
1,GO XENOBIOTIC CATABOLIC PROCESS,0.00011406,0.50551,0.42986,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,5.1351e-07,0.50522,0.49478,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,3.6435e-08,0.50519,0.44906,1,1
1,GO INTERLEUKIN 1 BETA PRODUCTION,1.6407e-09,0.50442,0.45544,1,1
1,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.785e-11,0.50337,0.54722,1,1
1,GO T CELL MEDIATED IMMUNITY,3.9309e-10,0.50319,0.44136,1,1
1,GO KERATAN SULFATE CATABOLIC PROCESS,9.2321e-08,0.50224,0.47596,1,1
1,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.1595e-09,0.50161,0.48207,1,1
1,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.2434e-08,0.50054,0.46589,1,1
1,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,1.4334e-08,0.49855,0.47923,1,1
1,GO ENTRY INTO HOST,7.2202e-11,0.49716,0.46028,1,1
1,GO MACROPHAGE CYTOKINE PRODUCTION,5.1304e-06,0.49703,0.48117,1,1
1,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.3228e-08,0.49619,0.45115,1,1
1,GO DENDRITIC CELL CYTOKINE PRODUCTION,2.4837e-07,0.49516,0.45445,1,1
1,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,1.2058e-07,0.49476,0.4945,1,1
1,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9546e-09,0.49459,0.43533,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.7687e-09,0.49381,0.44672,1,1
1,GO BRANCH ELONGATION OF AN EPITHELIUM,5.6487e-06,0.4905,0.48299,1,1
1,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,2.4586e-08,0.48977,0.44927,1,1
1,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,9.404e-07,0.48893,0.45218,1,1
1,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.8135e-09,0.48774,0.45395,1,1
1,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.785e-11,0.48761,0.45528,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,2.856e-06,0.48741,0.39157,1,1
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,6.2169e-06,0.48685,0.44243,1,1
1,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.9558e-07,0.48659,0.39947,1,1
1,GO POSITIVE REGULATION OF PHAGOCYTOSIS,8.7184e-11,0.48653,0.4791,1,1
1,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,5.1356e-08,0.48649,0.40357,1,1
1,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,2.4452e-09,0.48595,0.42527,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,7.1121e-10,0.48559,0.49348,1,1
1,GO ENDODERM DEVELOPMENT,2.6581e-10,0.48542,0.45733,1,1
1,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.00011218,0.4849,0.37681,1,1
1,GO PEPTIDE CROSS LINKING,8.3066e-07,0.48449,0.4022,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.3228e-08,0.48436,0.40756,1,1
1,GO REGULATION OF VIRAL GENOME REPLICATION,3.0296e-10,0.48294,0.45917,1,1
1,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.634e-09,0.48285,0.37148,1,1
1,GO METANEPHRIC EPITHELIUM DEVELOPMENT,2.402e-08,0.48254,0.48571,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.5027e-08,0.48238,0.46159,1,1
1,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.7797e-11,0.48157,0.52605,1,1
1,GO RIBONUCLEOSIDE CATABOLIC PROCESS,2.9805e-09,0.47933,0.51342,1,1
1,GO APOPTOTIC CELL CLEARANCE,2.6306e-11,0.47931,0.55238,1,1
1,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,4.9403e-11,0.47866,0.45497,1,1
1,GO INTERLEUKIN 13 PRODUCTION,9.0235e-07,0.47758,0.44478,1,1
1,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.016938,0.47735,0.20306,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,3.0296e-10,0.47624,0.47234,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.969e-07,0.47618,0.38827,1,1
1,GO CELLULAR DEFENSE RESPONSE,2.8271e-07,0.47445,0.33426,1,1
1,GO INTERLEUKIN 8 PRODUCTION,8.0815e-10,0.47394,0.43531,1,1
1,GO PROTEIN ACTIVATION CASCADE,1.8135e-09,0.47334,0.44826,1,1
1,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,4.9361e-06,0.47226,0.38399,1,1
1,GO DEFENSE RESPONSE TO VIRUS,3.7319e-10,0.47219,0.41601,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,1.2328e-07,0.47094,0.35749,1,1
1,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,7.0017e-09,0.47066,0.47034,1,1
1,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,3.0811e-07,0.47056,0.36118,1,1
1,GO CELL ADHESION MEDIATED BY INTEGRIN,5.7536e-08,0.46869,0.43439,1,1
1,GO POSITIVE REGULATION OF COAGULATION,2.0398e-08,0.46835,0.40788,1,1
1,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,7.2129e-08,0.46703,0.54925,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00064263,0.46694,0.32366,1,1
1,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,7.892e-08,0.46573,0.52638,1,1
1,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,1.5217e-09,0.46555,0.41563,1,1
1,GO PROSTATIC BUD FORMATION,0.00011986,0.46553,0.42236,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MATURATION,9.9705e-11,0.46534,0.49305,1,1
1,GO CERAMIDE CATABOLIC PROCESS,2.0398e-08,0.46532,0.43761,1,1
1,GO RESPONSE TO TUMOR CELL,1.2027e-05,0.46479,0.35547,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.402e-08,0.46397,0.4156,1,1
1,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,3.2785e-11,0.46382,0.46888,1,1
1,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,4.0817e-11,0.46255,0.53888,1,1
1,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,1.2328e-07,0.46251,0.48572,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,4.8673e-09,0.46231,0.39524,1,1
1,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,1.4076e-07,0.46207,0.51422,1,1
1,GO PROSTANOID BIOSYNTHETIC PROCESS,2.8886e-07,0.4615,0.38877,1,1
1,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.8359e-10,0.46144,0.41678,1,1
1,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,3.0302e-06,0.46098,0.56309,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,9.1996e-11,0.4608,0.48602,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.0554e-07,0.46068,0.43539,1,1
1,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,3.9613e-05,0.45917,0.41631,1,1
1,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,2.7041e-11,0.45891,0.4902,1,1
1,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,3.4796e-08,0.45841,0.38384,1,1
1,GO GLOMERULAR MESANGIUM DEVELOPMENT,2.2397e-08,0.45799,0.54327,1,1
1,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,1.5713e-07,0.45619,0.45796,1,1
1,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.00046872,0.45478,0.3235,1,1
1,GO PINOCYTOSIS,8.2903e-10,0.4543,0.42137,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,9.4341e-06,0.45409,0.35563,1,1
1,GO REGULATION OF MEMBRANE INVAGINATION,2.538e-07,0.45362,0.43989,1,1
1,GO LATERAL MESODERM DEVELOPMENT,3.1729e-08,0.45317,0.4579,1,1
1,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.8573e-08,0.45265,0.48285,1,1
1,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.2784e-08,0.4526,0.38676,1,1
1,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.2785e-11,0.45236,0.49488,1,1
1,GO REGULATION OF COAGULATION,8.2864e-09,0.45211,0.4278,1,1
1,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,2.8753e-10,0.45171,0.4241,1,1
1,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,1.3376e-10,0.45136,0.43958,1,1
1,GO RESPONSE TO PROTOZOAN,5.77e-09,0.45128,0.45953,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,6.8396e-06,0.45109,0.45358,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,6.0565e-09,0.45016,0.38091,1,1
1,GO CYTOKINE METABOLIC PROCESS,1.6542e-10,0.45005,0.41833,1,1
1,GO PROSTATE GLAND MORPHOGENESIS,0.00018923,0.45,0.39398,1,1
1,GO DENDRITIC CELL DIFFERENTIATION,4.31e-06,0.44801,0.38399,1,1
1,GO COLLAGEN FIBRIL ORGANIZATION,5.8856e-08,0.44704,0.50075,1,1
1,GO BONE TRABECULA MORPHOGENESIS,1.0557e-05,0.44492,0.44645,1,1
1,GO REGULATION OF GLOMERULUS DEVELOPMENT,5.6085e-05,0.44466,0.42198,1,1
1,GO MONONUCLEAR CELL DIFFERENTIATION,3.6435e-08,0.44442,0.45286,1,1
1,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,2.8262e-08,0.44405,0.58062,1,1
1,GO REGULATION OF CELL KILLING,7.969e-07,0.44288,0.32143,1,1
1,GO AMYLOID FIBRIL FORMATION,3.6877e-06,0.44264,0.44706,1,1
1,GO REGULATION OF PHAGOCYTOSIS,2.457e-10,0.44229,0.39757,1,1
1,GO CELLULAR RESPONSE TO INTERFERON BETA,5.2445e-07,0.44219,0.3878,1,1
1,GO REGULATION OF VIRAL LIFE CYCLE,6.4805e-11,0.44136,0.45452,1,1
1,GO MYELOID DENDRITIC CELL DIFFERENTIATION,6.6066e-07,0.44065,0.39229,1,1
1,GO HIPPO SIGNALING,9.4407e-08,0.4403,0.44805,1,1
1,GO REGULATION OF T HELPER CELL DIFFERENTIATION,5.2359e-09,0.44003,0.41138,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,7.8976e-09,0.43994,0.5143,1,1
1,GO CELLULAR RESPONSE TO SALT STRESS,1.8594e-09,0.43944,0.47835,1,1
1,GO ALPHA BETA T CELL PROLIFERATION,2.9859e-05,0.43928,0.31711,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL BUD,1.5052e-06,0.43922,0.48815,1,1
1,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.1097e-10,0.439,0.48709,1,1
1,GO CHEMOKINE PRODUCTION,3.0811e-07,0.43853,0.33424,1,1
1,GO INTERLEUKIN 2 PRODUCTION,3.0296e-10,0.43792,0.39579,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,8.8282e-08,0.43757,0.3782,1,1
1,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.8976e-09,0.43749,0.39496,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.8976e-09,0.43742,0.35886,1,1
1,GO REGULATION OF AMYLOID BETA CLEARANCE,2.0879e-07,0.43682,0.40462,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,4.1456e-06,0.43646,0.32404,1,1
1,GO B CELL MEDIATED IMMUNITY,4.8673e-09,0.43627,0.42029,1,1
1,GO BASE CONVERSION OR SUBSTITUTION EDITING,2.0429e-07,0.43593,0.42962,1,1
1,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.00012804,0.43593,0.46115,1,1
1,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,6.4434e-08,0.43578,0.37011,1,1
1,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,1.1375e-05,0.43479,0.44192,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,1.3376e-10,0.43454,0.45805,1,1
1,GO VIRAL GENOME REPLICATION,2.9515e-10,0.43446,0.40856,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,2.2926e-08,0.43444,0.4169,1,1
1,GO RESPONSE TO INTERLEUKIN 15,5.7582e-06,0.43442,0.3309,1,1
1,GO RAP PROTEIN SIGNAL TRANSDUCTION,2.0983e-10,0.43415,0.49227,1,1
1,GO INTERLEUKIN 17 PRODUCTION,3.0295e-08,0.43381,0.37765,1,1
1,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0010558,0.43321,0.34255,1,1
1,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,2.5884e-05,0.43312,0.40155,1,1
1,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,9.7998e-07,0.43295,0.38521,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.634e-09,0.43253,0.35192,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.7614e-08,0.43252,0.5081,1,1
1,GO VENOUS BLOOD VESSEL DEVELOPMENT,5.4184e-05,0.43187,0.31199,1,1
1,GO REGULATION OF COLLAGEN METABOLIC PROCESS,1.9926e-08,0.43155,0.47198,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,3.4003e-08,0.431,0.42432,1,1
1,GO THYMOCYTE APOPTOTIC PROCESS,1.0781e-08,0.43007,0.41844,1,1
1,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0033799,0.42958,0.2886,1,1
1,GO METANEPHRIC GLOMERULUS DEVELOPMENT,2.0776e-06,0.42847,0.44463,1,1
1,GO INTERFERON ALPHA PRODUCTION,3.1004e-08,0.42722,0.3573,1,1
1,GO NEGATIVE REGULATION OF LIPID TRANSPORT,2.7614e-08,0.4263,0.35563,1,1
1,GO VASCULOGENESIS,1.3737e-10,0.42595,0.44119,1,1
1,GO RESPONSE TO THYROID HORMONE,6.8396e-06,0.42573,0.3401,1,1
1,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.8161e-07,0.42569,0.4967,1,1
1,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,1.6994e-06,0.4256,0.44492,1,1
1,GO BIOLOGICAL PHASE,2.6914e-06,0.42453,0.48253,1,1
1,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,1.8723e-07,0.42403,0.36672,1,1
1,GO POSITIVE REGULATION OF CELL KILLING,1.5576e-05,0.42396,0.2957,1,1
1,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,4.6881e-08,0.42389,0.37218,1,1
1,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,3.1312e-09,0.42383,0.42019,1,1
1,GO MEMBRANE PROTEIN PROTEOLYSIS,2.0983e-10,0.42369,0.42054,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,1.2143e-08,0.4235,0.42801,1,1
1,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,1.1579e-08,0.42319,0.40618,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.8856e-08,0.42311,0.35055,1,1
1,GO TRABECULA FORMATION,2.1196e-06,0.42307,0.39282,1,1
1,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,6.4699e-07,0.4228,0.42079,1,1
1,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00014362,0.42262,0.32634,1,1
1,GO REGULATION OF PINOCYTOSIS,1.5372e-07,0.42219,0.35566,1,1
1,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,8.2864e-09,0.42204,0.52025,1,1
1,GO MYELOID DENDRITIC CELL ACTIVATION,1.0212e-06,0.42154,0.33317,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.1338e-07,0.42077,0.32609,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,3.5412e-09,0.42058,0.41759,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,3.2894e-09,0.42012,0.42871,1,1
1,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.00031414,0.41999,0.45442,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,3.5794e-07,0.41946,0.32425,1,1
1,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,4.4285e-07,0.41873,0.48707,1,1
1,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,6.4434e-08,0.41797,0.482,1,1
1,GO RETINAL METABOLIC PROCESS,8.5858e-05,0.41781,0.34341,1,1
1,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.0565e-09,0.41739,0.37593,1,1
1,GO NEGATIVE REGULATION OF LIPID STORAGE,2.65e-07,0.41738,0.35309,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,4.4807e-06,0.41698,0.46943,1,1
1,GO RESPONSE TO HYPEROXIA,6.2993e-08,0.41686,0.38832,1,1
1,GO POSITIVE REGULATION OF STEROL TRANSPORT,3.2894e-09,0.41685,0.43371,1,1
1,GO MONONUCLEAR CELL MIGRATION,5.8856e-08,0.41598,0.32914,1,1
1,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.0062877,0.41524,0.30579,1,1
1,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,8.6328e-08,0.41507,0.44417,1,1
1,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,4.2271e-06,0.41488,0.30949,1,1
1,GO SERTOLI CELL DEVELOPMENT,2.1338e-07,0.41485,0.42801,1,1
1,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,4.7488e-06,0.41463,0.3241,1,1
1,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.3351e-08,0.41424,0.40871,1,1
1,GO REGULATION OF MONONUCLEAR CELL MIGRATION,3.247e-08,0.41421,0.36237,1,1
1,GO AMYLOID BETA CLEARANCE,2.457e-10,0.41418,0.39997,1,1
1,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.9078e-09,0.41377,0.36619,1,1
1,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,8.1138e-06,0.41329,0.39765,1,1
1,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,7.2964e-10,0.41317,0.46103,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,7.1726e-09,0.41193,0.46447,1,1
1,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,1.0004e-06,0.41188,0.39294,1,1
1,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,4.3946e-06,0.41119,0.39745,1,1
1,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,1.3671e-08,0.41104,0.35932,1,1
1,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.9905e-10,0.411,0.38059,1,1
1,GO PROGRAMMED NECROTIC CELL DEATH,1.3999e-08,0.41072,0.36007,1,1
1,GO INTEGRIN MEDIATED SIGNALING PATHWAY,3.4516e-10,0.41066,0.45408,1,1
1,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.7721e-08,0.4104,0.46733,1,1
1,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,7.6205e-11,0.40957,0.47072,1,1
1,GO MACROPHAGE MIGRATION,7.6792e-10,0.40928,0.36247,1,1
1,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,3.8983e-07,0.40916,0.47686,1,1
1,GO REVERSE CHOLESTEROL TRANSPORT,0.00016629,0.40908,0.34867,1,1
1,GO CYTOKINE MEDIATED SIGNALING PATHWAY,6.9323e-10,0.40866,0.34976,1,1
1,GO REGULATION OF TRANSPOSITION,1.439e-07,0.40837,0.44405,1,1
1,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.0296e-10,0.40765,0.38173,1,1
1,GO CELL SUBSTRATE JUNCTION ORGANIZATION,3.6293e-09,0.4074,0.43062,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.3467e-08,0.40718,0.40968,1,1
1,GO RESPONSE TO VIRUS,2.5223e-10,0.4071,0.36244,1,1
1,GO MONOCYTE CHEMOTAXIS,5.4701e-07,0.40685,0.32907,1,1
1,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,8.2864e-09,0.40638,0.34724,1,1
1,GO T CELL CYTOKINE PRODUCTION,5.4967e-09,0.40591,0.35107,1,1
1,GO CD40 SIGNALING PATHWAY,1.5604e-09,0.40542,0.42721,1,1
1,GO CELLULAR RESPONSE TO DSRNA,2.9371e-11,0.40501,0.44584,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,2.8886e-07,0.40468,0.35639,1,1
1,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,1.9393e-05,0.40431,0.43701,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,4.4749e-10,0.40426,0.47975,1,1
1,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.5066e-09,0.40396,0.31786,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,2.6386e-06,0.40356,0.31561,1,1
1,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.6109e-10,0.40314,0.3717,1,1
1,GO SALIVARY GLAND DEVELOPMENT,1.3671e-08,0.40293,0.47338,1,1
1,GO T CELL APOPTOTIC PROCESS,2.801e-10,0.40285,0.36863,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.658e-10,0.4019,0.33058,1,1
1,GO RESPONSE TO INTERLEUKIN 12,1.6823e-09,0.40164,0.36885,1,1
1,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,1.8389e-10,0.4014,0.42034,1,1
1,GO REGULATION OF KERATINOCYTE PROLIFERATION,4.3946e-06,0.40062,0.42644,1,1
1,GO LEUKOCYTE MEDIATED IMMUNITY,3.1312e-09,0.40057,0.3159,1,1
1,GO MOVEMENT IN HOST ENVIRONMENT,1.3737e-10,0.40009,0.39123,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,9.4407e-08,0.39979,0.30838,1,1
1,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,5.2253e-10,0.39955,0.39232,1,1
1,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,7.5266e-09,0.39944,0.43542,1,1
1,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,1.064e-06,0.3993,0.39737,1,1
1,GO REGULATION OF MYOBLAST FUSION,1.1041e-08,0.3989,0.4531,1,1
1,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00026858,0.39878,0.2882,1,1
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,4.5239e-09,0.39868,0.45128,1,1
1,GO GAP JUNCTION ASSEMBLY,3.357e-07,0.39815,0.42148,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,3.2094e-09,0.39801,0.35668,1,1
1,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,4.1552e-07,0.39789,0.39153,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.0429e-07,0.39763,0.4014,1,1
1,GO I KAPPAB KINASE NF KAPPAB SIGNALING,4.4749e-10,0.39721,0.34984,1,1
1,GO REGULATION OF T CELL CYTOKINE PRODUCTION,6.0565e-09,0.39708,0.36978,1,1
1,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,8.7184e-11,0.39644,0.47595,1,1
1,GO SKELETAL MUSCLE CELL PROLIFERATION,2.3467e-08,0.39601,0.43412,1,1
1,GO PROSTANOID METABOLIC PROCESS,2.3784e-07,0.39593,0.34494,1,1
1,GO LEUKOCYTE MEDIATED CYTOTOXICITY,3.8149e-08,0.39531,0.34818,1,1
1,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,6.4592e-06,0.39508,0.39315,1,1
1,GO LYMPHOCYTE MEDIATED IMMUNITY,1.9546e-09,0.39491,0.37205,1,1
1,GO REGULATION OF PODOSOME ASSEMBLY,2.856e-06,0.39472,0.41455,1,1
1,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,1.2886e-07,0.39421,0.44344,1,1
1,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.6828e-05,0.39383,0.31653,1,1
1,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.00038422,0.39318,0.3174,1,1
1,GO I KAPPAB PHOSPHORYLATION,1.2759e-09,0.39304,0.35744,1,1
1,GO NEGATIVE REGULATION OF WOUND HEALING,1.6514e-08,0.39302,0.38863,1,1
1,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,5.9498e-07,0.39279,0.41754,1,1
1,GO GLAND MORPHOGENESIS,1.2886e-07,0.39245,0.39929,1,1
1,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.439e-07,0.39202,0.34311,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,4.8359e-10,0.39199,0.34229,1,1
1,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,7.5266e-09,0.39189,0.37625,1,1
1,GO ENTRY OF BACTERIUM INTO HOST CELL,9.2585e-06,0.3909,0.43195,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,1.6407e-09,0.39081,0.3994,1,1
1,GO HYPOTONIC RESPONSE,1.0424e-06,0.39073,0.32803,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION,1.6986e-10,0.3904,0.34475,1,1
1,GO BASEMENT MEMBRANE ORGANIZATION,2.8925e-08,0.39038,0.52043,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,4.2784e-08,0.38992,0.32155,1,1
1,GO CHAPERONE MEDIATED AUTOPHAGY,0.00016629,0.38972,0.33526,1,1
1,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,2.0879e-07,0.38946,0.36773,1,1
1,GO MACROPHAGE PROLIFERATION,1.0424e-06,0.38884,0.42623,1,1
1,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,3.2094e-09,0.38873,0.32614,1,1
1,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,4.1456e-06,0.38871,0.36181,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,4.3946e-06,0.38847,0.30145,1,1
1,GO HYALURONAN METABOLIC PROCESS,1.887e-11,0.38842,0.39764,1,1
1,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,5.3747e-08,0.38805,0.3527,1,1
1,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,2.1595e-09,0.38754,0.36672,1,1
1,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0034692,0.38704,0.22898,1,1
1,GO POSITIVE REGULATION OF T CELL PROLIFERATION,1.4334e-08,0.38692,0.36178,1,1
1,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,2.0881e-08,0.38682,0.35327,1,1
1,GO STEROID ESTERIFICATION,9.1829e-05,0.38667,0.32795,1,1
1,GO INTERFERON BETA PRODUCTION,4.7501e-09,0.38659,0.34596,1,1
1,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.9805e-09,0.38634,0.31807,1,1
1,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,5.9432e-10,0.38619,0.44441,1,1
1,GO IMMUNE EFFECTOR PROCESS,1.6001e-09,0.38614,0.31899,1,1
1,GO PROSTATE GLAND DEVELOPMENT,6.0759e-07,0.38591,0.41232,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.6761e-05,0.38554,0.38833,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.6418e-07,0.38552,0.34626,1,1
1,GO MYELOID LEUKOCYTE ACTIVATION,1.3039e-08,0.38549,0.30395,1,1
1,GO POSITIVE REGULATION OF CELL ADHESION,8.4877e-09,0.38516,0.33759,1,1
1,GO REGULATION OF SYMBIOTIC PROCESS,1.3376e-10,0.38513,0.36682,1,1
1,GO INNATE IMMUNE RESPONSE,2.0546e-09,0.38488,0.33561,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,2.3268e-09,0.38455,0.46864,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,3.3214e-05,0.38449,0.24521,1,1
1,GO COLLAGEN CATABOLIC PROCESS,3.1004e-08,0.38388,0.36611,1,1
1,GO COMPLEMENT ACTIVATION,1.5386e-08,0.38379,0.48045,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,4.5239e-09,0.38374,0.35629,1,1
1,GO NATURAL KILLER CELL ACTIVATION,5.0922e-10,0.38321,0.34912,1,1
1,GO VAGINA DEVELOPMENT,6.0565e-09,0.38294,0.42862,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,5.2538e-08,0.38283,0.36231,1,1
1,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,4.9872e-09,0.38277,0.33022,1,1
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.4877e-09,0.38267,0.40241,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,3.4296e-07,0.38243,0.38336,1,1
1,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.0020367,0.38237,0.2331,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,7.892e-08,0.38219,0.35324,1,1
1,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.65e-07,0.38181,0.39065,1,1
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.0025277,0.38083,0.33592,1,1
1,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.5756e-08,0.38049,0.38404,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,3.5794e-07,0.38009,0.32981,1,1
1,GO MUSCLE CELL FATE COMMITMENT,1.9989e-07,0.37959,0.35268,1,1
1,GO T CELL PROLIFERATION,1.1535e-07,0.37946,0.29515,1,1
1,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,5.332e-06,0.37924,0.36729,1,1
1,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,2.3239e-05,0.3785,0.41635,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,4.9228e-07,0.37846,0.36844,1,1
1,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,3.4296e-07,0.37801,0.35976,1,1
1,GO HEME METABOLIC PROCESS,1.484e-09,0.37783,0.37542,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.8135e-09,0.37749,0.37213,1,1
1,GO CELLULAR COPPER ION HOMEOSTASIS,2.5756e-08,0.37731,0.38362,1,1
1,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.9926e-08,0.37644,0.36165,1,1
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,8.4415e-08,0.37616,0.35469,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,4.2444e-07,0.37604,0.31714,1,1
1,GO PLATELET AGGREGATION,1.069e-09,0.37589,0.39563,1,1
1,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,2.0364e-06,0.37566,0.34445,1,1
1,GO GRANULOCYTE CHEMOTAXIS,1.3878e-06,0.37563,0.28133,1,1
1,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,3.5606e-08,0.37559,0.32946,1,1
1,GO PIGMENT ACCUMULATION,4.4285e-07,0.37475,0.38972,1,1
1,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,8.5867e-06,0.37464,0.43105,1,1
1,GO ENDOTHELIAL CELL CHEMOTAXIS,1.1316e-06,0.37433,0.43181,1,1
1,GO EXTRACELLULAR MATRIX ASSEMBLY,1.0169e-05,0.37432,0.48041,1,1
1,GO RESPONSE TO HYDROPEROXIDE,0.001118,0.37431,0.29382,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,2.3853e-09,0.37419,0.39372,1,1
1,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,1.6129e-08,0.37417,0.33718,1,1
1,GO SKELETAL MUSCLE TISSUE REGENERATION,5.9116e-09,0.37413,0.38513,1,1
1,GO REGULATION OF PLATELET ACTIVATION,1.0756e-05,0.37398,0.38341,1,1
1,GO CYSTEINE METABOLIC PROCESS,0.00046165,0.3738,0.2839,1,1
1,GO AMINE CATABOLIC PROCESS,8.1138e-06,0.37345,0.32028,1,1
1,GO PLATELET DEGRANULATION,8.6937e-09,0.37342,0.40293,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.2328e-07,0.37323,0.33328,1,1
1,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,6.8348e-09,0.37306,0.42364,1,1
1,GO FIBROBLAST MIGRATION,8.7237e-10,0.37299,0.37907,1,1
1,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,9.6538e-08,0.37278,0.52055,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,6.0079e-05,0.37254,0.35345,1,1
1,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,2.5359e-06,0.37244,0.29202,1,1
1,GO REGULATION OF IMMUNE EFFECTOR PROCESS,8.2903e-10,0.37173,0.34815,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,3.2094e-09,0.37144,0.37604,1,1
1,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,1.3671e-08,0.37125,0.42332,1,1
1,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.6129e-08,0.37094,0.35004,1,1
1,GO COLLAGEN METABOLIC PROCESS,2.7e-09,0.37081,0.42582,1,1
1,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,7.0522e-08,0.37068,0.30843,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,4.6356e-09,0.36988,0.35237,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,1.6129e-08,0.36929,0.34119,1,1
1,GO AMINOGLYCAN CATABOLIC PROCESS,3.1312e-09,0.36829,0.42695,1,1
1,GO DEFENSE RESPONSE TO OTHER ORGANISM,2.0546e-09,0.36777,0.31208,1,1
1,GO TYPE I INTERFERON PRODUCTION,1.1533e-09,0.36763,0.33466,1,1
1,GO MACROPHAGE DIFFERENTIATION,9.3415e-09,0.36727,0.35291,1,1
1,GO NEGATIVE REGULATION OF CELL CELL ADHESION,9.404e-07,0.36664,0.29094,1,1
1,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,1.1579e-08,0.36659,0.35888,1,1
1,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,8.5043e-10,0.36607,0.34984,1,1
1,GO NEGATIVE REGULATION OF CELL ACTIVATION,7.0522e-08,0.36585,0.29292,1,1
1,GO PROTEIN OXIDATION,9.4959e-05,0.36495,0.37407,1,1
1,GO LEUKOCYTE APOPTOTIC PROCESS,1.0964e-09,0.36465,0.34373,1,1
1,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.00010852,0.36463,0.24949,1,1
1,GO POSITIVE REGULATION OF HAIR CYCLE,8.3013e-05,0.36443,0.34783,1,1
1,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,4.1403e-10,0.36423,0.40135,1,1
1,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.8839e-05,0.36395,0.31164,1,1
1,GO RESPONSE TO ANGIOTENSIN,1.2131e-09,0.36393,0.37723,1,1
1,GO GRANULOCYTE MIGRATION,6.7411e-08,0.36376,0.30008,1,1
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,2.6386e-06,0.36342,0.31517,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.6514e-08,0.36299,0.33949,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.064e-06,0.36287,0.43071,1,1
1,GO RESPONSE TO DSRNA,6.8348e-09,0.36267,0.3233,1,1
1,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,4.5526e-11,0.36265,0.40975,1,1
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.8369e-09,0.36257,0.33305,1,1
1,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.4112e-09,0.36242,0.31732,1,1
1,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,6.2169e-06,0.3624,0.29978,1,1
1,GO REGULATION OF RESPONSE TO TUMOR CELL,2.4528e-05,0.36228,0.29533,1,1
1,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,2.2824e-05,0.36163,0.32086,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,1.5713e-07,0.36148,0.29468,1,1
1,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,6.2565e-10,0.36134,0.35935,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.1282e-07,0.36092,0.3275,1,1
1,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,1.0781e-08,0.36072,0.30696,1,1
1,GO MAMMARY GLAND DUCT MORPHOGENESIS,1.2281e-06,0.36066,0.36006,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,1.9136e-07,0.36063,0.37204,1,1
1,GO RESPONSE TO CYTOKINE,1.2131e-09,0.3601,0.30068,1,1
1,GO REGULATION OF MYOBLAST DIFFERENTIATION,2.0776e-06,0.3599,0.32555,1,1
1,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,1.471e-07,0.35971,0.4129,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,6.895e-08,0.35951,0.38517,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,2.402e-08,0.35925,0.33357,1,1
1,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,4.9069e-08,0.35914,0.29944,1,1
1,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,8.0898e-09,0.35864,0.38822,1,1
1,GO MACROPHAGE CHEMOTAXIS,8.4877e-09,0.3585,0.35848,1,1
1,GO REGULATION OF LEUKOCYTE PROLIFERATION,4.3355e-07,0.35808,0.29796,1,1
1,GO REGULATION OF RECEPTOR BINDING,0.00014839,0.35803,0.30573,1,1
1,GO NUCLEOSIDE CATABOLIC PROCESS,1.0781e-08,0.35755,0.36913,1,1
1,GO EXTRACELLULAR STRUCTURE ORGANIZATION,1.1858e-08,0.35744,0.41121,1,1
1,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,3.5794e-07,0.35716,0.33631,1,1
1,GO CYTOKINE PRODUCTION,5.1101e-09,0.35711,0.30008,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.3599e-06,0.35635,0.35816,1,1
1,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,3.6162e-06,0.35625,0.3474,1,1
1,GO FOAM CELL DIFFERENTIATION,3.9872e-06,0.35615,0.34572,1,1
1,GO INTERLEUKIN 12 PRODUCTION,2.3239e-05,0.35577,0.26474,1,1
1,GO AORTIC VALVE DEVELOPMENT,9.5999e-07,0.35523,0.37657,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,1.3325e-06,0.35511,0.34485,1,1
1,GO REGULATION OF ISOTYPE SWITCHING,9.6538e-08,0.35457,0.33812,1,1
1,GO MYOBLAST FUSION,1.5037e-07,0.3544,0.38984,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,8.0815e-10,0.35373,0.41847,1,1
1,GO PHOSPHOLIPID HOMEOSTASIS,5.4184e-05,0.35322,0.29111,1,1
1,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,3.7282e-08,0.35288,0.37773,1,1
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,1.4472e-05,0.35264,0.31266,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,3.8347e-06,0.35258,0.34941,1,1
1,GO ADAPTIVE IMMUNE RESPONSE,2.9078e-09,0.35241,0.37926,1,1
1,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,4.2271e-06,0.35238,0.38893,1,1
1,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,3.9035e-08,0.35219,0.33917,1,1
1,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,6.9323e-10,0.35216,0.35979,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,5.8856e-08,0.35211,0.40773,1,1
1,GO NAD BIOSYNTHETIC PROCESS,0.0022095,0.35194,0.22282,1,1
1,GO TRANSPOSITION,2.1338e-07,0.35186,0.38716,1,1
1,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,8.9047e-09,0.35177,0.31469,1,1
1,GO INTERLEUKIN 10 PRODUCTION,0.0047798,0.35177,0.20682,1,1
1,GO REGULATION OF MACROPHAGE MIGRATION,1.5386e-08,0.35146,0.31732,1,1
1,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.0898e-09,0.35133,0.3461,1,1
1,GO WOUND HEALING,8.2864e-09,0.35102,0.32167,1,1
1,GO ALPHA BETA T CELL ACTIVATION,4.2444e-07,0.35037,0.29945,1,1
1,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,1.2534e-06,0.35031,0.33907,1,1
1,GO RESPONSE TO BACTERIUM,1.4334e-08,0.35026,0.29552,1,1
1,GO MULTI ORGANISM CELLULAR PROCESS,4.6881e-08,0.35011,0.40905,1,1
1,GO MITRAL VALVE DEVELOPMENT,8.3013e-05,0.35003,0.35469,1,1
1,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,1.3351e-08,0.34875,0.32387,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.00030449,0.34809,0.33548,1,1
1,GO REGULATION OF NIK NF KAPPAB SIGNALING,5.6451e-10,0.34806,0.32544,1,1
1,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,3.5794e-07,0.34777,0.36479,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00080175,0.34772,0.27848,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,7.3772e-08,0.34686,0.30341,1,1
1,GO EXOCRINE SYSTEM DEVELOPMENT,3.6162e-06,0.34684,0.37302,1,1
1,GO SUBSTRATE DEPENDENT CELL MIGRATION,5.2538e-08,0.34671,0.35823,1,1
1,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.2271e-06,0.34609,0.29081,1,1
1,GO ENAMEL MINERALIZATION,4.3946e-06,0.34608,0.41519,1,1
1,GO HOMOTYPIC CELL CELL ADHESION,9.0235e-07,0.34581,0.31566,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,8.3066e-07,0.34576,0.32574,1,1
1,GO REGULATION OF STEROL TRANSPORT,4.1025e-09,0.34525,0.36362,1,1
1,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,5.3256e-05,0.34486,0.34004,1,1
1,GO VIRAL LIFE CYCLE,4.8076e-11,0.34442,0.3373,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,5.2303e-06,0.34423,0.31365,1,1
1,GO REGULATION OF CELL SUBSTRATE ADHESION,1.0279e-08,0.34413,0.37569,1,1
1,GO T CELL MIGRATION,7.2129e-08,0.34404,0.32691,1,1
1,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.6654e-06,0.34397,0.40572,1,1
1,GO POSITIVE REGULATION OF ERAD PATHWAY,2.5756e-08,0.34356,0.31212,1,1
1,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,7.8911e-05,0.3429,0.27473,1,1
1,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,5.6487e-06,0.34267,0.32202,1,1
1,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.6579e-07,0.34231,0.33035,1,1
1,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.6514e-08,0.34213,0.35277,1,1
1,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,1.7309e-08,0.34185,0.29536,1,1
1,GO NECROTIC CELL DEATH,6.7411e-08,0.34179,0.31176,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,1.8701e-05,0.34168,0.28649,1,1
1,GO COPPER ION TRANSPORT,2.3274e-07,0.34161,0.31613,1,1
1,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.1307e-08,0.3413,0.37965,1,1
1,GO NEUTROPHIL MIGRATION,1.8053e-06,0.3412,0.26427,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,3.9613e-05,0.3412,0.29713,1,1
1,GO CHONDROCYTE PROLIFERATION,0.00063314,0.34114,0.33829,1,1
1,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.2534e-06,0.34083,0.39613,1,1
1,GO REGULATION OF MICROGLIAL CELL ACTIVATION,8.1623e-05,0.34081,0.24464,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,4.1456e-06,0.34079,0.37134,1,1
1,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,7.9617e-06,0.34031,0.31013,1,1
1,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,8.7502e-06,0.34021,0.34047,1,1
1,GO RESPONSE TO BIOTIC STIMULUS,3.7195e-09,0.34,0.2823,1,1
1,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,1.2954e-05,0.33936,0.26186,1,1
1,GO INTERLEUKIN 5 PRODUCTION,0.00065224,0.33931,0.30988,1,1
1,GO RESPONSE TO NITROSATIVE STRESS,2.7452e-06,0.33923,0.33653,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,2.0881e-08,0.33886,0.31722,1,1
1,GO TISSUE REMODELING,9.9803e-06,0.33882,0.27732,1,1
1,GO STORE OPERATED CALCIUM ENTRY,5.0323e-06,0.33859,0.27193,1,1
1,GO POSITIVE REGULATION OF CELL ACTIVATION,3.4003e-08,0.33833,0.29575,1,1
1,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.8793e-06,0.33825,0.32647,1,1
1,GO KERATAN SULFATE METABOLIC PROCESS,9.1205e-09,0.33803,0.33281,1,1
1,GO LEUKOCYTE PROLIFERATION,3.6567e-07,0.33796,0.28121,1,1
1,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,6.0991e-06,0.33784,0.35357,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.3196e-05,0.33769,0.32555,1,1
1,GO PHAGOCYTOSIS,8.7237e-10,0.33721,0.3391,1,1
1,GO POSITIVE REGULATION OF CELL CELL ADHESION,1.1794e-07,0.33708,0.30109,1,1
1,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,5.9432e-10,0.33697,0.319,1,1
1,GO REGULATION OF LEUKOCYTE MIGRATION,2.9602e-08,0.33695,0.30877,1,1
1,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,1.9044e-05,0.33609,0.29934,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,2.9078e-09,0.33564,0.27861,1,1
1,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,2.1338e-07,0.33543,0.29684,1,1
1,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,6.4699e-07,0.33542,0.35391,1,1
1,GO REGULATION OF CELL ADHESION,1.2281e-06,0.33535,0.26252,1,1
1,GO LEUKOCYTE CELL CELL ADHESION,8.6328e-08,0.33484,0.30505,1,1
1,GO PULMONARY VALVE DEVELOPMENT,7.2497e-05,0.33467,0.36437,1,1
1,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,2.2286e-07,0.33449,0.30112,1,1
1,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,3.2631e-05,0.33446,0.3138,1,1
1,GO PROTEIN DEGLYCOSYLATION,1.2604e-07,0.33404,0.35631,1,1
1,GO DENDRITIC CELL MIGRATION,0.00049802,0.33394,0.25957,1,1
1,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,1.1579e-08,0.33362,0.29874,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00043435,0.33352,0.21653,1,1
1,GO BEHAVIORAL RESPONSE TO PAIN,2.1196e-06,0.33337,0.39324,1,1
1,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,1.8793e-06,0.33288,0.30494,1,1
1,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.1726e-09,0.3328,0.30504,1,1
1,GO FORMATION OF PRIMARY GERM LAYER,3.9064e-09,0.33275,0.35637,1,1
1,GO EXTRACELLULAR MATRIX DISASSEMBLY,1.9064e-09,0.33227,0.41646,1,1
1,GO NEGATIVE REGULATION OF EXOCYTOSIS,1.2482e-05,0.33224,0.31237,1,1
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00024819,0.3322,0.24005,1,1
1,GO CELL CELL JUNCTION MAINTENANCE,2.5884e-05,0.33199,0.34486,1,1
1,GO LYMPHANGIOGENESIS,7.0522e-08,0.33198,0.37473,1,1
1,GO INFLAMMATORY RESPONSE,1.5372e-07,0.33188,0.273,1,1
1,GO MEMBRANE INVAGINATION,5.2359e-09,0.33157,0.33266,1,1
1,GO OSTEOCLAST DEVELOPMENT,5.0278e-07,0.33129,0.36345,1,1
1,GO MYELOID CELL APOPTOTIC PROCESS,1.0094e-07,0.33101,0.31632,1,1
1,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,2.5164e-08,0.33092,0.40335,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,2.5756e-08,0.33082,0.3026,1,1
1,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,5.3562e-07,0.33072,0.36285,1,1
1,GO CHONDROITIN SULFATE CATABOLIC PROCESS,6.9711e-06,0.33072,0.3944,1,1
1,GO FOCAL ADHESION ASSEMBLY,1.2143e-08,0.33048,0.37875,1,1
1,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.2482e-05,0.33041,0.25964,1,1
1,GO EMBRYO IMPLANTATION,5.1356e-08,0.33014,0.33971,1,1
1,GO ARGININE METABOLIC PROCESS,3.0811e-07,0.33012,0.33312,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,7.2129e-08,0.33011,0.30975,1,1
1,GO REGULATION OF B CELL MEDIATED IMMUNITY,7.6446e-07,0.32964,0.29132,1,1
1,GO LIPOPROTEIN LOCALIZATION,2.1621e-05,0.3296,0.31265,1,1
1,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.4334e-08,0.32922,0.30031,1,1
1,GO PHAGOCYTOSIS RECOGNITION,1.2792e-06,0.32914,0.35306,1,1
1,GO SERTOLI CELL DIFFERENTIATION,4.9361e-06,0.32883,0.32902,1,1
1,GO ODONTOGENESIS,2.9859e-05,0.32883,0.25963,1,1
1,GO CELL ACTIVATION,9.5677e-09,0.3288,0.26773,1,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,3.6162e-06,0.32873,0.30445,1,1
1,GO P38MAPK CASCADE,5.02e-08,0.32834,0.31222,1,1
1,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0002443,0.32831,0.31194,1,1
1,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0075485,0.32821,0.28352,1,1
1,GO LIPOPROTEIN CATABOLIC PROCESS,0.00029976,0.32802,0.23877,1,1
1,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,3.6567e-07,0.32773,0.36079,1,1
1,GO DEFENSE RESPONSE,1.9465e-08,0.32756,0.26641,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,4.4807e-06,0.32755,0.31712,1,1
1,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.8262e-07,0.32749,0.34331,1,1
1,GO LUNG MORPHOGENESIS,4.6578e-06,0.32704,0.34031,1,1
1,GO KERATINOCYTE PROLIFERATION,0.00015083,0.32676,0.32272,1,1
1,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,2.2775e-07,0.32585,0.29523,1,1
1,GO DEFENSE RESPONSE TO BACTERIUM,2.971e-06,0.32573,0.24374,1,1
1,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.6981e-08,0.32561,0.31694,1,1
1,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0046604,0.32559,0.22673,1,1
1,GO RESPONSE TO UV B,1.6761e-05,0.32553,0.33488,1,1
1,GO LENS FIBER CELL DEVELOPMENT,3.5646e-05,0.32548,0.31643,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,2.7078e-07,0.32526,0.30759,1,1
1,GO INTERFERON GAMMA PRODUCTION,1.3468e-07,0.32525,0.29727,1,1
1,GO RESPONSE TO PEPTIDOGLYCAN,1.3174e-07,0.32521,0.32279,1,1
1,GO ENDOTHELIAL CELL MORPHOGENESIS,0.0043184,0.32511,0.31925,1,1
1,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.0010865,0.32498,0.23182,1,1
1,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00020178,0.32479,0.31117,1,1
1,GO CELL SUBSTRATE ADHESION,2.2697e-09,0.32473,0.37314,1,1
1,GO VITAMIN D METABOLIC PROCESS,0.00017457,0.32471,0.2899,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,9.3381e-05,0.32465,0.24166,1,1
1,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.1806e-05,0.32459,0.27935,1,1
1,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,2.0776e-06,0.32424,0.31027,1,1
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.8419e-06,0.32417,0.31475,1,1
1,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,8.7316e-05,0.32398,0.27974,1,1
1,GO MODULATION BY HOST OF VIRAL PROCESS,1.0804e-10,0.32386,0.387,1,1
1,GO REGULATION OF STEM CELL DIFFERENTIATION,1.7687e-09,0.3236,0.31204,1,1
1,GO NIK NF KAPPAB SIGNALING,1.6109e-10,0.32345,0.32462,1,1
1,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,9.7991e-09,0.32307,0.34534,1,1
1,GO COPPER ION HOMEOSTASIS,4.1025e-09,0.32303,0.3534,1,1
1,GO CELL MATRIX ADHESION,2.2926e-08,0.32298,0.33627,1,1
1,GO INTERACTION WITH HOST,3.192e-10,0.32296,0.33072,1,1
1,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00049053,0.3226,0.22612,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,4.3082e-09,0.3226,0.31814,1,1
1,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,2.0364e-06,0.32259,0.29166,1,1
1,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,3.4773e-06,0.32252,0.27361,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.004e-09,0.32248,0.31449,1,1
1,GO REGULATION OF FIBROBLAST MIGRATION,4.7501e-09,0.32218,0.3809,1,1
1,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.2444e-07,0.322,0.31561,1,1
1,GO IMMUNOGLOBULIN SECRETION,4.31e-06,0.32171,0.30232,1,1
1,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.0020092,0.32145,0.28205,1,1
1,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,1.2434e-08,0.32145,0.31427,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION,3.6877e-06,0.32093,0.26444,1,1
1,GO SEMI LUNAR VALVE DEVELOPMENT,1.2534e-06,0.32092,0.37224,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,4.3946e-06,0.32087,0.29527,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,4.4807e-06,0.3208,0.35127,1,1
1,GO OSTEOBLAST DEVELOPMENT,6.4592e-06,0.32077,0.28076,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,8.6937e-09,0.32072,0.27159,1,1
1,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,8.6328e-08,0.32068,0.32989,1,1
1,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,1.9465e-08,0.32062,0.26247,1,1
1,GO EPITHELIAL CELL APOPTOTIC PROCESS,9.0235e-07,0.3205,0.29209,1,1
1,GO GLIAL CELL ACTIVATION,2.65e-07,0.32034,0.31618,1,1
1,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,3.3806e-05,0.32032,0.29908,1,1
1,GO POSITIVE REGULATION OF LIPID STORAGE,8.4877e-09,0.31987,0.33083,1,1
1,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,9.795e-06,0.31978,0.25753,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,4.1456e-06,0.31973,0.30725,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,1.1316e-06,0.31972,0.31099,1,1
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.2534e-06,0.3197,0.33237,1,1
1,GO PODOSOME ASSEMBLY,1.8419e-06,0.31956,0.36506,1,1
1,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,1.3468e-07,0.31909,0.32068,1,1
1,GO CELLULAR RESPONSE TO VIRUS,3.1004e-08,0.31908,0.30405,1,1
1,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.00029052,0.31885,0.30804,1,1
1,GO PROTEIN TARGETING TO LYSOSOME,1.1316e-06,0.31878,0.32796,1,1
1,GO MYOBLAST PROLIFERATION,0.0013633,0.31835,0.22266,1,1
1,GO T CELL ACTIVATION,6.0205e-08,0.31832,0.28731,1,1
1,GO NEUTROPHIL CHEMOTAXIS,7.8911e-05,0.31783,0.23363,1,1
1,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,1.3351e-08,0.31781,0.35704,1,1
1,GO REGULATION OF SPROUTING ANGIOGENESIS,2.5164e-08,0.31771,0.34092,1,1
1,GO PARAXIAL MESODERM DEVELOPMENT,1.7706e-05,0.31741,0.33689,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.00023294,0.31729,0.30507,1,1
1,GO REGULATION OF PROTEIN MATURATION,2.0437e-10,0.3171,0.32722,1,1
1,GO COAGULATION,7.5266e-09,0.31664,0.29635,1,1
1,GO STEROL TRANSPORT,6.6066e-07,0.31654,0.26452,1,1
1,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1064e-09,0.31643,0.32806,1,1
1,GO MYELOID LEUKOCYTE DIFFERENTIATION,1.9465e-08,0.31642,0.28846,1,1
1,GO REGULATION OF BONE MINERALIZATION,0.0001862,0.31632,0.24834,1,1
1,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,2.8814e-05,0.31521,0.35762,1,1
1,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.00059648,0.31517,0.23146,1,1
1,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.0527e-08,0.3151,0.29767,1,1
1,GO GAMMA DELTA T CELL ACTIVATION,0.019312,0.31486,0.18171,1,1
1,GO TRABECULA MORPHOGENESIS,1.5865e-05,0.31469,0.27518,1,1
1,GO REGULATION OF CELL ACTIVATION,1.2058e-07,0.31462,0.26564,1,1
1,GO PULMONARY VALVE MORPHOGENESIS,0.0022701,0.31439,0.32965,1,1
1,GO POSITIVE REGULATION OF WOUND HEALING,8.2686e-06,0.31431,0.32626,1,1
1,GO REGULATION OF LEUKOCYTE DEGRANULATION,2.2015e-05,0.31417,0.2819,1,1
1,GO POSITIVE REGULATION OF HEMOPOIESIS,3.4296e-07,0.31407,0.26078,1,1
1,GO MODULATION BY HOST OF SYMBIONT PROCESS,4.4148e-09,0.314,0.29028,1,1
1,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.6761e-05,0.31375,0.30777,1,1
1,GO REGULATION OF VASCULATURE DEVELOPMENT,2.2926e-08,0.3135,0.31479,1,1
1,GO NEGATIVE REGULATION OF CELL AGING,2.6386e-06,0.31349,0.29579,1,1
1,GO REGULATION OF CELL MATRIX ADHESION,3.4796e-08,0.31337,0.3578,1,1
1,GO RESPONSE TO ESTROGEN,7.1121e-10,0.31318,0.32787,1,1
1,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,7.7586e-05,0.31299,0.25467,1,1
1,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.00036124,0.31282,0.28289,1,1
1,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.001235,0.31257,0.32767,1,1
1,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,2.7312e-05,0.31244,0.39297,1,1
1,GO HEPATOCYTE DIFFERENTIATION,0.00058763,0.31243,0.28506,1,1
1,GO REGULATION OF IMMUNE RESPONSE,1.0781e-08,0.31218,0.27576,1,1
1,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00019541,0.31192,0.27523,1,1
1,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,2.7668e-07,0.31173,0.28659,1,1
1,GO CELLULAR RESPONSE TO ETHANOL,1.3325e-06,0.31149,0.32084,1,1
1,GO ENDOTHELIAL CELL MIGRATION,3.1004e-08,0.31144,0.3363,1,1
1,GO MUSCLE CELL MIGRATION,6.7105e-06,0.31101,0.28656,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0001803,0.3107,0.24321,1,1
1,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,5.5864e-07,0.31049,0.34315,1,1
1,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,1.6782e-07,0.31041,0.35859,1,1
1,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.00033955,0.31036,0.25969,1,1
1,GO REGULATION OF WOUND HEALING,1.5372e-07,0.31035,0.33072,1,1
1,GO TISSUE MIGRATION,6.4434e-08,0.31031,0.31898,1,1
1,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.9558e-07,0.3101,0.31427,1,1
1,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,5.0323e-06,0.31006,0.29512,1,1
1,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,6.6578e-05,0.3097,0.28187,1,1
1,GO RESPONSE TO TUMOR NECROSIS FACTOR,2.7e-09,0.30955,0.29661,1,1
1,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,9.819e-05,0.30947,0.32055,1,1
1,GO ETHER BIOSYNTHETIC PROCESS,3.1494e-05,0.30925,0.35977,1,1
1,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,6.895e-08,0.3092,0.34913,1,1
1,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,6.0205e-08,0.30854,0.35418,1,1
1,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,2.3784e-07,0.30839,0.29393,1,1
1,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,7.0522e-08,0.30831,0.29475,1,1
1,GO DERMATAN SULFATE METABOLIC PROCESS,0.0012177,0.30809,0.31271,1,1
1,GO REGULATION OF HUMORAL IMMUNE RESPONSE,4.3355e-07,0.30791,0.39881,1,1
1,GO GALACTOSE METABOLIC PROCESS,6.4592e-06,0.3078,0.31702,1,1
1,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,2.2505e-06,0.30762,0.32866,1,1
1,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.00013016,0.30747,0.27078,1,1
1,GO TRACHEA DEVELOPMENT,1.8363e-05,0.30734,0.33989,1,1
1,GO ALPHA BETA T CELL DIFFERENTIATION,1.6994e-06,0.30694,0.29817,1,1
1,GO TISSUE REGENERATION,1.5372e-07,0.30649,0.285,1,1
1,GO CELLULAR EXTRAVASATION,3.1479e-07,0.30646,0.277,1,1
1,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,3.8246e-05,0.30639,0.33247,1,1
1,GO RESPONSE TO VITAMIN,1.7071e-05,0.30634,0.25855,1,1
1,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,8.4415e-08,0.30607,0.26223,1,1
1,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.7442e-10,0.30597,0.32909,1,1
1,GO REGULATION OF EPITHELIAL CELL MIGRATION,4.6881e-08,0.30596,0.3335,1,1
1,GO POSITIVE REGULATION OF VASCULOGENESIS,4.5558e-05,0.30582,0.33281,1,1
1,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,9.4341e-06,0.30523,0.27051,1,1
1,GO REGULATION OF CELL FATE SPECIFICATION,0.0068504,0.30477,0.24379,1,1
1,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.5027e-08,0.30471,0.26909,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,2.5164e-08,0.30456,0.32988,1,1
1,GO RESPONSE TO SALT STRESS,3.9941e-08,0.30426,0.31266,1,1
1,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,6.8348e-09,0.30426,0.30124,1,1
1,GO REGULATION OF LYMPHOCYTE ACTIVATION,5.8856e-08,0.30413,0.27396,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.1316e-06,0.30412,0.29916,1,1
1,GO SYNCYTIUM FORMATION,2.6981e-08,0.30411,0.35862,1,1
1,GO REGULATION OF IMMUNE SYSTEM PROCESS,2.2926e-08,0.30408,0.24893,1,1
1,GO POSITIVE CHEMOTAXIS,4.8839e-05,0.30397,0.2534,1,1
1,GO REGULATION OF ERBB SIGNALING PATHWAY,3.4296e-07,0.30393,0.25998,1,1
1,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.2118e-07,0.30379,0.29298,1,1
1,GO REGULATION OF MACROPHAGE CHEMOTAXIS,2.0879e-07,0.30371,0.29873,1,1
1,GO RESPONSE TO CORTICOSTEROID,1.2281e-06,0.30364,0.2405,1,1
1,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,1.5277e-10,0.30312,0.31081,1,1
1,GO ANTIBACTERIAL HUMORAL RESPONSE,6.0079e-05,0.30298,0.28326,1,1
1,GO CELLULAR RESPONSE TO RETINOIC ACID,2.4837e-07,0.30251,0.34091,1,1
1,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,1.2604e-07,0.30249,0.30611,1,1
1,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,9.4407e-08,0.30196,0.31139,1,1
1,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00049053,0.30182,0.27053,1,1
1,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.3784e-07,0.30156,0.33794,1,1
1,GO LYMPHOCYTE APOPTOTIC PROCESS,9.2321e-08,0.30124,0.2943,1,1
1,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,1.3948e-05,0.30123,0.26129,1,1
1,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.9035e-08,0.30119,0.28232,1,1
1,GO REGULATION OF OSTEOCLAST DEVELOPMENT,4.7172e-05,0.30114,0.27856,1,1
1,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00017457,0.30096,0.31049,1,1
1,GO CELL CHEMOTAXIS,2.2958e-06,0.30083,0.25572,1,1
1,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.00091404,0.30077,0.26023,1,1
1,GO ACUTE INFLAMMATORY RESPONSE,4.2444e-07,0.30066,0.29375,1,1
1,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,3.9872e-06,0.30065,0.31087,1,1
1,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00055343,0.30061,0.25664,1,1
1,GO REGULATION OF T CELL ACTIVATION,2.4305e-07,0.30061,0.2737,1,1
1,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,2.0478e-05,0.3005,0.26831,1,1
1,GO RESPONSE TO INTERLEUKIN 1,2.6581e-10,0.30046,0.29664,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,3.8983e-07,0.30044,0.26701,1,1
1,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,5.9056e-05,0.30036,0.33672,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,2.8271e-07,0.30036,0.343,1,1
1,GO REGULATION OF CELL SHAPE,4.719e-07,0.29983,0.27364,1,1
1,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.2058e-07,0.29973,0.37398,1,1
1,GO RESPONSE TO RETINOIC ACID,1.9558e-07,0.2986,0.27986,1,1
1,GO VIRAL RNA GENOME REPLICATION,1.471e-07,0.29854,0.29933,1,1
1,GO CHOLESTEROL STORAGE,0.0007901,0.29824,0.29083,1,1
1,GO VASCULATURE DEVELOPMENT,3.1729e-08,0.29784,0.29414,1,1
1,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,5.2538e-08,0.29784,0.31795,1,1
1,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.5753e-08,0.29769,0.28142,1,1
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,9.4341e-06,0.29753,0.30105,1,1
1,GO POSITIVE REGULATION OF IMMUNE RESPONSE,1.3999e-08,0.29738,0.26717,1,1
1,GO INTERACTION WITH SYMBIONT,2.6362e-08,0.29727,0.27002,1,1
1,GO STRIATED MUSCLE CELL PROLIFERATION,5.8262e-07,0.29725,0.28094,1,1
1,GO REGULATION OF GASTRULATION,1.0036e-08,0.29723,0.30883,1,1
1,GO SMOOTH MUSCLE CELL PROLIFERATION,4.6881e-08,0.29708,0.31201,1,1
1,GO ACTIN FILAMENT NETWORK FORMATION,0.02128,0.29698,0.19938,1,1
1,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,1.439e-07,0.29647,0.32024,1,1
1,GO CELLULAR RESPONSE TO IRON ION,2.7804e-05,0.29625,0.30839,1,1
1,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,1.2058e-07,0.29608,0.29623,1,1
1,GO REGULATION OF VASCULOGENESIS,0.0013826,0.29601,0.27629,1,1
1,GO RIG I SIGNALING PATHWAY,2.7614e-08,0.29569,0.31823,1,1
1,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0005618,0.29564,0.26242,1,1
1,GO PLASMA MEMBRANE FUSION,0.0098086,0.2956,0.21071,1,1
1,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,2.2958e-06,0.29527,0.26778,1,1
1,GO LEUKOCYTE MIGRATION,4.6578e-06,0.29522,0.24802,1,1
1,GO SPROUTING ANGIOGENESIS,2.402e-08,0.29517,0.32628,1,1
1,GO REGULATION OF HORMONE METABOLIC PROCESS,7.4873e-07,0.29514,0.36043,1,1
1,GO REGULATION OF CELL CELL ADHESION,1.9563e-06,0.29502,0.25197,1,1
1,GO BONE GROWTH,1.4454e-06,0.29488,0.36419,1,1
1,GO LIVER REGENERATION,1.3761e-09,0.29433,0.32174,1,1
1,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,1.1165e-05,0.29412,0.29857,1,1
1,GO MODULATION OF PROCESS OF OTHER ORGANISM,9.6538e-08,0.29402,0.24607,1,1
1,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0021505,0.29381,0.22172,1,1
1,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,5.3747e-08,0.29364,0.31344,1,1
1,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,7.2414e-06,0.29354,0.30393,1,1
1,GO CHOLESTEROL EFFLUX,1.5372e-07,0.29354,0.2841,1,1
1,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.996e-06,0.29334,0.29407,1,1
1,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,4.31e-06,0.29327,0.28188,1,1
1,GO EMBRYONIC HINDLIMB MORPHOGENESIS,3.2057e-05,0.29276,0.29083,1,1
1,GO CELL KILLING,2.971e-06,0.29224,0.26044,1,1
1,GO REGULATION OF MAST CELL ACTIVATION,0.00022565,0.29181,0.25032,1,1
1,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00095459,0.29142,0.19679,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.8793e-06,0.2914,0.26665,1,1
1,GO RESPONSE TO X RAY,3.1729e-08,0.29137,0.37214,1,1
1,GO REGULATION OF PROTEIN POLYUBIQUITINATION,9.7998e-07,0.29136,0.27371,1,1
1,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,5.4356e-06,0.29114,0.31223,1,1
1,GO REGULATION OF INNATE IMMUNE RESPONSE,9.028e-08,0.29111,0.25486,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0043737,0.29106,0.28388,1,1
1,GO RESPONSE TO VITAMIN D,0.0099244,0.29105,0.19361,1,1
1,GO RESPONSE TO WOUNDING,1.9014e-08,0.29091,0.2881,1,1
1,GO CHONDROCYTE DEVELOPMENT,2.913e-06,0.29082,0.32091,1,1
1,GO LIPID STORAGE,1.9465e-08,0.29078,0.26928,1,1
1,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,4.4148e-09,0.29074,0.30915,1,1
1,GO GLOMERULUS DEVELOPMENT,5.3256e-05,0.29021,0.32731,1,1
1,GO SEQUESTERING OF TRIGLYCERIDE,5.1304e-06,0.28999,0.29768,1,1
1,GO STEM CELL DIVISION,0.00022208,0.28991,0.241,1,1
1,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,9.8716e-08,0.28983,0.33688,1,1
1,GO MYOBLAST DIFFERENTIATION,9.1205e-09,0.28969,0.32298,1,1
1,GO REGULATION OF B CELL APOPTOTIC PROCESS,7.8911e-05,0.28921,0.25742,1,1
1,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,5.4356e-06,0.28914,0.25751,1,1
1,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,8.0256e-05,0.28907,0.22045,1,1
1,GO LENS FIBER CELL DIFFERENTIATION,7.6446e-07,0.28903,0.29487,1,1
1,GO REGULATION OF CHOLESTEROL EFFLUX,1.8419e-06,0.28852,0.26714,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,6.2046e-07,0.28852,0.26551,1,1
1,GO HUMORAL IMMUNE RESPONSE,6.7724e-05,0.28847,0.25614,1,1
1,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,8.1138e-06,0.2884,0.27141,1,1
1,GO OSTEOBLAST DIFFERENTIATION,8.6328e-08,0.28836,0.28326,1,1
1,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00027716,0.28829,0.28465,1,1
1,GO 3 UTR MEDIATED MRNA DESTABILIZATION,1.7154e-07,0.28817,0.34285,1,1
1,GO ASTROCYTE DEVELOPMENT,1.1034e-07,0.28817,0.33187,1,1
1,GO ERK1 AND ERK2 CASCADE,9.3415e-09,0.28802,0.29504,1,1
1,GO LYMPHOCYTE ACTIVATION,6.4434e-08,0.28775,0.25973,1,1
1,GO MYELOID LEUKOCYTE MIGRATION,1.0756e-05,0.28746,0.23638,1,1
1,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,1.1086e-06,0.28744,0.3618,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.6066e-07,0.28739,0.22143,1,1
1,GO BLOOD VESSEL MORPHOGENESIS,2.6362e-08,0.28724,0.30122,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,1.2058e-07,0.28709,0.32174,1,1
1,GO ENDOTHELIAL CELL DEVELOPMENT,2.6386e-06,0.287,0.28733,1,1
1,GO RENAL FILTRATION,0.00067188,0.28659,0.32279,1,1
1,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.0027747,0.28655,0.21216,1,1
1,GO HAIR FOLLICLE MATURATION,2.8814e-05,0.28612,0.30403,1,1
1,GO REGULATION OF OSSIFICATION,1.5576e-05,0.286,0.24612,1,1
1,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.0169e-05,0.28594,0.31467,1,1
1,GO PHOSPHOLIPID CATABOLIC PROCESS,4.0314e-05,0.28578,0.22398,1,1
1,GO REGULATION OF HIPPO SIGNALING,0.0014022,0.28577,0.23556,1,1
1,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,2.5164e-08,0.28566,0.28629,1,1
1,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.00029052,0.28541,0.29536,1,1
1,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,3.8149e-08,0.28526,0.2893,1,1
1,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,7.3476e-09,0.28514,0.29801,1,1
1,GO REGULATION OF BIOMINERALIZATION,0.00013899,0.28493,0.23084,1,1
1,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,9.3381e-05,0.28464,0.26622,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.1535e-07,0.28457,0.27699,1,1
1,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,1.6994e-06,0.28457,0.25928,1,1
1,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,2.0429e-07,0.28441,0.27328,1,1
1,GO ASTROCYTE ACTIVATION,2.3274e-07,0.28372,0.3043,1,1
1,GO T CELL CHEMOTAXIS,2.4861e-06,0.28346,0.24715,1,1
1,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,7.2497e-05,0.28339,0.31551,1,1
1,GO REGULATION OF MACROPHAGE ACTIVATION,3.8924e-05,0.28331,0.26947,1,1
1,GO REGULATION OF AUTOPHAGOSOME MATURATION,8.1361e-07,0.28329,0.27554,1,1
1,GO REGULATION OF B CELL ACTIVATION,1.0169e-05,0.28326,0.24645,1,1
1,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00059648,0.28314,0.25648,1,1
1,GO CARDIAC SEPTUM MORPHOGENESIS,0.00095459,0.28305,0.21883,1,1
1,GO ACTIVATION OF MAPKK ACTIVITY,8.0712e-08,0.28283,0.29631,1,1
1,GO RESPONSE TO MANGANESE ION,1.2733e-08,0.28253,0.27817,1,1
1,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,4.719e-07,0.28235,0.25975,1,1
1,GO T CELL RECEPTOR SIGNALING PATHWAY,1.1245e-09,0.28219,0.27518,1,1
1,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,5.3562e-07,0.28192,0.31498,1,1
1,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.6321e-06,0.28181,0.30136,1,1
1,GO NEGATIVE REGULATION OF CHEMOTAXIS,1.1282e-07,0.28125,0.3215,1,1
1,GO LYMPH VESSEL DEVELOPMENT,8.4262e-06,0.28098,0.34684,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,6.8396e-06,0.28092,0.25388,1,1
1,GO RESPONSE TO DEXAMETHASONE,4.4771e-05,0.28092,0.22238,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.2397e-08,0.2805,0.29,1,1
1,GO SMOOTH MUSCLE CELL MIGRATION,7.5001e-05,0.27995,0.27452,1,1
1,GO TUBE MORPHOGENESIS,1.1789e-06,0.2798,0.23533,1,1
1,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.337e-06,0.27973,0.22742,1,1
1,GO AMEBOIDAL TYPE CELL MIGRATION,6.0205e-08,0.27965,0.27933,1,1
1,GO POSITIVE REGULATION OF VASOCONSTRICTION,9.3415e-09,0.27922,0.31804,1,1
1,GO REGULATION OF BMP SIGNALING PATHWAY,6.5837e-06,0.27906,0.26811,1,1
1,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,7.5217e-06,0.27906,0.27541,1,1
1,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.538e-07,0.27878,0.28429,1,1
1,GO REGENERATION,3.2094e-09,0.27876,0.25804,1,1
1,GO REPLICATIVE SENESCENCE,0.00019229,0.27874,0.26469,1,1
1,GO REGULATION OF AMYLOID BETA FORMATION,2.3239e-05,0.27867,0.2723,1,1
1,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0025961,0.27867,0.2218,1,1
1,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,1.8419e-06,0.27855,0.26976,1,1
1,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,1.1588e-05,0.27841,0.24604,1,1
1,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,5.02e-08,0.27805,0.24421,1,1
1,GO PLATELET ACTIVATION,4.5233e-07,0.27786,0.28097,1,1
1,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00082553,0.27772,0.27448,1,1
1,GO LEUKOTRIENE METABOLIC PROCESS,0.028852,0.27769,0.14072,1,1
1,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,2.4586e-08,0.27767,0.29445,1,1
1,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.0005618,0.27738,0.21663,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,9.658e-10,0.27726,0.3041,1,1
1,GO SEQUESTERING OF METAL ION,1.6457e-05,0.27726,0.2187,1,1
1,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,7.333e-07,0.27704,0.25289,1,1
1,GO RECEPTOR SIGNALING PATHWAY VIA STAT,2.0879e-07,0.27697,0.26983,1,1
1,GO REGULATION OF NECROTIC CELL DEATH,1.0212e-06,0.27677,0.29,1,1
1,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,4.6881e-08,0.27667,0.2597,1,1
1,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.3274e-07,0.27658,0.25278,1,1
1,GO OSTEOBLAST PROLIFERATION,0.0041031,0.27625,0.23255,1,1
1,GO NEGATIVE T CELL SELECTION,2.9332e-05,0.27623,0.30543,1,1
1,GO CARDIAC MUSCLE CELL PROLIFERATION,2.011e-05,0.27615,0.25819,1,1
1,GO PEPTIDYL TYROSINE MODIFICATION,8.4415e-08,0.2759,0.25621,1,1
1,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,5.332e-06,0.27573,0.3481,1,1
1,GO ACTIVATION OF IMMUNE RESPONSE,1.4677e-08,0.27549,0.26343,1,1
1,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,8.7316e-05,0.2754,0.27299,1,1
1,GO LYMPHOCYTE MIGRATION,2.2775e-07,0.27531,0.27316,1,1
1,GO LAMELLIPODIUM MORPHOGENESIS,0.0011503,0.27527,0.26299,1,1
1,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,1.1789e-06,0.27526,0.28838,1,1
1,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.9069e-08,0.27466,0.29032,1,1
1,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.00095459,0.27458,0.22936,1,1
1,GO LEUKOCYTE HOMEOSTASIS,3.5038e-07,0.27433,0.27019,1,1
1,GO REGULATION OF RESPONSE TO WOUNDING,2.5934e-07,0.27397,0.293,1,1
1,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,9.9844e-05,0.27392,0.23692,1,1
1,GO MUSCLE CELL PROLIFERATION,1.2434e-08,0.27363,0.29307,1,1
1,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.0781e-08,0.27352,0.28561,1,1
1,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,1.9563e-06,0.27347,0.33224,1,1
1,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,2.0853e-05,0.27336,0.23639,1,1
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,1.6158e-05,0.2733,0.28829,1,1
1,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.5794e-07,0.27314,0.26372,1,1
1,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.00011033,0.27313,0.28644,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.6514e-08,0.27306,0.26781,1,1
1,GO KERATINOCYTE MIGRATION,1.2328e-07,0.27277,0.27443,1,1
1,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,3.1479e-07,0.27273,0.32111,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE,1.6994e-06,0.27262,0.23946,1,1
1,GO BONE DEVELOPMENT,3.4098e-06,0.27241,0.24145,1,1
1,GO RECEPTOR BIOSYNTHETIC PROCESS,1.3769e-07,0.27221,0.27506,1,1
1,GO REPLACEMENT OSSIFICATION,7.1274e-05,0.27218,0.29385,1,1
1,GO OSSIFICATION,2.6386e-06,0.27206,0.23437,1,1
1,GO CORTICAL CYTOSKELETON ORGANIZATION,1.2759e-09,0.27199,0.29162,1,1
1,GO REGULATION OF CELLULAR EXTRAVASATION,6.0991e-06,0.27189,0.27968,1,1
1,GO LYMPHOCYTE CHEMOTAXIS,2.402e-08,0.27188,0.29185,1,1
1,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,4.1815e-08,0.27129,0.34084,1,1
1,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.0018006,0.27126,0.22023,1,1
1,GO PERICARDIUM DEVELOPMENT,0.00015331,0.27115,0.26467,1,1
1,GO TONGUE DEVELOPMENT,0.00045468,0.27097,0.25968,1,1
1,GO CHONDROCYTE DIFFERENTIATION,1.7154e-07,0.27089,0.30156,1,1
1,GO REGULATION OF LIPASE ACTIVITY,8.0712e-08,0.27029,0.2606,1,1
1,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.00023294,0.27021,0.36979,1,1
1,GO HOMOCYSTEINE METABOLIC PROCESS,0.0038478,0.26956,0.18025,1,1
1,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,9.6562e-05,0.26953,0.25838,1,1
1,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,1.3948e-05,0.26944,0.25536,1,1
1,GO AMINOGLYCAN METABOLIC PROCESS,4.6202e-07,0.26923,0.25359,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.475e-06,0.26882,0.27596,1,1
1,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.5037e-07,0.26872,0.28434,1,1
1,GO OSTEOCLAST DIFFERENTIATION,5.2538e-08,0.26834,0.263,1,1
1,GO IRON ION HOMEOSTASIS,1.5027e-08,0.2683,0.25321,1,1
1,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,2.402e-08,0.26829,0.27347,1,1
1,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0021505,0.26818,0.20571,1,1
1,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.0047198,0.26793,0.22638,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.2784e-08,0.26792,0.28918,1,1
1,GO T CELL DIFFERENTIATION IN THYMUS,1.5674e-06,0.26769,0.23234,1,1
1,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,1.4076e-07,0.26767,0.29257,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.0322e-07,0.26766,0.23537,1,1
1,GO REGULATION OF LIPID STORAGE,3.2859e-07,0.26746,0.25314,1,1
1,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00039622,0.26743,0.19836,1,1
1,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.8983e-07,0.26732,0.2417,1,1
1,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,6.1119e-05,0.26658,0.2332,1,1
1,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,3.0811e-07,0.26651,0.27276,1,1
1,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,1.3599e-06,0.26624,0.281,1,1
1,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,5.8262e-07,0.26618,0.23291,1,1
1,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,4.3946e-06,0.26591,0.28638,1,1
1,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,7.892e-08,0.26582,0.25001,1,1
1,GO CELLULAR OXIDANT DETOXIFICATION,5.3562e-07,0.26569,0.22203,1,1
1,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,2.7804e-05,0.26561,0.2442,1,1
1,GO MUSCLE CELL CELLULAR HOMEOSTASIS,2.0364e-06,0.26549,0.353,1,1
1,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,1.2733e-08,0.26546,0.28996,1,1
1,GO REGULATION OF PEPTIDASE ACTIVITY,1.5674e-06,0.26509,0.2512,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,4.6202e-07,0.26487,0.25451,1,1
1,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00028155,0.26484,0.22647,1,1
1,GO NEURAL CREST CELL DIFFERENTIATION,0.00028155,0.26451,0.20706,1,1
1,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,3.0811e-07,0.26439,0.33878,1,1
1,GO DENDRITIC CELL CHEMOTAXIS,4.7172e-05,0.26437,0.268,1,1
1,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.0062108,0.26432,0.22071,1,1
1,GO REGULATION OF MYELOID CELL DIFFERENTIATION,7.0522e-08,0.26425,0.24767,1,1
1,GO AORTA DEVELOPMENT,0.00067188,0.26388,0.22817,1,1
1,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.719e-07,0.26336,0.24163,1,1
1,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.00064263,0.26318,0.28336,1,1
1,GO GENITALIA MORPHOGENESIS,0.00053704,0.26305,0.28502,1,1
1,GO GASTRULATION,2.5164e-08,0.263,0.29055,1,1
1,GO REGULATION OF DEFENSE RESPONSE,7.7166e-08,0.26298,0.24033,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,7.0017e-09,0.2629,0.28043,1,1
1,GO RESPIRATORY SYSTEM DEVELOPMENT,0.00038422,0.26279,0.19777,1,1
1,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.010769,0.26268,0.19922,1,1
1,GO INTERLEUKIN 6 PRODUCTION,0.0001862,0.26255,0.21643,1,1
1,GO REGULATION OF FAT CELL DIFFERENTIATION,0.00010673,0.26238,0.2046,1,1
1,GO LEUKOCYTE CHEMOTAXIS,6.0079e-05,0.26237,0.22842,1,1
1,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,7.3772e-08,0.26209,0.30683,1,1
1,GO CARDIOBLAST DIFFERENTIATION,1.5014e-05,0.26202,0.2907,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,7.6657e-06,0.26197,0.25801,1,1
1,GO MYOTUBE DIFFERENTIATION,0.00013673,0.26173,0.18857,1,1
1,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,1.2716e-05,0.26156,0.24094,1,1
1,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0001803,0.26145,0.24846,1,1
1,GO LIVER MORPHOGENESIS,0.00027716,0.26135,0.27937,1,1
1,GO CERAMIDE TRANSPORT,1.5293e-05,0.2612,0.27299,1,1
1,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00025617,0.26108,0.30816,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,6.337e-06,0.2609,0.30059,1,1
1,GO REGULATION OF PROTEIN DEUBIQUITINATION,6.8348e-09,0.26083,0.34616,1,1
1,GO ERBB SIGNALING PATHWAY,8.8389e-07,0.26011,0.22989,1,1
1,GO LIPID IMPORT INTO CELL,0.00019229,0.26009,0.22073,1,1
1,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,1.7687e-09,0.26007,0.2868,1,1
1,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,7.2414e-06,0.26005,0.24852,1,1
1,GO STRESS FIBER ASSEMBLY,4.31e-06,0.25989,0.26407,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,7.1819e-07,0.25949,0.27744,1,1
1,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.00011033,0.25938,0.30563,1,1
1,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,3.6162e-06,0.25918,0.2801,1,1
1,GO TUMOR NECROSIS FACTOR SECRETION,4.5558e-05,0.25894,0.20803,1,1
1,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,7.3739e-05,0.25883,0.29774,1,1
1,GO PROTEIN LIPID COMPLEX ASSEMBLY,1.9563e-06,0.25882,0.23862,1,1
1,GO RECEPTOR CATABOLIC PROCESS,1.2328e-07,0.25849,0.32006,1,1
1,GO IRON ION TRANSMEMBRANE TRANSPORT,1.2058e-07,0.25849,0.26277,1,1
1,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,1.4454e-06,0.25821,0.30406,1,1
1,GO ACTIVATED T CELL PROLIFERATION,6.545e-05,0.25813,0.21406,1,1
1,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.6579e-07,0.25809,0.26607,1,1
1,GO FAT CELL DIFFERENTIATION,6.2175e-05,0.25788,0.19147,1,1
1,GO RESPONSE TO MINERALOCORTICOID,0.00011218,0.2578,0.19895,1,1
1,GO BONE REMODELING,4.4771e-05,0.25773,0.2569,1,1
1,GO ARTERY DEVELOPMENT,0.00013899,0.25773,0.23962,1,1
1,GO RESPONSE TO VITAMIN A,0.00024819,0.25764,0.21082,1,1
1,GO INTERLEUKIN 4 PRODUCTION,4.7488e-06,0.25737,0.2538,1,1
1,GO CELLULAR RESPONSE TO GAMMA RADIATION,1.5014e-05,0.25732,0.25579,1,1
1,GO REGULATION OF BONE DEVELOPMENT,6.9711e-06,0.25693,0.28369,1,1
1,GO TOOTH MINERALIZATION,3.9613e-05,0.25675,0.31147,1,1
1,GO NEGATIVE REGULATION OF PROTEOLYSIS,5.1351e-07,0.25669,0.23204,1,1
1,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00021511,0.25648,0.18888,1,1
1,GO HISTONE SERINE PHOSPHORYLATION,0.00084997,0.25629,0.17215,1,1
1,GO EPITHELIAL CELL PROLIFERATION,1.4741e-05,0.2561,0.22997,1,1
1,GO ANIMAL ORGAN REGENERATION,3.6361e-10,0.25583,0.31431,1,1
1,GO LYMPHOCYTE COSTIMULATION,6.4592e-06,0.25578,0.24986,1,1
1,GO MESENCHYMAL CELL DIFFERENTIATION,3.2631e-05,0.25575,0.21752,1,1
1,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,4.9228e-07,0.25574,0.28076,1,1
1,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,2.342e-06,0.25572,0.2748,1,1
1,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,5.7059e-05,0.25565,0.22146,1,1
1,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,5.3562e-07,0.25548,0.35353,1,1
1,GO REGULATION OF RECEPTOR RECYCLING,1.8701e-05,0.25536,0.2325,1,1
1,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,9.5999e-07,0.25524,0.24241,1,1
1,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,8.1138e-06,0.25504,0.26126,1,1
1,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,5.1356e-08,0.255,0.2521,1,1
1,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,3.9102e-06,0.25496,0.30558,1,1
1,GO MESENCHYME MORPHOGENESIS,0.00061456,0.25477,0.2365,1,1
1,GO GROWTH PLATE CARTILAGE DEVELOPMENT,1.2482e-05,0.2547,0.28284,1,1
1,GO AMINO SUGAR METABOLIC PROCESS,2.2926e-08,0.25434,0.26473,1,1
1,GO LAMELLIPODIUM ORGANIZATION,2.1234e-05,0.25383,0.22129,1,1
1,GO PEPTIDE CATABOLIC PROCESS,2.4837e-07,0.25374,0.28387,1,1
1,GO RESPONSE TO FLUID SHEAR STRESS,1.9989e-07,0.25371,0.34164,1,1
1,GO ASYMMETRIC CELL DIVISION,1.3948e-05,0.2537,0.26601,1,1
1,GO CELL REDOX HOMEOSTASIS,2.4837e-07,0.25362,0.21985,1,1
1,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,7.5001e-05,0.25319,0.19088,1,1
1,GO ASTROCYTE DIFFERENTIATION,7.5001e-05,0.25312,0.21712,1,1
1,GO LEUKOCYTE DIFFERENTIATION,4.1552e-07,0.25307,0.24296,1,1
1,GO PROTEIN LOCALIZATION TO ENDOSOME,0.00013673,0.25284,0.27164,1,1
1,GO REGULATION OF HEMOPOIESIS,1.0036e-08,0.25267,0.24717,1,1
1,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,8.4424e-05,0.25267,0.26892,1,1
1,GO FOREGUT MORPHOGENESIS,6.5837e-06,0.25258,0.28873,1,1
1,GO ISOTYPE SWITCHING TO IGG ISOTYPES,8.3013e-05,0.25256,0.23329,1,1
1,GO C21 STEROID HORMONE METABOLIC PROCESS,2.3661e-05,0.25184,0.25607,1,1
1,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,1.7706e-05,0.25147,0.26219,1,1
1,GO FACE DEVELOPMENT,9.2585e-06,0.25134,0.27277,1,1
1,GO CELLULAR RESPONSE TO LIPID,1.439e-07,0.25111,0.22496,1,1
1,GO INOSITOL LIPID MEDIATED SIGNALING,5.0323e-06,0.25107,0.22171,1,1
1,GO TRANSEPITHELIAL TRANSPORT,4.3236e-05,0.25106,0.20516,1,1
1,GO MESENCHYMAL CELL PROLIFERATION,0.0087156,0.25035,0.2023,1,1
1,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00017457,0.24979,0.21308,1,1
1,GO PEPTIDYL PROLINE MODIFICATION,7.0337e-07,0.24958,0.23692,1,1
1,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.0004e-06,0.24937,0.24,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.0025617,0.24929,0.24202,1,1
1,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,5.332e-06,0.24918,0.22734,1,1
1,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,7.2414e-06,0.24917,0.29347,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.5906e-08,0.24914,0.25053,1,1
1,GO CORONARY VASCULATURE DEVELOPMENT,3.4098e-06,0.24889,0.28969,1,1
1,GO RESPONSE TO INCREASED OXYGEN LEVELS,4.8416e-06,0.24834,0.25419,1,1
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0005133,0.24806,0.25268,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,9.086e-06,0.24801,0.21719,1,1
1,GO REGULATION OF LYSOSOMAL LUMEN PH,1.0169e-05,0.24798,0.24127,1,1
1,GO LYMPH VESSEL MORPHOGENESIS,1.3325e-06,0.24791,0.32001,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00099681,0.24787,0.23276,1,1
1,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,5.6487e-06,0.24786,0.28285,1,1
1,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,1.1794e-07,0.24721,0.24861,1,1
1,GO ERBB2 SIGNALING PATHWAY,3.0811e-07,0.24708,0.26329,1,1
1,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.00013016,0.24702,0.2192,1,1
1,GO EPITHELIAL TO MESENCHYMAL TRANSITION,6.2175e-05,0.24686,0.21999,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION,5.7582e-06,0.24679,0.23567,1,1
1,GO REGULATION OF RIBOSOME BIOGENESIS,7.7586e-05,0.24673,0.26931,1,1
1,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,4.7999e-05,0.24669,0.21775,1,1
1,GO REGULATION OF BODY FLUID LEVELS,1.3325e-06,0.24631,0.21834,1,1
1,GO MUSCLE FILAMENT SLIDING,9.404e-07,0.24625,0.25137,1,1
1,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.0095807,0.24604,0.21432,1,1
1,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.8886e-07,0.24591,0.27224,1,1
1,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,3.6877e-06,0.24546,0.24265,1,1
1,GO METANEPHRIC NEPHRON DEVELOPMENT,3.5022e-05,0.24539,0.2524,1,1
1,GO NEUROINFLAMMATORY RESPONSE,7.6283e-05,0.24522,0.22645,1,1
1,GO HYPEROSMOTIC SALINITY RESPONSE,0.0003557,0.24514,0.23912,1,1
1,GO SECRETION BY TISSUE,0.00058763,0.24512,0.17831,1,1
1,GO DETOXIFICATION,1.9044e-05,0.24504,0.18438,1,1
1,GO REGULATION OF LYMPHOCYTE MIGRATION,1.9175e-06,0.24495,0.27467,1,1
1,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,3.8347e-06,0.24455,0.24356,1,1
1,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.6914e-06,0.24454,0.35162,1,1
1,GO NEGATIVE REGULATION OF HEMOPOIESIS,2.5934e-07,0.24451,0.27987,1,1
1,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.5424e-05,0.2443,0.29497,1,1
1,GO TUBE DEVELOPMENT,1.3442e-05,0.24428,0.20083,1,1
1,GO RESPONSE TO INTERLEUKIN 7,0.0007786,0.24425,0.17805,1,1
1,GO SULFUR COMPOUND CATABOLIC PROCESS,7.333e-07,0.24416,0.27315,1,1
1,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,3.8161e-07,0.24385,0.28158,1,1
1,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.0019285,0.24382,0.19944,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.1041e-08,0.24303,0.26076,1,1
1,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,8.5867e-06,0.24299,0.21236,1,1
1,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,2.3239e-05,0.24289,0.25452,1,1
1,GO ACUTE PHASE RESPONSE,0.00040235,0.24261,0.1918,1,1
1,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0001179,0.24259,0.22656,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,9.9803e-06,0.2425,0.23998,1,1
1,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,6.7105e-06,0.24201,0.2658,1,1
1,GO VESICLE CARGO LOADING,1.7693e-06,0.24195,0.25646,1,1
1,GO CELLULAR RESPONSE TO VITAMIN,0.013093,0.2418,0.24446,1,1
1,GO MATERNAL PLACENTA DEVELOPMENT,2.856e-06,0.24165,0.2837,1,1
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,3.9872e-06,0.24122,0.22098,1,1
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,3.357e-07,0.24097,0.22486,1,1
1,GO NEURAL CREST CELL MIGRATION,0.00046165,0.24079,0.21642,1,1
1,GO MACROPHAGE ACTIVATION,0.00022927,0.2405,0.22919,1,1
1,GO REGULATION OF KERATINOCYTE MIGRATION,1.6654e-06,0.24047,0.25593,1,1
1,GO BIOLOGICAL ADHESION,7.1274e-05,0.24039,0.19249,1,1
1,GO RHO PROTEIN SIGNAL TRANSDUCTION,3.7605e-06,0.24021,0.23425,1,1
1,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.001422,0.24002,0.21988,1,1
1,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,7.6446e-07,0.23975,0.24895,1,1
1,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,6.7724e-05,0.23962,0.23337,1,1
1,GO CELLULAR RESPONSE TO OSMOTIC STRESS,4.1815e-08,0.2395,0.26889,1,1
1,GO CARNITINE METABOLIC PROCESS,0.00026438,0.23938,0.23267,1,1
1,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0012705,0.23923,0.30408,1,1
1,GO NEGATIVE REGULATION OF BIOMINERALIZATION,9.4341e-06,0.23922,0.32935,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,1.6761e-05,0.23907,0.2741,1,1
1,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.00095459,0.23902,0.2176,1,1
1,GO RESPONSE TO PARATHYROID HORMONE,0.0031247,0.23889,0.18969,1,1
1,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.0395e-05,0.23871,0.23849,1,1
1,GO REGULATION OF TRANSLATIONAL TERMINATION,0.001118,0.2386,0.20341,1,1
1,GO TERPENOID METABOLIC PROCESS,0.0005211,0.23856,0.17305,1,1
1,GO MESENCHYME DEVELOPMENT,9.795e-06,0.2383,0.20996,1,1
1,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0099244,0.23787,0.2462,1,1
1,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.022686,0.2377,0.13408,1,1
1,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.00014129,0.23766,0.23533,1,1
1,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,7.2414e-06,0.23765,0.27033,1,1
1,GO REGULATION OF GTP BINDING,0.0011021,0.23761,0.23971,1,1
1,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,3.2784e-06,0.23731,0.25291,1,1
1,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,1.0212e-06,0.23725,0.20445,1,1
1,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.00057029,0.23721,0.23443,1,1
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.022446,0.23693,0.18129,1,1
1,GO DECIDUALIZATION,0.00024045,0.2365,0.2968,1,1
1,GO UROGENITAL SYSTEM DEVELOPMENT,0.00029511,0.23641,0.19488,1,1
1,GO CARDIAC SEPTUM DEVELOPMENT,9.03e-05,0.23639,0.2247,1,1
1,GO PROTEIN TARGETING TO VACUOLE,3.7605e-06,0.23608,0.22943,1,1
1,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,7.3803e-06,0.23607,0.24745,1,1
1,GO T CELL DIFFERENTIATION,5.6487e-06,0.23599,0.22527,1,1
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.0005056,0.23589,0.22885,1,1
1,GO PROTEIN PROCESSING,1.8793e-06,0.23582,0.2066,1,1
1,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.6761e-05,0.23574,0.23256,1,1
1,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.0056958,0.23571,0.17231,1,1
1,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00087508,0.23564,0.21833,1,1
1,GO REGULATION OF STEM CELL DIVISION,0.028852,0.23551,0.13148,1,1
1,GO CYTOKINE SECRETION,0.0011021,0.23496,0.17827,1,1
1,GO POSITIVE REGULATION OF DEFENSE RESPONSE,3.8983e-07,0.23466,0.22564,1,1
1,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,2.7668e-07,0.23463,0.27128,1,1
1,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.3236e-05,0.23455,0.20637,1,1
1,GO B CELL ACTIVATION,2.4371e-06,0.23452,0.23897,1,1
1,GO PROTEIN KINASE A SIGNALING,1.8053e-06,0.23452,0.20992,1,1
1,GO BLOOD COAGULATION INTRINSIC PATHWAY,1.5014e-05,0.23442,0.23124,1,1
1,GO PIGMENT GRANULE ORGANIZATION,1.8053e-06,0.23432,0.28102,1,1
1,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,6.4592e-06,0.23406,0.24527,1,1
1,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,7.969e-07,0.23368,0.26252,1,1
1,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.00024045,0.23346,0.23591,1,1
1,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,5.7536e-08,0.23284,0.26883,1,1
1,GO POSITIVE REGULATION OF PROTEIN IMPORT,5.7582e-06,0.23274,0.25872,1,1
1,GO PLACENTA DEVELOPMENT,5.7582e-06,0.2326,0.21747,1,1
1,GO MYELOID CELL HOMEOSTASIS,3.4003e-08,0.23216,0.23678,1,1
1,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,3.8983e-07,0.23206,0.24607,1,1
1,GO HEPARIN METABOLIC PROCESS,9.1829e-05,0.23174,0.30383,1,1
1,GO POSITIVE REGULATION OF OSSIFICATION,0.00043435,0.2317,0.24045,1,1
1,GO CELLULAR RESPONSE TO NUTRIENT,0.02945,0.23161,0.17831,1,1
1,GO RESPONSE TO CORTICOSTERONE,0.011411,0.23161,0.1655,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,7.0337e-07,0.23156,0.27842,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,5.5864e-07,0.23151,0.24338,1,1
1,GO REGULATION OF PROTEOLYSIS,9.2321e-08,0.23093,0.21239,1,1
1,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,5.6487e-06,0.23084,0.22961,1,1
1,GO ACTIN CYTOSKELETON REORGANIZATION,1.9393e-05,0.23068,0.22165,1,1
1,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,1.6321e-06,0.23064,0.22615,1,1
1,GO REGULATION OF LIPID TRANSPORT,8.7502e-06,0.23049,0.21989,1,1
1,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,2.6386e-06,0.23047,0.18852,1,1
1,GO RESPONSE TO ISCHEMIA,1.2027e-05,0.23044,0.22001,1,1
1,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.0047798,0.23013,0.25567,1,1
1,GO POSITIVE REGULATION OF LIPASE ACTIVITY,9.404e-07,0.23006,0.21007,1,1
1,GO HYALURONAN BIOSYNTHETIC PROCESS,0.0028492,0.22997,0.18364,1,1
1,GO CIRCULATORY SYSTEM DEVELOPMENT,9.0235e-07,0.22954,0.22416,1,1
1,GO REGULATION OF CHEMOTAXIS,2.9332e-05,0.22938,0.20451,1,1
1,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.01016,0.22923,0.25368,1,1
1,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.0016806,0.22905,0.21761,1,1
1,GO TRANSITION METAL ION HOMEOSTASIS,5.8262e-07,0.229,0.20246,1,1
1,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,9.6129e-06,0.2289,0.22055,1,1
1,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,5.7051e-07,0.22884,0.24033,1,1
1,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,5.7051e-07,0.22871,0.23452,1,1
1,GO VITAMIN BIOSYNTHETIC PROCESS,0.00076726,0.2286,0.21517,1,1
1,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.0034692,0.22858,0.23591,1,1
1,GO POSITIVE REGULATION OF URINE VOLUME,5.1304e-06,0.22817,0.30289,1,1
1,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.00069207,0.22812,0.18211,1,1
1,GO CELLULAR RESPONSE TO X RAY,3.3214e-05,0.2276,0.31988,1,1
1,GO RESPONSE TO UV C,0.00020504,0.22753,0.22182,1,1
1,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,3.9102e-06,0.22693,0.27309,1,1
1,GO RESPONSE TO LIPID,3.2784e-06,0.22638,0.19728,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00011033,0.22635,0.2183,1,1
1,GO AMYLOID BETA FORMATION,2.3239e-05,0.2263,0.24359,1,1
1,GO BONE MORPHOGENESIS,7.105e-06,0.22581,0.25968,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,2.1621e-05,0.22574,0.23166,1,1
1,GO REGULATION OF SECONDARY METABOLIC PROCESS,2.9859e-05,0.2257,0.31652,1,1
1,GO ENDOCHONDRAL BONE MORPHOGENESIS,1.3325e-06,0.225,0.28511,1,1
1,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0020929,0.22479,0.16386,1,1
1,GO LIPID OXIDATION,1.3693e-05,0.22459,0.1934,1,1
1,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,1.1789e-06,0.22412,0.27149,1,1
1,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.001955,0.22409,0.21994,1,1
1,GO AMELOGENESIS,0.0011341,0.22407,0.22954,1,1
1,GO REGULATION OF MYOTUBE DIFFERENTIATION,9.2585e-06,0.22392,0.22595,1,1
1,GO HORMONE CATABOLIC PROCESS,0.051595,0.22383,0.16719,1,1
1,GO RESPONSE TO PROGESTERONE,0.00030449,0.22382,0.24061,1,1
1,GO RESPONSE TO NUTRIENT,4.0314e-05,0.22375,0.20142,1,1
1,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,2.0853e-05,0.22356,0.35651,1,1
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0010408,0.22346,0.24917,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.2954e-05,0.22323,0.2237,1,1
1,GO INTEGRIN ACTIVATION,0.00016361,0.22294,0.23466,1,1
1,GO FATTY ACID BETA OXIDATION,1.5865e-05,0.22292,0.19577,1,1
1,GO OLIGOPEPTIDE TRANSPORT,0.00062378,0.22284,0.23318,1,1
1,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.0016122,0.22276,0.18578,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.1086e-06,0.22254,0.21836,1,1
1,GO CARTILAGE DEVELOPMENT,2.8886e-07,0.2225,0.25819,1,1
1,GO IMMUNOGLOBULIN PRODUCTION,4.9069e-08,0.22248,0.23168,1,1
1,GO REGULATION OF LIPID LOCALIZATION,1.8053e-06,0.22219,0.21942,1,1
1,GO REGULATION OF CALCIUM ION IMPORT,1.6457e-05,0.222,0.23208,1,1
1,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,2.4861e-06,0.22157,0.19812,1,1
1,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.00013673,0.22092,0.20874,1,1
1,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00016901,0.22088,0.24,1,1
1,GO SMAD PROTEIN COMPLEX ASSEMBLY,4.3997e-05,0.22055,0.29255,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,7.1726e-09,0.2205,0.24741,1,1
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,5.3256e-05,0.22024,0.22413,1,1
1,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,8.0256e-05,0.22012,0.23157,1,1
1,GO RESPONSE TO HYDROGEN PEROXIDE,7.969e-07,0.22011,0.21423,1,1
1,GO VESICLE BUDDING FROM MEMBRANE,1.3056e-06,0.22003,0.19488,1,1
1,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,5.8049e-05,0.21999,0.21517,1,1
1,GO RESPONSE TO TESTOSTERONE,2.0364e-06,0.2197,0.26239,1,1
1,GO RESPONSE TO STEROID HORMONE,1.3442e-05,0.21962,0.19162,1,1
1,GO REGULATION OF LIPID KINASE ACTIVITY,2.8305e-05,0.21954,0.20882,1,1
1,GO PROTEIN ADP RIBOSYLATION,9.03e-05,0.21943,0.21391,1,1
1,GO PORE COMPLEX ASSEMBLY,6.2175e-05,0.21937,0.19574,1,1
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.0035146,0.21924,0.22932,1,1
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.0088198,0.21874,0.1759,1,1
1,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,9.819e-05,0.21871,0.22953,1,1
1,GO FATTY ACID HOMEOSTASIS,0.0062108,0.21865,0.19205,1,1
1,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,5.7059e-05,0.21854,0.27227,1,1
1,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.0027381,0.21841,0.20102,1,1
1,GO MYELOID CELL DIFFERENTIATION,6.0205e-08,0.2182,0.23096,1,1
1,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.2015e-05,0.2178,0.1958,1,1
1,GO RESPONSE TO GROWTH HORMONE,0.00091404,0.21758,0.23245,1,1
1,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00011596,0.21752,0.24768,1,1
1,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00068191,0.21742,0.17719,1,1
1,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,6.8888e-05,0.21723,0.20775,1,1
1,GO SYMBIOTIC PROCESS,1.2759e-09,0.21707,0.21116,1,1
1,GO NEGATIVE REGULATION OF OSSIFICATION,2.2824e-05,0.21704,0.2388,1,1
1,GO ACTIVATION OF INNATE IMMUNE RESPONSE,4.719e-07,0.21698,0.21053,1,1
1,GO BONE MATURATION,0.014658,0.21684,0.13214,1,1
1,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,3.094e-05,0.21666,0.19654,1,1
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,1.4472e-05,0.2165,0.21753,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,7.105e-06,0.216,0.20644,1,1
1,GO REGULATION OF PROTEIN COMPLEX STABILITY,7.5001e-05,0.21583,0.23701,1,1
1,GO BIOMINERALIZATION,0.00095459,0.2156,0.18587,1,1
1,GO RESPONSE TO FATTY ACID,0.020385,0.21533,0.12359,1,1
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00015331,0.21531,0.19901,1,1
1,GO PLATELET MORPHOGENESIS,1.4207e-05,0.21523,0.27406,1,1
1,GO REGULATION OF PROTEIN IMPORT,4.6578e-06,0.21512,0.23574,1,1
1,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.002631,0.21434,0.24816,1,1
1,GO INTERMEMBRANE LIPID TRANSFER,3.4773e-06,0.2143,0.23293,1,1
1,GO HINDLIMB MORPHOGENESIS,0.0018508,0.21364,0.19758,1,1
1,GO TETRAPYRROLE METABOLIC PROCESS,7.969e-07,0.21339,0.20096,1,1
1,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,1.0861e-06,0.21333,0.23028,1,1
1,GO UV PROTECTION,0.0026663,0.21326,0.21182,1,1
1,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,5.3562e-07,0.21325,0.26737,1,1
1,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.001235,0.21306,0.15916,1,1
1,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,1.0557e-05,0.21303,0.18547,1,1
1,GO POSITIVE REGULATION OF TRANSLATION,1.9136e-07,0.21236,0.20504,1,1
1,GO PEPTIDYL ASPARAGINE MODIFICATION,4.4285e-07,0.21224,0.2337,1,1
1,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,2.8886e-07,0.21217,0.2077,1,1
1,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.00014839,0.21214,0.20769,1,1
1,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,9.2585e-06,0.21212,0.19707,1,1
1,GO CONNECTIVE TISSUE DEVELOPMENT,1.3599e-06,0.21193,0.23696,1,1
1,GO PROTEIN KINASE B SIGNALING,5.0278e-07,0.21183,0.21957,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.8053e-06,0.21151,0.18813,1,1
1,GO ARTERY MORPHOGENESIS,0.0038478,0.21134,0.194,1,1
1,GO AMYLOID BETA METABOLIC PROCESS,6.8396e-06,0.21134,0.24929,1,1
1,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.00041488,0.21122,0.24168,1,1
1,GO FLUID TRANSPORT,7.5001e-05,0.21087,0.23162,1,1
1,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,6.4592e-06,0.21075,0.21235,1,1
1,GO RESPONSE TO OXIDATIVE STRESS,1.5027e-08,0.21053,0.21057,1,1
1,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00010497,0.21045,0.21352,1,1
1,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,3.758e-05,0.21041,0.23609,1,1
1,GO ACTOMYOSIN STRUCTURE ORGANIZATION,4.0314e-05,0.21033,0.21424,1,1
1,GO REGULATION OF EXOSOMAL SECRETION,0.00020504,0.20987,0.20585,1,1
1,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,7.0072e-05,0.20967,0.18779,1,1
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0016122,0.20944,0.31049,1,1
1,GO AMINO SUGAR BIOSYNTHETIC PROCESS,2.2416e-05,0.20925,0.20235,1,1
1,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,1.8032e-05,0.20922,0.21116,1,1
1,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,1.4741e-05,0.2092,0.20206,1,1
1,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,1.2281e-06,0.20917,0.22478,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.3784e-07,0.20908,0.19577,1,1
1,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,4.5239e-09,0.20898,0.22604,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.001422,0.20892,0.17969,1,1
1,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,2.4091e-05,0.20886,0.22233,1,1
1,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,3.9102e-06,0.20885,0.19408,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0029256,0.20872,0.22934,1,1
1,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,3.2859e-07,0.20832,0.22643,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,1.3599e-06,0.20813,0.21288,1,1
1,GO ERAD PATHWAY,7.333e-07,0.20786,0.19698,1,1
1,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,1.0322e-07,0.20785,0.21128,1,1
1,GO REGULATION OF HEART GROWTH,0.00016098,0.20778,0.18348,1,1
1,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00010852,0.20778,0.18729,1,1
1,GO POSITIVE REGULATION OF ENDOCYTOSIS,2.8814e-05,0.20775,0.20513,1,1
1,GO POSITIVE REGULATION OF LIPID LOCALIZATION,2.4305e-07,0.20765,0.26069,1,1
1,GO SUPEROXIDE METABOLIC PROCESS,5.332e-06,0.20764,0.21066,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.758e-05,0.20759,0.16752,1,1
1,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0016122,0.20752,0.21428,1,1
1,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,4.8839e-05,0.20746,0.20915,1,1
1,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.8701e-05,0.20744,0.2452,1,1
1,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.4454e-06,0.20739,0.2031,1,1
1,GO CELLULAR RESPONSE TO CHEMICAL STRESS,5.3747e-08,0.20724,0.20411,1,1
1,GO MESODERM MORPHOGENESIS,1.1086e-06,0.20722,0.23281,1,1
1,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,5.1446e-05,0.20703,0.24394,1,1
1,GO ENDODERMAL CELL FATE COMMITMENT,0.0010259,0.20688,0.16818,1,1
1,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.00039622,0.20677,0.19291,1,1
1,GO EXTRACELLULAR VESICLE BIOGENESIS,1.3442e-05,0.20649,0.20619,1,1
1,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,5.7051e-07,0.20607,0.20254,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS,1.1794e-07,0.20599,0.20586,1,1
1,GO CORONARY VASCULATURE MORPHOGENESIS,0.0054192,0.20596,0.2304,1,1
1,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00012388,0.20577,0.24457,1,1
1,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.00035024,0.20569,0.20854,1,1
1,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.4163e-06,0.20559,0.24955,1,1
1,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.0023637,0.20544,0.15976,1,1
1,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.00031414,0.20525,0.22492,1,1
1,GO POLYAMINE METABOLIC PROCESS,0.00071283,0.20509,0.15846,1,1
1,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,4.2487e-05,0.20482,0.22362,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00039622,0.20476,0.23648,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,2.9332e-05,0.20475,0.25557,1,1
1,GO LYMPHOCYTE DIFFERENTIATION,2.4861e-06,0.2045,0.22791,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.2631e-05,0.20446,0.21399,1,1
1,GO POSITIVE REGULATION OF MAPK CASCADE,6.0759e-07,0.2044,0.21477,1,1
1,GO ERYTHROCYTE HOMEOSTASIS,1.536e-06,0.20436,0.205,1,1
1,GO CELL CELL ADHESION,0.00086244,0.20424,0.15962,1,1
1,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.028556,0.2041,0.13407,1,1
1,GO CELL MOTILITY,9.6562e-05,0.20406,0.16686,1,1
1,GO HEART VALVE DEVELOPMENT,6.2175e-05,0.20397,0.26323,1,1
1,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,2.3891e-06,0.20378,0.20042,1,1
1,GO TRACHEA MORPHOGENESIS,6.4592e-06,0.20358,0.32338,1,1
1,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,5.2344e-05,0.20357,0.22163,1,1
1,GO RESPONSE TO ANTIBIOTIC,2.8886e-07,0.20348,0.22758,1,1
1,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.6782e-07,0.20334,0.21475,1,1
1,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.0062877,0.20281,0.13983,1,1
1,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.00020178,0.20266,0.19916,1,1
1,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.011022,0.20218,0.16649,1,1
1,GO TROPHECTODERMAL CELL DIFFERENTIATION,3.2146e-06,0.20204,0.20006,1,1
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.00073415,0.20203,0.17829,1,1
1,GO POSITIVE REGULATION OF VIRAL PROCESS,4.5822e-08,0.2019,0.20669,1,1
1,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0034692,0.20177,0.29395,1,1
1,GO ETHER METABOLIC PROCESS,0.00046165,0.20127,0.20094,1,1
1,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00013016,0.20106,0.1871,1,1
1,GO T HELPER CELL LINEAGE COMMITMENT,0.001955,0.20066,0.16771,1,1
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0022095,0.20065,0.18248,1,1
1,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.402e-08,0.20057,0.19885,1,1
1,GO BODY MORPHOGENESIS,0.00034485,0.20044,0.21952,1,1
1,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,1.5293e-05,0.20018,0.16995,1,1
1,GO NEPHRON DEVELOPMENT,0.0023321,0.19986,0.18185,1,1
1,GO BONE MINERALIZATION,0.014658,0.19982,0.16014,1,1
1,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,4.7172e-05,0.19975,0.16804,1,1
1,GO NEGATIVE REGULATION OF CELL DEATH,3.8161e-07,0.19926,0.17587,1,1
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,7.6446e-07,0.19925,0.25556,1,1
1,GO NEGATIVE REGULATION OF MAPK CASCADE,1.4741e-05,0.19912,0.19757,1,1
1,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,2.8001e-06,0.1991,0.2477,1,1
1,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.032278,0.19896,0.099665,1,1
1,GO RESPONSE TO BMP,0.0032078,0.19888,0.16309,1,1
1,GO OVULATION,0.01251,0.19871,0.15138,1,1
1,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00044103,0.19855,0.17493,1,1
1,GO UBIQUITIN DEPENDENT ERAD PATHWAY,8.3066e-07,0.19846,0.21251,1,1
1,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,6.4592e-06,0.19836,0.19485,1,1
1,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0051547,0.198,0.15551,1,1
1,GO POSITIVE REGULATION OF ORGAN GROWTH,0.00010673,0.19757,0.22044,1,1
1,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,7.5217e-06,0.19746,0.22413,1,1
1,GO GLUTATHIONE METABOLIC PROCESS,7.3739e-05,0.19735,0.19027,1,1
1,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,9.1829e-05,0.19723,0.23946,1,1
1,GO SELECTIVE AUTOPHAGY,1.439e-07,0.19719,0.21707,1,1
1,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,7.2414e-06,0.19712,0.20149,1,1
1,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0069343,0.19709,0.10868,1,1
1,GO FC RECEPTOR SIGNALING PATHWAY,7.333e-07,0.19696,0.19602,1,1
1,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,2.8305e-05,0.19659,0.24065,1,1
1,GO GLIAL CELL MIGRATION,0.0005133,0.19636,0.19554,1,1
1,GO CARDIAC CHAMBER DEVELOPMENT,0.001483,0.19613,0.15517,1,1
1,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,1.0557e-05,0.19592,0.26502,1,1
1,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.00029052,0.19577,0.19393,1,1
1,GO AUTOPHAGOSOME MATURATION,7.333e-07,0.1957,0.2124,1,1
1,GO REGULATION OF MAPK CASCADE,2.7452e-06,0.19554,0.19683,1,1
1,GO EMBRYONIC EYE MORPHOGENESIS,0.00072342,0.19527,0.21038,1,1
1,GO ACTIVATION OF JNKK ACTIVITY,0.0013633,0.19521,0.18966,1,1
1,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,1.6321e-06,0.19515,0.1903,1,1
1,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.00047589,0.19508,0.16309,1,1
1,GO EXOCYTOSIS,1.6158e-05,0.19484,0.17576,1,1
1,GO HOMEOSTASIS OF NUMBER OF CELLS,5.3562e-07,0.19479,0.19815,1,1
1,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,2.4861e-06,0.1946,0.18736,1,1
1,GO NUCLEAR ENVELOPE REASSEMBLY,9.819e-05,0.19452,0.17509,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.0063654,0.19436,0.18434,1,1
1,GO VIRAL TRANSLATION,0.0039992,0.19421,0.16621,1,1
1,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,8.9166e-06,0.1942,0.22259,1,1
1,GO NUCLEOSIDE SALVAGE,0.0023637,0.19402,0.17998,1,1
1,GO CELLULAR RESPONSE TO KETONE,0.0029645,0.19358,0.1376,1,1
1,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0038977,0.19347,0.24926,1,1
1,GO RECEPTOR RECYCLING,0.00029511,0.19294,0.15891,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.00014362,0.19281,0.17865,1,1
1,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.026838,0.19231,0.145,1,1
1,GO RESPONSE TO GAMMA RADIATION,6.337e-06,0.19231,0.21197,1,1
1,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.010041,0.19221,0.17961,1,1
1,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0050269,0.19211,0.16598,1,1
1,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.001955,0.1921,0.17349,1,1
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,3.094e-05,0.19208,0.22238,1,1
1,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.00054518,0.19198,0.1727,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,2.0776e-06,0.19198,0.20501,1,1
1,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,4.31e-06,0.19195,0.17114,1,1
1,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0066039,0.19177,0.16665,1,1
1,GO POST TRANSLATIONAL PROTEIN MODIFICATION,6.7411e-08,0.19144,0.20453,1,1
1,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0078263,0.1913,0.14553,1,1
1,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,1.0554e-07,0.19125,0.20193,1,1
1,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.5576e-05,0.191,0.19303,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,6.6578e-05,0.19098,0.16633,1,1
1,GO HISTONE H2B UBIQUITINATION,0.00091404,0.19075,0.15814,1,1
1,GO VESICLE TARGETING,3.1494e-05,0.19062,0.16808,1,1
1,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00059648,0.19039,0.20386,1,1
1,GO REGULATION OF FATTY ACID OXIDATION,0.0013255,0.19031,0.17908,1,1
1,GO PROTEOGLYCAN METABOLIC PROCESS,0.00049802,0.1903,0.17674,1,1
1,GO REGULATION OF CELL POPULATION PROLIFERATION,9.4959e-05,0.19028,0.15526,1,1
1,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,6.2169e-06,0.19026,0.23493,1,1
1,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.00062378,0.1901,0.22002,1,1
1,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,7.3803e-06,0.19006,0.20053,1,1
1,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00048316,0.18993,0.20678,1,1
1,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.00084997,0.18992,0.19747,1,1
1,GO RESPONSE TO IONIZING RADIATION,1.9563e-06,0.18989,0.20777,1,1
1,GO CARDIAC CHAMBER MORPHOGENESIS,0.0027747,0.18957,0.1637,1,1
1,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,6.1119e-05,0.18952,0.17584,1,1
1,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,3.9613e-05,0.1895,0.2351,1,1
1,GO RESPONSE TO CHEMOKINE,2.8001e-06,0.18942,0.21129,1,1
1,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,3.2784e-06,0.18937,0.19263,1,1
1,GO PEPTIDYL ARGININE MODIFICATION,0.017894,0.18935,0.10192,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00011033,0.18933,0.16924,1,1
1,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,5.7059e-05,0.18922,0.17948,1,1
1,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,1.8793e-06,0.18914,0.20243,1,1
1,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,1.5386e-08,0.18873,0.20785,1,1
1,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,1.536e-06,0.1885,0.19237,1,1
1,GO IMMUNE SYSTEM DEVELOPMENT,1.7154e-07,0.18844,0.20512,1,1
1,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.00010152,0.18833,0.20319,1,1
1,GO CELLULAR IRON ION HOMEOSTASIS,5.332e-06,0.18823,0.17946,1,1
1,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.2631e-05,0.18783,0.1631,1,1
1,GO RESPONSE TO GROWTH FACTOR,4.3236e-05,0.18779,0.17235,1,1
1,GO MANGANESE ION TRANSPORT,0.00029052,0.18751,0.19835,1,1
1,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.00039018,0.18726,0.19301,1,1
1,GO ENDOTHELIAL CELL PROLIFERATION,9.2585e-06,0.1872,0.25693,1,1
1,GO TOXIN TRANSPORT,0.0005133,0.18671,0.16381,1,1
1,GO RENAL VESICLE DEVELOPMENT,0.016027,0.18632,0.14871,1,1
1,GO ORGAN GROWTH,2.1234e-05,0.18613,0.20192,1,1
1,GO GOLGI TO VACUOLE TRANSPORT,0.0016806,0.18574,0.16183,1,1
1,GO MUSCLE ADAPTATION,0.00069207,0.18574,0.1572,1,1
1,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.00040235,0.1857,0.19265,1,1
1,GO RESPONSE TO REACTIVE OXYGEN SPECIES,1.475e-06,0.1856,0.18105,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.7385e-05,0.18549,0.18758,1,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.00016629,0.18534,0.18566,1,1
1,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.012227,0.18531,0.27958,1,1
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,2.6914e-06,0.18513,0.21057,1,1
1,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.1165e-05,0.1851,0.17019,1,1
1,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.9044e-05,0.18503,0.19601,1,1
1,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,4.6578e-06,0.18501,0.17716,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.00036686,0.18448,0.16706,1,1
1,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.020605,0.1844,0.17487,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,5.0323e-06,0.18438,0.23459,1,1
1,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,4.3946e-06,0.18421,0.19807,1,1
1,GO AUTOPHAGY OF NUCLEUS,1.9393e-05,0.18413,0.22701,1,1
1,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00034485,0.18398,0.18783,1,1
1,GO PRIMARY MIRNA PROCESSING,0.00031414,0.18379,0.20847,1,1
1,GO TISSUE HOMEOSTASIS,0.00075607,0.18372,0.14068,1,1
1,GO RESPONSE TO OXYGEN LEVELS,8.2686e-06,0.18355,0.16788,1,1
1,GO FATTY ACID TRANSPORT,0.00016361,0.1835,0.15786,1,1
1,GO HEMOGLOBIN METABOLIC PROCESS,0.00015331,0.18334,0.19903,1,1
1,GO POSITIVE REGULATION OF PROTEIN MATURATION,1.8032e-05,0.1833,0.24909,1,1
1,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,3.9872e-06,0.1833,0.17834,1,1
1,GO TISSUE MORPHOGENESIS,1.0169e-05,0.18311,0.17894,1,1
1,GO LIPID HOMEOSTASIS,0.00010852,0.18306,0.16565,1,1
1,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,7.1274e-05,0.18276,0.16756,1,1
1,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.00029052,0.18262,0.16942,1,1
1,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.00033432,0.18255,0.17427,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00017176,0.18244,0.21074,1,1
1,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.00092737,0.18243,0.18116,1,1
1,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,3.2146e-06,0.18237,0.24274,1,1
1,GO PIGMENT METABOLIC PROCESS,6.4592e-06,0.18235,0.18363,1,1
1,GO ACTIN FILAMENT BASED PROCESS,0.00027284,0.18229,0.15092,1,1
1,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.001422,0.18222,0.13956,1,1
1,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,9.5999e-07,0.18219,0.2328,1,1
1,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,6.5837e-06,0.18218,0.22228,1,1
1,GO REGULATION OF PROTEIN BINDING,1.7385e-05,0.18217,0.16602,1,1
1,GO RESPONSE TO OSMOTIC STRESS,7.2414e-06,0.18205,0.18229,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,6.3249e-05,0.18202,0.18087,1,1
1,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,4.1552e-07,0.18177,0.22635,1,1
1,GO RESPONSE TO AMYLOID BETA,0.02915,0.18165,0.12292,1,1
1,GO KETONE BIOSYNTHETIC PROCESS,1.3693e-05,0.18162,0.20438,1,1
1,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.001568,0.18157,0.24202,1,1
1,GO HEART MORPHOGENESIS,0.00083767,0.18143,0.15638,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.00036124,0.18134,0.22479,1,1
1,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,7.6657e-06,0.18131,0.23481,1,1
1,GO REGULATION OF URINE VOLUME,7.1819e-07,0.18129,0.24511,1,1
1,GO GLYCEROL ETHER METABOLIC PROCESS,0.00025617,0.18128,0.18694,1,1
1,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,5.9056e-05,0.1812,0.18694,1,1
1,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,5.2303e-06,0.1812,0.20992,1,1
1,GO REGULATION OF CARTILAGE DEVELOPMENT,0.001568,0.18119,0.20284,1,1
1,GO ACTIN FILAMENT ORGANIZATION,0.00013451,0.18089,0.16205,1,1
1,GO REGULATION OF MAP KINASE ACTIVITY,1.4741e-05,0.17993,0.18496,1,1
1,GO POSITIVE REGULATION OF HEART GROWTH,0.00046165,0.1799,0.21322,1,1
1,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.031953,0.17976,0.10344,1,1
1,GO MATURATION OF LSU RRNA,0.041789,0.17973,0.12361,1,1
1,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.010279,0.17968,0.16177,1,1
1,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.00036124,0.17968,0.19079,1,1
1,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.00018323,0.17964,0.16324,1,1
1,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.0023957,0.17964,0.15986,1,1
1,GO ENDOTHELIUM DEVELOPMENT,0.0020646,0.17963,0.17597,1,1
1,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.0028118,0.17954,0.17886,1,1
1,GO MUSCLE STRUCTURE DEVELOPMENT,0.00011406,0.17932,0.15974,1,1
1,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,8.4424e-05,0.17929,0.17387,1,1
1,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.011949,0.17899,0.1831,1,1
1,GO GTP METABOLIC PROCESS,0.00033955,0.17898,0.19269,1,1
1,GO CELL CELL RECOGNITION,5.4982e-08,0.17881,0.1929,1,1
1,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,6.2175e-05,0.17871,0.1771,1,1
1,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,5.2303e-06,0.17835,0.17637,1,1
1,GO RESPONSE TO MECHANICAL STIMULUS,0.0090315,0.17828,0.14496,1,1
1,GO PENTOSE METABOLIC PROCESS,0.0030038,0.17827,0.16847,1,1
1,GO ANIMAL ORGAN FORMATION,0.0014022,0.17826,0.16638,1,1
1,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.00069207,0.17811,0.13257,1,1
1,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,5.3256e-05,0.17791,0.16068,1,1
1,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,7.105e-06,0.17761,0.17825,1,1
1,GO REGULATION OF RESPONSE TO STRESS,3.8161e-07,0.1776,0.17434,1,1
1,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.5884e-05,0.17757,0.20145,1,1
1,GO REGULATION OF NEURON PROJECTION REGENERATION,0.0021798,0.17688,0.17991,1,1
1,GO REGULATION OF MUSCLE HYPERTROPHY,0.0013069,0.17679,0.17466,1,1
1,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.01251,0.17676,0.12325,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,9.03e-05,0.17675,0.15627,1,1
1,GO MAINTENANCE OF LOCATION,5.0278e-07,0.17675,0.17759,1,1
1,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.1446e-05,0.17658,0.19346,1,1
1,GO FEMALE GENITALIA DEVELOPMENT,0.010522,0.17649,0.15032,1,1
1,GO SARCOMERE ORGANIZATION,0.014332,0.17607,0.14445,1,1
1,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00026438,0.17606,0.19084,1,1
1,GO THYROID HORMONE METABOLIC PROCESS,9.9844e-05,0.17599,0.20561,1,1
1,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00052901,0.17595,0.2077,1,1
1,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.00029511,0.17591,0.17511,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION,5.8856e-08,0.17587,0.19879,1,1
1,GO PROTEIN LOCALIZATION TO LYSOSOME,0.000662,0.17586,0.18616,1,1
1,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.2482e-05,0.17575,0.16124,1,1
1,GO CELLULAR RESPONSE TO OXYGEN RADICAL,7.7586e-05,0.1753,0.13822,1,1
1,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.4098e-06,0.17524,0.19081,1,1
1,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.00015838,0.17506,0.15205,1,1
1,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,9.2585e-06,0.17491,0.17826,1,1
1,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0059116,0.17473,0.16739,1,1
1,GO CELLULAR RESPONSE TO FATTY ACID,0.02174,0.17417,0.13693,1,1
1,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.00030449,0.17413,0.14827,1,1
1,GO HEART TRABECULA MORPHOGENESIS,0.0021798,0.17405,0.18517,1,1
1,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,2.4091e-05,0.17384,0.19693,1,1
1,GO CELLULAR HORMONE METABOLIC PROCESS,0.00010323,0.17372,0.17397,1,1
1,GO POSITIVE REGULATION OF CELL DEATH,2.5884e-05,0.17372,0.16249,1,1
1,GO LYSOSOMAL TRANSPORT,3.094e-05,0.17356,0.17833,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY,2.3784e-07,0.17356,0.21005,1,1
1,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.00010673,0.17344,0.16485,1,1
1,GO CELLULAR KETONE METABOLIC PROCESS,4.719e-07,0.17335,0.17747,1,1
1,GO CYTOKINETIC PROCESS,1.5014e-05,0.1733,0.20078,1,1
1,GO REGULATION OF RUFFLE ASSEMBLY,0.0049019,0.17329,0.15676,1,1
1,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.00027716,0.17299,0.15961,1,1
1,GO REGULATION OF GLIAL CELL MIGRATION,2.2824e-05,0.17292,0.20671,1,1
1,GO HISTONE PHOSPHORYLATION,0.00016098,0.17269,0.14626,1,1
1,GO HEART DEVELOPMENT,0.00018323,0.17263,0.15848,1,1
1,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.0010865,0.17238,0.18372,1,1
1,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.010279,0.1723,0.17178,1,1
1,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.00011406,0.17228,0.17452,1,1
1,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,5.0278e-07,0.17218,0.2069,1,1
1,GO POSITIVE REGULATION OF PROTEIN BINDING,0.00022208,0.17218,0.15605,1,1
1,GO MESODERM DEVELOPMENT,4.3946e-06,0.17215,0.17783,1,1
1,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.00064263,0.17202,0.19778,1,1
1,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,2.6352e-05,0.17199,0.16886,1,1
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00080175,0.17153,0.16717,1,1
1,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0019023,0.17143,0.1741,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,1.5994e-06,0.17139,0.1926,1,1
1,GO REGULATION OF ORGAN GROWTH,3.8347e-06,0.1713,0.21466,1,1
1,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0011836,0.1711,0.20299,1,1
1,GO CELL AGING,3.7605e-06,0.17097,0.17263,1,1
1,GO CANONICAL WNT SIGNALING PATHWAY,1.0958e-05,0.17089,0.17881,1,1
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,5.2344e-05,0.17065,0.19634,1,1
1,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.031953,0.17042,0.14758,1,1
1,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0038478,0.16991,0.19192,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,3.0905e-06,0.16985,0.17875,1,1
1,GO APOPTOTIC SIGNALING PATHWAY,6.5837e-06,0.16972,0.16208,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,8.9166e-06,0.16969,0.24861,1,1
1,GO MYELOID CELL DEVELOPMENT,0.0072795,0.16944,0.15618,1,1
1,GO PROTEIN LOCALIZATION TO VACUOLE,7.6283e-05,0.16942,0.1788,1,1
1,GO CELLULAR LIPID CATABOLIC PROCESS,3.628e-05,0.1694,0.16338,1,1
1,GO REGULATION OF VIRAL TRANSCRIPTION,2.6386e-06,0.1692,0.1974,1,1
1,GO REGULATION OF CELL AGING,1.5865e-05,0.16877,0.17868,1,1
1,GO POSITIVE REGULATION OF JNK CASCADE,0.00159,0.16874,0.14395,1,1
1,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.0010558,0.16874,0.17306,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.00040235,0.16871,0.13799,1,1
1,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.017699,0.16864,0.12215,1,1
1,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0021215,0.16862,0.18412,1,1
1,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.0081133,0.16851,0.14729,1,1
1,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,4.5558e-05,0.16845,0.1766,1,1
1,GO LAMELLIPODIUM ASSEMBLY,7.5001e-05,0.16837,0.19027,1,1
1,GO SKELETAL SYSTEM DEVELOPMENT,0.00012186,0.16829,0.16571,1,1
1,GO MRNA TRANSCRIPTION,4.8839e-05,0.16784,0.23518,1,1
1,GO RESPONSE TO HORMONE,0.00013673,0.16768,0.14236,1,1
1,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.011678,0.16765,0.15178,1,1
1,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,1.9393e-05,0.1676,0.17914,1,1
1,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.00024819,0.16744,0.16061,1,1
1,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0047198,0.16741,0.16192,1,1
1,GO ORGANIC ACID CATABOLIC PROCESS,0.00024819,0.16739,0.13715,1,1
1,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.03902,0.16737,0.12231,1,1
1,GO NUCLEAR ENVELOPE ORGANIZATION,0.00099681,0.1671,0.14512,1,1
1,GO GOLGI VESICLE BUDDING,6.2175e-05,0.16705,0.15308,1,1
1,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.0958e-05,0.16674,0.16354,1,1
1,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,2.2015e-05,0.1664,0.17457,1,1
1,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.035336,0.16619,0.12225,1,1
1,GO VIRAL RELEASE FROM HOST CELL,6.337e-06,0.16584,0.1887,1,1
1,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00099681,0.16549,0.18383,1,1
1,GO RESPONSE TO KETONE,0.00033955,0.16518,0.15934,1,1
1,GO CARDIOCYTE DIFFERENTIATION,0.00049053,0.16511,0.16524,1,1
1,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0027381,0.16506,0.15224,1,1
1,GO MAMMARY GLAND DEVELOPMENT,0.0022701,0.16501,0.15116,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE,0.00011596,0.1649,0.13545,1,1
1,GO RECEPTOR MEDIATED ENDOCYTOSIS,4.5558e-05,0.16489,0.14637,1,1
1,GO DENDRITIC SPINE MAINTENANCE,0.014823,0.1645,0.1738,1,1
1,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.012087,0.16446,0.13059,1,1
1,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.00054518,0.16418,0.18174,1,1
1,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00013673,0.16416,0.21028,1,1
1,GO PLASMA MEMBRANE ORGANIZATION,0.0022701,0.16414,0.16461,1,1
1,GO LIPID CATABOLIC PROCESS,2.2015e-05,0.16395,0.15996,1,1
1,GO COPII COATED VESICLE CARGO LOADING,0.00020504,0.16389,0.18038,1,1
1,GO REGULATION OF CELL DEATH,8.9166e-06,0.16373,0.15144,1,1
1,GO EMBRYONIC HEART TUBE DEVELOPMENT,3.3214e-05,0.16344,0.1862,1,1
1,GO REGULATION OF T CELL CHEMOTAXIS,0.0056255,0.16315,0.13526,1,1
1,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.00075607,0.16308,0.14947,1,1
1,GO CELLULAR RESPONSE TO ATP,5.9056e-05,0.16285,0.1559,1,1
1,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,4.6578e-06,0.16277,0.17178,1,1
1,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00011986,0.16268,0.13611,1,1
1,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.030368,0.16262,0.15675,1,1
1,GO RESPONSE TO OXYGEN RADICAL,0.00010673,0.16259,0.13448,1,1
1,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.000662,0.16239,0.14705,1,1
1,GO REGULATION OF VACUOLE ORGANIZATION,2.7804e-05,0.16232,0.18493,1,1
1,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,6.3249e-05,0.16216,0.19981,1,1
1,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,5.1304e-06,0.16215,0.154,1,1
1,GO REGULATION OF MONOOXYGENASE ACTIVITY,3.8924e-05,0.16214,0.16493,1,1
1,GO ANIMAL ORGAN MORPHOGENESIS,0.0015463,0.16206,0.12891,1,1
1,GO MUSCLE ORGAN DEVELOPMENT,0.00048316,0.16201,0.13547,1,1
1,GO NEURAL TUBE DEVELOPMENT,0.0010558,0.162,0.15952,1,1
1,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.0032078,0.16197,0.16545,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,8.4805e-07,0.16185,0.17301,1,1
1,GO REGULATION OF MESODERM DEVELOPMENT,0.01829,0.16181,0.12137,1,1
1,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,6.4592e-06,0.16168,0.16141,1,1
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.0099244,0.16166,0.15697,1,1
1,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,3.2162e-07,0.16156,0.17984,1,1
1,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0020092,0.16153,0.13511,1,1
1,GO AGING,4.3946e-06,0.16146,0.16631,1,1
1,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0017277,0.16143,0.1261,1,1
1,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00010852,0.16124,0.1747,1,1
1,GO HEART GROWTH,0.00020504,0.16104,0.17048,1,1
1,GO REGULATION OF HYDROLASE ACTIVITY,7.5001e-05,0.16093,0.14385,1,1
1,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.00035024,0.16082,0.15281,1,1
1,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.001442,0.16059,0.1616,1,1
1,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,3.1494e-05,0.16054,0.21256,1,1
1,GO RAS PROTEIN SIGNAL TRANSDUCTION,5.1446e-05,0.16052,0.16496,1,1
1,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.00049802,0.16033,0.15005,1,1
1,GO ANION HOMEOSTASIS,0.0001179,0.16029,0.19041,1,1
1,GO MAINTENANCE OF LOCATION IN CELL,5.2303e-06,0.16017,0.15802,1,1
1,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.001955,0.16015,0.16706,1,1
1,GO LIPID MODIFICATION,0.00022208,0.15986,0.13686,1,1
1,GO MITOTIC CYTOKINETIC PROCESS,8.1623e-05,0.15954,0.18838,1,1
1,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,9.4959e-05,0.15945,0.13804,1,1
1,GO NATURAL KILLER CELL DIFFERENTIATION,0.0020929,0.15927,0.17675,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.013394,0.15926,0.11611,1,1
1,GO NEURAL TUBE FORMATION,0.002702,0.1591,0.15319,1,1
1,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.00046872,0.15905,0.17183,1,1
1,GO INTRACELLULAR LIPID TRANSPORT,0.00072342,0.159,0.18008,1,1
1,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0001862,0.15888,0.13919,1,1
1,GO REGULATION OF PROTEIN FOLDING,0.00052901,0.15884,0.17221,1,1
1,GO STEM CELL DIFFERENTIATION,3.4773e-06,0.1588,0.17704,1,1
1,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,3.0905e-06,0.15855,0.17532,1,1
1,GO REGULATION OF NUCLEASE ACTIVITY,0.0011836,0.15844,0.13888,1,1
1,GO REGULATION OF WNT SIGNALING PATHWAY,0.00010323,0.15809,0.15365,1,1
1,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,2.1338e-07,0.15786,0.2,1,1
1,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.00032408,0.15771,0.18647,1,1
1,GO MULTI ORGANISM LOCALIZATION,1.6761e-05,0.15768,0.19395,1,1
1,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,4.7488e-06,0.15766,0.20912,1,1
1,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,4.1026e-05,0.15763,0.1584,1,1
1,GO GENITALIA DEVELOPMENT,0.0034692,0.15757,0.13327,1,1
1,GO ENDOCYTIC RECYCLING,0.0022095,0.15745,0.13741,1,1
1,GO NEGATIVE CHEMOTAXIS,0.014172,0.15732,0.16311,1,1
1,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0062877,0.15711,0.20383,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,8.4424e-05,0.15707,0.15439,1,1
1,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,4.3997e-05,0.15707,0.15376,1,1
1,GO REGULATION OF VASOCONSTRICTION,6.7724e-05,0.15702,0.22118,1,1
1,GO MYOFIBRIL ASSEMBLY,0.02915,0.15671,0.12013,1,1
1,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,5.5127e-05,0.15647,0.17112,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00011218,0.15644,0.12904,1,1
1,GO RESPONSE TO ESTRADIOL,0.00037835,0.15628,0.1595,1,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0015463,0.15627,0.15757,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.001483,0.15612,0.1408,1,1
1,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0022095,0.15586,0.15709,1,1
1,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.0021215,0.15581,0.18805,1,1
1,GO REGULATION OF LIGASE ACTIVITY,0.0032501,0.15575,0.15666,1,1
1,GO MUSCLE CELL DIFFERENTIATION,0.0020367,0.15561,0.13192,1,1
1,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,9.2585e-06,0.15547,0.15038,1,1
1,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.051111,0.15541,0.11459,1,1
1,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00061456,0.15506,0.20965,1,1
1,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00028155,0.15501,0.14252,1,1
1,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.014332,0.15487,0.11802,1,1
1,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.001568,0.15476,0.18726,1,1
1,GO NEPHRON TUBULE FORMATION,0.05357,0.15474,0.15497,1,1
1,GO SPINDLE MIDZONE ASSEMBLY,0.012653,0.15457,0.13377,1,1
1,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.0024281,0.15456,0.14717,1,1
1,GO BODY FLUID SECRETION,6.545e-05,0.1545,0.16421,1,1
1,GO REGULATION OF PHOSPHORYLATION,5.2344e-05,0.1544,0.13828,1,1
1,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00096848,0.15423,0.13415,1,1
1,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.009139,0.15401,0.18591,1,1
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,7.6657e-06,0.15379,0.16208,1,1
1,GO ENDOCYTOSIS,0.00013673,0.15378,0.13893,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,3.9613e-05,0.15352,0.17684,1,1
1,GO CELLULAR RESPONSE TO DRUG,0.00026438,0.15341,0.14163,1,1
1,GO CELLULAR RESPONSE TO OXYGEN LEVELS,1.2954e-05,0.15337,0.15522,1,1
1,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.003607,0.15333,0.15538,1,1
1,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,2.0364e-06,0.15325,0.15799,1,1
1,GO PLASMA MEMBRANE TUBULATION,0.00015083,0.15258,0.21454,1,1
1,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,9.9844e-05,0.15233,0.15059,1,1
1,GO VIRION ASSEMBLY,1.3442e-05,0.15214,0.15653,1,1
1,GO VACUOLAR TRANSPORT,5.4184e-05,0.15209,0.14858,1,1
1,GO INTRACELLULAR STEROL TRANSPORT,0.0020646,0.15204,0.20426,1,1
1,GO JNK CASCADE,0.00084997,0.15181,0.12999,1,1
1,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.00052901,0.15151,0.12815,1,1
1,GO REGULATION OF JUN KINASE ACTIVITY,0.0077327,0.15135,0.12921,1,1
1,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,7.7586e-05,0.15126,0.14792,1,1
1,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,2.4972e-05,0.15117,0.14674,1,1
1,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00063314,0.15101,0.15727,1,1
1,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0035605,0.151,0.15595,1,1
1,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,9.404e-07,0.15097,0.18587,1,1
1,GO RESPONSE TO PEPTIDE,0.00013232,0.15083,0.13303,1,1
1,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00012388,0.15058,0.16197,1,1
1,GO MODULATION BY VIRUS OF HOST PROCESS,0.00074504,0.15026,0.15048,1,1
1,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.003166,0.14991,0.15449,1,1
1,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.00022565,0.1498,0.16075,1,1
1,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,7.7586e-05,0.14978,0.14773,1,1
1,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,1.064e-06,0.14977,0.17222,1,1
1,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0074579,0.14961,0.12198,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,6.3249e-05,0.14946,0.13723,1,1
1,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00013673,0.14945,0.13976,1,1
1,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.014172,0.14944,0.16703,1,1
1,GO REGULATION OF ACTIN FILAMENT LENGTH,0.00022565,0.14925,0.13901,1,1
1,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.0026663,0.14924,0.12452,1,1
1,GO FATTY ACID CATABOLIC PROCESS,0.0012886,0.14923,0.13597,1,1
1,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,2.7804e-05,0.1492,0.15891,1,1
1,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.00060545,0.14913,0.18625,1,1
1,GO PEROXISOMAL TRANSPORT,5.2344e-05,0.14909,0.16409,1,1
1,GO ENDOCARDIAL CUSHION FORMATION,0.01499,0.14907,0.1892,1,1
1,GO PROTEIN MATURATION,7.8124e-06,0.14905,0.15637,1,1
1,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.02174,0.14892,0.12126,1,1
1,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.0005789,0.1488,0.1254,1,1
1,GO MEMBRANE DISASSEMBLY,0.036048,0.14852,0.12918,1,1
1,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.00046872,0.14839,0.15035,1,1
1,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.016386,0.14817,0.20357,1,1
1,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.020828,0.14798,0.094257,1,1
1,GO POSITIVE REGULATION OF MITOPHAGY,0.0032078,0.14773,0.1801,1,1
1,GO MUSCLE TISSUE DEVELOPMENT,0.013546,0.14767,0.099304,1,1
1,GO DNA DEMETHYLATION,0.022686,0.14734,0.11919,1,1
1,GO REGULATION OF MULTI ORGANISM PROCESS,1.1165e-05,0.14716,0.14555,1,1
1,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.017506,0.14703,0.11297,1,1
1,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0010259,0.14692,0.15523,1,1
1,GO PEROXISOME ORGANIZATION,6.545e-05,0.14651,0.15316,1,1
1,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.00037257,0.1458,0.23328,1,1
1,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,2.6352e-05,0.14568,0.14901,1,1
1,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,9.795e-06,0.14529,0.13427,1,1
1,GO CELL VOLUME HOMEOSTASIS,0.0038977,0.14528,0.1251,1,1
1,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.00020504,0.14518,0.14177,1,1
1,GO PIGMENT CELL DIFFERENTIATION,0.034984,0.1451,0.10467,1,1
1,GO CELL CELL SIGNALING BY WNT,0.00039622,0.14501,0.13342,1,1
1,GO CELLULAR RESPONSE TO ALCOHOL,0.026286,0.145,0.12171,1,1
1,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.00014839,0.14434,0.13881,1,1
1,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.00091404,0.14431,0.15613,1,1
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0050904,0.14387,0.1247,1,1
1,GO MITOTIC CELL CYCLE ARREST,0.0056255,0.14375,0.14469,1,1
1,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.6321e-06,0.14358,0.16821,1,1
1,GO PROTEIN LOCALIZATION TO NUCLEUS,0.00034485,0.14333,0.13122,1,1
1,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0077327,0.14297,0.13531,1,1
1,GO PROTEASOME ASSEMBLY,0.0050269,0.14272,0.14278,1,1
1,GO SKELETAL SYSTEM MORPHOGENESIS,0.0025277,0.14222,0.1303,1,1
1,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0052854,0.14206,0.12038,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.0018508,0.14194,0.11852,1,1
1,GO MUSCLE HYPERTROPHY,0.018091,0.14178,0.11486,1,1
1,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.00016361,0.14138,0.13706,1,1
1,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.00025215,0.14052,0.17809,1,1
1,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.0013255,0.14039,0.15371,1,1
1,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.0077327,0.14029,0.18337,1,1
1,GO VACUOLE ORGANIZATION,6.7105e-06,0.14022,0.16534,1,1
1,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,4.7172e-05,0.14007,0.16468,1,1
1,GO COPII COATED VESICLE BUDDING,8.0256e-05,0.14001,0.14868,1,1
1,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.3249e-05,0.13995,0.16503,1,1
1,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,5.6487e-06,0.13986,0.16585,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.00036686,0.13972,0.1167,1,1
1,GO SCHWANN CELL DIFFERENTIATION,0.0053519,0.13962,0.13645,1,1
1,GO ESTROUS CYCLE,0.028852,0.13961,0.17177,1,1
1,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.023668,0.13948,0.11779,1,1
1,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.00020504,0.13941,0.13073,1,1
1,GO L GLUTAMATE IMPORT,0.023173,0.13935,0.12293,1,1
1,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,2.6352e-05,0.13935,0.1562,1,1
1,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.016752,0.13931,0.098457,1,1
1,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.026561,0.1392,0.17257,1,1
1,GO CELL JUNCTION DISASSEMBLY,0.0016122,0.13915,0.2058,1,1
1,GO LATERAL VENTRICLE DEVELOPMENT,0.032607,0.13873,0.17004,1,1
1,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.00020835,0.13853,0.20629,1,1
1,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0037498,0.13847,0.13702,1,1
1,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.016752,0.13811,0.1167,1,1
1,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0034692,0.13801,0.11481,1,1
1,GO RESPONSE TO STEROL,0.0043737,0.13786,0.1607,1,1
1,GO APOPTOTIC PROCESS,2.6352e-05,0.13779,0.1367,1,1
1,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.014494,0.13777,0.13379,1,1
1,GO RECEPTOR METABOLIC PROCESS,0.00022208,0.13766,0.13744,1,1
1,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.011022,0.13763,0.099795,1,1
1,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,1.3948e-05,0.13742,0.14063,1,1
1,GO TRIGLYCERIDE METABOLIC PROCESS,0.0012005,0.13731,0.14988,1,1
1,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.0038478,0.13708,0.14498,1,1
1,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0005133,0.13697,0.12788,1,1
1,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.02915,0.13695,0.12091,1,1
1,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.0060595,0.13691,0.1274,1,1
1,GO RESPONSE TO PEPTIDE HORMONE,0.00044103,0.13687,0.12206,1,1
1,GO ESTABLISHMENT OF TISSUE POLARITY,0.00011596,0.1365,0.15257,1,1
1,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,1.6158e-05,0.13644,0.14946,1,1
1,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,1.0861e-06,0.13636,0.14009,1,1
1,GO ACTIVATION OF JUN KINASE ACTIVITY,0.0020367,0.13604,0.15247,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0072795,0.13563,0.14517,1,1
1,GO REGULATION OF MUSCLE ADAPTATION,0.0050904,0.13561,0.13819,1,1
1,GO LONG CHAIN FATTY ACID TRANSPORT,0.0013443,0.13556,0.13025,1,1
1,GO PROTEIN K63 LINKED UBIQUITINATION,0.00046165,0.1354,0.11985,1,1
1,GO GOLGI VESICLE TRANSPORT,2.7452e-06,0.13537,0.14821,1,1
1,GO NUCLEOBASE METABOLIC PROCESS,0.0074579,0.13533,0.095615,1,1
1,GO ENDOSOME ORGANIZATION,0.00011596,0.135,0.14006,1,1
1,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,9.3381e-05,0.13484,0.19825,1,1
1,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.032938,0.13478,0.12531,1,1
1,GO POSITIVE REGULATION OF SIGNALING,0.0011021,0.1344,0.11358,1,1
1,GO RESPONSE TO MISFOLDED PROTEIN,0.0030436,0.1343,0.15288,1,1
1,GO EMBRYONIC MORPHOGENESIS,0.0007786,0.13424,0.13395,1,1
1,GO TAXIS,0.0071051,0.13421,0.11761,1,1
1,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0010558,0.13382,0.12064,1,1
1,GO MUSCLE ORGAN MORPHOGENESIS,0.0085105,0.13306,0.12258,1,1
1,GO SULFATION,0.0050269,0.13298,0.18907,1,1
1,GO CELLULAR RESPONSE TO UV,0.00022565,0.13293,0.14459,1,1
1,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.00025617,0.13266,0.13231,1,1
1,GO HORMONE BIOSYNTHETIC PROCESS,0.00034485,0.13263,0.17087,1,1
1,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.00011986,0.13243,0.13891,1,1
1,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0019023,0.13219,0.13769,1,1
1,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.00020504,0.13218,0.12452,1,1
1,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0099244,0.13218,0.15256,1,1
1,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.003654,0.13211,0.11478,1,1
1,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.033948,0.13211,0.10341,1,1
1,GO PROTEIN DESTABILIZATION,0.0083098,0.13207,0.11122,1,1
1,GO GLYCOSYL COMPOUND METABOLIC PROCESS,9.4959e-05,0.1317,0.13533,1,1
1,GO RUFFLE ORGANIZATION,0.0001179,0.13158,0.16674,1,1
1,GO POSITIVE REGULATION OF NEURON DEATH,0.02174,0.13148,0.10035,1,1
1,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,9.6129e-06,0.13122,0.12846,1,1
1,GO REGULATION OF LIPID CATABOLIC PROCESS,0.00035024,0.13109,0.17333,1,1
1,GO PROTEIN HOMOTETRAMERIZATION,1.4741e-05,0.13097,0.15727,1,1
1,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0025961,0.13084,0.17767,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.00032916,0.13078,0.14797,1,1
1,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00090088,0.13056,0.15212,1,1
1,GO NUCLEOSIDE METABOLIC PROCESS,6.1119e-05,0.13,0.14504,1,1
1,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.3693e-05,0.12982,0.12887,1,1
1,GO REGULATION OF PROTEIN SUMOYLATION,9.03e-05,0.12961,0.1519,1,1
1,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.00013016,0.1296,0.1515,1,1
1,GO PROTEIN AUTOPHOSPHORYLATION,0.001776,0.12955,0.13494,1,1
1,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0076401,0.12953,0.16092,1,1
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.0021215,0.12924,0.11801,1,1
1,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0032928,0.12914,0.12781,1,1
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.00084997,0.1289,0.13632,1,1
1,GO ANIMAL ORGAN MATURATION,0.044722,0.12874,0.10968,1,1
1,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.00040857,0.12855,0.14411,1,1
1,GO TONGUE MORPHOGENESIS,0.026838,0.12854,0.17458,1,1
1,GO BLASTOCYST FORMATION,0.00091404,0.12827,0.12618,1,1
1,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.01829,0.12812,0.10909,1,1
1,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.051595,0.12812,0.093971,1,1
1,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.016938,0.12786,0.098926,1,1
1,GO RESPONSE TO UV,0.00010497,0.12762,0.14408,1,1
1,GO RESPONSE TO PROSTAGLANDIN E,0.012653,0.12755,0.12638,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.024173,0.1275,0.10018,1,1
1,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.034636,0.12744,0.10792,1,1
1,GO PROTEIN CATABOLIC PROCESS,1.5014e-05,0.12714,0.12187,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.00059648,0.12707,0.12708,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0033799,0.12684,0.10335,1,1
1,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.030368,0.12683,0.11094,1,1
1,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.001235,0.12682,0.12953,1,1
1,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.00011986,0.1267,0.13089,1,1
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.040187,0.12657,0.10633,1,1
1,GO PROTEIN POLYUBIQUITINATION,0.00029976,0.1265,0.11486,1,1
1,GO STEROL METABOLIC PROCESS,0.0076401,0.1263,0.1148,1,1
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0077327,0.12627,0.12548,1,1
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS,2.206e-06,0.12616,0.13845,1,1
1,GO AMINE METABOLIC PROCESS,0.0018508,0.12591,0.10223,1,1
1,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.0002117,0.12591,0.14164,1,1
1,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.012798,0.12585,0.13016,1,1
1,GO CALCINEURIN MEDIATED SIGNALING,0.0071918,0.12552,0.13116,1,1
1,GO RESPONSE TO ACTIVITY,0.028852,0.12534,0.086246,1,1
1,GO NEGATIVE REGULATION OF GENE SILENCING,0.0017277,0.12519,0.13607,1,1
1,GO REGULATION OF GENE SILENCING,0.0035146,0.12518,0.11962,1,1
1,GO CORPUS CALLOSUM DEVELOPMENT,0.051111,0.12506,0.15152,1,1
1,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.0024281,0.12482,0.1164,1,1
1,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.054582,0.12476,0.093381,1,1
1,GO MITOTIC CYTOKINESIS,0.016938,0.1247,0.10618,1,1
1,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.016568,0.12416,0.11992,1,1
1,GO RNA DECAPPING,0.00029976,0.12411,0.15524,1,1
1,GO DNA DEALKYLATION,0.0010558,0.12404,0.15244,1,1
1,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.00042777,0.12389,0.1334,1,1
1,GO REGULATION OF PROTEIN KINASE ACTIVITY,8.1623e-05,0.12352,0.13633,1,1
1,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.0018764,0.12314,0.11886,1,1
1,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,2.2015e-05,0.1231,0.12408,1,1
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,7.7586e-05,0.12273,0.12678,1,1
1,GO NEUTRAL LIPID METABOLIC PROCESS,0.020385,0.12231,0.10632,1,1
1,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.044292,0.1223,0.086827,1,1
1,GO MATURATION OF 5 8S RRNA,0.051111,0.12202,0.097526,1,1
1,GO RNA DESTABILIZATION,0.00096848,0.12161,0.16668,1,1
1,GO PIGMENT BIOSYNTHETIC PROCESS,0.0015463,0.12147,0.12796,1,1
1,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.010645,0.12131,0.12585,1,1
1,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.00088789,0.12115,0.17419,1,1
1,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.0025617,0.1211,0.089189,1,1
1,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0051547,0.12083,0.12026,1,1
1,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.00012594,0.12064,0.12458,1,1
1,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0077327,0.12005,0.11264,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.0068504,0.11939,0.14078,1,1
1,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.0032078,0.11934,0.10799,1,1
1,GO REGULATION OF CELLULAR CATABOLIC PROCESS,1.6654e-06,0.11925,0.13978,1,1
1,GO REGULATION OF MIRNA METABOLIC PROCESS,0.024947,0.11923,0.12407,1,1
1,GO OVULATION CYCLE,0.0066851,0.11911,0.13319,1,1
1,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00019541,0.1189,0.14198,1,1
1,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,7.5001e-05,0.11877,0.13398,1,1
1,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.0098086,0.11858,0.13737,1,1
1,GO POSITIVE REGULATION OF MACROAUTOPHAGY,9.9803e-06,0.11856,0.17984,1,1
1,GO NEGATIVE REGULATION OF SIGNALING,4.7172e-05,0.11843,0.13699,1,1
1,GO SPERM EGG RECOGNITION,0.0035146,0.11811,0.099761,1,1
1,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.020828,0.11801,0.10213,1,1
1,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.026561,0.11797,0.090766,1,1
1,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.001568,0.11793,0.11693,1,1
1,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.00099681,0.11791,0.15418,1,1
1,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0021215,0.11744,0.1108,1,1
1,GO ACETYL COA METABOLIC PROCESS,0.026561,0.11743,0.11164,1,1
1,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.033608,0.11731,0.088569,1,1
1,GO MUSCLE CELL DEVELOPMENT,0.032938,0.11719,0.10447,1,1
1,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.033608,0.11715,0.077683,1,1
1,GO REGULATION OF BINDING,6.7724e-05,0.11713,0.13293,1,1
1,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0099244,0.11699,0.12569,1,1
1,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0032501,0.11684,0.12069,1,1
1,GO UV DAMAGE EXCISION REPAIR,0.0062108,0.1163,0.11661,1,1
1,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.025475,0.11569,0.12256,1,1
1,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.027686,0.11567,0.10296,1,1
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.00018323,0.11559,0.13737,1,1
1,GO IRON SULFUR CLUSTER ASSEMBLY,0.0094686,0.11548,0.12674,1,1
1,GO REGULATION OF CELL DIFFERENTIATION,0.021053,0.11455,0.09197,1,1
1,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0059852,0.11423,0.12349,1,1
1,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,6.1119e-05,0.11421,0.13946,1,1
1,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.044292,0.11406,0.077885,1,1
1,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.00083767,0.11401,0.1174,1,1
1,GO ESTABLISHMENT OF CELL POLARITY,0.0054192,0.11386,0.11018,1,1
1,GO PROTEIN FOLDING,0.0016122,0.11372,0.12435,1,1
1,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.052575,0.11277,0.064705,1,1
1,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0034692,0.11254,0.10507,1,1
1,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0024281,0.11195,0.13578,1,1
1,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.545e-05,0.11187,0.11465,1,1
1,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0137,0.11177,0.088849,1,1
1,GO HORMONE MEDIATED SIGNALING PATHWAY,0.016752,0.11161,0.091915,1,1
1,GO WHITE FAT CELL DIFFERENTIATION,0.026838,0.11119,0.11004,1,1
1,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.001704,0.11104,0.10338,1,1
1,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.030994,0.11066,0.1251,1,1
1,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0037498,0.11064,0.13151,1,1
1,GO RESPONSE TO ALCOHOL,0.044722,0.11045,0.083613,1,1
1,GO REGULATION OF BLOOD PRESSURE,0.031631,0.11013,0.093838,1,1
1,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.031311,0.10879,0.099931,1,1
1,GO VIRAL GENE EXPRESSION,0.036048,0.10876,0.099057,1,1
1,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0034692,0.1084,0.11343,1,1
1,GO SULFUR AMINO ACID METABOLIC PROCESS,0.011022,0.10832,0.1012,1,1
1,GO RESPONSE TO HEAT,0.00054518,0.1082,0.13005,1,1
1,GO RNA 5 END PROCESSING,0.015501,0.10815,0.13001,1,1
1,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0068504,0.10814,0.15656,1,1
1,GO HISTONE DEACETYLATION,0.036409,0.10803,0.078669,1,1
1,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0058389,0.10769,0.095508,1,1
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.034984,0.10718,0.088655,1,1
1,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.00060545,0.10708,0.11287,1,1
1,GO RESPONSE TO ORGANOPHOSPHORUS,0.0012705,0.10677,0.13792,1,1
1,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.00067188,0.10673,0.11414,1,1
1,GO GLYCEROLIPID CATABOLIC PROCESS,0.058247,0.10659,0.10258,1,1
1,GO NEGATIVE REGULATION OF CELL CYCLE,0.0022396,0.10652,0.079528,1,1
1,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.0002117,0.10636,0.12712,1,1
1,GO MEMBRANE ORGANIZATION,0.0016347,0.10603,0.10062,1,1
1,GO REGULATION OF MRNA BINDING,0.047827,0.10579,0.12794,1,1
1,GO MEGAKARYOCYTE DIFFERENTIATION,0.003166,0.10558,0.15105,1,1
1,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.014823,0.10541,0.12063,1,1
1,GO REGULATION OF CELLULAR RESPONSE TO STRESS,6.6578e-05,0.1054,0.12445,1,1
1,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.01128,0.10521,0.1103,1,1
1,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0005618,0.10516,0.14795,1,1
1,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.012798,0.10492,0.12225,1,1
1,GO MATURATION OF SSU RRNA,0.040981,0.10472,0.11894,1,1
1,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.00059648,0.10468,0.11861,1,1
1,GO RESPONSE TO TOXIC SUBSTANCE,0.0086125,0.10457,0.099193,1,1
1,GO VIRAL BUDDING,0.0052197,0.10438,0.1166,1,1
1,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0099244,0.10404,0.096758,1,1
1,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00084997,0.10394,0.12222,1,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.055609,0.10332,0.097679,1,1
1,GO RESPONSE TO ABIOTIC STIMULUS,0.00090088,0.10251,0.10186,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.043444,0.10242,0.082109,1,1
1,GO RESPONSE TO ATP,0.00031414,0.10235,0.14218,1,1
1,GO TRANSLESION SYNTHESIS,0.017506,0.10187,0.075219,1,1
1,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.003654,0.10175,0.10531,1,1
1,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.00069207,0.1014,0.10384,1,1
1,GO POSITIVE REGULATION OF BINDING,0.0020929,0.10132,0.1085,1,1
1,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.039406,0.10125,0.10814,1,1
1,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.016568,0.1007,0.11888,1,1
1,GO SMOOTHENED SIGNALING PATHWAY,0.01585,0.10061,0.10988,1,1
1,GO SPINDLE LOCALIZATION,0.053071,0.10041,0.076546,1,1
1,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.007921,0.1002,0.09558,1,1
1,GO RESPONSE TO NITROGEN COMPOUND,0.004964,0.10003,0.093471,1,1
1,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0034243,0.10002,0.11324,1,1
1,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.00071283,0.098852,0.11081,1,1
1,GO PEPTIDYL AMINO ACID MODIFICATION,0.0019023,0.097322,0.092614,1,1
1,GO CELLULAR SENESCENCE,0.00037835,0.097218,0.1333,1,1
1,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.011678,0.097073,0.10397,1,1
1,GO REGULATION OF AUTOPHAGY,0.00013232,0.096837,0.11711,1,1
1,GO PEPTIDE BIOSYNTHETIC PROCESS,0.020385,0.096797,0.074003,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.017699,0.096514,0.080933,1,1
1,GO REGULATION OF MRNA 3 END PROCESSING,0.010041,0.096196,0.1156,1,1
1,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.05063,0.095889,0.10012,1,1
1,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0022095,0.095586,0.1098,1,1
1,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0050904,0.095051,0.1102,1,1
1,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,6.4341e-05,0.095033,0.11688,1,1
1,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.0016575,0.094481,0.10722,1,1
1,GO CELLULAR RESPONSE TO HEAT,0.004964,0.094432,0.11549,1,1
1,GO PEPTIDE METABOLIC PROCESS,0.001442,0.09431,0.090255,1,1
1,GO NEGATIVE REGULATION OF GROWTH,0.0020929,0.094199,0.12601,1,1
1,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00049802,0.09399,0.10143,1,1
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0042095,0.093263,0.09521,1,1
1,GO MUSCLE SYSTEM PROCESS,0.036048,0.091856,0.093396,1,1
1,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00036686,0.09146,0.11657,1,1
1,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0030038,0.090949,0.08845,1,1
1,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0021798,0.090621,0.12257,1,1
1,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.053071,0.090088,0.079601,1,1
1,GO RNA MODIFICATION,0.013546,0.089833,0.10019,1,1
1,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.033608,0.089332,0.086528,1,1
1,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.003166,0.089036,0.11136,1,1
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.037139,0.087666,0.16515,1,1
1,GO CELLULAR COMPONENT DISASSEMBLY,0.00026024,0.087626,0.096159,1,1
1,GO LACTATION,0.03902,0.0876,0.10449,1,1
1,GO MACROMOLECULE CATABOLIC PROCESS,6.5837e-06,0.087489,0.11894,1,1
1,GO TEMPERATURE HOMEOSTASIS,0.054582,0.087392,0.082879,1,1
1,GO NCRNA PROCESSING,0.044722,0.087071,0.090639,1,1
1,GO RESPONSE TO TEMPERATURE STIMULUS,0.012367,0.087067,0.091664,1,1
1,GO REGULATION OF CELLULAR COMPONENT SIZE,0.012945,0.087035,0.090617,1,1
1,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00032916,0.086648,0.10426,1,1
1,GO REGULATION OF ATP METABOLIC PROCESS,0.040582,0.086579,0.073111,1,1
1,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0043184,0.086488,0.10839,1,1
1,GO REGULATION OF SENSORY PERCEPTION,0.022686,0.086425,0.084481,1,1
1,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.00014362,0.085899,0.10165,1,1
1,GO PROTEIN TETRAMERIZATION,0.0018256,0.085308,0.10634,1,1
1,GO POSTREPLICATION REPAIR,0.032278,0.085072,0.057463,1,1
1,GO POSITIVE REGULATION OF TRANSPORT,0.046921,0.085049,0.078669,1,1
1,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.014494,0.084141,0.10781,1,1
1,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.00016629,0.083944,0.10285,1,1
1,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.00054518,0.08044,0.10156,1,1
1,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.03006,0.080389,0.088722,1,1
1,GO NEGATIVE REGULATION OF TRANSPORT,0.006444,0.079945,0.090944,1,1
1,GO RNA CATABOLIC PROCESS,0.0081133,0.079154,0.088978,1,1
1,GO REGULATION OF ERAD PATHWAY,0.0010259,0.079067,0.13927,1,1
1,GO CYTOSKELETON ORGANIZATION,0.016752,0.078314,0.084658,1,1
1,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.033271,0.078029,0.098448,1,1
1,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.02915,0.077539,0.081989,1,1
1,GO HYPEROSMOTIC RESPONSE,0.026838,0.077136,0.10482,1,1
1,GO REGULATION OF DNA CATABOLIC PROCESS,0.037509,0.075794,0.091205,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.03068,0.075613,0.070466,1,1
1,GO ESTABLISHMENT OF RNA LOCALIZATION,0.033948,0.07455,0.081042,1,1
1,GO SULFATE TRANSPORT,0.028852,0.074455,0.07826,1,1
1,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0016575,0.074108,0.090936,1,1
1,GO REGULATION OF MITOTIC CELL CYCLE,0.012227,0.073759,0.064865,1,1
1,GO CELL CYCLE PHASE TRANSITION,0.024428,0.073003,0.058542,1,1
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.0078263,0.071005,0.070446,1,1
1,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.012798,0.066101,0.084664,1,1
1,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.017699,0.060814,0.10685,1,1
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.010645,0.060771,0.066583,1,1
1,GO MITOTIC CELL CYCLE,0.056652,0.060694,0.049342,1,1
1,GO REGULATION OF CELL CYCLE PROCESS,0.043866,0.060511,0.05012,1,1
1,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.015329,0.060441,0.10987,1,1
1,GO REGULATION OF CELL CYCLE,0.028264,0.059944,0.049158,1,1
1,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.017315,0.059592,0.083323,1,1
1,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0078263,0.057242,0.091669,1,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.016752,0.053135,0.093418,1,1
1,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.047827,0.052149,0.066199,1,1
1,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.017315,0.048522,0.054929,1,1
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.043025,0.047312,0.066367,1,1
1,GO PROTEIN TARGETING,0.016027,0.045624,0.072565,1,1
1,GO INTRACELLULAR TRANSPORT,0.017506,0.041724,0.061346,1,1
1,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.044292,0.040076,0.066968,1,1
1,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,2.4371e-06,0.51686,0.42919,1,0
1,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.969e-07,0.49012,0.47625,1,0
1,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.00044781,0.44569,0.3645,1,0
1,GO NOTOCHORD DEVELOPMENT,9.8716e-08,0.40074,0.50963,1,0
1,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,2.3239e-05,0.40036,0.38183,1,0
1,GO REGULATION OF MONOCYTE CHEMOTAXIS,3.3435e-06,0.37287,0.36015,1,0
1,GO MATURE B CELL DIFFERENTIATION,1.1806e-05,0.35993,0.37626,1,0
1,GO ETHANOL METABOLIC PROCESS,0.00048316,0.35468,0.30392,1,0
1,GO MEMBRANE LIPID CATABOLIC PROCESS,2.6914e-06,0.35191,0.30433,1,0
1,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.00054518,0.34958,0.36356,1,0
1,GO EOSINOPHIL MIGRATION,6.8888e-05,0.34217,0.35082,1,0
1,GO REGULATION OF PLATELET AGGREGATION,0.0034692,0.33549,0.28097,1,0
1,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0037985,0.33364,0.3392,1,0
1,GO RENAL ABSORPTION,0.020166,0.31755,0.23252,1,0
1,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00020178,0.30835,0.36542,1,0
1,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.036409,0.30475,0.2967,1,0
1,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00045468,0.30423,0.27193,1,0
1,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.00026024,0.29988,0.24831,1,0
1,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,5.7059e-05,0.29924,0.30597,1,0
1,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00012594,0.29117,0.33806,1,0
1,GO SUPEROXIDE ANION GENERATION,2.1621e-05,0.29069,0.30425,1,0
1,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.00032916,0.28671,0.2775,1,0
1,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.00054518,0.28589,0.33364,1,0
1,GO BLOOD VESSEL REMODELING,6.337e-06,0.28429,0.30029,1,0
1,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,1.7071e-05,0.28332,0.37394,1,0
1,GO EOSINOPHIL CHEMOTAXIS,0.001071,0.28084,0.32401,1,0
1,GO NEGATIVE REGULATION OF BONE REMODELING,0.00090088,0.27976,0.28295,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,2.3661e-05,0.27739,0.27975,1,0
1,GO PROTEIN DEMANNOSYLATION,4.2487e-05,0.27429,0.26428,1,0
1,GO RESPIRATORY BURST,0.001776,0.27344,0.19529,1,0
1,GO ACTIN FILAMENT SEVERING,0.0013069,0.27215,0.26795,1,0
1,GO AMINO SUGAR CATABOLIC PROCESS,2.7078e-07,0.27196,0.29138,1,0
1,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.00030928,0.26989,0.29096,1,0
1,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0015463,0.26985,0.21738,1,0
1,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.0037498,0.26791,0.22366,1,0
1,GO MESODERMAL CELL DIFFERENTIATION,4.5684e-06,0.26768,0.24625,1,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,1.1316e-06,0.26691,0.36715,1,0
1,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0039481,0.26593,0.32651,1,0
1,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.00014362,0.26498,0.24907,1,0
1,GO CYCLOOXYGENASE PATHWAY,0.027118,0.26274,0.22279,1,0
1,GO EPITHELIAL CELL CELL ADHESION,0.0095807,0.26191,0.31557,1,0
1,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,7.0072e-05,0.25957,0.22947,1,0
1,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.0033799,0.258,0.27134,1,0
1,GO FIBROBLAST APOPTOTIC PROCESS,0.00027284,0.25561,0.24803,1,0
1,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.00033432,0.25546,0.30399,1,0
1,GO MICROVILLUS ASSEMBLY,0.0027381,0.25485,0.21838,1,0
1,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,1.1375e-05,0.25421,0.27436,1,0
1,GO URETER DEVELOPMENT,0.00017457,0.25372,0.2483,1,0
1,GO HEPATOCYTE APOPTOTIC PROCESS,0.023919,0.25287,0.23527,1,0
1,GO ADHESION OF SYMBIONT TO HOST,0.002702,0.25064,0.25323,1,0
1,GO REGULATION OF KIDNEY DEVELOPMENT,9.4341e-06,0.25055,0.26955,1,0
1,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.011151,0.24982,0.21966,1,0
1,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.0045438,0.24861,0.28425,1,0
1,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0012005,0.2458,0.33004,1,0
1,GO MYELIN MAINTENANCE,0.016938,0.24267,0.21228,1,0
1,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00010323,0.24254,0.24882,1,0
1,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.0014624,0.24244,0.27225,1,0
1,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,9.6562e-05,0.24103,0.24726,1,0
1,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.0023009,0.23932,0.2076,1,0
1,GO MYOBLAST MIGRATION,0.00072342,0.23555,0.34677,1,0
1,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,5.9056e-05,0.23525,0.28399,1,0
1,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.016386,0.23445,0.17722,1,0
1,GO LEFT RIGHT AXIS SPECIFICATION,0.0025961,0.23445,0.27907,1,0
1,GO REGULATION OF B CELL DIFFERENTIATION,0.001071,0.23379,0.24922,1,0
1,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,1.5576e-05,0.23345,0.27365,1,0
1,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.0044298,0.2329,0.26913,1,0
1,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,9.03e-05,0.23192,0.22921,1,0
1,GO ISOPRENOID METABOLIC PROCESS,0.00021511,0.23126,0.16359,1,0
1,GO BARBED END ACTIN FILAMENT CAPPING,0.0029645,0.22997,0.20509,1,0
1,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,5.9834e-06,0.22981,0.22005,1,0
1,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.042609,0.22943,0.16247,1,0
1,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.043025,0.22812,0.19365,1,0
1,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.002702,0.22751,0.20146,1,0
1,GO RETINOL METABOLIC PROCESS,4.4771e-05,0.22749,0.2129,1,0
1,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,6.8888e-05,0.22493,0.30472,1,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0031247,0.22488,0.25332,1,0
1,GO POSITIVE REGULATION OF TISSUE REMODELING,2.3239e-05,0.22267,0.25144,1,0
1,GO NEUROBLAST DIVISION,0.008211,0.21887,0.20347,1,0
1,GO STEROL HOMEOSTASIS,0.00010852,0.21838,0.23401,1,0
1,GO PRIMARY ALCOHOL METABOLIC PROCESS,7.5001e-05,0.2177,0.20053,1,0
1,GO RESPONSE TO ACIDIC PH,0.033608,0.21713,0.13191,1,0
1,GO BILE ACID AND BILE SALT TRANSPORT,0.0096941,0.21649,0.15615,1,0
1,GO CELLULAR RESPONSE TO VITAMIN D,0.031953,0.21501,0.19611,1,0
1,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0070192,0.21478,0.17808,1,0
1,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00049802,0.21361,0.18451,1,0
1,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.022209,0.21315,0.14454,1,0
1,GO GLIAL CELL APOPTOTIC PROCESS,8.4424e-05,0.21314,0.36477,1,0
1,GO EMBRYONIC PLACENTA DEVELOPMENT,0.0052854,0.21313,0.16572,1,0
1,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.0085105,0.21308,0.16345,1,0
1,GO ICOSANOID METABOLIC PROCESS,0.002702,0.21215,0.17654,1,0
1,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0005133,0.2118,0.30394,1,0
1,GO B CELL HOMEOSTASIS,0.0022396,0.21142,0.21659,1,0
1,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,4.3997e-05,0.21116,0.24697,1,0
1,GO AXIS ELONGATION,0.00098255,0.21055,0.25927,1,0
1,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.011151,0.20997,0.1485,1,0
1,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00015583,0.20956,0.204,1,0
1,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,7.7586e-05,0.20899,0.22438,1,0
1,GO REGULATION OF TISSUE REMODELING,0.00057029,0.20841,0.20993,1,0
1,GO BONE RESORPTION,0.00021511,0.20817,0.23405,1,0
1,GO PROTEIN HYDROXYLATION,0.0033361,0.20767,0.25001,1,0
1,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.00010852,0.20708,0.22545,1,0
1,GO REGULATION OF ANOIKIS,0.01251,0.2069,0.18995,1,0
1,GO POSITIVE REGULATION OF T CELL MIGRATION,2.8814e-05,0.20583,0.23038,1,0
1,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0077327,0.2058,0.15157,1,0
1,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.0015038,0.20457,0.23887,1,0
1,GO B CELL PROLIFERATION,0.0018508,0.2033,0.20495,1,0
1,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0016806,0.20249,0.20489,1,0
1,GO CELLULAR RESPONSE TO IONIZING RADIATION,6.7105e-06,0.19864,0.22774,1,0
1,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.0024609,0.19803,0.26543,1,0
1,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0085105,0.19722,0.26032,1,0
1,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00026024,0.19587,0.2013,1,0
1,GO RESPONSE TO INTERLEUKIN 6,0.00041488,0.19566,0.18444,1,0
1,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.02128,0.19559,0.14833,1,0
1,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.00053704,0.19521,0.2526,1,0
1,GO NEGATIVE REGULATION OF ANOIKIS,0.03429,0.19502,0.19729,1,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00049053,0.19418,0.18865,1,0
1,GO MORPHOGENESIS OF AN EPITHELIUM,7.105e-06,0.19397,0.18694,1,0
1,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.00011596,0.19391,0.18842,1,0
1,GO IMMUNOLOGICAL MEMORY PROCESS,0.057711,0.19281,0.15048,1,0
1,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.0092477,0.1916,0.14102,1,0
1,GO REGULATION OF B CELL PROLIFERATION,0.0047798,0.19133,0.19936,1,0
1,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,3.1494e-05,0.19086,0.18671,1,0
1,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.022928,0.18931,0.18214,1,0
1,GO PROSTATE GLAND GROWTH,0.043025,0.18912,0.27289,1,0
1,GO INTRACELLULAR MRNA LOCALIZATION,4.2487e-05,0.18866,0.26008,1,0
1,GO REGULATION OF NEUTROPHIL MIGRATION,0.001071,0.18815,0.20483,1,0
1,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.0043737,0.18801,0.2358,1,0
1,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0026663,0.18753,0.19793,1,0
1,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.001704,0.18686,0.19679,1,0
1,GO CELLULAR RESPONSE TO CADMIUM ION,0.046031,0.1851,0.13869,1,0
1,GO HISTAMINE SECRETION,0.043444,0.18503,0.17674,1,0
1,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0012005,0.18466,0.18113,1,0
1,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,1.8032e-05,0.18434,0.19534,1,0
1,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.5865e-05,0.18386,0.19625,1,0
1,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00048316,0.18243,0.21164,1,0
1,GO EPITHELIAL CELL DEVELOPMENT,0.00016098,0.18197,0.19936,1,0
1,GO NUCLEOTIDE SALVAGE,0.016027,0.18141,0.18548,1,0
1,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.011949,0.18028,0.17661,1,0
1,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0092477,0.18023,0.1601,1,0
1,GO POSITIVE REGULATION OF BONE RESORPTION,0.0077327,0.18019,0.20815,1,0
1,GO GAS TRANSPORT,0.018898,0.17992,0.16001,1,0
1,GO KERATINOCYTE DIFFERENTIATION,0.0071051,0.17959,0.19355,1,0
1,GO RESPONSE TO PH,0.00071283,0.17907,0.17079,1,0
1,GO REGULATION OF EMBRYONIC DEVELOPMENT,7.7586e-05,0.17814,0.18451,1,0
1,GO ENGULFMENT OF APOPTOTIC CELL,0.0023321,0.1781,0.18157,1,0
1,GO PARAXIAL MESODERM MORPHOGENESIS,0.01849,0.1778,0.235,1,0
1,GO B CELL DIFFERENTIATION,3.6924e-05,0.17769,0.22316,1,0
1,GO SPHINGOMYELIN METABOLIC PROCESS,0.020385,0.17751,0.13694,1,0
1,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00013673,0.17691,0.17222,1,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.057179,0.17608,0.17032,1,0
1,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.0015463,0.17494,0.15219,1,0
1,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00038422,0.17465,0.18429,1,0
1,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.049212,0.17461,0.24453,1,0
1,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0065235,0.17447,0.25329,1,0
1,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00036124,0.17332,0.20703,1,0
1,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.011022,0.17305,0.16239,1,0
1,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0043184,0.17128,0.24564,1,0
1,GO POST GOLGI VESICLE MEDIATED TRANSPORT,2.971e-06,0.16866,0.20567,1,0
1,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.00046872,0.16843,0.19535,1,0
1,GO GLUCOCORTICOID METABOLIC PROCESS,0.0025277,0.16779,0.17105,1,0
1,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.0024609,0.16751,0.18736,1,0
1,GO FATTY ACID BIOSYNTHETIC PROCESS,0.00035024,0.16749,0.15349,1,0
1,GO RESPONSE TO CADMIUM ION,0.016205,0.16696,0.12641,1,0
1,GO PROGESTERONE METABOLIC PROCESS,0.019735,0.16683,0.15709,1,0
1,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.0104,0.16646,0.20169,1,0
1,GO ENDOCRINE PROCESS,0.00019541,0.16591,0.18813,1,0
1,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.014013,0.16498,0.14573,1,0
1,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00045468,0.16477,0.17902,1,0
1,GO SKIN DEVELOPMENT,0.0087156,0.16405,0.16912,1,0
1,GO L ASCORBIC ACID METABOLIC PROCESS,0.0042636,0.16301,0.21437,1,0
1,GO FIBROBLAST ACTIVATION,0.00039622,0.16286,0.25508,1,0
1,GO CARDIOLIPIN METABOLIC PROCESS,0.038637,0.16193,0.074446,1,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0034243,0.16178,0.16574,1,0
1,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.0035605,0.16093,0.1556,1,0
1,GO REGULATION OF HAIR CYCLE,0.00099681,0.16003,0.21132,1,0
1,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0012886,0.15905,0.1772,1,0
1,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.00012186,0.15889,0.18343,1,0
1,GO FATTY ACID DERIVATIVE TRANSPORT,0.045591,0.1587,0.099073,1,0
1,GO SKIN EPIDERMIS DEVELOPMENT,0.017506,0.15709,0.14974,1,0
1,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.0019023,0.15658,0.17045,1,0
1,GO XENOBIOTIC TRANSPORT,0.00033432,0.15615,0.18641,1,0
1,GO CELLULAR PIGMENTATION,4.3997e-05,0.15614,0.18196,1,0
1,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0098086,0.15454,0.11878,1,0
1,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.01499,0.15422,0.13447,1,0
1,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.010769,0.15399,0.1532,1,0
1,GO MAST CELL MEDIATED IMMUNITY,0.043866,0.15388,0.14673,1,0
1,GO O GLYCAN PROCESSING,0.031953,0.15271,0.12928,1,0
1,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.0049019,0.15263,0.16699,1,0
1,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.026286,0.15224,0.22735,1,0
1,GO REGULATION OF BONE REMODELING,0.01016,0.15157,0.17292,1,0
1,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0056958,0.15155,0.12471,1,0
1,GO NEGATIVE REGULATION OF AUTOPHAGY,0.0001803,0.1514,0.15541,1,0
1,GO VACUOLAR ACIDIFICATION,0.0012177,0.15062,0.14102,1,0
1,GO AUTOPHAGOSOME ORGANIZATION,5.0323e-06,0.14885,0.18806,1,0
1,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.001235,0.14859,0.17253,1,0
1,GO EPIDERMIS DEVELOPMENT,0.01499,0.14833,0.15105,1,0
1,GO ATRIAL SEPTUM MORPHOGENESIS,0.02521,0.14803,0.19289,1,0
1,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0047798,0.14796,0.14219,1,0
1,GO REGULATORY T CELL DIFFERENTIATION,0.03429,0.14765,0.16299,1,0
1,GO REGULATION OF LIPID METABOLIC PROCESS,3.9613e-05,0.1476,0.16744,1,0
1,GO MEMBRANE BIOGENESIS,0.010645,0.1474,0.15983,1,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.002702,0.14626,0.16213,1,0
1,GO NEURAL TUBE PATTERNING,0.0020929,0.14621,0.17659,1,0
1,GO EPITHELIAL TUBE MORPHOGENESIS,0.00090088,0.14615,0.1493,1,0
1,GO EPITHELIAL CELL DIFFERENTIATION,0.01128,0.14554,0.13443,1,0
1,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.032938,0.14536,0.15856,1,0
1,GO TRANSCYTOSIS,0.0022701,0.14502,0.18368,1,0
1,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.034636,0.14446,0.12749,1,0
1,GO ER NUCLEUS SIGNALING PATHWAY,0.0137,0.14443,0.11555,1,0
1,GO PROTEIN N LINKED GLYCOSYLATION,4.5684e-06,0.14428,0.18677,1,0
1,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.01128,0.14426,0.16961,1,0
1,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.001118,0.14381,0.16121,1,0
1,GO LYTIC VACUOLE ORGANIZATION,0.00086244,0.14364,0.14017,1,0
1,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.011949,0.14316,0.21511,1,0
1,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0018006,0.14284,0.14602,1,0
1,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.0056255,0.14232,0.18542,1,0
1,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0059852,0.14194,0.19931,1,0
1,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0065235,0.14186,0.18917,1,0
1,GO PHOSPHOLIPID TRANSPORT,0.023668,0.14163,0.12608,1,0
1,GO NEPHRON EPITHELIUM DEVELOPMENT,0.03068,0.14159,0.13525,1,0
1,GO HISTONE H4 DEACETYLATION,0.040582,0.1413,0.14751,1,0
1,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.016205,0.14116,0.12573,1,0
1,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.017125,0.14115,0.13635,1,0
1,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0087156,0.1411,0.15772,1,0
1,GO CARDIAC ATRIUM MORPHOGENESIS,0.037882,0.14068,0.13477,1,0
1,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.029754,0.13978,0.11537,1,0
1,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.0020092,0.13922,0.15357,1,0
1,GO LIPID LOCALIZATION,0.00021857,0.13874,0.1547,1,0
1,GO FATTY ACID METABOLIC PROCESS,6.545e-05,0.13853,0.15059,1,0
1,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.0037498,0.138,0.15785,1,0
1,GO EPITHELIUM DEVELOPMENT,0.001955,0.13788,0.13436,1,0
1,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.0046604,0.13774,0.1486,1,0
1,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.01829,0.13767,0.14009,1,0
1,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.033608,0.13709,0.12675,1,0
1,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0051547,0.13695,0.23044,1,0
1,GO MAST CELL ACTIVATION,0.059331,0.13689,0.12683,1,0
1,GO PROTEIN O LINKED GLYCOSYLATION,0.033271,0.13677,0.099959,1,0
1,GO MITOCHONDRIAL DEPOLARIZATION,0.0075485,0.13517,0.16681,1,0
1,GO REGULATION OF RENAL SYSTEM PROCESS,0.013093,0.13373,0.16181,1,0
1,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0025277,0.13358,0.12709,1,0
1,GO BROWN FAT CELL DIFFERENTIATION,0.03068,0.13283,0.11729,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.002702,0.13241,0.15834,1,0
1,GO BONE CELL DEVELOPMENT,0.019523,0.13174,0.17578,1,0
1,GO POSITIVE REGULATION OF CELL DIVISION,0.0042095,0.13053,0.13484,1,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.020828,0.1303,0.16158,1,0
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.018693,0.12855,0.14933,1,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.02174,0.12853,0.11663,1,0
1,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0019023,0.12827,0.13256,1,0
1,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,2.2015e-05,0.12786,0.16572,1,0
1,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.024173,0.12764,0.14066,1,0
1,GO EPITHELIAL TUBE FORMATION,0.0083098,0.12729,0.12488,1,0
1,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.028852,0.12676,0.14535,1,0
1,GO NADP METABOLIC PROCESS,0.017699,0.12647,0.11963,1,0
1,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.0059116,0.12629,0.11154,1,0
1,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.012798,0.12606,0.16399,1,0
1,GO RENAL TUBULE DEVELOPMENT,0.047372,0.12561,0.13482,1,0
1,GO GLIAL CELL PROLIFERATION,0.033948,0.12545,0.13457,1,0
1,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00046165,0.12539,0.16146,1,0
1,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.001071,0.12515,0.13455,1,0
1,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.040582,0.1248,0.11023,1,0
1,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.0037016,0.12437,0.17228,1,0
1,GO TUBE FORMATION,0.0062108,0.12423,0.12548,1,0
1,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0095807,0.12413,0.18439,1,0
1,GO MOLTING CYCLE,0.01995,0.12399,0.13234,1,0
1,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.0010113,0.1236,0.1094,1,0
1,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0022396,0.12356,0.13839,1,0
1,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0040509,0.12349,0.13733,1,0
1,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.023919,0.12285,0.1697,1,0
1,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.001568,0.12269,0.15186,1,0
1,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.01585,0.1223,0.1581,1,0
1,GO PROSTAGLANDIN TRANSPORT,0.036048,0.12175,0.12784,1,0
1,GO MALE SEX DIFFERENTIATION,0.0070192,0.12173,0.12369,1,0
1,GO REGULATION OF FATTY ACID BETA OXIDATION,0.0052854,0.12153,0.14542,1,0
1,GO EPIDERMAL CELL DIFFERENTIATION,0.054582,0.12144,0.13471,1,0
1,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0039481,0.12131,0.15606,1,0
1,GO GOLGI TO ENDOSOME TRANSPORT,0.0040509,0.12038,0.16563,1,0
1,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0053519,0.12037,0.19028,1,0
1,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.015501,0.12028,0.12188,1,0
1,GO PROTEOLYSIS,8.4262e-06,0.12023,0.1375,1,0
1,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00031414,0.12016,0.10609,1,0
1,GO INTERMEDIATE FILAMENT ORGANIZATION,0.034984,0.12015,0.13613,1,0
1,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.056128,0.11892,0.14642,1,0
1,GO RESPONSE TO DRUG,0.00029052,0.11862,0.14958,1,0
1,GO REGULATION OF T CELL MIGRATION,0.001568,0.11855,0.17424,1,0
1,GO MYELIN ASSEMBLY,0.010041,0.11847,0.18603,1,0
1,GO ACTIVATION OF MAPK ACTIVITY,0.00054518,0.11846,0.15454,1,0
1,GO MONOCARBOXYLIC ACID TRANSPORT,0.0049019,0.1177,0.1161,1,0
1,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.024687,0.11726,0.14039,1,0
1,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.025743,0.11702,0.11027,1,0
1,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.02915,0.11672,0.1319,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0003557,0.11626,0.1473,1,0
1,GO APICAL JUNCTION ASSEMBLY,0.024947,0.11539,0.15146,1,0
1,GO PROSTAGLANDIN SECRETION,0.007921,0.11487,0.15303,1,0
1,GO RESPONSE TO GONADOTROPIN,0.022209,0.11476,0.14289,1,0
1,GO REGULATION OF GTPASE ACTIVITY,0.022209,0.11474,0.1015,1,0
1,GO LIPID METABOLIC PROCESS,0.00048316,0.1147,0.123,1,0
1,GO SEQUESTERING OF CALCIUM ION,0.003166,0.11447,0.13,1,0
1,GO NEURON PROJECTION REGENERATION,0.040187,0.11355,0.12104,1,0
1,GO REGULATION OF CATABOLIC PROCESS,5.332e-06,0.11256,0.12984,1,0
1,GO RESPONSE TO IRON ION,0.043025,0.11212,0.10839,1,0
1,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.047827,0.11177,0.10139,1,0
1,GO GLYCOPROTEIN METABOLIC PROCESS,0.00046872,0.1116,0.13542,1,0
1,GO CELLULAR LIPID METABOLIC PROCESS,0.00087508,0.11157,0.11882,1,0
1,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00063314,0.1112,0.13766,1,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.027686,0.10961,0.090526,1,0
1,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.040582,0.10941,0.16315,1,0
1,GO ERYTHROCYTE DEVELOPMENT,0.0071918,0.10933,0.14406,1,0
1,GO IMPORT INTO NUCLEUS,0.0052197,0.1087,0.099097,1,0
1,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.0023637,0.10708,0.1044,1,0
1,GO B CELL APOPTOTIC PROCESS,0.0062108,0.10693,0.17794,1,0
1,GO REGULATION OF TRANSFERASE ACTIVITY,0.00021857,0.10651,0.12224,1,0
1,GO SULFUR COMPOUND TRANSPORT,0.00073415,0.10626,0.13713,1,0
1,GO MULTIVESICULAR BODY ORGANIZATION,0.007921,0.10517,0.10826,1,0
1,GO LIPID EXPORT FROM CELL,0.053071,0.10476,0.10568,1,0
1,GO ACTIVATION OF GTPASE ACTIVITY,0.034636,0.10465,0.10062,1,0
1,GO GLYCEROLIPID METABOLIC PROCESS,0.0030038,0.10456,0.09949,1,0
1,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.03902,0.10452,0.10979,1,0
1,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.0024609,0.10449,0.11139,1,0
1,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.030368,0.10406,0.16568,1,0
1,GO MUSCLE CELL APOPTOTIC PROCESS,0.010769,0.10307,0.11916,1,0
1,GO EMBRYONIC DIGIT MORPHOGENESIS,0.022686,0.10303,0.11357,1,0
1,GO EMBRYONIC HEMOPOIESIS,0.046474,0.10297,0.128,1,0
1,GO MIDBODY ABSCISSION,0.0052197,0.10248,0.16001,1,0
1,GO NON CANONICAL WNT SIGNALING PATHWAY,0.0010408,0.1021,0.12391,1,0
1,GO SECRETION,0.0039992,0.10203,0.11132,1,0
1,GO GLIAL CELL DEVELOPMENT,0.015329,0.10197,0.12491,1,0
1,GO PHOSPHOLIPID METABOLIC PROCESS,0.0023321,0.10189,0.10525,1,0
1,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.032938,0.10178,0.10706,1,0
1,GO RESPONSE TO INORGANIC SUBSTANCE,0.054074,0.10083,0.075821,1,0
1,GO PROTEIN IMPORT,0.00065224,0.10036,0.11633,1,0
1,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.023173,0.10021,0.15799,1,0
1,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.040187,0.099538,0.1006,1,0
1,GO APPENDAGE DEVELOPMENT,0.03006,0.098867,0.1123,1,0
1,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.055093,0.098841,0.11978,1,0
1,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.015674,0.09859,0.10031,1,0
1,GO SMALL MOLECULE CATABOLIC PROCESS,0.00042777,0.098429,0.11929,1,0
1,GO REGULATION OF PROTEIN STABILITY,0.00018923,0.09824,0.11699,1,0
1,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0054192,0.098098,0.10307,1,0
1,GO REGULATION OF STEROID METABOLIC PROCESS,0.011949,0.098096,0.11728,1,0
1,GO CELLULAR RESPONSE TO RADIATION,0.000286,0.097905,0.12546,1,0
1,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.00083767,0.097287,0.10412,1,0
1,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0099244,0.096882,0.12541,1,0
1,GO MAINTENANCE OF CELL NUMBER,0.025475,0.096712,0.11316,1,0
1,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00032408,0.096474,0.1145,1,0
1,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.048746,0.095923,0.097885,1,0
1,GO APPENDAGE MORPHOGENESIS,0.054582,0.095473,0.10383,1,0
1,GO VESICLE ORGANIZATION,0.0032078,0.09541,0.10512,1,0
1,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.0025277,0.095118,0.085168,1,0
1,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,7.6283e-05,0.094131,0.13014,1,0
1,GO ATP BIOSYNTHETIC PROCESS,0.017894,0.093817,0.11524,1,0
1,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.020605,0.093648,0.11643,1,0
1,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0068504,0.093425,0.15704,1,0
1,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.0005618,0.092981,0.14055,1,0
1,GO ORGANIC ACID METABOLIC PROCESS,6.6578e-05,0.092641,0.12376,1,0
1,GO GOLGI RIBBON FORMATION,0.01849,0.092506,0.14766,1,0
1,GO ALCOHOL METABOLIC PROCESS,0.0020646,0.092234,0.10959,1,0
1,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0011668,0.091683,0.11352,1,0
1,GO RRNA METHYLATION,0.058247,0.09166,0.09316,1,0
1,GO REGULATION OF FATTY ACID TRANSPORT,0.038258,0.091264,0.14798,1,0
1,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0032078,0.091235,0.094591,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.026013,0.090713,0.10017,1,0
1,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.019312,0.090238,0.088953,1,0
1,GO GLAND DEVELOPMENT,0.012945,0.088874,0.11393,1,0
1,GO GOLGI ORGANIZATION,0.001483,0.088676,0.12194,1,0
1,GO MULTIVESICULAR BODY SORTING PATHWAY,0.0046604,0.088612,0.11382,1,0
1,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.0077327,0.088509,0.085858,1,0
1,GO CELL CYCLE G1 S PHASE TRANSITION,0.01499,0.088246,0.084194,1,0
1,GO TRANSITION METAL ION TRANSPORT,0.0014624,0.088236,0.097185,1,0
1,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0048405,0.088051,0.1064,1,0
1,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.0020929,0.087842,0.10147,1,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.00028155,0.087652,0.12196,1,0
1,GO IN UTERO EMBRYONIC DEVELOPMENT,0.00088789,0.087576,0.11279,1,0
1,GO DISACCHARIDE METABOLIC PROCESS,0.039406,0.08735,0.13802,1,0
1,GO EMBRYONIC ORGAN DEVELOPMENT,0.014172,0.087158,0.097944,1,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS,0.019523,0.087014,0.1468,1,0
1,GO ECTODERM DEVELOPMENT,0.0050904,0.086313,0.12558,1,0
1,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.021053,0.086237,0.094974,1,0
1,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.014823,0.08573,0.086202,1,0
1,GO MUSCLE FIBER DEVELOPMENT,0.016205,0.085682,0.10181,1,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.016752,0.085184,0.10758,1,0
1,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.0044864,0.084996,0.10574,1,0
1,GO ADAPTIVE THERMOGENESIS,0.035336,0.083232,0.090566,1,0
1,GO REGULATION OF INTRACELLULAR TRANSPORT,0.00043435,0.08263,0.11079,1,0
1,GO REGULATION OF HISTONE DEACETYLATION,0.040582,0.082083,0.10835,1,0
1,GO GROWTH,0.011949,0.081989,0.094912,1,0
1,GO NEGATIVE REGULATION OF BINDING,0.00058763,0.081365,0.12227,1,0
1,GO ENDOSOMAL TRANSPORT,0.001442,0.080957,0.10162,1,0
1,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0050904,0.080359,0.11418,1,0
1,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0030038,0.079726,0.096348,1,0
1,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.0062877,0.079663,0.11628,1,0
1,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.014658,0.079115,0.093202,1,0
1,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.010522,0.078792,0.1392,1,0
1,GO REGULATION OF GROWTH,0.020828,0.078643,0.085566,1,0
1,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.026838,0.078597,0.14746,1,0
1,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.0067673,0.078328,0.13294,1,0
1,GO LYSOSOME LOCALIZATION,0.036409,0.078254,0.10261,1,0
1,GO STEROID METABOLIC PROCESS,0.0055559,0.077803,0.10841,1,0
1,GO OXIDATION REDUCTION PROCESS,0.00095459,0.077477,0.10078,1,0
1,GO RESPONSE TO INSULIN,0.01016,0.077438,0.099422,1,0
1,GO THIOESTER METABOLIC PROCESS,0.0046604,0.07667,0.12548,1,0
1,GO LEFT RIGHT PATTERN FORMATION,0.02915,0.076289,0.15905,1,0
1,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.019104,0.075259,0.073145,1,0
1,GO METAL ION HOMEOSTASIS,0.016752,0.07497,0.087185,1,0
1,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.040187,0.074959,0.10614,1,0
1,GO NEGATIVE REGULATION OF CELL GROWTH,0.01585,0.074926,0.10753,1,0
1,GO NUCLEAR TRANSPORT,0.021973,0.074839,0.072084,1,0
1,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.00092737,0.074494,0.099442,1,0
1,GO SPECIFICATION OF SYMMETRY,0.051111,0.073645,0.07096,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION,0.046031,0.073598,0.067909,1,0
1,GO CELLULAR AMIDE METABOLIC PROCESS,0.00071283,0.073009,0.091654,1,0
1,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.024947,0.072566,0.088152,1,0
1,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.0013443,0.07228,0.13074,1,0
1,GO REGULATION OF CELL DIVISION,0.030994,0.07212,0.080277,1,0
1,GO SPHINGOID METABOLIC PROCESS,0.041383,0.071775,0.10827,1,0
1,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.016386,0.071725,0.077759,1,0
1,GO NUCLEAR EXPORT,0.031311,0.071586,0.077069,1,0
1,GO REGULATION OF DNA RECOMBINATION,0.026838,0.070519,0.095915,1,0
1,GO EMBRYO DEVELOPMENT,0.0094686,0.070076,0.092747,1,0
1,GO RESPONSE TO ACID CHEMICAL,0.013394,0.06933,0.11059,1,0
1,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.014823,0.068822,0.057722,1,0
1,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.055093,0.068792,0.1297,1,0
1,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.026838,0.068278,0.070341,1,0
1,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.028556,0.067554,0.12372,1,0
1,GO MITOPHAGY,0.038637,0.067438,0.11,1,0
1,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.0012177,0.067426,0.10453,1,0
1,GO ENSHEATHMENT OF NEURONS,0.023419,0.067159,0.10488,1,0
1,GO DNA BIOSYNTHETIC PROCESS,0.004156,0.06694,0.080783,1,0
1,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.022686,0.066893,0.06243,1,0
1,GO LIPID BIOSYNTHETIC PROCESS,0.033271,0.066701,0.078738,1,0
1,GO CELLULAR ION HOMEOSTASIS,0.027973,0.0666,0.075349,1,0
1,GO AMIDE BIOSYNTHETIC PROCESS,0.027686,0.066477,0.063098,1,0
1,GO CARBOHYDRATE CATABOLIC PROCESS,0.013093,0.066125,0.095323,1,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.010522,0.065821,0.084577,1,0
1,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.0027747,0.065628,0.10405,1,0
1,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.0026663,0.065281,0.084582,1,0
1,GO AUTOPHAGY OF MITOCHONDRION,0.0086125,0.064722,0.090772,1,0
1,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.039795,0.063837,0.075327,1,0
1,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.023668,0.063359,0.10387,1,0
1,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.0104,0.062633,0.068534,1,0
1,GO PROTEIN SUMOYLATION,0.057179,0.062411,0.074877,1,0
1,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.046921,0.062013,0.075678,1,0
1,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.02945,0.062004,0.10728,1,0
1,GO CELL CYCLE ARREST,0.043866,0.061192,0.059332,1,0
1,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.02915,0.059871,0.069232,1,0
1,GO NON RECOMBINATIONAL REPAIR,0.031311,0.059153,0.067363,1,0
1,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.054582,0.059117,0.077419,1,0
1,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.0068504,0.058759,0.084426,1,0
1,GO HOMEOSTATIC PROCESS,0.013093,0.058118,0.082047,1,0
1,GO REGULATION OF TRANSLATIONAL INITIATION,0.043025,0.055689,0.077448,1,0
1,GO IRON ION TRANSPORT,0.016386,0.055686,0.087791,1,0
1,GO CERAMIDE METABOLIC PROCESS,0.057179,0.054482,0.081212,1,0
1,GO MACROAUTOPHAGY,0.00070238,0.053209,0.10652,1,0
1,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.037882,0.053069,0.075123,1,0
1,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.02945,0.052796,0.15084,1,0
1,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.015501,0.051309,0.087804,1,0
1,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.031311,0.051236,0.079834,1,0
1,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.01829,0.051126,0.074428,1,0
1,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.052083,0.050348,0.060259,1,0
1,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.056652,0.050338,0.065234,1,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.047827,0.050319,0.060697,1,0
1,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.0031247,0.049797,0.078384,1,0
1,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.043444,0.048628,0.1417,1,0
1,GO RESPONSE TO RADIATION,0.046474,0.048589,0.057413,1,0
1,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0039992,0.048469,0.084548,1,0
1,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.050154,0.045822,0.055927,1,0
1,GO CELLULAR HOMEOSTASIS,0.056652,0.045093,0.067382,1,0
1,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.028264,0.042715,0.10271,1,0
1,GO PROTEIN POLYMERIZATION,0.057179,0.042589,0.062984,1,0
1,GO CARBOHYDRATE METABOLIC PROCESS,0.0071918,0.040984,0.092024,1,0
1,GO ION HOMEOSTASIS,0.031953,0.039321,0.080269,1,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.02915,0.038222,0.076305,1,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.042197,0.037381,0.092282,1,0
1,GO PROTEIN LOCALIZATION TO ORGANELLE,0.010645,0.034745,0.064015,1,0
1,GO ORGANELLE DISASSEMBLY,0.033271,0.03088,0.070545,1,0
1,GO CELLULAR MACROMOLECULE LOCALIZATION,0.03006,0.029706,0.057595,1,0
1,GO MONOSACCHARIDE METABOLIC PROCESS,0.03429,0.029501,0.08379,1,0
1,GO REGULATION OF MACROAUTOPHAGY,0.014658,0.018987,0.09534,1,0
1,GO REGULATION OF CALCIUM ION TRANSPORT,0.02915,0.015987,0.091998,1,0
1,GO MESODERMAL CELL FATE SPECIFICATION,0.049212,-0.016077,-0.1928,1,0
1,GO LIMBIC SYSTEM DEVELOPMENT,0.02915,-0.038661,-0.10338,1,0
1,GO PROTEIN ACYLATION,0.0137,-0.04052,-0.052642,1,0
1,GO DNA PACKAGING,0.059331,-0.042256,-0.076652,1,0
1,GO REGULATION OF FEEDING BEHAVIOR,0.049212,-0.04313,-0.10865,1,0
1,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.058787,-0.046799,-0.061378,1,0
1,GO HEAD DEVELOPMENT,0.051595,-0.048735,-0.065045,1,0
1,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.057711,-0.049737,-0.10907,1,0
1,GO PROTEIN ACETYLATION,0.03068,-0.051695,-0.046244,1,0
1,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.052083,-0.057982,-0.071446,1,0
1,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.027686,-0.058768,-0.087361,1,0
1,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.036772,-0.06169,-0.065699,1,0
1,GO NUCLEOSOME ORGANIZATION,0.055093,-0.064748,-0.07839,1,0
1,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.043025,-0.065825,-0.088857,1,0
1,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.027118,-0.065991,-0.069207,1,0
1,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.021973,-0.066002,-0.19095,1,0
1,GO HIPPOCAMPUS DEVELOPMENT,0.0096941,-0.066152,-0.13059,1,0
1,GO HINDBRAIN MORPHOGENESIS,0.054582,-0.067588,-0.070262,1,0
1,GO ALDEHYDE CATABOLIC PROCESS,0.031631,-0.06829,-0.07306,1,0
1,GO PHOTOTRANSDUCTION,0.0071918,-0.068432,-0.090904,1,0
1,GO FOREBRAIN CELL MIGRATION,0.048285,-0.07084,-0.1008,1,0
1,GO PALLIUM DEVELOPMENT,0.0033361,-0.071888,-0.12055,1,0
1,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.01016,-0.075708,-0.099939,1,0
1,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.036772,-0.075905,-0.064358,1,0
1,GO REGULATION OF CELL CYCLE ARREST,0.059879,-0.0765,-0.058597,1,0
1,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.055093,-0.077048,-0.047611,1,0
1,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.049212,-0.079203,-0.068785,1,0
1,GO AXONAL FASCICULATION,0.022928,-0.079249,-0.2194,1,0
1,GO CELL PART MORPHOGENESIS,0.026286,-0.08122,-0.082175,1,0
1,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.049681,-0.082006,-0.09483,1,0
1,GO ATP DEPENDENT CHROMATIN REMODELING,0.014494,-0.0823,-0.1174,1,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.051595,-0.082675,-0.13574,1,0
1,GO CEREBRAL CORTEX DEVELOPMENT,0.0030436,-0.082881,-0.12745,1,0
1,GO TELENCEPHALON DEVELOPMENT,0.01251,-0.083419,-0.09005,1,0
1,GO TRANSPORT ALONG MICROTUBULE,0.046474,-0.08354,-0.059073,1,0
1,GO HISTONE H4 ACETYLATION,0.0094686,-0.083968,-0.080922,1,0
1,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.008211,-0.084165,-0.13021,1,0
1,GO CELL CYCLE DNA REPLICATION,0.040187,-0.084743,-0.1056,1,0
1,GO AXO DENDRITIC TRANSPORT,0.01128,-0.085882,-0.10173,1,0
1,GO ACROSOME ASSEMBLY,0.055609,-0.085904,-0.10606,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.032938,-0.086056,-0.142,1,0
1,GO NEURON DIFFERENTIATION,0.023919,-0.086327,-0.075997,1,0
1,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.004156,-0.086764,-0.10214,1,0
1,GO SENSORY PERCEPTION OF SMELL,0.040582,-0.087533,-0.087498,1,0
1,GO NUCLEOSOME ASSEMBLY,0.039406,-0.08758,-0.10357,1,0
1,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.039795,-0.088771,-0.13239,1,0
1,GO PROTON TRANSMEMBRANE TRANSPORT,0.0084096,-0.089351,-0.076315,1,0
1,GO REGULATION OF HEART RATE,0.050154,-0.089967,-0.088658,1,0
1,GO EPITHELIAL CELL MATURATION,0.021973,-0.090407,-0.17058,1,0
1,GO REGULATION OF CELL MATURATION,0.050154,-0.09069,-0.096142,1,0
1,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.036048,-0.093367,-0.13305,1,0
1,GO REGULATION OF DENDRITE DEVELOPMENT,0.0042636,-0.093625,-0.1165,1,0
1,GO PROTEIN DEMETHYLATION,0.052083,-0.093711,-0.08094,1,0
1,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.055093,-0.095286,-0.12147,1,0
1,GO FOREBRAIN DEVELOPMENT,0.017506,-0.095303,-0.090003,1,0
1,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.0034243,-0.095663,-0.11306,1,0
1,GO ACID SECRETION,0.017506,-0.095734,-0.086447,1,0
1,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.017315,-0.096045,-0.094884,1,0
1,GO REGULATION OF RESPONSE TO FOOD,0.024428,-0.096228,-0.10422,1,0
1,GO DORSAL VENTRAL PATTERN FORMATION,0.037509,-0.096333,-0.076174,1,0
1,GO NEURON PROJECTION ORGANIZATION,0.048285,-0.096671,-0.080844,1,0
1,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.007921,-0.097049,-0.12817,1,0
1,GO RESPONSE TO LEUCINE,0.051595,-0.097226,-0.14525,1,0
1,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.004964,-0.098226,-0.094366,1,0
1,GO NEURON DEVELOPMENT,0.020385,-0.10089,-0.078088,1,0
1,GO REGULATION OF CILIUM ASSEMBLY,0.03902,-0.10106,-0.075681,1,0
1,GO EATING BEHAVIOR,0.022928,-0.10149,-0.078394,1,0
1,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.024428,-0.10346,-0.092806,1,0
1,GO CELL FATE SPECIFICATION,0.021053,-0.10382,-0.14695,1,0
1,GO PROTEIN DEPOLYMERIZATION,0.0070192,-0.1039,-0.086649,1,0
1,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.039795,-0.10412,-0.05763,1,0
1,GO HISTONE METHYLATION,0.014494,-0.10497,-0.081579,1,0
1,GO PEPTIDYL LYSINE METHYLATION,0.021509,-0.106,-0.081353,1,0
1,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.042197,-0.10957,-0.10247,1,0
1,GO DETECTION OF LIGHT STIMULUS,0.00049053,-0.10975,-0.12181,1,0
1,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.030994,-0.11013,-0.2063,1,0
1,GO TELENCEPHALON GLIAL CELL MIGRATION,0.013093,-0.11043,-0.16331,1,0
1,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.046921,-0.11129,-0.059484,1,0
1,GO RESPONSE TO ALKALOID,0.0013826,-0.11187,-0.10525,1,0
1,GO AXONAL TRANSPORT,0.0047198,-0.11266,-0.12097,1,0
1,GO RESPONSE TO NICOTINE,0.036772,-0.11266,-0.1105,1,0
1,GO POSITIVE REGULATION OF HORMONE SECRETION,0.024428,-0.1133,-0.081388,1,0
1,GO REGULATION OF CIRCADIAN RHYTHM,0.0050269,-0.11335,-0.089095,1,0
1,GO NEGATIVE REGULATION OF BEHAVIOR,0.0074579,-0.11385,-0.1813,1,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.013243,-0.11455,-0.091186,1,0
1,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.004156,-0.11506,-0.098212,1,0
1,GO REGULATION OF HISTONE METHYLATION,0.055093,-0.11589,-0.062263,1,0
1,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.057179,-0.11616,-0.12856,1,0
1,GO RESPONSE TO NERVE GROWTH FACTOR,0.035691,-0.11767,-0.090799,1,0
1,GO REGULATION OF MEMBRANE PERMEABILITY,0.05063,-0.11804,-0.073969,1,0
1,GO MATING BEHAVIOR,0.013856,-0.11854,-0.11575,1,0
1,GO AXONEME ASSEMBLY,0.056652,-0.11864,-0.12288,1,0
1,GO HISTONE H4 K16 ACETYLATION,0.0034692,-0.11933,-0.12225,1,0
1,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.0090315,-0.12024,-0.15987,1,0
1,GO MICROTUBULE POLYMERIZATION,0.00034485,-0.12056,-0.13334,1,0
1,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0045438,-0.12097,-0.15953,1,0
1,GO CHROMATIN SILENCING,0.0137,-0.12109,-0.10136,1,0
1,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.021973,-0.12114,-0.13762,1,0
1,GO PROTEIN METHYLATION,0.0070192,-0.12189,-0.084657,1,0
1,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.0104,-0.12283,-0.1295,1,0
1,GO CARDIAC VENTRICLE FORMATION,0.058247,-0.12316,-0.21233,1,0
1,GO DEVELOPMENTAL MATURATION,0.023419,-0.12462,-0.071206,1,0
1,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0027747,-0.12485,-0.13433,1,0
1,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.004156,-0.1249,-0.12714,1,0
1,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.058247,-0.12512,-0.08904,1,0
1,GO ANTEROGRADE AXONAL TRANSPORT,0.0074579,-0.12573,-0.11431,1,0
1,GO RESPONSE TO FOOD,0.010279,-0.12603,-0.098382,1,0
1,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.033271,-0.12605,-0.077392,1,0
1,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.017125,-0.12644,-0.088603,1,0
1,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.019735,-0.12697,-0.097903,1,0
1,GO POSITIVE REGULATION OF RNA SPLICING,0.0005133,-0.1272,-0.11412,1,0
1,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.028264,-0.1273,-0.11074,1,0
1,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.033271,-0.12755,-0.091888,1,0
1,GO POSITIVE REGULATION OF MRNA PROCESSING,1.7071e-05,-0.12844,-0.16008,1,0
1,GO NERVOUS SYSTEM PROCESS,0.0033361,-0.12853,-0.093588,1,0
1,GO DETECTION OF VISIBLE LIGHT,0.00026438,-0.12886,-0.13481,1,0
1,GO EXCITATORY SYNAPSE ASSEMBLY,0.058787,-0.12922,-0.14525,1,0
1,GO COGNITION,0.01499,-0.12993,-0.090704,1,0
1,GO CELLULAR SODIUM ION HOMEOSTASIS,0.055609,-0.13063,-0.10727,1,0
1,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.0095807,-0.132,-0.16628,1,0
1,GO FAT CELL PROLIFERATION,0.034636,-0.13203,-0.14521,1,0
1,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00031414,-0.13228,-0.13121,1,0
1,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.056652,-0.13254,-0.16868,1,0
1,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.00023294,-0.13258,-0.15416,1,0
1,GO PEPTIDYL CYSTEINE MODIFICATION,0.018898,-0.13297,-0.065809,1,0
1,GO SECONDARY HEART FIELD SPECIFICATION,0.028556,-0.1353,-0.21314,1,0
1,GO HEAT GENERATION,0.010895,-0.13543,-0.13558,1,0
1,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.014332,-0.13548,-0.095874,1,0
1,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.0071918,-0.1355,-0.15795,1,0
1,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.055609,-0.13567,-0.10102,1,0
1,GO HISTONE H3 K4 METHYLATION,0.013546,-0.13597,-0.13007,1,0
1,GO REGULATION OF CAMP MEDIATED SIGNALING,0.0086125,-0.13645,-0.11589,1,0
1,GO MAST CELL MIGRATION,0.053071,-0.13905,-0.19448,1,0
1,GO POSTSYNAPSE ORGANIZATION,0.0059116,-0.13973,-0.12796,1,0
1,GO AMINO ACID TRANSPORT,0.00087508,-0.13978,-0.1369,1,0
1,GO WALKING BEHAVIOR,0.00028155,-0.14025,-0.19363,1,0
1,GO ERROR PRONE TRANSLESION SYNTHESIS,0.0094686,-0.14098,-0.1339,1,0
1,GO PHOTORECEPTOR CELL MAINTENANCE,0.0042636,-0.14156,-0.134,1,0
1,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.059331,-0.14272,-0.091978,1,0
1,GO HORMONE TRANSPORT,0.0013633,-0.14304,-0.12797,1,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.051111,-0.14307,-0.13846,1,0
1,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.0022095,-0.1431,-0.21924,1,0
1,GO ACTION POTENTIAL,0.0033361,-0.14391,-0.15524,1,0
1,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.027973,-0.14392,-0.085453,1,0
1,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.03068,-0.14476,-0.17259,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00015838,-0.1449,-0.16004,1,0
1,GO REPRODUCTIVE BEHAVIOR,0.0013826,-0.14532,-0.15195,1,0
1,GO CEREBELLAR CORTEX MORPHOGENESIS,0.0060595,-0.14629,-0.14562,1,0
1,GO REGULATION OF SYNAPSE ASSEMBLY,0.012367,-0.14649,-0.14808,1,0
1,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.0038478,-0.14687,-0.1754,1,0
1,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0032501,-0.14773,-0.15587,1,0
1,GO MAINTENANCE OF CELL POLARITY,0.02521,-0.14806,-0.097976,1,0
1,GO CELL DIFFERENTIATION IN HINDBRAIN,0.0037016,-0.1481,-0.173,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.013093,-0.14859,-0.10686,1,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.011813,-0.14894,-0.16611,1,0
1,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0012005,-0.14929,-0.16014,1,0
1,GO SYNAPTIC TRANSMISSION GABAERGIC,0.0010865,-0.14975,-0.13635,1,0
1,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0018764,-0.14979,-0.17056,1,0
1,GO INTRACILIARY TRANSPORT,0.056128,-0.15006,-0.10099,1,0
1,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0041031,-0.15062,-0.12015,1,0
1,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.040981,-0.15117,-0.075745,1,0
1,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.02174,-0.15163,-0.1816,1,0
1,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00068191,-0.15235,-0.14645,1,0
1,GO VESICLE DOCKING,0.0021505,-0.15294,-0.11281,1,0
1,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0055559,-0.15294,-0.16184,1,0
1,GO REGULATION OF INSULIN SECRETION,0.00049802,-0.15399,-0.15217,1,0
1,GO SENSORY PERCEPTION OF PAIN,0.0081133,-0.15461,-0.10585,1,0
1,GO MITOCHONDRION LOCALIZATION,0.00012186,-0.15475,-0.17913,1,0
1,GO REGULATION OF HORMONE SECRETION,0.0019285,-0.15557,-0.12136,1,0
1,GO CELLULAR RESPONSE TO CALCIUM ION,0.019104,-0.15594,-0.098945,1,0
1,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.049681,-0.15633,-0.078769,1,0
1,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.0034692,-0.157,-0.20818,1,0
1,GO MITOTIC SISTER CHROMATID COHESION,0.027973,-0.15722,-0.11903,1,0
1,GO DENDRITE MORPHOGENESIS,0.0011503,-0.15774,-0.15588,1,0
1,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0042095,-0.15799,-0.18131,1,0
1,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.052083,-0.15891,-0.060299,1,0
1,GO SPINAL CORD DEVELOPMENT,0.0010865,-0.15901,-0.16046,1,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.002702,-0.15919,-0.1763,1,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.024947,-0.16013,-0.12232,1,0
1,GO SEROTONIN SECRETION,0.023173,-0.16061,-0.23267,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0017517,-0.16083,-0.1463,1,0
1,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.0043184,-0.16118,-0.12402,1,0
1,GO DNA STRAND ELONGATION,0.0034692,-0.16132,-0.17051,1,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00037835,-0.16143,-0.19469,1,0
1,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.0042636,-0.16156,-0.13644,1,0
1,GO PROTEIN HETEROOLIGOMERIZATION,0.0007901,-0.16158,-0.14485,1,0
1,GO RESPONSE TO DIETARY EXCESS,0.030994,-0.16233,-0.15353,1,0
1,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.047827,-0.16333,-0.12607,1,0
1,GO NEUROMUSCULAR PROCESS,0.004156,-0.16357,-0.11984,1,0
1,GO MALE SEX DETERMINATION,0.050154,-0.16416,-0.1491,1,0
1,GO ENDOCRINE SYSTEM DEVELOPMENT,0.031953,-0.16514,-0.089654,1,0
1,GO MICROTUBULE BUNDLE FORMATION,0.016386,-0.16647,-0.1087,1,0
1,GO DENDRITE DEVELOPMENT,0.00096848,-0.16665,-0.14001,1,0
1,GO NEUROTRANSMITTER METABOLIC PROCESS,0.0083098,-0.16722,-0.16837,1,0
1,GO OXIDATIVE DEMETHYLATION,0.00095459,-0.16784,-0.1244,1,0
1,GO CELL JUNCTION MAINTENANCE,0.037139,-0.16821,-0.11666,1,0
1,GO BEHAVIOR,0.0019023,-0.16859,-0.11507,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.026838,-0.16878,-0.11907,1,0
1,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.057711,-0.16963,-0.16308,1,0
1,GO DENDRITIC SPINE MORPHOGENESIS,0.0057669,-0.16971,-0.15195,1,0
1,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0016575,-0.1699,-0.20114,1,0
1,GO PHOTORECEPTOR CELL DEVELOPMENT,1.0361e-05,-0.17065,-0.2133,1,0
1,GO ASSOCIATIVE LEARNING,0.0015249,-0.17139,-0.13967,1,0
1,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0034692,-0.17158,-0.19078,1,0
1,GO REGULATION OF POTASSIUM ION TRANSPORT,0.0033361,-0.17306,-0.116,1,0
1,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.013856,-0.17425,-0.20284,1,0
1,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00029052,-0.17425,-0.13519,1,0
1,GO NUCLEAR BODY ORGANIZATION,0.0062108,-0.17448,-0.13063,1,0
1,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.01128,-0.17515,-0.09746,1,0
1,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.010645,-0.17586,-0.10426,1,0
1,GO PRESYNAPSE ORGANIZATION,0.0034243,-0.17627,-0.17699,1,0
1,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.022446,-0.17667,-0.11532,1,0
1,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0010259,-0.17744,-0.17822,1,0
1,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.049681,-0.17757,-0.14667,1,0
1,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0022701,-0.17859,-0.20568,1,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0010558,-0.17903,-0.18983,1,0
1,GO CARDIAC CONDUCTION,0.0072795,-0.17941,-0.11721,1,0
1,GO HISTONE H3 K9 DEMETHYLATION,0.0090315,-0.17954,-0.13723,1,0
1,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00013451,-0.17994,-0.1746,1,0
1,GO PROTEIN PALMITOYLATION,0.0069343,-0.18032,-0.12854,1,0
1,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,6.1119e-05,-0.18064,-0.19168,1,0
1,GO ADRENAL GLAND DEVELOPMENT,0.023173,-0.18125,-0.12911,1,0
1,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0023009,-0.18286,-0.16698,1,0
1,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.00010152,-0.18309,-0.15375,1,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.012798,-0.18348,-0.16593,1,0
1,GO SECRETORY GRANULE LOCALIZATION,0.00044781,-0.18358,-0.30229,1,0
1,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.015674,-0.18381,-0.12622,1,0
1,GO HINDBRAIN DEVELOPMENT,0.00064263,-0.18433,-0.15368,1,0
1,GO ACROSOME REACTION,0.0046604,-0.18472,-0.12255,1,0
1,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.031953,-0.1851,-0.1128,1,0
1,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,3.094e-05,-0.18696,-0.19982,1,0
1,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00012594,-0.18748,-0.1808,1,0
1,GO MONOVALENT INORGANIC CATION TRANSPORT,0.0013633,-0.18752,-0.12128,1,0
1,GO STRIATUM DEVELOPMENT,0.0017517,-0.19084,-0.18103,1,0
1,GO SIGNAL RELEASE,0.00045468,-0.19212,-0.1383,1,0
1,GO NEURON MIGRATION,0.00033432,-0.19295,-0.19888,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.0077327,-0.19307,-0.20461,1,0
1,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.016938,-0.19308,-0.16271,1,0
1,GO MICROTUBULE DEPOLYMERIZATION,8.8796e-05,-0.19402,-0.23943,1,0
1,GO NEURAL RETINA DEVELOPMENT,0.00040857,-0.19665,-0.22921,1,0
1,GO NEGATIVE REGULATION OF RNA SPLICING,1.6761e-05,-0.19704,-0.18437,1,0
1,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.0039481,-0.19741,-0.14318,1,0
1,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.00084997,-0.19835,-0.15036,1,0
1,GO REGULATION OF PEPTIDE HORMONE SECRETION,7.5001e-05,-0.19862,-0.17895,1,0
1,GO REGULATION OF NEURON MATURATION,0.0054192,-0.19867,-0.24694,1,0
1,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00037835,-0.19892,-0.18612,1,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.0088198,-0.19957,-0.16908,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.00035024,-0.20003,-0.2062,1,0
1,GO RESPONSE TO LITHIUM ION,0.0017277,-0.20049,-0.23361,1,0
1,GO SYNAPSE ORGANIZATION,0.0016806,-0.20154,-0.15004,1,0
1,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.0023637,-0.20216,-0.17556,1,0
1,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00065224,-0.20258,-0.14877,1,0
1,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0055559,-0.20272,-0.2431,1,0
1,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.00023294,-0.20319,-0.19229,1,0
1,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.00057029,-0.20381,-0.16367,1,0
1,GO SEGMENT SPECIFICATION,0.027118,-0.20642,-0.17224,1,0
1,GO DETECTION OF ABIOTIC STIMULUS,0.00040235,-0.21001,-0.14246,1,0
1,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00013451,-0.21053,-0.16542,1,0
1,GO POSITIVE REGULATION OF EXOCYTOSIS,0.00011218,-0.21071,-0.17088,1,0
1,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.00013016,-0.21109,-0.17737,1,0
1,GO FOREBRAIN REGIONALIZATION,0.0087156,-0.21121,-0.18228,1,0
1,GO LONG TERM SYNAPTIC DEPRESSION,0.0034243,-0.21286,-0.18229,1,0
1,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.0014624,-0.21304,-0.21641,1,0
1,GO AMMONIUM ION METABOLIC PROCESS,0.0011341,-0.21348,-0.23958,1,0
1,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.0042095,-0.21357,-0.15015,1,0
1,GO CELL MIGRATION IN HINDBRAIN,0.030994,-0.21433,-0.14955,1,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.051595,-0.21446,-0.1725,1,0
1,GO INSULIN SECRETION,0.00011596,-0.21452,-0.17027,1,0
1,GO SYNAPTIC VESICLE TRANSPORT,4.1026e-05,-0.215,-0.20537,1,0
1,GO PARENTAL BEHAVIOR,0.026838,-0.21605,-0.16449,1,0
1,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,6.3249e-05,-0.21615,-0.18945,1,0
1,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.045591,-0.21626,-0.1698,1,0
1,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.00099681,-0.21641,-0.18536,1,0
1,GO MITOCHONDRION DISTRIBUTION,0.0017277,-0.21669,-0.17371,1,0
1,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.008211,-0.21672,-0.15306,1,0
1,GO MEMBRANE DEPOLARIZATION,0.0074579,-0.21686,-0.13573,1,0
1,GO LEARNING,0.00014362,-0.21725,-0.18563,1,0
1,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,7.0072e-05,-0.2173,-0.23026,1,0
1,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.030994,-0.21824,-0.17783,1,0
1,GO REGULATION OF TUBULIN DEACETYLATION,0.0070192,-0.21828,-0.21784,1,0
1,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,7.4873e-07,-0.21848,-0.22362,1,0
1,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.00081356,-0.22042,-0.22365,1,0
1,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.05063,-0.22117,-0.097136,1,0
1,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00014599,-0.22141,-0.26908,1,0
1,GO PEPTIDE HORMONE SECRETION,4.3997e-05,-0.22144,-0.18246,1,0
1,GO HISTONE H4 K5 ACETYLATION,0.00013232,-0.22188,-0.18895,1,0
1,GO FEEDING BEHAVIOR,3.2631e-05,-0.22247,-0.17305,1,0
1,GO REGULATION OF MICROTUBULE BINDING,6.3249e-05,-0.22338,-0.19227,1,0
1,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,8.2543e-08,-0.22581,-0.23869,1,0
1,GO METENCEPHALON DEVELOPMENT,2.9332e-05,-0.2261,-0.21981,1,0
1,GO NEURON CELLULAR HOMEOSTASIS,0.002702,-0.22915,-0.21591,1,0
1,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.014658,-0.23034,-0.15968,1,0
1,GO PHOTORECEPTOR CELL DIFFERENTIATION,9.9844e-05,-0.23192,-0.20445,1,0
1,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0015463,-0.23217,-0.21658,1,0
1,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,4.4771e-05,-0.23301,-0.23167,1,0
1,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.004964,-0.23533,-0.2411,1,0
1,GO REGULATION OF SYNAPSE MATURATION,0.00082553,-0.23815,-0.35762,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.00037257,-0.23863,-0.17276,1,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0045438,-0.24209,-0.20005,1,0
1,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.02521,-0.24235,-0.16234,1,0
1,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,4.2271e-06,-0.24303,-0.25466,1,0
1,GO CEREBELLAR CORTEX DEVELOPMENT,5.6085e-05,-0.24518,-0.21752,1,0
1,GO SYNAPTIC VESICLE RECYCLING,6.7105e-06,-0.24552,-0.22096,1,0
1,GO REGULATION OF SYNAPTIC PLASTICITY,6.4341e-05,-0.24697,-0.20625,1,0
1,GO CHROMATIN SILENCING AT TELOMERE,3.2162e-07,-0.24718,-0.24892,1,0
1,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0013069,-0.24803,-0.36388,1,0
1,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.00092737,-0.24842,-0.22753,1,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.00022208,-0.24855,-0.23548,1,0
1,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00039018,-0.25132,-0.22577,1,0
1,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.4771e-05,-0.25199,-0.26741,1,0
1,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0058389,-0.25201,-0.16156,1,0
1,GO NERVE DEVELOPMENT,0.01128,-0.25325,-0.15355,1,0
1,GO MRNA SPLICE SITE SELECTION,5.1304e-06,-0.26028,-0.25746,1,0
1,GO NEGATIVE REGULATION OF HISTONE METHYLATION,2.011e-05,-0.2611,-0.21865,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0078263,-0.26149,-0.19796,1,0
1,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0018764,-0.2623,-0.23122,1,0
1,GO NEUROTRANSMITTER UPTAKE,0.00012388,-0.26251,-0.21958,1,0
1,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00095459,-0.26268,-0.16233,1,0
1,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0026663,-0.26285,-0.21115,1,0
1,GO RESPONSE TO ACETYLCHOLINE,0.003166,-0.2633,-0.18891,1,0
1,GO LOCOMOTORY BEHAVIOR,0.00014839,-0.26376,-0.19431,1,0
1,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,1.5576e-05,-0.26436,-0.2539,1,0
1,GO REGULATION OF EXOCYTOSIS,3.758e-05,-0.26565,-0.17447,1,0
1,GO RESPONSE TO COCAINE,2.856e-06,-0.26672,-0.26284,1,0
1,GO CEREBELLAR CORTEX FORMATION,5.4184e-05,-0.26737,-0.25845,1,0
1,GO PROTEIN LOCALIZATION TO SYNAPSE,3.4409e-05,-0.2678,-0.24639,1,0
1,GO DIENCEPHALON DEVELOPMENT,0.0040509,-0.26839,-0.17586,1,0
1,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.0022095,-0.26842,-0.22001,1,0
1,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,9.1829e-05,-0.26927,-0.21565,1,0
1,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.0023009,-0.27014,-0.18659,1,0
1,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.042609,-0.27078,-0.12628,1,0
1,GO NEURON RECOGNITION,5.7059e-05,-0.27189,-0.29425,1,0
1,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,3.094e-05,-0.27359,-0.22064,1,0
1,GO REGULATION OF CELL PROJECTION SIZE,0.0052854,-0.27428,-0.22509,1,0
1,GO RECEPTOR LOCALIZATION TO SYNAPSE,3.4409e-05,-0.27903,-0.25793,1,0
1,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0022701,-0.27938,-0.1866,1,0
1,GO REGULATION OF MEMBRANE POTENTIAL,7.1274e-05,-0.28053,-0.19056,1,0
1,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00090088,-0.28072,-0.23008,1,0
1,GO AROMATIC AMINO ACID TRANSPORT,0.016386,-0.282,-0.18303,1,0
1,GO REGULATION OF REGULATED SECRETORY PATHWAY,3.9102e-06,-0.28232,-0.24636,1,0
1,GO GLIAL CELL FATE COMMITMENT,0.032938,-0.28361,-0.23717,1,0
1,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.00017457,-0.28369,-0.26582,1,0
1,GO SYNAPSE ASSEMBLY,4.0314e-05,-0.28458,-0.24887,1,0
1,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00026438,-0.28461,-0.3082,1,0
1,GO NOREPINEPHRINE TRANSPORT,0.0030038,-0.28491,-0.19041,1,0
1,GO PROTEIN POLYGLUTAMYLATION,2.6828e-05,-0.28739,-0.24697,1,0
1,GO SYNAPTIC SIGNALING,1.3442e-05,-0.28747,-0.21027,1,0
1,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,1.064e-06,-0.28752,-0.29283,1,0
1,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.7385e-05,-0.28808,-0.2204,1,0
1,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00029052,-0.28951,-0.19223,1,0
1,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0019285,-0.28963,-0.26666,1,0
1,GO PRESYNAPTIC ENDOCYTOSIS,3.0905e-06,-0.29035,-0.24908,1,0
1,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.035691,-0.29041,-0.19349,1,0
1,GO POTASSIUM ION TRANSPORT,4.5558e-05,-0.29174,-0.19846,1,0
1,GO RAB PROTEIN SIGNAL TRANSDUCTION,4.5558e-05,-0.29299,-0.25492,1,0
1,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,1.471e-07,-0.29307,-0.31464,1,0
1,GO NOREPINEPHRINE SECRETION,0.010041,-0.29446,-0.15288,1,0
1,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00044781,-0.2956,-0.25673,1,0
1,GO NEURON MATURATION,4.4771e-05,-0.29776,-0.24908,1,0
1,GO ACIDIC AMINO ACID TRANSPORT,5.0323e-06,-0.29791,-0.22253,1,0
1,GO REGULATION OF HEAT GENERATION,0.00036124,-0.29958,-0.24952,1,0
1,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0019819,-0.30001,-0.24807,1,0
1,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,4.4807e-06,-0.30319,-0.2904,1,0
1,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.8793e-06,-0.30684,-0.44058,1,0
1,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.012945,-0.30714,-0.2108,1,0
1,GO RESPONSE TO L GLUTAMATE,0.0005133,-0.30822,-0.28787,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.00049053,-0.30893,-0.26282,1,0
1,GO REGULATION OF CGMP MEDIATED SIGNALING,0.010279,-0.31128,-0.20447,1,0
1,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,1.1165e-05,-0.31318,-0.25876,1,0
1,GO REGULATION OF AMINO ACID TRANSPORT,0.00020178,-0.31333,-0.22165,1,0
1,GO SYNAPTIC MEMBRANE ADHESION,0.0041031,-0.31374,-0.26972,1,0
1,GO POSITIVE REGULATION OF HEAT GENERATION,0.00037835,-0.31642,-0.2766,1,0
1,GO NEUROTRANSMITTER REUPTAKE,9.3381e-05,-0.31779,-0.25437,1,0
1,GO SYNAPTIC VESICLE LOCALIZATION,1.1316e-06,-0.31873,-0.30553,1,0
1,GO DENDRITIC TRANSPORT,0.00032916,-0.31888,-0.23462,1,0
1,GO NEUROPEPTIDE SIGNALING PATHWAY,1.1588e-05,-0.32289,-0.24184,1,0
1,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.00044103,-0.32474,-0.27259,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00030928,-0.32546,-0.29578,1,0
1,GO NEURAL NUCLEUS DEVELOPMENT,2.5868e-06,-0.32621,-0.28339,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,1.8053e-06,-0.32652,-0.37679,1,0
1,GO ADULT LOCOMOTORY BEHAVIOR,2.8001e-06,-0.3272,-0.25811,1,0
1,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,2.8001e-06,-0.33249,-0.31675,1,0
1,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.001776,-0.33279,-0.23771,1,0
1,GO EXOCYTIC PROCESS,4.3946e-06,-0.33353,-0.24857,1,0
1,GO SUCKLING BEHAVIOR,7.7586e-05,-0.33725,-0.31722,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00013673,-0.33744,-0.33998,1,0
1,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.00072342,-0.33854,-0.32182,1,0
1,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.014658,-0.34087,-0.25936,1,0
1,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,7.3803e-06,-0.34189,-0.2924,1,0
1,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.012087,-0.34928,-0.1976,1,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,1.4472e-05,-0.34959,-0.35703,1,0
1,GO RESPONSE TO INSECTICIDE,0.00040235,-0.35228,-0.23567,1,0
1,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,2.4861e-06,-0.35373,-0.27036,1,0
1,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00091404,-0.35701,-0.24775,1,0
1,GO POSTSYNAPSE ASSEMBLY,0.00090088,-0.35793,-0.3031,1,0
1,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0001179,-0.36546,-0.26235,1,0
1,GO TRANSMISSION OF NERVE IMPULSE,0.00013232,-0.36591,-0.27421,1,0
1,GO SPINAL CORD PATTERNING,7.5001e-05,-0.36616,-0.32787,1,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00036686,-0.36711,-0.25062,1,0
1,GO CATECHOLAMINE METABOLIC PROCESS,2.6828e-05,-0.37012,-0.30205,1,0
1,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.8416e-06,-0.37177,-0.37095,1,0
1,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00030928,-0.37401,-0.24818,1,0
1,GO CATECHOLAMINE UPTAKE,4.8839e-05,-0.37404,-0.30102,1,0
1,GO GROOMING BEHAVIOR,2.6914e-06,-0.37437,-0.33141,1,0
1,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.00080175,-0.37454,-0.29365,1,0
1,GO CGMP METABOLIC PROCESS,0.00046165,-0.37749,-0.30646,1,0
1,GO REGULATION OF VESICLE FUSION,7.8052e-07,-0.38058,-0.37428,1,0
1,GO DOPAMINE METABOLIC PROCESS,2.4528e-05,-0.38067,-0.32442,1,0
1,GO SUBPALLIUM DEVELOPMENT,6.3249e-05,-0.38343,-0.30612,1,0
1,GO ADULT BEHAVIOR,1.439e-07,-0.38415,-0.31232,1,0
1,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.2784e-06,-0.3868,-0.40161,1,0
1,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,2.3661e-05,-0.38865,-0.38826,1,0
1,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00013451,-0.39279,-0.45228,1,0
1,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0010865,-0.39343,-0.37862,1,0
1,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,4.4771e-05,-0.39376,-0.27808,1,0
1,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.1789e-06,-0.39609,-0.34286,1,0
1,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0007901,-0.39669,-0.28284,1,0
1,GO NEURON FATE COMMITMENT,1.3878e-06,-0.39771,-0.40639,1,0
1,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00070238,-0.40139,-0.26125,1,0
1,GO DETECTION OF TEMPERATURE STIMULUS,0.00019857,-0.4025,-0.33931,1,0
1,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,3.758e-05,-0.40577,-0.3032,1,0
1,GO REGULATION OF NEUROTRANSMITTER LEVELS,7.0522e-08,-0.40632,-0.34823,1,0
1,GO NOSE DEVELOPMENT,0.00044781,-0.40759,-0.40825,1,0
1,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,7.7586e-05,-0.40888,-0.33954,1,0
1,GO MAINTENANCE OF SYNAPSE STRUCTURE,4.5684e-06,-0.41528,-0.42156,1,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.001955,-0.41679,-0.32354,1,0
1,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,1.8032e-05,-0.41815,-0.41831,1,0
1,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,2.2926e-08,-0.42318,-0.3623,1,0
1,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.9563e-06,-0.42652,-0.3504,1,0
1,GO THALAMUS DEVELOPMENT,0.00012388,-0.42937,-0.33412,1,0
1,GO NETRIN ACTIVATED SIGNALING PATHWAY,6.545e-05,-0.43336,-0.35565,1,0
1,GO DETECTION OF CALCIUM ION,1.8701e-05,-0.43491,-0.34942,1,0
1,GO STARTLE RESPONSE,3.9613e-05,-0.43496,-0.34005,1,0
1,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00098255,-0.4366,-0.35819,1,0
1,GO INHIBITORY SYNAPSE ASSEMBLY,6.8888e-05,-0.43665,-0.40125,1,0
1,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.00024045,-0.43788,-0.29166,1,0
1,GO INHIBITORY POSTSYNAPTIC POTENTIAL,7.6657e-06,-0.43846,-0.42636,1,0
1,GO GLUTAMATE SECRETION,2.0429e-07,-0.43897,-0.36547,1,0
1,GO STABILIZATION OF MEMBRANE POTENTIAL,0.00070238,-0.43973,-0.34033,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.0361e-05,-0.44183,-0.45068,1,0
1,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,7.7166e-08,-0.44358,-0.5017,1,0
1,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,3.1494e-05,-0.44407,-0.37543,1,0
1,GO DOPAMINE BIOSYNTHETIC PROCESS,0.00014129,-0.45314,-0.44403,1,0
1,GO NEURONAL ACTION POTENTIAL,1.9749e-05,-0.45838,-0.38766,1,0
1,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.7605e-06,-0.45998,-0.46548,1,0
1,GO SYNAPSE MATURATION,6.545e-05,-0.4611,-0.42867,1,0
1,GO DENSE CORE GRANULE TRANSPORT,1.9136e-07,-0.46702,-0.56914,1,0
1,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,5.3256e-05,-0.47638,-0.43184,1,0
1,GO NEUROTRANSMITTER TRANSPORT,1.6907e-08,-0.47986,-0.39996,1,0
1,GO INNERVATION,0.00026438,-0.48044,-0.36397,1,0
1,GO PROTEIN LOCALIZATION TO AXON,0.00039622,-0.48121,-0.44382,1,0
1,GO GROWTH HORMONE SECRETION,9.819e-05,-0.49142,-0.36606,1,0
1,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,1.3351e-08,-0.49174,-0.40701,1,0
1,GO REGULATION OF GLUTAMATE SECRETION,2.7452e-06,-0.49231,-0.37627,1,0
1,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.1588e-05,-0.4931,-0.45358,1,0
1,GO PREPULSE INHIBITION,3.3435e-06,-0.4967,-0.48534,1,0
1,GO POSITIVE REGULATION OF AMINE TRANSPORT,7.9617e-06,-0.5057,-0.39714,1,0
1,GO DORSAL SPINAL CORD DEVELOPMENT,3.094e-05,-0.50748,-0.36529,1,0
1,GO REGULATION OF SYNAPTIC VESICLE CYCLE,3.4553e-09,-0.50764,-0.45941,1,0
1,GO NEUROTRANSMITTER SECRETION,6.6717e-09,-0.51697,-0.44102,1,0
1,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.5674e-06,-0.52998,-0.47967,1,0
1,GO SYNAPTIC VESICLE MATURATION,5.4356e-06,-0.53185,-0.50529,1,0
1,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.00094089,-0.53195,-0.33354,1,0
1,GO AMINE TRANSPORT,3.357e-07,-0.53287,-0.42542,1,0
1,GO RESPONSE TO AUDITORY STIMULUS,1.8701e-05,-0.54052,-0.4072,1,0
1,GO VOCALIZATION BEHAVIOR,3.152e-06,-0.54391,-0.52006,1,0
1,GO NEURONAL ION CHANNEL CLUSTERING,4.6359e-05,-0.55404,-0.4312,1,0
1,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,3.4409e-05,-0.55865,-0.42077,1,0
1,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,8.3066e-07,-0.56569,-0.52987,1,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,5.2359e-09,-0.56815,-0.50719,1,0
1,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,6.8396e-06,-0.57517,-0.47303,1,0
1,GO SYNAPTIC VESICLE EXOCYTOSIS,2.004e-09,-0.57524,-0.47475,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS,2.0398e-08,-0.57678,-0.48922,1,0
1,GO NEGATIVE REGULATION OF AMINE TRANSPORT,8.4805e-07,-0.57962,-0.52565,1,0
1,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,9.2585e-06,-0.58472,-0.46745,1,0
1,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,8.8282e-08,-0.58844,-0.466,1,0
1,GO MONOAMINE TRANSPORT,8.3066e-07,-0.59222,-0.44003,1,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.0424e-06,-0.59878,-0.61098,1,0
1,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,2.2697e-09,-0.60764,-0.51683,1,0
1,GO FOREBRAIN NEURON FATE COMMITMENT,0.00019229,-0.61593,-0.54744,1,0
1,GO DENDRITE EXTENSION,1.2143e-08,-0.61847,-0.48199,1,0
1,GO NEURON FATE SPECIFICATION,1.9136e-07,-0.62497,-0.58119,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,2.634e-09,-0.63505,-0.5684,1,0
1,GO SYNAPTIC VESICLE PRIMING,2.004e-09,-0.65734,-0.5629,1,0
1,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,6.5125e-09,-0.65833,-0.55521,1,0
1,GO REGULATION OF DENDRITE EXTENSION,2.2926e-08,-0.66482,-0.54611,1,0
1,GO NEURON CELL CELL ADHESION,3.0811e-07,-0.66836,-0.60241,1,0
1,GO SYNAPTIC VESICLE DOCKING,2.4586e-08,-0.67478,-0.59899,1,0
1,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.5451e-08,-0.67487,-0.53187,1,0
1,GO DOPAMINE TRANSPORT,2.8925e-08,-0.68984,-0.58374,1,0
1,GO CATECHOLAMINE SECRETION,9.8716e-08,-0.70109,-0.57008,1,0
1,GO GANGLION DEVELOPMENT,3.6924e-05,-0.72626,-0.48831,1,0
1,GO SYNAPTIC VESICLE CLUSTERING,4.4787e-08,-0.73335,-0.64619,1,0
1,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,4.7999e-05,-0.74099,-0.50775,1,0
1,GO VESICLE FUSION TO PLASMA MEMBRANE,1.484e-09,-0.75721,-0.63647,1,0
1,GO REGULATION OF DOPAMINE SECRETION,8.6937e-09,-0.79023,-0.72621,1,0
1,GO GABAERGIC NEURON DIFFERENTIATION,1.3442e-05,-0.82287,-0.57751,1,0
1,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,4.9624e-10,-0.82375,-0.75775,1,0
1,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,4.7963e-08,-0.83598,-0.70249,1,0
1,GO MECHANOSENSORY BEHAVIOR,9.404e-07,-0.86416,-0.68763,1,0
1,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,1.6823e-09,-0.8738,-0.75899,1,0
1,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,2.2697e-09,-0.89206,-0.80883,1,0
1,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,1.0322e-07,-0.98747,-0.7843,1,0
1,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,2.9515e-10,-1.2273,-1.1233,1,0
1,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.098784,0.31635,0.22949,0,1
1,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.34627,0.24308,0.06873,0,1
1,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.1146,0.20634,0.13285,0,1
1,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.066192,0.19372,0.15363,0,1
1,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.09714,0.19248,0.12225,0,1
1,GO RESPONSE TO MUSCLE STRETCH,0.079071,0.18928,0.17958,0,1
1,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.1146,0.18682,0.073102,0,1
1,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.064418,0.18485,0.15511,0,1
1,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.066192,0.18021,0.10469,0,1
1,GO MIDDLE EAR MORPHOGENESIS,0.15214,0.17099,0.072738,0,1
1,GO AORTA MORPHOGENESIS,0.079765,0.16809,0.13628,0,1
1,GO PSEUDOURIDINE SYNTHESIS,0.10734,0.16717,0.078756,0,1
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.37173,0.15666,0.072774,0,1
1,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.10558,0.15449,0.1131,0,1
1,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.24252,0.15012,0.053253,0,1
1,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.10471,0.14881,0.092128,0,1
1,GO RRNA MODIFICATION,0.078382,0.14551,0.081942,0,1
1,GO ADHERENS JUNCTION ASSEMBLY,0.10558,0.14218,0.12911,0,1
1,GO DNA LIGATION,0.067397,0.13285,0.09833,0,1
1,GO POSITIVE REGULATION OF NEURON MIGRATION,0.081877,0.13263,0.13036,0,1
1,GO ROOF OF MOUTH DEVELOPMENT,0.26267,0.13067,0.049866,0,1
1,GO REGULATION OF STEM CELL PROLIFERATION,0.088486,0.12841,0.089368,0,1
1,GO PURINE CONTAINING COMPOUND SALVAGE,0.088486,0.1273,0.086855,0,1
1,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.11553,0.12548,0.092168,0,1
1,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.096327,0.11594,0.079978,0,1
1,GO CELLULAR GLUCAN METABOLIC PROCESS,0.080464,0.11557,0.078491,0,1
1,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.18595,0.11381,0.082053,0,1
1,GO NUCLEAR PORE ORGANIZATION,0.086981,0.11332,0.089223,0,1
1,GO DE NOVO PROTEIN FOLDING,0.076344,0.11283,0.084061,0,1
1,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.21587,0.11261,0.061746,0,1
1,GO NUCLEUS LOCALIZATION,0.12322,0.11182,0.10531,0,1
1,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.071756,0.11004,0.12728,0,1
1,GO NUCLEAR MIGRATION,0.35253,0.10987,0.083718,0,1
1,GO ACTIN MEDIATED CELL CONTRACTION,0.079071,0.10865,0.084992,0,1
1,GO CARNITINE SHUTTLE,0.09714,0.10799,0.094095,0,1
1,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.28578,0.10764,0.051335,0,1
1,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.088486,0.10653,0.067485,0,1
1,GO REGULATION OF CENTRIOLE REPLICATION,0.2458,0.10468,0.048609,0,1
1,GO ORGANELLE INHERITANCE,0.14983,0.10355,0.059326,0,1
1,GO STRIATED MUSCLE ADAPTATION,0.15921,0.10317,0.076846,0,1
1,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.25414,0.10197,0.054193,0,1
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.069238,0.10174,0.11369,0,1
1,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.11183,0.10055,0.079285,0,1
1,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.13763,0.099461,0.066321,0,1
1,GO CELLULAR RESPONSE TO MANGANESE ION,0.12924,0.099439,0.057925,0,1
1,GO FOLIC ACID METABOLIC PROCESS,0.11553,0.095268,0.077203,0,1
1,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.072397,0.094213,0.12043,0,1
1,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.20265,0.090684,0.072646,0,1
1,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.14088,0.090646,0.07199,0,1
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.24252,0.090269,0.085635,0,1
1,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.16654,0.086869,0.067363,0,1
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.25414,0.086618,0.041022,0,1
1,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.23605,0.085821,0.052367,0,1
1,GO MITOTIC SPINDLE ORGANIZATION,0.49487,0.085601,0.020479,0,1
1,GO RIBOSOME ASSEMBLY,0.1873,0.085446,0.065348,0,1
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.079071,0.085114,0.055393,0,1
1,GO PROTEIN MONOUBIQUITINATION,0.089246,0.085104,0.05135,0,1
1,GO REGULATION OF ENDOCYTIC RECYCLING,0.22503,0.0849,0.085167,0,1
1,GO NCRNA EXPORT FROM NUCLEUS,0.068619,0.08417,0.085763,0,1
1,GO TRNA METHYLATION,0.074349,0.083818,0.095322,0,1
1,GO RIBOSOME BIOGENESIS,0.074349,0.08233,0.084865,0,1
1,GO TELOMERASE RNA LOCALIZATION,0.14088,0.082157,0.063129,0,1
1,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.084763,0.082143,0.10586,0,1
1,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.10471,0.080408,0.070129,0,1
1,GO MITOTIC RECOMBINATION,0.1754,0.079899,0.070808,0,1
1,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.25583,0.07987,0.062054,0,1
1,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.11367,0.079447,0.061183,0,1
1,GO CYTOKINESIS,0.22658,0.07865,0.043025,0,1
1,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.46218,0.077794,0.035176,0,1
1,GO GASTRIC ACID SECRETION,0.84107,0.076946,0.014413,0,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.93382,0.076562,-0.004344,0,1
1,GO RENAL SODIUM EXCRETION,0.18062,0.076459,0.087739,0,1
1,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.18327,0.076096,0.074106,0,1
1,GO NCRNA METABOLIC PROCESS,0.075009,0.075927,0.074053,0,1
1,GO TRIGLYCERIDE CATABOLIC PROCESS,0.23605,0.075422,0.06618,0,1
1,GO REGULATION OF RNA BINDING,0.082591,0.075164,0.09057,0,1
1,GO TELOMERE ORGANIZATION,0.25924,0.075131,0.024411,0,1
1,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.10823,0.07448,0.032409,0,1
1,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.071756,0.072904,0.056529,0,1
1,GO RRNA METABOLIC PROCESS,0.079071,0.072678,0.082397,0,1
1,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.14755,0.072472,0.058195,0,1
1,GO RECEPTOR INTERNALIZATION,0.079765,0.071369,0.075948,0,1
1,GO TRNA METABOLIC PROCESS,0.2114,0.069307,0.046518,0,1
1,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.070488,0.068397,0.086103,0,1
1,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.10214,0.068193,0.068997,0,1
1,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.060988,0.068149,0.082287,0,1
1,GO MITOCHONDRIAL PROTEIN PROCESSING,0.14308,0.067839,0.081197,0,1
1,GO PEPTIDYL THREONINE MODIFICATION,0.16904,0.067814,0.054726,0,1
1,GO SNRNA PROCESSING,0.25583,0.067388,0.14322,0,1
1,GO REGULATION OF PROTEIN TARGETING,0.06986,0.066586,0.072042,0,1
1,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.33599,0.066516,0.060111,0,1
1,GO RNA METHYLATION,0.10646,0.066489,0.077618,0,1
1,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.36098,0.06562,0.041753,0,1
1,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.1262,0.06528,0.066191,0,1
1,GO TRICARBOXYLIC ACID CYCLE,0.65442,0.064868,0.0165,0,1
1,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.17669,0.064093,0.048645,0,1
1,GO POSITIVE REGULATION OF CYTOKINESIS,0.51035,0.063281,0.028341,0,1
1,GO TRANSLATIONAL INITIATION,0.20409,0.062786,0.061545,0,1
1,GO LACTATE METABOLIC PROCESS,0.065596,0.062734,0.095455,0,1
1,GO TRNA WOBBLE URIDINE MODIFICATION,0.19979,0.06267,0.064267,0,1
1,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.10471,0.062203,0.061445,0,1
1,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.19697,0.062139,0.048799,0,1
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.1262,0.062107,0.054503,0,1
1,GO PROTEIN COMPLEX OLIGOMERIZATION,0.13338,0.060924,0.05493,0,1
1,GO FEMALE GAMETE GENERATION,0.38933,0.060867,0.027347,0,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.22348,0.059987,0.041888,0,1
1,GO ALDITOL METABOLIC PROCESS,0.060432,0.059911,0.084556,0,1
1,GO RNA LOCALIZATION,0.066792,0.058773,0.070568,0,1
1,GO CELL CYCLE PROCESS,0.098784,0.057577,0.037779,0,1
1,GO TRNA PROCESSING,0.13549,0.057521,0.055968,0,1
1,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.44269,0.055872,0.023101,0,1
1,GO SPINDLE ORGANIZATION,0.75664,0.055837,0.0075682,0,1
1,GO RRNA TRANSCRIPTION,0.22042,0.054738,0.064755,0,1
1,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.89205,0.052854,-0.018538,0,1
1,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.20122,0.052523,0.059655,0,1
1,GO MRNA TRANSPORT,0.072397,0.052097,0.067753,0,1
1,GO CELL DIVISION,0.080464,0.051958,0.048442,0,1
1,GO REGULATION OF NUCLEAR DIVISION,0.15214,0.05147,0.028849,0,1
1,GO REGULATION OF MRNA METABOLIC PROCESS,0.069238,0.049861,0.05638,0,1
1,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.3442,0.049729,0.042347,0,1
1,GO DNA CATABOLIC PROCESS,0.1313,0.046863,0.043495,0,1
1,GO MEIOTIC SPINDLE ORGANIZATION,0.21437,0.04678,0.045652,0,1
1,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.80639,0.04658,0.014282,0,1
1,GO NUCLEOTIDE PHOSPHORYLATION,0.28945,0.043902,0.042853,0,1
1,GO RNA 3 END PROCESSING,0.3442,0.043671,0.033546,0,1
1,GO TRANSCRIPTION BY RNA POLYMERASE III,0.3739,0.042726,0.026365,0,1
1,GO CELL CYCLE,0.072397,0.042063,0.039605,0,1
1,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.11742,0.04146,0.057454,0,1
1,GO RNA PROCESSING,0.30255,0.041028,0.040279,0,1
1,GO MRNA CLEAVAGE,0.27317,0.040418,0.042102,0,1
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.4355,0.03874,0.020321,0,1
1,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.61687,0.037575,0.0299,0,1
1,GO NUCLEUS ORGANIZATION,0.085497,0.03757,0.060858,0,1
1,GO APOPTOTIC DNA FRAGMENTATION,0.34835,0.037498,0.02303,0,1
1,GO MITOTIC CELL CYCLE CHECKPOINT,0.28578,0.035624,0.024531,0,1
1,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.19417,0.033946,0.035657,0,1
1,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.17029,0.033558,0.035843,0,1
1,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.52082,0.032413,0.042579,0,1
1,GO AEROBIC RESPIRATION,0.48215,0.030512,0.01583,0,1
1,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.59144,0.030417,0.0099228,0,1
1,GO SNRNA METABOLIC PROCESS,0.30446,0.02986,0.10477,0,1
1,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.090011,0.029741,0.0462,0,1
1,GO CELL CYCLE CHECKPOINT,0.52082,0.022715,0.0094692,0,1
1,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,1.3948e-05,0.38295,0.37622,0,0
1,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.8198e-07,0.34291,0.41188,0,0
1,GO TROPHOBLAST CELL MIGRATION,3.2146e-06,0.33699,0.37286,0,0
1,GO REGULATION OF GLOMERULAR FILTRATION,0.00031414,0.3345,0.39305,0,0
1,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.077698,0.30899,0.19781,0,0
1,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.00081356,0.28109,0.2972,0,0
1,GO BASEMENT MEMBRANE ASSEMBLY,1.5865e-05,0.27852,0.49556,0,0
1,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,9.9844e-05,0.27656,0.4064,0,0
1,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00040857,0.2704,0.39885,0,0
1,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,2.011e-05,0.2675,0.31899,0,0
1,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1.5014e-05,0.26437,0.2426,0,0
1,GO MAMMARY GLAND MORPHOGENESIS,1.4454e-06,0.26093,0.35481,0,0
1,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.00011596,0.25963,0.27328,0,0
1,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.0023321,0.25756,0.28567,0,0
1,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.0024281,0.25737,0.38085,0,0
1,GO FIBROBLAST PROLIFERATION,1.0861e-06,0.24487,0.30317,0,0
1,GO EPIDERMIS MORPHOGENESIS,0.020828,0.24461,0.23763,0,0
1,GO LABYRINTHINE LAYER MORPHOGENESIS,0.065005,0.24071,0.2133,0,0
1,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,1.5865e-05,0.2334,0.3283,0,0
1,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.29502,0.23327,0.051047,0,0
1,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0096941,0.23127,0.14782,0,0
1,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.00022927,0.22829,0.21798,0,0
1,GO NADPH REGENERATION,0.00024819,0.22526,0.20433,0,0
1,GO PEPTIDYL PROLINE HYDROXYLATION,0.012653,0.22282,0.24455,0,0
1,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.00040235,0.22274,0.19023,0,0
1,GO BRONCHUS DEVELOPMENT,0.031311,0.21855,0.23796,0,0
1,GO OXYGEN TRANSPORT,0.14755,0.21845,0.099046,0,0
1,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.13763,0.21738,0.23703,0,0
1,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.010895,0.21718,0.20454,0,0
1,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.012367,0.21337,0.16362,0,0
1,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.0047798,0.21136,0.21011,0,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,2.8305e-05,0.20749,0.24016,0,0
1,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.2253e-05,0.20721,0.21708,0,0
1,GO NEPHRIC DUCT MORPHOGENESIS,0.21738,0.20347,0.098586,0,0
1,GO METANEPHROS DEVELOPMENT,3.5022e-05,0.20233,0.22271,0,0
1,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.013546,0.2017,0.20442,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.1653,0.20101,0.13654,0,0
1,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.00096848,0.19982,0.15904,0,0
1,GO RESPONSE TO PROSTAGLANDIN,0.003607,0.19849,0.187,0,0
1,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.0023957,0.19701,0.32044,0,0
1,GO MIDGUT DEVELOPMENT,0.0020367,0.19517,0.25746,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.027118,0.1903,0.17188,0,0
1,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,4.4771e-05,0.18787,0.18957,0,0
1,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.081168,0.18617,0.21666,0,0
1,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.14419,0.18543,0.18006,0,0
1,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,1.0169e-05,0.18282,0.22611,0,0
1,GO HEAD MORPHOGENESIS,0.00022565,0.1817,0.25226,0,0
1,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,1.7385e-05,0.18136,0.17062,0,0
1,GO ETHANOL CATABOLIC PROCESS,0.072397,0.18133,0.20085,0,0
1,GO GLYCOSIDE METABOLIC PROCESS,0.044722,0.17877,0.092947,0,0
1,GO VASCULAR WOUND HEALING,0.18194,0.17871,0.075707,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.01251,0.17787,0.19369,0,0
1,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00083767,0.17314,0.25458,0,0
1,GO SOMATIC STEM CELL DIVISION,0.16042,0.17265,0.16555,0,0
1,GO REGULATION OF ODONTOGENESIS,0.0044298,0.17137,0.2376,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0039481,0.17055,0.1689,0,0
1,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.065005,0.16928,0.10673,0,0
1,GO REGULATION OF CELL FATE COMMITMENT,0.013546,0.16806,0.18701,0,0
1,GO LABYRINTHINE LAYER DEVELOPMENT,0.063836,0.16767,0.12812,0,0
1,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.12126,0.16766,0.11737,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.0018508,0.16341,0.21599,0,0
1,GO RESPONSE TO INTERLEUKIN 4,9.2585e-06,0.16287,0.19271,0,0
1,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.11647,0.16264,0.14328,0,0
1,GO POSITIVE REGULATION OF LIPID TRANSPORT,8.2686e-06,0.16145,0.23261,0,0
1,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,8.1623e-05,0.16139,0.1953,0,0
1,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,6.0079e-05,0.16136,0.19985,0,0
1,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00091404,0.15999,0.19603,0,0
1,GO LYMPHOCYTE HOMEOSTASIS,0.00080175,0.15966,0.18693,0,0
1,GO MALE GENITALIA DEVELOPMENT,0.079765,0.15888,0.098665,0,0
1,GO LEYDIG CELL DIFFERENTIATION,0.27495,0.15823,0.10138,0,0
1,GO HISTAMINE TRANSPORT,0.11837,0.15743,0.11973,0,0
1,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.0092477,0.15738,0.15672,0,0
1,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.073043,0.15655,0.11088,0,0
1,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.62832,0.15519,-0.0067138,0,0
1,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0068504,0.15451,0.30213,0,0
1,GO KIDNEY EPITHELIUM DEVELOPMENT,0.03006,0.15439,0.14395,0,0
1,GO KERATINOCYTE DEVELOPMENT,0.13549,0.15286,0.14536,0,0
1,GO HEART TRABECULA FORMATION,0.01829,0.15255,0.19654,0,0
1,GO RESPONSE TO INACTIVITY,0.20554,0.15052,0.080374,0,0
1,GO CELLULAR RESPONSE TO COPPER ION,0.37827,0.14993,0.029378,0,0
1,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.12224,0.14881,0.087226,0,0
1,GO REGULATION OF HEART MORPHOGENESIS,0.0067673,0.14838,0.18924,0,0
1,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00047589,0.1471,0.22199,0,0
1,GO SULFUR COMPOUND METABOLIC PROCESS,1.5052e-06,0.14661,0.1661,0,0
1,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.075674,0.14572,0.12317,0,0
1,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.15447,0.14427,0.11808,0,0
1,GO GAMMA DELTA T CELL DIFFERENTIATION,0.96284,0.14293,-0.069285,0,0
1,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.11837,0.14144,0.10419,0,0
1,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.12822,0.14125,0.18662,0,0
1,GO OUTFLOW TRACT MORPHOGENESIS,0.0037498,0.14092,0.1971,0,0
1,GO INTESTINAL LIPID ABSORPTION,0.25583,0.14091,0.065302,0,0
1,GO RESPONSE TO WATER,0.16778,0.14086,0.097715,0,0
1,GO ACYLGLYCEROL HOMEOSTASIS,0.067397,0.1402,0.10358,0,0
1,GO DRUG CATABOLIC PROCESS,0.1146,0.13892,0.080802,0,0
1,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.086237,0.13804,0.14222,0,0
1,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.12924,0.13699,0.12278,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.45972,0.13589,0.071358,0,0
1,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.17669,0.1357,0.066921,0,0
1,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.0055559,0.13431,0.1834,0,0
1,GO PSEUDOPODIUM ORGANIZATION,0.09714,0.13404,0.15394,0,0
1,GO DRUG METABOLIC PROCESS,0.0051547,0.13393,0.14594,0,0
1,GO CAMP METABOLIC PROCESS,0.02174,0.13367,0.16142,0,0
1,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.093126,0.13352,0.15132,0,0
1,GO PROTEIN NITROSYLATION,0.14755,0.13338,0.074796,0,0
1,GO POSITIVE REGULATION OF CELL AGING,0.032278,0.13294,0.13284,0,0
1,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.1387,0.13285,0.093648,0,0
1,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.17669,0.13249,0.16102,0,0
1,GO NEGATIVE REGULATION OF JNK CASCADE,0.00069207,0.13197,0.1595,0,0
1,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.0068504,0.13196,0.17822,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.35253,0.13164,0.037476,0,0
1,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.00094089,0.13007,0.16824,0,0
1,GO PROTEIN AUTO ADP RIBOSYLATION,0.09714,0.12977,0.13863,0,0
1,GO LIPID DIGESTION,0.6055,0.12959,0.013628,0,0
1,GO POSITIVE THYMIC T CELL SELECTION,0.11367,0.12959,0.13515,0,0
1,GO REGULATION OF WATER LOSS VIA SKIN,0.10734,0.12913,0.131,0,0
1,GO BLASTODERM SEGMENTATION,0.095518,0.12904,0.12259,0,0
1,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.024428,0.12897,0.11538,0,0
1,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.42602,0.12871,0.10275,0,0
1,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.14755,0.12829,0.11787,0,0
1,GO MAGNESIUM ION HOMEOSTASIS,0.20845,0.12722,0.13759,0,0
1,GO SHORT TERM MEMORY,0.24252,0.12721,0.081915,0,0
1,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.086237,0.1266,0.097661,0,0
1,GO FORELIMB MORPHOGENESIS,0.34008,0.12614,0.062984,0,0
1,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0052197,0.12554,0.13717,0,0
1,GO ESTROGEN METABOLIC PROCESS,0.00068191,0.12528,0.1651,0,0
1,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.15098,0.12492,0.13916,0,0
1,GO RETINOIC ACID METABOLIC PROCESS,0.088486,0.1243,0.10078,0,0
1,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.25753,0.12422,0.098388,0,0
1,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,9.9844e-05,0.12358,0.18113,0,0
1,GO GLYCINE METABOLIC PROCESS,0.14197,0.12348,0.077947,0,0
1,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.090782,0.12326,0.13637,0,0
1,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.00021511,0.12301,0.20196,0,0
1,GO PROTEIN TRIMERIZATION,0.1754,0.12271,0.071814,0,0
1,GO POLYSACCHARIDE CATABOLIC PROCESS,0.001118,0.12055,0.15395,0,0
1,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.42133,0.11999,0.066821,0,0
1,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,8.7316e-05,0.11968,0.21301,0,0
1,GO PIGMENTATION,0.063836,0.11941,0.083822,0,0
1,GO INACTIVATION OF MAPK ACTIVITY,0.0050904,0.11931,0.20382,0,0
1,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.014013,0.1192,0.18376,0,0
1,GO LIPOXYGENASE PATHWAY,0.49231,0.11912,0.062575,0,0
1,GO BILE ACID METABOLIC PROCESS,0.53672,0.11907,0.022816,0,0
1,GO CELL AGGREGATION,0.51035,0.11842,0.062748,0,0
1,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.1533,0.11817,0.11002,0,0
1,GO DEVELOPMENTAL PIGMENTATION,0.15447,0.11761,0.061414,0,0
1,GO GRANULOCYTE DIFFERENTIATION,0.063258,0.11661,0.12011,0,0
1,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.35674,0.11621,0.057181,0,0
1,GO TRNA CATABOLIC PROCESS,0.17283,0.11494,0.12416,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.062684,0.11487,0.10405,0,0
1,GO CELLULAR RESPONSE TO AMYLOID BETA,0.031311,0.1148,0.13158,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.041789,0.11305,0.10303,0,0
1,GO HEART VALVE FORMATION,0.20265,0.11276,0.095324,0,0
1,GO SYNAPTIC VESICLE BUDDING,0.093918,0.11253,0.10224,0,0
1,GO REGULATION OF GONAD DEVELOPMENT,0.17411,0.11244,0.066832,0,0
1,GO ARACHIDONIC ACID SECRETION,0.19838,0.11212,0.045064,0,0
1,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.096327,0.11152,0.093317,0,0
1,GO DIGESTIVE TRACT MORPHOGENESIS,0.20554,0.11142,0.079229,0,0
1,GO HORMONE METABOLIC PROCESS,0.0028118,0.1113,0.12402,0,0
1,GO CARDIAC VENTRICLE DEVELOPMENT,0.099614,0.11128,0.08367,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.3442,0.11127,0.081386,0,0
1,GO REGULATION OF ENDOCYTOSIS,0.0029645,0.11112,0.11464,0,0
1,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.35043,0.11061,0.044019,0,0
1,GO SCHWANN CELL DEVELOPMENT,0.086237,0.1102,0.092922,0,0
1,GO DIGESTIVE SYSTEM DEVELOPMENT,0.18327,0.11019,0.076012,0,0
1,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.178,0.1101,0.087217,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.38933,0.10962,0.072062,0,0
1,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.0014624,0.10912,0.11569,0,0
1,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.11647,0.10889,0.040293,0,0
1,GO CELLULAR RESPONSE TO ZINC ION,0.87926,0.10784,-0.035899,0,0
1,GO BICARBONATE TRANSPORT,0.054582,0.10751,0.087852,0,0
1,GO ANOIKIS,0.080464,0.10724,0.11264,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.025475,0.10718,0.10459,0,0
1,GO MICROVILLUS ORGANIZATION,0.23605,0.10652,0.074201,0,0
1,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.099614,0.10599,0.076361,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.043866,0.10594,0.13143,0,0
1,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.10214,0.1049,0.093029,0,0
1,GO PROXIMAL DISTAL PATTERN FORMATION,0.37608,0.10466,0.05418,0,0
1,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.16407,0.10442,0.093673,0,0
1,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.075674,0.10437,0.18095,0,0
1,GO RUFFLE ASSEMBLY,0.0049019,0.10413,0.13084,0,0
1,GO NEGATIVE REGULATION OF DNA REPLICATION,0.079765,0.10365,0.10376,0,0
1,GO PHAGOSOME MATURATION,0.099614,0.10348,0.081581,0,0
1,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.003607,0.10226,0.12621,0,0
1,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.1387,0.10151,0.11808,0,0
1,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.22814,0.10147,0.066231,0,0
1,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.0032928,0.10144,0.13028,0,0
1,GO B CELL RECEPTOR SIGNALING PATHWAY,0.093126,0.1014,0.1744,0,0
1,GO RESPONSE TO FUNGUS,0.14983,0.10052,0.071531,0,0
1,GO LINOLEIC ACID METABOLIC PROCESS,0.1653,0.10024,0.084577,0,0
1,GO PROTEIN STABILIZATION,0.00027284,0.099851,0.1259,0,0
1,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.019735,0.099656,0.12013,0,0
1,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.20554,0.099528,0.080848,0,0
1,GO RESPONSE TO COPPER ION,0.16778,0.099392,0.079486,0,0
1,GO ACTIN FILAMENT BASED MOVEMENT,0.096327,0.098766,0.081082,0,0
1,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.08331,0.098176,0.12923,0,0
1,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.17669,0.097951,0.059257,0,0
1,GO OVULATION CYCLE PROCESS,0.11933,0.09778,0.070003,0,0
1,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.9693,0.09766,-0.041805,0,0
1,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.1873,0.097589,0.068799,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.082591,0.0975,0.073676,0,0
1,GO POSITIVE REGULATION OF GLIOGENESIS,0.01585,0.097495,0.11446,0,0
1,GO REGULATION OF MYELINATION,0.010645,0.097287,0.11686,0,0
1,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.10823,0.096461,0.065337,0,0
1,GO DORSAL VENTRAL AXIS SPECIFICATION,0.14642,0.095318,0.19209,0,0
1,GO REGULATION OF INTEGRIN ACTIVATION,0.25078,0.094593,0.059813,0,0
1,GO COCHLEA MORPHOGENESIS,0.35463,0.094358,0.050195,0,0
1,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.08331,0.094232,0.12374,0,0
1,GO ACTIN FILAMENT DEPOLYMERIZATION,0.1453,0.094185,0.087824,0,0
1,GO INNER CELL MASS CELL PROLIFERATION,0.017699,0.094128,0.1659,0,0
1,GO ENERGY RESERVE METABOLIC PROCESS,0.1313,0.094105,0.069222,0,0
1,GO RADIAL GLIAL CELL DIFFERENTIATION,0.16904,0.093912,0.11427,0,0
1,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.21738,0.092815,0.077271,0,0
1,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.11553,0.09236,0.067965,0,0
1,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.27673,0.09214,0.069171,0,0
1,GO ATP TRANSPORT,0.37608,0.091865,0.041167,0,0
1,GO INTERMEDIATE FILAMENT BASED PROCESS,0.098784,0.091783,0.093907,0,0
1,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.20265,0.091628,0.086343,0,0
1,GO REGULATION OF PROTON TRANSPORT,0.068006,0.091412,0.093973,0,0
1,GO CHLORIDE ION HOMEOSTASIS,0.20122,0.091399,0.078218,0,0
1,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.2644,0.091153,0.075899,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.32393,0.090843,0.025768,0,0
1,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.32993,0.090754,0.080656,0,0
1,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.30255,0.090658,0.053619,0,0
1,GO TRNA 5 LEADER REMOVAL,0.014013,0.090657,0.13666,0,0
1,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.075009,0.090614,0.077142,0,0
1,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.21288,0.090311,0.10554,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.15447,0.089975,0.086823,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0016122,0.08934,0.10261,0,0
1,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.13549,0.089312,0.063738,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.77829,0.089262,0.023401,0,0
1,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.10912,0.089207,0.1059,0,0
1,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.072397,0.089207,0.11149,0,0
1,GO TERPENOID BIOSYNTHETIC PROCESS,0.3739,0.089135,0.050217,0,0
1,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.25246,0.088766,0.094433,0,0
1,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.10912,0.088665,0.0774,0,0
1,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0054192,0.088558,0.10531,0,0
1,GO AMINO ACID IMPORT,0.41666,0.088166,0.060246,0,0
1,GO CARDIAC MUSCLE CELL CONTRACTION,0.92738,0.088106,-0.014617,0,0
1,GO DETOXIFICATION OF INORGANIC COMPOUND,0.84741,0.087783,-0.032723,0,0
1,GO TRNA 5 END PROCESSING,0.023419,0.08745,0.12795,0,0
1,GO REGULATION OF TUBE SIZE,0.0065235,0.087334,0.12605,0,0
1,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.12322,0.086322,0.10355,0,0
1,GO BILE ACID BIOSYNTHETIC PROCESS,0.67206,0.086002,0.012966,0,0
1,GO EXTRACELLULAR TRANSPORT,0.21738,0.085894,0.065022,0,0
1,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.41203,0.08589,0.04165,0,0
1,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.24745,0.085567,0.090163,0,0
1,GO RENAL SYSTEM PROCESS,0.10646,0.085547,0.10669,0,0
1,GO BLASTOCYST GROWTH,0.024173,0.085369,0.13674,0,0
1,GO RETINAL ROD CELL DIFFERENTIATION,0.72603,0.084789,0.020597,0,0
1,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.031631,0.084715,0.089027,0,0
1,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.6515,0.084171,0.034742,0,0
1,GO NOTCH RECEPTOR PROCESSING,0.26267,0.083908,0.093702,0,0
1,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.063836,0.083845,0.096412,0,0
1,GO REGULATION OF REPRODUCTIVE PROCESS,0.011678,0.083843,0.081351,0,0
1,GO LOCOMOTOR RHYTHM,0.10385,0.083749,0.10035,0,0
1,GO KIDNEY MESENCHYME DEVELOPMENT,0.33599,0.083695,0.065833,0,0
1,GO HETEROTYPIC CELL CELL ADHESION,0.071756,0.083351,0.12016,0,0
1,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0046604,0.083233,0.14078,0,0
1,GO STEROID CATABOLIC PROCESS,0.1262,0.08316,0.10998,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.0016122,0.083134,0.10656,0,0
1,GO RESPONSE TO NITRIC OXIDE,0.12822,0.082714,0.061316,0,0
1,GO RESPONSE TO ZINC ION,0.098784,0.082575,0.079303,0,0
1,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.32993,0.082533,0.070896,0,0
1,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.35253,0.082476,0.049127,0,0
1,GO CELL CELL JUNCTION ASSEMBLY,0.13444,0.082151,0.092713,0,0
1,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.30066,0.082121,0.020975,0,0
1,GO POSITIVE REGULATION OF AXON EXTENSION,0.10912,0.082046,0.086072,0,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.13338,0.081929,0.10051,0,0
1,GO NEGATIVE REGULATION OF DNA REPAIR,0.23766,0.081802,0.056308,0,0
1,GO LUNG ALVEOLUS DEVELOPMENT,0.31409,0.081786,0.082756,0,0
1,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.37827,0.081473,0.074318,0,0
1,GO NEGATIVE REGULATION OF SECRETION,0.084034,0.081079,0.065247,0,0
1,GO WATER TRANSPORT,0.11553,0.080557,0.13931,0,0
1,GO MESODERMAL CELL FATE COMMITMENT,0.99838,0.080462,-0.049292,0,0
1,GO ARACHIDONIC ACID METABOLIC PROCESS,0.071756,0.080192,0.1232,0,0
1,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.46218,0.080146,0.04143,0,0
1,GO EMBRYONIC ORGAN MORPHOGENESIS,0.13027,0.080097,0.060933,0,0
1,GO TYPE B PANCREATIC CELL PROLIFERATION,0.39832,0.080027,0.10288,0,0
1,GO DORSAL AORTA DEVELOPMENT,0.91451,0.079985,0.026804,0,0
1,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.080464,0.079712,0.11844,0,0
1,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.178,0.079491,0.081595,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.13027,0.079439,0.087711,0,0
1,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.40973,0.079332,0.047323,0,0
1,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.40058,0.079045,0.03697,0,0
1,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.73212,0.078858,0.025253,0,0
1,GO NEGATIVE REGULATION OF AXON EXTENSION,0.20992,0.078165,0.071441,0,0
1,GO REGULATION OF DNA BINDING,0.15447,0.077989,0.050024,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.3871,0.076972,0.0788,0,0
1,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.20122,0.076711,0.061496,0,0
1,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.23286,0.076634,0.053139,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.1252,0.076605,0.097652,0,0
1,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.35886,0.076537,0.03913,0,0
1,GO MESONEPHROS DEVELOPMENT,0.14308,0.076377,0.09623,0,0
1,GO NEPHRON MORPHOGENESIS,0.15447,0.076021,0.080761,0,0
1,GO POSITIVE T CELL SELECTION,0.1533,0.07587,0.097979,0,0
1,GO RESPONSE TO MUSCLE ACTIVITY,0.21587,0.075438,0.088536,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.41434,0.075419,0.066092,0,0
1,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.27853,0.075181,0.098397,0,0
1,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.82526,0.074761,-0.012895,0,0
1,GO RESPONSE TO CAMP,0.01128,0.074608,0.13078,0,0
1,GO ALPHA AMINO ACID METABOLIC PROCESS,0.040981,0.074582,0.064025,0,0
1,GO ORGAN INDUCTION,0.069238,0.07456,0.1241,0,0
1,GO STEM CELL PROLIFERATION,0.15098,0.074547,0.064141,0,0
1,GO GLIOGENESIS,0.10558,0.074397,0.077885,0,0
1,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.1653,0.074375,0.20695,0,0
1,GO NEGATIVE REGULATION OF DNA BINDING,0.17029,0.07409,0.05944,0,0
1,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.29877,0.07404,0.04068,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.049681,0.073876,0.12912,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.46218,0.073777,0.055869,0,0
1,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.53406,0.073723,0.044517,0,0
1,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.26614,0.073575,0.082385,0,0
1,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.81581,0.073554,0.033096,0,0
1,GO PIGMENT GRANULE LOCALIZATION,0.10214,0.073124,0.074921,0,0
1,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.11933,0.073121,0.056309,0,0
1,GO PROTEIN KINASE C SIGNALING,0.20122,0.072826,0.094644,0,0
1,GO CELL JUNCTION ASSEMBLY,0.28761,0.072723,0.056006,0,0
1,GO CELL CELL JUNCTION ORGANIZATION,0.26964,0.07258,0.075781,0,0
1,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.10045,0.07254,0.071263,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.065005,0.072399,0.081468,0,0
1,GO REGULATION OF MICROVILLUS ORGANIZATION,0.40973,0.07219,0.037536,0,0
1,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041789,0.072127,0.10552,0,0
1,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.081168,0.071877,0.079137,0,0
1,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.30446,0.071739,0.042615,0,0
1,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.054074,0.071251,0.095212,0,0
1,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.00094089,0.071071,0.094087,0,0
1,GO CYTOCHROME COMPLEX ASSEMBLY,0.12421,0.070963,0.069175,0,0
1,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.41434,0.070905,0.051578,0,0
1,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.10558,0.070867,0.095397,0,0
1,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.0002443,0.070855,0.097671,0,0
1,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.09714,0.070827,0.13201,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.040981,0.070804,0.10601,0,0
1,GO CELL PROLIFERATION IN HINDBRAIN,0.22658,0.070724,0.061792,0,0
1,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.074349,0.070514,0.061889,0,0
1,GO TETRAHYDROFOLATE INTERCONVERSION,0.27673,0.070018,0.032811,0,0
1,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.37608,0.069953,0.054551,0,0
1,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.12721,0.069883,0.089391,0,0
1,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.24911,0.069784,0.03111,0,0
1,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.071119,0.069705,0.064784,0,0
1,GO PANCREATIC JUICE SECRETION,0.38488,0.069697,0.050253,0,0
1,GO TRNA WOBBLE BASE MODIFICATION,0.25583,0.068831,0.056874,0,0
1,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.15921,0.068799,0.077573,0,0
1,GO RELAXATION OF CARDIAC MUSCLE,0.80639,0.068543,-0.060464,0,0
1,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.25246,0.068539,0.061474,0,0
1,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.62832,0.068271,0.028752,0,0
1,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.99515,0.068227,-0.062917,0,0
1,GO NEPHRIC DUCT DEVELOPMENT,0.75048,0.06818,0.01316,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.063258,0.068002,0.084304,0,0
1,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.20122,0.067924,0.079466,0,0
1,GO COENZYME A METABOLIC PROCESS,0.081877,0.067643,0.080587,0,0
1,GO CELLULAR RESPONSE TO CAMP,0.065005,0.067582,0.1024,0,0
1,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.016568,0.067541,0.12048,0,0
1,GO ATRIAL SEPTUM DEVELOPMENT,0.14308,0.06738,0.11608,0,0
1,GO ZINC ION TRANSPORT,0.24252,0.067371,0.069652,0,0
1,GO CARBOHYDRATE TRANSPORT,0.10823,0.06728,0.061047,0,0
1,GO CARDIAC CELL DEVELOPMENT,0.2644,0.06703,0.066724,0,0
1,GO T CELL LINEAGE COMMITMENT,0.13444,0.066983,0.087541,0,0
1,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.15921,0.066932,0.087724,0,0
1,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.55287,0.066794,0.031709,0,0
1,GO PROTEIN K48 LINKED UBIQUITINATION,0.17283,0.066689,0.053032,0,0
1,GO POLYSACCHARIDE METABOLIC PROCESS,0.24089,0.066302,0.051712,0,0
1,GO PROTEIN CONTAINING COMPLEX REMODELING,0.065596,0.066241,0.1305,0,0
1,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.20992,0.066127,0.053839,0,0
1,GO MODIFIED AMINO ACID TRANSPORT,0.05357,0.066054,0.090465,0,0
1,GO REGULATION OF NEUROBLAST PROLIFERATION,0.80953,0.066034,0.020157,0,0
1,GO VASODILATION,0.55016,0.065943,0.035061,0,0
1,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.1754,0.065817,0.045368,0,0
1,GO PIRNA METABOLIC PROCESS,0.71996,0.065781,0.016693,0,0
1,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.31604,0.065575,0.052306,0,0
1,GO REGULATION OF TRANSLATIONAL ELONGATION,0.32195,0.065497,0.047071,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.39156,0.065278,0.035567,0,0
1,GO REGULATION OF CELL MORPHOGENESIS,0.22658,0.065201,0.057993,0,0
1,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.50258,0.065183,0.037165,0,0
1,GO REGULATION OF GASTRIC ACID SECRETION,0.35886,0.065088,0.056962,0,0
1,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.06986,0.064984,0.090359,0,0
1,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.1387,0.06475,0.05028,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.54746,0.064739,0.021814,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.11183,0.064685,0.059828,0,0
1,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.13338,0.064514,0.076175,0,0
1,GO VITAMIN TRANSPORT,0.39381,0.064392,0.042335,0,0
1,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.099614,0.064357,0.07099,0,0
1,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.81267,0.064299,0.018979,0,0
1,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.12126,0.064291,0.11903,0,0
1,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.35463,0.064163,0.1033,0,0
1,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.078382,0.064056,0.13134,0,0
1,GO CELLULAR RESPONSE TO STEROL,0.16407,0.063933,0.093395,0,0
1,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.39381,0.063695,0.080006,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.066792,0.063645,0.07858,0,0
1,GO SENSORY ORGAN DEVELOPMENT,0.52082,0.063591,0.029269,0,0
1,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.27853,0.063543,0.094944,0,0
1,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.76899,0.063072,-0.0079505,0,0
1,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.1914,0.062673,0.08518,0,0
1,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.20845,0.062576,0.068782,0,0
1,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.47963,0.062252,0.044904,0,0
1,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.22503,0.062247,0.11559,0,0
1,GO REGULATION OF CENTROSOME DUPLICATION,0.10045,0.062159,0.062588,0,0
1,GO RESPONSE TO COLD,0.45482,0.062046,0.051986,0,0
1,GO CAMERA TYPE EYE DEVELOPMENT,0.19557,0.061968,0.06309,0,0
1,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.99192,0.061917,0.0045766,0,0
1,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.44752,0.06172,0.049435,0,0
1,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.35674,0.06152,0.047211,0,0
1,GO RESPONSE TO ETHANOL,0.32993,0.061389,0.043226,0,0
1,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.13656,0.061355,0.071956,0,0
1,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.15098,0.061281,0.063889,0,0
1,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.38047,0.061184,0.053638,0,0
1,GO GENE SILENCING,0.12421,0.060903,0.057319,0,0
1,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.10385,0.060841,0.056015,0,0
1,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.58864,0.06066,0.025833,0,0
1,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.58864,0.060569,0.030774,0,0
1,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.16163,0.060556,0.061292,0,0
1,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.12029,0.060355,0.056023,0,0
1,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.046921,0.060336,0.087932,0,0
1,GO POSITIVE REGULATION OF FERTILIZATION,0.61402,0.060113,-0.038912,0,0
1,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.87287,0.059977,-0.0356,0,0
1,GO RESPONSE TO AXON INJURY,0.14642,0.05988,0.090203,0,0
1,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.062114,0.059828,0.12979,0,0
1,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.084034,0.059788,0.062881,0,0
1,GO VITAMIN METABOLIC PROCESS,0.025475,0.059774,0.092116,0,0
1,GO SIGNAL PEPTIDE PROCESSING,0.12029,0.059646,0.094722,0,0
1,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.02174,0.059569,0.11809,0,0
1,GO GDP METABOLIC PROCESS,0.7814,0.058964,-0.027909,0,0
1,GO GANGLIOSIDE METABOLIC PROCESS,0.47712,0.058806,0.058664,0,0
1,GO GOLGI LOCALIZATION,0.84424,0.058726,0.0064884,0,0
1,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.10823,0.058679,0.064664,0,0
1,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.35886,0.058664,0.064354,0,0
1,GO NOTCH SIGNALING PATHWAY,0.52345,0.058618,0.037373,0,0
1,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.14088,0.058185,0.099872,0,0
1,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.44028,0.058075,0.084393,0,0
1,GO ER OVERLOAD RESPONSE,0.55287,0.058044,0.041155,0,0
1,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.33599,0.057963,0.032892,0,0
1,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.79387,0.057961,-0.023354,0,0
1,GO REGULATION OF AXON GUIDANCE,0.178,0.057746,0.075593,0,0
1,GO DIOL BIOSYNTHETIC PROCESS,0.15921,0.057574,0.056274,0,0
1,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.0047198,0.057555,0.088913,0,0
1,GO REGULATION OF RESPIRATORY BURST,0.92416,0.057268,-0.0043338,0,0
1,GO NEGATIVE REGULATION OF CELL DIVISION,0.43075,0.057238,0.046294,0,0
1,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.1252,0.057219,0.052166,0,0
1,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.11742,0.056972,0.076241,0,0
1,GO PYRUVATE METABOLIC PROCESS,0.318,0.056523,0.045327,0,0
1,GO SMOOTH MUSCLE CONTRACTION,0.10129,0.056488,0.081113,0,0
1,GO ACTIN CROSSLINK FORMATION,0.94348,0.056308,-0.01483,0,0
1,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.42367,0.055573,0.059798,0,0
1,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.38047,0.055572,0.034628,0,0
1,GO UBIQUINONE METABOLIC PROCESS,0.41666,0.055558,0.029432,0,0
1,GO PRO B CELL DIFFERENTIATION,0.21738,0.055435,0.11395,0,0
1,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.10646,0.055409,0.099769,0,0
1,GO MUSCLE CONTRACTION,0.095518,0.055376,0.080697,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.099614,0.055245,0.071208,0,0
1,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.41666,0.055173,0.041561,0,0
1,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.017699,0.055135,0.067752,0,0
1,GO REGULATION OF GLUCONEOGENESIS,0.15214,0.055064,0.055446,0,0
1,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.20992,0.05491,0.051852,0,0
1,GO CARTILAGE MORPHOGENESIS,0.44028,0.054874,0.081855,0,0
1,GO PROTEIN AUTOUBIQUITINATION,0.093918,0.054865,0.05984,0,0
1,GO CELL GROWTH,0.073043,0.054744,0.075484,0,0
1,GO POSITIVE REGULATION OF GROWTH,0.081877,0.054545,0.070327,0,0
1,GO CALCIUM MEDIATED SIGNALING,0.15214,0.054385,0.066795,0,0
1,GO RESPONSE TO LEAD ION,0.1754,0.053658,0.070962,0,0
1,GO SENSORY SYSTEM DEVELOPMENT,0.35886,0.053602,0.044304,0,0
1,GO REGULATION OF MUSCLE CONTRACTION,0.27495,0.053257,0.053146,0,0
1,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.29315,0.053253,0.073237,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.31997,0.053133,0.057925,0,0
1,GO COLLECTING DUCT DEVELOPMENT,0.42367,0.053128,0.037418,0,0
1,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.35043,0.052943,0.13318,0,0
1,GO CELLULAR HYPEROSMOTIC RESPONSE,0.29689,0.052704,0.058482,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.42602,0.052648,0.041718,0,0
1,GO REGULATION OF EXCRETION,0.11367,0.052583,0.10052,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.67206,0.052172,0.033462,0,0
1,GO REGULATION OF ANIMAL ORGAN FORMATION,0.31604,0.051913,0.062243,0,0
1,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.10214,0.05151,0.075171,0,0
1,GO STEROID HORMONE SECRETION,0.2913,0.051311,0.07727,0,0
1,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.47712,0.051184,0.044986,0,0
1,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.60268,0.051091,0.043553,0,0
1,GO AMP METABOLIC PROCESS,0.1793,0.051087,0.094076,0,0
1,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.28033,0.051039,0.050531,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.50258,0.051035,0.022253,0,0
1,GO PEPTIDYL SERINE MODIFICATION,0.10385,0.051001,0.059058,0,0
1,GO SEX DIFFERENTIATION,0.21288,0.050709,0.050313,0,0
1,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.079071,0.050604,0.070884,0,0
1,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.1873,0.050144,0.11274,0,0
1,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.1453,0.050048,0.075167,0,0
1,GO MACROMOLECULE DEACYLATION,0.093918,0.05,0.056273,0,0
1,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.14308,0.04983,0.079302,0,0
1,GO RESPONSE TO LEPTIN,0.22971,0.049814,0.082843,0,0
1,GO NODAL SIGNALING PATHWAY,0.64858,0.049752,0.015242,0,0
1,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.69286,0.049694,0.024351,0,0
1,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.31997,0.049574,0.094317,0,0
1,GO PEPTIDYL LYSINE TRIMETHYLATION,0.28761,0.049381,0.056839,0,0
1,GO RESPONSE TO STEROL DEPLETION,0.20845,0.049357,0.074167,0,0
1,GO DEVELOPMENTAL GROWTH,0.12029,0.04918,0.064156,0,0
1,GO HISTONE MRNA METABOLIC PROCESS,0.23605,0.049079,0.029434,0,0
1,GO ALANINE TRANSPORT,0.63697,0.04885,0.036366,0,0
1,GO REGULATION OF CELLULAR LOCALIZATION,0.19697,0.048751,0.046743,0,0
1,GO FUCOSE METABOLIC PROCESS,0.46218,0.048735,0.03635,0,0
1,GO TRNA MODIFICATION,0.11742,0.048635,0.065646,0,0
1,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.86649,0.04856,0.0064215,0,0
1,GO DEFINITIVE HEMOPOIESIS,0.19003,0.048538,0.10486,0,0
1,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.11183,0.0485,0.07727,0,0
1,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.74128,0.048315,0.024919,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.62545,0.048058,-0.022821,0,0
1,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.19003,0.047788,0.054374,0,0
1,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.087731,0.047766,0.061837,0,0
1,GO POST EMBRYONIC DEVELOPMENT,0.43789,0.047673,0.048754,0,0
1,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.13444,0.047455,0.069355,0,0
1,GO RESPONSE TO SALT,0.40973,0.047359,0.02039,0,0
1,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.080464,0.04733,0.092767,0,0
1,GO POSITIVE REGULATION OF CELL GROWTH,0.1453,0.047237,0.063156,0,0
1,GO HEART INDUCTION,0.80953,0.047217,-0.0060883,0,0
1,GO LEUKOCYTE TETHERING OR ROLLING,0.318,0.047132,0.073118,0,0
1,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.067397,0.047108,0.063199,0,0
1,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.10129,0.047035,0.069585,0,0
1,GO POLYOL METABOLIC PROCESS,0.15447,0.046856,0.052137,0,0
1,GO SPLEEN DEVELOPMENT,0.15098,0.046671,0.076132,0,0
1,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.41203,0.046667,0.056359,0,0
1,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.4355,0.046543,0.038741,0,0
1,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.15214,0.046534,0.048108,0,0
1,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.11092,0.046454,0.065391,0,0
1,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.32993,0.046402,0.071914,0,0
1,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.27495,0.046332,0.044818,0,0
1,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.66616,0.046201,0.03995,0,0
1,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.63697,0.046127,-0.036986,0,0
1,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.14755,0.045863,0.13258,0,0
1,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.61687,0.045646,0.026252,0,0
1,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.6312,0.045556,0.012436,0,0
1,GO NEUROTROPHIN SIGNALING PATHWAY,0.68988,0.045505,0.02259,0,0
1,GO REPRODUCTION,0.11647,0.04543,0.053727,0,0
1,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.5665,0.045248,0.033069,0,0
1,GO VIRAL LATENCY,0.28213,0.045145,0.03261,0,0
1,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.38267,0.045093,0.053426,0,0
1,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.18595,0.045041,0.075609,0,0
1,GO GONADOTROPIN SECRETION,0.090782,0.044902,0.10407,0,0
1,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.091558,0.044626,0.054192,0,0
1,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.3739,0.044517,-0.0017168,0,0
1,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.71391,0.044481,0.012189,0,0
1,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.19417,0.044264,0.078033,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.20699,0.04419,0.041662,0,0
1,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.9113,0.043962,-0.011404,0,0
1,GO CYTOPLASMIC TRANSLATION,0.33194,0.043906,0.034298,0,0
1,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.34213,0.043848,0.070063,0,0
1,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.35674,0.043813,0.034944,0,0
1,GO URONIC ACID METABOLIC PROCESS,0.1453,0.043767,0.04168,0,0
1,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.86649,0.043762,0.020732,0,0
1,GO LYMPH NODE DEVELOPMENT,0.31409,0.043664,0.088464,0,0
1,GO POSITIVE REGULATION OF DNA BINDING,0.44269,0.043548,0.030686,0,0
1,GO CELL MORPHOGENESIS,0.61402,0.043444,0.029855,0,0
1,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.45727,0.043416,0.060729,0,0
1,GO P BODY ASSEMBLY,0.572,0.043256,0.034233,0,0
1,GO REGULATION OF PROTEIN DEACETYLATION,0.40743,0.043226,0.042805,0,0
1,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.077018,0.043201,0.058526,0,0
1,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.93382,0.043048,-0.013018,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.797,0.042664,0.028508,0,0
1,GO EPITHELIAL CELL MORPHOGENESIS,0.58029,0.04261,0.070929,0,0
1,GO SENSORY ORGAN MORPHOGENESIS,0.6055,0.042547,0.025623,0,0
1,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.10912,0.042525,0.067633,0,0
1,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.30446,0.042509,0.044011,0,0
1,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.47461,0.042476,0.055572,0,0
1,GO SEGMENTATION,0.52874,0.042374,0.038114,0,0
1,GO RESPIRATORY SYSTEM PROCESS,0.5,0.04237,0.03252,0,0
1,GO DNA INTEGRITY CHECKPOINT,0.58864,0.042127,0.022053,0,0
1,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.48976,0.041942,0.037755,0,0
1,GO INOSITOL METABOLIC PROCESS,0.72603,0.041875,-0.024249,0,0
1,GO CYTOSOLIC TRANSPORT,0.062684,0.041796,0.074415,0,0
1,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.79387,0.041576,0.0059725,0,0
1,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.32195,0.041147,0.044015,0,0
1,GO THYMIC T CELL SELECTION,0.061549,0.041105,0.13047,0,0
1,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.4355,0.041081,0.049667,0,0
1,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.44994,0.041,0.044364,0,0
1,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.095518,0.040816,0.10684,0,0
1,GO CENTRIOLE ASSEMBLY,0.48976,0.04079,0.021935,0,0
1,GO REGULATION OF ORGANELLE ORGANIZATION,0.077698,0.040774,0.048374,0,0
1,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.97899,0.040646,-0.0010536,0,0
1,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.72907,0.040611,-0.010907,0,0
1,GO CARDIAC VENTRICLE MORPHOGENESIS,0.58585,0.040438,0.02155,0,0
1,GO LIPID PHOSPHORYLATION,0.18866,0.04024,0.066133,0,0
1,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.20699,0.040196,0.11292,0,0
1,GO MEMBRANE FUSION,0.31021,0.040068,0.044383,0,0
1,GO STEROID BIOSYNTHETIC PROCESS,0.44752,0.040065,0.027284,0,0
1,GO BASE EXCISION REPAIR AP SITE FORMATION,0.86649,0.040036,-0.028381,0,0
1,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.5394,0.040004,0.04857,0,0
1,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.074349,0.039848,0.055204,0,0
1,GO REGULATION OF ENDOCRINE PROCESS,0.12126,0.039819,0.088021,0,0
1,GO CARDIAC ATRIUM DEVELOPMENT,0.34008,0.039744,0.069899,0,0
1,GO MITOCHONDRIAL RNA PROCESSING,0.77829,0.039734,0.016546,0,0
1,GO REGULATION OF CELLULAR PH,0.26614,0.039691,0.039822,0,0
1,GO MULTICELLULAR ORGANISM GROWTH,0.53406,0.03967,0.041577,0,0
1,GO RESPONSE TO METAL ION,0.59986,0.039606,0.035969,0,0
1,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.20122,0.039533,0.063561,0,0
1,GO DNA METABOLIC PROCESS,0.25246,0.039464,0.026401,0,0
1,GO REGULATION OF PROTEIN POLYMERIZATION,0.26095,0.039463,0.04457,0,0
1,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.14755,0.039315,0.061761,0,0
1,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.28033,0.039144,0.070148,0,0
1,GO MITOCHONDRIAL TRANSCRIPTION,0.19697,0.039027,0.0412,0,0
1,GO REGULATION OF CENTROSOME CYCLE,0.33396,0.038831,0.025647,0,0
1,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.72299,0.038828,0.016664,0,0
1,GO MITOCHONDRIAL DNA REPLICATION,0.23286,0.038762,0.046946,0,0
1,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.98546,0.038678,0.011137,0,0
1,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.43075,0.038552,0.033887,0,0
1,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.50258,0.038502,0.070293,0,0
1,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.22348,0.038226,0.028194,0,0
1,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.46466,0.038218,0.035303,0,0
1,GO GLYCOSYLATION,0.11647,0.038156,0.063786,0,0
1,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.25246,0.037832,0.084557,0,0
1,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.11837,0.03768,0.053103,0,0
1,GO EXECUTION PHASE OF APOPTOSIS,0.09796,0.037587,0.055427,0,0
1,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.72907,0.037499,-0.0094118,0,0
1,GO REGULATION OF PH,0.22195,0.037453,0.044588,0,0
1,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.23445,0.037447,0.025981,0,0
1,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.65442,0.037408,0.020955,0,0
1,GO REGULATION OF LYASE ACTIVITY,0.26614,0.037374,0.044068,0,0
1,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.18866,0.037355,0.072039,0,0
1,GO EXPLORATION BEHAVIOR,0.72603,0.037214,0.00060496,0,0
1,GO REGULATION OF ATPASE ACTIVITY,0.15447,0.037112,0.045063,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE,0.43789,0.037088,0.032329,0,0
1,GO RNA SURVEILLANCE,0.57476,0.037047,0.0074132,0,0
1,GO ENDOCRINE HORMONE SECRETION,0.065596,0.037003,0.10601,0,0
1,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.90167,0.036786,-0.0073945,0,0
1,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.30637,0.036739,0.031522,0,0
1,GO TRNA TRANSPORT,0.26614,0.03671,0.048756,0,0
1,GO TRANSCRIPTION BY RNA POLYMERASE I,0.26789,0.03652,0.050679,0,0
1,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.59705,0.036508,0.018936,0,0
1,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.1453,0.036476,0.072639,0,0
1,GO METAPHASE PLATE CONGRESSION,0.56925,0.036445,-0.00092536,0,0
1,GO INTRACELLULAR PROTEIN TRANSPORT,0.024947,0.036443,0.058831,0,0
1,GO PURINE NUCLEOTIDE TRANSPORT,0.61402,0.036368,0.02593,0,0
1,GO G2 DNA DAMAGE CHECKPOINT,0.40286,0.03627,0.026425,0,0
1,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.16778,0.03615,0.068319,0,0
1,GO CIRCULATORY SYSTEM PROCESS,0.46466,0.035824,0.047404,0,0
1,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.38488,0.035672,0.017093,0,0
1,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.78451,0.035525,0.0043302,0,0
1,GO MRNA METABOLIC PROCESS,0.30637,0.035297,0.034267,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.44752,0.035154,0.022553,0,0
1,GO EAR DEVELOPMENT,0.66616,0.03487,-0.024431,0,0
1,GO KIDNEY MORPHOGENESIS,0.33803,0.03482,0.05765,0,0
1,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.41666,0.034816,0.10056,0,0
1,GO REGULATION OF SULFUR METABOLIC PROCESS,0.44028,0.034662,0.059202,0,0
1,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.6691,0.034403,0.013844,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.64858,0.034242,0.024902,0,0
1,GO REGULATION OF DEPHOSPHORYLATION,0.27673,0.034166,0.039097,0,0
1,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.43312,0.034164,0.028692,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.36311,0.033859,0.060358,0,0
1,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.33599,0.033762,0.042094,0,0
1,GO REGULATION OF CHROMOSOME SEPARATION,0.35253,0.033577,0.016953,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.23128,0.033556,0.033043,0,0
1,GO REGULATION OF CELL SIZE,0.11933,0.033481,0.067607,0,0
1,GO REGULATION OF DNA METABOLIC PROCESS,0.13549,0.033471,0.04598,0,0
1,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.80012,0.033318,-0.017319,0,0
1,GO NCRNA 3 END PROCESSING,0.51557,0.033214,0.076136,0,0
1,GO REGULATION OF PROSTAGLANDIN SECRETION,0.072397,0.033073,0.11548,0,0
1,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.38488,0.03297,0.027689,0,0
1,GO PEROXISOMAL MEMBRANE TRANSPORT,0.36956,0.032891,0.032793,0,0
1,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.66321,0.032827,0.044413,0,0
1,GO EYE MORPHOGENESIS,0.46218,0.032613,0.03906,0,0
1,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.39606,0.032314,0.022522,0,0
1,GO WATER HOMEOSTASIS,0.68689,0.032306,0.030415,0,0
1,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.65442,0.032203,0.018265,0,0
1,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.37608,0.031805,0.030024,0,0
1,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.22348,0.031485,0.043484,0,0
1,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.13234,0.031364,0.071288,0,0
1,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.71996,0.031045,0.010048,0,0
1,GO HISTONE MONOUBIQUITINATION,0.37173,0.030925,0.038955,0,0
1,GO SPINDLE ASSEMBLY,0.86649,0.030911,-0.0040198,0,0
1,GO REGULATION OF DNA REPAIR,0.61972,0.030725,0.013267,0,0
1,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.13979,0.030037,0.060424,0,0
1,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.33396,0.029982,0.049064,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.066192,0.02997,0.098709,0,0
1,GO POSITIVE REGULATION OF MYELINATION,0.28213,0.029914,0.054011,0,0
1,GO ERYTHROCYTE MATURATION,0.15565,0.029892,0.12337,0,0
1,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.97576,0.029876,0.00091127,0,0
1,GO CELL PROJECTION ASSEMBLY,0.1793,0.029611,0.057774,0,0
1,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.81267,0.029607,-0.0051356,0,0
1,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.35674,0.029585,0.044643,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.19557,0.029549,0.059243,0,0
1,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.44994,0.029503,0.04412,0,0
1,GO PARTURITION,0.50776,0.029463,0.036628,0,0
1,GO MACROMOLECULE DEPALMITOYLATION,0.2913,0.029451,0.042837,0,0
1,GO PROTEIN LOCALIZATION TO MEMBRANE,0.17029,0.029381,0.046862,0,0
1,GO REGULATION OF PEPTIDE TRANSPORT,0.40743,0.029234,0.038727,0,0
1,GO POSITIVE REGULATION OF DNA REPLICATION,0.86331,0.029144,0.0010005,0,0
1,GO PROTEIN TARGETING TO MITOCHONDRION,0.93704,0.029118,0.0061696,0,0
1,GO T CELL SELECTION,0.15565,0.028946,0.1009,0,0
1,GO ONE CARBON METABOLIC PROCESS,0.5583,0.028769,0.021755,0,0
1,GO CELL CYCLE G2 M PHASE TRANSITION,0.11742,0.028537,0.043041,0,0
1,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.82211,0.02848,0.013004,0,0
1,GO NEUTRAL LIPID CATABOLIC PROCESS,0.62545,0.028426,0.022578,0,0
1,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.42367,0.028173,0.042077,0,0
1,GO CELL PROLIFERATION IN FOREBRAIN,0.52082,0.028024,0.036682,0,0
1,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.797,0.027944,-0.017722,0,0
1,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.57752,0.027862,0.050157,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.73822,0.02778,0.017902,0,0
1,GO MIDBRAIN DEVELOPMENT,0.22348,0.027734,0.065287,0,0
1,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.95316,0.027677,-0.0033966,0,0
1,GO NEURON DEATH,0.46713,0.027584,0.040801,0,0
1,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.10299,0.027499,0.058744,0,0
1,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.97253,0.027468,0.0067521,0,0
1,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.45972,0.027428,0.051234,0,0
1,GO ACTIN FILAMENT BASED TRANSPORT,0.93704,0.027102,0.012486,0,0
1,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.47211,0.027085,0.044979,0,0
1,GO REGULATION OF PHOSPHATASE ACTIVITY,0.36741,0.026986,0.035622,0,0
1,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.47963,0.026983,0.037381,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.30637,0.026886,0.094231,0,0
1,GO MITOCHONDRIAL TRANSLATION,0.5314,0.026816,0.017526,0,0
1,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.97899,0.026795,0.0040826,0,0
1,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.81581,0.026726,0.044313,0,0
1,GO GLIAL CELL DIFFERENTIATION,0.38933,0.026173,0.052985,0,0
1,GO REGULATION OF CHROMOSOME SEGREGATION,0.74128,0.026161,-0.0093058,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.38267,0.025926,-0.076428,0,0
1,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.26789,0.025916,0.046107,0,0
1,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.69885,0.025747,-0.02099,0,0
1,GO DNA GEOMETRIC CHANGE,0.46466,0.025628,0.023509,0,0
1,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.86012,0.025616,0.010644,0,0
1,GO PROTEIN HOMOOLIGOMERIZATION,0.32792,0.025554,0.037742,0,0
1,GO ORGANELLE ASSEMBLY,0.318,0.025508,0.032475,0,0
1,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.95639,0.025442,-0.033898,0,0
1,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.41203,0.025436,0.044076,0,0
1,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.22971,0.025415,0.076657,0,0
1,GO REGULATION OF RECEPTOR CLUSTERING,0.48468,0.025285,0.075236,0,0
1,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.08331,0.025184,0.090211,0,0
1,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.56925,0.025125,0.020764,0,0
1,GO AMINO ACID ACTIVATION,0.86649,0.025043,0.0083583,0,0
1,GO FEMALE SEX DIFFERENTIATION,0.50776,0.024985,0.031794,0,0
1,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.6312,0.024973,0.016088,0,0
1,GO MYOTUBE CELL DEVELOPMENT,0.46218,0.024795,0.013798,0,0
1,GO RNA CAPPING,0.45238,0.024777,0.025975,0,0
1,GO MITOCHONDRIAL GENE EXPRESSION,0.44752,0.02474,0.019856,0,0
1,GO PHOSPHATE ION TRANSPORT,0.50776,0.024709,0.03661,0,0
1,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.72907,0.024327,0.020537,0,0
1,GO REGULATION OF POSITIVE CHEMOTAXIS,0.49231,0.024247,0.061035,0,0
1,GO CHROMOSOME LOCALIZATION,0.6691,0.024172,0.00014761,0,0
1,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.28213,0.024065,0.0332,0,0
1,GO QUINONE METABOLIC PROCESS,0.53406,0.024048,-0.0019709,0,0
1,GO GMP METABOLIC PROCESS,0.90809,0.02392,0.014913,0,0
1,GO COMMISSURAL NEURON AXON GUIDANCE,0.71391,0.023915,0.05356,0,0
1,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.74741,0.023851,0.0084907,0,0
1,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.82526,0.023839,0.020139,0,0
1,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.26267,0.023824,0.055693,0,0
1,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.42602,0.023759,0.033018,0,0
1,GO REGULATION OF TELOMERASE ACTIVITY,0.28761,0.023572,0.056436,0,0
1,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.61117,0.023529,0.023698,0,0
1,GO DIET INDUCED THERMOGENESIS,0.80012,0.023424,0.018828,0,0
1,GO AXON EXTENSION,0.7814,0.023304,0.019517,0,0
1,GO CORNIFICATION,0.47963,0.023289,0.092517,0,0
1,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.60834,0.023121,0.035577,0,0
1,GO POLYOL BIOSYNTHETIC PROCESS,0.19003,0.023085,0.050592,0,0
1,GO REGULATION OF VASCULAR PERMEABILITY,0.29502,0.023063,0.077557,0,0
1,GO V D J RECOMBINATION,0.5665,0.023055,0.059214,0,0
1,GO BASIC AMINO ACID TRANSPORT,0.51035,0.02292,0.043443,0,0
1,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.92738,0.022818,0.0089715,0,0
1,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.14308,0.022706,0.076449,0,0
1,GO MEMBRANE LIPID METABOLIC PROCESS,0.65442,0.022687,0.035377,0,0
1,GO CELLULAR RESPONSE TO PH,0.73212,0.022577,0.022588,0,0
1,GO ELECTRON TRANSPORT CHAIN,0.32195,0.022393,0.026569,0,0
1,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.41666,0.022379,0.075786,0,0
1,GO GLUCOSE IMPORT,0.32195,0.022251,0.039402,0,0
1,GO MITOTIC NUCLEAR DIVISION,0.63408,0.022248,-0.0012495,0,0
1,GO ACTIN NUCLEATION,0.27495,0.021869,0.035567,0,0
1,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.71996,0.02178,-0.0043489,0,0
1,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.58307,0.021655,0.011861,0,0
1,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.5583,0.021537,0.018435,0,0
1,GO RETINA HOMEOSTASIS,0.49743,0.021414,0.023344,0,0
1,GO NEGATIVE REGULATION OF TOR SIGNALING,0.77519,0.021274,-0.0031288,0,0
1,GO ACTIVATION OF MAPKKK ACTIVITY,0.59705,0.021053,0.045091,0,0
1,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.44752,0.021002,0.11361,0,0
1,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.88565,0.020826,0.02207,0,0
1,GO COENZYME A BIOSYNTHETIC PROCESS,0.71693,0.020667,0.017097,0,0
1,GO ATP METABOLIC PROCESS,0.59144,0.020625,0.016754,0,0
1,GO RNA INTERFERENCE,0.71391,0.020327,0.0037788,0,0
1,GO CELLULAR RESPONSE TO STARVATION,0.68392,0.020313,0.031132,0,0
1,GO MITOCHONDRION ORGANIZATION,0.44994,0.020287,0.02517,0,0
1,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.69586,0.020104,0.004361,0,0
1,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.63408,0.019965,0.011193,0,0
1,GO DIOL METABOLIC PROCESS,0.47211,0.019921,0.033779,0,0
1,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.80012,0.019772,-0.02717,0,0
1,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.58307,0.019724,0.030968,0,0
1,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.92738,0.019591,-0.014049,0,0
1,GO CHEMICAL HOMEOSTASIS,0.16285,0.019575,0.060511,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.9693,0.019512,0.012057,0,0
1,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.046031,0.019381,0.07118,0,0
1,GO NEGATIVE REGULATION OF AXONOGENESIS,0.92416,0.019163,0.0046458,0,0
1,GO DIGESTIVE SYSTEM PROCESS,0.68689,0.019077,-0.017483,0,0
1,GO CHROMOSOME SEGREGATION,0.87926,0.019034,-0.015727,0,0
1,GO PROTEIN DEPHOSPHORYLATION,0.5394,0.018833,0.025901,0,0
1,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.52874,0.018815,0.037428,0,0
1,GO REGULATION OF CELLULAR RESPIRATION,0.44752,0.018792,0.044784,0,0
1,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.94993,0.018765,-0.017696,0,0
1,GO POST ANAL TAIL MORPHOGENESIS,0.67206,0.018661,-0.036409,0,0
1,GO MULTI ORGANISM PROCESS,0.25753,0.018634,0.037668,0,0
1,GO TRANSLATIONAL TERMINATION,0.25583,0.018565,0.049144,0,0
1,GO LIPOPROTEIN METABOLIC PROCESS,0.18595,0.018562,0.067315,0,0
1,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.91772,0.018358,-0.046583,0,0
1,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.43789,0.018353,0.043839,0,0
1,GO REGULATION OF GOLGI ORGANIZATION,0.22814,0.018293,0.059535,0,0
1,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.64567,0.018183,0.025403,0,0
1,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.17029,0.018036,0.073666,0,0
1,GO L AMINO ACID TRANSPORT,0.85059,0.018012,0.0033026,0,0
1,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.7814,0.017998,-0.019858,0,0
1,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.3739,0.017923,0.039085,0,0
1,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.68094,0.017752,-0.0016833,0,0
1,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.23766,0.017711,0.069395,0,0
1,GO MIRNA METABOLIC PROCESS,0.54477,0.017704,0.040732,0,0
1,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.80953,0.017586,0.020953,0,0
1,GO OUTER DYNEIN ARM ASSEMBLY,0.78451,0.017376,-0.017495,0,0
1,GO CLATHRIN COAT ASSEMBLY,0.72907,0.017226,0.041263,0,0
1,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.14088,0.017135,0.082272,0,0
1,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.2714,0.017044,0.045144,0,0
1,GO SECONDARY METABOLIC PROCESS,0.60268,0.016996,0.014019,0,0
1,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.99515,0.016822,0.0050236,0,0
1,GO REGULATION OF EXIT FROM MITOSIS,0.87926,0.016664,-0.028684,0,0
1,GO CENTROSOME DUPLICATION,0.59705,0.016493,0.0191,0,0
1,GO RNA EXPORT FROM NUCLEUS,0.61972,0.016121,0.015149,0,0
1,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.87606,0.016014,0.018821,0,0
1,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.58029,0.015942,0.026837,0,0
1,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.25924,0.015917,0.046371,0,0
1,GO REGULATION OF ORGANELLE ASSEMBLY,0.18461,0.015701,0.052489,0,0
1,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.70486,0.015605,0.017634,0,0
1,GO NEGATIVE REGULATION OF NEURON DEATH,0.73212,0.015588,0.019056,0,0
1,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.84741,0.015482,0.0045647,0,0
1,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.46218,0.01545,0.046587,0,0
1,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.96607,0.01543,0.0021578,0,0
1,GO T CELL HOMEOSTASIS,0.36526,0.015223,0.068508,0,0
1,GO ESCRT COMPLEX DISASSEMBLY,0.41666,0.015062,0.060166,0,0
1,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.73822,0.014849,0.024058,0,0
1,GO CELLULAR RESPIRATION,0.54746,0.014831,0.013891,0,0
1,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.59705,0.014825,0.031152,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.73212,0.01472,0.03046,0,0
1,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.29689,0.014433,0.053574,0,0
1,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.52609,0.014389,0.020945,0,0
1,GO TRIPARTITE REGIONAL SUBDIVISION,0.77519,0.014216,0.011829,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.57752,0.014191,0.025057,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.65442,0.01419,0.024343,0,0
1,GO COBALAMIN METABOLIC PROCESS,0.71996,0.014163,-0.026486,0,0
1,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.22195,0.014104,0.067053,0,0
1,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.78763,0.014071,-0.0033271,0,0
1,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.73212,0.013774,0.028783,0,0
1,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.32393,0.013754,0.022568,0,0
1,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.23445,0.013682,0.072226,0,0
1,GO DIVALENT INORGANIC CATION TRANSPORT,0.19417,0.013671,0.055021,0,0
1,GO INTRA S DNA DAMAGE CHECKPOINT,0.19697,0.01367,0.06337,0,0
1,GO ORGANELLE FISSION,0.66028,0.013594,-0.0023932,0,0
1,GO ANDROGEN METABOLIC PROCESS,0.23128,0.013593,0.059343,0,0
1,GO MRNA 3 END PROCESSING,0.77209,0.013561,0.014926,0,0
1,GO CELL FATE COMMITMENT,0.52874,0.013303,-0.034427,0,0
1,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.6515,0.013153,0.027258,0,0
1,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.99192,0.013111,0.0096922,0,0
1,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.22348,0.013064,0.065673,0,0
1,GO REGULATION OF HISTONE UBIQUITINATION,0.50516,0.012658,0.042226,0,0
1,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.69586,0.012618,0.032484,0,0
1,GO DNA RECOMBINATION,0.58585,0.012298,0.022033,0,0
1,GO REGULATION OF FILOPODIUM ASSEMBLY,0.2913,0.012296,-0.044502,0,0
1,GO EAR MORPHOGENESIS,0.89205,0.012272,0.0022673,0,0
1,GO ALCOHOL BIOSYNTHETIC PROCESS,0.71693,0.012267,0.018581,0,0
1,GO RESPONSE TO CALCIUM ION,0.78763,0.01221,0.02135,0,0
1,GO INTESTINAL ABSORPTION,0.79075,0.012205,0.024845,0,0
1,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.94993,0.011861,-0.0091435,0,0
1,GO RESPONSE TO MAGNESIUM ION,0.70486,0.011609,-0.037928,0,0
1,GO DNA MODIFICATION,0.28213,0.011608,0.041972,0,0
1,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.95316,0.011494,0.0078607,0,0
1,GO MELANOCYTE DIFFERENTIATION,0.71089,0.01146,-0.038361,0,0
1,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.42367,0.011454,0.056879,0,0
1,GO TOR SIGNALING,0.70486,0.011313,0.024019,0,0
1,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.53672,0.011258,0.036339,0,0
1,GO DOUBLE STRAND BREAK REPAIR,0.87926,0.011142,0.00064119,0,0
1,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.18194,0.010996,0.073098,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.50776,0.010891,0.047065,0,0
1,GO REGULATION OF DEVELOPMENTAL GROWTH,0.89846,0.01089,0.017598,0,0
1,GO PHAGOLYSOSOME ASSEMBLY,0.42133,0.010858,0.069384,0,0
1,GO BLASTOCYST DEVELOPMENT,0.5314,0.010842,0.017545,0,0
1,GO CERAMIDE BIOSYNTHETIC PROCESS,0.82211,0.01067,0.010035,0,0
1,GO NUCLEOTIDE TRANSPORT,0.48215,0.010605,0.030983,0,0
1,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.66028,0.010506,0.012,0,0
1,GO REGULATION OF DNA REPLICATION,0.38267,0.010495,0.02188,0,0
1,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.49231,0.010429,0.024228,0,0
1,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.36526,0.010396,0.085292,0,0
1,GO MULTICELLULAR ORGANISM REPRODUCTION,0.57476,0.010356,0.022623,0,0
1,GO SPHINGOLIPID METABOLIC PROCESS,0.50516,0.01034,0.048026,0,0
1,GO NUCLEOTIDE EXCISION REPAIR,0.68392,0.010294,0.012323,0,0
1,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.57752,0.01011,0.035449,0,0
1,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.81896,0.0096366,0.020534,0,0
1,GO OVARIAN FOLLICLE DEVELOPMENT,0.51557,0.009567,-0.02112,0,0
1,GO MRNA EXPORT FROM NUCLEUS,0.98222,0.0093188,-0.0034947,0,0
1,GO ZINC ION HOMEOSTASIS,0.38488,0.0090534,0.067912,0,0
1,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.31215,0.0089216,0.052172,0,0
1,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.69885,0.0088843,0.048327,0,0
1,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.58864,0.0088174,0.033737,0,0
1,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.67206,0.0087954,-0.021534,0,0
1,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.68988,0.0087734,-0.012383,0,0
1,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.23445,0.0086461,0.079544,0,0
1,GO LUNG EPITHELIUM DEVELOPMENT,0.97899,0.0086096,-0.0032137,0,0
1,GO CRISTAE FORMATION,0.92738,0.0085629,0.02385,0,0
1,GO POSITIVE REGULATION OF CELL CYCLE,0.60834,0.0085361,0.0133,0,0
1,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.98222,0.0085171,0.015218,0,0
1,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.63697,0.0083216,0.030429,0,0
1,GO POSITIVE REGULATION OF INSULIN SECRETION,0.61117,0.0080998,-0.022292,0,0
1,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.79387,0.0078347,-0.031084,0,0
1,GO DETERMINATION OF ADULT LIFESPAN,0.88245,0.0075645,0.015401,0,0
1,GO VESICLE LOCALIZATION,0.95316,0.0072596,0.014523,0,0
1,GO NUCLEAR CHROMOSOME SEGREGATION,0.99838,0.0072416,-0.02485,0,0
1,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.74741,0.0071432,0.019237,0,0
1,GO NEURON PROJECTION GUIDANCE,0.318,0.0070085,-0.051298,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.31604,0.0069371,0.061242,0,0
1,GO PHOTOPERIODISM,0.95316,0.0068775,0.0029666,0,0
1,GO METANEPHROS MORPHOGENESIS,0.94026,0.0068346,0.0027156,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.37608,0.0066862,0.023179,0,0
1,GO DEPHOSPHORYLATION,0.6055,0.0064472,0.027523,0,0
1,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.86968,0.0063649,0.011718,0,0
1,GO SENSORY PERCEPTION OF TASTE,0.37827,0.0063354,-0.063547,0,0
1,GO DIGESTION,0.41666,0.006027,-0.035755,0,0
1,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.93382,0.0059926,-0.00461,0,0
1,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.91772,0.0057526,-0.0052647,0,0
1,GO LUNG CELL DIFFERENTIATION,0.66616,0.0056699,-0.038122,0,0
1,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.69885,0.005634,0.02727,0,0
1,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.91772,0.0055994,0.012665,0,0
1,GO DNA REPAIR,0.93382,0.0054886,-0.00070797,0,0
1,GO MITOTIC METAPHASE PLATE CONGRESSION,0.73822,0.0054361,-0.017146,0,0
1,GO VENTRICULAR SYSTEM DEVELOPMENT,0.71391,0.0053718,0.042372,0,0
1,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.86012,0.0053003,0.0062907,0,0
1,GO RRNA 3 END PROCESSING,0.79075,0.0052623,-0.004945,0,0
1,GO DNA METHYLATION OR DEMETHYLATION,0.44752,0.0051477,0.037321,0,0
1,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.51557,0.0050855,-0.010086,0,0
1,GO NCRNA CATABOLIC PROCESS,0.33803,0.0050677,0.051982,0,0
1,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.3739,0.0049292,0.080524,0,0
1,GO LIPOSACCHARIDE METABOLIC PROCESS,0.43789,0.0048463,0.03919,0,0
1,GO MALE MEIOTIC NUCLEAR DIVISION,0.51819,0.0048383,-0.036175,0,0
1,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.62545,0.0046,0.024255,0,0
1,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.8379,0.0043629,0.019685,0,0
1,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.86968,0.0040946,0.023737,0,0
1,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,1,0.004078,0.0047539,0,0
1,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.35463,0.0040673,0.043235,0,0
1,GO SODIUM ION HOMEOSTASIS,0.55558,0.0040533,-0.04204,0,0
1,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.5394,0.0037067,-0.056155,0,0
1,GO SISTER CHROMATID SEGREGATION,0.76899,0.00361,-0.039774,0,0
1,GO ALCOHOL CATABOLIC PROCESS,0.49487,0.0035384,0.044631,0,0
1,GO SNORNA 3 END PROCESSING,0.40514,0.0035141,-0.062923,0,0
1,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.71996,0.0035061,0.038538,0,0
1,GO CELL JUNCTION ORGANIZATION,0.82211,0.0033676,0.0065233,0,0
1,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.68988,0.0033584,0.048209,0,0
1,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.66616,0.0033005,0.011174,0,0
1,GO ADHERENS JUNCTION ORGANIZATION,0.47712,0.0031747,-0.040912,0,0
1,GO NAD METABOLIC PROCESS,0.77519,0.0025826,-0.0073169,0,0
1,GO LIPID DROPLET ORGANIZATION,0.36741,0.0023255,0.060838,0,0
1,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.68689,0.0022433,0.016521,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.6055,0.0021896,-0.010183,0,0
1,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.90809,0.0021404,0.014212,0,0
1,GO NEUROBLAST PROLIFERATION,0.57476,0.0020636,-0.037698,0,0
1,GO HISTONE H3 K27 METHYLATION,0.69286,0.0020171,-0.019529,0,0
1,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.65442,0.0019144,-0.021426,0,0
1,GO CHROMOSOME SEPARATION,0.75356,0.0018077,-0.0047623,0,0
1,GO IMP METABOLIC PROCESS,0.90167,0.0017671,-0.0090525,0,0
1,GO REGULATION OF SPINDLE ORGANIZATION,0.80953,0.0015535,0.0026415,0,0
1,GO RESPONSE TO STARVATION,0.84741,0.0013799,0.027284,0,0
1,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.61972,0.00028201,0.029818,0,0
1,GO HISTONE UBIQUITINATION,0.68689,0.00025229,0.016954,0,0
1,GO CAMERA TYPE EYE MORPHOGENESIS,0.81896,9.7419e-05,-0.0093347,0,0
1,GO RESPONSE TO LIGHT STIMULUS,0.90167,5.4008e-05,0.010482,0,0
1,GO REGULATION OF CYTOKINESIS,0.68689,-0.00011526,0.0019116,0,0
1,GO RHYTHMIC BEHAVIOR,0.37608,-0.00013459,-0.047827,0,0
1,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.42602,-0.00018249,-0.052642,0,0
1,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.85694,-0.00023367,-0.0012606,0,0
1,GO MANNOSYLATION,0.797,-0.00031936,0.03223,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.95961,-0.00052663,0.0075166,0,0
1,GO REGULATION OF FERTILIZATION,0.68094,-0.00059911,-0.020871,0,0
1,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.69286,-0.00070866,-0.010334,0,0
1,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.85694,-0.00071677,0.0065851,0,0
1,GO RHYTHMIC PROCESS,0.63408,-0.00077059,-0.0023666,0,0
1,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.92738,-0.0012167,0.023568,0,0
1,GO MITOTIC SISTER CHROMATID SEGREGATION,0.90167,-0.0012917,-0.031398,0,0
1,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.34008,-0.0014235,0.053915,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.89526,-0.0014515,0.0070954,0,0
1,GO FERTILIZATION,0.5,-0.0017712,-0.017468,0,0
1,GO REGULATION OF GLUCOSE IMPORT,0.9113,-0.0019122,0.0094697,0,0
1,GO CONVERGENT EXTENSION,0.85059,-0.0019717,0.026532,0,0
1,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.5665,-0.0020785,0.032116,0,0
1,GO CELL RECOGNITION,0.73212,-0.0021004,-0.0018729,0,0
1,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.37173,-0.0023915,0.096208,0,0
1,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.68988,-0.0024712,0.038603,0,0
1,GO HISTONE H3 ACETYLATION,0.94348,-0.0027373,0.01126,0,0
1,GO METHIONINE METABOLIC PROCESS,0.87926,-0.0028016,-0.011626,0,0
1,GO REGIONALIZATION,0.41666,-0.0028458,-0.030459,0,0
1,GO NEURAL CREST FORMATION,0.76899,-0.002899,0.04865,0,0
1,GO MITOCHONDRIAL TRANSPORT,0.92094,-0.0030225,0.0063547,0,0
1,GO REGULATION OF HISTONE MODIFICATION,0.86012,-0.0030953,0.021755,0,0
1,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.95961,-0.0031447,-0.016265,0,0
1,GO RNA STABILIZATION,0.9113,-0.0032083,-0.0033664,0,0
1,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.82842,-0.0032492,0.015442,0,0
1,GO RESPONSE TO REDOX STATE,0.50776,-0.0033155,0.041312,0,0
1,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.65734,-0.003613,0.030282,0,0
1,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.60268,-0.0036204,0.028076,0,0
1,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.93382,-0.0036258,-0.016732,0,0
1,GO ORGANELLE FUSION,0.44752,-0.0036604,-0.0076308,0,0
1,GO HISTONE H3 K9 ACETYLATION,0.95961,-0.0037097,0.014686,0,0
1,GO DEVELOPMENTAL INDUCTION,0.93382,-0.0037662,0.00092117,0,0
1,GO REGULATION OF TOR SIGNALING,0.71391,-0.0042516,0.0036036,0,0
1,GO MONOSACCHARIDE CATABOLIC PROCESS,0.83158,-0.0043193,0.02085,0,0
1,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.97253,-0.0043907,-0.023262,0,0
1,GO PROTEIN TARGETING TO MEMBRANE,0.58864,-0.0044041,0.023612,0,0
1,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.97253,-0.0044074,0.0067052,0,0
1,GO RESPONSE TO CAFFEINE,0.90809,-0.0045688,0.010604,0,0
1,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.74741,-0.0045734,-0.01883,0,0
1,GO IRON COORDINATION ENTITY TRANSPORT,0.71391,-0.0046483,0.032243,0,0
1,GO REGULATION OF GLIOGENESIS,0.92416,-0.0046583,-0.00084804,0,0
1,GO REGULATION OF TELOMERE CAPPING,0.78763,-0.0047646,-0.0047321,0,0
1,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.72603,-0.0047861,-0.012564,0,0
1,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.47461,-0.0048849,-0.094424,0,0
1,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.99192,-0.0049434,-0.0056247,0,0
1,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.86649,-0.0052628,-0.00040239,0,0
1,GO REGULATION OF CELL DEVELOPMENT,0.70787,-0.0054125,-0.0035766,0,0
1,GO ORGANELLE MEMBRANE FUSION,0.94026,-0.0054675,0.0094209,0,0
1,GO TRANSLATIONAL ELONGATION,0.48722,-0.0054835,0.025478,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.68094,-0.0055032,0.021996,0,0
1,GO SOMITOGENESIS,0.83474,-0.0055665,0.0073796,0,0
1,GO PATTERN SPECIFICATION PROCESS,0.47712,-0.0057908,-0.024215,0,0
1,GO RESPONSE TO CARBOHYDRATE,0.89205,-0.0058016,0.026532,0,0
1,GO CRANIAL NERVE MORPHOGENESIS,0.6515,-0.0058368,-0.018006,0,0
1,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.79387,-0.0059673,-0.015776,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.68988,-0.0060591,0.044945,0,0
1,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.63408,-0.0061294,-0.023305,0,0
1,GO REGULATION OF EXTENT OF CELL GROWTH,0.8379,-0.0062904,0.0011917,0,0
1,GO HEXOSE CATABOLIC PROCESS,0.77829,-0.0062908,-0.00084727,0,0
1,GO MICROTUBULE ANCHORING,0.97899,-0.0063345,0.019061,0,0
1,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.70787,-0.0063446,0.0051053,0,0
1,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.75664,-0.0066146,0.029655,0,0
1,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.78763,-0.0067586,-0.0012946,0,0
1,GO SKELETAL MUSCLE CONTRACTION,0.68689,-0.0068722,0.021016,0,0
1,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.79075,-0.0068967,0.019405,0,0
1,GO MITOTIC SPINDLE ASSEMBLY,0.98869,-0.0069221,-0.012319,0,0
1,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.85376,-0.0069407,0.029701,0,0
1,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.9693,-0.0071168,0.01422,0,0
1,GO CELLULAR RESPONSE TO ALKALOID,0.58585,-0.0071172,-0.017483,0,0
1,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.78451,-0.0071181,-0.0028554,0,0
1,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.35886,-0.0071409,0.073044,0,0
1,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.5314,-0.0071548,0.05572,0,0
1,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.79387,-0.0073092,-0.0071462,0,0
1,GO FACIAL NERVE MORPHOGENESIS,0.9113,-0.0073478,0.030142,0,0
1,GO SEXUAL REPRODUCTION,0.61687,-0.0074304,-0.0081779,0,0
1,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.50516,-0.0074969,-0.048653,0,0
1,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.64276,-0.0074998,0.02906,0,0
1,GO PROTEIN NEDDYLATION,0.68392,-0.0076373,0.034341,0,0
1,GO REGULATION OF MITOPHAGY,0.40743,-0.0076827,0.075808,0,0
1,GO CALCIUM ION IMPORT,0.47461,-0.0076915,-0.015147,0,0
1,GO CENTRIOLE CENTRIOLE COHESION,0.68094,-0.0077581,0.026184,0,0
1,GO DNA REPLICATION,0.89205,-0.0078415,-0.012339,0,0
1,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.44994,-0.0081643,-0.017269,0,0
1,GO REGULATION OF DEACETYLASE ACTIVITY,0.66616,-0.0082581,-0.002022,0,0
1,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.87606,-0.0083478,0.0042391,0,0
1,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.82842,-0.0083682,0.013208,0,0
1,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.80639,-0.0086183,-0.015983,0,0
1,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.35043,-0.0086512,-0.058764,0,0
1,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.27495,-0.0086751,0.082361,0,0
1,GO NEURAL PRECURSOR CELL PROLIFERATION,0.2114,-0.0086992,-0.066338,0,0
1,GO PEPTIDYL LYSINE MODIFICATION,0.44269,-0.0088702,-0.011168,0,0
1,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.76281,-0.0090126,0.028496,0,0
1,GO MEIOTIC CELL CYCLE,0.47963,-0.009029,-0.041014,0,0
1,GO RENAL WATER HOMEOSTASIS,0.72907,-0.0090319,0.031297,0,0
1,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.97899,-0.0090786,0.0043494,0,0
1,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.80012,-0.0093341,0.0053384,0,0
1,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.797,-0.0097808,-0.0072542,0,0
1,GO INNER EAR MORPHOGENESIS,0.84741,-0.0099003,-0.019704,0,0
1,GO PROTEIN HETEROTETRAMERIZATION,0.78451,-0.009914,-0.012586,0,0
1,GO DNA CONFORMATION CHANGE,0.69286,-0.0099987,-0.022685,0,0
1,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.80326,-0.010092,-0.0084318,0,0
1,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.45238,-0.010267,-0.014633,0,0
1,GO PEPTIDYL METHIONINE MODIFICATION,0.98546,-0.010271,0.017291,0,0
1,GO RESPONSE TO MONOSACCHARIDE,0.59986,-0.010273,0.0036991,0,0
1,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.40058,-0.010359,-0.060322,0,0
1,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.41203,-0.010654,-0.04962,0,0
1,GO REGULATION OF CHROMOSOME ORGANIZATION,0.81896,-0.010721,-0.0044623,0,0
1,GO VESICLE CYTOSKELETAL TRAFFICKING,0.17029,-0.01101,-0.051434,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.99838,-0.011039,-0.02175,0,0
1,GO OXIDATIVE PHOSPHORYLATION,0.59705,-0.011078,-0.021647,0,0
1,GO OOGENESIS,0.46713,-0.011099,-0.034058,0,0
1,GO REGULATION OF CYCLASE ACTIVITY,0.87606,-0.01129,-0.0015803,0,0
1,GO ANION TRANSMEMBRANE TRANSPORT,0.81267,-0.011327,0.00888,0,0
1,GO REGULATION OF CHROMATIN ORGANIZATION,0.94671,-0.01174,0.01133,0,0
1,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.61972,-0.012224,-0.0037951,0,0
1,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.49231,-0.012261,-0.032904,0,0
1,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.48468,-0.012272,-0.061326,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.45972,-0.012281,-0.041535,0,0
1,GO CGMP MEDIATED SIGNALING,0.87287,-0.012306,0.00091185,0,0
1,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.94671,-0.01231,-0.00090213,0,0
1,GO SPERM CAPACITATION,0.53406,-0.012357,0.049749,0,0
1,GO SNRNA TRANSCRIPTION,0.94348,-0.012436,0.017694,0,0
1,GO UTERUS DEVELOPMENT,0.36956,-0.012446,-0.052281,0,0
1,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.94348,-0.012531,0.011433,0,0
1,GO THYROID GLAND DEVELOPMENT,0.87287,-0.012589,0.0091315,0,0
1,GO REGULATION OF MICROTUBULE BASED PROCESS,0.15098,-0.01261,-0.046959,0,0
1,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.96284,-0.012643,0.0175,0,0
1,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.62545,-0.012747,-0.0096626,0,0
1,GO HISTONE H2A UBIQUITINATION,0.47461,-0.012945,0.036464,0,0
1,GO CILIUM MOVEMENT,0.59144,-0.013002,-0.022726,0,0
1,GO THIOESTER BIOSYNTHETIC PROCESS,0.4355,-0.013007,0.05195,0,0
1,GO EMBRYONIC BODY MORPHOGENESIS,0.47211,-0.013035,0.082905,0,0
1,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.51819,-0.013094,0.070083,0,0
1,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.94671,-0.01311,0.010696,0,0
1,GO VITAMIN CATABOLIC PROCESS,0.44994,-0.013163,-0.08484,0,0
1,GO RESPONSE TO INTERLEUKIN 2,0.54746,-0.013387,0.060096,0,0
1,GO CARDIAC MUSCLE CONTRACTION,0.54477,-0.013447,-0.025055,0,0
1,GO C4 DICARBOXYLATE TRANSPORT,0.83158,-0.013501,0.0022425,0,0
1,GO REGULATION OF SODIUM ION TRANSPORT,0.59986,-0.013528,-0.014934,0,0
1,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.59424,-0.013544,-0.034285,0,0
1,GO REGULATION OF DNA METHYLATION,0.87606,-0.013554,0.021279,0,0
1,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.61402,-0.013579,-0.019399,0,0
1,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.83474,-0.013698,0.016149,0,0
1,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.48976,-0.01374,-0.025544,0,0
1,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.98869,-0.01376,0.0011097,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.85376,-0.014182,-0.02097,0,0
1,GO REGULATION OF RNA SPLICING,0.14755,-0.014225,-0.046668,0,0
1,GO RESPONSE TO ETHER,0.92094,-0.014341,-0.012428,0,0
1,GO DEMETHYLATION,0.87926,-0.014366,0.0098329,0,0
1,GO RNA POLYADENYLATION,0.5665,-0.014393,0.034177,0,0
1,GO AUTOPHAGIC CELL DEATH,0.84107,-0.014396,0.0099046,0,0
1,GO EXCRETION,0.74741,-0.014796,0.031547,0,0
1,GO MITOCHONDRION MORPHOGENESIS,0.57752,-0.014808,-0.001714,0,0
1,GO CENTROSOME SEPARATION,0.73212,-0.01487,-0.00070581,0,0
1,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.94026,-0.014931,-0.0042499,0,0
1,GO NADH METABOLIC PROCESS,0.65442,-0.015432,-0.021229,0,0
1,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.37173,-0.015543,-0.072975,0,0
1,GO RETINAL CONE CELL DIFFERENTIATION,0.90488,-0.015577,-0.027459,0,0
1,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.84741,-0.015644,-0.0097001,0,0
1,GO GAMETE GENERATION,0.70486,-0.015828,-0.0079297,0,0
1,GO REGULATION OF SPINDLE CHECKPOINT,0.91451,-0.016096,-0.02647,0,0
1,GO RESPONSE TO ELECTRICAL STIMULUS,0.80326,-0.016101,0.0086008,0,0
1,GO DEFENSE RESPONSE TO FUNGUS,0.58029,-0.016359,-0.023536,0,0
1,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.56376,-0.016462,-0.02241,0,0
1,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.99515,-0.016481,0.013923,0,0
1,GO RESPONSE TO IMMOBILIZATION STRESS,0.79387,-0.016547,-0.005562,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.7659,-0.016588,0.036603,0,0
1,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.82842,-0.016703,-0.02543,0,0
1,GO ORGANELLE LOCALIZATION,0.52082,-0.016816,-0.0081546,0,0
1,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.91451,-0.016982,0.01418,0,0
1,GO MAINTENANCE OF ORGANELLE LOCATION,0.83158,-0.017054,0.0082395,0,0
1,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.82526,-0.017123,0.0058065,0,0
1,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.91451,-0.017161,0.011124,0,0
1,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.64858,-0.017182,0.010571,0,0
1,GO ADAPTATION OF SIGNALING PATHWAY,0.36098,-0.017189,-0.052411,0,0
1,GO SNORNA METABOLIC PROCESS,0.55558,-0.017323,-0.046406,0,0
1,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.39606,-0.017455,0.056841,0,0
1,GO REGULATION OF MITOCHONDRIAL FUSION,0.59705,-0.017496,-0.012764,0,0
1,GO SINGLE FERTILIZATION,0.37173,-0.017635,-0.024257,0,0
1,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.95316,-0.017743,0.0031225,0,0
1,GO NEURON APOPTOTIC PROCESS,0.74128,-0.01778,-0.0016247,0,0
1,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.9113,-0.017855,0.025282,0,0
1,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.81896,-0.01788,0.066478,0,0
1,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.67798,-0.018127,-0.014219,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.5665,-0.018216,-0.030735,0,0
1,GO REGULATION OF GLIAL CELL PROLIFERATION,0.56103,-0.018239,0.052813,0,0
1,GO CENTROMERE COMPLEX ASSEMBLY,0.60834,-0.018528,-0.052397,0,0
1,GO CHROMOSOME ORGANIZATION,0.61687,-0.018528,-0.015204,0,0
1,GO REGULATION OF TRANSPORT,0.99838,-0.018711,0.019683,0,0
1,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.57752,-0.018814,-0.029452,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.36741,-0.018967,-0.036801,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.95316,-0.019001,0.012832,0,0
1,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.99515,-0.019083,0.030163,0,0
1,GO EXIT FROM MITOSIS,0.47963,-0.019108,-0.031227,0,0
1,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.82211,-0.019407,0.0054665,0,0
1,GO MITOCHONDRIAL FISSION,0.97576,-0.019521,0.012888,0,0
1,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.66028,-0.019858,0.042855,0,0
1,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.19278,-0.020048,-0.069055,0,0
1,GO METHYLATION,0.46713,-0.020136,-0.0084463,0,0
1,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.80326,-0.020202,0.0079903,0,0
1,GO REGULATION OF PEPTIDE SECRETION,0.64276,-0.020294,0.00080781,0,0
1,GO REGULATION OF METAL ION TRANSPORT,0.34835,-0.020374,0.054264,0,0
1,GO INTERSTRAND CROSS LINK REPAIR,0.30066,-0.020451,-0.062224,0,0
1,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.89526,-0.020626,0.011779,0,0
1,GO POSITIVE REGULATION OF DNA REPAIR,0.69586,-0.020984,0.011015,0,0
1,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.68392,-0.021118,0.034094,0,0
1,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.64858,-0.021158,-0.0029306,0,0
1,GO CELLULAR COMPONENT MAINTENANCE,0.42367,-0.021437,-0.024602,0,0
1,GO RNA SPLICING,0.34213,-0.021489,-0.027819,0,0
1,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.75972,-0.021523,-0.0088543,0,0
1,GO MISMATCH REPAIR,0.67501,-0.021597,-0.018022,0,0
1,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.71089,-0.021609,-0.0077906,0,0
1,GO NEUTRAL AMINO ACID TRANSPORT,0.41434,-0.021647,-0.027545,0,0
1,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.97253,-0.021716,0.016822,0,0
1,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.23927,-0.021753,-0.029819,0,0
1,GO ANATOMICAL STRUCTURE MATURATION,0.73212,-0.021806,0.0014267,0,0
1,GO TRANSFERRIN TRANSPORT,0.21288,-0.021871,-0.04384,0,0
1,GO INDOLALKYLAMINE METABOLIC PROCESS,0.50258,-0.022025,-0.038606,0,0
1,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.95961,-0.022445,0.0099774,0,0
1,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.56925,-0.022844,-0.025311,0,0
1,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.71693,-0.022948,-0.011904,0,0
1,GO GPI ANCHOR METABOLIC PROCESS,0.42838,-0.023053,-0.03302,0,0
1,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.87287,-0.02391,0.034942,0,0
1,GO MOTOR NEURON AXON GUIDANCE,0.5583,-0.023928,-0.011154,0,0
1,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.69586,-0.024157,-0.035007,0,0
1,GO INORGANIC ANION TRANSPORT,0.97899,-0.024235,0.018936,0,0
1,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.9306,-0.02429,0.0061294,0,0
1,GO MALE GAMETE GENERATION,0.48976,-0.024434,-0.0168,0,0
1,GO GLUCOSE METABOLIC PROCESS,0.67798,-0.024447,0.032336,0,0
1,GO GLUTAMINE METABOLIC PROCESS,0.5665,-0.024507,-0.03729,0,0
1,GO MAGNESIUM ION TRANSPORT,0.84424,-0.024707,0.0035308,0,0
1,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.28945,-0.024899,-0.027423,0,0
1,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.95961,-0.025022,0.02143,0,0
1,GO FILOPODIUM ASSEMBLY,0.45972,-0.02504,-0.022791,0,0
1,GO MEIOTIC CELL CYCLE PROCESS,0.64567,-0.025068,-0.03764,0,0
1,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.88245,-0.025138,-0.0053121,0,0
1,GO SPERM MOTILITY,0.29877,-0.025195,-0.037173,0,0
1,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.52345,-0.025413,-0.048038,0,0
1,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.60268,-0.025726,-0.013617,0,0
1,GO PH REDUCTION,0.72299,-0.025737,-0.008349,0,0
1,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.34008,-0.025814,-0.035526,0,0
1,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.24416,-0.025817,-0.05605,0,0
1,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.36098,-0.026249,-0.052669,0,0
1,GO PROTEIN AUTOPROCESSING,0.95639,-0.026257,0.00061767,0,0
1,GO AXON DEVELOPMENT,0.12224,-0.02642,-0.065742,0,0
1,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.67798,-0.026433,0.020247,0,0
1,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.30066,-0.026639,-0.066394,0,0
1,GO OLIGODENDROCYTE DIFFERENTIATION,0.84424,-0.026812,-0.0061384,0,0
1,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.79387,-0.026906,-0.0053272,0,0
1,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.81581,-0.027158,-0.019108,0,0
1,GO PROTEIN K11 LINKED UBIQUITINATION,0.94993,-0.027356,0.0070457,0,0
1,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.35674,-0.027516,-0.051257,0,0
1,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.54208,-0.028026,-0.015692,0,0
1,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.85059,-0.028135,0.0096771,0,0
1,GO MEIOTIC CHROMOSOME SEGREGATION,0.84741,-0.02814,-0.032069,0,0
1,GO EPITHELIAL CELL FATE COMMITMENT,0.19417,-0.028187,-0.17512,0,0
1,GO PROTEIN LOCALIZATION TO CHROMATIN,0.83474,-0.028255,-0.011095,0,0
1,GO TORC1 SIGNALING,0.30255,-0.028373,-0.021212,0,0
1,GO REGULATION OF CHROMATIN BINDING,0.61117,-0.028387,-0.031159,0,0
1,GO GERM CELL DEVELOPMENT,0.22814,-0.02855,-0.034526,0,0
1,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.59705,-0.02859,0.0036322,0,0
1,GO NCRNA TRANSCRIPTION,0.75048,-0.028608,0.0044631,0,0
1,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.090011,-0.028627,-0.057483,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.42602,-0.028679,-0.04648,0,0
1,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.45482,-0.028764,-0.033489,0,0
1,GO BASE EXCISION REPAIR,0.27853,-0.028796,-0.043679,0,0
1,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.59144,-0.028855,-0.065707,0,0
1,GO HISTONE H3 DEACETYLATION,0.84424,-0.028892,0.023273,0,0
1,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.59424,-0.028897,-0.01354,0,0
1,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.80953,-0.028931,0.00070686,0,0
1,GO REGULATION OF TRANSLATIONAL FIDELITY,0.59144,-0.029178,-0.054107,0,0
1,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.85694,-0.02918,0.0053047,0,0
1,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.44752,-0.029198,-0.025309,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.6312,-0.029228,0.0042999,0,0
1,GO ADIPOSE TISSUE DEVELOPMENT,0.87926,-0.029395,0.015215,0,0
1,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.89846,-0.029456,0.0084039,0,0
1,GO PROTEIN LOCALIZATION TO CILIUM,0.8379,-0.029575,-0.0030029,0,0
1,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.5,-0.029869,-0.0080843,0,0
1,GO RESPONSE TO AMINE,0.48468,-0.030168,-0.02823,0,0
1,GO KILLING OF CELLS OF OTHER ORGANISM,0.44269,-0.030362,-0.035255,0,0
1,GO MULTICELLULAR ORGANISM AGING,0.64858,-0.03038,-0.013034,0,0
1,GO RESPONSE TO EPINEPHRINE,0.66616,-0.030389,0.04196,0,0
1,GO COVALENT CHROMATIN MODIFICATION,0.43789,-0.030496,-0.011508,0,0
1,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.88885,-0.030601,0.021169,0,0
1,GO REGULATION OF SPINDLE ASSEMBLY,0.73212,-0.030645,-0.006325,0,0
1,GO HISTONE H3 K14 ACETYLATION,0.77829,-0.030704,-0.016976,0,0
1,GO RETROGRADE AXONAL TRANSPORT,0.30637,-0.030704,-0.054212,0,0
1,GO MRNA PROCESSING,0.41666,-0.030717,-0.022351,0,0
1,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.92094,-0.030866,0.012389,0,0
1,GO PROTEIN DENEDDYLATION,0.92416,-0.031084,0.0029151,0,0
1,GO REGULATION OF ANION TRANSPORT,0.67798,-0.031346,0.0060893,0,0
1,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.5314,-0.031381,-0.023452,0,0
1,GO ERROR FREE TRANSLESION SYNTHESIS,0.13979,-0.031563,-0.062998,0,0
1,GO CARBOHYDRATE PHOSPHORYLATION,0.98222,-0.031913,0.015975,0,0
1,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.69885,-0.032267,-0.014761,0,0
1,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.9306,-0.032325,0.0098477,0,0
1,GO HISTONE H3 K9 TRIMETHYLATION,0.87287,-0.032445,0.002926,0,0
1,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.30066,-0.03248,-0.042559,0,0
1,GO REGULATION OF PROTEIN ACETYLATION,0.23927,-0.032742,-0.018405,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.89526,-0.032916,0.0067629,0,0
1,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.62258,-0.03344,-0.0042517,0,0
1,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.14197,-0.033567,-0.046371,0,0
1,GO RELAXATION OF MUSCLE,0.93382,-0.033736,-0.021748,0,0
1,GO CHROMOSOME CONDENSATION,0.47963,-0.033942,-0.056612,0,0
1,GO POSITIVE REGULATION OF CELL MATURATION,0.99515,-0.034079,0.0092352,0,0
1,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.062684,-0.034115,-0.10933,0,0
1,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.55558,-0.034538,-0.018689,0,0
1,GO ENERGY HOMEOSTASIS,0.38933,-0.034638,-0.049115,0,0
1,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.67798,-0.03472,-0.0025566,0,0
1,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.19417,-0.034892,-0.040265,0,0
1,GO MICROTUBULE BASED PROCESS,0.16778,-0.035118,-0.037613,0,0
1,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.085497,-0.035462,-0.096895,0,0
1,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.35253,-0.035692,-0.036618,0,0
1,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.94671,-0.03572,0.0046103,0,0
1,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.39156,-0.035798,-0.063239,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.55016,-0.035873,-0.016018,0,0
1,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.88565,-0.035964,0.0038058,0,0
1,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.29689,-0.036524,-0.014835,0,0
1,GO OOCYTE MATURATION,0.3739,-0.036647,-0.049254,0,0
1,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.59986,-0.036703,-0.047527,0,0
1,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.99515,-0.036923,0.017416,0,0
1,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.23766,-0.036983,-0.032285,0,0
1,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.42602,-0.037142,-0.018716,0,0
1,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.81267,-0.037258,0.027861,0,0
1,GO POSITIVE REGULATION OF AXONOGENESIS,0.50776,-0.037281,-0.0088927,0,0
1,GO PENILE ERECTION,0.40973,-0.037442,-0.056813,0,0
1,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.50258,-0.037446,-0.050171,0,0
1,GO MOTILE CILIUM ASSEMBLY,0.56376,-0.037449,-0.031798,0,0
1,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.39381,-0.037459,-0.059799,0,0
1,GO REGULATION OF NEURON MIGRATION,0.30829,-0.037562,-0.066205,0,0
1,GO ANION TRANSPORT,0.98546,-0.037698,0.019327,0,0
1,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.18866,-0.037747,-0.076244,0,0
1,GO MECHANORECEPTOR DIFFERENTIATION,0.43312,-0.037797,-0.032212,0,0
1,GO STRESS GRANULE ASSEMBLY,0.32393,-0.038598,-0.037556,0,0
1,GO REGULATION OF CELL CYCLE CHECKPOINT,0.20409,-0.038695,-0.068384,0,0
1,GO NEGATIVE REGULATION OF ION TRANSPORT,0.48976,-0.039037,-0.0063872,0,0
1,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.24089,-0.039223,-0.090367,0,0
1,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.73822,-0.039261,-0.042307,0,0
1,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.30829,-0.039467,-0.029424,0,0
1,GO APICAL PROTEIN LOCALIZATION,0.39606,-0.039537,-0.049254,0,0
1,GO HETEROCHROMATIN ORGANIZATION,0.35463,-0.039789,-0.02745,0,0
1,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.44752,-0.040204,-0.013973,0,0
1,GO STRIATED MUSCLE CONTRACTION,0.25246,-0.040222,-0.03804,0,0
1,GO MEIOSIS I CELL CYCLE PROCESS,0.23286,-0.040652,-0.071116,0,0
1,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.19697,-0.040974,-0.02623,0,0
1,GO SOMITE DEVELOPMENT,0.2913,-0.040998,-0.03429,0,0
1,GO SUBSTANTIA NIGRA DEVELOPMENT,0.22658,-0.041069,-0.042353,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.38933,-0.041161,-0.054292,0,0
1,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.61972,-0.041221,0.0015616,0,0
1,GO CELL PROJECTION ORGANIZATION,0.40058,-0.041804,-0.013688,0,0
1,GO FRUCTOSE METABOLIC PROCESS,0.47461,-0.041861,-0.07916,0,0
1,GO PROTEIN INSERTION INTO MEMBRANE,0.58029,-0.042134,-0.019044,0,0
1,GO TOXIN METABOLIC PROCESS,0.35886,-0.042181,-0.058197,0,0
1,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.44028,-0.042246,-0.012061,0,0
1,GO FATTY ACYL COA METABOLIC PROCESS,0.98222,-0.042276,0.0070872,0,0
1,GO RECOMBINATIONAL REPAIR,0.20122,-0.042592,-0.042698,0,0
1,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.64567,-0.042757,-0.055865,0,0
1,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.9306,-0.042911,0.017984,0,0
1,GO PHAGOSOME ACIDIFICATION,0.22042,-0.042941,-0.051143,0,0
1,GO REGULATION OF MITOCHONDRIAL FISSION,0.6691,-0.043107,-0.0060575,0,0
1,GO SECOND MESSENGER MEDIATED SIGNALING,0.6312,-0.043462,-0.0068504,0,0
1,GO KERATINIZATION,0.82842,-0.043514,0.047182,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.96607,-0.043679,-0.0038873,0,0
1,GO THYMUS DEVELOPMENT,0.72299,-0.043769,0.008155,0,0
1,GO L SERINE METABOLIC PROCESS,0.95639,-0.043838,-0.019199,0,0
1,GO HISTONE H3 K4 TRIMETHYLATION,0.52609,-0.043849,0.059442,0,0
1,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.1533,-0.04404,-0.093224,0,0
1,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.65442,-0.044103,-0.01727,0,0
1,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.095518,-0.044347,-0.07382,0,0
1,GO POSITIVE REGULATION OF TOR SIGNALING,0.17411,-0.044386,-0.032827,0,0
1,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.27495,-0.044755,-0.03616,0,0
1,GO POLYOL CATABOLIC PROCESS,0.15565,-0.044759,-0.060591,0,0
1,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.97576,-0.044788,-0.0026634,0,0
1,GO IMPORT ACROSS PLASMA MEMBRANE,0.6312,-0.044959,0.0012093,0,0
1,GO KETONE BODY METABOLIC PROCESS,0.35253,-0.045075,-0.069452,0,0
1,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.10045,-0.045183,-0.053546,0,0
1,GO CARDIAC CELL FATE COMMITMENT,0.78451,-0.045377,0.0064838,0,0
1,GO REGULATION OF TORC1 SIGNALING,0.20554,-0.04551,-0.042056,0,0
1,GO EMBRYONIC PATTERN SPECIFICATION,0.27495,-0.045638,-0.045604,0,0
1,GO TRANSMEMBRANE TRANSPORT,0.54208,-0.045786,0.0010123,0,0
1,GO DENTATE GYRUS DEVELOPMENT,0.28945,-0.045812,-0.12279,0,0
1,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.35043,-0.04594,-0.043136,0,0
1,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.73517,-0.045974,0.0030885,0,0
1,GO REGULATION OF HORMONE LEVELS,0.14983,-0.046035,-0.037105,0,0
1,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.25078,-0.046073,-0.039218,0,0
1,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.31409,-0.046191,-0.035179,0,0
1,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.18866,-0.046279,-0.0834,0,0
1,GO REGULATION OF CHROMATIN ASSEMBLY,0.53672,-0.046379,-0.028483,0,0
1,GO DETECTION OF STIMULUS,0.12822,-0.046427,-0.035309,0,0
1,GO POSITIVE REGULATION OF HEART RATE,0.99192,-0.046655,0.026451,0,0
1,GO ORGANIC ANION TRANSPORT,0.90488,-0.046776,0.023935,0,0
1,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.27853,-0.046804,-0.059842,0,0
1,GO REGULATION OF TRANSPORTER ACTIVITY,0.80953,-0.046875,0.0067046,0,0
1,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.77829,-0.046917,0.0022179,0,0
1,GO INCLUSION BODY ASSEMBLY,0.36311,-0.046932,-0.061483,0,0
1,GO LIPID TRANSLOCATION,0.80639,-0.04713,-0.0035656,0,0
1,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.22658,-0.047307,-0.041455,0,0
1,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.64567,-0.047675,-0.014128,0,0
1,GO POSITIVE REGULATION OF ANION TRANSPORT,0.38047,-0.047875,-0.021151,0,0
1,GO TELOMERE CAPPING,0.26789,-0.048009,-0.025728,0,0
1,GO REGULATION OF HISTONE H4 ACETYLATION,0.62258,-0.048074,-0.014124,0,0
1,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.14869,-0.048122,-0.060398,0,0
1,GO HOMOLOGOUS RECOMBINATION,0.3442,-0.048351,-0.042172,0,0
1,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.1914,-0.048568,-0.059728,0,0
1,GO MITOCHONDRIAL GENOME MAINTENANCE,0.13656,-0.049019,-0.073352,0,0
1,GO CIRCADIAN RHYTHM,0.19417,-0.049077,-0.028902,0,0
1,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.37173,-0.049485,-0.016337,0,0
1,GO MEMBRANE HYPERPOLARIZATION,0.62258,-0.049555,-0.033147,0,0
1,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.33194,-0.049923,-0.048881,0,0
1,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.98869,-0.049997,-0.0035269,0,0
1,GO NEURON PROJECTION ARBORIZATION,0.45238,-0.050017,-0.03914,0,0
1,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.49487,-0.050096,-0.028483,0,0
1,GO CELL CELL SIGNALING,0.12224,-0.050244,-0.033605,0,0
1,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.25583,-0.050287,-0.048607,0,0
1,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.46466,-0.050619,-0.027565,0,0
1,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.26095,-0.050706,-0.052412,0,0
1,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.25753,-0.050759,-0.024683,0,0
1,GO KINETOCHORE ORGANIZATION,0.57752,-0.050769,-0.077287,0,0
1,GO HISTONE H3 K9 MODIFICATION,0.1793,-0.051086,-0.040695,0,0
1,GO OLIGODENDROCYTE DEVELOPMENT,0.37173,-0.051392,-0.035876,0,0
1,GO ANATOMICAL STRUCTURE REGRESSION,0.86968,-0.051438,-0.027139,0,0
1,GO CELLULAR COMPONENT MORPHOGENESIS,0.063836,-0.051448,-0.062664,0,0
1,GO REGULATION OF ACTIN NUCLEATION,0.29315,-0.051619,-0.046679,0,0
1,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.41666,-0.051638,-0.038902,0,0
1,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.6312,-0.05214,-0.007257,0,0
1,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.85694,-0.052254,0.0088472,0,0
1,GO GLUCOSE CATABOLIC PROCESS,0.43312,-0.052361,-0.040887,0,0
1,GO MEIOTIC CHROMOSOME SEPARATION,0.2913,-0.052573,-0.052373,0,0
1,GO CELLULAR RESPONSE TO LITHIUM ION,0.62545,-0.052583,-0.045783,0,0
1,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.2714,-0.052631,-0.076601,0,0
1,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.9113,-0.052755,0.0098797,0,0
1,GO CHROMATIN ORGANIZATION,0.25924,-0.053003,-0.026158,0,0
1,GO DEVELOPMENTAL CELL GROWTH,0.12322,-0.05314,-0.048504,0,0
1,GO MEMBRANE DOCKING,0.13549,-0.053358,-0.040032,0,0
1,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.94993,-0.05375,0.020712,0,0
1,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.69885,-0.053839,-0.0022875,0,0
1,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.93382,-0.053886,-0.010098,0,0
1,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.53672,-0.053913,-0.028444,0,0
1,GO MEMBRANE REPOLARIZATION,0.19417,-0.053967,-0.041178,0,0
1,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.14755,-0.054232,-0.048584,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.29877,-0.054308,-0.035235,0,0
1,GO DNA METHYLATION,0.81267,-0.05451,-0.002844,0,0
1,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.29502,-0.05477,-0.032677,0,0
1,GO CHEMOSENSORY BEHAVIOR,0.23766,-0.0548,-0.06555,0,0
1,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.15921,-0.05484,-0.060799,0,0
1,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.40286,-0.055266,-0.027436,0,0
1,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.58029,-0.055313,-0.027141,0,0
1,GO HISTONE EXCHANGE,0.32195,-0.055508,-0.063821,0,0
1,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.18194,-0.05561,-0.080967,0,0
1,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.28395,-0.055697,-0.027277,0,0
1,GO METHIONINE BIOSYNTHETIC PROCESS,0.25414,-0.055761,-0.055605,0,0
1,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.32393,-0.056381,-0.05016,0,0
1,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.20992,-0.056403,-0.061991,0,0
1,GO CARBOHYDRATE HOMEOSTASIS,0.30255,-0.056438,-0.016674,0,0
1,GO LOCALIZATION WITHIN MEMBRANE,0.54746,-0.056451,-0.016808,0,0
1,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.29502,-0.05646,-0.042779,0,0
1,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.38933,-0.056917,-0.023131,0,0
1,GO SENSORY PERCEPTION,0.065596,-0.056933,-0.048549,0,0
1,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.57752,-0.056974,-0.032621,0,0
1,GO DNA DEPENDENT DNA REPLICATION,0.23927,-0.057053,-0.060429,0,0
1,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.11092,-0.057114,-0.031419,0,0
1,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.089246,-0.057196,-0.06679,0,0
1,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.41899,-0.057507,-0.029497,0,0
1,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.10214,-0.057705,-0.10185,0,0
1,GO LONG TERM MEMORY,0.95316,-0.057718,0.014993,0,0
1,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.68689,-0.057908,-0.0045411,0,0
1,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.51557,-0.057994,-0.037877,0,0
1,GO REGULATION OF RECEPTOR INTERNALIZATION,0.1387,-0.057995,-0.045595,0,0
1,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.20554,-0.058083,-0.052207,0,0
1,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.6312,-0.058421,0.075872,0,0
1,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.15214,-0.058506,-0.063732,0,0
1,GO PROTEIN REFOLDING,0.72603,-0.05852,-0.011978,0,0
1,GO REGULATION OF MRNA PROCESSING,0.1453,-0.05854,-0.049671,0,0
1,GO ORGANIC ACID TRANSPORT,0.45238,-0.058788,-0.0065416,0,0
1,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.12322,-0.058949,-0.05566,0,0
1,GO REGULATION OF CATION CHANNEL ACTIVITY,0.32592,-0.059029,-0.029131,0,0
1,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.82526,-0.059149,-0.005724,0,0
1,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.55016,-0.05918,-0.0022207,0,0
1,GO NEUROGENESIS,0.11553,-0.059495,-0.046768,0,0
1,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.80012,-0.059503,-0.011456,0,0
1,GO NEURON PROJECTION EXTENSION,0.078382,-0.059547,-0.068843,0,0
1,GO PEPTIDYL LYSINE DIMETHYLATION,0.12029,-0.059558,-0.060826,0,0
1,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.178,-0.059587,-0.074787,0,0
1,GO MITOCHONDRIAL FUSION,0.31021,-0.059994,-0.023315,0,0
1,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.31215,-0.060005,-0.029492,0,0
1,GO CARDIAC MYOFIBRIL ASSEMBLY,0.22971,-0.060175,-0.076692,0,0
1,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.54746,-0.060225,-0.024663,0,0
1,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.7659,-0.060496,0.032351,0,0
1,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.5583,-0.060638,0.0014065,0,0
1,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.44269,-0.060804,-0.034279,0,0
1,GO REGULATION OF APPETITE,0.06986,-0.061329,-0.068416,0,0
1,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.71996,-0.061332,-0.0047573,0,0
1,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.096327,-0.062159,-0.098272,0,0
1,GO BRAIN MORPHOGENESIS,0.26095,-0.062161,-0.057508,0,0
1,GO REPLICATION FORK PROCESSING,0.27853,-0.062366,-0.037191,0,0
1,GO CHROMATIN DISASSEMBLY,0.65442,-0.062544,-0.026861,0,0
1,GO LONG TERM SYNAPTIC POTENTIATION,0.17411,-0.062727,-0.056049,0,0
1,GO DENDRITIC SPINE DEVELOPMENT,0.18595,-0.062744,-0.048168,0,0
1,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.31021,-0.062762,-0.04344,0,0
1,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.30066,-0.062861,-0.063717,0,0
1,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.43789,-0.062915,-0.074423,0,0
1,GO NEURON REMODELING,0.44028,-0.063328,-0.046675,0,0
1,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.077018,-0.063402,-0.063707,0,0
1,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.17283,-0.06407,-0.057372,0,0
1,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.67501,-0.064161,-0.024996,0,0
1,GO DNA REPLICATION INITIATION,0.10912,-0.064262,-0.12401,0,0
1,GO REGULATION OF HELICASE ACTIVITY,0.89846,-0.064364,0.0036828,0,0
1,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.55016,-0.064392,-0.02556,0,0
1,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.79075,-0.064507,0.0076656,0,0
1,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.081168,-0.06459,-0.054475,0,0
1,GO PEPTIDYL LYSINE ACETYLATION,0.061549,-0.064678,-0.042731,0,0
1,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.2644,-0.065105,-0.034624,0,0
1,GO REGULATION OF ACTION POTENTIAL,0.075674,-0.065108,-0.11282,0,0
1,GO CEREBRAL CORTEX CELL MIGRATION,0.044292,-0.065157,-0.11853,0,0
1,GO MICROTUBULE NUCLEATION,0.14308,-0.0655,-0.035666,0,0
1,GO TELENCEPHALON REGIONALIZATION,0.27673,-0.065549,-0.10055,0,0
1,GO POSITIVE REGULATION OF SECRETION,0.5314,-0.065609,-0.0053154,0,0
1,GO RECEPTOR CLUSTERING,0.1873,-0.065841,-0.070707,0,0
1,GO HISTONE DEUBIQUITINATION,0.55558,-0.065845,-0.0066353,0,0
1,GO DOSAGE COMPENSATION,0.30255,-0.066046,-0.036269,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.13656,-0.066265,-0.047048,0,0
1,GO SECRETORY GRANULE ORGANIZATION,0.15683,-0.066267,-0.056827,0,0
1,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.26095,-0.066492,-0.054728,0,0
1,GO EXPORT ACROSS PLASMA MEMBRANE,0.43075,-0.06658,-0.021657,0,0
1,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.29315,-0.066884,-0.040371,0,0
1,GO SISTER CHROMATID COHESION,0.11367,-0.066978,-0.082821,0,0
1,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.18461,-0.06698,-0.036355,0,0
1,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.060988,-0.066994,-0.049451,0,0
1,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.33396,-0.06779,-0.032843,0,0
1,GO OOCYTE DIFFERENTIATION,0.030368,-0.067854,-0.08331,0,0
1,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.1873,-0.067901,-0.067205,0,0
1,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.21889,-0.068085,-0.048299,0,0
1,GO SINGLE STRAND BREAK REPAIR,0.37608,-0.068202,-0.03668,0,0
1,GO HISTONE H3 K9 METHYLATION,0.060988,-0.068669,-0.068376,0,0
1,GO CARDIAC CHAMBER FORMATION,0.15802,-0.0687,-0.13669,0,0
1,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.12924,-0.068738,-0.057588,0,0
1,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.29689,-0.068792,-0.029603,0,0
1,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.079765,-0.068835,-0.066057,0,0
1,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.1533,-0.068861,-0.061186,0,0
1,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.21437,-0.068865,-0.020031,0,0
1,GO KINETOCHORE ASSEMBLY,0.85059,-0.06919,-0.024779,0,0
1,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.54208,-0.06924,-0.014174,0,0
1,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.11092,-0.069327,-0.076967,0,0
1,GO RESPONSE TO GLUCAGON,0.51035,-0.069365,-0.020789,0,0
1,GO RESPONSE TO AMINO ACID STARVATION,0.14869,-0.069478,-0.045784,0,0
1,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.26267,-0.070292,-0.032412,0,0
1,GO RESPONSE TO PAIN,0.82211,-0.070586,-0.0050896,0,0
1,GO REGULATION OF NEURON DIFFERENTIATION,0.076344,-0.070598,-0.063251,0,0
1,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.1873,-0.070622,-0.05381,0,0
1,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.36098,-0.070846,-0.029077,0,0
1,GO MRNA METHYLATION,0.1653,-0.070872,-0.053609,0,0
1,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.17669,-0.071111,-0.11452,0,0
1,GO ECTODERMAL PLACODE DEVELOPMENT,0.89526,-0.071273,-0.012916,0,0
1,GO HEART FIELD SPECIFICATION,0.13763,-0.071399,-0.12937,0,0
1,GO REGULATION OF ICOSANOID SECRETION,0.9693,-0.07147,0.012238,0,0
1,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.48215,-0.071699,-0.048581,0,0
1,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.089246,-0.071753,-0.10081,0,0
1,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.095518,-0.071881,-0.094778,0,0
1,GO PEPTIDYL ARGININE METHYLATION,0.35043,-0.072008,-0.046512,0,0
1,GO MITOTIC DNA REPLICATION,0.26614,-0.072291,-0.084662,0,0
1,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.73212,-0.072524,-0.039595,0,0
1,GO GENETIC IMPRINTING,0.16904,-0.073119,-0.052067,0,0
1,GO ENDOCRINE PANCREAS DEVELOPMENT,0.37173,-0.073344,-0.034345,0,0
1,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.37173,-0.073692,-0.048497,0,0
1,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.32592,-0.073713,-0.038258,0,0
1,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.53672,-0.073853,-0.023337,0,0
1,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.066192,-0.07397,-0.08291,0,0
1,GO POSITIVE REGULATION OF ION TRANSPORT,0.55016,-0.074509,-0.0076186,0,0
1,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.39381,-0.074585,-0.027021,0,0
1,GO MICROTUBULE BASED TRANSPORT,0.1453,-0.074752,-0.040597,0,0
1,GO HISTONE H2A ACETYLATION,0.10129,-0.075228,-0.075573,0,0
1,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.1533,-0.075298,-0.10921,0,0
1,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.13549,-0.075375,-0.058753,0,0
1,GO CHROMATIN REMODELING,0.10299,-0.075383,-0.06327,0,0
1,GO CILIUM ORGANIZATION,0.38488,-0.076581,-0.025078,0,0
1,GO CHROMATIN REMODELING AT CENTROMERE,0.18461,-0.076673,-0.12017,0,0
1,GO CELLULAR GLUCOSE HOMEOSTASIS,0.091558,-0.076951,-0.038588,0,0
1,GO PEPTIDE SECRETION,0.36311,-0.077193,-0.012366,0,0
1,GO FEAR RESPONSE,0.10471,-0.077707,-0.062845,0,0
1,GO POTASSIUM ION HOMEOSTASIS,0.10558,-0.077797,-0.08158,0,0
1,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.24089,-0.077987,-0.058708,0,0
1,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.25414,-0.07813,-0.055085,0,0
1,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.28578,-0.078133,-0.038334,0,0
1,GO HEART FORMATION,0.30829,-0.078431,-0.060443,0,0
1,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.13979,-0.078661,-0.074557,0,0
1,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.17283,-0.078872,-0.096042,0,0
1,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.22503,-0.079014,-0.039698,0,0
1,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.26267,-0.079414,-0.031881,0,0
1,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.29689,-0.079508,-0.073693,0,0
1,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.43075,-0.079754,-0.021378,0,0
1,GO MICROTUBULE ANCHORING AT CENTROSOME,0.26614,-0.079823,-0.028175,0,0
1,GO DNA REPLICATION CHECKPOINT,0.077698,-0.080004,-0.12908,0,0
1,GO REGULATION OF ACROSOME REACTION,0.31997,-0.080296,-0.067106,0,0
1,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.22042,-0.080354,-0.064135,0,0
1,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.36526,-0.080498,-0.034479,0,0
1,GO PROTEIN O LINKED MANNOSYLATION,0.71996,-0.080554,0.0055892,0,0
1,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.074349,-0.080605,-0.094225,0,0
1,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.21437,-0.080729,-0.048047,0,0
1,GO DETECTION OF MECHANICAL STIMULUS,0.17283,-0.08088,-0.095166,0,0
1,GO FUCOSYLATION,0.13444,-0.080961,-0.058502,0,0
1,GO COPULATION,0.58029,-0.081149,-0.025242,0,0
1,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.090011,-0.081198,-0.049829,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.075674,-0.081821,-0.041873,0,0
1,GO AXIS SPECIFICATION,0.21889,-0.081926,-0.047245,0,0
1,GO MICROTUBULE BASED MOVEMENT,0.099614,-0.082039,-0.052531,0,0
1,GO REGULATION OF MRNA POLYADENYLATION,0.22814,-0.082642,-0.031808,0,0
1,GO RRNA CATABOLIC PROCESS,0.73517,-0.082893,-0.019008,0,0
1,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.33194,-0.082989,-0.049292,0,0
1,GO N GLYCAN PROCESSING,0.96607,-0.083125,0.020286,0,0
1,GO MITOTIC CHROMOSOME CONDENSATION,0.18327,-0.083497,-0.097486,0,0
1,GO DNA DOUBLE STRAND BREAK PROCESSING,0.48976,-0.083587,-0.032417,0,0
1,GO IMPORT INTO CELL,0.13763,-0.083736,-0.042764,0,0
1,GO REGULATION OF SISTER CHROMATID COHESION,0.178,-0.083803,-0.064301,0,0
1,GO PROTEIN MANNOSYLATION,0.52345,-0.083977,-0.0069296,0,0
1,GO HYPOTHALAMUS DEVELOPMENT,0.22503,-0.084483,-0.06651,0,0
1,GO EMBRYONIC BRAIN DEVELOPMENT,0.12822,-0.084563,-0.085059,0,0
1,GO ION TRANSPORT,0.24911,-0.084698,-0.019348,0,0
1,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.11837,-0.085178,-0.086791,0,0
1,GO HEART PROCESS,0.19557,-0.085367,-0.031885,0,0
1,GO GLUTAMATE METABOLIC PROCESS,0.51296,-0.08573,-0.010984,0,0
1,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.1262,-0.085834,-0.055644,0,0
1,GO MEMBRANE FISSION,0.081168,-0.085921,-0.095722,0,0
1,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.082591,-0.085956,-0.059484,0,0
1,GO FEVER GENERATION,0.13763,-0.086303,-0.09811,0,0
1,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.14642,-0.086414,-0.077218,0,0
1,GO REGULATION OF MEMBRANE REPOLARIZATION,0.30446,-0.086456,-0.019724,0,0
1,GO CELL MATURATION,0.16285,-0.086571,-0.034755,0,0
1,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.29502,-0.086621,-0.052474,0,0
1,GO REGULATION OF AXONOGENESIS,0.075674,-0.086689,-0.06789,0,0
1,GO DIACYLGLYCEROL METABOLIC PROCESS,0.24911,-0.087112,-0.049514,0,0
1,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.11183,-0.087377,-0.05391,0,0
1,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.41899,-0.088286,-0.028627,0,0
1,GO SPERMATID DIFFERENTIATION,0.20699,-0.088313,-0.041814,0,0
1,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.16285,-0.088371,-0.067017,0,0
1,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.47963,-0.088416,-0.033085,0,0
1,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.040582,-0.088787,-0.089813,0,0
1,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.10385,-0.088916,-0.076448,0,0
1,GO REGULATION OF BEHAVIOR,0.033608,-0.088973,-0.085862,0,0
1,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.47712,-0.089045,-0.014891,0,0
1,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.20122,-0.089408,-0.087902,0,0
1,GO POSITIVE REGULATION OF VESICLE FUSION,0.86649,-0.08964,0.050226,0,0
1,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.22042,-0.089682,-0.064614,0,0
1,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.063258,-0.089768,-0.10621,0,0
1,GO CHLORIDE TRANSPORT,0.16285,-0.089866,-0.034922,0,0
1,GO REGULATION OF OOGENESIS,0.047372,-0.09008,-0.068771,0,0
1,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.46466,-0.090132,-0.04755,0,0
1,GO METAL ION TRANSPORT,0.29502,-0.090216,-0.019085,0,0
1,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.14642,-0.09037,-0.077161,0,0
1,GO SENSORY PERCEPTION OF BITTER TASTE,0.34627,-0.090966,-0.025055,0,0
1,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.13656,-0.091225,-0.025861,0,0
1,GO CYTOPLASM ORGANIZATION,0.47211,-0.091226,-0.0079877,0,0
1,GO G0 TO G1 TRANSITION,0.14088,-0.091265,-0.065773,0,0
1,GO ION TRANSMEMBRANE TRANSPORT,0.12322,-0.091971,-0.03698,0,0
1,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.066792,-0.092334,-0.056093,0,0
1,GO DENDRITE SELF AVOIDANCE,0.64276,-0.092616,-0.021548,0,0
1,GO AXO DENDRITIC PROTEIN TRANSPORT,0.024687,-0.092874,-0.12896,0,0
1,GO MICROTUBULE SEVERING,0.1262,-0.093055,-0.069729,0,0
1,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.2114,-0.093601,-0.0702,0,0
1,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.34627,-0.094301,-0.023482,0,0
1,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.1453,-0.094754,-0.029945,0,0
1,GO 3 UTR MEDIATED MRNA STABILIZATION,0.075009,-0.095354,-0.07256,0,0
1,GO CELL FATE DETERMINATION,0.23605,-0.095354,-0.061923,0,0
1,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.33599,-0.095437,-0.037313,0,0
1,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.36526,-0.09558,-0.021737,0,0
1,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.15565,-0.096316,-0.045764,0,0
1,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.34835,-0.09639,-0.030969,0,0
1,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.42133,-0.096577,-0.02511,0,0
1,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.36956,-0.096942,-0.079552,0,0
1,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.10214,-0.096982,-0.050889,0,0
1,GO ASTRAL MICROTUBULE ORGANIZATION,0.12224,-0.097449,-0.066272,0,0
1,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.38933,-0.097609,-0.03204,0,0
1,GO SEQUESTERING OF ACTIN MONOMERS,0.79075,-0.097615,0.019927,0,0
1,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.2114,-0.098812,-0.063745,0,0
1,GO STEROL BIOSYNTHETIC PROCESS,0.081168,-0.099011,-0.080785,0,0
1,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.32792,-0.10031,-0.076301,0,0
1,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.26267,-0.10039,-0.045031,0,0
1,GO REGULATION OF PROTEIN GLYCOSYLATION,0.17156,-0.10108,-0.074969,0,0
1,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.35886,-0.10128,-0.084195,0,0
1,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.095518,-0.10156,-0.063036,0,0
1,GO MATING,0.089246,-0.10217,-0.063811,0,0
1,GO CORTICOSTEROID HORMONE SECRETION,0.58307,-0.10279,-0.030554,0,0
1,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.23128,-0.10318,-0.045429,0,0
1,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.5,-0.10352,-0.085235,0,0
1,GO CATION TRANSMEMBRANE TRANSPORT,0.06986,-0.10374,-0.049475,0,0
1,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.18461,-0.10378,-0.047497,0,0
1,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.090011,-0.10392,-0.060969,0,0
1,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.63408,-0.10437,-0.0084974,0,0
1,GO PANCREAS DEVELOPMENT,0.099614,-0.10441,-0.076708,0,0
1,GO MRNA MODIFICATION,0.25246,-0.10446,-0.047013,0,0
1,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.065005,-0.10446,-0.051476,0,0
1,GO REGULATION OF CARDIAC CONDUCTION,0.26267,-0.10464,-0.025111,0,0
1,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.18062,-0.1051,-0.082208,0,0
1,GO MEGAKARYOCYTE DEVELOPMENT,0.54477,-0.10541,-0.035357,0,0
1,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.1914,-0.10584,-0.029899,0,0
1,GO REGULATION OF SECRETION,0.081168,-0.10636,-0.045402,0,0
1,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.2458,-0.10721,-0.10169,0,0
1,GO ENDOCARDIUM DEVELOPMENT,0.35886,-0.10723,-0.050796,0,0
1,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.19697,-0.10738,-0.070391,0,0
1,GO CATION TRANSPORT,0.077698,-0.10755,-0.044935,0,0
1,GO REGULATION OF CILIUM MOVEMENT,0.077698,-0.10818,-0.081096,0,0
1,GO GASTRULATION WITH MOUTH FORMING SECOND,0.76899,-0.10842,-0.01094,0,0
1,GO RESPONSE TO FORSKOLIN,0.21587,-0.1085,-0.085619,0,0
1,GO SLEEP,0.17669,-0.10909,-0.067174,0,0
1,GO HAIR CELL DIFFERENTIATION,0.47712,-0.10976,-0.031506,0,0
1,GO REGULATION OF MEIOTIC CELL CYCLE,0.027973,-0.1098,-0.09156,0,0
1,GO INNER DYNEIN ARM ASSEMBLY,0.086981,-0.10996,-0.15062,0,0
1,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.0057669,-0.10998,-0.13812,0,0
1,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.15098,-0.11003,-0.090673,0,0
1,GO SPERMATID NUCLEUS DIFFERENTIATION,0.14755,-0.11083,-0.039372,0,0
1,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.1313,-0.11092,-0.094367,0,0
1,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.019104,-0.11137,-0.1234,0,0
1,GO SECONDARY PALATE DEVELOPMENT,0.37827,-0.11272,-0.032416,0,0
1,GO COCHLEA DEVELOPMENT,0.068619,-0.11312,-0.10195,0,0
1,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.10129,-0.11316,-0.16347,0,0
1,GO SEX DETERMINATION,0.062684,-0.11431,-0.10355,0,0
1,GO HISTONE H3 K36 METHYLATION,0.071756,-0.11436,-0.098493,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0076401,-0.11513,-0.20027,0,0
1,GO REGULATION OF SYSTEM PROCESS,0.12822,-0.11515,-0.038281,0,0
1,GO RESPONSE TO CATECHOLAMINE,0.0076401,-0.11539,-0.095695,0,0
1,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.43789,-0.11547,-0.029944,0,0
1,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0081133,-0.11565,-0.11774,0,0
1,GO NON MOTILE CILIUM ASSEMBLY,0.23286,-0.11618,-0.048832,0,0
1,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.060432,-0.11626,-0.067648,0,0
1,GO HISTONE H2A MONOUBIQUITINATION,0.13763,-0.11826,-0.054857,0,0
1,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.070488,-0.11861,-0.097305,0,0
1,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.1653,-0.11877,-0.095321,0,0
1,GO SPERM AXONEME ASSEMBLY,0.22503,-0.11907,-0.071748,0,0
1,GO RESPONSE TO AMPHETAMINE,0.089246,-0.11964,-0.10328,0,0
1,GO ADULT HEART DEVELOPMENT,0.087731,-0.12009,-0.1094,0,0
1,GO ORGANIC CATION TRANSPORT,0.22042,-0.12051,-0.059764,0,0
1,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.15098,-0.12061,-0.096259,0,0
1,GO POSITIVE REGULATION OF HEART CONTRACTION,0.20992,-0.12217,-0.048143,0,0
1,GO REGULATION OF BLOOD CIRCULATION,0.1793,-0.12327,-0.034159,0,0
1,GO CALCIUM ION IMPORT INTO CYTOSOL,0.074349,-0.12337,-0.10292,0,0
1,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.062114,-0.1237,-0.14922,0,0
1,GO GLYCINE TRANSPORT,0.6691,-0.12416,-0.041867,0,0
1,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.064418,-0.12485,-0.084909,0,0
1,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.81267,-0.12601,-0.0058256,0,0
1,GO SNARE COMPLEX ASSEMBLY,0.1252,-0.12625,-0.067303,0,0
1,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.071119,-0.12637,-0.10906,0,0
1,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.10214,-0.12657,-0.09797,0,0
1,GO SODIUM ION TRANSPORT,0.071756,-0.12658,-0.05984,0,0
1,GO REGULATION OF COLLATERAL SPROUTING,0.11553,-0.12771,-0.097564,0,0
1,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.6515,-0.12822,-0.035529,0,0
1,GO DIVALENT METAL ION EXPORT,0.20265,-0.12994,-0.091347,0,0
1,GO RESPONSE TO POTASSIUM ION,0.10299,-0.12997,-0.13078,0,0
1,GO NEGATIVE REGULATION OF GLIOGENESIS,0.063258,-0.13049,-0.1071,0,0
1,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.093126,-0.13209,-0.065921,0,0
1,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.079765,-0.13251,-0.065798,0,0
1,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.023419,-0.13639,-0.07682,0,0
1,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.093126,-0.13787,-0.11485,0,0
1,GO REGULATION OF ION TRANSPORT,0.066792,-0.13966,-0.054581,0,0
1,GO COLLATERAL SPROUTING,0.12721,-0.14018,-0.071723,0,0
1,GO OPTIC NERVE DEVELOPMENT,0.081877,-0.14101,-0.14763,0,0
1,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0077327,-0.14158,-0.16903,0,0
1,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.081168,-0.14209,-0.079037,0,0
1,GO EMBRYONIC AXIS SPECIFICATION,0.00038422,-0.14246,-0.17102,0,0
1,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.18461,-0.14342,-0.048696,0,0
1,GO MEMORY,0.032607,-0.14351,-0.087541,0,0
1,GO REGULATION OF ORGANIC ACID TRANSPORT,0.078382,-0.14401,-0.069665,0,0
1,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.11092,-0.14607,-0.11307,0,0
1,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.32993,-0.14731,-0.06413,0,0
1,GO VISUAL BEHAVIOR,0.00084997,-0.14765,-0.11416,0,0
1,GO CRANIAL NERVE DEVELOPMENT,0.093918,-0.14805,-0.093154,0,0
1,GO MALE MEIOSIS I,0.078382,-0.15493,-0.1126,0,0
1,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.54477,-0.15535,-0.03346,0,0
1,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.12721,-0.15632,-0.067115,0,0
1,GO OTIC VESICLE DEVELOPMENT,0.072397,-0.15723,-0.15568,0,0
1,GO SKELETAL MUSCLE ADAPTATION,0.26964,-0.15726,-0.048307,0,0
1,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.10299,-0.15746,-0.048875,0,0
1,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.0007901,-0.15835,-0.1546,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.0041031,-0.15952,-0.25058,0,0
1,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.081168,-0.16113,-0.080669,0,0
1,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00037257,-0.16315,-0.16086,0,0
1,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.091558,-0.16387,-0.058412,0,0
1,GO AMINE BIOSYNTHETIC PROCESS,0.13027,-0.16527,-0.073324,0,0
1,GO RESPONSE TO DOPAMINE,0.00064263,-0.16829,-0.12297,0,0
1,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.016938,-0.16936,-0.1944,0,0
1,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.009139,-0.16981,-0.15179,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.010645,-0.17019,-0.10487,0,0
1,GO POSITIVE REGULATION OF BEHAVIOR,0.023919,-0.17322,-0.14485,0,0
1,GO LYSINE METABOLIC PROCESS,0.26267,-0.17598,-0.038581,0,0
1,GO TUBULIN DEACETYLATION,0.027401,-0.17606,-0.13731,0,0
1,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.0010113,-0.17622,-0.20232,0,0
1,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.09714,-0.1764,-0.11073,0,0
1,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.25753,-0.18482,-0.055613,0,0
1,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.18461,-0.18509,-0.12054,0,0
1,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0098086,-0.18875,-0.17918,0,0
1,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.11275,-0.19052,-0.097731,0,0
1,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.062114,-0.1933,-0.097524,0,0
1,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.011022,-0.19982,-0.17427,0,0
1,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.14308,-0.21144,-0.1466,0,0
1,GO FOREBRAIN GENERATION OF NEURONS,0.0022095,-0.21202,-0.17568,0,0
1,GO INTRACILIARY RETROGRADE TRANSPORT,0.10299,-0.21474,-0.10752,0,0
1,GO LIMB BUD FORMATION,0.25924,-0.21868,-0.068694,0,0
1,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.003166,-0.21897,-0.16963,0,0
1,GO SIALYLATION,0.2913,-0.2216,-0.11336,0,0
1,GO OLFACTORY LOBE DEVELOPMENT,0.021053,-0.22244,-0.15095,0,0
1,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.010279,-0.22407,-0.15704,0,0
1,GO RETINA LAYER FORMATION,0.00011033,-0.22504,-0.37687,0,0
1,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.15802,-0.22515,-0.13577,0,0
1,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.070488,-0.22828,-0.16976,0,0
1,GO CIRCADIAN SLEEP WAKE CYCLE,0.00061456,-0.23135,-0.21839,0,0
1,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.0025277,-0.23507,-0.27923,0,0
1,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.03006,-0.24002,-0.18226,0,0
1,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.01995,-0.24318,-0.18917,0,0
1,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.10823,-0.25995,-0.13627,0,0
1,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.00033955,-0.26143,-0.28184,0,0
1,GO FOREBRAIN NEURON DEVELOPMENT,0.001442,-0.26236,-0.2461,0,0
1,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00022565,-0.26479,-0.2201,0,0
1,GO DICARBOXYLIC ACID TRANSPORT,2.4528e-05,-0.26725,-0.18713,0,0
1,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.027118,-0.2813,-0.28969,0,0
1,GO NOREPINEPHRINE METABOLIC PROCESS,0.001568,-0.28209,-0.27306,0,0
1,GO REFLEX,0.0068504,-0.30917,-0.23399,0,0
1,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.0137,-0.32707,-0.23935,0,0
1,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.00010152,-0.33721,-0.2767,0,0
1,GO RETINAL GANGLION CELL AXON GUIDANCE,0.0002117,-0.33832,-0.39191,0,0
1,GO FOREBRAIN NEURON DIFFERENTIATION,0.00023667,-0.33936,-0.2601,0,0
1,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0010408,-0.33974,-0.28865,0,0
1,GO SEROTONIN TRANSPORT,0.00070238,-0.34489,-0.2942,0,0
1,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.19003,-0.34816,-0.087785,0,0
1,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.079765,-0.36726,-0.19961,0,0
1,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,2.3891e-06,-0.37089,-0.3757,0,0
1,GO PITUITARY GLAND DEVELOPMENT,0.003654,-0.39253,-0.21775,0,0
1,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,7.1274e-05,-0.43713,-0.31645,0,0
1,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.1858e-08,-0.45264,-0.51106,0,0
1,GO SPONTANEOUS SYNAPTIC TRANSMISSION,1.5052e-06,-0.48053,-0.40884,0,0
1,GO BEHAVIORAL RESPONSE TO COCAINE,4.1751e-05,-0.48408,-0.43516,0,0
1,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,2.342e-06,-0.5705,-0.49785,0,0
1,GO REGULATION OF GROWTH HORMONE SECRETION,7.8124e-06,-0.78938,-0.58955,0,0
1,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,1.1316e-06,-1.0365,-0.8215,0,0
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,8.1138e-06,1.1399,0.92949,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,9.6129e-06,1.0171,0.77768,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,3.2162e-07,0.84435,0.70768,1,1
2,GO ETHANOL OXIDATION,2.7e-09,0.80203,0.71618,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,5.4967e-09,0.7945,0.68621,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,1.2032e-06,0.78282,0.56488,1,1
2,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,2.9979e-12,0.76804,0.68656,1,1
2,GO ETHER BIOSYNTHETIC PROCESS,2.9515e-10,0.742,0.79167,1,1
2,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00011596,0.70795,0.51213,1,1
2,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,1.1415e-11,0.70261,0.70139,1,1
2,GO T HELPER 1 CELL DIFFERENTIATION,8.1361e-07,0.6728,0.53769,1,1
2,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,2.2505e-06,0.65479,0.47747,1,1
2,GO T CELL MEDIATED CYTOTOXICITY,6.8885e-07,0.64804,0.4918,1,1
2,GO MESENCHYMAL CELL APOPTOTIC PROCESS,8.2686e-06,0.63941,0.54892,1,1
2,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,1.4472e-05,0.62562,0.51997,1,1
2,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,2.0983e-10,0.62367,0.60385,1,1
2,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,3.8983e-07,0.61908,0.50231,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00014362,0.60494,0.43994,1,1
2,GO MYOBLAST MIGRATION,9.1829e-05,0.60232,0.46945,1,1
2,GO NEGATIVE REGULATION OF CELL KILLING,4.3236e-05,0.60207,0.43202,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,4.2784e-08,0.5671,0.59519,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.0395e-05,0.55099,0.38667,1,1
2,GO OTIC VESICLE DEVELOPMENT,1.0958e-05,0.54837,0.4452,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.00022565,0.54289,0.43885,1,1
2,GO PROSTATE GLAND GROWTH,1.2328e-07,0.54015,0.54587,1,1
2,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,1.0557e-05,0.53917,0.4366,1,1
2,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,4.6881e-08,0.53648,0.53613,1,1
2,GO INFLAMMATORY RESPONSE TO WOUNDING,2.5424e-05,0.52966,0.4614,1,1
2,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,7.2497e-05,0.52925,0.36589,1,1
2,GO T HELPER 2 CELL DIFFERENTIATION,2.7804e-05,0.52533,0.4497,1,1
2,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.00015083,0.52421,0.40367,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,2.538e-07,0.50851,0.42478,1,1
2,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,7.0522e-08,0.50566,0.42751,1,1
2,GO BIOLOGICAL PHASE,1.9393e-05,0.49531,0.46756,1,1
2,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,4.8416e-06,0.49523,0.48952,1,1
2,GO RESPONSE TO INTERFERON BETA,0.0023009,0.48709,0.34599,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,8.0712e-08,0.48315,0.48561,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,1.8573e-08,0.47966,0.40772,1,1
2,GO T HELPER 1 TYPE IMMUNE RESPONSE,5.3747e-08,0.4796,0.44042,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,7.105e-06,0.4777,0.35642,1,1
2,GO RESPONSE TO INTERLEUKIN 18,0.00028155,0.47489,0.45097,1,1
2,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.00016361,0.4735,0.40511,1,1
2,GO PROSTANOID BIOSYNTHETIC PROCESS,9.3415e-09,0.47132,0.47772,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00011218,0.47017,0.34593,1,1
2,GO HEPATOCYTE DIFFERENTIATION,4.8839e-05,0.46922,0.37562,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,2.2416e-05,0.46892,0.34176,1,1
2,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00011406,0.46802,0.32735,1,1
2,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.6487e-06,0.46103,0.41307,1,1
2,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,5.6487e-06,0.46084,0.31849,1,1
2,GO ETHANOL METABOLIC PROCESS,2.7078e-07,0.45901,0.45912,1,1
2,GO IMMUNE RESPONSE TO TUMOR CELL,1.0322e-07,0.45776,0.43457,1,1
2,GO SKELETAL MUSCLE TISSUE REGENERATION,8.4415e-08,0.4577,0.37956,1,1
2,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.00036124,0.45474,0.39693,1,1
2,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.00075607,0.44476,0.34791,1,1
2,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,8.5858e-05,0.44424,0.45287,1,1
2,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.2954e-05,0.44371,0.3957,1,1
2,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,8.0815e-10,0.4403,0.4308,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00042128,0.4345,0.33992,1,1
2,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.0037498,0.43376,0.32365,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,9.4959e-05,0.43142,0.38413,1,1
2,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.010279,0.42987,0.2855,1,1
2,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00014129,0.42863,0.29781,1,1
2,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,9.4959e-05,0.4251,0.36691,1,1
2,GO TOLERANCE INDUCTION,0.0012177,0.4234,0.32058,1,1
2,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.2046e-07,0.41927,0.40582,1,1
2,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,7.3739e-05,0.41555,0.327,1,1
2,GO PROTEIN DNA COMPLEX DISASSEMBLY,1.9014e-08,0.41151,0.39571,1,1
2,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,1.2058e-07,0.41072,0.38681,1,1
2,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,3.4773e-06,0.40971,0.4084,1,1
2,GO PROSTANOID METABOLIC PROCESS,6.2046e-07,0.40967,0.37765,1,1
2,GO TYPE 2 IMMUNE RESPONSE,0.00011986,0.40847,0.28544,1,1
2,GO DETOXIFICATION OF INORGANIC COMPOUND,0.040981,0.4073,0.44961,1,1
2,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.00011033,0.40595,0.33886,1,1
2,GO CYCLOOXYGENASE PATHWAY,0.00058763,0.40545,0.34556,1,1
2,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,4.7501e-09,0.40492,0.40354,1,1
2,GO INFLAMMATORY CELL APOPTOTIC PROCESS,2.4972e-05,0.40165,0.33352,1,1
2,GO LYSINE METABOLIC PROCESS,0.00044103,0.40056,0.39712,1,1
2,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,8.2864e-09,0.40012,0.41236,1,1
2,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.0013443,0.39992,0.31607,1,1
2,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00053704,0.39963,0.29778,1,1
2,GO REGULATION OF T CELL MEDIATED IMMUNITY,1.5014e-05,0.39682,0.26634,1,1
2,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00019541,0.39569,0.38902,1,1
2,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.00014129,0.39465,0.34609,1,1
2,GO MONONUCLEAR CELL DIFFERENTIATION,1.2281e-06,0.3932,0.3811,1,1
2,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0012177,0.39278,0.31603,1,1
2,GO REGULATION OF RESPONSE TO TUMOR CELL,5.2445e-07,0.39188,0.3349,1,1
2,GO PSEUDOPODIUM ORGANIZATION,4.2487e-05,0.39162,0.39085,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00017176,0.38948,0.37982,1,1
2,GO REGULATION OF T HELPER CELL DIFFERENTIATION,5.3256e-05,0.3882,0.31699,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,3.5022e-05,0.38788,0.27472,1,1
2,GO ETHER METABOLIC PROCESS,1.7154e-07,0.38754,0.37326,1,1
2,GO GLYCEROL ETHER METABOLIC PROCESS,5.02e-08,0.3846,0.3689,1,1
2,GO NEURAL CREST FORMATION,0.0001862,0.38384,0.29769,1,1
2,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.7071e-05,0.3815,0.3126,1,1
2,GO BARBED END ACTIN FILAMENT CAPPING,0.00014599,0.37924,0.33389,1,1
2,GO T CELL MEDIATED IMMUNITY,1.1165e-05,0.3752,0.28555,1,1
2,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.00010673,0.37446,0.38735,1,1
2,GO REGULATION OF TOLERANCE INDUCTION,0.0083098,0.37295,0.20406,1,1
2,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.00046872,0.37291,0.2555,1,1
2,GO DENDRITIC CELL MIGRATION,6.7105e-06,0.3712,0.32133,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,3.4098e-06,0.36988,0.33605,1,1
2,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.00096848,0.36876,0.33673,1,1
2,GO REGULATION OF T CELL APOPTOTIC PROCESS,5.9056e-05,0.36822,0.27659,1,1
2,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,4.6578e-06,0.36793,0.35394,1,1
2,GO RESPONSE TO TYPE I INTERFERON,0.0072795,0.36738,0.24738,1,1
2,GO REGULATION OF GASTRIC ACID SECRETION,6.4699e-07,0.36667,0.38896,1,1
2,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,5.0278e-07,0.36654,0.38285,1,1
2,GO CELLULAR RESPONSE TO ANTIBIOTIC,5.0563e-05,0.36564,0.35189,1,1
2,GO POSITIVE REGULATION OF CELL KILLING,0.0002443,0.36541,0.24581,1,1
2,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00017457,0.363,0.36803,1,1
2,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,2.971e-06,0.36211,0.33691,1,1
2,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00084997,0.36134,0.27962,1,1
2,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0071051,0.36113,0.27657,1,1
2,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00022565,0.35807,0.23474,1,1
2,GO CARDIOLIPIN METABOLIC PROCESS,2.5756e-08,0.35752,0.33786,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00033432,0.35632,0.26244,1,1
2,GO INTERLEUKIN 13 PRODUCTION,0.00010673,0.35571,0.3532,1,1
2,GO LIMB BUD FORMATION,0.0030038,0.35508,0.3839,1,1
2,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,4.5684e-06,0.35206,0.29734,1,1
2,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00025215,0.35171,0.33754,1,1
2,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.0054192,0.35167,0.25191,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00012186,0.3509,0.29756,1,1
2,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,1.3174e-07,0.35033,0.31645,1,1
2,GO REGULATION OF DNA METHYLATION,9.795e-06,0.34986,0.27926,1,1
2,GO NOTOCHORD DEVELOPMENT,0.00052901,0.34942,0.36165,1,1
2,GO TRIPARTITE REGIONAL SUBDIVISION,0.00011596,0.34827,0.30381,1,1
2,GO L ASCORBIC ACID METABOLIC PROCESS,0.0002443,0.34754,0.31989,1,1
2,GO INTERLEUKIN 8 PRODUCTION,0.00014362,0.34709,0.26569,1,1
2,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,8.1623e-05,0.34408,0.26385,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,5.4184e-05,0.34233,0.28588,1,1
2,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.0001179,0.34147,0.31543,1,1
2,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,6.0759e-07,0.341,0.29979,1,1
2,GO OXYGEN TRANSPORT,0.0039992,0.34048,0.29455,1,1
2,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.7922e-07,0.34027,0.34881,1,1
2,GO REGULATION OF CELL KILLING,0.00015838,0.33785,0.2316,1,1
2,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,5.2344e-05,0.33694,0.28641,1,1
2,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.0010259,0.33666,0.32933,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00031907,0.33551,0.2922,1,1
2,GO POSITIVE REGULATION OF T CELL PROLIFERATION,6.4341e-05,0.33457,0.23905,1,1
2,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0001862,0.33438,0.26766,1,1
2,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,6.8396e-06,0.33376,0.40703,1,1
2,GO ICOSANOID BIOSYNTHETIC PROCESS,2.4371e-06,0.32941,0.32607,1,1
2,GO PSEUDOURIDINE SYNTHESIS,1.8142e-08,0.32893,0.36163,1,1
2,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00034485,0.32884,0.36142,1,1
2,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.00039018,0.3281,0.27341,1,1
2,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0035605,0.32803,0.32099,1,1
2,GO HAIR FOLLICLE MATURATION,8.5858e-05,0.32699,0.30939,1,1
2,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,8.1623e-05,0.32595,0.27847,1,1
2,GO BRANCH ELONGATION OF AN EPITHELIUM,0.00088789,0.32543,0.34933,1,1
2,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.0020646,0.32518,0.32199,1,1
2,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0020092,0.32517,0.23243,1,1
2,GO POSITIVE REGULATION OF PROTEIN IMPORT,4.6578e-06,0.32386,0.29913,1,1
2,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.00063314,0.32092,0.23983,1,1
2,GO INTERLEUKIN 2 PRODUCTION,1.2534e-06,0.31751,0.30012,1,1
2,GO RETINAL METABOLIC PROCESS,0.032938,0.31697,0.21049,1,1
2,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,6.7724e-05,0.31591,0.35594,1,1
2,GO ENTRY OF BACTERIUM INTO HOST CELL,0.020166,0.31549,0.24896,1,1
2,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,2.7804e-05,0.31429,0.28863,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0027747,0.31062,0.21778,1,1
2,GO T CELL CHEMOTAXIS,4.9694e-05,0.31025,0.24847,1,1
2,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.048285,0.30942,0.19665,1,1
2,GO SENSORY PERCEPTION OF BITTER TASTE,6.895e-08,0.3093,0.37954,1,1
2,GO INTERLEUKIN 1 PRODUCTION,0.00084997,0.30833,0.24113,1,1
2,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0002443,0.30793,0.23982,1,1
2,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00014129,0.30682,0.25633,1,1
2,GO RESPONSE TO INTERFERON GAMMA,0.0029645,0.30668,0.21698,1,1
2,GO LEUKOCYTE MEDIATED CYTOTOXICITY,8.1623e-05,0.30648,0.23261,1,1
2,GO SOMATIC STEM CELL POPULATION MAINTENANCE,3.3214e-05,0.30608,0.24699,1,1
2,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.00046165,0.30599,0.29666,1,1
2,GO LINOLEIC ACID METABOLIC PROCESS,2.6914e-06,0.30441,0.40081,1,1
2,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,2.2824e-05,0.30378,0.28151,1,1
2,GO MONOCYTE CHEMOTAXIS,0.00020835,0.30255,0.24414,1,1
2,GO NEGATIVE REGULATION OF CELL DIVISION,0.0022396,0.30077,0.17961,1,1
2,GO RESPONSE TO TUMOR CELL,4.8839e-05,0.29956,0.27503,1,1
2,GO PORE COMPLEX ASSEMBLY,4.6881e-08,0.29879,0.28767,1,1
2,GO CHONDROCYTE PROLIFERATION,0.00011986,0.29824,0.34548,1,1
2,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.0557e-05,0.29794,0.2626,1,1
2,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.00031414,0.2976,0.22847,1,1
2,GO GAS TRANSPORT,0.0012886,0.29756,0.27527,1,1
2,GO REGULATION OF MICROVILLUS ORGANIZATION,0.0032078,0.29687,0.30247,1,1
2,GO T CELL APOPTOTIC PROCESS,0.00016361,0.29646,0.20905,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0032078,0.29594,0.21079,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00039622,0.29534,0.26517,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.996e-06,0.29493,0.29245,1,1
2,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,2.4837e-07,0.29477,0.30018,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOLUS,3.4003e-08,0.29368,0.33294,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,1.9989e-07,0.29351,0.27387,1,1
2,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,1.2281e-06,0.29339,0.27264,1,1
2,GO ACTIN FILAMENT SEVERING,0.0035605,0.2925,0.30535,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.001776,0.29235,0.18462,1,1
2,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0086125,0.29159,0.21755,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.001235,0.2914,0.19831,1,1
2,GO PENTOSE METABOLIC PROCESS,2.7668e-07,0.29136,0.37104,1,1
2,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,2.5359e-06,0.29111,0.26006,1,1
2,GO MRNA MODIFICATION,2.5424e-05,0.29099,0.23816,1,1
2,GO TETRAHYDROFOLATE INTERCONVERSION,2.6914e-06,0.29082,0.35041,1,1
2,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.6352e-05,0.29012,0.26262,1,1
2,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.00067188,0.28868,0.30671,1,1
2,GO AMINE CATABOLIC PROCESS,5.2344e-05,0.28765,0.29298,1,1
2,GO RIG I SIGNALING PATHWAY,6.9711e-06,0.28749,0.24152,1,1
2,GO MATURATION OF LSU RRNA,1.0756e-05,0.28726,0.30285,1,1
2,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.0039992,0.28716,0.20635,1,1
2,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.022686,0.28707,0.21974,1,1
2,GO MONONUCLEAR CELL MIGRATION,6.545e-05,0.28666,0.23866,1,1
2,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.0020092,0.2863,0.2062,1,1
2,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,1.2716e-05,0.28588,0.32684,1,1
2,GO FRUCTOSE METABOLIC PROCESS,0.0017517,0.28553,0.32238,1,1
2,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.03429,0.28435,0.17832,1,1
2,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.00068191,0.28417,0.19879,1,1
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.00015838,0.28322,0.22496,1,1
2,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0002117,0.28237,0.2213,1,1
2,GO REGULATION OF PODOSOME ASSEMBLY,0.0062877,0.28232,0.24771,1,1
2,GO LEFT RIGHT AXIS SPECIFICATION,0.0013069,0.28148,0.30183,1,1
2,GO POSITIVE REGULATION OF COAGULATION,0.00064263,0.28137,0.2238,1,1
2,GO AMP METABOLIC PROCESS,0.00012804,0.28135,0.2827,1,1
2,GO BLASTODERM SEGMENTATION,0.0018764,0.28049,0.2584,1,1
2,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,5.9498e-07,0.2803,0.26333,1,1
2,GO MATURATION OF SSU RRNA,1.0958e-05,0.27944,0.26556,1,1
2,GO MYELOID CELL APOPTOTIC PROCESS,0.00098255,0.2794,0.21681,1,1
2,GO FIBROBLAST ACTIVATION,3.4098e-06,0.27918,0.31054,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.00027284,0.27851,0.22574,1,1
2,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,9.819e-05,0.27783,0.22374,1,1
2,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.0048405,0.27782,0.24031,1,1
2,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00016098,0.27678,0.29256,1,1
2,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00074504,0.27653,0.24875,1,1
2,GO RETINOL METABOLIC PROCESS,3.3214e-05,0.27647,0.23788,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00031907,0.27571,0.23987,1,1
2,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0070192,0.27531,0.28609,1,1
2,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.0137,0.27527,0.1828,1,1
2,GO IMP METABOLIC PROCESS,0.0011836,0.27507,0.27145,1,1
2,GO HEMOGLOBIN METABOLIC PROCESS,1.3948e-05,0.27505,0.23617,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0012005,0.27469,0.21872,1,1
2,GO CHROMATIN DISASSEMBLY,2.8305e-05,0.27415,0.2258,1,1
2,GO MUSCLE CELL FATE COMMITMENT,0.0076401,0.27389,0.18324,1,1
2,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.0046018,0.27282,0.19464,1,1
2,GO CELLULAR HYPEROSMOTIC RESPONSE,0.016938,0.27274,0.13737,1,1
2,GO PHOSPHOLIPID CATABOLIC PROCESS,2.5884e-05,0.27161,0.23768,1,1
2,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00057029,0.27153,0.22608,1,1
2,GO EPITHELIAL CELL CELL ADHESION,0.0065235,0.2714,0.3098,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.00014599,0.27139,0.24031,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,1.6994e-06,0.27128,0.28844,1,1
2,GO MATURE B CELL DIFFERENTIATION,0.0047198,0.27105,0.19368,1,1
2,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0012886,0.27088,0.20095,1,1
2,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,3.4098e-06,0.27057,0.29845,1,1
2,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.00012594,0.27054,0.25862,1,1
2,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.2482e-05,0.27013,0.23629,1,1
2,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.0015249,0.26985,0.20301,1,1
2,GO PEPTIDE CROSS LINKING,0.0032928,0.26977,0.22216,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,7.2497e-05,0.2697,0.27606,1,1
2,GO NEUROBLAST DIVISION,0.0021505,0.26904,0.27102,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.0010113,0.26838,0.20883,1,1
2,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.0073682,0.26577,0.19389,1,1
2,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0018764,0.26534,0.19018,1,1
2,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,2.011e-05,0.26523,0.26487,1,1
2,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0074579,0.26436,0.14286,1,1
2,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00010152,0.26329,0.23918,1,1
2,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0095807,0.26327,0.29382,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.00037835,0.26276,0.25592,1,1
2,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0005056,0.26171,0.25044,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00091404,0.26167,0.17546,1,1
2,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.00073415,0.26129,0.22759,1,1
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,6.0079e-05,0.26082,0.29346,1,1
2,GO RRNA MODIFICATION,2.2775e-07,0.26051,0.25483,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0011836,0.26035,0.18256,1,1
2,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.5576e-05,0.25989,0.26168,1,1
2,GO ECTODERMAL PLACODE DEVELOPMENT,0.039795,0.25966,0.17192,1,1
2,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.0010865,0.25941,0.19264,1,1
2,GO MICROVILLUS ASSEMBLY,0.0060595,0.25892,0.22247,1,1
2,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,8.0256e-05,0.25857,0.20326,1,1
2,GO MYELOID DENDRITIC CELL ACTIVATION,0.001235,0.25819,0.16876,1,1
2,GO REGULATION OF VIRAL TRANSCRIPTION,1.2792e-06,0.25817,0.21589,1,1
2,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0083098,0.2576,0.23041,1,1
2,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.013856,0.25731,0.15294,1,1
2,GO LAMELLIPODIUM ORGANIZATION,5.2344e-05,0.25701,0.20307,1,1
2,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,1.2032e-06,0.2565,0.27086,1,1
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.00048316,0.25624,0.23663,1,1
2,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.0096941,0.25594,0.21697,1,1
2,GO FIBROBLAST APOPTOTIC PROCESS,0.00061456,0.25573,0.23645,1,1
2,GO ERBB2 SIGNALING PATHWAY,0.00067188,0.25558,0.20187,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,6.6578e-05,0.25411,0.2293,1,1
2,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00069207,0.25408,0.19997,1,1
2,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00019857,0.25403,0.23499,1,1
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.004156,0.25323,0.17129,1,1
2,GO FOREGUT MORPHOGENESIS,0.014332,0.2532,0.1999,1,1
2,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,5.5412e-06,0.25227,0.23417,1,1
2,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,3.6162e-06,0.25224,0.2514,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0001803,0.25091,0.22111,1,1
2,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00065224,0.2506,0.17115,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0011836,0.24957,0.17318,1,1
2,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.020166,0.24936,0.19826,1,1
2,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.045591,0.24929,0.12818,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0023009,0.24864,0.17156,1,1
2,GO REGULATION OF MIRNA METABOLIC PROCESS,2.6828e-05,0.24819,0.22646,1,1
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00027716,0.248,0.18326,1,1
2,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,1.0004e-06,0.24695,0.24171,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,3.4409e-05,0.24691,0.24748,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.00019229,0.24645,0.2777,1,1
2,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,1.1588e-05,0.24563,0.22396,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0040509,0.24554,0.18439,1,1
2,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,6.0079e-05,0.2445,0.21171,1,1
2,GO CYTOPLASM ORGANIZATION,0.00015838,0.24355,0.30516,1,1
2,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.0023321,0.24346,0.24272,1,1
2,GO INTERACTION WITH SYMBIONT,7.0072e-05,0.24291,0.19828,1,1
2,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.049681,0.24254,0.12389,1,1
2,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0018006,0.24251,0.28336,1,1
2,GO GTP METABOLIC PROCESS,9.7998e-07,0.24237,0.27304,1,1
2,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,8.3013e-05,0.24207,0.27739,1,1
2,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00024819,0.24195,0.21955,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0018764,0.24175,0.19261,1,1
2,GO REGULATION OF LIPASE ACTIVITY,6.8396e-06,0.24155,0.20843,1,1
2,GO REGULATION OF B CELL PROLIFERATION,0.0041031,0.24154,0.16502,1,1
2,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.042197,0.24152,0.15637,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.000286,0.24151,0.21721,1,1
2,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,1.8363e-05,0.24145,0.2334,1,1
2,GO PROTEIN DEGLYCOSYLATION,0.01128,0.24099,0.15978,1,1
2,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.013093,0.24085,0.18329,1,1
2,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.011949,0.24062,0.1943,1,1
2,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.022928,0.24034,0.1587,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0018508,0.24017,0.18914,1,1
2,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.048285,0.24001,0.19417,1,1
2,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.00014599,0.23966,0.22436,1,1
2,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.02945,0.23958,0.16538,1,1
2,GO ADAPTIVE IMMUNE RESPONSE,0.00038422,0.23892,0.19561,1,1
2,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,3.3435e-06,0.23888,0.26512,1,1
2,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.013394,0.23865,0.20518,1,1
2,GO ARACHIDONIC ACID SECRETION,8.9166e-06,0.23859,0.24481,1,1
2,GO LAMELLIPODIUM MORPHOGENESIS,0.00072342,0.23844,0.24049,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00012388,0.23803,0.25643,1,1
2,GO VIRAL TRANSLATION,6.2169e-06,0.23799,0.27665,1,1
2,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.019312,0.23717,0.15727,1,1
2,GO L SERINE METABOLIC PROCESS,0.0030839,0.23674,0.22613,1,1
2,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.0050904,0.23665,0.16012,1,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,8.1623e-05,0.23636,0.2039,1,1
2,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.0085105,0.23593,0.15428,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.00087508,0.23575,0.18476,1,1
2,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.001422,0.23575,0.24645,1,1
2,GO MICROVILLUS ORGANIZATION,0.0078263,0.23561,0.22717,1,1
2,GO REGULATION OF TELOMERASE ACTIVITY,1.2281e-06,0.23499,0.21425,1,1
2,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00046165,0.23465,0.18522,1,1
2,GO LEUKOTRIENE METABOLIC PROCESS,0.00063314,0.23422,0.21746,1,1
2,GO NEPHRON TUBULE FORMATION,0.00159,0.23411,0.25754,1,1
2,GO INTERLEUKIN 1 BETA PRODUCTION,0.018898,0.2341,0.18156,1,1
2,GO PROTEIN ADP RIBOSYLATION,0.00040857,0.23397,0.2026,1,1
2,GO ASYMMETRIC CELL DIVISION,0.0062108,0.23341,0.17517,1,1
2,GO REGULATION OF STEM CELL DIFFERENTIATION,0.00022565,0.23208,0.20764,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.00037835,0.23112,0.27241,1,1
2,GO NEGATIVE T CELL SELECTION,0.0037985,0.23096,0.14296,1,1
2,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0022095,0.23092,0.16398,1,1
2,GO PEPTIDYL ARGININE MODIFICATION,3.8983e-07,0.23083,0.26736,1,1
2,GO SERTOLI CELL DEVELOPMENT,0.0030436,0.23048,0.24844,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.032607,0.22952,0.19011,1,1
2,GO NUCLEOBASE BIOSYNTHETIC PROCESS,2.3661e-05,0.22951,0.25886,1,1
2,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,6.3249e-05,0.22905,0.19288,1,1
2,GO LEUKOCYTE PROLIFERATION,0.001422,0.22859,0.15689,1,1
2,GO REGULATION OF HORMONE METABOLIC PROCESS,0.021053,0.22815,0.15148,1,1
2,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0020929,0.22804,0.16055,1,1
2,GO ETHANOL CATABOLIC PROCESS,0.019523,0.22802,0.20853,1,1
2,GO CORNIFICATION,0.0038478,0.22783,0.2584,1,1
2,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.0039992,0.22761,0.21869,1,1
2,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0050269,0.22735,0.17508,1,1
2,GO DENDRITIC CELL CHEMOTAXIS,0.00012388,0.2273,0.23894,1,1
2,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,5.8049e-05,0.2272,0.31394,1,1
2,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.001704,0.22712,0.17655,1,1
2,GO SECRETION BY TISSUE,0.0066851,0.22673,0.15123,1,1
2,GO ZYMOGEN ACTIVATION,0.032278,0.22665,0.18769,1,1
2,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0059852,0.22651,0.17299,1,1
2,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0093576,0.22647,0.20996,1,1
2,GO PROSTATE GLAND DEVELOPMENT,0.0029645,0.22614,0.2704,1,1
2,GO RNA 5 END PROCESSING,3.0302e-06,0.22583,0.23005,1,1
2,GO RNA DECAPPING,0.00086244,0.22535,0.15408,1,1
2,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.012367,0.22519,0.17102,1,1
2,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,2.1234e-05,0.22497,0.24781,1,1
2,GO NAD BIOSYNTHETIC PROCESS,0.042609,0.22488,0.14353,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.001442,0.22466,0.15366,1,1
2,GO REGULATION OF MAST CELL ACTIVATION,0.0042636,0.22404,0.18658,1,1
2,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00088789,0.22399,0.16573,1,1
2,GO BILE ACID AND BILE SALT TRANSPORT,0.032938,0.22385,0.129,1,1
2,GO RESPONSE TO INTERLEUKIN 1,0.00017176,0.22274,0.16913,1,1
2,GO T CELL RECEPTOR SIGNALING PATHWAY,1.2027e-05,0.22221,0.19632,1,1
2,GO AMINO ACID ACTIVATION,2.3891e-06,0.22213,0.2325,1,1
2,GO MITOCHONDRIAL RNA METABOLIC PROCESS,5.0563e-05,0.22202,0.22946,1,1
2,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.057711,0.22199,0.13033,1,1
2,GO MRNA METHYLATION,0.014013,0.22165,0.15098,1,1
2,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00010497,0.22144,0.22132,1,1
2,GO REGULATION OF MACROPHAGE ACTIVATION,0.0037016,0.22141,0.15928,1,1
2,GO MOVEMENT IN HOST ENVIRONMENT,0.010769,0.22136,0.15082,1,1
2,GO RESPONSE TO X RAY,0.0005618,0.22115,0.23321,1,1
2,GO LEUKOCYTE APOPTOTIC PROCESS,0.0014022,0.22112,0.17557,1,1
2,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00088789,0.2211,0.23362,1,1
2,GO RESPONSE TO PROTOZOAN,0.010279,0.2207,0.17968,1,1
2,GO ZINC ION HOMEOSTASIS,0.0083098,0.22068,0.20242,1,1
2,GO HEPATOCYTE APOPTOTIC PROCESS,0.0022701,0.2205,0.34814,1,1
2,GO CELLULAR RESPONSE TO RETINOIC ACID,0.0081133,0.21997,0.19349,1,1
2,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,2.9332e-05,0.21967,0.1958,1,1
2,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,6.337e-06,0.21967,0.23343,1,1
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,3.8246e-05,0.21964,0.20169,1,1
2,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.6654e-06,0.2195,0.22719,1,1
2,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0016122,0.21949,0.16203,1,1
2,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0081133,0.2186,0.18712,1,1
2,GO MIRNA METABOLIC PROCESS,4.3997e-05,0.21765,0.17925,1,1
2,GO LYMPHOCYTE APOPTOTIC PROCESS,0.00054518,0.21764,0.17932,1,1
2,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.022446,0.21759,0.12387,1,1
2,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,1.2027e-05,0.21727,0.22434,1,1
2,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.001704,0.21701,0.19268,1,1
2,GO STEM CELL DIVISION,0.010645,0.21656,0.17691,1,1
2,GO ALDITOL METABOLIC PROCESS,1.7693e-06,0.21651,0.302,1,1
2,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0033361,0.21605,0.24503,1,1
2,GO PROTEIN DEMANNOSYLATION,0.012367,0.21571,0.14016,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0037985,0.21547,0.19165,1,1
2,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0015249,0.21517,0.2253,1,1
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0020367,0.21505,0.18552,1,1
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.00010497,0.21494,0.191,1,1
2,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0005133,0.21446,0.15914,1,1
2,GO ERYTHROCYTE MATURATION,0.0022701,0.21444,0.24586,1,1
2,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.006444,0.21415,0.17905,1,1
2,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,6.3249e-05,0.21392,0.20245,1,1
2,GO B CELL HOMEOSTASIS,0.015159,0.21388,0.1451,1,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.059331,0.21384,0.13508,1,1
2,GO RESPONSE TO INTERLEUKIN 15,0.000662,0.21374,0.2176,1,1
2,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0017277,0.21241,0.24964,1,1
2,GO PODOSOME ASSEMBLY,0.015329,0.21218,0.19838,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.045591,0.21195,0.11217,1,1
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00099681,0.21158,0.14327,1,1
2,GO INTERFERON GAMMA PRODUCTION,0.00080175,0.2114,0.16144,1,1
2,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.017894,0.2114,0.14681,1,1
2,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.00026438,0.21129,0.19349,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00039018,0.21098,0.1878,1,1
2,GO B CELL RECEPTOR SIGNALING PATHWAY,0.0015463,0.21094,0.20648,1,1
2,GO RENAL VESICLE DEVELOPMENT,0.018693,0.21094,0.14247,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.014013,0.21076,0.19118,1,1
2,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,9.795e-06,0.21053,0.22209,1,1
2,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00064263,0.21049,0.18455,1,1
2,GO LAMELLIPODIUM ASSEMBLY,0.00031907,0.21047,0.16738,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.010522,0.20991,0.12519,1,1
2,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.00096848,0.20988,0.18043,1,1
2,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,9.404e-07,0.20952,0.20918,1,1
2,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.00015083,0.2094,0.19351,1,1
2,GO I KAPPAB PHOSPHORYLATION,0.00016098,0.20926,0.21618,1,1
2,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0013826,0.20853,0.16556,1,1
2,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.012367,0.20852,0.15464,1,1
2,GO RNA INTERFERENCE,0.00057029,0.20812,0.18129,1,1
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0065235,0.20782,0.15162,1,1
2,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.012653,0.20766,0.12553,1,1
2,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0013633,0.20757,0.15953,1,1
2,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.00098255,0.20756,0.1875,1,1
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.012945,0.2066,0.13591,1,1
2,GO MITOCHONDRIAL DNA REPLICATION,0.00021857,0.20568,0.19589,1,1
2,GO CELLULAR OXIDANT DETOXIFICATION,0.00029976,0.20479,0.16682,1,1
2,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.0005133,0.20468,0.17177,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.0050904,0.20447,0.18336,1,1
2,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.00086244,0.20441,0.15914,1,1
2,GO CYTOPLASMIC TRANSLATIONAL INITIATION,2.6828e-05,0.20436,0.2293,1,1
2,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.004964,0.20419,0.19278,1,1
2,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.024428,0.20413,0.14409,1,1
2,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0023637,0.20409,0.17274,1,1
2,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.00095459,0.20392,0.22355,1,1
2,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.016568,0.20374,0.12116,1,1
2,GO VESICLE CARGO LOADING,0.0058389,0.20374,0.13736,1,1
2,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,9.03e-05,0.20366,0.19431,1,1
2,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,3.5022e-05,0.20362,0.23541,1,1
2,GO PEPTIDYL METHIONINE MODIFICATION,0.00073415,0.20354,0.19447,1,1
2,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.0095807,0.20352,0.21731,1,1
2,GO HIPPO SIGNALING,0.0070192,0.2035,0.23381,1,1
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.008211,0.20339,0.14254,1,1
2,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,7.8911e-05,0.20318,0.16698,1,1
2,GO B CELL APOPTOTIC PROCESS,0.0042095,0.20317,0.1619,1,1
2,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.00081356,0.20235,0.17001,1,1
2,GO REGULATION OF PROTEIN IMPORT,0.00012186,0.20193,0.21091,1,1
2,GO HISTONE H4 DEACETYLATION,0.0033799,0.20062,0.183,1,1
2,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.0016347,0.20055,0.16507,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.0019819,0.20051,0.17032,1,1
2,GO PIGMENT METABOLIC PROCESS,0.0016347,0.19989,0.1488,1,1
2,GO HISTONE MRNA METABOLIC PROCESS,3.8983e-07,0.19982,0.17759,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0030038,0.19964,0.15622,1,1
2,GO HISTONE H3 K9 ACETYLATION,4.1751e-05,0.19952,0.19905,1,1
2,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.00071283,0.19942,0.19674,1,1
2,GO T CELL PROLIFERATION,0.00088789,0.19929,0.16905,1,1
2,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.016938,0.19903,0.13383,1,1
2,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.013394,0.19845,0.14707,1,1
2,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.01995,0.19843,0.20424,1,1
2,GO TRNA CATABOLIC PROCESS,0.036772,0.19773,0.18921,1,1
2,GO TYPE I INTERFERON PRODUCTION,0.0022095,0.19749,0.17208,1,1
2,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.030994,0.19737,0.12931,1,1
2,GO AMINO SUGAR METABOLIC PROCESS,0.0050269,0.19723,0.13215,1,1
2,GO ERYTHROCYTE DEVELOPMENT,0.0073682,0.19701,0.14403,1,1
2,GO REGULATION OF KIDNEY DEVELOPMENT,0.033948,0.19602,0.12367,1,1
2,GO TRACHEA DEVELOPMENT,0.016205,0.19579,0.17182,1,1
2,GO TONGUE MORPHOGENESIS,0.049681,0.19564,0.18135,1,1
2,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,1.8701e-05,0.19525,0.2624,1,1
2,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.012227,0.19518,0.17557,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0047798,0.19444,0.14772,1,1
2,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0040509,0.19436,0.16677,1,1
2,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.00030928,0.19436,0.18712,1,1
2,GO NIK NF KAPPAB SIGNALING,0.00025215,0.19423,0.17525,1,1
2,GO LEUKOCYTE CELL CELL ADHESION,0.0038977,0.1941,0.15143,1,1
2,GO GRANULOCYTE DIFFERENTIATION,0.0028872,0.19369,0.18371,1,1
2,GO FATTY ACID BIOSYNTHETIC PROCESS,2.9332e-05,0.19358,0.19354,1,1
2,GO ISOPRENOID METABOLIC PROCESS,0.018693,0.19298,0.10689,1,1
2,GO B CELL PROLIFERATION,0.002631,0.19269,0.15997,1,1
2,GO TRNA METABOLIC PROCESS,9.4341e-06,0.19267,0.17578,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00071283,0.19266,0.14973,1,1
2,GO INTERLEUKIN 10 PRODUCTION,0.0049019,0.19204,0.16741,1,1
2,GO GASTRIC ACID SECRETION,0.00028155,0.19128,0.20123,1,1
2,GO MITOCHONDRIAL PROTEIN PROCESSING,0.001955,0.19092,0.16222,1,1
2,GO RESPONSE TO ANTIBIOTIC,0.0015038,0.19063,0.148,1,1
2,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0044864,0.1904,0.1502,1,1
2,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.0137,0.19037,0.17596,1,1
2,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.00044103,0.19028,0.15932,1,1
2,GO CARNITINE SHUTTLE,0.0010865,0.18982,0.20183,1,1
2,GO CELLULAR RESPONSE TO ETHANOL,0.0068504,0.1898,0.18726,1,1
2,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.009139,0.18967,0.15932,1,1
2,GO REGULATION OF SPROUTING ANGIOGENESIS,0.00080175,0.18961,0.2045,1,1
2,GO MITOCHONDRIAL TRANSCRIPTION,0.00045468,0.18937,0.20885,1,1
2,GO TETRAPYRROLE METABOLIC PROCESS,0.00011986,0.1892,0.17551,1,1
2,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.00016361,0.18907,0.15572,1,1
2,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0083098,0.18891,0.12176,1,1
2,GO NUCLEOTIDE SALVAGE,0.046031,0.18881,0.14755,1,1
2,GO MAGNESIUM ION HOMEOSTASIS,0.047372,0.18869,0.1919,1,1
2,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0023009,0.18866,0.16587,1,1
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.020828,0.18817,0.15395,1,1
2,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0013443,0.18757,0.20761,1,1
2,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.02521,0.18748,0.13147,1,1
2,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.041383,0.18726,0.095104,1,1
2,GO NUCLEAR PORE ORGANIZATION,2.8814e-05,0.1872,0.23703,1,1
2,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,4.8839e-05,0.18716,0.14759,1,1
2,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.0081133,0.18702,0.17271,1,1
2,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0012705,0.1866,0.15435,1,1
2,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00023294,0.1863,0.22053,1,1
2,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0087156,0.18626,0.1302,1,1
2,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00096848,0.18617,0.20241,1,1
2,GO MALE GENITALIA DEVELOPMENT,0.004156,0.18597,0.18055,1,1
2,GO B CELL MEDIATED IMMUNITY,0.0083098,0.18508,0.15898,1,1
2,GO T CELL CYTOKINE PRODUCTION,0.00039622,0.18478,0.18627,1,1
2,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0020646,0.18407,0.1672,1,1
2,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00026024,0.18363,0.19103,1,1
2,GO FATTY ACID HOMEOSTASIS,0.0096941,0.18298,0.16471,1,1
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0021505,0.18229,0.18626,1,1
2,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.0052197,0.18181,0.18778,1,1
2,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0022701,0.18176,0.19524,1,1
2,GO CELL AGGREGATION,0.00035024,0.18121,0.23492,1,1
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.015159,0.18106,0.10271,1,1
2,GO INTERACTION WITH HOST,0.0094686,0.1807,0.13783,1,1
2,GO REGULATION OF IMMUNE RESPONSE,0.0032501,0.18056,0.13375,1,1
2,GO PURINE CONTAINING COMPOUND SALVAGE,0.0027747,0.18043,0.18562,1,1
2,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.017894,0.18037,0.17789,1,1
2,GO VIRAL GENE EXPRESSION,8.2686e-06,0.18007,0.19957,1,1
2,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0076401,0.18002,0.146,1,1
2,GO REGULATION OF T CELL CHEMOTAXIS,0.01128,0.17995,0.18002,1,1
2,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.014013,0.17889,0.18519,1,1
2,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.012367,0.17864,0.21981,1,1
2,GO LYMPHOCYTE CHEMOTAXIS,0.0025961,0.17794,0.15407,1,1
2,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0081133,0.17777,0.15598,1,1
2,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.0028118,0.17766,0.13855,1,1
2,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0034243,0.17758,0.13634,1,1
2,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.02174,0.17743,0.2089,1,1
2,GO KERATINOCYTE DIFFERENTIATION,0.016386,0.17732,0.18565,1,1
2,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.026561,0.17676,0.16675,1,1
2,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00027284,0.17655,0.17377,1,1
2,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0050904,0.17649,0.16263,1,1
2,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.054074,0.17644,0.1142,1,1
2,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,7.2497e-05,0.17627,0.18657,1,1
2,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00024045,0.17604,0.21668,1,1
2,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.00042128,0.17587,0.1862,1,1
2,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.0016347,0.17582,0.13155,1,1
2,GO ACTIVATION OF IMMUNE RESPONSE,0.0014624,0.1757,0.14514,1,1
2,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.02174,0.17557,0.14778,1,1
2,GO REGULATION OF HAIR CYCLE,0.011151,0.17516,0.16886,1,1
2,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.0043737,0.17482,0.16315,1,1
2,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.00069207,0.17475,0.19969,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,3.0395e-05,0.17449,0.14771,1,1
2,GO ACTIN CYTOSKELETON REORGANIZATION,0.0024941,0.17444,0.16499,1,1
2,GO MAINTENANCE OF CELL NUMBER,0.0011021,0.17435,0.15723,1,1
2,GO CELL KILLING,0.0025961,0.17367,0.14944,1,1
2,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.013856,0.17357,0.13235,1,1
2,GO URETER DEVELOPMENT,0.016386,0.17355,0.16012,1,1
2,GO FATTY ACID TRANSPORT,0.0013633,0.17343,0.1263,1,1
2,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00034485,0.17296,0.18204,1,1
2,GO REGULATION OF CELL CELL ADHESION,0.017699,0.17289,0.11633,1,1
2,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.0058389,0.17277,0.23233,1,1
2,GO EPIDERMAL CELL DIFFERENTIATION,0.027401,0.17274,0.14702,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.00076726,0.17259,0.18245,1,1
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0021215,0.17258,0.14426,1,1
2,GO DETOXIFICATION,0.00019541,0.17242,0.18123,1,1
2,GO MACROPHAGE CHEMOTAXIS,0.011544,0.17201,0.13015,1,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.05357,0.17184,0.11793,1,1
2,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.028264,0.17109,0.15848,1,1
2,GO RESPIRATORY BURST,0.0065235,0.17103,0.16983,1,1
2,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0022095,0.17028,0.12418,1,1
2,GO PIGMENT GRANULE ORGANIZATION,0.00086244,0.17002,0.21796,1,1
2,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.020385,0.16989,0.13591,1,1
2,GO SNORNA 3 END PROCESSING,0.0022701,0.16936,0.16081,1,1
2,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.012227,0.16925,0.15185,1,1
2,GO SENSORY PERCEPTION OF TASTE,0.00028155,0.16898,0.2811,1,1
2,GO SYMBIOTIC PROCESS,0.00044103,0.16831,0.13049,1,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.0015038,0.16822,0.16838,1,1
2,GO FATTY ACID DERIVATIVE TRANSPORT,0.00075607,0.16813,0.15019,1,1
2,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.001704,0.16808,0.19156,1,1
2,GO HISTONE H2B UBIQUITINATION,0.0048405,0.16794,0.13408,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.0020367,0.16784,0.16443,1,1
2,GO ALPHA BETA T CELL ACTIVATION,0.0043737,0.16755,0.16011,1,1
2,GO RESPONSE TO INTERLEUKIN 7,0.0047798,0.16745,0.13953,1,1
2,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.017894,0.1673,0.10346,1,1
2,GO RESPONSE TO STEROL DEPLETION,0.001118,0.16723,0.21004,1,1
2,GO DNA LIGATION,0.0013069,0.16717,0.16561,1,1
2,GO ACETYL COA METABOLIC PROCESS,0.004156,0.16711,0.19287,1,1
2,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0094686,0.16683,0.14219,1,1
2,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,7.3739e-05,0.16678,0.19862,1,1
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.012087,0.16666,0.14147,1,1
2,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.017894,0.16651,0.10762,1,1
2,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.012798,0.16638,0.12437,1,1
2,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.031311,0.16626,0.10122,1,1
2,GO LEUKOCYTE MEDIATED IMMUNITY,0.0104,0.16616,0.12178,1,1
2,GO PLATELET MORPHOGENESIS,0.002702,0.16566,0.19367,1,1
2,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00030449,0.16552,0.17515,1,1
2,GO MIDDLE EAR MORPHOGENESIS,0.019104,0.16529,0.14514,1,1
2,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.0015249,0.16512,0.14727,1,1
2,GO CYTOKINE PRODUCTION,0.010522,0.16511,0.12607,1,1
2,GO REGULATION OF GENE SILENCING,0.00011596,0.16507,0.14156,1,1
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.030368,0.16496,0.15146,1,1
2,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.027686,0.16496,0.12782,1,1
2,GO REGULATION OF B CELL DIFFERENTIATION,0.049212,0.16492,0.15484,1,1
2,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.001442,0.16487,0.1515,1,1
2,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.020605,0.16469,0.11797,1,1
2,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00011218,0.16448,0.14771,1,1
2,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.00072342,0.16427,0.19028,1,1
2,GO PURINE NUCLEOSIDE METABOLIC PROCESS,3.2146e-06,0.164,0.17903,1,1
2,GO LIPID IMPORT INTO CELL,0.028556,0.164,0.12706,1,1
2,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00039018,0.16373,0.14956,1,1
2,GO MACROPHAGE MIGRATION,0.013093,0.16343,0.1323,1,1
2,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00033955,0.16343,0.15317,1,1
2,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0049019,0.16342,0.18478,1,1
2,GO SPLICEOSOMAL SNRNP ASSEMBLY,2.4972e-05,0.16321,0.16287,1,1
2,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.00015838,0.16275,0.14306,1,1
2,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.006444,0.16273,0.12924,1,1
2,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.020605,0.16268,0.16867,1,1
2,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.014013,0.1626,0.1409,1,1
2,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.0005211,0.16249,0.16465,1,1
2,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0043184,0.16242,0.17289,1,1
2,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.018693,0.16183,0.11197,1,1
2,GO REGULATION OF T CELL ACTIVATION,0.0043737,0.16176,0.13841,1,1
2,GO REGULATION OF SYMBIOTIC PROCESS,0.0048405,0.16173,0.16833,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,2.5868e-06,0.16133,0.20115,1,1
2,GO REGULATION OF CELL ACTIVATION,0.007921,0.16114,0.12207,1,1
2,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.014823,0.16095,0.12264,1,1
2,GO REGULATION OF DEFENSE RESPONSE,0.0099244,0.16078,0.11506,1,1
2,GO POSITIVE REGULATION OF T CELL MIGRATION,0.006444,0.16052,0.15522,1,1
2,GO VIRAL LATENCY,0.057711,0.1605,0.089262,1,1
2,GO OXIDATIVE DEMETHYLATION,0.0094686,0.16045,0.093425,1,1
2,GO REGULATION OF PROTEIN SUMOYLATION,0.0042636,0.16028,0.1151,1,1
2,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.031953,0.16016,0.11146,1,1
2,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,6.337e-06,0.16002,0.18373,1,1
2,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.031953,0.15994,0.097681,1,1
2,GO REGULATION OF B CELL ACTIVATION,0.022446,0.15977,0.11574,1,1
2,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0095807,0.15968,0.12684,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.033948,0.15954,0.13474,1,1
2,GO RESPONSE TO HYDROGEN PEROXIDE,0.011544,0.15939,0.11852,1,1
2,GO TERPENOID METABOLIC PROCESS,0.046921,0.15936,0.10202,1,1
2,GO TISSUE REGENERATION,0.037882,0.15887,0.12152,1,1
2,GO INTERFERON BETA PRODUCTION,0.014823,0.15872,0.15037,1,1
2,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.017125,0.15818,0.15108,1,1
2,GO CHEMOKINE PRODUCTION,0.0084096,0.15805,0.15303,1,1
2,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,5.3256e-05,0.15791,0.16551,1,1
2,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.023668,0.1579,0.31617,1,1
2,GO NCRNA EXPORT FROM NUCLEUS,7.0072e-05,0.15723,0.17754,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.007921,0.15717,0.131,1,1
2,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0041031,0.15708,0.13134,1,1
2,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00032408,0.15699,0.16922,1,1
2,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.027118,0.15697,0.13083,1,1
2,GO VIRAL LIFE CYCLE,0.0081133,0.15694,0.13576,1,1
2,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.016752,0.15687,0.15878,1,1
2,GO INNATE IMMUNE RESPONSE,0.0028872,0.15686,0.15388,1,1
2,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.024687,0.15682,0.11346,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.022686,0.15681,0.099783,1,1
2,GO TRNA TRANSPORT,1.4207e-05,0.1568,0.18282,1,1
2,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0032078,0.15676,0.13478,1,1
2,GO ERBB SIGNALING PATHWAY,0.0080166,0.15664,0.12071,1,1
2,GO REGULATION OF CELL MATURATION,0.010041,0.1564,0.12876,1,1
2,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.013243,0.15603,0.12832,1,1
2,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.037882,0.15588,0.11139,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0066851,0.15586,0.17505,1,1
2,GO REGULATION OF LEUKOCYTE MIGRATION,0.057179,0.15582,0.084018,1,1
2,GO ICOSANOID METABOLIC PROCESS,0.0052197,0.1558,0.14572,1,1
2,GO GOLGI LOCALIZATION,0.006444,0.15561,0.14824,1,1
2,GO KERATINIZATION,0.033608,0.15555,0.15855,1,1
2,GO RESPONSE TO BACTERIUM,0.03068,0.15529,0.090211,1,1
2,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.040981,0.15526,0.087715,1,1
2,GO GLUCOCORTICOID METABOLIC PROCESS,0.027686,0.15501,0.1391,1,1
2,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0020367,0.15478,0.14966,1,1
2,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.056652,0.15461,0.14116,1,1
2,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0030436,0.15397,0.20135,1,1
2,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,5.6085e-05,0.15395,0.16436,1,1
2,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.009139,0.15366,0.12414,1,1
2,GO T CELL ACTIVATION,0.0098086,0.15363,0.12747,1,1
2,GO ALPHA BETA T CELL DIFFERENTIATION,0.01128,0.15306,0.16354,1,1
2,GO GRANULOCYTE CHEMOTAXIS,0.034636,0.15305,0.10494,1,1
2,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00098255,0.15299,0.15004,1,1
2,GO BLASTOCYST FORMATION,3.5022e-05,0.15292,0.17715,1,1
2,GO AXIS ELONGATION,0.024173,0.15274,0.19875,1,1
2,GO EPIDERMIS DEVELOPMENT,0.049212,0.1526,0.1237,1,1
2,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.01251,0.15256,0.14423,1,1
2,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.022686,0.15239,0.16889,1,1
2,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00010852,0.15173,0.14465,1,1
2,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,9.3381e-05,0.15168,0.15476,1,1
2,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00031907,0.15154,0.17126,1,1
2,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0029256,0.15126,0.17034,1,1
2,GO MYELOID LEUKOCYTE ACTIVATION,0.01128,0.15121,0.11758,1,1
2,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.021053,0.15116,0.12248,1,1
2,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.01585,0.15115,0.13985,1,1
2,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.0062108,0.15104,0.14766,1,1
2,GO LIPID OXIDATION,0.020166,0.15098,0.10104,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.009139,0.15092,0.14213,1,1
2,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.00020504,0.15088,0.24662,1,1
2,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.011151,0.15072,0.1116,1,1
2,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.0068504,0.15028,0.14311,1,1
2,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.056652,0.15011,0.18164,1,1
2,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0046018,0.15005,0.13349,1,1
2,GO TOXIN TRANSPORT,0.012798,0.14998,0.11764,1,1
2,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.0011836,0.14989,0.13452,1,1
2,GO RESPONSE TO BIOTIC STIMULUS,0.016938,0.14974,0.10902,1,1
2,GO REGULATION OF TRANSLATIONAL FIDELITY,0.00044781,0.14953,0.17263,1,1
2,GO RESPONSE TO GONADOTROPIN,0.010895,0.14946,0.15791,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00065224,0.14941,0.15025,1,1
2,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.026561,0.14913,0.090598,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0023009,0.14912,0.13026,1,1
2,GO FATTY ACID METABOLIC PROCESS,0.0022396,0.14884,0.11529,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0020367,0.14871,0.12789,1,1
2,GO V D J RECOMBINATION,0.058787,0.14797,0.13533,1,1
2,GO SPROUTING ANGIOGENESIS,0.02521,0.14776,0.12067,1,1
2,GO RESPONSE TO IONIZING RADIATION,0.0020929,0.14751,0.1482,1,1
2,GO REGULATION OF T CELL DIFFERENTIATION,0.020166,0.14735,0.12816,1,1
2,GO REGULATION OF MRNA CATABOLIC PROCESS,0.00023667,0.14706,0.1311,1,1
2,GO RESPONSE TO VIRUS,0.01849,0.14687,0.1284,1,1
2,GO RESPONSE TO CYTOKINE,0.01829,0.14684,0.1101,1,1
2,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.01128,0.14673,0.16269,1,1
2,GO MITOCHONDRIAL TRANSLATION,7.6657e-06,0.14672,0.20107,1,1
2,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.038258,0.14663,0.16361,1,1
2,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.020828,0.14651,0.13458,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.042609,0.14646,0.14249,1,1
2,GO OVULATION,0.0054192,0.14634,0.16489,1,1
2,GO REGULATION OF BONE DEVELOPMENT,0.0092477,0.14595,0.14663,1,1
2,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.059879,0.14568,0.090821,1,1
2,GO INTERMEDIATE FILAMENT ORGANIZATION,0.0058389,0.14526,0.17074,1,1
2,GO NEGATIVE REGULATION OF GENE SILENCING,0.00031907,0.14519,0.1674,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.040582,0.14487,0.11908,1,1
2,GO HOMEOSTASIS OF NUMBER OF CELLS,0.039795,0.14484,0.097465,1,1
2,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0053519,0.1448,0.11878,1,1
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.031631,0.14468,0.1229,1,1
2,GO RRNA TRANSCRIPTION,0.00047589,0.14443,0.18204,1,1
2,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.0019285,0.14421,0.16734,1,1
2,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.013243,0.14418,0.12592,1,1
2,GO MULTI ORGANISM LOCALIZATION,0.00058763,0.14404,0.13442,1,1
2,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,3.8246e-05,0.144,0.15575,1,1
2,GO CELLULAR RESPONSE TO CHOLESTEROL,0.01251,0.14399,0.16645,1,1
2,GO SNORNA METABOLIC PROCESS,0.0021505,0.14392,0.14575,1,1
2,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.00039622,0.14366,0.13597,1,1
2,GO GLUTAMINE METABOLIC PROCESS,0.00015331,0.14352,0.20328,1,1
2,GO RIBONUCLEOSIDE METABOLIC PROCESS,2.8814e-05,0.14339,0.15846,1,1
2,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.051595,0.14296,0.12982,1,1
2,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.0029256,0.14292,0.12197,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.00023294,0.14267,0.1318,1,1
2,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00031907,0.14262,0.13059,1,1
2,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0041031,0.1425,0.12175,1,1
2,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.0050904,0.1425,0.13722,1,1
2,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.03006,0.14222,0.10682,1,1
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,9.086e-06,0.1416,0.15322,1,1
2,GO LONG CHAIN FATTY ACID TRANSPORT,0.0007786,0.14155,0.14324,1,1
2,GO ACTIN FILAMENT ORGANIZATION,0.047827,0.14148,0.072705,1,1
2,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.034636,0.14125,0.095463,1,1
2,GO METANEPHRIC NEPHRON DEVELOPMENT,0.054074,0.14124,0.14033,1,1
2,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.030994,0.14106,0.12152,1,1
2,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.00069207,0.14054,0.15645,1,1
2,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.00024045,0.14045,0.1601,1,1
2,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.016205,0.14,0.11204,1,1
2,GO LATERAL VENTRICLE DEVELOPMENT,0.028852,0.13999,0.15085,1,1
2,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.0083098,0.13987,0.19271,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.020828,0.13978,0.092421,1,1
2,GO NEGATIVE REGULATION OF AUTOPHAGY,0.016938,0.13964,0.095113,1,1
2,GO NEUTRAL LIPID METABOLIC PROCESS,0.0044298,0.13952,0.12241,1,1
2,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.003654,0.13932,0.11289,1,1
2,GO T CELL DIFFERENTIATION,0.016752,0.13897,0.11964,1,1
2,GO IMMUNE EFFECTOR PROCESS,0.011949,0.13886,0.12176,1,1
2,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.01585,0.13881,0.12959,1,1
2,GO AEROBIC RESPIRATION,0.00013899,0.13876,0.15265,1,1
2,GO PRIMARY MIRNA PROCESSING,0.00022208,0.13876,0.22605,1,1
2,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0083098,0.1386,0.1143,1,1
2,GO NUCLEAR MIGRATION,0.048285,0.13838,0.10718,1,1
2,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.02945,0.13694,0.11465,1,1
2,GO NUCLEUS LOCALIZATION,0.047827,0.13687,0.098322,1,1
2,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.0011836,0.13668,0.10771,1,1
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.036048,0.13655,0.1044,1,1
2,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.03902,0.13653,0.098128,1,1
2,GO REGULATION OF STEROID METABOLIC PROCESS,0.0054192,0.13649,0.12789,1,1
2,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0029256,0.13641,0.11971,1,1
2,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.024173,0.13638,0.099424,1,1
2,GO SPERM EGG RECOGNITION,0.001776,0.13631,0.11433,1,1
2,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.019104,0.13595,0.14181,1,1
2,GO RESPONSE TO GAMMA RADIATION,0.0018256,0.13538,0.15303,1,1
2,GO LYMPHOCYTE COSTIMULATION,0.02915,0.13528,0.10107,1,1
2,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,4.1026e-05,0.13464,0.15255,1,1
2,GO B CELL DIFFERENTIATION,0.028264,0.1343,0.10904,1,1
2,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.039406,0.13422,0.12454,1,1
2,GO REGULATION OF HEMOPOIESIS,0.013394,0.13396,0.12395,1,1
2,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.0001803,0.13394,0.15702,1,1
2,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.0016122,0.13389,0.13013,1,1
2,GO FEVER GENERATION,0.02915,0.13387,0.12391,1,1
2,GO TRNA WOBBLE BASE MODIFICATION,0.021973,0.13374,0.097208,1,1
2,GO LYMPHANGIOGENESIS,0.034984,0.13374,0.14307,1,1
2,GO FC RECEPTOR SIGNALING PATHWAY,0.0023321,0.13341,0.1376,1,1
2,GO RNA POLYADENYLATION,0.0071051,0.13316,0.11271,1,1
2,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.056652,0.1331,0.093024,1,1
2,GO LYMPHOCYTE ACTIVATION,0.016752,0.13303,0.10651,1,1
2,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.00029052,0.13293,0.14431,1,1
2,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.031953,0.13293,0.087996,1,1
2,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.00018923,0.13274,0.18761,1,1
2,GO SNRNA PROCESSING,4.7172e-05,0.13265,0.18975,1,1
2,GO RESPONSE TO UV,0.035691,0.13247,0.089377,1,1
2,GO DNA DOUBLE STRAND BREAK PROCESSING,0.01829,0.13232,0.1234,1,1
2,GO REGULATION OF INFLAMMATORY RESPONSE,0.03006,0.13215,0.092468,1,1
2,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.035691,0.13185,0.10725,1,1
2,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.054074,0.13178,0.082177,1,1
2,GO ORGANIC ACID CATABOLIC PROCESS,0.022928,0.13135,0.086723,1,1
2,GO LYMPHOCYTE DIFFERENTIATION,0.013394,0.13123,0.11561,1,1
2,GO PROTEIN AUTOPHOSPHORYLATION,0.018898,0.13082,0.094702,1,1
2,GO REGULATION OF TRANSLATIONAL INITIATION,0.0023957,0.13065,0.10656,1,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0057669,0.1306,0.19628,1,1
2,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.012087,0.13053,0.13936,1,1
2,GO TRIGLYCERIDE METABOLIC PROCESS,0.014823,0.13053,0.098427,1,1
2,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.046474,0.13026,0.089965,1,1
2,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0055559,0.1302,0.15083,1,1
2,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.010769,0.13005,0.13573,1,1
2,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0011668,0.12974,0.17919,1,1
2,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.011544,0.12974,0.12342,1,1
2,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.041383,0.12895,0.10075,1,1
2,GO LIPID HOMEOSTASIS,0.054582,0.12883,0.07279,1,1
2,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.0056958,0.12856,0.12066,1,1
2,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.003166,0.12803,0.11043,1,1
2,GO MYELOID CELL HOMEOSTASIS,0.023419,0.12771,0.10716,1,1
2,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.0040509,0.12767,0.14733,1,1
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.035691,0.12741,0.11078,1,1
2,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.024428,0.12727,0.095043,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE,0.0013826,0.12722,0.13017,1,1
2,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.039406,0.12721,0.23365,1,1
2,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.010522,0.12676,0.10332,1,1
2,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.024173,0.1267,0.15408,1,1
2,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.0014022,0.12669,0.11263,1,1
2,GO REGULATION OF LIPID KINASE ACTIVITY,0.05063,0.12665,0.096332,1,1
2,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.00042777,0.12635,0.11103,1,1
2,GO MRNA TRANSCRIPTION,0.024428,0.1262,0.1291,1,1
2,GO ACTIN FILAMENT DEPOLYMERIZATION,0.034984,0.12619,0.1069,1,1
2,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.024947,0.12606,0.15939,1,1
2,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.057711,0.12588,0.097366,1,1
2,GO CELL ACTIVATION,0.044722,0.12555,0.085708,1,1
2,GO MRNA CLEAVAGE,0.0013255,0.12413,0.11692,1,1
2,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.059879,0.12376,0.091871,1,1
2,GO RNA CATABOLIC PROCESS,6.9711e-06,0.1237,0.14057,1,1
2,GO HISTONE DEUBIQUITINATION,0.0029645,0.12369,0.12546,1,1
2,GO REGULATION OF LIPID METABOLIC PROCESS,0.01128,0.12354,0.097604,1,1
2,GO LYMPH VESSEL DEVELOPMENT,0.057711,0.12346,0.16679,1,1
2,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.033948,0.12342,0.080464,1,1
2,GO DEFENSE RESPONSE,0.037139,0.12322,0.091324,1,1
2,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.015501,0.12314,0.15744,1,1
2,GO GMP METABOLIC PROCESS,0.0093576,0.12311,0.13517,1,1
2,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.01995,0.12311,0.15707,1,1
2,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.013546,0.12298,0.11867,1,1
2,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0013826,0.12292,0.15702,1,1
2,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.017315,0.12289,0.14109,1,1
2,GO NCRNA CATABOLIC PROCESS,0.0018508,0.12279,0.15652,1,1
2,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.0037985,0.1227,0.13813,1,1
2,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.024428,0.12268,0.087691,1,1
2,GO PIGMENT BIOSYNTHETIC PROCESS,0.0019023,0.12262,0.14408,1,1
2,GO RESPONSE TO SALT,0.0015038,0.12233,0.16739,1,1
2,GO RESPONSE TO OXIDATIVE STRESS,0.052083,0.12233,0.07614,1,1
2,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.027686,0.12219,0.094469,1,1
2,GO PROTEIN SUMOYLATION,0.0034692,0.12211,0.11139,1,1
2,GO MESODERMAL CELL DIFFERENTIATION,0.052575,0.122,0.11491,1,1
2,GO HISTONE H3 K4 TRIMETHYLATION,0.0050904,0.12188,0.14972,1,1
2,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.044292,0.1215,0.082987,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00013899,0.12112,0.13153,1,1
2,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.0071051,0.12111,0.11652,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0059116,0.12082,0.10186,1,1
2,GO STEROL BIOSYNTHETIC PROCESS,0.0055559,0.12082,0.13622,1,1
2,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.036772,0.12049,0.097472,1,1
2,GO LIPID MODIFICATION,0.052575,0.12047,0.068614,1,1
2,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.049212,0.12031,0.082144,1,1
2,GO REGULATION OF ACTIN NUCLEATION,0.052083,0.12014,0.09793,1,1
2,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.0028872,0.11957,0.10298,1,1
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.011678,0.11939,0.091889,1,1
2,GO SERTOLI CELL DIFFERENTIATION,0.03006,0.11934,0.15807,1,1
2,GO REGULATION OF ACTIN FILAMENT LENGTH,0.01585,0.11916,0.085113,1,1
2,GO MONOSACCHARIDE CATABOLIC PROCESS,0.0020367,0.11896,0.14,1,1
2,GO INOSITOL LIPID MEDIATED SIGNALING,0.022446,0.11893,0.11178,1,1
2,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0025617,0.11865,0.13243,1,1
2,GO RNA PROCESSING,0.00013016,0.11861,0.13168,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0016122,0.11843,0.15754,1,1
2,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00031414,0.118,0.13123,1,1
2,GO MRNA 3 END PROCESSING,0.0042636,0.11776,0.10942,1,1
2,GO NEGATIVE REGULATION OF DNA REPAIR,0.01251,0.11764,0.11322,1,1
2,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.019735,0.11713,0.10887,1,1
2,GO GOLGI RIBBON FORMATION,0.043444,0.117,0.10677,1,1
2,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.014172,0.11677,0.12101,1,1
2,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.011544,0.11656,0.14841,1,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.057711,0.11623,0.13777,1,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.0010408,0.116,0.096378,1,1
2,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.014658,0.11563,0.099643,1,1
2,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.022928,0.11538,0.095971,1,1
2,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.003166,0.11532,0.13799,1,1
2,GO RNA 3 END PROCESSING,0.00041488,0.11492,0.12535,1,1
2,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.01849,0.11479,0.10828,1,1
2,GO INTERLEUKIN 4 PRODUCTION,0.043025,0.11474,0.11007,1,1
2,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.054582,0.11464,0.12728,1,1
2,GO POSITIVE REGULATION OF CELL ADHESION,0.037509,0.11433,0.107,1,1
2,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.03006,0.11426,0.1241,1,1
2,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0071918,0.11423,0.085551,1,1
2,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.024428,0.114,0.096683,1,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.0072795,0.1137,0.11632,1,1
2,GO CELLULAR KETONE METABOLIC PROCESS,0.0049019,0.11285,0.10599,1,1
2,GO GLYCEROLIPID METABOLIC PROCESS,0.0030839,0.11268,0.10188,1,1
2,GO GENE SILENCING,0.00086244,0.11207,0.097349,1,1
2,GO TELOMERE ORGANIZATION,0.0010558,0.11197,0.12001,1,1
2,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0011021,0.11196,0.11426,1,1
2,GO HEXOSE CATABOLIC PROCESS,0.0089251,0.11129,0.12406,1,1
2,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.033271,0.11085,0.076008,1,1
2,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.0011503,0.11022,0.099844,1,1
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0060595,0.1099,0.10436,1,1
2,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.048746,0.10935,0.071681,1,1
2,GO THYMUS DEVELOPMENT,0.010522,0.10927,0.11885,1,1
2,GO THIOESTER METABOLIC PROCESS,0.0032928,0.10901,0.15651,1,1
2,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.00059648,0.109,0.11573,1,1
2,GO RESPONSE TO OXYGEN RADICAL,0.011022,0.10875,0.10684,1,1
2,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046921,0.10868,0.089126,1,1
2,GO POSITIVE REGULATION OF PROTEOLYSIS,0.041789,0.10858,0.085552,1,1
2,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.0013633,0.10856,0.13143,1,1
2,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0025617,0.10829,0.15363,1,1
2,GO HUMORAL IMMUNE RESPONSE,0.055609,0.10818,0.073587,1,1
2,GO ERYTHROCYTE HOMEOSTASIS,0.033271,0.10805,0.10292,1,1
2,GO DNA GEOMETRIC CHANGE,0.003654,0.10804,0.1011,1,1
2,GO CELLULAR LIPID METABOLIC PROCESS,0.012945,0.10777,0.084891,1,1
2,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.024687,0.10759,0.11534,1,1
2,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.013394,0.10752,0.092805,1,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.028264,0.10746,0.085034,1,1
2,GO PROTEIN LOCALIZATION TO NUCLEUS,0.03006,0.1073,0.091101,1,1
2,GO CELLULAR RESPONSE TO ALCOHOL,0.015159,0.1072,0.11896,1,1
2,GO CELLULAR RESPONSE TO UV,0.040981,0.10697,0.090822,1,1
2,GO DNA METHYLATION,0.00044781,0.1064,0.13088,1,1
2,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.041383,0.1056,0.069619,1,1
2,GO RNA EXPORT FROM NUCLEUS,0.00099681,0.10556,0.12425,1,1
2,GO HISTONE H3 K14 ACETYLATION,0.0104,0.10514,0.090121,1,1
2,GO PROTEIN IMPORT,0.020828,0.10467,0.089503,1,1
2,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.003654,0.10454,0.1374,1,1
2,GO BASE EXCISION REPAIR,0.0070192,0.10396,0.093589,1,1
2,GO NUCLEOSIDE METABOLIC PROCESS,0.00027716,0.1037,0.12228,1,1
2,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0013443,0.10287,0.10692,1,1
2,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.041383,0.10274,0.079178,1,1
2,GO PROTEIN TRIMERIZATION,0.043444,0.10264,0.11216,1,1
2,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.047372,0.10223,0.16375,1,1
2,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00095459,0.10197,0.11671,1,1
2,GO RNA LOCALIZATION,0.0012527,0.10183,0.12341,1,1
2,GO POSITIVE REGULATION OF HEMOPOIESIS,0.048285,0.10178,0.11067,1,1
2,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0023009,0.10162,0.10859,1,1
2,GO MRNA METABOLIC PROCESS,0.00025215,0.10154,0.10918,1,1
2,GO LEUKOCYTE DIFFERENTIATION,0.026013,0.10148,0.10177,1,1
2,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0086125,0.10119,0.090908,1,1
2,GO ALCOHOL BIOSYNTHETIC PROCESS,0.024687,0.10096,0.08698,1,1
2,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.025475,0.10025,0.14781,1,1
2,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.056652,0.10004,0.10263,1,1
2,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.002631,0.099873,0.10597,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.003166,0.099708,0.13149,1,1
2,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0067673,0.09938,0.098422,1,1
2,GO FATTY ACYL COA METABOLIC PROCESS,0.026013,0.099241,0.14089,1,1
2,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.014823,0.099178,0.0782,1,1
2,GO NUCLEAR EXPORT,0.0040509,0.098678,0.1077,1,1
2,GO CELL CYCLE G1 S PHASE TRANSITION,0.03902,0.098398,0.08083,1,1
2,GO TRNA WOBBLE URIDINE MODIFICATION,0.024173,0.098045,0.088226,1,1
2,GO REGULATION OF CHROMATIN ASSEMBLY,0.052083,0.097849,0.077655,1,1
2,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.037882,0.0969,0.14125,1,1
2,GO P BODY ASSEMBLY,0.021509,0.096494,0.086751,1,1
2,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.054074,0.096059,0.091986,1,1
2,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.027118,0.096049,0.071731,1,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.019735,0.095665,0.090277,1,1
2,GO PROTEIN NEDDYLATION,0.050154,0.095017,0.069818,1,1
2,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0084096,0.094868,0.089126,1,1
2,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.021053,0.094432,0.072786,1,1
2,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.0033799,0.094227,0.087973,1,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0030038,0.094214,0.10686,1,1
2,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.024687,0.094026,0.10103,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.001776,0.093906,0.096704,1,1
2,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.01829,0.093043,0.089265,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.0027747,0.092938,0.10844,1,1
2,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.028556,0.092569,0.081229,1,1
2,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.013093,0.092562,0.11797,1,1
2,GO PHOSPHOLIPID METABOLIC PROCESS,0.027118,0.09249,0.078662,1,1
2,GO DNA BIOSYNTHETIC PROCESS,0.015329,0.092385,0.071716,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.016752,0.092208,0.10315,1,1
2,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0037985,0.092169,0.094515,1,1
2,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.042197,0.091906,0.099605,1,1
2,GO ALCOHOL METABOLIC PROCESS,0.0042095,0.091689,0.10262,1,1
2,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.012367,0.091641,0.11523,1,1
2,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.003654,0.091633,0.10452,1,1
2,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0025277,0.091447,0.10441,1,1
2,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.0096941,0.091346,0.087655,1,1
2,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.018091,0.091343,0.081195,1,1
2,GO CARBOHYDRATE CATABOLIC PROCESS,0.046031,0.090853,0.069765,1,1
2,GO REGULATION OF HISTONE UBIQUITINATION,0.03902,0.090798,0.068964,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.027686,0.09047,0.063307,1,1
2,GO MRNA EXPORT FROM NUCLEUS,0.0043737,0.089921,0.10241,1,1
2,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.011544,0.089803,0.085881,1,1
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.045155,0.08966,0.058926,1,1
2,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0022396,0.089403,0.11497,1,1
2,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.0021798,0.089383,0.092932,1,1
2,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.028852,0.089219,0.10871,1,1
2,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.046474,0.08915,0.061497,1,1
2,GO OXIDATION REDUCTION PROCESS,0.012798,0.088925,0.081292,1,1
2,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.015501,0.088898,0.083124,1,1
2,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0022095,0.088455,0.1124,1,1
2,GO LIPID METABOLIC PROCESS,0.042197,0.088194,0.065971,1,1
2,GO PROTEIN POLYUBIQUITINATION,0.059879,0.088184,0.064263,1,1
2,GO ACTIN NUCLEATION,0.01849,0.087995,0.089454,1,1
2,GO IMMUNE SYSTEM DEVELOPMENT,0.051595,0.087818,0.085195,1,1
2,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.045155,0.087715,0.056813,1,1
2,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.043444,0.08713,0.084388,1,1
2,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0075485,0.086636,0.088735,1,1
2,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.056652,0.086536,0.085572,1,1
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0050269,0.085291,0.089855,1,1
2,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.009139,0.084902,0.082026,1,1
2,GO LIPID BIOSYNTHETIC PROCESS,0.0092477,0.083728,0.086342,1,1
2,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.02521,0.083652,0.085121,1,1
2,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.055609,0.082851,0.058311,1,1
2,GO MRNA TRANSPORT,0.0071051,0.082327,0.10214,1,1
2,GO CELLULAR RESPIRATION,0.0047198,0.082182,0.10082,1,1
2,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.009139,0.082075,0.10431,1,1
2,GO ORGANIC ACID METABOLIC PROCESS,0.01128,0.081755,0.081947,1,1
2,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.019523,0.081721,0.10117,1,1
2,GO HISTONE H3 ACETYLATION,0.016568,0.081112,0.065968,1,1
2,GO PEPTIDYL TYROSINE MODIFICATION,0.043025,0.080232,0.092159,1,1
2,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.047827,0.079469,0.064667,1,1
2,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.037139,0.079094,0.09157,1,1
2,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0026663,0.078772,0.10982,1,1
2,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.001071,0.078298,0.11914,1,1
2,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.011151,0.077585,0.11489,1,1
2,GO CELL CYCLE PHASE TRANSITION,0.048746,0.076384,0.056681,1,1
2,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.021973,0.076131,0.074813,1,1
2,GO REGULATION OF MRNA METABOLIC PROCESS,0.0059116,0.076058,0.082081,1,1
2,GO CELLULAR RESPONSE TO DRUG,0.01499,0.075108,0.09999,1,1
2,GO STEROL METABOLIC PROCESS,0.026838,0.074496,0.092815,1,1
2,GO RNA SPLICING,0.010522,0.073221,0.080738,1,1
2,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.02915,0.073023,0.086375,1,1
2,GO DNA MODIFICATION,0.014013,0.071855,0.086048,1,1
2,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.010645,0.071156,0.14114,1,1
2,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.016752,0.071061,0.086033,1,1
2,GO MRNA PROCESSING,0.010279,0.07078,0.081304,1,1
2,GO SMALL MOLECULE CATABOLIC PROCESS,0.027686,0.070137,0.071921,1,1
2,GO PEROXISOME ORGANIZATION,0.044292,0.068713,0.070119,1,1
2,GO CHROMATIN REMODELING,0.01585,0.068231,0.070045,1,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.013394,0.068135,0.083426,1,1
2,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.034984,0.067925,0.083119,1,1
2,GO METHYLATION,0.022209,0.066418,0.067296,1,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.039406,0.066375,0.10178,1,1
2,GO DNA METABOLIC PROCESS,0.040187,0.065778,0.049685,1,1
2,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.028556,0.065146,0.064267,1,1
2,GO MITOCHONDRION MORPHOGENESIS,0.056128,0.064108,0.084292,1,1
2,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.016938,0.063571,0.070358,1,1
2,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.016938,0.061803,0.096822,1,1
2,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.037139,0.06048,0.063804,1,1
2,GO OXIDATIVE PHOSPHORYLATION,0.026286,0.058075,0.083677,1,1
2,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.028852,0.052671,0.070758,1,1
2,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.026561,0.048577,0.078258,1,1
2,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.033948,0.046281,0.064668,1,1
2,GO POLYOL METABOLIC PROCESS,0.048746,0.040413,0.083395,1,1
2,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00054518,0.61584,0.42177,1,0
2,GO MUCUS SECRETION,5.9056e-05,0.48392,0.48308,1,0
2,GO RESPONSE TO INTERFERON ALPHA,0.0055559,0.45174,0.28235,1,0
2,GO NEUTROPHIL HOMEOSTASIS,0.0021798,0.41415,0.31226,1,0
2,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0088198,0.39305,0.29224,1,0
2,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.007921,0.39161,0.29642,1,0
2,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0041031,0.39051,0.30818,1,0
2,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.0007901,0.38653,0.30366,1,0
2,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0062877,0.38271,0.28448,1,0
2,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.014172,0.37784,0.29741,1,0
2,GO BLEB ASSEMBLY,0.037509,0.33415,0.26212,1,0
2,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.0052854,0.32341,0.25045,1,0
2,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00028155,0.31557,0.28527,1,0
2,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.051111,0.31111,0.16394,1,0
2,GO HEME METABOLIC PROCESS,2.0853e-05,0.3087,0.26936,1,0
2,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,1.6761e-05,0.29406,0.32996,1,0
2,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.024428,0.28973,0.19331,1,0
2,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.024687,0.28678,0.16324,1,0
2,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.042609,0.28299,0.2181,1,0
2,GO CYSTEINE METABOLIC PROCESS,0.0005789,0.28267,0.28514,1,0
2,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0049019,0.27632,0.2674,1,0
2,GO COLLAGEN BIOSYNTHETIC PROCESS,0.015329,0.27612,0.20759,1,0
2,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.00061456,0.27469,0.22117,1,0
2,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,3.2631e-05,0.27323,0.2384,1,0
2,GO RETINAL ROD CELL DIFFERENTIATION,0.02915,0.27042,0.14769,1,0
2,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0075485,0.26341,0.20692,1,0
2,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.0042636,0.25415,0.26287,1,0
2,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,8.5867e-06,0.25399,0.27845,1,0
2,GO THYMOCYTE APOPTOTIC PROCESS,0.003654,0.24559,0.22052,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,8.3013e-05,0.24552,0.25688,1,0
2,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,4.1751e-05,0.24524,0.24258,1,0
2,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0030038,0.2434,0.22791,1,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0078263,0.24078,0.18885,1,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.010041,0.2404,0.23261,1,0
2,GO REGULATION OF TRANSLATIONAL TERMINATION,0.00014599,0.23939,0.2237,1,0
2,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.00099681,0.23909,0.25399,1,0
2,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.039406,0.23885,0.1869,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00026024,0.23829,0.25265,1,0
2,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.041383,0.23729,0.19535,1,0
2,GO RESPONSE TO INTERLEUKIN 12,0.00012804,0.2369,0.22153,1,0
2,GO REGULATION OF RIBOSOME BIOGENESIS,6.5837e-06,0.23527,0.29087,1,0
2,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.0065235,0.23512,0.20376,1,0
2,GO GLYCOPROTEIN CATABOLIC PROCESS,0.057711,0.23114,0.12739,1,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.021053,0.23,0.13058,1,0
2,GO MITOCHONDRIAL RNA PROCESSING,0.0066851,0.22979,0.18392,1,0
2,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0095807,0.22979,0.17353,1,0
2,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00013451,0.22952,0.22474,1,0
2,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.038637,0.22945,0.19818,1,0
2,GO ANTIGEN PROCESSING AND PRESENTATION,0.00059648,0.22569,0.17084,1,0
2,GO DETECTION OF BIOTIC STIMULUS,0.027686,0.22508,0.16838,1,0
2,GO LIPOPROTEIN CATABOLIC PROCESS,0.014823,0.22347,0.16461,1,0
2,GO ENTRY INTO HOST,0.0080166,0.22276,0.17057,1,0
2,GO CELLULAR RESPONSE TO SALT STRESS,0.0021505,0.22196,0.29285,1,0
2,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.0023009,0.22183,0.23832,1,0
2,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.002702,0.22153,0.30616,1,0
2,GO MATURATION OF 5 8S RRNA,1.3442e-05,0.22005,0.25354,1,0
2,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,6.4592e-06,0.21588,0.27566,1,0
2,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.004156,0.21476,0.17107,1,0
2,GO CHRONIC INFLAMMATORY RESPONSE,0.011813,0.21372,0.19923,1,0
2,GO POSITIVE REGULATION OF CELL MATURATION,0.0023637,0.21234,0.27061,1,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.057711,0.21224,0.13166,1,0
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.023173,0.21103,0.15439,1,0
2,GO OSTEOBLAST DEVELOPMENT,0.00070238,0.21064,0.22839,1,0
2,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.019104,0.20886,0.18845,1,0
2,GO REGULATION OF VIRAL GENOME REPLICATION,0.010645,0.20688,0.17747,1,0
2,GO CD40 SIGNALING PATHWAY,0.015674,0.20587,0.13593,1,0
2,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,3.628e-05,0.20566,0.24813,1,0
2,GO AMINO SUGAR CATABOLIC PROCESS,0.050154,0.20256,0.12278,1,0
2,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.00049802,0.20114,0.16268,1,0
2,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0045438,0.20087,0.17235,1,0
2,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.048285,0.20014,0.22713,1,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0083098,0.19915,0.2487,1,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00020178,0.19761,0.24932,1,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.014658,0.19679,0.15209,1,0
2,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.002631,0.19547,0.16471,1,0
2,GO INTERLEUKIN 17 PRODUCTION,0.0030038,0.19314,0.17855,1,0
2,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.022928,0.19158,0.14232,1,0
2,GO RIBOSOME BIOGENESIS,6.8885e-07,0.19149,0.23628,1,0
2,GO PROTEASOME ASSEMBLY,0.00037835,0.18997,0.16047,1,0
2,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.012227,0.18975,0.18841,1,0
2,GO APOPTOTIC CELL CLEARANCE,0.014494,0.18961,0.14051,1,0
2,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00075607,0.18892,0.16214,1,0
2,GO RIBOSOME ASSEMBLY,4.1026e-05,0.18868,0.21449,1,0
2,GO HISTONE SERINE PHOSPHORYLATION,0.00046872,0.18783,0.18519,1,0
2,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.057179,0.18739,0.14192,1,0
2,GO RRNA METABOLIC PROCESS,1.2281e-06,0.18729,0.22136,1,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0041031,0.18637,0.18406,1,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.0059852,0.18599,0.19334,1,0
2,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.024947,0.18552,0.23056,1,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.052083,0.18488,0.13749,1,0
2,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,1.9749e-05,0.18456,0.22969,1,0
2,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.002702,0.18434,0.22453,1,0
2,GO NCRNA PROCESSING,1.9175e-06,0.1841,0.21076,1,0
2,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,1.3948e-05,0.18404,0.22266,1,0
2,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.025475,0.18381,0.10878,1,0
2,GO HOMOCYSTEINE METABOLIC PROCESS,0.0012705,0.18312,0.2656,1,0
2,GO GLYCINE METABOLIC PROCESS,0.0044298,0.1831,0.18865,1,0
2,GO TRNA METHYLATION,0.00023294,0.18039,0.19511,1,0
2,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.045155,0.18029,0.14179,1,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.011544,0.17988,0.15172,1,0
2,GO TRNA MODIFICATION,0.00024819,0.17942,0.16203,1,0
2,GO PIGMENT ACCUMULATION,0.012367,0.17895,0.20794,1,0
2,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.054074,0.17831,0.16695,1,0
2,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.043866,0.17827,0.17505,1,0
2,GO ZYMOGEN INHIBITION,0.01849,0.1781,0.18112,1,0
2,GO GLUTATHIONE METABOLIC PROCESS,2.0478e-05,0.17749,0.23293,1,0
2,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.011544,0.1773,0.12332,1,0
2,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.01128,0.1763,0.1518,1,0
2,GO RRNA METHYLATION,8.5867e-06,0.17428,0.22353,1,0
2,GO RESPONSE TO ANGIOTENSIN,0.003607,0.17392,0.19208,1,0
2,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.016027,0.1732,0.1932,1,0
2,GO CELLULAR RESPONSE TO COPPER ION,0.057179,0.17296,0.24279,1,0
2,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.012367,0.17163,0.18323,1,0
2,GO CYTOKINE METABOLIC PROCESS,0.019104,0.17138,0.12016,1,0
2,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0068504,0.17104,0.13558,1,0
2,GO RESPONSE TO MANGANESE ION,0.001955,0.17104,0.1554,1,0
2,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.028264,0.16976,0.14161,1,0
2,GO PINOCYTOSIS,0.012367,0.16921,0.14173,1,0
2,GO ALPHA BETA T CELL PROLIFERATION,0.043025,0.16862,0.1282,1,0
2,GO TRICARBOXYLIC ACID CYCLE,0.00015083,0.16834,0.19099,1,0
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0021215,0.16814,0.17466,1,0
2,GO MITOCHONDRIAL GENE EXPRESSION,1.1165e-05,0.16798,0.1979,1,0
2,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.023173,0.16625,0.17139,1,0
2,GO TRNA PROCESSING,3.5022e-05,0.16603,0.16568,1,0
2,GO NCRNA METABOLIC PROCESS,3.2146e-06,0.16594,0.19031,1,0
2,GO RESPONSE TO CADMIUM ION,0.0025277,0.16588,0.19195,1,0
2,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.03006,0.16416,0.1354,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.006444,0.16354,0.16472,1,0
2,GO POLYAMINE BIOSYNTHETIC PROCESS,0.003166,0.16248,0.13441,1,0
2,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0016347,0.16214,0.1863,1,0
2,GO INTERFERON ALPHA PRODUCTION,0.041789,0.16207,0.1469,1,0
2,GO COCHLEA MORPHOGENESIS,0.024687,0.16082,0.13065,1,0
2,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0035146,0.16067,0.14944,1,0
2,GO ARGININE METABOLIC PROCESS,0.026838,0.16064,0.15325,1,0
2,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.058787,0.16026,0.11796,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.0087156,0.16006,0.17346,1,0
2,GO DEFENSE RESPONSE TO VIRUS,0.014013,0.15925,0.15375,1,0
2,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.025475,0.15859,0.25567,1,0
2,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0011668,0.15758,0.13263,1,0
2,GO INTERLEUKIN 5 PRODUCTION,0.03068,0.15715,0.20486,1,0
2,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.0071918,0.15684,0.18161,1,0
2,GO KERATAN SULFATE METABOLIC PROCESS,0.043444,0.15652,0.11382,1,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.027401,0.15609,0.12337,1,0
2,GO CELLULAR RESPONSE TO VIRUS,0.0040509,0.15608,0.15916,1,0
2,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0075485,0.15593,0.20895,1,0
2,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.0077327,0.1559,0.19843,1,0
2,GO STEROL HOMEOSTASIS,0.036409,0.15515,0.11042,1,0
2,GO COPPER ION TRANSPORT,0.014013,0.15396,0.13574,1,0
2,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.036409,0.15267,0.1585,1,0
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.032607,0.15231,0.12542,1,0
2,GO TELOMERASE RNA LOCALIZATION,3.2057e-05,0.15196,0.23475,1,0
2,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.056128,0.1517,0.12606,1,0
2,GO RNA METHYLATION,9.3381e-05,0.15149,0.17156,1,0
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.014658,0.15059,0.16026,1,0
2,GO PHAGOCYTOSIS RECOGNITION,0.02915,0.15039,0.15976,1,0
2,GO REGULATION OF VIRAL LIFE CYCLE,0.016568,0.15014,0.16496,1,0
2,GO REGULATION OF PLATELET ACTIVATION,0.036409,0.14846,0.16289,1,0
2,GO MODULATION BY HOST OF VIRAL PROCESS,0.0060595,0.14762,0.14789,1,0
2,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.057711,0.14749,0.091313,1,0
2,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.040187,0.14741,0.12064,1,0
2,GO POSITIVE REGULATION OF TRANSLATION,6.0079e-05,0.14688,0.15388,1,0
2,GO RNA MODIFICATION,3.0395e-05,0.14667,0.16533,1,0
2,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0051547,0.14618,0.15216,1,0
2,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.00045468,0.14616,0.1518,1,0
2,GO DENDRITIC CELL APOPTOTIC PROCESS,0.047372,0.14535,0.18726,1,0
2,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00015838,0.14514,0.17953,1,0
2,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.033608,0.1416,0.098448,1,0
2,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.031953,0.14158,0.10702,1,0
2,GO AMYLOID BETA CLEARANCE,0.037509,0.14141,0.12377,1,0
2,GO VIRAL GENOME REPLICATION,0.023419,0.13934,0.14356,1,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.012798,0.13908,0.14357,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.042609,0.13813,0.16935,1,0
2,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.007921,0.13772,0.17985,1,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0099244,0.13743,0.14657,1,0
2,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.011151,0.13742,0.11537,1,0
2,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00035024,0.13641,0.1264,1,0
2,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.01016,0.13545,0.12642,1,0
2,GO REGULATION OF PHAGOCYTOSIS,0.019735,0.13523,0.12131,1,0
2,GO IRON ION HOMEOSTASIS,0.02128,0.13407,0.10224,1,0
2,GO TRANSLATIONAL INITIATION,0.00081356,0.13308,0.15646,1,0
2,GO PHAGOCYTOSIS,0.014332,0.13282,0.12816,1,0
2,GO IRON ION TRANSMEMBRANE TRANSPORT,0.0047798,0.13281,0.14138,1,0
2,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.004156,0.13269,0.11498,1,0
2,GO TRANSLATIONAL TERMINATION,5.3256e-05,0.13155,0.17873,1,0
2,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0032078,0.13111,0.15199,1,0
2,GO CELLULAR COPPER ION HOMEOSTASIS,0.02128,0.1308,0.13537,1,0
2,GO DNA DEAMINATION,0.048746,0.1306,0.17377,1,0
2,GO CELL REDOX HOMEOSTASIS,0.00022565,0.13048,0.16484,1,0
2,GO NUCLEOBASE METABOLIC PROCESS,0.00013016,0.1298,0.17295,1,0
2,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.043866,0.12776,0.1015,1,0
2,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.0010408,0.12739,0.1286,1,0
2,GO CELL CELL RECOGNITION,0.00061456,0.12731,0.12985,1,0
2,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.009139,0.12683,0.13777,1,0
2,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.0052854,0.12579,0.13108,1,0
2,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0054872,0.1247,0.1284,1,0
2,GO PEPTIDYL PROLINE MODIFICATION,0.0077327,0.12278,0.1169,1,0
2,GO RESPONSE TO PEPTIDOGLYCAN,0.0054192,0.12223,0.15207,1,0
2,GO REGULATION OF PROTEIN MATURATION,0.027686,0.12199,0.12125,1,0
2,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0052197,0.12152,0.16079,1,0
2,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.045155,0.12146,0.12275,1,0
2,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.046921,0.12069,0.15726,1,0
2,GO NADP METABOLIC PROCESS,0.036048,0.12068,0.11777,1,0
2,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.002631,0.11941,0.15249,1,0
2,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.034636,0.11822,0.10821,1,0
2,GO RECEPTOR BIOSYNTHETIC PROCESS,0.011411,0.11666,0.11979,1,0
2,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.048746,0.1165,0.085567,1,0
2,GO STRESS GRANULE ASSEMBLY,0.046921,0.11609,0.084745,1,0
2,GO SULFUR AMINO ACID METABOLIC PROCESS,0.03006,0.1159,0.11232,1,0
2,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.010279,0.11581,0.17258,1,0
2,GO LIVER REGENERATION,0.028556,0.11547,0.11258,1,0
2,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.0017517,0.11471,0.17772,1,0
2,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.051595,0.11414,0.13764,1,0
2,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.02521,0.11342,0.15361,1,0
2,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.036048,0.11189,0.11242,1,0
2,GO CORTICAL CYTOSKELETON ORGANIZATION,0.034636,0.11039,0.084944,1,0
2,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.053071,0.11014,0.14931,1,0
2,GO CELLULAR IRON ION HOMEOSTASIS,0.022446,0.10902,0.089908,1,0
2,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.056128,0.10863,0.098096,1,0
2,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.017699,0.10862,0.15494,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.039795,0.10807,0.14082,1,0
2,GO TRANSITION METAL ION HOMEOSTASIS,0.001422,0.10618,0.12747,1,0
2,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.046474,0.10595,0.095021,1,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.031631,0.10257,0.11939,1,0
2,GO SPINDLE MIDZONE ASSEMBLY,0.046474,0.10247,0.1062,1,0
2,GO PEPTIDE BIOSYNTHETIC PROCESS,8.3013e-05,0.10152,0.12672,1,0
2,GO RNA SURVEILLANCE,0.001442,0.10136,0.14534,1,0
2,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.051111,0.10098,0.12061,1,0
2,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.013856,0.10062,0.12568,1,0
2,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.02521,0.099033,0.11068,1,0
2,GO RESPONSE TO NITROSATIVE STRESS,0.03902,0.098473,0.14201,1,0
2,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.057179,0.096804,0.099861,1,0
2,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00047589,0.095927,0.14391,1,0
2,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.044722,0.095577,0.10353,1,0
2,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.013856,0.095115,0.12309,1,0
2,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.013394,0.095078,0.1163,1,0
2,GO PEPTIDE METABOLIC PROCESS,0.00065224,0.09466,0.10542,1,0
2,GO B CELL ACTIVATION,0.027118,0.092895,0.10262,1,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS,0.058787,0.091911,0.13566,1,0
2,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.037139,0.091515,0.12611,1,0
2,GO AMIDE BIOSYNTHETIC PROCESS,0.000286,0.09087,0.11534,1,0
2,GO CYTOPLASMIC TRANSLATION,0.0077327,0.090058,0.13587,1,0
2,GO POLYAMINE METABOLIC PROCESS,0.046474,0.089063,0.084351,1,0
2,GO CYTOCHROME COMPLEX ASSEMBLY,0.011678,0.088623,0.12503,1,0
2,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.045155,0.087511,0.06559,1,0
2,GO TRANSLATIONAL ELONGATION,0.001483,0.087412,0.13111,1,0
2,GO RESPONSE TO THYROID HORMONE,0.055093,0.086759,0.1382,1,0
2,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.0046018,0.085929,0.12401,1,0
2,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.036409,0.085846,0.10561,1,0
2,GO VIRAL RELEASE FROM HOST CELL,0.036048,0.085256,0.098879,1,0
2,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.03068,0.084099,0.12849,1,0
2,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.00035024,0.082592,0.10228,1,0
2,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.054582,0.082037,0.10349,1,0
2,GO REGULATION OF NUCLEASE ACTIVITY,0.013093,0.081679,0.11893,1,0
2,GO BODY FLUID SECRETION,0.056652,0.081293,0.080815,1,0
2,GO MYOBLAST DIFFERENTIATION,0.056652,0.079967,0.11763,1,0
2,GO COPPER ION HOMEOSTASIS,0.038637,0.078743,0.11022,1,0
2,GO CELLULAR AMIDE METABOLIC PROCESS,0.0013826,0.078425,0.10111,1,0
2,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.043025,0.077468,0.078747,1,0
2,GO PEROXISOMAL TRANSPORT,0.047372,0.076417,0.074309,1,0
2,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.024173,0.076348,0.12037,1,0
2,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.029754,0.07542,0.070634,1,0
2,GO STEROID BIOSYNTHETIC PROCESS,0.037882,0.075241,0.070512,1,0
2,GO NUCLEAR TRANSPORT,0.028556,0.074587,0.079229,1,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.05063,0.074403,0.094849,1,0
2,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.010769,0.072435,0.10918,1,0
2,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.0031247,0.071564,0.085379,1,0
2,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.02174,0.071417,0.085781,1,0
2,GO DIGESTIVE SYSTEM PROCESS,0.047372,0.071009,0.083081,1,0
2,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.021053,0.069202,0.10112,1,0
2,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.056128,0.068702,0.10129,1,0
2,GO REGULATION OF LYSOSOMAL LUMEN PH,0.042609,0.064278,0.11665,1,0
2,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.010895,0.058976,0.13495,1,0
2,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.05063,0.052111,0.12124,1,0
2,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.054582,0.050366,0.094532,1,0
2,GO TRANSCRIPTION BY RNA POLYMERASE III,0.017506,0.049003,0.076155,1,0
2,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.028264,0.048588,0.12615,1,0
2,GO FOLIC ACID METABOLIC PROCESS,0.037139,0.048137,0.13579,1,0
2,GO NUCLEAR ENVELOPE REASSEMBLY,0.047827,0.045851,0.089568,1,0
2,GO ELECTRON TRANSPORT CHAIN,0.045155,0.034454,0.074834,1,0
2,GO RESPONSE TO STARVATION,0.046921,-0.025673,-0.070651,1,0
2,GO MEIOSIS I CELL CYCLE PROCESS,0.059331,-0.0305,-0.062288,1,0
2,GO NEURON DEATH,0.027401,-0.031473,-0.068763,1,0
2,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.038258,-0.031574,-0.082799,1,0
2,GO CIRCULATORY SYSTEM PROCESS,0.040187,-0.034739,-0.071522,1,0
2,GO MEIOTIC CELL CYCLE,0.051595,-0.036882,-0.055854,1,0
2,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.035691,-0.041919,-0.071037,1,0
2,GO SEXUAL REPRODUCTION,0.038637,-0.042618,-0.06255,1,0
2,GO MALE GAMETE GENERATION,0.051111,-0.043728,-0.065694,1,0
2,GO CELL GROWTH,0.033271,-0.044975,-0.073511,1,0
2,GO NEURON APOPTOTIC PROCESS,0.035336,-0.045572,-0.067353,1,0
2,GO NEGATIVE REGULATION OF ION TRANSPORT,0.041383,-0.047355,-0.063335,1,0
2,GO REGULATION OF TRANSPORT,0.014494,-0.047444,-0.072656,1,0
2,GO PROTEIN HOMOOLIGOMERIZATION,0.043866,-0.049285,-0.047316,1,0
2,GO ORGANELLE LOCALIZATION,0.037509,-0.05076,-0.056852,1,0
2,GO REGULATION OF VASOCONSTRICTION,0.010769,-0.052174,-0.1401,1,0
2,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.058787,-0.054273,-0.09809,1,0
2,GO DIVALENT INORGANIC CATION TRANSPORT,0.055093,-0.055495,-0.05886,1,0
2,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.028264,-0.055559,-0.069995,1,0
2,GO CHEMOSENSORY BEHAVIOR,0.026838,-0.05561,-0.11237,1,0
2,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.0062877,-0.055741,-0.10198,1,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.054582,-0.056781,-0.099052,1,0
2,GO MICROTUBULE BASED PROCESS,0.019523,-0.057996,-0.077655,1,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.0078263,-0.059017,-0.088935,1,0
2,GO INORGANIC ANION TRANSPORT,0.020828,-0.060919,-0.070763,1,0
2,GO ENSHEATHMENT OF NEURONS,0.057179,-0.060922,-0.083424,1,0
2,GO REGULATION OF NEURON MIGRATION,0.037882,-0.06187,-0.13614,1,0
2,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0076401,-0.062609,-0.10705,1,0
2,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.05063,-0.062902,-0.091174,1,0
2,GO CELL FATE COMMITMENT,0.0068504,-0.063474,-0.10466,1,0
2,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.046031,-0.063665,-0.087808,1,0
2,GO RESPONSE TO CARBOHYDRATE,0.034636,-0.067475,-0.067803,1,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.05063,-0.067651,-0.078465,1,0
2,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.055609,-0.067984,-0.082754,1,0
2,GO RETINOIC ACID METABOLIC PROCESS,0.046921,-0.06858,-0.12927,1,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.047827,-0.068622,-0.071422,1,0
2,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.034984,-0.068759,-0.098595,1,0
2,GO TRANSMEMBRANE TRANSPORT,0.016205,-0.070837,-0.064764,1,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.031631,-0.071126,-0.081537,1,0
2,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.019735,-0.071279,-0.093823,1,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.01829,-0.071942,-0.060586,1,0
2,GO CELL JUNCTION ORGANIZATION,0.024687,-0.072295,-0.093381,1,0
2,GO CELL MORPHOGENESIS,0.021973,-0.072461,-0.093254,1,0
2,GO NEGATIVE REGULATION OF NEURON DEATH,0.0058389,-0.072485,-0.083132,1,0
2,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.047372,-0.073396,-0.086696,1,0
2,GO ANDROGEN METABOLIC PROCESS,0.036772,-0.073483,-0.12345,1,0
2,GO RHYTHMIC PROCESS,0.021053,-0.073504,-0.06604,1,0
2,GO MICROTUBULE POLYMERIZATION,0.0073682,-0.073777,-0.1313,1,0
2,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.02128,-0.073786,-0.13432,1,0
2,GO POSITIVE REGULATION OF AXON EXTENSION,0.016938,-0.075613,-0.13127,1,0
2,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.020166,-0.075808,-0.071177,1,0
2,GO CELL PROJECTION ORGANIZATION,0.0024609,-0.075968,-0.10636,1,0
2,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.0066851,-0.077019,-0.1109,1,0
2,GO POLYSACCHARIDE METABOLIC PROCESS,0.008211,-0.077294,-0.10291,1,0
2,GO CIRCADIAN RHYTHM,0.0015038,-0.078066,-0.096893,1,0
2,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0012886,-0.078123,-0.12339,1,0
2,GO POSITIVE REGULATION OF GROWTH,0.0074579,-0.078165,-0.096016,1,0
2,GO INOSITOL METABOLIC PROCESS,0.036048,-0.078751,-0.11638,1,0
2,GO RESPONSE TO METAL ION,0.012798,-0.079042,-0.07909,1,0
2,GO CELLULAR GLUCAN METABOLIC PROCESS,0.046474,-0.079956,-0.082406,1,0
2,GO ANION TRANSMEMBRANE TRANSPORT,0.056128,-0.080007,-0.051758,1,0
2,GO TRANSPORT ALONG MICROTUBULE,0.0028492,-0.080445,-0.10762,1,0
2,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.01251,-0.080975,-0.10134,1,0
2,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.040187,-0.081015,-0.1299,1,0
2,GO HIPPOCAMPUS DEVELOPMENT,0.017699,-0.08109,-0.086334,1,0
2,GO ANATOMICAL STRUCTURE MATURATION,0.0031247,-0.081227,-0.10153,1,0
2,GO CARBOHYDRATE HOMEOSTASIS,0.008211,-0.081439,-0.092746,1,0
2,GO REGULATION OF CIRCADIAN RHYTHM,0.0039481,-0.081822,-0.097281,1,0
2,GO POSITIVE REGULATION OF ION TRANSPORT,0.014494,-0.081909,-0.068114,1,0
2,GO MICROTUBULE BASED TRANSPORT,0.0052197,-0.082054,-0.10857,1,0
2,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.01829,-0.082452,-0.083711,1,0
2,GO REGULATION OF EXTENT OF CELL GROWTH,0.0066851,-0.082525,-0.14147,1,0
2,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0059852,-0.082911,-0.10597,1,0
2,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.019104,-0.083728,-0.049248,1,0
2,GO GLIOGENESIS,0.027973,-0.084197,-0.08736,1,0
2,GO HINDBRAIN MORPHOGENESIS,0.0066851,-0.085053,-0.11041,1,0
2,GO REGULATION OF TRANSPORTER ACTIVITY,0.023173,-0.085183,-0.080046,1,0
2,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.034984,-0.085307,-0.14359,1,0
2,GO REGULATION OF CELL MORPHOGENESIS,0.037882,-0.085922,-0.085364,1,0
2,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.0042636,-0.085981,-0.12037,1,0
2,GO GERM CELL DEVELOPMENT,0.0057669,-0.08605,-0.099707,1,0
2,GO CARBOHYDRATE TRANSPORT,0.01995,-0.086152,-0.088,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.058787,-0.086811,-0.078103,1,0
2,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0049019,-0.087377,-0.090373,1,0
2,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.0039481,-0.087789,-0.11553,1,0
2,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.00086244,-0.087792,-0.081415,1,0
2,GO ION TRANSPORT,0.0034692,-0.088579,-0.08512,1,0
2,GO SPERMATID DIFFERENTIATION,0.0088198,-0.088922,-0.10505,1,0
2,GO REGULATION OF HEART RATE,0.0092477,-0.089346,-0.10594,1,0
2,GO ERROR PRONE TRANSLESION SYNTHESIS,0.012945,-0.08972,-0.089415,1,0
2,GO MECHANORECEPTOR DIFFERENTIATION,0.027973,-0.08975,-0.10254,1,0
2,GO REGULATION OF CILIUM ASSEMBLY,0.036048,-0.089872,-0.098742,1,0
2,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.016568,-0.089957,-0.12455,1,0
2,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.044722,-0.090304,-0.10015,1,0
2,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.0050269,-0.091397,-0.11296,1,0
2,GO RESPONSE TO MONOSACCHARIDE,0.0050269,-0.091542,-0.093592,1,0
2,GO REGULATION OF ICOSANOID SECRETION,0.05063,-0.091554,-0.089795,1,0
2,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0023637,-0.091736,-0.13492,1,0
2,GO REGULATION OF HORMONE LEVELS,0.0007786,-0.092397,-0.12027,1,0
2,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.023919,-0.092429,-0.11902,1,0
2,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.046921,-0.092739,-0.082821,1,0
2,GO HEART PROCESS,0.0030436,-0.092751,-0.10444,1,0
2,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0039481,-0.093229,-0.11985,1,0
2,GO CILIUM ORGANIZATION,0.0031247,-0.093804,-0.12407,1,0
2,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.047827,-0.094468,-0.096734,1,0
2,GO SYNAPTIC TRANSMISSION GABAERGIC,0.036772,-0.09448,-0.099484,1,0
2,GO AXON EXTENSION,0.0075485,-0.094764,-0.12295,1,0
2,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.057711,-0.095483,-0.077108,1,0
2,GO REGULATION OF DEVELOPMENTAL GROWTH,0.003166,-0.096089,-0.10922,1,0
2,GO ECTODERM DEVELOPMENT,0.022686,-0.096374,-0.092731,1,0
2,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.028556,-0.09663,-0.10707,1,0
2,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.034984,-0.096797,-0.081959,1,0
2,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0137,-0.097175,-0.11048,1,0
2,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.0025617,-0.097382,-0.1352,1,0
2,GO MULTICELLULAR ORGANISM GROWTH,0.010279,-0.097755,-0.080652,1,0
2,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.0019023,-0.097756,-0.10371,1,0
2,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.059331,-0.097901,-0.14627,1,0
2,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0062108,-0.098425,-0.128,1,0
2,GO NEUROGENESIS,0.00030449,-0.098769,-0.12899,1,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0058389,-0.09881,-0.11595,1,0
2,GO RESPONSE TO INTERLEUKIN 6,0.020385,-0.098882,-0.13107,1,0
2,GO REGULATION OF TORC1 SIGNALING,0.0066039,-0.098993,-0.11332,1,0
2,GO REGULATION OF CELL DEVELOPMENT,0.002631,-0.099167,-0.10542,1,0
2,GO MATING,0.0066851,-0.09918,-0.10981,1,0
2,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.0010259,-0.099375,-0.12279,1,0
2,GO EATING BEHAVIOR,0.042609,-0.099847,-0.082479,1,0
2,GO GLUCOSE IMPORT,0.028556,-0.099924,-0.0761,1,0
2,GO PROTEIN DEPOLYMERIZATION,0.0038478,-0.10001,-0.098589,1,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.03429,-0.10042,-0.11327,1,0
2,GO DETECTION OF VISIBLE LIGHT,0.014823,-0.10042,-0.021604,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.055609,-0.10047,-0.11153,1,0
2,GO POSITIVE REGULATION OF MYELINATION,0.037139,-0.10113,-0.080154,1,0
2,GO ALDEHYDE CATABOLIC PROCESS,0.0025277,-0.10154,-0.12917,1,0
2,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0030038,-0.10157,-0.12608,1,0
2,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0043737,-0.10204,-0.12336,1,0
2,GO REGULATION OF SULFUR METABOLIC PROCESS,0.01849,-0.10316,-0.13926,1,0
2,GO ORGANELLE MEMBRANE FUSION,0.042609,-0.1035,-0.077574,1,0
2,GO TRANSFERRIN TRANSPORT,0.010279,-0.1037,-0.099861,1,0
2,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.0010865,-0.10372,-0.13982,1,0
2,GO LIMBIC SYSTEM DEVELOPMENT,0.0068504,-0.10422,-0.096149,1,0
2,GO SPERM MOTILITY,0.003654,-0.10427,-0.12965,1,0
2,GO AXON DEVELOPMENT,0.0011668,-0.1045,-0.14271,1,0
2,GO TORC1 SIGNALING,0.021053,-0.10505,-0.082535,1,0
2,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.014013,-0.10547,-0.16143,1,0
2,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.0037498,-0.10568,-0.11135,1,0
2,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.010522,-0.10568,-0.10262,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.040187,-0.1058,-0.083453,1,0
2,GO OLIGODENDROCYTE DIFFERENTIATION,0.011813,-0.10608,-0.1199,1,0
2,GO PLASMA MEMBRANE ORGANIZATION,0.016386,-0.10662,-0.11047,1,0
2,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.020166,-0.10675,-0.079845,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00029511,-0.10685,-0.10608,1,0
2,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.047372,-0.10708,-0.15271,1,0
2,GO CELLULAR COMPONENT MORPHOGENESIS,0.0003557,-0.10761,-0.14419,1,0
2,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.05357,-0.10803,-0.069432,1,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.044292,-0.1082,-0.068566,1,0
2,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0021798,-0.10824,-0.12776,1,0
2,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.0068504,-0.10838,-0.11959,1,0
2,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.0045438,-0.1087,-0.12688,1,0
2,GO REGULATION OF PEPTIDE SECRETION,0.0030038,-0.1093,-0.11109,1,0
2,GO MICROTUBULE BASED MOVEMENT,0.0013069,-0.10932,-0.12135,1,0
2,GO LYTIC VACUOLE ORGANIZATION,0.036048,-0.10941,-0.077814,1,0
2,GO SOMITE DEVELOPMENT,0.046031,-0.10957,-0.080399,1,0
2,GO POSITIVE REGULATION OF SECRETION,0.00012804,-0.11,-0.13533,1,0
2,GO REGULATION OF CATION CHANNEL ACTIVITY,0.025743,-0.11004,-0.088973,1,0
2,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.0090315,-0.11007,-0.1803,1,0
2,GO PHAGOSOME MATURATION,0.042197,-0.11032,-0.086354,1,0
2,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.0054872,-0.11033,-0.13073,1,0
2,GO SENSORY SYSTEM DEVELOPMENT,0.056652,-0.11041,-0.074847,1,0
2,GO MITOCHONDRION LOCALIZATION,0.0024609,-0.11053,-0.14218,1,0
2,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,8.4424e-05,-0.11071,-0.17909,1,0
2,GO REGULATION OF MEMBRANE REPOLARIZATION,0.0039992,-0.11075,-0.13699,1,0
2,GO SECOND MESSENGER MEDIATED SIGNALING,0.00069207,-0.11108,-0.10981,1,0
2,GO ENERGY RESERVE METABOLIC PROCESS,0.038637,-0.11132,-0.075849,1,0
2,GO PROTEIN HETEROOLIGOMERIZATION,0.0024609,-0.11136,-0.10771,1,0
2,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.009139,-0.11176,-0.12183,1,0
2,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.033271,-0.11188,-0.10289,1,0
2,GO REGULATION OF RESPONSE TO FOOD,0.0022095,-0.11192,-0.14991,1,0
2,GO NEURON PROJECTION GUIDANCE,0.0022701,-0.11243,-0.1462,1,0
2,GO DEVELOPMENTAL CELL GROWTH,0.00010497,-0.11401,-0.1573,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.032278,-0.11413,-0.10649,1,0
2,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.021509,-0.11434,-0.18299,1,0
2,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0035146,-0.11503,-0.16068,1,0
2,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.015501,-0.11529,-0.099879,1,0
2,GO AXO DENDRITIC TRANSPORT,0.0037985,-0.11531,-0.11924,1,0
2,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.01995,-0.11558,-0.089495,1,0
2,GO ANIMAL ORGAN MATURATION,0.057179,-0.11565,-0.1069,1,0
2,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.056652,-0.11575,-0.14835,1,0
2,GO RESPONSE TO LEUCINE,0.024947,-0.11582,-0.17028,1,0
2,GO GLIAL CELL DIFFERENTIATION,0.0058389,-0.11583,-0.11311,1,0
2,GO LOCALIZATION WITHIN MEMBRANE,0.0067673,-0.11587,-0.12501,1,0
2,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.020166,-0.11632,-0.1047,1,0
2,GO REGULATION OF SODIUM ION TRANSPORT,0.017315,-0.11636,-0.10107,1,0
2,GO METAL ION TRANSPORT,0.0005211,-0.1164,-0.10497,1,0
2,GO REGULATION OF BLOOD CIRCULATION,0.00057029,-0.11651,-0.12686,1,0
2,GO RECEPTOR CLUSTERING,0.02128,-0.11657,-0.12892,1,0
2,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.022446,-0.1166,-0.071665,1,0
2,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.0030038,-0.11685,-0.12499,1,0
2,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.00082553,-0.11709,-0.12005,1,0
2,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.00031907,-0.11718,-0.15546,1,0
2,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.0016575,-0.11719,-0.17026,1,0
2,GO REGULATION OF DNA BINDING,0.012087,-0.11782,-0.094674,1,0
2,GO NEURON DIFFERENTIATION,5.7059e-05,-0.11792,-0.15104,1,0
2,GO CELL JUNCTION MAINTENANCE,0.015501,-0.1188,-0.1439,1,0
2,GO SENSORY PERCEPTION OF SMELL,0.0043184,-0.11887,-0.12595,1,0
2,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00044781,-0.11926,-0.15257,1,0
2,GO HEAD DEVELOPMENT,0.00011033,-0.11934,-0.13999,1,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.015329,-0.11953,-0.12978,1,0
2,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.0007786,-0.11967,-0.15072,1,0
2,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.0066039,-0.11968,-0.10697,1,0
2,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0018508,-0.11977,-0.12903,1,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.013093,-0.12012,-0.11832,1,0
2,GO CHROMATIN SILENCING AT TELOMERE,0.020385,-0.12022,-0.084571,1,0
2,GO MICROTUBULE ANCHORING AT CENTROSOME,0.00071283,-0.12023,-0.21933,1,0
2,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,5.9056e-05,-0.12034,-0.14081,1,0
2,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.0018256,-0.12038,-0.11435,1,0
2,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.00058763,-0.1207,-0.11009,1,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.033608,-0.12086,-0.11812,1,0
2,GO RESPONSE TO MECHANICAL STIMULUS,0.017125,-0.12087,-0.10534,1,0
2,GO PHOTORECEPTOR CELL MAINTENANCE,0.022446,-0.12138,-0.089463,1,0
2,GO MEMBRANE REPOLARIZATION,0.004156,-0.12221,-0.13737,1,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.013093,-0.12227,-0.18064,1,0
2,GO ANTEROGRADE AXONAL TRANSPORT,0.0039992,-0.12228,-0.12368,1,0
2,GO AXONAL TRANSPORT,0.0020646,-0.12236,-0.13708,1,0
2,GO PROTEIN MANNOSYLATION,0.041789,-0.12262,-0.11235,1,0
2,GO L AMINO ACID TRANSPORT,0.023419,-0.12277,-0.062079,1,0
2,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.010645,-0.12278,-0.10283,1,0
2,GO MICROTUBULE SEVERING,0.018693,-0.1234,-0.14476,1,0
2,GO REGULATION OF CYCLASE ACTIVITY,0.025743,-0.1235,-0.095195,1,0
2,GO IMPORT INTO CELL,0.0018256,-0.12379,-0.11994,1,0
2,GO PEPTIDE SECRETION,0.00014839,-0.12392,-0.13888,1,0
2,GO CELLULAR GLUCOSE HOMEOSTASIS,0.0043737,-0.12403,-0.09234,1,0
2,GO CELL PART MORPHOGENESIS,0.00012594,-0.12458,-0.1573,1,0
2,GO MUSCLE ORGAN MORPHOGENESIS,0.051111,-0.12467,-0.080983,1,0
2,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.00083767,-0.1247,-0.20679,1,0
2,GO FEMALE SEX DIFFERENTIATION,0.023919,-0.12561,-0.083367,1,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,8.5858e-05,-0.12573,-0.15032,1,0
2,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.00027284,-0.12638,-0.13118,1,0
2,GO RESPONSE TO ALKALOID,7.5001e-05,-0.12644,-0.1451,1,0
2,GO CELL CELL SIGNALING,4.1751e-05,-0.1267,-0.13264,1,0
2,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0066851,-0.12756,-0.19965,1,0
2,GO REGULATION OF SYSTEM PROCESS,3.8924e-05,-0.12786,-0.14301,1,0
2,GO MEMBRANE DOCKING,2.8305e-05,-0.12788,-0.13441,1,0
2,GO IMPORT ACROSS PLASMA MEMBRANE,0.0044298,-0.12788,-0.10199,1,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.00021857,-0.12845,-0.14276,1,0
2,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.01016,-0.12865,-0.15598,1,0
2,GO RESPONSE TO REDOX STATE,0.015159,-0.12875,-0.14137,1,0
2,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.055093,-0.12876,-0.13903,1,0
2,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.012367,-0.129,-0.11328,1,0
2,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.023668,-0.12939,-0.12467,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0026663,-0.12997,-0.16527,1,0
2,GO ENERGY HOMEOSTASIS,0.0015249,-0.13007,-0.17973,1,0
2,GO CATION TRANSPORT,0.0003557,-0.13085,-0.11008,1,0
2,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.002702,-0.13092,-0.11082,1,0
2,GO HYPOTHALAMUS DEVELOPMENT,0.0011341,-0.13124,-0.18421,1,0
2,GO RESPONSE TO FOOD,0.00014362,-0.13163,-0.14271,1,0
2,GO REGULATION OF GLUCOSE IMPORT,0.0053519,-0.13234,-0.10941,1,0
2,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00025617,-0.13367,-0.16529,1,0
2,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0018508,-0.13369,-0.12013,1,0
2,GO NERVOUS SYSTEM PROCESS,0.00012388,-0.13406,-0.12538,1,0
2,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0046604,-0.13414,-0.16103,1,0
2,GO CATION TRANSMEMBRANE TRANSPORT,0.00016361,-0.13466,-0.1175,1,0
2,GO RELAXATION OF MUSCLE,0.019735,-0.13472,-0.12457,1,0
2,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037139,-0.13537,-0.13971,1,0
2,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.01499,-0.13539,-0.093629,1,0
2,GO FEAR RESPONSE,0.0018508,-0.13663,-0.12807,1,0
2,GO REPRODUCTIVE BEHAVIOR,0.0011021,-0.1373,-0.14568,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00032916,-0.13775,-0.18567,1,0
2,GO REGULATION OF NEURON DIFFERENTIATION,0.00010852,-0.13815,-0.15595,1,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0032078,-0.13821,-0.13395,1,0
2,GO ION TRANSMEMBRANE TRANSPORT,0.00061456,-0.13848,-0.10775,1,0
2,GO CELLULAR RESPONSE TO ALKALOID,0.0074579,-0.13902,-0.11859,1,0
2,GO REGULATION OF DENDRITE MORPHOGENESIS,0.0019285,-0.13921,-0.14886,1,0
2,GO ADIPOSE TISSUE DEVELOPMENT,0.01829,-0.13931,-0.12383,1,0
2,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.0084096,-0.13938,-0.13563,1,0
2,GO REGULATION OF AXONOGENESIS,0.00088789,-0.14069,-0.16355,1,0
2,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.00029052,-0.1407,-0.20147,1,0
2,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.0075485,-0.14073,-0.11519,1,0
2,GO ORGANIC CATION TRANSPORT,0.0046018,-0.14082,-0.12627,1,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.0063654,-0.14139,-0.15113,1,0
2,GO DETECTION OF ABIOTIC STIMULUS,0.00047589,-0.14147,-0.10111,1,0
2,GO REGULATION OF DENDRITE DEVELOPMENT,0.00076726,-0.14148,-0.1515,1,0
2,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,8.3013e-05,-0.14163,-0.16417,1,0
2,GO REGULATION OF RECEPTOR CLUSTERING,0.031311,-0.14294,-0.17407,1,0
2,GO RESPONSE TO NICOTINE,0.035691,-0.14312,-0.096134,1,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.012087,-0.1433,-0.14455,1,0
2,GO CELL FATE SPECIFICATION,0.0018256,-0.14338,-0.15278,1,0
2,GO REGIONALIZATION,0.011949,-0.1435,-0.10577,1,0
2,GO FAT CELL PROLIFERATION,0.0057669,-0.14369,-0.16326,1,0
2,GO SMOOTHENED SIGNALING PATHWAY,0.05357,-0.14408,-0.093507,1,0
2,GO REGULATION OF SECRETION,5.7059e-05,-0.1444,-0.13412,1,0
2,GO FACIAL NERVE MORPHOGENESIS,0.033271,-0.14453,-0.23081,1,0
2,GO SPERM CAPACITATION,0.00021857,-0.14463,-0.2014,1,0
2,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.031631,-0.14487,-0.16362,1,0
2,GO NEURAL PRECURSOR CELL PROLIFERATION,9.3381e-05,-0.14496,-0.16997,1,0
2,GO VENTRAL SPINAL CORD DEVELOPMENT,0.0071918,-0.14549,-0.13003,1,0
2,GO PROTEIN O LINKED MANNOSYLATION,0.026286,-0.14552,-0.12819,1,0
2,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.046031,-0.14577,-0.12386,1,0
2,GO NEURON DEVELOPMENT,3.3806e-05,-0.14589,-0.16082,1,0
2,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.012367,-0.14603,-0.14697,1,0
2,GO PATTERN SPECIFICATION PROCESS,0.0059852,-0.14611,-0.11011,1,0
2,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.0049019,-0.14648,-0.22427,1,0
2,GO NEUROBLAST PROLIFERATION,0.0016122,-0.14723,-0.18849,1,0
2,GO POSITIVE REGULATION OF CELL GROWTH,0.00096848,-0.14824,-0.12586,1,0
2,GO ACTION POTENTIAL,0.00075607,-0.14898,-0.13827,1,0
2,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00092737,-0.14899,-0.17316,1,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.045155,-0.14921,-0.1339,1,0
2,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.001568,-0.14921,-0.16707,1,0
2,GO CARDIAC VENTRICLE DEVELOPMENT,0.040582,-0.14922,-0.087089,1,0
2,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.036048,-0.14944,-0.19322,1,0
2,GO DENDRITE MORPHOGENESIS,0.00082553,-0.14976,-0.17277,1,0
2,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0022396,-0.1498,-0.23303,1,0
2,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.048746,-0.15039,-0.11055,1,0
2,GO PROTEIN LOCALIZATION TO LYSOSOME,0.0074579,-0.15109,-0.14189,1,0
2,GO REGULATION OF PROTEIN GLYCOSYLATION,0.027973,-0.15138,-0.14787,1,0
2,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0013826,-0.15239,-0.17458,1,0
2,GO RESPONSE TO AMYLOID BETA,0.014013,-0.15249,-0.10749,1,0
2,GO POSTSYNAPSE ORGANIZATION,0.00083767,-0.15252,-0.16172,1,0
2,GO DENDRITE SELF AVOIDANCE,0.0083098,-0.15261,-0.16806,1,0
2,GO CARDIAC CHAMBER FORMATION,0.055609,-0.15265,-0.17204,1,0
2,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.00069207,-0.15309,-0.1694,1,0
2,GO RESPONSE TO COLD,0.0032928,-0.15324,-0.14927,1,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.0055559,-0.1533,-0.16381,1,0
2,GO RESPONSE TO CALCIUM ION,7.0072e-05,-0.15335,-0.16197,1,0
2,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.01016,-0.15335,-0.091843,1,0
2,GO REGULATION OF CAMP MEDIATED SIGNALING,0.00059648,-0.15338,-0.17456,1,0
2,GO COLLATERAL SPROUTING,0.0037016,-0.15359,-0.19549,1,0
2,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.00013899,-0.1536,-0.16488,1,0
2,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0018006,-0.15383,-0.16419,1,0
2,GO SODIUM ION TRANSPORT,0.00015838,-0.15384,-0.1425,1,0
2,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,6.8888e-05,-0.15424,-0.12811,1,0
2,GO POSITIVE REGULATION OF HORMONE SECRETION,2.5884e-05,-0.15489,-0.17445,1,0
2,GO OLIGODENDROCYTE DEVELOPMENT,0.00013016,-0.15605,-0.18496,1,0
2,GO NEURAL RETINA DEVELOPMENT,0.00047589,-0.1567,-0.19519,1,0
2,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.010522,-0.15714,-0.15911,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00015838,-0.15738,-0.16683,1,0
2,GO NEURON PROJECTION EXTENSION,2.4528e-05,-0.15749,-0.18637,1,0
2,GO NEGATIVE REGULATION OF GLIOGENESIS,0.0013069,-0.15789,-0.17924,1,0
2,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.021973,-0.15811,-0.12606,1,0
2,GO MEMBRANE FISSION,0.0054872,-0.15812,-0.16687,1,0
2,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.033948,-0.1587,-0.090978,1,0
2,GO CARDIAC VENTRICLE FORMATION,0.046474,-0.1588,-0.20917,1,0
2,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0044298,-0.1597,-0.20173,1,0
2,GO NATURAL KILLER CELL DIFFERENTIATION,0.00092737,-0.15973,-0.20396,1,0
2,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.015159,-0.15978,-0.2621,1,0
2,GO RDNA HETEROCHROMATIN ASSEMBLY,0.001422,-0.16045,-0.15178,1,0
2,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.013243,-0.1609,-0.14589,1,0
2,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00014362,-0.16116,-0.17947,1,0
2,GO MULTICELLULAR ORGANISM AGING,0.0019285,-0.16251,-0.12782,1,0
2,GO OUTER DYNEIN ARM ASSEMBLY,0.0005618,-0.16277,-0.26709,1,0
2,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.01128,-0.16283,-0.11436,1,0
2,GO HYALURONAN BIOSYNTHETIC PROCESS,0.003166,-0.16327,-0.15954,1,0
2,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.027973,-0.16399,-0.12785,1,0
2,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0098086,-0.16424,-0.17033,1,0
2,GO SENSORY PERCEPTION OF PAIN,4.0314e-05,-0.16444,-0.17987,1,0
2,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00096848,-0.1646,-0.16207,1,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.054074,-0.16475,-0.15334,1,0
2,GO CELLULAR RESPONSE TO NUTRIENT,0.052083,-0.16648,-0.1178,1,0
2,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.0030436,-0.16748,-0.16882,1,0
2,GO REGULATION OF FERTILIZATION,0.00073415,-0.16768,-0.15713,1,0
2,GO PHOTORECEPTOR CELL DEVELOPMENT,4.3236e-05,-0.16899,-0.18491,1,0
2,GO MONOVALENT INORGANIC CATION TRANSPORT,2.856e-06,-0.16974,-0.16578,1,0
2,GO DENDRITE DEVELOPMENT,0.00035024,-0.17021,-0.16235,1,0
2,GO INDOLALKYLAMINE METABOLIC PROCESS,0.03902,-0.17039,-0.12683,1,0
2,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00013016,-0.17049,-0.18358,1,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00013451,-0.17108,-0.18164,1,0
2,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.00029511,-0.17145,-0.21022,1,0
2,GO EXPORT ACROSS PLASMA MEMBRANE,0.00026024,-0.17146,-0.17306,1,0
2,GO REGULATION OF SYNAPSE ASSEMBLY,0.001071,-0.17243,-0.17906,1,0
2,GO PEPTIDYL CYSTEINE MODIFICATION,0.0001179,-0.17356,-0.17159,1,0
2,GO EPITHELIAL CELL MATURATION,0.00033432,-0.17364,-0.25085,1,0
2,GO POSITIVE REGULATION OF BONE RESORPTION,0.033608,-0.17421,-0.16595,1,0
2,GO CRANIAL NERVE DEVELOPMENT,0.00044781,-0.1745,-0.20642,1,0
2,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.03006,-0.17452,-0.12101,1,0
2,GO DEVELOPMENTAL INDUCTION,0.0019819,-0.17473,-0.196,1,0
2,GO REGULATION OF APPETITE,1.5037e-07,-0.17513,-0.19942,1,0
2,GO HEART TRABECULA MORPHOGENESIS,0.023668,-0.17619,-0.11526,1,0
2,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.00025215,-0.17663,-0.20302,1,0
2,GO RELAXATION OF CARDIAC MUSCLE,0.026561,-0.17682,-0.14294,1,0
2,GO REGULATION OF ORGANIC ACID TRANSPORT,1.3693e-05,-0.17684,-0.18014,1,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.00017741,-0.17753,-0.16805,1,0
2,GO CORTICOSTEROID HORMONE SECRETION,0.052575,-0.1779,-0.1314,1,0
2,GO ENDOCARDIAL CUSHION FORMATION,0.016752,-0.17809,-0.17021,1,0
2,GO LONG TERM MEMORY,0.001442,-0.17861,-0.16137,1,0
2,GO PANCREAS DEVELOPMENT,0.0024609,-0.17901,-0.16369,1,0
2,GO RESPONSE TO CAFFEINE,0.043866,-0.17906,-0.084458,1,0
2,GO CARDIAC ATRIUM MORPHOGENESIS,0.019735,-0.17914,-0.16977,1,0
2,GO COGNITION,9.9803e-06,-0.17941,-0.17972,1,0
2,GO FEEDING BEHAVIOR,1.2482e-05,-0.17962,-0.1679,1,0
2,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0066851,-0.18166,-0.12179,1,0
2,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,6.0991e-06,-0.18262,-0.20555,1,0
2,GO STRIATUM DEVELOPMENT,0.000662,-0.18287,-0.20527,1,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00080175,-0.18331,-0.17502,1,0
2,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.00023294,-0.18345,-0.16868,1,0
2,GO TELENCEPHALON DEVELOPMENT,2.0853e-05,-0.18353,-0.16387,1,0
2,GO PALLIUM DEVELOPMENT,4.2487e-05,-0.18383,-0.15419,1,0
2,GO ADULT HEART DEVELOPMENT,0.00061456,-0.18445,-0.21637,1,0
2,GO RESPONSE TO PH,0.0065235,-0.18457,-0.13073,1,0
2,GO CALCIUM ION IMPORT,1.9044e-05,-0.18457,-0.18127,1,0
2,GO REGULATION OF POTASSIUM ION TRANSPORT,8.0256e-05,-0.1851,-0.162,1,0
2,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0023637,-0.18522,-0.20933,1,0
2,GO REGULATION OF HORMONE SECRETION,8.2686e-06,-0.18539,-0.17856,1,0
2,GO FOREBRAIN DEVELOPMENT,7.5217e-06,-0.18562,-0.17936,1,0
2,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00014129,-0.18643,-0.16092,1,0
2,GO PROTEIN LOCALIZATION TO CILIUM,0.002631,-0.18675,-0.1869,1,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.016027,-0.18763,-0.23794,1,0
2,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.0032078,-0.1882,-0.19989,1,0
2,GO ALANINE TRANSPORT,0.0137,-0.18826,-0.15805,1,0
2,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,2.1234e-05,-0.18857,-0.21716,1,0
2,GO HORMONE TRANSPORT,3.6162e-06,-0.18895,-0.18315,1,0
2,GO CEREBRAL CORTEX DEVELOPMENT,7.2497e-05,-0.18928,-0.16136,1,0
2,GO NEURON PROJECTION REGENERATION,0.012945,-0.18935,-0.13298,1,0
2,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0016347,-0.19119,-0.16015,1,0
2,GO DEVELOPMENTAL MATURATION,1.3056e-06,-0.19139,-0.19196,1,0
2,GO N GLYCAN PROCESSING,0.01499,-0.19139,-0.19134,1,0
2,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.01016,-0.19152,-0.16654,1,0
2,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00022927,-0.19154,-0.20978,1,0
2,GO CARDIAC CONDUCTION,0.00016098,-0.19179,-0.17155,1,0
2,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.035691,-0.19205,-0.19804,1,0
2,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,8.7316e-05,-0.19214,-0.19981,1,0
2,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.02521,-0.19218,-0.11974,1,0
2,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00015583,-0.1927,-0.17071,1,0
2,GO REGULATION OF INSULIN SECRETION,8.7502e-06,-0.19272,-0.18677,1,0
2,GO ACROSOME ASSEMBLY,0.00014599,-0.19387,-0.25464,1,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0055559,-0.19403,-0.18235,1,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0022095,-0.19418,-0.20137,1,0
2,GO LONG TERM SYNAPTIC POTENTIATION,0.00011033,-0.19495,-0.21036,1,0
2,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00013673,-0.19559,-0.16203,1,0
2,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.035336,-0.19572,-0.10171,1,0
2,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,6.3359e-07,-0.19583,-0.2031,1,0
2,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.00070238,-0.19595,-0.17832,1,0
2,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.0003557,-0.19613,-0.18351,1,0
2,GO REGULATION OF COLLATERAL SPROUTING,0.015501,-0.19617,-0.18407,1,0
2,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00083767,-0.1962,-0.17271,1,0
2,GO RESPONSE TO NERVE GROWTH FACTOR,7.6657e-06,-0.19632,-0.18379,1,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.012087,-0.19654,-0.14123,1,0
2,GO REGULATION OF ACROSOME REACTION,0.00040857,-0.19679,-0.23071,1,0
2,GO SPINAL CORD DEVELOPMENT,0.00010497,-0.19714,-0.18327,1,0
2,GO REGULATION OF CARDIAC CONDUCTION,1.2027e-05,-0.19777,-0.19042,1,0
2,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0076401,-0.19786,-0.17223,1,0
2,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,3.4098e-06,-0.1979,-0.20673,1,0
2,GO REGULATION OF MESODERM DEVELOPMENT,0.0035146,-0.19791,-0.14795,1,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.011151,-0.19814,-0.17209,1,0
2,GO HINDBRAIN DEVELOPMENT,1.8419e-06,-0.19825,-0.21799,1,0
2,GO RESPONSE TO COCAINE,1.7071e-05,-0.19832,-0.20349,1,0
2,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.00013016,-0.1984,-0.17479,1,0
2,GO COCHLEA DEVELOPMENT,0.00030449,-0.19886,-0.17458,1,0
2,GO THALAMUS DEVELOPMENT,0.0012005,-0.19888,-0.2211,1,0
2,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.001955,-0.19925,-0.20175,1,0
2,GO AMINO ACID TRANSPORT,1.8053e-06,-0.19931,-0.19439,1,0
2,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.0032928,-0.19969,-0.19594,1,0
2,GO REGULATION OF POSITIVE CHEMOTAXIS,0.0043184,-0.20018,-0.17547,1,0
2,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,1.8032e-05,-0.20129,-0.20414,1,0
2,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.00054518,-0.20134,-0.21697,1,0
2,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,1.0361e-05,-0.20164,-0.18238,1,0
2,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.00074504,-0.20205,-0.23612,1,0
2,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00040857,-0.20251,-0.15096,1,0
2,GO SEROTONIN SECRETION,0.010522,-0.20302,-0.1611,1,0
2,GO POSITIVE REGULATION OF EXOCYTOSIS,6.2046e-07,-0.20346,-0.21197,1,0
2,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,4.1751e-05,-0.20368,-0.21421,1,0
2,GO BEHAVIOR,3.9822e-07,-0.20374,-0.19978,1,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,4.9069e-08,-0.20378,-0.21429,1,0
2,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,5.4356e-06,-0.20489,-0.17259,1,0
2,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.0043184,-0.20516,-0.17236,1,0
2,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,5.9056e-05,-0.20537,-0.19066,1,0
2,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.0070192,-0.20554,-0.21564,1,0
2,GO ANATOMICAL STRUCTURE REGRESSION,0.00064263,-0.20612,-0.28512,1,0
2,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.0314e-05,-0.20636,-0.21709,1,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.0076401,-0.20686,-0.19006,1,0
2,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.015501,-0.20708,-0.1657,1,0
2,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0032078,-0.20739,-0.13735,1,0
2,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.02174,-0.20745,-0.17641,1,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00059648,-0.20746,-0.16871,1,0
2,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.00027716,-0.20799,-0.19798,1,0
2,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,6.7724e-05,-0.20898,-0.2452,1,0
2,GO NEGATIVE REGULATION OF DNA BINDING,0.0038478,-0.209,-0.13913,1,0
2,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0043737,-0.20927,-0.18411,1,0
2,GO MITOCHONDRION DISTRIBUTION,0.00098255,-0.20954,-0.19951,1,0
2,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00033432,-0.21027,-0.20365,1,0
2,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,4.8198e-07,-0.21172,-0.22947,1,0
2,GO SYNAPSE ORGANIZATION,5.7059e-05,-0.21201,-0.19862,1,0
2,GO POSITIVE REGULATION OF FERTILIZATION,0.0030038,-0.21232,-0.18746,1,0
2,GO ASSOCIATIVE LEARNING,6.545e-05,-0.21242,-0.1819,1,0
2,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00033955,-0.21338,-0.22629,1,0
2,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.011022,-0.21347,-0.19479,1,0
2,GO RESPONSE TO MAGNESIUM ION,0.058787,-0.21368,-0.12192,1,0
2,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.5424e-05,-0.21418,-0.17756,1,0
2,GO POSITIVE REGULATION OF ANION TRANSPORT,7.9617e-06,-0.21426,-0.18972,1,0
2,GO FOREBRAIN CELL MIGRATION,7.6283e-05,-0.21438,-0.18773,1,0
2,GO CELLULAR RESPONSE TO PH,0.0017517,-0.21446,-0.13014,1,0
2,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.0025277,-0.21478,-0.2501,1,0
2,GO RESPONSE TO POTASSIUM ION,0.0022701,-0.21541,-0.21966,1,0
2,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0034692,-0.21565,-0.16495,1,0
2,GO CELL MIGRATION IN HINDBRAIN,0.0031247,-0.21577,-0.2043,1,0
2,GO ENDOCRINE SYSTEM DEVELOPMENT,0.00011596,-0.21788,-0.20821,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.002702,-0.21826,-0.1717,1,0
2,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.022928,-0.21855,-0.15488,1,0
2,GO NEUROMUSCULAR PROCESS,3.9613e-05,-0.21998,-0.18074,1,0
2,GO REGULATION OF POSTSYNAPSE ORGANIZATION,9.819e-05,-0.22004,-0.21621,1,0
2,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.026286,-0.22096,-0.14287,1,0
2,GO ACROSOME REACTION,2.913e-06,-0.22096,-0.23231,1,0
2,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0013443,-0.22176,-0.25555,1,0
2,GO BRANCHING MORPHOGENESIS OF A NERVE,0.021509,-0.22202,-0.17967,1,0
2,GO CELLULAR RESPONSE TO CALCIUM ION,3.152e-06,-0.22277,-0.21924,1,0
2,GO INSULIN SECRETION,4.4807e-06,-0.22318,-0.19798,1,0
2,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0040509,-0.22399,-0.17443,1,0
2,GO DETECTION OF MECHANICAL STIMULUS,0.0067673,-0.22455,-0.1561,1,0
2,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,2.5868e-06,-0.22492,-0.23819,1,0
2,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00060545,-0.22514,-0.1791,1,0
2,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.00159,-0.22533,-0.28009,1,0
2,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.048746,-0.22632,-0.17172,1,0
2,GO MALE MEIOSIS I,0.00011033,-0.22729,-0.26178,1,0
2,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.0022396,-0.22834,-0.20316,1,0
2,GO SECRETORY GRANULE LOCALIZATION,0.00038422,-0.22843,-0.29179,1,0
2,GO DENDRITIC TRANSPORT,0.0028872,-0.22846,-0.18916,1,0
2,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,4.0314e-05,-0.22891,-0.19409,1,0
2,GO CARDIAC ATRIUM DEVELOPMENT,0.0030038,-0.22902,-0.21992,1,0
2,GO PROTEIN KINASE C SIGNALING,4.4771e-05,-0.23102,-0.27788,1,0
2,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.0010408,-0.23108,-0.17515,1,0
2,GO SIALYLATION,0.007921,-0.23109,-0.20089,1,0
2,GO SECONDARY PALATE DEVELOPMENT,0.00021511,-0.23124,-0.2521,1,0
2,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,1.7693e-06,-0.23187,-0.21858,1,0
2,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,4.9694e-05,-0.2327,-0.2808,1,0
2,GO DORSAL AORTA DEVELOPMENT,0.0038478,-0.23281,-0.18718,1,0
2,GO SIGNAL RELEASE,1.0322e-07,-0.23346,-0.20267,1,0
2,GO REGULATION OF PEPTIDE HORMONE SECRETION,1.7534e-07,-0.2338,-0.23488,1,0
2,GO CEREBELLAR CORTEX MORPHOGENESIS,1.0756e-05,-0.23434,-0.23124,1,0
2,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0046604,-0.23437,-0.20733,1,0
2,GO ATRIAL SEPTUM MORPHOGENESIS,0.0063654,-0.23493,-0.27243,1,0
2,GO COPULATION,0.0012527,-0.23682,-0.19255,1,0
2,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00092737,-0.23705,-0.22603,1,0
2,GO INTRACILIARY TRANSPORT,0.0012177,-0.23862,-0.21766,1,0
2,GO MAINTENANCE OF CELL POLARITY,1.9749e-05,-0.23888,-0.27756,1,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00098255,-0.23924,-0.26218,1,0
2,GO REGULATION OF CGMP MEDIATED SIGNALING,0.001422,-0.23927,-0.26808,1,0
2,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,3.8246e-05,-0.24016,-0.23002,1,0
2,GO METENCEPHALON DEVELOPMENT,6.4699e-07,-0.24029,-0.23935,1,0
2,GO REGULATION OF TUBULIN DEACETYLATION,0.0030038,-0.24031,-0.22827,1,0
2,GO HORMONE CATABOLIC PROCESS,0.0084096,-0.24088,-0.21405,1,0
2,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.004964,-0.24118,-0.20312,1,0
2,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.4741e-05,-0.24254,-0.23493,1,0
2,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,4.0314e-05,-0.24529,-0.22045,1,0
2,GO MICROTUBULE DEPOLYMERIZATION,2.971e-06,-0.24537,-0.28384,1,0
2,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.0062877,-0.24613,-0.2279,1,0
2,GO GROOMING BEHAVIOR,1.1588e-05,-0.24726,-0.25973,1,0
2,GO NEUROTRANSMITTER UPTAKE,0.0044298,-0.24849,-0.17341,1,0
2,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.00020504,-0.24862,-0.29243,1,0
2,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,4.7488e-06,-0.2488,-0.22283,1,0
2,GO REGULATION OF MICROTUBULE BINDING,2.1338e-07,-0.25033,-0.30807,1,0
2,GO POTASSIUM ION TRANSPORT,2.1807e-07,-0.25085,-0.23606,1,0
2,GO LUNG EPITHELIUM DEVELOPMENT,0.013243,-0.25282,-0.20782,1,0
2,GO VITAMIN CATABOLIC PROCESS,0.0052854,-0.25308,-0.22995,1,0
2,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,3.5022e-05,-0.25395,-0.22155,1,0
2,GO PROTEIN POLYGLUTAMYLATION,1.0169e-05,-0.25619,-0.26792,1,0
2,GO LEARNING,1.3196e-05,-0.25657,-0.22696,1,0
2,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.000286,-0.25704,-0.2412,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.00055343,-0.25725,-0.30361,1,0
2,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,1.8318e-07,-0.25746,-0.25449,1,0
2,GO PEPTIDE HORMONE SECRETION,1.2058e-07,-0.25774,-0.23792,1,0
2,GO MULTICELLULAR ORGANISMAL SIGNALING,3.5461e-06,-0.25859,-0.2174,1,0
2,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0020367,-0.2586,-0.25793,1,0
2,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.00099681,-0.26131,-0.27679,1,0
2,GO SECRETORY GRANULE ORGANIZATION,4.5233e-07,-0.2622,-0.27586,1,0
2,GO MICROTUBULE BUNDLE FORMATION,5.3562e-07,-0.26354,-0.25954,1,0
2,GO NEURON MIGRATION,6.8396e-06,-0.26355,-0.24873,1,0
2,GO MAST CELL MIGRATION,0.026838,-0.26423,-0.1649,1,0
2,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,5.0323e-06,-0.26444,-0.27131,1,0
2,GO REGULATION OF EXOCYTOSIS,2.3891e-06,-0.26571,-0.21647,1,0
2,GO DIVALENT METAL ION EXPORT,0.00029052,-0.26581,-0.23847,1,0
2,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.0011668,-0.26608,-0.21574,1,0
2,GO SYNAPSE ASSEMBLY,5.7582e-06,-0.26647,-0.24903,1,0
2,GO POSITIVE REGULATION OF AXONOGENESIS,5.2344e-05,-0.26704,-0.2233,1,0
2,GO AMMONIUM ION METABOLIC PROCESS,4.0657e-06,-0.26809,-0.30938,1,0
2,GO AMINE BIOSYNTHETIC PROCESS,4.1026e-05,-0.26812,-0.22126,1,0
2,GO TYPE B PANCREATIC CELL PROLIFERATION,7.5001e-05,-0.26966,-0.3512,1,0
2,GO MULTICELLULAR ORGANISMAL MOVEMENT,5.9834e-06,-0.27047,-0.24599,1,0
2,GO CEREBELLAR CORTEX DEVELOPMENT,2.0879e-07,-0.27128,-0.26564,1,0
2,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0104,-0.27204,-0.18723,1,0
2,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.039795,-0.27245,-0.16523,1,0
2,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,6.1119e-05,-0.27316,-0.24441,1,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00018323,-0.27405,-0.22631,1,0
2,GO REGULATION OF CILIUM MOVEMENT,2.4972e-05,-0.27467,-0.20287,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,3.5606e-08,-0.27518,-0.28074,1,0
2,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.00013899,-0.27563,-0.32269,1,0
2,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.004156,-0.27854,-0.19875,1,0
2,GO NEURON PROJECTION ARBORIZATION,8.4424e-05,-0.2793,-0.26234,1,0
2,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,4.2042e-09,-0.28048,-0.31075,1,0
2,GO REGULATION OF SYNAPSE MATURATION,0.00015838,-0.2806,-0.34626,1,0
2,GO REGULATION OF NERVOUS SYSTEM PROCESS,9.2321e-08,-0.28064,-0.28138,1,0
2,GO REGULATION OF MEMBRANE POTENTIAL,4.9069e-08,-0.28065,-0.25503,1,0
2,GO MEMBRANE DEPOLARIZATION,3.7356e-07,-0.28269,-0.27585,1,0
2,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,7.5001e-05,-0.28297,-0.24913,1,0
2,GO LONG TERM SYNAPTIC DEPRESSION,4.2271e-06,-0.28301,-0.29041,1,0
2,GO CGMP METABOLIC PROCESS,0.001235,-0.28304,-0.26616,1,0
2,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,6.7105e-06,-0.28348,-0.27142,1,0
2,GO ADULT LOCOMOTORY BEHAVIOR,3.8149e-08,-0.28366,-0.28343,1,0
2,GO MAINTENANCE OF SYNAPSE STRUCTURE,9.1829e-05,-0.28384,-0.30857,1,0
2,GO MEMBRANE BIOGENESIS,7.5001e-05,-0.2839,-0.25096,1,0
2,GO SEQUESTERING OF ACTIN MONOMERS,0.0066039,-0.28644,-0.24804,1,0
2,GO NEUROPEPTIDE SIGNALING PATHWAY,2.8262e-08,-0.28659,-0.28688,1,0
2,GO EXCITATORY SYNAPSE ASSEMBLY,3.094e-05,-0.28883,-0.30745,1,0
2,GO PRESYNAPSE ORGANIZATION,1.0004e-06,-0.28907,-0.31091,1,0
2,GO EXPLORATION BEHAVIOR,2.65e-07,-0.29029,-0.35175,1,0
2,GO NEUROTRANSMITTER METABOLIC PROCESS,3.152e-06,-0.29029,-0.29436,1,0
2,GO RESPONSE TO ACETYLCHOLINE,0.00020504,-0.29047,-0.2524,1,0
2,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.00010152,-0.29053,-0.33232,1,0
2,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.00016361,-0.29098,-0.32801,1,0
2,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,4.0657e-06,-0.29147,-0.33465,1,0
2,GO NEURON RECOGNITION,3.758e-05,-0.29236,-0.26454,1,0
2,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,2.1807e-07,-0.29253,-0.30567,1,0
2,GO NEUROTRANSMITTER REUPTAKE,0.00026858,-0.29405,-0.2346,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,5.6245e-08,-0.29561,-0.31182,1,0
2,GO VESICLE DOCKING,1.8573e-08,-0.29689,-0.26887,1,0
2,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,4.0657e-06,-0.29696,-0.30512,1,0
2,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0015463,-0.29736,-0.28864,1,0
2,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.001118,-0.2979,-0.21448,1,0
2,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.00058763,-0.29802,-0.24445,1,0
2,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,6.0079e-05,-0.3002,-0.27496,1,0
2,GO LOCOMOTORY BEHAVIOR,3.1729e-08,-0.30023,-0.27863,1,0
2,GO PROTEIN PALMITOYLATION,7.969e-07,-0.30141,-0.28301,1,0
2,GO SYNAPTIC VESICLE TRANSPORT,3.2859e-07,-0.30153,-0.28622,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,2.6828e-05,-0.30181,-0.31793,1,0
2,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,1.9136e-07,-0.3029,-0.31128,1,0
2,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.0001179,-0.30429,-0.29153,1,0
2,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.00096848,-0.3047,-0.20836,1,0
2,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,1.3174e-07,-0.30528,-0.30358,1,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.0020646,-0.30544,-0.26054,1,0
2,GO NEURAL NUCLEUS DEVELOPMENT,1.1282e-07,-0.3068,-0.32109,1,0
2,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,7.105e-06,-0.30859,-0.29554,1,0
2,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,4.0678e-07,-0.30921,-0.3265,1,0
2,GO OPTIC NERVE DEVELOPMENT,3.0302e-06,-0.30929,-0.37694,1,0
2,GO REGULATION OF NEUROTRANSMITTER UPTAKE,9.819e-05,-0.30937,-0.25207,1,0
2,GO MYELIN MAINTENANCE,0.00032916,-0.31009,-0.31005,1,0
2,GO REGULATION OF SYNAPTIC PLASTICITY,5.6245e-08,-0.31041,-0.30906,1,0
2,GO LUNG ALVEOLUS DEVELOPMENT,0.0016122,-0.31067,-0.25005,1,0
2,GO REGULATION OF AMINO ACID TRANSPORT,7.2129e-08,-0.31187,-0.30454,1,0
2,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0013069,-0.3119,-0.28847,1,0
2,GO SYNAPTIC SIGNALING,1.5753e-08,-0.31284,-0.28737,1,0
2,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,1.4112e-09,-0.3131,-0.35479,1,0
2,GO CELL DIFFERENTIATION IN HINDBRAIN,1.2032e-06,-0.31324,-0.29802,1,0
2,GO NEURON MATURATION,1.2482e-05,-0.31432,-0.24021,1,0
2,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.00018923,-0.31472,-0.26168,1,0
2,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,5.3747e-08,-0.31514,-0.29089,1,0
2,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.3312e-10,-0.31573,-0.31879,1,0
2,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,4.1552e-07,-0.3175,-0.29365,1,0
2,GO PROTEIN LOCALIZATION TO SYNAPSE,8.6328e-08,-0.31811,-0.35108,1,0
2,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.1806e-05,-0.31934,-0.27112,1,0
2,GO ATRIAL SEPTUM DEVELOPMENT,0.0016575,-0.32032,-0.29863,1,0
2,GO DIENCEPHALON DEVELOPMENT,5.1356e-08,-0.32152,-0.33714,1,0
2,GO NEURON CELLULAR HOMEOSTASIS,1.3693e-05,-0.32192,-0.3226,1,0
2,GO CELL FATE DETERMINATION,1.6457e-05,-0.32224,-0.24752,1,0
2,GO RAB PROTEIN SIGNAL TRANSDUCTION,4.9694e-05,-0.32225,-0.28253,1,0
2,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.00083767,-0.32395,-0.23917,1,0
2,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00048316,-0.32437,-0.28197,1,0
2,GO SUCKLING BEHAVIOR,6.4341e-05,-0.32832,-0.31161,1,0
2,GO PARENTAL BEHAVIOR,3.0905e-06,-0.32856,-0.33922,1,0
2,GO RESPONSE TO MUSCLE STRETCH,0.00029052,-0.329,-0.29444,1,0
2,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00022565,-0.32946,-0.28863,1,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0043737,-0.32951,-0.24912,1,0
2,GO ACIDIC AMINO ACID TRANSPORT,2.1375e-08,-0.33027,-0.31,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,5.4356e-06,-0.33248,-0.36104,1,0
2,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,1.8793e-06,-0.33357,-0.30678,1,0
2,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,4.6359e-05,-0.33425,-0.32319,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,1.9563e-06,-0.33598,-0.3316,1,0
2,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,4.4771e-05,-0.33628,-0.24037,1,0
2,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,5.4701e-07,-0.33633,-0.42777,1,0
2,GO INCLUSION BODY ASSEMBLY,6.4592e-06,-0.33662,-0.32295,1,0
2,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,1.9393e-05,-0.33736,-0.33773,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,1.5576e-05,-0.33754,-0.34505,1,0
2,GO REGULATION OF REGULATED SECRETORY PATHWAY,1.4076e-07,-0.33839,-0.29576,1,0
2,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,3.4098e-06,-0.33844,-0.27504,1,0
2,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,1.6654e-06,-0.3396,-0.343,1,0
2,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.001955,-0.33991,-0.2668,1,0
2,GO CEREBELLAR CORTEX FORMATION,5.7051e-07,-0.34043,-0.30274,1,0
2,GO SYNAPTIC VESICLE LOCALIZATION,1.536e-06,-0.34176,-0.34273,1,0
2,GO SYNAPTIC VESICLE RECYCLING,2.8925e-08,-0.34642,-0.32714,1,0
2,GO AXONEME ASSEMBLY,7.6446e-07,-0.34712,-0.32666,1,0
2,GO GAMMA AMINOBUTYRIC ACID SECRETION,5.6245e-08,-0.34876,-0.36978,1,0
2,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,1.0169e-05,-0.34942,-0.34181,1,0
2,GO NERVE DEVELOPMENT,3.357e-07,-0.35014,-0.32558,1,0
2,GO NOTCH RECEPTOR PROCESSING,6.7724e-05,-0.35098,-0.29156,1,0
2,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,2.1234e-05,-0.35156,-0.25524,1,0
2,GO LEYDIG CELL DIFFERENTIATION,0.026561,-0.35166,-0.3035,1,0
2,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,2.5164e-08,-0.35289,-0.3349,1,0
2,GO RESPONSE TO DIETARY EXCESS,1.0861e-06,-0.35353,-0.3567,1,0
2,GO ADULT BEHAVIOR,3.7195e-09,-0.35365,-0.32457,1,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,2.9602e-08,-0.35382,-0.34115,1,0
2,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,3.628e-05,-0.35496,-0.30125,1,0
2,GO EXOCYTIC PROCESS,3.1729e-08,-0.3551,-0.30669,1,0
2,GO REGULATION OF TRANS SYNAPTIC SIGNALING,1.2434e-08,-0.35583,-0.31744,1,0
2,GO REGULATION OF INCLUSION BODY ASSEMBLY,6.4341e-05,-0.35617,-0.3377,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,1.5674e-06,-0.35878,-0.38859,1,0
2,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.6994e-06,-0.36049,-0.32394,1,0
2,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,2.1196e-06,-0.36558,-0.41061,1,0
2,GO TELENCEPHALON REGIONALIZATION,1.8701e-05,-0.36566,-0.36575,1,0
2,GO REGULATION OF VESICLE FUSION,2.6352e-05,-0.36735,-0.30176,1,0
2,GO LUNG CELL DIFFERENTIATION,0.0087156,-0.36799,-0.26272,1,0
2,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,5.3562e-07,-0.36805,-0.38365,1,0
2,GO RESPONSE TO FORSKOLIN,0.00042777,-0.37029,-0.3017,1,0
2,GO RECEPTOR LOCALIZATION TO SYNAPSE,4.6202e-07,-0.37081,-0.33349,1,0
2,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,2.4371e-06,-0.37136,-0.30672,1,0
2,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,3.2094e-09,-0.37272,-0.38525,1,0
2,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.9989e-07,-0.37306,-0.35605,1,0
2,GO SPERM AXONEME ASSEMBLY,8.1623e-05,-0.37434,-0.273,1,0
2,GO TOXIN METABOLIC PROCESS,7.6283e-05,-0.37462,-0.29341,1,0
2,GO DORSAL VENTRAL PATTERN FORMATION,1.2281e-06,-0.37568,-0.30882,1,0
2,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.1307e-08,-0.37684,-0.32946,1,0
2,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,1.0554e-07,-0.37874,-0.36534,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.9014e-08,-0.38052,-0.41317,1,0
2,GO UTERINE SMOOTH MUSCLE CONTRACTION,9.2321e-08,-0.38103,-0.39674,1,0
2,GO PRESYNAPTIC ENDOCYTOSIS,5.1356e-08,-0.38115,-0.34338,1,0
2,GO REGULATION OF PROTEIN KINASE C SIGNALING,6.2046e-07,-0.38403,-0.47508,1,0
2,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,5.3647e-09,-0.38588,-0.33838,1,0
2,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.6654e-06,-0.38784,-0.39033,1,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,1.064e-06,-0.38984,-0.38979,1,0
2,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,4.0657e-06,-0.39225,-0.39279,1,0
2,GO REGULATION OF PRESYNAPSE ORGANIZATION,1.6321e-06,-0.39226,-0.35316,1,0
2,GO NEUROEPITHELIAL CELL DIFFERENTIATION,2.971e-06,-0.39537,-0.32126,1,0
2,GO DETECTION OF TEMPERATURE STIMULUS,1.1282e-07,-0.39628,-0.46805,1,0
2,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,1.1316e-06,-0.39829,-0.37207,1,0
2,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,4.7501e-09,-0.40538,-0.38132,1,0
2,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,1.0212e-06,-0.40681,-0.3622,1,0
2,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,1.2058e-07,-0.40791,-0.36924,1,0
2,GO ADRENAL GLAND DEVELOPMENT,3.0156e-07,-0.41102,-0.40584,1,0
2,GO CALCIUM ION IMPORT INTO CYTOSOL,7.3772e-08,-0.41109,-0.4076,1,0
2,GO ENDOTHELIAL CELL MORPHOGENESIS,0.034636,-0.4115,-0.18338,1,0
2,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,8.2543e-08,-0.41174,-0.42385,1,0
2,GO REGULATION OF NEUROTRANSMITTER LEVELS,2.188e-08,-0.41261,-0.36078,1,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,4.7999e-05,-0.41424,-0.35368,1,0
2,GO INHIBITORY SYNAPSE ASSEMBLY,1.1165e-05,-0.41748,-0.35251,1,0
2,GO REGULATION OF NEURON PROJECTION ARBORIZATION,9.795e-06,-0.41984,-0.35746,1,0
2,GO RESPONSE TO LITHIUM ION,9.2118e-07,-0.42082,-0.38785,1,0
2,GO FOREBRAIN REGIONALIZATION,4.3082e-09,-0.42132,-0.43835,1,0
2,GO CATECHOLAMINE METABOLIC PROCESS,1.5688e-10,-0.42276,-0.44423,1,0
2,GO NOREPINEPHRINE SECRETION,4.3082e-09,-0.42369,-0.39679,1,0
2,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,1.0036e-08,-0.42522,-0.39503,1,0
2,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,1.8573e-08,-0.42562,-0.38771,1,0
2,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,1.0094e-07,-0.42646,-0.44879,1,0
2,GO TRANSMISSION OF NERVE IMPULSE,4.4148e-09,-0.42927,-0.39401,1,0
2,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,5.0278e-07,-0.43789,-0.43743,1,0
2,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.1274e-05,-0.43964,-0.40582,1,0
2,GO NEUROTRANSMITTER TRANSPORT,3.9941e-08,-0.44366,-0.38391,1,0
2,GO NEURON FATE COMMITMENT,6.7411e-08,-0.44482,-0.40631,1,0
2,GO CATECHOLAMINE UPTAKE,4.4787e-08,-0.44732,-0.40947,1,0
2,GO GLUTAMATE SECRETION,1.0527e-08,-0.45264,-0.42201,1,0
2,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,9.9803e-06,-0.45337,-0.43141,1,0
2,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,4.4787e-08,-0.45377,-0.41194,1,0
2,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,5.2253e-10,-0.45621,-0.47387,1,0
2,GO PROTEIN LOCALIZATION TO AXON,5.6085e-05,-0.45672,-0.45143,1,0
2,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,2.206e-06,-0.45851,-0.41445,1,0
2,GO DETECTION OF CALCIUM ION,1.3039e-08,-0.45966,-0.45565,1,0
2,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.4982e-08,-0.46344,-0.44218,1,0
2,GO STARTLE RESPONSE,1.6129e-08,-0.46529,-0.45635,1,0
2,GO NOREPINEPHRINE TRANSPORT,4.9872e-09,-0.46533,-0.3793,1,0
2,GO NEURONAL ACTION POTENTIAL,4.719e-07,-0.47058,-0.39245,1,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,5.9116e-09,-0.47264,-0.46799,1,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.00010152,-0.47361,-0.41268,1,0
2,GO SYNAPSE MATURATION,1.8318e-07,-0.48134,-0.5279,1,0
2,GO SYNAPTIC MEMBRANE ADHESION,2.9805e-09,-0.49004,-0.55263,1,0
2,GO POSTSYNAPSE ASSEMBLY,1.3468e-07,-0.49202,-0.48816,1,0
2,GO DENSE CORE GRANULE TRANSPORT,2.8886e-07,-0.49331,-0.52141,1,0
2,GO NEUROTRANSMITTER SECRETION,3.4796e-08,-0.49785,-0.42463,1,0
2,GO PRESYNAPTIC MEMBRANE ORGANIZATION,7.1819e-07,-0.49787,-0.50604,1,0
2,GO SPINAL CORD PATTERNING,1.8723e-07,-0.49822,-0.46023,1,0
2,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,8.5867e-06,-0.49967,-0.4229,1,0
2,GO DOPAMINE METABOLIC PROCESS,2.1543e-10,-0.50307,-0.47848,1,0
2,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00070238,-0.50549,-0.40986,1,0
2,GO SYNAPTIC VESICLE EXOCYTOSIS,6.5906e-08,-0.50577,-0.43825,1,0
2,GO DENDRITE EXTENSION,2.4452e-09,-0.50852,-0.4692,1,0
2,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,3.9822e-07,-0.51101,-0.45295,1,0
2,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,1.5014e-05,-0.51238,-0.41736,1,0
2,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,1.0781e-08,-0.51419,-0.41712,1,0
2,GO REGULATION OF SYNAPTIC VESICLE CYCLE,1.6782e-07,-0.51973,-0.43085,1,0
2,GO SYNAPTIC VESICLE PRIMING,1.8723e-07,-0.52881,-0.51513,1,0
2,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00014599,-0.53071,-0.39643,1,0
2,GO PREPULSE INHIBITION,7.969e-07,-0.53231,-0.5212,1,0
2,GO RESPONSE TO AUDITORY STIMULUS,5.9498e-07,-0.53727,-0.45263,1,0
2,GO SUBPALLIUM DEVELOPMENT,3.8118e-09,-0.53897,-0.5078,1,0
2,GO GLIAL CELL FATE COMMITMENT,3.9102e-06,-0.54106,-0.49755,1,0
2,GO NEURONAL ION CHANNEL CLUSTERING,6.0205e-08,-0.54355,-0.53068,1,0
2,GO NEGATIVE REGULATION OF AMINE TRANSPORT,4.1456e-06,-0.55214,-0.46559,1,0
2,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,9.1996e-11,-0.55514,-0.52632,1,0
2,GO AMINE TRANSPORT,6.0979e-10,-0.55937,-0.49823,1,0
2,GO REGULATION OF GLUTAMATE SECRETION,1.1858e-08,-0.56176,-0.4704,1,0
2,GO NEURON FATE SPECIFICATION,9.5999e-07,-0.57043,-0.44798,1,0
2,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,9.7998e-07,-0.57116,-0.53705,1,0
2,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,7.969e-07,-0.58814,-0.54495,1,0
2,GO SECONDARY HEART FIELD SPECIFICATION,1.4454e-06,-0.58947,-0.57029,1,0
2,GO MONOAMINE TRANSPORT,3.8301e-10,-0.59177,-0.53878,1,0
2,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,9.2321e-08,-0.59282,-0.50445,1,0
2,GO RESPONSE TO INSECTICIDE,1.2682e-10,-0.60262,-0.57308,1,0
2,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,3.5461e-06,-0.61387,-0.57417,1,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,6.5906e-08,-0.61413,-0.47473,1,0
2,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.9558e-07,-0.61582,-0.57956,1,0
2,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,7.0017e-09,-0.61911,-0.48883,1,0
2,GO POSITIVE REGULATION OF AMINE TRANSPORT,2.559e-11,-0.62013,-0.60038,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,1.3039e-08,-0.62349,-0.58518,1,0
2,GO STABILIZATION OF MEMBRANE POTENTIAL,6.8348e-09,-0.62656,-0.59656,1,0
2,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.1097e-10,-0.63648,-0.63845,1,0
2,GO REGULATION OF DENDRITE EXTENSION,3.1098e-10,-0.63935,-0.60276,1,0
2,GO DOPAMINE BIOSYNTHETIC PROCESS,5.6317e-09,-0.64343,-0.61078,1,0
2,GO VOCALIZATION BEHAVIOR,9.2321e-08,-0.64418,-0.57456,1,0
2,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,3.1098e-10,-0.64578,-0.60764,1,0
2,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,7.4177e-11,-0.652,-0.67975,1,0
2,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.206e-06,-0.65891,-0.52536,1,0
2,GO INHIBITORY POSTSYNAPTIC POTENTIAL,6.2565e-10,-0.66192,-0.65165,1,0
2,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,1.5753e-08,-0.66625,-0.57701,1,0
2,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.2131e-09,-0.67055,-0.64176,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS,1.6986e-10,-0.67088,-0.6093,1,0
2,GO DOPAMINE TRANSPORT,1.8135e-09,-0.67589,-0.63024,1,0
2,GO DORSAL SPINAL CORD DEVELOPMENT,6.6581e-11,-0.6782,-0.63559,1,0
2,GO SYNAPTIC VESICLE CLUSTERING,2.4528e-05,-0.68506,-0.54861,1,0
2,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,9.4499e-11,-0.68931,-0.64444,1,0
2,GO CATECHOLAMINE SECRETION,2.1595e-09,-0.68988,-0.62313,1,0
2,GO INNERVATION,2.3312e-10,-0.70253,-0.69381,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,3.4296e-07,-0.7094,-0.56902,1,0
2,GO GROWTH HORMONE SECRETION,6.8406e-11,-0.71059,-0.65652,1,0
2,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.2565e-10,-0.71749,-0.62981,1,0
2,GO NEURON CELL CELL ADHESION,7.0017e-09,-0.72689,-0.67986,1,0
2,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,9.9705e-11,-0.72832,-0.70861,1,0
2,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.5052e-06,-0.74046,-0.57214,1,0
2,GO VESICLE FUSION TO PLASMA MEMBRANE,2.9514e-07,-0.74226,-0.60744,1,0
2,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,8.0712e-08,-0.74553,-0.70463,1,0
2,GO GANGLION DEVELOPMENT,4.0033e-09,-0.7559,-0.65975,1,0
2,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,1.3505e-11,-0.75837,-0.73958,1,0
2,GO REGULATION OF DOPAMINE SECRETION,8.2543e-08,-0.76326,-0.68599,1,0
2,GO SYNAPTIC VESICLE DOCKING,3.1004e-08,-0.7646,-0.65791,1,0
2,GO SYNAPTIC VESICLE MATURATION,2.5066e-09,-0.7693,-0.70538,1,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,1.0964e-09,-0.77356,-0.74247,1,0
2,GO NOSE DEVELOPMENT,1.9989e-07,-0.78207,-0.58137,1,0
2,GO MECHANOSENSORY BEHAVIOR,3.2859e-07,-0.80114,-0.65565,1,0
2,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,1.1535e-07,-0.85353,-0.678,1,0
2,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,5.0922e-10,-0.89978,-0.86662,1,0
2,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,1.5102e-11,-0.90127,-0.80665,1,0
2,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,9.9705e-11,-0.90664,-0.84857,1,0
2,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,3.055e-09,-1.0156,-0.90853,1,0
2,GO GABAERGIC NEURON DIFFERENTIATION,1.0804e-10,-1.0862,-0.9803,1,0
2,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,6.7105e-06,-1.1842,-0.86453,1,0
2,GO FOREBRAIN NEURON FATE COMMITMENT,6.4805e-11,-1.2442,-1.1894,1,0
2,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.061549,0.37947,0.216,0,1
2,GO REGULATION OF HIPPO SIGNALING,0.060432,0.32965,0.14701,0,1
2,GO REGULATION OF METANEPHROS DEVELOPMENT,0.068619,0.2938,0.18857,0,1
2,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.093126,0.27917,0.13835,0,1
2,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.065005,0.27184,0.14547,0,1
2,GO CELLULAR RESPONSE TO ZINC ION,0.17156,0.26321,0.20784,0,1
2,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.062684,0.25442,0.1603,0,1
2,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.14197,0.24811,0.19711,0,1
2,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.10912,0.24697,0.11567,0,1
2,GO LABYRINTHINE LAYER MORPHOGENESIS,0.075009,0.24546,0.15325,0,1
2,GO DENDRITIC CELL DIFFERENTIATION,0.081168,0.24007,0.12172,0,1
2,GO LEUKOCYTE AGGREGATION,0.30255,0.23407,0.074463,0,1
2,GO DETECTION OF OTHER ORGANISM,0.066792,0.23184,0.14903,0,1
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.11553,0.23127,0.1113,0,1
2,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.090011,0.22918,0.12145,0,1
2,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.096327,0.21688,0.14338,0,1
2,GO PEPTIDYL PROLINE HYDROXYLATION,0.14088,0.21083,0.097198,0,1
2,GO RESPONSE TO HYDROPEROXIDE,0.12822,0.20608,0.13477,0,1
2,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.11275,0.20527,0.18884,0,1
2,GO LATERAL MESODERM DEVELOPMENT,0.38933,0.19694,0.072192,0,1
2,GO BEHAVIORAL RESPONSE TO PAIN,0.20122,0.19681,0.12964,0,1
2,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.18595,0.19307,0.15515,0,1
2,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.073694,0.19028,0.14328,0,1
2,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.40514,0.19023,0.031534,0,1
2,GO REGULATION OF GASTRULATION,0.16163,0.18883,0.093123,0,1
2,GO SKELETAL MUSCLE CELL PROLIFERATION,0.12029,0.18279,0.15451,0,1
2,GO POSITIVE REGULATION OF WOUND HEALING,0.087731,0.17965,0.12099,0,1
2,GO RENAL ABSORPTION,0.54477,0.1767,0.040166,0,1
2,GO HETEROTYPIC CELL CELL ADHESION,0.13979,0.17527,0.079399,0,1
2,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.085497,0.17225,0.15756,0,1
2,GO INTESTINAL ABSORPTION,0.10129,0.1717,0.11559,0,1
2,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.11002,0.17107,0.14875,0,1
2,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.13656,0.17,0.06517,0,1
2,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.1873,0.16795,0.11978,0,1
2,GO POSITIVE REGULATION OF HAIR CYCLE,0.13027,0.16749,0.14117,0,1
2,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.1453,0.16539,0.095905,0,1
2,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.062114,0.16494,0.12574,0,1
2,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.37608,0.16346,0.052354,0,1
2,GO ADHESION OF SYMBIONT TO HOST,0.19003,0.16296,0.093835,0,1
2,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.072397,0.16277,0.15688,0,1
2,GO LEUKOCYTE HOMEOSTASIS,0.087731,0.15971,0.080391,0,1
2,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.22195,0.15937,0.071545,0,1
2,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.36311,0.1577,0.056443,0,1
2,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.22195,0.15764,0.085906,0,1
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.093126,0.15742,0.11443,0,1
2,GO BRONCHUS DEVELOPMENT,0.18595,0.15697,0.094453,0,1
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.066792,0.15691,0.11079,0,1
2,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.16163,0.15633,0.1094,0,1
2,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.066792,0.15557,0.10088,0,1
2,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.10823,0.15165,0.10798,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.20992,0.15074,0.084553,0,1
2,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42133,0.15049,0.034864,0,1
2,GO GRANULOCYTE MIGRATION,0.066792,0.15048,0.096726,0,1
2,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.20992,0.14954,0.089006,0,1
2,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.13656,0.14658,0.086537,0,1
2,GO RESPONSE TO DEXAMETHASONE,0.10129,0.14639,0.10859,0,1
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.12224,0.14601,0.084414,0,1
2,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.063836,0.14595,0.097795,0,1
2,GO TONGUE DEVELOPMENT,0.10471,0.14463,0.11649,0,1
2,GO ANTIBACTERIAL HUMORAL RESPONSE,0.077698,0.14388,0.093428,0,1
2,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.37608,0.14374,0.063663,0,1
2,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.16285,0.14201,0.08303,0,1
2,GO REGULATION OF MACROPHAGE MIGRATION,0.064418,0.14066,0.10549,0,1
2,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.21437,0.14045,0.14778,0,1
2,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.12721,0.14,0.099702,0,1
2,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.081168,0.13983,0.077562,0,1
2,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.098784,0.13892,0.092632,0,1
2,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.099614,0.13856,0.086093,0,1
2,GO ENAMEL MINERALIZATION,0.071119,0.13794,0.19883,0,1
2,GO NEPHRON EPITHELIUM DEVELOPMENT,0.13444,0.13627,0.079709,0,1
2,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.10471,0.13593,0.089611,0,1
2,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.066192,0.13572,0.097406,0,1
2,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.068006,0.1357,0.099682,0,1
2,GO PLASMA MEMBRANE FUSION,0.12126,0.13515,0.11765,0,1
2,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.075009,0.13487,0.069833,0,1
2,GO HISTONE MONOUBIQUITINATION,0.1252,0.13303,0.056391,0,1
2,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.27317,0.13294,0.076515,0,1
2,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.092339,0.13248,0.089254,0,1
2,GO INTERMEMBRANE LIPID TRANSFER,0.071756,0.13188,0.10046,0,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.15683,0.13176,0.078459,0,1
2,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.20409,0.13088,0.064398,0,1
2,GO METANEPHROS DEVELOPMENT,0.069238,0.13062,0.10052,0,1
2,GO SKIN DEVELOPMENT,0.093918,0.13038,0.11886,0,1
2,GO RESPONSE TO RETINOIC ACID,0.25078,0.12794,0.061785,0,1
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.25753,0.12785,0.07378,0,1
2,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.080464,0.12779,0.086327,0,1
2,GO EMBRYONIC PLACENTA DEVELOPMENT,0.2458,0.12738,0.05032,0,1
2,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.11367,0.12699,0.069332,0,1
2,GO BONE GROWTH,0.069238,0.1267,0.14334,0,1
2,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.35043,0.12661,0.054724,0,1
2,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.35253,0.12519,0.05284,0,1
2,GO ACTIN FILAMENT BASED PROCESS,0.1793,0.1244,0.047927,0,1
2,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.064418,0.12437,0.1222,0,1
2,GO ACTIN FILAMENT BASED MOVEMENT,0.087731,0.12404,0.071224,0,1
2,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.14197,0.12403,0.13489,0,1
2,GO APICAL JUNCTION ASSEMBLY,0.25583,0.12396,0.053573,0,1
2,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.42133,0.12387,0.049821,0,1
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.16778,0.12371,0.077091,0,1
2,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.54477,0.12355,0.029271,0,1
2,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.11367,0.12312,0.1373,0,1
2,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.13656,0.12264,0.087037,0,1
2,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.1387,0.12244,0.08302,0,1
2,GO STRESS FIBER ASSEMBLY,0.32393,0.12215,0.056938,0,1
2,GO GLOMERULUS DEVELOPMENT,0.16654,0.12214,0.10848,0,1
2,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.075009,0.12166,0.092544,0,1
2,GO REGULATORY T CELL DIFFERENTIATION,0.13338,0.12142,0.1073,0,1
2,GO REGULATION OF PEPTIDASE ACTIVITY,0.15802,0.12137,0.064834,0,1
2,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.11647,0.12104,0.097246,0,1
2,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.094715,0.12053,0.10764,0,1
2,GO LEUKOCYTE CHEMOTAXIS,0.060432,0.11996,0.080858,0,1
2,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.38047,0.11981,0.038068,0,1
2,GO MYELOID LEUKOCYTE MIGRATION,0.11553,0.11967,0.071123,0,1
2,GO FIBROBLAST PROLIFERATION,0.26267,0.1196,0.065275,0,1
2,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.10823,0.11877,0.090933,0,1
2,GO HYPEROSMOTIC SALINITY RESPONSE,0.18062,0.1187,0.086213,0,1
2,GO FATTY ACID CATABOLIC PROCESS,0.18327,0.1174,0.050253,0,1
2,GO CELL CHEMOTAXIS,0.074349,0.11739,0.077824,0,1
2,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.42133,0.11724,0.036773,0,1
2,GO RESPONSE TO COPPER ION,0.084763,0.1167,0.14261,0,1
2,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.22348,0.11645,0.092204,0,1
2,GO INFLAMMATORY RESPONSE,0.14197,0.11611,0.062351,0,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.18461,0.11502,0.09,0,1
2,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.3442,0.11499,0.056829,0,1
2,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.14755,0.11483,0.096823,0,1
2,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.3871,0.11377,0.042495,0,1
2,GO COPII COATED VESICLE CARGO LOADING,0.10471,0.11359,0.062778,0,1
2,GO STEM CELL DIFFERENTIATION,0.10471,0.1134,0.074294,0,1
2,GO RNA DESTABILIZATION,0.086237,0.11312,0.089441,0,1
2,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.073694,0.1129,0.086334,0,1
2,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.092339,0.11203,0.080226,0,1
2,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.061549,0.1115,0.10231,0,1
2,GO DENDRITIC SPINE MAINTENANCE,0.34008,0.11097,0.058245,0,1
2,GO POSITIVE REGULATION OF ORGAN GROWTH,0.14983,0.11075,0.079619,0,1
2,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.1653,0.11041,0.085434,0,1
2,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.071119,0.11006,0.075069,0,1
2,GO DIACYLGLYCEROL METABOLIC PROCESS,0.091558,0.1097,0.13007,0,1
2,GO LIVER MORPHOGENESIS,0.25753,0.10926,0.066801,0,1
2,GO CELLULAR PIGMENTATION,0.16904,0.1091,0.086255,0,1
2,GO PLACENTA DEVELOPMENT,0.16407,0.10879,0.062707,0,1
2,GO REGULATION OF WATER LOSS VIA SKIN,0.46466,0.10874,0.04585,0,1
2,GO CELLULAR HORMONE METABOLIC PROCESS,0.2114,0.1087,0.040164,0,1
2,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.1793,0.10812,0.074775,0,1
2,GO ACUTE PHASE RESPONSE,0.070488,0.10801,0.09514,0,1
2,GO NEPHRON DEVELOPMENT,0.25246,0.10742,0.062555,0,1
2,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.11367,0.10742,0.068538,0,1
2,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.068619,0.10736,0.096341,0,1
2,GO REGULATION OF PROTEOLYSIS,0.17411,0.10727,0.057853,0,1
2,GO IMPORT INTO NUCLEUS,0.09796,0.10726,0.074685,0,1
2,GO NEUTROPHIL MIGRATION,0.1262,0.10662,0.062898,0,1
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.061549,0.10658,0.09897,0,1
2,GO GENITALIA MORPHOGENESIS,0.2114,0.10631,0.075065,0,1
2,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.23286,0.10583,0.10334,0,1
2,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.20122,0.10575,0.074511,0,1
2,GO HYPEROSMOTIC RESPONSE,0.093918,0.10473,0.074526,0,1
2,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.06986,0.10461,0.093047,0,1
2,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.45727,0.10391,0.036682,0,1
2,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.20265,0.10327,0.055159,0,1
2,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.32792,0.10289,0.040544,0,1
2,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.19838,0.10288,0.071277,0,1
2,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.18461,0.10288,0.059009,0,1
2,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.10129,0.10285,0.096051,0,1
2,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.10823,0.10269,0.057477,0,1
2,GO LABYRINTHINE LAYER DEVELOPMENT,0.46466,0.10252,0.031304,0,1
2,GO MITRAL VALVE DEVELOPMENT,0.065005,0.10242,0.22135,0,1
2,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.11837,0.10229,0.076882,0,1
2,GO NEGATIVE REGULATION OF BEHAVIOR,0.17029,0.1022,0.11415,0,1
2,GO MUSCLE CELL MIGRATION,0.15447,0.10201,0.083726,0,1
2,GO HYPOTONIC RESPONSE,0.066792,0.10188,0.12674,0,1
2,GO HISTONE UBIQUITINATION,0.12224,0.10134,0.044593,0,1
2,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.21738,0.10111,0.06304,0,1
2,GO RESPONSE TO OXYGEN LEVELS,0.10734,0.10075,0.054429,0,1
2,GO NEUTROPHIL CHEMOTAXIS,0.073043,0.10048,0.065473,0,1
2,GO THIOESTER BIOSYNTHETIC PROCESS,0.12322,0.10038,0.11009,0,1
2,GO MALE SEX DIFFERENTIATION,0.22971,0.10027,0.064193,0,1
2,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.1453,0.10023,0.050954,0,1
2,GO KIDNEY MESENCHYME DEVELOPMENT,0.10129,0.10012,0.098126,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.23128,0.099934,0.058825,0,1
2,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.089246,0.099852,0.10834,0,1
2,GO NAD METABOLIC PROCESS,0.082591,0.099814,0.098188,0,1
2,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.2714,0.099783,0.051102,0,1
2,GO REGULATION OF CELLULAR RESPIRATION,0.089246,0.099446,0.099703,0,1
2,GO CARDIAC MUSCLE CELL CONTRACTION,0.068619,0.099289,0.093216,0,1
2,GO REGULATION OF ODONTOGENESIS,0.54208,0.09887,0.010211,0,1
2,GO RRNA CATABOLIC PROCESS,0.14088,0.098243,0.073959,0,1
2,GO POSITIVE CHEMOTAXIS,0.1453,0.098098,0.065868,0,1
2,GO REGULATION OF CELL ADHESION,0.089246,0.097765,0.084436,0,1
2,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.28395,0.097165,0.058073,0,1
2,GO POSITIVE REGULATION OF HEART GROWTH,0.28395,0.096292,0.067701,0,1
2,GO CELLULAR LIPID CATABOLIC PROCESS,0.086237,0.096223,0.070447,0,1
2,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.21889,0.095836,0.068473,0,1
2,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.11837,0.09551,0.05878,0,1
2,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.08331,0.095484,0.068933,0,1
2,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.15447,0.095081,0.087246,0,1
2,GO REGULATION OF GTP BINDING,0.13338,0.094874,0.10156,0,1
2,GO BASE EXCISION REPAIR AP SITE FORMATION,0.24911,0.094666,0.067951,0,1
2,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.068006,0.094415,0.063079,0,1
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.29502,0.094341,0.067589,0,1
2,GO PROTEIN LOCALIZATION TO CHROMATIN,0.12126,0.094173,0.061611,0,1
2,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.54208,0.093744,0.041623,0,1
2,GO MESODERMAL CELL FATE COMMITMENT,0.2644,0.093723,0.073397,0,1
2,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.071119,0.093638,0.07472,0,1
2,GO NEGATIVE REGULATION OF CELL DEATH,0.11837,0.093627,0.054325,0,1
2,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.19557,0.093173,0.041425,0,1
2,GO REGULATION OF RNA BINDING,0.068006,0.092952,0.083912,0,1
2,GO REGULATION OF RESPONSE TO STRESS,0.12721,0.09247,0.052494,0,1
2,GO REGULATION OF HISTONE H4 ACETYLATION,0.10385,0.092446,0.088693,0,1
2,GO GOLGI VESICLE TRANSPORT,0.10912,0.091537,0.041893,0,1
2,GO MOLTING CYCLE,0.34835,0.091333,0.066908,0,1
2,GO ENDOCRINE PROCESS,0.14983,0.090997,0.062312,0,1
2,GO MACROPHAGE ACTIVATION,0.19003,0.090798,0.054165,0,1
2,GO NEGATIVE REGULATION OF JNK CASCADE,0.17029,0.090715,0.075996,0,1
2,GO POSITIVE REGULATION OF AUTOPHAGY,0.22348,0.090501,0.05013,0,1
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.1252,0.090375,0.084543,0,1
2,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.33803,0.090265,0.086124,0,1
2,GO GOLGI VESICLE BUDDING,0.061549,0.090086,0.0532,0,1
2,GO GENITALIA DEVELOPMENT,0.26614,0.090083,0.041322,0,1
2,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.24416,0.090057,0.062943,0,1
2,GO RESPONSE TO STEROID HORMONE,0.2714,0.088942,0.042022,0,1
2,GO REGULATION OF CATABOLIC PROCESS,0.085497,0.088859,0.049794,0,1
2,GO MAMMARY GLAND DEVELOPMENT,0.39606,0.088739,0.048079,0,1
2,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.33599,0.088709,0.01948,0,1
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.18194,0.088518,0.046507,0,1
2,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.25414,0.088358,0.019761,0,1
2,GO REGULATION OF CELL SHAPE,0.079071,0.087993,0.085228,0,1
2,GO CELLULAR RESPONSE TO RADIATION,0.095518,0.087922,0.075232,0,1
2,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.39832,0.087849,0.032912,0,1
2,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.13656,0.086944,0.078522,0,1
2,GO CELLULAR RESPONSE TO LIPID,0.10823,0.086905,0.066552,0,1
2,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.2644,0.086653,0.047558,0,1
2,GO NEURAL TUBE DEVELOPMENT,0.44994,0.086607,0.052347,0,1
2,GO REGULATION OF ORGAN GROWTH,0.34213,0.086582,0.048437,0,1
2,GO LIPID CATABOLIC PROCESS,0.14642,0.086559,0.053866,0,1
2,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.3442,0.086558,0.045471,0,1
2,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.077018,0.086385,0.060225,0,1
2,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.178,0.086156,0.033384,0,1
2,GO HISTONE DEACETYLATION,0.16407,0.086045,0.027204,0,1
2,GO PROTEIN PROCESSING,0.47712,0.086038,0.02925,0,1
2,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.075009,0.085613,0.072794,0,1
2,GO NEURAL TUBE FORMATION,0.2458,0.085393,0.067221,0,1
2,GO REGULATION OF FATTY ACID OXIDATION,0.27673,0.08504,0.07055,0,1
2,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.090782,0.084783,0.068052,0,1
2,GO RESPONSE TO CORTICOSTEROID,0.2114,0.084496,0.050583,0,1
2,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.25414,0.08444,0.045219,0,1
2,GO NON RECOMBINATIONAL REPAIR,0.073043,0.08428,0.064416,0,1
2,GO ACTIN MEDIATED CELL CONTRACTION,0.11367,0.083824,0.070661,0,1
2,GO REGULATION OF ERBB SIGNALING PATHWAY,0.10385,0.08366,0.067467,0,1
2,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.25414,0.083275,0.095283,0,1
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.16163,0.083024,0.063781,0,1
2,GO KIDNEY EPITHELIUM DEVELOPMENT,0.24416,0.082945,0.064846,0,1
2,GO ACTIVATION OF JNKK ACTIVITY,0.27673,0.082881,0.069174,0,1
2,GO RESPONSE TO TOXIC SUBSTANCE,0.077018,0.082747,0.063697,0,1
2,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.17029,0.08244,0.038471,0,1
2,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.45727,0.082411,0.029726,0,1
2,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.22503,0.082324,0.042867,0,1
2,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.33599,0.082106,0.021789,0,1
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.13656,0.081746,0.042495,0,1
2,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.63697,0.081508,0.025648,0,1
2,GO EMBRYONIC DIGIT MORPHOGENESIS,0.28395,0.081445,0.052086,0,1
2,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.091558,0.081394,0.083005,0,1
2,GO MODULATION BY VIRUS OF HOST PROCESS,0.14419,0.081279,0.082284,0,1
2,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.23445,0.080701,0.036306,0,1
2,GO REGULATION OF LIPID LOCALIZATION,0.22814,0.080692,0.048954,0,1
2,GO REGULATION OF RUFFLE ASSEMBLY,0.18866,0.080341,0.04666,0,1
2,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.070488,0.079906,0.13862,0,1
2,GO ALCOHOL CATABOLIC PROCESS,0.075009,0.07983,0.09518,0,1
2,GO PROTEOLYSIS,0.28213,0.079643,0.031839,0,1
2,GO FOCAL ADHESION ASSEMBLY,0.19838,0.079265,0.093444,0,1
2,GO VITAMIN METABOLIC PROCESS,0.22971,0.079151,0.053103,0,1
2,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.19278,0.078971,0.064137,0,1
2,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.45727,0.078614,0.03635,0,1
2,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.066192,0.078363,0.092006,0,1
2,GO MEGAKARYOCYTE DIFFERENTIATION,0.068006,0.077965,0.084926,0,1
2,GO SUPEROXIDE METABOLIC PROCESS,0.14983,0.077781,0.06559,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.2714,0.077495,0.047751,0,1
2,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.24089,0.07713,0.034536,0,1
2,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.42602,0.077044,0.028072,0,1
2,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.13549,0.076632,0.063511,0,1
2,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.081877,0.076309,0.076428,0,1
2,GO REGULATION OF PROTEIN STABILITY,0.076344,0.074888,0.052137,0,1
2,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.89846,0.074599,0.010054,0,1
2,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.060432,0.074398,0.12,0,1
2,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.21437,0.074218,0.037892,0,1
2,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.33803,0.073505,0.057674,0,1
2,GO EPITHELIAL TUBE FORMATION,0.1533,0.073495,0.072496,0,1
2,GO PYRUVATE METABOLIC PROCESS,0.20554,0.073321,0.056161,0,1
2,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.30255,0.073318,0.039811,0,1
2,GO PROTEIN MATURATION,0.318,0.07325,0.027931,0,1
2,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.088486,0.073085,0.050344,0,1
2,GO PEPTIDYL LYSINE DIMETHYLATION,0.25078,0.073038,0.039707,0,1
2,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.34835,0.073027,0.033271,0,1
2,GO MAINTENANCE OF ORGANELLE LOCATION,0.19979,0.072946,0.055652,0,1
2,GO REGULATION OF HISTONE PHOSPHORYLATION,0.61402,0.072705,0.038318,0,1
2,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.19003,0.072676,0.037504,0,1
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.25078,0.072524,0.040501,0,1
2,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.21889,0.072348,0.044234,0,1
2,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.24416,0.072319,0.055261,0,1
2,GO MESODERM DEVELOPMENT,0.51296,0.07227,0.025522,0,1
2,GO ANION HOMEOSTASIS,0.12029,0.072107,0.081711,0,1
2,GO CELL AGING,0.06986,0.072048,0.06913,0,1
2,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.060988,0.071429,0.095515,0,1
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.35253,0.071424,0.020482,0,1
2,GO UV PROTECTION,0.37827,0.071302,0.064901,0,1
2,GO PHOTOPERIODISM,0.42367,0.071159,0.024834,0,1
2,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.071756,0.07113,0.068177,0,1
2,GO DNA REPLICATION INITIATION,0.19697,0.070852,0.071266,0,1
2,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.73822,0.070445,0.014209,0,1
2,GO GLYCOPROTEIN METABOLIC PROCESS,0.74435,0.070442,0.0031583,0,1
2,GO REGULATION OF HELICASE ACTIVITY,0.68988,0.070307,0.0035125,0,1
2,GO REGULATION OF CHROMOSOME SEPARATION,0.13763,0.069386,0.057579,0,1
2,GO REGULATION OF CELL DEATH,0.24911,0.069239,0.038341,0,1
2,GO PROTEIN MONOUBIQUITINATION,0.1453,0.069185,0.034435,0,1
2,GO REGULATION OF LIPID CATABOLIC PROCESS,0.23286,0.06909,0.07068,0,1
2,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.37173,0.069063,0.049884,0,1
2,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.5,0.068343,0.020682,0,1
2,GO RESPONSE TO ALCOHOL,0.31604,0.067855,0.0382,0,1
2,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.26267,0.067716,0.088376,0,1
2,GO ANTIMICROBIAL HUMORAL RESPONSE,0.38488,0.067686,0.018396,0,1
2,GO CHROMOSOME SEPARATION,0.23286,0.067494,0.04296,0,1
2,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.11183,0.067475,0.049574,0,1
2,GO TUBE MORPHOGENESIS,0.59424,0.067454,0.028397,0,1
2,GO RESPONSE TO LIPID,0.31409,0.067169,0.035922,0,1
2,GO PIGMENTATION,0.81896,0.067141,0.0099066,0,1
2,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.16042,0.06685,0.067822,0,1
2,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.2458,0.06625,0.045318,0,1
2,GO REGULATION OF CELL POPULATION PROLIFERATION,0.3739,0.06619,0.032643,0,1
2,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.077698,0.066105,0.062391,0,1
2,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.33194,0.06576,0.040297,0,1
2,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.14869,0.065759,0.059846,0,1
2,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.2714,0.065628,0.032699,0,1
2,GO MACROMOLECULE CATABOLIC PROCESS,0.073694,0.06559,0.051934,0,1
2,GO RESPONSE TO CHEMOKINE,0.080464,0.065576,0.07498,0,1
2,GO MYELOID CELL DIFFERENTIATION,0.070488,0.065451,0.088674,0,1
2,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.26614,0.065365,0.037378,0,1
2,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.82526,0.065172,0.011463,0,1
2,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.067397,0.064742,0.067525,0,1
2,GO REGULATION OF INTRACELLULAR TRANSPORT,0.34008,0.064545,0.027615,0,1
2,GO RESPONSE TO RADIATION,0.090782,0.064409,0.047904,0,1
2,GO MONOSACCHARIDE METABOLIC PROCESS,0.10912,0.064381,0.047414,0,1
2,GO IN UTERO EMBRYONIC DEVELOPMENT,0.24416,0.063831,0.043309,0,1
2,GO DNA CONFORMATION CHANGE,0.062114,0.063573,0.054201,0,1
2,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.13338,0.063511,0.039964,0,1
2,GO NEGATIVE REGULATION OF MAPK CASCADE,0.2714,0.063331,0.049355,0,1
2,GO UROGENITAL SYSTEM DEVELOPMENT,0.46962,0.063122,0.046454,0,1
2,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.70787,0.062898,0.041402,0,1
2,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.25414,0.062855,0.064746,0,1
2,GO REGULATION OF HYDROLASE ACTIVITY,0.35674,0.062494,0.03049,0,1
2,GO REGULATION OF ATP METABOLIC PROCESS,0.20265,0.062329,0.046549,0,1
2,GO RESPONSE TO HORMONE,0.72603,0.062194,0.010069,0,1
2,GO TUBE FORMATION,0.18595,0.0621,0.068937,0,1
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.31604,0.062056,0.064575,0,1
2,GO RESPONSE TO DRUG,0.30066,0.061837,0.042678,0,1
2,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.75356,0.061767,0.009821,0,1
2,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.32195,0.061678,0.035886,0,1
2,GO NUCLEOTIDE PHOSPHORYLATION,0.17669,0.061491,0.058489,0,1
2,GO ACTIVATION OF GTPASE ACTIVITY,0.4451,0.061419,0.02293,0,1
2,GO NEGATIVE REGULATION OF CELL CYCLE,0.46466,0.061323,0.025736,0,1
2,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.2458,0.06058,0.083753,0,1
2,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.33599,0.060569,0.035971,0,1
2,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.23766,0.060242,0.037126,0,1
2,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.59986,0.060085,0.033086,0,1
2,GO REGULATION OF DNA REPAIR,0.32993,0.05932,0.026459,0,1
2,GO LIPID LOCALIZATION,0.36311,0.05918,0.032317,0,1
2,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.6312,0.059173,0.021182,0,1
2,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.27495,0.059115,0.031545,0,1
2,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.72603,0.058691,0.016441,0,1
2,GO EPITHELIUM DEVELOPMENT,0.95316,0.05862,0.0092762,0,1
2,GO APOPTOTIC SIGNALING PATHWAY,0.17156,0.058446,0.046818,0,1
2,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.17156,0.058025,0.064662,0,1
2,GO REGULATION OF JUN KINASE ACTIVITY,0.73822,0.058005,0.022195,0,1
2,GO DNA INTEGRITY CHECKPOINT,0.22042,0.057722,0.042578,0,1
2,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.17029,0.057571,0.047946,0,1
2,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.22814,0.05753,0.039653,0,1
2,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.5394,0.057417,0.020783,0,1
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.75972,0.05726,0.033403,0,1
2,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.36956,0.057195,0.030981,0,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.079071,0.057161,0.043615,0,1
2,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.14308,0.056792,0.056863,0,1
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.6691,0.056592,0.017394,0,1
2,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.67206,0.055923,0.024037,0,1
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.69286,0.055477,-0.011763,0,1
2,GO MITOCHONDRIAL TRANSPORT,0.068006,0.055451,0.062512,0,1
2,GO CARBOHYDRATE METABOLIC PROCESS,0.22814,0.055182,0.034142,0,1
2,GO GLYCEROLIPID CATABOLIC PROCESS,0.10823,0.054792,0.087842,0,1
2,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.60834,0.054758,0.01843,0,1
2,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.58029,0.054596,0.018692,0,1
2,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.6691,0.05434,0.013509,0,1
2,GO REGULATION OF DNA METABOLIC PROCESS,0.10912,0.054159,0.045592,0,1
2,GO REGULATION OF TRANSFERASE ACTIVITY,0.797,0.054137,0.0079979,0,1
2,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.53406,0.054059,0.018412,0,1
2,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.54477,0.053872,0.022664,0,1
2,GO STEROID METABOLIC PROCESS,0.077698,0.053858,0.05866,0,1
2,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.30255,0.053775,0.02816,0,1
2,GO DOUBLE STRAND BREAK REPAIR,0.11553,0.053704,0.052855,0,1
2,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.25246,0.05361,0.038859,0,1
2,GO REGULATION OF CHROMOSOME SEGREGATION,0.318,0.053314,0.038541,0,1
2,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.36311,0.05295,0.045586,0,1
2,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.41899,0.052893,0.029285,0,1
2,GO RESPONSE TO ABIOTIC STIMULUS,0.64276,0.052714,0.01888,0,1
2,GO APOPTOTIC PROCESS,0.46466,0.052668,0.022104,0,1
2,GO PEPTIDYL AMINO ACID MODIFICATION,0.36956,0.052314,0.021541,0,1
2,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.27673,0.052272,0.032885,0,1
2,GO PIGMENT GRANULE LOCALIZATION,0.16285,0.052234,0.080761,0,1
2,GO POSITIVE REGULATION OF CELL DEATH,0.48215,0.051919,0.024617,0,1
2,GO REGULATION OF T CELL MIGRATION,0.33194,0.051257,0.047146,0,1
2,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.10045,0.050885,0.055212,0,1
2,GO REGULATION OF MITOTIC CELL CYCLE,0.3739,0.050832,0.025951,0,1
2,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.25583,0.050318,0.065838,0,1
2,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.71391,0.050189,0.012944,0,1
2,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.47963,0.049906,0.02523,0,1
2,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.16778,0.049609,0.037525,0,1
2,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.47963,0.049475,0.015289,0,1
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.081877,0.049382,0.057635,0,1
2,GO ENDODERMAL CELL FATE COMMITMENT,0.69286,0.049164,0.005253,0,1
2,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.80639,0.049025,0.027606,0,1
2,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.11553,0.04846,0.044191,0,1
2,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.4451,0.047803,0.019182,0,1
2,GO PROTEIN AUTOUBIQUITINATION,0.55287,0.047781,0.011306,0,1
2,GO REGULATION OF CENTRIOLE REPLICATION,0.6312,0.047548,0.014259,0,1
2,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.35886,0.047519,0.029613,0,1
2,GO DNA RECOMBINATION,0.099614,0.046963,0.056324,0,1
2,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.21437,0.046724,0.053267,0,1
2,GO NEGATIVE REGULATION OF RNA SPLICING,0.2714,0.04665,0.031675,0,1
2,GO POSTREPLICATION REPAIR,0.15921,0.046597,0.051961,0,1
2,GO NEGATIVE REGULATION OF SECRETION,0.39606,0.046585,0.028023,0,1
2,GO MACROAUTOPHAGY,0.16778,0.04589,0.032785,0,1
2,GO MITOTIC SISTER CHROMATID COHESION,0.33803,0.0455,0.052043,0,1
2,GO CELL CYCLE G2 M PHASE TRANSITION,0.16654,0.045008,0.038681,0,1
2,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.50776,0.044742,0.012919,0,1
2,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.13444,0.044409,0.062824,0,1
2,GO ENDOSOME ORGANIZATION,0.49231,0.043661,0.033026,0,1
2,GO MACROMOLECULE DEACYLATION,0.71089,0.042816,-0.0044718,0,1
2,GO MITOTIC CELL CYCLE,0.32195,0.042712,0.028428,0,1
2,GO REGULATION OF SPINDLE ORGANIZATION,0.6515,0.042605,0.027637,0,1
2,GO NUCLEOTIDE EXCISION REPAIR,0.19557,0.041903,0.034495,0,1
2,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.92416,0.041867,0.0028377,0,1
2,GO NCRNA TRANSCRIPTION,0.081168,0.040855,0.062144,0,1
2,GO DNA REPAIR,0.062114,0.040577,0.044362,0,1
2,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.80639,0.040551,0.002581,0,1
2,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.98869,0.040529,-0.0056447,0,1
2,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.075674,0.040242,0.057913,0,1
2,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.11092,0.039695,0.045304,0,1
2,GO COVALENT CHROMATIN MODIFICATION,0.38267,0.039212,0.015042,0,1
2,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.82211,0.039076,-0.01581,0,1
2,GO REGULATION OF CHROMATIN ORGANIZATION,0.57476,0.038971,0.013197,0,1
2,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.089246,0.038777,0.047036,0,1
2,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.18461,0.038483,0.051486,0,1
2,GO BLASTOCYST DEVELOPMENT,0.26614,0.038332,0.039326,0,1
2,GO NEGATIVE REGULATION OF TRANSPORT,0.84107,0.038326,0.0025487,0,1
2,GO DNA DEPENDENT DNA REPLICATION,0.20845,0.038325,0.059226,0,1
2,GO CERAMIDE METABOLIC PROCESS,0.91772,0.037291,0.0012091,0,1
2,GO REGULATION OF CELL CYCLE PROCESS,0.29502,0.037055,0.026973,0,1
2,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.2714,0.035229,0.037543,0,1
2,GO REGULATION OF CHROMOSOME ORGANIZATION,0.14869,0.035189,0.040164,0,1
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.59144,0.034564,0.021127,0,1
2,GO C4 DICARBOXYLATE TRANSPORT,0.82526,0.034407,0.033088,0,1
2,GO REGULATION OF AUTOPHAGY,0.48722,0.033682,0.01443,0,1
2,GO REGULATION OF EXIT FROM MITOSIS,0.75048,0.033327,0.00075393,0,1
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.70486,0.032136,0.014151,0,1
2,GO CELL CYCLE PROCESS,0.35253,0.030866,0.021756,0,1
2,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.28033,0.030101,0.023355,0,1
2,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.5314,0.029688,0.019849,0,1
2,GO REGULATION OF MACROAUTOPHAGY,0.41666,0.027226,0.011661,0,1
2,GO REGULATION OF ORGANELLE ORGANIZATION,0.75048,0.026359,-0.0033149,0,1
2,GO CHROMATIN ORGANIZATION,0.52345,0.025668,0.0082599,0,1
2,GO CHROMOSOME ORGANIZATION,0.19278,0.022289,0.029329,0,1
2,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.24745,0.019444,0.039422,0,1
2,GO CELL CYCLE,0.57476,0.019285,0.01158,0,1
2,GO REGULATION OF REPRODUCTIVE PROCESS,0.90167,0.017694,-0.0022292,0,1
2,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.14197,0.24809,0.1139,0,0
2,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.14197,0.22057,0.10849,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.086237,0.22025,0.14545,0,0
2,GO EPIBOLY,0.087731,0.2131,0.14467,0,0
2,GO NADPH REGENERATION,0.0084096,0.20627,0.16973,0,0
2,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.071119,0.19677,0.15009,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.0030839,0.1967,0.17758,0,0
2,GO TRNA 5 LEADER REMOVAL,3.6877e-06,0.19545,0.21886,0,0
2,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.029754,0.1946,0.16037,0,0
2,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.058787,0.19424,0.1588,0,0
2,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.20122,0.19383,0.10795,0,0
2,GO CELLULAR RESPONSE TO CADMIUM ION,0.061549,0.19148,0.16008,0,0
2,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0013255,0.1891,0.14362,0,0
2,GO HYALURONAN CATABOLIC PROCESS,0.22348,0.18619,0.115,0,0
2,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.45238,0.18581,0.031223,0,0
2,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.11002,0.18446,0.081349,0,0
2,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.27495,0.18379,0.054572,0,0
2,GO ENDODERMAL CELL DIFFERENTIATION,0.25414,0.18346,0.11551,0,0
2,GO PROTEIN ACTIVATION CASCADE,0.095518,0.18009,0.098131,0,0
2,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.36098,0.17779,0.065927,0,0
2,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.064418,0.17742,0.099788,0,0
2,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.20554,0.17696,0.079169,0,0
2,GO GERMINAL CENTER FORMATION,0.11183,0.17538,0.12057,0,0
2,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.29315,0.175,0.085488,0,0
2,GO VASCULOGENESIS,0.1793,0.17369,0.08006,0,0
2,GO COLLAGEN FIBRIL ORGANIZATION,0.086981,0.17346,0.14681,0,0
2,GO CYTOLYSIS,0.093918,0.17256,0.14447,0,0
2,GO TRNA 5 END PROCESSING,3.628e-05,0.17195,0.18336,0,0
2,GO ELASTIC FIBER ASSEMBLY,0.21587,0.17168,0.11965,0,0
2,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.067397,0.17158,0.12456,0,0
2,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.1262,0.16923,0.090438,0,0
2,GO VITAMIN BIOSYNTHETIC PROCESS,0.076344,0.16838,0.11713,0,0
2,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.08331,0.16834,0.11322,0,0
2,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.18461,0.16801,0.087603,0,0
2,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.24089,0.16481,0.076005,0,0
2,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.09796,0.16463,0.13324,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.12224,0.16291,0.081845,0,0
2,GO ENDODERM FORMATION,0.30446,0.16082,0.090077,0,0
2,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.30829,0.16081,0.05069,0,0
2,GO TROPHOBLAST CELL MIGRATION,0.055609,0.1607,0.16496,0,0
2,GO EMBRYO IMPLANTATION,0.063258,0.16027,0.098967,0,0
2,GO CELLULAR RESPONSE TO INTERFERON BETA,0.1146,0.15965,0.12578,0,0
2,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.11647,0.15433,0.12183,0,0
2,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.063836,0.15388,0.10156,0,0
2,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.063258,0.15388,0.11915,0,0
2,GO CELL CELL JUNCTION MAINTENANCE,0.08331,0.15319,0.13626,0,0
2,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.068619,0.15185,0.11014,0,0
2,GO CELLULAR DEFENSE RESPONSE,0.11933,0.15062,0.079241,0,0
2,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.74741,0.15062,0.0074863,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.23128,0.1501,0.093611,0,0
2,GO REGULATION OF GLOMERULAR FILTRATION,0.1793,0.14936,0.14076,0,0
2,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.095518,0.1472,0.086297,0,0
2,GO GLYCOLIPID CATABOLIC PROCESS,0.30829,0.1463,0.068357,0,0
2,GO C21 STEROID HORMONE METABOLIC PROCESS,0.15802,0.14492,0.05292,0,0
2,GO CELL ADHESION MEDIATED BY INTEGRIN,0.093126,0.14475,0.1165,0,0
2,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.67206,0.14439,-0.00090021,0,0
2,GO COLLAGEN CATABOLIC PROCESS,0.10385,0.14427,0.10033,0,0
2,GO T CELL MIGRATION,0.22503,0.14359,0.07502,0,0
2,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.099614,0.14215,0.091488,0,0
2,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.44994,0.14127,0.031831,0,0
2,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.077018,0.14087,0.12353,0,0
2,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.0042636,0.14079,0.12159,0,0
2,GO FIBRINOLYSIS,0.83158,0.14033,0.020839,0,0
2,GO FATTY ACID BETA OXIDATION,0.077698,0.14015,0.063086,0,0
2,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.096327,0.14007,0.18153,0,0
2,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.1252,0.13909,0.098857,0,0
2,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.73212,0.13805,0.010494,0,0
2,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.13444,0.13721,0.081209,0,0
2,GO IMMUNOLOGICAL MEMORY PROCESS,0.078382,0.13711,0.17112,0,0
2,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.26614,0.13687,0.058399,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.19278,0.13685,0.14555,0,0
2,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.66616,0.13588,0.01968,0,0
2,GO OLIGOPEPTIDE TRANSPORT,0.30255,0.13379,0.083911,0,0
2,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.1793,0.1333,0.074097,0,0
2,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.39832,0.13319,0.085138,0,0
2,GO STORE OPERATED CALCIUM ENTRY,0.071119,0.13235,0.10342,0,0
2,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.38488,0.13218,0.079398,0,0
2,GO INTRACELLULAR MRNA LOCALIZATION,0.33194,0.13201,0.076266,0,0
2,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.48976,0.13186,0.017756,0,0
2,GO PLASMINOGEN ACTIVATION,0.06986,0.13155,0.1405,0,0
2,GO ACTIN FILAMENT BASED TRANSPORT,0.19697,0.12962,0.078973,0,0
2,GO REGULATION OF COAGULATION,0.63408,0.12904,0.026176,0,0
2,GO PARAXIAL MESODERM DEVELOPMENT,0.55016,0.12865,0.05603,0,0
2,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.11553,0.1284,0.12944,0,0
2,GO GOLGI TO VACUOLE TRANSPORT,0.47963,0.1278,0.05044,0,0
2,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.20992,0.12679,0.058985,0,0
2,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.31215,0.12667,0.047627,0,0
2,GO ENDODERM DEVELOPMENT,0.30637,0.1257,0.074883,0,0
2,GO AUTOPHAGY OF NUCLEUS,0.33396,0.12503,0.051346,0,0
2,GO XENOBIOTIC CATABOLIC PROCESS,0.22658,0.12475,0.14705,0,0
2,GO SOMATIC STEM CELL DIVISION,0.11553,0.12468,0.18674,0,0
2,GO SMOOTH MUSCLE CELL PROLIFERATION,0.21889,0.12464,0.054606,0,0
2,GO REGULATION OF CALCIUM ION IMPORT,0.32195,0.12407,0.044352,0,0
2,GO POSITIVE REGULATION OF NEURON MIGRATION,0.18194,0.12281,0.10549,0,0
2,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.67798,0.12276,0.025906,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.10823,0.1223,0.08314,0,0
2,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.19979,0.12226,0.15696,0,0
2,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.74435,0.12225,0.05303,0,0
2,GO COMPLEMENT ACTIVATION,0.18595,0.12217,0.072693,0,0
2,GO HISTAMINE SECRETION,0.40058,0.12197,0.045716,0,0
2,GO CELL CELL JUNCTION ASSEMBLY,0.58585,0.12166,0.020446,0,0
2,GO POSITIVE REGULATION OF CELL AGING,0.060432,0.12047,0.10501,0,0
2,GO NUCLEOSIDE CATABOLIC PROCESS,0.42367,0.12045,0.035993,0,0
2,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.58585,0.12025,0.04932,0,0
2,GO GASTRULATION,0.46466,0.11955,0.042037,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.18595,0.11948,0.10295,0,0
2,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.072397,0.11945,0.15493,0,0
2,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.21288,0.1194,0.057718,0,0
2,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.178,0.11924,0.10498,0,0
2,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.67206,0.11874,0.030903,0,0
2,GO NCRNA 3 END PROCESSING,0.00055343,0.11833,0.15285,0,0
2,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.94348,0.11795,-0.055575,0,0
2,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.17029,0.11773,0.066114,0,0
2,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.26267,0.11772,0.058025,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION,0.10214,0.11764,0.088751,0,0
2,GO VIRAL RNA GENOME REPLICATION,0.1387,0.11714,0.081787,0,0
2,GO SIGNAL PEPTIDE PROCESSING,0.12721,0.11712,0.076906,0,0
2,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.10646,0.11678,0.10368,0,0
2,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.71391,0.11577,0.019423,0,0
2,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.21437,0.11511,0.064598,0,0
2,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.30066,0.11498,0.050147,0,0
2,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.084034,0.11492,0.12269,0,0
2,GO PHOSPHOLIPID HOMEOSTASIS,0.18062,0.11442,0.085604,0,0
2,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.0062108,0.11397,0.1178,0,0
2,GO VITAMIN D BIOSYNTHETIC PROCESS,0.48976,0.11358,0.060596,0,0
2,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.93382,0.11349,0.018627,0,0
2,GO GDP METABOLIC PROCESS,0.21587,0.1133,0.073636,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.97576,0.11314,-0.018232,0,0
2,GO PROXIMAL DISTAL PATTERN FORMATION,0.29689,0.11207,0.095245,0,0
2,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.1873,0.11205,0.07506,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17411,0.11197,0.082668,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.78763,0.11186,0.0093094,0,0
2,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.26095,0.11118,0.10159,0,0
2,GO AXONAL FASCICULATION,0.7659,0.11071,-0.004085,0,0
2,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.2458,0.11027,0.10191,0,0
2,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.41666,0.11016,0.068463,0,0
2,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.32993,0.1098,0.089321,0,0
2,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.34213,0.10965,0.061,0,0
2,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.32993,0.10948,0.02224,0,0
2,GO GALACTOSE METABOLIC PROCESS,0.68392,0.10927,5.2019e-05,0,0
2,GO TRANSCRIPTION BY RNA POLYMERASE I,0.0018006,0.10927,0.14313,0,0
2,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.39606,0.10876,0.05142,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.15565,0.10856,0.062356,0,0
2,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.50258,0.10852,0.049441,0,0
2,GO RESPONSE TO ESTROGEN,0.10734,0.10851,0.09641,0,0
2,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.70185,0.10846,0.023341,0,0
2,GO SEQUESTERING OF METAL ION,0.095518,0.10836,0.13551,0,0
2,GO REGULATION OF FIBRINOLYSIS,0.13027,0.10811,0.097992,0,0
2,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.11553,0.10806,0.071096,0,0
2,GO PROTEIN HYDROXYLATION,0.20265,0.10766,0.048246,0,0
2,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.20992,0.10744,0.078321,0,0
2,GO CELL CELL JUNCTION ORGANIZATION,0.48468,0.10727,0.031178,0,0
2,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.24416,0.10659,0.071293,0,0
2,GO COBALAMIN METABOLIC PROCESS,0.33803,0.10609,0.049721,0,0
2,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.060432,0.10558,0.098855,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.61972,0.10518,0.0054504,0,0
2,GO SNRNA METABOLIC PROCESS,0.00015331,0.10463,0.15024,0,0
2,GO EMBRYONIC BRAIN DEVELOPMENT,0.086237,0.1043,0.11578,0,0
2,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.81267,0.10405,0.0068593,0,0
2,GO REGULATION OF STEROL TRANSPORT,0.21738,0.10403,0.080639,0,0
2,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.058247,0.10279,0.099215,0,0
2,GO INTERLEUKIN 12 PRODUCTION,0.090011,0.10242,0.093348,0,0
2,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.25583,0.1024,0.025669,0,0
2,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.35674,0.10161,0.040617,0,0
2,GO ACUTE INFLAMMATORY RESPONSE,0.20265,0.10115,0.055398,0,0
2,GO HEART VALVE FORMATION,0.14308,0.10083,0.11781,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.20122,0.10003,0.086543,0,0
2,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.18062,0.099934,0.089404,0,0
2,GO CELLULAR RESPONSE TO DSRNA,0.19417,0.099889,0.068568,0,0
2,GO RENAL TUBULE DEVELOPMENT,0.23128,0.099863,0.072587,0,0
2,GO MYOBLAST PROLIFERATION,0.17411,0.099663,0.08124,0,0
2,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.31409,0.09959,0.097021,0,0
2,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.2114,0.099535,0.083088,0,0
2,GO REGULATION OF AMYLOID BETA FORMATION,0.13234,0.099366,0.089558,0,0
2,GO REGULATION OF VASCULATURE DEVELOPMENT,0.10385,0.099352,0.080267,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.2714,0.099197,0.08141,0,0
2,GO RECEPTOR CATABOLIC PROCESS,0.063836,0.099104,0.12558,0,0
2,GO RESPONSE TO DSRNA,0.17669,0.098923,0.058812,0,0
2,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.20699,0.098875,0.083535,0,0
2,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.078382,0.098725,0.076026,0,0
2,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.23927,0.098311,0.12287,0,0
2,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.099614,0.098124,0.11193,0,0
2,GO SULFUR COMPOUND METABOLIC PROCESS,0.012087,0.098091,0.096961,0,0
2,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.34835,0.09802,0.039727,0,0
2,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.47211,0.097942,0.032615,0,0
2,GO REGULATION OF NEURON MATURATION,0.11275,0.097761,0.12984,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.077698,0.097715,0.19178,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.24745,0.097697,0.080468,0,0
2,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.12029,0.097402,0.078164,0,0
2,GO PIGMENT CELL DIFFERENTIATION,0.84741,0.097293,0.0085471,0,0
2,GO BILE ACID METABOLIC PROCESS,0.081168,0.097212,0.092452,0,0
2,GO PERICARDIUM DEVELOPMENT,0.37173,0.097146,0.04188,0,0
2,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.01499,0.096621,0.15598,0,0
2,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.047372,0.096385,0.094763,0,0
2,GO RESPONSE TO OSMOTIC STRESS,0.10471,0.096072,0.065044,0,0
2,GO DIGESTION,0.18194,0.096033,0.051932,0,0
2,GO HISTONE PHOSPHORYLATION,0.090011,0.095636,0.063802,0,0
2,GO CELLULAR RESPONSE TO X RAY,0.13656,0.095556,0.12623,0,0
2,GO MIDGUT DEVELOPMENT,0.51557,0.095124,0.073069,0,0
2,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.82526,0.094958,-0.023494,0,0
2,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.040981,0.094918,0.14963,0,0
2,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.073694,0.094881,0.088289,0,0
2,GO AORTA MORPHOGENESIS,0.21738,0.094831,0.08933,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.21437,0.094811,0.056394,0,0
2,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.4451,0.094662,0.054756,0,0
2,GO REGULATION OF GLIAL CELL PROLIFERATION,0.12421,0.094437,0.096551,0,0
2,GO RESPONSE TO UV C,0.26267,0.094388,0.099246,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.7814,0.094333,0.00073648,0,0
2,GO REGULATION OF STEM CELL DIVISION,0.19003,0.094275,0.089129,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.080464,0.094001,0.099109,0,0
2,GO MALE SEX DETERMINATION,0.56925,0.09348,0.031695,0,0
2,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.2714,0.0929,0.073826,0,0
2,GO ALPHA AMINO ACID METABOLIC PROCESS,0.0062108,0.092763,0.1055,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.32592,0.092601,0.052888,0,0
2,GO POSITIVE REGULATION OF VESICLE FUSION,0.19003,0.092529,0.13455,0,0
2,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.12421,0.092453,0.054542,0,0
2,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.51557,0.092288,0.034111,0,0
2,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.10299,0.092275,0.14977,0,0
2,GO MAMMARY GLAND MORPHOGENESIS,0.028556,0.092078,0.17482,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.22971,0.091979,0.07899,0,0
2,GO TISSUE HOMEOSTASIS,0.178,0.091971,0.044811,0,0
2,GO LEFT RIGHT PATTERN FORMATION,0.091558,0.091662,0.10054,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.51557,0.091404,0.025409,0,0
2,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.35043,0.091258,0.059488,0,0
2,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.0034692,0.091055,0.1067,0,0
2,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.09796,0.090406,0.13714,0,0
2,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.11742,0.090355,0.081006,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.44994,0.090073,0.09557,0,0
2,GO AMYLOID BETA METABOLIC PROCESS,0.18461,0.089941,0.056763,0,0
2,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.33194,0.089418,0.067393,0,0
2,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.14308,0.088935,0.097037,0,0
2,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.178,0.088824,0.074598,0,0
2,GO RESPONSE TO L GLUTAMATE,0.48722,0.08861,0.048357,0,0
2,GO RESPONSE TO INTERLEUKIN 4,0.032607,0.088602,0.10144,0,0
2,GO VESICLE TARGETING,0.23128,0.088578,0.033838,0,0
2,GO RETINAL CONE CELL DIFFERENTIATION,0.94993,0.088566,0.024561,0,0
2,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.1252,0.088321,0.12647,0,0
2,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.52082,0.08798,0.11423,0,0
2,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.48215,0.087842,0.028886,0,0
2,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.041789,0.087587,0.078563,0,0
2,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.060988,0.087397,0.095238,0,0
2,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.060432,0.087395,0.10803,0,0
2,GO MAST CELL ACTIVATION,0.47461,0.087386,0.048496,0,0
2,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.12421,0.08736,0.10439,0,0
2,GO PROSTATIC BUD FORMATION,0.54208,0.087234,0.015553,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.10558,0.087199,0.088364,0,0
2,GO BLOOD VESSEL MORPHOGENESIS,0.43789,0.087101,0.038974,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.80639,0.086932,-0.00081126,0,0
2,GO RESPONSE TO TESTOSTERONE,0.15214,0.08691,0.07842,0,0
2,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.16654,0.08688,0.10252,0,0
2,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.22971,0.086679,0.059533,0,0
2,GO RESPONSE TO ISCHEMIA,0.25414,0.086578,0.058362,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.23927,0.086277,0.069643,0,0
2,GO POSITIVE REGULATION OF LIPID STORAGE,0.11092,0.086194,0.096142,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.37608,0.086159,0.032094,0,0
2,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.38933,0.086097,0.05051,0,0
2,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.23927,0.086075,0.048948,0,0
2,GO GONADOTROPIN SECRETION,0.20699,0.086057,0.043642,0,0
2,GO NECROTIC CELL DEATH,0.11275,0.085672,0.068495,0,0
2,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.26267,0.085538,0.064763,0,0
2,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.17156,0.085477,0.03782,0,0
2,GO DEFENSE RESPONSE TO BACTERIUM,0.060988,0.085235,0.07841,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.062684,0.085157,0.10393,0,0
2,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.38267,0.085151,0.051018,0,0
2,GO FILOPODIUM ASSEMBLY,0.32792,0.085076,0.048476,0,0
2,GO GLUCOSE CATABOLIC PROCESS,0.1873,0.085012,0.087192,0,0
2,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.44752,0.084968,0.043483,0,0
2,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.26614,0.084547,0.029959,0,0
2,GO REGULATION OF NECROTIC CELL DEATH,0.073694,0.084496,0.090559,0,0
2,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.090782,0.084236,0.1047,0,0
2,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.55016,0.084201,0.018524,0,0
2,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.013856,0.084145,0.13659,0,0
2,GO T CELL EXTRAVASATION,0.79387,0.083776,0.022235,0,0
2,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.070488,0.083544,0.11898,0,0
2,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.43075,0.08349,0.12231,0,0
2,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.093918,0.083451,0.072365,0,0
2,GO RRNA 3 END PROCESSING,0.023419,0.083308,0.10768,0,0
2,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.28945,0.083262,0.070206,0,0
2,GO REPLICATION FORK PROCESSING,0.15683,0.083164,0.075492,0,0
2,GO VASCULATURE DEVELOPMENT,0.31215,0.083025,0.050512,0,0
2,GO CELL CELL ADHESION,0.50776,0.08279,0.026578,0,0
2,GO NEGATIVE REGULATION OF WOUND HEALING,0.95639,0.082584,-0.0020529,0,0
2,GO MACROPHAGE DIFFERENTIATION,0.23605,0.082533,0.067762,0,0
2,GO PANCREATIC JUICE SECRETION,0.80012,0.081331,0.026634,0,0
2,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.14308,0.081216,0.12042,0,0
2,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.1754,0.081068,0.10205,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.1873,0.080967,0.10696,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.25078,0.080853,0.072966,0,0
2,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.28213,0.08074,0.096355,0,0
2,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.036409,0.080723,0.1126,0,0
2,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.49743,0.080591,0.02193,0,0
2,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.38047,0.080566,0.048762,0,0
2,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.68094,0.080442,0.013433,0,0
2,GO COPII COATED VESICLE BUDDING,0.063258,0.080098,0.051802,0,0
2,GO REGULATION OF MRNA BINDING,0.061549,0.079976,0.10248,0,0
2,GO MEMBRANE PROTEIN PROTEOLYSIS,0.19557,0.079589,0.08263,0,0
2,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.21437,0.079578,0.040989,0,0
2,GO RUFFLE ORGANIZATION,0.30255,0.079551,0.025376,0,0
2,GO LIPOPROTEIN LOCALIZATION,0.24911,0.079534,0.061519,0,0
2,GO LYMPHOCYTE MIGRATION,0.40743,0.078831,0.036711,0,0
2,GO HEMIDESMOSOME ASSEMBLY,0.14088,0.078744,0.22377,0,0
2,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.43789,0.078554,0.031247,0,0
2,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.11742,0.078548,0.13595,0,0
2,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.42133,0.078494,0.029778,0,0
2,GO ERK1 AND ERK2 CASCADE,0.10045,0.078342,0.077109,0,0
2,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.50258,0.078209,0.03245,0,0
2,GO TRANSEPITHELIAL TRANSPORT,0.17029,0.078097,0.074166,0,0
2,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.43312,0.077861,0.042954,0,0
2,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.081877,0.077464,0.086498,0,0
2,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.14755,0.077439,0.060379,0,0
2,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.075674,0.077424,0.12121,0,0
2,GO GAMMA DELTA T CELL ACTIVATION,0.21288,0.077355,0.11244,0,0
2,GO REGULATION OF URINE VOLUME,0.13444,0.077105,0.082978,0,0
2,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.43312,0.076976,0.03114,0,0
2,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.1653,0.076776,0.099643,0,0
2,GO PLATELET ACTIVATION,0.29315,0.076661,0.054963,0,0
2,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.081877,0.076588,0.059545,0,0
2,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.70185,0.076439,0.027752,0,0
2,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.1754,0.076426,0.068864,0,0
2,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.26614,0.076379,0.047175,0,0
2,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.58029,0.0763,0.047706,0,0
2,GO RETROGRADE AXONAL TRANSPORT,0.3871,0.076243,0.046836,0,0
2,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.25753,0.076236,0.087511,0,0
2,GO GAP JUNCTION ASSEMBLY,0.68094,0.076189,0.017617,0,0
2,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.18062,0.076183,0.12861,0,0
2,GO O GLYCAN PROCESSING,0.32993,0.076102,0.068822,0,0
2,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.58307,0.076018,0.032361,0,0
2,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.41434,0.07592,0.040976,0,0
2,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.25924,0.075675,0.056378,0,0
2,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.12224,0.075657,0.12129,0,0
2,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.19278,0.075553,0.078165,0,0
2,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.13027,0.075534,0.0718,0,0
2,GO BONE MORPHOGENESIS,0.22658,0.075444,0.085803,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.94993,0.075356,-0.031945,0,0
2,GO PROTEIN K63 LINKED UBIQUITINATION,0.20845,0.075354,0.052267,0,0
2,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.19697,0.075183,0.075045,0,0
2,GO NEGATIVE REGULATION OF AXON EXTENSION,0.81896,0.075078,-0.0068259,0,0
2,GO DRUG CATABOLIC PROCESS,0.31409,0.074875,0.06779,0,0
2,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.25583,0.074662,0.06196,0,0
2,GO PROTEIN NITROSYLATION,0.19979,0.074453,0.092497,0,0
2,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.33396,0.074412,0.023274,0,0
2,GO MANGANESE ION TRANSPORT,0.39381,0.074396,0.051472,0,0
2,GO AMYLOID BETA FORMATION,0.21889,0.074052,0.06674,0,0
2,GO KERATAN SULFATE CATABOLIC PROCESS,0.92094,0.074039,0.0034401,0,0
2,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.25583,0.073942,0.049397,0,0
2,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.10214,0.073837,0.090492,0,0
2,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.96607,0.073806,-0.0095858,0,0
2,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.43312,0.073725,0.026032,0,0
2,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.40743,0.073424,0.032964,0,0
2,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.066192,0.073357,0.065942,0,0
2,GO MACROPHAGE CYTOKINE PRODUCTION,0.82842,0.07308,-0.0056723,0,0
2,GO CYTOKINE SECRETION,0.26614,0.072892,0.048115,0,0
2,GO ARTERY MORPHOGENESIS,0.21889,0.072452,0.087043,0,0
2,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.74435,0.072337,0.012566,0,0
2,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.57752,0.072317,0.062096,0,0
2,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.53406,0.072232,0.048344,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.39606,0.072199,0.042788,0,0
2,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.97253,0.072062,-0.025872,0,0
2,GO ASTROCYTE DEVELOPMENT,0.49487,0.072057,0.045927,0,0
2,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.33803,0.072037,0.059386,0,0
2,GO MACROMOLECULE DEPALMITOYLATION,0.15565,0.072037,0.078913,0,0
2,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.086237,0.072022,0.097012,0,0
2,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.11837,0.071989,0.10835,0,0
2,GO NODAL SIGNALING PATHWAY,0.21587,0.071651,0.062844,0,0
2,GO RESPONSE TO INACTIVITY,0.67206,0.071629,0.037978,0,0
2,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.33194,0.071614,0.082776,0,0
2,GO LIPID DROPLET ORGANIZATION,0.32993,0.071556,0.040694,0,0
2,GO REGULATION OF CELL SUBSTRATE ADHESION,0.39156,0.071066,0.046888,0,0
2,GO CYTOKINETIC PROCESS,0.25246,0.07084,0.065117,0,0
2,GO NEPHRON MORPHOGENESIS,0.25924,0.07078,0.038385,0,0
2,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.51557,0.070615,0.023233,0,0
2,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.70185,0.07049,0.012782,0,0
2,GO PROSTATE GLAND MORPHOGENESIS,0.43789,0.070242,0.11037,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.61687,0.070162,0.031092,0,0
2,GO PROTEIN KINASE B SIGNALING,0.2114,0.070122,0.055917,0,0
2,GO FORMATION OF PRIMARY GERM LAYER,0.73822,0.070111,0.018799,0,0
2,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.30637,0.069949,0.088541,0,0
2,GO MULTIVESICULAR BODY ORGANIZATION,0.25924,0.069932,0.060597,0,0
2,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.14869,0.069814,0.06045,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.34835,0.069665,0.066784,0,0
2,GO RESPONSE TO HYPEROXIA,0.68094,0.069656,0.020841,0,0
2,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.088486,0.069509,0.094121,0,0
2,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.13763,0.06946,0.14869,0,0
2,GO REGULATION OF MYOBLAST FUSION,0.79075,0.069371,0.0053395,0,0
2,GO STEROID ESTERIFICATION,0.23766,0.06934,0.06018,0,0
2,GO LYMPHOCYTE HOMEOSTASIS,0.24252,0.069297,0.053644,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.40743,0.069184,0.038914,0,0
2,GO COLLAGEN METABOLIC PROCESS,0.34835,0.068801,0.059189,0,0
2,GO TUMOR NECROSIS FACTOR SECRETION,0.1146,0.068491,0.092307,0,0
2,GO LYMPH VESSEL MORPHOGENESIS,0.14197,0.068445,0.10849,0,0
2,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.94026,0.068321,-0.0073827,0,0
2,GO DEVELOPMENTAL PIGMENTATION,0.95961,0.068248,0.0025674,0,0
2,GO MONOCARBOXYLIC ACID TRANSPORT,0.073043,0.068146,0.064834,0,0
2,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.68689,0.068032,0.025982,0,0
2,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.22042,0.06801,0.07885,0,0
2,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.22814,0.067628,0.077191,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.093126,0.067532,0.064805,0,0
2,GO RESPONSE TO FATTY ACID,0.5394,0.067412,0.028509,0,0
2,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.10045,0.067388,0.23651,0,0
2,GO CORONARY VASCULATURE MORPHOGENESIS,0.69286,0.067335,0.01923,0,0
2,GO HISTONE H2A UBIQUITINATION,0.63986,0.067278,0.013049,0,0
2,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.11933,0.067253,0.059761,0,0
2,GO BONE DEVELOPMENT,0.54208,0.067204,0.046339,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.68689,0.066932,0.031099,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.38933,0.066793,0.042325,0,0
2,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.39156,0.066789,0.064892,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.91451,0.066611,-0.016732,0,0
2,GO PHOSPHOLIPID TRANSPORT,0.797,0.066383,0.0098011,0,0
2,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.44028,0.066088,0.032605,0,0
2,GO REGULATION OF CELL AGING,0.28945,0.066079,0.044436,0,0
2,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.38047,0.065981,0.081485,0,0
2,GO RESPONSE TO KETONE,0.35253,0.065969,0.040249,0,0
2,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.22195,0.065678,0.021951,0,0
2,GO ANIMAL ORGAN REGENERATION,0.23445,0.065511,0.047473,0,0
2,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.23445,0.065448,0.089641,0,0
2,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.30255,0.06531,0.095949,0,0
2,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.31021,0.06527,0.071214,0,0
2,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.28213,0.065175,0.037423,0,0
2,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.084034,0.065107,0.064493,0,0
2,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.079071,0.064954,0.1057,0,0
2,GO REGULATION OF ISOTYPE SWITCHING,0.48215,0.064915,0.064723,0,0
2,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.21437,0.064776,0.10243,0,0
2,GO PROGRAMMED NECROTIC CELL DEATH,0.41434,0.064578,0.033913,0,0
2,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.71089,0.064466,0.016643,0,0
2,GO PROTEIN OXIDATION,0.5,0.064465,0.044952,0,0
2,GO CHOLESTEROL STORAGE,0.27495,0.06444,0.098299,0,0
2,GO DETERMINATION OF ADULT LIFESPAN,0.27317,0.064415,0.088918,0,0
2,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.20554,0.06435,0.086987,0,0
2,GO ENDOTHELIAL CELL MIGRATION,0.3871,0.064301,0.04576,0,0
2,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.1533,0.064284,0.082703,0,0
2,GO RNA CAPPING,0.024428,0.064204,0.064139,0,0
2,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.40743,0.064159,0.035803,0,0
2,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.40973,0.063831,0.031554,0,0
2,GO PEPTIDE CATABOLIC PROCESS,0.18194,0.063796,0.079299,0,0
2,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.22042,0.063768,0.074245,0,0
2,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.31409,0.063715,0.10697,0,0
2,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.59705,0.063607,0.028337,0,0
2,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.086981,0.063365,0.067945,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.21437,0.063066,0.061129,0,0
2,GO AMEBOIDAL TYPE CELL MIGRATION,0.37608,0.062879,0.046997,0,0
2,GO HISTONE H3 K9 MODIFICATION,0.24745,0.0628,0.043717,0,0
2,GO KERATINOCYTE PROLIFERATION,0.21437,0.062772,0.13755,0,0
2,GO MUSCLE ADAPTATION,0.71089,0.062692,-0.011784,0,0
2,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.80953,0.062645,0.0048873,0,0
2,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.37173,0.062565,0.066468,0,0
2,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.5314,0.062519,0.05554,0,0
2,GO SPLEEN DEVELOPMENT,0.14869,0.062239,0.076578,0,0
2,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.27853,0.062133,0.042405,0,0
2,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.26095,0.062033,0.072952,0,0
2,GO REGULATION OF LIPID TRANSPORT,0.26964,0.061879,0.050885,0,0
2,GO RESPONSE TO MURAMYL DIPEPTIDE,0.075674,0.061764,0.1498,0,0
2,GO LEUKOCYTE MIGRATION,0.29689,0.061757,0.044108,0,0
2,GO DNA STRAND ELONGATION,0.12421,0.06174,0.074281,0,0
2,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.97899,0.061666,-0.0096711,0,0
2,GO CORONARY VASCULATURE DEVELOPMENT,0.58864,0.0616,0.040593,0,0
2,GO POSITIVE REGULATION OF URINE VOLUME,0.34213,0.061589,0.10857,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.86331,0.061584,0.0079881,0,0
2,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.22042,0.061574,0.070143,0,0
2,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.032938,0.061519,0.058875,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.28761,0.061211,0.048619,0,0
2,GO REGULATION OF PLATELET AGGREGATION,0.90809,0.061095,0.010716,0,0
2,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.86968,0.061078,0.018573,0,0
2,GO EPITHELIAL CELL MORPHOGENESIS,0.84424,0.060996,0.025172,0,0
2,GO INNER CELL MASS CELL PROLIFERATION,0.16904,0.060749,0.063818,0,0
2,GO FEMALE GAMETE GENERATION,0.30637,0.060607,0.026145,0,0
2,GO REGULATION OF TRANSLATIONAL ELONGATION,0.40058,0.060574,0.059799,0,0
2,GO POLYOL BIOSYNTHETIC PROCESS,0.10385,0.060287,0.073705,0,0
2,GO REPLICATIVE SENESCENCE,0.68988,0.060245,0.013056,0,0
2,GO MESONEPHROS DEVELOPMENT,0.73517,0.060162,0.0081184,0,0
2,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.19278,0.060103,0.16863,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.16163,0.059705,0.049227,0,0
2,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.30066,0.059353,0.049435,0,0
2,GO VIRION ASSEMBLY,0.1533,0.059348,0.062992,0,0
2,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.026013,0.059334,0.069826,0,0
2,GO IMMUNOGLOBULIN PRODUCTION,0.19979,0.05913,0.065436,0,0
2,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.06986,0.058965,0.081891,0,0
2,GO SELECTIVE AUTOPHAGY,0.16163,0.058952,0.056156,0,0
2,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.51557,0.058923,0.011232,0,0
2,GO POLYOL CATABOLIC PROCESS,0.93704,0.058671,-0.00030138,0,0
2,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.45972,0.05862,0.032934,0,0
2,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.58307,0.058467,0.022734,0,0
2,GO MEMBRANE LIPID CATABOLIC PROCESS,0.8379,0.058436,0.01413,0,0
2,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.76899,0.058353,-0.044274,0,0
2,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.15683,0.058339,0.14497,0,0
2,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.60268,0.057608,0.053879,0,0
2,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.47211,0.057469,0.033064,0,0
2,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.078382,0.05722,0.076357,0,0
2,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.48722,0.057159,0.029126,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.68988,0.057021,0.034286,0,0
2,GO MYOTUBE DIFFERENTIATION,0.5,0.056945,0.035154,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.1533,0.056833,0.063223,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.27495,0.05682,0.052215,0,0
2,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.55558,0.05679,0.059086,0,0
2,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.32393,0.05671,0.063778,0,0
2,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.5,0.056646,0.013158,0,0
2,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.54477,0.056506,0.034196,0,0
2,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.178,0.056433,0.070697,0,0
2,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.46466,0.05642,0.042058,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.7659,0.056266,0.0022599,0,0
2,GO AGING,0.57476,0.056027,0.018452,0,0
2,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.58585,0.055867,0.012374,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.15447,0.055817,0.092033,0,0
2,GO REGENERATION,0.32792,0.055723,0.049464,0,0
2,GO VESICLE BUDDING FROM MEMBRANE,0.28578,0.055713,0.033194,0,0
2,GO MYOBLAST FUSION,0.34213,0.055584,0.061304,0,0
2,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.68689,0.055565,0.012319,0,0
2,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.55016,0.055409,0.027477,0,0
2,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.071756,0.055347,0.097271,0,0
2,GO REGULATION OF LYMPHOCYTE MIGRATION,0.63408,0.055343,0.02483,0,0
2,GO RNA STABILIZATION,0.19979,0.054882,0.056348,0,0
2,GO POSITIVE REGULATION OF HEAT GENERATION,0.37173,0.054786,0.051843,0,0
2,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.43312,0.054713,0.036479,0,0
2,GO BILE ACID BIOSYNTHETIC PROCESS,0.23286,0.054537,0.056295,0,0
2,GO CELLULAR COMPONENT DISASSEMBLY,0.10129,0.054532,0.047257,0,0
2,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.41899,0.054494,0.043859,0,0
2,GO ACYLGLYCEROL HOMEOSTASIS,0.25924,0.054409,0.064099,0,0
2,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.2114,0.054359,0.057281,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.43789,0.054312,0.04388,0,0
2,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.28578,0.054302,0.048387,0,0
2,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.82842,0.054265,0.012159,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.41203,0.054233,0.037832,0,0
2,GO REGULATION OF BLOOD PRESSURE,0.94993,0.054199,-0.0046484,0,0
2,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.69286,0.054169,0.024512,0,0
2,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.59144,0.054168,0.053846,0,0
2,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.12721,0.054081,0.082304,0,0
2,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.797,0.054055,-0.018455,0,0
2,GO PROTEIN CATABOLIC PROCESS,0.36741,0.053993,0.026522,0,0
2,GO HAIR CELL DIFFERENTIATION,0.39606,0.053921,0.060868,0,0
2,GO HISTAMINE TRANSPORT,0.88565,0.053541,-0.021527,0,0
2,GO TRANSCYTOSIS,0.63986,0.05296,0.029939,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.22195,0.052781,0.083896,0,0
2,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.25414,0.052778,0.092121,0,0
2,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.41203,0.052709,0.071261,0,0
2,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.1914,0.052653,0.10542,0,0
2,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.48722,0.052619,0.032927,0,0
2,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.26095,0.052593,0.06288,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.16904,0.052582,0.085798,0,0
2,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.77829,0.052579,-0.0031653,0,0
2,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.69885,0.05256,0.020465,0,0
2,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.42602,0.052491,0.068401,0,0
2,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.54477,0.052436,0.016704,0,0
2,GO GLIAL CELL ACTIVATION,0.35043,0.052141,0.046105,0,0
2,GO LUNG MORPHOGENESIS,0.40058,0.052138,0.095394,0,0
2,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.18866,0.05203,0.039978,0,0
2,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.91451,0.051954,-0.0052802,0,0
2,GO EMBRYONIC HEMOPOIESIS,0.58307,0.051951,0.031228,0,0
2,GO INTERLEUKIN 6 PRODUCTION,0.21288,0.051871,0.061042,0,0
2,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.62258,0.051869,0.025491,0,0
2,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.26095,0.051832,0.075325,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.16654,0.051793,0.076769,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.48976,0.051771,0.044767,0,0
2,GO PROTEIN TARGETING TO MITOCHONDRION,0.095518,0.05169,0.06579,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.1146,0.051625,0.06907,0,0
2,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.24089,0.051558,0.046209,0,0
2,GO T CELL DIFFERENTIATION IN THYMUS,0.4451,0.051543,0.0316,0,0
2,GO RESPONSE TO ZINC ION,0.32993,0.051491,0.068432,0,0
2,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.73517,0.05148,-0.017496,0,0
2,GO PEPTIDYL LYSINE TRIMETHYLATION,0.23286,0.051392,0.05437,0,0
2,GO PROTEIN STABILIZATION,0.31409,0.051274,0.036754,0,0
2,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.48722,0.051057,0.023659,0,0
2,GO ACTIVATION OF MAPKKK ACTIVITY,0.55287,0.05093,0.041106,0,0
2,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.93382,0.050914,-0.018411,0,0
2,GO RESPONSE TO VITAMIN A,0.18327,0.050894,0.078694,0,0
2,GO CELLULAR SENESCENCE,0.36311,0.050811,0.029737,0,0
2,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.10558,0.050741,0.045935,0,0
2,GO BIOLOGICAL ADHESION,0.63408,0.05069,0.017921,0,0
2,GO CELLULAR EXTRAVASATION,0.21437,0.050668,0.058021,0,0
2,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.18327,0.050524,0.077078,0,0
2,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.15683,0.05051,0.083701,0,0
2,GO EPITHELIAL CELL DIFFERENTIATION,0.69885,0.050257,0.022372,0,0
2,GO REGULATION OF WOUND HEALING,0.49743,0.050254,0.035454,0,0
2,GO LACTATION,0.36956,0.050123,0.047335,0,0
2,GO VITAMIN D METABOLIC PROCESS,0.94993,0.050107,0.00010211,0,0
2,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.29315,0.049753,0.05608,0,0
2,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.22195,0.049721,0.07693,0,0
2,GO RESPONSE TO UV B,0.59424,0.049623,0.04541,0,0
2,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.7659,0.049512,0.017166,0,0
2,GO HOMOTYPIC CELL CELL ADHESION,0.19417,0.049401,0.10375,0,0
2,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.77209,0.049338,-0.043055,0,0
2,GO POLYSACCHARIDE CATABOLIC PROCESS,0.3739,0.049299,0.045601,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.22042,0.049147,0.078669,0,0
2,GO QUINONE METABOLIC PROCESS,0.47461,0.049121,0.014571,0,0
2,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.086981,0.049089,0.053401,0,0
2,GO EPITHELIAL TUBE MORPHOGENESIS,0.39832,0.049008,0.04151,0,0
2,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.49743,0.048831,0.038384,0,0
2,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.062684,0.048451,0.079874,0,0
2,GO CELLULAR RESPONSE TO STEROL,0.18327,0.048442,0.084717,0,0
2,GO NEGATIVE REGULATION OF COAGULATION,0.72603,0.048326,-0.033871,0,0
2,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.2913,0.048095,0.042186,0,0
2,GO T HELPER CELL LINEAGE COMMITMENT,0.18866,0.048094,0.074932,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.41666,0.047918,0.057637,0,0
2,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.29689,0.047912,0.067035,0,0
2,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.32393,0.047739,0.059781,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.95961,0.047616,-0.0057537,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.59424,0.047612,0.044672,0,0
2,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.64567,0.047586,0.014754,0,0
2,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.318,0.047558,0.054219,0,0
2,GO REGULATION OF FEEDING BEHAVIOR,0.12224,0.04748,0.07307,0,0
2,GO ACTIVATION OF MAPKK ACTIVITY,0.88885,0.047474,-0.0096611,0,0
2,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.70486,0.047472,0.008004,0,0
2,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.48722,0.04747,0.035695,0,0
2,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.69885,0.047389,0.031619,0,0
2,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.14419,0.04729,0.086387,0,0
2,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.16285,0.047144,0.080246,0,0
2,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.50776,0.047138,0.046089,0,0
2,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.44994,0.046996,0.032797,0,0
2,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.64858,0.046939,0.012463,0,0
2,GO RESPONSE TO XENOBIOTIC STIMULUS,0.15921,0.046903,0.06731,0,0
2,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.74741,0.046887,0.014735,0,0
2,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.58029,0.046867,0.015871,0,0
2,GO RETINA HOMEOSTASIS,0.15683,0.046782,0.05857,0,0
2,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.31604,0.046746,0.049284,0,0
2,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.1793,0.046711,0.060565,0,0
2,GO REGULATION OF RENAL SYSTEM PROCESS,0.85376,0.046691,0.010195,0,0
2,GO RESPONSE TO MUSCLE ACTIVITY,0.1873,0.046674,0.086935,0,0
2,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.61687,0.046658,0.022268,0,0
2,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.67206,0.046535,0.021821,0,0
2,GO REGULATION OF MRNA 3 END PROCESSING,0.28395,0.046515,0.048907,0,0
2,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.078382,0.046499,0.090178,0,0
2,GO RENAL SYSTEM PROCESS,0.95961,0.04638,-0.011047,0,0
2,GO NUCLEOSOME ORGANIZATION,0.47712,0.046359,0.02664,0,0
2,GO KETONE BODY METABOLIC PROCESS,0.30446,0.046264,0.062031,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.33194,0.04624,0.043504,0,0
2,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.40973,0.046174,0.030865,0,0
2,GO INTERMEDIATE FILAMENT BASED PROCESS,0.8379,0.045883,0.038716,0,0
2,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.61402,0.045747,0.037766,0,0
2,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.99515,0.045665,0.00024096,0,0
2,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.45238,0.045618,0.032372,0,0
2,GO REGULATION OF PHOSPHORYLATION,0.89205,0.045584,0.0013125,0,0
2,GO REGULATION OF BODY FLUID LEVELS,0.69286,0.045373,0.011563,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.39156,0.045331,0.017092,0,0
2,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.24252,0.045247,0.033217,0,0
2,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.58864,0.045231,0.026411,0,0
2,GO EXIT FROM MITOSIS,0.53672,0.045175,0.0074396,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.56925,0.045162,0.016284,0,0
2,GO PLATELET DEGRANULATION,0.86331,0.045145,-0.0014418,0,0
2,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.63986,0.045013,0.075139,0,0
2,GO SMOOTH MUSCLE CELL MIGRATION,0.73212,0.044948,0.0065816,0,0
2,GO DE NOVO PROTEIN FOLDING,0.84741,0.044933,-0.0085245,0,0
2,GO PROTEIN O LINKED GLYCOSYLATION,0.46218,0.044903,0.040552,0,0
2,GO SCHWANN CELL DIFFERENTIATION,0.69885,0.044888,0.013861,0,0
2,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.94993,0.044881,-0.01001,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.5,0.044829,0.040045,0,0
2,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.62832,0.044657,0.046703,0,0
2,GO PEPTIDYL THREONINE MODIFICATION,0.48722,0.044503,0.018928,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.22658,0.044471,0.059735,0,0
2,GO HISTONE H3 DEACETYLATION,0.36098,0.044439,0.032767,0,0
2,GO POSITIVE REGULATION OF JNK CASCADE,0.74741,0.044428,0.016328,0,0
2,GO MEMBRANE INVAGINATION,0.32792,0.044407,0.052349,0,0
2,GO AORTA DEVELOPMENT,0.53672,0.044334,0.054794,0,0
2,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.89846,0.04428,-0.012729,0,0
2,GO RESPONSE TO PEPTIDE HORMONE,0.67501,0.044265,0.01348,0,0
2,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.4355,0.044172,0.037222,0,0
2,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.45727,0.044126,0.034676,0,0
2,GO NADH METABOLIC PROCESS,0.34835,0.044119,0.059062,0,0
2,GO TRACHEA MORPHOGENESIS,0.83474,0.044111,-0.0030956,0,0
2,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.65734,0.044012,0.06127,0,0
2,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.89846,0.04399,-0.012299,0,0
2,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.19417,0.043781,0.068035,0,0
2,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.87287,0.043691,-0.012727,0,0
2,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.69885,0.043476,0.023618,0,0
2,GO TISSUE MIGRATION,0.1387,0.043411,0.083587,0,0
2,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.34835,0.043406,0.022994,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.83474,0.043321,-0.003265,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.15565,0.043251,0.059052,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.92738,0.043075,0.015051,0,0
2,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.35043,0.043038,0.11147,0,0
2,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.49487,0.043006,0.026469,0,0
2,GO ACTIN CROSSLINK FORMATION,0.30637,0.042932,-0.09844,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.75972,0.042927,0.0041451,0,0
2,GO TISSUE REMODELING,0.82526,0.042877,-0.018774,0,0
2,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.43789,0.042851,0.036551,0,0
2,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.72603,0.042686,-0.018835,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.95639,0.042662,0.0010495,0,0
2,GO SARCOMERE ORGANIZATION,0.76899,0.042657,0.013081,0,0
2,GO MITOTIC CYTOKINETIC PROCESS,0.68392,0.042587,0.033875,0,0
2,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.7659,0.042501,0.0074881,0,0
2,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.99515,0.042497,0.014552,0,0
2,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.5,0.04247,0.028725,0,0
2,GO AUTOPHAGOSOME MATURATION,0.36311,0.042438,0.040547,0,0
2,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.67798,0.042339,0.023719,0,0
2,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.67501,0.042166,0.020412,0,0
2,GO PROTEIN DESTABILIZATION,0.41434,0.042082,0.039811,0,0
2,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.47963,0.04205,0.050439,0,0
2,GO PARAXIAL MESODERM MORPHOGENESIS,0.70486,0.041996,-0.020797,0,0
2,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.26095,0.041882,0.095216,0,0
2,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.41666,0.041533,0.06798,0,0
2,GO CIRCULATORY SYSTEM DEVELOPMENT,0.76281,0.041482,0.016148,0,0
2,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.10299,0.041443,0.05473,0,0
2,GO NON CANONICAL WNT SIGNALING PATHWAY,0.80012,0.041418,0.0098655,0,0
2,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.20409,0.041397,0.093635,0,0
2,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.49231,0.041392,0.047565,0,0
2,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.93382,0.04126,-0.032165,0,0
2,GO REGULATION OF ATPASE ACTIVITY,0.71996,0.041043,0.010812,0,0
2,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.31021,0.041042,0.033464,0,0
2,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.82526,0.041015,0.0073419,0,0
2,GO RESPONSE TO NUTRIENT,0.71391,0.040855,0.020623,0,0
2,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.94348,0.040827,0.00023439,0,0
2,GO WOUND HEALING,0.45238,0.04081,0.038057,0,0
2,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.27853,0.040714,0.034052,0,0
2,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.83474,0.040533,0.0057183,0,0
2,GO NEGATIVE REGULATION OF LIPID STORAGE,0.6691,0.040512,0.016635,0,0
2,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.73822,0.040381,0.007364,0,0
2,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.71996,0.040346,0.012798,0,0
2,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.66616,0.040316,0.01778,0,0
2,GO RESPONSE TO HEAT,0.13763,0.040244,0.067393,0,0
2,GO LIPID PHOSPHORYLATION,0.58864,0.04024,0.018157,0,0
2,GO TERPENOID BIOSYNTHETIC PROCESS,0.89205,0.04022,0.031238,0,0
2,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.26789,0.040169,0.054956,0,0
2,GO REGULATION OF RNA SPLICING,0.26964,0.040039,0.031372,0,0
2,GO MITOTIC CYTOKINESIS,0.47211,0.040031,0.038134,0,0
2,GO BLASTOCYST GROWTH,0.096327,0.039996,0.079884,0,0
2,GO RESPONSE TO LIGHT STIMULUS,0.30829,0.039862,0.025939,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.72299,0.039754,0.051615,0,0
2,GO SPHINGOID METABOLIC PROCESS,0.56925,0.039657,0.050421,0,0
2,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.5665,0.039651,0.024978,0,0
2,GO REGULATION OF MYELINATION,0.72907,0.039521,0.019129,0,0
2,GO REGULATION OF BONE MINERALIZATION,0.87287,0.039461,0.001055,0,0
2,GO MULTIVESICULAR BODY SORTING PATHWAY,0.66616,0.039457,0.028393,0,0
2,GO PLATELET AGGREGATION,0.21288,0.039417,0.0829,0,0
2,GO P38MAPK CASCADE,0.74741,0.039347,0.012381,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.093126,0.039278,0.083349,0,0
2,GO TRANSLESION SYNTHESIS,0.22195,0.039182,0.050199,0,0
2,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.20992,0.039174,0.037542,0,0
2,GO SPINDLE ASSEMBLY,0.3871,0.038934,0.019258,0,0
2,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.25753,0.038928,0.026921,0,0
2,GO NEPHRIC DUCT MORPHOGENESIS,0.69885,0.0389,0.082977,0,0
2,GO LIPID EXPORT FROM CELL,0.47461,0.038884,0.035541,0,0
2,GO GLYCOSYLATION,0.92094,0.038709,-0.018295,0,0
2,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.99838,0.038676,0.0090681,0,0
2,GO COAGULATION,0.61402,0.038658,0.022446,0,0
2,GO FLUID TRANSPORT,0.94993,0.038579,-0.018788,0,0
2,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.41666,0.038545,0.062744,0,0
2,GO RUFFLE ASSEMBLY,0.71089,0.038534,-0.0020393,0,0
2,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.68988,0.038518,0.036581,0,0
2,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.29877,0.038433,0.076608,0,0
2,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.42367,0.038403,0.072019,0,0
2,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.81581,0.038151,-0.043642,0,0
2,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.28213,0.038148,0.042899,0,0
2,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.95639,0.038065,-0.0013162,0,0
2,GO REGULATION OF DNA CATABOLIC PROCESS,0.39606,0.038039,0.024865,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.92416,0.037958,0.0014895,0,0
2,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.94026,0.037957,-0.0074086,0,0
2,GO REGULATION OF MAP KINASE ACTIVITY,0.7659,0.037902,0.0086773,0,0
2,GO REGULATION OF PINOCYTOSIS,0.58864,0.037884,0.050688,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.5583,0.037882,0.020184,0,0
2,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.86649,0.037875,0.0024043,0,0
2,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.19979,0.037778,0.11976,0,0
2,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.64567,0.03768,0.032673,0,0
2,GO NEGATIVE REGULATION OF BONE REMODELING,0.88245,0.03768,-0.024561,0,0
2,GO RESPONSE TO WATER,0.55016,0.037619,0.056305,0,0
2,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.71089,0.037541,0.0082332,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.24089,0.037503,0.059201,0,0
2,GO NATURAL KILLER CELL ACTIVATION,0.42838,0.037334,0.036405,0,0
2,GO REGULATION OF PROTEIN BINDING,0.86012,0.037304,0.0042858,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.40058,0.037216,0.077852,0,0
2,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.74741,0.037204,0.011775,0,0
2,GO ACTIVATION OF JUN KINASE ACTIVITY,0.88245,0.037122,-0.011828,0,0
2,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.4451,0.037084,0.044291,0,0
2,GO DENTATE GYRUS DEVELOPMENT,0.58864,0.037016,0.010271,0,0
2,GO SKIN MORPHOGENESIS,0.68689,0.036998,0.070133,0,0
2,GO REGULATION OF DNA RECOMBINATION,0.46713,0.036947,0.046782,0,0
2,GO ENDOSOME TO LYSOSOME TRANSPORT,0.96284,0.036934,-0.0078585,0,0
2,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.97253,0.036842,-0.0090564,0,0
2,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.68988,0.036811,0.011907,0,0
2,GO REGULATION OF FIBROBLAST MIGRATION,0.93704,0.036739,0.0033975,0,0
2,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.75972,0.036661,0.017473,0,0
2,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.2644,0.036655,0.060431,0,0
2,GO RESPONSE TO INSULIN,0.73212,0.036513,0.011357,0,0
2,GO REGULATION OF MITOCHONDRIAL FUSION,0.25753,0.036365,0.07091,0,0
2,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.66028,0.036174,0.019897,0,0
2,GO DNA METHYLATION OR DEMETHYLATION,0.063258,0.036064,0.07692,0,0
2,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.34627,0.035993,0.041685,0,0
2,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.71996,0.03588,0.03354,0,0
2,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.81581,0.035774,0.0058673,0,0
2,GO G0 TO G1 TRANSITION,0.36098,0.035718,0.026205,0,0
2,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.7814,0.035698,-0.037396,0,0
2,GO REGULATION OF LIPID STORAGE,0.66321,0.035653,0.018296,0,0
2,GO HETEROCHROMATIN ORGANIZATION,0.70787,0.035595,0.01143,0,0
2,GO SKIN EPIDERMIS DEVELOPMENT,0.58585,0.035577,0.053609,0,0
2,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.84424,0.035514,0.012328,0,0
2,GO ESTABLISHMENT OF TISSUE POLARITY,0.3871,0.03545,0.032584,0,0
2,GO ONE CARBON METABOLIC PROCESS,0.98222,0.035303,0.0035315,0,0
2,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.21738,0.035242,0.044149,0,0
2,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.91772,0.035226,-0.012849,0,0
2,GO MITOCHONDRIAL DEPOLARIZATION,0.90488,0.034867,0.0061389,0,0
2,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.096327,0.034846,0.065299,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.86968,0.034827,0.027559,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.34213,0.034718,0.033872,0,0
2,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.24089,0.034701,0.043002,0,0
2,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.67501,0.034587,0.00039933,0,0
2,GO REGULATION OF CELL MATRIX ADHESION,0.45727,0.034527,0.046846,0,0
2,GO REGULATION OF GTPASE ACTIVITY,0.60834,0.034481,0.01432,0,0
2,GO MITOTIC SPINDLE ASSEMBLY,0.74435,0.034384,0.011567,0,0
2,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.73212,0.034327,0.026972,0,0
2,GO PEROXISOMAL MEMBRANE TRANSPORT,0.39156,0.034316,0.055552,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION,0.59705,0.034294,-0.020367,0,0
2,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.95961,0.034264,-0.0074486,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.84741,0.034263,-0.0066285,0,0
2,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.33194,0.034036,0.044706,0,0
2,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.29502,0.034027,0.079633,0,0
2,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.55016,0.033984,0.04021,0,0
2,GO REGULATION OF MAPK CASCADE,0.66321,0.033941,0.016202,0,0
2,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.34835,0.033885,0.051027,0,0
2,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.89846,0.033751,0.017219,0,0
2,GO RESPONSE TO SALT STRESS,0.15921,0.033686,0.10445,0,0
2,GO THYROID HORMONE METABOLIC PROCESS,0.40973,0.033665,0.03424,0,0
2,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.31215,0.033631,0.083553,0,0
2,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.20409,0.033578,0.093803,0,0
2,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.81267,0.03351,-0.001062,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.99515,0.033484,-0.0013667,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.80639,0.03338,0.0091663,0,0
2,GO RESPONSE TO VITAMIN D,0.64276,0.033374,0.017818,0,0
2,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.45482,0.033236,0.030617,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.73517,0.033191,0.026801,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.54477,0.033123,0.021927,0,0
2,GO ATP METABOLIC PROCESS,0.26964,0.033005,0.045812,0,0
2,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.97253,0.032845,-0.0032866,0,0
2,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.91772,0.03268,-0.0047354,0,0
2,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.19278,0.032676,0.035729,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.078382,0.032429,0.052321,0,0
2,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.36526,0.032374,0.060159,0,0
2,GO MUSCLE FILAMENT SLIDING,0.57476,0.032356,0.029765,0,0
2,GO INNER EAR MORPHOGENESIS,0.45238,0.032331,0.035802,0,0
2,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.092339,0.032299,0.087087,0,0
2,GO ADHERENS JUNCTION ORGANIZATION,0.64276,0.032293,-0.030576,0,0
2,GO EAR MORPHOGENESIS,0.31997,0.03225,0.041971,0,0
2,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.96607,0.03225,-0.0012154,0,0
2,GO CENTROSOME SEPARATION,0.88885,0.032204,0.00024511,0,0
2,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.35463,0.032154,0.055214,0,0
2,GO KIDNEY MORPHOGENESIS,0.58029,0.032031,0.016763,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.60268,0.031986,-0.018419,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.61972,0.031965,0.014159,0,0
2,GO ORGAN GROWTH,0.73822,0.031826,0.04147,0,0
2,GO CELLULAR RESPONSE TO FATTY ACID,0.72299,0.031715,-0.025205,0,0
2,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.56925,0.031698,0.016969,0,0
2,GO CELLULAR RESPONSE TO HEAT,0.21437,0.031698,0.064555,0,0
2,GO POSITIVE REGULATION OF PROTEIN BINDING,0.84741,0.031655,0.0025734,0,0
2,GO PHOTOTRANSDUCTION,0.22195,0.031654,0.10264,0,0
2,GO SHORT TERM MEMORY,0.37827,0.031517,0.10643,0,0
2,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.39832,0.031463,0.036008,0,0
2,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.48215,0.031433,0.015678,0,0
2,GO ESTROGEN METABOLIC PROCESS,0.48976,0.031288,0.04861,0,0
2,GO DECIDUALIZATION,1,0.031244,-0.013119,0,0
2,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.95961,0.031216,0.0030886,0,0
2,GO POSITIVE REGULATION OF CHEMOTAXIS,0.70787,0.031196,0.0058869,0,0
2,GO JNK CASCADE,0.61687,0.031192,0.024551,0,0
2,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.46466,0.031179,0.034859,0,0
2,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.94671,0.031063,0.0063835,0,0
2,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.98222,0.031031,-0.00083885,0,0
2,GO SEQUESTERING OF CALCIUM ION,0.75972,0.030932,0.017854,0,0
2,GO MAST CELL MEDIATED IMMUNITY,0.45727,0.030844,0.051388,0,0
2,GO MITOTIC CELL CYCLE CHECKPOINT,0.67206,0.030738,0.014192,0,0
2,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.7814,0.030704,0.008797,0,0
2,GO REPLACEMENT OSSIFICATION,0.28761,0.030691,0.089577,0,0
2,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.9693,0.030604,-0.011463,0,0
2,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.5583,0.030469,0.022438,0,0
2,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.31997,0.030412,0.050142,0,0
2,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.3739,0.030392,0.071668,0,0
2,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.81267,0.030138,0.0095208,0,0
2,GO RESPONSE TO ETHANOL,0.89205,0.030019,0.019643,0,0
2,GO HOMEOSTATIC PROCESS,0.87926,0.029989,-0.00059363,0,0
2,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.24089,0.029744,0.037021,0,0
2,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.50516,0.029695,0.05094,0,0
2,GO RENAL FILTRATION,0.98222,0.029691,-0.0017543,0,0
2,GO REGULATION OF FATTY ACID BETA OXIDATION,0.72299,0.029689,0.03391,0,0
2,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.572,0.029621,0.032719,0,0
2,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.73212,0.029525,0.042556,0,0
2,GO CELL SUBSTRATE ADHESION,0.46962,0.029392,0.044292,0,0
2,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.22348,0.029349,0.044455,0,0
2,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.90488,0.029317,-0.030192,0,0
2,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.48976,0.029301,0.096333,0,0
2,GO POSITIVE REGULATION OF RNA SPLICING,0.63408,0.029245,-0.038715,0,0
2,GO CYTOSKELETON ORGANIZATION,0.99192,0.029241,-0.0042383,0,0
2,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.38488,0.029203,0.060577,0,0
2,GO MYOFIBRIL ASSEMBLY,0.81267,0.029146,0.0048989,0,0
2,GO REGULATION OF ACTION POTENTIAL,0.44028,0.029091,0.039453,0,0
2,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.88245,0.028976,-0.01413,0,0
2,GO CERAMIDE BIOSYNTHETIC PROCESS,0.9693,0.028866,0.0032193,0,0
2,GO RESPONSE TO NITRIC OXIDE,0.53406,0.028828,0.031462,0,0
2,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.69286,0.028713,0.013223,0,0
2,GO REGULATION OF FILOPODIUM ASSEMBLY,0.72603,0.028701,0.022549,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.15683,0.028671,0.082059,0,0
2,GO MITOTIC SISTER CHROMATID SEGREGATION,0.27317,0.028622,0.037279,0,0
2,GO CELLULAR RESPONSE TO IRON ION,0.48722,0.028621,0.072285,0,0
2,GO TUBE DEVELOPMENT,0.98546,0.028272,0.0062712,0,0
2,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.92416,0.028267,-0.0024802,0,0
2,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.59986,0.028245,-0.019566,0,0
2,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.65734,0.028187,0.024567,0,0
2,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.86331,0.028059,-0.0051786,0,0
2,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.6691,0.027937,0.038387,0,0
2,GO XENOBIOTIC TRANSPORT,0.94993,0.027685,-0.0072142,0,0
2,GO ER NUCLEUS SIGNALING PATHWAY,0.48722,0.027622,0.028451,0,0
2,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.75972,0.027541,0.018046,0,0
2,GO CELLULAR RESPONSE TO KETONE,0.46466,0.027478,0.037618,0,0
2,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.31021,0.02747,0.043212,0,0
2,GO METHIONINE METABOLIC PROCESS,0.99515,0.027284,-0.011823,0,0
2,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.54746,0.027281,-0.033755,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.87606,0.027281,-0.0016695,0,0
2,GO SULFUR COMPOUND CATABOLIC PROCESS,0.5,0.027111,0.043217,0,0
2,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.55287,0.026928,0.047454,0,0
2,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.83158,0.026843,-0.033171,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.1653,0.026787,0.088117,0,0
2,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.32792,0.026684,0.066155,0,0
2,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.5,0.026634,0.098839,0,0
2,GO MEMBRANE DISASSEMBLY,0.75356,0.026596,0.027126,0,0
2,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.21738,0.026556,0.072109,0,0
2,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.80953,0.026536,-0.012667,0,0
2,GO EPITHELIAL STRUCTURE MAINTENANCE,0.2714,0.026445,0.070268,0,0
2,GO SEX DETERMINATION,0.66028,0.026436,-0.03875,0,0
2,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.69885,0.026428,0.017977,0,0
2,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.25924,0.026411,0.047688,0,0
2,GO MITOCHONDRION ORGANIZATION,0.25414,0.02641,0.033797,0,0
2,GO GLIAL CELL PROLIFERATION,0.4355,0.026346,0.05075,0,0
2,GO PRO B CELL DIFFERENTIATION,0.50516,0.026341,0.091119,0,0
2,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.65442,0.026143,0.017533,0,0
2,GO REGULATION OF MRNA PROCESSING,0.69586,0.026082,0.010904,0,0
2,GO LIPID STORAGE,0.80012,0.026076,0.0136,0,0
2,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.6515,0.025955,0.016337,0,0
2,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.48976,0.025934,-0.027094,0,0
2,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.21738,0.025923,0.050874,0,0
2,GO PEPTIDYL LYSINE MODIFICATION,0.41899,0.02576,0.016057,0,0
2,GO SNRNA TRANSCRIPTION,0.19003,0.025743,0.044569,0,0
2,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.16285,0.025618,0.045844,0,0
2,GO REGULATION OF EXCRETION,0.98222,0.025441,0.023657,0,0
2,GO RESPONSE TO STEROL,0.3871,0.025389,0.049435,0,0
2,GO EXOCYTOSIS,0.81581,0.025194,0.009126,0,0
2,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.10299,0.025036,0.055348,0,0
2,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.76899,0.025017,0.015792,0,0
2,GO CHROMATIN SILENCING,0.44269,0.024906,0.032599,0,0
2,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.3871,0.024766,0.036859,0,0
2,GO REGULATION OF CENTROSOME CYCLE,0.98869,0.02446,0.0048469,0,0
2,GO ERAD PATHWAY,0.48468,0.024434,0.029426,0,0
2,GO HYALURONAN METABOLIC PROCESS,0.59144,0.024412,-0.032145,0,0
2,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.18595,0.024384,0.070361,0,0
2,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.65442,0.024357,0.030354,0,0
2,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.84424,0.024352,0.011207,0,0
2,GO IRON SULFUR CLUSTER ASSEMBLY,0.18327,0.024249,0.067311,0,0
2,GO HOMOLOGOUS RECOMBINATION,0.40743,0.024039,0.02846,0,0
2,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.62832,0.023994,0.016041,0,0
2,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.86968,0.023958,0.019337,0,0
2,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.19557,0.023941,0.028015,0,0
2,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.57476,0.023924,0.029823,0,0
2,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.58307,0.023817,0.049509,0,0
2,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.76281,0.023778,0.0079907,0,0
2,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.8379,0.023746,0.018317,0,0
2,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.72299,0.023549,0.022254,0,0
2,GO VAGINA DEVELOPMENT,0.84741,0.023468,-0.020427,0,0
2,GO ESTABLISHMENT OF CELL POLARITY,0.78763,0.023435,0.0072206,0,0
2,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.19838,0.023371,0.10194,0,0
2,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.50258,0.023324,-0.034515,0,0
2,GO HORMONE METABOLIC PROCESS,0.77209,0.023315,-0.0020003,0,0
2,GO PROTEIN POLYMERIZATION,0.52345,0.02328,0.013093,0,0
2,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.74741,0.023259,-0.01134,0,0
2,GO GLIAL CELL APOPTOTIC PROCESS,0.99515,0.023147,-0.0046951,0,0
2,GO NEGATIVE REGULATION OF GROWTH,0.76281,0.023064,-0.015697,0,0
2,GO EPITHELIAL CELL DEVELOPMENT,0.88885,0.023057,-0.0019352,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.49743,0.023026,0.018795,0,0
2,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.33599,0.02297,0.029243,0,0
2,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.92416,0.022919,-0.0015035,0,0
2,GO REGULATION OF TELOMERE CAPPING,0.48468,0.022733,0.033073,0,0
2,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.82842,0.02264,-0.0081967,0,0
2,GO PEPTIDYL LYSINE ACETYLATION,0.94671,0.022584,-0.0071759,0,0
2,GO AMINO SUGAR BIOSYNTHETIC PROCESS,1,0.0225,0.0017807,0,0
2,GO SISTER CHROMATID SEGREGATION,0.3739,0.022479,0.03156,0,0
2,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.54746,0.022451,0.047139,0,0
2,GO SISTER CHROMATID COHESION,0.66616,0.022443,0.023808,0,0
2,GO NEGATIVE REGULATION OF CELL GROWTH,0.39606,0.022383,-0.044795,0,0
2,GO G2 DNA DAMAGE CHECKPOINT,0.66616,0.022381,0.017076,0,0
2,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.91772,0.022346,0.0043213,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.30829,0.022146,0.042753,0,0
2,GO MUSCLE CELL PROLIFERATION,0.46218,0.022145,0.034003,0,0
2,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.96284,0.022099,-0.0047558,0,0
2,GO CELL CYCLE CHECKPOINT,0.56925,0.022086,0.022406,0,0
2,GO REGULATION OF CELLULAR COMPONENT SIZE,0.95639,0.022085,-0.0051824,0,0
2,GO PROTEIN KINASE A SIGNALING,0.56376,0.022039,0.027678,0,0
2,GO POSITIVE REGULATION OF MAPK CASCADE,0.72907,0.021992,0.013195,0,0
2,GO NEURAL CREST CELL DIFFERENTIATION,0.90167,0.02199,0.017731,0,0
2,GO APPENDAGE DEVELOPMENT,0.75972,0.021894,0.023108,0,0
2,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.85694,0.021806,0.011567,0,0
2,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.86649,0.021795,-0.057728,0,0
2,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.83474,0.021709,-0.022076,0,0
2,GO URONIC ACID METABOLIC PROCESS,0.33194,0.02167,0.040299,0,0
2,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.80326,0.021664,4.1116e-05,0,0
2,GO PROTEIN K48 LINKED UBIQUITINATION,0.55558,0.021607,0.032442,0,0
2,GO PROTEIN TARGETING TO MEMBRANE,0.38047,0.021488,0.04681,0,0
2,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.70185,0.021241,0.015734,0,0
2,GO KETONE BIOSYNTHETIC PROCESS,0.98222,0.021181,-0.019104,0,0
2,GO LIPID DIGESTION,0.74741,0.021125,-0.064732,0,0
2,GO REGULATION OF MUSCLE HYPERTROPHY,0.39156,0.021105,-0.046132,0,0
2,GO SENSORY ORGAN MORPHOGENESIS,0.67798,0.02103,0.014902,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.82526,0.020932,0.014155,0,0
2,GO MYELOID CELL DEVELOPMENT,0.42838,0.020814,0.062385,0,0
2,GO SYNCYTIUM FORMATION,0.25078,0.020567,0.060525,0,0
2,GO DIOL METABOLIC PROCESS,0.89846,0.020561,0.012186,0,0
2,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.76899,0.020354,-0.013215,0,0
2,GO RECOMBINATIONAL REPAIR,0.41899,0.02035,0.037611,0,0
2,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.61687,0.020312,0.023228,0,0
2,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.91451,0.020299,0.010709,0,0
2,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.86012,0.020269,-0.020889,0,0
2,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.2644,0.019946,0.057325,0,0
2,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.24089,0.019894,0.10436,0,0
2,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.80639,0.019879,-0.012624,0,0
2,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.81267,0.01974,-0.0075328,0,0
2,GO SULFUR COMPOUND TRANSPORT,0.88245,0.019698,0.0042935,0,0
2,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.99192,0.019535,-0.0038054,0,0
2,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.24911,0.019529,0.099696,0,0
2,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.55016,0.019382,0.062333,0,0
2,GO DISACCHARIDE METABOLIC PROCESS,0.15802,0.019344,0.094443,0,0
2,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.73517,0.019199,0.026003,0,0
2,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.19697,0.019078,0.080889,0,0
2,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.98222,0.019032,-0.0057547,0,0
2,GO EMBRYONIC ORGAN DEVELOPMENT,0.93704,0.018952,0.005958,0,0
2,GO REGULATION OF CHEMOTAXIS,0.80953,0.018928,-0.0019322,0,0
2,GO KERATINOCYTE MIGRATION,0.30066,0.018924,0.073772,0,0
2,GO RESPONSE TO MINERALOCORTICOID,0.68689,0.018872,0.012502,0,0
2,GO REGULATION OF SPINDLE ASSEMBLY,0.48976,0.018846,0.05549,0,0
2,GO CHROMOSOME CONDENSATION,0.80012,0.018799,0.018341,0,0
2,GO NEURAL CREST CELL MIGRATION,0.98869,0.018781,-0.0042326,0,0
2,GO HISTONE H2A MONOUBIQUITINATION,0.65734,0.018692,-0.041417,0,0
2,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.98546,0.018645,-0.029053,0,0
2,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.71391,0.018628,0.009091,0,0
2,GO VIRAL BUDDING,0.51819,0.018591,0.037246,0,0
2,GO FACE DEVELOPMENT,0.98222,0.018575,0.0090544,0,0
2,GO AUTOPHAGY OF MITOCHONDRION,0.80326,0.018541,-0.0034756,0,0
2,GO PROTEIN AUTO ADP RIBOSYLATION,0.5,0.018536,0.070236,0,0
2,GO REGULATION OF HISTONE DEACETYLATION,0.97576,0.01846,-0.0081144,0,0
2,GO REGULATION OF DEPHOSPHORYLATION,0.63697,0.018452,-0.016029,0,0
2,GO CELL MOTILITY,0.93704,0.018449,-0.0042086,0,0
2,GO RECEPTOR METABOLIC PROCESS,0.89526,0.0184,0.010131,0,0
2,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.47963,0.018389,-0.020572,0,0
2,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.98546,0.018377,9.4319e-05,0,0
2,GO REGULATION OF RESPONSE TO WOUNDING,0.54477,0.018362,0.031707,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.90809,0.018359,0.017752,0,0
2,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.797,0.01835,-0.018811,0,0
2,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.35253,0.018272,0.029482,0,0
2,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.87926,0.018212,0.00027991,0,0
2,GO ARTERY DEVELOPMENT,0.33396,0.017989,0.078303,0,0
2,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.2114,0.017953,0.10808,0,0
2,GO CELLULAR RESPONSE TO PEPTIDE,0.71391,0.017929,-0.010117,0,0
2,GO GLUCOSE METABOLIC PROCESS,0.77829,0.017862,-0.00068861,0,0
2,GO PROTEIN TARGETING,0.47712,0.017762,0.03824,0,0
2,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.44752,0.017752,-0.043834,0,0
2,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.80639,0.017741,-0.036394,0,0
2,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.91772,0.017705,-0.0001111,0,0
2,GO REGULATION OF CHROMATIN BINDING,0.73212,0.017573,0.026732,0,0
2,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.51035,0.01748,0.040269,0,0
2,GO PROTEIN CONTAINING COMPLEX REMODELING,0.47712,0.01744,0.048034,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.87606,0.017426,-0.013851,0,0
2,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.47211,0.017263,0.075023,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.18595,0.017205,0.042438,0,0
2,GO RESPONSE TO WOUNDING,0.76899,0.017201,0.011714,0,0
2,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.61402,0.017086,-0.0086572,0,0
2,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.5,0.016925,0.032514,0,0
2,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.16163,0.016749,0.074875,0,0
2,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.73212,0.016704,-0.00034177,0,0
2,GO INTRACELLULAR LIPID TRANSPORT,0.2913,0.016656,0.070971,0,0
2,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.88885,0.016627,0.0095685,0,0
2,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.89205,0.016602,0.0078029,0,0
2,GO MESODERM MORPHOGENESIS,0.58864,0.016587,0.016671,0,0
2,GO RECEPTOR INTERNALIZATION,0.64276,0.016514,-0.0073935,0,0
2,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.90809,0.016512,-0.013369,0,0
2,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.5314,0.016471,0.051644,0,0
2,GO EPITHELIAL CELL PROLIFERATION,0.88885,0.016215,-0.0060928,0,0
2,GO MEMBRANE LIPID METABOLIC PROCESS,0.94026,0.016211,-0.0023539,0,0
2,GO CARNITINE METABOLIC PROCESS,0.94026,0.016147,0.00032481,0,0
2,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.84424,0.016097,0.0049261,0,0
2,GO MITOTIC NUCLEAR DIVISION,0.64567,0.016082,0.015302,0,0
2,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.63408,0.015905,-0.019849,0,0
2,GO GPI ANCHOR METABOLIC PROCESS,0.92738,0.015857,0.0058105,0,0
2,GO PEPTIDYL ARGININE METHYLATION,0.3871,0.015829,0.054627,0,0
2,GO NEGATIVE REGULATION OF DNA REPLICATION,0.97576,0.015808,0.042531,0,0
2,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.96607,0.0158,0.0022122,0,0
2,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.98869,0.015669,-0.0019329,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.23445,0.015665,0.063057,0,0
2,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.48468,0.015661,0.023537,0,0
2,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.7814,0.015614,0.029551,0,0
2,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.9306,0.01536,-0.0040931,0,0
2,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.69586,0.015138,-0.026549,0,0
2,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.84741,0.015059,-0.01494,0,0
2,GO PROTEIN LOCALIZATION TO ORGANELLE,0.38488,0.014983,0.022518,0,0
2,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.82526,0.014975,-0.019432,0,0
2,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.25246,0.014972,0.086256,0,0
2,GO MORPHOGENESIS OF AN EPITHELIUM,0.60834,0.014961,0.02736,0,0
2,GO BONE REMODELING,0.5394,0.014898,-0.035463,0,0
2,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.98222,0.014871,0.0089889,0,0
2,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.14755,0.014852,-0.089691,0,0
2,GO RENAL SODIUM EXCRETION,0.99192,0.014811,0.015552,0,0
2,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.69586,0.014747,0.015133,0,0
2,GO EXTRACELLULAR MATRIX ASSEMBLY,0.69885,0.014697,0.012628,0,0
2,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.73212,0.014521,0.015012,0,0
2,GO POSITIVE REGULATION OF DNA REPAIR,0.90488,0.014461,0.0040704,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.97576,0.014447,0.0016954,0,0
2,GO RESPONSE TO ENDOGENOUS STIMULUS,0.49231,0.014424,-0.025547,0,0
2,GO NEUTRAL AMINO ACID TRANSPORT,0.95639,0.014421,0.031413,0,0
2,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.82526,0.014382,-0.013814,0,0
2,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.94026,0.014307,0.014286,0,0
2,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.80639,0.014271,0.0050239,0,0
2,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.86331,0.014233,0.016567,0,0
2,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.61402,0.014185,0.018727,0,0
2,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.79075,0.014097,0.016067,0,0
2,GO REGULATION OF CELL CYCLE,0.92738,0.014089,0.0033506,0,0
2,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.54208,0.014043,-0.024809,0,0
2,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.88565,0.014014,-0.009205,0,0
2,GO GLYCOSIDE METABOLIC PROCESS,0.53406,0.014007,0.020008,0,0
2,GO PROTEIN K11 LINKED UBIQUITINATION,0.52609,0.013974,0.032836,0,0
2,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.77519,0.013872,-0.017776,0,0
2,GO MISMATCH REPAIR,0.77519,0.013794,-0.013823,0,0
2,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.35463,0.013788,0.045581,0,0
2,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.318,0.013772,0.042861,0,0
2,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.63697,0.013771,-0.025058,0,0
2,GO MATERNAL PLACENTA DEVELOPMENT,0.92738,0.013765,-0.0028675,0,0
2,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.52609,0.013682,-0.034731,0,0
2,GO REGULATION OF MUSCLE CONTRACTION,0.59705,0.013651,-0.020763,0,0
2,GO DNA PACKAGING,0.81267,0.013648,0.005767,0,0
2,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.90488,0.013599,-0.01274,0,0
2,GO RESPONSE TO IRON ION,0.9113,0.013563,0.018011,0,0
2,GO SUBSTANTIA NIGRA DEVELOPMENT,0.63408,0.01354,-0.027495,0,0
2,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.57752,0.013492,0.029666,0,0
2,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.74128,0.013423,0.010763,0,0
2,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.90809,0.013243,-0.028289,0,0
2,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.93704,0.013229,0.0060041,0,0
2,GO POSITIVE REGULATION OF OSSIFICATION,0.21288,0.01312,-0.087694,0,0
2,GO EMBRYO DEVELOPMENT,0.96284,0.013034,0.0050943,0,0
2,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.40058,0.012945,-0.035923,0,0
2,GO AORTIC VALVE DEVELOPMENT,0.6055,0.012926,0.053758,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.34213,0.012908,-0.041593,0,0
2,GO CELL MATRIX ADHESION,0.61972,0.012893,0.030693,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION,0.84107,0.012877,-0.014512,0,0
2,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.83474,0.012667,0.01072,0,0
2,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.52345,0.012547,0.015729,0,0
2,GO FAT CELL DIFFERENTIATION,0.87926,0.012534,0.0073673,0,0
2,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.6312,0.012511,0.027806,0,0
2,GO MITOTIC SPINDLE ORGANIZATION,0.68988,0.012459,-0.017051,0,0
2,GO FIBROBLAST MIGRATION,0.88245,0.012336,0.019694,0,0
2,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.34627,0.012271,0.070504,0,0
2,GO RESPONSE TO PEPTIDE,0.98222,0.012052,-0.0008976,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.63408,0.012034,0.03093,0,0
2,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.97253,0.012025,-0.0018655,0,0
2,GO PROTEIN HOMOTETRAMERIZATION,0.28761,0.01191,0.049924,0,0
2,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.6055,0.011881,0.031955,0,0
2,GO PEPTIDYL ASPARAGINE MODIFICATION,0.61687,0.011768,0.023577,0,0
2,GO MACROPHAGE PROLIFERATION,0.98869,0.011579,0.00031104,0,0
2,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.66321,0.011577,-0.018702,0,0
2,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.9113,0.011557,0.0025519,0,0
2,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.46466,0.011484,0.049144,0,0
2,GO SEMI LUNAR VALVE DEVELOPMENT,0.98222,0.011331,0.026269,0,0
2,GO CELL CYCLE DNA REPLICATION,0.82842,0.011257,0.022809,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.90809,0.011255,-0.0071996,0,0
2,GO POST ANAL TAIL MORPHOGENESIS,0.5394,0.011186,-0.038413,0,0
2,GO INTRA S DNA DAMAGE CHECKPOINT,0.48468,0.011092,0.032367,0,0
2,GO REGULATION OF BIOMINERALIZATION,0.80953,0.011082,-0.017043,0,0
2,GO REGULATION OF HEART GROWTH,0.85059,0.010917,-0.0071517,0,0
2,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.80012,0.010916,-0.011404,0,0
2,GO PROGESTERONE METABOLIC PROCESS,0.68988,0.01091,-0.0031092,0,0
2,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.61117,0.010905,0.023916,0,0
2,GO OSTEOBLAST PROLIFERATION,0.65734,0.010802,0.028436,0,0
2,GO RESPONSE TO ACTIVITY,0.28213,0.010788,0.043289,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.54477,0.010725,0.034248,0,0
2,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.75356,0.010667,0.015839,0,0
2,GO REGULATION OF MEMBRANE INVAGINATION,0.88565,0.010663,0.0092141,0,0
2,GO GLAND DEVELOPMENT,0.5583,0.010661,-0.019756,0,0
2,GO INTRACELLULAR TRANSPORT,0.70787,0.010628,0.0047241,0,0
2,GO PROTEIN HETEROTETRAMERIZATION,0.79075,0.010592,0.018653,0,0
2,GO REGULATION OF PROTON TRANSPORT,0.31021,0.010508,-0.071617,0,0
2,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.59144,0.010454,0.018964,0,0
2,GO PENILE ERECTION,0.68094,0.010361,0.0062596,0,0
2,GO SECRETION,0.48976,0.010227,-0.029114,0,0
2,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.63408,0.010128,0.042962,0,0
2,GO SEX DIFFERENTIATION,0.56376,0.0099343,-0.019563,0,0
2,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.5665,0.0099279,-0.02587,0,0
2,GO NEGATIVE REGULATION OF AXONOGENESIS,0.81267,0.0098753,-0.018596,0,0
2,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.5583,0.0098459,-0.023734,0,0
2,GO CALCINEURIN MEDIATED SIGNALING,0.75356,0.0097957,0.021218,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE,0.55016,0.0097344,-0.017024,0,0
2,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.39381,0.0097164,-0.032538,0,0
2,GO AMINO ACID BETAINE METABOLIC PROCESS,0.68392,0.0096348,0.014651,0,0
2,GO RESPONSE TO ACID CHEMICAL,0.87606,0.0095747,0.01238,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.91451,0.0095334,0.011269,0,0
2,GO REGULATION OF GLUCONEOGENESIS,0.77209,0.0095137,-0.012964,0,0
2,GO CENTRIOLE ASSEMBLY,0.62545,0.0094319,0.015644,0,0
2,GO REGULATION OF RECEPTOR RECYCLING,0.9693,0.0094076,0.010913,0,0
2,GO REGULATION OF ERAD PATHWAY,0.79075,0.0093571,0.014843,0,0
2,GO RESPONSE TO PROSTAGLANDIN,0.83158,0.0089976,0.015389,0,0
2,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.65734,0.0088157,0.022482,0,0
2,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.57752,0.0087189,0.088426,0,0
2,GO REGULATION OF AMYLOID BETA CLEARANCE,0.73212,0.0087036,0.022045,0,0
2,GO HISTONE H3 K9 DEMETHYLATION,0.82526,0.0085277,-0.0065906,0,0
2,GO MUSCLE HYPERTROPHY,0.38933,0.0083551,-0.039203,0,0
2,GO CORPUS CALLOSUM DEVELOPMENT,0.93704,0.0082949,0.01795,0,0
2,GO ATP BIOSYNTHETIC PROCESS,0.86012,0.0081901,-0.0026333,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.8379,0.0081546,0.0078183,0,0
2,GO REGULATION OF HISTONE MODIFICATION,0.88885,0.0081405,-0.011726,0,0
2,GO ENDOTHELIAL CELL DEVELOPMENT,0.78763,0.0080827,-0.017878,0,0
2,GO BLOOD VESSEL REMODELING,0.92738,0.0080559,-0.012172,0,0
2,GO HISTONE H3 K9 METHYLATION,0.98546,0.0079975,0.0052851,0,0
2,GO DIOL BIOSYNTHETIC PROCESS,0.66028,0.0077671,0.016511,0,0
2,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.54746,0.0075093,0.044388,0,0
2,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.64858,0.0074881,0.033329,0,0
2,GO PROTEIN ACETYLATION,0.75048,0.007363,-0.011428,0,0
2,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.82211,0.0072313,0.012208,0,0
2,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.77519,0.0071147,0.021344,0,0
2,GO CELLULAR RESPONSE TO MANGANESE ION,0.71089,0.0070539,0.028438,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.90167,0.0069754,0.010766,0,0
2,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.75048,0.0068841,0.020002,0,0
2,GO MAINTENANCE OF LOCATION,0.86649,0.0068248,0.0091884,0,0
2,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.90488,0.0067492,0.0045616,0,0
2,GO REGULATION OF ANOIKIS,0.61972,0.0067403,0.044199,0,0
2,GO CELL DIVISION,0.57476,0.0067289,0.021025,0,0
2,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.94993,0.006556,0.004696,0,0
2,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.65734,0.0065531,0.029104,0,0
2,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.36526,0.0064791,0.032929,0,0
2,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.70185,0.0063915,-0.016401,0,0
2,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.67206,0.0062837,-0.022229,0,0
2,GO HISTONE H3 K4 METHYLATION,0.68392,0.0061979,0.023018,0,0
2,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.86968,0.0061899,0.011889,0,0
2,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.99192,0.0061618,-0.0035472,0,0
2,GO NEURON REMODELING,0.68988,0.0061189,-0.041633,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.85059,0.0061025,0.0089407,0,0
2,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.74128,0.006059,0.023972,0,0
2,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.66028,0.0058561,-0.032533,0,0
2,GO POSITIVE REGULATION OF VASCULOGENESIS,0.73517,0.0058256,0.0089293,0,0
2,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.47461,0.0058086,0.036916,0,0
2,GO REGULATION OF ORGANELLE ASSEMBLY,0.81896,0.0057663,-0.014345,0,0
2,GO RESPONSE TO ESTRADIOL,0.94993,0.0057389,-0.0029682,0,0
2,GO SEGMENTATION,0.77209,0.0057312,0.023584,0,0
2,GO METHIONINE BIOSYNTHETIC PROCESS,0.95639,0.0056262,-0.024875,0,0
2,GO ACTIVATION OF MAPK ACTIVITY,0.61402,0.0056203,-0.019537,0,0
2,GO APPENDAGE MORPHOGENESIS,0.99515,0.0055785,0.010566,0,0
2,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.4451,0.0055219,0.035707,0,0
2,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.58029,0.005508,-0.011198,0,0
2,GO CELLULAR MACROMOLECULE LOCALIZATION,0.58864,0.0054525,-0.021746,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.94993,0.0054389,-0.0060281,0,0
2,GO MESENCHYME MORPHOGENESIS,0.47211,0.0054336,-0.045697,0,0
2,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.22042,0.0053057,-0.058517,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.58585,0.0052221,-0.01803,0,0
2,GO CHOLESTEROL EFFLUX,0.67798,0.005205,0.029262,0,0
2,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.85376,0.0050064,0.026181,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.63408,0.004917,-0.030466,0,0
2,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.94671,0.0047613,0.0092974,0,0
2,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.86968,0.0047559,0.048979,0,0
2,GO MEMBRANE ORGANIZATION,0.30066,0.0046716,-0.034215,0,0
2,GO POSITIVE REGULATION OF SIGNALING,0.45238,0.0046312,-0.029199,0,0
2,GO SULFATION,0.76899,0.0044959,-0.018935,0,0
2,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.74128,0.0043372,0.017097,0,0
2,GO ORGANELLE INHERITANCE,0.76899,0.0043109,0.017551,0,0
2,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.64276,0.0042687,0.038273,0,0
2,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.318,0.0041564,-0.035104,0,0
2,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.5394,0.0041149,0.077617,0,0
2,GO HISTONE H4 K5 ACETYLATION,0.62258,0.0040323,-0.024183,0,0
2,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.61972,0.0038073,0.020459,0,0
2,GO T CELL HOMEOSTASIS,1,0.0037373,0.011246,0,0
2,GO ANOIKIS,0.84107,0.003556,0.027476,0,0
2,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.64858,0.0034799,-0.016227,0,0
2,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.55558,0.0034585,-0.018776,0,0
2,GO HORMONE BIOSYNTHETIC PROCESS,0.96607,0.0033847,0.011108,0,0
2,GO REGULATION OF CELL DIVISION,0.68094,0.0033655,-0.014998,0,0
2,GO PROTEIN REFOLDING,0.94026,0.0032228,-0.0068452,0,0
2,GO NEGATIVE REGULATION OF CELL AGING,0.28395,0.0032153,0.077494,0,0
2,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.73212,0.0031532,0.023555,0,0
2,GO PROTEIN INSERTION INTO MEMBRANE,0.63986,0.0031456,-0.022474,0,0
2,GO COENZYME A METABOLIC PROCESS,0.94026,0.0031151,0.0074048,0,0
2,GO CANONICAL WNT SIGNALING PATHWAY,0.67206,0.0030493,-0.013617,0,0
2,GO REGULATION OF RECEPTOR BINDING,0.36311,0.0030056,0.090531,0,0
2,GO T CELL SELECTION,0.69586,0.0029266,0.023503,0,0
2,GO NUCLEAR CHROMOSOME SEGREGATION,0.76899,0.0028662,0.0086821,0,0
2,GO AMINOGLYCAN CATABOLIC PROCESS,0.75048,0.0028463,0.0059936,0,0
2,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.82842,0.002824,0.0089154,0,0
2,GO CHROMOSOME SEGREGATION,0.62832,0.0027645,0.015442,0,0
2,GO ENDOSOMAL TRANSPORT,0.78763,0.0026394,0.0057722,0,0
2,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.68689,0.0025755,-0.014999,0,0
2,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.47712,0.0025578,0.037239,0,0
2,GO DNA REPLICATION CHECKPOINT,0.64567,0.0024013,0.047182,0,0
2,GO MEMBRANE HYPERPOLARIZATION,0.90809,0.002311,-0.0015553,0,0
2,GO POSITIVE REGULATION OF TRANSPORT,0.23128,0.0021854,-0.042896,0,0
2,GO CERAMIDE CATABOLIC PROCESS,0.71391,0.0021782,0.021696,0,0
2,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.9306,0.0020245,-0.006646,0,0
2,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.52874,0.0018521,0.02755,0,0
2,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.68689,0.0017638,-0.020279,0,0
2,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.83158,0.0017145,-0.006326,0,0
2,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.29689,0.0016868,-0.033832,0,0
2,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.91451,0.0016775,0.020188,0,0
2,GO CARTILAGE DEVELOPMENT,0.99515,0.0016281,0.0041753,0,0
2,GO AUTOPHAGOSOME ORGANIZATION,0.69885,0.00135,0.016094,0,0
2,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.95316,0.0013378,-0.003394,0,0
2,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.5314,0.0012701,0.023351,0,0
2,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.77519,0.0012152,-0.016552,0,0
2,GO REGULATION OF MEMBRANE PERMEABILITY,0.71391,0.001189,-0.0069129,0,0
2,GO MANNOSYLATION,0.53672,0.0011734,-0.037148,0,0
2,GO WATER TRANSPORT,0.40973,0.00086948,-0.071061,0,0
2,GO STEROL TRANSPORT,0.71089,0.00074256,0.019765,0,0
2,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.68392,0.00073383,-0.014329,0,0
2,GO PROTEIN N LINKED GLYCOSYLATION,1,0.00053557,-0.0055008,0,0
2,GO NUCLEUS ORGANIZATION,0.96284,0.00047746,-0.0094361,0,0
2,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.99192,0.00047404,-0.0054806,0,0
2,GO REGULATION OF CENTROSOME DUPLICATION,0.76281,0.00044461,-0.0061276,0,0
2,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.45238,0.00034118,-0.028074,0,0
2,GO ORGANELLE ASSEMBLY,0.40743,0.00029465,-0.026599,0,0
2,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.47461,1.5137e-05,0.047056,0,0
2,GO LACTATE METABOLIC PROCESS,0.96607,-8.4133e-06,-0.0075581,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.9113,-3.1528e-05,0.0060032,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.26964,-7.1368e-05,0.12304,0,0
2,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.53406,-8.1538e-05,-0.026441,0,0
2,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.82842,-0.00012378,0.013617,0,0
2,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.44269,-0.00020198,-0.047901,0,0
2,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.83158,-0.00030946,-0.018145,0,0
2,GO DEPHOSPHORYLATION,0.41203,-0.00035998,-0.025316,0,0
2,GO CRANIAL NERVE MORPHOGENESIS,0.4451,-0.0003926,-0.057739,0,0
2,GO MEMBRANE RAFT ORGANIZATION,0.91451,-0.00046266,0.01747,0,0
2,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.43075,-0.00058121,-0.021867,0,0
2,GO HEAT GENERATION,0.86012,-0.00085095,0.01117,0,0
2,GO METAPHASE PLATE CONGRESSION,0.99515,-0.00088096,0.012535,0,0
2,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.81896,-0.00093184,0.0075143,0,0
2,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.99515,-0.0010277,0.00016675,0,0
2,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.96607,-0.0010788,0.018518,0,0
2,GO INTERSTRAND CROSS LINK REPAIR,0.64858,-0.001123,0.016152,0,0
2,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.50258,-0.0011634,-0.022609,0,0
2,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.30829,-0.0012441,-0.035905,0,0
2,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.72603,-0.0013392,-0.025326,0,0
2,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.80326,-0.0014164,-0.0099286,0,0
2,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.84424,-0.0016824,-0.0066337,0,0
2,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.37173,-0.0017513,-0.038733,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.32592,-0.0018091,-0.033559,0,0
2,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.6691,-0.0018883,-0.021621,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.86968,-0.0020532,-0.0081657,0,0
2,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.93704,-0.0020932,0.0011179,0,0
2,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.36956,-0.0022752,-0.032126,0,0
2,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.42367,-0.0022779,0.059723,0,0
2,GO REGULATION OF PROTEIN ACETYLATION,0.92416,-0.0022955,0.0086401,0,0
2,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.75664,-0.0023476,0.028797,0,0
2,GO REGULATION OF PEPTIDE TRANSPORT,0.13549,-0.0024466,-0.049339,0,0
2,GO PROSTAGLANDIN TRANSPORT,0.73212,-0.0024896,-0.015916,0,0
2,GO RESPONSE TO FLUID SHEAR STRESS,0.78451,-0.0025843,0.020395,0,0
2,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.97899,-0.0026962,0.012123,0,0
2,GO ASTROCYTE ACTIVATION,0.70787,-0.0027047,-0.022982,0,0
2,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.92094,-0.0028105,0.0077042,0,0
2,GO TOR SIGNALING,0.41899,-0.002828,-0.024677,0,0
2,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.8379,-0.002918,0.0038605,0,0
2,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.82211,-0.0030169,0.0052415,0,0
2,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.48468,-0.0030232,-0.058811,0,0
2,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.87287,-0.0031056,-0.0010329,0,0
2,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.62545,-0.0031095,-0.014596,0,0
2,GO REGULATION OF PROTEIN POLYMERIZATION,0.91772,-0.0031854,-0.0074481,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.76899,-0.0032088,-0.009536,0,0
2,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.92094,-0.0032549,0.014803,0,0
2,GO SPINDLE LOCALIZATION,0.86331,-0.0033114,-0.014948,0,0
2,GO INTRACELLULAR PROTEIN TRANSPORT,0.75664,-0.0033227,0.0086565,0,0
2,GO L GLUTAMATE IMPORT,0.51035,-0.0033499,-0.039806,0,0
2,GO POSITIVE REGULATION OF BINDING,0.44028,-0.0033875,-0.022809,0,0
2,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.25078,-0.0034014,-0.041986,0,0
2,GO MITOTIC METAPHASE PLATE CONGRESSION,0.6055,-0.003469,0.027327,0,0
2,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.90167,-0.0038105,0.0077106,0,0
2,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.51557,-0.0038176,-0.040936,0,0
2,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.50258,-0.0038246,0.055641,0,0
2,GO RESPONSE TO INORGANIC SUBSTANCE,0.48468,-0.0038979,-0.019509,0,0
2,GO VACUOLE ORGANIZATION,0.66321,-0.0039082,-0.015364,0,0
2,GO FERTILIZATION,0.38047,-0.0040259,-0.031688,0,0
2,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.6055,-0.004116,-0.017564,0,0
2,GO MEIOTIC CHROMOSOME SEGREGATION,0.75048,-0.0043755,-0.02042,0,0
2,GO PROTEIN TETRAMERIZATION,0.98546,-0.004376,0.014522,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.50258,-0.0044727,0.039095,0,0
2,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.9306,-0.0045418,0.0046571,0,0
2,GO RESPONSE TO TEMPERATURE STIMULUS,0.51557,-0.0047955,-0.0067096,0,0
2,GO BICARBONATE TRANSPORT,0.89526,-0.004804,-0.0221,0,0
2,GO WALKING BEHAVIOR,0.6312,-0.0048242,-0.02673,0,0
2,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.73822,-0.0048695,-0.0098922,0,0
2,GO MULTI ORGANISM CELLULAR PROCESS,0.92738,-0.004926,-0.015967,0,0
2,GO SPECIFICATION OF SYMMETRY,0.77829,-0.0050078,-0.020698,0,0
2,GO KINETOCHORE ASSEMBLY,0.72603,-0.0053876,-0.0218,0,0
2,GO SUPEROXIDE ANION GENERATION,0.64858,-0.0054672,0.033233,0,0
2,GO MODIFIED AMINO ACID TRANSPORT,0.90488,-0.0056997,0.019287,0,0
2,GO REGULATION OF CHOLESTEROL EFFLUX,0.93382,-0.0057555,0.0027995,0,0
2,GO NEGATIVE REGULATION OF OSSIFICATION,0.84741,-0.0058814,0.016474,0,0
2,GO VESICLE ORGANIZATION,0.38267,-0.0059539,-0.03098,0,0
2,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.86012,-0.0060215,0.015148,0,0
2,GO NEGATIVE CHEMOTAXIS,0.23128,-0.0062104,-0.096643,0,0
2,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.5665,-0.0062123,-0.018179,0,0
2,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.32993,-0.0062307,-0.030781,0,0
2,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.96284,-0.00624,0.01324,0,0
2,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.16285,-0.0064252,-0.13526,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.53672,-0.0064279,-0.025817,0,0
2,GO HINDLIMB MORPHOGENESIS,0.80012,-0.0064623,0.032134,0,0
2,GO BODY MORPHOGENESIS,0.29502,-0.0064749,-0.064543,0,0
2,GO CYTOSOLIC TRANSPORT,0.48722,-0.0064892,-0.030339,0,0
2,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.51035,-0.0066848,-0.020451,0,0
2,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.5314,-0.0068349,-0.023226,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.4451,-0.0069183,-0.022364,0,0
2,GO POSITIVE REGULATION OF MRNA PROCESSING,0.62258,-0.0070357,-0.013073,0,0
2,GO REGULATION OF SENSORY PERCEPTION,0.97576,-0.0070358,0.0035102,0,0
2,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.88885,-0.0070702,-0.021047,0,0
2,GO POSITIVE REGULATION OF NEURON DEATH,0.54208,-0.0071005,-0.026292,0,0
2,GO ENDOCYTOSIS,0.70486,-0.0072465,-0.018115,0,0
2,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.20409,-0.007345,-0.071896,0,0
2,GO CELLULAR RESPONSE TO LITHIUM ION,0.97899,-0.007349,-0.002845,0,0
2,GO GANGLIOSIDE METABOLIC PROCESS,0.2458,-0.0073843,-0.05455,0,0
2,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.85694,-0.0073906,0.020642,0,0
2,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.31409,-0.007435,-0.042413,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.84741,-0.0074962,0.031046,0,0
2,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.39156,-0.0075728,-0.032149,0,0
2,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.50776,-0.0075988,-0.017027,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.46466,-0.0076516,-0.060037,0,0
2,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.81581,-0.0078381,0.016281,0,0
2,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.57752,-0.0080031,0.029749,0,0
2,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.60834,-0.0080057,-0.021321,0,0
2,GO HISTONE METHYLATION,0.797,-0.0081342,-0.0032141,0,0
2,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.73822,-0.0084222,-0.017711,0,0
2,GO MICROTUBULE NUCLEATION,0.42133,-0.0084421,-0.063228,0,0
2,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.80326,-0.0085383,-0.0074412,0,0
2,GO REGULATION OF BINDING,0.41203,-0.008628,-0.025866,0,0
2,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.71089,-0.0086473,-0.011996,0,0
2,GO CELLULAR RESPONSE TO CAMP,0.70787,-0.0086483,0.020183,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.95961,-0.0089616,0.0019866,0,0
2,GO SODIUM ION HOMEOSTASIS,0.28761,-0.0090655,-0.052622,0,0
2,GO UV DAMAGE EXCISION REPAIR,0.572,-0.0093199,-0.037532,0,0
2,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.38933,-0.0094421,-0.02756,0,0
2,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.70787,-0.0094968,-0.0053853,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.31604,-0.0095308,0.05906,0,0
2,GO REGULATION OF MULTI ORGANISM PROCESS,0.7814,-0.0096402,-0.003035,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY,0.46466,-0.0096659,-0.026289,0,0
2,GO REGULATION OF HISTONE METHYLATION,0.6312,-0.0097032,-0.0085038,0,0
2,GO ATP DEPENDENT CHROMATIN REMODELING,0.9693,-0.010164,-0.0048243,0,0
2,GO APICAL PROTEIN LOCALIZATION,0.10471,-0.010201,-0.15253,0,0
2,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.68094,-0.010211,0.00060079,0,0
2,GO OOCYTE DIFFERENTIATION,0.81267,-0.010325,-0.013615,0,0
2,GO CELL VOLUME HOMEOSTASIS,0.95639,-0.010394,0.00050393,0,0
2,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.4451,-0.010452,0.087711,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.77829,-0.010454,-0.00042581,0,0
2,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.8379,-0.010521,-0.019889,0,0
2,GO REGULATION OF CELLULAR EXTRAVASATION,0.7659,-0.010541,0.02488,0,0
2,GO PHOSPHATE ION TRANSPORT,0.5,-0.010542,-0.032319,0,0
2,GO PROTEIN LOCALIZATION TO ENDOSOME,0.32993,-0.010583,-0.054029,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.64567,-0.010806,-0.010624,0,0
2,GO CELL CYCLE ARREST,0.72907,-0.010858,-0.010273,0,0
2,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.77209,-0.010947,-0.0079563,0,0
2,GO SKELETAL SYSTEM DEVELOPMENT,0.97899,-0.010961,0.011199,0,0
2,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.92416,-0.011039,0.038742,0,0
2,GO CHEMICAL HOMEOSTASIS,0.25414,-0.011119,-0.039589,0,0
2,GO CELL CELL SIGNALING BY WNT,0.62545,-0.011248,-0.013881,0,0
2,GO ERROR FREE TRANSLESION SYNTHESIS,0.89526,-0.011251,0.0013207,0,0
2,GO NEGATIVE REGULATION OF SIGNALING,0.39381,-0.01155,-0.02869,0,0
2,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.71089,-0.011558,0.019209,0,0
2,GO POSITIVE REGULATION OF GLIOGENESIS,0.60268,-0.011563,-0.02381,0,0
2,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.78763,-0.011699,0.026331,0,0
2,GO AMINE METABOLIC PROCESS,0.87606,-0.011747,0.0013128,0,0
2,GO ENDOTHELIAL CELL PROLIFERATION,0.59705,-0.011774,-0.029646,0,0
2,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.86012,-0.011827,0.0027246,0,0
2,GO REPRODUCTION,0.28945,-0.011942,-0.035638,0,0
2,GO SPHINGOLIPID METABOLIC PROCESS,0.60268,-0.011957,-0.016005,0,0
2,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.5583,-0.011999,-0.022137,0,0
2,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.6312,-0.012026,-0.026914,0,0
2,GO REGULATION OF NEUTROPHIL MIGRATION,0.62545,-0.012061,-0.034017,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.77519,-0.012118,-0.011237,0,0
2,GO WHITE FAT CELL DIFFERENTIATION,0.94671,-0.012158,0.0089542,0,0
2,GO MAINTENANCE OF LOCATION IN CELL,0.68392,-0.012274,0.021307,0,0
2,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.31997,-0.012336,-0.039778,0,0
2,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.89205,-0.012443,0.008854,0,0
2,GO DENDRITIC SPINE DEVELOPMENT,0.22348,-0.012468,-0.059599,0,0
2,GO CARDIAC MUSCLE CONTRACTION,0.76281,-0.012482,-0.0065201,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.93382,-0.012574,0.065864,0,0
2,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.84741,-0.012594,0.0096216,0,0
2,GO POSITIVE REGULATION OF HEART RATE,0.49743,-0.012876,-0.027527,0,0
2,GO PROTEIN ACYLATION,0.13338,-0.012905,-0.04453,0,0
2,GO ASTRAL MICROTUBULE ORGANIZATION,0.63408,-0.013009,-0.039936,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.67501,-0.013161,0.04899,0,0
2,GO DIGESTIVE TRACT MORPHOGENESIS,0.9306,-0.013224,0.018699,0,0
2,GO SEQUESTERING OF TRIGLYCERIDE,0.64567,-0.013238,-0.04092,0,0
2,GO REGULATION OF PH,0.31997,-0.013245,-0.030759,0,0
2,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.6515,-0.013301,-0.023186,0,0
2,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.47211,-0.013496,-0.019309,0,0
2,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.88565,-0.013639,0.029992,0,0
2,GO RESPONSE TO GROWTH HORMONE,0.98546,-0.013682,0.014081,0,0
2,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.67501,-0.013704,-0.024461,0,0
2,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.74128,-0.014014,-0.023847,0,0
2,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.55287,-0.014071,-0.015944,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.52874,-0.01409,-0.02293,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.572,-0.014169,-0.043926,0,0
2,GO LYSOSOME LOCALIZATION,0.45727,-0.014205,-0.027938,0,0
2,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.86968,-0.014336,0.0051528,0,0
2,GO TRANSITION METAL ION TRANSPORT,0.87287,-0.014344,-0.00358,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.5665,-0.014651,-0.049437,0,0
2,GO REGULATION OF FAT CELL DIFFERENTIATION,0.68689,-0.014773,-0.017326,0,0
2,GO REGULATION OF MUSCLE ADAPTATION,0.23445,-0.014791,-0.064205,0,0
2,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.54477,-0.014928,-0.023627,0,0
2,GO MEMBRANE FUSION,0.14308,-0.015081,-0.059035,0,0
2,GO MUSCLE STRUCTURE DEVELOPMENT,0.52082,-0.015179,-0.02452,0,0
2,GO REGULATION OF NUCLEAR DIVISION,0.84741,-0.015283,-0.0018976,0,0
2,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.58029,-0.015292,0.028847,0,0
2,GO BRAIN MORPHOGENESIS,0.29877,-0.015339,-0.060202,0,0
2,GO REGULATION OF MRNA POLYADENYLATION,0.29502,-0.01547,-0.032093,0,0
2,GO REGULATION OF PHOSPHATASE ACTIVITY,0.33194,-0.015586,-0.02721,0,0
2,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.89846,-0.015627,0.027578,0,0
2,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.86012,-0.015652,-0.0023391,0,0
2,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.25753,-0.015674,-0.045994,0,0
2,GO POST EMBRYONIC DEVELOPMENT,0.95961,-0.015773,0.0033362,0,0
2,GO RESPONSE TO NITROGEN COMPOUND,0.33396,-0.015818,-0.028179,0,0
2,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.7659,-0.015819,0.018255,0,0
2,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.36741,-0.015848,-0.039588,0,0
2,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.21587,-0.015877,-0.05472,0,0
2,GO LIPOSACCHARIDE METABOLIC PROCESS,0.92738,-0.015922,0.00044688,0,0
2,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.1914,-0.015983,-0.040545,0,0
2,GO REGULATION OF CELL CYCLE CHECKPOINT,0.93382,-0.016044,0.0018116,0,0
2,GO AMINOGLYCAN METABOLIC PROCESS,0.98546,-0.016052,-0.0064907,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.65442,-0.016236,-0.020786,0,0
2,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.49231,-0.016266,-0.065539,0,0
2,GO AMYLOID FIBRIL FORMATION,0.6691,-0.016274,-0.037727,0,0
2,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.60834,-0.016289,-0.026117,0,0
2,GO TISSUE MORPHOGENESIS,0.95639,-0.016294,0.005439,0,0
2,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.67501,-0.016345,-0.017655,0,0
2,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.58307,-0.016355,-0.029295,0,0
2,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.97253,-0.016388,-0.016103,0,0
2,GO CELLULAR RESPONSE TO ATP,0.46713,-0.016415,-0.038413,0,0
2,GO DNA REPLICATION,0.90167,-0.01644,0.022724,0,0
2,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.87606,-0.016458,0.01364,0,0
2,GO OSTEOCLAST DEVELOPMENT,0.81267,-0.01653,-0.012811,0,0
2,GO THYMIC T CELL SELECTION,0.97899,-0.016655,-0.0030961,0,0
2,GO UBIQUINONE METABOLIC PROCESS,0.36741,-0.016712,0.043069,0,0
2,GO ORGANELLE FISSION,0.39381,-0.016732,-0.022454,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.318,-0.016765,-0.030026,0,0
2,GO EPIDERMIS MORPHOGENESIS,0.30446,-0.016832,0.13777,0,0
2,GO EMBRYONIC MORPHOGENESIS,0.77209,-0.016916,-0.0065424,0,0
2,GO EXECUTION PHASE OF APOPTOSIS,0.15683,-0.016943,-0.037802,0,0
2,GO VESICLE CYTOSKELETAL TRAFFICKING,0.31021,-0.016967,-0.049761,0,0
2,GO CELLULAR HOMEOSTASIS,0.38267,-0.016989,-0.020491,0,0
2,GO RESPONSE TO EPINEPHRINE,0.86649,-0.017117,-0.010975,0,0
2,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.7814,-0.017232,0.028596,0,0
2,GO ADAPTIVE THERMOGENESIS,0.16778,-0.017235,-0.049804,0,0
2,GO HEART VALVE DEVELOPMENT,0.5314,-0.017259,-0.02502,0,0
2,GO DNA DEALKYLATION,0.63986,-0.017339,0.03689,0,0
2,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.98222,-0.017411,0.00027254,0,0
2,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.24089,-0.017423,-0.046574,0,0
2,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.42602,-0.01745,-0.033227,0,0
2,GO COLLECTING DUCT DEVELOPMENT,0.47211,-0.017454,-0.069389,0,0
2,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.69586,-0.017504,-0.012065,0,0
2,GO PROTEIN DENEDDYLATION,0.67798,-0.01752,-0.016384,0,0
2,GO MITOTIC CHROMOSOME CONDENSATION,0.34213,-0.017539,-0.029682,0,0
2,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.797,-0.017652,0.013822,0,0
2,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.40514,-0.01766,-0.041509,0,0
2,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.43075,-0.017815,-0.064476,0,0
2,GO NEUROINFLAMMATORY RESPONSE,0.49487,-0.017845,-0.032575,0,0
2,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.54208,-0.018,-0.020567,0,0
2,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.51819,-0.018053,-0.045813,0,0
2,GO SINGLE FERTILIZATION,0.16778,-0.018082,-0.040515,0,0
2,GO REGULATION OF SISTER CHROMATID COHESION,0.72907,-0.018148,-0.0050203,0,0
2,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.572,-0.018275,-0.009503,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.84424,-0.018287,0.017887,0,0
2,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.79387,-0.018359,0.0094196,0,0
2,GO TELOMERE CAPPING,0.99192,-0.018381,0.0025583,0,0
2,GO IMMUNOGLOBULIN SECRETION,0.71089,-0.018456,-0.034517,0,0
2,GO REGULATION OF CELL FATE COMMITMENT,0.64276,-0.018565,0.057867,0,0
2,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.52874,-0.01867,-0.03306,0,0
2,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.89205,-0.01878,-0.0040423,0,0
2,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.59986,-0.018804,-0.018764,0,0
2,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.73517,-0.018842,0.034939,0,0
2,GO NEGATIVE REGULATION OF TOR SIGNALING,0.60834,-0.018869,-0.019998,0,0
2,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.48722,-0.018901,-0.034628,0,0
2,GO SPINDLE ORGANIZATION,0.92416,-0.018913,-0.0094896,0,0
2,GO REGULATION OF CALCIUM ION TRANSPORT,0.56103,-0.018926,-0.016221,0,0
2,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.49487,-0.018939,-0.018715,0,0
2,GO REGULATION OF GOLGI ORGANIZATION,0.72603,-0.018947,-0.0077176,0,0
2,GO HISTONE EXCHANGE,0.77519,-0.018983,-0.0072589,0,0
2,GO HISTONE H3 K27 METHYLATION,0.38933,-0.019134,-0.039214,0,0
2,GO PROSTAGLANDIN SECRETION,0.72603,-0.019141,0.022764,0,0
2,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.32393,-0.019189,-0.051337,0,0
2,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.20554,-0.019269,-0.037185,0,0
2,GO EMBRYONIC EYE MORPHOGENESIS,0.99838,-0.019508,0.025571,0,0
2,GO IRON ION TRANSPORT,0.48722,-0.019512,-0.02238,0,0
2,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.318,-0.019651,-0.052244,0,0
2,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.9113,-0.019673,0.0082678,0,0
2,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.5314,-0.019719,-0.034938,0,0
2,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.68392,-0.019766,-0.04021,0,0
2,GO MIDBRAIN DEVELOPMENT,0.87287,-0.019775,0.017535,0,0
2,GO MITOCHONDRIAL FUSION,0.72603,-0.019801,-0.0076032,0,0
2,GO PEPTIDYL LYSINE METHYLATION,0.61402,-0.019821,-0.0085827,0,0
2,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.39832,-0.019852,-0.03302,0,0
2,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.95961,-0.019999,0.042719,0,0
2,GO RESPONSE TO ATP,0.66028,-0.020132,-0.011331,0,0
2,GO FOAM CELL DIFFERENTIATION,0.84107,-0.020174,0.010334,0,0
2,GO GOLGI ORGANIZATION,0.94348,-0.020366,-0.0022264,0,0
2,GO REGULATION OF METAL ION TRANSPORT,0.25246,-0.020374,-0.035396,0,0
2,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.70486,-0.020401,0.026385,0,0
2,GO TAXIS,0.5314,-0.020504,-0.030039,0,0
2,GO REGULATION OF MICROTUBULE BASED PROCESS,0.11742,-0.020558,-0.066468,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.80953,-0.020637,-0.0014324,0,0
2,GO RESPONSE TO PROGESTERONE,0.75664,-0.020652,0.037727,0,0
2,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.53672,-0.020715,-0.048683,0,0
2,GO VASCULAR WOUND HEALING,0.35674,-0.020724,-0.078108,0,0
2,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.76281,-0.020739,-0.0065056,0,0
2,GO RESPONSE TO IMMOBILIZATION STRESS,0.52082,-0.020864,-0.058356,0,0
2,GO REGULATION OF GONAD DEVELOPMENT,0.98546,-0.020892,-0.0014656,0,0
2,GO CELL PROLIFERATION IN HINDBRAIN,0.3871,-0.021089,-0.053168,0,0
2,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.46218,-0.021131,-0.022239,0,0
2,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.76899,-0.021182,-0.0081805,0,0
2,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.62545,-0.02126,-0.027227,0,0
2,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.99515,-0.021293,0.0075347,0,0
2,GO HISTONE H4 K16 ACETYLATION,0.7659,-0.021313,-0.0037789,0,0
2,GO MEIOTIC CHROMOSOME SEPARATION,0.62545,-0.021369,-0.020163,0,0
2,GO CRISTAE FORMATION,0.52345,-0.021372,0.056729,0,0
2,GO REGULATION OF TOR SIGNALING,0.28945,-0.02141,-0.036734,0,0
2,GO PROTEOGLYCAN METABOLIC PROCESS,0.72603,-0.021575,-0.016119,0,0
2,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.5583,-0.021593,0.050293,0,0
2,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.80639,-0.021614,-0.02968,0,0
2,GO HEART DEVELOPMENT,0.57476,-0.021821,-0.020217,0,0
2,GO CHONDROCYTE DEVELOPMENT,0.80639,-0.021905,0.038211,0,0
2,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.40286,-0.022022,-0.029835,0,0
2,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.73822,-0.022084,0.029759,0,0
2,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.62258,-0.022205,-0.0065745,0,0
2,GO CELLULAR ION HOMEOSTASIS,0.28213,-0.022263,-0.030118,0,0
2,GO DETECTION OF LIGHT STIMULUS,0.23128,-0.022331,0.024685,0,0
2,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.28578,-0.022385,-0.05374,0,0
2,GO VACUOLAR ACIDIFICATION,0.79075,-0.022428,-0.0092783,0,0
2,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.89846,-0.022478,0.036343,0,0
2,GO MUSCLE TISSUE DEVELOPMENT,0.40058,-0.022494,-0.027996,0,0
2,GO COENZYME A BIOSYNTHETIC PROCESS,0.71996,-0.022655,0.0032742,0,0
2,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.77209,-0.022687,-0.0024277,0,0
2,GO REGULATION OF VACUOLE ORGANIZATION,0.84741,-0.022711,0.0083073,0,0
2,GO REGULATION OF CELLULAR LOCALIZATION,0.1914,-0.022769,-0.035258,0,0
2,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.22348,-0.022769,-0.051435,0,0
2,GO OOGENESIS,0.62545,-0.02278,-0.028737,0,0
2,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.36311,-0.022795,-0.02642,0,0
2,GO APOPTOTIC DNA FRAGMENTATION,0.39832,-0.022797,-0.022579,0,0
2,GO RESPONSE TO VITAMIN,0.68988,-0.022877,0.031397,0,0
2,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.63697,-0.0231,-0.016361,0,0
2,GO GROWTH,0.23766,-0.023127,-0.03763,0,0
2,GO NEURAL TUBE PATTERNING,0.56376,-0.02327,-0.0094957,0,0
2,GO T CELL LINEAGE COMMITMENT,0.79075,-0.023474,-0.023787,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.50258,-0.023503,-0.025183,0,0
2,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.27673,-0.023517,-0.03679,0,0
2,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.63408,-0.023628,-0.01767,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.97576,-0.023791,0.0034857,0,0
2,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.29315,-0.023811,-0.037507,0,0
2,GO MIDBODY ABSCISSION,0.77209,-0.02387,0.012939,0,0
2,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.49487,-0.023916,-0.01654,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.087731,-0.024086,-0.10353,0,0
2,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.98222,-0.024467,0.0089504,0,0
2,GO REGULATION OF STEM CELL PROLIFERATION,0.7659,-0.02459,-0.0154,0,0
2,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.16407,-0.024656,-0.11336,0,0
2,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.43312,-0.024696,-0.050678,0,0
2,GO ORGANELLE DISASSEMBLY,0.87606,-0.024777,-0.0086792,0,0
2,GO SENSORY PERCEPTION,0.19417,-0.02486,-0.038248,0,0
2,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.38267,-0.024973,-0.033053,0,0
2,GO PROTEIN DEPHOSPHORYLATION,0.28213,-0.025045,-0.030863,0,0
2,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.33803,-0.025166,-0.037632,0,0
2,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.78763,-0.025283,-0.028973,0,0
2,GO PROTEIN DEMETHYLATION,0.83474,-0.025353,-0.0052055,0,0
2,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.35253,-0.025366,-0.082917,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.40973,-0.025524,-0.024727,0,0
2,GO EOSINOPHIL MIGRATION,0.88885,-0.025757,-0.021351,0,0
2,GO CYTOKINESIS,0.30255,-0.025783,-0.034455,0,0
2,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.17669,-0.025799,-0.094555,0,0
2,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.94671,-0.025802,0.035811,0,0
2,GO BASEMENT MEMBRANE ASSEMBLY,0.43789,-0.025939,-0.091184,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.34213,-0.02608,-0.070396,0,0
2,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.09796,-0.026179,-0.066013,0,0
2,GO CELL JUNCTION ASSEMBLY,0.21437,-0.02624,-0.060186,0,0
2,GO CARDIAC CELL DEVELOPMENT,0.34213,-0.026279,-0.035928,0,0
2,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.88885,-0.026361,0.025973,0,0
2,GO PROTEIN LOCALIZATION TO MEMBRANE,0.21437,-0.026419,-0.026748,0,0
2,GO RESPONSE TO MISFOLDED PROTEIN,0.44028,-0.026581,-0.022063,0,0
2,GO HISTONE H3 K36 METHYLATION,0.93382,-0.026596,0.0020386,0,0
2,GO LIPOXYGENASE PATHWAY,0.98222,-0.026658,-0.014648,0,0
2,GO HISTONE H2A ACETYLATION,0.99515,-0.026708,0.0037277,0,0
2,GO TOOTH MINERALIZATION,0.58307,-0.026822,0.070927,0,0
2,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.44028,-0.027066,-0.036088,0,0
2,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.83474,-0.027083,0.0030214,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.46713,-0.027287,-0.011035,0,0
2,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.46962,-0.027491,0.067994,0,0
2,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.86012,-0.027536,-0.0016297,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.58307,-0.02765,-0.02119,0,0
2,GO CERAMIDE TRANSPORT,0.51819,-0.027652,0.067188,0,0
2,GO REGULATION OF PROTEIN TARGETING,0.58307,-0.027704,-0.01047,0,0
2,GO EOSINOPHIL CHEMOTAXIS,0.66321,-0.027879,-0.042568,0,0
2,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.69885,-0.027991,-0.029497,0,0
2,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.40973,-0.028068,-0.038185,0,0
2,GO PIRNA METABOLIC PROCESS,0.53672,-0.028071,-0.07257,0,0
2,GO INTEGRIN ACTIVATION,0.79387,-0.028627,-0.033587,0,0
2,GO RADIAL GLIAL CELL DIFFERENTIATION,0.46466,-0.028713,-0.063942,0,0
2,GO WATER HOMEOSTASIS,0.14869,-0.028728,-0.087954,0,0
2,GO DENDRITIC SPINE MORPHOGENESIS,0.20409,-0.02885,-0.07944,0,0
2,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.89846,-0.028878,0.01906,0,0
2,GO MUSCLE ORGAN DEVELOPMENT,0.23128,-0.029095,-0.047103,0,0
2,GO CARDIAC SEPTUM DEVELOPMENT,0.59986,-0.029154,-0.029607,0,0
2,GO CALCIUM MEDIATED SIGNALING,0.25583,-0.029222,-0.032687,0,0
2,GO CELLULAR RESPONSE TO STARVATION,0.089246,-0.029242,-0.066361,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.79075,-0.029334,-0.0069381,0,0
2,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.20122,-0.029351,-0.059877,0,0
2,GO UTERUS DEVELOPMENT,0.39606,-0.029429,-0.052542,0,0
2,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.17411,-0.029459,-0.064534,0,0
2,GO REGULATION OF DNA REPLICATION,0.55287,-0.029495,-0.0070959,0,0
2,GO MAGNESIUM ION TRANSPORT,0.28395,-0.029593,-0.082344,0,0
2,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.22814,-0.029603,-0.04719,0,0
2,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.5583,-0.02968,-0.017012,0,0
2,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.79075,-0.029779,-0.023741,0,0
2,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.48976,-0.029826,-0.012797,0,0
2,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.90167,-0.029928,1.1955e-05,0,0
2,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.81267,-0.029937,-0.01954,0,0
2,GO REGULATION OF CELL SIZE,0.093126,-0.030019,-0.066188,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.47211,-0.030078,-0.06832,0,0
2,GO NEGATIVE REGULATION OF BINDING,0.27673,-0.030117,-0.044246,0,0
2,GO MYELIN ASSEMBLY,0.6055,-0.030127,-0.041641,0,0
2,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.77519,-0.030178,0.0073056,0,0
2,GO REGULATION OF SPINDLE CHECKPOINT,0.42838,-0.030245,-0.035463,0,0
2,GO MUSCLE CELL APOPTOTIC PROCESS,0.37173,-0.030266,-0.028124,0,0
2,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.7659,-0.030307,-0.026589,0,0
2,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.86649,-0.030319,0.010705,0,0
2,GO LENS FIBER CELL DEVELOPMENT,0.86012,-0.030405,0.010498,0,0
2,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.28033,-0.030472,-0.055208,0,0
2,GO CHLORIDE ION HOMEOSTASIS,0.99515,-0.030518,-0.007514,0,0
2,GO REGULATION OF ENDOCYTOSIS,0.35463,-0.030627,-0.029366,0,0
2,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.5665,-0.030849,-0.037081,0,0
2,GO PEPTIDYL SERINE MODIFICATION,0.35043,-0.030915,-0.026704,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.40973,-0.030968,-0.042092,0,0
2,GO DNA CATABOLIC PROCESS,0.28761,-0.031062,-0.027614,0,0
2,GO EYE MORPHOGENESIS,0.88245,-0.031178,-0.0046141,0,0
2,GO CENTROSOME DUPLICATION,0.33599,-0.031216,-0.038481,0,0
2,GO RECEPTOR RECYCLING,0.71089,-0.031308,-0.012196,0,0
2,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.61117,-0.031376,-0.04045,0,0
2,GO REGULATION OF CELLULAR PH,0.66321,-0.031556,-0.01282,0,0
2,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.68689,-0.031557,0.0067241,0,0
2,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.19838,-0.031573,-0.10784,0,0
2,GO ENDOTHELIAL CELL CHEMOTAXIS,0.75356,-0.031702,-0.033238,0,0
2,GO PROTEIN METHYLATION,0.58307,-0.031772,-0.013158,0,0
2,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.67798,-0.031837,-0.037045,0,0
2,GO SINGLE STRAND BREAK REPAIR,0.76899,-0.031937,-0.021013,0,0
2,GO ASTROCYTE DIFFERENTIATION,0.73822,-0.031995,-0.0064279,0,0
2,GO REGULATION OF VASCULAR PERMEABILITY,0.21437,-0.032015,-0.062856,0,0
2,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.50516,-0.032016,-0.019826,0,0
2,GO RESPONSE TO ETHER,0.64567,-0.032197,-0.015189,0,0
2,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.82211,-0.032203,0.01498,0,0
2,GO POSITIVE T CELL SELECTION,0.78763,-0.032223,0.019803,0,0
2,GO METAL ION HOMEOSTASIS,0.32592,-0.032231,-0.029352,0,0
2,GO BONE RESORPTION,0.45727,-0.032321,-0.047199,0,0
2,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.46466,-0.032443,-0.029752,0,0
2,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.21738,-0.032453,-0.067687,0,0
2,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.89846,-0.032518,0.039412,0,0
2,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.59705,-0.032552,-0.047178,0,0
2,GO MULTI ORGANISM PROCESS,0.10299,-0.032737,-0.050771,0,0
2,GO CHROMOSOME LOCALIZATION,0.20845,-0.032815,-0.028911,0,0
2,GO MUSCLE CELL DIFFERENTIATION,0.57752,-0.032864,-0.018254,0,0
2,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.28213,-0.033098,-0.036733,0,0
2,GO REGULATION OF CELL DIFFERENTIATION,0.20122,-0.033275,-0.043231,0,0
2,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.28213,-0.033355,-0.047624,0,0
2,GO REGULATION OF HEAT GENERATION,0.83158,-0.033356,-0.0065653,0,0
2,GO CARTILAGE MORPHOGENESIS,0.38488,-0.033467,-0.071719,0,0
2,GO TEMPERATURE HOMEOSTASIS,0.20845,-0.033491,-0.042408,0,0
2,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.86968,-0.033512,0.011014,0,0
2,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.10299,-0.033521,-0.068067,0,0
2,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.74741,-0.033838,0.0086805,0,0
2,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.58307,-0.033985,-0.0047076,0,0
2,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.26964,-0.034213,-0.068809,0,0
2,GO REGULATION OF AXON GUIDANCE,0.6055,-0.034515,-0.047626,0,0
2,GO VESICLE LOCALIZATION,0.30829,-0.03462,-0.046301,0,0
2,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.40743,-0.034734,-0.02724,0,0
2,GO LEUKOCYTE TETHERING OR ROLLING,0.58307,-0.034783,-0.024183,0,0
2,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.39832,-0.034923,-0.032874,0,0
2,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.9693,-0.034999,0.0090724,0,0
2,GO BONE MINERALIZATION,0.16407,-0.035056,-0.074856,0,0
2,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.55016,-0.035062,-0.019637,0,0
2,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.42838,-0.035511,-0.016289,0,0
2,GO HORMONE MEDIATED SIGNALING PATHWAY,0.38047,-0.03558,-0.032402,0,0
2,GO MUSCLE SYSTEM PROCESS,0.23286,-0.035816,-0.044922,0,0
2,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.78763,-0.035902,-0.010308,0,0
2,GO REGULATION OF INTEGRIN ACTIVATION,0.40973,-0.035953,-0.073305,0,0
2,GO CARDIOCYTE DIFFERENTIATION,0.79387,-0.036153,-0.0038339,0,0
2,GO NUCLEOSIDE SALVAGE,0.91772,-0.03632,0.0046764,0,0
2,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.56925,-0.03638,-0.055888,0,0
2,GO MULTICELLULAR ORGANISM REPRODUCTION,0.1313,-0.036454,-0.049341,0,0
2,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.99192,-0.036539,-0.00086404,0,0
2,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.8379,-0.036575,0.0026948,0,0
2,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.54746,-0.036791,-0.024269,0,0
2,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.25078,-0.036819,-0.026649,0,0
2,GO ER OVERLOAD RESPONSE,0.93382,-0.036892,-0.013291,0,0
2,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.69286,-0.036905,0.0374,0,0
2,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.7814,-0.036966,-0.0074659,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.088486,-0.037007,-0.11493,0,0
2,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.30446,-0.037122,-0.033196,0,0
2,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.10912,-0.037198,-0.048841,0,0
2,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.7814,-0.037369,-0.0075519,0,0
2,GO REGULATION OF GROWTH,0.090011,-0.037397,-0.057192,0,0
2,GO MOTOR NEURON AXON GUIDANCE,0.67501,-0.0374,-0.035778,0,0
2,GO MUSCLE CELL DEVELOPMENT,0.3442,-0.037477,-0.042357,0,0
2,GO MICROTUBULE ANCHORING,0.1914,-0.037544,-0.071546,0,0
2,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.22348,-0.037622,-0.056156,0,0
2,GO ENDOCYTIC RECYCLING,0.6312,-0.03767,-0.015329,0,0
2,GO CELLULAR COMPONENT MAINTENANCE,0.18194,-0.037674,-0.063936,0,0
2,GO EMBRYONIC ORGAN MORPHOGENESIS,0.78451,-0.03821,-0.0041732,0,0
2,GO THYROID GLAND DEVELOPMENT,0.24911,-0.038254,-0.090965,0,0
2,GO DETECTION OF STIMULUS,0.28945,-0.038274,-0.021699,0,0
2,GO MITOPHAGY,0.47712,-0.038606,-0.031012,0,0
2,GO SLEEP,0.97899,-0.038631,0.018448,0,0
2,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.27673,-0.038812,-0.035423,0,0
2,GO NUCLEOSOME ASSEMBLY,0.38267,-0.038822,-0.027427,0,0
2,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.5665,-0.038898,-0.062168,0,0
2,GO DEVELOPMENTAL GROWTH,0.093918,-0.038937,-0.05748,0,0
2,GO ZINC ION TRANSPORT,0.73517,-0.039098,0.0082834,0,0
2,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.21288,-0.039331,-0.040557,0,0
2,GO CELL RECOGNITION,0.080464,-0.039458,-0.052547,0,0
2,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.36098,-0.039529,-0.053262,0,0
2,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.58029,-0.039588,-0.031337,0,0
2,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.81267,-0.039696,0.0056309,0,0
2,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.81267,-0.039705,0.005753,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.61402,-0.039812,-0.019909,0,0
2,GO HEART GROWTH,0.23128,-0.039863,-0.042383,0,0
2,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.56103,-0.039986,-0.027612,0,0
2,GO RESPONSE TO ORGANOPHOSPHORUS,0.18194,-0.040053,-0.043223,0,0
2,GO METANEPHROS MORPHOGENESIS,0.11183,-0.040128,-0.092041,0,0
2,GO PH REDUCTION,0.79075,-0.0402,-0.0047632,0,0
2,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.14642,-0.040478,-0.061387,0,0
2,GO NEUROTROPHIN SIGNALING PATHWAY,0.60268,-0.040521,-0.028576,0,0
2,GO GLAND MORPHOGENESIS,0.41899,-0.040529,0.082194,0,0
2,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.95961,-0.040567,0.010525,0,0
2,GO DOSAGE COMPENSATION,0.41203,-0.040588,-0.010783,0,0
2,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.93704,-0.0407,0.011786,0,0
2,GO MESENCHYMAL CELL PROLIFERATION,0.63697,-0.041053,-0.023777,0,0
2,GO GOLGI TO ENDOSOME TRANSPORT,0.88245,-0.041055,-0.0051246,0,0
2,GO NEURON PROJECTION ORGANIZATION,0.13549,-0.041091,-0.06845,0,0
2,GO GAMMA DELTA T CELL DIFFERENTIATION,0.73517,-0.041226,0.042916,0,0
2,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.34835,-0.04139,-0.056354,0,0
2,GO BONE TRABECULA MORPHOGENESIS,0.7659,-0.041501,0.066021,0,0
2,GO ION HOMEOSTASIS,0.2714,-0.041592,-0.030942,0,0
2,GO BIOMINERALIZATION,0.32592,-0.041856,-0.053309,0,0
2,GO AXIS SPECIFICATION,0.27495,-0.041922,-0.056189,0,0
2,GO NUCLEAR ENVELOPE ORGANIZATION,0.34008,-0.041931,-0.023581,0,0
2,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.094715,-0.041963,-0.07782,0,0
2,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.38488,-0.042255,-0.034896,0,0
2,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.46713,-0.042285,-0.038982,0,0
2,GO CHONDROCYTE DIFFERENTIATION,0.89526,-0.042391,-0.0044328,0,0
2,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.068619,-0.042475,-0.092421,0,0
2,GO MUSCLE CONTRACTION,0.09796,-0.042563,-0.059848,0,0
2,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.59986,-0.04264,-0.036201,0,0
2,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.073043,-0.042755,-0.095897,0,0
2,GO REGULATION OF OSSIFICATION,0.6691,-0.042985,-0.01955,0,0
2,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.16042,-0.042989,-0.065158,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.4355,-0.04321,-0.023482,0,0
2,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.52874,-0.043236,-0.026371,0,0
2,GO REGULATION OF PROTEIN FOLDING,0.19278,-0.043367,-0.035049,0,0
2,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.48976,-0.043394,-0.052558,0,0
2,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.44269,-0.043542,0.051249,0,0
2,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.92416,-0.043576,0.025651,0,0
2,GO MESODERMAL CELL FATE SPECIFICATION,0.24911,-0.043755,-0.061249,0,0
2,GO HISTONE H4 ACETYLATION,0.34213,-0.04377,-0.03296,0,0
2,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.1262,-0.043832,-0.051489,0,0
2,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.23927,-0.044041,-0.04101,0,0
2,GO VACUOLAR TRANSPORT,0.50516,-0.044246,-0.022133,0,0
2,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.15921,-0.044624,-0.077959,0,0
2,GO POSITIVE REGULATION OF ERAD PATHWAY,0.89205,-0.044747,0.018069,0,0
2,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.25246,-0.044776,-0.058856,0,0
2,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.50516,-0.044928,-0.023423,0,0
2,GO SALIVARY GLAND DEVELOPMENT,0.77829,-0.044954,-0.0082688,0,0
2,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.572,-0.045023,-0.030784,0,0
2,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.30255,-0.045115,-0.034132,0,0
2,GO CELL PROLIFERATION IN FOREBRAIN,0.80953,-0.045263,-0.010101,0,0
2,GO TRABECULA FORMATION,0.99838,-0.045285,-0.0054019,0,0
2,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.14308,-0.045544,-0.10848,0,0
2,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.26614,-0.045635,-0.060605,0,0
2,GO ANIMAL ORGAN MORPHOGENESIS,0.28945,-0.045684,-0.035131,0,0
2,GO REGULATION OF RECEPTOR INTERNALIZATION,0.68392,-0.045691,-0.011995,0,0
2,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.09714,-0.045704,-0.099053,0,0
2,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.49743,-0.045746,-0.035977,0,0
2,GO CAMERA TYPE EYE MORPHOGENESIS,0.6312,-0.045875,-0.022109,0,0
2,GO RESPIRATORY SYSTEM DEVELOPMENT,0.20699,-0.046129,-0.070278,0,0
2,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.2114,-0.046194,-0.028301,0,0
2,GO OSSIFICATION,0.45238,-0.046253,-0.03435,0,0
2,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.27673,-0.046296,-0.051637,0,0
2,GO ORGANIC ANION TRANSPORT,0.2714,-0.046316,-0.037508,0,0
2,GO OUTFLOW TRACT MORPHOGENESIS,0.28578,-0.046595,-0.082848,0,0
2,GO REGULATION OF KERATINOCYTE MIGRATION,0.48722,-0.0466,-0.015337,0,0
2,GO RESPONSE TO LEAD ION,0.44752,-0.046914,-0.040855,0,0
2,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.1252,-0.04702,-0.054594,0,0
2,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.88245,-0.047082,0.031599,0,0
2,GO MEIOTIC CELL CYCLE PROCESS,0.037139,-0.047349,-0.062742,0,0
2,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.20409,-0.047372,-0.11265,0,0
2,GO REGULATION OF NEUROBLAST PROLIFERATION,0.35463,-0.047499,-0.062839,0,0
2,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.29502,-0.047504,-0.037642,0,0
2,GO AMELOGENESIS,0.26614,-0.047573,0.10178,0,0
2,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.23445,-0.04759,-0.061771,0,0
2,GO REGULATION OF CELL CYCLE ARREST,0.1262,-0.047724,-0.04729,0,0
2,GO SULFATE TRANSPORT,0.19697,-0.048047,-0.055595,0,0
2,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.42838,-0.048147,-0.038396,0,0
2,GO MEIOTIC SPINDLE ORGANIZATION,0.71693,-0.048573,-0.02297,0,0
2,GO REGULATION OF CYTOKINESIS,0.30255,-0.04863,-0.042069,0,0
2,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.58307,-0.048657,-0.021508,0,0
2,GO GAMETE GENERATION,0.062114,-0.048692,-0.063036,0,0
2,GO PROTEIN FOLDING,0.25753,-0.048747,-0.015279,0,0
2,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.69586,-0.04884,0.022848,0,0
2,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.74128,-0.049019,-0.01848,0,0
2,GO DEMETHYLATION,0.65442,-0.049413,-0.0072441,0,0
2,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.15214,-0.049582,-0.17389,0,0
2,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.35043,-0.049813,-0.043407,0,0
2,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.35674,-0.049912,-0.031367,0,0
2,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.13027,-0.050021,-0.045357,0,0
2,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.22971,-0.050244,-0.022457,0,0
2,GO TRIGLYCERIDE CATABOLIC PROCESS,0.77519,-0.050355,-0.019301,0,0
2,GO STRIATED MUSCLE CELL PROLIFERATION,0.68392,-0.050676,-0.0019979,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.089246,-0.050967,-0.075997,0,0
2,GO EAR DEVELOPMENT,0.31021,-0.051067,-0.038551,0,0
2,GO REGULATION OF TRANSPOSITION,0.97899,-0.051344,-0.0014853,0,0
2,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.20699,-0.051462,-0.041064,0,0
2,GO POSITIVE REGULATION OF CYTOKINESIS,0.14642,-0.051482,-0.06306,0,0
2,GO PLASMA MEMBRANE TUBULATION,0.46962,-0.051492,-0.0185,0,0
2,GO SKELETAL SYSTEM MORPHOGENESIS,0.98222,-0.051532,0.01646,0,0
2,GO FUCOSYLATION,0.13656,-0.051684,-0.074988,0,0
2,GO MRNA SPLICE SITE SELECTION,0.082591,-0.051868,-0.10024,0,0
2,GO CELL PROJECTION ASSEMBLY,0.318,-0.051906,-0.036303,0,0
2,GO PURINE NUCLEOTIDE TRANSPORT,0.051595,-0.052125,-0.081874,0,0
2,GO PROTEIN TARGETING TO VACUOLE,0.318,-0.052126,-0.04157,0,0
2,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.80639,-0.052165,0.0029122,0,0
2,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.16163,-0.052225,-0.081126,0,0
2,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.43312,-0.052369,-0.021462,0,0
2,GO LENS FIBER CELL DIFFERENTIATION,0.59424,-0.052408,-0.01997,0,0
2,GO ANION TRANSPORT,0.12322,-0.052774,-0.048858,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.23286,-0.052831,-0.065669,0,0
2,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.71996,-0.053118,-0.017861,0,0
2,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.18327,-0.053399,-0.040348,0,0
2,GO SCHWANN CELL DEVELOPMENT,0.23605,-0.053552,-0.053076,0,0
2,GO PROTEIN COMPLEX OLIGOMERIZATION,0.06986,-0.053664,-0.043396,0,0
2,GO POSITIVE REGULATION OF CELL DIVISION,0.28213,-0.053681,-0.044969,0,0
2,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.11367,-0.053723,-0.054021,0,0
2,GO REGULATION OF VASCULOGENESIS,0.16778,-0.053916,-0.10433,0,0
2,GO STRIATED MUSCLE CONTRACTION,0.14642,-0.054099,-0.050457,0,0
2,GO COMMISSURAL NEURON AXON GUIDANCE,0.23927,-0.054204,-0.12809,0,0
2,GO AUTOPHAGIC CELL DEATH,0.67501,-0.054218,-0.011795,0,0
2,GO ATP TRANSPORT,0.17283,-0.054232,-0.049093,0,0
2,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.13763,-0.054306,-0.082041,0,0
2,GO GENETIC IMPRINTING,0.49743,-0.054323,-0.026299,0,0
2,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.29502,-0.054428,-0.045106,0,0
2,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.30255,-0.05448,-0.040214,0,0
2,GO CONNECTIVE TISSUE DEVELOPMENT,0.64858,-0.054752,-0.016865,0,0
2,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.69286,-0.054964,-0.032744,0,0
2,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.1914,-0.055367,-0.045078,0,0
2,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.1653,-0.055469,-0.069114,0,0
2,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.1387,-0.055483,-0.077421,0,0
2,GO NOTCH SIGNALING PATHWAY,0.042609,-0.055867,-0.076827,0,0
2,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.40286,-0.055906,-0.059462,0,0
2,GO ACTIVATED T CELL PROLIFERATION,0.75048,-0.055909,0.024422,0,0
2,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.44028,-0.055925,-0.037967,0,0
2,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.77209,-0.055926,-0.012378,0,0
2,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.17283,-0.055981,-0.074065,0,0
2,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.20265,-0.056045,-0.042436,0,0
2,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.59986,-0.056157,-0.020944,0,0
2,GO MESENCHYME DEVELOPMENT,0.43075,-0.056245,-0.033646,0,0
2,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.46962,-0.056281,-0.080799,0,0
2,GO SPHINGOMYELIN METABOLIC PROCESS,0.24911,-0.0564,-0.078451,0,0
2,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.32792,-0.056511,-0.07788,0,0
2,GO MITOCHONDRIAL GENOME MAINTENANCE,0.30255,-0.05652,-0.042375,0,0
2,GO NUCLEOTIDE TRANSPORT,0.044292,-0.056665,-0.079774,0,0
2,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.44028,-0.056704,-0.048261,0,0
2,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.68988,-0.056829,-0.0053055,0,0
2,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.61972,-0.056903,-0.024073,0,0
2,GO STEM CELL PROLIFERATION,0.26964,-0.056933,-0.058845,0,0
2,GO CELLULAR SODIUM ION HOMEOSTASIS,0.2913,-0.056938,-0.048694,0,0
2,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.33194,-0.057193,-0.062449,0,0
2,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.83474,-0.057321,0.011344,0,0
2,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.22503,-0.057718,-0.046839,0,0
2,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.18194,-0.058028,-0.069547,0,0
2,GO REGULATION OF PROTEIN DEACETYLATION,0.062114,-0.05822,-0.087792,0,0
2,GO LIPID TRANSLOCATION,0.14308,-0.05824,-0.094582,0,0
2,GO SMOOTH MUSCLE CONTRACTION,0.10214,-0.058369,-0.067873,0,0
2,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.27853,-0.058574,-0.07084,0,0
2,GO MYOTUBE CELL DEVELOPMENT,0.20699,-0.058674,-0.055803,0,0
2,GO CELL JUNCTION DISASSEMBLY,0.69586,-0.058764,-0.0082849,0,0
2,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.16285,-0.058895,-0.048784,0,0
2,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.096327,-0.059059,-0.071016,0,0
2,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.21587,-0.059195,-0.062646,0,0
2,GO STEROID CATABOLIC PROCESS,0.18461,-0.059211,-0.076765,0,0
2,GO MEGAKARYOCYTE DEVELOPMENT,0.80012,-0.059293,0.04527,0,0
2,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.063258,-0.059344,-0.059984,0,0
2,GO RESPONSE TO AMINE,0.16042,-0.05946,-0.056255,0,0
2,GO PULMONARY VALVE MORPHOGENESIS,0.17411,-0.059468,-0.10391,0,0
2,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.15921,-0.059492,-0.063638,0,0
2,GO NEUTRAL LIPID CATABOLIC PROCESS,0.25924,-0.059801,-0.057106,0,0
2,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.13656,-0.059811,-0.04416,0,0
2,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.38047,-0.060014,-0.054566,0,0
2,GO LIPOPROTEIN METABOLIC PROCESS,0.14755,-0.060054,-0.057272,0,0
2,GO OOCYTE MATURATION,0.47963,-0.060301,-0.040407,0,0
2,GO POSITIVE REGULATION OF TOR SIGNALING,0.074349,-0.060411,-0.067365,0,0
2,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.32993,-0.060688,-0.052163,0,0
2,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.18062,-0.060923,-0.04903,0,0
2,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.081877,-0.060935,-0.21207,0,0
2,GO CONVERGENT EXTENSION,0.81581,-0.061402,0.028146,0,0
2,GO OSTEOBLAST DIFFERENTIATION,0.52082,-0.061474,-0.023083,0,0
2,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.3739,-0.0615,-0.050875,0,0
2,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.797,-0.061507,-0.03425,0,0
2,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.18062,-0.061592,-0.056461,0,0
2,GO TELENCEPHALON GLIAL CELL MIGRATION,0.11002,-0.061627,-0.10242,0,0
2,GO ACID SECRETION,0.16904,-0.061654,-0.038911,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.38267,-0.061676,-0.041962,0,0
2,GO VENTRICULAR SYSTEM DEVELOPMENT,0.18327,-0.061693,-0.055301,0,0
2,GO RESPONSE TO CAMP,0.084763,-0.061733,-0.068207,0,0
2,GO HEART MORPHOGENESIS,0.54477,-0.06183,-0.021854,0,0
2,GO CARDIAC MYOFIBRIL ASSEMBLY,0.21437,-0.061916,-0.086856,0,0
2,GO ADHERENS JUNCTION ASSEMBLY,0.090782,-0.062104,-0.13731,0,0
2,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.26789,-0.062126,-0.093929,0,0
2,GO GLIAL CELL DEVELOPMENT,0.13549,-0.062208,-0.061392,0,0
2,GO RESPONSE TO BMP,0.16163,-0.062249,-0.069109,0,0
2,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.17029,-0.062321,-0.046966,0,0
2,GO CENTRIOLE CENTRIOLE COHESION,0.59144,-0.062338,-0.03579,0,0
2,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.084763,-0.062432,-0.090859,0,0
2,GO SENSORY ORGAN DEVELOPMENT,0.13763,-0.062622,-0.055615,0,0
2,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.22814,-0.06274,-0.040516,0,0
2,GO RESPONSE TO GROWTH FACTOR,0.36311,-0.062753,-0.035032,0,0
2,GO VISUAL BEHAVIOR,0.1252,-0.063091,-0.07063,0,0
2,GO LAYER FORMATION IN CEREBRAL CORTEX,0.31021,-0.063278,-0.06427,0,0
2,GO DEFINITIVE HEMOPOIESIS,0.13763,-0.063293,-0.06285,0,0
2,GO POTASSIUM ION HOMEOSTASIS,0.088486,-0.063294,-0.083569,0,0
2,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.59424,-0.063426,-0.031578,0,0
2,GO CARDIAC CHAMBER DEVELOPMENT,0.45238,-0.063674,-0.029906,0,0
2,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.063258,-0.063693,-0.071373,0,0
2,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.077018,-0.063702,-0.097439,0,0
2,GO POSITIVE REGULATION OF MITOPHAGY,0.30446,-0.063881,-0.048554,0,0
2,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.063836,-0.063925,-0.088295,0,0
2,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.5583,-0.064067,-0.029126,0,0
2,GO RESPONSE TO PROSTAGLANDIN E,0.29689,-0.064246,-0.033753,0,0
2,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.24911,-0.064579,-0.040659,0,0
2,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.12822,-0.0646,-0.093426,0,0
2,GO REGULATION OF GLIAL CELL MIGRATION,0.43789,-0.065034,-0.01967,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.19838,-0.065104,-0.05281,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.46466,-0.065336,-0.056852,0,0
2,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.63697,-0.065355,-0.011834,0,0
2,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.2458,-0.065422,-0.054086,0,0
2,GO RESPONSE TO LEPTIN,0.6055,-0.065511,0.00032349,0,0
2,GO BONE MATURATION,0.21288,-0.065576,-0.073183,0,0
2,GO MELANOCYTE DIFFERENTIATION,0.1793,-0.065613,-0.070243,0,0
2,GO SOMITOGENESIS,0.19417,-0.065729,-0.042783,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.27853,-0.065841,-0.052068,0,0
2,GO NON MOTILE CILIUM ASSEMBLY,0.58307,-0.065896,-0.035637,0,0
2,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.088486,-0.065949,-0.055637,0,0
2,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.033271,-0.06596,-0.065546,0,0
2,GO REGULATION OF MITOPHAGY,0.12421,-0.066013,-0.078104,0,0
2,GO EMBRYONIC BODY MORPHOGENESIS,0.44028,-0.066309,-0.062616,0,0
2,GO REGULATION OF TISSUE REMODELING,0.27317,-0.066323,-0.068575,0,0
2,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.22503,-0.06654,-0.019879,0,0
2,GO OVARIAN FOLLICLE DEVELOPMENT,0.063258,-0.066588,-0.091678,0,0
2,GO ESCRT COMPLEX DISASSEMBLY,0.28761,-0.066863,-0.046242,0,0
2,GO RENAL WATER HOMEOSTASIS,0.085497,-0.066875,-0.09428,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.26614,-0.067045,-0.065345,0,0
2,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.36098,-0.067204,-0.061652,0,0
2,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.52874,-0.067302,-0.022027,0,0
2,GO BROWN FAT CELL DIFFERENTIATION,0.56376,-0.06779,-0.028546,0,0
2,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.27495,-0.068115,-0.056833,0,0
2,GO DNA DEMETHYLATION,0.25583,-0.06833,-0.038229,0,0
2,GO PHAGOLYSOSOME ASSEMBLY,0.18866,-0.068415,-0.077441,0,0
2,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.54208,-0.068925,0.0080497,0,0
2,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.30446,-0.069484,-0.030207,0,0
2,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.16904,-0.069578,-0.1239,0,0
2,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.38267,-0.069642,-0.054667,0,0
2,GO BASEMENT MEMBRANE ORGANIZATION,0.78451,-0.069833,-0.025545,0,0
2,GO ENGULFMENT OF APOPTOTIC CELL,0.13444,-0.070043,-0.081696,0,0
2,GO EMBRYONIC PATTERN SPECIFICATION,0.47461,-0.070168,-0.034653,0,0
2,GO BONE CELL DEVELOPMENT,0.71391,-0.070191,0.014521,0,0
2,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.071756,-0.070401,-0.078395,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.10471,-0.070876,-0.076394,0,0
2,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.81581,-0.07149,0.0017986,0,0
2,GO ODONTOGENESIS,0.95961,-0.071578,0.0017998,0,0
2,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.084763,-0.071693,-0.073722,0,0
2,GO SECONDARY METABOLIC PROCESS,0.11367,-0.071743,-0.1026,0,0
2,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.44994,-0.071888,-0.068782,0,0
2,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.88565,-0.072102,0.070982,0,0
2,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.27853,-0.072416,-0.11951,0,0
2,GO ORGANIC ACID TRANSPORT,0.069238,-0.072432,-0.052463,0,0
2,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.36311,-0.072436,-0.054538,0,0
2,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.11647,-0.07251,-0.073345,0,0
2,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0056255,-0.072616,-0.11151,0,0
2,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.78763,-0.072617,0.0021013,0,0
2,GO EXCRETION,0.11837,-0.072875,-0.054865,0,0
2,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.067397,-0.073081,-0.072097,0,0
2,GO REGULATION OF CELL FATE SPECIFICATION,0.73517,-0.073364,0.01161,0,0
2,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.27317,-0.073594,-0.045123,0,0
2,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.13656,-0.073755,-0.028303,0,0
2,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.086981,-0.073784,-0.08668,0,0
2,GO EPITHELIAL CELL FATE COMMITMENT,0.50516,-0.073808,-0.055176,0,0
2,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.30255,-0.073875,-0.039189,0,0
2,GO INTRACELLULAR STEROL TRANSPORT,0.99515,-0.073936,0.021608,0,0
2,GO PULMONARY VALVE DEVELOPMENT,0.33803,-0.073955,-0.068881,0,0
2,GO REGULATION OF DEACETYLASE ACTIVITY,0.39832,-0.074041,-0.0478,0,0
2,GO MITOCHONDRIAL FISSION,0.028556,-0.074237,-0.098571,0,0
2,GO DRUG METABOLIC PROCESS,0.52609,-0.074333,-0.015152,0,0
2,GO OVULATION CYCLE PROCESS,0.081877,-0.074345,-0.067894,0,0
2,GO REGULATION OF EXOSOMAL SECRETION,0.25246,-0.074347,-0.050061,0,0
2,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.13444,-0.074399,-0.10922,0,0
2,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.40514,-0.075125,-0.0081436,0,0
2,GO CARDIAC MUSCLE CELL PROLIFERATION,0.23128,-0.075158,-0.036952,0,0
2,GO MESENCHYMAL CELL DIFFERENTIATION,0.4451,-0.075564,-0.037563,0,0
2,GO ORGANELLE FUSION,0.073043,-0.076253,-0.058403,0,0
2,GO REGULATION OF TUBE SIZE,0.0020367,-0.076526,-0.11678,0,0
2,GO HISTONE H3 K9 TRIMETHYLATION,0.30255,-0.076551,-0.040562,0,0
2,GO REGULATION OF BEHAVIOR,0.077698,-0.076577,-0.079429,0,0
2,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.20699,-0.076791,-0.071667,0,0
2,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.14308,-0.076952,-0.075686,0,0
2,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.72907,-0.077177,-0.023608,0,0
2,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0098086,-0.077374,-0.074331,0,0
2,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.56925,-0.077442,-0.026486,0,0
2,GO LYSOSOMAL TRANSPORT,0.30829,-0.077459,-0.038193,0,0
2,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.53406,-0.078105,-0.016674,0,0
2,GO MUSCLE FIBER DEVELOPMENT,0.096327,-0.078589,-0.07608,0,0
2,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.20554,-0.078757,-0.076304,0,0
2,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.082591,-0.078855,-0.060109,0,0
2,GO PROTEIN LOCALIZATION TO VACUOLE,0.08331,-0.079133,-0.069848,0,0
2,GO RESPONSE TO PAIN,0.096327,-0.079189,-0.10818,0,0
2,GO REGULATION OF NEURON PROJECTION REGENERATION,0.53406,-0.079463,-0.020672,0,0
2,GO MATING BEHAVIOR,0.18595,-0.079796,-0.060129,0,0
2,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.14869,-0.079847,-0.0488,0,0
2,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.072397,-0.080362,-0.090377,0,0
2,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.16778,-0.08058,-0.064727,0,0
2,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.037139,-0.080734,-0.064959,0,0
2,GO RESPONSE TO CORTICOSTERONE,0.16904,-0.081043,-0.09565,0,0
2,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.19003,-0.081294,-0.060647,0,0
2,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.066792,-0.081309,-0.074399,0,0
2,GO PROTON TRANSMEMBRANE TRANSPORT,0.093918,-0.081446,-0.048573,0,0
2,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.56103,-0.08155,-0.0072152,0,0
2,GO CELLULAR RESPONSE TO VITAMIN D,0.50776,-0.08233,-0.04403,0,0
2,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.096327,-0.082734,-0.10915,0,0
2,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.072397,-0.083012,-0.12974,0,0
2,GO ADAPTATION OF SIGNALING PATHWAY,0.14983,-0.083166,-0.066977,0,0
2,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.13979,-0.083386,-0.060583,0,0
2,GO RESPONSE TO AMPHETAMINE,0.032278,-0.083524,-0.098182,0,0
2,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.14983,-0.083547,-0.074504,0,0
2,GO REGULATION OF GLIOGENESIS,0.088486,-0.083596,-0.065941,0,0
2,GO CENTROMERE COMPLEX ASSEMBLY,0.37173,-0.083667,-0.022856,0,0
2,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.28395,-0.083685,-0.072478,0,0
2,GO OSTEOCLAST DIFFERENTIATION,0.83474,-0.083785,-0.0023907,0,0
2,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.077698,-0.084017,-0.074091,0,0
2,GO POSITIVE REGULATION OF TISSUE REMODELING,0.36741,-0.084046,-0.077915,0,0
2,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.030368,-0.084797,-0.080535,0,0
2,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.13979,-0.085215,-0.13459,0,0
2,GO CHROMATIN REMODELING AT CENTROMERE,0.19979,-0.085306,-0.04182,0,0
2,GO INTESTINAL LIPID ABSORPTION,0.63408,-0.085571,-0.072791,0,0
2,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.35043,-0.086098,-0.074838,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.63986,-0.086201,-0.022051,0,0
2,GO HEAD MORPHOGENESIS,0.34627,-0.086381,-0.053536,0,0
2,GO ANIMAL ORGAN FORMATION,0.23927,-0.086481,-0.068942,0,0
2,GO REGULATION OF CARTILAGE DEVELOPMENT,0.30446,-0.087063,-0.059799,0,0
2,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.34008,-0.08736,-0.052523,0,0
2,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.46466,-0.087453,-0.056957,0,0
2,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.55016,-0.087671,0.090276,0,0
2,GO GLIAL CELL MIGRATION,0.55016,-0.088231,-0.011893,0,0
2,GO POSITIVE REGULATION OF DNA REPLICATION,0.19417,-0.088468,-0.04543,0,0
2,GO CARDIAC CHAMBER MORPHOGENESIS,0.26964,-0.088588,-0.054933,0,0
2,GO CARDIAC SEPTUM MORPHOGENESIS,0.22348,-0.088616,-0.078457,0,0
2,GO MITOTIC CELL CYCLE ARREST,0.27317,-0.088749,-0.092768,0,0
2,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.20845,-0.088882,-0.087374,0,0
2,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.78763,-0.0889,-0.012701,0,0
2,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.69586,-0.088982,-0.0026767,0,0
2,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.081877,-0.089002,-0.086925,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.12224,-0.089105,-0.078809,0,0
2,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.69586,-0.08914,-0.05074,0,0
2,GO REGULATION OF ENDOCYTIC RECYCLING,0.074349,-0.089236,-0.11816,0,0
2,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.11183,-0.089549,-0.070751,0,0
2,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.043866,-0.089673,-0.14148,0,0
2,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.014823,-0.089738,-0.081357,0,0
2,GO CARDIOBLAST DIFFERENTIATION,0.32792,-0.089904,-0.065687,0,0
2,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.1873,-0.090478,-0.087041,0,0
2,GO AMINO ACID IMPORT,0.1914,-0.090599,-0.028864,0,0
2,GO FORELIMB MORPHOGENESIS,0.26789,-0.090649,-0.069233,0,0
2,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.017894,-0.090665,-0.099305,0,0
2,GO CAMERA TYPE EYE DEVELOPMENT,0.12322,-0.090755,-0.059146,0,0
2,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.17411,-0.090786,-0.099182,0,0
2,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.15447,-0.090793,-0.052014,0,0
2,GO GLUTAMATE METABOLIC PROCESS,0.19838,-0.090859,-0.029672,0,0
2,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.12322,-0.09151,-0.082406,0,0
2,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.49487,-0.09172,-0.020812,0,0
2,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.10823,-0.091833,-0.10826,0,0
2,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.74128,-0.09216,-0.0045326,0,0
2,GO REGULATION OF ENDOCRINE PROCESS,0.11933,-0.092581,-0.071525,0,0
2,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.23927,-0.093091,-0.071451,0,0
2,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.042609,-0.093121,-0.11078,0,0
2,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.27317,-0.093267,-0.062963,0,0
2,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.16778,-0.093278,-0.065284,0,0
2,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.080464,-0.093515,-0.065778,0,0
2,GO CARBOHYDRATE PHOSPHORYLATION,0.36311,-0.093692,-0.022137,0,0
2,GO SYNAPTIC VESICLE BUDDING,0.43312,-0.093876,-0.034801,0,0
2,GO REGULATION OF FATTY ACID TRANSPORT,0.14983,-0.094023,-0.055834,0,0
2,GO VITAMIN TRANSPORT,0.17156,-0.094116,-0.065676,0,0
2,GO RESPIRATORY SYSTEM PROCESS,0.17669,-0.094822,-0.065307,0,0
2,GO PROTEIN AUTOPROCESSING,0.13444,-0.094985,-0.081492,0,0
2,GO REGULATION OF LYASE ACTIVITY,0.062114,-0.095035,-0.073055,0,0
2,GO SPERMATID NUCLEUS DIFFERENTIATION,0.082591,-0.095238,-0.093691,0,0
2,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.12224,-0.095444,-0.083767,0,0
2,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.14419,-0.09602,-0.095847,0,0
2,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.11002,-0.096168,-0.10709,0,0
2,GO DIET INDUCED THERMOGENESIS,0.11647,-0.096239,-0.081583,0,0
2,GO EXOCRINE SYSTEM DEVELOPMENT,0.50776,-0.096358,-0.031122,0,0
2,GO KINETOCHORE ORGANIZATION,0.21587,-0.096606,-0.063551,0,0
2,GO ENDOCARDIUM DEVELOPMENT,0.81267,-0.097455,-0.0071081,0,0
2,GO EMBRYONIC AXIS SPECIFICATION,0.071119,-0.097667,-0.08408,0,0
2,GO CGMP MEDIATED SIGNALING,0.096327,-0.098357,-0.095254,0,0
2,GO REGULATION OF PROSTAGLANDIN SECRETION,0.20122,-0.098366,-0.069288,0,0
2,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.16407,-0.098495,-0.12055,0,0
2,GO TRABECULA MORPHOGENESIS,0.2714,-0.0986,-0.045131,0,0
2,GO PHAGOSOME ACIDIFICATION,0.075674,-0.098818,-0.07517,0,0
2,GO ENDOCRINE HORMONE SECRETION,0.14088,-0.09949,-0.061986,0,0
2,GO REGULATION OF ANION TRANSPORT,0.0039481,-0.099884,-0.10429,0,0
2,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.1313,-0.09997,-0.098261,0,0
2,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.18062,-0.10001,-0.065721,0,0
2,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.0071918,-0.10008,-0.16616,0,0
2,GO HEPARIN METABOLIC PROCESS,0.22658,-0.10039,-0.073834,0,0
2,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.032278,-0.10071,-0.11059,0,0
2,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.0067673,-0.10074,-0.077096,0,0
2,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.070488,-0.10079,-0.085006,0,0
2,GO POSITIVE REGULATION OF DNA BINDING,0.033608,-0.10081,-0.069524,0,0
2,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.11933,-0.10082,-0.080892,0,0
2,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.13338,-0.10122,-0.11727,0,0
2,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.20845,-0.1013,-0.058725,0,0
2,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.10214,-0.10139,-0.072975,0,0
2,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.032278,-0.10171,-0.092321,0,0
2,GO KILLING OF CELLS OF OTHER ORGANISM,0.015329,-0.10176,-0.098524,0,0
2,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.22348,-0.10183,-0.091128,0,0
2,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.6055,-0.1023,-0.043562,0,0
2,GO TRANSPOSITION,0.72299,-0.10244,-0.019965,0,0
2,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.26789,-0.10249,-0.086893,0,0
2,GO PROTEIN TARGETING TO LYSOSOME,0.20265,-0.10257,-0.083155,0,0
2,GO REGULATION OF BONE REMODELING,0.11275,-0.10297,-0.10457,0,0
2,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.0075485,-0.10364,-0.13393,0,0
2,GO VASODILATION,0.060988,-0.10416,-0.11082,0,0
2,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.22348,-0.10469,-0.047403,0,0
2,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.40514,-0.10488,-0.04329,0,0
2,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.069238,-0.10537,-0.13644,0,0
2,GO HEART TRABECULA FORMATION,0.052575,-0.10583,-0.12822,0,0
2,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.099614,-0.10588,-0.071373,0,0
2,GO MITOTIC DNA REPLICATION,0.34627,-0.10604,-0.016394,0,0
2,GO FEMALE GENITALIA DEVELOPMENT,0.45238,-0.10654,-0.03192,0,0
2,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.35463,-0.10687,-0.048042,0,0
2,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.062684,-0.10691,-0.069541,0,0
2,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.13763,-0.10692,-0.068346,0,0
2,GO OVULATION CYCLE,0.13549,-0.10732,-0.055225,0,0
2,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.41434,-0.1074,-0.029578,0,0
2,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.12924,-0.10746,-0.078054,0,0
2,GO ENDOTHELIUM DEVELOPMENT,0.076344,-0.10749,-0.094166,0,0
2,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.97899,-0.10757,0.022202,0,0
2,GO RESPONSE TO ELECTRICAL STIMULUS,0.10045,-0.10772,-0.088465,0,0
2,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.178,-0.10774,-0.082775,0,0
2,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.09796,-0.10784,-0.06851,0,0
2,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00011218,-0.10786,-0.15421,0,0
2,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.096327,-0.10797,-0.099679,0,0
2,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.33599,-0.10821,0.14316,0,0
2,GO ACTIN FILAMENT NETWORK FORMATION,0.11367,-0.10833,-0.14476,0,0
2,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.42602,-0.10855,-0.045593,0,0
2,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.082591,-0.10856,-0.057497,0,0
2,GO AROMATIC AMINO ACID TRANSPORT,0.19557,-0.1087,-0.047649,0,0
2,GO NEGATIVE REGULATION OF ANOIKIS,0.42838,-0.10964,-0.062439,0,0
2,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.48722,-0.11007,-0.036571,0,0
2,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.43312,-0.11049,-0.041929,0,0
2,GO ROOF OF MOUTH DEVELOPMENT,0.070488,-0.11078,-0.077827,0,0
2,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.1387,-0.11164,-0.098873,0,0
2,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.59986,-0.11169,-0.0077538,0,0
2,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.10471,-0.1118,-0.1171,0,0
2,GO POSITIVE THYMIC T CELL SELECTION,0.14869,-0.11186,-0.07268,0,0
2,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.10129,-0.11234,-0.074491,0,0
2,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.35043,-0.1126,-0.036672,0,0
2,GO CELL MATURATION,0.0005618,-0.11315,-0.12898,0,0
2,GO MITOTIC RECOMBINATION,0.33599,-0.11351,-0.024813,0,0
2,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.10471,-0.11401,-0.072687,0,0
2,GO RESPONSE TO ACIDIC PH,0.32592,-0.11412,-0.047075,0,0
2,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.25414,-0.11423,-0.098557,0,0
2,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.077698,-0.11472,-0.09692,0,0
2,GO CILIUM MOVEMENT,0.002631,-0.1149,-0.138,0,0
2,GO REGULATION OF HEART MORPHOGENESIS,0.22348,-0.11515,-0.07738,0,0
2,GO PARTURITION,0.022928,-0.11517,-0.15659,0,0
2,GO RESPONSE TO PARATHYROID HORMONE,0.11275,-0.11526,-0.11805,0,0
2,GO REGULATION OF BMP SIGNALING PATHWAY,0.32993,-0.11594,-0.049846,0,0
2,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.43312,-0.11596,-0.048286,0,0
2,GO EXTRACELLULAR VESICLE BIOGENESIS,0.15921,-0.11597,-0.055149,0,0
2,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.44269,-0.11618,-0.019263,0,0
2,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.086237,-0.11731,-0.13359,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.0012886,-0.1176,-0.13726,0,0
2,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.12721,-0.11796,-0.066601,0,0
2,GO POSITIVE REGULATION OF HEART CONTRACTION,0.026013,-0.11861,-0.097806,0,0
2,GO ESTROUS CYCLE,0.22658,-0.1191,-0.0763,0,0
2,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.09796,-0.1193,-0.15149,0,0
2,GO RESPONSE TO GLUCAGON,0.010895,-0.1194,-0.11042,0,0
2,GO FUCOSE METABOLIC PROCESS,0.47712,-0.11941,-0.027082,0,0
2,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.20122,-0.12079,-0.08259,0,0
2,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0025277,-0.12115,-0.097742,0,0
2,GO RHYTHMIC BEHAVIOR,0.027401,-0.12122,-0.092965,0,0
2,GO GASTRULATION WITH MOUTH FORMING SECOND,0.1387,-0.12308,-0.11613,0,0
2,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.21738,-0.12372,-0.053744,0,0
2,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.22503,-0.1248,-0.1143,0,0
2,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.19979,-0.12538,-0.11104,0,0
2,GO REGULATION OF CELL PROJECTION SIZE,0.86012,-0.12551,0.080455,0,0
2,GO REGULATION OF LIGASE ACTIVITY,0.069238,-0.12619,-0.083418,0,0
2,GO DIGESTIVE SYSTEM DEVELOPMENT,0.02915,-0.12625,-0.11516,0,0
2,GO REGULATION OF RESPIRATORY BURST,0.11837,-0.12634,-0.081997,0,0
2,GO RESPONSE TO AXON INJURY,0.003607,-0.1265,-0.13842,0,0
2,GO ENDOCRINE PANCREAS DEVELOPMENT,0.35043,-0.12657,-0.050285,0,0
2,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.17029,-0.12678,-0.059249,0,0
2,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.13763,-0.12705,-0.12116,0,0
2,GO MALE MEIOTIC NUCLEAR DIVISION,0.00084997,-0.12713,-0.1734,0,0
2,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.18062,-0.12797,-0.11191,0,0
2,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.042609,-0.12815,-0.12823,0,0
2,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0047198,-0.12832,-0.15701,0,0
2,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.21437,-0.12852,-0.0846,0,0
2,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.15447,-0.12878,-0.10509,0,0
2,GO STEROID HORMONE SECRETION,0.34213,-0.12921,-0.053238,0,0
2,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.013546,-0.12929,-0.10027,0,0
2,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.27853,-0.1302,-0.080347,0,0
2,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.2714,-0.13024,-0.091356,0,0
2,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.15098,-0.13055,-0.10826,0,0
2,GO DERMATAN SULFATE METABOLIC PROCESS,0.11933,-0.13191,-0.15341,0,0
2,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.25414,-0.13346,-0.054296,0,0
2,GO CELLULAR RESPONSE TO VITAMIN,0.22042,-0.13456,-0.070132,0,0
2,GO VENTRICULAR SEPTUM DEVELOPMENT,0.11183,-0.13466,-0.080711,0,0
2,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.33194,-0.13545,-0.055694,0,0
2,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.044722,-0.13567,-0.11304,0,0
2,GO CIRCADIAN SLEEP WAKE CYCLE,0.17283,-0.136,-0.073471,0,0
2,GO BEHAVIORAL RESPONSE TO COCAINE,0.10734,-0.13647,-0.17848,0,0
2,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.013856,-0.13758,-0.078843,0,0
2,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.093126,-0.13762,-0.10854,0,0
2,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.051595,-0.13844,-0.097364,0,0
2,GO SKELETAL MUSCLE CONTRACTION,0.0045438,-0.13888,-0.14698,0,0
2,GO CLATHRIN COAT ASSEMBLY,0.14755,-0.1391,-0.076443,0,0
2,GO EXTRACELLULAR TRANSPORT,0.10646,-0.13946,-0.10142,0,0
2,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.1262,-0.13972,-0.12425,0,0
2,GO REGULATION OF MITOCHONDRIAL FISSION,0.0052854,-0.14003,-0.14016,0,0
2,GO REGULATION OF ION TRANSPORT,0.00016629,-0.14031,-0.12511,0,0
2,GO SNARE COMPLEX ASSEMBLY,0.12029,-0.14055,-0.056164,0,0
2,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.00037835,-0.14366,-0.12546,0,0
2,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.63408,-0.14455,-0.028443,0,0
2,GO BASIC AMINO ACID TRANSPORT,0.028556,-0.14601,-0.13272,0,0
2,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.14869,-0.14706,-0.10088,0,0
2,GO LYMPH NODE DEVELOPMENT,0.0071051,-0.14764,-0.15544,0,0
2,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.070488,-0.14773,-0.14998,0,0
2,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.00062378,-0.14861,-0.11517,0,0
2,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.31997,-0.14889,-0.087671,0,0
2,GO CHLORIDE TRANSPORT,0.00011986,-0.14999,-0.14079,0,0
2,GO REGULATION OF MEIOTIC CELL CYCLE,5.4184e-05,-0.15067,-0.17017,0,0
2,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.20699,-0.15102,-0.11706,0,0
2,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.061549,-0.15105,-0.11976,0,0
2,GO IRON COORDINATION ENTITY TRANSPORT,0.066792,-0.15154,-0.12846,0,0
2,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.14308,-0.15367,-0.075352,0,0
2,GO STRIATED MUSCLE ADAPTATION,0.079071,-0.15518,-0.11205,0,0
2,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.14419,-0.15811,-0.087254,0,0
2,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.001118,-0.16107,-0.18898,0,0
2,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.11837,-0.16116,-0.076283,0,0
2,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.065596,-0.16163,-0.13136,0,0
2,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.090782,-0.1621,-0.1579,0,0
2,GO AXONAL TRANSPORT OF MITOCHONDRION,0.2644,-0.16234,-0.090488,0,0
2,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.021509,-0.16247,-0.16103,0,0
2,GO NUCLEAR BODY ORGANIZATION,0.070488,-0.16253,-0.12454,0,0
2,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.10558,-0.16272,-0.093139,0,0
2,GO ORGAN INDUCTION,0.040981,-0.16821,-0.14548,0,0
2,GO KERATINOCYTE DEVELOPMENT,0.11742,-0.16833,-0.17233,0,0
2,GO RESPONSE TO INTERLEUKIN 2,0.33194,-0.16849,-0.048011,0,0
2,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.068619,-0.16866,-0.082864,0,0
2,GO DEFENSE RESPONSE TO FUNGUS,1.2954e-05,-0.17026,-0.22178,0,0
2,GO MEMORY,2.1234e-05,-0.17028,-0.18437,0,0
2,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.0022701,-0.17076,-0.18352,0,0
2,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.0061347,-0.17198,-0.14884,0,0
2,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.0054192,-0.17241,-0.11802,0,0
2,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.015329,-0.17347,-0.17016,0,0
2,GO AXO DENDRITIC PROTEIN TRANSPORT,0.00092737,-0.17359,-0.19125,0,0
2,GO RESPONSE TO FUNGUS,0.0071918,-0.17593,-0.13236,0,0
2,GO SEGMENT SPECIFICATION,0.1252,-0.17608,-0.097864,0,0
2,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.062114,-0.1769,-0.14729,0,0
2,GO INACTIVATION OF MAPK ACTIVITY,0.0063654,-0.17722,-0.19026,0,0
2,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.12029,-0.17824,-0.15222,0,0
2,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.1793,-0.17955,-0.11272,0,0
2,GO REGULATION OF OOGENESIS,1.3442e-05,-0.17957,-0.17647,0,0
2,GO REVERSE CHOLESTEROL TRANSPORT,0.24745,-0.17959,-0.094737,0,0
2,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0018508,-0.18043,-0.23794,0,0
2,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.014823,-0.18072,-0.15106,0,0
2,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.012087,-0.1825,-0.13012,0,0
2,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,1.7071e-05,-0.18348,-0.18203,0,0
2,GO CEREBRAL CORTEX CELL MIGRATION,0.0013255,-0.18352,-0.16646,0,0
2,GO NEPHRIC DUCT DEVELOPMENT,0.1313,-0.1861,-0.096708,0,0
2,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.024428,-0.18722,-0.18237,0,0
2,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,6.0079e-05,-0.1914,-0.1711,0,0
2,GO TUBULIN DEACETYLATION,0.00030449,-0.19249,-0.22927,0,0
2,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.08331,-0.19302,-0.087403,0,0
2,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.27673,-0.19349,-0.087409,0,0
2,GO GLYCINE TRANSPORT,0.13338,-0.19357,-0.088513,0,0
2,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.066192,-0.1974,-0.13874,0,0
2,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0012177,-0.19779,-0.18242,0,0
2,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.0056255,-0.19987,-0.20019,0,0
2,GO CAMP METABOLIC PROCESS,0.00044781,-0.20096,-0.22057,0,0
2,GO CHAPERONE MEDIATED AUTOPHAGY,0.10558,-0.20377,-0.10658,0,0
2,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.13763,-0.20487,-0.13729,0,0
2,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0026663,-0.20673,-0.18278,0,0
2,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.011151,-0.2079,-0.23903,0,0
2,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.0040509,-0.20856,-0.15306,0,0
2,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00037257,-0.21134,-0.22749,0,0
2,GO RESPONSE TO AMINO ACID STARVATION,2.7312e-05,-0.21136,-0.18605,0,0
2,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.36956,-0.21153,-0.075742,0,0
2,GO 3 UTR MEDIATED MRNA STABILIZATION,0.00019229,-0.21211,-0.2239,0,0
2,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00036124,-0.21213,-0.22609,0,0
2,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,3.6877e-06,-0.21557,-0.18931,0,0
2,GO SKELETAL MUSCLE ADAPTATION,0.0037985,-0.2169,-0.20648,0,0
2,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.087731,-0.2176,-0.12019,0,0
2,GO PROTEIN LOCALIZATION TO CELL JUNCTION,5.3562e-07,-0.21844,-0.2724,0,0
2,GO CELLULAR RESPONSE TO AMYLOID BETA,0.0037498,-0.22309,-0.1442,0,0
2,GO REGULATION OF ANIMAL ORGAN FORMATION,0.019312,-0.2288,-0.15458,0,0
2,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0081133,-0.23746,-0.26298,0,0
2,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.19557,-0.23774,-0.1465,0,0
2,GO RETINA LAYER FORMATION,0.0020367,-0.23823,-0.25608,0,0
2,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.012798,-0.24143,-0.19594,0,0
2,GO LOCOMOTOR RHYTHM,0.039406,-0.24256,-0.10777,0,0
2,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0007786,-0.24551,-0.22576,0,0
2,GO INTRACILIARY RETROGRADE TRANSPORT,0.0050269,-0.24739,-0.23104,0,0
2,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.11837,-0.25175,-0.10932,0,0
2,GO RESPONSE TO CATECHOLAMINE,4.4787e-08,-0.25583,-0.25089,0,0
2,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.00010852,-0.25683,-0.26715,0,0
2,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.000662,-0.26228,-0.21634,0,0
2,GO INNER DYNEIN ARM ASSEMBLY,0.00017741,-0.26414,-0.36846,0,0
2,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0015038,-0.27153,-0.25197,0,0
2,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,5.2445e-07,-0.2719,-0.3093,0,0
2,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00029052,-0.27566,-0.23597,0,0
2,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00037257,-0.28109,-0.33755,0,0
2,GO SEROTONIN TRANSPORT,0.00034485,-0.28292,-0.23427,0,0
2,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.0302e-06,-0.29072,-0.2656,0,0
2,GO CARDIAC CELL FATE COMMITMENT,0.0055559,-0.29146,-0.23303,0,0
2,GO RESPONSE TO DOPAMINE,1.2131e-09,-0.29805,-0.27906,0,0
2,GO MOTILE CILIUM ASSEMBLY,0.00091404,-0.30249,-0.25272,0,0
2,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0010113,-0.31039,-0.25939,0,0
2,GO INDUCTION OF POSITIVE CHEMOTAXIS,4.1751e-05,-0.31295,-0.34845,0,0
2,GO DICARBOXYLIC ACID TRANSPORT,1.439e-07,-0.31378,-0.25859,0,0
2,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,1.1165e-05,-0.31453,-0.28498,0,0
2,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0029256,-0.32262,-0.26502,0,0
2,GO HEART FORMATION,3.3214e-05,-0.32367,-0.31552,0,0
2,GO POSITIVE REGULATION OF BEHAVIOR,1.9393e-05,-0.32404,-0.29927,0,0
2,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,1.3878e-06,-0.33857,-0.2811,0,0
2,GO DORSAL VENTRAL AXIS SPECIFICATION,0.077018,-0.33919,-0.13715,0,0
2,GO OLFACTORY LOBE DEVELOPMENT,6.2993e-08,-0.36047,-0.36707,0,0
2,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.003607,-0.36498,-0.27272,0,0
2,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.00034485,-0.37485,-0.3448,0,0
2,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,3.6567e-07,-0.37906,-0.36352,0,0
2,GO FOREBRAIN NEURON DEVELOPMENT,3.4098e-06,-0.42257,-0.39391,0,0
2,GO FOREBRAIN GENERATION OF NEURONS,6.6717e-09,-0.42495,-0.41416,0,0
2,GO NOREPINEPHRINE METABOLIC PROCESS,6.7411e-08,-0.42992,-0.49687,0,0
2,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,2.0398e-08,-0.43021,-0.41764,0,0
2,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,4.4807e-06,-0.445,-0.47992,0,0
2,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,3.8149e-08,-0.47741,-0.46404,0,0
2,GO HEART INDUCTION,6.8888e-05,-0.48264,-0.48153,0,0
2,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.6654e-06,-0.49704,-0.52185,0,0
2,GO SPONTANEOUS SYNAPTIC TRANSMISSION,4.7488e-06,-0.50709,-0.44727,0,0
2,GO PITUITARY GLAND DEVELOPMENT,9.7991e-09,-0.52561,-0.49117,0,0
2,GO REFLEX,4.6202e-07,-0.52831,-0.49683,0,0
2,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,6.205e-09,-0.54321,-0.48521,0,0
2,GO FOREBRAIN NEURON DIFFERENTIATION,1.5217e-09,-0.56173,-0.509,0,0
2,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,4.719e-07,-0.56532,-0.5449,0,0
2,GO HEART FIELD SPECIFICATION,1.3174e-07,-0.6378,-0.56336,0,0
2,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,1.0361e-05,-0.67942,-0.56161,0,0
2,GO REGULATION OF GROWTH HORMONE SECRETION,3.8301e-10,-0.83814,-0.79475,0,0
2,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,8.7184e-11,-1.2815,-1.1777,0,0
3,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,5.9432e-10,0.9096,0.85476,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,1.8573e-08,0.79065,0.70829,1,1
3,GO SYNAPSE MATURATION,9.5999e-07,0.60479,0.52994,1,1
3,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,1.7154e-07,0.59681,0.69532,1,1
3,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,7.892e-08,0.56159,0.50752,1,1
3,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,3.2162e-07,0.55042,0.51181,1,1
3,GO REGULATION OF SYNAPSE MATURATION,7.6657e-06,0.54817,0.46085,1,1
3,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,2.3784e-07,0.54047,0.5477,1,1
3,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,7.8124e-06,0.52729,0.43095,1,1
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,6.6066e-07,0.5246,0.4849,1,1
3,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,1.1165e-05,0.51794,0.44516,1,1
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,1.8032e-05,0.51306,0.49752,1,1
3,GO RESPONSE TO L GLUTAMATE,6.3569e-09,0.51224,0.47974,1,1
3,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,1.8793e-06,0.50362,0.4183,1,1
3,GO SECRETORY GRANULE LOCALIZATION,1.1165e-05,0.49975,0.40287,1,1
3,GO NEURON CELLULAR HOMEOSTASIS,2.9805e-09,0.48601,0.47636,1,1
3,GO DENSE CORE GRANULE TRANSPORT,0.00015083,0.48584,0.39269,1,1
3,GO POSTSYNAPSE ASSEMBLY,4.2271e-06,0.43111,0.45002,1,1
3,GO SYNAPTIC VESICLE MATURATION,3.6877e-06,0.42834,0.43331,1,1
3,GO GLYCINE TRANSPORT,0.0011021,0.42547,0.32714,1,1
3,GO OPIOID RECEPTOR SIGNALING PATHWAY,1.5753e-08,0.41566,0.45162,1,1
3,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,1.0169e-05,0.41289,0.44449,1,1
3,GO CYTOPLASMIC TRANSLATIONAL INITIATION,6.7461e-07,0.40191,0.33344,1,1
3,GO CYTOPLASMIC TRANSLATION,1.1789e-06,0.39893,0.33767,1,1
3,GO NEGATIVE REGULATION OF LYASE ACTIVITY,1.2281e-06,0.39535,0.36981,1,1
3,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,1.155e-06,0.39179,0.38481,1,1
3,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.00037835,0.38668,0.34584,1,1
3,GO CORPUS CALLOSUM DEVELOPMENT,1.0036e-08,0.38257,0.43748,1,1
3,GO DENTATE GYRUS DEVELOPMENT,3.4098e-06,0.38012,0.42905,1,1
3,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,2.8001e-06,0.37872,0.36267,1,1
3,GO EXCITATORY SYNAPSE ASSEMBLY,1.5014e-05,0.3786,0.35523,1,1
3,GO BRANCHING MORPHOGENESIS OF A NERVE,6.5837e-06,0.37728,0.46404,1,1
3,GO MYOBLAST PROLIFERATION,8.2543e-08,0.37653,0.35533,1,1
3,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,6.545e-05,0.37603,0.35177,1,1
3,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,2.2824e-05,0.37453,0.33593,1,1
3,GO SYNAPTIC MEMBRANE ADHESION,0.0039992,0.37324,0.28244,1,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION,3.0395e-05,0.37181,0.32725,1,1
3,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00010323,0.3693,0.39505,1,1
3,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,1.0557e-05,0.36892,0.36668,1,1
3,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,5.2445e-07,0.36549,0.3884,1,1
3,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.00018923,0.36395,0.34967,1,1
3,GO IMP METABOLIC PROCESS,5.8698e-06,0.35782,0.38108,1,1
3,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.6001e-09,0.35748,0.36129,1,1
3,GO TELENCEPHALON GLIAL CELL MIGRATION,1.1588e-05,0.3571,0.32278,1,1
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,1.9393e-05,0.35513,0.31258,1,1
3,GO ANATOMICAL STRUCTURE REGRESSION,0.001422,0.3539,0.28595,1,1
3,GO CARDIAC VENTRICLE FORMATION,0.0011503,0.35385,0.34164,1,1
3,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00092737,0.35357,0.31582,1,1
3,GO SUCKLING BEHAVIOR,1.996e-06,0.35143,0.37546,1,1
3,GO RESPONSE TO ELECTRICAL STIMULUS,5.3562e-07,0.3502,0.30823,1,1
3,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,5.5127e-05,0.34852,0.3481,1,1
3,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,8.5867e-06,0.34409,0.3281,1,1
3,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,1.4741e-05,0.34094,0.35367,1,1
3,GO TRANSLATIONAL INITIATION,1.5865e-05,0.34035,0.28988,1,1
3,GO TRICARBOXYLIC ACID METABOLIC PROCESS,2.971e-06,0.33968,0.37049,1,1
3,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00052901,0.33772,0.27966,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.00021857,0.33749,0.30708,1,1
3,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,1.3039e-08,0.33426,0.31962,1,1
3,GO PROTEIN LOCALIZATION TO AXON,0.00040857,0.33284,0.41664,1,1
3,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00021857,0.33121,0.28677,1,1
3,GO CARDIAC CHAMBER FORMATION,0.00091404,0.32914,0.31891,1,1
3,GO L GLUTAMATE IMPORT,7.1274e-05,0.32803,0.22995,1,1
3,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00010323,0.327,0.30513,1,1
3,GO POSITIVE REGULATION OF NEURON MIGRATION,0.0011021,0.32663,0.3038,1,1
3,GO MATURATION OF LSU RRNA,2.1624e-06,0.32595,0.34098,1,1
3,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,2.4091e-05,0.32564,0.37471,1,1
3,GO UV PROTECTION,5.0323e-06,0.3233,0.33007,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00025215,0.32325,0.30863,1,1
3,GO SYNAPTIC VESICLE CLUSTERING,0.0057669,0.31812,0.33349,1,1
3,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,2.8305e-05,0.31605,0.27717,1,1
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.01016,0.31423,0.21864,1,1
3,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.2032e-06,0.31255,0.35709,1,1
3,GO PEPTIDYL SERINE DEPHOSPHORYLATION,4.2271e-06,0.31191,0.31204,1,1
3,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,3.0811e-07,0.31092,0.3596,1,1
3,GO POSITIVE REGULATION OF VESICLE FUSION,0.0039481,0.31033,0.25863,1,1
3,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,1.1588e-05,0.30354,0.32803,1,1
3,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,2.6386e-06,0.30291,0.347,1,1
3,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,3.9613e-05,0.3023,0.27489,1,1
3,GO MODIFICATION OF SYNAPTIC STRUCTURE,2.0776e-06,0.30213,0.3112,1,1
3,GO REGULATION OF CYTOPLASMIC TRANSLATION,2.8262e-08,0.30175,0.29023,1,1
3,GO RIBOSOME ASSEMBLY,5.7582e-06,0.30149,0.31976,1,1
3,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00017457,0.30054,0.36723,1,1
3,GO VESICLE FUSION TO PLASMA MEMBRANE,5.1304e-06,0.29917,0.3572,1,1
3,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,4.2271e-06,0.29798,0.28711,1,1
3,GO REGULATION OF MRNA BINDING,5.1304e-06,0.29533,0.29232,1,1
3,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,1.3693e-05,0.29433,0.30348,1,1
3,GO REGULATION OF VESICLE FUSION,1.5293e-05,0.29422,0.31486,1,1
3,GO PHAGOCYTOSIS RECOGNITION,4.5558e-05,0.29263,0.25369,1,1
3,GO REGULATION OF NEURON MIGRATION,0.0032078,0.29166,0.19409,1,1
3,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,3.7605e-06,0.29117,0.30531,1,1
3,GO GLYCINE METABOLIC PROCESS,0.0066851,0.29027,0.19142,1,1
3,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.0361e-05,0.28934,0.28827,1,1
3,GO CHAPERONE MEDIATED AUTOPHAGY,0.00020835,0.28778,0.29887,1,1
3,GO OXYGEN TRANSPORT,0.027973,0.28705,0.26886,1,1
3,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,3.628e-05,0.28572,0.33177,1,1
3,GO NEUROTRANSMITTER REUPTAKE,8.7316e-05,0.28365,0.2575,1,1
3,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,4.7172e-05,0.28352,0.28936,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,4.1026e-05,0.28262,0.26007,1,1
3,GO CGMP METABOLIC PROCESS,0.0005618,0.28074,0.29579,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,7.7586e-05,0.28003,0.28132,1,1
3,GO ADULT HEART DEVELOPMENT,0.00010323,0.27979,0.32536,1,1
3,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.008211,0.27885,0.23492,1,1
3,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.00012388,0.27851,0.254,1,1
3,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,2.1807e-07,0.27806,0.33329,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0025617,0.27803,0.23792,1,1
3,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.00015583,0.27794,0.26041,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.00017176,0.27781,0.22739,1,1
3,GO LAYER FORMATION IN CEREBRAL CORTEX,0.0023321,0.27701,0.22789,1,1
3,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.00092737,0.27668,0.35521,1,1
3,GO PSEUDOURIDINE SYNTHESIS,0.0018764,0.27627,0.24529,1,1
3,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.0018256,0.27604,0.28683,1,1
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,9.9844e-05,0.27537,0.24692,1,1
3,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.00026858,0.27519,0.28646,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00055343,0.27512,0.24003,1,1
3,GO EMBRYONIC BRAIN DEVELOPMENT,2.4371e-06,0.27407,0.26648,1,1
3,GO DIVALENT METAL ION EXPORT,1.2027e-05,0.27331,0.34992,1,1
3,GO TELOMERASE RNA LOCALIZATION,1.1588e-05,0.27049,0.27764,1,1
3,GO PROTEIN TARGETING TO MEMBRANE,2.4528e-05,0.26911,0.22085,1,1
3,GO AROMATIC AMINO ACID TRANSPORT,0.0046018,0.26878,0.3052,1,1
3,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.00038422,0.26818,0.27158,1,1
3,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,9.795e-06,0.26686,0.28549,1,1
3,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,3.6877e-06,0.26669,0.32321,1,1
3,GO HOMOCYSTEINE METABOLIC PROCESS,4.0314e-05,0.26473,0.34631,1,1
3,GO PENTOSE METABOLIC PROCESS,0.0001803,0.26233,0.20895,1,1
3,GO AMP METABOLIC PROCESS,0.00069207,0.26201,0.22378,1,1
3,GO CELL PROLIFERATION IN HINDBRAIN,0.0047198,0.26158,0.19168,1,1
3,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,9.086e-06,0.26093,0.29708,1,1
3,GO VIRAL TRANSLATION,9.2585e-06,0.26067,0.27334,1,1
3,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00054518,0.25908,0.22368,1,1
3,GO NEURON PROJECTION ORGANIZATION,1.5293e-05,0.25763,0.24534,1,1
3,GO REGULATION OF CGMP MEDIATED SIGNALING,0.013856,0.25643,0.20673,1,1
3,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,6.6578e-05,0.25529,0.25504,1,1
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,5.6487e-06,0.25501,0.25839,1,1
3,GO SIALYLATION,0.00094089,0.25456,0.33229,1,1
3,GO SYNAPTIC TRANSMISSION GABAERGIC,0.00060545,0.25403,0.18237,1,1
3,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.00021511,0.25392,0.24565,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0007901,0.25214,0.34617,1,1
3,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,7.8124e-06,0.25213,0.24995,1,1
3,GO MATURATION OF SSU RRNA,2.9859e-05,0.25207,0.27057,1,1
3,GO PURINE CONTAINING COMPOUND SALVAGE,0.00074504,0.252,0.21501,1,1
3,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.011022,0.25165,0.22015,1,1
3,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,3.5646e-05,0.25077,0.26399,1,1
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,1.1165e-05,0.2487,0.23915,1,1
3,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.00013451,0.24847,0.27342,1,1
3,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0018508,0.24754,0.26009,1,1
3,GO NEURON REMODELING,0.00036124,0.24532,0.23291,1,1
3,GO REGULATION OF RNA BINDING,1.4207e-05,0.2453,0.23934,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0002117,0.24492,0.25956,1,1
3,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,2.8814e-05,0.24372,0.26298,1,1
3,GO ADAPTATION OF SIGNALING PATHWAY,0.0001179,0.24364,0.25057,1,1
3,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.00061456,0.24034,0.27949,1,1
3,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.00054518,0.24032,0.24187,1,1
3,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,2.2015e-05,0.23925,0.19328,1,1
3,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00046165,0.23846,0.17173,1,1
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.0030436,0.23818,0.24299,1,1
3,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.00014839,0.23769,0.24756,1,1
3,GO PROTEIN TRIMERIZATION,6.2175e-05,0.23732,0.24317,1,1
3,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,5.1446e-05,0.23698,0.30186,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.00064263,0.23564,0.19343,1,1
3,GO DENDRITIC SPINE MORPHOGENESIS,0.00025617,0.23505,0.24019,1,1
3,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.037882,0.23383,0.13919,1,1
3,GO GTP METABOLIC PROCESS,2.3661e-05,0.23303,0.23066,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.000662,0.2319,0.19493,1,1
3,GO PURINE NUCLEOBASE METABOLIC PROCESS,3.8246e-05,0.23042,0.28037,1,1
3,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.003607,0.2302,0.21496,1,1
3,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.000286,0.22997,0.1912,1,1
3,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.055609,0.22909,0.19368,1,1
3,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.00014362,0.2287,0.1798,1,1
3,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,9.819e-05,0.22649,0.22424,1,1
3,GO GLUTAMATE SECRETION,6.545e-05,0.22525,0.25031,1,1
3,GO REGULATION OF LYASE ACTIVITY,8.1138e-06,0.22457,0.227,1,1
3,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.00019857,0.22432,0.23687,1,1
3,GO GAS TRANSPORT,0.008211,0.22391,0.24152,1,1
3,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0063654,0.22332,0.18742,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0030038,0.2233,0.18405,1,1
3,GO VITAMIN CATABOLIC PROCESS,0.024947,0.2233,0.21826,1,1
3,GO NEUROTRANSMITTER UPTAKE,0.00017741,0.22189,0.21312,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.0026663,0.22175,0.19433,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0088198,0.22067,0.14294,1,1
3,GO NAD METABOLIC PROCESS,5.332e-06,0.22049,0.27192,1,1
3,GO MESODERMAL CELL FATE SPECIFICATION,0.027686,0.22017,0.15168,1,1
3,GO ARGININE METABOLIC PROCESS,0.0012527,0.21847,0.23254,1,1
3,GO SYNAPTIC VESICLE PRIMING,0.00094089,0.21843,0.25468,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,1.6158e-05,0.21449,0.21815,1,1
3,GO VIRAL GENE EXPRESSION,0.00035024,0.21417,0.20067,1,1
3,GO CELL PROLIFERATION IN FOREBRAIN,0.026286,0.21363,0.17013,1,1
3,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00049802,0.21317,0.22071,1,1
3,GO CHEMOSENSORY BEHAVIOR,0.00033432,0.21315,0.18776,1,1
3,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.031953,0.21296,0.15045,1,1
3,GO NOREPINEPHRINE TRANSPORT,0.00049802,0.2129,0.20133,1,1
3,GO RIBONUCLEOTIDE CATABOLIC PROCESS,9.6129e-06,0.21246,0.24909,1,1
3,GO STRESS GRANULE ASSEMBLY,0.00054518,0.21173,0.16717,1,1
3,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00018323,0.21165,0.20592,1,1
3,GO MATURATION OF 5 8S RRNA,0.00054518,0.21149,0.22443,1,1
3,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.028852,0.21143,0.1801,1,1
3,GO LONG TERM MEMORY,0.00012186,0.21073,0.21807,1,1
3,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,1.9749e-05,0.20869,0.26044,1,1
3,GO ACYLGLYCEROL HOMEOSTASIS,0.014013,0.20784,0.14496,1,1
3,GO REGULATION OF POSTSYNAPSE ORGANIZATION,3.628e-05,0.20646,0.24244,1,1
3,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.0057669,0.20576,0.17659,1,1
3,GO SYNAPTIC VESICLE EXOCYTOSIS,0.00022565,0.20568,0.22061,1,1
3,GO LATERAL VENTRICLE DEVELOPMENT,0.0013255,0.20565,0.23734,1,1
3,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.001704,0.20442,0.16341,1,1
3,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.0062877,0.20442,0.1765,1,1
3,GO REGULATION OF GONAD DEVELOPMENT,0.000662,0.20437,0.20358,1,1
3,GO TRNA MODIFICATION,0.00015083,0.20381,0.1947,1,1
3,GO PEPTIDYL ARGININE METHYLATION,0.00011218,0.20338,0.21263,1,1
3,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0018508,0.20295,0.31973,1,1
3,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.001442,0.20009,0.17119,1,1
3,GO LONG TERM SYNAPTIC DEPRESSION,0.0025617,0.19995,0.19299,1,1
3,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.00029052,0.19927,0.1826,1,1
3,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0042095,0.19918,0.16467,1,1
3,GO TRANSLATIONAL ELONGATION,2.9859e-05,0.19918,0.19693,1,1
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.00096848,0.19832,0.18099,1,1
3,GO TETRAHYDROFOLATE INTERCONVERSION,0.024428,0.19764,0.13143,1,1
3,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.0005056,0.19737,0.22032,1,1
3,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.019312,0.197,0.14356,1,1
3,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.0046018,0.1969,0.16532,1,1
3,GO MECHANOSENSORY BEHAVIOR,0.017506,0.19657,0.30451,1,1
3,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,2.0364e-06,0.19608,0.1867,1,1
3,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.00071283,0.19565,0.22805,1,1
3,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.020166,0.1955,0.14649,1,1
3,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.001442,0.19547,0.18582,1,1
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,8.1623e-05,0.19541,0.18411,1,1
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0094686,0.19518,0.18162,1,1
3,GO SYNAPSE ORGANIZATION,0.0011503,0.19487,0.16042,1,1
3,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,9.0235e-07,0.19461,0.2147,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.00041488,0.19441,0.17532,1,1
3,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.0031247,0.19393,0.21233,1,1
3,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,2.8814e-05,0.19346,0.2191,1,1
3,GO REGULATION OF TRANSLATIONAL ELONGATION,8.3013e-05,0.19346,0.17006,1,1
3,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00049802,0.19325,0.20556,1,1
3,GO MITOCHONDRIAL TRANSCRIPTION,0.0050904,0.19177,0.16181,1,1
3,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.00098255,0.19097,0.20973,1,1
3,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.013243,0.19072,0.18377,1,1
3,GO DORSAL VENTRAL AXIS SPECIFICATION,0.015501,0.19003,0.18346,1,1
3,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.00047589,0.18927,0.20218,1,1
3,GO REGULATION OF CYCLASE ACTIVITY,2.3661e-05,0.18922,0.21986,1,1
3,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.001118,0.18921,0.14265,1,1
3,GO LEARNING,0.00045468,0.18889,0.18721,1,1
3,GO MITOCHONDRIAL RNA PROCESSING,0.018898,0.18866,0.21344,1,1
3,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.0021505,0.1868,0.17756,1,1
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.00019857,0.18668,0.20621,1,1
3,GO AMINO ACID TRANSMEMBRANE TRANSPORT,7.5217e-06,0.18627,0.21251,1,1
3,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0028872,0.18564,0.18223,1,1
3,GO CGMP MEDIATED SIGNALING,0.00069207,0.18494,0.18436,1,1
3,GO CALCIUM ION IMPORT INTO CYTOSOL,0.003654,0.18408,0.20976,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.9393e-05,0.18299,0.18885,1,1
3,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.00016098,0.18276,0.21671,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.031953,0.18276,0.12415,1,1
3,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.051111,0.18235,0.16063,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.00042128,0.18026,0.23637,1,1
3,GO SNORNA 3 END PROCESSING,0.00045468,0.17915,0.26062,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.00055343,0.17885,0.16037,1,1
3,GO CELL JUNCTION DISASSEMBLY,0.000286,0.17882,0.21165,1,1
3,GO PROTEIN LOCALIZATION TO SYNAPSE,0.0046018,0.17823,0.17929,1,1
3,GO REGULATION OF SPINDLE CHECKPOINT,0.00059648,0.17774,0.13719,1,1
3,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.00048316,0.17771,0.17844,1,1
3,GO AMINO ACID IMPORT,0.0051547,0.17753,0.16108,1,1
3,GO SHORT TERM MEMORY,0.011411,0.17752,0.24394,1,1
3,GO ACIDIC AMINO ACID TRANSPORT,0.00019229,0.17684,0.17648,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,1.1588e-05,0.17664,0.18614,1,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00080175,0.17657,0.21224,1,1
3,GO AEROBIC RESPIRATION,0.00088789,0.17633,0.14511,1,1
3,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0137,0.17599,0.1302,1,1
3,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.001704,0.1759,0.17926,1,1
3,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.001568,0.17563,0.18516,1,1
3,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.001568,0.17561,0.1979,1,1
3,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0054872,0.17509,0.15731,1,1
3,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.00052901,0.17496,0.17535,1,1
3,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,5.5127e-05,0.17434,0.17108,1,1
3,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,6.0079e-05,0.1737,0.20097,1,1
3,GO REGULATION OF CATION CHANNEL ACTIVITY,0.00023667,0.17274,0.17545,1,1
3,GO MITOCHONDRION LOCALIZATION,0.00034485,0.17266,0.161,1,1
3,GO ACTIVATION OF MAPKKK ACTIVITY,0.036409,0.17218,0.13588,1,1
3,GO RESPONSE TO INTERLEUKIN 7,0.00031907,0.1715,0.15968,1,1
3,GO TRANSLATIONAL TERMINATION,0.0019285,0.17057,0.17019,1,1
3,GO REGULATION OF SYNAPTIC PLASTICITY,0.00060545,0.1702,0.18748,1,1
3,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0075485,0.17007,0.20261,1,1
3,GO REGULATION OF DENDRITE MORPHOGENESIS,0.00036686,0.16976,0.18437,1,1
3,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.00020504,0.16969,0.2328,1,1
3,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0084096,0.16968,0.14021,1,1
3,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.00036124,0.16946,0.2102,1,1
3,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.0056255,0.16863,0.17037,1,1
3,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.010522,0.16851,0.15256,1,1
3,GO POSITIVE REGULATION OF MRNA PROCESSING,0.00013451,0.1682,0.14094,1,1
3,GO FOLIC ACID METABOLIC PROCESS,0.0055559,0.16814,0.16533,1,1
3,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.00014839,0.16797,0.18296,1,1
3,GO NEUROTRANSMITTER TRANSPORT,0.002702,0.16687,0.1788,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.0060595,0.16675,0.16001,1,1
3,GO WALKING BEHAVIOR,2.6352e-05,0.16663,0.24272,1,1
3,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0011341,0.16652,0.15321,1,1
3,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00016361,0.16602,0.18705,1,1
3,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.028556,0.16512,0.12284,1,1
3,GO RIBOSOME BIOGENESIS,0.00014839,0.16477,0.22195,1,1
3,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.000662,0.16466,0.16832,1,1
3,GO COLLAGEN METABOLIC PROCESS,0.035691,0.16441,0.12993,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,3.6924e-05,0.16383,0.18569,1,1
3,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.0029256,0.16381,0.1775,1,1
3,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.00036686,0.16307,0.15045,1,1
3,GO OXIDATIVE PHOSPHORYLATION,0.00027716,0.16285,0.14831,1,1
3,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0025617,0.16263,0.13204,1,1
3,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00014129,0.16211,0.16922,1,1
3,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.0042095,0.16184,0.17274,1,1
3,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.00010673,0.16141,0.18363,1,1
3,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.012945,0.16087,0.13799,1,1
3,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.001704,0.16081,0.16835,1,1
3,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.001776,0.16069,0.19557,1,1
3,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.0052197,0.16042,0.1675,1,1
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.0029645,0.16033,0.19131,1,1
3,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.024428,0.15919,0.12325,1,1
3,GO FATTY ACID HOMEOSTASIS,0.0035146,0.159,0.21555,1,1
3,GO REGULATION OF SYNAPSE ASSEMBLY,0.0076401,0.15874,0.14365,1,1
3,GO RRNA TRANSCRIPTION,9.9844e-05,0.15853,0.19119,1,1
3,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.0032078,0.15851,0.17084,1,1
3,GO DENDRITE SELF AVOIDANCE,0.052575,0.15847,0.14649,1,1
3,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0046018,0.15833,0.18758,1,1
3,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00059648,0.15782,0.19519,1,1
3,GO DENDRITIC TRANSPORT,0.003654,0.15769,0.2015,1,1
3,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.00045468,0.15716,0.1582,1,1
3,GO URONIC ACID METABOLIC PROCESS,0.0054872,0.15658,0.11122,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.0007901,0.15607,0.14074,1,1
3,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.0020092,0.15594,0.15902,1,1
3,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0046018,0.15591,0.15974,1,1
3,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.00036686,0.15566,0.15658,1,1
3,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0013255,0.15536,0.13943,1,1
3,GO MITOCHONDRIAL TRANSLATION,0.0018508,0.15498,0.1777,1,1
3,GO MRNA MODIFICATION,0.00096848,0.15496,0.20133,1,1
3,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.0035146,0.15437,0.15798,1,1
3,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,6.1119e-05,0.15423,0.17178,1,1
3,GO GLUCOSE CATABOLIC PROCESS,0.0052197,0.15364,0.18943,1,1
3,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.0062877,0.15351,0.15232,1,1
3,GO HISTONE MRNA METABOLIC PROCESS,0.00060545,0.15304,0.12686,1,1
3,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.0074579,0.1528,0.15129,1,1
3,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.0049019,0.15279,0.14886,1,1
3,GO PHOTORECEPTOR CELL DEVELOPMENT,0.045155,0.15278,0.134,1,1
3,GO RRNA METABOLIC PROCESS,0.00021857,0.1516,0.20087,1,1
3,GO PEPTIDE BIOSYNTHETIC PROCESS,0.00022927,0.15137,0.1358,1,1
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.0032501,0.15134,0.16347,1,1
3,GO L AMINO ACID TRANSPORT,0.00039622,0.15072,0.18111,1,1
3,GO NADH METABOLIC PROCESS,0.00014599,0.15067,0.22574,1,1
3,GO REGULATION OF DENDRITE DEVELOPMENT,0.0024609,0.15067,0.14397,1,1
3,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0010408,0.15054,0.16055,1,1
3,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.052575,0.15049,0.11417,1,1
3,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0042636,0.14951,0.14544,1,1
3,GO NUCLEOBASE METABOLIC PROCESS,0.00019229,0.14828,0.19233,1,1
3,GO TRNA METHYLATION,0.0014022,0.14767,0.16995,1,1
3,GO NUCLEOTIDE SALVAGE,0.016027,0.14715,0.19626,1,1
3,GO CRISTAE FORMATION,0.0087156,0.14711,0.1757,1,1
3,GO IRON COORDINATION ENTITY TRANSPORT,0.010041,0.14471,0.14339,1,1
3,GO ALDEHYDE CATABOLIC PROCESS,0.01016,0.14454,0.09972,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.024947,0.14423,0.12484,1,1
3,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.0038478,0.14422,0.16271,1,1
3,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0011021,0.14282,0.13211,1,1
3,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0011836,0.14229,0.14647,1,1
3,GO ONE CARBON METABOLIC PROCESS,0.0058389,0.14147,0.13023,1,1
3,GO MITOCHONDRION DISTRIBUTION,0.0054192,0.14014,0.15559,1,1
3,GO PROTEIN HETEROOLIGOMERIZATION,0.00040857,0.14,0.14788,1,1
3,GO REGULATION OF TRANSLATIONAL INITIATION,0.0005211,0.13985,0.11753,1,1
3,GO ASSOCIATIVE LEARNING,0.0030038,0.13978,0.14064,1,1
3,GO NEUROTRANSMITTER SECRETION,0.0071051,0.13922,0.17094,1,1
3,GO GLUTAMINE METABOLIC PROCESS,0.00019229,0.13921,0.18283,1,1
3,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.011678,0.13851,0.14375,1,1
3,GO DENDRITIC SPINE DEVELOPMENT,0.0016122,0.1382,0.17428,1,1
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.003166,0.13796,0.14612,1,1
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.027118,0.13742,0.16842,1,1
3,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0016575,0.13736,0.13045,1,1
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.0054872,0.13712,0.15312,1,1
3,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.0060595,0.13671,0.18808,1,1
3,GO REGULATION OF MRNA POLYADENYLATION,0.0028872,0.13635,0.11802,1,1
3,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.033608,0.13558,0.11286,1,1
3,GO AMIDE BIOSYNTHETIC PROCESS,0.00028155,0.13531,0.12115,1,1
3,GO MITOCHONDRIAL GENE EXPRESSION,0.0022095,0.13454,0.17754,1,1
3,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.013093,0.13452,0.22321,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.00016901,0.13428,0.11703,1,1
3,GO REGULATION OF TRANSLATIONAL TERMINATION,0.0087156,0.1337,0.1653,1,1
3,GO TRNA WOBBLE BASE MODIFICATION,0.0056255,0.13243,0.15864,1,1
3,GO RRNA MODIFICATION,0.0055559,0.13235,0.18879,1,1
3,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.00088789,0.13232,0.19621,1,1
3,GO SNORNA METABOLIC PROCESS,0.00068191,0.1318,0.25612,1,1
3,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.018091,0.13179,0.13307,1,1
3,GO PROTEIN TARGETING TO MITOCHONDRION,9.03e-05,0.13178,0.13535,1,1
3,GO ACETYL COA BIOSYNTHETIC PROCESS,0.013856,0.13176,0.14718,1,1
3,GO RNA POLYADENYLATION,0.0048405,0.13097,0.1086,1,1
3,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0023957,0.13056,0.13597,1,1
3,GO LIPID IMPORT INTO CELL,0.057711,0.13029,0.1092,1,1
3,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.053071,0.12954,0.13189,1,1
3,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.017125,0.12938,0.10754,1,1
3,GO IMPORT INTO CELL,0.00029052,0.12911,0.15057,1,1
3,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.0019819,0.12859,0.13646,1,1
3,GO RNA SURVEILLANCE,0.0095807,0.12831,0.12988,1,1
3,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0059852,0.12816,0.154,1,1
3,GO TRANSEPITHELIAL TRANSPORT,0.0048405,0.12673,0.11772,1,1
3,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.0098086,0.12655,0.13409,1,1
3,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.0040509,0.12626,0.26271,1,1
3,GO CELLULAR RESPIRATION,0.0012177,0.12581,0.13213,1,1
3,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.0005618,0.12431,0.17042,1,1
3,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.0007901,0.12415,0.12421,1,1
3,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.00026438,0.1227,0.14206,1,1
3,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.012945,0.1224,0.12158,1,1
3,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.051111,0.12233,0.11222,1,1
3,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0075485,0.12228,0.13048,1,1
3,GO NCRNA PROCESSING,0.00069207,0.121,0.1692,1,1
3,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.010522,0.12096,0.17371,1,1
3,GO DNA REPLICATION INITIATION,0.010769,0.12053,0.11103,1,1
3,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.016205,0.11879,0.11611,1,1
3,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0014624,0.11781,0.12075,1,1
3,GO CARDIAC CONDUCTION,0.01016,0.11707,0.12511,1,1
3,GO PROTEIN NITROSYLATION,0.02128,0.11535,0.14589,1,1
3,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0028492,0.11532,0.12127,1,1
3,GO POSITIVE REGULATION OF TRANSLATION,0.0027381,0.11358,0.10539,1,1
3,GO HEPARIN METABOLIC PROCESS,0.033271,0.11319,0.1775,1,1
3,GO PEPTIDE METABOLIC PROCESS,0.001422,0.11258,0.10167,1,1
3,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00030449,0.11192,0.14803,1,1
3,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.035691,0.11137,0.099931,1,1
3,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.059879,0.11099,0.11313,1,1
3,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.016752,0.11054,0.22655,1,1
3,GO L SERINE METABOLIC PROCESS,0.044722,0.10917,0.1836,1,1
3,GO PROTEIN DENEDDYLATION,0.019104,0.10901,0.10719,1,1
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.013394,0.10852,0.11772,1,1
3,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.0085105,0.10829,0.13736,1,1
3,GO AMINO ACID TRANSPORT,0.00031907,0.10689,0.14924,1,1
3,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.0018764,0.1068,0.10621,1,1
3,GO NEGATIVE REGULATION OF BEHAVIOR,0.01995,0.10669,0.13075,1,1
3,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.0078263,0.10565,0.10498,1,1
3,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.049681,0.10515,0.15515,1,1
3,GO HISTONE SERINE PHOSPHORYLATION,0.055093,0.10449,0.085949,1,1
3,GO TRICARBOXYLIC ACID CYCLE,0.012945,0.10428,0.11378,1,1
3,GO PROTEIN TARGETING,0.00018923,0.10423,0.10706,1,1
3,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.011022,0.10421,0.13834,1,1
3,GO STRIATUM DEVELOPMENT,0.02915,0.10375,0.13698,1,1
3,GO TRNA PROCESSING,0.0019023,0.10318,0.14935,1,1
3,GO RNA METHYLATION,0.010645,0.10199,0.11648,1,1
3,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.0039481,0.10159,0.084411,1,1
3,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.010769,0.10112,0.11358,1,1
3,GO POSITIVE REGULATION OF ION TRANSPORT,0.031953,0.10104,0.084703,1,1
3,GO REGULATION OF TRANSPORTER ACTIVITY,0.013243,0.09994,0.10593,1,1
3,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.0038977,0.099347,0.12327,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.0024281,0.09899,0.11501,1,1
3,GO RNA CATABOLIC PROCESS,0.0019285,0.098794,0.11387,1,1
3,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.0058389,0.098576,0.11707,1,1
3,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0039992,0.098384,0.14874,1,1
3,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.0013633,0.097699,0.10468,1,1
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.001422,0.096822,0.12609,1,1
3,GO RESPONSE TO NITRIC OXIDE,0.0059116,0.095731,0.095634,1,1
3,GO REGULATION OF MEMBRANE POTENTIAL,0.039406,0.093694,0.10117,1,1
3,GO NCRNA METABOLIC PROCESS,0.0022701,0.093617,0.1418,1,1
3,GO CELLULAR RESPONSE TO HEAT,0.0089251,0.093316,0.093553,1,1
3,GO CELLULAR RESPONSE TO PH,0.026286,0.089654,0.088471,1,1
3,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.0034243,0.089074,0.10898,1,1
3,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0089251,0.088621,0.10951,1,1
3,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.013243,0.088318,0.10959,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0056255,0.087987,0.11832,1,1
3,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.035336,0.087572,0.088305,1,1
3,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.0019285,0.087544,0.092663,1,1
3,GO RNA 5 END PROCESSING,0.0075485,0.086892,0.16784,1,1
3,GO PROTEIN TETRAMERIZATION,0.0030038,0.085451,0.10137,1,1
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.020166,0.085321,0.092135,1,1
3,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.012945,0.08497,0.082242,1,1
3,GO RRNA METHYLATION,0.036048,0.084319,0.128,1,1
3,GO MRNA METABOLIC PROCESS,0.0022701,0.084215,0.091646,1,1
3,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.0063654,0.084136,0.092821,1,1
3,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.022686,0.083937,0.075104,1,1
3,GO ALDITOL METABOLIC PROCESS,0.0086125,0.083306,0.16118,1,1
3,GO REGULATION OF CALCIUM ION TRANSPORT,0.0062877,0.082565,0.098041,1,1
3,GO CELLULAR AMIDE METABOLIC PROCESS,0.0030839,0.08019,0.086243,1,1
3,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.0084096,0.079687,0.10692,1,1
3,GO CELLULAR RESPONSE TO DRUG,0.0060595,0.079548,0.11393,1,1
3,GO TRNA METABOLIC PROCESS,0.0096941,0.079414,0.11687,1,1
3,GO ATP METABOLIC PROCESS,0.0012886,0.079302,0.099512,1,1
3,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.001776,0.079265,0.093195,1,1
3,GO RNA 3 END PROCESSING,0.048285,0.077498,0.062448,1,1
3,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.026013,0.077404,0.10573,1,1
3,GO CARBOHYDRATE PHOSPHORYLATION,0.048746,0.077223,0.11175,1,1
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.0025617,0.076384,0.076664,1,1
3,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.043444,0.075522,0.069459,1,1
3,GO IRON SULFUR CLUSTER ASSEMBLY,0.049681,0.074889,0.10294,1,1
3,GO RNA PROCESSING,0.0046018,0.074425,0.097125,1,1
3,GO LIVER REGENERATION,0.027686,0.07353,0.094596,1,1
3,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.015674,0.071946,0.081507,1,1
3,GO CATION TRANSMEMBRANE TRANSPORT,0.037139,0.071098,0.073784,1,1
3,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.013093,0.070825,0.11381,1,1
3,GO EXPORT ACROSS PLASMA MEMBRANE,0.05357,0.070009,0.1065,1,1
3,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.044292,0.069455,0.068897,1,1
3,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.037139,0.069225,0.071347,1,1
3,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.015501,0.069013,0.091671,1,1
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.056128,0.068078,0.061617,1,1
3,GO REGULATION OF PROTEIN TARGETING,0.041789,0.058196,0.078185,1,1
3,GO CELLULAR GLUCOSE HOMEOSTASIS,0.049681,0.056692,0.081669,1,1
3,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.034636,0.054784,0.0623,1,1
3,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.011544,0.048769,0.11452,1,1
3,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.027401,0.048088,0.073835,1,1
3,GO PREPULSE INHIBITION,0.0052854,0.31363,0.27881,1,0
3,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00023294,0.28362,0.35664,1,0
3,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.0001862,0.26551,0.34143,1,0
3,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0066039,0.25464,0.33175,1,0
3,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,1.0557e-05,0.25362,0.32366,1,0
3,GO NEGATIVE CHEMOTAXIS,0.0001179,0.25236,0.27788,1,0
3,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.027118,0.24712,0.17428,1,0
3,GO INNERVATION,0.0075485,0.24678,0.25698,1,0
3,GO HEART VALVE FORMATION,0.00055343,0.2451,0.26656,1,0
3,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.00046165,0.24415,0.2795,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.00071283,0.24011,0.21515,1,0
3,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.0016122,0.22986,0.239,1,0
3,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.0012886,0.21786,0.21865,1,0
3,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.01995,0.21686,0.19154,1,0
3,GO NEGATIVE REGULATION OF AXONOGENESIS,0.010769,0.21531,0.17522,1,0
3,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0059852,0.21423,0.18508,1,0
3,GO ELASTIC FIBER ASSEMBLY,0.016205,0.21357,0.24451,1,0
3,GO VOCALIZATION BEHAVIOR,0.041789,0.20542,0.22,1,0
3,GO NEGATIVE REGULATION OF AXON EXTENSION,0.002631,0.20326,0.19994,1,0
3,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0071918,0.19844,0.16632,1,0
3,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.011813,0.19808,0.22819,1,0
3,GO SYNAPTIC VESICLE DOCKING,0.048746,0.18996,0.197,1,0
3,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.00031907,0.18719,0.226,1,0
3,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.049212,0.18688,0.23061,1,0
3,GO MICROTUBULE DEPOLYMERIZATION,0.02128,0.18515,0.14132,1,0
3,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0037498,0.18413,0.20079,1,0
3,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.021053,0.18344,0.23987,1,0
3,GO NEURON RECOGNITION,0.0035146,0.18111,0.1971,1,0
3,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.00057029,0.17927,0.21502,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.056652,0.177,0.13429,1,0
3,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.039406,0.17699,0.15445,1,0
3,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.025743,0.17511,0.15254,1,0
3,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.015674,0.17252,0.16436,1,0
3,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.039406,0.16932,0.15676,1,0
3,GO REGULATION OF EXTENT OF CELL GROWTH,0.00074504,0.16753,0.17431,1,0
3,GO POSTSYNAPSE ORGANIZATION,0.00037835,0.16512,0.19159,1,0
3,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.008211,0.16232,0.16314,1,0
3,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.0021505,0.15939,0.20356,1,0
3,GO AXONAL FASCICULATION,0.048285,0.15871,0.18946,1,0
3,GO COLLATERAL SPROUTING,0.0068504,0.15526,0.17763,1,0
3,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.0062877,0.15404,0.14978,1,0
3,GO AXON EXTENSION,0.0019819,0.15316,0.15587,1,0
3,GO CORONARY VASCULATURE MORPHOGENESIS,0.022446,0.15309,0.16525,1,0
3,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00038422,0.14997,0.24622,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.029754,0.14884,0.16741,1,0
3,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.050154,0.14723,0.16595,1,0
3,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.001118,0.14685,0.16655,1,0
3,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.0030038,0.14604,0.14257,1,0
3,GO REGULATION OF AXONOGENESIS,0.0052197,0.14598,0.15154,1,0
3,GO MEMBRANE REPOLARIZATION,0.0015038,0.14441,0.15522,1,0
3,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.030994,0.14408,0.153,1,0
3,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.0052854,0.14279,0.23761,1,0
3,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.00016361,0.14229,0.15799,1,0
3,GO NEURON PROJECTION EXTENSION,0.001955,0.13906,0.14548,1,0
3,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.047372,0.13814,0.15156,1,0
3,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0030436,0.13759,0.1377,1,0
3,GO RESPONSE TO CAFFEINE,0.0080166,0.13644,0.14222,1,0
3,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.02915,0.13588,0.13388,1,0
3,GO MEMBRANE DISASSEMBLY,0.045155,0.13476,0.10902,1,0
3,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.006444,0.13453,0.13708,1,0
3,GO COLLAGEN BIOSYNTHETIC PROCESS,0.02174,0.13441,0.178,1,0
3,GO FOREBRAIN CELL MIGRATION,0.004156,0.13175,0.15395,1,0
3,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.0015038,0.1311,0.14969,1,0
3,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.017315,0.13042,0.16424,1,0
3,GO NEURON PROJECTION GUIDANCE,0.02174,0.13004,0.13114,1,0
3,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0070192,0.12935,0.15673,1,0
3,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.027118,0.12879,0.14501,1,0
3,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.012798,0.12651,0.14013,1,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.031631,0.12585,0.10941,1,0
3,GO SYNAPTIC VESICLE LOCALIZATION,0.053071,0.1234,0.1327,1,0
3,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.041789,0.12319,0.15114,1,0
3,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.031953,0.12293,0.16986,1,0
3,GO REGULATION OF RECEPTOR INTERNALIZATION,0.01585,0.1225,0.107,1,0
3,GO RELAXATION OF MUSCLE,0.0094686,0.12168,0.1436,1,0
3,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.034636,0.12091,0.12028,1,0
3,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.0020367,0.1207,0.17861,1,0
3,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.025743,0.11852,0.13944,1,0
3,GO BONE GROWTH,0.050154,0.11721,0.14503,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.0054192,0.11698,0.14051,1,0
3,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.012367,0.11691,0.14905,1,0
3,GO DENDRITE MORPHOGENESIS,0.02521,0.11467,0.12465,1,0
3,GO NEUROMUSCULAR PROCESS,0.0037498,0.11463,0.1395,1,0
3,GO DEVELOPMENTAL CELL GROWTH,0.0054192,0.11445,0.11846,1,0
3,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.02521,0.11414,0.10872,1,0
3,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.0014022,0.11402,0.13907,1,0
3,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.03902,0.11281,0.2198,1,0
3,GO SYNAPTIC SIGNALING,0.014172,0.11223,0.12039,1,0
3,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.014658,0.11193,0.11861,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.038637,0.11176,0.15324,1,0
3,GO AXO DENDRITIC TRANSPORT,0.053071,0.11035,0.087239,1,0
3,GO DENDRITE DEVELOPMENT,0.013243,0.10961,0.12245,1,0
3,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.057711,0.10851,0.11014,1,0
3,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.034984,0.10838,0.11471,1,0
3,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.0087156,0.10729,0.13756,1,0
3,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.019735,0.10668,0.10209,1,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.031311,0.10559,0.10793,1,0
3,GO IMPORT ACROSS PLASMA MEMBRANE,0.0021215,0.10534,0.12041,1,0
3,GO CERAMIDE TRANSPORT,0.016752,0.10518,0.12494,1,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.021053,0.10465,0.14415,1,0
3,GO TRNA WOBBLE URIDINE MODIFICATION,0.0081133,0.10406,0.14976,1,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.044722,0.1039,0.10777,1,0
3,GO SULFUR COMPOUND CATABOLIC PROCESS,0.0072795,0.10359,0.13642,1,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0033799,0.10357,0.12748,1,0
3,GO REGULATION OF AXON GUIDANCE,0.044722,0.10321,0.13597,1,0
3,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.05063,0.10321,0.10912,1,0
3,GO CEREBELLAR CORTEX DEVELOPMENT,0.0089251,0.10173,0.14888,1,0
3,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.008211,0.1004,0.1313,1,0
3,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.024428,0.099411,0.14381,1,0
3,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.029754,0.09932,0.18982,1,0
3,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.050154,0.09875,0.080213,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.044722,0.09758,0.10416,1,0
3,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.007921,0.096699,0.1558,1,0
3,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.058247,0.096388,0.1033,1,0
3,GO CORONARY VASCULATURE DEVELOPMENT,0.052083,0.095657,0.11321,1,0
3,GO RESPONSE TO AMYLOID BETA,0.010522,0.095579,0.1233,1,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.021053,0.09548,0.12533,1,0
3,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0042095,0.094685,0.16713,1,0
3,GO COCHLEA DEVELOPMENT,0.035336,0.092968,0.099505,1,0
3,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.039795,0.090797,0.099686,1,0
3,GO CELL PART MORPHOGENESIS,0.017125,0.09043,0.11081,1,0
3,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.056128,0.089745,0.10881,1,0
3,GO AXON DEVELOPMENT,0.011813,0.089464,0.12693,1,0
3,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.043025,0.088616,0.1278,1,0
3,GO POSITIVE REGULATION OF AXONOGENESIS,0.017125,0.087923,0.13979,1,0
3,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.024173,0.08705,0.094984,1,0
3,GO NEURONAL ION CHANNEL CLUSTERING,0.026013,0.084922,0.2567,1,0
3,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.011411,0.08421,0.1194,1,0
3,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.026561,0.084127,0.09877,1,0
3,GO HIPPOCAMPUS DEVELOPMENT,0.037139,0.083674,0.11772,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0096941,0.083577,0.11446,1,0
3,GO REGULATION OF CELL CYCLE ARREST,0.052083,0.082876,0.057079,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.00020504,0.082745,0.12455,1,0
3,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.054074,0.08202,0.078689,1,0
3,GO AXONAL TRANSPORT OF MITOCHONDRION,0.01251,0.081341,0.21922,1,0
3,GO METENCEPHALON DEVELOPMENT,0.032938,0.080651,0.10308,1,0
3,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.025475,0.080037,0.11134,1,0
3,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.01829,0.0799,0.090741,1,0
3,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.019735,0.078631,0.078751,1,0
3,GO MITOCHONDRIAL PROTEIN PROCESSING,0.033948,0.07835,0.12588,1,0
3,GO RECEPTOR INTERNALIZATION,0.026838,0.075092,0.099354,1,0
3,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.032938,0.074636,0.08632,1,0
3,GO CELLULAR COMPONENT MORPHOGENESIS,0.051111,0.074477,0.087755,1,0
3,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.01995,0.07382,0.15903,1,0
3,GO INHIBITORY SYNAPSE ASSEMBLY,0.016027,0.073703,0.26586,1,0
3,GO REGULATION OF TELOMERE MAINTENANCE,0.058247,0.073314,0.077843,1,0
3,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0038478,0.073202,0.12868,1,0
3,GO MODULATION BY HOST OF VIRAL PROCESS,0.028264,0.073162,0.0997,1,0
3,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.046921,0.072419,0.11368,1,0
3,GO REGULATION OF CELL SIZE,0.034636,0.071492,0.093792,1,0
3,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,0.0057669,0.066695,0.13073,1,0
3,GO CELLULAR IRON ION HOMEOSTASIS,0.059879,0.064724,0.080491,1,0
3,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.039406,0.064222,0.1079,1,0
3,GO POTASSIUM ION TRANSPORT,0.041383,0.063996,0.094268,1,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.03006,0.062973,0.091588,1,0
3,GO RNA MODIFICATION,0.011544,0.06175,0.11367,1,0
3,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.007921,0.061458,0.077506,1,0
3,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.019735,0.059011,0.10223,1,0
3,GO COGNITION,0.01829,0.058921,0.10767,1,0
3,GO MIRNA METABOLIC PROCESS,0.050154,0.057453,0.075386,1,0
3,GO HYPOTONIC RESPONSE,0.054074,0.057039,0.11773,1,0
3,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.03429,0.054843,0.093659,1,0
3,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,0.058247,0.054455,0.054247,1,0
3,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.028556,0.051942,0.12191,1,0
3,GO TRNA TRANSPORT,0.040582,0.050442,0.10533,1,0
3,GO FATTY ACYL COA METABOLIC PROCESS,0.021509,0.047326,0.12903,1,0
3,GO NCRNA TRANSCRIPTION,0.023419,0.044366,0.073998,1,0
3,GO EXCRETION,0.056652,0.043138,0.083094,1,0
3,GO PROTEIN HOMOOLIGOMERIZATION,0.020828,0.042167,0.07383,1,0
3,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.044292,0.041623,0.078568,1,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.036048,0.028693,0.1009,1,0
3,GO PIGMENT BIOSYNTHETIC PROCESS,0.042197,0.017358,0.11615,1,0
3,GO SISTER CHROMATID SEGREGATION,0.042197,-0.02466,-0.048774,1,0
3,GO CELLULAR RESPONSE TO STARVATION,0.031311,-0.031614,-0.054049,1,0
3,GO REGULATION OF DEPHOSPHORYLATION,0.049212,-0.03394,-0.042541,1,0
3,GO REGULATION OF ORGANELLE ASSEMBLY,0.03006,-0.033975,-0.039545,1,0
3,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.055093,-0.035151,-0.035176,1,0
3,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.03006,-0.036194,-0.032025,1,0
3,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.038258,-0.036777,-0.097145,1,0
3,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.050154,-0.038923,-0.039479,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.057179,-0.039178,-0.029087,1,0
3,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.058787,-0.039318,-0.03249,1,0
3,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.02915,-0.039327,-0.042065,1,0
3,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.057711,-0.039675,-0.029117,1,0
3,GO ORGANELLE LOCALIZATION,0.0099244,-0.041381,-0.042303,1,0
3,GO PEPTIDYL LYSINE ACETYLATION,0.058787,-0.041488,-0.035764,1,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.01251,-0.04194,-0.037354,1,0
3,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.047372,-0.042285,-0.047421,1,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.010645,-0.043465,-0.038841,1,0
3,GO MITOTIC CELL CYCLE,0.039406,-0.043812,-0.034777,1,0
3,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.040981,-0.043887,-0.041411,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.011411,-0.043952,-0.049485,1,0
3,GO MANNOSYLATION,0.035336,-0.044329,-0.085586,1,0
3,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.039406,-0.04448,-0.040917,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.059331,-0.044551,-0.036087,1,0
3,GO PEPTIDYL AMINO ACID MODIFICATION,0.0083098,-0.045,-0.042689,1,0
3,GO CHROMOSOME SEGREGATION,0.057179,-0.045025,-0.043951,1,0
3,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.054074,-0.045135,-0.047583,1,0
3,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.040187,-0.045372,-0.074948,1,0
3,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.015329,-0.045625,-0.036613,1,0
3,GO MEMBRANE FUSION,0.031311,-0.046263,-0.058255,1,0
3,GO REGULATION OF PHOSPHORYLATION,0.022209,-0.04627,-0.043524,1,0
3,GO HISTONE H3 K9 METHYLATION,0.035691,-0.046578,-0.067655,1,0
3,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.0053519,-0.046803,-0.051462,1,0
3,GO RESPONSE TO ENDOGENOUS STIMULUS,0.032607,-0.046883,-0.042536,1,0
3,GO PEPTIDYL SERINE MODIFICATION,0.036772,-0.047161,-0.039326,1,0
3,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.048746,-0.047773,-0.067331,1,0
3,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.03006,-0.048056,-0.048155,1,0
3,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.024947,-0.048125,-0.05221,1,0
3,GO REGULATION OF CELL CYCLE,0.0087156,-0.048142,-0.036492,1,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.01016,-0.048174,-0.047545,1,0
3,GO RESPIRATORY SYSTEM DEVELOPMENT,0.011678,-0.048729,-0.096105,1,0
3,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.028264,-0.048729,-0.04721,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.044722,-0.048935,-0.036613,1,0
3,GO RESPONSE TO GROWTH FACTOR,0.033271,-0.04896,-0.060683,1,0
3,GO HISTONE H3 K9 MODIFICATION,0.031311,-0.049097,-0.069699,1,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0071051,-0.049279,-0.062861,1,0
3,GO SINGLE FERTILIZATION,0.03902,-0.049354,-0.043988,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.044292,-0.049586,-0.044203,1,0
3,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.05357,-0.049628,-0.052145,1,0
3,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.023173,-0.050036,-0.071536,1,0
3,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.012653,-0.05052,-0.058676,1,0
3,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.0086125,-0.051177,-0.044618,1,0
3,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.022446,-0.051345,-0.044088,1,0
3,GO REGULATION OF TRANSFERASE ACTIVITY,0.020605,-0.051838,-0.040196,1,0
3,GO CIRCULATORY SYSTEM DEVELOPMENT,0.048285,-0.051913,-0.055053,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.048746,-0.051986,-0.050493,1,0
3,GO CELLULAR RESPONSE TO PEPTIDE,0.059879,-0.052017,-0.035594,1,0
3,GO ORGANELLE ASSEMBLY,0.0037985,-0.052462,-0.049374,1,0
3,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.032278,-0.052629,-0.039306,1,0
3,GO SISTER CHROMATID COHESION,0.043025,-0.052734,-0.067048,1,0
3,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.054074,-0.053307,-0.040362,1,0
3,GO SPINDLE ORGANIZATION,0.048746,-0.053337,-0.042105,1,0
3,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.059331,-0.053521,-0.035969,1,0
3,GO CELL CYCLE,0.0069343,-0.053624,-0.039133,1,0
3,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.026561,-0.053941,-0.04826,1,0
3,GO CYTOSOLIC TRANSPORT,0.014823,-0.053943,-0.044343,1,0
3,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.0039992,-0.054004,-0.047452,1,0
3,GO TOR SIGNALING,0.03429,-0.054663,-0.037286,1,0
3,GO NUCLEAR CHROMOSOME SEGREGATION,0.0094686,-0.054929,-0.062028,1,0
3,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.03006,-0.055346,-0.051131,1,0
3,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.043866,-0.055661,-0.039631,1,0
3,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.015159,-0.056179,-0.04494,1,0
3,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.052575,-0.056224,-0.043232,1,0
3,GO NEGATIVE REGULATION OF GROWTH,0.056128,-0.056659,-0.039187,1,0
3,GO REGULATION OF INTRACELLULAR TRANSPORT,0.057711,-0.056735,-0.030457,1,0
3,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.014013,-0.056874,-0.048515,1,0
3,GO REGULATION OF CHROMATIN ORGANIZATION,0.030368,-0.057302,-0.041148,1,0
3,GO POSITIVE REGULATION OF SIGNALING,0.0067673,-0.057477,-0.057554,1,0
3,GO MEMBRANE DOCKING,0.032607,-0.05752,-0.046889,1,0
3,GO CELL JUNCTION ASSEMBLY,0.031631,-0.057671,-0.068579,1,0
3,GO CELLULAR LIPID METABOLIC PROCESS,0.022209,-0.057741,-0.054432,1,0
3,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.023419,-0.058005,-0.039527,1,0
3,GO RESPONSE TO OXIDATIVE STRESS,0.031631,-0.058175,-0.050502,1,0
3,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.032278,-0.058254,-0.047365,1,0
3,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.012087,-0.058515,-0.05364,1,0
3,GO DNA INTEGRITY CHECKPOINT,0.011949,-0.058578,-0.06086,1,0
3,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.046474,-0.058602,-0.039188,1,0
3,GO LIPID METABOLIC PROCESS,0.03006,-0.058957,-0.049365,1,0
3,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.046921,-0.059039,-0.069966,1,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.039406,-0.059467,-0.070407,1,0
3,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.028852,-0.059531,-0.061312,1,0
3,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.018693,-0.059981,-0.10087,1,0
3,GO SYMBIOTIC PROCESS,0.0137,-0.060103,-0.060599,1,0
3,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0048405,-0.060166,-0.082015,1,0
3,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.030994,-0.060746,-0.05305,1,0
3,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0077327,-0.060886,-0.046281,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.023668,-0.061324,-0.051283,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.039795,-0.06153,-0.040695,1,0
3,GO RESPONSE TO CORTICOSTEROID,0.047372,-0.061826,-0.067647,1,0
3,GO POSITIVE REGULATION OF CELL DEATH,0.059331,-0.062125,-0.038035,1,0
3,GO G2 DNA DAMAGE CHECKPOINT,0.031311,-0.062282,-0.071797,1,0
3,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.032607,-0.062572,-0.056042,1,0
3,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.031311,-0.062789,-0.038834,1,0
3,GO REGULATION OF MAP KINASE ACTIVITY,0.035691,-0.062965,-0.05252,1,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.013093,-0.063131,-0.045627,1,0
3,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.0047798,-0.063352,-0.070045,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.047827,-0.063447,-0.070763,1,0
3,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.041789,-0.06353,-0.084323,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.040582,-0.063535,-0.050558,1,0
3,GO BLOOD VESSEL MORPHOGENESIS,0.043025,-0.063594,-0.070887,1,0
3,GO PROTEIN MANNOSYLATION,0.055093,-0.063696,-0.06935,1,0
3,GO REGULATION OF ACTIN FILAMENT LENGTH,0.027973,-0.063865,-0.054914,1,0
3,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.00052901,-0.063919,-0.064882,1,0
3,GO MITOTIC NUCLEAR DIVISION,0.015674,-0.063998,-0.055053,1,0
3,GO VESICLE ORGANIZATION,0.0051547,-0.064001,-0.069858,1,0
3,GO APOPTOTIC PROCESS,0.019312,-0.064088,-0.046842,1,0
3,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.026286,-0.064419,-0.052121,1,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.033948,-0.064586,-0.050432,1,0
3,GO HISTONE H4 ACETYLATION,0.02521,-0.065273,-0.050192,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0056958,-0.065464,-0.05922,1,0
3,GO REGULATION OF TOR SIGNALING,0.023668,-0.065596,-0.052466,1,0
3,GO BLASTOCYST DEVELOPMENT,0.032938,-0.065636,-0.043715,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.037139,-0.066006,-0.088463,1,0
3,GO REGULATION OF APPETITE,0.019312,-0.066028,-0.093317,1,0
3,GO PHOSPHOLIPID METABOLIC PROCESS,0.0051547,-0.066055,-0.059343,1,0
3,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.016386,-0.066276,-0.065663,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.034636,-0.0663,-0.073411,1,0
3,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.030368,-0.066641,-0.079726,1,0
3,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.012087,-0.067124,-0.052865,1,0
3,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.014658,-0.067156,-0.05293,1,0
3,GO PROTEIN CATABOLIC PROCESS,0.011022,-0.067159,-0.044504,1,0
3,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.023173,-0.067265,-0.044977,1,0
3,GO ACTIN FILAMENT BASED PROCESS,0.013546,-0.067452,-0.060627,1,0
3,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.011949,-0.067453,-0.059797,1,0
3,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.017506,-0.067465,-0.065291,1,0
3,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.0016347,-0.067561,-0.087999,1,0
3,GO BIOLOGICAL ADHESION,0.028556,-0.067583,-0.071922,1,0
3,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.038637,-0.067633,-0.062657,1,0
3,GO HUMORAL IMMUNE RESPONSE,0.004964,-0.067769,-0.12235,1,0
3,GO GLYCOSYLATION,0.0084096,-0.067851,-0.082948,1,0
3,GO LIPID MODIFICATION,0.013546,-0.067886,-0.062231,1,0
3,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.014494,-0.068207,-0.065187,1,0
3,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.0090315,-0.068251,-0.064564,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0089251,-0.068266,-0.065167,1,0
3,GO FATTY ACID METABOLIC PROCESS,0.024687,-0.068378,-0.06648,1,0
3,GO ORGANELLE FISSION,0.00095459,-0.068392,-0.063771,1,0
3,GO REGULATION OF JUN KINASE ACTIVITY,0.05357,-0.068778,-0.051983,1,0
3,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.046921,-0.06884,-0.050877,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.042609,-0.068971,-0.054534,1,0
3,GO REGULATION OF MITOTIC CELL CYCLE,0.00046165,-0.069094,-0.060267,1,0
3,GO CYTOKINESIS,0.00088789,-0.06912,-0.084726,1,0
3,GO SPHINGOLIPID METABOLIC PROCESS,0.040582,-0.06913,-0.055023,1,0
3,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.017699,-0.06925,-0.089794,1,0
3,GO CELLULAR GLUCAN METABOLIC PROCESS,0.049681,-0.069423,-0.055235,1,0
3,GO MITOTIC SPINDLE ORGANIZATION,0.054074,-0.069447,-0.055116,1,0
3,GO CELL DIVISION,0.016568,-0.069447,-0.047472,1,0
3,GO ANTIMICROBIAL HUMORAL RESPONSE,0.0047198,-0.069449,-0.12806,1,0
3,GO NUCLEUS ORGANIZATION,0.009139,-0.069546,-0.047743,1,0
3,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.020828,-0.069823,-0.065198,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0042636,-0.069879,-0.077073,1,0
3,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.050154,-0.070074,-0.062308,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.046031,-0.070393,-0.046079,1,0
3,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.051595,-0.070517,-0.1042,1,0
3,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0020646,-0.070628,-0.06717,1,0
3,GO NUCLEAR ENVELOPE ORGANIZATION,0.0068504,-0.070656,-0.068855,1,0
3,GO CIRCADIAN RHYTHM,0.0077327,-0.070687,-0.055722,1,0
3,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.011151,-0.070702,-0.054864,1,0
3,GO REGULATION OF CILIUM ASSEMBLY,0.033271,-0.070731,-0.068771,1,0
3,GO SENSORY ORGAN DEVELOPMENT,0.02945,-0.070834,-0.055252,1,0
3,GO CELL CYCLE CHECKPOINT,0.0016575,-0.070838,-0.071928,1,0
3,GO ERAD PATHWAY,0.0056255,-0.070932,-0.076705,1,0
3,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.01499,-0.070973,-0.073094,1,0
3,GO DNA MODIFICATION,0.056128,-0.071004,-0.041183,1,0
3,GO THYMUS DEVELOPMENT,0.041789,-0.071011,-0.088256,1,0
3,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.021973,-0.071022,-0.069632,1,0
3,GO POSITIVE REGULATION OF CELL CYCLE,0.00071283,-0.071081,-0.063067,1,0
3,GO NON RECOMBINATIONAL REPAIR,0.00075607,-0.071083,-0.078912,1,0
3,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.00038422,-0.071157,-0.095169,1,0
3,GO DETECTION OF STIMULUS,0.014013,-0.071269,-0.057306,1,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.0060595,-0.071274,-0.052658,1,0
3,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.014494,-0.071333,-0.058077,1,0
3,GO PROTEIN INSERTION INTO MEMBRANE,0.013546,-0.071452,-0.056568,1,0
3,GO VACUOLE ORGANIZATION,0.02945,-0.07146,-0.051814,1,0
3,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.022446,-0.071483,-0.061582,1,0
3,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.055609,-0.071518,-0.036216,1,0
3,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.058787,-0.071539,-0.074272,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.036772,-0.071593,-0.045545,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0023957,-0.071613,-0.051715,1,0
3,GO RESPONSE TO STEROID HORMONE,0.01499,-0.071721,-0.07025,1,0
3,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.02915,-0.07177,-0.097205,1,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.022928,-0.071807,-0.077028,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.016027,-0.07199,-0.096277,1,0
3,GO REGULATION OF BLOOD PRESSURE,0.042609,-0.072068,-0.059016,1,0
3,GO PIGMENT CELL DIFFERENTIATION,0.032938,-0.072073,-0.079961,1,0
3,GO MACROAUTOPHAGY,0.00075607,-0.072148,-0.063984,1,0
3,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.034984,-0.072165,-0.07617,1,0
3,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.00065224,-0.072186,-0.067126,1,0
3,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.006444,-0.07235,-0.090853,1,0
3,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.00094089,-0.0724,-0.058609,1,0
3,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.01849,-0.072605,-0.052528,1,0
3,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.011813,-0.072716,-0.11636,1,0
3,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.046031,-0.072774,-0.10364,1,0
3,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.015329,-0.072791,-0.053915,1,0
3,GO DEMETHYLATION,0.026838,-0.07286,-0.04646,1,0
3,GO RESPONSE TO INORGANIC SUBSTANCE,0.01849,-0.072865,-0.049906,1,0
3,GO LIPID EXPORT FROM CELL,0.052083,-0.073188,-0.092717,1,0
3,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0096941,-0.073268,-0.10012,1,0
3,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.013093,-0.073311,-0.073704,1,0
3,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0084096,-0.07349,-0.064732,1,0
3,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.037139,-0.07398,-0.056023,1,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS,0.032278,-0.07398,-0.043542,1,0
3,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.02945,-0.074068,-0.085887,1,0
3,GO REGULATION OF SECRETION,0.024428,-0.074141,-0.055634,1,0
3,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.017125,-0.074165,-0.079437,1,0
3,GO MULTI ORGANISM PROCESS,0.0015038,-0.074321,-0.062414,1,0
3,GO GLYCEROL ETHER METABOLIC PROCESS,0.008211,-0.074545,-0.14578,1,0
3,GO CYTOSKELETON ORGANIZATION,0.011151,-0.074591,-0.050298,1,0
3,GO RESPONSE TO KETONE,0.02915,-0.075283,-0.062144,1,0
3,GO EMBRYO DEVELOPMENT,0.0022095,-0.075307,-0.070425,1,0
3,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.015674,-0.075497,-0.058631,1,0
3,GO REGULATION OF CELL MATURATION,0.015501,-0.075572,-0.073645,1,0
3,GO SELECTIVE AUTOPHAGY,0.045591,-0.075652,-0.058531,1,0
3,GO SEXUAL REPRODUCTION,0.0010113,-0.075762,-0.070008,1,0
3,GO OOGENESIS,0.016938,-0.075775,-0.081782,1,0
3,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.010041,-0.075956,-0.051386,1,0
3,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.0042636,-0.076048,-0.097251,1,0
3,GO CELLULAR RESPONSE TO LIPID,0.031631,-0.076336,-0.061748,1,0
3,GO MEMBRANE LIPID METABOLIC PROCESS,0.011022,-0.076363,-0.070973,1,0
3,GO HETEROCHROMATIN ORGANIZATION,0.0044864,-0.076378,-0.068424,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.0077327,-0.076421,-0.07554,1,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.02174,-0.076574,-0.079603,1,0
3,GO REGULATION OF VASOCONSTRICTION,0.017125,-0.076694,-0.076665,1,0
3,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.011949,-0.076707,-0.061218,1,0
3,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.037882,-0.076825,-0.057921,1,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.05357,-0.07693,-0.10125,1,0
3,GO CELL MOTILITY,0.010279,-0.077337,-0.068913,1,0
3,GO ORGANELLE DISASSEMBLY,0.01016,-0.07738,-0.05665,1,0
3,GO REGULATION OF CELL DEATH,0.012653,-0.077589,-0.054144,1,0
3,GO POSITIVE REGULATION OF ERAD PATHWAY,0.043444,-0.077632,-0.068836,1,0
3,GO LEUKOCYTE HOMEOSTASIS,0.041789,-0.077913,-0.074231,1,0
3,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.022209,-0.078008,-0.079952,1,0
3,GO HISTONE UBIQUITINATION,0.0028492,-0.078033,-0.077843,1,0
3,GO MUSCLE CELL DIFFERENTIATION,0.017506,-0.078437,-0.068992,1,0
3,GO GOLGI VESICLE TRANSPORT,0.0071051,-0.078665,-0.058031,1,0
3,GO NEGATIVE REGULATION OF CELL DEATH,0.0046604,-0.078666,-0.068494,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION,0.0025961,-0.078815,-0.058594,1,0
3,GO RNA DECAPPING,0.024173,-0.078949,-0.059273,1,0
3,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.027686,-0.07896,-0.050572,1,0
3,GO REGULATION OF HYDROLASE ACTIVITY,0.0056958,-0.078988,-0.065694,1,0
3,GO ACTIN FILAMENT ORGANIZATION,0.0034692,-0.079058,-0.084843,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.0010259,-0.079145,-0.070916,1,0
3,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.0137,-0.079155,-0.067135,1,0
3,GO MULTI ORGANISM CELLULAR PROCESS,0.032607,-0.079221,-0.13242,1,0
3,GO DNA DEALKYLATION,0.013093,-0.079357,-0.095746,1,0
3,GO LYSOSOMAL TRANSPORT,0.057711,-0.079515,-0.055417,1,0
3,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0034243,-0.07955,-0.070298,1,0
3,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.044292,-0.079685,-0.046611,1,0
3,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.0059852,-0.079927,-0.06858,1,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.046031,-0.079928,-0.08915,1,0
3,GO RESPONSE TO XENOBIOTIC STIMULUS,0.016752,-0.079944,-0.093028,1,0
3,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.02174,-0.080195,-0.065437,1,0
3,GO P38MAPK CASCADE,0.048285,-0.081033,-0.085209,1,0
3,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.010522,-0.081197,-0.068816,1,0
3,GO TUMOR NECROSIS FACTOR SECRETION,0.016205,-0.081297,-0.10103,1,0
3,GO LYMPHOCYTE ACTIVATION,0.0059116,-0.081488,-0.087327,1,0
3,GO AGING,0.0046604,-0.081517,-0.072075,1,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.057711,-0.081682,-0.07327,1,0
3,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.015159,-0.081716,-0.095577,1,0
3,GO REGULATION OF CYTOKINESIS,0.019104,-0.081719,-0.06442,1,0
3,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0057669,-0.081773,-0.081362,1,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0070192,-0.082017,-0.093157,1,0
3,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.037509,-0.082101,-0.064193,1,0
3,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0083098,-0.082287,-0.068419,1,0
3,GO CELL AGING,0.018091,-0.082357,-0.078389,1,0
3,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0042095,-0.082366,-0.055478,1,0
3,GO LIPOPROTEIN METABOLIC PROCESS,0.017506,-0.082482,-0.072534,1,0
3,GO GLYCEROLIPID METABOLIC PROCESS,0.0027747,-0.083029,-0.067234,1,0
3,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00075607,-0.083113,-0.11278,1,0
3,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.016027,-0.083129,-0.076879,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.053071,-0.083161,-0.05915,1,0
3,GO RESPONSE TO ALCOHOL,0.016386,-0.083199,-0.061725,1,0
3,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.0024941,-0.083331,-0.099788,1,0
3,GO AMEBOIDAL TYPE CELL MIGRATION,0.022686,-0.083374,-0.073807,1,0
3,GO NEUTROPHIL MIGRATION,0.052083,-0.083419,-0.06841,1,0
3,GO MONOSACCHARIDE METABOLIC PROCESS,0.022446,-0.08345,-0.049105,1,0
3,GO AUTOPHAGY OF MITOCHONDRION,0.028556,-0.083501,-0.050007,1,0
3,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0054872,-0.083648,-0.070087,1,0
3,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.033608,-0.083691,-0.063256,1,0
3,GO RESPONSE TO BACTERIUM,0.011544,-0.083705,-0.099175,1,0
3,GO LIPID BIOSYNTHETIC PROCESS,0.0099244,-0.083962,-0.058203,1,0
3,GO PEPTIDYL ASPARAGINE MODIFICATION,0.023419,-0.084012,-0.10331,1,0
3,GO NEGATIVE REGULATION OF SECRETION,0.02174,-0.084026,-0.059312,1,0
3,GO GLUCOSE METABOLIC PROCESS,0.016205,-0.084186,-0.056114,1,0
3,GO ESTABLISHMENT OF CELL POLARITY,0.0095807,-0.084221,-0.063233,1,0
3,GO POLYOL CATABOLIC PROCESS,0.02521,-0.084267,-0.086418,1,0
3,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.036048,-0.084351,-0.081428,1,0
3,GO BODY MORPHOGENESIS,0.05063,-0.084421,-0.086212,1,0
3,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.05063,-0.084499,-0.061542,1,0
3,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.019312,-0.084531,-0.055657,1,0
3,GO LEUKOCYTE DIFFERENTIATION,0.003654,-0.08471,-0.091446,1,0
3,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0047198,-0.08512,-0.066785,1,0
3,GO REGULATION OF VIRAL TRANSCRIPTION,0.032938,-0.085294,-0.058846,1,0
3,GO METAPHASE PLATE CONGRESSION,0.00015838,-0.0853,-0.11219,1,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.051111,-0.085306,-0.063253,1,0
3,GO DOSAGE COMPENSATION,0.020166,-0.085452,-0.088389,1,0
3,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.003166,-0.085491,-0.091993,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.011544,-0.085511,-0.087884,1,0
3,GO NEGATIVE REGULATION OF MAPK CASCADE,0.033948,-0.085577,-0.054552,1,0
3,GO MALE GAMETE GENERATION,0.00044103,-0.08566,-0.083675,1,0
3,GO REGULATION OF OSSIFICATION,0.018091,-0.085847,-0.090906,1,0
3,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.057711,-0.08595,-0.051276,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.017894,-0.086033,-0.095496,1,0
3,GO GERM CELL DEVELOPMENT,0.00159,-0.08611,-0.08519,1,0
3,GO RESPONSE TO ESTRADIOL,0.01995,-0.086309,-0.072621,1,0
3,GO REGULATION OF CELL DIVISION,0.0050904,-0.086324,-0.069308,1,0
3,GO GPI ANCHOR METABOLIC PROCESS,0.014823,-0.086343,-0.11108,1,0
3,GO FATTY ACID CATABOLIC PROCESS,0.033608,-0.086518,-0.073858,1,0
3,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.0071918,-0.086707,-0.090922,1,0
3,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.0072795,-0.086762,-0.084035,1,0
3,GO RESPONSE TO INTERLEUKIN 1,0.029754,-0.086772,-0.075258,1,0
3,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.054582,-0.086855,-0.12524,1,0
3,GO LIPID LOCALIZATION,0.01829,-0.086861,-0.07292,1,0
3,GO MULTICELLULAR ORGANISM REPRODUCTION,0.00039018,-0.087074,-0.075111,1,0
3,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.0084096,-0.087095,-0.081873,1,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.030994,-0.087133,-0.056268,1,0
3,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.042197,-0.087394,-0.076671,1,0
3,GO REGULATION OF IMMUNE RESPONSE,0.0050904,-0.087439,-0.094455,1,0
3,GO RENAL SYSTEM PROCESS,0.0055559,-0.087615,-0.10329,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.011813,-0.087723,-0.091723,1,0
3,GO SEX DIFFERENTIATION,0.015674,-0.087781,-0.063108,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.014658,-0.087973,-0.12278,1,0
3,GO RESPONSE TO BMP,0.009139,-0.087976,-0.10413,1,0
3,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.014013,-0.08811,-0.12732,1,0
3,GO SPERM MOTILITY,0.014332,-0.088373,-0.077069,1,0
3,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0020367,-0.088423,-0.091477,1,0
3,GO REGULATION OF CELL POPULATION PROLIFERATION,0.0037498,-0.088483,-0.078266,1,0
3,GO REGULATION OF CIRCADIAN RHYTHM,0.0014624,-0.088522,-0.084689,1,0
3,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.03006,-0.088576,-0.05027,1,0
3,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0058389,-0.088632,-0.072706,1,0
3,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.0068504,-0.088649,-0.097506,1,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.010895,-0.08867,-0.079821,1,0
3,GO MITOTIC CELL CYCLE CHECKPOINT,0.0012177,-0.088715,-0.074286,1,0
3,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.028556,-0.088751,-0.069543,1,0
3,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.0028492,-0.088947,-0.088738,1,0
3,GO PIGMENTATION,0.024173,-0.088958,-0.071826,1,0
3,GO RESPONSE TO LIPID,0.027686,-0.089321,-0.057556,1,0
3,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.0044298,-0.089411,-0.086705,1,0
3,GO RECEPTOR BIOSYNTHETIC PROCESS,0.046474,-0.089482,-0.079324,1,0
3,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.00027716,-0.089568,-0.081535,1,0
3,GO SKIN EPIDERMIS DEVELOPMENT,0.022686,-0.089696,-0.10651,1,0
3,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.016938,-0.08976,-0.07758,1,0
3,GO PROTEIN AUTOUBIQUITINATION,0.0041031,-0.089806,-0.07457,1,0
3,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.057711,-0.089991,-0.15074,1,0
3,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.022928,-0.090092,-0.11167,1,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0056958,-0.090136,-0.085412,1,0
3,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.0049019,-0.09019,-0.10114,1,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.0060595,-0.090228,-0.073685,1,0
3,GO SECRETION,0.0059852,-0.090322,-0.064742,1,0
3,GO POSITIVE REGULATION OF SECRETION,0.0021505,-0.090337,-0.088186,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0093576,-0.090396,-0.082495,1,0
3,GO ANIMAL ORGAN FORMATION,0.020166,-0.090402,-0.10622,1,0
3,GO ACTIVATION OF IMMUNE RESPONSE,0.0060595,-0.090619,-0.088966,1,0
3,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.032607,-0.090666,-0.068835,1,0
3,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0023957,-0.090909,-0.095951,1,0
3,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.014494,-0.090935,-0.052722,1,0
3,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0094686,-0.090949,-0.052221,1,0
3,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.0053519,-0.091064,-0.077297,1,0
3,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.01251,-0.091189,-0.12291,1,0
3,GO POSITIVE REGULATION OF NUCLEAR DIVISION,6.6578e-05,-0.091191,-0.10503,1,0
3,GO TISSUE MORPHOGENESIS,0.0021505,-0.091237,-0.089153,1,0
3,GO CRANIAL NERVE DEVELOPMENT,0.034984,-0.091355,-0.12385,1,0
3,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.020385,-0.091453,-0.063331,1,0
3,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.004156,-0.091535,-0.10226,1,0
3,GO CELLULAR SENESCENCE,0.009139,-0.091776,-0.096235,1,0
3,GO REGULATION OF PROTEOLYSIS,0.0021798,-0.091801,-0.083845,1,0
3,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.028556,-0.091945,-0.1017,1,0
3,GO PLATELET MORPHOGENESIS,0.0065235,-0.091964,-0.15605,1,0
3,GO REGULATION OF PEPTIDE TRANSPORT,0.00043435,-0.092034,-0.077684,1,0
3,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.027401,-0.092098,-0.084675,1,0
3,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.00016629,-0.092137,-0.099114,1,0
3,GO ERYTHROCYTE MATURATION,0.026838,-0.092223,-0.09598,1,0
3,GO FC RECEPTOR SIGNALING PATHWAY,0.01995,-0.092277,-0.065281,1,0
3,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.026286,-0.092489,-0.080079,1,0
3,GO SECONDARY PALATE DEVELOPMENT,0.048746,-0.092692,-0.11607,1,0
3,GO LYMPHOCYTE DIFFERENTIATION,0.0011836,-0.092729,-0.10219,1,0
3,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.0028492,-0.092732,-0.096284,1,0
3,GO FIBROBLAST MIGRATION,0.012367,-0.092784,-0.11617,1,0
3,GO B CELL HOMEOSTASIS,0.033948,-0.093046,-0.10574,1,0
3,GO RESPONSE TO GAMMA RADIATION,0.010645,-0.093082,-0.081035,1,0
3,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.001235,-0.093162,-0.10773,1,0
3,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.0051547,-0.093187,-0.091401,1,0
3,GO TUBE MORPHOGENESIS,0.0046018,-0.09323,-0.094434,1,0
3,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.010522,-0.093313,-0.083667,1,0
3,GO DEPHOSPHORYLATION,0.0024609,-0.093457,-0.060808,1,0
3,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0068504,-0.093526,-0.1008,1,0
3,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.01251,-0.093648,-0.12879,1,0
3,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.007921,-0.09369,-0.061953,1,0
3,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.041383,-0.093813,-0.10069,1,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.0024609,-0.093813,-0.090934,1,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0085105,-0.09385,-0.058694,1,0
3,GO RETINA HOMEOSTASIS,0.037509,-0.093886,-0.045665,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.031311,-0.093982,-0.07568,1,0
3,GO GAMETE GENERATION,0.00016901,-0.094255,-0.086274,1,0
3,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.039406,-0.094274,-0.072885,1,0
3,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.0027381,-0.094452,-0.081791,1,0
3,GO MUSCLE HYPERTROPHY,0.059331,-0.094776,-0.063461,1,0
3,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.035336,-0.094785,-0.076984,1,0
3,GO MYELOID DENDRITIC CELL ACTIVATION,0.0083098,-0.094824,-0.12911,1,0
3,GO EXOCYTOSIS,0.0093576,-0.094895,-0.073101,1,0
3,GO DEVELOPMENTAL PIGMENTATION,0.013243,-0.094918,-0.086355,1,0
3,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0081133,-0.094925,-0.10173,1,0
3,GO NEGATIVE T CELL SELECTION,0.02174,-0.094956,-0.078575,1,0
3,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.023668,-0.095097,-0.10413,1,0
3,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.016205,-0.095151,-0.069093,1,0
3,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.011678,-0.095244,-0.072273,1,0
3,GO REGULATION OF ERAD PATHWAY,0.013243,-0.09537,-0.05734,1,0
3,GO PATTERN SPECIFICATION PROCESS,0.019312,-0.095437,-0.064932,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00024045,-0.095497,-0.081507,1,0
3,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.056652,-0.095527,-0.064239,1,0
3,GO MESODERM DEVELOPMENT,0.021053,-0.095533,-0.068477,1,0
3,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.0049019,-0.095745,-0.067055,1,0
3,GO REGULATION OF HEMOPOIESIS,0.0018256,-0.095878,-0.097453,1,0
3,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.035691,-0.095977,-0.081683,1,0
3,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.016568,-0.095993,-0.07028,1,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00019857,-0.096134,-0.10714,1,0
3,GO NUCLEAR ENVELOPE REASSEMBLY,0.052575,-0.096135,-0.070766,1,0
3,GO TUBE DEVELOPMENT,0.002631,-0.096159,-0.091916,1,0
3,GO RESPONSE TO ACTIVITY,0.049681,-0.096165,-0.065334,1,0
3,GO REPLACEMENT OSSIFICATION,0.042609,-0.096171,-0.11487,1,0
3,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.003166,-0.096311,-0.1005,1,0
3,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0038977,-0.096345,-0.072045,1,0
3,GO LYMPHOCYTE APOPTOTIC PROCESS,0.016752,-0.09637,-0.10565,1,0
3,GO SPROUTING ANGIOGENESIS,0.034984,-0.096514,-0.079622,1,0
3,GO ANATOMICAL STRUCTURE MATURATION,0.020828,-0.096647,-0.057734,1,0
3,GO PROSTANOID BIOSYNTHETIC PROCESS,0.030368,-0.096792,-0.16026,1,0
3,GO RESPONSE TO FOOD,0.003654,-0.096848,-0.11989,1,0
3,GO REGULATION OF MUSCLE HYPERTROPHY,0.0072795,-0.097157,-0.1028,1,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0104,-0.097164,-0.052076,1,0
3,GO PROTEIN K63 LINKED UBIQUITINATION,0.002702,-0.097204,-0.086369,1,0
3,GO NEGATIVE REGULATION OF OSSIFICATION,0.014823,-0.097336,-0.10613,1,0
3,GO LYMPH VESSEL MORPHOGENESIS,0.03006,-0.097338,-0.11835,1,0
3,GO RESPONSE TO ISCHEMIA,0.028264,-0.097403,-0.077516,1,0
3,GO DNA DOUBLE STRAND BREAK PROCESSING,0.017894,-0.097415,-0.11072,1,0
3,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.0040509,-0.09759,-0.088384,1,0
3,GO RESPONSE TO HYDROGEN PEROXIDE,0.0062877,-0.097649,-0.079802,1,0
3,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.0062877,-0.097874,-0.13374,1,0
3,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.0024281,-0.097894,-0.075272,1,0
3,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0023637,-0.097953,-0.11052,1,0
3,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.01585,-0.097956,-0.083697,1,0
3,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0030436,-0.097974,-0.083876,1,0
3,GO CELL FATE COMMITMENT,0.0086125,-0.098127,-0.078961,1,0
3,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.031311,-0.098128,-0.14762,1,0
3,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.0031247,-0.098272,-0.098469,1,0
3,GO PROTEIN POLYUBIQUITINATION,1.6158e-05,-0.09829,-0.10127,1,0
3,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.023173,-0.098359,-0.11202,1,0
3,GO INOSITOL METABOLIC PROCESS,0.03902,-0.098409,-0.087423,1,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.0039992,-0.098557,-0.11925,1,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.0104,-0.098712,-0.10336,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.01251,-0.098899,-0.073069,1,0
3,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0023957,-0.098915,-0.086032,1,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.014658,-0.098969,-0.077631,1,0
3,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.010041,-0.099108,-0.074824,1,0
3,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.003607,-0.09915,-0.094966,1,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.033271,-0.099188,-0.1191,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.036772,-0.099237,-0.11557,1,0
3,GO GLAND MORPHOGENESIS,0.019104,-0.09924,-0.13921,1,0
3,GO MEIOTIC CELL CYCLE,1.1375e-05,-0.09941,-0.10503,1,0
3,GO COAGULATION,0.0053519,-0.099544,-0.10327,1,0
3,GO REGULATION OF PH,0.00086244,-0.099562,-0.083777,1,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.038258,-0.099624,-0.079738,1,0
3,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.00019229,-0.099633,-0.11322,1,0
3,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.0071051,-0.099735,-0.098738,1,0
3,GO PROTEIN MATURATION,0.00098255,-0.099827,-0.083849,1,0
3,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.0137,-0.099844,-0.078923,1,0
3,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.027118,-0.099879,-0.11596,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS,0.00020504,-0.10018,-0.10779,1,0
3,GO CELL MATRIX ADHESION,0.0092477,-0.10025,-0.10335,1,0
3,GO REGULATION OF HISTONE H4 ACETYLATION,0.023419,-0.10028,-0.093429,1,0
3,GO ERBB SIGNALING PATHWAY,0.0057669,-0.10031,-0.093891,1,0
3,GO PROTEOLYSIS,0.00015083,-0.10033,-0.082757,1,0
3,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.048746,-0.10033,-0.076042,1,0
3,GO OLIGODENDROCYTE DIFFERENTIATION,0.013856,-0.1004,-0.10466,1,0
3,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.01128,-0.10043,-0.11586,1,0
3,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.0018256,-0.10047,-0.097809,1,0
3,GO COPII COATED VESICLE BUDDING,0.0023637,-0.1005,-0.081708,1,0
3,GO STEROID METABOLIC PROCESS,0.011544,-0.10052,-0.078083,1,0
3,GO MODULATION BY VIRUS OF HOST PROCESS,0.017699,-0.10055,-0.074267,1,0
3,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.01251,-0.1007,-0.09565,1,0
3,GO MORPHOGENESIS OF AN EPITHELIUM,0.0005618,-0.10078,-0.10489,1,0
3,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0076401,-0.10081,-0.10895,1,0
3,GO LYMPHOCYTE CHEMOTAXIS,0.028556,-0.10087,-0.082985,1,0
3,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.0010408,-0.10098,-0.11342,1,0
3,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.0050269,-0.10104,-0.096616,1,0
3,GO HORMONE TRANSPORT,0.01499,-0.10105,-0.07566,1,0
3,GO CHROMOSOME LOCALIZATION,0.00011596,-0.10126,-0.1122,1,0
3,GO DIGESTIVE TRACT MORPHOGENESIS,0.053071,-0.1013,-0.094073,1,0
3,GO LYMPHOCYTE COSTIMULATION,0.030994,-0.10132,-0.082057,1,0
3,GO EPITHELIAL CELL PROLIFERATION,0.0043184,-0.10133,-0.11253,1,0
3,GO EMBRYONIC ORGAN MORPHOGENESIS,0.0014624,-0.10135,-0.10752,1,0
3,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.0012705,-0.10137,-0.10242,1,0
3,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.040187,-0.1015,-0.067357,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.014332,-0.10197,-0.12383,1,0
3,GO REGULATION OF KERATINOCYTE MIGRATION,0.022686,-0.10218,-0.083351,1,0
3,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.046474,-0.10264,-0.073016,1,0
3,GO AMINO ACID BETAINE METABOLIC PROCESS,0.046474,-0.10271,-0.095237,1,0
3,GO TUBE FORMATION,0.00048316,-0.10313,-0.11718,1,0
3,GO REGULATION OF HORMONE LEVELS,0.0053519,-0.10329,-0.081699,1,0
3,GO DNA METHYLATION OR DEMETHYLATION,0.0062877,-0.1033,-0.068312,1,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.027118,-0.10331,-0.083877,1,0
3,GO HISTONE H2B UBIQUITINATION,0.0042636,-0.10337,-0.11736,1,0
3,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.00044781,-0.10343,-0.086608,1,0
3,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.001442,-0.10369,-0.079029,1,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0042636,-0.1038,-0.11986,1,0
3,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.022928,-0.10381,-0.067526,1,0
3,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.0018006,-0.10392,-0.092335,1,0
3,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0034692,-0.10396,-0.079735,1,0
3,GO ADIPOSE TISSUE DEVELOPMENT,0.058787,-0.10404,-0.081385,1,0
3,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.059331,-0.10407,-0.091923,1,0
3,GO IMMUNE SYSTEM DEVELOPMENT,0.00026024,-0.10417,-0.099295,1,0
3,GO VESICLE BUDDING FROM MEMBRANE,0.00037835,-0.10421,-0.10908,1,0
3,GO ENDOSOMAL TRANSPORT,1.2027e-05,-0.10429,-0.098941,1,0
3,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.014332,-0.1043,-0.074006,1,0
3,GO ECTODERM DEVELOPMENT,0.0030436,-0.10448,-0.11868,1,0
3,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.0032501,-0.10455,-0.12055,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.0012527,-0.10474,-0.068581,1,0
3,GO REGULATION OF CELL ACTIVATION,0.0027381,-0.10477,-0.10219,1,0
3,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.0047798,-0.10516,-0.099613,1,0
3,GO REGULATION OF T CELL DIFFERENTIATION,0.0030436,-0.10518,-0.11367,1,0
3,GO STEM CELL PROLIFERATION,0.0023321,-0.10521,-0.11247,1,0
3,GO RESPONSE TO ANTIBIOTIC,0.023419,-0.10525,-0.082844,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0077327,-0.10542,-0.1217,1,0
3,GO SPECIFICATION OF SYMMETRY,0.00074504,-0.10555,-0.094916,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.027686,-0.10558,-0.072104,1,0
3,GO REGULATION OF CELLULAR PH,0.0010259,-0.10563,-0.085055,1,0
3,GO GOLGI LOCALIZATION,0.046031,-0.10583,-0.069807,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0010113,-0.10584,-0.11526,1,0
3,GO MEIOSIS I CELL CYCLE PROCESS,0.00076726,-0.10589,-0.1107,1,0
3,GO MUSCLE CELL DEVELOPMENT,0.0075485,-0.10605,-0.07994,1,0
3,GO EAR DEVELOPMENT,0.0038478,-0.10619,-0.096727,1,0
3,GO REGULATION OF FIBROBLAST MIGRATION,0.0092477,-0.10649,-0.11683,1,0
3,GO GOLGI VESICLE BUDDING,0.0013826,-0.10682,-0.089796,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0025277,-0.10685,-0.11911,1,0
3,GO REGULATION OF GASTRULATION,0.016752,-0.10692,-0.098451,1,0
3,GO FEMALE GAMETE GENERATION,0.0093576,-0.10693,-0.066926,1,0
3,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.052083,-0.10699,-0.11387,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00098255,-0.10723,-0.10793,1,0
3,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.057711,-0.10746,-0.11347,1,0
3,GO VENTRAL SPINAL CORD DEVELOPMENT,0.027401,-0.10755,-0.090378,1,0
3,GO APOPTOTIC SIGNALING PATHWAY,0.00083767,-0.10763,-0.08479,1,0
3,GO MACROPHAGE DIFFERENTIATION,0.024173,-0.108,-0.11103,1,0
3,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.010645,-0.10817,-0.092775,1,0
3,GO PROTEIN MONOUBIQUITINATION,0.00015583,-0.10835,-0.086329,1,0
3,GO REGULATION OF HORMONE SECRETION,0.01849,-0.1084,-0.075498,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.003607,-0.10861,-0.17245,1,0
3,GO LIPOSACCHARIDE METABOLIC PROCESS,0.0025277,-0.10864,-0.096523,1,0
3,GO RESPONSE TO WOUNDING,0.0038977,-0.10886,-0.10936,1,0
3,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.017506,-0.10888,-0.10623,1,0
3,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.0055559,-0.10896,-0.1347,1,0
3,GO CARBOHYDRATE TRANSPORT,0.0013443,-0.10904,-0.083751,1,0
3,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.024947,-0.10928,-0.1294,1,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0035605,-0.10961,-0.12135,1,0
3,GO PINOCYTOSIS,0.018898,-0.10961,-0.1129,1,0
3,GO MAINTENANCE OF CELL NUMBER,0.0016347,-0.10966,-0.099852,1,0
3,GO NEURONAL ACTION POTENTIAL,0.055093,-0.10975,-0.13909,1,0
3,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.023668,-0.10978,-0.06993,1,0
3,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0031247,-0.10983,-0.10977,1,0
3,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.023173,-0.10984,-0.16253,1,0
3,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.0080166,-0.10987,-0.15691,1,0
3,GO REGULATION OF RESPONSE TO STRESS,0.00086244,-0.11,-0.079333,1,0
3,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.0096941,-0.11009,-0.08166,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0041031,-0.11012,-0.11569,1,0
3,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.038637,-0.11027,-0.061435,1,0
3,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,6.4341e-05,-0.11031,-0.0977,1,0
3,GO NEPHRON MORPHOGENESIS,0.0066039,-0.11036,-0.12235,1,0
3,GO POSITIVE REGULATION OF DNA REPLICATION,0.0020092,-0.11042,-0.079666,1,0
3,GO PROTEIN O LINKED GLYCOSYLATION,0.00013673,-0.11052,-0.17557,1,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.029754,-0.11055,-0.12758,1,0
3,GO POSITIVE REGULATION OF CELL ACTIVATION,0.001704,-0.11058,-0.11251,1,0
3,GO REGULATION OF CELL SUBSTRATE ADHESION,0.011022,-0.11061,-0.10539,1,0
3,GO POSITIVE REGULATION OF OSSIFICATION,0.014494,-0.11062,-0.10582,1,0
3,GO RESPONSE TO SALT STRESS,0.018898,-0.11069,-0.097003,1,0
3,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.000662,-0.11069,-0.10133,1,0
3,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.0022701,-0.1107,-0.079605,1,0
3,GO SECRETION BY TISSUE,0.033948,-0.11092,-0.10159,1,0
3,GO POSITIVE REGULATION OF MITOPHAGY,0.059879,-0.11095,-0.074381,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.020385,-0.11136,-0.10226,1,0
3,GO RETINOL METABOLIC PROCESS,0.019312,-0.11151,-0.13602,1,0
3,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.00084997,-0.11152,-0.11449,1,0
3,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.00076726,-0.11152,-0.11166,1,0
3,GO REGULATION OF BODY FLUID LEVELS,0.00049053,-0.11166,-0.11241,1,0
3,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.029754,-0.11178,-0.070533,1,0
3,GO RESPONSE TO ETHER,0.0074579,-0.11185,-0.10416,1,0
3,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.055609,-0.11187,-0.065182,1,0
3,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.014013,-0.11189,-0.070864,1,0
3,GO RESPIRATORY BURST,0.017125,-0.11191,-0.14259,1,0
3,GO REGULATION OF SPROUTING ANGIOGENESIS,0.019735,-0.11196,-0.093858,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.012653,-0.11244,-0.11625,1,0
3,GO PEPTIDE SECRETION,0.0053519,-0.11247,-0.076514,1,0
3,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.0066851,-0.11249,-0.11844,1,0
3,GO CELL ACTIVATION,0.0022396,-0.11251,-0.10217,1,0
3,GO MACROPHAGE MIGRATION,0.041383,-0.1127,-0.092886,1,0
3,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.001568,-0.11277,-0.12853,1,0
3,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.026286,-0.11278,-0.077547,1,0
3,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.032607,-0.11282,-0.079875,1,0
3,GO REGULATION OF CENTRIOLE REPLICATION,0.00043435,-0.11288,-0.15255,1,0
3,GO REGULATION OF ICOSANOID SECRETION,0.014172,-0.11292,-0.13181,1,0
3,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.0048405,-0.1132,-0.089267,1,0
3,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.039406,-0.11333,-0.12095,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.011949,-0.11334,-0.071988,1,0
3,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.0037498,-0.11334,-0.1962,1,0
3,GO SPERM AXONEME ASSEMBLY,0.049681,-0.11346,-0.11466,1,0
3,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.0035146,-0.11355,-0.11036,1,0
3,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.042197,-0.11359,-0.10622,1,0
3,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0062877,-0.11372,-0.12439,1,0
3,GO RESPONSE TO BIOTIC STIMULUS,0.001422,-0.11467,-0.11444,1,0
3,GO FACE DEVELOPMENT,0.0037985,-0.11487,-0.12623,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0028118,-0.11488,-0.08977,1,0
3,GO REPRODUCTION,7.6283e-05,-0.11512,-0.088893,1,0
3,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.039406,-0.11524,-0.090511,1,0
3,GO MAMMARY GLAND DEVELOPMENT,0.0043737,-0.1154,-0.10819,1,0
3,GO REGULATION OF NUCLEAR DIVISION,7.5001e-05,-0.11541,-0.09144,1,0
3,GO APPENDAGE DEVELOPMENT,0.004964,-0.11543,-0.10832,1,0
3,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0062877,-0.11557,-0.10862,1,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.017699,-0.11571,-0.16772,1,0
3,GO MUSCLE ADAPTATION,0.0018006,-0.11583,-0.10266,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.011678,-0.11585,-0.091104,1,0
3,GO REGULATION OF INNATE IMMUNE RESPONSE,0.0019023,-0.11588,-0.11618,1,0
3,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.010895,-0.11591,-0.12501,1,0
3,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.0030038,-0.11597,-0.1224,1,0
3,GO APPENDAGE MORPHOGENESIS,0.0044864,-0.11613,-0.12383,1,0
3,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.00027284,-0.11618,-0.14604,1,0
3,GO REGULATION OF VASCULATURE DEVELOPMENT,0.0024941,-0.11628,-0.11613,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0023957,-0.11638,-0.090947,1,0
3,GO POSITIVE CHEMOTAXIS,0.0024609,-0.11695,-0.15491,1,0
3,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.0012886,-0.11697,-0.13062,1,0
3,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0040509,-0.11704,-0.10578,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.021973,-0.11723,-0.12899,1,0
3,GO WHITE FAT CELL DIFFERENTIATION,0.044292,-0.11734,-0.080011,1,0
3,GO REGULATION OF ENDOCRINE PROCESS,0.0087156,-0.1175,-0.11539,1,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.027973,-0.11759,-0.12024,1,0
3,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.030368,-0.11763,-0.1425,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.016938,-0.11772,-0.12968,1,0
3,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0083098,-0.11783,-0.077703,1,0
3,GO SPERMATID DIFFERENTIATION,0.0084096,-0.11787,-0.095659,1,0
3,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00036686,-0.11796,-0.10074,1,0
3,GO ETHER METABOLIC PROCESS,0.0045438,-0.11811,-0.17707,1,0
3,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.017315,-0.11819,-0.078586,1,0
3,GO GOLGI TO VACUOLE TRANSPORT,0.0055559,-0.11828,-0.09749,1,0
3,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.009139,-0.11853,-0.11416,1,0
3,GO T CELL DIFFERENTIATION,0.00057029,-0.11863,-0.12283,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00035024,-0.11871,-0.090161,1,0
3,GO REGULATION OF SISTER CHROMATID COHESION,0.0088198,-0.11879,-0.098041,1,0
3,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.027401,-0.11895,-0.080573,1,0
3,GO ACTIVATION OF JUN KINASE ACTIVITY,0.00159,-0.11897,-0.10192,1,0
3,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0029256,-0.11898,-0.11582,1,0
3,GO INFLAMMATORY RESPONSE,0.0013069,-0.1191,-0.11295,1,0
3,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.027118,-0.11913,-0.10524,1,0
3,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.0027381,-0.11914,-0.088082,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.00038422,-0.11919,-0.11466,1,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.012367,-0.11922,-0.11644,1,0
3,GO DIOL BIOSYNTHETIC PROCESS,0.0065235,-0.11935,-0.12591,1,0
3,GO MOLTING CYCLE,0.0051547,-0.11949,-0.11791,1,0
3,GO ACTIVATION OF GTPASE ACTIVITY,0.00020504,-0.11954,-0.10915,1,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0013069,-0.11972,-0.17743,1,0
3,GO ACUTE INFLAMMATORY RESPONSE,0.0062877,-0.11995,-0.1369,1,0
3,GO GOLGI ORGANIZATION,5.1304e-06,-0.12027,-0.12169,1,0
3,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0094686,-0.12031,-0.10829,1,0
3,GO REGULATION OF FAT CELL DIFFERENTIATION,0.0031247,-0.1204,-0.11484,1,0
3,GO CELL CELL ADHESION,0.001071,-0.12047,-0.11477,1,0
3,GO MITOTIC SPINDLE ASSEMBLY,0.00075607,-0.12053,-0.10998,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.031311,-0.12066,-0.11574,1,0
3,GO HISTONE H2A MONOUBIQUITINATION,0.0030038,-0.12069,-0.10081,1,0
3,GO COPULATION,0.035336,-0.12082,-0.11009,1,0
3,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00010152,-0.12083,-0.098191,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.0093576,-0.12086,-0.087056,1,0
3,GO NATURAL KILLER CELL ACTIVATION,0.0016122,-0.121,-0.13926,1,0
3,GO ADAPTIVE THERMOGENESIS,0.0016806,-0.12112,-0.084841,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.010895,-0.1213,-0.1281,1,0
3,GO V D J RECOMBINATION,0.0033361,-0.1213,-0.18206,1,0
3,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.028852,-0.12146,-0.10353,1,0
3,GO POSITIVE REGULATION OF CELL DIVISION,0.014658,-0.12147,-0.083452,1,0
3,GO MITOTIC CYTOKINESIS,0.00023667,-0.12158,-0.12177,1,0
3,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0071051,-0.12163,-0.21399,1,0
3,GO LENS FIBER CELL DIFFERENTIATION,0.052083,-0.12182,-0.10424,1,0
3,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.012945,-0.12192,-0.10641,1,0
3,GO MYELOID CELL DIFFERENTIATION,0.00015331,-0.12192,-0.10877,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00032916,-0.12195,-0.093045,1,0
3,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0027747,-0.122,-0.12818,1,0
3,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.003654,-0.12206,-0.13732,1,0
3,GO TISSUE MIGRATION,0.0066851,-0.12209,-0.1023,1,0
3,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0019023,-0.12216,-0.12412,1,0
3,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.0047198,-0.12238,-0.16035,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0095807,-0.1224,-0.14819,1,0
3,GO IN UTERO EMBRYONIC DEVELOPMENT,9.3381e-05,-0.12252,-0.093072,1,0
3,GO MYOTUBE DIFFERENTIATION,0.0031247,-0.12263,-0.11789,1,0
3,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.015159,-0.12263,-0.095192,1,0
3,GO POSTREPLICATION REPAIR,0.00019541,-0.1228,-0.092519,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.051595,-0.12301,-0.071912,1,0
3,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.032938,-0.12319,-0.15176,1,0
3,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,2.011e-05,-0.12327,-0.10948,1,0
3,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.0047198,-0.12333,-0.11867,1,0
3,GO WOUND HEALING,0.0024281,-0.12335,-0.12256,1,0
3,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,1.9044e-05,-0.12339,-0.12361,1,0
3,GO ACTIN FILAMENT DEPOLYMERIZATION,0.0020367,-0.1234,-0.12892,1,0
3,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.003607,-0.12341,-0.11925,1,0
3,GO CELLULAR RESPONSE TO ALCOHOL,0.0011341,-0.12346,-0.10287,1,0
3,GO PROTEIN DEGLYCOSYLATION,0.026013,-0.12356,-0.12349,1,0
3,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,4.3997e-05,-0.12378,-0.10064,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.00062378,-0.12391,-0.11505,1,0
3,GO SENSORY ORGAN MORPHOGENESIS,0.00083767,-0.12392,-0.10576,1,0
3,GO CENTRIOLE ASSEMBLY,0.00040235,-0.12394,-0.14299,1,0
3,GO CELLULAR RESPONSE TO IRON ION,0.018898,-0.12407,-0.17175,1,0
3,GO T CELL ACTIVATION,0.00064263,-0.12413,-0.12483,1,0
3,GO REGULATION OF PROTEIN IMPORT,0.0104,-0.12414,-0.09251,1,0
3,GO SENSORY PERCEPTION OF BITTER TASTE,0.00036686,-0.12434,-0.1533,1,0
3,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.0088198,-0.12435,-0.12615,1,0
3,GO REGULATION OF MESODERM DEVELOPMENT,0.026286,-0.12438,-0.092313,1,0
3,GO PH REDUCTION,0.00061456,-0.12457,-0.11554,1,0
3,GO REGULATION OF CHEMOTAXIS,0.0045438,-0.12476,-0.091502,1,0
3,GO PHOSPHOLIPID TRANSPORT,0.001776,-0.12478,-0.12228,1,0
3,GO T CELL PROLIFERATION,0.0027381,-0.12501,-0.12486,1,0
3,GO LEUKOCYTE PROLIFERATION,0.0010113,-0.12506,-0.12627,1,0
3,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.0030436,-0.12506,-0.10489,1,0
3,GO TEMPERATURE HOMEOSTASIS,0.0060595,-0.12509,-0.066629,1,0
3,GO INTERLEUKIN 4 PRODUCTION,0.0067673,-0.1251,-0.13359,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.0095807,-0.1252,-0.1104,1,0
3,GO PLASMA MEMBRANE FUSION,0.051111,-0.12526,-0.15027,1,0
3,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.010279,-0.12527,-0.13887,1,0
3,GO IMMUNOGLOBULIN PRODUCTION,0.0023957,-0.12533,-0.088203,1,0
3,GO INTEGRIN ACTIVATION,0.03429,-0.12544,-0.096941,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0086125,-0.1256,-0.10281,1,0
3,GO POLYAMINE METABOLIC PROCESS,0.03902,-0.12577,-0.08628,1,0
3,GO REGULATION OF DEFENSE RESPONSE,0.00012594,-0.12606,-0.12845,1,0
3,GO MICROTUBULE BUNDLE FORMATION,0.0056255,-0.12607,-0.11632,1,0
3,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.01016,-0.12631,-0.12253,1,0
3,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.0080166,-0.12651,-0.093468,1,0
3,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.031631,-0.12651,-0.11058,1,0
3,GO EYE MORPHOGENESIS,0.0060595,-0.12669,-0.093806,1,0
3,GO PROTEIN K48 LINKED UBIQUITINATION,5.9056e-05,-0.12686,-0.124,1,0
3,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.012227,-0.12696,-0.10758,1,0
3,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,1.2954e-05,-0.12697,-0.1125,1,0
3,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0069343,-0.12705,-0.10215,1,0
3,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.022209,-0.12708,-0.12987,1,0
3,GO REGULATION OF CELL SHAPE,0.0065235,-0.12709,-0.095606,1,0
3,GO RNA DESTABILIZATION,0.012087,-0.12731,-0.075984,1,0
3,GO GLAND DEVELOPMENT,8.7316e-05,-0.12743,-0.12738,1,0
3,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.0050269,-0.12744,-0.093791,1,0
3,GO REGIONALIZATION,0.0026663,-0.12759,-0.093808,1,0
3,GO CAMERA TYPE EYE MORPHOGENESIS,0.0027747,-0.12761,-0.10583,1,0
3,GO LEUKOCYTE APOPTOTIC PROCESS,0.0035605,-0.12772,-0.12879,1,0
3,GO LEUKOCYTE CELL CELL ADHESION,0.0011668,-0.12785,-0.12436,1,0
3,GO VESICLE TARGETING,0.00015083,-0.12803,-0.12189,1,0
3,GO AUTOPHAGOSOME ORGANIZATION,0.00037835,-0.12808,-0.10347,1,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.0041031,-0.1281,-0.11024,1,0
3,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.00055343,-0.12818,-0.14145,1,0
3,GO TISSUE HOMEOSTASIS,1.0557e-05,-0.12822,-0.14178,1,0
3,GO REGULATION OF PEPTIDASE ACTIVITY,0.00012594,-0.12827,-0.14928,1,0
3,GO REGULATION OF HISTONE DEACETYLATION,0.0104,-0.12839,-0.11107,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0059116,-0.12854,-0.11986,1,0
3,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.01128,-0.1286,-0.096601,1,0
3,GO MEIOTIC CHROMOSOME SEGREGATION,0.00094089,-0.12864,-0.1135,1,0
3,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.038258,-0.12871,-0.13006,1,0
3,GO PEPTIDYL TYROSINE MODIFICATION,0.00096848,-0.12879,-0.11086,1,0
3,GO REGULATION OF KIDNEY DEVELOPMENT,0.016568,-0.12893,-0.11091,1,0
3,GO EMBRYONIC MORPHOGENESIS,0.00025617,-0.12896,-0.11014,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00059648,-0.12898,-0.12264,1,0
3,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.00026438,-0.12904,-0.11819,1,0
3,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.0073682,-0.12906,-0.098038,1,0
3,GO ACUTE PHASE RESPONSE,0.0073682,-0.12912,-0.12896,1,0
3,GO REGULATION OF HAIR CYCLE,0.0063654,-0.12932,-0.14777,1,0
3,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.00094089,-0.12935,-0.14849,1,0
3,GO REGULATION OF T CELL ACTIVATION,0.0011021,-0.12952,-0.11813,1,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0137,-0.12957,-0.1046,1,0
3,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.0047198,-0.1296,-0.154,1,0
3,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.027401,-0.12968,-0.13258,1,0
3,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.00026438,-0.12985,-0.15614,1,0
3,GO REGULATION OF PEPTIDE SECRETION,0.00095459,-0.12985,-0.095701,1,0
3,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.0056958,-0.12988,-0.10342,1,0
3,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0059116,-0.12994,-0.12644,1,0
3,GO DEFENSE RESPONSE,0.00026438,-0.13029,-0.13036,1,0
3,GO B CELL PROLIFERATION,0.0076401,-0.13032,-0.11764,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.029754,-0.13033,-0.14928,1,0
3,GO REGULATION OF LEUKOCYTE MIGRATION,0.0090315,-0.13037,-0.09093,1,0
3,GO RESPONSE TO CYTOKINE,0.00081356,-0.13038,-0.11942,1,0
3,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.00053704,-0.13044,-0.11111,1,0
3,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.050154,-0.13045,-0.12423,1,0
3,GO EXIT FROM MITOSIS,0.004964,-0.13045,-0.091826,1,0
3,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0044298,-0.13053,-0.12695,1,0
3,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.012653,-0.13059,-0.073338,1,0
3,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.0048405,-0.13072,-0.1067,1,0
3,GO POSITIVE REGULATION OF NEURON DEATH,0.0045438,-0.13078,-0.092001,1,0
3,GO ER NUCLEUS SIGNALING PATHWAY,0.022209,-0.13086,-0.096696,1,0
3,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.0033799,-0.13095,-0.14658,1,0
3,GO RESPONSE TO IRON ION,0.001955,-0.13096,-0.14884,1,0
3,GO DIGESTIVE SYSTEM PROCESS,0.0023957,-0.13096,-0.12012,1,0
3,GO REGULATION OF INFLAMMATORY RESPONSE,0.00035024,-0.13101,-0.12083,1,0
3,GO VACUOLAR TRANSPORT,0.0010558,-0.13106,-0.090983,1,0
3,GO MYOBLAST DIFFERENTIATION,0.00049053,-0.13129,-0.16608,1,0
3,GO RESPONSE TO PEPTIDOGLYCAN,0.0054192,-0.13147,-0.13429,1,0
3,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.0075485,-0.13166,-0.11486,1,0
3,GO CARDIOCYTE DIFFERENTIATION,0.022209,-0.13172,-0.079462,1,0
3,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0087156,-0.13176,-0.084215,1,0
3,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.019312,-0.1318,-0.14339,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.020605,-0.13181,-0.11406,1,0
3,GO AMYLOID BETA CLEARANCE,0.0094686,-0.1319,-0.13163,1,0
3,GO FAT CELL DIFFERENTIATION,7.2497e-05,-0.132,-0.14045,1,0
3,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0016122,-0.13205,-0.12407,1,0
3,GO REGULATION OF NEUTROPHIL MIGRATION,0.011544,-0.13222,-0.11597,1,0
3,GO HISTONE MONOUBIQUITINATION,2.4371e-06,-0.13243,-0.14022,1,0
3,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.00022927,-0.13259,-0.11722,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00018923,-0.13262,-0.15855,1,0
3,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.023419,-0.13266,-0.11671,1,0
3,GO SPINDLE LOCALIZATION,0.00061456,-0.13276,-0.11345,1,0
3,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.0010865,-0.13294,-0.14339,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.059879,-0.1331,-0.071051,1,0
3,GO INNER EAR MORPHOGENESIS,0.0022396,-0.13323,-0.12317,1,0
3,GO MYELOID LEUKOCYTE ACTIVATION,0.0037498,-0.13352,-0.11365,1,0
3,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0001803,-0.13352,-0.1099,1,0
3,GO HISTONE H3 K9 TRIMETHYLATION,0.037509,-0.13371,-0.075911,1,0
3,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.00025617,-0.13377,-0.13649,1,0
3,GO MULTICELLULAR ORGANISM AGING,0.00086244,-0.13382,-0.13424,1,0
3,GO REGULATION OF CELL ADHESION,0.0012527,-0.13386,-0.12788,1,0
3,GO INTERLEUKIN 17 PRODUCTION,0.032607,-0.13394,-0.11513,1,0
3,GO PROTEIN DESTABILIZATION,9.03e-05,-0.13398,-0.12419,1,0
3,GO METANEPHRIC NEPHRON DEVELOPMENT,0.0096941,-0.13427,-0.13591,1,0
3,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.01849,-0.13427,-0.16754,1,0
3,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0104,-0.13433,-0.12425,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.00016098,-0.13452,-0.13344,1,0
3,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.02128,-0.13453,-0.14281,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.0028872,-0.13457,-0.13584,1,0
3,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0076401,-0.13473,-0.16472,1,0
3,GO MICROTUBULE SEVERING,0.0059852,-0.13482,-0.13984,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0002117,-0.13487,-0.16097,1,0
3,GO MEMBRANE FISSION,0.010895,-0.13549,-0.10008,1,0
3,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.003607,-0.13551,-0.11319,1,0
3,GO EATING BEHAVIOR,0.025475,-0.13552,-0.078839,1,0
3,GO REGULATION OF CILIUM MOVEMENT,0.014172,-0.13553,-0.11194,1,0
3,GO EMBRYONIC ORGAN DEVELOPMENT,9.03e-05,-0.13562,-0.12102,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.011949,-0.13567,-0.14549,1,0
3,GO RESPONSE TO COLD,0.0012527,-0.13567,-0.15604,1,0
3,GO MECHANORECEPTOR DIFFERENTIATION,0.0084096,-0.13576,-0.116,1,0
3,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.00069207,-0.1359,-0.14539,1,0
3,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.010041,-0.13597,-0.13664,1,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0042636,-0.13609,-0.1086,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION,0.0029256,-0.13613,-0.12566,1,0
3,GO CELLULAR PIGMENTATION,0.00014362,-0.13636,-0.13714,1,0
3,GO CYTOKINE PRODUCTION,0.0001862,-0.13647,-0.14051,1,0
3,GO CILIUM ORGANIZATION,0.00020178,-0.13654,-0.12383,1,0
3,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,4.6359e-05,-0.13659,-0.15241,1,0
3,GO GRANULOCYTE MIGRATION,0.0051547,-0.13661,-0.1129,1,0
3,GO LIPID STORAGE,0.049681,-0.13671,-0.071127,1,0
3,GO REGULATION OF MACROPHAGE MIGRATION,0.0077327,-0.13691,-0.12044,1,0
3,GO KETONE BIOSYNTHETIC PROCESS,0.018693,-0.13696,-0.10792,1,0
3,GO HEMOGLOBIN METABOLIC PROCESS,0.00041488,-0.13722,-0.14123,1,0
3,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.056128,-0.13722,-0.11176,1,0
3,GO KERATINOCYTE PROLIFERATION,0.0037985,-0.13735,-0.19093,1,0
3,GO INNATE IMMUNE RESPONSE,0.00075607,-0.13745,-0.13992,1,0
3,GO TRANSLESION SYNTHESIS,2.3661e-05,-0.13747,-0.12313,1,0
3,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.00068191,-0.13759,-0.11607,1,0
3,GO CELL DIFFERENTIATION IN SPINAL CORD,0.0052854,-0.1376,-0.12655,1,0
3,GO MATURE B CELL DIFFERENTIATION,0.02521,-0.13761,-0.14873,1,0
3,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.001955,-0.13764,-0.13104,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION,0.0010865,-0.13793,-0.13857,1,0
3,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,9.4959e-05,-0.13796,-0.16479,1,0
3,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.00039622,-0.13799,-0.14083,1,0
3,GO HISTONE H2A UBIQUITINATION,0.00041488,-0.138,-0.11415,1,0
3,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0076401,-0.13801,-0.1309,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.00033955,-0.1381,-0.15396,1,0
3,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,1.3693e-05,-0.1381,-0.18435,1,0
3,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00026024,-0.13813,-0.16933,1,0
3,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0013443,-0.13817,-0.12336,1,0
3,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.00053704,-0.13862,-0.12309,1,0
3,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,4.4771e-05,-0.13875,-0.1398,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.013093,-0.13884,-0.10582,1,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0030436,-0.13905,-0.12543,1,0
3,GO ENDOCRINE HORMONE SECRETION,0.00037257,-0.13927,-0.14302,1,0
3,GO NEURAL TUBE DEVELOPMENT,2.2824e-05,-0.13929,-0.14099,1,0
3,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.0043737,-0.13959,-0.17659,1,0
3,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.0037016,-0.1396,-0.17426,1,0
3,GO NEGATIVE REGULATION OF BONE REMODELING,0.05063,-0.1397,-0.14286,1,0
3,GO KIDNEY MORPHOGENESIS,0.0010865,-0.1398,-0.1466,1,0
3,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.056652,-0.13983,-0.12685,1,0
3,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.00010152,-0.14007,-0.14229,1,0
3,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00010852,-0.14008,-0.11562,1,0
3,GO MESENCHYME MORPHOGENESIS,0.0025277,-0.14011,-0.1411,1,0
3,GO POSITIVE REGULATION OF CYTOKINESIS,0.0030436,-0.14012,-0.11804,1,0
3,GO T CELL CYTOKINE PRODUCTION,0.02128,-0.14017,-0.10722,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.00053704,-0.1402,-0.16774,1,0
3,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.0032078,-0.14044,-0.14913,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.009139,-0.14049,-0.16341,1,0
3,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0087156,-0.14052,-0.13662,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.0104,-0.14055,-0.15523,1,0
3,GO PROTEIN KINASE B SIGNALING,0.00010852,-0.1412,-0.13356,1,0
3,GO FOAM CELL DIFFERENTIATION,0.039795,-0.14121,-0.11733,1,0
3,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.012798,-0.14122,-0.13329,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0023009,-0.14124,-0.13704,1,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.024428,-0.14136,-0.14462,1,0
3,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00037257,-0.14137,-0.13306,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,7.1274e-05,-0.14139,-0.13797,1,0
3,GO LACTATE METABOLIC PROCESS,0.052083,-0.14145,-0.10459,1,0
3,GO ORGANOPHOSPHATE ESTER TRANSPORT,6.6578e-05,-0.14161,-0.12703,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.0085105,-0.14164,-0.14029,1,0
3,GO ENDOCRINE PROCESS,0.000662,-0.14165,-0.14886,1,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00064263,-0.14166,-0.11579,1,0
3,GO LEUKOTRIENE METABOLIC PROCESS,0.038258,-0.14171,-0.11137,1,0
3,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.0054872,-0.1418,-0.1249,1,0
3,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.0015249,-0.14183,-0.17301,1,0
3,GO PHAGOSOME ACIDIFICATION,0.013856,-0.14185,-0.10747,1,0
3,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.001071,-0.14188,-0.17839,1,0
3,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.3806e-05,-0.14189,-0.14518,1,0
3,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.0055559,-0.14212,-0.12062,1,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00033432,-0.14224,-0.14654,1,0
3,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.0069343,-0.14234,-0.11977,1,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.026013,-0.14238,-0.12403,1,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.0011021,-0.1424,-0.17284,1,0
3,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.012087,-0.1424,-0.13581,1,0
3,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.027401,-0.14245,-0.16784,1,0
3,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.0053519,-0.14249,-0.12791,1,0
3,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,7.0337e-07,-0.14302,-0.14327,1,0
3,GO EPITHELIUM DEVELOPMENT,6.0759e-07,-0.14303,-0.16125,1,0
3,GO RESPONSE TO REDOX STATE,0.013394,-0.14307,-0.12092,1,0
3,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0015038,-0.14309,-0.11976,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00075607,-0.1431,-0.12552,1,0
3,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.0029645,-0.14312,-0.12742,1,0
3,GO B CELL ACTIVATION,0.00010152,-0.14341,-0.13005,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.018091,-0.14347,-0.1088,1,0
3,GO ACTIN NUCLEATION,0.00016098,-0.14351,-0.12029,1,0
3,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.027401,-0.14352,-0.07889,1,0
3,GO POSITIVE REGULATION OF PEPTIDE SECRETION,2.4091e-05,-0.14361,-0.13945,1,0
3,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.0056958,-0.14365,-0.15081,1,0
3,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00055343,-0.14366,-0.14608,1,0
3,GO MALE SEX DIFFERENTIATION,9.4959e-05,-0.1438,-0.14087,1,0
3,GO EAR MORPHOGENESIS,0.00049802,-0.14388,-0.12742,1,0
3,GO MONONUCLEAR CELL MIGRATION,0.0071051,-0.14392,-0.1299,1,0
3,GO EXECUTION PHASE OF APOPTOSIS,5.0323e-06,-0.14394,-0.12312,1,0
3,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,5.6487e-06,-0.14407,-0.15324,1,0
3,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.0010865,-0.14411,-0.14753,1,0
3,GO REGULATION OF T CELL CHEMOTAXIS,0.0092477,-0.14411,-0.1069,1,0
3,GO NEGATIVE REGULATION OF WOUND HEALING,0.055609,-0.14423,-0.10514,1,0
3,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.0002117,-0.14435,-0.14226,1,0
3,GO RESPONSE TO OSMOTIC STRESS,0.00032408,-0.14443,-0.11001,1,0
3,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.00094089,-0.1445,-0.1585,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0017517,-0.14463,-0.1529,1,0
3,GO ARTERY MORPHOGENESIS,0.001071,-0.14474,-0.14166,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.0016347,-0.14474,-0.1746,1,0
3,GO REGULATION OF MUSCLE ADAPTATION,0.00012186,-0.14479,-0.13817,1,0
3,GO PARENTAL BEHAVIOR,0.057711,-0.1448,-0.16057,1,0
3,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.0057669,-0.14494,-0.12348,1,0
3,GO CELL PROJECTION ASSEMBLY,2.6828e-05,-0.14496,-0.1121,1,0
3,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.00062378,-0.14504,-0.1564,1,0
3,GO ENDOCYTIC RECYCLING,0.00011033,-0.14512,-0.13035,1,0
3,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.003607,-0.14527,-0.15928,1,0
3,GO CYTOKINE SECRETION,0.001071,-0.14535,-0.12316,1,0
3,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.0077327,-0.1455,-0.12678,1,0
3,GO LEUKOCYTE CHEMOTAXIS,0.00070238,-0.14561,-0.13503,1,0
3,GO RESPONSE TO INTERLEUKIN 2,0.015674,-0.14572,-0.11418,1,0
3,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.00092737,-0.14574,-0.122,1,0
3,GO INTERACTION WITH HOST,0.00012594,-0.14586,-0.15168,1,0
3,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00031907,-0.14597,-0.11444,1,0
3,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.003166,-0.14598,-0.15386,1,0
3,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0019819,-0.14601,-0.12803,1,0
3,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.059331,-0.14601,-0.10297,1,0
3,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.016205,-0.14607,-0.11133,1,0
3,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00064263,-0.14613,-0.10421,1,0
3,GO REGULATION OF HORMONE METABOLIC PROCESS,0.025743,-0.14624,-0.13478,1,0
3,GO EPITHELIAL CELL MATURATION,0.021973,-0.14631,-0.11746,1,0
3,GO REPLICATIVE SENESCENCE,0.040187,-0.14639,-0.12653,1,0
3,GO EPITHELIAL TUBE MORPHOGENESIS,2.2015e-05,-0.14642,-0.14499,1,0
3,GO MAST CELL MEDIATED IMMUNITY,0.0025277,-0.14646,-0.1853,1,0
3,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.0028118,-0.14648,-0.1241,1,0
3,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00038422,-0.14652,-0.11351,1,0
3,GO REGULATION OF GLUCOSE METABOLIC PROCESS,3.3806e-05,-0.14675,-0.13785,1,0
3,GO ENDOTHELIAL CELL MIGRATION,0.0039481,-0.14693,-0.11778,1,0
3,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.003654,-0.14698,-0.10534,1,0
3,GO DIENCEPHALON DEVELOPMENT,0.0016806,-0.147,-0.1662,1,0
3,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.0043184,-0.1471,-0.12939,1,0
3,GO CELLULAR RESPONSE TO ALKALOID,5.2344e-05,-0.14723,-0.17945,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.00027284,-0.14726,-0.13795,1,0
3,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0046604,-0.14727,-0.15354,1,0
3,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.050154,-0.14729,-0.12402,1,0
3,GO INTERMEDIATE FILAMENT BASED PROCESS,0.0012005,-0.14739,-0.15312,1,0
3,GO VITAMIN D METABOLIC PROCESS,0.040187,-0.14791,-0.1307,1,0
3,GO AMMONIUM ION METABOLIC PROCESS,0.015329,-0.14793,-0.14644,1,0
3,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.0021798,-0.14798,-0.18868,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0023637,-0.14823,-0.13842,1,0
3,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,1.1588e-05,-0.14827,-0.15847,1,0
3,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0018764,-0.14835,-0.15978,1,0
3,GO PEPTIDE CROSS LINKING,0.0041031,-0.14839,-0.18294,1,0
3,GO REGULATION OF PINOCYTOSIS,0.00099681,-0.14845,-0.15974,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0011668,-0.14854,-0.12718,1,0
3,GO RESPONSE TO DSRNA,0.0030436,-0.14864,-0.11638,1,0
3,GO ANIMAL ORGAN MATURATION,0.028264,-0.14869,-0.10269,1,0
3,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00084997,-0.14877,-0.13688,1,0
3,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0002443,-0.14886,-0.1355,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0018256,-0.14902,-0.17473,1,0
3,GO MYELOID LEUKOCYTE MIGRATION,0.0012886,-0.14905,-0.12531,1,0
3,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.0012527,-0.14912,-0.14739,1,0
3,GO GOLGI TO ENDOSOME TRANSPORT,0.0043737,-0.14925,-0.12061,1,0
3,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.00023667,-0.14927,-0.11668,1,0
3,GO TELOMERE CAPPING,0.0005211,-0.14936,-0.11024,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00086244,-0.14939,-0.14754,1,0
3,GO BONE RESORPTION,0.00052901,-0.1494,-0.16088,1,0
3,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0078263,-0.14941,-0.1101,1,0
3,GO REGULATION OF PROTEIN SUMOYLATION,0.00044103,-0.14956,-0.11898,1,0
3,GO REGULATION OF MEMBRANE INVAGINATION,0.016386,-0.1496,-0.17039,1,0
3,GO DEVELOPMENTAL INDUCTION,0.00076726,-0.14966,-0.17794,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0005211,-0.14968,-0.15447,1,0
3,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0077327,-0.1497,-0.14863,1,0
3,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.016027,-0.14986,-0.12043,1,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.00015331,-0.14994,-0.18887,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00020178,-0.15016,-0.14381,1,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037139,-0.15064,-0.11936,1,0
3,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.019523,-0.15067,-0.14423,1,0
3,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00014599,-0.15079,-0.12297,1,0
3,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.0056255,-0.15095,-0.27971,1,0
3,GO MYOTUBE CELL DEVELOPMENT,0.014013,-0.151,-0.12149,1,0
3,GO LEUKOCYTE MIGRATION,0.000286,-0.1511,-0.13693,1,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0025277,-0.15113,-0.14605,1,0
3,GO RESPONSE TO UV C,0.00059648,-0.15114,-0.17943,1,0
3,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,3.5022e-05,-0.15133,-0.15906,1,0
3,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.0137,-0.15135,-0.10409,1,0
3,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.01128,-0.15141,-0.15637,1,0
3,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.00065224,-0.15149,-0.13915,1,0
3,GO MATERNAL PLACENTA DEVELOPMENT,0.037882,-0.15149,-0.12475,1,0
3,GO CYTOKINE METABOLIC PROCESS,0.0007786,-0.15166,-0.15509,1,0
3,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0017277,-0.15169,-0.13157,1,0
3,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.035691,-0.152,-0.16673,1,0
3,GO ENDOCRINE PANCREAS DEVELOPMENT,0.011411,-0.15203,-0.13451,1,0
3,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.020385,-0.15205,-0.14653,1,0
3,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.0084096,-0.1525,-0.11755,1,0
3,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.023668,-0.15254,-0.14184,1,0
3,GO REGULATION OF ISOTYPE SWITCHING,0.0011668,-0.15265,-0.14801,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.001235,-0.15279,-0.18007,1,0
3,GO MESODERM MORPHOGENESIS,0.0062108,-0.15282,-0.11047,1,0
3,GO OVARIAN FOLLICLE DEVELOPMENT,0.0024941,-0.15304,-0.15145,1,0
3,GO REGULATION OF SPINDLE ORGANIZATION,3.628e-05,-0.15308,-0.13257,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.0002443,-0.1531,-0.16599,1,0
3,GO EPITHELIAL TUBE FORMATION,3.3435e-06,-0.15334,-0.16167,1,0
3,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.05063,-0.15339,-0.14557,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0011668,-0.15342,-0.1268,1,0
3,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,9.4959e-05,-0.15346,-0.16318,1,0
3,GO BRANCH ELONGATION OF AN EPITHELIUM,0.0070192,-0.15348,-0.28238,1,0
3,GO GOLGI RIBBON FORMATION,0.0024609,-0.1535,-0.14499,1,0
3,GO REGULATION OF B CELL ACTIVATION,0.00023294,-0.15355,-0.14293,1,0
3,GO PROTEIN PROCESSING,5.4184e-05,-0.15367,-0.13912,1,0
3,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.00087508,-0.15387,-0.12731,1,0
3,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.0076401,-0.15395,-0.15364,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.0057669,-0.15435,-0.14442,1,0
3,GO RESPONSE TO MURAMYL DIPEPTIDE,0.010769,-0.15479,-0.15694,1,0
3,GO LYMPHOCYTE MEDIATED IMMUNITY,0.00053704,-0.155,-0.16155,1,0
3,GO DIOL METABOLIC PROCESS,0.023173,-0.15508,-0.11246,1,0
3,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00027716,-0.15515,-0.14522,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.0012177,-0.15533,-0.21883,1,0
3,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.0042095,-0.15559,-0.12656,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,7.3739e-05,-0.15565,-0.19037,1,0
3,GO GRANULOCYTE CHEMOTAXIS,0.0084096,-0.15585,-0.10503,1,0
3,GO METANEPHROS MORPHOGENESIS,0.043025,-0.1559,-0.11342,1,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.0034243,-0.15608,-0.11996,1,0
3,GO DNA DEMETHYLATION,0.00063314,-0.1561,-0.1432,1,0
3,GO RIG I SIGNALING PATHWAY,0.00027284,-0.15619,-0.15956,1,0
3,GO DIGESTION,7.6283e-05,-0.15632,-0.15777,1,0
3,GO IMMUNOGLOBULIN SECRETION,0.0024941,-0.15651,-0.17758,1,0
3,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.003166,-0.15659,-0.15149,1,0
3,GO REGULATION OF CELL CELL ADHESION,0.00018323,-0.15669,-0.15251,1,0
3,GO PEPTIDYL THREONINE MODIFICATION,9.6129e-06,-0.15673,-0.12494,1,0
3,GO VIRAL LIFE CYCLE,0.00013232,-0.15718,-0.14476,1,0
3,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.036048,-0.15719,-0.1056,1,0
3,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,8.1623e-05,-0.15746,-0.14762,1,0
3,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,1.4076e-07,-0.15749,-0.15889,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,7.8911e-05,-0.15755,-0.20752,1,0
3,GO RESPONSE TO ANGIOTENSIN,0.00047589,-0.15758,-0.16945,1,0
3,GO REGULATION OF NEURON MATURATION,0.03429,-0.15775,-0.11594,1,0
3,GO PIGMENT GRANULE LOCALIZATION,0.001422,-0.15796,-0.14825,1,0
3,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0029645,-0.15816,-0.13951,1,0
3,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00027284,-0.15818,-0.17502,1,0
3,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,4.3946e-06,-0.15819,-0.16081,1,0
3,GO MESONEPHROS DEVELOPMENT,0.00015583,-0.15825,-0.1753,1,0
3,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.00081356,-0.15829,-0.20259,1,0
3,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0016575,-0.15834,-0.20337,1,0
3,GO REGULATION OF MAST CELL ACTIVATION,0.0093576,-0.15844,-0.15206,1,0
3,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00096848,-0.15849,-0.1346,1,0
3,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.02945,-0.15856,-0.15918,1,0
3,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.0027747,-0.1587,-0.14228,1,0
3,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.0052197,-0.15872,-0.14588,1,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.000662,-0.15882,-0.18021,1,0
3,GO HISTAMINE TRANSPORT,0.012945,-0.15893,-0.20642,1,0
3,GO CELL KILLING,0.00095459,-0.15896,-0.15846,1,0
3,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.001955,-0.159,-0.11108,1,0
3,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.0016575,-0.15903,-0.16385,1,0
3,GO CELL CHEMOTAXIS,0.00010152,-0.1591,-0.15822,1,0
3,GO T HELPER 1 CELL DIFFERENTIATION,0.025743,-0.15914,-0.21065,1,0
3,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00025215,-0.15917,-0.144,1,0
3,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00013016,-0.1592,-0.16037,1,0
3,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0035605,-0.15929,-0.1725,1,0
3,GO CELL JUNCTION MAINTENANCE,0.016568,-0.15931,-0.13963,1,0
3,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.00011033,-0.15945,-0.18236,1,0
3,GO NEUROTRANSMITTER METABOLIC PROCESS,0.036772,-0.1595,-0.10581,1,0
3,GO RESPONSE TO PROGESTERONE,0.0007901,-0.15951,-0.19485,1,0
3,GO SUPEROXIDE METABOLIC PROCESS,0.0019819,-0.15952,-0.12206,1,0
3,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.7172e-05,-0.15968,-0.17177,1,0
3,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.014823,-0.1597,-0.1382,1,0
3,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.012367,-0.15971,-0.11934,1,0
3,GO MONOCYTE CHEMOTAXIS,0.0010865,-0.15974,-0.17632,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.0043184,-0.15974,-0.10926,1,0
3,GO QUATERNARY AMMONIUM GROUP TRANSPORT,4.6359e-05,-0.15984,-0.19359,1,0
3,GO SEX DETERMINATION,0.0010558,-0.16015,-0.19492,1,0
3,GO UROGENITAL SYSTEM DEVELOPMENT,4.9694e-05,-0.16018,-0.15141,1,0
3,GO CHEMOKINE PRODUCTION,0.00032916,-0.1603,-0.16772,1,0
3,GO ADHERENS JUNCTION ORGANIZATION,0.01016,-0.16034,-0.10969,1,0
3,GO ETHANOL METABOLIC PROCESS,0.0137,-0.16051,-0.18078,1,0
3,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0026663,-0.16057,-0.14566,1,0
3,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.00065224,-0.16071,-0.15858,1,0
3,GO DETERMINATION OF ADULT LIFESPAN,0.001776,-0.16074,-0.1653,1,0
3,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.2631e-05,-0.16079,-0.17135,1,0
3,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.0022095,-0.16081,-0.20951,1,0
3,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0012177,-0.16099,-0.14256,1,0
3,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.0017277,-0.16133,-0.21301,1,0
3,GO VIRAL RNA GENOME REPLICATION,0.00042777,-0.16141,-0.15498,1,0
3,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0002117,-0.16149,-0.19736,1,0
3,GO FORELIMB MORPHOGENESIS,0.016027,-0.16154,-0.14557,1,0
3,GO LEUKOCYTE MEDIATED IMMUNITY,0.0007786,-0.16164,-0.13584,1,0
3,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0012527,-0.16167,-0.12866,1,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00030449,-0.1617,-0.15329,1,0
3,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.00044103,-0.16202,-0.15092,1,0
3,GO RESPONSE TO OXYGEN RADICAL,0.0018006,-0.16211,-0.11317,1,0
3,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.021973,-0.16221,-0.16825,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0034243,-0.16222,-0.1935,1,0
3,GO NON MOTILE CILIUM ASSEMBLY,0.0056255,-0.16227,-0.12556,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.0013255,-0.16231,-0.1185,1,0
3,GO IMMUNE EFFECTOR PROCESS,0.00033955,-0.16263,-0.14331,1,0
3,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0024941,-0.16274,-0.15113,1,0
3,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00098255,-0.16283,-0.16267,1,0
3,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00074504,-0.16286,-0.1752,1,0
3,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.00091404,-0.16319,-0.14853,1,0
3,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.0001179,-0.16321,-0.16396,1,0
3,GO TYPE B PANCREATIC CELL PROLIFERATION,0.023173,-0.1633,-0.18195,1,0
3,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.0084096,-0.16344,-0.21571,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.00058763,-0.16352,-0.11438,1,0
3,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.009139,-0.16362,-0.11714,1,0
3,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.0022396,-0.16363,-0.13541,1,0
3,GO MITOTIC METAPHASE PLATE CONGRESSION,9.0235e-07,-0.16368,-0.16033,1,0
3,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.042609,-0.16408,-0.17224,1,0
3,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.054582,-0.16437,-0.10538,1,0
3,GO RESPONSE TO LEPTIN,0.00019229,-0.16451,-0.2243,1,0
3,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.001235,-0.16466,-0.13605,1,0
3,GO RDNA HETEROCHROMATIN ASSEMBLY,6.4592e-06,-0.16472,-0.20057,1,0
3,GO SKELETAL MUSCLE CELL PROLIFERATION,0.020385,-0.16475,-0.17932,1,0
3,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0078263,-0.16487,-0.16557,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00011033,-0.16513,-0.19045,1,0
3,GO POSITIVE REGULATION OF HORMONE SECRETION,7.3739e-05,-0.16529,-0.17775,1,0
3,GO LUNG MORPHOGENESIS,0.001235,-0.1653,-0.18553,1,0
3,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.00030449,-0.16545,-0.13244,1,0
3,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.056652,-0.16552,-0.16034,1,0
3,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.03006,-0.16556,-0.11246,1,0
3,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.00061456,-0.16564,-0.15884,1,0
3,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00046872,-0.1657,-0.13477,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.00023294,-0.16573,-0.16422,1,0
3,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.0014022,-0.16638,-0.14249,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.00015083,-0.16652,-0.16641,1,0
3,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0021798,-0.16674,-0.13002,1,0
3,GO NEPHRON EPITHELIUM DEVELOPMENT,7.1274e-05,-0.16686,-0.17681,1,0
3,GO REPRODUCTIVE SYSTEM DEVELOPMENT,7.6657e-06,-0.16701,-0.14968,1,0
3,GO RESPONSE TO TUMOR NECROSIS FACTOR,6.6578e-05,-0.16705,-0.1607,1,0
3,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.0023321,-0.16709,-0.12717,1,0
3,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0084096,-0.1674,-0.1528,1,0
3,GO CYTOPLASM ORGANIZATION,0.0019023,-0.1675,-0.19589,1,0
3,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.00049053,-0.16754,-0.15501,1,0
3,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,7.8911e-05,-0.16768,-0.26731,1,0
3,GO CARDIAC ATRIUM MORPHOGENESIS,0.024428,-0.16785,-0.12081,1,0
3,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.00046165,-0.16794,-0.17439,1,0
3,GO ALPHA BETA T CELL ACTIVATION,7.2414e-06,-0.16808,-0.1891,1,0
3,GO DEFENSE RESPONSE TO BACTERIUM,5.7059e-05,-0.1682,-0.1706,1,0
3,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.003607,-0.16831,-0.1374,1,0
3,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.018693,-0.16844,-0.13011,1,0
3,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.004156,-0.16865,-0.15355,1,0
3,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0020367,-0.16866,-0.2004,1,0
3,GO PROTEIN DEMANNOSYLATION,0.001118,-0.16875,-0.16705,1,0
3,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0059852,-0.16883,-0.3691,1,0
3,GO AXIS ELONGATION,0.039795,-0.16883,-0.15171,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013673,-0.16885,-0.14623,1,0
3,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.3997e-05,-0.16897,-0.14477,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.013093,-0.16916,-0.11566,1,0
3,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.058787,-0.16919,-0.12394,1,0
3,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0033799,-0.16927,-0.17696,1,0
3,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.00054518,-0.16944,-0.19228,1,0
3,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00074504,-0.16953,-0.18312,1,0
3,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.00086244,-0.16955,-0.13272,1,0
3,GO POSITIVE REGULATION OF HEMOPOIESIS,9.4959e-05,-0.16965,-0.15464,1,0
3,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.001568,-0.16978,-0.13417,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION,0.00025617,-0.16985,-0.15887,1,0
3,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0099244,-0.16998,-0.17408,1,0
3,GO ENTRY INTO HOST,0.0005618,-0.17042,-0.19152,1,0
3,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0086125,-0.17059,-0.23412,1,0
3,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.00025215,-0.17069,-0.17028,1,0
3,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.001118,-0.17137,-0.15618,1,0
3,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.0033361,-0.17145,-0.11406,1,0
3,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.015329,-0.17149,-0.11697,1,0
3,GO NEURAL TUBE FORMATION,6.8885e-07,-0.17158,-0.18358,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.014172,-0.17184,-0.22803,1,0
3,GO ACTIN CYTOSKELETON REORGANIZATION,0.00020835,-0.1725,-0.12326,1,0
3,GO MITOCHONDRIAL DEPOLARIZATION,0.056128,-0.17258,-0.098622,1,0
3,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,4.2487e-05,-0.17267,-0.14694,1,0
3,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.03e-05,-0.17273,-0.16763,1,0
3,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.00016629,-0.17276,-0.11569,1,0
3,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0014022,-0.1729,-0.13705,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0029256,-0.17298,-0.15908,1,0
3,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0020367,-0.17302,-0.13404,1,0
3,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.055609,-0.17359,-0.11862,1,0
3,GO ERYTHROCYTE HOMEOSTASIS,1.5014e-05,-0.1738,-0.16168,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.00015331,-0.17391,-0.20108,1,0
3,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00075607,-0.17416,-0.16799,1,0
3,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.0010558,-0.17416,-0.17844,1,0
3,GO REGULATION OF ACTIN NUCLEATION,5.3256e-05,-0.17423,-0.18007,1,0
3,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.00053704,-0.17428,-0.17866,1,0
3,GO REGULATION OF MYOBLAST FUSION,0.010522,-0.1743,-0.15652,1,0
3,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.00015583,-0.17458,-0.20074,1,0
3,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.00018323,-0.17469,-0.13428,1,0
3,GO NEURAL NUCLEUS DEVELOPMENT,0.00091404,-0.17511,-0.15834,1,0
3,GO ADAPTIVE IMMUNE RESPONSE,0.00023667,-0.17516,-0.17681,1,0
3,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.6162e-06,-0.17522,-0.18007,1,0
3,GO CARNITINE METABOLIC PROCESS,0.032938,-0.17533,-0.10271,1,0
3,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.023173,-0.17544,-0.18244,1,0
3,GO BONE REMODELING,0.0020646,-0.17551,-0.14174,1,0
3,GO REGULATION OF CHROMATIN ASSEMBLY,5.2344e-05,-0.17554,-0.14395,1,0
3,GO CYTOKINE MEDIATED SIGNALING PATHWAY,8.4424e-05,-0.17555,-0.16973,1,0
3,GO SECONDARY METABOLIC PROCESS,0.00026438,-0.17557,-0.17636,1,0
3,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00047589,-0.17568,-0.14347,1,0
3,GO RESPONSE TO INTERLEUKIN 6,1.3693e-05,-0.17586,-0.21072,1,0
3,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0041031,-0.17595,-0.16919,1,0
3,GO ERYTHROCYTE DEVELOPMENT,9.6562e-05,-0.17598,-0.14848,1,0
3,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.0012705,-0.17605,-0.14958,1,0
3,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.00039622,-0.17641,-0.13957,1,0
3,GO DISACCHARIDE METABOLIC PROCESS,0.01829,-0.17646,-0.12526,1,0
3,GO REGULATION OF MEMBRANE PERMEABILITY,5.5412e-06,-0.1766,-0.15518,1,0
3,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.044722,-0.17684,-0.14111,1,0
3,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.4528e-05,-0.17743,-0.18187,1,0
3,GO REGULATION OF B CELL PROLIFERATION,0.0018006,-0.17754,-0.14651,1,0
3,GO CYTOLYSIS,0.01829,-0.17755,-0.1669,1,0
3,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.032278,-0.17759,-0.13287,1,0
3,GO N GLYCAN PROCESSING,0.040187,-0.17792,-0.14215,1,0
3,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.0029645,-0.17806,-0.1841,1,0
3,GO DETECTION OF MECHANICAL STIMULUS,0.0090315,-0.17818,-0.16121,1,0
3,GO INTRACILIARY TRANSPORT,0.001235,-0.1783,-0.169,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.6657e-06,-0.17878,-0.21453,1,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0011668,-0.17893,-0.14473,1,0
3,GO SUBPALLIUM DEVELOPMENT,0.020828,-0.17894,-0.13616,1,0
3,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.00057029,-0.17894,-0.1862,1,0
3,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.00065224,-0.17915,-0.19709,1,0
3,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,6.7724e-05,-0.17923,-0.20495,1,0
3,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.025475,-0.17925,-0.088823,1,0
3,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.0069343,-0.1794,-0.13932,1,0
3,GO REGULATION OF RUFFLE ASSEMBLY,2.2015e-05,-0.17942,-0.16744,1,0
3,GO HYPOTHALAMUS DEVELOPMENT,0.0017277,-0.17951,-0.17957,1,0
3,GO REGULATION OF T HELPER CELL DIFFERENTIATION,5.8049e-05,-0.17956,-0.20502,1,0
3,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,3.8924e-05,-0.17959,-0.22342,1,0
3,GO ER OVERLOAD RESPONSE,0.023919,-0.18043,-0.14154,1,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0018006,-0.18047,-0.18784,1,0
3,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.00029511,-0.18049,-0.20726,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0001862,-0.18073,-0.15477,1,0
3,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0025277,-0.18091,-0.15057,1,0
3,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.00065224,-0.18105,-0.16623,1,0
3,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.00084997,-0.18118,-0.14264,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0010113,-0.18118,-0.12537,1,0
3,GO SEGMENT SPECIFICATION,0.012227,-0.18155,-0.20384,1,0
3,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,7.1819e-07,-0.18204,-0.21603,1,0
3,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,3.8924e-05,-0.18219,-0.15871,1,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.0022701,-0.1822,-0.21378,1,0
3,GO REGULATION OF TISSUE REMODELING,0.00087508,-0.1825,-0.16413,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00013232,-0.18277,-0.18882,1,0
3,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.0010558,-0.18278,-0.14502,1,0
3,GO ICOSANOID METABOLIC PROCESS,1.1375e-05,-0.1829,-0.22234,1,0
3,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.0023009,-0.18291,-0.17714,1,0
3,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.016205,-0.18314,-0.16954,1,0
3,GO MYELOID CELL HOMEOSTASIS,3.2784e-06,-0.18343,-0.17565,1,0
3,GO B CELL DIFFERENTIATION,1.1588e-05,-0.18346,-0.1595,1,0
3,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.00030449,-0.18355,-0.14515,1,0
3,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,9.4341e-06,-0.18371,-0.20991,1,0
3,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0031247,-0.18387,-0.14094,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.00016629,-0.18388,-0.17306,1,0
3,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.0012527,-0.18405,-0.23376,1,0
3,GO NEURON FATE COMMITMENT,0.010522,-0.18421,-0.16227,1,0
3,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.001483,-0.18465,-0.16256,1,0
3,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.023919,-0.18479,-0.21213,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.0049019,-0.18482,-0.1909,1,0
3,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.03006,-0.18484,-0.19884,1,0
3,GO O GLYCAN PROCESSING,1.6457e-05,-0.18503,-0.26095,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.0001179,-0.18514,-0.22572,1,0
3,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.03068,-0.18521,-0.14377,1,0
3,GO MYELOID CELL DEVELOPMENT,3.3806e-05,-0.18542,-0.14358,1,0
3,GO RENAL TUBULE DEVELOPMENT,4.1026e-05,-0.18543,-0.19054,1,0
3,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.01829,-0.18564,-0.12323,1,0
3,GO REGULATION OF B CELL DIFFERENTIATION,0.00090088,-0.18618,-0.186,1,0
3,GO CELLULAR RESPONSE TO DSRNA,0.00065224,-0.1863,-0.17943,1,0
3,GO REGULATION OF CHROMATIN BINDING,0.00010673,-0.18639,-0.18941,1,0
3,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.001422,-0.18645,-0.15881,1,0
3,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.01251,-0.18655,-0.11846,1,0
3,GO GENETIC IMPRINTING,0.00070238,-0.18679,-0.1644,1,0
3,GO CELLULAR RESPONSE TO VIRUS,1.6158e-05,-0.18696,-0.19268,1,0
3,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.012798,-0.18732,-0.1113,1,0
3,GO POSITIVE REGULATION OF HAIR CYCLE,0.026013,-0.1876,-0.16805,1,0
3,GO TYPE I INTERFERON PRODUCTION,0.00011218,-0.18776,-0.16596,1,0
3,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.0090315,-0.18795,-0.25612,1,0
3,GO NEPHRON DEVELOPMENT,2.2015e-05,-0.18797,-0.18368,1,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.00021857,-0.18807,-0.14845,1,0
3,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,3.9613e-05,-0.18824,-0.16834,1,0
3,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,9.1829e-05,-0.1886,-0.20337,1,0
3,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.0005211,-0.18874,-0.19294,1,0
3,GO BIOLOGICAL PHASE,0.058247,-0.18874,-0.18547,1,0
3,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.00052901,-0.18887,-0.23626,1,0
3,GO CARDIAC ATRIUM DEVELOPMENT,0.026013,-0.18922,-0.1087,1,0
3,GO APICAL PROTEIN LOCALIZATION,0.00049053,-0.18931,-0.15411,1,0
3,GO NEGATIVE REGULATION OF LIPID STORAGE,0.001568,-0.18951,-0.15881,1,0
3,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.0018764,-0.18961,-0.19396,1,0
3,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.00033955,-0.18964,-0.23888,1,0
3,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.0016122,-0.18976,-0.23141,1,0
3,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0022095,-0.1899,-0.17539,1,0
3,GO NEUTROPHIL HOMEOSTASIS,0.020166,-0.18998,-0.16854,1,0
3,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,8.1138e-06,-0.19063,-0.21374,1,0
3,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.00094089,-0.19092,-0.19266,1,0
3,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,1.1375e-05,-0.19105,-0.22798,1,0
3,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00011033,-0.19106,-0.20763,1,0
3,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.00010152,-0.19118,-0.26061,1,0
3,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0002117,-0.19126,-0.17351,1,0
3,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,4.8839e-05,-0.19144,-0.17209,1,0
3,GO ADHERENS JUNCTION ASSEMBLY,0.020605,-0.19147,-0.12283,1,0
3,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.033948,-0.19201,-0.1467,1,0
3,GO PLATELET ACTIVATION,0.00037835,-0.19211,-0.15426,1,0
3,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.003166,-0.19211,-0.16911,1,0
3,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0034243,-0.19234,-0.16474,1,0
3,GO RESPONSE TO MECHANICAL STIMULUS,0.00028155,-0.19257,-0.14675,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,6.0079e-05,-0.19288,-0.19815,1,0
3,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0011021,-0.19295,-0.18572,1,0
3,GO SEQUESTERING OF ACTIN MONOMERS,0.013856,-0.19312,-0.24958,1,0
3,GO MEGAKARYOCYTE DIFFERENTIATION,2.5934e-07,-0.19329,-0.17545,1,0
3,GO B CELL MEDIATED IMMUNITY,0.00038422,-0.19385,-0.18313,1,0
3,GO BONE CELL DEVELOPMENT,0.00040857,-0.19398,-0.15011,1,0
3,GO CELLULAR DEFENSE RESPONSE,2.7452e-06,-0.19402,-0.24046,1,0
3,GO PROGRAMMED NECROTIC CELL DEATH,1.5293e-05,-0.19405,-0.21425,1,0
3,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.007921,-0.19408,-0.25021,1,0
3,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,1.1165e-05,-0.19433,-0.18917,1,0
3,GO EPITHELIAL CELL DEVELOPMENT,4.9228e-07,-0.19434,-0.2191,1,0
3,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0068504,-0.19472,-0.13758,1,0
3,GO T HELPER 17 TYPE IMMUNE RESPONSE,3.5461e-06,-0.19521,-0.17664,1,0
3,GO T CELL MEDIATED IMMUNITY,0.00084997,-0.19529,-0.19749,1,0
3,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.0018764,-0.19532,-0.17184,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.000286,-0.19538,-0.19689,1,0
3,GO RESPONSE TO VIRUS,2.1234e-05,-0.19542,-0.18372,1,0
3,GO REGULATION OF CELL KILLING,7.3739e-05,-0.19567,-0.2213,1,0
3,GO ENDOSOME ORGANIZATION,4.719e-07,-0.19622,-0.16701,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.00084997,-0.19641,-0.18232,1,0
3,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.013546,-0.19678,-0.17159,1,0
3,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,9.2118e-07,-0.19732,-0.19713,1,0
3,GO CELLULAR RESPONSE TO INTERFERON BETA,0.051111,-0.19735,-0.13996,1,0
3,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,1.3693e-05,-0.19743,-0.17974,1,0
3,GO OLIGOPEPTIDE TRANSPORT,0.00045468,-0.19756,-0.25403,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.0072795,-0.1981,-0.11501,1,0
3,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.0071051,-0.19866,-0.20076,1,0
3,GO TISSUE REMODELING,0.00015583,-0.19868,-0.17729,1,0
3,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00021857,-0.19871,-0.24277,1,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.6321e-06,-0.19875,-0.20334,1,0
3,GO ERBB2 SIGNALING PATHWAY,6.4341e-05,-0.19891,-0.1848,1,0
3,GO MOVEMENT IN HOST ENVIRONMENT,4.2487e-05,-0.19892,-0.19184,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00027716,-0.19903,-0.18224,1,0
3,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,1.1806e-05,-0.19918,-0.21991,1,0
3,GO EMBRYONIC DIGIT MORPHOGENESIS,1.5865e-05,-0.20003,-0.18315,1,0
3,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.00086244,-0.20019,-0.13384,1,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0038478,-0.20021,-0.18178,1,0
3,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.0053519,-0.20025,-0.22332,1,0
3,GO CENTROSOME DUPLICATION,1.3468e-07,-0.20039,-0.2047,1,0
3,GO MAST CELL ACTIVATION,0.0017517,-0.20048,-0.18524,1,0
3,GO CELL FATE SPECIFICATION,3.9613e-05,-0.20052,-0.19737,1,0
3,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00023667,-0.2009,-0.21281,1,0
3,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00070238,-0.20117,-0.24914,1,0
3,GO MALE GENITALIA DEVELOPMENT,0.010522,-0.2013,-0.162,1,0
3,GO INTERLEUKIN 6 PRODUCTION,3.0302e-06,-0.20137,-0.20629,1,0
3,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,6.3249e-05,-0.20143,-0.18526,1,0
3,GO B CELL APOPTOTIC PROCESS,3.8246e-05,-0.20149,-0.23105,1,0
3,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,9.4341e-06,-0.20162,-0.21559,1,0
3,GO IMMUNE RESPONSE TO TUMOR CELL,0.015159,-0.20186,-0.17866,1,0
3,GO RESPONSE TO INACTIVITY,0.0028118,-0.20197,-0.16885,1,0
3,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.014172,-0.2021,-0.192,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.2784e-06,-0.20222,-0.20483,1,0
3,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.00016629,-0.2027,-0.18611,1,0
3,GO INTERLEUKIN 13 PRODUCTION,0.019312,-0.2034,-0.17311,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00080175,-0.20341,-0.20555,1,0
3,GO AUTOPHAGOSOME MATURATION,5.1446e-05,-0.20358,-0.16202,1,0
3,GO NECROTIC CELL DEATH,3.4409e-05,-0.20373,-0.19166,1,0
3,GO ACTIVATED T CELL PROLIFERATION,0.00034485,-0.20374,-0.17795,1,0
3,GO VIRION ASSEMBLY,7.5451e-08,-0.20375,-0.18531,1,0
3,GO MICROVILLUS ASSEMBLY,0.022928,-0.20382,-0.1453,1,0
3,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0046018,-0.20401,-0.17084,1,0
3,GO RESPONSE TO IMMOBILIZATION STRESS,0.00068191,-0.20408,-0.19027,1,0
3,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.00034485,-0.2043,-0.19998,1,0
3,GO CARDIAC MYOFIBRIL ASSEMBLY,0.0023009,-0.20434,-0.17763,1,0
3,GO INTERLEUKIN 8 PRODUCTION,8.1623e-05,-0.20446,-0.20396,1,0
3,GO T CELL EXTRAVASATION,0.029754,-0.20447,-0.17493,1,0
3,GO REGULATION OF CELL MATRIX ADHESION,0.00035024,-0.20463,-0.16784,1,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,9.819e-05,-0.20485,-0.16332,1,0
3,GO ALPHA BETA T CELL DIFFERENTIATION,7.8052e-07,-0.20537,-0.22708,1,0
3,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.001568,-0.2056,-0.18726,1,0
3,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,1.8053e-06,-0.20561,-0.2024,1,0
3,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.016386,-0.20566,-0.26386,1,0
3,GO ENDOTHELIUM DEVELOPMENT,4.7999e-05,-0.20582,-0.1753,1,0
3,GO SOMATIC STEM CELL POPULATION MAINTENANCE,3.628e-05,-0.20623,-0.18353,1,0
3,GO PROSTANOID METABOLIC PROCESS,0.00026858,-0.20624,-0.26365,1,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.00026438,-0.20642,-0.24838,1,0
3,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00039622,-0.20644,-0.17131,1,0
3,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0020367,-0.20656,-0.17065,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.00010852,-0.20681,-0.17543,1,0
3,GO ZYMOGEN ACTIVATION,0.0025961,-0.2071,-0.20239,1,0
3,GO RESPONSE TO INTERFERON GAMMA,0.0021215,-0.20712,-0.19615,1,0
3,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.012087,-0.20738,-0.15094,1,0
3,GO POSITIVE REGULATION OF BONE RESORPTION,0.0046604,-0.20775,-0.18119,1,0
3,GO ENDOTHELIAL CELL DEVELOPMENT,5.3256e-05,-0.2078,-0.18144,1,0
3,GO VIRAL RELEASE FROM HOST CELL,1.3174e-07,-0.20789,-0.20199,1,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0022396,-0.20798,-0.16352,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.0023321,-0.20805,-0.22678,1,0
3,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0012527,-0.2085,-0.14598,1,0
3,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.0062877,-0.20856,-0.21566,1,0
3,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.0025277,-0.20873,-0.18339,1,0
3,GO SENSORY PERCEPTION OF TASTE,8.6579e-07,-0.20908,-0.22743,1,0
3,GO FRUCTOSE METABOLIC PROCESS,0.0076401,-0.20935,-0.24004,1,0
3,GO POSITIVE REGULATION OF CELL KILLING,5.3256e-05,-0.2096,-0.23459,1,0
3,GO CARDIOBLAST DIFFERENTIATION,0.015674,-0.21015,-0.15892,1,0
3,GO ANTIBACTERIAL HUMORAL RESPONSE,6.7724e-05,-0.21043,-0.26982,1,0
3,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,6.6578e-05,-0.21044,-0.2246,1,0
3,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.018693,-0.21047,-0.11757,1,0
3,GO T CELL SELECTION,0.00014839,-0.21119,-0.16811,1,0
3,GO REGULATION OF COAGULATION,0.001422,-0.21121,-0.19768,1,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0017517,-0.21231,-0.20191,1,0
3,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,1.5293e-05,-0.21268,-0.21573,1,0
3,GO INTERLEUKIN 12 PRODUCTION,2.856e-06,-0.2128,-0.24309,1,0
3,GO REGULATION OF RECEPTOR BINDING,0.0068504,-0.21317,-0.16596,1,0
3,GO OTIC VESICLE DEVELOPMENT,0.011022,-0.21435,-0.23896,1,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.00088789,-0.21442,-0.18418,1,0
3,GO REGULATION OF VASCULOGENESIS,0.0086125,-0.21473,-0.18167,1,0
3,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00012388,-0.21484,-0.20972,1,0
3,GO REGULATION OF CENTROSOME CYCLE,5.3747e-08,-0.21503,-0.20148,1,0
3,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.0067673,-0.21515,-0.1651,1,0
3,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.00046872,-0.21588,-0.22313,1,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00048316,-0.21598,-0.21399,1,0
3,GO SUPEROXIDE ANION GENERATION,0.00052901,-0.21689,-0.21822,1,0
3,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00013451,-0.2169,-0.2869,1,0
3,GO LIPID DIGESTION,0.001422,-0.21693,-0.31343,1,0
3,GO DORSAL VENTRAL PATTERN FORMATION,3.0395e-05,-0.21706,-0.17374,1,0
3,GO GERMINAL CENTER FORMATION,0.0012886,-0.21729,-0.26434,1,0
3,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.00036686,-0.21788,-0.25924,1,0
3,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0014624,-0.21797,-0.14677,1,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION,9.4959e-05,-0.21801,-0.15688,1,0
3,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0040509,-0.21837,-0.21781,1,0
3,GO REGULATION OF SYMBIOTIC PROCESS,7.3803e-06,-0.21847,-0.19521,1,0
3,GO DEFENSE RESPONSE TO VIRUS,1.8053e-06,-0.21876,-0.241,1,0
3,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,7.6657e-06,-0.21903,-0.19749,1,0
3,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.00026024,-0.21988,-0.17841,1,0
3,GO ENDODERMAL CELL FATE COMMITMENT,6.8888e-05,-0.22044,-0.2061,1,0
3,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.00012804,-0.22057,-0.19951,1,0
3,GO NEGATIVE REGULATION OF CELL CELL ADHESION,2.5884e-05,-0.22071,-0.21288,1,0
3,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.00029511,-0.22075,-0.21486,1,0
3,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0005211,-0.22077,-0.27173,1,0
3,GO PLATELET AGGREGATION,5.6085e-05,-0.22093,-0.21856,1,0
3,GO ZYMOGEN INHIBITION,6.545e-05,-0.22112,-0.306,1,0
3,GO PROXIMAL DISTAL PATTERN FORMATION,0.0044298,-0.22113,-0.19858,1,0
3,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.5127e-05,-0.22127,-0.20291,1,0
3,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.00022565,-0.22162,-0.18713,1,0
3,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.023173,-0.22174,-0.14239,1,0
3,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,8.1361e-07,-0.22208,-0.25253,1,0
3,GO NEGATIVE REGULATION OF B CELL ACTIVATION,4.4771e-05,-0.22213,-0.22351,1,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.014658,-0.22248,-0.20578,1,0
3,GO EMBRYONIC BODY MORPHOGENESIS,0.0013826,-0.2231,-0.19307,1,0
3,GO MULTIVESICULAR BODY SORTING PATHWAY,9.4407e-08,-0.22332,-0.2093,1,0
3,GO ENDOCRINE SYSTEM DEVELOPMENT,1.0756e-05,-0.22389,-0.21356,1,0
3,GO REGULATION OF RESPIRATORY BURST,5.0563e-05,-0.22463,-0.20673,1,0
3,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0022396,-0.22593,-0.2216,1,0
3,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.00095459,-0.22597,-0.20232,1,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.010041,-0.2261,-0.1954,1,0
3,GO GANGLION DEVELOPMENT,0.019735,-0.22611,-0.16597,1,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.8814e-05,-0.22635,-0.2427,1,0
3,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.00043435,-0.22685,-0.24581,1,0
3,GO INTERLEUKIN 10 PRODUCTION,8.2686e-06,-0.22716,-0.24865,1,0
3,GO REGULATION OF RESPONSE TO WOUNDING,6.8888e-05,-0.22719,-0.19219,1,0
3,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0011668,-0.22744,-0.19585,1,0
3,GO INTERLEUKIN 1 BETA PRODUCTION,0.0001803,-0.22781,-0.20509,1,0
3,GO DENDRITIC CELL CYTOKINE PRODUCTION,4.4771e-05,-0.22824,-0.28208,1,0
3,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.00054518,-0.22841,-0.16917,1,0
3,GO REGULATORY T CELL DIFFERENTIATION,0.00020504,-0.22851,-0.26419,1,0
3,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,5.8049e-05,-0.22861,-0.1902,1,0
3,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,2.0478e-05,-0.22923,-0.21552,1,0
3,GO POSITIVE REGULATION OF CHROMATIN BINDING,3.4409e-05,-0.2298,-0.23699,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00018923,-0.22981,-0.25333,1,0
3,GO BLOOD VESSEL REMODELING,0.00016629,-0.22998,-0.1969,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.9749e-05,-0.23013,-0.2239,1,0
3,GO MULTIVESICULAR BODY ORGANIZATION,7.6792e-10,-0.23051,-0.24142,1,0
3,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0012177,-0.23173,-0.22209,1,0
3,GO INTERFERON BETA PRODUCTION,4.2487e-05,-0.23181,-0.18904,1,0
3,GO GLOMERULUS DEVELOPMENT,2.7804e-05,-0.23198,-0.24664,1,0
3,GO SPERM CAPACITATION,8.4424e-05,-0.23219,-0.19204,1,0
3,GO T CELL MEDIATED CYTOTOXICITY,0.0072795,-0.23233,-0.25829,1,0
3,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.0047198,-0.23249,-0.2018,1,0
3,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0001179,-0.23263,-0.17151,1,0
3,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,7.3803e-06,-0.23277,-0.20642,1,0
3,GO REGULATION OF BONE REMODELING,0.00072342,-0.23302,-0.17822,1,0
3,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0037985,-0.23306,-0.28055,1,0
3,GO CYTOKINETIC PROCESS,1.9014e-08,-0.23366,-0.23127,1,0
3,GO PANCREAS DEVELOPMENT,5.6487e-06,-0.23408,-0.23737,1,0
3,GO POSITIVE REGULATION OF CHEMOTAXIS,2.4091e-05,-0.23428,-0.1857,1,0
3,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0054872,-0.23475,-0.27821,1,0
3,GO POSITIVE T CELL SELECTION,0.00020178,-0.23489,-0.18411,1,0
3,GO RUFFLE ORGANIZATION,9.8716e-08,-0.23512,-0.19425,1,0
3,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,8.3013e-05,-0.23517,-0.19315,1,0
3,GO POLYAMINE BIOSYNTHETIC PROCESS,0.00015331,-0.23557,-0.19411,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,9.3381e-05,-0.23606,-0.24461,1,0
3,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.00045468,-0.23637,-0.18935,1,0
3,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.00041488,-0.23648,-0.21139,1,0
3,GO REGULATION OF WOUND HEALING,2.0478e-05,-0.2371,-0.22872,1,0
3,GO OUTER DYNEIN ARM ASSEMBLY,0.00016361,-0.23717,-0.26123,1,0
3,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.00019857,-0.23753,-0.21533,1,0
3,GO CENTROSOME SEPARATION,0.00011406,-0.2376,-0.21057,1,0
3,GO INDOLALKYLAMINE METABOLIC PROCESS,0.039406,-0.2379,-0.13,1,0
3,GO BROWN FAT CELL DIFFERENTIATION,5.2303e-06,-0.23907,-0.25384,1,0
3,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.0028492,-0.23951,-0.25222,1,0
3,GO ACTIN FILAMENT NETWORK FORMATION,0.0049019,-0.23955,-0.22903,1,0
3,GO CELL FATE DETERMINATION,5.332e-06,-0.23963,-0.23452,1,0
3,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0011668,-0.24006,-0.17611,1,0
3,GO REGULATION OF CENTROSOME DUPLICATION,7.0522e-08,-0.2403,-0.21784,1,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,9.1829e-05,-0.24162,-0.24299,1,0
3,GO MUSCLE CELL MIGRATION,2.5424e-05,-0.24167,-0.2214,1,0
3,GO PLACENTA DEVELOPMENT,5.0278e-07,-0.24187,-0.20645,1,0
3,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,1.536e-06,-0.24196,-0.26947,1,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.1196e-06,-0.24203,-0.23016,1,0
3,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,4.6359e-05,-0.24206,-0.23416,1,0
3,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,5.9834e-06,-0.24218,-0.22356,1,0
3,GO MAGNESIUM ION TRANSPORT,3.094e-05,-0.24299,-0.21757,1,0
3,GO VIRAL GENOME REPLICATION,9.795e-06,-0.24328,-0.21994,1,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.3693e-05,-0.24344,-0.22182,1,0
3,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.052083,-0.24383,-0.13528,1,0
3,GO PLACENTA BLOOD VESSEL DEVELOPMENT,3.3806e-05,-0.24436,-0.17815,1,0
3,GO MICROVILLUS ORGANIZATION,0.00039018,-0.24459,-0.22947,1,0
3,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,4.3236e-05,-0.24463,-0.1898,1,0
3,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,5.0278e-07,-0.24465,-0.24415,1,0
3,GO LIVER MORPHOGENESIS,0.00059648,-0.24468,-0.21749,1,0
3,GO BILE ACID METABOLIC PROCESS,1.4454e-06,-0.24546,-0.24565,1,0
3,GO EOSINOPHIL CHEMOTAXIS,0.017315,-0.24547,-0.21356,1,0
3,GO POSITIVE REGULATION OF COAGULATION,5.8049e-05,-0.24551,-0.2482,1,0
3,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.042197,-0.2461,-0.14289,1,0
3,GO MYOFIBRIL ASSEMBLY,3.5646e-05,-0.24612,-0.19067,1,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,7.3739e-05,-0.24697,-0.22786,1,0
3,GO EMBRYONIC HEMOPOIESIS,2.011e-05,-0.2478,-0.25141,1,0
3,GO GASTRULATION WITH MOUTH FORMING SECOND,0.00075607,-0.24853,-0.19787,1,0
3,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.00065224,-0.24874,-0.31001,1,0
3,GO ALPHA BETA T CELL PROLIFERATION,6.2175e-05,-0.24908,-0.25888,1,0
3,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.0071918,-0.24908,-0.18544,1,0
3,GO EXTRACELLULAR VESICLE BIOGENESIS,2.188e-08,-0.24941,-0.26084,1,0
3,GO POSITIVE REGULATION OF VASCULOGENESIS,0.024687,-0.25004,-0.17717,1,0
3,GO INTERLEUKIN 1 PRODUCTION,3.628e-05,-0.25011,-0.23601,1,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,1.9558e-07,-0.25048,-0.22765,1,0
3,GO EOSINOPHIL MIGRATION,0.007921,-0.25185,-0.21663,1,0
3,GO SMOOTH MUSCLE CELL MIGRATION,6.7724e-05,-0.25191,-0.22007,1,0
3,GO MYOBLAST MIGRATION,0.012087,-0.25207,-0.22802,1,0
3,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,6.9711e-06,-0.2521,-0.23944,1,0
3,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,7.8052e-07,-0.25212,-0.2377,1,0
3,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.001235,-0.25222,-0.2677,1,0
3,GO EPITHELIAL CELL DIFFERENTIATION,6.7411e-08,-0.2523,-0.23599,1,0
3,GO ATRIAL SEPTUM DEVELOPMENT,0.0047798,-0.25243,-0.17207,1,0
3,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00061456,-0.25259,-0.23954,1,0
3,GO ESTROUS CYCLE,0.0026663,-0.25281,-0.19951,1,0
3,GO MALE SEX DETERMINATION,1.5014e-05,-0.25298,-0.30996,1,0
3,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.016568,-0.25328,-0.20136,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0035605,-0.25348,-0.215,1,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,8.6328e-08,-0.25396,-0.2689,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,3.7605e-06,-0.2541,-0.23111,1,0
3,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.2784e-06,-0.25502,-0.22463,1,0
3,GO AXONEME ASSEMBLY,5.6085e-05,-0.25508,-0.23267,1,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,1.4472e-05,-0.2554,-0.22777,1,0
3,GO PROTEIN AUTO ADP RIBOSYLATION,6.3249e-05,-0.2557,-0.32545,1,0
3,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.0032501,-0.25597,-0.20428,1,0
3,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.00031907,-0.25604,-0.20496,1,0
3,GO INTERLEUKIN 5 PRODUCTION,0.034984,-0.25616,-0.14227,1,0
3,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,2.7078e-07,-0.25644,-0.29029,1,0
3,GO SPLEEN DEVELOPMENT,1.6062e-07,-0.25688,-0.22702,1,0
3,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,9.4959e-05,-0.25717,-0.24804,1,0
3,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00031414,-0.2578,-0.22917,1,0
3,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,1.2032e-06,-0.25872,-0.24212,1,0
3,GO SPINAL CORD PATTERNING,0.00032916,-0.25903,-0.25302,1,0
3,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,8.4262e-06,-0.2598,-0.22914,1,0
3,GO REGULATION OF SPINDLE ASSEMBLY,2.7078e-07,-0.26107,-0.23119,1,0
3,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.00013232,-0.26108,-0.26712,1,0
3,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0015463,-0.26165,-0.18298,1,0
3,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,6.337e-06,-0.2623,-0.23943,1,0
3,GO B CELL RECEPTOR SIGNALING PATHWAY,4.6359e-05,-0.26262,-0.2289,1,0
3,GO CELL CELL JUNCTION MAINTENANCE,0.0025277,-0.26263,-0.24566,1,0
3,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.0099244,-0.26576,-0.19571,1,0
3,GO POSITIVE REGULATION OF TISSUE REMODELING,8.4262e-06,-0.26703,-0.25097,1,0
3,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,1.536e-06,-0.26718,-0.3281,1,0
3,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,9.9844e-05,-0.26793,-0.20594,1,0
3,GO HOMOTYPIC CELL CELL ADHESION,4.1456e-06,-0.26833,-0.26639,1,0
3,GO PROTEIN ADP RIBOSYLATION,2.6386e-06,-0.26837,-0.23949,1,0
3,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,6.2993e-08,-0.26935,-0.29377,1,0
3,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,2.1621e-05,-0.26959,-0.2367,1,0
3,GO HORMONE CATABOLIC PROCESS,0.00019541,-0.27014,-0.25503,1,0
3,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.00010497,-0.27042,-0.24863,1,0
3,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.001235,-0.27052,-0.2798,1,0
3,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.047827,-0.27073,-0.125,1,0
3,GO ACTIN FILAMENT BASED TRANSPORT,0.00012804,-0.27107,-0.22902,1,0
3,GO RESPONSE TO INTERFERON BETA,0.0018764,-0.27119,-0.33387,1,0
3,GO INTESTINAL LIPID ABSORPTION,0.0007786,-0.27194,-0.34241,1,0
3,GO PIGMENT ACCUMULATION,0.0021505,-0.27264,-0.20505,1,0
3,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.0032501,-0.27274,-0.24516,1,0
3,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.00011986,-0.27306,-0.23493,1,0
3,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,2.913e-06,-0.27364,-0.261,1,0
3,GO TRANSCYTOSIS,1.3056e-06,-0.27387,-0.22463,1,0
3,GO ATRIAL SEPTUM MORPHOGENESIS,0.015329,-0.27398,-0.18319,1,0
3,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.00012186,-0.27482,-0.19608,1,0
3,GO REGULATION OF VIRAL LIFE CYCLE,1.734e-06,-0.27518,-0.25785,1,0
3,GO NEGATIVE REGULATION OF CELL KILLING,0.0087156,-0.27529,-0.27803,1,0
3,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0011503,-0.27555,-0.3329,1,0
3,GO SECONDARY HEART FIELD SPECIFICATION,0.00049802,-0.27614,-0.3245,1,0
3,GO GDP METABOLIC PROCESS,0.0013826,-0.27646,-0.20018,1,0
3,GO SPHINGOMYELIN METABOLIC PROCESS,0.00054518,-0.27665,-0.19633,1,0
3,GO EXTRACELLULAR TRANSPORT,8.5867e-06,-0.27665,-0.26948,1,0
3,GO DENDRITIC CELL DIFFERENTIATION,9.6562e-05,-0.27709,-0.26856,1,0
3,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,3.4296e-07,-0.27758,-0.26067,1,0
3,GO REGULATION OF PLATELET ACTIVATION,0.0005056,-0.27767,-0.25922,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.0557e-05,-0.27798,-0.24247,1,0
3,GO MYELOID CELL APOPTOTIC PROCESS,4.3236e-05,-0.2783,-0.23523,1,0
3,GO MEMBRANE RAFT ORGANIZATION,0.0021215,-0.27928,-0.26517,1,0
3,GO LEFT RIGHT AXIS SPECIFICATION,5.4184e-05,-0.27938,-0.27303,1,0
3,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.001955,-0.2797,-0.26875,1,0
3,GO REGULATION OF NOTCH SIGNALING PATHWAY,1.2281e-06,-0.27975,-0.21736,1,0
3,GO REGULATION OF NECROTIC CELL DEATH,4.1456e-06,-0.28058,-0.25185,1,0
3,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0078263,-0.2809,-0.25787,1,0
3,GO RENAL ABSORPTION,0.001442,-0.28092,-0.28461,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0063654,-0.28259,-0.21827,1,0
3,GO REGULATION OF VIRAL GENOME REPLICATION,2.1624e-06,-0.2832,-0.27485,1,0
3,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.6446e-07,-0.28337,-0.28931,1,0
3,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,8.5867e-06,-0.28357,-0.26511,1,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,7.1274e-05,-0.28463,-0.28163,1,0
3,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.016752,-0.28647,-0.23621,1,0
3,GO AMINE BIOSYNTHETIC PROCESS,0.00030928,-0.28688,-0.23837,1,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,2.856e-06,-0.2887,-0.26988,1,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,7.1274e-05,-0.28875,-0.23027,1,0
3,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,3.7605e-06,-0.29122,-0.32153,1,0
3,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,1.2534e-06,-0.2914,-0.24419,1,0
3,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,1.0557e-05,-0.29178,-0.25092,1,0
3,GO LEFT RIGHT PATTERN FORMATION,1.8053e-06,-0.29187,-0.27572,1,0
3,GO CELL CELL JUNCTION ORGANIZATION,1.3174e-07,-0.2927,-0.24714,1,0
3,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,2.3891e-06,-0.29344,-0.32738,1,0
3,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.9175e-06,-0.29537,-0.28467,1,0
3,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.00076726,-0.29581,-0.29514,1,0
3,GO T HELPER CELL LINEAGE COMMITMENT,1.3325e-06,-0.29633,-0.26577,1,0
3,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00035024,-0.29668,-0.24219,1,0
3,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.00022927,-0.2967,-0.28425,1,0
3,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.00069207,-0.29683,-0.21174,1,0
3,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,1.9393e-05,-0.2973,-0.23287,1,0
3,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.023668,-0.29735,-0.29471,1,0
3,GO SKIN DEVELOPMENT,4.6881e-08,-0.29837,-0.27952,1,0
3,GO ADRENAL GLAND DEVELOPMENT,1.2482e-05,-0.29905,-0.28944,1,0
3,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0015463,-0.29918,-0.312,1,0
3,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,6.545e-05,-0.30047,-0.33856,1,0
3,GO HEPATOCYTE DIFFERENTIATION,2.971e-06,-0.30055,-0.32875,1,0
3,GO PRO B CELL DIFFERENTIATION,1.4207e-05,-0.30065,-0.26735,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,2.011e-05,-0.30066,-0.25521,1,0
3,GO EPIDERMIS DEVELOPMENT,4.5822e-08,-0.30126,-0.27108,1,0
3,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00017457,-0.3015,-0.26945,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00033955,-0.3018,-0.33054,1,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00036686,-0.30182,-0.2337,1,0
3,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.0023957,-0.30253,-0.28096,1,0
3,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.028852,-0.3026,-0.18857,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT,3.6361e-10,-0.30353,-0.30481,1,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0058389,-0.30394,-0.31457,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,1.0554e-07,-0.30413,-0.27434,1,0
3,GO DECIDUALIZATION,0.004156,-0.3069,-0.22405,1,0
3,GO FOREBRAIN NEURON FATE COMMITMENT,0.0027381,-0.30712,-0.35971,1,0
3,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00013016,-0.30748,-0.32617,1,0
3,GO DOPAMINE BIOSYNTHETIC PROCESS,0.01251,-0.30836,-0.22841,1,0
3,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,7.2414e-06,-0.30848,-0.30456,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,6.7105e-06,-0.30883,-0.27387,1,0
3,GO REGULATION OF EXOSOMAL SECRETION,6.5906e-08,-0.30901,-0.2726,1,0
3,GO SARCOMERE ORGANIZATION,1.3196e-05,-0.30926,-0.24249,1,0
3,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.00040857,-0.30942,-0.27553,1,0
3,GO WATER HOMEOSTASIS,5.8262e-07,-0.30945,-0.28546,1,0
3,GO ECTODERMAL PLACODE DEVELOPMENT,0.00018323,-0.30955,-0.32931,1,0
3,GO NEGATIVE REGULATION OF VIRAL PROCESS,3.3435e-06,-0.30973,-0.31251,1,0
3,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,3.3214e-05,-0.31008,-0.35405,1,0
3,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,4.1552e-07,-0.31115,-0.29178,1,0
3,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,5.1446e-05,-0.31126,-0.24,1,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.00038422,-0.31176,-0.31441,1,0
3,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.001776,-0.31187,-0.23621,1,0
3,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.0016575,-0.31292,-0.28406,1,0
3,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00023667,-0.31306,-0.23836,1,0
3,GO EMBRYONIC PLACENTA DEVELOPMENT,7.3476e-09,-0.3136,-0.31687,1,0
3,GO LIPID TRANSLOCATION,7.3803e-06,-0.31472,-0.26164,1,0
3,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00090088,-0.31508,-0.29622,1,0
3,GO CELL CELL JUNCTION ASSEMBLY,3.247e-08,-0.31513,-0.2657,1,0
3,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,1.0169e-05,-0.31623,-0.32465,1,0
3,GO REGULATION OF INTEGRIN ACTIVATION,3.0156e-07,-0.31767,-0.28214,1,0
3,GO T CELL LINEAGE COMMITMENT,7.5451e-08,-0.31772,-0.29022,1,0
3,GO ACTIN FILAMENT SEVERING,7.2497e-05,-0.31801,-0.31712,1,0
3,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,7.8778e-10,-0.31847,-0.33232,1,0
3,GO HETEROTYPIC CELL CELL ADHESION,1.2058e-07,-0.31971,-0.30264,1,0
3,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.00038422,-0.32033,-0.29045,1,0
3,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,4.3236e-05,-0.32046,-0.3422,1,0
3,GO HAIR CELL DIFFERENTIATION,8.1138e-06,-0.32054,-0.25471,1,0
3,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.017315,-0.32069,-0.26517,1,0
3,GO ENDOTHELIAL CELL MORPHOGENESIS,0.00038422,-0.3217,-0.33127,1,0
3,GO HISTAMINE SECRETION,0.00071283,-0.32421,-0.31147,1,0
3,GO TOLERANCE INDUCTION,0.00023294,-0.32447,-0.3562,1,0
3,GO OSTEOBLAST PROLIFERATION,3.8983e-07,-0.32466,-0.33075,1,0
3,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,4.7488e-06,-0.32589,-0.28424,1,0
3,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.00031414,-0.32613,-0.36358,1,0
3,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,1.0169e-05,-0.32639,-0.34708,1,0
3,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.342e-06,-0.3264,-0.33288,1,0
3,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,2.0879e-07,-0.32727,-0.36875,1,0
3,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.00044103,-0.32809,-0.30379,1,0
3,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,5.7536e-08,-0.32814,-0.38314,1,0
3,GO PARAXIAL MESODERM DEVELOPMENT,8.9166e-06,-0.33036,-0.31514,1,0
3,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.00029511,-0.33258,-0.28662,1,0
3,GO SIGNAL PEPTIDE PROCESSING,1.475e-06,-0.33418,-0.29832,1,0
3,GO RESPONSE TO NITROSATIVE STRESS,1.0322e-07,-0.33611,-0.35334,1,0
3,GO VIRAL BUDDING,6.2565e-10,-0.3363,-0.29026,1,0
3,GO BARBED END ACTIN FILAMENT CAPPING,4.8198e-07,-0.33706,-0.35964,1,0
3,GO TRANSPOSITION,8.6579e-07,-0.3372,-0.364,1,0
3,GO RESPONSE TO WATER,3.0302e-06,-0.33721,-0.33236,1,0
3,GO INTERFERON ALPHA PRODUCTION,7.105e-06,-0.33731,-0.2657,1,0
3,GO NOTCH RECEPTOR PROCESSING,5.7582e-06,-0.33756,-0.36236,1,0
3,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0001862,-0.33828,-0.32268,1,0
3,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.4098e-06,-0.34098,-0.33141,1,0
3,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,4.2444e-07,-0.34105,-0.32866,1,0
3,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,4.6578e-06,-0.3413,-0.28806,1,0
3,GO GAP JUNCTION ASSEMBLY,2.5868e-06,-0.3424,-0.37549,1,0
3,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.8701e-05,-0.34244,-0.31561,1,0
3,GO DETECTION OF OTHER ORGANISM,7.7586e-05,-0.34267,-0.32348,1,0
3,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.0024609,-0.34314,-0.20602,1,0
3,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.5677e-09,-0.34343,-0.37296,1,0
3,GO REGULATION OF PLATELET AGGREGATION,2.8814e-05,-0.34375,-0.39008,1,0
3,GO ENDOCARDIUM DEVELOPMENT,1.3878e-06,-0.34383,-0.34975,1,0
3,GO TOXIN METABOLIC PROCESS,6.3249e-05,-0.34394,-0.30684,1,0
3,GO ANOIKIS,1.5027e-08,-0.34487,-0.3366,1,0
3,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,1.1165e-05,-0.34594,-0.29227,1,0
3,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.00073415,-0.34758,-0.41444,1,0
3,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.00023667,-0.34794,-0.27536,1,0
3,GO RETINAL METABOLIC PROCESS,0.0099244,-0.34801,-0.23463,1,0
3,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,1.8723e-07,-0.34914,-0.34417,1,0
3,GO MITOTIC CYTOKINETIC PROCESS,5.3602e-11,-0.35015,-0.32358,1,0
3,GO REGULATION OF CELL FATE SPECIFICATION,4.7488e-06,-0.35032,-0.33315,1,0
3,GO LUNG EPITHELIUM DEVELOPMENT,1.4163e-06,-0.3521,-0.32058,1,0
3,GO INTESTINAL ABSORPTION,5.4356e-06,-0.35342,-0.33524,1,0
3,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00014362,-0.35353,-0.31686,1,0
3,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0078263,-0.35515,-0.35405,1,0
3,GO GLIAL CELL APOPTOTIC PROCESS,5.4184e-05,-0.36149,-0.32876,1,0
3,GO DNA DEAMINATION,0.00020178,-0.36172,-0.31367,1,0
3,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,2.8305e-05,-0.36198,-0.35358,1,0
3,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,2.856e-06,-0.36268,-0.42073,1,0
3,GO ENDOTHELIAL CELL CHEMOTAXIS,3.0905e-06,-0.36272,-0.36458,1,0
3,GO LABYRINTHINE LAYER DEVELOPMENT,1.0781e-08,-0.36285,-0.36353,1,0
3,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0005618,-0.36469,-0.35287,1,0
3,GO HEMATOPOIETIC STEM CELL PROLIFERATION,1.5753e-08,-0.36685,-0.33895,1,0
3,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.7356e-07,-0.36772,-0.40597,1,0
3,GO RESPONSE TO INTERFERON ALPHA,0.00011596,-0.37133,-0.39815,1,0
3,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.00022565,-0.37163,-0.38847,1,0
3,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00011033,-0.37301,-0.35721,1,0
3,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00017176,-0.37527,-0.25358,1,0
3,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.0021505,-0.3753,-0.31577,1,0
3,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.004964,-0.37653,-0.36478,1,0
3,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0013443,-0.37921,-0.31098,1,0
3,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,9.2118e-07,-0.37924,-0.37719,1,0
3,GO LYSINE METABOLIC PROCESS,9.086e-06,-0.37934,-0.33343,1,0
3,GO PROGESTERONE METABOLIC PROCESS,1.155e-06,-0.38205,-0.46615,1,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.00019541,-0.3827,-0.32882,1,0
3,GO NEURONAL STEM CELL POPULATION MAINTENANCE,2.913e-06,-0.38334,-0.33466,1,0
3,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,5.0922e-10,-0.38352,-0.38037,1,0
3,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,6.3359e-07,-0.38352,-0.37863,1,0
3,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,1.2253e-05,-0.38443,-0.32927,1,0
3,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,5.2344e-05,-0.38621,-0.33134,1,0
3,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.00052901,-0.38661,-0.26531,1,0
3,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,6.4699e-07,-0.38747,-0.32946,1,0
3,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,4.4807e-06,-0.38893,-0.39344,1,0
3,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,1.9387e-10,-0.38905,-0.34652,1,0
3,GO BILE ACID AND BILE SALT TRANSPORT,5.9498e-07,-0.38909,-0.36133,1,0
3,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00076726,-0.39056,-0.41445,1,0
3,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.0010558,-0.39252,-0.31643,1,0
3,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,1.4454e-06,-0.39315,-0.35852,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0010558,-0.39462,-0.41101,1,0
3,GO REGULATION OF TRANSPOSITION,1.064e-06,-0.39497,-0.39009,1,0
3,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,3.3435e-06,-0.39635,-0.40223,1,0
3,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.5386e-08,-0.40204,-0.36661,1,0
3,GO KERATINOCYTE DIFFERENTIATION,4.0033e-09,-0.4055,-0.39407,1,0
3,GO REGULATION OF RECEPTOR CLUSTERING,1.7071e-05,-0.40552,-0.38318,1,0
3,GO RESPONSE TO TYPE I INTERFERON,5.0323e-06,-0.40837,-0.4238,1,0
3,GO REGULATION OF ANOIKIS,2.0881e-08,-0.40844,-0.42266,1,0
3,GO EPIDERMAL CELL DIFFERENTIATION,1.1307e-08,-0.41047,-0.36068,1,0
3,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,1.4334e-08,-0.41275,-0.35317,1,0
3,GO REGULATION OF MICROVILLUS ORGANIZATION,2.5359e-06,-0.41292,-0.40006,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.536e-06,-0.41509,-0.40117,1,0
3,GO POSITIVE REGULATION OF CELL MATURATION,3.9941e-08,-0.41612,-0.40147,1,0
3,GO MEGAKARYOCYTE DEVELOPMENT,5.5864e-07,-0.41617,-0.36486,1,0
3,GO RESPONSE TO INTERLEUKIN 18,1.5014e-05,-0.41894,-0.41204,1,0
3,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00043435,-0.4221,-0.3791,1,0
3,GO REGULATION OF TOLERANCE INDUCTION,1.1282e-07,-0.42237,-0.43036,1,0
3,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.7e-09,-0.42254,-0.42354,1,0
3,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,9.9064e-10,-0.42496,-0.39516,1,0
3,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,4.4787e-08,-0.42945,-0.39724,1,0
3,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,4.7488e-06,-0.43229,-0.38472,1,0
3,GO PHARYNGEAL SYSTEM DEVELOPMENT,6.337e-06,-0.43244,-0.36284,1,0
3,GO POSITIVE REGULATION OF WOUND HEALING,1.8573e-08,-0.43289,-0.39112,1,0
3,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00029052,-0.43299,-0.33354,1,0
3,GO NEURON FATE SPECIFICATION,0.00011986,-0.43431,-0.3181,1,0
3,GO RESPONSE TO FORSKOLIN,1.4207e-05,-0.43457,-0.32706,1,0
3,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.7998e-07,-0.44354,-0.46286,1,0
3,GO MIDBODY ABSCISSION,1.5102e-11,-0.44451,-0.42332,1,0
3,GO MAINTENANCE OF BLOOD BRAIN BARRIER,3.8301e-10,-0.44506,-0.43581,1,0
3,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,1.5576e-05,-0.44619,-0.37452,1,0
3,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,8.7316e-05,-0.45094,-0.36534,1,0
3,GO MUCUS SECRETION,0.00032408,-0.45187,-0.40156,1,0
3,GO IMMUNOLOGICAL MEMORY PROCESS,1.2058e-07,-0.46443,-0.41275,1,0
3,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,4.9228e-07,-0.46496,-0.44305,1,0
3,GO RESPONSE TO LITHIUM ION,5.02e-08,-0.46597,-0.42807,1,0
3,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,4.6202e-07,-0.4681,-0.36304,1,0
3,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,1.2716e-05,-0.47104,-0.41521,1,0
3,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,1.2131e-09,-0.4779,-0.43781,1,0
3,GO ENTRY OF BACTERIUM INTO HOST CELL,9.028e-08,-0.48127,-0.51008,1,0
3,GO LEYDIG CELL DIFFERENTIATION,3.4098e-06,-0.48494,-0.44105,1,0
3,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,2.8305e-05,-0.49063,-0.37959,1,0
3,GO APICAL JUNCTION ASSEMBLY,8.2618e-11,-0.49821,-0.4617,1,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,2.3661e-05,-0.50021,-0.34208,1,0
3,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,4.0678e-07,-0.51317,-0.3877,1,0
3,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,3.3806e-05,-0.51442,-0.40655,1,0
3,GO PARAXIAL MESODERM MORPHOGENESIS,4.7963e-08,-0.51579,-0.49537,1,0
3,GO GLIAL CELL FATE COMMITMENT,3.152e-06,-0.52865,-0.50504,1,0
3,GO NEGATIVE REGULATION OF ANOIKIS,2.4452e-09,-0.53432,-0.58317,1,0
3,GO KERATINIZATION,1.4334e-08,-0.54062,-0.47192,1,0
3,GO GAMMA DELTA T CELL ACTIVATION,4.0868e-08,-0.55333,-0.44962,1,0
3,GO EPITHELIAL CELL CELL ADHESION,7.6792e-10,-0.57402,-0.61891,1,0
3,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,3.2631e-05,-0.58133,-0.56033,1,0
3,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.3039e-08,-0.58399,-0.51569,1,0
3,GO REGULATION OF WATER LOSS VIA SKIN,6.0205e-08,-0.58761,-0.53026,1,0
3,GO LUNG CELL DIFFERENTIATION,1.1307e-08,-0.58864,-0.54834,1,0
3,GO CORNIFICATION,2.8925e-08,-0.58971,-0.52518,1,0
3,GO PSEUDOPODIUM ORGANIZATION,1.0424e-06,-0.59201,-0.4498,1,0
3,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.5674e-06,-0.6139,-0.56208,1,0
3,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,1.3999e-08,-0.61562,-0.58928,1,0
3,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,3.6435e-08,-0.63303,-0.5465,1,0
3,GO EPITHELIAL CELL MORPHOGENESIS,7.1726e-09,-0.65277,-0.57108,1,0
3,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,3.2764e-10,-0.65408,-0.60947,1,0
3,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.4677e-08,-0.6623,-0.62544,1,0
3,GO NOSE DEVELOPMENT,2.3891e-06,-0.73917,-0.54754,1,0
3,GO EMBRYONIC PLACENTA MORPHOGENESIS,5.0922e-10,-0.75735,-0.69495,1,0
3,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,8.2618e-11,-0.77526,-0.6984,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,1.1165e-05,-0.84038,-0.73403,1,0
3,GO HEPATOCYTE APOPTOTIC PROCESS,3.5597e-11,-0.84663,-0.87432,1,0
3,GO LABYRINTHINE LAYER MORPHOGENESIS,1.3024e-10,-0.86067,-0.76541,1,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,9.795e-06,-1.0165,-0.87957,1,0
3,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,2.0437e-10,-1.0261,-0.92704,1,0
3,GO FACIAL NERVE MORPHOGENESIS,0.075009,0.26625,0.17374,0,1
3,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.10646,0.25333,0.11494,0,1
3,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.093918,0.22361,0.13823,0,1
3,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.090011,0.20496,0.14611,0,1
3,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.094715,0.20131,0.1057,0,1
3,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.12029,0.19753,0.14584,0,1
3,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.10471,0.19348,0.11892,0,1
3,GO EXTRACELLULAR MATRIX ASSEMBLY,0.094715,0.18488,0.12487,0,1
3,GO REGULATION OF DOPAMINE SECRETION,0.06986,0.17856,0.19851,0,1
3,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.25753,0.16781,0.12866,0,1
3,GO REGULATION OF HIPPO SIGNALING,0.093126,0.15824,0.14364,0,1
3,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.1313,0.15598,0.10379,0,1
3,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.14755,0.15501,0.12276,0,1
3,GO REVERSE CHOLESTEROL TRANSPORT,0.24911,0.1501,0.080386,0,1
3,GO NAD BIOSYNTHETIC PROCESS,0.12924,0.1448,0.097561,0,1
3,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.060432,0.13727,0.13638,0,1
3,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.074349,0.13724,0.12447,0,1
3,GO PROSTAGLANDIN SECRETION,0.071756,0.13112,0.08299,0,1
3,GO REGULATION OF HISTONE PHOSPHORYLATION,0.23445,0.13038,0.070168,0,1
3,GO DENDRITIC SPINE MAINTENANCE,0.074349,0.12599,0.11828,0,1
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.081168,0.12343,0.12935,0,1
3,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.12126,0.11593,0.081188,0,1
3,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.066192,0.11222,0.09594,0,1
3,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.084034,0.11107,0.082386,0,1
3,GO HISTONE H3 K9 DEMETHYLATION,0.062114,0.11019,0.12753,0,1
3,GO RESPONSE TO PROSTAGLANDIN E,0.077018,0.10889,0.076276,0,1
3,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.14642,0.09985,0.056116,0,1
3,GO COPPER ION HOMEOSTASIS,0.13979,0.099529,0.077866,0,1
3,GO REGULATION OF POTASSIUM ION TRANSPORT,0.066792,0.09915,0.07762,0,1
3,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.2114,0.098621,0.067126,0,1
3,GO REGULATION OF CELLULAR RESPIRATION,0.081877,0.098471,0.090392,0,1
3,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.14088,0.096503,0.08502,0,1
3,GO TOOTH MINERALIZATION,0.15683,0.094996,0.10423,0,1
3,GO PROTEOGLYCAN METABOLIC PROCESS,0.091558,0.094143,0.078727,0,1
3,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.24745,0.092325,0.097951,0,1
3,GO SYNAPTIC VESICLE RECYCLING,0.10912,0.09219,0.089286,0,1
3,GO BASIC AMINO ACID TRANSPORT,0.34213,0.090132,0.093966,0,1
3,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.27495,0.089678,0.048554,0,1
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.12421,0.089564,0.067787,0,1
3,GO PROTEIN KINASE A SIGNALING,0.61402,0.089389,0.016672,0,1
3,GO CYTOCHROME COMPLEX ASSEMBLY,0.1146,0.089029,0.08296,0,1
3,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.071119,0.087268,0.068711,0,1
3,GO PRESYNAPTIC ENDOCYTOSIS,0.091558,0.084329,0.098936,0,1
3,GO ACETYL COA METABOLIC PROCESS,0.22503,0.081635,0.074633,0,1
3,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.13763,0.079665,0.060786,0,1
3,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.35043,0.07712,0.056622,0,1
3,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.14869,0.075025,0.053399,0,1
3,GO BLASTOCYST FORMATION,0.063258,0.070922,0.061529,0,1
3,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.318,0.069922,0.046484,0,1
3,GO REGULATION OF CELL CYCLE CHECKPOINT,0.10734,0.069176,0.050198,0,1
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.11647,0.069119,0.098909,0,1
3,GO ZINC ION TRANSPORT,0.29689,0.068994,0.049413,0,1
3,GO MATING,0.40743,0.063942,0.033335,0,1
3,GO NUCLEOSIDE METABOLIC PROCESS,0.084034,0.062155,0.058169,0,1
3,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.29689,0.060274,0.04636,0,1
3,GO MRNA PROCESSING,0.060988,0.05835,0.06101,0,1
3,GO ELECTRON TRANSPORT CHAIN,0.098784,0.057793,0.054361,0,1
3,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.078382,0.057684,0.054564,0,1
3,GO APOPTOTIC DNA FRAGMENTATION,0.18194,0.052516,0.041243,0,1
3,GO RESPONSE TO INTERLEUKIN 4,0.6312,0.052403,0.022867,0,1
3,GO RESPONSE TO MISFOLDED PROTEIN,0.31604,0.050693,0.049201,0,1
3,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.24745,0.049752,0.036079,0,1
3,GO PROTEIN NEDDYLATION,0.077018,0.044566,0.072174,0,1
3,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.10471,0.040385,0.03795,0,1
3,GO MAINTENANCE OF PROTEIN LOCATION,0.20265,0.029685,0.048252,0,1
3,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.94671,0.027995,0.0079166,0,1
3,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0055559,0.33659,0.32825,0,0
3,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0052197,0.28118,0.23394,0,0
3,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.09796,0.25762,0.19741,0,0
3,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00041488,0.24373,0.23917,0,0
3,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0050269,0.23421,0.25858,0,0
3,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0037016,0.21644,0.22166,0,0
3,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.20409,0.21369,0.10793,0,0
3,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.0010259,0.20394,0.2682,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.017125,0.19892,0.12905,0,0
3,GO PROTEIN OXIDATION,0.10045,0.19614,0.1103,0,0
3,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.086981,0.18031,0.1735,0,0
3,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.079765,0.17748,0.22713,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.16042,0.17535,0.098114,0,0
3,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.077018,0.1727,0.15746,0,0
3,GO LEUKOCYTE AGGREGATION,0.21738,0.16724,0.074437,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.034636,0.16112,0.13547,0,0
3,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.086237,0.15995,0.13392,0,0
3,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.1873,0.15876,0.10556,0,0
3,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.079071,0.15603,0.154,0,0
3,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.086237,0.15463,0.11594,0,0
3,GO THALAMUS DEVELOPMENT,0.32993,0.15409,0.070388,0,0
3,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.0037016,0.15031,0.14364,0,0
3,GO MIDGUT DEVELOPMENT,0.6055,0.14692,0.028311,0,0
3,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.076344,0.14034,0.15277,0,0
3,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.065005,0.1403,0.11542,0,0
3,GO REGULATION OF TUBULIN DEACETYLATION,0.1262,0.13869,0.11508,0,0
3,GO TELENCEPHALON REGIONALIZATION,0.20265,0.13852,0.11377,0,0
3,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.14642,0.13377,0.10099,0,0
3,GO AXO DENDRITIC PROTEIN TRANSPORT,0.042609,0.13274,0.13156,0,0
3,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.28033,0.13175,0.092093,0,0
3,GO RESPIRATORY SYSTEM PROCESS,0.0034243,0.13024,0.18255,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.12322,0.12985,0.13489,0,0
3,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.31604,0.12924,0.063974,0,0
3,GO CARTILAGE MORPHOGENESIS,0.17283,0.12912,0.11573,0,0
3,GO PULMONARY VALVE MORPHOGENESIS,0.59986,0.12866,0.036745,0,0
3,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.064418,0.12845,0.15827,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.076344,0.12822,0.10113,0,0
3,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.056128,0.1282,0.14858,0,0
3,GO AORTA DEVELOPMENT,0.1754,0.12705,0.084198,0,0
3,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.10912,0.12679,0.15102,0,0
3,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.060432,0.12674,0.12323,0,0
3,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.070488,0.12522,0.10645,0,0
3,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.045591,0.12518,0.11238,0,0
3,GO FIBRINOLYSIS,0.28033,0.1251,0.037335,0,0
3,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.054074,0.12487,0.13241,0,0
3,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.073043,0.12205,0.1159,0,0
3,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.12126,0.12201,0.1247,0,0
3,GO BONE TRABECULA MORPHOGENESIS,0.15921,0.12143,0.10492,0,0
3,GO ENAMEL MINERALIZATION,0.48976,0.12078,0.065356,0,0
3,GO BEHAVIORAL RESPONSE TO PAIN,0.30255,0.12038,0.10282,0,0
3,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.33194,0.12031,0.029758,0,0
3,GO REGULATION OF COLLATERAL SPROUTING,0.23128,0.11931,0.090408,0,0
3,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.013394,0.11854,0.17278,0,0
3,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.11367,0.11847,0.082834,0,0
3,GO TRIGLYCERIDE CATABOLIC PROCESS,0.16778,0.11801,0.098958,0,0
3,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.20554,0.11446,0.071767,0,0
3,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.18062,0.11385,0.088009,0,0
3,GO GLIAL CELL MIGRATION,0.077698,0.1138,0.10556,0,0
3,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.1252,0.11246,0.05813,0,0
3,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.24089,0.11131,0.11341,0,0
3,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.022686,0.11071,0.11593,0,0
3,GO SEQUESTERING OF METAL ION,0.15683,0.11066,0.052789,0,0
3,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.10823,0.11045,0.16334,0,0
3,GO MATING BEHAVIOR,0.081877,0.1102,0.098294,0,0
3,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.17029,0.11013,0.12601,0,0
3,GO COLLAGEN FIBRIL ORGANIZATION,0.14755,0.10941,0.091006,0,0
3,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.014172,0.10932,0.11904,0,0
3,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.08331,0.10889,0.12107,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.0083098,0.10878,0.17715,0,0
3,GO RESPONSE TO ACETYLCHOLINE,0.12029,0.10875,0.11959,0,0
3,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.059331,0.10827,0.15999,0,0
3,GO REGULATION OF RIBOSOME BIOGENESIS,0.092339,0.10793,0.10643,0,0
3,GO PHOSPHOLIPID HOMEOSTASIS,0.19697,0.10737,0.0773,0,0
3,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.1873,0.10731,0.074607,0,0
3,GO PRESYNAPSE ORGANIZATION,0.08331,0.10667,0.10504,0,0
3,GO CELLULAR COPPER ION HOMEOSTASIS,0.11367,0.1062,0.095904,0,0
3,GO REGULATION OF METANEPHROS DEVELOPMENT,0.36098,0.10587,0.082338,0,0
3,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.066792,0.10573,0.090435,0,0
3,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.22814,0.10493,0.077514,0,0
3,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.11275,0.10493,0.11511,0,0
3,GO MOTOR NEURON AXON GUIDANCE,0.079765,0.10475,0.11097,0,0
3,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.21889,0.10473,0.090595,0,0
3,GO GANGLIOSIDE METABOLIC PROCESS,0.10045,0.10469,0.11953,0,0
3,GO CYCLOOXYGENASE PATHWAY,0.44028,0.10387,0.051512,0,0
3,GO RESPONSE TO AMINE,0.015159,0.10384,0.11365,0,0
3,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.05357,0.10381,0.11387,0,0
3,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.091558,0.10373,0.089506,0,0
3,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.12029,0.10333,0.099259,0,0
3,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.18194,0.10251,0.10227,0,0
3,GO COCHLEA MORPHOGENESIS,0.24089,0.10236,0.068918,0,0
3,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.066192,0.10236,0.12166,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.19979,0.10195,0.1578,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.39606,0.10173,0.06764,0,0
3,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.14983,0.10044,0.089049,0,0
3,GO NEPHRIC DUCT MORPHOGENESIS,0.1146,0.10033,0.15374,0,0
3,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.29689,0.098525,0.044157,0,0
3,GO REPLICATION FORK PROCESSING,0.1914,0.098291,0.064068,0,0
3,GO ALANINE TRANSPORT,0.089246,0.09802,0.16154,0,0
3,GO DOPAMINE TRANSPORT,0.46962,0.097991,0.090946,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.066192,0.097883,0.20077,0,0
3,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.11742,0.097529,0.11028,0,0
3,GO POSITIVE REGULATION OF ORGAN GROWTH,0.061549,0.097435,0.11026,0,0
3,GO REPRODUCTIVE BEHAVIOR,0.21288,0.096724,0.074389,0,0
3,GO CATECHOLAMINE UPTAKE,0.20992,0.095821,0.11119,0,0
3,GO PROTEIN DEMETHYLATION,0.18461,0.095705,0.071954,0,0
3,GO GROOMING BEHAVIOR,0.23128,0.09524,0.063158,0,0
3,GO TUBULIN DEACETYLATION,0.092339,0.095217,0.11721,0,0
3,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.50516,0.095091,0.059305,0,0
3,GO LONG TERM SYNAPTIC POTENTIATION,0.13338,0.094803,0.084054,0,0
3,GO SYNAPSE ASSEMBLY,0.10471,0.094659,0.08945,0,0
3,GO REGULATION OF PROTEIN GLYCOSYLATION,0.21288,0.09462,0.081606,0,0
3,GO NADPH REGENERATION,0.51035,0.093897,0.037586,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.028852,0.093897,0.099415,0,0
3,GO MONONUCLEAR CELL DIFFERENTIATION,0.20845,0.093762,0.10161,0,0
3,GO MRNA METHYLATION,0.065005,0.093271,0.12472,0,0
3,GO AXONAL TRANSPORT,0.082591,0.092926,0.090075,0,0
3,GO NEURAL CREST CELL MIGRATION,0.071756,0.092896,0.12708,0,0
3,GO PROTEIN CONTAINING COMPLEX REMODELING,0.09714,0.092738,0.083709,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.014658,0.092318,0.13859,0,0
3,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.31409,0.092281,0.11618,0,0
3,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.52874,0.091867,0.059378,0,0
3,GO PROTEIN HETEROTETRAMERIZATION,0.023173,0.091483,0.093115,0,0
3,GO BEHAVIORAL RESPONSE TO COCAINE,0.28945,0.091062,0.12228,0,0
3,GO RESPONSE TO POTASSIUM ION,0.4451,0.090608,0.059938,0,0
3,GO BONE MORPHOGENESIS,0.36956,0.090042,0.043833,0,0
3,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.20699,0.089881,0.10525,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.094715,0.08987,0.094293,0,0
3,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.13549,0.089818,0.089216,0,0
3,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.11933,0.089815,0.11803,0,0
3,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.10646,0.089726,0.087856,0,0
3,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.572,0.088383,0.051189,0,0
3,GO CELL RECOGNITION,0.0069343,0.088376,0.10152,0,0
3,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.68988,0.088263,0.031088,0,0
3,GO TRNA 5 END PROCESSING,0.01585,0.087996,0.13159,0,0
3,GO DICARBOXYLIC ACID TRANSPORT,0.02915,0.087465,0.10454,0,0
3,GO NOREPINEPHRINE SECRETION,0.13338,0.087281,0.094277,0,0
3,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.14755,0.086951,0.086558,0,0
3,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.063836,0.086791,0.09566,0,0
3,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.24252,0.086581,0.088215,0,0
3,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.073043,0.086027,0.10773,0,0
3,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.11275,0.086024,0.11968,0,0
3,GO RETINAL CONE CELL DIFFERENTIATION,0.71996,0.08595,0.089393,0,0
3,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.32792,0.085856,0.03481,0,0
3,GO STABILIZATION OF MEMBRANE POTENTIAL,0.61687,0.085206,0.060804,0,0
3,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.008211,0.0851,0.1087,0,0
3,GO MEMBRANE HYPERPOLARIZATION,0.078382,0.084956,0.12666,0,0
3,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.12421,0.08485,0.084875,0,0
3,GO CELL AGGREGATION,0.18595,0.084577,0.062268,0,0
3,GO FIBROBLAST APOPTOTIC PROCESS,0.34835,0.083539,0.061514,0,0
3,GO RESPONSE TO MUSCLE ACTIVITY,0.086237,0.0832,0.088456,0,0
3,GO MRNA SPLICE SITE SELECTION,0.22348,0.083023,0.060826,0,0
3,GO REGULATION OF CAMP MEDIATED SIGNALING,0.17411,0.082577,0.08011,0,0
3,GO POSITIVE REGULATION OF HEART GROWTH,0.14197,0.082535,0.089387,0,0
3,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.1533,0.081616,0.083819,0,0
3,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.10734,0.080834,0.15614,0,0
3,GO POSITIVE REGULATION OF AXON EXTENSION,0.15098,0.08038,0.097398,0,0
3,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.56103,0.07996,0.044299,0,0
3,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.15447,0.079952,0.099698,0,0
3,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.32792,0.079475,0.062285,0,0
3,GO NEURON MIGRATION,0.1387,0.079358,0.098082,0,0
3,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.69286,0.079223,0.027863,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.44269,0.07922,0.046456,0,0
3,GO CEREBELLAR CORTEX MORPHOGENESIS,0.15921,0.079094,0.085859,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.33396,0.079019,0.046663,0,0
3,GO REGULATION OF CARDIAC CONDUCTION,0.069238,0.078961,0.086306,0,0
3,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.94026,0.078258,0.017426,0,0
3,GO SNRNA PROCESSING,0.1873,0.07777,0.026721,0,0
3,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.1653,0.077674,0.064108,0,0
3,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.18194,0.07726,0.066039,0,0
3,GO RESPONSE TO HYPEROXIA,0.41666,0.076794,0.057772,0,0
3,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.48976,0.076694,0.051797,0,0
3,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.32393,0.076176,0.072053,0,0
3,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.35253,0.075814,0.04586,0,0
3,GO CELLULAR RESPONSE TO MANGANESE ION,0.11092,0.075513,0.079756,0,0
3,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.0081133,0.075491,0.10213,0,0
3,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.22348,0.075174,0.079304,0,0
3,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.069238,0.075099,0.079907,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.35463,0.0748,0.053073,0,0
3,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.08331,0.074478,0.12172,0,0
3,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.077698,0.073958,0.058745,0,0
3,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.99838,0.073658,-0.0041545,0,0
3,GO METHIONINE BIOSYNTHETIC PROCESS,0.34835,0.073129,0.019595,0,0
3,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.24252,0.073061,0.050688,0,0
3,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.28213,0.072765,0.065446,0,0
3,GO XENOBIOTIC TRANSPORT,0.23128,0.072306,0.065215,0,0
3,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.32592,0.072138,0.084735,0,0
3,GO GLUCOCORTICOID METABOLIC PROCESS,0.57752,0.071951,0.03115,0,0
3,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.023173,0.071919,0.085908,0,0
3,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.12721,0.071874,0.092098,0,0
3,GO RENAL VESICLE DEVELOPMENT,0.23286,0.07185,0.084281,0,0
3,GO RESPONSE TO MANGANESE ION,0.26095,0.071848,0.055638,0,0
3,GO DETECTION OF VISIBLE LIGHT,0.072397,0.071603,0.17844,0,0
3,GO ENDODERM FORMATION,0.35043,0.071556,0.054159,0,0
3,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.70787,0.071338,-0.0018108,0,0
3,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.24745,0.071142,0.070781,0,0
3,GO NEUROBLAST DIVISION,0.090011,0.071071,0.14686,0,0
3,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.090011,0.071047,0.070359,0,0
3,GO PYRUVATE METABOLIC PROCESS,0.034984,0.070475,0.092473,0,0
3,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.09714,0.070088,0.10057,0,0
3,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.20122,0.070017,0.079123,0,0
3,GO CELLULAR RESPONSE TO ETHANOL,0.31021,0.069958,0.070118,0,0
3,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.36956,0.069661,0.048089,0,0
3,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.14088,0.06965,0.069876,0,0
3,GO TRABECULA FORMATION,0.34213,0.069482,0.058334,0,0
3,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.18327,0.069447,0.11178,0,0
3,GO SEROTONIN TRANSPORT,0.12224,0.069305,0.1139,0,0
3,GO REGULATION OF SYSTEM PROCESS,0.13763,0.069202,0.066208,0,0
3,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.58307,0.069157,0.02148,0,0
3,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.86331,0.06878,-0.032438,0,0
3,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.1453,0.068768,0.062241,0,0
3,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.096327,0.068767,0.098055,0,0
3,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.14197,0.068711,0.090435,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.318,0.068362,0.048718,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.12421,0.067906,0.062181,0,0
3,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.46713,0.067841,0.05003,0,0
3,GO REGULATION OF GLUTAMATE SECRETION,0.24911,0.067571,0.080631,0,0
3,GO REGULATION OF ACROSOME REACTION,0.56376,0.067409,0.044341,0,0
3,GO REGULATION OF METAL ION TRANSPORT,0.040981,0.06738,0.074936,0,0
3,GO SALIVARY GLAND DEVELOPMENT,0.52082,0.067129,0.053781,0,0
3,GO HEME METABOLIC PROCESS,0.090011,0.067003,0.10338,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.78763,0.066765,-0.0049083,0,0
3,GO SEQUESTERING OF CALCIUM ION,0.23128,0.066705,0.061305,0,0
3,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.10214,0.06664,0.10469,0,0
3,GO RECEPTOR CLUSTERING,0.1653,0.066523,0.10125,0,0
3,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.63986,0.066465,0.02713,0,0
3,GO RESPONSE TO DOPAMINE,0.074349,0.066464,0.085766,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.10129,0.066391,0.11079,0,0
3,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.3871,0.066385,0.06078,0,0
3,GO ETHER BIOSYNTHETIC PROCESS,0.77519,0.066141,-0.052501,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.21587,0.066123,0.056004,0,0
3,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.26789,0.066,0.057638,0,0
3,GO ADULT BEHAVIOR,0.18327,0.065977,0.085158,0,0
3,GO SPERMATID NUCLEUS DIFFERENTIATION,0.33599,0.065917,0.046253,0,0
3,GO NEURON CELL CELL ADHESION,0.86012,0.065797,0.0061154,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.084763,0.065715,0.050837,0,0
3,GO SKELETAL MUSCLE CONTRACTION,0.042197,0.065419,0.11295,0,0
3,GO REGULATION OF HEART RATE,0.30829,0.064777,0.054182,0,0
3,GO STRIATED MUSCLE CONTRACTION,0.11092,0.064756,0.07125,0,0
3,GO STARTLE RESPONSE,0.42838,0.064731,0.069897,0,0
3,GO MEMBRANE DEPOLARIZATION,0.20845,0.064678,0.07345,0,0
3,GO NUCLEUS LOCALIZATION,0.1873,0.064518,0.078572,0,0
3,GO PROTEASOME ASSEMBLY,0.23927,0.064413,0.061691,0,0
3,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.065596,0.064186,0.082232,0,0
3,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.5394,0.064086,0.050304,0,0
3,GO NUCLEAR PORE ORGANIZATION,0.09796,0.063983,0.091365,0,0
3,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.24911,0.063943,0.051793,0,0
3,GO CARDIAC MUSCLE CONTRACTION,0.1914,0.063905,0.068177,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.47461,0.063728,0.024153,0,0
3,GO DENDRITIC CELL APOPTOTIC PROCESS,0.71089,0.063634,0.019475,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE I,0.037139,0.063464,0.093162,0,0
3,GO MICROTUBULE POLYMERIZATION,0.069238,0.063463,0.087316,0,0
3,GO RENAL SODIUM EXCRETION,0.25583,0.063087,0.042854,0,0
3,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.28761,0.062987,0.078479,0,0
3,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.16654,0.062867,0.080781,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.43075,0.062378,0.037686,0,0
3,GO RESPONSE TO LEAD ION,0.19838,0.06228,0.066834,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.16904,0.062263,0.058542,0,0
3,GO ANTEROGRADE AXONAL TRANSPORT,0.1313,0.061975,0.077306,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.35253,0.061924,0.065034,0,0
3,GO PEPTIDYL METHIONINE MODIFICATION,0.32993,0.061885,0.044116,0,0
3,GO CARDIAC MUSCLE CELL CONTRACTION,0.11002,0.061881,0.099831,0,0
3,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.0032928,0.061869,0.10945,0,0
3,GO LIMB BUD FORMATION,0.22814,0.061629,0.1489,0,0
3,GO PHAGOLYSOSOME ASSEMBLY,0.19979,0.060895,0.084627,0,0
3,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.17669,0.060862,0.055178,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.1146,0.060633,0.066922,0,0
3,GO COENZYME A METABOLIC PROCESS,0.099614,0.060609,0.079012,0,0
3,GO SYNAPTIC VESICLE TRANSPORT,0.26789,0.060599,0.068021,0,0
3,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.19003,0.060473,0.056813,0,0
3,GO PEPTIDYL ARGININE MODIFICATION,0.10299,0.060461,0.065998,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.45972,0.060365,0.043013,0,0
3,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.40743,0.060218,0.051345,0,0
3,GO REGULATION OF MRNA PROCESSING,0.068619,0.060197,0.062314,0,0
3,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.075674,0.060175,0.087702,0,0
3,GO LOCALIZATION WITHIN MEMBRANE,0.26267,0.060116,0.071422,0,0
3,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.024428,0.059939,0.082954,0,0
3,GO SODIUM ION TRANSPORT,0.37173,0.059548,0.038107,0,0
3,GO REGULATION OF AMYLOID BETA FORMATION,0.50258,0.059132,0.062403,0,0
3,GO PROTEIN HOMOTETRAMERIZATION,0.12721,0.059085,0.053313,0,0
3,GO CELLULAR RESPONSE TO AMYLOID BETA,0.21889,0.058703,0.076503,0,0
3,GO MONOVALENT INORGANIC CATION TRANSPORT,0.27317,0.058346,0.044818,0,0
3,GO POSITIVE REGULATION OF RNA SPLICING,0.35253,0.058265,0.035252,0,0
3,GO REGULATION OF MITOCHONDRIAL FISSION,0.40973,0.058264,0.057803,0,0
3,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.18062,0.05825,0.086219,0,0
3,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.1754,0.05809,0.097883,0,0
3,GO REGULATION OF LIGASE ACTIVITY,0.39832,0.058072,0.051924,0,0
3,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.11837,0.058015,0.066892,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.21288,0.057991,0.050329,0,0
3,GO MUSCLE CELL FATE COMMITMENT,0.52082,0.057665,0.018973,0,0
3,GO NEPHRIC DUCT DEVELOPMENT,0.39156,0.057645,0.061248,0,0
3,GO THIOESTER METABOLIC PROCESS,0.068006,0.057626,0.079311,0,0
3,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.098784,0.057546,0.086258,0,0
3,GO REGULATION OF FIBRINOLYSIS,0.66028,0.057386,-0.0095455,0,0
3,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.047372,0.057339,0.081688,0,0
3,GO DNA REPLICATION CHECKPOINT,0.36956,0.057091,0.045612,0,0
3,GO RRNA 3 END PROCESSING,0.22814,0.057078,0.062113,0,0
3,GO SPINDLE MIDZONE ASSEMBLY,0.69885,0.056963,0.02222,0,0
3,GO ADHESION OF SYMBIONT TO HOST,0.90809,0.056952,-0.0089099,0,0
3,GO HEART PROCESS,0.20122,0.056836,0.056695,0,0
3,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.28945,0.056791,0.045386,0,0
3,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.23445,0.056769,0.061859,0,0
3,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.39381,0.056426,0.055317,0,0
3,GO PLASMINOGEN ACTIVATION,0.30066,0.056167,0.050336,0,0
3,GO REGULATION OF CELLULAR EXTRAVASATION,0.16778,0.056004,0.10538,0,0
3,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.086237,0.055817,0.079098,0,0
3,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.24089,0.055776,0.03683,0,0
3,GO POST ANAL TAIL MORPHOGENESIS,0.36956,0.055233,0.06638,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.12224,0.055099,0.059006,0,0
3,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.70185,0.055083,0.017482,0,0
3,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.43312,0.054979,0.02513,0,0
3,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.21738,0.05483,0.054249,0,0
3,GO BASEMENT MEMBRANE ASSEMBLY,0.32393,0.054699,0.093656,0,0
3,GO TOXIN TRANSPORT,0.22814,0.054552,0.057823,0,0
3,GO REGULATION OF MIRNA METABOLIC PROCESS,0.31409,0.054394,0.069393,0,0
3,GO REGULATION OF NEURON DIFFERENTIATION,0.086981,0.05431,0.080166,0,0
3,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.090011,0.054258,0.09242,0,0
3,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.092339,0.054099,0.084241,0,0
3,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.13027,0.053944,0.080423,0,0
3,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.85059,0.053736,0.029152,0,0
3,GO MULTICELLULAR ORGANISMAL SIGNALING,0.20554,0.053636,0.070799,0,0
3,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.075674,0.053482,0.084085,0,0
3,GO CATION TRANSPORT,0.1914,0.053462,0.051439,0,0
3,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.10299,0.053332,0.076804,0,0
3,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.52874,0.053309,0.042108,0,0
3,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.38488,0.053212,0.051613,0,0
3,GO FEEDING BEHAVIOR,0.11647,0.053188,0.067771,0,0
3,GO STORE OPERATED CALCIUM ENTRY,0.37173,0.053187,0.058713,0,0
3,GO MITOCHONDRIAL GENOME MAINTENANCE,0.10823,0.053154,0.095059,0,0
3,GO RESPONSE TO CALCIUM ION,0.21288,0.053082,0.061671,0,0
3,GO RNA STABILIZATION,0.27853,0.052981,0.042537,0,0
3,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.39832,0.052818,0.067483,0,0
3,GO TELENCEPHALON DEVELOPMENT,0.10471,0.052805,0.074495,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.41666,0.052797,0.05488,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.30829,0.052752,0.089863,0,0
3,GO METAL ION TRANSPORT,0.11275,0.052742,0.056642,0,0
3,GO AMINO SUGAR METABOLIC PROCESS,0.18866,0.052636,0.063036,0,0
3,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.51296,0.052616,0.025825,0,0
3,GO CELL CYCLE DNA REPLICATION,0.43075,0.052383,0.034782,0,0
3,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.25078,0.052356,0.062927,0,0
3,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.53406,0.052224,0.047402,0,0
3,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.36311,0.052223,0.046259,0,0
3,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.33599,0.052184,0.046,0,0
3,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.094715,0.052053,0.053604,0,0
3,GO NEGATIVE REGULATION OF DNA REPAIR,0.72603,0.052015,0.017676,0,0
3,GO TRNA 5 LEADER REMOVAL,0.2458,0.052011,0.072446,0,0
3,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.13234,0.051994,0.048232,0,0
3,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.23128,0.051984,0.11038,0,0
3,GO NCRNA 3 END PROCESSING,0.060988,0.051891,0.07458,0,0
3,GO ACTIVATION OF JNKK ACTIVITY,0.95316,0.051842,0.00081053,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.34627,0.051731,0.072795,0,0
3,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.52345,0.051618,0.042033,0,0
3,GO ACTION POTENTIAL,0.26095,0.051452,0.060766,0,0
3,GO ORGANIC CATION TRANSPORT,0.22042,0.051451,0.062736,0,0
3,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.16042,0.051289,0.05351,0,0
3,GO NEURON MATURATION,0.15447,0.051264,0.10154,0,0
3,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.047827,0.051061,0.091857,0,0
3,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.13549,0.050985,0.088718,0,0
3,GO RRNA CATABOLIC PROCESS,0.73517,0.050984,0.023616,0,0
3,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.87606,0.050919,0.010228,0,0
3,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.5394,0.050863,0.024747,0,0
3,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.71996,0.050826,0.00023348,0,0
3,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.091558,0.050723,0.068329,0,0
3,GO FEAR RESPONSE,0.72299,0.050648,0.003263,0,0
3,GO RESPONSE TO CATECHOLAMINE,0.13979,0.050381,0.072507,0,0
3,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.34213,0.050372,0.045177,0,0
3,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.082591,0.050364,0.099313,0,0
3,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.44752,0.050334,0.038212,0,0
3,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.78451,0.050165,0.035583,0,0
3,GO FOREBRAIN REGIONALIZATION,0.52609,0.05011,0.033089,0,0
3,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.1387,0.050044,0.084065,0,0
3,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.34008,0.049977,0.053497,0,0
3,GO CELLULAR RESPONSE TO X RAY,0.40973,0.049886,0.04319,0,0
3,GO ENDODERM DEVELOPMENT,0.9306,0.049445,0.0069027,0,0
3,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.86649,0.049406,-0.017877,0,0
3,GO REGULATION OF CELL MORPHOGENESIS,0.14419,0.049396,0.069493,0,0
3,GO RESPONSE TO AMINO ACID STARVATION,0.21889,0.049331,0.063705,0,0
3,GO NUCLEOTIDE EXCISION REPAIR,0.21587,0.049295,0.038578,0,0
3,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.21288,0.04924,0.072724,0,0
3,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.11933,0.049193,0.1066,0,0
3,GO HISTONE H3 K36 METHYLATION,0.80639,0.049069,-0.013853,0,0
3,GO REGULATION OF SENSORY PERCEPTION,0.32592,0.049036,0.07186,0,0
3,GO RNA CAPPING,0.067397,0.049006,0.059317,0,0
3,GO CELLULAR RESPONSE TO ATP,0.10299,0.048956,0.074366,0,0
3,GO ODONTOGENESIS,0.36098,0.04883,0.053065,0,0
3,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.3442,0.04868,0.092718,0,0
3,GO PROTEIN REFOLDING,0.82211,0.048674,0.036288,0,0
3,GO PHOSPHATE ION TRANSPORT,0.096327,0.048639,0.06074,0,0
3,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.19278,0.048582,0.078864,0,0
3,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.18062,0.048562,0.04901,0,0
3,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.20699,0.048471,0.070367,0,0
3,GO DE NOVO PROTEIN FOLDING,0.50776,0.048326,0.052842,0,0
3,GO CAMP METABOLIC PROCESS,0.38488,0.048303,0.057547,0,0
3,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.71996,0.048279,0.0079221,0,0
3,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.16285,0.048211,0.061903,0,0
3,GO NEURON DEVELOPMENT,0.081877,0.048202,0.079693,0,0
3,GO REGULATION OF EXCRETION,0.13549,0.048128,0.083327,0,0
3,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.37173,0.048068,0.039173,0,0
3,GO RESPONSE TO SALT,0.2913,0.048068,0.046458,0,0
3,GO PROTEIN COMPLEX OLIGOMERIZATION,0.020605,0.04803,0.076123,0,0
3,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.14419,0.048003,0.052536,0,0
3,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.16654,0.047923,0.062415,0,0
3,GO POSITIVE REGULATION OF LIPID STORAGE,0.31409,0.04769,0.071416,0,0
3,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.36741,0.04765,0.05758,0,0
3,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.73517,0.047585,0.02444,0,0
3,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.090011,0.04753,0.075516,0,0
3,GO COPPER ION TRANSPORT,0.42838,0.047352,0.033015,0,0
3,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.1252,0.047039,0.065767,0,0
3,GO RESPONSE TO LEUCINE,0.84741,0.046975,0.027313,0,0
3,GO RESPONSE TO ATP,0.15683,0.046819,0.055469,0,0
3,GO T CELL HOMEOSTASIS,0.62258,0.046762,0.016479,0,0
3,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.29877,0.046746,0.081619,0,0
3,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.14308,0.046718,0.1486,0,0
3,GO MEMORY,0.092339,0.046684,0.08017,0,0
3,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.98546,0.046548,0.0017328,0,0
3,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.36956,0.046438,0.077323,0,0
3,GO CELLULAR SODIUM ION HOMEOSTASIS,0.47211,0.046324,0.044599,0,0
3,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.19557,0.046305,0.059722,0,0
3,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.79387,0.046296,0.0080814,0,0
3,GO INTRACELLULAR LIPID TRANSPORT,0.62258,0.046267,0.038238,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.91451,0.046148,-0.0014188,0,0
3,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.51819,0.046129,0.029881,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.55558,0.046045,0.032361,0,0
3,GO LEUKOCYTE TETHERING OR ROLLING,0.21437,0.046005,0.048864,0,0
3,GO ACROSOME REACTION,0.74128,0.045988,0.019052,0,0
3,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.29877,0.045985,0.049723,0,0
3,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.048746,0.045959,0.065532,0,0
3,GO INTERSTRAND CROSS LINK REPAIR,0.46466,0.045829,0.025402,0,0
3,GO RNA LOCALIZATION,0.060432,0.045808,0.073912,0,0
3,GO POSITIVE REGULATION OF HEART RATE,0.77829,0.045764,0.027782,0,0
3,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.99838,0.045548,-0.029076,0,0
3,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.08331,0.045422,0.071732,0,0
3,GO NEURON DIFFERENTIATION,0.14755,0.04542,0.064624,0,0
3,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.24911,0.045336,0.039865,0,0
3,GO RNA SPLICING,0.095518,0.045172,0.05598,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.30637,0.045166,0.076736,0,0
3,GO REGULATION OF NEURON PROJECTION REGENERATION,0.51035,0.045137,0.044235,0,0
3,GO PROSTAGLANDIN TRANSPORT,0.72603,0.045134,0.0075845,0,0
3,GO MICROTUBULE ANCHORING,0.78763,0.045078,-0.012724,0,0
3,GO ION TRANSMEMBRANE TRANSPORT,0.1453,0.045074,0.0546,0,0
3,GO MRNA 3 END PROCESSING,0.12822,0.044964,0.050315,0,0
3,GO RESPONSE TO VITAMIN A,0.43789,0.044738,0.042611,0,0
3,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.10214,0.044726,0.086202,0,0
3,GO SULFUR COMPOUND METABOLIC PROCESS,0.25753,0.044707,0.048802,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.14755,0.044518,0.04877,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.6055,0.04449,0.034362,0,0
3,GO NEUTRAL LIPID CATABOLIC PROCESS,0.44269,0.044464,0.053113,0,0
3,GO GMP METABOLIC PROCESS,0.52609,0.044446,0.048415,0,0
3,GO PROTEIN ACTIVATION CASCADE,0.71996,0.044324,0.0095702,0,0
3,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.11553,0.044302,0.13595,0,0
3,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.32592,0.04422,0.093095,0,0
3,GO PROTEIN LOCALIZATION TO MEMBRANE,0.24911,0.044157,0.039244,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.99515,0.04408,-0.0093066,0,0
3,GO MITOTIC CELL CYCLE ARREST,0.69586,0.043739,0.020758,0,0
3,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.55558,0.043675,0.017607,0,0
3,GO VAGINA DEVELOPMENT,0.47963,0.0434,0.067925,0,0
3,GO ANION HOMEOSTASIS,0.10558,0.04335,0.089128,0,0
3,GO LOCOMOTORY BEHAVIOR,0.1533,0.043012,0.08209,0,0
3,GO GLIAL CELL ACTIVATION,0.75048,0.042985,0.019667,0,0
3,GO SULFUR AMINO ACID METABOLIC PROCESS,0.22348,0.042861,0.063273,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.15447,0.042552,0.13443,0,0
3,GO TRIGLYCERIDE METABOLIC PROCESS,0.96284,0.042504,0.017021,0,0
3,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.13656,0.042446,0.097872,0,0
3,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.78763,0.04196,0.014012,0,0
3,GO DIVALENT INORGANIC CATION TRANSPORT,0.10734,0.041952,0.059156,0,0
3,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.22348,0.041756,0.05088,0,0
3,GO PROTEIN FOLDING,0.093126,0.041744,0.057524,0,0
3,GO REGULATION OF ION TRANSPORT,0.15214,0.041685,0.059967,0,0
3,GO LACTATION,0.1653,0.041647,0.085651,0,0
3,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.23445,0.041643,0.048894,0,0
3,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.22658,0.041575,0.057809,0,0
3,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.37827,0.041514,0.030876,0,0
3,GO TELOMERE ORGANIZATION,0.18461,0.04126,0.04999,0,0
3,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.44028,0.04101,0.067242,0,0
3,GO CATECHOLAMINE SECRETION,0.13444,0.04064,0.15264,0,0
3,GO THYROID HORMONE METABOLIC PROCESS,0.82211,0.04017,-0.021359,0,0
3,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.42367,0.040135,0.053607,0,0
3,GO ENDOCARDIAL CUSHION FORMATION,0.89205,0.039995,0.013728,0,0
3,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.24416,0.03991,0.065151,0,0
3,GO CELL JUNCTION ORGANIZATION,0.82526,0.039864,0.021208,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.19979,0.039793,0.1003,0,0
3,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.57752,0.039738,0.041924,0,0
3,GO MITOCHONDRIAL FISSION,0.50258,0.039719,0.050134,0,0
3,GO RESPONSE TO HYDROPEROXIDE,0.77519,0.039649,0.025003,0,0
3,GO MUSCLE FILAMENT SLIDING,0.42838,0.039583,0.05017,0,0
3,GO REGULATION OF ENDOCYTIC RECYCLING,0.17029,0.03953,0.10927,0,0
3,GO ZINC ION HOMEOSTASIS,0.72299,0.039478,-0.034455,0,0
3,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.57476,0.039419,0.01816,0,0
3,GO MITOCHONDRIAL DNA REPLICATION,0.39381,0.039334,0.046036,0,0
3,GO GLUTATHIONE METABOLIC PROCESS,0.48468,0.039286,0.028934,0,0
3,GO RESPONSE TO INTERLEUKIN 12,0.70486,0.039195,0.011316,0,0
3,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.99515,0.039041,-0.0076223,0,0
3,GO INTERMEMBRANE LIPID TRANSFER,0.55287,0.039025,0.040317,0,0
3,GO REGULATION OF STEROL TRANSPORT,0.318,0.038998,0.050582,0,0
3,GO SNRNA METABOLIC PROCESS,0.62545,0.038946,0.013665,0,0
3,GO BICARBONATE TRANSPORT,0.32592,0.038943,0.035883,0,0
3,GO BEHAVIOR,0.14197,0.038834,0.064351,0,0
3,GO IRON ION TRANSMEMBRANE TRANSPORT,0.32195,0.03873,0.038765,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.14088,0.038443,0.12411,0,0
3,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.30255,0.038341,0.063643,0,0
3,GO REGULATION OF FATTY ACID BETA OXIDATION,0.52082,0.038316,0.044807,0,0
3,GO NEUROGENESIS,0.29689,0.038256,0.047909,0,0
3,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.071756,0.03789,0.068918,0,0
3,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.30446,0.037769,0.075525,0,0
3,GO IRON ION HOMEOSTASIS,0.46466,0.037668,0.038907,0,0
3,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.11933,0.037616,0.060083,0,0
3,GO REGULATION OF EXOCYTOSIS,0.51557,0.037545,0.038621,0,0
3,GO REGULATION OF MRNA METABOLIC PROCESS,0.13979,0.037494,0.048734,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.32592,0.037444,0.047901,0,0
3,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.21437,0.037383,0.051624,0,0
3,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.2913,0.037266,0.040746,0,0
3,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.96284,0.037002,0.013109,0,0
3,GO REGULATION OF MRNA 3 END PROCESSING,0.3871,0.03697,0.041997,0,0
3,GO PALLIUM DEVELOPMENT,0.29877,0.036726,0.055199,0,0
3,GO MAINTENANCE OF CELL POLARITY,0.57476,0.036702,0.042729,0,0
3,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.77829,0.036453,0.021407,0,0
3,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.13027,0.036221,0.12422,0,0
3,GO TRANSMEMBRANE TRANSPORT,0.19838,0.036163,0.041544,0,0
3,GO MONOAMINE TRANSPORT,0.72299,0.036129,0.067117,0,0
3,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.36526,0.035846,0.044336,0,0
3,GO RETROGRADE AXONAL TRANSPORT,0.90167,0.035804,0.017916,0,0
3,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.66321,0.035648,0.014729,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.53406,0.035495,0.03764,0,0
3,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.86012,0.035476,0.01693,0,0
3,GO PLASMA MEMBRANE ORGANIZATION,0.64567,0.03534,0.039837,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.26614,0.034839,0.094233,0,0
3,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.43075,0.034825,0.040608,0,0
3,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.30829,0.034676,0.030965,0,0
3,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.76281,0.034654,0.020501,0,0
3,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.20699,0.034524,0.081358,0,0
3,GO CELLULAR RESPONSE TO UV,0.55558,0.034365,0.027313,0,0
3,GO ATP DEPENDENT CHROMATIN REMODELING,0.60268,0.034361,0.026998,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.64567,0.034252,0.013307,0,0
3,GO ALPHA AMINO ACID METABOLIC PROCESS,0.26789,0.034009,0.049161,0,0
3,GO MRNA CLEAVAGE,0.1653,0.033997,0.049296,0,0
3,GO NUCLEAR MIGRATION,0.39381,0.033936,0.058526,0,0
3,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.4355,0.033918,0.049919,0,0
3,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.31604,0.033916,0.059717,0,0
3,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.46218,0.033786,0.060118,0,0
3,GO MUSCLE ORGAN MORPHOGENESIS,0.68689,0.033689,0.025043,0,0
3,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.70486,0.033656,0.016588,0,0
3,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.5665,0.033651,0.055573,0,0
3,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.25753,0.033631,0.05915,0,0
3,GO ACTIN MEDIATED CELL CONTRACTION,0.24911,0.033114,0.068474,0,0
3,GO CHOLESTEROL EFFLUX,0.70486,0.03302,0.013557,0,0
3,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.28945,0.033004,0.060282,0,0
3,GO NUCLEAR TRANSPORT,0.28945,0.032912,0.032773,0,0
3,GO RESPONSE TO ORGANOPHOSPHORUS,0.2644,0.032864,0.049071,0,0
3,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.23766,0.03286,0.088029,0,0
3,GO CHROMATIN SILENCING,0.80953,0.03284,0.016233,0,0
3,GO NUCLEOTIDE PHOSPHORYLATION,0.021053,0.032808,0.097647,0,0
3,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.19417,0.0328,0.048787,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.43075,0.032755,0.067296,0,0
3,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.76899,0.032741,0.023327,0,0
3,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.24416,0.03273,0.051729,0,0
3,GO REGULATION OF MEMBRANE REPOLARIZATION,0.23766,0.032709,0.06051,0,0
3,GO EMBRYONIC PATTERN SPECIFICATION,0.51296,0.032684,0.032009,0,0
3,GO RESPONSE TO HEAT,0.078382,0.032677,0.0658,0,0
3,GO PEPTIDYL PROLINE MODIFICATION,0.2913,0.032483,0.050208,0,0
3,GO ARTERY DEVELOPMENT,0.81581,0.032468,0.012681,0,0
3,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.71996,0.032464,-0.038041,0,0
3,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.14308,0.032281,0.080803,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.22658,0.032236,0.070301,0,0
3,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.21288,0.032162,0.063715,0,0
3,GO REGULATION OF LIPID CATABOLIC PROCESS,0.35886,0.032058,0.050715,0,0
3,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.42133,0.032058,0.033238,0,0
3,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.32792,0.032046,0.051925,0,0
3,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.66028,0.031824,0.024123,0,0
3,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.77209,0.031706,0.0084851,0,0
3,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.97253,0.031689,0.0051955,0,0
3,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.91772,0.031654,0.015284,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.41666,0.031627,0.04009,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.44994,0.030756,0.032777,0,0
3,GO REGULATION OF ATP METABOLIC PROCESS,0.63986,0.030753,0.026971,0,0
3,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.61687,0.030552,0.012815,0,0
3,GO CELLULAR RESPONSE TO CHOLESTEROL,0.75664,0.030512,0.039184,0,0
3,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.2714,0.030433,0.03724,0,0
3,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.38047,0.030288,0.053875,0,0
3,GO OXIDATIVE DEMETHYLATION,0.2114,0.030202,0.047861,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.71391,0.030119,0.066865,0,0
3,GO SECRETORY GRANULE ORGANIZATION,0.82526,0.030091,0.016699,0,0
3,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.97253,0.029837,0.0058586,0,0
3,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.56103,0.029723,0.043122,0,0
3,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.30066,0.02971,0.038404,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.48215,0.029676,0.028623,0,0
3,GO CHLORIDE ION HOMEOSTASIS,0.73822,0.029674,0.032255,0,0
3,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.20265,0.029662,0.076991,0,0
3,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.11092,0.029542,0.075778,0,0
3,GO VITAMIN TRANSPORT,0.17029,0.029518,0.10556,0,0
3,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.53406,0.029381,0.046042,0,0
3,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.79387,0.029176,-0.021566,0,0
3,GO ERROR FREE TRANSLESION SYNTHESIS,0.48468,0.029161,0.024212,0,0
3,GO RESPONSE TO CAMP,0.1533,0.029122,0.067853,0,0
3,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.098784,0.029115,0.055414,0,0
3,GO CELL GROWTH,0.5394,0.028949,0.030735,0,0
3,GO SULFATION,0.38047,0.028912,-0.071311,0,0
3,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.98869,0.028828,-0.0030758,0,0
3,GO NERVOUS SYSTEM PROCESS,0.34213,0.028659,0.039733,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.74128,0.028374,0.018672,0,0
3,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.49231,0.028308,-0.028672,0,0
3,GO PROTON TRANSMEMBRANE TRANSPORT,0.94348,0.028031,0.0064406,0,0
3,GO MESODERMAL CELL FATE COMMITMENT,0.71089,0.028012,0.017662,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.99838,0.027929,-0.0012232,0,0
3,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.90167,0.027749,-0.016858,0,0
3,GO PROTEIN STABILIZATION,0.94993,0.027228,0.012349,0,0
3,GO RESPONSE TO AXON INJURY,0.77519,0.027222,0.021409,0,0
3,GO REGULATION OF STEM CELL DIFFERENTIATION,0.80012,0.027195,-0.018709,0,0
3,GO ADULT LOCOMOTORY BEHAVIOR,0.44028,0.027187,0.05433,0,0
3,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.20699,0.027171,0.054947,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.63986,0.026862,0.044345,0,0
3,GO MITOCHONDRION ORGANIZATION,0.23445,0.026769,0.036796,0,0
3,GO RNA INTERFERENCE,0.62545,0.026646,0.033843,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.42367,0.026574,0.049216,0,0
3,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.45238,0.026474,0.035501,0,0
3,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.98869,0.026429,-0.021921,0,0
3,GO FOREBRAIN NEURON DEVELOPMENT,0.62832,0.026345,0.045339,0,0
3,GO HISTONE DEUBIQUITINATION,0.572,0.026318,0.018598,0,0
3,GO DNA DEPENDENT DNA REPLICATION,0.45972,0.0263,0.027935,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.50258,0.026256,0.030504,0,0
3,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.3442,0.026198,0.064965,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.55287,0.026008,0.027981,0,0
3,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.42133,0.025862,0.041708,0,0
3,GO ENGULFMENT OF APOPTOTIC CELL,0.68689,0.0258,-0.027646,0,0
3,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.70486,0.025798,0.021336,0,0
3,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.72299,0.025787,0.0241,0,0
3,GO VESICLE CARGO LOADING,0.68094,0.025729,0.016266,0,0
3,GO MRNA TRANSPORT,0.46466,0.025487,0.039386,0,0
3,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.42367,0.025483,0.037999,0,0
3,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.16407,0.025473,0.053186,0,0
3,GO XENOBIOTIC CATABOLIC PROCESS,0.68392,0.025456,0.059815,0,0
3,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.12421,0.025424,0.048757,0,0
3,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.80953,0.025414,0.016513,0,0
3,GO REGULATION OF BLOOD CIRCULATION,0.41899,0.025265,0.043099,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.89205,0.025237,-0.018697,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.31021,0.025105,0.033932,0,0
3,GO HORMONE BIOSYNTHETIC PROCESS,0.20992,0.024896,0.071715,0,0
3,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.7814,0.024819,0.016085,0,0
3,GO PEPTIDYL LYSINE DIMETHYLATION,0.37827,0.024765,0.039092,0,0
3,GO NUCLEAR EXPORT,0.31409,0.024729,0.037484,0,0
3,GO EMBRYONIC AXIS SPECIFICATION,0.82211,0.024555,0.012749,0,0
3,GO BASE EXCISION REPAIR,0.23927,0.024538,0.046355,0,0
3,GO PROTEIN DEPOLYMERIZATION,0.98546,0.024518,0.010991,0,0
3,GO REGULATION OF PROTON TRANSPORT,0.39832,0.024367,0.039978,0,0
3,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.58864,0.024188,0.02208,0,0
3,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.10385,0.024166,0.1837,0,0
3,GO PROTEIN LOCALIZATION TO ORGANELLE,0.32393,0.024069,0.029439,0,0
3,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.72907,0.024014,0.0080273,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.062114,0.023871,0.072062,0,0
3,GO MONOSACCHARIDE CATABOLIC PROCESS,0.26095,0.023821,0.060711,0,0
3,GO CELLULAR RESPONSE TO CALCIUM ION,0.24252,0.023811,0.069094,0,0
3,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.86968,0.023798,0.00076705,0,0
3,GO AMINO ACID ACTIVATION,0.062114,0.023635,0.11576,0,0
3,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.20409,0.023454,0.057922,0,0
3,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.36741,0.023404,0.028929,0,0
3,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.94993,0.023379,0.025119,0,0
3,GO COPII COATED VESICLE CARGO LOADING,0.90809,0.023359,0.0031116,0,0
3,GO RNA EXPORT FROM NUCLEUS,0.22658,0.02326,0.058347,0,0
3,GO TORC1 SIGNALING,0.41434,0.023094,0.042696,0,0
3,GO MULTI ORGANISM LOCALIZATION,0.57476,0.022969,0.019977,0,0
3,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.76899,0.02285,-0.063287,0,0
3,GO TRANSCRIPTION BY RNA POLYMERASE III,0.17411,0.022685,0.050037,0,0
3,GO CORTICOSTEROID HORMONE SECRETION,0.97253,0.022674,-0.023041,0,0
3,GO INACTIVATION OF MAPK ACTIVITY,0.84424,0.022604,0.0022786,0,0
3,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.8379,0.022563,0.014165,0,0
3,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.49487,0.022518,0.04115,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.66321,0.022504,0.049388,0,0
3,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.36311,0.022491,0.034541,0,0
3,GO REGULATION OF CELL DEVELOPMENT,0.40514,0.022298,0.041319,0,0
3,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.23286,0.022131,0.11552,0,0
3,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.75356,0.022125,0.002403,0,0
3,GO CHROMATIN DISASSEMBLY,0.33599,0.022032,0.086501,0,0
3,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.26267,0.022027,0.07156,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.30637,0.022027,0.042848,0,0
3,GO CHROMOSOME CONDENSATION,0.89205,0.021951,0.0067857,0,0
3,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.66028,0.021919,0.041058,0,0
3,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.37608,0.021912,0.047398,0,0
3,GO NCRNA CATABOLIC PROCESS,0.59705,0.021779,0.030834,0,0
3,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.52874,0.021663,0.063881,0,0
3,GO OVULATION CYCLE PROCESS,0.36956,0.021653,0.048856,0,0
3,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.45727,0.021564,0.03789,0,0
3,GO CHLORIDE TRANSPORT,0.48722,0.021339,0.029408,0,0
3,GO CRANIAL NERVE MORPHOGENESIS,0.58307,0.021221,0.034996,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.43075,0.021079,0.035859,0,0
3,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.50516,0.02104,-0.033883,0,0
3,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.66321,0.021034,0.021639,0,0
3,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.42602,0.020955,0.038921,0,0
3,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.71996,0.020887,-0.0064194,0,0
3,GO LIMBIC SYSTEM DEVELOPMENT,0.34213,0.020682,0.059597,0,0
3,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.32993,0.020636,0.060602,0,0
3,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.11742,0.020603,0.050592,0,0
3,GO REGULATION OF HISTONE METHYLATION,0.94993,0.020597,0.0143,0,0
3,GO NCRNA EXPORT FROM NUCLEUS,0.11553,0.020555,0.084655,0,0
3,GO VENTRICULAR SYSTEM DEVELOPMENT,0.56103,0.020499,0.038841,0,0
3,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.97576,0.02039,0.0065521,0,0
3,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.58029,0.020287,-0.023234,0,0
3,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.84741,0.020237,0.01461,0,0
3,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.82211,0.020187,-0.018474,0,0
3,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.99192,0.020079,0.0050157,0,0
3,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.11002,0.020033,0.077971,0,0
3,GO POLYOL METABOLIC PROCESS,0.51557,0.020027,0.031953,0,0
3,GO ION TRANSPORT,0.43312,0.019889,0.03163,0,0
3,GO POSITIVE REGULATION OF DNA BINDING,0.5583,0.019366,0.023317,0,0
3,GO CELLULAR RESPONSE TO RETINOIC ACID,0.94993,0.019115,0.00083262,0,0
3,GO NADP METABOLIC PROCESS,0.95639,0.018842,-0.0048271,0,0
3,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.97576,0.01884,-0.0046428,0,0
3,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.61972,0.018811,0.03045,0,0
3,GO RESPONSE TO AMPHETAMINE,0.6312,0.018788,0.02152,0,0
3,GO MITOCHONDRIAL TRANSPORT,0.45238,0.018696,0.029465,0,0
3,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.94026,0.018653,-0.00040308,0,0
3,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.86012,0.018576,-0.016771,0,0
3,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.57752,0.018519,0.043327,0,0
3,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.63986,0.018164,-0.0073667,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.69586,0.017964,-0.03532,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.41434,0.017937,0.05183,0,0
3,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.97253,0.017794,0.010682,0,0
3,GO DNA GEOMETRIC CHANGE,0.88245,0.017671,0.012591,0,0
3,GO RESPONSE TO COCAINE,0.50258,0.017603,0.047848,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.30446,0.017402,0.047137,0,0
3,GO AMINOGLYCAN METABOLIC PROCESS,0.87926,0.017396,0.0016183,0,0
3,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.26095,0.017187,0.040936,0,0
3,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.84741,0.017052,0.012294,0,0
3,GO REGULATION OF PROSTAGLANDIN SECRETION,0.40973,0.016954,-0.061429,0,0
3,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.52874,0.016839,0.03905,0,0
3,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.23286,0.016694,0.044581,0,0
3,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.88885,0.016639,0.023103,0,0
3,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.51296,0.016579,-0.024754,0,0
3,GO REGULATION OF MRNA CATABOLIC PROCESS,0.22971,0.016447,0.043387,0,0
3,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.70486,0.016438,0.023946,0,0
3,GO COMMISSURAL NEURON AXON GUIDANCE,0.62258,0.016309,0.052179,0,0
3,GO PLASMA MEMBRANE TUBULATION,0.21738,0.016272,0.08126,0,0
3,GO DEVELOPMENTAL GROWTH,0.7659,0.01623,0.02175,0,0
3,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.95316,0.01613,-0.048518,0,0
3,GO HISTONE H3 K4 TRIMETHYLATION,0.75664,0.016043,-0.013489,0,0
3,GO ENDODERMAL CELL DIFFERENTIATION,0.75972,0.015948,0.0046202,0,0
3,GO PROTEIN HYDROXYLATION,0.84424,0.015906,0.0038827,0,0
3,GO NEGATIVE REGULATION OF NEURON DEATH,0.71391,0.015707,0.0019125,0,0
3,GO EXPLORATION BEHAVIOR,0.13656,0.015693,0.1389,0,0
3,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.85694,0.015649,0.014399,0,0
3,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.59986,0.01561,0.02749,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.75972,0.015512,0.021475,0,0
3,GO MYELIN MAINTENANCE,0.73517,0.015255,0.035645,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.59986,0.015226,0.036869,0,0
3,GO NUCLEOSIDE SALVAGE,0.36311,0.01508,0.041222,0,0
3,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,0.46962,0.015051,0.038997,0,0
3,GO PROTEIN PALMITOYLATION,0.67798,0.014985,-0.010987,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING,0.25924,0.014823,0.057706,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.60268,0.014807,0.030524,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.6055,0.014751,0.024026,0,0
3,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.77829,0.014729,-0.014933,0,0
3,GO HEART TRABECULA FORMATION,0.57752,0.014498,-0.050613,0,0
3,GO RESPONSE TO THYROID HORMONE,0.97253,0.014444,-0.012476,0,0
3,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.90809,0.014117,-0.019285,0,0
3,GO REGULATION OF DNA CATABOLIC PROCESS,0.46962,0.014084,0.041789,0,0
3,GO SCHWANN CELL DEVELOPMENT,0.89205,0.013985,0.0030859,0,0
3,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.1387,0.013947,0.073861,0,0
3,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.81896,0.013806,0.028691,0,0
3,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.21288,0.013802,0.074234,0,0
3,GO MITOTIC CHROMOSOME CONDENSATION,0.98869,0.013663,-0.0080035,0,0
3,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.51557,0.01363,0.028559,0,0
3,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.76899,0.013588,0.017311,0,0
3,GO PEPTIDYL PROLINE HYDROXYLATION,0.90809,0.01349,0.00070321,0,0
3,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.92738,0.013388,0.016256,0,0
3,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.80639,0.013181,0.012798,0,0
3,GO STEROID HORMONE SECRETION,0.27673,0.013155,-0.080176,0,0
3,GO KIDNEY MESENCHYME DEVELOPMENT,0.5583,0.013134,0.01972,0,0
3,GO DETECTION OF LIGHT STIMULUS,0.95316,0.012997,0.10827,0,0
3,GO PEPTIDE CATABOLIC PROCESS,0.71391,0.012974,0.026294,0,0
3,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.38933,0.012953,0.040242,0,0
3,GO REGULATION OF BIOMINERALIZATION,0.2913,0.012829,-0.042622,0,0
3,GO ENSHEATHMENT OF NEURONS,0.58585,0.012814,-0.0057001,0,0
3,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.30066,0.012778,0.057491,0,0
3,GO REGULATION OF RESPONSE TO FOOD,0.51819,0.012758,-0.040764,0,0
3,GO REGULATION OF HISTONE UBIQUITINATION,0.98546,0.012502,0.014292,0,0
3,GO ENDOTHELIAL CELL PROLIFERATION,0.75664,0.012459,-0.0059561,0,0
3,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.80953,0.012272,0.021964,0,0
3,GO VESICLE CYTOSKELETAL TRAFFICKING,0.82842,0.012264,0.0037454,0,0
3,GO HEART VALVE DEVELOPMENT,0.69586,0.012235,0.034692,0,0
3,GO WATER TRANSPORT,0.94348,0.012185,-0.011724,0,0
3,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.61402,0.012054,0.018331,0,0
3,GO ESTABLISHMENT OF TISSUE POLARITY,0.81581,0.012038,0.013498,0,0
3,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.81267,0.01201,0.026096,0,0
3,GO METHYLATION,0.34213,0.011956,0.033501,0,0
3,GO NEGATIVE REGULATION OF CELL AGING,0.69586,0.011755,-0.019484,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.80012,0.011691,0.015701,0,0
3,GO REGULATION OF FILOPODIUM ASSEMBLY,0.5314,0.011574,0.055322,0,0
3,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.15921,0.011527,0.069503,0,0
3,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.38267,0.011462,0.037976,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.87287,0.011456,0.019905,0,0
3,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.73517,0.011448,0.037289,0,0
3,GO CELL MORPHOGENESIS,0.45727,0.011422,0.041339,0,0
3,GO METHIONINE METABOLIC PROCESS,0.97899,0.011327,-0.0091831,0,0
3,GO APOPTOTIC CELL CLEARANCE,0.91772,0.011292,-0.027277,0,0
3,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.34627,0.011206,0.053192,0,0
3,GO FUCOSYLATION,0.32792,0.011195,-0.048335,0,0
3,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.86012,0.011181,-0.007034,0,0
3,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.80639,0.011159,0.0030604,0,0
3,GO THIOESTER BIOSYNTHETIC PROCESS,0.081877,0.011141,0.10391,0,0
3,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.7814,0.011106,0.027823,0,0
3,GO PROTEIN IMPORT,0.92738,0.011094,0.009053,0,0
3,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.96284,0.01108,-0.012816,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.86012,0.01107,0.0069767,0,0
3,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.81581,0.011022,0.00089649,0,0
3,GO METAL ION HOMEOSTASIS,0.86968,0.010978,0.0079768,0,0
3,GO FIBROBLAST ACTIVATION,0.55016,0.010897,-0.039627,0,0
3,GO RESPONSE TO PARATHYROID HORMONE,0.58029,0.010852,0.084197,0,0
3,GO REGULATION OF FERTILIZATION,0.84741,0.01078,0.0073753,0,0
3,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.63986,0.010588,0.058047,0,0
3,GO COENZYME A BIOSYNTHETIC PROCESS,0.48976,0.010546,0.053878,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.9113,0.010526,0.011988,0,0
3,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.71996,0.0105,0.010674,0,0
3,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.61117,0.010332,0.040638,0,0
3,GO VESICLE DOCKING,0.87606,0.010323,0.023852,0,0
3,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.70787,0.01027,0.019453,0,0
3,GO NERVE DEVELOPMENT,0.89526,0.010211,0.012863,0,0
3,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.73822,0.010187,0.024752,0,0
3,GO RESPONSE TO ZINC ION,0.98869,0.010149,-0.014274,0,0
3,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.56103,0.010052,0.029742,0,0
3,GO DNA REPAIR,0.99838,0.0097141,0.0047528,0,0
3,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.29689,0.009685,0.059354,0,0
3,GO RESPONSE TO UV,0.86649,0.0096167,0.0092893,0,0
3,GO POSITIVE REGULATION OF TOR SIGNALING,0.61972,0.0094082,-0.010163,0,0
3,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.96607,0.0093956,0.010571,0,0
3,GO CELLULAR HOMEOSTASIS,0.43312,0.0093054,0.033227,0,0
3,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.80953,0.0090164,0.023487,0,0
3,GO NEURON PROJECTION ARBORIZATION,0.93704,0.0089413,0.02496,0,0
3,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.82211,0.0089187,0.018781,0,0
3,GO REGULATION OF GENE SILENCING,0.67501,0.0087923,0.021752,0,0
3,GO RESPONSE TO NERVE GROWTH FACTOR,0.41666,0.0087322,0.046609,0,0
3,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.7659,0.0086267,0.021362,0,0
3,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.22195,0.0085924,0.057062,0,0
3,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.44028,0.0084467,-0.028497,0,0
3,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.51035,0.0083424,-0.048687,0,0
3,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.84741,0.0083367,0.013927,0,0
3,GO ION HOMEOSTASIS,0.797,0.008326,0.019955,0,0
3,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.85694,0.008256,0.02299,0,0
3,GO MUSCLE CONTRACTION,0.34835,0.0082236,0.044021,0,0
3,GO POSITIVE REGULATION OF MYELINATION,0.58585,0.0081578,0.040648,0,0
3,GO REGULATION OF DEVELOPMENTAL GROWTH,0.58307,0.0080051,0.027155,0,0
3,GO POSITIVE REGULATION OF URINE VOLUME,0.72907,0.0080011,0.019754,0,0
3,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.6312,0.007923,-0.043619,0,0
3,GO INTRACELLULAR PROTEIN TRANSPORT,0.78451,0.0078508,0.004925,0,0
3,GO DENDRITE EXTENSION,0.61972,0.007815,0.064422,0,0
3,GO NEUROTROPHIN SIGNALING PATHWAY,0.98222,0.00772,0.0056278,0,0
3,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.52609,0.0076956,0.036419,0,0
3,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.97576,0.0073814,0.0053246,0,0
3,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.71996,0.0073593,0.029052,0,0
3,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.22814,0.0073451,0.15887,0,0
3,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.67206,0.0073311,0.041469,0,0
3,GO POSITIVE REGULATION OF ANION TRANSPORT,0.61117,0.0071133,-0.016535,0,0
3,GO CELLULAR OXIDANT DETOXIFICATION,0.96284,0.0070728,-0.0036345,0,0
3,GO RESPONSE TO PROTOZOAN,0.86331,0.0069947,-0.013186,0,0
3,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.79075,0.0067686,0.01526,0,0
3,GO REGULATION OF LIPID KINASE ACTIVITY,0.56376,0.0067232,0.033146,0,0
3,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.2714,0.0066796,0.050557,0,0
3,GO MAINTENANCE OF LOCATION IN CELL,0.51035,0.0066448,0.041275,0,0
3,GO POSITIVE REGULATION OF FERTILIZATION,0.24089,0.0066201,0.082131,0,0
3,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.76281,0.0062621,0.0053827,0,0
3,GO LAMELLIPODIUM MORPHOGENESIS,0.23766,0.0062463,-0.08001,0,0
3,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.55558,0.0061902,-0.0025297,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.87926,0.0060933,-0.014467,0,0
3,GO UBIQUINONE METABOLIC PROCESS,0.88885,0.0058914,-0.0083885,0,0
3,GO CHROMATIN REMODELING,0.72907,0.0058551,-0.003451,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.32195,0.0054834,-0.04723,0,0
3,GO ANION TRANSMEMBRANE TRANSPORT,0.38488,0.0054508,0.040737,0,0
3,GO OSTEOBLAST DEVELOPMENT,0.7814,0.0054148,-0.027784,0,0
3,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.74435,0.0053938,0.0048569,0,0
3,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.71089,0.0053123,-0.014364,0,0
3,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.39381,0.0052836,0.028711,0,0
3,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.43789,0.0052297,-0.07991,0,0
3,GO HISTONE H4 K16 ACETYLATION,0.54746,0.0051573,-0.017152,0,0
3,GO VASODILATION,0.69586,0.0050651,0.01528,0,0
3,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.71391,0.0049045,0.019152,0,0
3,GO COLLAGEN CATABOLIC PROCESS,0.77209,0.004902,0.023971,0,0
3,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.80012,0.0048853,-0.0066754,0,0
3,GO REGULATION OF CHOLESTEROL EFFLUX,0.62545,0.0047453,-0.016629,0,0
3,GO ORGANIC ACID TRANSPORT,0.35043,0.0047316,0.04012,0,0
3,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.97253,0.0047069,0.0021279,0,0
3,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.84107,0.0047043,0.017739,0,0
3,GO NEURON DEATH,0.52874,0.0044968,-0.0066317,0,0
3,GO INORGANIC ANION TRANSPORT,0.80953,0.0043809,0.010791,0,0
3,GO CARDIOLIPIN METABOLIC PROCESS,0.28033,0.004364,0.057858,0,0
3,GO CHRONIC INFLAMMATORY RESPONSE,0.74128,0.0043341,-0.047769,0,0
3,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.61972,0.0042269,0.029989,0,0
3,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.63408,0.0042242,0.037225,0,0
3,GO PIGMENT METABOLIC PROCESS,0.1914,0.0042015,0.077573,0,0
3,GO CELL CELL SIGNALING,0.73212,0.0041247,0.022322,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY,0.79075,0.004084,0.020893,0,0
3,GO PEROXISOMAL MEMBRANE TRANSPORT,0.7814,0.0038946,0.024,0,0
3,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.80012,0.0038311,-0.0064734,0,0
3,GO BONE DEVELOPMENT,0.69286,0.0038114,-0.0086064,0,0
3,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.88245,0.0037826,0.0051871,0,0
3,GO DEVELOPMENTAL MATURATION,0.84107,0.00373,0.023421,0,0
3,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.98222,0.0037276,0.014452,0,0
3,GO REGULATION OF OOGENESIS,0.86331,0.0036989,-0.0081058,0,0
3,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.5583,0.0036117,-0.0093416,0,0
3,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.83158,0.0035896,0.020339,0,0
3,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.81896,0.003514,-0.0067346,0,0
3,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.96607,0.0034733,0.018036,0,0
3,GO OUTFLOW TRACT MORPHOGENESIS,0.89526,0.0034604,0.018298,0,0
3,GO NEUROPEPTIDE SIGNALING PATHWAY,0.62258,0.0033754,0.036901,0,0
3,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.93382,0.0033137,0.031599,0,0
3,GO ANIMAL ORGAN REGENERATION,0.87926,0.0032011,0.0092475,0,0
3,GO AMYLOID BETA FORMATION,0.99838,0.0031562,0.020404,0,0
3,GO REGULATION OF MICROTUBULE BINDING,0.37827,0.0031494,0.073365,0,0
3,GO SNARE COMPLEX ASSEMBLY,0.88565,0.0030842,-0.0050006,0,0
3,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.97899,0.0030768,0.016238,0,0
3,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.88565,0.0030032,0.0069304,0,0
3,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.75356,0.0029446,0.0013662,0,0
3,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.52874,0.0028358,-0.015329,0,0
3,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.80953,0.0028287,0.020346,0,0
3,GO RESPONSE TO IONIZING RADIATION,0.073043,0.0027816,-0.05549,0,0
3,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.77829,0.0027263,-0.010386,0,0
3,GO POLYOL BIOSYNTHETIC PROCESS,0.74741,0.0026627,-0.0022465,0,0
3,GO CELLULAR RESPONSE TO RADIATION,0.89205,0.0026406,0.0097021,0,0
3,GO SKELETAL SYSTEM MORPHOGENESIS,0.39156,0.0026023,-0.027868,0,0
3,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.64276,0.0025959,-0.0026263,0,0
3,GO TRACHEA DEVELOPMENT,0.90488,0.0024328,-0.0046907,0,0
3,GO REGULATION OF LIPASE ACTIVITY,0.87287,0.0023264,0.006767,0,0
3,GO OVULATION CYCLE,0.45238,0.0022718,0.046303,0,0
3,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.21288,0.002142,0.12875,0,0
3,GO NEGATIVE REGULATION OF ION TRANSPORT,0.61687,0.0020558,0.031754,0,0
3,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.51557,0.0020182,-0.064482,0,0
3,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.80012,0.0020163,0.031039,0,0
3,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.58029,0.0019024,-0.038226,0,0
3,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.55287,0.0017476,0.035836,0,0
3,GO OSTEOCLAST DEVELOPMENT,0.70185,0.001534,0.040778,0,0
3,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.74435,0.0014515,0.029373,0,0
3,GO CEREBELLAR CORTEX FORMATION,0.80012,0.00139,0.035614,0,0
3,GO MESENCHYMAL CELL PROLIFERATION,0.92738,0.0009983,0.015122,0,0
3,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.21288,0.00097727,-0.046266,0,0
3,GO PORE COMPLEX ASSEMBLY,0.75356,0.00092911,0.010886,0,0
3,GO ESTABLISHMENT OF RNA LOCALIZATION,0.40743,0.00090815,0.041805,0,0
3,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.53406,0.00090029,0.032428,0,0
3,GO GLYCEROLIPID CATABOLIC PROCESS,0.91451,0.00075369,0.015213,0,0
3,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.36098,0.00069329,0.046316,0,0
3,GO RESPONSE TO LIGHT STIMULUS,0.57476,0.00065938,0.035068,0,0
3,GO REGULATION OF DNA BINDING,0.86649,0.00063716,0.0040483,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.98222,0.00057234,-0.0006873,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.9113,0.00049015,0.013891,0,0
3,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.79075,0.00040192,0.012376,0,0
3,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.82526,0.0003881,-0.00028621,0,0
3,GO FUCOSE METABOLIC PROCESS,0.25078,0.00035407,-0.080099,0,0
3,GO SYNCYTIUM FORMATION,0.45972,0.00034334,-0.034091,0,0
3,GO MICROTUBULE NUCLEATION,0.88565,0.00029682,0.029492,0,0
3,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.52082,0.00025132,-0.0084581,0,0
3,GO ACTIVATION OF MAPKK ACTIVITY,0.5583,0.00010502,-0.01635,0,0
3,GO NEUROBLAST PROLIFERATION,0.72299,3.7872e-05,0.023642,0,0
3,GO CELLULAR ION HOMEOSTASIS,0.95961,9.7396e-06,0.012034,0,0
3,GO ENDOCYTOSIS,0.80953,-0.00024614,0.0095042,0,0
3,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.49487,-0.00042017,-0.015384,0,0
3,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.6055,-0.00043523,0.037076,0,0
3,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.87606,-0.000441,0.012588,0,0
3,GO CEREBRAL CORTEX CELL MIGRATION,0.45972,-0.00050059,0.056679,0,0
3,GO REGULATION OF AMYLOID BETA CLEARANCE,0.63986,-0.00062242,-0.03159,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.61972,-0.00069713,-0.019789,0,0
3,GO CALCIUM ION REGULATED EXOCYTOSIS,0.82842,-0.00081369,0.060075,0,0
3,GO GROWTH,0.52082,-0.0008187,-0.0023139,0,0
3,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.78451,-0.00086571,-0.00021719,0,0
3,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.83474,-0.00096574,0.037066,0,0
3,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.87606,-0.0010298,0.037616,0,0
3,GO SMOOTH MUSCLE CONTRACTION,0.49231,-0.0012584,0.036421,0,0
3,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.81896,-0.0013879,-0.0067216,0,0
3,GO AORTIC VALVE DEVELOPMENT,0.80326,-0.0014294,0.023537,0,0
3,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.70185,-0.0014295,-0.015047,0,0
3,GO CHROMOSOME SEPARATION,0.96284,-0.0014961,0.01083,0,0
3,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.82526,-0.0014985,0.0057178,0,0
3,GO REGULATION OF GROWTH,0.30829,-0.0015642,-0.011854,0,0
3,GO MULTICELLULAR ORGANISM GROWTH,0.48976,-0.0016005,-0.010987,0,0
3,GO RESPONSE TO ESTROGEN,0.85694,-0.0016198,-0.0024514,0,0
3,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.94671,-0.0016902,-0.011239,0,0
3,GO MRNA EXPORT FROM NUCLEUS,0.3739,-0.0016941,0.045482,0,0
3,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.94026,-0.0017448,0.0069169,0,0
3,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.62545,-0.0018346,-0.048116,0,0
3,GO REGULATION OF ENDOCYTOSIS,0.96607,-0.0018784,0.01905,0,0
3,GO HISTONE H3 K27 METHYLATION,0.95961,-0.0020703,0.010507,0,0
3,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.61687,-0.0021105,-0.027352,0,0
3,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.94026,-0.0021185,0.058279,0,0
3,GO DETOXIFICATION,0.79075,-0.0021286,-0.0081543,0,0
3,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.90167,-0.0021441,0.0099522,0,0
3,GO POSITIVE REGULATION OF BINDING,0.49487,-0.0021738,0.0036665,0,0
3,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.64858,-0.0022137,-0.010354,0,0
3,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.75972,-0.0022144,0.0089079,0,0
3,GO CELL CYCLE ARREST,0.88885,-0.0022627,0.0078136,0,0
3,GO CIRCULATORY SYSTEM PROCESS,0.62258,-0.0023395,-0.0029707,0,0
3,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.85694,-0.0023744,0.019502,0,0
3,GO THYROID GLAND DEVELOPMENT,0.52345,-0.0024086,-0.066387,0,0
3,GO INTRACELLULAR MRNA LOCALIZATION,0.52345,-0.0026655,-0.02305,0,0
3,GO SEGMENTATION,0.8379,-0.0027189,-0.0036071,0,0
3,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.81581,-0.0028318,0.019106,0,0
3,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.77829,-0.0028322,0.025235,0,0
3,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.73822,-0.0028495,0.018265,0,0
3,GO CELL REDOX HOMEOSTASIS,0.98869,-0.0028905,-0.0058794,0,0
3,GO HISTONE METHYLATION,0.90488,-0.0030807,0.0035529,0,0
3,GO STEROL BIOSYNTHETIC PROCESS,0.60268,-0.0031506,0.058714,0,0
3,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.91451,-0.0031969,0.0084527,0,0
3,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.58864,-0.0033709,-0.00047836,0,0
3,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.65442,-0.0034812,-0.010886,0,0
3,GO REGULATION OF RNA SPLICING,0.94348,-0.0035634,0.0072055,0,0
3,GO RESPONSE TO TEMPERATURE STIMULUS,0.90809,-0.0035996,0.023982,0,0
3,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.59424,-0.0036439,-0.0012653,0,0
3,GO MUSCLE SYSTEM PROCESS,0.69586,-0.0036611,0.026719,0,0
3,GO ALCOHOL BIOSYNTHETIC PROCESS,0.68392,-0.0036836,0.028388,0,0
3,GO CARDIAC CHAMBER MORPHOGENESIS,0.32195,-0.0036973,-0.033345,0,0
3,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.56925,-0.0037961,-0.0061277,0,0
3,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.4355,-0.0040376,-0.011645,0,0
3,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.91451,-0.0040378,0.010076,0,0
3,GO RESPONSE TO GLUCAGON,1,-0.004079,0.018355,0,0
3,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.80326,-0.0041365,-0.005455,0,0
3,GO NEGATIVE REGULATION OF BINDING,0.80953,-0.0041694,0.0094877,0,0
3,GO MUSCLE ORGAN DEVELOPMENT,0.91451,-0.004171,0.003637,0,0
3,GO CONVERGENT EXTENSION,0.92416,-0.0042402,0.013971,0,0
3,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.46962,-0.0043104,-0.028647,0,0
3,GO CHROMATIN REMODELING AT CENTROMERE,0.87606,-0.0043648,0.018986,0,0
3,GO BODY FLUID SECRETION,0.83474,-0.0044448,0.0094284,0,0
3,GO SKELETAL MUSCLE TISSUE REGENERATION,0.56103,-0.0045653,0.010674,0,0
3,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.42602,-0.0046733,-0.016704,0,0
3,GO HISTONE EXCHANGE,0.85376,-0.0048008,0.0041422,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.37827,-0.0048961,-0.034444,0,0
3,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1,-0.0049907,-0.01038,0,0
3,GO G0 TO G1 TRANSITION,0.71693,-0.0050273,-0.0083837,0,0
3,GO DNA METABOLIC PROCESS,0.59986,-0.0052383,-0.0012548,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.78451,-0.0053707,0.032829,0,0
3,GO INNER CELL MASS CELL PROLIFERATION,0.84741,-0.0054881,0.019322,0,0
3,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.84424,-0.0054934,-0.025033,0,0
3,GO REGULATION OF SODIUM ION TRANSPORT,0.51819,-0.0055225,0.043919,0,0
3,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.99838,-0.0055476,0.00068206,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.84424,-0.0056029,-0.019608,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.96284,-0.0056087,-0.0017992,0,0
3,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.44028,-0.0056267,-0.025223,0,0
3,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.74741,-0.0057965,-0.0098863,0,0
3,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.5583,-0.0059002,0.035535,0,0
3,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.82211,-0.0059395,0.020665,0,0
3,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.70486,-0.0061012,0.02524,0,0
3,GO PULMONARY VALVE DEVELOPMENT,0.4451,-0.006198,-0.054467,0,0
3,GO COMPLEMENT ACTIVATION,0.7659,-0.0062865,-0.041882,0,0
3,GO TONGUE MORPHOGENESIS,0.53406,-0.0063555,-0.081003,0,0
3,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.78451,-0.006457,-0.013854,0,0
3,GO MAINTENANCE OF LOCATION,0.81581,-0.0065242,0.029893,0,0
3,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.75048,-0.006526,0.028892,0,0
3,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.70486,-0.00653,0.03971,0,0
3,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.80012,-0.0065357,0.005039,0,0
3,GO RECOMBINATIONAL REPAIR,0.67798,-0.0065683,-0.012917,0,0
3,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,1,-0.0067414,0.011993,0,0
3,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.63408,-0.0068206,0.0020303,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.95639,-0.0068442,0.021915,0,0
3,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.97899,-0.0068609,-0.0021614,0,0
3,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.90488,-0.006954,-0.00013253,0,0
3,GO DEFENSE RESPONSE TO FUNGUS,0.80639,-0.0070511,0.0015032,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.64858,-0.0070976,-0.027505,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.2458,-0.0071396,-0.059535,0,0
3,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.9113,-0.0071755,0.011375,0,0
3,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.87606,-0.0072203,0.022336,0,0
3,GO CHROMATIN SILENCING AT TELOMERE,0.50516,-0.0072417,0.038697,0,0
3,GO CALCIUM MEDIATED SIGNALING,0.70787,-0.0072909,-0.0034063,0,0
3,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.66321,-0.0073594,-0.0083869,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.42838,-0.0076487,-0.008953,0,0
3,GO CELL PROJECTION ORGANIZATION,0.90809,-0.0076564,0.0096586,0,0
3,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.80012,-0.0076884,0.0097058,0,0
3,GO REGULATION OF CHROMOSOME SEPARATION,0.80012,-0.0077458,0.016489,0,0
3,GO MACROMOLECULE CATABOLIC PROCESS,0.59144,-0.0077936,0.00040332,0,0
3,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.40058,-0.0078303,-0.030147,0,0
3,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.77829,-0.0078936,0.038688,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.40743,-0.0079047,-0.010121,0,0
3,GO CENTRIOLE CENTRIOLE COHESION,0.81896,-0.008,0.0008992,0,0
3,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.35463,-0.008107,0.069301,0,0
3,GO CELL CYCLE G2 M PHASE TRANSITION,0.58307,-0.008191,-0.0093708,0,0
3,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.86012,-0.0082269,-0.011846,0,0
3,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.75972,-0.0082569,-0.0054905,0,0
3,GO REGULATION OF MACROAUTOPHAGY,0.26267,-0.0082619,-0.0095724,0,0
3,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.77519,-0.0083968,-0.01932,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.45972,-0.0084562,-0.036626,0,0
3,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.67206,-0.0084786,-0.006064,0,0
3,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.59424,-0.0085635,0.042203,0,0
3,GO FOREBRAIN DEVELOPMENT,0.98869,-0.0086626,0.016379,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.58585,-0.0086824,-0.023798,0,0
3,GO NEURON APOPTOTIC PROCESS,0.30255,-0.0088294,-0.014941,0,0
3,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.94993,-0.0088626,0.014,0,0
3,GO CELLULAR RESPONSE TO COPPER ION,0.19417,-0.0089465,-0.14647,0,0
3,GO REGULATION OF PROTEIN POLYMERIZATION,0.65734,-0.0089563,-0.00014712,0,0
3,GO REGULATION OF CELLULAR COMPONENT SIZE,0.72299,-0.0089867,0.0068103,0,0
3,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.87287,-0.0090213,0.012286,0,0
3,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.88245,-0.0090435,0.026694,0,0
3,GO REGULATION OF DNA REPAIR,0.68689,-0.0091265,-0.0041727,0,0
3,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.33803,-0.0091646,0.076361,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.78451,-0.0093633,-0.017218,0,0
3,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.9306,-0.0093732,0.012865,0,0
3,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.5665,-0.0093998,0.051185,0,0
3,GO DRUG METABOLIC PROCESS,0.61687,-0.0094058,-0.02903,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.51819,-0.0094625,-0.0099347,0,0
3,GO TERPENOID METABOLIC PROCESS,0.52874,-0.009505,-0.029462,0,0
3,GO PROTEIN ACYLATION,0.48468,-0.0095952,-0.006662,0,0
3,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.99515,-0.0098096,0.011985,0,0
3,GO PHOTOPERIODISM,0.66028,-0.009888,-0.016883,0,0
3,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.22503,-0.0099202,-0.025885,0,0
3,GO TRANSITION METAL ION TRANSPORT,0.71996,-0.010185,-0.0045463,0,0
3,GO PROTEIN POLYGLUTAMYLATION,0.58307,-0.010194,-0.026575,0,0
3,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.80326,-0.01024,0.022884,0,0
3,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.8379,-0.010515,0.011383,0,0
3,GO HINDBRAIN MORPHOGENESIS,0.9693,-0.010555,0.01413,0,0
3,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.59705,-0.010628,-0.027369,0,0
3,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.51819,-0.010825,-0.035433,0,0
3,GO MIDBRAIN DEVELOPMENT,0.31215,-0.010902,-0.031767,0,0
3,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.82526,-0.010922,-0.010415,0,0
3,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.19557,-0.010935,-0.02479,0,0
3,GO URETER DEVELOPMENT,0.47461,-0.010998,-0.091715,0,0
3,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.93704,-0.011039,0.0093544,0,0
3,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.46713,-0.011055,-0.03993,0,0
3,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.41666,-0.011057,-0.0023982,0,0
3,GO POLYSACCHARIDE CATABOLIC PROCESS,0.74435,-0.011086,-0.00049953,0,0
3,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.64567,-0.011106,-0.022999,0,0
3,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.62545,-0.011218,-0.0042668,0,0
3,GO CLATHRIN DEPENDENT ENDOCYTOSIS,1,-0.011237,0.020589,0,0
3,GO REGULATION OF CHROMOSOME ORGANIZATION,0.61402,-0.011314,-0.0030084,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.54208,-0.011432,0.041135,0,0
3,GO ASYMMETRIC CELL DIVISION,0.64276,-0.01145,-0.028327,0,0
3,GO IRON ION TRANSPORT,0.77519,-0.011481,0.0035579,0,0
3,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.68988,-0.011606,-0.029851,0,0
3,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.80953,-0.011614,0.020687,0,0
3,GO PROTEIN POLYMERIZATION,0.53406,-0.011691,-0.0045909,0,0
3,GO CARTILAGE DEVELOPMENT,0.53672,-0.011751,-0.018195,0,0
3,GO OPTIC NERVE DEVELOPMENT,0.94993,-0.01183,0.0087178,0,0
3,GO REGULATION OF CELL PROJECTION SIZE,0.94026,-0.011903,-0.002811,0,0
3,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.76899,-0.011931,-0.023043,0,0
3,GO EXOCYTIC PROCESS,0.797,-0.01194,0.039214,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.17029,-0.011953,-0.05587,0,0
3,GO DORSAL AORTA DEVELOPMENT,0.55558,-0.012103,-0.039085,0,0
3,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.71996,-0.012124,0.015723,0,0
3,GO ACROSOME ASSEMBLY,0.60834,-0.012213,0.065172,0,0
3,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.97576,-0.012222,0.031944,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.52345,-0.012405,-0.009476,0,0
3,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.58307,-0.012485,-0.018232,0,0
3,GO VISUAL BEHAVIOR,0.88565,-0.012535,0.0052001,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.25246,-0.012559,-0.018646,0,0
3,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.17029,-0.012604,-0.053177,0,0
3,GO LIPID PHOSPHORYLATION,0.69586,-0.012616,0.0017953,0,0
3,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.38488,-0.012638,-0.020543,0,0
3,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.82842,-0.01266,-0.0069278,0,0
3,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.13549,-0.012737,-0.021992,0,0
3,GO RECEPTOR METABOLIC PROCESS,0.93704,-0.012747,0.020604,0,0
3,GO CARBOHYDRATE CATABOLIC PROCESS,0.6312,-0.012848,0.034127,0,0
3,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.90809,-0.012848,-0.0038739,0,0
3,GO DNA RECOMBINATION,0.26614,-0.012864,-0.027413,0,0
3,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.23927,-0.012958,-0.071446,0,0
3,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.42838,-0.012962,-0.037176,0,0
3,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.95316,-0.012998,0.023469,0,0
3,GO T CELL DIFFERENTIATION IN THYMUS,0.92416,-0.013007,-0.0022471,0,0
3,GO REGULATION OF URINE VOLUME,1,-0.013034,0.010753,0,0
3,GO HEXOSE CATABOLIC PROCESS,0.51296,-0.013172,0.046994,0,0
3,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.16407,-0.013226,-0.01982,0,0
3,GO REGULATION OF FEEDING BEHAVIOR,0.92094,-0.013264,0.010609,0,0
3,GO TAXIS,0.40058,-0.013422,-0.01218,0,0
3,GO PROTEIN ACETYLATION,0.45727,-0.013508,-0.0096351,0,0
3,GO DNA PACKAGING,0.49231,-0.013559,-0.010042,0,0
3,GO REGULATION OF CELLULAR LOCALIZATION,0.68988,-0.013807,0.005352,0,0
3,GO MIDDLE EAR MORPHOGENESIS,0.52609,-0.013928,-0.059781,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.28578,-0.013978,-0.016585,0,0
3,GO RESPONSE TO MONOSACCHARIDE,0.66321,-0.014117,0.0039158,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.83158,-0.014149,-0.0051761,0,0
3,GO CARDIAC VENTRICLE MORPHOGENESIS,0.71693,-0.014157,0.04007,0,0
3,GO ANION TRANSPORT,0.85059,-0.014183,0.0069963,0,0
3,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.95316,-0.014195,0.014476,0,0
3,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.9693,-0.014264,0.014309,0,0
3,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.51819,-0.014357,0.022124,0,0
3,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.46218,-0.014396,-0.01179,0,0
3,GO NUCLEAR BODY ORGANIZATION,0.78451,-0.014486,0.013538,0,0
3,GO BIOMINERALIZATION,0.35886,-0.014488,-0.031203,0,0
3,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.46466,-0.014511,-0.0032898,0,0
3,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.68988,-0.01453,-0.020206,0,0
3,GO RESPONSE TO RADIATION,0.38488,-0.01453,-0.0035621,0,0
3,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.5665,-0.014642,-0.002235,0,0
3,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.53406,-0.014682,-0.016677,0,0
3,GO SECOND MESSENGER MEDIATED SIGNALING,0.86331,-0.01472,0.018787,0,0
3,GO DNA STRAND ELONGATION,0.62258,-0.014838,0.0005712,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.69286,-0.014882,0.026903,0,0
3,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.91772,-0.01492,0.010658,0,0
3,GO REGULATION OF ATPASE ACTIVITY,0.80953,-0.014925,0.020428,0,0
3,GO HINDBRAIN DEVELOPMENT,0.89205,-0.015002,0.0096868,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.72603,-0.015008,-0.014729,0,0
3,GO STRIATED MUSCLE CELL PROLIFERATION,0.32393,-0.015094,-0.045049,0,0
3,GO PEPTIDYL LYSINE MODIFICATION,0.20845,-0.015096,-0.016851,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.19697,-0.015181,-0.089126,0,0
3,GO LONG CHAIN FATTY ACID TRANSPORT,0.91451,-0.01521,0.0038462,0,0
3,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.94671,-0.015272,-0.010167,0,0
3,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.22503,-0.015347,-0.022713,0,0
3,GO NEGATIVE REGULATION OF CELL CYCLE,0.077698,-0.015375,-0.029587,0,0
3,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.71391,-0.015419,0.04597,0,0
3,GO REGULATION OF VACUOLE ORGANIZATION,0.61117,-0.015476,-0.0022883,0,0
3,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.90809,-0.015534,0.0032421,0,0
3,GO HEART GROWTH,0.69586,-0.015563,0.0011565,0,0
3,GO MISMATCH REPAIR,0.63697,-0.015598,-0.0026022,0,0
3,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.40286,-0.015725,-0.044027,0,0
3,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.49487,-0.015802,-0.022065,0,0
3,GO REGULATION OF CHROMOSOME SEGREGATION,0.69286,-0.015818,-0.00018849,0,0
3,GO INTERACTION WITH SYMBIONT,0.93382,-0.015845,0.00083167,0,0
3,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.89846,-0.015868,-0.0094374,0,0
3,GO PHAGOSOME MATURATION,0.41203,-0.01593,-0.022091,0,0
3,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.9113,-0.015967,0.012537,0,0
3,GO REGULATION OF RECEPTOR RECYCLING,0.51296,-0.01602,-0.023935,0,0
3,GO CELL CYCLE G1 S PHASE TRANSITION,0.30637,-0.016128,-0.022382,0,0
3,GO HAIR FOLLICLE MATURATION,0.26964,-0.016302,-0.063946,0,0
3,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.77519,-0.016321,0.0038151,0,0
3,GO HISTONE H3 K14 ACETYLATION,0.33194,-0.016389,-0.038936,0,0
3,GO INTRACELLULAR TRANSPORT,0.41203,-0.016457,-0.0020729,0,0
3,GO RESPONSE TO CARBOHYDRATE,0.55287,-0.016483,0.0011386,0,0
3,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.14869,-0.016566,-0.034725,0,0
3,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.44269,-0.016591,0.038335,0,0
3,GO SPINAL CORD DEVELOPMENT,0.56376,-0.016604,-0.018536,0,0
3,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.90809,-0.01671,-0.001098,0,0
3,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.87287,-0.016771,0.029518,0,0
3,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.43789,-0.016873,-0.04027,0,0
3,GO GROWTH HORMONE SECRETION,0.43075,-0.01705,-0.033214,0,0
3,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.59144,-0.017053,-0.03872,0,0
3,GO SOMITE DEVELOPMENT,0.45727,-0.017101,-0.023316,0,0
3,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.2458,-0.017107,-0.048195,0,0
3,GO MITOTIC RECOMBINATION,0.79075,-0.017269,0.012109,0,0
3,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.72603,-0.017301,0.026603,0,0
3,GO HEMIDESMOSOME ASSEMBLY,0.46466,-0.017316,-0.11894,0,0
3,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.93382,-0.017371,0.018853,0,0
3,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.3442,-0.017372,-0.024575,0,0
3,GO NEGATIVE REGULATION OF GENE SILENCING,0.92416,-0.017517,0.013738,0,0
3,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.84741,-0.017604,0.034487,0,0
3,GO REGULATION OF HEART GROWTH,0.78763,-0.017631,0.024192,0,0
3,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.69586,-0.017637,0.022725,0,0
3,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.97576,-0.017649,-0.02769,0,0
3,GO REGULATION OF CELL DIFFERENTIATION,0.27317,-0.017658,-0.018563,0,0
3,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.59705,-0.017747,-0.019792,0,0
3,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.74741,-0.017848,-0.006905,0,0
3,GO DRUG CATABOLIC PROCESS,0.87606,-0.017873,-0.007834,0,0
3,GO CEREBRAL CORTEX DEVELOPMENT,0.86968,-0.018018,0.02209,0,0
3,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.47963,-0.018167,-0.020313,0,0
3,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.22503,-0.018315,-0.013927,0,0
3,GO DETOXIFICATION OF INORGANIC COMPOUND,0.64567,-0.0185,-0.14825,0,0
3,GO NUCLEOSOME ORGANIZATION,0.94671,-0.018531,0.0070903,0,0
3,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.42367,-0.01864,0.059223,0,0
3,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.14869,-0.018667,-0.090069,0,0
3,GO GLIOGENESIS,0.2714,-0.018803,-0.02641,0,0
3,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.29315,-0.018894,-0.053826,0,0
3,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.71089,-0.018946,0.052277,0,0
3,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.95639,-0.01895,0.017017,0,0
3,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.84107,-0.019073,0.0073037,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.48468,-0.019117,0.058369,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.81581,-0.019213,-0.012994,0,0
3,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.96607,-0.019355,0.015596,0,0
3,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.38933,-0.019372,-0.037625,0,0
3,GO REGULATION OF CARTILAGE DEVELOPMENT,0.11647,-0.019417,-0.083585,0,0
3,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.69586,-0.019553,-0.0051107,0,0
3,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.79387,-0.019581,0.043465,0,0
3,GO MESODERMAL CELL DIFFERENTIATION,0.74741,-0.019592,-0.023903,0,0
3,GO SNRNA TRANSCRIPTION,0.89205,-0.019682,0.0094617,0,0
3,GO NON CANONICAL WNT SIGNALING PATHWAY,0.91451,-0.019688,0.011297,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE,0.6691,-0.01969,-0.011445,0,0
3,GO RESPONSE TO RETINOIC ACID,0.21889,-0.019723,-0.041842,0,0
3,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.66616,-0.019724,0.0099759,0,0
3,GO NOREPINEPHRINE METABOLIC PROCESS,0.44752,-0.019729,-0.033795,0,0
3,GO MITOCHONDRION MORPHOGENESIS,0.75664,-0.019729,0.0329,0,0
3,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.94993,-0.019756,0.0072204,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.7659,-0.019888,0.010566,0,0
3,GO RESPONSE TO AUDITORY STIMULUS,0.74435,-0.019903,-0.0044849,0,0
3,GO SENSORY PERCEPTION OF PAIN,0.76899,-0.019925,-0.00018159,0,0
3,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.40286,-0.019989,-0.012493,0,0
3,GO NEGATIVE REGULATION OF RNA SPLICING,0.82526,-0.020062,0.036661,0,0
3,GO TRANSITION METAL ION HOMEOSTASIS,0.89205,-0.020118,0.016074,0,0
3,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.4451,-0.020195,-0.016353,0,0
3,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.77209,-0.020231,0.03288,0,0
3,GO IMPORT INTO NUCLEUS,0.33396,-0.020242,-0.016173,0,0
3,GO RESPONSE TO ACID CHEMICAL,0.68094,-0.020247,0.0077518,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.091558,-0.020264,-0.043178,0,0
3,GO INTERMEDIATE FILAMENT ORGANIZATION,0.46466,-0.02037,-0.045341,0,0
3,GO REGULATION OF MICROTUBULE BASED PROCESS,0.52082,-0.020425,-0.011326,0,0
3,GO CHOLESTEROL STORAGE,0.75972,-0.020512,0.027211,0,0
3,GO REGULATION OF ACTION POTENTIAL,0.69586,-0.02052,-0.009803,0,0
3,GO DNA CONFORMATION CHANGE,0.66028,-0.020656,-0.0027044,0,0
3,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.52082,-0.020665,-0.034475,0,0
3,GO RESPONSE TO PROSTAGLANDIN,0.99515,-0.020748,0.00016522,0,0
3,GO MACROMOLECULE DEACYLATION,0.80953,-0.02104,0.0070057,0,0
3,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.49231,-0.02108,-0.018589,0,0
3,GO REGULATION OF TORC1 SIGNALING,0.99838,-0.021245,0.014496,0,0
3,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.39381,-0.021344,-0.0078108,0,0
3,GO NEGATIVE REGULATION OF AUTOPHAGY,0.60268,-0.02143,-0.0019226,0,0
3,GO REGULATION OF TELOMERASE ACTIVITY,0.59705,-0.021448,-0.0052152,0,0
3,GO PROTEIN LOCALIZATION TO LYSOSOME,0.72907,-0.021474,-0.0084878,0,0
3,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.89526,-0.021551,-0.024238,0,0
3,GO PROTEIN TARGETING TO LYSOSOME,0.2714,-0.021669,-0.065027,0,0
3,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.43312,-0.021699,-0.031082,0,0
3,GO CELL CYCLE PHASE TRANSITION,0.15565,-0.021853,-0.023931,0,0
3,GO CALCIUM ION IMPORT,0.84741,-0.021854,0.02928,0,0
3,GO REGULATION OF BONE MINERALIZATION,0.2458,-0.021872,-0.051312,0,0
3,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.27673,-0.022001,-0.061848,0,0
3,GO HISTONE H3 K4 METHYLATION,0.14755,-0.022029,-0.040598,0,0
3,GO NEUTRAL AMINO ACID TRANSPORT,0.30255,-0.022036,0.071768,0,0
3,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.58864,-0.022036,-0.021168,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.22503,-0.022239,-0.011843,0,0
3,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.54208,-0.022407,-0.071979,0,0
3,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.51557,-0.022445,-0.040146,0,0
3,GO STEROL TRANSPORT,0.47963,-0.022462,-0.017027,0,0
3,GO DOUBLE STRAND BREAK REPAIR,0.25246,-0.022561,-0.021603,0,0
3,GO RESPONSE TO DRUG,0.88565,-0.022591,0.016085,0,0
3,GO MICROTUBULE ANCHORING AT CENTROSOME,0.70787,-0.022619,-0.0087928,0,0
3,GO REGULATION OF PROTEIN STABILITY,0.20699,-0.022638,-0.018434,0,0
3,GO PROTEIN METHYLATION,0.33803,-0.022649,-0.013535,0,0
3,GO RESPONSE TO STEROL,0.53406,-0.022693,-0.005927,0,0
3,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.78451,-0.022704,0.0035802,0,0
3,GO REGULATION OF CATABOLIC PROCESS,0.34835,-0.022714,-0.0050633,0,0
3,GO ORGANIC ANION TRANSPORT,0.7814,-0.022724,0.0030668,0,0
3,GO OXIDATION REDUCTION PROCESS,0.80326,-0.022856,0.018741,0,0
3,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.67501,-0.02306,0.0054258,0,0
3,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.46962,-0.023068,-0.0042612,0,0
3,GO ACTIVATION OF MAPK ACTIVITY,0.14755,-0.023239,-0.032142,0,0
3,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.58029,-0.023258,-0.039536,0,0
3,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.72299,-0.023265,0.0017016,0,0
3,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.74435,-0.023268,-0.0030909,0,0
3,GO FEVER GENERATION,0.91772,-0.023293,-0.0046177,0,0
3,GO HEART MORPHOGENESIS,0.20554,-0.023304,-0.037087,0,0
3,GO POSITIVE REGULATION OF T CELL MIGRATION,0.62832,-0.023319,-0.017065,0,0
3,GO CELLULAR RESPONSE TO ZINC ION,0.85694,-0.023539,-0.053286,0,0
3,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.81267,-0.023564,0.026865,0,0
3,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.25924,-0.02375,-0.026037,0,0
3,GO REGULATION OF T CELL MIGRATION,0.37173,-0.023763,-0.030202,0,0
3,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.22042,-0.023764,-0.040471,0,0
3,GO LENS FIBER CELL DEVELOPMENT,0.38267,-0.023791,-0.047606,0,0
3,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.56103,-0.02391,-0.024268,0,0
3,GO HORMONE MEDIATED SIGNALING PATHWAY,0.090782,-0.023944,-0.042602,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.33599,-0.024002,-0.055746,0,0
3,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.78451,-0.024011,0.0018017,0,0
3,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.83474,-0.02402,4.752e-05,0,0
3,GO DNA REPLICATION,0.59144,-0.024029,-0.014603,0,0
3,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.86331,-0.0241,0.06443,0,0
3,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.42133,-0.024137,-0.009906,0,0
3,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.72603,-0.024296,0.0022035,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.94026,-0.024298,0.01856,0,0
3,GO TRANSPORT ALONG MICROTUBULE,0.93382,-0.024371,0.008808,0,0
3,GO REGULATION OF SULFUR METABOLIC PROCESS,0.82211,-0.024386,0.030045,0,0
3,GO COVALENT CHROMATIN MODIFICATION,0.18461,-0.024454,-0.020168,0,0
3,GO CONNECTIVE TISSUE DEVELOPMENT,0.20554,-0.024515,-0.043964,0,0
3,GO PROTEIN SUMOYLATION,0.33599,-0.024531,-0.014166,0,0
3,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.71089,-0.024595,-0.003805,0,0
3,GO PEPTIDYL LYSINE METHYLATION,0.25924,-0.024598,-0.020027,0,0
3,GO LYMPHOCYTE HOMEOSTASIS,0.5314,-0.024634,-0.022367,0,0
3,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.71693,-0.024638,0.00086324,0,0
3,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.62258,-0.024642,-0.033722,0,0
3,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.75048,-0.024695,0.0086375,0,0
3,GO RESPONSE TO ETHANOL,0.35886,-0.024752,-0.017112,0,0
3,GO MITOTIC SISTER CHROMATID SEGREGATION,0.14755,-0.024772,-0.030821,0,0
3,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.66028,-0.024806,0.038269,0,0
3,GO QUINONE METABOLIC PROCESS,0.055609,-0.024897,-0.13077,0,0
3,GO FATTY ACID TRANSPORT,0.86649,-0.024934,0.0059623,0,0
3,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.7814,-0.024991,-0.017951,0,0
3,GO RESPONSE TO STARVATION,0.1653,-0.025043,-0.031265,0,0
3,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.77209,-0.025051,0.028901,0,0
3,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.56925,-0.025153,-0.0078358,0,0
3,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.95961,-0.025295,-0.0064169,0,0
3,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.61972,-0.025432,0.057488,0,0
3,GO NEGATIVE REGULATION OF SIGNALING,0.10129,-0.025518,-0.027154,0,0
3,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.27853,-0.02567,-0.046492,0,0
3,GO VESICLE LOCALIZATION,0.10045,-0.025705,-0.033912,0,0
3,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.87926,-0.025726,0.0090094,0,0
3,GO DNA LIGATION,0.34835,-0.025843,-0.043335,0,0
3,GO TETRAPYRROLE METABOLIC PROCESS,0.797,-0.025994,0.01236,0,0
3,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.5665,-0.025997,-0.0076715,0,0
3,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.79387,-0.026009,0.037291,0,0
3,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.59705,-0.026073,-0.0082273,0,0
3,GO CELLULAR MACROMOLECULE LOCALIZATION,0.15214,-0.026131,-0.012436,0,0
3,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.45727,-0.026254,-0.012476,0,0
3,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.83474,-0.026497,0.0029423,0,0
3,GO EMBRYONIC EYE MORPHOGENESIS,0.39606,-0.026627,-0.026524,0,0
3,GO LINOLEIC ACID METABOLIC PROCESS,0.54477,-0.026682,-0.05532,0,0
3,GO RHYTHMIC BEHAVIOR,0.5314,-0.026695,-0.010751,0,0
3,GO REGULATION OF DNA METHYLATION,0.51296,-0.026751,-0.039365,0,0
3,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.35253,-0.026836,-0.011921,0,0
3,GO DERMATAN SULFATE METABOLIC PROCESS,0.73517,-0.026874,0.057648,0,0
3,GO CHROMATIN ORGANIZATION,0.079071,-0.026887,-0.032216,0,0
3,GO REGULATION OF GLIAL CELL MIGRATION,0.4355,-0.026918,-0.024288,0,0
3,GO REGULATION OF PROTEIN FOLDING,0.77519,-0.027012,-0.001702,0,0
3,GO ENERGY HOMEOSTASIS,0.52345,-0.027127,-0.027974,0,0
3,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.47963,-0.027171,-0.023996,0,0
3,GO ERROR PRONE TRANSLESION SYNTHESIS,0.12322,-0.027265,-0.046421,0,0
3,GO DNA CATABOLIC PROCESS,0.071119,-0.02729,-0.050851,0,0
3,GO LYMPH NODE DEVELOPMENT,0.71693,-0.027294,-0.015712,0,0
3,GO DENDRITIC CELL CHEMOTAXIS,0.14869,-0.027378,-0.084337,0,0
3,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.77829,-0.027458,0.0060819,0,0
3,GO POSITIVE THYMIC T CELL SELECTION,0.080464,-0.027542,-0.099619,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.89205,-0.027569,0.018573,0,0
3,GO REGULATION OF LYMPHOCYTE MIGRATION,0.32592,-0.02761,-0.032037,0,0
3,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.081877,-0.027646,-0.034672,0,0
3,GO ACTIN FILAMENT BASED MOVEMENT,0.72603,-0.027693,0.0088645,0,0
3,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.57476,-0.027697,0.054677,0,0
3,GO ANIMAL ORGAN MORPHOGENESIS,0.1387,-0.027845,-0.03623,0,0
3,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.41203,-0.027855,-0.031275,0,0
3,GO TRANSMISSION OF NERVE IMPULSE,0.80953,-0.027988,0.013708,0,0
3,GO ISOPRENOID METABOLIC PROCESS,0.40058,-0.028057,-0.031285,0,0
3,GO CELLULAR LIPID CATABOLIC PROCESS,0.3871,-0.028058,-0.022227,0,0
3,GO BONE MINERALIZATION,0.3442,-0.028103,-0.03221,0,0
3,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.46962,-0.028107,-0.0017847,0,0
3,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.77829,-0.028108,-0.011049,0,0
3,GO T CELL MIGRATION,0.40058,-0.02815,-0.035368,0,0
3,GO GRANULOCYTE DIFFERENTIATION,0.15921,-0.028173,-0.069502,0,0
3,GO CELLULAR HYPEROSMOTIC RESPONSE,0.74128,-0.028292,0.035652,0,0
3,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.46218,-0.028318,0.00082967,0,0
3,GO MACROPHAGE ACTIVATION,0.6055,-0.028409,-0.0089189,0,0
3,GO RESPONSE TO MAGNESIUM ION,0.31409,-0.02841,-0.073766,0,0
3,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.72907,-0.028414,-0.0084698,0,0
3,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.37608,-0.028525,-0.025883,0,0
3,GO REGULATION OF GLIOGENESIS,0.24416,-0.028568,-0.030749,0,0
3,GO NEURAL CREST CELL DIFFERENTIATION,0.99192,-0.028641,0.012271,0,0
3,GO PROSTATE GLAND GROWTH,0.57752,-0.028681,-0.093998,0,0
3,GO RESPONSE TO CHEMOKINE,0.46713,-0.02873,-0.024345,0,0
3,GO NEURAL RETINA DEVELOPMENT,0.72907,-0.028733,0.028699,0,0
3,GO CELL VOLUME HOMEOSTASIS,0.17156,-0.028735,-0.038577,0,0
3,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.84424,-0.028758,0.0074701,0,0
3,GO CHEMICAL HOMEOSTASIS,0.48722,-0.028808,-0.0071711,0,0
3,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.38488,-0.028842,-0.019473,0,0
3,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.94348,-0.028923,0.00085017,0,0
3,GO SENSORY PERCEPTION,0.32592,-0.028987,-0.018617,0,0
3,GO DETECTION OF TEMPERATURE STIMULUS,0.36098,-0.028987,0.098243,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.4451,-0.029064,-0.049831,0,0
3,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.85694,-0.029096,0.0096974,0,0
3,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.28033,-0.029259,-0.062014,0,0
3,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.79075,-0.029328,0.027762,0,0
3,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.68392,-0.029341,-0.00041051,0,0
3,GO MACROPHAGE PROLIFERATION,0.86331,-0.029468,-0.0067043,0,0
3,GO LYTIC VACUOLE ORGANIZATION,0.66321,-0.029511,-0.0088064,0,0
3,GO CLATHRIN COAT ASSEMBLY,0.89526,-0.029582,0.009246,0,0
3,GO LIPID CATABOLIC PROCESS,0.38933,-0.029599,-0.017015,0,0
3,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.84741,-0.029669,0.038487,0,0
3,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.89526,-0.029808,0.0081701,0,0
3,GO KERATAN SULFATE METABOLIC PROCESS,0.797,-0.029841,-0.00037607,0,0
3,GO CELLULAR RESPONSE TO CAMP,0.88565,-0.029858,0.028316,0,0
3,GO MODIFIED AMINO ACID TRANSPORT,0.50516,-0.029866,-0.031948,0,0
3,GO BLASTOCYST GROWTH,0.54746,-0.029924,-0.027357,0,0
3,GO CANONICAL WNT SIGNALING PATHWAY,0.26789,-0.029934,-0.021547,0,0
3,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.21437,-0.029935,-0.013286,0,0
3,GO SENSORY PERCEPTION OF SMELL,0.29877,-0.029938,-0.04738,0,0
3,GO UV DAMAGE EXCISION REPAIR,0.37608,-0.029982,-0.026562,0,0
3,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.59144,-0.030061,-0.024692,0,0
3,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.36741,-0.030112,-0.025913,0,0
3,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.75972,-0.030145,0.030372,0,0
3,GO REGULATION OF MITOPHAGY,0.21288,-0.030148,-0.043032,0,0
3,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.22503,-0.03018,-0.014523,0,0
3,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.42838,-0.030186,-0.013117,0,0
3,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.52874,-0.030266,-0.0096715,0,0
3,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.58029,-0.030294,-0.098999,0,0
3,GO REGULATION OF PROTEIN ACETYLATION,0.1453,-0.030322,-0.037033,0,0
3,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.47461,-0.030397,-0.026158,0,0
3,GO DNA BIOSYNTHETIC PROCESS,0.23766,-0.030408,-0.010101,0,0
3,GO BASE EXCISION REPAIR AP SITE FORMATION,0.6055,-0.030435,-0.025229,0,0
3,GO STEM CELL DIFFERENTIATION,0.17156,-0.030439,-0.032887,0,0
3,GO SMALL MOLECULE CATABOLIC PROCESS,0.1653,-0.030448,-0.030471,0,0
3,GO CELL CELL SIGNALING BY WNT,0.43789,-0.030526,-0.011104,0,0
3,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.5394,-0.030659,-0.018652,0,0
3,GO RESPONSE TO FATTY ACID,0.68392,-0.030793,-0.0032479,0,0
3,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.19278,-0.030858,-0.048742,0,0
3,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.5665,-0.030874,-0.076668,0,0
3,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.32195,-0.030899,-0.008789,0,0
3,GO CARBOHYDRATE HOMEOSTASIS,0.51819,-0.030956,-0.0053992,0,0
3,GO REGULATION OF BINDING,0.18461,-0.031263,-0.02019,0,0
3,GO ALCOHOL CATABOLIC PROCESS,0.39606,-0.031333,-0.043474,0,0
3,GO HEAD DEVELOPMENT,0.60834,-0.031347,0.00032448,0,0
3,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.39381,-0.031364,-0.020499,0,0
3,GO OLIGODENDROCYTE DEVELOPMENT,0.18327,-0.031483,-0.057672,0,0
3,GO POSITIVE REGULATION OF EXOCYTOSIS,0.41203,-0.031517,-0.018423,0,0
3,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.53406,-0.031521,-0.0077649,0,0
3,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.46713,-0.031587,-0.03086,0,0
3,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.84424,-0.031711,-0.0010465,0,0
3,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.82526,-0.031727,0.048342,0,0
3,GO CARDIAC MUSCLE CELL PROLIFERATION,0.86331,-0.031763,-0.0039338,0,0
3,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.88245,-0.031838,0.0088705,0,0
3,GO GENE SILENCING,0.20554,-0.031854,-0.017949,0,0
3,GO STEROID CATABOLIC PROCESS,0.44269,-0.031881,-0.050875,0,0
3,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.38933,-0.031966,-0.020845,0,0
3,GO ORGANELLE MEMBRANE FUSION,0.34213,-0.031994,-0.019552,0,0
3,GO MEMBRANE ORGANIZATION,0.12224,-0.032032,-0.022816,0,0
3,GO PEROXISOMAL TRANSPORT,0.52082,-0.032038,-0.013182,0,0
3,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.33803,-0.032099,-0.027395,0,0
3,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.572,-0.03214,-0.0044045,0,0
3,GO VITAMIN BIOSYNTHETIC PROCESS,0.88245,-0.03216,0.015345,0,0
3,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.797,-0.032209,0.0031303,0,0
3,GO DETECTION OF ABIOTIC STIMULUS,0.40973,-0.032237,0.0087148,0,0
3,GO POSITIVE REGULATION OF CELL AGING,0.19278,-0.032343,-0.07298,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.24745,-0.032446,-0.033264,0,0
3,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.2114,-0.0327,-0.032047,0,0
3,GO RETINOIC ACID METABOLIC PROCESS,0.3871,-0.032738,-0.067247,0,0
3,GO NEGATIVE REGULATION OF CELL GROWTH,0.24745,-0.032741,-0.014216,0,0
3,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.54477,-0.032868,0.0030789,0,0
3,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.19557,-0.032912,-0.030012,0,0
3,GO SKELETAL SYSTEM DEVELOPMENT,0.13027,-0.033055,-0.042581,0,0
3,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.90809,-0.033102,0.014098,0,0
3,GO CARDIAC CHAMBER DEVELOPMENT,0.58864,-0.033113,-0.0036606,0,0
3,GO POTASSIUM ION HOMEOSTASIS,0.65442,-0.033195,-0.007545,0,0
3,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.57476,-0.033206,-0.033153,0,0
3,GO C4 DICARBOXYLATE TRANSPORT,0.59705,-0.0333,0.048503,0,0
3,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.27853,-0.033322,-0.01257,0,0
3,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.48722,-0.033352,-0.0085633,0,0
3,GO HISTONE DEACETYLATION,0.48976,-0.033422,-0.0096111,0,0
3,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.1252,-0.033424,-0.032325,0,0
3,GO PROTEIN AUTOPROCESSING,0.36956,-0.033434,-0.029557,0,0
3,GO MUSCLE TISSUE DEVELOPMENT,0.080464,-0.033491,-0.042498,0,0
3,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.41666,-0.033502,0.090733,0,0
3,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.094715,-0.033536,-0.07974,0,0
3,GO MEMBRANE BIOGENESIS,0.53672,-0.033581,-0.029374,0,0
3,GO RESPONSE TO X RAY,0.33194,-0.033653,-0.055347,0,0
3,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.061549,-0.033735,-0.038708,0,0
3,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.4355,-0.03377,-0.017946,0,0
3,GO NEUROINFLAMMATORY RESPONSE,0.69885,-0.033939,-0.0065814,0,0
3,GO MITOPHAGY,0.22195,-0.033994,-0.032859,0,0
3,GO HEAD MORPHOGENESIS,0.10823,-0.034049,-0.076816,0,0
3,GO REGULATION OF WNT SIGNALING PATHWAY,0.25078,-0.034176,-0.024337,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.68689,-0.034302,-0.0091362,0,0
3,GO REGULATION OF ODONTOGENESIS,0.75048,-0.034376,-0.034913,0,0
3,GO STEROID ESTERIFICATION,0.70185,-0.034391,-0.044603,0,0
3,GO LYMPH VESSEL DEVELOPMENT,0.65442,-0.034402,-0.021913,0,0
3,GO CARDIAC SEPTUM DEVELOPMENT,0.76281,-0.034449,-0.0019187,0,0
3,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.84741,-0.034469,0.014298,0,0
3,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.74128,-0.034543,-0.0016418,0,0
3,GO REGULATION OF MULTI ORGANISM PROCESS,0.41899,-0.034572,-0.013895,0,0
3,GO PHOSPHOLIPID CATABOLIC PROCESS,0.18062,-0.034581,-0.063392,0,0
3,GO AMELOGENESIS,0.63697,-0.034684,-0.027008,0,0
3,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.79075,-0.034685,0.0018769,0,0
3,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.7659,-0.034707,0.028648,0,0
3,GO REGULATION OF MUSCLE CONTRACTION,0.22042,-0.03474,-0.029279,0,0
3,GO MESENCHYME DEVELOPMENT,0.33599,-0.03476,-0.031594,0,0
3,GO ORGANIC ACID METABOLIC PROCESS,0.64567,-0.034819,0.0024385,0,0
3,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.32792,-0.034837,-0.041888,0,0
3,GO CHROMOSOME ORGANIZATION,0.096327,-0.034958,-0.023769,0,0
3,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.37827,-0.034966,-0.0096098,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.11367,-0.035181,-0.023822,0,0
3,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.85694,-0.03534,0.0075947,0,0
3,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.24745,-0.035371,-0.02799,0,0
3,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.36956,-0.035507,-0.021703,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.20122,-0.035535,-0.076493,0,0
3,GO ACID SECRETION,0.67798,-0.035605,-0.014168,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.13656,-0.03572,-0.091359,0,0
3,GO RHYTHMIC PROCESS,0.1873,-0.035722,-0.016255,0,0
3,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.077018,-0.035805,-0.032255,0,0
3,GO FERTILIZATION,0.11553,-0.035845,-0.025866,0,0
3,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.062684,-0.035855,-0.040297,0,0
3,GO BLASTODERM SEGMENTATION,0.37608,-0.035859,0.09407,0,0
3,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.14755,-0.035891,-0.065357,0,0
3,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.10214,-0.035946,-0.11153,0,0
3,GO RESPONSE TO ABIOTIC STIMULUS,0.19838,-0.036113,-0.015212,0,0
3,GO REGULATION OF PHOSPHATASE ACTIVITY,0.064418,-0.036248,-0.055396,0,0
3,GO REGULATION OF CALCIUM ION IMPORT,0.89846,-0.036258,0.0041168,0,0
3,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.49487,-0.036267,-0.0089563,0,0
3,GO FOREGUT MORPHOGENESIS,0.28578,-0.036498,-0.068742,0,0
3,GO TRABECULA MORPHOGENESIS,0.35674,-0.036542,-0.031507,0,0
3,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.64276,-0.036549,-0.045851,0,0
3,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.40514,-0.036566,-0.023575,0,0
3,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.15683,-0.036599,-0.052557,0,0
3,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.55016,-0.036654,-0.010807,0,0
3,GO VITAMIN METABOLIC PROCESS,0.58864,-0.036676,-0.0053924,0,0
3,GO PROTEIN LOCALIZATION TO NUCLEUS,0.078382,-0.036737,-0.03733,0,0
3,GO HOMEOSTATIC PROCESS,0.076344,-0.036764,-0.026846,0,0
3,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.44994,-0.036777,-0.014547,0,0
3,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.53672,-0.036793,-0.016624,0,0
3,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.26964,-0.036828,-0.029266,0,0
3,GO ORGANELLE INHERITANCE,0.41203,-0.036923,-0.015281,0,0
3,GO PEPTIDYL LYSINE TRIMETHYLATION,0.26095,-0.037008,-0.027833,0,0
3,GO MEIOTIC CHROMOSOME SEPARATION,0.027401,-0.037063,-0.095458,0,0
3,GO REGULATION OF CELL CYCLE PROCESS,0.08331,-0.037071,-0.026937,0,0
3,GO HISTONE PHOSPHORYLATION,0.34835,-0.037099,-0.030842,0,0
3,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.11183,-0.037149,-0.02943,0,0
3,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.16904,-0.037264,-0.050563,0,0
3,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.26789,-0.037386,-0.039348,0,0
3,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.94348,-0.037606,-0.0037532,0,0
3,GO CERAMIDE METABOLIC PROCESS,0.085497,-0.037711,-0.049182,0,0
3,GO MYELIN ASSEMBLY,0.68988,-0.037763,0.047821,0,0
3,GO LUNG ALVEOLUS DEVELOPMENT,0.28213,-0.037783,-0.038845,0,0
3,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.75048,-0.037835,-0.015394,0,0
3,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.86649,-0.037897,0.025327,0,0
3,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.48215,-0.037933,-0.034108,0,0
3,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.12822,-0.037955,-0.048081,0,0
3,GO FEMALE SEX DIFFERENTIATION,0.36526,-0.037982,-0.020037,0,0
3,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.19417,-0.038003,-0.012505,0,0
3,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.14755,-0.038061,-0.027241,0,0
3,GO POSITIVE REGULATION OF DNA REPAIR,0.37173,-0.038069,-0.016144,0,0
3,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.28213,-0.038089,-0.015185,0,0
3,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.4451,-0.038259,-0.021295,0,0
3,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.062684,-0.03832,-0.078267,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.75356,-0.038327,-0.0022996,0,0
3,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.90488,-0.038378,0.014894,0,0
3,GO REGULATION OF CELL AGING,0.22042,-0.03838,-0.052443,0,0
3,GO LAMELLIPODIUM ASSEMBLY,0.16285,-0.038477,-0.038288,0,0
3,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.44028,-0.038505,-0.017336,0,0
3,GO NEUTRAL LIPID METABOLIC PROCESS,0.45238,-0.038583,-0.0084994,0,0
3,GO REGULATION OF AUTOPHAGY,0.077698,-0.038621,-0.022662,0,0
3,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.19838,-0.038632,-0.07354,0,0
3,GO CELL CELL RECOGNITION,0.29877,-0.038742,-0.024398,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.28395,-0.038761,-0.070021,0,0
3,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.3739,-0.038833,-0.032071,0,0
3,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.51819,-0.038913,-0.021601,0,0
3,GO CARBOHYDRATE METABOLIC PROCESS,0.34213,-0.039008,-0.0052076,0,0
3,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.12322,-0.039296,-0.034785,0,0
3,GO HISTONE H3 K9 ACETYLATION,0.22195,-0.039317,-0.051437,0,0
3,GO REGULATION OF PROTEIN MATURATION,0.23286,-0.039324,-0.035519,0,0
3,GO RESPONSE TO CORTICOSTERONE,0.52874,-0.039408,-0.033589,0,0
3,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.26964,-0.039416,-0.018705,0,0
3,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.065596,-0.039435,-0.039743,0,0
3,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.28213,-0.039447,-0.027546,0,0
3,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.45238,-0.039457,-0.010061,0,0
3,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.088486,-0.039465,-0.029604,0,0
3,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.067397,-0.039473,-0.044235,0,0
3,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.49487,-0.039486,-0.023164,0,0
3,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.1252,-0.039584,-0.042785,0,0
3,GO KERATAN SULFATE CATABOLIC PROCESS,0.95961,-0.039597,-0.013179,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.25414,-0.039611,-0.11965,0,0
3,GO MITOTIC SISTER CHROMATID COHESION,0.4451,-0.039718,-0.035812,0,0
3,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.090011,-0.039973,-0.02671,0,0
3,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.10045,-0.040002,-0.036358,0,0
3,GO INOSITOL LIPID MEDIATED SIGNALING,0.079071,-0.04005,-0.059143,0,0
3,GO CELL CYCLE PROCESS,0.08331,-0.040076,-0.02479,0,0
3,GO REGULATION OF TRANSPORT,0.2644,-0.040213,-0.012999,0,0
3,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.69885,-0.040215,-0.022549,0,0
3,GO ENERGY RESERVE METABOLIC PROCESS,0.28761,-0.040351,-0.018701,0,0
3,GO ORGANIC ACID CATABOLIC PROCESS,0.25414,-0.04038,-0.029363,0,0
3,GO REGULATION OF HELICASE ACTIVITY,0.19417,-0.040445,-0.069778,0,0
3,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.069238,-0.040465,-0.0741,0,0
3,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.64276,-0.040532,-0.014268,0,0
3,GO MESENCHYMAL CELL DIFFERENTIATION,0.14869,-0.040591,-0.050505,0,0
3,GO LYSOSOME LOCALIZATION,0.086981,-0.040648,-0.066486,0,0
3,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.33599,-0.040651,-0.021117,0,0
3,GO FATTY ACID BIOSYNTHETIC PROCESS,0.18595,-0.040705,-0.045434,0,0
3,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.11553,-0.040756,-0.032142,0,0
3,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.13234,-0.040759,-0.031169,0,0
3,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.10646,-0.040822,0.1164,0,0
3,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.064418,-0.040829,-0.028339,0,0
3,GO T CELL RECEPTOR SIGNALING PATHWAY,0.14642,-0.040956,-0.053883,0,0
3,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.36098,-0.04101,-0.048456,0,0
3,GO RECEPTOR RECYCLING,0.46962,-0.041053,-0.013176,0,0
3,GO CYSTEINE METABOLIC PROCESS,0.98222,-0.041201,0.0090443,0,0
3,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.48215,-0.04134,-0.016636,0,0
3,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.73212,-0.041381,0.037488,0,0
3,GO ARACHIDONIC ACID SECRETION,0.49743,-0.041467,-0.027756,0,0
3,GO MEMBRANE INVAGINATION,0.12822,-0.041494,-0.052355,0,0
3,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.1453,-0.041845,-0.029776,0,0
3,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.45972,-0.041858,-0.03351,0,0
3,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.19278,-0.041885,-0.019058,0,0
3,GO ORGANELLE FUSION,0.32993,-0.041899,-0.015804,0,0
3,GO REGENERATION,0.28578,-0.042025,-0.026107,0,0
3,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.22814,-0.042075,-0.025372,0,0
3,GO HEART DEVELOPMENT,0.087731,-0.042166,-0.045468,0,0
3,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.23927,-0.042204,-0.059408,0,0
3,GO POSITIVE REGULATION OF MAPK CASCADE,0.14197,-0.042208,-0.031827,0,0
3,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.99515,-0.042254,0.012093,0,0
3,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.075009,-0.042279,-0.042446,0,0
3,GO 3 UTR MEDIATED MRNA STABILIZATION,0.70787,-0.042536,-0.029716,0,0
3,GO CENTROMERE COMPLEX ASSEMBLY,0.49231,-0.042586,-0.023204,0,0
3,GO CERAMIDE BIOSYNTHETIC PROCESS,0.1387,-0.042669,-0.046731,0,0
3,GO CELL SUBSTRATE ADHESION,0.21587,-0.04269,-0.044656,0,0
3,GO DETECTION OF BIOTIC STIMULUS,0.61687,-0.042755,-0.049994,0,0
3,GO LIPOPROTEIN CATABOLIC PROCESS,0.73822,-0.042953,-0.012646,0,0
3,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.31604,-0.04303,-0.0069404,0,0
3,GO HISTONE H2A ACETYLATION,0.1754,-0.043034,-0.047559,0,0
3,GO HISTONE H4 K5 ACETYLATION,0.55558,-0.04316,-0.01074,0,0
3,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.45482,-0.043263,-0.025928,0,0
3,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.14197,-0.043317,-0.055037,0,0
3,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.68094,-0.043592,-0.0084103,0,0
3,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.22195,-0.043612,-0.059839,0,0
3,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.36741,-0.043699,-0.013529,0,0
3,GO RESPONSE TO INSULIN,0.074349,-0.043731,-0.032906,0,0
3,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.84741,-0.04388,-0.03694,0,0
3,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.090011,-0.043984,-0.090216,0,0
3,GO TISSUE REGENERATION,0.14642,-0.044008,-0.06739,0,0
3,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.85059,-0.044047,0.010186,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.72299,-0.044147,0.0087819,0,0
3,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.11275,-0.044175,-0.05695,0,0
3,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.56103,-0.044349,-0.05944,0,0
3,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.79387,-0.044452,-0.0025723,0,0
3,GO REGULATION OF ORGANELLE ORGANIZATION,0.067397,-0.044584,-0.020603,0,0
3,GO INTERLEUKIN 2 PRODUCTION,0.52609,-0.044651,-0.038155,0,0
3,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.1793,-0.044702,-0.048195,0,0
3,GO RESPONSE TO PEPTIDE,0.084763,-0.044704,-0.02826,0,0
3,GO REGULATION OF MAPK CASCADE,0.064418,-0.044721,-0.042789,0,0
3,GO RESPONSE TO PEPTIDE HORMONE,0.084034,-0.044726,-0.0281,0,0
3,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.1387,-0.044772,-0.068565,0,0
3,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.97253,-0.044808,0.024762,0,0
3,GO PENILE ERECTION,0.87926,-0.044809,-0.0046867,0,0
3,GO PLATELET DEGRANULATION,0.36311,-0.044834,-0.046353,0,0
3,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.15683,-0.044835,-0.094985,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.12721,-0.044881,-0.059585,0,0
3,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.71693,-0.044947,0.028854,0,0
3,GO REGULATION OF REPRODUCTIVE PROCESS,0.051595,-0.044954,-0.037084,0,0
3,GO PROTEIN AUTOPHOSPHORYLATION,0.26964,-0.04497,-0.013837,0,0
3,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.86649,-0.044974,0.022161,0,0
3,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.42367,-0.044983,-0.042091,0,0
3,GO MICROTUBULE BASED MOVEMENT,0.18595,-0.044996,-0.031205,0,0
3,GO REGULATION OF HISTONE MODIFICATION,0.072397,-0.045154,-0.035233,0,0
3,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.38933,-0.045193,-0.037962,0,0
3,GO INTERFERON GAMMA PRODUCTION,0.19979,-0.045403,-0.052438,0,0
3,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.10471,-0.045451,-0.030765,0,0
3,GO FORMATION OF PRIMARY GERM LAYER,0.68988,-0.045552,-0.012411,0,0
3,GO OVULATION,0.37173,-0.045582,-0.048426,0,0
3,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.21437,-0.045642,-0.089545,0,0
3,GO PEROXISOME ORGANIZATION,0.41434,-0.045689,-0.017506,0,0
3,GO SOMITOGENESIS,0.21587,-0.045769,-0.037827,0,0
3,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.10214,-0.045774,-0.043605,0,0
3,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.070488,-0.045802,-0.033571,0,0
3,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.13338,-0.045923,-0.058317,0,0
3,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.72907,-0.045951,-0.0064209,0,0
3,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.5394,-0.046035,-0.021962,0,0
3,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.178,-0.046035,-0.035312,0,0
3,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.21288,-0.046042,-0.11976,0,0
3,GO REGULATION OF DNA METABOLIC PROCESS,0.20122,-0.046114,-0.014908,0,0
3,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.19838,-0.046248,-0.054684,0,0
3,GO MYOBLAST FUSION,0.30637,-0.046257,-0.057219,0,0
3,GO INCLUSION BODY ASSEMBLY,0.78451,-0.046291,0.065408,0,0
3,GO POLYSACCHARIDE METABOLIC PROCESS,0.10558,-0.046324,-0.047328,0,0
3,GO ALCOHOL METABOLIC PROCESS,0.30829,-0.046341,-0.020456,0,0
3,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.25583,-0.046448,-0.026598,0,0
3,GO ORGAN GROWTH,0.23605,-0.046609,-0.033141,0,0
3,GO PROTEIN N LINKED GLYCOSYLATION,0.086981,-0.046641,-0.054654,0,0
3,GO AMINE METABOLIC PROCESS,0.077698,-0.046722,-0.056723,0,0
3,GO ASTRAL MICROTUBULE ORGANIZATION,0.87287,-0.046743,-0.0019916,0,0
3,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.76899,-0.04675,-0.0064831,0,0
3,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.051595,-0.046803,-0.074975,0,0
3,GO BRAIN MORPHOGENESIS,0.51819,-0.046817,-0.024557,0,0
3,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.51819,-0.046885,-0.060321,0,0
3,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.81581,-0.046911,0.044775,0,0
3,GO SEMI LUNAR VALVE DEVELOPMENT,0.63986,-0.04699,-0.01873,0,0
3,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.318,-0.046999,-0.065641,0,0
3,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.51035,-0.047086,-0.011115,0,0
3,GO FILOPODIUM ASSEMBLY,0.64858,-0.047175,0.040118,0,0
3,GO NEURON PROJECTION REGENERATION,0.89205,-0.047211,0.0074834,0,0
3,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.42838,-0.047215,0.043281,0,0
3,GO ASTROCYTE DIFFERENTIATION,0.37827,-0.047264,-0.033706,0,0
3,GO REGULATION OF DNA REPLICATION,0.093918,-0.047332,-0.039051,0,0
3,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.55016,-0.047444,-0.037317,0,0
3,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.14197,-0.047477,-0.098941,0,0
3,GO P BODY ASSEMBLY,0.081168,-0.047556,-0.042688,0,0
3,GO GLYCOPROTEIN METABOLIC PROCESS,0.13549,-0.04757,-0.041937,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.1387,-0.047616,-0.096881,0,0
3,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.10558,-0.047641,-0.040969,0,0
3,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.38267,-0.047649,-0.024236,0,0
3,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.091558,-0.047659,-0.051851,0,0
3,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.1313,-0.047772,-0.035341,0,0
3,GO PANCREATIC JUICE SECRETION,0.29877,-0.047801,-0.047925,0,0
3,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.25246,-0.047813,-0.040763,0,0
3,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.22814,-0.047844,-0.069518,0,0
3,GO OOCYTE MATURATION,0.40743,-0.047858,-0.02077,0,0
3,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.62832,-0.047876,-0.0092465,0,0
3,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.20265,-0.047988,-0.047965,0,0
3,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.11933,-0.048087,-0.033051,0,0
3,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.49231,-0.04833,-0.0063967,0,0
3,GO SUBSTANTIA NIGRA DEVELOPMENT,0.36098,-0.048353,-0.038498,0,0
3,GO TRANSFERRIN TRANSPORT,0.21437,-0.048467,-0.033115,0,0
3,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.17669,-0.0485,-0.13739,0,0
3,GO LATERAL MESODERM DEVELOPMENT,0.27853,-0.048537,-0.087261,0,0
3,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.61972,-0.0486,-0.0092746,0,0
3,GO GLIAL CELL PROLIFERATION,0.17669,-0.048614,-0.074497,0,0
3,GO HISTONE H3 ACETYLATION,0.065596,-0.048661,-0.038287,0,0
3,GO NEGATIVE REGULATION OF GLIOGENESIS,0.072397,-0.048698,-0.092008,0,0
3,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.094715,-0.048838,-0.024863,0,0
3,GO ATP TRANSPORT,0.58864,-0.048953,-0.00054609,0,0
3,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.72299,-0.049008,-0.01626,0,0
3,GO STEROL HOMEOSTASIS,0.31604,-0.04912,-0.049436,0,0
3,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.38488,-0.049131,-0.019836,0,0
3,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.1262,-0.049157,-0.038334,0,0
3,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.10299,-0.049274,-0.039901,0,0
3,GO REGULATION OF PODOSOME ASSEMBLY,0.12721,-0.049542,-0.11266,0,0
3,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.25078,-0.049544,-0.067583,0,0
3,GO EMBRYO IMPLANTATION,0.26789,-0.049548,-0.056881,0,0
3,GO RESPONSE TO NITROGEN COMPOUND,0.10385,-0.049744,-0.023529,0,0
3,GO REGULATION OF ANION TRANSPORT,0.16163,-0.049753,-0.043168,0,0
3,GO PROTEIN LOCALIZATION TO CILIUM,0.15802,-0.0498,-0.057253,0,0
3,GO SODIUM ION HOMEOSTASIS,0.11837,-0.049859,-0.052953,0,0
3,GO I KAPPAB PHOSPHORYLATION,0.33803,-0.050142,-0.041852,0,0
3,GO SPERM EGG RECOGNITION,0.30829,-0.050144,-0.022999,0,0
3,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.59144,-0.050161,-0.034265,0,0
3,GO REGULATION OF NUCLEASE ACTIVITY,0.067397,-0.050187,-0.081743,0,0
3,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.42367,-0.050195,-0.02321,0,0
3,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.10471,-0.050197,-0.078235,0,0
3,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.94348,-0.050326,0.042482,0,0
3,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.3739,-0.050326,-0.044004,0,0
3,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.9693,-0.050347,0.007039,0,0
3,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.084034,-0.05059,-0.033036,0,0
3,GO REGULATION OF ORGAN GROWTH,0.70486,-0.050606,-0.0015567,0,0
3,GO NUCLEOSOME ASSEMBLY,0.38488,-0.05078,-0.024968,0,0
3,GO REGULATION OF MACROPHAGE ACTIVATION,0.39606,-0.051011,-0.041438,0,0
3,GO FOCAL ADHESION ASSEMBLY,0.1793,-0.051027,-0.04395,0,0
3,GO REGULATION OF DEACETYLASE ACTIVITY,0.23286,-0.051129,-0.049659,0,0
3,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.18194,-0.051178,-0.01881,0,0
3,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.062114,-0.051311,-0.032861,0,0
3,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.16285,-0.051376,-0.083495,0,0
3,GO STEM CELL DIVISION,0.33599,-0.051386,-0.045182,0,0
3,GO NEGATIVE REGULATION OF TRANSPORT,0.17029,-0.051434,-0.020245,0,0
3,GO MUSCLE FIBER DEVELOPMENT,0.20845,-0.051473,-0.04884,0,0
3,GO MANGANESE ION TRANSPORT,0.42367,-0.051577,-0.025548,0,0
3,GO OSSIFICATION,0.11647,-0.051653,-0.054862,0,0
3,GO MICROTUBULE BASED PROCESS,0.20122,-0.051669,-0.025323,0,0
3,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.35674,-0.051684,-0.092521,0,0
3,GO ERK1 AND ERK2 CASCADE,0.25924,-0.051915,-0.033206,0,0
3,GO NEURAL PRECURSOR CELL PROLIFERATION,0.1754,-0.051923,-0.031602,0,0
3,GO GLIAL CELL DIFFERENTIATION,0.22195,-0.052039,-0.030916,0,0
3,GO REGULATION OF TUBE SIZE,0.050154,-0.052045,-0.058867,0,0
3,GO REGULATION OF GASTRIC ACID SECRETION,0.13444,-0.052105,-0.090879,0,0
3,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.3871,-0.052166,-0.042822,0,0
3,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.08331,-0.0523,-0.094218,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.36956,-0.052341,-0.055008,0,0
3,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.071119,-0.052351,-0.033674,0,0
3,GO LYMPHANGIOGENESIS,0.48976,-0.05237,-0.036799,0,0
3,GO EXOCRINE SYSTEM DEVELOPMENT,0.44028,-0.052374,-0.035607,0,0
3,GO MUSCLE CELL APOPTOTIC PROCESS,0.30829,-0.052424,-0.02269,0,0
3,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.2644,-0.052433,-0.070253,0,0
3,GO CHONDROCYTE DEVELOPMENT,0.45482,-0.05255,-0.047208,0,0
3,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.30829,-0.052553,-0.034266,0,0
3,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.27317,-0.052695,-0.019424,0,0
3,GO AMYLOID BETA METABOLIC PROCESS,0.26614,-0.052861,-0.028624,0,0
3,GO LAMELLIPODIUM ORGANIZATION,0.12029,-0.05289,-0.046794,0,0
3,GO POSITIVE REGULATION OF TRANSPORT,0.062114,-0.05293,-0.032145,0,0
3,GO HIPPO SIGNALING,0.6312,-0.052936,-0.0314,0,0
3,GO REGULATION OF MYELINATION,0.72299,-0.053002,0.0054588,0,0
3,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.5314,-0.053035,0.00064547,0,0
3,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.20554,-0.053116,-0.038637,0,0
3,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.22658,-0.053123,-0.025713,0,0
3,GO ASTROCYTE DEVELOPMENT,0.5583,-0.053166,-0.021045,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.11647,-0.05317,-0.061908,0,0
3,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.23927,-0.053179,-0.03475,0,0
3,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.67501,-0.053201,-0.0070655,0,0
3,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.29502,-0.053219,-0.051851,0,0
3,GO MICROTUBULE BASED TRANSPORT,0.16285,-0.053233,-0.028885,0,0
3,GO POSITIVE REGULATION OF PROTEIN BINDING,0.36311,-0.053241,-0.013132,0,0
3,GO NUCLEOSIDE CATABOLIC PROCESS,0.1453,-0.053346,-0.077948,0,0
3,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.091558,-0.053529,-0.051644,0,0
3,GO REGULATION OF PROTEIN BINDING,0.14642,-0.053583,-0.027294,0,0
3,GO PROTEIN TARGETING TO VACUOLE,0.095518,-0.053586,-0.051691,0,0
3,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.75048,-0.053595,0.016985,0,0
3,GO RESPONSE TO NICOTINE,0.39606,-0.053639,-0.05142,0,0
3,GO MALE MEIOTIC NUCLEAR DIVISION,0.11837,-0.053659,-0.093746,0,0
3,GO JNK CASCADE,0.077018,-0.053711,-0.035601,0,0
3,GO CELLULAR RESPONSE TO KETONE,0.10558,-0.053755,-0.052531,0,0
3,GO REGULATION OF BEHAVIOR,0.67206,-0.053796,-6.3407e-05,0,0
3,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.12029,-0.053869,-0.027871,0,0
3,GO POSITIVE REGULATION OF CELL GROWTH,0.099614,-0.053882,-0.034038,0,0
3,GO RESPONSE TO TOXIC SUBSTANCE,0.13338,-0.053943,-0.039569,0,0
3,GO CELLULAR EXTRAVASATION,0.23927,-0.054065,-0.033326,0,0
3,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.08331,-0.054161,-0.047417,0,0
3,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.43312,-0.054176,-0.069151,0,0
3,GO MAST CELL MIGRATION,0.19417,-0.054382,-0.11374,0,0
3,GO PEPTIDYL CYSTEINE MODIFICATION,0.30829,-0.054394,-0.023089,0,0
3,GO PHOTORECEPTOR CELL MAINTENANCE,0.75356,-0.054708,0.020015,0,0
3,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.18595,-0.055097,-0.017587,0,0
3,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.20845,-0.055102,-0.028911,0,0
3,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.49487,-0.055224,-0.032862,0,0
3,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.46713,-0.055392,0.0036161,0,0
3,GO TONGUE DEVELOPMENT,0.086981,-0.055397,-0.1358,0,0
3,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.22195,-0.055608,-0.026077,0,0
3,GO OSTEOBLAST DIFFERENTIATION,0.40743,-0.055651,-0.027049,0,0
3,GO REGULATION OF BMP SIGNALING PATHWAY,0.48976,-0.055778,-0.020958,0,0
3,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.19838,-0.056013,-0.041064,0,0
3,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.30829,-0.056051,-0.058206,0,0
3,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.11933,-0.056209,-0.061423,0,0
3,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.29877,-0.056218,-0.082059,0,0
3,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.081877,-0.056268,-0.074826,0,0
3,GO GLUCOSE IMPORT,0.19003,-0.056495,-0.025445,0,0
3,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.22503,-0.056512,-0.1004,0,0
3,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.16904,-0.056591,-0.033278,0,0
3,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.23445,-0.056599,-0.049085,0,0
3,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.084763,-0.05684,-0.039778,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY,0.36311,-0.056849,-0.010719,0,0
3,GO REGULATION OF FATTY ACID OXIDATION,0.59144,-0.056883,-0.015164,0,0
3,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.086981,-0.057056,-0.051136,0,0
3,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.073694,-0.057105,-0.06496,0,0
3,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.088486,-0.057142,-0.029943,0,0
3,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.1313,-0.057181,-0.053415,0,0
3,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.1146,-0.057259,-0.035705,0,0
3,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.13979,-0.057274,-0.075711,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.11742,-0.057391,-0.070012,0,0
3,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.92738,-0.057417,0.0071443,0,0
3,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.10558,-0.057466,-0.032736,0,0
3,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.20699,-0.057471,-0.077474,0,0
3,GO REGULATION OF PHAGOCYTOSIS,0.093126,-0.057471,-0.069146,0,0
3,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.22042,-0.057494,-0.047612,0,0
3,GO MUSCLE STRUCTURE DEVELOPMENT,0.081877,-0.057521,-0.042715,0,0
3,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.48468,-0.057558,-0.034548,0,0
3,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.10385,-0.057587,-0.086877,0,0
3,GO SMOOTH MUSCLE CELL PROLIFERATION,0.20845,-0.057639,-0.050097,0,0
3,GO REGULATION OF STEM CELL PROLIFERATION,0.18461,-0.05764,-0.055726,0,0
3,GO THYMIC T CELL SELECTION,0.14869,-0.057677,-0.060753,0,0
3,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.33599,-0.05773,-0.02918,0,0
3,GO HINDLIMB MORPHOGENESIS,0.25414,-0.05779,-0.063961,0,0
3,GO MUSCLE CELL PROLIFERATION,0.16042,-0.057919,-0.049635,0,0
3,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.13549,-0.057956,-0.060025,0,0
3,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.318,-0.058498,-0.038136,0,0
3,GO REGULATION OF RENAL SYSTEM PROCESS,0.090782,-0.05863,-0.080399,0,0
3,GO LYMPHOCYTE MIGRATION,0.19278,-0.058663,-0.045999,0,0
3,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.11647,-0.058666,-0.038059,0,0
3,GO NEURAL TUBE PATTERNING,0.099614,-0.058754,-0.081954,0,0
3,GO CAMERA TYPE EYE DEVELOPMENT,0.20409,-0.058778,-0.028464,0,0
3,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.15565,-0.058823,-0.018054,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.11742,-0.058829,-0.076825,0,0
3,GO RESPONSE TO INTERLEUKIN 15,0.08331,-0.058979,-0.095147,0,0
3,GO REGULATION OF GLUCOSE IMPORT,0.25078,-0.059101,-0.032249,0,0
3,GO REGULATION OF INSULIN SECRETION,0.30446,-0.059204,-0.023198,0,0
3,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.38933,-0.059242,-0.025087,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.35463,-0.059281,-0.056246,0,0
3,GO SPINDLE ASSEMBLY,0.016386,-0.059346,-0.054511,0,0
3,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.68988,-0.059395,-0.013933,0,0
3,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.82842,-0.05942,-0.027453,0,0
3,GO STEROID BIOSYNTHETIC PROCESS,0.19979,-0.05955,-0.028633,0,0
3,GO SMOOTHENED SIGNALING PATHWAY,0.079071,-0.059576,-0.052635,0,0
3,GO RESPONSE TO HORMONE,0.075009,-0.059629,-0.036216,0,0
3,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.19278,-0.059651,-0.056478,0,0
3,GO STEROL METABOLIC PROCESS,0.41203,-0.059663,-0.016543,0,0
3,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.41899,-0.059708,-0.060993,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.35253,-0.059827,-0.0018219,0,0
3,GO PROTEIN DEPHOSPHORYLATION,0.10734,-0.05983,-0.023187,0,0
3,GO REGULATION OF LIPID METABOLIC PROCESS,0.11837,-0.059954,-0.035385,0,0
3,GO PROTEIN LOCALIZATION TO VACUOLE,0.18194,-0.060205,-0.038554,0,0
3,GO RESPONSE TO PAIN,0.2458,-0.060461,-0.077153,0,0
3,GO MONOCARBOXYLIC ACID TRANSPORT,0.85059,-0.06047,0.0058571,0,0
3,GO RESPONSE TO ALKALOID,0.38488,-0.06063,-0.020482,0,0
3,GO GLIAL CELL DEVELOPMENT,0.23286,-0.060755,-0.028635,0,0
3,GO LIPID OXIDATION,0.11742,-0.060864,-0.051964,0,0
3,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.073043,-0.060937,-0.077409,0,0
3,GO HYALURONAN CATABOLIC PROCESS,0.6515,-0.06095,-0.05413,0,0
3,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.08331,-0.061055,-0.037651,0,0
3,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.16407,-0.061094,-0.03647,0,0
3,GO RESPONSE TO MINERALOCORTICOID,0.13656,-0.061153,-0.058141,0,0
3,GO POSITIVE REGULATION OF GROWTH,0.079071,-0.061192,-0.035625,0,0
3,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.17283,-0.061241,-0.067557,0,0
3,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.10299,-0.061371,-0.053504,0,0
3,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.44269,-0.061514,-0.016084,0,0
3,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.42367,-0.061565,-0.035347,0,0
3,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.14197,-0.061709,-0.063065,0,0
3,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.10823,-0.06177,-0.040024,0,0
3,GO PIRNA METABOLIC PROCESS,0.23286,-0.061776,-0.082255,0,0
3,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.18461,-0.061829,-0.039765,0,0
3,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.19417,-0.061954,-0.051363,0,0
3,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.16285,-0.061996,-0.075141,0,0
3,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.16163,-0.062017,-0.039452,0,0
3,GO REGULATION OF DNA RECOMBINATION,0.17156,-0.062071,-0.035989,0,0
3,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.46713,-0.062091,-0.033301,0,0
3,GO NEGATIVE REGULATION OF CELL DIVISION,0.80326,-0.062109,-0.0045446,0,0
3,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.77519,-0.062203,0.019559,0,0
3,GO RESPONSE TO FLUID SHEAR STRESS,0.1754,-0.062242,-0.050039,0,0
3,GO RESPONSE TO PH,0.18194,-0.062368,-0.036451,0,0
3,GO RELAXATION OF CARDIAC MUSCLE,0.73517,-0.062375,-0.022204,0,0
3,GO RESPONSE TO METAL ION,0.076344,-0.062551,-0.04121,0,0
3,GO REGULATION OF GLUCONEOGENESIS,0.15214,-0.062557,-0.042451,0,0
3,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.16407,-0.062741,-0.081631,0,0
3,GO RESPONSE TO TUMOR CELL,0.30446,-0.062868,-0.068259,0,0
3,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.15447,-0.062927,-0.070911,0,0
3,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.10823,-0.063033,-0.049693,0,0
3,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.6691,-0.063103,0.024227,0,0
3,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.27317,-0.063136,-0.03797,0,0
3,GO NEGATIVE REGULATION OF DNA REPLICATION,0.12721,-0.06328,-0.061432,0,0
3,GO VACUOLAR ACIDIFICATION,0.18461,-0.063282,-0.059994,0,0
3,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.5665,-0.063327,-0.020316,0,0
3,GO POSITIVE REGULATION OF HEART CONTRACTION,0.30637,-0.063403,-0.041285,0,0
3,GO PROTEIN LOCALIZATION TO CHROMATIN,0.16407,-0.063408,-0.036928,0,0
3,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.1653,-0.06343,-0.088013,0,0
3,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.18866,-0.063451,-0.074783,0,0
3,GO T CELL APOPTOTIC PROCESS,0.1873,-0.063665,-0.070322,0,0
3,GO NEUTROPHIL CHEMOTAXIS,0.098784,-0.063755,-0.052412,0,0
3,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.080464,-0.064182,-0.059472,0,0
3,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.13979,-0.064212,-0.026085,0,0
3,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.09714,-0.064298,-0.069436,0,0
3,GO AMINOGLYCAN CATABOLIC PROCESS,0.41434,-0.064335,-0.040351,0,0
3,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.10823,-0.064392,-0.16258,0,0
3,GO RESPONSE TO DEXAMETHASONE,0.36311,-0.064396,-0.032211,0,0
3,GO AMINE TRANSPORT,0.81581,-0.0645,0.034583,0,0
3,GO REGULATION OF LIPID TRANSPORT,0.26614,-0.064981,-0.036436,0,0
3,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.24416,-0.065223,-0.041708,0,0
3,GO PROSTATE GLAND MORPHOGENESIS,0.33194,-0.065652,-0.10517,0,0
3,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.098784,-0.065692,-0.072012,0,0
3,GO PHOTOTRANSDUCTION,0.14419,-0.065734,0.059033,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.64567,-0.065793,-0.019501,0,0
3,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.068006,-0.065878,-0.087419,0,0
3,GO GASTRIC ACID SECRETION,0.20554,-0.065966,-0.05118,0,0
3,GO TRIPARTITE REGIONAL SUBDIVISION,0.20699,-0.066015,-0.075023,0,0
3,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.1387,-0.066022,-0.056191,0,0
3,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.46466,-0.066147,-0.029331,0,0
3,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.47963,-0.066269,-0.037243,0,0
3,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.14642,-0.066292,-0.07587,0,0
3,GO NODAL SIGNALING PATHWAY,0.39381,-0.0665,-0.053382,0,0
3,GO PRIMARY MIRNA PROCESSING,0.1914,-0.0665,-0.053014,0,0
3,GO FATTY ACID BETA OXIDATION,0.1653,-0.066505,-0.043839,0,0
3,GO PROTEIN KINASE C SIGNALING,0.29315,-0.066561,-0.037858,0,0
3,GO CARDIAC VENTRICLE DEVELOPMENT,0.2714,-0.066768,-0.022437,0,0
3,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.10214,-0.066823,-0.039933,0,0
3,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.41434,-0.066924,-0.052024,0,0
3,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.073694,-0.066989,-0.051356,0,0
3,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.60834,-0.067009,-0.0087082,0,0
3,GO NIK NF KAPPAB SIGNALING,0.095518,-0.067011,-0.063737,0,0
3,GO MAINTENANCE OF ORGANELLE LOCATION,0.16285,-0.067037,-0.045122,0,0
3,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.24416,-0.067182,-0.055101,0,0
3,GO RESPONSE TO OXYGEN LEVELS,0.41666,-0.067248,-0.0097918,0,0
3,GO LIPID DROPLET ORGANIZATION,0.098784,-0.067399,-0.056582,0,0
3,GO SINGLE STRAND BREAK REPAIR,0.1453,-0.067419,-0.059126,0,0
3,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.25246,-0.067437,-0.066732,0,0
3,GO CALCINEURIN MEDIATED SIGNALING,0.21738,-0.067444,-0.037376,0,0
3,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.063836,-0.067497,-0.033805,0,0
3,GO VASCULATURE DEVELOPMENT,0.06986,-0.067636,-0.057869,0,0
3,GO FIBROBLAST PROLIFERATION,0.85376,-0.067895,0.0078376,0,0
3,GO PHAGOCYTOSIS,0.20845,-0.067962,-0.042737,0,0
3,GO REGULATION OF BONE DEVELOPMENT,0.36741,-0.068009,-0.031955,0,0
3,GO POSITIVE REGULATION OF GLIOGENESIS,0.03068,-0.068019,-0.088837,0,0
3,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.1873,-0.06814,-0.058984,0,0
3,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.2114,-0.068167,-0.076986,0,0
3,GO AXIS SPECIFICATION,0.19979,-0.06823,-0.0332,0,0
3,GO CD40 SIGNALING PATHWAY,0.077018,-0.06837,-0.087244,0,0
3,GO STRESS FIBER ASSEMBLY,0.12822,-0.068385,-0.048848,0,0
3,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.090011,-0.068477,-0.087784,0,0
3,GO INTRACELLULAR STEROL TRANSPORT,0.48215,-0.068492,-0.03969,0,0
3,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.58307,-0.06853,0.13213,0,0
3,GO EPITHELIAL STRUCTURE MAINTENANCE,0.17029,-0.068573,-0.05467,0,0
3,GO SEQUESTERING OF TRIGLYCERIDE,0.66028,-0.068706,0.0029684,0,0
3,GO NEURAL CREST FORMATION,0.41203,-0.068934,-0.062191,0,0
3,GO SIGNAL RELEASE,0.1754,-0.069148,-0.026236,0,0
3,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.9113,-0.069166,0.029256,0,0
3,GO REGULATION OF DENDRITE EXTENSION,0.96284,-0.06942,0.045315,0,0
3,GO RESPONSE TO GROWTH HORMONE,0.18461,-0.069475,-0.061629,0,0
3,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.45238,-0.069929,-0.037736,0,0
3,GO CHONDROCYTE DIFFERENTIATION,0.13979,-0.070113,-0.062499,0,0
3,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.28033,-0.070162,-0.093052,0,0
3,GO COBALAMIN METABOLIC PROCESS,0.1252,-0.070343,-0.0779,0,0
3,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.026838,-0.070488,-0.063743,0,0
3,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.22814,-0.070563,-0.041974,0,0
3,GO AMINO SUGAR CATABOLIC PROCESS,0.51819,-0.070707,-0.022318,0,0
3,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.84741,-0.070773,-0.013186,0,0
3,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.44752,-0.070781,-0.068153,0,0
3,GO POSITIVE REGULATION OF JNK CASCADE,0.079765,-0.071032,-0.04213,0,0
3,GO ETHANOL CATABOLIC PROCESS,0.43312,-0.071128,-0.065045,0,0
3,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.22814,-0.071467,-0.057525,0,0
3,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.08331,-0.071471,-0.14771,0,0
3,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.24252,-0.071538,-0.052499,0,0
3,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.34213,-0.071566,-0.091227,0,0
3,GO RESPONSE TO FUNGUS,0.13234,-0.071619,-0.051287,0,0
3,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.081877,-0.071667,-0.12637,0,0
3,GO HYPEROSMOTIC SALINITY RESPONSE,0.11647,-0.072001,-0.094265,0,0
3,GO REGULATION OF LIPID LOCALIZATION,0.23286,-0.072334,-0.031328,0,0
3,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.22658,-0.07247,-0.079348,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.24416,-0.072491,-0.062247,0,0
3,GO ROOF OF MOUTH DEVELOPMENT,0.0081133,-0.072527,-0.10325,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.11647,-0.072585,-0.050931,0,0
3,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.45972,-0.072714,-0.038622,0,0
3,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.5,-0.073004,-0.04963,0,0
3,GO PROSTATIC BUD FORMATION,0.40514,-0.073047,-0.10547,0,0
3,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.1653,-0.073132,-0.042662,0,0
3,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.94671,-0.073172,0.01828,0,0
3,GO RESPONSE TO EPINEPHRINE,0.65442,-0.073332,-0.028836,0,0
3,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.318,-0.073335,-0.077912,0,0
3,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.073043,-0.07348,-0.10185,0,0
3,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.12822,-0.073568,-0.043184,0,0
3,GO RECEPTOR CATABOLIC PROCESS,0.086981,-0.073608,-0.056988,0,0
3,GO REGULATION OF LIPID STORAGE,0.10214,-0.073947,-0.048652,0,0
3,GO SPHINGOID METABOLIC PROCESS,0.13763,-0.074013,-0.066575,0,0
3,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.1653,-0.074192,-0.036585,0,0
3,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.066192,-0.074375,-0.092812,0,0
3,GO REGULATION OF GTPASE ACTIVITY,0.11183,-0.074379,-0.024988,0,0
3,GO LIPID HOMEOSTASIS,0.21437,-0.074381,-0.038416,0,0
3,GO RESPONSE TO VITAMIN,0.14983,-0.074398,-0.062069,0,0
3,GO HEAT GENERATION,0.10471,-0.074406,-0.10444,0,0
3,GO SULFATE TRANSPORT,0.080464,-0.074411,-0.041915,0,0
3,GO HYPEROSMOTIC RESPONSE,0.074349,-0.074836,-0.057877,0,0
3,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.11647,-0.074931,-0.027489,0,0
3,GO CELLULAR COMPONENT MAINTENANCE,0.19278,-0.075051,-0.045012,0,0
3,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.096327,-0.075059,-0.052077,0,0
3,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.44028,-0.075085,-0.054844,0,0
3,GO LIPOPROTEIN LOCALIZATION,0.22971,-0.075089,-0.049402,0,0
3,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.1387,-0.075155,-0.040225,0,0
3,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.33194,-0.075394,-0.055172,0,0
3,GO ACTIN CROSSLINK FORMATION,0.94993,-0.075458,0.054128,0,0
3,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.1262,-0.075571,-0.052496,0,0
3,GO MEMBRANE LIPID CATABOLIC PROCESS,0.13656,-0.075662,-0.084092,0,0
3,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.3442,-0.075787,-0.03163,0,0
3,GO COLLECTING DUCT DEVELOPMENT,0.1313,-0.075878,-0.11276,0,0
3,GO PIGMENT GRANULE ORGANIZATION,0.12822,-0.075977,-0.049217,0,0
3,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.47461,-0.076023,-0.014578,0,0
3,GO ARACHIDONIC ACID METABOLIC PROCESS,0.090782,-0.076097,-0.076209,0,0
3,GO GASTRULATION,0.19278,-0.076145,-0.042664,0,0
3,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.31215,-0.076289,-0.059048,0,0
3,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.086981,-0.076369,-0.074388,0,0
3,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.095518,-0.076371,-0.076344,0,0
3,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.082591,-0.076411,-0.082962,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.79387,-0.076434,0.0049286,0,0
3,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.77209,-0.076536,0.020238,0,0
3,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.55287,-0.07667,-0.023275,0,0
3,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.23286,-0.076728,-0.077509,0,0
3,GO CELLULAR RESPONSE TO STEROL,0.65442,-0.076886,0.00099769,0,0
3,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.072397,-0.077045,-0.060859,0,0
3,GO PROTEIN O LINKED MANNOSYLATION,0.42838,-0.077262,-0.032784,0,0
3,GO KINETOCHORE ORGANIZATION,0.11553,-0.077551,-0.075948,0,0
3,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.20845,-0.077597,-0.032634,0,0
3,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.075009,-0.077747,-0.082962,0,0
3,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.4451,-0.077987,-0.037598,0,0
3,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.11647,-0.078,-0.082528,0,0
3,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.077018,-0.078079,-0.072272,0,0
3,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.085497,-0.0781,-0.031664,0,0
3,GO PROSTATE GLAND DEVELOPMENT,0.11742,-0.078132,-0.10804,0,0
3,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.42367,-0.078177,-0.053498,0,0
3,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.63697,-0.078263,0.0070476,0,0
3,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.21288,-0.078424,-0.044198,0,0
3,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.33803,-0.078488,-0.08813,0,0
3,GO SENSORY SYSTEM DEVELOPMENT,0.088486,-0.078596,-0.044005,0,0
3,GO RESPONSE TO VITAMIN D,0.52874,-0.078662,-0.012317,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.075009,-0.078978,-0.063715,0,0
3,GO DIET INDUCED THERMOGENESIS,0.5394,-0.079016,-0.010228,0,0
3,GO GENITALIA DEVELOPMENT,0.1387,-0.079057,-0.059886,0,0
3,GO SCHWANN CELL DIFFERENTIATION,0.099614,-0.079227,-0.050193,0,0
3,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.14088,-0.079286,-0.1019,0,0
3,GO FLUID TRANSPORT,0.081877,-0.079445,-0.082169,0,0
3,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0056958,-0.079644,-0.083701,0,0
3,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.14983,-0.079656,-0.073345,0,0
3,GO CORTICAL CYTOSKELETON ORGANIZATION,0.064418,-0.079689,-0.053826,0,0
3,GO SULFUR COMPOUND TRANSPORT,0.10471,-0.079692,-0.043285,0,0
3,GO CELLULAR KETONE METABOLIC PROCESS,0.063258,-0.079808,-0.055538,0,0
3,GO MAGNESIUM ION HOMEOSTASIS,0.28033,-0.080072,-0.089718,0,0
3,GO FATTY ACID DERIVATIVE TRANSPORT,0.48722,-0.08016,-0.013359,0,0
3,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.047372,-0.080175,-0.071953,0,0
3,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.48468,-0.080177,-0.050189,0,0
3,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.88885,-0.080334,0.020175,0,0
3,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.40973,-0.080529,-0.025833,0,0
3,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.090011,-0.080595,-0.033246,0,0
3,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.39381,-0.080647,-0.022931,0,0
3,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.046921,-0.080777,-0.04411,0,0
3,GO T CELL CHEMOTAXIS,0.12224,-0.080897,-0.059119,0,0
3,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.40743,-0.081119,-0.032792,0,0
3,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.45482,-0.081317,-0.013197,0,0
3,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.85376,-0.081447,-0.01392,0,0
3,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.3442,-0.081565,-0.066531,0,0
3,GO REGULATION OF LYSOSOMAL LUMEN PH,0.063258,-0.081585,-0.11479,0,0
3,GO AMINE CATABOLIC PROCESS,0.099614,-0.081735,-0.086543,0,0
3,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.13338,-0.081786,-0.067653,0,0
3,GO MEMBRANE PROTEIN PROTEOLYSIS,0.14869,-0.08205,-0.074856,0,0
3,GO STRIATED MUSCLE ADAPTATION,0.16285,-0.08247,-0.041386,0,0
3,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.90809,-0.082847,0.022456,0,0
3,GO NEGATIVE REGULATION OF TOR SIGNALING,0.18461,-0.082852,-0.029766,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.35886,-0.083068,-0.048106,0,0
3,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.46466,-0.083266,-0.040585,0,0
3,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.08331,-0.083693,-0.057863,0,0
3,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.1313,-0.08373,-0.047905,0,0
3,GO HISTONE H4 DEACETYLATION,0.065596,-0.083778,-0.091935,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.068006,-0.083805,-0.047919,0,0
3,GO OSTEOCLAST DIFFERENTIATION,0.22042,-0.083839,-0.03172,0,0
3,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.065596,-0.083864,-0.058661,0,0
3,GO ASTROCYTE ACTIVATION,0.10471,-0.083916,-0.069766,0,0
3,GO DEFINITIVE HEMOPOIESIS,0.085497,-0.083924,-0.094701,0,0
3,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.23445,-0.084063,-0.04638,0,0
3,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.34835,-0.084749,-0.059811,0,0
3,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.084763,-0.08489,-0.10495,0,0
3,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.09714,-0.084916,-0.047959,0,0
3,GO CARNITINE SHUTTLE,0.46713,-0.084926,-0.018769,0,0
3,GO VENTRICULAR SEPTUM DEVELOPMENT,0.36956,-0.085145,-0.028284,0,0
3,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.17156,-0.085182,-0.055747,0,0
3,GO VASCULOGENESIS,0.37608,-0.085243,-0.040996,0,0
3,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.092339,-0.085622,-0.086883,0,0
3,GO CHONDROCYTE PROLIFERATION,0.54746,-0.0858,-0.0416,0,0
3,GO REGULATION OF ORGANIC ACID TRANSPORT,0.072397,-0.085822,-0.063049,0,0
3,GO BONE MATURATION,0.33396,-0.085927,-0.041368,0,0
3,GO AUTOPHAGIC CELL DEATH,0.049681,-0.085961,-0.095416,0,0
3,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.095518,-0.085974,-0.081206,0,0
3,GO HOMOLOGOUS RECOMBINATION,0.1914,-0.086156,-0.044994,0,0
3,GO REGULATION OF STEROID METABOLIC PROCESS,0.09796,-0.086755,-0.052745,0,0
3,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.20122,-0.086785,-0.091059,0,0
3,GO RENAL FILTRATION,0.28945,-0.086814,-0.060356,0,0
3,GO BASEMENT MEMBRANE ORGANIZATION,0.22195,-0.086835,-0.082115,0,0
3,GO REGULATION OF VASCULAR PERMEABILITY,0.093126,-0.086967,-0.064059,0,0
3,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.21437,-0.087083,-0.067621,0,0
3,GO PODOSOME ASSEMBLY,0.1653,-0.087146,-0.074678,0,0
3,GO CARDIAC SEPTUM MORPHOGENESIS,0.20409,-0.087162,-0.064622,0,0
3,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.065005,-0.08722,-0.12296,0,0
3,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.079765,-0.087414,-0.068,0,0
3,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.076344,-0.087925,-0.1316,0,0
3,GO SLEEP,0.19979,-0.087932,-0.044901,0,0
3,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.26789,-0.088127,-0.052841,0,0
3,GO DNA METHYLATION,0.24745,-0.08838,-0.02974,0,0
3,GO KINETOCHORE ASSEMBLY,0.15802,-0.088484,-0.064061,0,0
3,GO CELLULAR HORMONE METABOLIC PROCESS,0.13027,-0.088618,-0.06271,0,0
3,GO METANEPHROS DEVELOPMENT,0.011411,-0.088731,-0.11917,0,0
3,GO CELLULAR RESPONSE TO VITAMIN D,0.3871,-0.089007,-0.044742,0,0
3,GO RESPONSE TO UV B,0.12126,-0.089042,-0.1382,0,0
3,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.024173,-0.089147,-0.0607,0,0
3,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.070488,-0.089318,-0.078441,0,0
3,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.10734,-0.089591,-0.070213,0,0
3,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.066792,-0.08963,-0.05836,0,0
3,GO REGULATION OF GOLGI ORGANIZATION,0.10734,-0.09,-0.071891,0,0
3,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.052575,-0.090002,-0.063559,0,0
3,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.065005,-0.090003,-0.056848,0,0
3,GO MACROPHAGE CHEMOTAXIS,0.062684,-0.0901,-0.086577,0,0
3,GO MEIOTIC CELL CYCLE PROCESS,0.00011596,-0.090278,-0.091723,0,0
3,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.22814,-0.09046,-0.029992,0,0
3,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.14419,-0.090522,-0.059188,0,0
3,GO C21 STEROID HORMONE METABOLIC PROCESS,0.077698,-0.090574,-0.11755,0,0
3,GO KERATINOCYTE MIGRATION,0.10129,-0.09059,-0.054973,0,0
3,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.33396,-0.090677,-0.10471,0,0
3,GO MRNA TRANSCRIPTION,0.17029,-0.091155,-0.042793,0,0
3,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.58864,-0.09119,-0.017356,0,0
3,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.178,-0.091422,-0.07517,0,0
3,GO CELLULAR RESPONSE TO VITAMIN,0.26095,-0.091473,-0.069935,0,0
3,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.1146,-0.091802,-0.06131,0,0
3,GO CATECHOLAMINE METABOLIC PROCESS,0.19417,-0.091861,-0.046938,0,0
3,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.59986,-0.091966,-0.015926,0,0
3,GO PEPTIDE HORMONE SECRETION,0.093918,-0.092023,-0.049373,0,0
3,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.084763,-0.092066,-0.14556,0,0
3,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.084034,-0.092134,-0.15603,0,0
3,GO AUTOPHAGY OF NUCLEUS,0.098784,-0.092346,-0.063568,0,0
3,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.13444,-0.092557,-0.055723,0,0
3,GO ATP BIOSYNTHETIC PROCESS,0.16163,-0.092567,-0.040859,0,0
3,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.31215,-0.092599,-0.10013,0,0
3,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.24416,-0.092768,-0.062912,0,0
3,GO POST EMBRYONIC DEVELOPMENT,0.06986,-0.092988,-0.051685,0,0
3,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.10823,-0.09306,-0.04142,0,0
3,GO NATURAL KILLER CELL DIFFERENTIATION,0.068619,-0.093063,-0.088152,0,0
3,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.26964,-0.093073,-0.086326,0,0
3,GO FEMALE GENITALIA DEVELOPMENT,0.17669,-0.093171,-0.065274,0,0
3,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.062684,-0.093242,-0.090663,0,0
3,GO SKIN MORPHOGENESIS,0.26789,-0.093367,-0.097238,0,0
3,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.079765,-0.093617,-0.044919,0,0
3,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.14983,-0.093773,-0.051306,0,0
3,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.17411,-0.093798,-0.083641,0,0
3,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.066792,-0.094497,-0.11284,0,0
3,GO KETONE BODY METABOLIC PROCESS,0.42133,-0.094783,-0.046169,0,0
3,GO REGULATION OF RESPONSE TO TUMOR CELL,0.10646,-0.094802,-0.10923,0,0
3,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.086237,-0.094819,-0.1063,0,0
3,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.24252,-0.095008,-0.097763,0,0
3,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.28578,-0.095167,-0.096876,0,0
3,GO BLEB ASSEMBLY,0.26614,-0.095392,-0.1744,0,0
3,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.058787,-0.095644,-0.061571,0,0
3,GO REGULATION OF PROTEIN DEACETYLATION,0.1653,-0.095861,-0.045824,0,0
3,GO HISTONE H3 DEACETYLATION,0.43075,-0.0961,-0.016887,0,0
3,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.1793,-0.096176,-0.052974,0,0
3,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.13656,-0.096326,-0.11886,0,0
3,GO MALE MEIOSIS I,0.10385,-0.096467,-0.15272,0,0
3,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.12029,-0.096688,-0.06493,0,0
3,GO GALACTOSE METABOLIC PROCESS,0.1793,-0.096788,-0.081323,0,0
3,GO REGULATION OF EXIT FROM MITOSIS,0.024687,-0.096884,-0.093294,0,0
3,GO CELL MATURATION,0.0056958,-0.096936,-0.075058,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.28761,-0.097252,-0.074146,0,0
3,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.1313,-0.097326,-0.15508,0,0
3,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.65442,-0.09735,0.005559,0,0
3,GO ESTROGEN METABOLIC PROCESS,0.090011,-0.097504,-0.070024,0,0
3,GO INSULIN SECRETION,0.090011,-0.097877,-0.05398,0,0
3,GO RESPONSE TO CADMIUM ION,0.071119,-0.098059,-0.091437,0,0
3,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.11647,-0.098416,-0.060535,0,0
3,GO CARDIAC CELL DEVELOPMENT,0.02521,-0.098502,-0.07433,0,0
3,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.077018,-0.098634,-0.056965,0,0
3,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.1793,-0.098665,-0.028982,0,0
3,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.21587,-0.098814,-0.097287,0,0
3,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.26964,-0.099247,-0.037389,0,0
3,GO VIRAL LATENCY,0.060988,-0.099555,-0.063124,0,0
3,GO PERICARDIUM DEVELOPMENT,0.2114,-0.099572,-0.066949,0,0
3,GO REGULATION OF AMINO ACID TRANSPORT,0.1653,-0.099923,-0.047478,0,0
3,GO RESPONSE TO GONADOTROPIN,0.13979,-0.099943,-0.072103,0,0
3,GO RESPONSE TO STEROL DEPLETION,0.22042,-0.099951,-0.084828,0,0
3,GO CELLULAR RESPONSE TO FATTY ACID,0.1387,-0.099998,-0.061406,0,0
3,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.11837,-0.10017,-0.05956,0,0
3,GO SYNAPTIC VESICLE BUDDING,0.32993,-0.10034,-0.041153,0,0
3,GO RESPONSE TO NUTRIENT,0.073043,-0.10063,-0.057877,0,0
3,GO RESPONSE TO MUSCLE STRETCH,0.59424,-0.1014,-0.026123,0,0
3,GO MELANOCYTE DIFFERENTIATION,0.031631,-0.10177,-0.10129,0,0
3,GO SERTOLI CELL DEVELOPMENT,0.25753,-0.10195,-0.085668,0,0
3,GO PROTEIN K11 LINKED UBIQUITINATION,0.015159,-0.102,-0.0876,0,0
3,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.084763,-0.10203,-0.075221,0,0
3,GO MEIOTIC SPINDLE ORGANIZATION,0.2114,-0.10211,-0.038552,0,0
3,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.0030839,-0.10224,-0.10815,0,0
3,GO REGULATION OF STEM CELL DIVISION,0.069238,-0.10259,-0.10129,0,0
3,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.10299,-0.10266,-0.068041,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.13027,-0.10276,-0.082427,0,0
3,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.037509,-0.10284,-0.19113,0,0
3,GO NEGATIVE REGULATION OF COAGULATION,0.318,-0.10285,-0.081573,0,0
3,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.13234,-0.10319,-0.080752,0,0
3,GO HYALURONAN METABOLIC PROCESS,0.19557,-0.10374,-0.050963,0,0
3,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.33599,-0.10397,-0.054812,0,0
3,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.2114,-0.10423,-0.048439,0,0
3,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.086981,-0.10424,-0.071063,0,0
3,GO HORMONE METABOLIC PROCESS,0.015329,-0.1043,-0.094601,0,0
3,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.11933,-0.10452,-0.064167,0,0
3,GO GLUTAMATE METABOLIC PROCESS,0.049212,-0.10464,-0.073283,0,0
3,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.67798,-0.10467,-0.027929,0,0
3,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.29689,-0.10475,-0.062695,0,0
3,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.18595,-0.1049,-0.086423,0,0
3,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.12924,-0.10551,-0.065581,0,0
3,GO MITOCHONDRIAL FUSION,0.064418,-0.10554,-0.046626,0,0
3,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.2644,-0.10556,-0.062976,0,0
3,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.081168,-0.10603,-0.0617,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.068006,-0.10617,-0.097125,0,0
3,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.17283,-0.10708,-0.064862,0,0
3,GO MACROMOLECULE DEPALMITOYLATION,0.24089,-0.10716,-0.054156,0,0
3,GO AMYLOID FIBRIL FORMATION,0.28578,-0.10756,-0.082202,0,0
3,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.073043,-0.10781,-0.098282,0,0
3,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.19278,-0.10793,-0.06642,0,0
3,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.067397,-0.10861,-0.11442,0,0
3,GO MITRAL VALVE DEVELOPMENT,0.11183,-0.10892,-0.10425,0,0
3,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.57752,-0.10903,-0.048018,0,0
3,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.004156,-0.10958,-0.11517,0,0
3,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.10299,-0.10962,-0.10863,0,0
3,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.081877,-0.10968,-0.10002,0,0
3,GO ANDROGEN METABOLIC PROCESS,0.12721,-0.11066,-0.076036,0,0
3,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.072397,-0.11091,-0.095209,0,0
3,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.40973,-0.11106,-0.033489,0,0
3,GO GLYCOPROTEIN CATABOLIC PROCESS,0.36526,-0.11109,-0.061304,0,0
3,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.062114,-0.11151,-0.088286,0,0
3,GO INFLAMMATORY RESPONSE TO WOUNDING,0.22658,-0.11151,-0.11382,0,0
3,GO RESPONSE TO COPPER ION,0.079071,-0.11175,-0.11505,0,0
3,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.064418,-0.11242,-0.057798,0,0
3,GO RESPONSE TO TESTOSTERONE,0.10129,-0.11256,-0.068166,0,0
3,GO REGULATION OF PEPTIDE HORMONE SECRETION,0.068006,-0.11257,-0.057801,0,0
3,GO DOPAMINE METABOLIC PROCESS,0.25924,-0.11285,-0.049738,0,0
3,GO RESPONSE TO ACIDIC PH,0.16904,-0.11304,-0.080689,0,0
3,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.0031247,-0.11311,-0.11974,0,0
3,GO TROPHOBLAST CELL MIGRATION,0.34627,-0.11324,-0.059139,0,0
3,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.17029,-0.11349,-0.092415,0,0
3,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.3739,-0.11376,-0.083264,0,0
3,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.081168,-0.11412,-0.080358,0,0
3,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.016938,-0.11479,-0.11402,0,0
3,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.14419,-0.11495,-0.11788,0,0
3,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.062114,-0.11498,-0.13649,0,0
3,GO VITAMIN D BIOSYNTHETIC PROCESS,0.11183,-0.11512,-0.10965,0,0
3,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.048746,-0.11536,-0.069542,0,0
3,GO REGULATION OF GLIAL CELL PROLIFERATION,0.086981,-0.11621,-0.10191,0,0
3,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.066792,-0.11706,-0.10193,0,0
3,GO REGULATION OF FATTY ACID TRANSPORT,0.19697,-0.11721,-0.0597,0,0
3,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.23927,-0.1176,-0.062114,0,0
3,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.13763,-0.11774,-0.080733,0,0
3,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.00025215,-0.11827,-0.088153,0,0
3,GO HYALURONAN BIOSYNTHETIC PROCESS,0.082591,-0.11844,-0.073648,0,0
3,GO FAT CELL PROLIFERATION,0.15921,-0.11848,-0.083386,0,0
3,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.084034,-0.11893,-0.11259,0,0
3,GO RESPONSE TO INSECTICIDE,0.52874,-0.119,-0.02976,0,0
3,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.3871,-0.11903,-0.077259,0,0
3,GO NOTOCHORD DEVELOPMENT,0.060432,-0.11918,-0.14831,0,0
3,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.45238,-0.11976,-0.026167,0,0
3,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.28213,-0.11994,-0.061925,0,0
3,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.19979,-0.12007,-0.14648,0,0
3,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.31997,-0.12015,-0.032264,0,0
3,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.11002,-0.12017,-0.061375,0,0
3,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.064418,-0.12025,-0.055874,0,0
3,GO TRNA CATABOLIC PROCESS,0.072397,-0.12034,-0.14328,0,0
3,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.17283,-0.12058,-0.076476,0,0
3,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.075009,-0.12067,-0.14063,0,0
3,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.10646,-0.12074,-0.084301,0,0
3,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.3739,-0.12137,-0.048208,0,0
3,GO DIACYLGLYCEROL METABOLIC PROCESS,0.06986,-0.12142,-0.095683,0,0
3,GO TRACHEA MORPHOGENESIS,0.12322,-0.12152,-0.082207,0,0
3,GO NUCLEOTIDE TRANSPORT,0.0076401,-0.12213,-0.082419,0,0
3,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.13027,-0.12219,-0.081279,0,0
3,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.51557,-0.12222,-0.074539,0,0
3,GO CILIUM MOVEMENT,0.0010865,-0.12245,-0.10999,0,0
3,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.14088,-0.12268,-0.1208,0,0
3,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.23766,-0.12286,-0.056195,0,0
3,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0049019,-0.12402,-0.1071,0,0
3,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.1914,-0.12423,-0.08968,0,0
3,GO REGULATION OF GLOMERULAR FILTRATION,0.10471,-0.12433,-0.14316,0,0
3,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.020605,-0.12492,-0.092562,0,0
3,GO THYMOCYTE APOPTOTIC PROCESS,0.086981,-0.12498,-0.11568,0,0
3,GO MITOTIC DNA REPLICATION,0.13979,-0.12505,-0.063129,0,0
3,GO KILLING OF CELLS OF OTHER ORGANISM,0.001118,-0.12542,-0.12151,0,0
3,GO DENDRITIC CELL MIGRATION,0.069238,-0.12558,-0.11499,0,0
3,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.079765,-0.12574,-0.11881,0,0
3,GO CERAMIDE CATABOLIC PROCESS,0.2644,-0.12575,-0.065988,0,0
3,GO HEART TRABECULA MORPHOGENESIS,0.11367,-0.12583,-0.068705,0,0
3,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.073694,-0.12618,-0.14189,0,0
3,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.22658,-0.12704,-0.089735,0,0
3,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.10558,-0.1272,-0.071378,0,0
3,GO UTERUS DEVELOPMENT,0.30637,-0.12722,-0.039579,0,0
3,GO SERTOLI CELL DIFFERENTIATION,0.11367,-0.12761,-0.10411,0,0
3,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.3871,-0.12796,-0.039982,0,0
3,GO CELLULAR RESPONSE TO CADMIUM ION,0.062684,-0.12807,-0.1502,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.099614,-0.12817,-0.11648,0,0
3,GO POSITIVE REGULATION OF HEAT GENERATION,0.17283,-0.12824,-0.11927,0,0
3,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.099614,-0.12924,-0.15109,0,0
3,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.17669,-0.12969,-0.072745,0,0
3,GO GENITALIA MORPHOGENESIS,0.46218,-0.13,-0.051456,0,0
3,GO INTRA S DNA DAMAGE CHECKPOINT,0.0048405,-0.13083,-0.11064,0,0
3,GO NOTCH SIGNALING PATHWAY,1.7071e-05,-0.13132,-0.14611,0,0
3,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.065005,-0.13193,-0.16283,0,0
3,GO T HELPER 2 CELL DIFFERENTIATION,0.14642,-0.13233,-0.15468,0,0
3,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.36311,-0.13268,-0.045827,0,0
3,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.11647,-0.13293,-0.081059,0,0
3,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.063258,-0.13315,-0.13568,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.066192,-0.13386,-0.075405,0,0
3,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.1313,-0.13427,-0.10872,0,0
3,GO SEROTONIN SECRETION,0.15802,-0.13435,-0.062209,0,0
3,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.11092,-0.13457,-0.11169,0,0
3,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.063836,-0.13476,-0.1062,0,0
3,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.3739,-0.13478,-0.076428,0,0
3,GO EPIBOLY,0.13763,-0.13501,-0.093175,0,0
3,GO TYPE 2 IMMUNE RESPONSE,0.063836,-0.13538,-0.13804,0,0
3,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.178,-0.13609,-0.065751,0,0
3,GO CELLULAR RESPONSE TO SALT STRESS,0.21738,-0.13728,-0.07646,0,0
3,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.16285,-0.13761,-0.099293,0,0
3,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.090782,-0.13801,-0.10724,0,0
3,GO REGULATION OF MITOCHONDRIAL FUSION,0.069238,-0.13943,-0.059574,0,0
3,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.10385,-0.13974,-0.0922,0,0
3,GO REGULATION OF MEIOTIC CELL CYCLE,0.000286,-0.13976,-0.11269,0,0
3,GO OLFACTORY LOBE DEVELOPMENT,0.25924,-0.13997,-0.059417,0,0
3,GO BILE ACID BIOSYNTHETIC PROCESS,0.016386,-0.14,-0.095183,0,0
3,GO OOCYTE DIFFERENTIATION,0.0031247,-0.14109,-0.12605,0,0
3,GO TERPENOID BIOSYNTHETIC PROCESS,0.017315,-0.14166,-0.22542,0,0
3,GO RESPONSE TO DIETARY EXCESS,0.073043,-0.14167,-0.11738,0,0
3,GO PURINE NUCLEOTIDE TRANSPORT,0.0037985,-0.14192,-0.0974,0,0
3,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.00042777,-0.14217,-0.13116,0,0
3,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.12126,-0.14314,-0.13146,0,0
3,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.081877,-0.14328,-0.082163,0,0
3,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.048746,-0.14471,-0.1128,0,0
3,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.075009,-0.14479,-0.087156,0,0
3,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.08331,-0.14616,-0.14084,0,0
3,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.21437,-0.14625,-0.0591,0,0
3,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.10299,-0.14671,-0.11186,0,0
3,GO REGULATION OF HEAT GENERATION,0.10558,-0.14727,-0.12759,0,0
3,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.19557,-0.14733,-0.078447,0,0
3,GO LOCOMOTOR RHYTHM,0.22503,-0.14757,-0.047992,0,0
3,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.016386,-0.1489,-0.096773,0,0
3,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.066192,-0.14948,-0.14121,0,0
3,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.087731,-0.14953,-0.12504,0,0
3,GO CELLULAR RESPONSE TO NUTRIENT,0.066192,-0.15099,-0.096482,0,0
3,GO EPITHELIAL CELL FATE COMMITMENT,0.11553,-0.15263,-0.085216,0,0
3,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.23286,-0.15304,-0.064594,0,0
3,GO NEGATIVE REGULATION OF JNK CASCADE,0.014494,-0.15306,-0.085744,0,0
3,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,4.9361e-06,-0.15317,-0.19032,0,0
3,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.079071,-0.15396,-0.061973,0,0
3,GO L ASCORBIC ACID METABOLIC PROCESS,0.095518,-0.15485,-0.11532,0,0
3,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.20409,-0.15526,-0.096105,0,0
3,GO RENAL WATER HOMEOSTASIS,0.042197,-0.15781,-0.092544,0,0
3,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.41666,-0.15822,-0.040868,0,0
3,GO ORGAN INDUCTION,0.0052854,-0.15887,-0.15963,0,0
3,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.11367,-0.15925,-0.15045,0,0
3,GO MACROPHAGE CYTOKINE PRODUCTION,0.14088,-0.1627,-0.11324,0,0
3,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.10471,-0.16417,-0.11725,0,0
3,GO EPIDERMIS MORPHOGENESIS,0.01829,-0.16489,-0.17258,0,0
3,GO SKELETAL MUSCLE ADAPTATION,0.050154,-0.16526,-0.088407,0,0
3,GO AORTA MORPHOGENESIS,0.0066851,-0.16549,-0.168,0,0
3,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.060988,-0.16579,-0.1532,0,0
3,GO REGULATION OF GTP BINDING,0.18461,-0.1658,-0.078098,0,0
3,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.0028492,-0.1665,-0.13998,0,0
3,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.074349,-0.16751,-0.13923,0,0
3,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.10214,-0.16802,-0.12773,0,0
3,GO RETINAL ROD CELL DIFFERENTIATION,0.10471,-0.16886,-0.12827,0,0
3,GO NEPHRON TUBULE FORMATION,0.24089,-0.16954,-0.1306,0,0
3,GO GLYCOLIPID CATABOLIC PROCESS,0.18194,-0.17193,-0.099368,0,0
3,GO KIDNEY EPITHELIUM DEVELOPMENT,6.7724e-05,-0.17229,-0.18021,0,0
3,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0013633,-0.17796,-0.10878,0,0
3,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.1252,-0.17797,-0.098318,0,0
3,GO DETECTION OF CALCIUM ION,0.064418,-0.17885,-0.14346,0,0
3,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.00010852,-0.17939,-0.16006,0,0
3,GO INTRACILIARY RETROGRADE TRANSPORT,0.056128,-0.1799,-0.12923,0,0
3,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.30446,-0.18,-0.067467,0,0
3,GO REGULATION OF TELOMERE CAPPING,0.003166,-0.18006,-0.11576,0,0
3,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.0090315,-0.18263,-0.16114,0,0
3,GO SOMATIC STEM CELL DIVISION,0.074349,-0.186,-0.14158,0,0
3,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0024609,-0.18807,-0.16943,0,0
3,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0017277,-0.18935,-0.22896,0,0
3,GO ETHANOL OXIDATION,0.060988,-0.18935,-0.18856,0,0
3,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.022686,-0.1911,-0.17294,0,0
3,GO DORSAL SPINAL CORD DEVELOPMENT,0.10045,-0.19298,-0.093532,0,0
3,GO VASCULAR WOUND HEALING,0.0095807,-0.19442,-0.17811,0,0
3,GO PARTURITION,0.046921,-0.19562,-0.12388,0,0
3,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.062684,-0.19772,-0.11668,0,0
3,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.00067188,-0.19831,-0.18872,0,0
3,GO DIGESTIVE SYSTEM DEVELOPMENT,1.6158e-05,-0.19879,-0.18737,0,0
3,GO PHOSPHOLIPID DEPHOSPHORYLATION,3.2631e-05,-0.19969,-0.16836,0,0
3,GO HEART FORMATION,0.0050904,-0.20017,-0.15394,0,0
3,GO HEART FIELD SPECIFICATION,0.006444,-0.20186,-0.1921,0,0
3,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.026838,-0.20255,-0.17252,0,0
3,GO REGULATION OF HEART MORPHOGENESIS,0.014823,-0.20356,-0.1506,0,0
3,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,2.6914e-06,-0.20679,-0.191,0,0
3,GO REGULATION OF GROWTH HORMONE SECRETION,0.032607,-0.20735,-0.1802,0,0
3,GO FOREBRAIN GENERATION OF NEURONS,0.0017517,-0.20804,-0.16619,0,0
3,GO FOREBRAIN NEURON DIFFERENTIATION,0.0033361,-0.20811,-0.18546,0,0
3,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.008211,-0.21038,-0.17781,0,0
3,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.17669,-0.21262,-0.074463,0,0
3,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.16778,-0.21476,-0.14298,0,0
3,GO HEART INDUCTION,0.069238,-0.21551,-0.11865,0,0
3,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,5.6085e-05,-0.21623,-0.22086,0,0
3,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,8.8796e-05,-0.21809,-0.25101,0,0
3,GO CELL MIGRATION IN HINDBRAIN,0.075009,-0.22146,-0.12014,0,0
3,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.0062108,-0.2322,-0.26269,0,0
3,GO ESCRT COMPLEX DISASSEMBLY,2.0776e-06,-0.23513,-0.27388,0,0
3,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.0067673,-0.23629,-0.16488,0,0
3,GO T HELPER 17 CELL LINEAGE COMMITMENT,1.2716e-05,-0.23786,-0.22145,0,0
3,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.026286,-0.23971,-0.18707,0,0
3,GO RUFFLE ASSEMBLY,2.9514e-07,-0.24143,-0.18663,0,0
3,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.00098255,-0.24152,-0.17607,0,0
3,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0018508,-0.2436,-0.16717,0,0
3,GO POSITIVE REGULATION OF BEHAVIOR,0.0022396,-0.24728,-0.2097,0,0
3,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,3.2146e-06,-0.25353,-0.25989,0,0
3,GO CELLULAR RESPONSE TO LITHIUM ION,8.8796e-05,-0.25758,-0.25969,0,0
3,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.077018,-0.2593,-0.097163,0,0
3,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.3236e-05,-0.26002,-0.19927,0,0
3,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0033799,-0.26403,-0.18732,0,0
3,GO MOTILE CILIUM ASSEMBLY,0.00027716,-0.26508,-0.2732,0,0
3,GO GLYCOSIDE METABOLIC PROCESS,0.0088198,-0.26549,-0.22713,0,0
3,GO RADIAL GLIAL CELL DIFFERENTIATION,0.0035146,-0.26659,-0.21953,0,0
3,GO LIPOXYGENASE PATHWAY,0.0016122,-0.27348,-0.28132,0,0
3,GO BRONCHUS DEVELOPMENT,0.001776,-0.2741,-0.28394,0,0
3,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.019735,-0.27505,-0.16872,0,0
3,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.001071,-0.27533,-0.21606,0,0
3,GO MAMMARY GLAND MORPHOGENESIS,0.00012186,-0.27572,-0.22853,0,0
3,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.0042095,-0.28594,-0.22393,0,0
3,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,2.8886e-07,-0.29071,-0.29084,0,0
3,GO REGULATION OF CELL FATE COMMITMENT,4.3355e-07,-0.29198,-0.30428,0,0
3,GO GONADOTROPIN SECRETION,2.9514e-07,-0.30458,-0.3152,0,0
3,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0002443,-0.31232,-0.25722,0,0
3,GO GABAERGIC NEURON DIFFERENTIATION,0.060988,-0.31309,-0.15276,0,0
3,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.8419e-06,-0.32148,-0.29634,0,0
3,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,2.4091e-05,-0.33185,-0.333,0,0
3,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00030449,-0.34307,-0.25506,0,0
3,GO INNER DYNEIN ARM ASSEMBLY,1.5674e-06,-0.38671,-0.42855,0,0
3,GO RETINA LAYER FORMATION,0.00082553,-0.38699,-0.28266,0,0
3,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00015838,-0.38857,-0.34646,0,0
3,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,1.1858e-08,-0.3937,-0.48557,0,0
3,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,1.7706e-05,-0.40702,-0.35756,0,0
3,GO PITUITARY GLAND DEVELOPMENT,1.996e-06,-0.40928,-0.3695,0,0
3,GO REFLEX,1.4741e-05,-0.41491,-0.38794,0,0
3,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00032916,-0.42131,-0.30742,0,0
3,GO KERATINOCYTE DEVELOPMENT,0.0010865,-0.43586,-0.33701,0,0
3,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.0037498,-0.46094,-0.33113,0,0
3,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.4076e-07,-0.4742,-0.45204,0,0
3,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,4.3082e-09,-0.48088,-0.52507,0,0
3,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.019735,-0.5064,-0.22641,0,0
3,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,1.2058e-07,-0.50689,-0.42382,0,0
3,GO CARDIAC CELL FATE COMMITMENT,1.3325e-06,-0.5398,-0.44146,0,0
3,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,1.0791e-07,-0.54171,-0.45176,0,0
3,GO GAMMA DELTA T CELL DIFFERENTIATION,2.8925e-08,-0.63258,-0.56935,0,0
3,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,1.0554e-07,-0.63714,-0.5336,0,0
3,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,1.5753e-08,-0.72296,-0.59028,0,0
4,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,4.1456e-06,0.74456,0.77586,1,1
4,GO HISTAMINE SECRETION,4.719e-07,0.65521,0.52931,1,1
4,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,9.4407e-08,0.637,0.64574,1,1
4,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,1.484e-09,0.60984,0.56425,1,1
4,GO HISTAMINE TRANSPORT,6.0205e-08,0.56642,0.51063,1,1
4,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,7.3772e-08,0.55505,0.51836,1,1
4,GO RENAL ABSORPTION,1.9563e-06,0.53281,0.47794,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,2.9805e-09,0.51594,0.53862,1,1
4,GO NEGATIVE REGULATION OF ANOIKIS,2.402e-08,0.51578,0.60448,1,1
4,GO CELL MIGRATION INVOLVED IN GASTRULATION,2.0429e-07,0.50612,0.48057,1,1
4,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00040235,0.48753,0.47855,1,1
4,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,2.2697e-09,0.48541,0.486,1,1
4,GO O GLYCAN PROCESSING,5.2359e-09,0.4821,0.43727,1,1
4,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.6321e-06,0.47892,0.46648,1,1
4,GO DOPAMINE BIOSYNTHETIC PROCESS,3.357e-07,0.47832,0.54781,1,1
4,GO REGULATION OF PLATELET AGGREGATION,5.2445e-07,0.47817,0.47268,1,1
4,GO INTESTINAL LIPID ABSORPTION,8.8389e-07,0.46933,0.5539,1,1
4,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,5.2303e-06,0.46888,0.47272,1,1
4,GO TOLERANCE INDUCTION,0.00032408,0.46743,0.37491,1,1
4,GO RESPONSE TO TYPE I INTERFERON,8.1623e-05,0.46672,0.3697,1,1
4,GO REGULATION OF GLOMERULUS DEVELOPMENT,2.2416e-05,0.46287,0.45614,1,1
4,GO RESPONSE TO MAGNESIUM ION,3.1479e-07,0.46075,0.44884,1,1
4,GO SPHINGOMYELIN METABOLIC PROCESS,1.1097e-10,0.45921,0.46758,1,1
4,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,8.5867e-06,0.45346,0.41641,1,1
4,GO REGULATION OF ANOIKIS,4.9069e-08,0.45255,0.46096,1,1
4,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.00013899,0.4524,0.33477,1,1
4,GO POSITIVE REGULATION OF CELL MATURATION,6.3359e-07,0.45097,0.39626,1,1
4,GO INTESTINAL ABSORPTION,3.2894e-09,0.45071,0.49325,1,1
4,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.00011986,0.44934,0.39833,1,1
4,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,1.734e-06,0.44372,0.44354,1,1
4,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.0018006,0.44167,0.32628,1,1
4,GO MUCUS SECRETION,0.00022565,0.43751,0.43693,1,1
4,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,4.0868e-08,0.42876,0.45853,1,1
4,GO TOXIN METABOLIC PROCESS,3.247e-08,0.42701,0.43336,1,1
4,GO DENDRITIC CELL DIFFERENTIATION,5.2344e-05,0.42605,0.32987,1,1
4,GO AMMONIUM ION METABOLIC PROCESS,4.4749e-10,0.42255,0.47664,1,1
4,GO REGULATION OF WATER LOSS VIA SKIN,2.0879e-07,0.42191,0.41778,1,1
4,GO GERMINAL CENTER FORMATION,0.00012804,0.41715,0.31777,1,1
4,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00020835,0.41659,0.33971,1,1
4,GO REGULATION OF SUPEROXIDE ANION GENERATION,2.7312e-05,0.41466,0.36858,1,1
4,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0012527,0.41352,0.31132,1,1
4,GO NEURONAL ACTION POTENTIAL,1.8723e-07,0.41146,0.42863,1,1
4,GO REGULATION OF PLATELET ACTIVATION,2.0776e-06,0.4107,0.37549,1,1
4,GO T CELL MEDIATED CYTOTOXICITY,0.0034243,0.40842,0.26327,1,1
4,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,9.9844e-05,0.40123,0.35823,1,1
4,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,1.0004e-06,0.39864,0.42108,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.00086244,0.39809,0.3667,1,1
4,GO RESPONSE TO IMMOBILIZATION STRESS,4.3774e-08,0.39622,0.39495,1,1
4,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,7.7586e-05,0.39621,0.39082,1,1
4,GO FRUCTOSE METABOLIC PROCESS,0.00063314,0.39453,0.37004,1,1
4,GO ADHESION OF SYMBIONT TO HOST,1.6654e-06,0.3903,0.41439,1,1
4,GO ADRENAL GLAND DEVELOPMENT,4.719e-07,0.39021,0.38585,1,1
4,GO IMMUNOLOGICAL MEMORY PROCESS,1.5293e-05,0.38969,0.35187,1,1
4,GO RESPONSE TO PAIN,4.9872e-09,0.38479,0.40112,1,1
4,GO DETECTION OF OTHER ORGANISM,0.00011596,0.38436,0.37425,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.9175e-06,0.38051,0.33773,1,1
4,GO CELLULAR RESPONSE TO COPPER ION,0.0086125,0.37834,0.34647,1,1
4,GO REGULATION OF VASCULOGENESIS,2.8001e-06,0.37805,0.37425,1,1
4,GO LABYRINTHINE LAYER MORPHOGENESIS,2.3239e-05,0.37733,0.40287,1,1
4,GO DENDRITIC CELL APOPTOTIC PROCESS,0.00012594,0.37448,0.34365,1,1
4,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.00016901,0.37304,0.30234,1,1
4,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,2.4528e-05,0.37115,0.32621,1,1
4,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,7.6657e-06,0.37097,0.47675,1,1
4,GO RESPONSE TO INTERFERON BETA,0.0028872,0.3703,0.27557,1,1
4,GO PARAXIAL MESODERM MORPHOGENESIS,0.00030928,0.36911,0.29698,1,1
4,GO LIPID DIGESTION,2.0478e-05,0.36828,0.44129,1,1
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,4.5684e-06,0.3669,0.42804,1,1
4,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,5.8262e-07,0.36556,0.44782,1,1
4,GO CORNIFICATION,1.4163e-06,0.36514,0.33537,1,1
4,GO REGULATION OF MICROVILLUS ORGANIZATION,6.3249e-05,0.36457,0.41479,1,1
4,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.00014599,0.36284,0.32594,1,1
4,GO RESPONSE TO DIETARY EXCESS,4.8198e-07,0.3628,0.359,1,1
4,GO ANTIBACTERIAL HUMORAL RESPONSE,5.0323e-06,0.35983,0.28852,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.00033955,0.3588,0.34681,1,1
4,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.00025215,0.35807,0.33711,1,1
4,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,9.4407e-08,0.35758,0.35198,1,1
4,GO REGULATION OF TOLERANCE INDUCTION,0.00034485,0.35661,0.32498,1,1
4,GO PROTEIN O LINKED GLYCOSYLATION,3.7195e-09,0.35655,0.33903,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.7502e-06,0.35651,0.31678,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,5.5127e-05,0.35298,0.32676,1,1
4,GO RESPONSE TO COLD,3.6435e-08,0.35248,0.32589,1,1
4,GO MEMBRANE LIPID CATABOLIC PROCESS,5.9498e-07,0.35228,0.36135,1,1
4,GO REGULATION OF B CELL APOPTOTIC PROCESS,3.2631e-05,0.35024,0.28224,1,1
4,GO CELLULAR RESPONSE TO ZINC ION,0.015501,0.34881,0.34617,1,1
4,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00015583,0.34862,0.32139,1,1
4,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,3.8924e-05,0.34776,0.31762,1,1
4,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,7.9617e-06,0.34689,0.37203,1,1
4,GO HEPATOCYTE APOPTOTIC PROCESS,3.4409e-05,0.34497,0.41012,1,1
4,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,1.8032e-05,0.34437,0.32329,1,1
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.00047589,0.34408,0.29117,1,1
4,GO NEUROTRANSMITTER METABOLIC PROCESS,1.1316e-06,0.34272,0.31213,1,1
4,GO CORTICOSTEROID HORMONE SECRETION,0.00013673,0.3421,0.29471,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,6.2169e-06,0.3419,0.36052,1,1
4,GO BARBED END ACTIN FILAMENT CAPPING,0.00013232,0.34131,0.29936,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.00070238,0.33844,0.28118,1,1
4,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.00012186,0.33842,0.33698,1,1
4,GO MEMBRANE RAFT ORGANIZATION,0.00057029,0.33836,0.31244,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.001071,0.33796,0.26274,1,1
4,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.9175e-06,0.33725,0.47148,1,1
4,GO RESPONSE TO EPINEPHRINE,1.5865e-05,0.33656,0.38373,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,3.3806e-05,0.3343,0.2757,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,1.6457e-05,0.33302,0.29927,1,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0012705,0.33207,0.26668,1,1
4,GO PHAGOLYSOSOME ASSEMBLY,2.1338e-07,0.33114,0.38215,1,1
4,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.8983e-07,0.33109,0.35457,1,1
4,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.0020367,0.33051,0.23309,1,1
4,GO BILE ACID AND BILE SALT TRANSPORT,7.1274e-05,0.33018,0.37063,1,1
4,GO LEYDIG CELL DIFFERENTIATION,8.4424e-05,0.32661,0.36812,1,1
4,GO KERATINIZATION,2.3274e-07,0.32596,0.31995,1,1
4,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.0020092,0.3258,0.27501,1,1
4,GO REGULATION OF DENDRITE EXTENSION,9.0235e-07,0.32556,0.34844,1,1
4,GO AMINE BIOSYNTHETIC PROCESS,2.2139e-09,0.32395,0.36322,1,1
4,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.0014022,0.32314,0.26975,1,1
4,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,5.1304e-06,0.32305,0.37478,1,1
4,GO RELAXATION OF CARDIAC MUSCLE,1.1806e-05,0.32302,0.32468,1,1
4,GO RESPONSE TO REDOX STATE,9.0235e-07,0.32225,0.29282,1,1
4,GO NEGATIVE REGULATION OF TISSUE REMODELING,4.6578e-06,0.32173,0.32915,1,1
4,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,2.6352e-05,0.3206,0.3263,1,1
4,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.045591,0.31996,0.21471,1,1
4,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,2.4528e-05,0.3183,0.26995,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,7.105e-06,0.31745,0.31544,1,1
4,GO ENTRY OF BACTERIUM INTO HOST CELL,0.00042777,0.31693,0.31601,1,1
4,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.0017277,0.31691,0.23228,1,1
4,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,4.3946e-06,0.3156,0.39235,1,1
4,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,5.8049e-05,0.3148,0.39824,1,1
4,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,1.0861e-06,0.31444,0.39773,1,1
4,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,4.1026e-05,0.31425,0.30781,1,1
4,GO REGULATION OF BONE REMODELING,1.7154e-07,0.314,0.3192,1,1
4,GO ACTIN FILAMENT SEVERING,2.0478e-05,0.3138,0.33124,1,1
4,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.011e-05,0.31328,0.26264,1,1
4,GO DOPAMINE TRANSPORT,9.7998e-07,0.31319,0.39524,1,1
4,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,8.4415e-08,0.31148,0.30677,1,1
4,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.00029511,0.31133,0.38269,1,1
4,GO ANOIKIS,9.2321e-08,0.31118,0.35436,1,1
4,GO LIPID TRANSLOCATION,8.6328e-08,0.31058,0.32294,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00015083,0.30893,0.28205,1,1
4,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.00032408,0.30863,0.28335,1,1
4,GO REGULATION OF DOPAMINE SECRETION,1.5865e-05,0.30766,0.41156,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,2.913e-06,0.30739,0.36746,1,1
4,GO GLYCOLIPID CATABOLIC PROCESS,5.0563e-05,0.30728,0.37246,1,1
4,GO REGULATION OF NEURON MATURATION,7.8124e-06,0.30718,0.28841,1,1
4,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,9.3381e-05,0.30705,0.35794,1,1
4,GO REGULATION OF TISSUE REMODELING,4.719e-07,0.30694,0.30191,1,1
4,GO MYELIN MAINTENANCE,0.00040857,0.30583,0.31298,1,1
4,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,1.6457e-05,0.30579,0.34456,1,1
4,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.00080175,0.30357,0.26121,1,1
4,GO HYPOTHALAMUS DEVELOPMENT,2.7452e-06,0.30274,0.29349,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.5713e-07,0.3025,0.32133,1,1
4,GO PROGESTERONE METABOLIC PROCESS,0.0014624,0.30182,0.34881,1,1
4,GO REGULATION OF CGMP MEDIATED SIGNALING,0.0085105,0.30169,0.2139,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,1.2482e-05,0.30158,0.261,1,1
4,GO RESPONSE TO COPPER ION,0.00016901,0.30152,0.33903,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00026024,0.30147,0.3468,1,1
4,GO NEGATIVE REGULATION OF COAGULATION,0.0019819,0.30032,0.21918,1,1
4,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,3.628e-05,0.29987,0.3651,1,1
4,GO EPITHELIAL CELL CELL ADHESION,0.0047798,0.29979,0.24224,1,1
4,GO CELLULAR DEFENSE RESPONSE,6.8396e-06,0.29954,0.25927,1,1
4,GO TYPE B PANCREATIC CELL PROLIFERATION,4.7172e-05,0.29915,0.35217,1,1
4,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.2775e-07,0.29883,0.29021,1,1
4,GO KERATAN SULFATE CATABOLIC PROCESS,0.00013899,0.29872,0.31861,1,1
4,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,2.4371e-06,0.29784,0.29041,1,1
4,GO REGULATION OF EXOSOMAL SECRETION,3.2859e-07,0.29687,0.29898,1,1
4,GO SUPEROXIDE ANION GENERATION,9.6562e-05,0.29673,0.26834,1,1
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.0086125,0.2965,0.2888,1,1
4,GO RESPONSE TO INTERFERON GAMMA,0.00075607,0.29633,0.21433,1,1
4,GO RESPONSE TO FORSKOLIN,0.00159,0.29629,0.25274,1,1
4,GO REGULATION OF RESPIRATORY BURST,8.4415e-08,0.29563,0.34401,1,1
4,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,9.4959e-05,0.29429,0.28885,1,1
4,GO REGULATION OF PROTEIN COMPLEX STABILITY,2.3274e-07,0.29304,0.3116,1,1
4,GO CELL ADHESION MEDIATED BY INTEGRIN,1.2027e-05,0.29273,0.30359,1,1
4,GO VITAMIN D METABOLIC PROCESS,4.7999e-05,0.29136,0.30039,1,1
4,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,4.5684e-06,0.29069,0.27333,1,1
4,GO NOTCH RECEPTOR PROCESSING,0.00041488,0.2898,0.30718,1,1
4,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.010895,0.28936,0.20959,1,1
4,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.00049053,0.28923,0.24892,1,1
4,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,7.2414e-06,0.28908,0.26931,1,1
4,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,7.8124e-06,0.28904,0.27452,1,1
4,GO STEROID HORMONE SECRETION,0.00038422,0.289,0.22588,1,1
4,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,3.2057e-05,0.28866,0.28733,1,1
4,GO POSITIVE REGULATION OF WOUND HEALING,3.0302e-06,0.28844,0.2981,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,2.2824e-05,0.28801,0.28609,1,1
4,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.00016629,0.28796,0.32618,1,1
4,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.0022396,0.28766,0.23657,1,1
4,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.00072342,0.28745,0.31415,1,1
4,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,8.5858e-05,0.28594,0.28493,1,1
4,GO B CELL APOPTOTIC PROCESS,1.8419e-06,0.28551,0.29351,1,1
4,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.0056958,0.2851,0.18797,1,1
4,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,4.7172e-05,0.28497,0.30767,1,1
4,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,3.3806e-05,0.28454,0.2887,1,1
4,GO HOMOTYPIC CELL CELL ADHESION,1.5052e-06,0.28453,0.29923,1,1
4,GO BASE CONVERSION OR SUBSTITUTION EDITING,3.0395e-05,0.28408,0.30508,1,1
4,GO BLOOD VESSEL REMODELING,6.3249e-05,0.28331,0.24608,1,1
4,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00010852,0.28225,0.2689,1,1
4,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,2.7312e-05,0.2822,0.24174,1,1
4,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.2146e-06,0.28201,0.31399,1,1
4,GO ZYMOGEN ACTIVATION,0.00015083,0.28172,0.26606,1,1
4,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.017506,0.2808,0.29122,1,1
4,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0040509,0.28058,0.2678,1,1
4,GO LUNG ALVEOLUS DEVELOPMENT,1.5674e-06,0.28042,0.27786,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS,6.6066e-07,0.28034,0.32601,1,1
4,GO MICROVILLUS ORGANIZATION,3.5022e-05,0.28026,0.32312,1,1
4,GO RESPONSE TO LITHIUM ION,2.9514e-07,0.27969,0.3574,1,1
4,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.0037985,0.27955,0.17977,1,1
4,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.00016901,0.27938,0.2293,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.00038422,0.27936,0.2076,1,1
4,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,6.2046e-07,0.27894,0.2809,1,1
4,GO VASODILATION,1.6457e-05,0.27862,0.24987,1,1
4,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.0023009,0.27851,0.20493,1,1
4,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,2.2824e-05,0.27833,0.3603,1,1
4,GO GALACTOSE METABOLIC PROCESS,0.00011986,0.27788,0.30311,1,1
4,GO PLASMA MEMBRANE FUSION,0.00021511,0.27786,0.28349,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,1.5994e-06,0.27745,0.27598,1,1
4,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,4.4771e-05,0.27743,0.25376,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,0.00019541,0.27704,0.26575,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.0279e-08,0.2769,0.32926,1,1
4,GO ALPHA BETA T CELL PROLIFERATION,0.00012804,0.27624,0.26669,1,1
4,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.0002443,0.27569,0.36895,1,1
4,GO CERAMIDE CATABOLIC PROCESS,0.00041488,0.27548,0.30258,1,1
4,GO RESPONSE TO STEROL DEPLETION,3.2859e-07,0.27548,0.32314,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.00017176,0.27499,0.20787,1,1
4,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0010259,0.27493,0.30461,1,1
4,GO RESPONSE TO CORTICOSTERONE,0.0015038,0.27488,0.19539,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0024281,0.27419,0.21537,1,1
4,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,5.02e-08,0.27418,0.29667,1,1
4,GO REGULATION OF INTEGRIN ACTIVATION,5.8856e-08,0.27363,0.33789,1,1
4,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,4.3997e-05,0.27353,0.26543,1,1
4,GO DETECTION OF CALCIUM ION,7.2414e-06,0.2725,0.35507,1,1
4,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,4.5684e-06,0.27144,0.27625,1,1
4,GO REGULATION OF LEUKOCYTE DEGRANULATION,2.0478e-05,0.27126,0.27326,1,1
4,GO AMINOGLYCAN CATABOLIC PROCESS,0.00061456,0.26982,0.20127,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.008211,0.2698,0.19195,1,1
4,GO BEHAVIORAL RESPONSE TO PAIN,0.001235,0.26969,0.24871,1,1
4,GO SEQUESTERING OF ACTIN MONOMERS,0.0066851,0.26863,0.22376,1,1
4,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,9.2585e-06,0.26776,0.2682,1,1
4,GO CATECHOLAMINE UPTAKE,8.1623e-05,0.26775,0.29103,1,1
4,GO MITOCHONDRIAL DEPOLARIZATION,1.155e-06,0.26758,0.2644,1,1
4,GO POSITIVE REGULATION OF CELL KILLING,0.00091404,0.26752,0.22187,1,1
4,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.7059e-05,0.26691,0.22862,1,1
4,GO CELL CELL ADHESION MEDIATED BY CADHERIN,9.4341e-06,0.26664,0.30668,1,1
4,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,6.6066e-07,0.26656,0.27056,1,1
4,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0013069,0.26644,0.27182,1,1
4,GO TISSUE REMODELING,6.0991e-06,0.26568,0.24704,1,1
4,GO CELLULAR RESPONSE TO CADMIUM ION,0.0025277,0.26562,0.27224,1,1
4,GO APICAL JUNCTION ASSEMBLY,7.8052e-07,0.26548,0.27956,1,1
4,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,3.9613e-05,0.26544,0.27104,1,1
4,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.00025215,0.26519,0.25346,1,1
4,GO REGULATION OF ACROSOME REACTION,0.00090088,0.26516,0.22224,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00044781,0.26454,0.20751,1,1
4,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.0013443,0.26448,0.2444,1,1
4,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,9.9844e-05,0.26371,0.31058,1,1
4,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,6.4341e-05,0.26364,0.24731,1,1
4,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,8.1138e-06,0.26313,0.29367,1,1
4,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.0026663,0.26261,0.22625,1,1
4,GO RESPONSE TO INTERLEUKIN 18,0.0057669,0.26198,0.27464,1,1
4,GO MACROPHAGE CYTOKINE PRODUCTION,0.001442,0.26194,0.23255,1,1
4,GO OLIGODENDROCYTE DEVELOPMENT,4.7172e-05,0.26152,0.22054,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,2.5424e-05,0.26151,0.27415,1,1
4,GO PHAGOSOME ACIDIFICATION,9.1205e-09,0.26134,0.28792,1,1
4,GO RESPONSE TO GONADOTROPIN,1.3442e-05,0.26125,0.22692,1,1
4,GO DETERMINATION OF ADULT LIFESPAN,3.628e-05,0.26114,0.26922,1,1
4,GO REGULATION OF CELL KILLING,0.00052901,0.26052,0.20689,1,1
4,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.0099244,0.26025,0.23865,1,1
4,GO CELLULAR RESPONSE TO INTERFERON BETA,0.0005618,0.2601,0.25964,1,1
4,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.00015083,0.26008,0.20734,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.8363e-05,0.26,0.24905,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,9.6129e-06,0.2591,0.23889,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.8888e-05,0.25904,0.34108,1,1
4,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0045438,0.25877,0.21319,1,1
4,GO REGULATION OF ICOSANOID SECRETION,1.1282e-07,0.25872,0.28493,1,1
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.0030038,0.25872,0.25666,1,1
4,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.0021505,0.2587,0.19288,1,1
4,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.013546,0.25795,0.21838,1,1
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.00012804,0.25784,0.20977,1,1
4,GO BONE RESORPTION,9.5999e-07,0.25762,0.2647,1,1
4,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0074579,0.25718,0.14931,1,1
4,GO REGULATION OF NEUTROPHIL MIGRATION,2.4091e-05,0.257,0.25085,1,1
4,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.0032078,0.25695,0.16758,1,1
4,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.00082553,0.2569,0.2605,1,1
4,GO REGULATION OF MYOBLAST FUSION,6.3249e-05,0.25682,0.25809,1,1
4,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,8.8796e-05,0.25658,0.21132,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1624e-06,0.25649,0.32578,1,1
4,GO HYALURONAN BIOSYNTHETIC PROCESS,1.8363e-05,0.2564,0.24925,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0044298,0.25605,0.30273,1,1
4,GO DIET INDUCED THERMOGENESIS,1.0169e-05,0.25599,0.24263,1,1
4,GO REGULATION OF RECEPTOR BINDING,0.0104,0.25584,0.19576,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.0083098,0.25576,0.16508,1,1
4,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00044781,0.25568,0.25508,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0030038,0.25556,0.19932,1,1
4,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.0020929,0.25546,0.2001,1,1
4,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,3.8924e-05,0.25532,0.41121,1,1
4,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.010769,0.25476,0.30944,1,1
4,GO INDOLALKYLAMINE METABOLIC PROCESS,3.9872e-06,0.25428,0.30839,1,1
4,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,8.5867e-06,0.25426,0.36038,1,1
4,GO POSITIVE REGULATION OF BONE RESORPTION,0.0005056,0.25411,0.26853,1,1
4,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,3.4098e-06,0.25395,0.25581,1,1
4,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.012227,0.25384,0.22638,1,1
4,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.00016629,0.25321,0.27802,1,1
4,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.00011033,0.25293,0.19542,1,1
4,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,3.5646e-05,0.2529,0.22258,1,1
4,GO REGULATION OF COAGULATION,0.0001862,0.25201,0.23548,1,1
4,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,2.7668e-07,0.25197,0.2504,1,1
4,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0050269,0.25178,0.31453,1,1
4,GO RESPONSE TO NITROSATIVE STRESS,0.0026663,0.25165,0.20693,1,1
4,GO REGULATION OF B CELL PROLIFERATION,2.8305e-05,0.25152,0.22926,1,1
4,GO STEROID ESTERIFICATION,0.0022095,0.251,0.25027,1,1
4,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,2.7804e-05,0.2507,0.22733,1,1
4,GO HETEROTYPIC CELL CELL ADHESION,0.00088789,0.2495,0.19692,1,1
4,GO EOSINOPHIL CHEMOTAXIS,0.00015583,0.24867,0.32141,1,1
4,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.00029976,0.24841,0.2186,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,2.0853e-05,0.24803,0.25063,1,1
4,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00065224,0.24777,0.28573,1,1
4,GO IMMUNOGLOBULIN SECRETION,0.00022927,0.24752,0.23551,1,1
4,GO OPTIC NERVE DEVELOPMENT,0.00068191,0.24608,0.25443,1,1
4,GO EOSINOPHIL MIGRATION,0.00036686,0.24593,0.3001,1,1
4,GO RESPONSE TO ACIDIC PH,0.00040857,0.24587,0.27661,1,1
4,GO DOPAMINE METABOLIC PROCESS,3.9872e-06,0.24544,0.29187,1,1
4,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.00095459,0.24516,0.24764,1,1
4,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.00054518,0.24467,0.22035,1,1
4,GO RESPIRATORY BURST,1.9393e-05,0.24454,0.25577,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.004156,0.2439,0.1645,1,1
4,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.012087,0.24384,0.17962,1,1
4,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.00019541,0.24339,0.29479,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00063314,0.24335,0.2521,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.0013255,0.24323,0.25365,1,1
4,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,8.7316e-05,0.24293,0.22474,1,1
4,GO BONE REMODELING,4.8416e-06,0.2427,0.25277,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.00090088,0.24263,0.27898,1,1
4,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,3.5038e-07,0.24222,0.26213,1,1
4,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0022701,0.24208,0.29568,1,1
4,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.001776,0.24197,0.17157,1,1
4,GO CARBOHYDRATE DERIVATIVE TRANSPORT,1.9989e-07,0.24153,0.26584,1,1
4,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,4.6359e-05,0.24143,0.20285,1,1
4,GO REGULATION OF PROSTAGLANDIN SECRETION,3.6877e-06,0.24101,0.24917,1,1
4,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.00059648,0.24074,0.17917,1,1
4,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,2.5424e-05,0.24039,0.23405,1,1
4,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0026663,0.24034,0.28792,1,1
4,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.001235,0.23993,0.18795,1,1
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0017277,0.23973,0.20726,1,1
4,GO INTERLEUKIN 12 PRODUCTION,0.00014839,0.23967,0.21458,1,1
4,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,1.9393e-05,0.23925,0.22281,1,1
4,GO DIGESTIVE SYSTEM PROCESS,4.2444e-07,0.23904,0.23395,1,1
4,GO PANCREATIC JUICE SECRETION,0.0019819,0.23894,0.17323,1,1
4,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.00013673,0.23861,0.20819,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.0038478,0.23829,0.18339,1,1
4,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.9872e-06,0.23788,0.2315,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.6538e-08,0.23788,0.28169,1,1
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.0021215,0.23751,0.21521,1,1
4,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.0030839,0.2374,0.25098,1,1
4,GO INTERLEUKIN 10 PRODUCTION,0.00042128,0.23712,0.20449,1,1
4,GO PHAGOSOME MATURATION,6.5837e-06,0.23708,0.22719,1,1
4,GO CELL CELL JUNCTION ASSEMBLY,1.734e-06,0.23689,0.22414,1,1
4,GO PHOSPHOLIPID CATABOLIC PROCESS,1.7706e-05,0.23689,0.23062,1,1
4,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.027686,0.23632,0.14298,1,1
4,GO GASTRULATION WITH MOUTH FORMING SECOND,3.094e-05,0.23606,0.26133,1,1
4,GO T CELL MEDIATED IMMUNITY,0.0047198,0.23595,0.15615,1,1
4,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.00060545,0.23568,0.24719,1,1
4,GO KERATAN SULFATE METABOLIC PROCESS,4.1026e-05,0.23563,0.24259,1,1
4,GO HAIR CELL DIFFERENTIATION,0.000286,0.23549,0.19389,1,1
4,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.0028118,0.23505,0.18467,1,1
4,GO INOSITOL METABOLIC PROCESS,0.0001179,0.235,0.21794,1,1
4,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,3.9872e-06,0.23461,0.23548,1,1
4,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,7.0337e-07,0.23423,0.2813,1,1
4,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.0022095,0.23414,0.16827,1,1
4,GO NEGATIVE REGULATION OF BLOOD PRESSURE,1.8363e-05,0.23413,0.2204,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,1.9393e-05,0.234,0.24098,1,1
4,GO REGULATION OF CELL PROJECTION SIZE,0.00038422,0.2339,0.26182,1,1
4,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,0.0037016,0.23375,0.20989,1,1
4,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.012087,0.23331,0.17043,1,1
4,GO N GLYCAN PROCESSING,0.0018256,0.23327,0.24754,1,1
4,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.016205,0.23309,0.16069,1,1
4,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.000662,0.23259,0.20777,1,1
4,GO MAST CELL ACTIVATION,1.6761e-05,0.23245,0.26477,1,1
4,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.0056958,0.23215,0.14238,1,1
4,GO ETHER METABOLIC PROCESS,6.545e-05,0.23197,0.20429,1,1
4,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,1.6457e-05,0.23166,0.21829,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.00022927,0.23166,0.19892,1,1
4,GO NEURON CELL CELL ADHESION,0.042609,0.23146,0.19989,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.0016806,0.23124,0.24206,1,1
4,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0005056,0.23111,0.33217,1,1
4,GO DNA DEAMINATION,0.0010113,0.23108,0.30253,1,1
4,GO SECRETION BY TISSUE,0.00019229,0.23102,0.20254,1,1
4,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.000662,0.2309,0.20918,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.012227,0.23058,0.13262,1,1
4,GO POSITIVE REGULATION OF TISSUE REMODELING,5.3256e-05,0.23044,0.26578,1,1
4,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.0035605,0.23033,0.20567,1,1
4,GO RESPONSE TO MUSCLE STRETCH,0.00020835,0.23012,0.31868,1,1
4,GO RESPONSE TO MINERALOCORTICOID,0.00010852,0.23006,0.20377,1,1
4,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.001955,0.22982,0.24964,1,1
4,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.0053519,0.22981,0.18497,1,1
4,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,5.4184e-05,0.22978,0.24524,1,1
4,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.00016098,0.22957,0.2135,1,1
4,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,9.2585e-06,0.22928,0.25176,1,1
4,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0024609,0.2292,0.20474,1,1
4,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,3.5646e-05,0.22908,0.26581,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0071051,0.22906,0.18974,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,6.2169e-06,0.22898,0.2273,1,1
4,GO WATER HOMEOSTASIS,1.5052e-06,0.22889,0.25837,1,1
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00027716,0.22869,0.21113,1,1
4,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.0010259,0.22866,0.20372,1,1
4,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,3.6924e-05,0.22843,0.18919,1,1
4,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.00046165,0.22842,0.21502,1,1
4,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.5674e-06,0.22842,0.30605,1,1
4,GO CELL CELL JUNCTION ORGANIZATION,3.628e-05,0.22836,0.20434,1,1
4,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,2.856e-06,0.22821,0.22401,1,1
4,GO FUCOSE METABOLIC PROCESS,0.0083098,0.22819,0.17023,1,1
4,GO NEPHRIC DUCT DEVELOPMENT,0.010645,0.2278,0.19633,1,1
4,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.013093,0.22768,0.13724,1,1
4,GO GLYCOSYLATION,2.3784e-07,0.22757,0.22576,1,1
4,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.3997e-05,0.22658,0.22261,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,4.9361e-06,0.22645,0.22683,1,1
4,GO NEGATIVE REGULATION OF B CELL ACTIVATION,6.7724e-05,0.2263,0.22029,1,1
4,GO REGULATION OF THE FORCE OF HEART CONTRACTION,7.1274e-05,0.22589,0.20035,1,1
4,GO NEGATIVE REGULATION OF BONE REMODELING,0.00010152,0.22589,0.29813,1,1
4,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,1.2604e-07,0.2258,0.23115,1,1
4,GO NEGATIVE REGULATION OF WOUND HEALING,0.00084997,0.2257,0.19226,1,1
4,GO OLIGOPEPTIDE TRANSPORT,0.0055559,0.22556,0.1894,1,1
4,GO SNARE COMPLEX ASSEMBLY,1.8363e-05,0.22553,0.24155,1,1
4,GO GAP JUNCTION ASSEMBLY,0.0016575,0.22548,0.24294,1,1
4,GO MYOBLAST FUSION,0.00027284,0.22542,0.21243,1,1
4,GO REGULATION OF ACTION POTENTIAL,4.7172e-05,0.22542,0.23776,1,1
4,GO MEMBRANE DEPOLARIZATION,1.5014e-05,0.2253,0.22725,1,1
4,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.00016629,0.22523,0.28361,1,1
4,GO POSITIVE REGULATION OF B CELL PROLIFERATION,1.8701e-05,0.22504,0.24623,1,1
4,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,4.9361e-06,0.22485,0.25546,1,1
4,GO REGULATION OF GLUCOSE METABOLIC PROCESS,5.9498e-07,0.22478,0.20715,1,1
4,GO PHOSPHOLIPID TRANSPORT,8.1361e-07,0.22471,0.23527,1,1
4,GO DIGESTION,7.8052e-07,0.22468,0.2334,1,1
4,GO PROTEIN DEMANNOSYLATION,4.5558e-05,0.22463,0.2624,1,1
4,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.00064263,0.22435,0.25023,1,1
4,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.00013016,0.2243,0.17902,1,1
4,GO POSITIVE REGULATION OF AMINE TRANSPORT,1.3442e-05,0.22423,0.29433,1,1
4,GO MAGNESIUM ION TRANSPORT,7.9617e-06,0.22415,0.27014,1,1
4,GO SENSORY PERCEPTION OF SMELL,0.00013673,0.22394,0.21114,1,1
4,GO MATURE B CELL DIFFERENTIATION,0.0011836,0.22372,0.24297,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.00053704,0.22365,0.18526,1,1
4,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0093576,0.22344,0.20158,1,1
4,GO INTRACELLULAR STEROL TRANSPORT,0.00031414,0.22335,0.23588,1,1
4,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,9.819e-05,0.2232,0.23762,1,1
4,GO KERATINOCYTE DIFFERENTIATION,7.2414e-06,0.22318,0.2279,1,1
4,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.00022927,0.22278,0.22491,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00042777,0.22263,0.22102,1,1
4,GO PLATELET DEGRANULATION,0.00030928,0.22255,0.20807,1,1
4,GO EPITHELIAL CELL MORPHOGENESIS,0.00023667,0.22252,0.3288,1,1
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.016027,0.22233,0.13818,1,1
4,GO ORGANIC HYDROXY COMPOUND TRANSPORT,5.4701e-07,0.22217,0.21621,1,1
4,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,1.2027e-05,0.22194,0.19002,1,1
4,GO T HELPER CELL LINEAGE COMMITMENT,0.00023294,0.22177,0.19204,1,1
4,GO RESPONSE TO INTERLEUKIN 2,4.2487e-05,0.22173,0.22277,1,1
4,GO LYTIC VACUOLE ORGANIZATION,1.3351e-08,0.22139,0.26793,1,1
4,GO CELLULAR RESPONSE TO STEROL DEPLETION,9.2118e-07,0.22134,0.28281,1,1
4,GO VACUOLAR ACIDIFICATION,5.2445e-07,0.22116,0.24845,1,1
4,GO EPITHELIAL CELL FATE COMMITMENT,0.043444,0.22107,0.14517,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00068191,0.22099,0.20744,1,1
4,GO ALANINE TRANSPORT,0.010522,0.22047,0.14773,1,1
4,GO CELL KILLING,0.00027284,0.22042,0.18486,1,1
4,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.00022565,0.22031,0.27852,1,1
4,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.0022701,0.22031,0.24513,1,1
4,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.020605,0.22027,0.16962,1,1
4,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0002443,0.22012,0.22623,1,1
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.002702,0.22002,0.2255,1,1
4,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.00046872,0.21989,0.20097,1,1
4,GO RESPONSE TO LEPTIN,2.9859e-05,0.21946,0.21172,1,1
4,GO REGULATION OF PROTEIN GLYCOSYLATION,0.00012186,0.2191,0.29096,1,1
4,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.00022208,0.2189,0.2404,1,1
4,GO REGULATION OF MYOTUBE DIFFERENTIATION,2.0478e-05,0.21882,0.2126,1,1
4,GO ENDOTHELIAL CELL CHEMOTAXIS,5.5127e-05,0.21878,0.29216,1,1
4,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00030928,0.21877,0.21471,1,1
4,GO REGULATORY T CELL DIFFERENTIATION,8.3013e-05,0.21859,0.27939,1,1
4,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.0047198,0.21857,0.16788,1,1
4,GO LUNG CELL DIFFERENTIATION,0.0010408,0.2185,0.27663,1,1
4,GO PROTEIN O LINKED MANNOSYLATION,3.094e-05,0.218,0.23876,1,1
4,GO MAST CELL MEDIATED IMMUNITY,0.00013451,0.21784,0.23583,1,1
4,GO AMYLOID FIBRIL FORMATION,0.0066039,0.21767,0.19016,1,1
4,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.0027747,0.2174,0.20004,1,1
4,GO SPHINGOLIPID METABOLIC PROCESS,1.8318e-07,0.2173,0.21802,1,1
4,GO REGULATION OF MEMBRANE REPOLARIZATION,0.00014362,0.21722,0.19395,1,1
4,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.0054872,0.21716,0.19785,1,1
4,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.1026e-05,0.21684,0.19816,1,1
4,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.0050904,0.21671,0.22287,1,1
4,GO L ASCORBIC ACID METABOLIC PROCESS,0.00071283,0.21669,0.25304,1,1
4,GO REGULATION OF RESPONSE TO TUMOR CELL,0.018693,0.21619,0.14877,1,1
4,GO METHIONINE METABOLIC PROCESS,8.8796e-05,0.21609,0.19656,1,1
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00011986,0.21579,0.24028,1,1
4,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,5.2344e-05,0.21559,0.22477,1,1
4,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,6.7724e-05,0.21531,0.19393,1,1
4,GO PLASMINOGEN ACTIVATION,0.0074579,0.21502,0.19993,1,1
4,GO MEMBRANE LIPID METABOLIC PROCESS,1.1034e-07,0.21441,0.21689,1,1
4,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.012798,0.21424,0.15994,1,1
4,GO ORGANOPHOSPHATE ESTER TRANSPORT,5.02e-08,0.21415,0.2251,1,1
4,GO TRANSCYTOSIS,0.00020504,0.21359,0.19903,1,1
4,GO REGULATION OF ORGANIC ACID TRANSPORT,5.1446e-05,0.21353,0.19659,1,1
4,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.0003557,0.21307,0.21504,1,1
4,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.00012388,0.21304,0.19067,1,1
4,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,4.5684e-06,0.21302,0.25995,1,1
4,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.0011503,0.21276,0.2181,1,1
4,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.0013826,0.2125,0.21797,1,1
4,GO RESPONSE TO GROWTH HORMONE,1.8363e-05,0.2123,0.25415,1,1
4,GO GOLGI TO ENDOSOME TRANSPORT,8.8796e-05,0.21208,0.21018,1,1
4,GO LIPOSACCHARIDE METABOLIC PROCESS,2.342e-06,0.21205,0.22403,1,1
4,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00059648,0.2119,0.25556,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.00015331,0.21056,0.22206,1,1
4,GO EPIDERMAL CELL DIFFERENTIATION,1.1588e-05,0.21006,0.21906,1,1
4,GO EMBRYONIC PLACENTA DEVELOPMENT,0.00042128,0.2098,0.18538,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,5.8049e-05,0.20973,0.21355,1,1
4,GO REGULATION OF ACTIN NUCLEATION,8.9166e-06,0.2094,0.2385,1,1
4,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.0002443,0.20939,0.22626,1,1
4,GO LEUKOTRIENE METABOLIC PROCESS,0.0013633,0.20895,0.17777,1,1
4,GO DIOL BIOSYNTHETIC PROCESS,3.3214e-05,0.20895,0.27274,1,1
4,GO REGULATION OF WOUND HEALING,2.8305e-05,0.20894,0.23606,1,1
4,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.00012388,0.20886,0.19051,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.0012005,0.20856,0.21401,1,1
4,GO SECONDARY METABOLIC PROCESS,0.00031414,0.20825,0.2119,1,1
4,GO DEFENSE RESPONSE TO BACTERIUM,4.8416e-06,0.20823,0.19872,1,1
4,GO GLOMERULUS DEVELOPMENT,0.0015038,0.20817,0.19936,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.00012594,0.20795,0.30733,1,1
4,GO POSITIVE REGULATION OF COAGULATION,0.0039481,0.20775,0.17571,1,1
4,GO DIOL METABOLIC PROCESS,3.2057e-05,0.20765,0.25879,1,1
4,GO DORSAL AORTA DEVELOPMENT,0.010645,0.20744,0.17362,1,1
4,GO REGULATION OF MUSCLE HYPERTROPHY,0.00057029,0.20738,0.16835,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.0019023,0.20737,0.17691,1,1
4,GO DEFENSE RESPONSE TO VIRUS,0.0016347,0.20716,0.1642,1,1
4,GO INTERMEDIATE FILAMENT BASED PROCESS,0.00042777,0.20619,0.18384,1,1
4,GO REGULATION OF AMINO ACID TRANSPORT,0.004156,0.20617,0.1595,1,1
4,GO MAINTENANCE OF CELL POLARITY,0.0011668,0.2061,0.20589,1,1
4,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.0302e-06,0.20601,0.187,1,1
4,GO OSTEOBLAST PROLIFERATION,0.00068191,0.20573,0.22277,1,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.01499,0.20563,0.16457,1,1
4,GO REGULATION OF B CELL ACTIVATION,0.00015083,0.20546,0.17271,1,1
4,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,5.5864e-07,0.20545,0.23158,1,1
4,GO SMOOTH MUSCLE CELL MIGRATION,0.0027381,0.20527,0.18279,1,1
4,GO ORGANELLE MEMBRANE FUSION,3.9872e-06,0.20473,0.19402,1,1
4,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.00013673,0.20471,0.17481,1,1
4,GO INNATE IMMUNE RESPONSE,0.00019857,0.20469,0.16515,1,1
4,GO EXTRACELLULAR VESICLE BIOGENESIS,2.4371e-06,0.20456,0.23449,1,1
4,GO B CELL MEDIATED IMMUNITY,0.0021215,0.20453,0.15447,1,1
4,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.00016098,0.20452,0.20654,1,1
4,GO GDP METABOLIC PROCESS,0.001776,0.20434,0.22388,1,1
4,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,2.8814e-05,0.2043,0.19711,1,1
4,GO TRANSFERRIN TRANSPORT,5.2538e-08,0.20427,0.24397,1,1
4,GO MALE MEIOSIS I,0.024687,0.20408,0.21959,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.0054192,0.20406,0.16615,1,1
4,GO REGULATION OF HEART RATE,2.2824e-05,0.20397,0.20207,1,1
4,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,3.9941e-08,0.20395,0.23091,1,1
4,GO B CELL PROLIFERATION,0.00014839,0.20378,0.18563,1,1
4,GO CYTOPLASM ORGANIZATION,0.00072342,0.20377,0.21482,1,1
4,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.545e-05,0.20376,0.18233,1,1
4,GO LABYRINTHINE LAYER DEVELOPMENT,7.8911e-05,0.20372,0.23261,1,1
4,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.8814e-05,0.20367,0.19681,1,1
4,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,2.6828e-05,0.20334,0.19864,1,1
4,GO ACTIN FILAMENT DEPOLYMERIZATION,1.2027e-05,0.20333,0.21021,1,1
4,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,3.3214e-05,0.20251,0.22171,1,1
4,GO REGULATION OF LYSOSOMAL LUMEN PH,4.4771e-05,0.20247,0.24144,1,1
4,GO AMYLOID BETA METABOLIC PROCESS,0.00082553,0.20243,0.17364,1,1
4,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,8.9166e-06,0.20235,0.18374,1,1
4,GO LATE ENDOSOME TO VACUOLE TRANSPORT,1.3196e-05,0.20218,0.19817,1,1
4,GO INTEGRIN ACTIVATION,3.1494e-05,0.20217,0.23136,1,1
4,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.00013673,0.20213,0.26964,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.00074504,0.20189,0.17081,1,1
4,GO MEMBRANE FUSION,3.2784e-06,0.2018,0.18988,1,1
4,GO LYMPHOCYTE MEDIATED IMMUNITY,0.0018508,0.20162,0.14611,1,1
4,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0028492,0.20148,0.13728,1,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.00072342,0.20137,0.17764,1,1
4,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0022095,0.20132,0.25089,1,1
4,GO CHEMOKINE PRODUCTION,0.01128,0.2013,0.13061,1,1
4,GO FUCOSYLATION,0.00083767,0.20128,0.18295,1,1
4,GO REGULATION OF FERTILIZATION,0.00020178,0.20128,0.18096,1,1
4,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.007921,0.20057,0.1949,1,1
4,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.0023957,0.20055,0.19873,1,1
4,GO RESPONSE TO INTERLEUKIN 15,0.0068504,0.20027,0.17528,1,1
4,GO POSITIVE REGULATION OF HAIR CYCLE,0.013243,0.20002,0.17978,1,1
4,GO REGULATION OF POSITIVE CHEMOTAXIS,0.00030928,0.19977,0.2026,1,1
4,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,1.536e-06,0.19972,0.2136,1,1
4,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.00052901,0.19954,0.22114,1,1
4,GO PLATELET ACTIVATION,0.00061456,0.1995,0.17451,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION,0.0010558,0.19922,0.16115,1,1
4,GO RESPONSE TO WATER,0.00012804,0.19914,0.25748,1,1
4,GO FOAM CELL DIFFERENTIATION,0.00032916,0.19912,0.20711,1,1
4,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.0051547,0.19885,0.2064,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.00095459,0.19884,0.17435,1,1
4,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,9.03e-05,0.19869,0.19358,1,1
4,GO REGULATION OF FATTY ACID TRANSPORT,3.8924e-05,0.19841,0.22672,1,1
4,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,3.5022e-05,0.19833,0.16502,1,1
4,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.0030038,0.19832,0.21107,1,1
4,GO REGULATION OF INNATE IMMUNE RESPONSE,0.00013232,0.19811,0.16143,1,1
4,GO RESPONSE TO INSECTICIDE,0.0062108,0.19793,0.21625,1,1
4,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.00049802,0.19787,0.27359,1,1
4,GO HUMORAL IMMUNE RESPONSE,0.00019857,0.19777,0.15001,1,1
4,GO TYPE I INTERFERON PRODUCTION,0.0007901,0.19762,0.1603,1,1
4,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.4098e-06,0.19761,0.19925,1,1
4,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.0025617,0.19747,0.21183,1,1
4,GO B CELL RECEPTOR SIGNALING PATHWAY,0.00037257,0.19745,0.22201,1,1
4,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.011411,0.19718,0.15226,1,1
4,GO ENTRY INTO HOST,0.00082553,0.1971,0.19363,1,1
4,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,3.2631e-05,0.19709,0.19244,1,1
4,GO POSITIVE REGULATION OF FERTILIZATION,0.0037985,0.19688,0.19402,1,1
4,GO POSITIVE REGULATION OF EXOCYTOSIS,9.7998e-07,0.19686,0.23037,1,1
4,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.006444,0.19673,0.18531,1,1
4,GO SIGNAL PEPTIDE PROCESSING,1.4207e-05,0.19671,0.26731,1,1
4,GO REGULATION OF NECROTIC CELL DEATH,0.00015838,0.19662,0.19773,1,1
4,GO PROTEIN DEGLYCOSYLATION,0.00014839,0.1965,0.2429,1,1
4,GO RESPONSE TO METAL ION,6.2046e-07,0.19609,0.17994,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,8.8796e-05,0.19589,0.23044,1,1
4,GO DISACCHARIDE METABOLIC PROCESS,0.00019541,0.19582,0.27407,1,1
4,GO HEART TRABECULA MORPHOGENESIS,0.0052197,0.19575,0.14605,1,1
4,GO MOVEMENT IN HOST ENVIRONMENT,0.00035024,0.19556,0.18513,1,1
4,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.00044781,0.19547,0.19845,1,1
4,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.00039622,0.19534,0.16682,1,1
4,GO REGULATION OF BLOOD PRESSURE,1.9044e-05,0.19533,0.16545,1,1
4,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.013394,0.19524,0.13793,1,1
4,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.00017741,0.1952,0.19588,1,1
4,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.0011021,0.19469,0.15933,1,1
4,GO RESPONSE TO AUDITORY STIMULUS,0.049681,0.19429,0.16582,1,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0069343,0.19426,0.14124,1,1
4,GO PROSTAGLANDIN TRANSPORT,0.00032916,0.19402,0.20302,1,1
4,GO IMMUNE RESPONSE TO TUMOR CELL,0.0089251,0.19386,0.20765,1,1
4,GO TRANSPOSITION,0.00048316,0.1938,0.26051,1,1
4,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,3.6567e-07,0.19375,0.22144,1,1
4,GO POLYSACCHARIDE METABOLIC PROCESS,1.2281e-06,0.19356,0.20712,1,1
4,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.00159,0.1934,0.17858,1,1
4,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00024045,0.19305,0.19631,1,1
4,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.0010865,0.19295,0.21082,1,1
4,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,9.819e-05,0.19292,0.16385,1,1
4,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.00033432,0.19268,0.19463,1,1
4,GO CERAMIDE METABOLIC PROCESS,3.5461e-06,0.19258,0.19969,1,1
4,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.002702,0.19254,0.22862,1,1
4,GO STEROID BIOSYNTHETIC PROCESS,7.6657e-06,0.19253,0.18602,1,1
4,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.00041488,0.19247,0.17691,1,1
4,GO LEUKOCYTE MEDIATED IMMUNITY,6.7724e-05,0.19229,0.17936,1,1
4,GO RESPONSE TO INACTIVITY,0.021509,0.19219,0.18559,1,1
4,GO SKIN DEVELOPMENT,8.7316e-05,0.19205,0.18136,1,1
4,GO GROOMING BEHAVIOR,0.0052197,0.19205,0.16401,1,1
4,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.0002117,0.19204,0.19646,1,1
4,GO INTERFERON ALPHA PRODUCTION,0.0005056,0.19203,0.17413,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.00059648,0.19198,0.18939,1,1
4,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.0021215,0.19188,0.19324,1,1
4,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.00037835,0.19173,0.16161,1,1
4,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.00015583,0.19159,0.16146,1,1
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,5.3256e-05,0.19116,0.18377,1,1
4,GO VIRAL GENOME REPLICATION,0.00049802,0.19093,0.17409,1,1
4,GO RESPONSE TO TUMOR CELL,0.0060595,0.19068,0.19865,1,1
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.00014839,0.19052,0.19061,1,1
4,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.5127e-05,0.19013,0.18307,1,1
4,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0010558,0.19005,0.15543,1,1
4,GO REGULATION OF VIRAL GENOME REPLICATION,0.00057029,0.19002,0.19675,1,1
4,GO REGULATION OF VESICLE FUSION,0.0062108,0.1899,0.20318,1,1
4,GO PROSTAGLANDIN SECRETION,0.0017277,0.18987,0.16783,1,1
4,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.001483,0.18959,0.14086,1,1
4,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.0060595,0.18934,0.16061,1,1
4,GO MICROVILLUS ASSEMBLY,0.016568,0.18907,0.1747,1,1
4,GO AMYLOID BETA FORMATION,0.0066851,0.18899,0.14902,1,1
4,GO LIVER MORPHOGENESIS,0.00052901,0.18894,0.2275,1,1
4,GO SPHINGOID METABOLIC PROCESS,0.001442,0.18888,0.19155,1,1
4,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,9.03e-05,0.1886,0.18787,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.014332,0.18853,0.18906,1,1
4,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.0011341,0.18846,0.18026,1,1
4,GO LUNG EPITHELIUM DEVELOPMENT,0.0023957,0.1884,0.20263,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.0037985,0.18827,0.14264,1,1
4,GO LEUKOCYTE MIGRATION,6.7724e-05,0.18826,0.18146,1,1
4,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00042777,0.18826,0.24417,1,1
4,GO REGULATION OF TRANSPOSITION,0.0024609,0.18814,0.24386,1,1
4,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,5.6085e-05,0.18812,0.16703,1,1
4,GO INSULIN SECRETION,6.8885e-07,0.18786,0.19807,1,1
4,GO REGULATION OF SULFUR METABOLIC PROCESS,0.0019285,0.1876,0.19481,1,1
4,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.00019229,0.18742,0.15762,1,1
4,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00057029,0.18737,0.24637,1,1
4,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.002702,0.18724,0.13205,1,1
4,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0077327,0.1872,0.14245,1,1
4,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,9.0235e-07,0.18696,0.22336,1,1
4,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.00033955,0.18691,0.16569,1,1
4,GO CATECHOLAMINE METABOLIC PROCESS,2.0478e-05,0.18648,0.24234,1,1
4,GO REGULATION OF AMYLOID BETA FORMATION,0.011022,0.18635,0.15683,1,1
4,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.00075607,0.18619,0.17962,1,1
4,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00010673,0.18613,0.21171,1,1
4,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.00016361,0.1861,0.18351,1,1
4,GO INTERLEUKIN 8 PRODUCTION,0.001118,0.18607,0.17805,1,1
4,GO ACUTE INFLAMMATORY RESPONSE,0.00010152,0.18604,0.19514,1,1
4,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,9.4341e-06,0.18603,0.21983,1,1
4,GO BONE CELL DEVELOPMENT,0.012227,0.1857,0.14537,1,1
4,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0044298,0.18544,0.14226,1,1
4,GO ANTIMICROBIAL HUMORAL RESPONSE,1.0756e-05,0.1854,0.1906,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.0024609,0.18515,0.14517,1,1
4,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,3.9102e-06,0.18511,0.17173,1,1
4,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.0011341,0.18509,0.14369,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.0035605,0.18494,0.15533,1,1
4,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.012087,0.18477,0.12355,1,1
4,GO GLYCEROL ETHER METABOLIC PROCESS,0.001483,0.18473,0.14794,1,1
4,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.0012005,0.18436,0.18053,1,1
4,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.0027747,0.18433,0.21716,1,1
4,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.0035605,0.18415,0.16511,1,1
4,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.00026024,0.18407,0.27183,1,1
4,GO PROTEIN HYDROXYLATION,0.0044864,0.18406,0.18924,1,1
4,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,3.152e-06,0.18351,0.195,1,1
4,GO AMYLOID BETA CLEARANCE,0.0046018,0.18337,0.15293,1,1
4,GO CELLULAR RESPONSE TO STEROL,0.00011033,0.18269,0.21504,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0028492,0.18268,0.15075,1,1
4,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.00035024,0.18225,0.15912,1,1
4,GO CELLULAR RESPONSE TO CHOLESTEROL,0.0025617,0.18223,0.17681,1,1
4,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.0093576,0.18221,0.12343,1,1
4,GO POSITIVE REGULATION OF DEFENSE RESPONSE,7.2497e-05,0.182,0.15807,1,1
4,GO POSITIVE REGULATION OF VASCULOGENESIS,0.0077327,0.18183,0.24032,1,1
4,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.004964,0.18177,0.15995,1,1
4,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.0020929,0.18172,0.15709,1,1
4,GO GLYCOGEN BIOSYNTHETIC PROCESS,4.3997e-05,0.18154,0.19432,1,1
4,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.052575,0.18146,0.12057,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.0018006,0.18135,0.14757,1,1
4,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0032501,0.18122,0.13016,1,1
4,GO STEROL HOMEOSTASIS,0.00070238,0.18102,0.18233,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.00088789,0.18089,0.18431,1,1
4,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,1.8363e-05,0.18086,0.22666,1,1
4,GO CELLULAR GLUCAN METABOLIC PROCESS,2.3661e-05,0.18066,0.18166,1,1
4,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0012527,0.18061,0.17372,1,1
4,GO STEROID METABOLIC PROCESS,1.2253e-05,0.18061,0.1928,1,1
4,GO ENDOCRINE PROCESS,0.00029511,0.18036,0.16813,1,1
4,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.020605,0.18012,0.14842,1,1
4,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.00018323,0.18002,0.1912,1,1
4,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,8.8796e-05,0.18,0.18859,1,1
4,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.00072342,0.17993,0.17182,1,1
4,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,3.3806e-05,0.17967,0.19168,1,1
4,GO LINOLEIC ACID METABOLIC PROCESS,0.0067673,0.17965,0.17446,1,1
4,GO NEGATIVE REGULATION OF LIPID STORAGE,0.00159,0.17964,0.17681,1,1
4,GO MANNOSYLATION,2.2416e-05,0.17954,0.20721,1,1
4,GO ADAPTIVE IMMUNE RESPONSE,0.0030436,0.17935,0.14234,1,1
4,GO MYELOID LEUKOCYTE MIGRATION,0.00027284,0.17933,0.15506,1,1
4,GO PIRNA METABOLIC PROCESS,0.038637,0.17919,0.15599,1,1
4,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.023919,0.17918,0.17923,1,1
4,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0049019,0.17905,0.13254,1,1
4,GO MEGAKARYOCYTE DEVELOPMENT,0.0025961,0.17904,0.22829,1,1
4,GO NEUROPEPTIDE SIGNALING PATHWAY,0.00055343,0.17858,0.16399,1,1
4,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0030038,0.17834,0.1619,1,1
4,GO RESPONSE TO CADMIUM ION,0.0029256,0.17783,0.17761,1,1
4,GO STEROL TRANSPORT,0.00033432,0.17762,0.17981,1,1
4,GO REGULATION OF VIRAL LIFE CYCLE,0.0001803,0.17758,0.20688,1,1
4,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,9.03e-05,0.1775,0.22307,1,1
4,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0033361,0.17747,0.22474,1,1
4,GO REGULATION OF STRIATED MUSCLE CONTRACTION,6.7724e-05,0.17737,0.17919,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.0053519,0.17733,0.12931,1,1
4,GO STEROL BIOSYNTHETIC PROCESS,6.4341e-05,0.17718,0.1683,1,1
4,GO CATECHOLAMINE SECRETION,0.00021857,0.17717,0.28119,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.0005133,0.17705,0.17319,1,1
4,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0041031,0.17699,0.14399,1,1
4,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.00013899,0.17692,0.18592,1,1
4,GO AMINO ACID BETAINE METABOLIC PROCESS,0.0013443,0.1769,0.19827,1,1
4,GO POLYOL CATABOLIC PROCESS,0.00033955,0.17675,0.1642,1,1
4,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.0010865,0.17661,0.14978,1,1
4,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.042197,0.17653,0.10926,1,1
4,GO PLATELET AGGREGATION,0.00026438,0.17652,0.21481,1,1
4,GO NEURON MATURATION,0.0028492,0.17649,0.16672,1,1
4,GO PROGRAMMED NECROTIC CELL DEATH,0.00052901,0.17642,0.17783,1,1
4,GO CERAMIDE BIOSYNTHETIC PROCESS,4.2271e-06,0.17636,0.19911,1,1
4,GO STEROL METABOLIC PROCESS,2.3239e-05,0.1763,0.18127,1,1
4,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.00070238,0.17625,0.20471,1,1
4,GO ENERGY HOMEOSTASIS,0.001235,0.17624,0.1864,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.00016361,0.17621,0.15383,1,1
4,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00019857,0.17619,0.2251,1,1
4,GO MAINTENANCE OF BLOOD BRAIN BARRIER,2.3239e-05,0.17614,0.25099,1,1
4,GO MUSCLE ADAPTATION,0.00012594,0.17611,0.17346,1,1
4,GO RESPONSE TO PH,0.00014362,0.17611,0.19327,1,1
4,GO POSITIVE REGULATION OF ANION TRANSPORT,5.4184e-05,0.17611,0.18701,1,1
4,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.0067673,0.17608,0.14268,1,1
4,GO PODOSOME ASSEMBLY,0.033608,0.17576,0.13417,1,1
4,GO ENDOTHELIUM DEVELOPMENT,0.016205,0.17545,0.12602,1,1
4,GO REGULATION OF DEACETYLASE ACTIVITY,0.0015463,0.17528,0.21079,1,1
4,GO MYELOID LEUKOCYTE ACTIVATION,2.7312e-05,0.17513,0.18821,1,1
4,GO REGULATION OF RESPONSE TO WOUNDING,0.00020504,0.17511,0.19433,1,1
4,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.00031907,0.17505,0.19054,1,1
4,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.036048,0.17486,0.16866,1,1
4,GO ENDOCARDIUM DEVELOPMENT,0.0028492,0.17478,0.19088,1,1
4,GO DEFENSE RESPONSE,0.00011406,0.17438,0.15536,1,1
4,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.00054518,0.17419,0.19639,1,1
4,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.0007901,0.17385,0.22896,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.00096848,0.17361,0.15423,1,1
4,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.0025277,0.1736,0.14327,1,1
4,GO EXOCYTIC PROCESS,0.00010152,0.1735,0.19561,1,1
4,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.0023009,0.17349,0.14597,1,1
4,GO PROTON TRANSMEMBRANE TRANSPORT,2.1338e-07,0.17345,0.18303,1,1
4,GO PIGMENTATION,0.00054518,0.17342,0.12995,1,1
4,GO TRANSMISSION OF NERVE IMPULSE,0.00032916,0.17341,0.22314,1,1
4,GO POSITIVE CHEMOTAXIS,0.0028118,0.17301,0.14293,1,1
4,GO LIPID EXPORT FROM CELL,0.00098255,0.17295,0.16713,1,1
4,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.020605,0.17287,0.14118,1,1
4,GO FATTY ACID DERIVATIVE TRANSPORT,0.00063314,0.17277,0.159,1,1
4,GO NERVE DEVELOPMENT,0.01128,0.17276,0.15508,1,1
4,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.00013232,0.17267,0.15031,1,1
4,GO SODIUM ION HOMEOSTASIS,0.00073415,0.17265,0.1396,1,1
4,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,0.0026663,0.17255,0.14552,1,1
4,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,3.5461e-06,0.17254,0.20722,1,1
4,GO RENAL SYSTEM PROCESS,0.0022396,0.17242,0.15294,1,1
4,GO ZINC ION HOMEOSTASIS,0.015329,0.1724,0.1931,1,1
4,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,2.1621e-05,0.17196,0.1678,1,1
4,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00014129,0.17193,0.15615,1,1
4,GO LIPID LOCALIZATION,2.5868e-06,0.1719,0.19374,1,1
4,GO REGULATION OF STEROID METABOLIC PROCESS,7.0072e-05,0.17173,0.18737,1,1
4,GO BASEMENT MEMBRANE ORGANIZATION,0.026838,0.17149,0.16467,1,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.0020646,0.17137,0.14804,1,1
4,GO RECEPTOR CATABOLIC PROCESS,0.0067673,0.17134,0.13722,1,1
4,GO REGULATION OF BODY FLUID LEVELS,0.00047589,0.17099,0.14901,1,1
4,GO AMELOGENESIS,0.044292,0.17098,0.15674,1,1
4,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.0054872,0.17092,0.17569,1,1
4,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.00036124,0.17058,0.13782,1,1
4,GO RESPONSE TO XENOBIOTIC STIMULUS,0.00096848,0.17049,0.14644,1,1
4,GO CYTOKINE METABOLIC PROCESS,0.0005211,0.17048,0.15397,1,1
4,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00032916,0.1704,0.17373,1,1
4,GO EPIDERMIS DEVELOPMENT,0.00011986,0.1704,0.17152,1,1
4,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.00067188,0.16998,0.16077,1,1
4,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.00069207,0.16995,0.14725,1,1
4,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00016098,0.1699,0.17601,1,1
4,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.0070192,0.16982,0.13209,1,1
4,GO REGULATION OF RUFFLE ASSEMBLY,0.0019285,0.16977,0.16077,1,1
4,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,1.3325e-06,0.16974,0.16716,1,1
4,GO MUSCLE HYPERTROPHY,1.9749e-05,0.16973,0.19688,1,1
4,GO AMINO SUGAR CATABOLIC PROCESS,0.0058389,0.16966,0.15821,1,1
4,GO AMINE TRANSPORT,8.1623e-05,0.16965,0.23992,1,1
4,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.012087,0.16963,0.14922,1,1
4,GO HEXOSE CATABOLIC PROCESS,0.016752,0.16962,0.13088,1,1
4,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0022396,0.16922,0.15079,1,1
4,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.00042777,0.16922,0.167,1,1
4,GO MULTIVESICULAR BODY SORTING PATHWAY,1.0756e-05,0.1692,0.18842,1,1
4,GO CELLULAR RESPONSE TO ALKALOID,1.2253e-05,0.16899,0.18977,1,1
4,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.00015838,0.1688,0.17224,1,1
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.0059116,0.16868,0.13351,1,1
4,GO PH REDUCTION,3.4098e-06,0.1686,0.18261,1,1
4,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,6.0079e-05,0.1686,0.18342,1,1
4,GO CYTOKINE PRODUCTION,0.001442,0.16816,0.13909,1,1
4,GO REGULATION OF PEPTIDE HORMONE SECRETION,7.2414e-06,0.16815,0.18234,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0071918,0.1681,0.14095,1,1
4,GO REGULATION OF INSULIN SECRETION,5.5412e-06,0.16808,0.1766,1,1
4,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,3.4098e-06,0.16783,0.17734,1,1
4,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.00020178,0.1678,0.18186,1,1
4,GO METHIONINE BIOSYNTHETIC PROCESS,0.0033799,0.16751,0.19115,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.0042095,0.1675,0.12992,1,1
4,GO ACTION POTENTIAL,6.0079e-05,0.16744,0.18223,1,1
4,GO BILE ACID METABOLIC PROCESS,0.00029511,0.16741,0.19802,1,1
4,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.00031414,0.16738,0.19092,1,1
4,GO GLYCOPROTEIN METABOLIC PROCESS,7.2497e-05,0.16731,0.16175,1,1
4,GO CELLULAR PIGMENTATION,0.00049802,0.16728,0.1468,1,1
4,GO AMINOGLYCAN METABOLIC PROCESS,0.0007901,0.16727,0.16245,1,1
4,GO PEPTIDE HORMONE SECRETION,5.0323e-06,0.16721,0.18561,1,1
4,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.023668,0.16718,0.11664,1,1
4,GO VESICLE TARGETING,0.0029256,0.16708,0.12738,1,1
4,GO REGULATION OF PEPTIDASE ACTIVITY,7.5001e-05,0.16708,0.17094,1,1
4,GO RESPONSE TO CALCIUM ION,6.4341e-05,0.16704,0.1657,1,1
4,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.0012005,0.16703,0.19431,1,1
4,GO POLYAMINE BIOSYNTHETIC PROCESS,0.01128,0.16697,0.12888,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.6352e-05,0.16692,0.22111,1,1
4,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.00074504,0.16681,0.14823,1,1
4,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.017506,0.1668,0.11932,1,1
4,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.0011503,0.16662,0.14832,1,1
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0030436,0.16653,0.17764,1,1
4,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.0020646,0.16636,0.14495,1,1
4,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.029754,0.16626,0.12651,1,1
4,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00030928,0.16624,0.19754,1,1
4,GO B CELL ACTIVATION,0.0012177,0.16603,0.12921,1,1
4,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.031953,0.166,0.13925,1,1
4,GO NECROTIC CELL DEATH,0.00059648,0.16585,0.16939,1,1
4,GO SENSORY PERCEPTION OF TASTE,5.7059e-05,0.16584,0.15907,1,1
4,GO ANDROGEN METABOLIC PROCESS,0.00018323,0.16583,0.22877,1,1
4,GO REVERSE CHOLESTEROL TRANSPORT,0.0066851,0.16563,0.26665,1,1
4,GO MONOAMINE TRANSPORT,0.00014362,0.16555,0.25639,1,1
4,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.00069207,0.16533,0.1863,1,1
4,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.00073415,0.16525,0.18207,1,1
4,GO REGULATION OF NOTCH SIGNALING PATHWAY,4.7999e-05,0.1651,0.20983,1,1
4,GO CELLULAR RESPONSE TO CALCIUM ION,3.8246e-05,0.16505,0.19883,1,1
4,GO REGULATION OF MAST CELL ACTIVATION,0.00059648,0.1647,0.21117,1,1
4,GO MONOCYTE CHEMOTAXIS,0.0089251,0.16468,0.13305,1,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.011022,0.1643,0.14932,1,1
4,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.00022565,0.16429,0.16898,1,1
4,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.001483,0.16419,0.13563,1,1
4,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.022928,0.164,0.1233,1,1
4,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0056255,0.16394,0.18883,1,1
4,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.043025,0.16391,0.17728,1,1
4,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.0015463,0.1639,0.15411,1,1
4,GO VESICLE ORGANIZATION,0.00011986,0.16382,0.14029,1,1
4,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,1.2716e-05,0.16379,0.179,1,1
4,GO RESPONSE TO STEROL,0.00039622,0.16362,0.18629,1,1
4,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.00090088,0.16358,0.16702,1,1
4,GO CARBOHYDRATE TRANSPORT,8.8389e-07,0.16355,0.18421,1,1
4,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.001422,0.16349,0.15391,1,1
4,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.051111,0.16342,0.10948,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.023173,0.16336,0.11473,1,1
4,GO ACROSOME REACTION,0.011151,0.16326,0.13486,1,1
4,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.0051547,0.16325,0.15555,1,1
4,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0093576,0.1632,0.1579,1,1
4,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.0137,0.16297,0.12617,1,1
4,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0020929,0.16247,0.133,1,1
4,GO NEGATIVE REGULATION OF CELL ADHESION,0.0056255,0.16235,0.14393,1,1
4,GO LIPOPROTEIN METABOLIC PROCESS,3.758e-05,0.1623,0.15838,1,1
4,GO LEUKOCYTE CHEMOTAXIS,0.0005056,0.16201,0.14697,1,1
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.028852,0.16197,0.11636,1,1
4,GO RESPONSE TO VIRUS,0.0012705,0.16194,0.1465,1,1
4,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.0025961,0.16187,0.17177,1,1
4,GO REGULATION OF HORMONE METABOLIC PROCESS,0.013856,0.16182,0.16348,1,1
4,GO IMMUNE EFFECTOR PROCESS,0.00016361,0.16143,0.16761,1,1
4,GO REGULATION OF HORMONE SECRETION,8.9166e-06,0.16134,0.17074,1,1
4,GO ADIPOSE TISSUE DEVELOPMENT,0.0040509,0.1612,0.14237,1,1
4,GO MYOTUBE DIFFERENTIATION,0.00029052,0.16092,0.16571,1,1
4,GO PROTEIN PROCESSING,6.5837e-06,0.16092,0.18751,1,1
4,GO PLASMA MEMBRANE ORGANIZATION,0.00017457,0.16075,0.18714,1,1
4,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00098255,0.16064,0.20307,1,1
4,GO KETONE BIOSYNTHETIC PROCESS,0.0034243,0.16063,0.17204,1,1
4,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.0030436,0.1606,0.1296,1,1
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0028872,0.16044,0.26092,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.011949,0.16036,0.15154,1,1
4,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.00096848,0.16033,0.16283,1,1
4,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.0087156,0.16002,0.14446,1,1
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.00011986,0.15985,0.17284,1,1
4,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.016752,0.15982,0.21711,1,1
4,GO REGULATION OF PODOSOME ASSEMBLY,0.043866,0.15978,0.14639,1,1
4,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.0038478,0.15956,0.1668,1,1
4,GO WOUND HEALING,0.0050269,0.15951,0.1349,1,1
4,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.0059116,0.15944,0.16573,1,1
4,GO RESPONSE TO INORGANIC SUBSTANCE,5.0323e-06,0.15942,0.14943,1,1
4,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00013016,0.15932,0.16278,1,1
4,GO NUCLEOSIDE CATABOLIC PROCESS,0.003654,0.15907,0.15863,1,1
4,GO MIDBODY ABSCISSION,3.1494e-05,0.159,0.19956,1,1
4,GO ENDOCYTIC RECYCLING,0.00033955,0.15892,0.15937,1,1
4,GO RESPONSE TO CAFFEINE,0.0042636,0.15891,0.15283,1,1
4,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.0030038,0.15888,0.13973,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0104,0.15888,0.15415,1,1
4,GO REGULATION OF B CELL DIFFERENTIATION,0.016568,0.15881,0.12496,1,1
4,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.8839e-05,0.15875,0.18119,1,1
4,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,5.1304e-06,0.1587,0.15801,1,1
4,GO PEPTIDE SECRETION,1.6654e-06,0.15867,0.17718,1,1
4,GO SPERM CAPACITATION,0.001442,0.15852,0.15879,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.026286,0.15825,0.12358,1,1
4,GO REGULATION OF CARDIAC CONDUCTION,0.0005056,0.15814,0.14727,1,1
4,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,0.0007901,0.15791,0.18078,1,1
4,GO EXOCYTOSIS,1.1165e-05,0.15789,0.17182,1,1
4,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.0013069,0.15783,0.17396,1,1
4,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0019023,0.15782,0.17598,1,1
4,GO UBIQUINONE METABOLIC PROCESS,0.0002443,0.15745,0.17398,1,1
4,GO MACROMOLECULE DEPALMITOYLATION,0.0024941,0.15738,0.15495,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0028118,0.15728,0.16072,1,1
4,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.001422,0.15706,0.15839,1,1
4,GO HORMONE TRANSPORT,3.4773e-06,0.15699,0.182,1,1
4,GO GRANULOCYTE CHEMOTAXIS,0.0023957,0.15694,0.11927,1,1
4,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00039018,0.15691,0.15877,1,1
4,GO ALCOHOL BIOSYNTHETIC PROCESS,6.8888e-05,0.15682,0.15237,1,1
4,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.0095807,0.15677,0.12668,1,1
4,GO REGULATION OF RENAL SYSTEM PROCESS,0.024947,0.15655,0.13657,1,1
4,GO RESPONSE TO PEPTIDOGLYCAN,0.0037498,0.15644,0.14167,1,1
4,GO REGULATION OF VASCULAR PERMEABILITY,0.00092737,0.15638,0.17332,1,1
4,GO EPITHELIAL STRUCTURE MAINTENANCE,0.0030038,0.1562,0.15143,1,1
4,GO INCLUSION BODY ASSEMBLY,0.013856,0.15613,0.18635,1,1
4,GO B CELL HOMEOSTASIS,0.0043184,0.15612,0.15287,1,1
4,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.0016806,0.15609,0.15069,1,1
4,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,5.2344e-05,0.15602,0.19521,1,1
4,GO POSITIVE REGULATION OF PROTEIN BINDING,0.0038977,0.1559,0.12943,1,1
4,GO REGULATION OF MUSCLE ADAPTATION,0.00027284,0.1558,0.17054,1,1
4,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.00033955,0.1558,0.15086,1,1
4,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,1.0756e-05,0.15579,0.16293,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.0076401,0.15565,0.13225,1,1
4,GO MEMBRANE FISSION,0.020385,0.15555,0.1492,1,1
4,GO GLIAL CELL APOPTOTIC PROCESS,0.01829,0.15549,0.16583,1,1
4,GO APICAL PROTEIN LOCALIZATION,0.044722,0.15548,0.10888,1,1
4,GO MYELIN ASSEMBLY,0.0042095,0.1554,0.19034,1,1
4,GO VIRION ASSEMBLY,0.00018923,0.15502,0.12682,1,1
4,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.0033361,0.15498,0.13661,1,1
4,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.028264,0.15496,0.12301,1,1
4,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.0022701,0.15489,0.16196,1,1
4,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.0031247,0.15485,0.14759,1,1
4,GO ER NUCLEUS SIGNALING PATHWAY,0.0029256,0.15485,0.14629,1,1
4,GO CHLORIDE ION HOMEOSTASIS,0.055609,0.15483,0.10947,1,1
4,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0042095,0.15482,0.11913,1,1
4,GO MULTICELLULAR ORGANISMAL SIGNALING,0.00046872,0.15446,0.15982,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,6.7724e-05,0.15441,0.15563,1,1
4,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,2.2824e-05,0.1544,0.14741,1,1
4,GO INFLAMMATORY RESPONSE,0.00038422,0.1543,0.1424,1,1
4,GO GRANULOCYTE MIGRATION,0.0010408,0.15418,0.14068,1,1
4,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.0042636,0.15386,0.12938,1,1
4,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.00043435,0.15377,0.13526,1,1
4,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0016122,0.15371,0.18661,1,1
4,GO T CELL LINEAGE COMMITMENT,0.00088789,0.15351,0.16335,1,1
4,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,8.5858e-05,0.15326,0.13585,1,1
4,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.020385,0.15309,0.25229,1,1
4,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.0068504,0.15299,0.16091,1,1
4,GO RESPONSE TO INTERLEUKIN 6,0.00063314,0.15296,0.17975,1,1
4,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00017176,0.15288,0.16935,1,1
4,GO REGULATION OF CELL MATRIX ADHESION,0.0047198,0.15285,0.17058,1,1
4,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0028872,0.15281,0.14892,1,1
4,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.00096848,0.15272,0.1258,1,1
4,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00010497,0.1527,0.19231,1,1
4,GO INTERACTION WITH HOST,0.0011836,0.15241,0.14548,1,1
4,GO RESPONSE TO INSULIN,0.00013016,0.15239,0.13298,1,1
4,GO NEUTROPHIL MIGRATION,0.00092737,0.15237,0.13939,1,1
4,GO AUTOPHAGY OF NUCLEUS,0.028264,0.15232,0.1073,1,1
4,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.036409,0.15227,0.13569,1,1
4,GO POSITIVE REGULATION OF HORMONE SECRETION,2.5884e-05,0.15222,0.1741,1,1
4,GO DEVELOPMENTAL INDUCTION,0.0076401,0.15202,0.13825,1,1
4,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.00011033,0.15193,0.19626,1,1
4,GO TERPENOID METABOLIC PROCESS,0.01829,0.15192,0.11948,1,1
4,GO SUPEROXIDE METABOLIC PROCESS,0.0026663,0.15179,0.14137,1,1
4,GO CARBOHYDRATE HOMEOSTASIS,4.5684e-06,0.15168,0.1627,1,1
4,GO RESPONSE TO MECHANICAL STIMULUS,8.0256e-05,0.15151,0.17671,1,1
4,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,2.2015e-05,0.15145,0.16619,1,1
4,GO LEUKOCYTE PROLIFERATION,0.0011341,0.15138,0.14206,1,1
4,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.00084997,0.15133,0.12526,1,1
4,GO REGULATION OF FATTY ACID OXIDATION,0.045591,0.15129,0.1067,1,1
4,GO SEQUESTERING OF CALCIUM ION,0.00159,0.15128,0.12756,1,1
4,GO LYMPHOCYTE COSTIMULATION,0.040187,0.15121,0.097867,1,1
4,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.0062877,0.15112,0.12787,1,1
4,GO POSITIVE REGULATION OF CHEMOTAXIS,0.00072342,0.15105,0.15054,1,1
4,GO POSITIVE REGULATION OF SECRETION,5.7582e-06,0.15103,0.16243,1,1
4,GO STRIATED MUSCLE ADAPTATION,0.00082553,0.15096,0.17607,1,1
4,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.045591,0.15094,0.12703,1,1
4,GO RESPONSE TO THYROID HORMONE,0.024947,0.15093,0.158,1,1
4,GO PROTEIN TARGETING TO VACUOLE,0.0029645,0.15075,0.14872,1,1
4,GO CELL JUNCTION ASSEMBLY,0.0056255,0.15071,0.1189,1,1
4,GO REGULATION OF ERBB SIGNALING PATHWAY,0.0137,0.15061,0.11564,1,1
4,GO COAGULATION,0.0038478,0.15024,0.12934,1,1
4,GO REGULATION OF PEPTIDE SECRETION,2.206e-06,0.15011,0.17109,1,1
4,GO REGULATION OF HORMONE LEVELS,3.9102e-06,0.14998,0.1679,1,1
4,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0015038,0.14983,0.2085,1,1
4,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,6.337e-06,0.1498,0.18043,1,1
4,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.0021215,0.14956,0.14432,1,1
4,GO MEMBRANE PROTEIN PROTEOLYSIS,0.0067673,0.14944,0.1389,1,1
4,GO REGULATION OF ENDOCRINE PROCESS,0.00010497,0.1493,0.18592,1,1
4,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.0012005,0.14912,0.1625,1,1
4,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.042609,0.14911,0.13161,1,1
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.024687,0.14904,0.12344,1,1
4,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.038637,0.14895,0.15887,1,1
4,GO CELL CHEMOTAXIS,0.00074504,0.14863,0.14963,1,1
4,GO RESPONSE TO IRON ION,0.001568,0.14843,0.16264,1,1
4,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0065235,0.14842,0.19563,1,1
4,GO MECHANORECEPTOR DIFFERENTIATION,0.00020504,0.14838,0.1613,1,1
4,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.00026438,0.14822,0.1561,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.0034692,0.14818,0.16781,1,1
4,GO ENERGY RESERVE METABOLIC PROCESS,0.00070238,0.14803,0.14437,1,1
4,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.024428,0.14798,0.12411,1,1
4,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.010895,0.14795,0.12895,1,1
4,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.001071,0.14757,0.11973,1,1
4,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.001235,0.14754,0.14862,1,1
4,GO PROTEIN MANNOSYLATION,0.00062378,0.14739,0.17527,1,1
4,GO ARACHIDONIC ACID METABOLIC PROCESS,0.00049802,0.14728,0.19133,1,1
4,GO ADULT LOCOMOTORY BEHAVIOR,0.00081356,0.14727,0.17005,1,1
4,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.00092737,0.1471,0.15706,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.0042095,0.14705,0.15739,1,1
4,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.0090315,0.14703,0.11962,1,1
4,GO AUTOPHAGOSOME MATURATION,0.00014599,0.147,0.17149,1,1
4,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.0046604,0.14673,0.13233,1,1
4,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.0069343,0.14672,0.13868,1,1
4,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00099681,0.1467,0.16787,1,1
4,GO VIRAL BUDDING,0.00011596,0.14663,0.15456,1,1
4,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.00029052,0.14641,0.14139,1,1
4,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.00027284,0.14637,0.13614,1,1
4,GO SYNCYTIUM FORMATION,0.0034692,0.14637,0.15236,1,1
4,GO FATTY ACID BIOSYNTHETIC PROCESS,0.0010408,0.14635,0.12735,1,1
4,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.00010673,0.14626,0.15392,1,1
4,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.0026663,0.14624,0.13277,1,1
4,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.0035146,0.14619,0.12838,1,1
4,GO ACUTE PHASE RESPONSE,0.00044781,0.14586,0.17594,1,1
4,GO ISOPRENOID METABOLIC PROCESS,0.0073682,0.14586,0.12725,1,1
4,GO GLUCOSE METABOLIC PROCESS,3.3435e-06,0.14585,0.16792,1,1
4,GO REGULATION OF HISTONE H4 ACETYLATION,0.0035146,0.14582,0.1398,1,1
4,GO DENDRITE EXTENSION,0.00016901,0.14579,0.23546,1,1
4,GO REGULATION OF KERATINOCYTE MIGRATION,0.002631,0.14572,0.14517,1,1
4,GO REGULATION OF CELLULAR PH,8.6579e-07,0.14569,0.16796,1,1
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.036409,0.14566,0.12891,1,1
4,GO ORGANELLE FUSION,2.4528e-05,0.1455,0.15547,1,1
4,GO LYSOSOME LOCALIZATION,0.00049053,0.14548,0.15652,1,1
4,GO GLAND DEVELOPMENT,0.0066039,0.14547,0.10748,1,1
4,GO REGULATION OF LIGASE ACTIVITY,0.019104,0.14545,0.10906,1,1
4,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0074579,0.14536,0.13649,1,1
4,GO RESPONSE TO PROGESTERONE,0.02128,0.14528,0.12094,1,1
4,GO REGULATION OF APPETITE,0.011151,0.14527,0.10011,1,1
4,GO PLATELET MORPHOGENESIS,0.0024609,0.14511,0.16992,1,1
4,GO VACUOLE ORGANIZATION,1.4163e-06,0.145,0.17566,1,1
4,GO POSITIVE REGULATION OF MYELINATION,0.000286,0.14492,0.15411,1,1
4,GO POSITIVE REGULATION OF BLOOD CIRCULATION,1.5293e-05,0.14489,0.16985,1,1
4,GO INTERLEUKIN 1 BETA PRODUCTION,0.022446,0.14469,0.12026,1,1
4,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.01251,0.14465,0.13774,1,1
4,GO PROTEIN N LINKED GLYCOSYLATION,0.00027716,0.1446,0.15584,1,1
4,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.022686,0.14444,0.13269,1,1
4,GO REGULATION OF INFLAMMATORY RESPONSE,0.00067188,0.14441,0.13852,1,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.0022396,0.14437,0.1433,1,1
4,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0054872,0.14436,0.11656,1,1
4,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.0017277,0.1443,0.18525,1,1
4,GO ORGANIC ANION TRANSPORT,8.4262e-06,0.14418,0.15152,1,1
4,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.041789,0.14416,0.10518,1,1
4,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.6761e-05,0.14396,0.17531,1,1
4,GO ARACHIDONIC ACID SECRETION,0.0028492,0.14378,0.14742,1,1
4,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,1.9749e-05,0.14377,0.15831,1,1
4,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0019023,0.1437,0.16419,1,1
4,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0047798,0.14364,0.1409,1,1
4,GO CELL CELL ADHESION,0.0027381,0.14352,0.13318,1,1
4,GO POSITIVE REGULATION OF INSULIN SECRETION,0.00022208,0.14349,0.14951,1,1
4,GO REGULATION OF CELL SUBSTRATE ADHESION,0.05063,0.14345,0.10952,1,1
4,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.0007786,0.14337,0.16965,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.01016,0.14321,0.15793,1,1
4,GO EATING BEHAVIOR,0.00029511,0.14302,0.16858,1,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.0099244,0.14301,0.13824,1,1
4,GO SENSORY PERCEPTION OF BITTER TASTE,0.00016901,0.14274,0.12611,1,1
4,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0040509,0.1425,0.12544,1,1
4,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.025475,0.14241,0.12165,1,1
4,GO ACID SECRETION,0.00020178,0.1424,0.14857,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.002702,0.14236,0.10269,1,1
4,GO PROTEIN TARGETING TO LYSOSOME,0.0045438,0.14229,0.20397,1,1
4,GO NATURAL KILLER CELL ACTIVATION,0.046474,0.14219,0.088782,1,1
4,GO RESPONSE TO WOUNDING,0.0098086,0.1421,0.12161,1,1
4,GO NEUTROPHIL CHEMOTAXIS,0.0038478,0.14195,0.11104,1,1
4,GO RESPONSE TO BACTERIUM,0.00060545,0.14176,0.13621,1,1
4,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.00082553,0.14174,0.12091,1,1
4,GO GPI ANCHOR METABOLIC PROCESS,1.0557e-05,0.14163,0.20387,1,1
4,GO CELLULAR RESPONSE TO KETONE,0.01251,0.14158,0.11155,1,1
4,GO ACTIN NUCLEATION,9.6129e-06,0.14156,0.18574,1,1
4,GO GOLGI VESICLE BUDDING,0.00084997,0.14153,0.12718,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.047827,0.14128,0.082913,1,1
4,GO RESPONSE TO BIOTIC STIMULUS,0.00040235,0.14115,0.13835,1,1
4,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.055093,0.1408,0.13541,1,1
4,GO REGULATION OF MACROPHAGE ACTIVATION,0.017125,0.14075,0.12007,1,1
4,GO BIOLOGICAL ADHESION,0.011411,0.14073,0.11113,1,1
4,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.022686,0.14072,0.14313,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.00062378,0.14052,0.15617,1,1
4,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0044298,0.1405,0.14648,1,1
4,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.00057029,0.14037,0.16096,1,1
4,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.023419,0.14018,0.11637,1,1
4,GO ADHERENS JUNCTION ORGANIZATION,0.026013,0.14004,0.11159,1,1
4,GO RESPONSE TO ALCOHOL,0.0011021,0.14002,0.12235,1,1
4,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.028264,0.13989,0.09701,1,1
4,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.0020929,0.1398,0.16107,1,1
4,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.00075607,0.13964,0.14953,1,1
4,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.010041,0.1395,0.12966,1,1
4,GO ALPHA BETA T CELL ACTIVATION,0.0071051,0.13942,0.12052,1,1
4,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.037139,0.13921,0.12811,1,1
4,GO SECRETION,1.1165e-05,0.13919,0.14925,1,1
4,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.058247,0.13903,0.091043,1,1
4,GO VITAMIN TRANSPORT,0.00159,0.13893,0.15622,1,1
4,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,7.3739e-05,0.1389,0.1309,1,1
4,GO CALCIUM ION IMPORT,0.00061456,0.13851,0.13204,1,1
4,GO CELLULAR RESPONSE TO STARVATION,1.9393e-05,0.13842,0.15804,1,1
4,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.0017277,0.1384,0.13762,1,1
4,GO PROTEIN LOCALIZATION TO CELL SURFACE,6.8888e-05,0.13832,0.15426,1,1
4,GO REGULATION OF CELL CELL ADHESION,0.0007901,0.13818,0.15704,1,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.024173,0.13817,0.14905,1,1
4,GO TISSUE HOMEOSTASIS,0.00044781,0.13763,0.1399,1,1
4,GO MEMBRANE REPOLARIZATION,0.0051547,0.13738,0.14065,1,1
4,GO LONG CHAIN FATTY ACID TRANSPORT,0.00071283,0.13737,0.13699,1,1
4,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.001483,0.13726,0.13488,1,1
4,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.0019819,0.13713,0.13596,1,1
4,GO EPITHELIAL CELL DIFFERENTIATION,0.00090088,0.1371,0.14732,1,1
4,GO ALCOHOL METABOLIC PROCESS,0.0005211,0.13707,0.13953,1,1
4,GO RETINOL METABOLIC PROCESS,0.01251,0.13695,0.1781,1,1
4,GO VESICLE BUDDING FROM MEMBRANE,0.0022701,0.13677,0.12103,1,1
4,GO INTERLEUKIN 1 PRODUCTION,0.009139,0.13677,0.13215,1,1
4,GO REGULATION OF BLOOD CIRCULATION,0.0014624,0.13674,0.12242,1,1
4,GO MULTIVESICULAR BODY ORGANIZATION,8.0256e-05,0.13659,0.14638,1,1
4,GO REGULATION OF SECRETION,1.4207e-05,0.13659,0.14735,1,1
4,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.054074,0.13621,0.12081,1,1
4,GO ENDOCRINE HORMONE SECRETION,0.00073415,0.13614,0.13764,1,1
4,GO NADP METABOLIC PROCESS,0.01016,0.13609,0.14941,1,1
4,GO REGULATION OF GLUCONEOGENESIS,3.5022e-05,0.13595,0.17029,1,1
4,GO MONOSACCHARIDE CATABOLIC PROCESS,0.03902,0.13558,0.10144,1,1
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.0011021,0.13555,0.14076,1,1
4,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.0044298,0.13536,0.2174,1,1
4,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.00029511,0.13524,0.1211,1,1
4,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.049681,0.13523,0.13258,1,1
4,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.02128,0.13522,0.12475,1,1
4,GO REGULATION OF MUSCLE CONTRACTION,0.001235,0.13515,0.11969,1,1
4,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.3693e-05,0.13502,0.15574,1,1
4,GO REGULATION OF PH,8.8389e-07,0.13494,0.16479,1,1
4,GO REGULATION OF DEFENSE RESPONSE,0.00030928,0.13489,0.13864,1,1
4,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.01016,0.13487,0.14236,1,1
4,GO B CELL DIFFERENTIATION,0.001422,0.13484,0.12775,1,1
4,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.00015838,0.13475,0.15676,1,1
4,GO ZINC ION TRANSPORT,0.0085105,0.13469,0.10843,1,1
4,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.0017517,0.13463,0.11854,1,1
4,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.013093,0.13424,0.18944,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.037509,0.13397,0.10845,1,1
4,GO REGULATION OF SYMBIOTIC PROCESS,0.00057029,0.13384,0.15295,1,1
4,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.0062108,0.13367,0.13947,1,1
4,GO RESPONSE TO NUTRIENT,0.0071051,0.1336,0.11841,1,1
4,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.0012005,0.13347,0.16134,1,1
4,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.0019023,0.13345,0.14316,1,1
4,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.0044864,0.13331,0.14514,1,1
4,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.00026438,0.13303,0.135,1,1
4,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.0001179,0.1328,0.17962,1,1
4,GO PIGMENT GRANULE LOCALIZATION,0.004156,0.13258,0.13765,1,1
4,GO SIGNAL RELEASE,5.6085e-05,0.13254,0.14649,1,1
4,GO CELLULAR RESPONSE TO DSRNA,0.022928,0.13253,0.11549,1,1
4,GO LYMPHOCYTE MIGRATION,0.0059852,0.13216,0.11581,1,1
4,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.023919,0.13212,0.10786,1,1
4,GO CHEMICAL HOMEOSTASIS,3.5022e-05,0.13185,0.13105,1,1
4,GO RESPONSE TO ISCHEMIA,0.0024941,0.13179,0.14583,1,1
4,GO COPII COATED VESICLE BUDDING,0.0017517,0.13161,0.11691,1,1
4,GO NEUTRAL LIPID CATABOLIC PROCESS,0.003607,0.13149,0.15473,1,1
4,GO AMINE METABOLIC PROCESS,1.3878e-06,0.13145,0.17063,1,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.0104,0.13138,0.1318,1,1
4,GO GLYCEROLIPID CATABOLIC PROCESS,0.00011596,0.13119,0.1642,1,1
4,GO DETECTION OF MECHANICAL STIMULUS,0.059879,0.1311,0.12434,1,1
4,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.05357,0.1311,0.09181,1,1
4,GO LIPID STORAGE,0.0013826,0.131,0.1557,1,1
4,GO REGULATION OF CELL ADHESION,0.003166,0.13098,0.13692,1,1
4,GO CELLULAR RESPONSE TO VIRUS,0.020605,0.13085,0.10758,1,1
4,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.029754,0.1308,0.1504,1,1
4,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.0046018,0.13066,0.10818,1,1
4,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.00090088,0.13064,0.11921,1,1
4,GO EPITHELIAL CELL DEVELOPMENT,0.0087156,0.13049,0.13074,1,1
4,GO ADAPTIVE THERMOGENESIS,7.5217e-06,0.13041,0.1649,1,1
4,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.056128,0.12998,0.096237,1,1
4,GO FATTY ACID TRANSPORT,0.0032928,0.12998,0.12407,1,1
4,GO FATTY ACID CATABOLIC PROCESS,0.0007901,0.12994,0.14195,1,1
4,GO REGULATION OF CELL MATURATION,0.0037498,0.12988,0.11904,1,1
4,GO HEART PROCESS,0.0025617,0.12956,0.11314,1,1
4,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,3.5646e-05,0.12956,0.13788,1,1
4,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.003607,0.12955,0.11379,1,1
4,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.0038977,0.1294,0.12516,1,1
4,GO MANGANESE ION TRANSPORT,0.0062108,0.12932,0.13175,1,1
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.02128,0.12915,0.16097,1,1
4,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.046921,0.12913,0.092269,1,1
4,GO BROWN FAT CELL DIFFERENTIATION,0.00068191,0.12909,0.17378,1,1
4,GO PEPTIDYL ASPARAGINE MODIFICATION,0.0037016,0.12878,0.1385,1,1
4,GO REGULATION OF HISTONE DEACETYLATION,0.0019023,0.12856,0.16502,1,1
4,GO ATP BIOSYNTHETIC PROCESS,0.059879,0.12854,0.11645,1,1
4,GO REGULATION OF CELL ACTIVATION,0.0053519,0.12848,0.10693,1,1
4,GO REGULATION OF RECEPTOR RECYCLING,0.011411,0.12835,0.12746,1,1
4,GO CELLULAR LIPID CATABOLIC PROCESS,9.6562e-05,0.12827,0.15803,1,1
4,GO RESPONSE TO STARVATION,6.8888e-05,0.12822,0.14442,1,1
4,GO CIRCULATORY SYSTEM PROCESS,0.00028155,0.12818,0.12617,1,1
4,GO MONONUCLEAR CELL MIGRATION,0.027973,0.12801,0.091661,1,1
4,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.0096941,0.12801,0.10459,1,1
4,GO ENGULFMENT OF APOPTOTIC CELL,0.013093,0.12799,0.11889,1,1
4,GO SULFUR COMPOUND TRANSPORT,0.0012005,0.1278,0.13153,1,1
4,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.0035605,0.12763,0.18741,1,1
4,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.0042095,0.12753,0.12328,1,1
4,GO FAT CELL DIFFERENTIATION,0.0078263,0.12737,0.11525,1,1
4,GO T CELL PROLIFERATION,0.0025961,0.12725,0.13851,1,1
4,GO ARTERY MORPHOGENESIS,0.054582,0.12718,0.082514,1,1
4,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.01251,0.12707,0.12466,1,1
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.0012527,0.12704,0.10981,1,1
4,GO EPITHELIUM DEVELOPMENT,0.0023321,0.12698,0.11564,1,1
4,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.0013443,0.12698,0.1223,1,1
4,GO NEURON REMODELING,0.046474,0.12697,0.13999,1,1
4,GO REGULATION OF EXOCYTOSIS,0.00022565,0.12671,0.1527,1,1
4,GO GLUCOSE IMPORT,0.0050904,0.1267,0.1087,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.0137,0.12667,0.10709,1,1
4,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.00029052,0.12654,0.14813,1,1
4,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.037509,0.12647,0.095324,1,1
4,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.0023321,0.12646,0.15453,1,1
4,GO PHOSPHOLIPID METABOLIC PROCESS,5.4184e-05,0.12638,0.12742,1,1
4,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.014658,0.12638,0.12699,1,1
4,GO CELLULAR LIPID METABOLIC PROCESS,0.00010852,0.12624,0.13169,1,1
4,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.035691,0.12618,0.10864,1,1
4,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.046474,0.12612,0.10481,1,1
4,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.057711,0.12589,0.12227,1,1
4,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.0059116,0.12582,0.12106,1,1
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.013394,0.12576,0.13336,1,1
4,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,1.0958e-05,0.12567,0.14886,1,1
4,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.0010113,0.12561,0.16866,1,1
4,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.0012886,0.1256,0.12632,1,1
4,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.00028155,0.12551,0.19532,1,1
4,GO PROTEIN DESTABILIZATION,0.00036124,0.12525,0.14198,1,1
4,GO CELL ACTIVATION,0.00081356,0.12522,0.13583,1,1
4,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.014013,0.12498,0.13183,1,1
4,GO RESPONSE TO KETONE,0.0086125,0.12496,0.10233,1,1
4,GO LIPID BIOSYNTHETIC PROCESS,3.2631e-05,0.12485,0.13687,1,1
4,GO CRANIAL NERVE DEVELOPMENT,0.045155,0.12483,0.12478,1,1
4,GO MUSCLE CELL DEVELOPMENT,0.0052197,0.12463,0.10402,1,1
4,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0016122,0.1246,0.11539,1,1
4,GO MONOCARBOXYLIC ACID TRANSPORT,0.00061456,0.12448,0.13238,1,1
4,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.0071051,0.12444,0.11794,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.018898,0.12441,0.11682,1,1
4,GO MACROPHAGE ACTIVATION,0.0010113,0.1244,0.14546,1,1
4,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.0028492,0.12438,0.13008,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0013633,0.12431,0.13943,1,1
4,GO RESPONSE TO DEXAMETHASONE,0.011949,0.12428,0.11442,1,1
4,GO RESPONSE TO HYDROGEN PEROXIDE,0.0012177,0.12427,0.13146,1,1
4,GO CELLULAR RESPONSE TO PEPTIDE,0.0050269,0.12422,0.10039,1,1
4,GO ACTIVATION OF GTPASE ACTIVITY,0.011022,0.12418,0.10167,1,1
4,GO DEVELOPMENTAL PIGMENTATION,0.057179,0.12416,0.085,1,1
4,GO ALPHA BETA T CELL DIFFERENTIATION,0.011813,0.12415,0.11472,1,1
4,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.03068,0.12383,0.11084,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.003607,0.12372,0.12631,1,1
4,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.00084997,0.12354,0.16458,1,1
4,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.011151,0.12333,0.097346,1,1
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.6386e-06,0.12331,0.15364,1,1
4,GO MULTICELLULAR ORGANISM AGING,0.00067188,0.12269,0.14843,1,1
4,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.020166,0.12259,0.1273,1,1
4,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.0061347,0.1225,0.13661,1,1
4,GO POSITIVE REGULATION OF CELL ADHESION,0.0039481,0.12229,0.13842,1,1
4,GO RESPONSE TO CYTOKINE,0.00098255,0.12219,0.13146,1,1
4,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,0.0038478,0.12214,0.11466,1,1
4,GO ACTIN FILAMENT ORGANIZATION,0.032938,0.12181,0.09381,1,1
4,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.051111,0.12178,0.11763,1,1
4,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00035024,0.12159,0.1374,1,1
4,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.00014839,0.12132,0.15361,1,1
4,GO RELAXATION OF MUSCLE,0.014494,0.12123,0.13094,1,1
4,GO THIOESTER BIOSYNTHETIC PROCESS,0.0052854,0.1212,0.13684,1,1
4,GO MONOVALENT INORGANIC CATION TRANSPORT,2.6828e-05,0.12114,0.14918,1,1
4,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.00032916,0.12107,0.12382,1,1
4,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.014172,0.12089,0.099951,1,1
4,GO LIPID DROPLET ORGANIZATION,0.00058763,0.12087,0.14554,1,1
4,GO POSITIVE REGULATION OF PEPTIDE SECRETION,4.4771e-05,0.12085,0.14968,1,1
4,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,8.4424e-05,0.1207,0.13949,1,1
4,GO PROTEIN MATURATION,2.2824e-05,0.12059,0.14635,1,1
4,GO GOLGI RIBBON FORMATION,0.016752,0.12051,0.13011,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.013093,0.12043,0.11335,1,1
4,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.0086125,0.1202,0.12123,1,1
4,GO T CELL SELECTION,0.0056255,0.12019,0.11147,1,1
4,GO IMPORT ACROSS PLASMA MEMBRANE,0.011411,0.1197,0.10712,1,1
4,GO SODIUM ION TRANSPORT,0.00015083,0.11961,0.14017,1,1
4,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00084997,0.1196,0.13728,1,1
4,GO LIPID METABOLIC PROCESS,7.8911e-05,0.11953,0.13225,1,1
4,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.0012005,0.11911,0.12616,1,1
4,GO LAMELLIPODIUM MORPHOGENESIS,0.01251,0.11905,0.18366,1,1
4,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.012087,0.11895,0.16177,1,1
4,GO METAL ION HOMEOSTASIS,0.00057029,0.11879,0.10899,1,1
4,GO RESPONSE TO CORTICOSTEROID,0.019312,0.11876,0.10304,1,1
4,GO ANION TRANSPORT,1.5576e-05,0.1187,0.1389,1,1
4,GO LIPID HOMEOSTASIS,0.0025617,0.11865,0.13348,1,1
4,GO MONOSACCHARIDE METABOLIC PROCESS,1.3948e-05,0.11838,0.15979,1,1
4,GO CYTOKINETIC PROCESS,0.001483,0.11835,0.12727,1,1
4,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.0056255,0.11835,0.10414,1,1
4,GO RESPONSE TO CARBOHYDRATE,0.00069207,0.11824,0.11828,1,1
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.023419,0.11824,0.11388,1,1
4,GO FATTY ACID METABOLIC PROCESS,0.00054518,0.11811,0.12966,1,1
4,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.033271,0.11782,0.10523,1,1
4,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00099681,0.11768,0.14964,1,1
4,GO REGULATION OF FAT CELL DIFFERENTIATION,0.024687,0.11762,0.10811,1,1
4,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.044722,0.11743,0.12051,1,1
4,GO PROTEIN LOCALIZATION TO VACUOLE,0.011678,0.11741,0.12185,1,1
4,GO ACTIVATION OF IMMUNE RESPONSE,0.0015038,0.11722,0.12001,1,1
4,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.030368,0.11712,0.12502,1,1
4,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.00046872,0.11707,0.12464,1,1
4,GO RESPONSE TO OSMOTIC STRESS,0.0044298,0.11706,0.11399,1,1
4,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.0022095,0.11695,0.11769,1,1
4,GO CARNITINE SHUTTLE,0.006444,0.11687,0.15515,1,1
4,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.020385,0.11679,0.11965,1,1
4,GO VIRAL RELEASE FROM HOST CELL,0.0011503,0.11658,0.13326,1,1
4,GO POSITIVE T CELL SELECTION,0.015329,0.1165,0.10777,1,1
4,GO ION TRANSMEMBRANE TRANSPORT,0.00019229,0.11648,0.11875,1,1
4,GO GLIAL CELL DEVELOPMENT,0.014172,0.11647,0.11,1,1
4,GO NEGATIVE REGULATION OF TOR SIGNALING,0.030994,0.11644,0.10366,1,1
4,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.019735,0.11641,0.12577,1,1
4,GO ORGANIC ACID TRANSPORT,0.00013673,0.11641,0.13252,1,1
4,GO CATION TRANSPORT,0.00028155,0.11635,0.11515,1,1
4,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,5.7059e-05,0.11635,0.12689,1,1
4,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.03006,0.11629,0.13436,1,1
4,GO EXECUTION PHASE OF APOPTOSIS,1.8701e-05,0.11626,0.12833,1,1
4,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.00046165,0.11601,0.14442,1,1
4,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.0032501,0.11599,0.13243,1,1
4,GO T CELL DIFFERENTIATION,0.01499,0.11591,0.089521,1,1
4,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.028852,0.1155,0.08253,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.0041031,0.11549,0.13423,1,1
4,GO INTERLEUKIN 6 PRODUCTION,0.00027284,0.11543,0.16831,1,1
4,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.00024045,0.11532,0.11749,1,1
4,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0021505,0.11528,0.10165,1,1
4,GO MITOTIC CYTOKINETIC PROCESS,0.0043184,0.11519,0.12525,1,1
4,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.00032916,0.11519,0.11883,1,1
4,GO MUSCLE SYSTEM PROCESS,0.0083098,0.11513,0.088341,1,1
4,GO RESPONSE TO PEPTIDE HORMONE,0.001483,0.11501,0.10662,1,1
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.039406,0.115,0.10571,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.030368,0.11496,0.10909,1,1
4,GO INORGANIC ANION TRANSPORT,0.00033955,0.11496,0.11273,1,1
4,GO CELLULAR KETONE METABOLIC PROCESS,0.0010865,0.11492,0.11829,1,1
4,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.00046165,0.11459,0.13378,1,1
4,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.0028118,0.11453,0.1731,1,1
4,GO POSITIVE REGULATION OF MITOPHAGY,0.0020367,0.11444,0.17068,1,1
4,GO ER OVERLOAD RESPONSE,0.023668,0.11435,0.14786,1,1
4,GO IRON ION TRANSPORT,1.7071e-05,0.11428,0.15994,1,1
4,GO SELECTIVE AUTOPHAGY,0.00036124,0.11415,0.14003,1,1
4,GO ACTIVATED T CELL PROLIFERATION,0.0056958,0.11414,0.1437,1,1
4,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.00072342,0.114,0.10942,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.1621e-05,0.11391,0.14114,1,1
4,GO CELLULAR RESPONSE TO FATTY ACID,0.0094686,0.11379,0.14816,1,1
4,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.00011406,0.11363,0.12812,1,1
4,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.031311,0.11361,0.13347,1,1
4,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.03068,0.11347,0.09076,1,1
4,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.022446,0.11337,0.11707,1,1
4,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.00075607,0.11337,0.10316,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.010645,0.11326,0.11105,1,1
4,GO CALCIUM MEDIATED SIGNALING,0.00061456,0.11308,0.093898,1,1
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.001442,0.11308,0.11596,1,1
4,GO CYTOKINE SECRETION,0.00046165,0.11292,0.1563,1,1
4,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.022446,0.11285,0.081809,1,1
4,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.006444,0.11285,0.15113,1,1
4,GO POSITIVE REGULATION OF CELL ACTIVATION,0.0093576,0.11278,0.10104,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.006444,0.11274,0.10966,1,1
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.00019229,0.11265,0.12878,1,1
4,GO AGING,0.0033799,0.11259,0.094478,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0054192,0.11258,0.11906,1,1
4,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.016027,0.11243,0.12628,1,1
4,GO ION TRANSPORT,3.3806e-05,0.11236,0.12811,1,1
4,GO AUTOPHAGOSOME ORGANIZATION,0.00042777,0.11234,0.13901,1,1
4,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.020828,0.11216,0.11467,1,1
4,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.0028872,0.11199,0.11078,1,1
4,GO T CELL ACTIVATION,0.0052854,0.11191,0.11103,1,1
4,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.024687,0.1119,0.11664,1,1
4,GO POSITIVE REGULATION OF JNK CASCADE,0.0021798,0.11182,0.12715,1,1
4,GO POLYOL BIOSYNTHETIC PROCESS,8.7316e-05,0.11163,0.15616,1,1
4,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.013243,0.1116,0.10849,1,1
4,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.0007901,0.1114,0.1201,1,1
4,GO RESPONSE TO OXYGEN RADICAL,0.02915,0.11131,0.10295,1,1
4,GO PROTEOLYSIS,0.00054518,0.11105,0.10578,1,1
4,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.00080175,0.11095,0.15067,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.020166,0.11078,0.12758,1,1
4,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0032928,0.11075,0.11609,1,1
4,GO CELLULAR RESPONSE TO ALCOHOL,0.01829,0.11071,0.11227,1,1
4,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.016752,0.11065,0.13216,1,1
4,GO LEUKOCYTE DIFFERENTIATION,0.0055559,0.11055,0.10067,1,1
4,GO RESPONSE TO TESTOSTERONE,0.023668,0.1104,0.10439,1,1
4,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.0051547,0.11039,0.12024,1,1
4,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.00012186,0.11005,0.12367,1,1
4,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.0029645,0.10996,0.13882,1,1
4,GO CERAMIDE TRANSPORT,0.052083,0.10987,0.12361,1,1
4,GO LYMPHOCYTE DIFFERENTIATION,0.017699,0.10977,0.082586,1,1
4,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.0018006,0.10954,0.13327,1,1
4,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.016386,0.10944,0.13943,1,1
4,GO RESPONSE TO HORMONE,0.0050904,0.10936,0.09858,1,1
4,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.003654,0.10931,0.11314,1,1
4,GO ION HOMEOSTASIS,0.00036686,0.10931,0.11098,1,1
4,GO RESPONSE TO FATTY ACID,0.033608,0.10925,0.10176,1,1
4,GO REGULATION OF IMMUNE RESPONSE,0.0042095,0.10921,0.1103,1,1
4,GO RESPONSE TO ALKALOID,0.00063314,0.10911,0.13213,1,1
4,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.013243,0.10891,0.10458,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.012087,0.10874,0.097041,1,1
4,GO CELLULAR HORMONE METABOLIC PROCESS,0.03429,0.10871,0.11598,1,1
4,GO T CELL MIGRATION,0.033608,0.1087,0.11034,1,1
4,GO REGULATION OF SYSTEM PROCESS,0.006444,0.10864,0.096746,1,1
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.035691,0.10858,0.10386,1,1
4,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.0030436,0.10857,0.10098,1,1
4,GO TRANSITION METAL ION TRANSPORT,3.3806e-05,0.10852,0.13919,1,1
4,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.030368,0.10851,0.12897,1,1
4,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.0012005,0.10851,0.12328,1,1
4,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.0032928,0.10844,0.11138,1,1
4,GO MUSCLE CELL MIGRATION,0.043025,0.10835,0.11372,1,1
4,GO REGULATION OF PROTEIN DEACETYLATION,0.0096941,0.10819,0.11813,1,1
4,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.00099681,0.10801,0.12268,1,1
4,GO DETECTION OF STIMULUS,9.2585e-06,0.10772,0.1306,1,1
4,GO MEMBRANE ORGANIZATION,0.00069207,0.10769,0.10793,1,1
4,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.049212,0.10758,0.11175,1,1
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0030038,0.10742,0.13035,1,1
4,GO FC RECEPTOR SIGNALING PATHWAY,0.0038977,0.10739,0.10529,1,1
4,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.0081133,0.10709,0.12218,1,1
4,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.029754,0.10708,0.10814,1,1
4,GO TRIGLYCERIDE METABOLIC PROCESS,0.0084096,0.10696,0.099053,1,1
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0050269,0.10667,0.14197,1,1
4,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0011341,0.10663,0.12697,1,1
4,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.022928,0.10648,0.12151,1,1
4,GO REGULATION OF PROTEOLYSIS,0.0013255,0.10645,0.11255,1,1
4,GO POSITIVE REGULATION OF CELL GROWTH,0.0070192,0.1062,0.094428,1,1
4,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.00054518,0.10619,0.11816,1,1
4,GO LEUKOCYTE CELL CELL ADHESION,0.0045438,0.10604,0.12282,1,1
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0099244,0.1059,0.12125,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.00024045,0.10571,0.11973,1,1
4,GO XENOBIOTIC TRANSPORT,0.013243,0.10569,0.13727,1,1
4,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.016568,0.10565,0.084691,1,1
4,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.010279,0.10564,0.11889,1,1
4,GO CHOLESTEROL EFFLUX,0.016752,0.10535,0.1112,1,1
4,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.00090088,0.10527,0.184,1,1
4,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0046604,0.10526,0.10433,1,1
4,GO RESPONSE TO COCAINE,0.037509,0.10526,0.10573,1,1
4,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.010522,0.10506,0.11325,1,1
4,GO REGULATION OF JUN KINASE ACTIVITY,0.016938,0.10498,0.1137,1,1
4,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0010408,0.10493,0.10499,1,1
4,GO RESPONSE TO STEROID HORMONE,0.023419,0.10491,0.08898,1,1
4,GO MOLTING CYCLE,0.037139,0.10489,0.08295,1,1
4,GO RESPONSE TO TOXIC SUBSTANCE,0.0038478,0.10429,0.10981,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.033271,0.10428,0.082684,1,1
4,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.015501,0.1041,0.10227,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.01251,0.10406,0.10026,1,1
4,GO CARBOHYDRATE METABOLIC PROCESS,9.4959e-05,0.10397,0.12706,1,1
4,GO REGULATION OF PEPTIDE TRANSPORT,2.0478e-05,0.10389,0.12901,1,1
4,GO ENDOSOME ORGANIZATION,0.00058763,0.10386,0.13325,1,1
4,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.027973,0.10386,0.086079,1,1
4,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.014494,0.10386,0.085669,1,1
4,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.056652,0.10379,0.085433,1,1
4,GO RESPONSE TO OXIDATIVE STRESS,0.0034692,0.10375,0.1032,1,1
4,GO RESPONSE TO PEPTIDE,0.0028872,0.10373,0.10238,1,1
4,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.01995,0.1037,0.10901,1,1
4,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.0063654,0.10367,0.102,1,1
4,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.014658,0.10358,0.10014,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0104,0.10342,0.10488,1,1
4,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.00067188,0.10326,0.11383,1,1
4,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.0047198,0.10325,0.09623,1,1
4,GO LIPID CATABOLIC PROCESS,0.00023667,0.10311,0.13927,1,1
4,GO CATION TRANSMEMBRANE TRANSPORT,0.0007786,0.10299,0.11146,1,1
4,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.010279,0.1027,0.10019,1,1
4,GO REGULATION OF MITOPHAGY,0.003607,0.10268,0.14442,1,1
4,GO REGULATION OF PROTEIN BINDING,0.0056958,0.10253,0.10705,1,1
4,GO METAL ION TRANSPORT,0.00084997,0.10251,0.1067,1,1
4,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.0012705,0.10235,0.12601,1,1
4,GO PHOTOTRANSDUCTION,0.011151,0.10218,0.061593,1,1
4,GO PROTEIN LOCALIZATION TO LYSOSOME,0.045591,0.10216,0.12469,1,1
4,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.0030839,0.10184,0.10459,1,1
4,GO DIVALENT INORGANIC CATION TRANSPORT,0.011022,0.10178,0.084933,1,1
4,GO PRESYNAPTIC ENDOCYTOSIS,0.024687,0.10178,0.12395,1,1
4,GO REGULATION OF LIPID CATABOLIC PROCESS,0.0052197,0.10171,0.11705,1,1
4,GO INTERFERON BETA PRODUCTION,0.046474,0.10167,0.10244,1,1
4,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.027118,0.10166,0.1004,1,1
4,GO MUSCLE CELL APOPTOTIC PROCESS,0.006444,0.10164,0.11937,1,1
4,GO VACUOLAR TRANSPORT,0.0011503,0.1016,0.12281,1,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.0066039,0.10145,0.11436,1,1
4,GO POSITIVE REGULATION OF SIGNALING,0.0015249,0.10117,0.099509,1,1
4,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.03068,0.10112,0.12033,1,1
4,GO REGULATION OF T CELL ACTIVATION,0.012653,0.10109,0.10123,1,1
4,GO REGULATION OF PROTEIN LOCALIZATION,0.0010113,0.10109,0.09765,1,1
4,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.019523,0.10083,0.099334,1,1
4,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.0030038,0.10081,0.10332,1,1
4,GO INTRACELLULAR LIPID TRANSPORT,0.0057669,0.10078,0.15328,1,1
4,GO ENDOCYTOSIS,0.012798,0.10074,0.095827,1,1
4,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.015674,0.10071,0.090679,1,1
4,GO TRANSMEMBRANE TRANSPORT,4.9694e-05,0.1004,0.11773,1,1
4,GO REGULATION OF LEUKOCYTE MIGRATION,0.023919,0.10027,0.10065,1,1
4,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.00027716,0.1002,0.12036,1,1
4,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.05357,0.10001,0.07144,1,1
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,6.545e-05,0.10001,0.12265,1,1
4,GO VIRAL LIFE CYCLE,0.001422,0.099965,0.12787,1,1
4,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.038258,0.099956,0.090997,1,1
4,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.017315,0.099619,0.13237,1,1
4,GO REGULATION OF GLUCOSE IMPORT,0.0066851,0.099588,0.10543,1,1
4,GO RESPONSE TO ENDOGENOUS STIMULUS,0.0046604,0.09934,0.09464,1,1
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.016027,0.099323,0.12061,1,1
4,GO REGULATION OF VACUOLE ORGANIZATION,0.0058389,0.099252,0.11545,1,1
4,GO GOLGI ORGANIZATION,0.0003557,0.09922,0.1224,1,1
4,GO APOPTOTIC SIGNALING PATHWAY,0.00039622,0.099172,0.11753,1,1
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.00064263,0.098956,0.10574,1,1
4,GO JNK CASCADE,0.0070192,0.098801,0.10129,1,1
4,GO POSITIVE REGULATION OF HEMOPOIESIS,0.026286,0.098795,0.086038,1,1
4,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.0050904,0.098608,0.1015,1,1
4,GO MUSCLE CELL DIFFERENTIATION,0.046474,0.098389,0.072451,1,1
4,GO RECEPTOR RECYCLING,0.011949,0.098202,0.12003,1,1
4,GO REGULATION OF LIPID STORAGE,0.0075485,0.098179,0.12748,1,1
4,GO REGULATION OF TOR SIGNALING,0.00044103,0.09813,0.12146,1,1
4,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.012087,0.098114,0.10599,1,1
4,GO RESPONSE TO OXYGEN LEVELS,0.0094686,0.098038,0.093608,1,1
4,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.001422,0.098012,0.11494,1,1
4,GO REGULATION OF MEMBRANE PERMEABILITY,0.0039992,0.097994,0.11475,1,1
4,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.032278,0.097472,0.081512,1,1
4,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.012653,0.097423,0.14073,1,1
4,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.0007786,0.097382,0.10544,1,1
4,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.0074579,0.097377,0.087699,1,1
4,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.03429,0.097368,0.10475,1,1
4,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.014658,0.097202,0.11206,1,1
4,GO RESPONSE TO ACTIVITY,0.023173,0.097161,0.094008,1,1
4,GO POLYOL METABOLIC PROCESS,0.0075485,0.097074,0.093277,1,1
4,GO NEUTRAL LIPID METABOLIC PROCESS,0.0059852,0.096996,0.095657,1,1
4,GO GLYCEROLIPID METABOLIC PROCESS,0.00015331,0.096983,0.11915,1,1
4,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.041383,0.09679,0.086127,1,1
4,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.03006,0.096696,0.090786,1,1
4,GO ENDOSOME TO LYSOSOME TRANSPORT,0.0018256,0.096249,0.11732,1,1
4,GO REGULATION OF CELLULAR RESPIRATION,0.013394,0.09614,0.13717,1,1
4,GO LYMPHOCYTE APOPTOTIC PROCESS,0.0056958,0.096062,0.12963,1,1
4,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.0050269,0.096005,0.098661,1,1
4,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.021509,0.095956,0.10998,1,1
4,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.05063,0.095736,0.14058,1,1
4,GO SOMITOGENESIS,0.0065235,0.095647,0.1074,1,1
4,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.0090315,0.095639,0.10393,1,1
4,GO DETECTION OF ABIOTIC STIMULUS,0.01995,0.095556,0.085803,1,1
4,GO REGULATION OF HYDROLASE ACTIVITY,0.014494,0.095518,0.090324,1,1
4,GO PIGMENT GRANULE ORGANIZATION,0.052575,0.095179,0.088154,1,1
4,GO REGULATION OF T CELL MIGRATION,0.0054192,0.095061,0.15088,1,1
4,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.0056255,0.095027,0.14126,1,1
4,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.012653,0.09501,0.099126,1,1
4,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.020605,0.094978,0.11034,1,1
4,GO REGULATION OF LIPID METABOLIC PROCESS,0.0012705,0.094922,0.11903,1,1
4,GO PROTEIN DEPOLYMERIZATION,0.023919,0.094879,0.098788,1,1
4,GO ELECTRON TRANSPORT CHAIN,0.0015038,0.09482,0.11655,1,1
4,GO RESPONSE TO ETHANOL,0.0054872,0.09457,0.096729,1,1
4,GO CELLULAR ION HOMEOSTASIS,0.00067188,0.09441,0.10288,1,1
4,GO REGULATION OF GROWTH,0.032278,0.094409,0.073728,1,1
4,GO ANION TRANSMEMBRANE TRANSPORT,0.00033432,0.094226,0.11721,1,1
4,GO CIRCADIAN RHYTHM,0.0018006,0.094099,0.11022,1,1
4,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.00021511,0.093808,0.12319,1,1
4,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.0052854,0.093783,0.099319,1,1
4,GO REGULATION OF T CELL DIFFERENTIATION,0.055093,0.093621,0.071435,1,1
4,GO OXIDATIVE PHOSPHORYLATION,0.0031247,0.093266,0.10621,1,1
4,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.01499,0.093197,0.095599,1,1
4,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.0052854,0.093172,0.090726,1,1
4,GO LYMPHOCYTE ACTIVATION,0.011544,0.093097,0.092691,1,1
4,GO IMPORT INTO CELL,0.049212,0.09283,0.08499,1,1
4,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.015674,0.092557,0.088026,1,1
4,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.0078263,0.092507,0.12886,1,1
4,GO RESPONSE TO LIPID,0.015501,0.092333,0.091634,1,1
4,GO REGULATION OF CELLULAR LOCALIZATION,0.03006,0.092185,0.065221,1,1
4,GO REGULATION OF TRANSPORT,0.00099681,0.092155,0.096845,1,1
4,GO POTASSIUM ION TRANSPORT,0.0075485,0.092149,0.11985,1,1
4,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.024173,0.09206,0.1388,1,1
4,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.022928,0.091736,0.098784,1,1
4,GO SPLEEN DEVELOPMENT,0.033948,0.09168,0.087792,1,1
4,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.013394,0.091562,0.10068,1,1
4,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.0090315,0.09136,0.11989,1,1
4,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.0066039,0.091171,0.11754,1,1
4,GO CYTOCHROME COMPLEX ASSEMBLY,0.036409,0.091049,0.1041,1,1
4,GO PROTEIN AUTOUBIQUITINATION,0.0042636,0.091002,0.090612,1,1
4,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.0010113,0.090895,0.1158,1,1
4,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.037139,0.090542,0.11373,1,1
4,GO RESPONSE TO DRUG,0.0084096,0.090387,0.1031,1,1
4,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.025475,0.090196,0.07742,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.0047798,0.090132,0.09942,1,1
4,GO CELL CELL RECOGNITION,0.0012705,0.089908,0.13164,1,1
4,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.012798,0.089617,0.086597,1,1
4,GO RESPONSE TO DSRNA,0.010279,0.08931,0.10703,1,1
4,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.032938,0.089143,0.10126,1,1
4,GO ORGANELLE DISASSEMBLY,0.00030449,0.088891,0.11589,1,1
4,GO RESPONSE TO NITROGEN COMPOUND,0.001568,0.088663,0.096859,1,1
4,GO SOMITE DEVELOPMENT,0.058787,0.088432,0.073186,1,1
4,GO KERATINOCYTE MIGRATION,0.041789,0.088429,0.086821,1,1
4,GO RESPONSE TO ETHER,0.052083,0.088385,0.086164,1,1
4,GO RESPONSE TO ACID CHEMICAL,0.010645,0.088049,0.094336,1,1
4,GO LEUKOCYTE TETHERING OR ROLLING,0.013546,0.087759,0.09828,1,1
4,GO PEPTIDYL TYROSINE MODIFICATION,0.018898,0.087696,0.105,1,1
4,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.049681,0.087335,0.076987,1,1
4,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.040187,0.087192,0.082742,1,1
4,GO POSITIVE REGULATION OF TRANSPORT,0.001704,0.086917,0.097293,1,1
4,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.020828,0.08668,0.11362,1,1
4,GO POSITIVE REGULATION OF AUTOPHAGY,0.0083098,0.086624,0.10607,1,1
4,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.020166,0.086485,0.11015,1,1
4,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.040187,0.086258,0.088914,1,1
4,GO SYMBIOTIC PROCESS,0.013243,0.086049,0.074213,1,1
4,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.019104,0.085797,0.088593,1,1
4,GO MALE SEX DIFFERENTIATION,0.032278,0.085779,0.089074,1,1
4,GO AUTOPHAGY OF MITOCHONDRION,0.0013826,0.085662,0.12306,1,1
4,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.014823,0.085435,0.092383,1,1
4,GO TOR SIGNALING,0.0005056,0.085428,0.1042,1,1
4,GO ENDOSOMAL TRANSPORT,0.0037985,0.085173,0.087589,1,1
4,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.0018764,0.085165,0.11312,1,1
4,GO ACTIVATION OF MAPK ACTIVITY,0.0045438,0.084884,0.1033,1,1
4,GO REGULATION OF HEMOPOIESIS,0.020166,0.084759,0.084457,1,1
4,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.020605,0.084681,0.086526,1,1
4,GO LYSOSOMAL TRANSPORT,0.019104,0.084551,0.10669,1,1
4,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.052083,0.084543,0.099472,1,1
4,GO OXIDATION REDUCTION PROCESS,0.001568,0.084418,0.10698,1,1
4,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.0022095,0.084339,0.10156,1,1
4,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.00024045,0.084002,0.1109,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.01585,0.083986,0.086615,1,1
4,GO MESONEPHROS DEVELOPMENT,0.017506,0.083953,0.1066,1,1
4,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.0071051,0.083714,0.088716,1,1
4,GO REGULATION OF ACTIN FILAMENT LENGTH,0.047372,0.082922,0.080396,1,1
4,GO PULMONARY VALVE DEVELOPMENT,0.045155,0.082909,0.159,1,1
4,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.024173,0.082445,0.091035,1,1
4,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.023173,0.082439,0.098209,1,1
4,GO SENSORY PERCEPTION,0.0027381,0.082367,0.084835,1,1
4,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.0021215,0.082268,0.12794,1,1
4,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.0067673,0.082111,0.1286,1,1
4,GO REGULATION OF MAP KINASE ACTIVITY,0.0057669,0.082064,0.1145,1,1
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0037016,0.082051,0.098413,1,1
4,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.000286,0.081954,0.11143,1,1
4,GO ENSHEATHMENT OF NEURONS,0.059331,0.081757,0.082094,1,1
4,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.030368,0.081505,0.092346,1,1
4,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.036409,0.081275,0.1032,1,1
4,GO CYTOSOLIC TRANSPORT,0.0066039,0.080941,0.09245,1,1
4,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.017125,0.080549,0.081894,1,1
4,GO CELLULAR HOMEOSTASIS,0.0016806,0.080462,0.089899,1,1
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.039406,0.079613,0.067436,1,1
4,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0137,0.079598,0.090003,1,1
4,GO HOMEOSTATIC PROCESS,0.0005211,0.079571,0.10069,1,1
4,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.016938,0.07919,0.086444,1,1
4,GO MITOPHAGY,0.0029256,0.079148,0.13325,1,1
4,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.00052901,0.079144,0.13777,1,1
4,GO MAINTENANCE OF LOCATION IN CELL,0.0060595,0.078895,0.097089,1,1
4,GO MACROAUTOPHAGY,0.00041488,0.078505,0.1052,1,1
4,GO PEPTIDYL THREONINE MODIFICATION,0.016027,0.078329,0.097423,1,1
4,GO POSITIVE REGULATION OF TOR SIGNALING,0.010645,0.077878,0.10193,1,1
4,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.059331,0.077798,0.061196,1,1
4,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.0083098,0.077474,0.099217,1,1
4,GO LIPID MODIFICATION,0.0046018,0.077084,0.10351,1,1
4,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.02521,0.076918,0.078873,1,1
4,GO PROTEIN K48 LINKED UBIQUITINATION,0.012945,0.076915,0.092313,1,1
4,GO POSITIVE REGULATION OF CELL DEATH,0.02521,0.07628,0.081586,1,1
4,GO NON CANONICAL WNT SIGNALING PATHWAY,0.011678,0.076111,0.094449,1,1
4,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.0054192,0.076042,0.083975,1,1
4,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.028852,0.075983,0.080629,1,1
4,GO NEGATIVE REGULATION OF SECRETION,0.0016575,0.07538,0.10202,1,1
4,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.0045438,0.07521,0.10531,1,1
4,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.038258,0.075184,0.10201,1,1
4,GO PEPTIDYL SERINE MODIFICATION,0.023668,0.074876,0.073206,1,1
4,GO PROTEIN POLYUBIQUITINATION,0.0028872,0.074853,0.086184,1,1
4,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.012087,0.07458,0.10152,1,1
4,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.012945,0.074189,0.084557,1,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.040981,0.073858,0.067761,1,1
4,GO CELLULAR RESPIRATION,0.01585,0.073169,0.088978,1,1
4,GO REGULATION OF MAPK CASCADE,0.022686,0.073142,0.087511,1,1
4,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.0030038,0.072577,0.13794,1,1
4,GO AEROBIC RESPIRATION,0.02945,0.072538,0.088531,1,1
4,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.021509,0.072503,0.092207,1,1
4,GO REGULATION OF PHOSPHORYLATION,0.028264,0.072225,0.074783,1,1
4,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.015501,0.071896,0.080037,1,1
4,GO REGULATION OF RESPONSE TO STRESS,0.0063654,0.071844,0.08951,1,1
4,GO RESPONSE TO ABIOTIC STIMULUS,0.010279,0.071004,0.076783,1,1
4,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.0089251,0.070205,0.085353,1,1
4,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.0067673,0.069735,0.080793,1,1
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.014823,0.069431,0.083184,1,1
4,GO SPERM EGG RECOGNITION,0.014013,0.069247,0.090431,1,1
4,GO CARBOHYDRATE CATABOLIC PROCESS,0.03068,0.068775,0.08727,1,1
4,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.018091,0.068577,0.09654,1,1
4,GO NEGATIVE REGULATION OF SIGNALING,0.049681,0.068227,0.067442,1,1
4,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.014013,0.067966,0.074359,1,1
4,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.057179,0.067928,0.05986,1,1
4,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.02915,0.067817,0.073355,1,1
4,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.031311,0.06752,0.073349,1,1
4,GO HEAT GENERATION,0.049212,0.067119,0.10511,1,1
4,GO ACTIN FILAMENT BASED MOVEMENT,0.042609,0.066605,0.090591,1,1
4,GO BODY FLUID SECRETION,0.042609,0.066557,0.084482,1,1
4,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.036772,0.06647,0.069583,1,1
4,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.032278,0.066359,0.063784,1,1
4,GO TRANSLESION SYNTHESIS,0.054074,0.0658,0.066794,1,1
4,GO REGULATION OF AUTOPHAGY,0.0010113,0.065597,0.104,1,1
4,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.049681,0.064559,0.068447,1,1
4,GO IMMUNE SYSTEM DEVELOPMENT,0.0076401,0.064519,0.088619,1,1
4,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.011544,0.06376,0.07795,1,1
4,GO APOPTOTIC PROCESS,0.011022,0.063728,0.080758,1,1
4,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.009139,0.063513,0.090895,1,1
4,GO POSITIVE REGULATION OF MAPK CASCADE,0.027973,0.063242,0.086468,1,1
4,GO MAINTENANCE OF LOCATION,0.014013,0.062162,0.089048,1,1
4,GO BLASTOCYST DEVELOPMENT,0.0056958,0.061727,0.075551,1,1
4,GO ESTABLISHMENT OF TISSUE POLARITY,0.056652,0.061487,0.068662,1,1
4,GO REGULATION OF ATP METABOLIC PROCESS,0.03006,0.061127,0.083426,1,1
4,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.0073682,0.060965,0.088494,1,1
4,GO MYELOID CELL DIFFERENTIATION,0.0104,0.059311,0.093732,1,1
4,GO PROTEIN CATABOLIC PROCESS,0.0073682,0.059117,0.074493,1,1
4,GO POSITIVE REGULATION OF PROTEOLYSIS,0.0092477,0.058949,0.093729,1,1
4,GO REGULATION OF PROTEIN TARGETING,0.049212,0.058876,0.070814,1,1
4,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.042197,0.058717,0.073414,1,1
4,GO REGULATION OF PROTEIN STABILITY,0.012653,0.058641,0.073691,1,1
4,GO ORGANELLE INHERITANCE,0.023919,0.057511,0.084619,1,1
4,GO CELLULAR COMPONENT DISASSEMBLY,0.037882,0.056952,0.061364,1,1
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.037509,0.056855,0.065177,1,1
4,GO ERYTHROCYTE HOMEOSTASIS,0.028852,0.056756,0.092902,1,1
4,GO GOLGI VESICLE TRANSPORT,0.011813,0.053626,0.085972,1,1
4,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.032607,0.052101,0.081728,1,1
4,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.0066039,0.05199,0.071519,1,1
4,GO POSITIVE REGULATION OF VIRAL PROCESS,0.0070192,0.051681,0.089263,1,1
4,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.012653,0.050322,0.080237,1,1
4,GO MULTI ORGANISM PROCESS,0.037509,0.047965,0.059866,1,1
4,GO REGULATION OF CATABOLIC PROCESS,0.054074,0.045622,0.058109,1,1
4,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.022928,0.045595,0.095287,1,1
4,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.01585,0.045412,0.067748,1,1
4,GO RESPONSE TO MISFOLDED PROTEIN,0.059331,0.044927,0.10455,1,1
4,GO REGULATION OF MACROAUTOPHAGY,0.0089251,0.04339,0.085648,1,1
4,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.03429,0.035725,0.053338,1,1
4,GO THIOESTER METABOLIC PROCESS,0.046031,0.032093,0.086668,1,1
4,GO INTRACELLULAR TRANSPORT,0.03429,0.03129,0.052821,1,1
4,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.057179,0.030503,0.057713,1,1
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.004964,0.64242,0.60464,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.0037016,0.51072,0.51772,1,0
4,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.023668,0.38136,0.31037,1,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.03902,0.37237,0.24299,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.00072342,0.34869,0.25603,1,0
4,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.00080175,0.32317,0.31242,1,0
4,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0081133,0.30054,0.305,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0014022,0.29288,0.26616,1,0
4,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.05063,0.27994,0.28745,1,0
4,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0016347,0.27255,0.29406,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.003166,0.27021,0.22113,1,0
4,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.0023957,0.26941,0.26959,1,0
4,GO RESPONSE TO INTERFERON ALPHA,0.030368,0.26294,0.19325,1,0
4,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.002702,0.25549,0.2507,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.0040509,0.24527,0.22756,1,0
4,GO ACTIN FILAMENT NETWORK FORMATION,0.0028492,0.24224,0.26767,1,0
4,GO PROTEIN KINASE C SIGNALING,0.00039622,0.22892,0.23269,1,0
4,GO VITAMIN D BIOSYNTHETIC PROCESS,0.00040235,0.22802,0.27485,1,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0005056,0.22332,0.24896,1,0
4,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.023173,0.20426,0.12149,1,0
4,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.0015038,0.20239,0.18832,1,0
4,GO DETECTION OF BIOTIC STIMULUS,0.018091,0.20138,0.15209,1,0
4,GO ICOSANOID METABOLIC PROCESS,0.00013232,0.20056,0.20687,1,0
4,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.0083098,0.19791,0.24537,1,0
4,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.024173,0.19238,0.20647,1,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.0047798,0.19161,0.16641,1,0
4,GO REGULATION OF RECEPTOR CLUSTERING,0.036772,0.19152,0.18866,1,0
4,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.0075485,0.18874,0.23528,1,0
4,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.0020367,0.18232,0.23284,1,0
4,GO DORSAL SPINAL CORD DEVELOPMENT,0.040582,0.18009,0.15464,1,0
4,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.010279,0.17936,0.25327,1,0
4,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.0023637,0.17525,0.14248,1,0
4,GO ZYMOGEN INHIBITION,0.0052854,0.17396,0.17224,1,0
4,GO FLUID TRANSPORT,0.00096848,0.1738,0.15189,1,0
4,GO COPULATION,0.0062108,0.17336,0.15984,1,0
4,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.011411,0.17331,0.16191,1,0
4,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.027973,0.17306,0.17604,1,0
4,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.0057669,0.17116,0.21849,1,0
4,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.01849,0.17096,0.14834,1,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0054872,0.17007,0.15148,1,0
4,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.021509,0.16988,0.20402,1,0
4,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.013856,0.16613,0.13276,1,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.002631,0.16426,0.19147,1,0
4,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.0019819,0.16372,0.13777,1,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.022446,0.16318,0.1295,1,0
4,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.0047198,0.16303,0.15062,1,0
4,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.045591,0.16193,0.11228,1,0
4,GO DETECTION OF TEMPERATURE STIMULUS,0.014658,0.15835,0.19865,1,0
4,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.0046604,0.15716,0.1873,1,0
4,GO DENDRITIC CELL MIGRATION,0.024173,0.15654,0.11341,1,0
4,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0024609,0.15531,0.19258,1,0
4,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.029754,0.15439,0.13564,1,0
4,GO METANEPHROS MORPHOGENESIS,0.059331,0.15409,0.11738,1,0
4,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.040981,0.1526,0.16063,1,0
4,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.022928,0.15047,0.17706,1,0
4,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.0033361,0.15018,0.14649,1,0
4,GO REGULATION OF FIBRINOLYSIS,0.010041,0.14981,0.16275,1,0
4,GO MEMBRANE HYPERPOLARIZATION,0.01251,0.14887,0.12933,1,0
4,GO NEGATIVE REGULATION OF OSSIFICATION,0.013394,0.14495,0.1255,1,0
4,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.019735,0.14452,0.20413,1,0
4,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.0056255,0.14423,0.19598,1,0
4,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0013633,0.14377,0.14615,1,0
4,GO RESPONSE TO INTERLEUKIN 1,0.0039992,0.14225,0.095295,1,0
4,GO HYALURONAN METABOLIC PROCESS,0.0092477,0.14164,0.12107,1,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.033271,0.14152,0.12101,1,0
4,GO REGULATION OF ISOTYPE SWITCHING,0.028556,0.1407,0.098348,1,0
4,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00091404,0.14045,0.1813,1,0
4,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.031631,0.13969,0.11343,1,0
4,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0019023,0.13956,0.16359,1,0
4,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.014172,0.13919,0.12999,1,0
4,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.00063314,0.13908,0.20194,1,0
4,GO BIOMINERALIZATION,0.0037985,0.13878,0.13751,1,0
4,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.0022701,0.13711,0.13033,1,0
4,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.00025617,0.13663,0.13095,1,0
4,GO NEURAL NUCLEUS DEVELOPMENT,0.022686,0.13613,0.14732,1,0
4,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0094686,0.13551,0.17641,1,0
4,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.0076401,0.13447,0.10941,1,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.012227,0.13384,0.087697,1,0
4,GO REGULATION OF SODIUM ION TRANSPORT,0.0044298,0.13367,0.13283,1,0
4,GO VITAMIN BIOSYNTHETIC PROCESS,0.0034243,0.13354,0.16995,1,0
4,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.0084096,0.13279,0.12006,1,0
4,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.026561,0.13243,0.11241,1,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.027118,0.13196,0.11319,1,0
4,GO VIRAL RNA GENOME REPLICATION,0.0022095,0.13185,0.14312,1,0
4,GO REGULATION OF AMYLOID BETA CLEARANCE,0.048285,0.13091,0.15644,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.010522,0.13043,0.13598,1,0
4,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.016386,0.13013,0.10737,1,0
4,GO RESPONSE TO ANGIOTENSIN,0.03429,0.12959,0.12681,1,0
4,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.05063,0.12959,0.17403,1,0
4,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.0093576,0.12917,0.14123,1,0
4,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.021973,0.12916,0.10371,1,0
4,GO DIENCEPHALON DEVELOPMENT,0.021973,0.12859,0.1546,1,0
4,GO RETINAL METABOLIC PROCESS,0.058247,0.12644,0.21471,1,0
4,GO PROTEIN AUTO ADP RIBOSYLATION,0.040981,0.12634,0.17215,1,0
4,GO BONE MINERALIZATION,0.013546,0.12613,0.12212,1,0
4,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.043025,0.12533,0.1039,1,0
4,GO ACTIN FILAMENT BASED TRANSPORT,0.038637,0.12525,0.13083,1,0
4,GO COLLAGEN CATABOLIC PROCESS,0.054074,0.12445,0.11536,1,0
4,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.0074579,0.12419,0.14558,1,0
4,GO MYELOID CELL DEVELOPMENT,0.026286,0.12419,0.10072,1,0
4,GO PROTEIN LOCALIZATION TO AXON,0.037882,0.12409,0.22938,1,0
4,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.0074579,0.12375,0.1334,1,0
4,GO KERATINOCYTE PROLIFERATION,0.03429,0.12348,0.11846,1,0
4,GO CELL MATRIX ADHESION,0.011678,0.12332,0.13262,1,0
4,GO RESPONSE TO BMP,0.056128,0.12208,0.090671,1,0
4,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.040981,0.1215,0.10375,1,0
4,GO TYPE 2 IMMUNE RESPONSE,0.028556,0.12085,0.12344,1,0
4,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.0069343,0.12023,0.10963,1,0
4,GO CARNITINE METABOLIC PROCESS,0.027686,0.12008,0.14175,1,0
4,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.027973,0.11937,0.10007,1,0
4,GO CD40 SIGNALING PATHWAY,0.022209,0.11903,0.10816,1,0
4,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.019312,0.11861,0.12899,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.020828,0.11842,0.109,1,0
4,GO TEMPERATURE HOMEOSTASIS,0.00014839,0.11775,0.14035,1,0
4,GO REGULATION OF CARTILAGE DEVELOPMENT,0.0056255,0.11759,0.14558,1,0
4,GO EXPORT ACROSS PLASMA MEMBRANE,0.023668,0.11722,0.11366,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.0016806,0.117,0.14968,1,0
4,GO PROTEIN KINASE B SIGNALING,0.024428,0.1166,0.096865,1,0
4,GO DNA DEMETHYLATION,0.016205,0.11631,0.1221,1,0
4,GO NEPHRON DEVELOPMENT,0.052575,0.1153,0.094021,1,0
4,GO AMEBOIDAL TYPE CELL MIGRATION,0.052575,0.11505,0.088917,1,0
4,GO VESICLE DOCKING,0.023173,0.11435,0.1051,1,0
4,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.021509,0.11352,0.1513,1,0
4,GO STRESS FIBER ASSEMBLY,0.05357,0.11277,0.10598,1,0
4,GO POSITIVE REGULATION OF OSSIFICATION,0.03068,0.11227,0.11192,1,0
4,GO RESPONSE TO PROTOZOAN,0.026838,0.11215,0.10902,1,0
4,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.011678,0.11203,0.09318,1,0
4,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0057669,0.11133,0.10812,1,0
4,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.0062108,0.11122,0.11216,1,0
4,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.027973,0.11036,0.11922,1,0
4,GO REGULATION OF CHEMOTAXIS,0.0066039,0.11032,0.10865,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.017506,0.1099,0.12045,1,0
4,GO COPPER ION HOMEOSTASIS,0.0078263,0.10927,0.13962,1,0
4,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.012653,0.10892,0.16412,1,0
4,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.0052854,0.10888,0.16713,1,0
4,GO SENSORY PERCEPTION OF PAIN,0.0025277,0.10861,0.12647,1,0
4,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0023321,0.10856,0.12097,1,0
4,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.003607,0.10838,0.10731,1,0
4,GO MAMMARY GLAND DEVELOPMENT,0.042609,0.1083,0.098839,1,0
4,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.026561,0.10772,0.10929,1,0
4,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.0021798,0.10762,0.14748,1,0
4,GO CELLULAR GLUCOSE HOMEOSTASIS,0.00074504,0.10705,0.12391,1,0
4,GO LIPOPROTEIN CATABOLIC PROCESS,0.034984,0.10703,0.15391,1,0
4,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0046604,0.10654,0.11166,1,0
4,GO REGULATION OF OSSIFICATION,0.022686,0.10621,0.098943,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.023919,0.10606,0.092558,1,0
4,GO COPPER ION TRANSPORT,0.0076401,0.10593,0.1366,1,0
4,GO OLIGODENDROCYTE DIFFERENTIATION,0.033608,0.10537,0.10803,1,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.028556,0.1052,0.11564,1,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.010279,0.10502,0.12365,1,0
4,GO EPITHELIAL CELL PROLIFERATION,0.052575,0.10473,0.083984,1,0
4,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.043025,0.1043,0.10211,1,0
4,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.0053519,0.10382,0.1521,1,0
4,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.030994,0.10378,0.11006,1,0
4,GO ORGANIC CATION TRANSPORT,0.059331,0.10356,0.096149,1,0
4,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.048285,0.10315,0.1889,1,0
4,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.058247,0.1029,0.12147,1,0
4,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.036048,0.10254,0.11914,1,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.017315,0.10249,0.12014,1,0
4,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.006444,0.10239,0.10087,1,0
4,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.002631,0.10216,0.15332,1,0
4,GO NIK NF KAPPAB SIGNALING,0.013856,0.10156,0.086969,1,0
4,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.012367,0.10144,0.098829,1,0
4,GO ANIMAL ORGAN MATURATION,0.021053,0.10141,0.12419,1,0
4,GO REGULATION OF LIPID TRANSPORT,0.0019819,0.10115,0.13569,1,0
4,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.01995,0.10094,0.12173,1,0
4,GO CELLULAR COPPER ION HOMEOSTASIS,0.020166,0.10083,0.13445,1,0
4,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.014013,0.10056,0.094647,1,0
4,GO SECOND MESSENGER MEDIATED SIGNALING,0.00055343,0.1005,0.10949,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.011022,0.10022,0.16036,1,0
4,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.014172,0.099662,0.12997,1,0
4,GO REGULATION OF MEMBRANE POTENTIAL,0.057179,0.099543,0.091485,1,0
4,GO ENDOTHELIAL CELL MIGRATION,0.017315,0.099209,0.1222,1,0
4,GO PANCREAS DEVELOPMENT,0.038258,0.098886,0.11418,1,0
4,GO CELL REDOX HOMEOSTASIS,0.01499,0.098882,0.10713,1,0
4,GO FATTY ACID BETA OXIDATION,0.032938,0.098563,0.088816,1,0
4,GO NEGATIVE REGULATION OF MAPK CASCADE,0.035691,0.098489,0.094053,1,0
4,GO REGULATION OF T CELL CHEMOTAXIS,0.035336,0.098182,0.097929,1,0
4,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.0042636,0.097976,0.1168,1,0
4,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.052575,0.097784,0.081124,1,0
4,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.046031,0.097748,0.094286,1,0
4,GO CELL MOTILITY,0.022446,0.097459,0.091186,1,0
4,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.0098086,0.097458,0.12577,1,0
4,GO SINGLE FERTILIZATION,0.0086125,0.097188,0.081167,1,0
4,GO RESPONSE TO MONOSACCHARIDE,0.00042128,0.096435,0.1256,1,0
4,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.012798,0.096387,0.17664,1,0
4,GO DNA DEALKYLATION,0.040582,0.095973,0.093792,1,0
4,GO MULTI ORGANISM CELLULAR PROCESS,0.059331,0.095972,0.09761,1,0
4,GO POSITIVE REGULATION OF ION TRANSPORT,0.0070192,0.095735,0.09324,1,0
4,GO CARDIAC CONDUCTION,0.010645,0.095395,0.11501,1,0
4,GO TISSUE MIGRATION,0.017699,0.095226,0.11506,1,0
4,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.046474,0.095021,0.098564,1,0
4,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.027973,0.094755,0.11045,1,0
4,GO ENDOCRINE SYSTEM DEVELOPMENT,0.0104,0.094663,0.1343,1,0
4,GO MALE GENITALIA DEVELOPMENT,0.018898,0.09453,0.13675,1,0
4,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.011022,0.093848,0.094924,1,0
4,GO ANATOMICAL STRUCTURE MATURATION,0.010041,0.093559,0.090916,1,0
4,GO REGULATION OF CHROMATIN ASSEMBLY,0.0074579,0.093325,0.11238,1,0
4,GO ENDOCRINE PANCREAS DEVELOPMENT,0.059879,0.09266,0.10895,1,0
4,GO CHOLESTEROL STORAGE,0.015501,0.092606,0.16459,1,0
4,GO SECRETORY GRANULE ORGANIZATION,0.03068,0.092224,0.11504,1,0
4,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.01849,0.092034,0.15195,1,0
4,GO IMMUNOGLOBULIN PRODUCTION,0.011151,0.092003,0.091079,1,0
4,GO HORMONE CATABOLIC PROCESS,0.027686,0.091984,0.14657,1,0
4,GO REPRODUCTIVE BEHAVIOR,0.036772,0.091626,0.096539,1,0
4,GO DEVELOPMENTAL MATURATION,0.031953,0.091622,0.086031,1,0
4,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.059331,0.091071,0.076048,1,0
4,GO FATTY ACYL COA METABOLIC PROCESS,0.019523,0.090786,0.1271,1,0
4,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.0073682,0.090076,0.11619,1,0
4,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.035336,0.089906,0.094332,1,0
4,GO OSSIFICATION,0.049212,0.089828,0.080312,1,0
4,GO PEROXISOMAL TRANSPORT,0.0041031,0.089707,0.11362,1,0
4,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.045155,0.089551,0.090769,1,0
4,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.048285,0.089533,0.11201,1,0
4,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.016752,0.089118,0.086933,1,0
4,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.03429,0.089091,0.084177,1,0
4,GO REGULATION OF LIPID LOCALIZATION,0.0030436,0.088882,0.123,1,0
4,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.0089251,0.088605,0.087433,1,0
4,GO RUFFLE ORGANIZATION,0.0137,0.088556,0.11424,1,0
4,GO TRANSITION METAL ION HOMEOSTASIS,0.013093,0.088343,0.10394,1,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS,0.036048,0.087859,0.13075,1,0
4,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.052575,0.087642,0.11416,1,0
4,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.030368,0.087145,0.087838,1,0
4,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.0024281,0.08705,0.13269,1,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.058247,0.086963,0.092501,1,0
4,GO SARCOMERE ORGANIZATION,0.044722,0.086325,0.10275,1,0
4,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.019312,0.086244,0.28161,1,0
4,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.045155,0.08621,0.088634,1,0
4,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.0098086,0.086096,0.11298,1,0
4,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.042609,0.085691,0.093694,1,0
4,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.042197,0.085581,0.095143,1,0
4,GO POTASSIUM ION HOMEOSTASIS,0.048285,0.085568,0.09014,1,0
4,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.015501,0.085186,0.092534,1,0
4,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.03902,0.084779,0.16421,1,0
4,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.03429,0.084589,0.074968,1,0
4,GO PEPTIDYL CYSTEINE MODIFICATION,0.02128,0.084563,0.086969,1,0
4,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.047372,0.083951,0.098278,1,0
4,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.016205,0.083871,0.097385,1,0
4,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.027686,0.083368,0.10485,1,0
4,GO VESICLE LOCALIZATION,0.0090315,0.083271,0.084305,1,0
4,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.057711,0.082965,0.15699,1,0
4,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.026561,0.082945,0.11063,1,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.021509,0.082884,0.11349,1,0
4,GO MYOFIBRIL ASSEMBLY,0.018898,0.082461,0.11256,1,0
4,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.021053,0.082438,0.094216,1,0
4,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.03429,0.08243,0.13995,1,0
4,GO PEROXISOME ORGANIZATION,0.0077327,0.082344,0.10211,1,0
4,GO ACTIVATION OF JUN KINASE ACTIVITY,0.021973,0.082244,0.11354,1,0
4,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.052083,0.081973,0.069194,1,0
4,GO REGULATION OF CELL POPULATION PROLIFERATION,0.024687,0.081721,0.083231,1,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.035336,0.081525,0.07406,1,0
4,GO MATING,0.0077327,0.081453,0.11113,1,0
4,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.041383,0.081249,0.097314,1,0
4,GO T CELL RECEPTOR SIGNALING PATHWAY,0.018091,0.08106,0.086921,1,0
4,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.048285,0.081044,0.091605,1,0
4,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.0093576,0.080755,0.12394,1,0
4,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.019312,0.080562,0.10448,1,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.043444,0.080445,0.078533,1,0
4,GO REGULATION OF MACROPHAGE MIGRATION,0.02128,0.080405,0.085128,1,0
4,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.0024941,0.08025,0.12229,1,0
4,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.050154,0.080059,0.10937,1,0
4,GO FEEDING BEHAVIOR,0.028852,0.079446,0.08831,1,0
4,GO MEGAKARYOCYTE DIFFERENTIATION,0.049681,0.079351,0.078844,1,0
4,GO NEGATIVE REGULATION OF GROWTH,0.01849,0.078916,0.096119,1,0
4,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.020166,0.078316,0.080234,1,0
4,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.015329,0.07796,0.10298,1,0
4,GO ORGANIC ACID CATABOLIC PROCESS,0.023919,0.077805,0.082512,1,0
4,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.050154,0.077699,0.074342,1,0
4,GO PHAGOCYTOSIS,0.016752,0.07715,0.11292,1,0
4,GO NEGATIVE REGULATION OF AUTOPHAGY,0.052083,0.076666,0.089709,1,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.05063,0.076147,0.093373,1,0
4,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.016027,0.075336,0.091724,1,0
4,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,0.0088198,0.074931,0.12489,1,0
4,GO LIPID OXIDATION,0.0078263,0.074716,0.10552,1,0
4,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.028264,0.074632,0.078578,1,0
4,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.0038977,0.074426,0.1066,1,0
4,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.042609,0.073774,0.093573,1,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.016752,0.073674,0.09657,1,0
4,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.051111,0.073597,0.073804,1,0
4,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0069343,0.073537,0.10057,1,0
4,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.02915,0.073408,0.087421,1,0
4,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.017125,0.072972,0.10159,1,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.059331,0.072893,0.088293,1,0
4,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.026013,0.072316,0.066756,1,0
4,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.043025,0.072311,0.10946,1,0
4,GO POSITIVE REGULATION OF NUCLEAR DIVISION,0.032607,0.072149,0.06921,1,0
4,GO RHYTHMIC PROCESS,0.033271,0.071455,0.070475,1,0
4,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.032938,0.070909,0.074837,1,0
4,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.011678,0.070563,0.10501,1,0
4,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,0.033948,0.07042,0.066543,1,0
4,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.019735,0.070185,0.087577,1,0
4,GO SMALL MOLECULE CATABOLIC PROCESS,0.0047798,0.069757,0.097338,1,0
4,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0071918,0.069616,0.10559,1,0
4,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.018693,0.069237,0.12097,1,0
4,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.02174,0.067876,0.10012,1,0
4,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.019312,0.067699,0.076822,1,0
4,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.033608,0.067462,0.090395,1,0
4,GO TRNA CATABOLIC PROCESS,0.049681,0.067117,0.16797,1,0
4,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.020828,0.066965,0.077729,1,0
4,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.03068,0.066662,0.13195,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.03068,0.066331,0.091322,1,0
4,GO MEMBRANE INVAGINATION,0.039795,0.066323,0.10345,1,0
4,GO REPRODUCTION,0.027973,0.06614,0.066976,1,0
4,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.022686,0.0658,0.12636,1,0
4,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.037509,0.065795,0.07587,1,0
4,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.031631,0.064732,0.08004,1,0
4,GO REGULATION OF CELL DEATH,0.02128,0.064728,0.076422,1,0
4,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.010279,0.064233,0.089338,1,0
4,GO ATP METABOLIC PROCESS,0.010522,0.063538,0.078369,1,0
4,GO LEUKOCYTE APOPTOTIC PROCESS,0.021509,0.063087,0.10691,1,0
4,GO DEPHOSPHORYLATION,0.01585,0.062276,0.072479,1,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.055609,0.061404,0.078532,1,0
4,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.01128,0.061333,0.084696,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.014494,0.060255,0.092401,1,0
4,GO ERAD PATHWAY,0.021509,0.059578,0.084295,1,0
4,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.031953,0.059551,0.08005,1,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.033948,0.059477,0.072678,1,0
4,GO NEGATIVE REGULATION OF CELL DEATH,0.054074,0.059333,0.065378,1,0
4,GO UBIQUITIN DEPENDENT ERAD PATHWAY,0.009139,0.058471,0.10136,1,0
4,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.049681,0.058142,0.076653,1,0
4,GO ORGANIC ACID METABOLIC PROCESS,0.002631,0.056771,0.097893,1,0
4,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.047372,0.055597,0.070133,1,0
4,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.043444,0.055432,0.092457,1,0
4,GO RESPONSE TO CHEMOKINE,0.027118,0.053627,0.068189,1,0
4,GO REGULATION OF MULTI ORGANISM PROCESS,0.041383,0.050664,0.082603,1,0
4,GO POSITIVE REGULATION OF NEURON DEATH,0.056652,0.050659,0.097803,1,0
4,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.048746,0.049347,0.075223,1,0
4,GO PROTEIN HOMOOLIGOMERIZATION,0.044722,0.048773,0.05972,1,0
4,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.03902,0.047829,0.098931,1,0
4,GO FERTILIZATION,0.037509,0.046771,0.059286,1,0
4,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.045591,0.045697,0.076964,1,0
4,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.059331,0.045291,0.072607,1,0
4,GO RESPONSE TO TEMPERATURE STIMULUS,0.02915,0.044772,0.076647,1,0
4,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.049212,0.043639,0.069857,1,0
4,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.027686,0.043209,0.10394,1,0
4,GO NEGATIVE REGULATION OF TRANSPORT,0.043025,0.042762,0.06274,1,0
4,GO SEXUAL REPRODUCTION,0.059331,0.041678,0.05086,1,0
4,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.021509,0.040751,0.090155,1,0
4,GO CELLULAR MACROMOLECULE LOCALIZATION,0.052083,0.037678,0.048911,1,0
4,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,0.043866,0.034865,0.048529,1,0
4,GO DNA CATABOLIC PROCESS,0.022928,0.026307,0.078803,1,0
4,GO NUCLEAR EXPORT,0.027973,-0.035316,-0.05351,1,0
4,GO DNA METABOLIC PROCESS,0.052575,-0.038705,-0.029367,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.039795,-0.039059,-0.040304,1,0
4,GO LOCALIZATION WITHIN MEMBRANE,0.051111,-0.042974,-0.087146,1,0
4,GO REGULATION OF MRNA METABOLIC PROCESS,0.048746,-0.043344,-0.037891,1,0
4,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.047827,-0.043907,-0.092833,1,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.02915,-0.046435,-0.064477,1,0
4,GO REGULATION OF RNA SPLICING,0.040187,-0.048272,-0.047114,1,0
4,GO SISTER CHROMATID SEGREGATION,0.047827,-0.048319,-0.04337,1,0
4,GO MRNA METABOLIC PROCESS,0.011813,-0.049673,-0.060522,1,0
4,GO PEPTIDYL LYSINE DIMETHYLATION,0.045155,-0.050099,-0.073408,1,0
4,GO SNRNA TRANSCRIPTION,0.041383,-0.050846,-0.049498,1,0
4,GO CHROMATIN REMODELING,0.025475,-0.05099,-0.049234,1,0
4,GO DNA REPAIR,0.01829,-0.051254,-0.042428,1,0
4,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.055609,-0.051358,-0.073199,1,0
4,GO PEPTIDYL LYSINE TRIMETHYLATION,0.046474,-0.052042,-0.065257,1,0
4,GO PROTEIN NEDDYLATION,0.020385,-0.052639,-0.085808,1,0
4,GO BASE EXCISION REPAIR,0.01829,-0.053625,-0.061362,1,0
4,GO MRNA CLEAVAGE,0.032938,-0.053774,-0.061848,1,0
4,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.046921,-0.054544,-0.03678,1,0
4,GO DNA PACKAGING,0.053071,-0.055415,-0.044174,1,0
4,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.059331,-0.05596,-0.0588,1,0
4,GO NUCLEOSOME ORGANIZATION,0.051111,-0.056856,-0.057306,1,0
4,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.040981,-0.057994,-0.062063,1,0
4,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.033948,-0.058282,-0.059038,1,0
4,GO REGULATION OF GENE EXPRESSION EPIGENETIC,0.057711,-0.058321,-0.046405,1,0
4,GO RNA SURVEILLANCE,0.035336,-0.058503,-0.075307,1,0
4,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.0104,-0.059087,-0.073784,1,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.047827,-0.059498,-0.048076,1,0
4,GO RESPONSE TO UV,0.02174,-0.060297,-0.059821,1,0
4,GO MITOTIC SISTER CHROMATID SEGREGATION,0.037882,-0.060856,-0.048834,1,0
4,GO ESTABLISHMENT OF RNA LOCALIZATION,0.011022,-0.061499,-0.065471,1,0
4,GO NEGATIVE REGULATION OF DNA RECOMBINATION,0.017894,-0.062862,-0.082249,1,0
4,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,0.0065235,-0.063188,-0.069022,1,0
4,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.040187,-0.063256,-0.055904,1,0
4,GO CHROMOSOME SEGREGATION,0.019735,-0.064108,-0.051447,1,0
4,GO DNA CONFORMATION CHANGE,0.028556,-0.06554,-0.049631,1,0
4,GO DOUBLE STRAND BREAK REPAIR,0.0076401,-0.065771,-0.062525,1,0
4,GO RRNA METABOLIC PROCESS,0.041789,-0.066832,-0.079138,1,0
4,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.034984,-0.066862,-0.054378,1,0
4,GO NEGATIVE REGULATION OF DNA REPAIR,0.01849,-0.067353,-0.072007,1,0
4,GO MRNA PROCESSING,0.0039481,-0.06745,-0.071419,1,0
4,GO REGULATION OF CILIUM ASSEMBLY,0.042197,-0.06771,-0.08014,1,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.042197,-0.06787,-0.046803,1,0
4,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.041383,-0.068941,-0.058085,1,0
4,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.040582,-0.069083,-0.042223,1,0
4,GO CELL CYCLE G2 M PHASE TRANSITION,0.05357,-0.069268,-0.03735,1,0
4,GO REGULATION OF CHROMOSOME SEPARATION,0.013546,-0.069604,-0.078263,1,0
4,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.040187,-0.071099,-0.13978,1,0
4,GO DNA REPLICATION CHECKPOINT,0.027686,-0.071101,-0.093404,1,0
4,GO TELOMERE ORGANIZATION,0.0040509,-0.071235,-0.068295,1,0
4,GO REGULATION OF MICROTUBULE BASED MOVEMENT,0.058247,-0.071746,-0.068238,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.039795,-0.072255,-0.079284,1,0
4,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.033608,-0.072294,-0.054058,1,0
4,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.021053,-0.07246,-0.075301,1,0
4,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.036048,-0.072714,-0.045578,1,0
4,GO RNA SPLICING,0.0018006,-0.072773,-0.078954,1,0
4,GO REGULATION OF HISTONE PHOSPHORYLATION,0.047827,-0.072933,-0.080345,1,0
4,GO TRANSLATIONAL INITIATION,0.044722,-0.073105,-0.095136,1,0
4,GO PROTEIN SUMOYLATION,0.028852,-0.073197,-0.044393,1,0
4,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.046921,-0.073234,-0.055826,1,0
4,GO REGULATION OF POSTSYNAPSE ORGANIZATION,0.043444,-0.073707,-0.10576,1,0
4,GO TRANSCRIPTION BY RNA POLYMERASE III,0.012798,-0.074006,-0.06849,1,0
4,GO NCRNA PROCESSING,0.022928,-0.074116,-0.087889,1,0
4,GO TRNA PROCESSING,0.016205,-0.074444,-0.091685,1,0
4,GO REGULATION OF DNA RECOMBINATION,0.054074,-0.07486,-0.051807,1,0
4,GO NEGATIVE REGULATION OF AXONOGENESIS,0.052575,-0.074864,-0.12044,1,0
4,GO RNA LOCALIZATION,0.0023637,-0.074866,-0.081926,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.002631,-0.075087,-0.07682,1,0
4,GO NCRNA TRANSCRIPTION,0.0061347,-0.075172,-0.066526,1,0
4,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.045155,-0.075228,-0.13788,1,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.0034243,-0.075813,-0.095094,1,0
4,GO RNA STABILIZATION,0.02915,-0.076974,-0.056597,1,0
4,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.009139,-0.077015,-0.070049,1,0
4,GO HISTONE H3 K9 ACETYLATION,0.01585,-0.077538,-0.094782,1,0
4,GO LIVER REGENERATION,0.035691,-0.07811,-0.08508,1,0
4,GO POSITIVE REGULATION OF DNA REPAIR,0.0032928,-0.078157,-0.076558,1,0
4,GO NEURAL TUBE PATTERNING,0.02128,-0.078211,-0.10914,1,0
4,GO DNA GEOMETRIC CHANGE,0.014332,-0.079123,-0.070105,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.027401,-0.07927,-0.11393,1,0
4,GO RNA 3 END PROCESSING,0.014332,-0.079852,-0.065508,1,0
4,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.012227,-0.079863,-0.073264,1,0
4,GO RNA PROCESSING,0.0066851,-0.080102,-0.070854,1,0
4,GO MATURATION OF 5 8S RRNA,0.041383,-0.080348,-0.10779,1,0
4,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.037139,-0.080816,-0.1175,1,0
4,GO REGULATION OF DNA METABOLIC PROCESS,0.0049019,-0.081489,-0.050069,1,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.019523,-0.081583,-0.075635,1,0
4,GO DNA REPLICATION,0.0073682,-0.081704,-0.060191,1,0
4,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,0.014658,-0.082201,-0.060423,1,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.032607,-0.082501,-0.074086,1,0
4,GO CHROMOSOME SEPARATION,0.0074579,-0.083224,-0.080623,1,0
4,GO RETROGRADE AXONAL TRANSPORT,0.044722,-0.083444,-0.11508,1,0
4,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.0104,-0.08353,-0.078875,1,0
4,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0017277,-0.083614,-0.07791,1,0
4,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.048285,-0.084207,-0.099242,1,0
4,GO CELL CYCLE DNA REPLICATION,0.0033799,-0.084251,-0.090203,1,0
4,GO MRNA EXPORT FROM NUCLEUS,0.0023009,-0.084381,-0.084426,1,0
4,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.055609,-0.084559,-0.086795,1,0
4,GO REGULATION OF LYASE ACTIVITY,0.043866,-0.085629,-0.080635,1,0
4,GO MRNA TRANSPORT,0.0060595,-0.085772,-0.073575,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.0046018,-0.086249,-0.071215,1,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.03068,-0.086255,-0.072005,1,0
4,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.056128,-0.08635,-0.046749,1,0
4,GO MRNA 3 END PROCESSING,0.0054872,-0.08661,-0.078419,1,0
4,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.0080166,-0.086807,-0.090819,1,0
4,GO MITOCHONDRION LOCALIZATION,0.017894,-0.087811,-0.065877,1,0
4,GO MITOTIC G2 M TRANSITION CHECKPOINT,0.044292,-0.087886,-0.069904,1,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.014823,-0.087952,-0.087231,1,0
4,GO CELLULAR RESPONSE TO LIGHT STIMULUS,0.0104,-0.088641,-0.064499,1,0
4,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.059879,-0.088662,-0.082536,1,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0030839,-0.088787,-0.1027,1,0
4,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.014332,-0.089001,-0.060545,1,0
4,GO RIBOSOME BIOGENESIS,0.027401,-0.089164,-0.096628,1,0
4,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,0.041789,-0.08938,-0.10797,1,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.040187,-0.089829,-0.12672,1,0
4,GO CELLULAR RESPONSE TO UV,0.003607,-0.090253,-0.088129,1,0
4,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.0015249,-0.090735,-0.10642,1,0
4,GO CENTRIOLE ASSEMBLY,0.022446,-0.091447,-0.074146,1,0
4,GO RNA EXPORT FROM NUCLEUS,0.003654,-0.091911,-0.086235,1,0
4,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.001568,-0.092137,-0.10319,1,0
4,GO ADULT HEART DEVELOPMENT,0.027686,-0.092347,-0.15533,1,0
4,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0018256,-0.093048,-0.083087,1,0
4,GO DNA STRAND ELONGATION,0.031953,-0.093146,-0.07455,1,0
4,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.00036686,-0.093776,-0.098623,1,0
4,GO RRNA TRANSCRIPTION,0.0083098,-0.094024,-0.11078,1,0
4,GO DNA RECOMBINATION,0.0071051,-0.094845,-0.056082,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.0055559,-0.094994,-0.10776,1,0
4,GO CYTOPLASMIC TRANSLATION,0.01499,-0.095163,-0.11632,1,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0037498,-0.095166,-0.096497,1,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.01995,-0.096028,-0.14255,1,0
4,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,0.056652,-0.096162,-0.14247,1,0
4,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.0031247,-0.096239,-0.09896,1,0
4,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0075485,-0.096331,-0.090643,1,0
4,GO NEGATIVE REGULATION OF DNA BINDING,0.032607,-0.096693,-0.071283,1,0
4,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.016938,-0.096947,-0.079594,1,0
4,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.024428,-0.096967,-0.1159,1,0
4,GO RECOMBINATIONAL REPAIR,0.0020646,-0.09716,-0.087297,1,0
4,GO DENDRITIC SPINE DEVELOPMENT,0.056128,-0.097305,-0.093009,1,0
4,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.016386,-0.09741,-0.10271,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.046474,-0.098705,-0.1097,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.025743,-0.098845,-0.061293,1,0
4,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.0063654,-0.098868,-0.071212,1,0
4,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.055609,-0.099163,-0.1203,1,0
4,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.0073682,-0.099208,-0.1205,1,0
4,GO LYMPHANGIOGENESIS,0.011544,-0.099314,-0.14665,1,0
4,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.043444,-0.099988,-0.089457,1,0
4,GO G0 TO G1 TRANSITION,0.010769,-0.10001,-0.08829,1,0
4,GO NEURON PROJECTION ORGANIZATION,0.059879,-0.10042,-0.094828,1,0
4,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.017125,-0.10052,-0.14101,1,0
4,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.034984,-0.10055,-0.18858,1,0
4,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.042197,-0.10084,-0.091708,1,0
4,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0048405,-0.10086,-0.093912,1,0
4,GO ERYTHROCYTE MATURATION,0.041789,-0.10137,-0.10867,1,0
4,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.053071,-0.10147,-0.10587,1,0
4,GO REGULATION OF NEURON PROJECTION REGENERATION,0.045591,-0.10148,-0.10774,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.011544,-0.10216,-0.12622,1,0
4,GO SULFATION,0.040981,-0.10274,-0.10472,1,0
4,GO INTERSTRAND CROSS LINK REPAIR,0.0011503,-0.10277,-0.088553,1,0
4,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.0066039,-0.1028,-0.071623,1,0
4,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0037016,-0.10329,-0.1462,1,0
4,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00044781,-0.10329,-0.092396,1,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.00040857,-0.1039,-0.10456,1,0
4,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.033608,-0.10401,-0.081279,1,0
4,GO REGULATION OF DNA REPAIR,0.001235,-0.10435,-0.078548,1,0
4,GO MESODERMAL CELL DIFFERENTIATION,0.055093,-0.10442,-0.083172,1,0
4,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.02174,-0.1048,-0.14381,1,0
4,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.013093,-0.10485,-0.094533,1,0
4,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.026013,-0.10486,-0.14295,1,0
4,GO TETRAHYDROFOLATE INTERCONVERSION,0.058247,-0.10489,-0.13857,1,0
4,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.049212,-0.1052,-0.086013,1,0
4,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.031311,-0.10539,-0.13416,1,0
4,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.0084096,-0.10559,-0.13051,1,0
4,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.054074,-0.1057,-0.078733,1,0
4,GO BONE MORPHOGENESIS,0.023668,-0.10602,-0.10421,1,0
4,GO BRAIN MORPHOGENESIS,0.02128,-0.10622,-0.1111,1,0
4,GO NEGATIVE REGULATION OF RNA SPLICING,0.031631,-0.10669,-0.057097,1,0
4,GO NEURAL CREST CELL MIGRATION,0.023668,-0.1067,-0.12219,1,0
4,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.02945,-0.10676,-0.089573,1,0
4,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0022396,-0.10698,-0.11864,1,0
4,GO TRNA METHYLATION,0.02915,-0.10716,-0.091885,1,0
4,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.02915,-0.10718,-0.088898,1,0
4,GO HISTONE MRNA METABOLIC PROCESS,0.0010113,-0.10727,-0.09986,1,0
4,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.014494,-0.10754,-0.10398,1,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.042609,-0.10853,-0.17555,1,0
4,GO REGULATION OF MESODERM DEVELOPMENT,0.043866,-0.10862,-0.095295,1,0
4,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,0.016027,-0.10867,-0.097546,1,0
4,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.028556,-0.10867,-0.11504,1,0
4,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,0.037509,-0.10868,-0.11814,1,0
4,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.026561,-0.10896,-0.11437,1,0
4,GO CHROMOSOME CONDENSATION,0.019312,-0.10899,-0.081821,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.015329,-0.10904,-0.1076,1,0
4,GO CHROMATIN REMODELING AT CENTROMERE,0.008211,-0.10916,-0.11702,1,0
4,GO NCRNA EXPORT FROM NUCLEUS,0.011151,-0.10961,-0.098902,1,0
4,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.0071918,-0.10985,-0.12765,1,0
4,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0024281,-0.11017,-0.082664,1,0
4,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0043737,-0.11021,-0.10138,1,0
4,GO TRNA WOBBLE URIDINE MODIFICATION,0.0005789,-0.11053,-0.13896,1,0
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.049681,-0.11105,-0.083096,1,0
4,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.0088198,-0.1111,-0.077249,1,0
4,GO STRESS GRANULE ASSEMBLY,0.0025961,-0.11111,-0.11679,1,0
4,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.00028155,-0.11153,-0.11939,1,0
4,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.0062108,-0.11304,-0.11213,1,0
4,GO TRNA TRANSPORT,0.0059116,-0.11362,-0.10148,1,0
4,GO REGULATION OF MRNA PROCESSING,0.001118,-0.1138,-0.092722,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.019104,-0.11405,-0.11447,1,0
4,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,0.019523,-0.11425,-0.11172,1,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0044298,-0.11465,-0.11933,1,0
4,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0024941,-0.11471,-0.094816,1,0
4,GO RRNA MODIFICATION,0.037509,-0.11472,-0.091569,1,0
4,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00064263,-0.11493,-0.087606,1,0
4,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,0.01585,-0.11517,-0.1017,1,0
4,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.016205,-0.11548,-0.1198,1,0
4,GO HISTONE H3 K9 DEMETHYLATION,0.013856,-0.11558,-0.14687,1,0
4,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.031953,-0.11573,-0.10419,1,0
4,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0021798,-0.11611,-0.10665,1,0
4,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.0035605,-0.11627,-0.14152,1,0
4,GO NON MOTILE CILIUM ASSEMBLY,0.02174,-0.11639,-0.10132,1,0
4,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0066851,-0.11658,-0.092183,1,0
4,GO REGULATION OF TELOMERE MAINTENANCE,0.00094089,-0.11673,-0.094416,1,0
4,GO COCHLEA MORPHOGENESIS,0.044722,-0.11714,-0.11241,1,0
4,GO MITOTIC RECOMBINATION,0.029754,-0.11736,-0.097847,1,0
4,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.044292,-0.11743,-0.077333,1,0
4,GO REGULATION OF CYCLASE ACTIVITY,0.01499,-0.1175,-0.11592,1,0
4,GO NEPHRON TUBULE FORMATION,0.05063,-0.11774,-0.16209,1,0
4,GO MESODERMAL CELL FATE SPECIFICATION,0.023668,-0.11778,-0.12779,1,0
4,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.012798,-0.11802,-0.10208,1,0
4,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.034636,-0.11832,-0.11574,1,0
4,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.0057669,-0.1184,-0.076477,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.030994,-0.11889,-0.10155,1,0
4,GO REGULATION OF NEURON MIGRATION,0.012087,-0.11908,-0.15954,1,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0046604,-0.11983,-0.097642,1,0
4,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.032938,-0.12068,-0.099056,1,0
4,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0030839,-0.12148,-0.084958,1,0
4,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.017315,-0.12172,-0.13542,1,0
4,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.0092477,-0.1224,-0.1023,1,0
4,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.024687,-0.12244,-0.082527,1,0
4,GO MICROTUBULE SEVERING,0.043025,-0.12311,-0.10461,1,0
4,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.034636,-0.12326,-0.12201,1,0
4,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.040187,-0.12377,-0.084019,1,0
4,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.01829,-0.12383,-0.14291,1,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.0033799,-0.12393,-0.1206,1,0
4,GO MITOTIC CHROMOSOME CONDENSATION,0.01585,-0.12417,-0.1105,1,0
4,GO MEMBRANE DISASSEMBLY,0.033608,-0.12446,-0.10694,1,0
4,GO TRNA MODIFICATION,0.0074579,-0.1245,-0.10914,1,0
4,GO CENTROMERE COMPLEX ASSEMBLY,0.02174,-0.12463,-0.10384,1,0
4,GO MATURATION OF SSU RRNA,0.010895,-0.12612,-0.1344,1,0
4,GO INTRACELLULAR MRNA LOCALIZATION,0.024687,-0.12681,-0.10473,1,0
4,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.0045438,-0.12764,-0.17012,1,0
4,GO EMBRYONIC EYE MORPHOGENESIS,0.036772,-0.12766,-0.12218,1,0
4,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.0052197,-0.12868,-0.0992,1,0
4,GO DNA DEPENDENT DNA REPLICATION,0.00015331,-0.12883,-0.10518,1,0
4,GO REGULATION OF TELOMERASE ACTIVITY,0.026838,-0.12981,-0.074382,1,0
4,GO PROTEIN LOCALIZATION TO CILIUM,0.0070192,-0.13003,-0.11853,1,0
4,GO DNA DOUBLE STRAND BREAK PROCESSING,0.023173,-0.1306,-0.092256,1,0
4,GO POSITIVE REGULATION OF ORGAN GROWTH,0.019735,-0.13064,-0.098372,1,0
4,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.0019819,-0.13137,-0.12648,1,0
4,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0011503,-0.13151,-0.10313,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.0096941,-0.13206,-0.13348,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.00090088,-0.1322,-0.15575,1,0
4,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0030839,-0.13343,-0.10812,1,0
4,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.040981,-0.13533,-0.12981,1,0
4,GO EMBRYONIC FORELIMB MORPHOGENESIS,0.012798,-0.13538,-0.15528,1,0
4,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.00036686,-0.1355,-0.1155,1,0
4,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0065235,-0.13562,-0.11848,1,0
4,GO REPLICATION FORK PROCESSING,0.00014599,-0.136,-0.16619,1,0
4,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.011949,-0.13678,-0.10186,1,0
4,GO MITOTIC SISTER CHROMATID COHESION,0.033271,-0.13725,-0.10239,1,0
4,GO CELLULAR HYPEROSMOTIC RESPONSE,0.045591,-0.13759,-0.1118,1,0
4,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.00030928,-0.1377,-0.12268,1,0
4,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.018898,-0.13771,-0.13082,1,0
4,GO CELLULAR RESPONSE TO X RAY,0.0032501,-0.13772,-0.14897,1,0
4,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0054872,-0.1384,-0.11451,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.000286,-0.13855,-0.14349,1,0
4,GO HINDLIMB MORPHOGENESIS,0.055609,-0.13924,-0.10251,1,0
4,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.053071,-0.13932,-0.11266,1,0
4,GO MRNA METHYLATION,0.0066039,-0.13958,-0.11463,1,0
4,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.00045468,-0.13971,-0.15594,1,0
4,GO DENDRITIC SPINE MORPHOGENESIS,0.011411,-0.14025,-0.15723,1,0
4,GO DNA REPLICATION INITIATION,9.4959e-05,-0.14028,-0.14391,1,0
4,GO HISTONE DEUBIQUITINATION,0.015329,-0.14029,-0.073373,1,0
4,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,0.0022095,-0.14074,-0.2464,1,0
4,GO HYPEROSMOTIC SALINITY RESPONSE,0.0038977,-0.14079,-0.18405,1,0
4,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.019735,-0.14142,-0.11153,1,0
4,GO REGULATION OF HIPPO SIGNALING,0.045155,-0.14159,-0.12117,1,0
4,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,0.031311,-0.14241,-0.12837,1,0
4,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.029754,-0.14355,-0.15369,1,0
4,GO REGULATION OF RIBOSOME BIOGENESIS,0.024428,-0.14377,-0.12564,1,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.052083,-0.1448,-0.13614,1,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0085105,-0.14483,-0.17233,1,0
4,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,8.7502e-06,-0.14496,-0.12325,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0016347,-0.14518,-0.12073,1,0
4,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.0092477,-0.1457,-0.10007,1,0
4,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.059331,-0.14642,-0.11711,1,0
4,GO REGULATION OF SPINDLE CHECKPOINT,0.0013255,-0.1466,-0.14968,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,0.00036686,-0.14789,-0.11836,1,0
4,GO CARDIOBLAST DIFFERENTIATION,0.011678,-0.14813,-0.16134,1,0
4,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.047372,-0.1514,-0.11852,1,0
4,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.02915,-0.15141,-0.12673,1,0
4,GO PROTEIN LOCALIZATION TO CHROMOSOME,9.819e-05,-0.15291,-0.11783,1,0
4,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.0093576,-0.15308,-0.14338,1,0
4,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00084997,-0.15373,-0.11836,1,0
4,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.00036124,-0.1539,-0.13773,1,0
4,GO MATURATION OF LSU RRNA,0.016752,-0.15499,-0.15192,1,0
4,GO DNA LIGATION,0.016386,-0.15513,-0.10926,1,0
4,GO HIPPO SIGNALING,0.015674,-0.15569,-0.15184,1,0
4,GO CELLULAR RESPONSE TO SALT STRESS,0.0047198,-0.15586,-0.20686,1,0
4,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.0083098,-0.15761,-0.1213,1,0
4,GO TONGUE DEVELOPMENT,0.0062877,-0.15764,-0.19875,1,0
4,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.00092737,-0.158,-0.15166,1,0
4,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.012087,-0.15822,-0.14162,1,0
4,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.019104,-0.15856,-0.15634,1,0
4,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.011022,-0.15872,-0.15413,1,0
4,GO POSITIVE REGULATION OF NEURON MIGRATION,0.016752,-0.15879,-0.18118,1,0
4,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,1.0557e-05,-0.16009,-0.1685,1,0
4,GO MRNA MODIFICATION,0.0054872,-0.16052,-0.12782,1,0
4,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.01128,-0.16086,-0.22709,1,0
4,GO MRNA SPLICE SITE SELECTION,0.00072342,-0.16104,-0.1651,1,0
4,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.012087,-0.16164,-0.26165,1,0
4,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.0073682,-0.1625,-0.14211,1,0
4,GO RESPONSE TO PARATHYROID HORMONE,0.0069343,-0.16254,-0.16066,1,0
4,GO RESPONSE TO L GLUTAMATE,0.040981,-0.16392,-0.15254,1,0
4,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00075607,-0.16395,-0.18521,1,0
4,GO SPLICEOSOMAL SNRNP ASSEMBLY,1.0756e-05,-0.16467,-0.1559,1,0
4,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.02521,-0.16485,-0.20403,1,0
4,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,0.00030928,-0.16556,-0.20013,1,0
4,GO TELOMERASE RNA LOCALIZATION,0.0019819,-0.16704,-0.17294,1,0
4,GO TRACHEA DEVELOPMENT,0.0043184,-0.16707,-0.18614,1,0
4,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,2.4528e-05,-0.16766,-0.21346,1,0
4,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,0.00025215,-0.16791,-0.20787,1,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.05063,-0.16819,-0.13764,1,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.045155,-0.16884,-0.18538,1,0
4,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0092477,-0.16914,-0.17808,1,0
4,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0071918,-0.1703,-0.15849,1,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.0042095,-0.17241,-0.1786,1,0
4,GO TELENCEPHALON GLIAL CELL MIGRATION,0.026561,-0.17422,-0.12117,1,0
4,GO COMMISSURAL NEURON AXON GUIDANCE,0.0030839,-0.17463,-0.25138,1,0
4,GO TRNA WOBBLE BASE MODIFICATION,0.00033955,-0.17757,-0.15196,1,0
4,GO PROTEIN DEMETHYLATION,0.014658,-0.17811,-0.11523,1,0
4,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.0057669,-0.17911,-0.13775,1,0
4,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.043025,-0.17926,-0.16892,1,0
4,GO VIRAL TRANSLATION,0.0058389,-0.17983,-0.16276,1,0
4,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.043866,-0.17995,-0.11341,1,0
4,GO MYOBLAST MIGRATION,0.013394,-0.18053,-0.2316,1,0
4,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.014658,-0.18087,-0.14623,1,0
4,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.0023321,-0.18157,-0.12745,1,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,8.2686e-06,-0.18166,-0.18508,1,0
4,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.006444,-0.18198,-0.22016,1,0
4,GO MUSCLE CELL FATE COMMITMENT,0.016027,-0.18309,-0.14833,1,0
4,GO CELL PROLIFERATION IN FOREBRAIN,0.0019285,-0.18314,-0.18798,1,0
4,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.004156,-0.18358,-0.19297,1,0
4,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.025475,-0.18379,-0.1425,1,0
4,GO RESPONSE TO ELECTRICAL STIMULUS,0.0038977,-0.18485,-0.17193,1,0
4,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.014172,-0.18566,-0.1768,1,0
4,GO LONG TERM SYNAPTIC DEPRESSION,0.007921,-0.18873,-0.16732,1,0
4,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,0.013546,-0.18895,-0.23438,1,0
4,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,1.9393e-05,-0.18905,-0.18756,1,0
4,GO EMBRYONIC BRAIN DEVELOPMENT,1.1806e-05,-0.18912,-0.23031,1,0
4,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00042777,-0.18928,-0.21942,1,0
4,GO SPERMATID NUCLEUS DIFFERENTIATION,0.0013069,-0.18997,-0.15694,1,0
4,GO CHROMATIN DISASSEMBLY,9.3381e-05,-0.19046,-0.19863,1,0
4,GO PROSTATE GLAND GROWTH,0.0025617,-0.19152,-0.23106,1,0
4,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.0020646,-0.19265,-0.21152,1,0
4,GO RETINAL ROD CELL DIFFERENTIATION,0.02521,-0.19291,-0.1807,1,0
4,GO NEUROBLAST DIVISION,0.056128,-0.1938,-0.13436,1,0
4,GO UV PROTECTION,0.0063654,-0.19473,-0.1724,1,0
4,GO HEART VALVE FORMATION,0.032607,-0.19542,-0.17577,1,0
4,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.010895,-0.1961,-0.13764,1,0
4,GO CELL PROLIFERATION IN HINDBRAIN,0.0014624,-0.19699,-0.20309,1,0
4,GO GTP METABOLIC PROCESS,0.0007786,-0.19746,-0.18058,1,0
4,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.019312,-0.19766,-0.13428,1,0
4,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0011021,-0.19842,-0.18195,1,0
4,GO EXCITATORY SYNAPSE ASSEMBLY,0.0032928,-0.19887,-0.2387,1,0
4,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00049802,-0.2003,-0.18398,1,0
4,GO LATERAL VENTRICLE DEVELOPMENT,0.0019023,-0.20041,-0.25104,1,0
4,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,0.00065224,-0.20158,-0.21301,1,0
4,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.00068191,-0.20252,-0.22118,1,0
4,GO DENDRITE SELF AVOIDANCE,0.0047198,-0.2027,-0.18835,1,0
4,GO V D J RECOMBINATION,0.0027381,-0.20399,-0.18685,1,0
4,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,6.7724e-05,-0.20475,-0.18045,1,0
4,GO MYOBLAST PROLIFERATION,6.3249e-05,-0.206,-0.23391,1,0
4,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,2.9859e-05,-0.20619,-0.21353,1,0
4,GO NEURAL CREST FORMATION,0.013394,-0.20629,-0.17814,1,0
4,GO REGULATION OF NEUROBLAST PROLIFERATION,0.0025277,-0.20773,-0.18407,1,0
4,GO POSTSYNAPSE ASSEMBLY,0.026286,-0.20908,-0.21861,1,0
4,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.042609,-0.21085,-0.14176,1,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.042609,-0.21093,-0.15751,1,0
4,GO SYNAPTIC VESICLE CLUSTERING,0.054074,-0.21112,-0.18943,1,0
4,GO SPINDLE MIDZONE ASSEMBLY,0.0007901,-0.21261,-0.17708,1,0
4,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.0071918,-0.2145,-0.17034,1,0
4,GO LIMB BUD FORMATION,0.026286,-0.21564,-0.21207,1,0
4,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.00038422,-0.21676,-0.1726,1,0
4,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,9.3381e-05,-0.21939,-0.21295,1,0
4,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,8.8796e-05,-0.21969,-0.19018,1,0
4,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.013243,-0.21996,-0.21419,1,0
4,GO BONE GROWTH,0.0076401,-0.22168,-0.16245,1,0
4,GO NUCLEAR PORE ORGANIZATION,0.0017517,-0.22222,-0.16311,1,0
4,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.034636,-0.22459,-0.17401,1,0
4,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00038422,-0.22771,-0.24686,1,0
4,GO DORSAL VENTRAL AXIS SPECIFICATION,0.0046018,-0.23027,-0.20154,1,0
4,GO PHAGOCYTOSIS RECOGNITION,0.0020929,-0.23058,-0.19744,1,0
4,GO CHONDROCYTE PROLIFERATION,0.010522,-0.23078,-0.1765,1,0
4,GO NEGATIVE REGULATION OF LYASE ACTIVITY,0.00036686,-0.23258,-0.25907,1,0
4,GO CENTRIOLE CENTRIOLE COHESION,0.00032916,-0.23291,-0.20461,1,0
4,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,0.008211,-0.23872,-0.14306,1,0
4,GO CORPUS CALLOSUM DEVELOPMENT,0.00086244,-0.24197,-0.22503,1,0
4,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.0035605,-0.24406,-0.19561,1,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.011678,-0.24555,-0.17031,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,0.0041031,-0.25056,-0.2868,1,0
4,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.009139,-0.25188,-0.26276,1,0
4,GO LATERAL MESODERM DEVELOPMENT,0.00026858,-0.25287,-0.26432,1,0
4,GO PROTEIN DNA COMPLEX DISASSEMBLY,1.6761e-05,-0.25478,-0.24738,1,0
4,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.0011668,-0.2603,-0.286,1,0
4,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.7534e-07,-0.26174,-0.22186,1,0
4,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,0.0010259,-0.26753,-0.22289,1,0
4,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,0.00036124,-0.27171,-0.2112,1,0
4,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.00039018,-0.2742,-0.25229,1,0
4,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.0007901,-0.27879,-0.24916,1,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00022927,-0.2791,-0.29565,1,0
4,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,0.0010113,-0.27989,-0.23423,1,0
4,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,4.0314e-05,-0.28059,-0.22237,1,0
4,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00010673,-0.28524,-0.30437,1,0
4,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.032278,-0.28551,-0.18917,1,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,5.2344e-05,-0.28684,-0.27172,1,0
4,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.0014022,-0.29503,-0.29163,1,0
4,GO TELENCEPHALON REGIONALIZATION,0.0087156,-0.29917,-0.22194,1,0
4,GO GROWTH PLATE CARTILAGE DEVELOPMENT,3.1494e-05,-0.30384,-0.25894,1,0
4,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.0018256,-0.31711,-0.28141,1,0
4,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00088789,-0.33122,-0.27208,1,0
4,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.0025961,-0.33175,-0.27404,1,0
4,GO CARDIAC CHAMBER FORMATION,4.1751e-05,-0.39052,-0.35875,1,0
4,GO CARDIAC VENTRICLE FORMATION,7.2497e-05,-0.3929,-0.37296,1,0
4,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,6.545e-05,-0.4038,-0.39629,1,0
4,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.0039992,-0.40432,-0.36641,1,0
4,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.00019541,-0.40589,-0.35842,1,0
4,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00072342,-0.41902,-0.40796,1,0
4,GO DETOXIFICATION OF INORGANIC COMPOUND,0.066192,0.34767,0.43265,0,1
4,GO MECHANOSENSORY BEHAVIOR,0.1252,0.27456,0.17578,0,1
4,GO HEMIDESMOSOME ASSEMBLY,0.17029,0.25511,0.092113,0,1
4,GO REGULATION OF GLOMERULAR FILTRATION,0.09714,0.23699,0.17687,0,1
4,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.062114,0.23554,0.19616,0,1
4,GO XENOBIOTIC CATABOLIC PROCESS,0.19278,0.22847,0.14237,0,1
4,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.090782,0.2091,0.15126,0,1
4,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.1453,0.20744,0.14039,0,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.10214,0.18847,0.080515,0,1
4,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.071119,0.18127,0.10107,0,1
4,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.090782,0.17726,0.15183,0,1
4,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.12126,0.16911,0.11388,0,1
4,GO POSITIVE REGULATION OF CHROMATIN BINDING,0.16042,0.16587,0.081328,0,1
4,GO OUTER DYNEIN ARM ASSEMBLY,0.073043,0.16266,0.094813,0,1
4,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.066192,0.16216,0.10261,0,1
4,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.066792,0.16215,0.13175,0,1
4,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.09796,0.16088,0.12218,0,1
4,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.081877,0.16005,0.12963,0,1
4,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.090782,0.15939,0.11246,0,1
4,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.12029,0.15909,0.12313,0,1
4,GO INTERLEUKIN 13 PRODUCTION,0.19697,0.15676,0.11188,0,1
4,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.19838,0.15551,0.079462,0,1
4,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.080464,0.1555,0.15521,0,1
4,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.10823,0.15215,0.075497,0,1
4,GO PHOSPHOLIPID HOMEOSTASIS,0.23927,0.15115,0.074888,0,1
4,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.10471,0.14948,0.06743,0,1
4,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.063258,0.14776,0.12098,0,1
4,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.070488,0.14577,0.11643,0,1
4,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.10385,0.14575,0.094568,0,1
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.095518,0.1438,0.10254,0,1
4,GO FEMALE GENITALIA DEVELOPMENT,0.20992,0.14272,0.058621,0,1
4,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.11367,0.14239,0.095294,0,1
4,GO EPIDERMIS MORPHOGENESIS,0.068619,0.14181,0.10206,0,1
4,GO PARENTAL BEHAVIOR,0.072397,0.1417,0.13388,0,1
4,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.070488,0.14135,0.082315,0,1
4,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.079765,0.1413,0.092061,0,1
4,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.10299,0.14052,0.098842,0,1
4,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.26614,0.13913,0.077897,0,1
4,GO NUCLEOTIDE SALVAGE,0.11367,0.13752,0.09658,0,1
4,GO C21 STEROID HORMONE METABOLIC PROCESS,0.10558,0.13719,0.13598,0,1
4,GO PROTEIN ADP RIBOSYLATION,0.062114,0.13528,0.099799,0,1
4,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.068006,0.13492,0.116,0,1
4,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.071119,0.13342,0.13128,0,1
4,GO RESPONSE TO AMINE,0.11002,0.13258,0.078473,0,1
4,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.063258,0.13247,0.12192,0,1
4,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.069238,0.13142,0.11018,0,1
4,GO SEQUESTERING OF TRIGLYCERIDE,0.08331,0.13123,0.11415,0,1
4,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.067397,0.13116,0.10837,0,1
4,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.063836,0.13073,0.089959,0,1
4,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.20699,0.13011,0.07214,0,1
4,GO PARAXIAL MESODERM DEVELOPMENT,0.095518,0.12934,0.10578,0,1
4,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.11742,0.12807,0.079554,0,1
4,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.087731,0.12467,0.096207,0,1
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.38047,0.12442,0.037661,0,1
4,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.068006,0.12401,0.11442,0,1
4,GO ALDEHYDE CATABOLIC PROCESS,0.16163,0.12242,0.053868,0,1
4,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.073694,0.12128,0.081422,0,1
4,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.085497,0.1211,0.11693,0,1
4,GO PIGMENT ACCUMULATION,0.11553,0.1208,0.10493,0,1
4,GO T CELL CYTOKINE PRODUCTION,0.071119,0.12043,0.086561,0,1
4,GO OSTEOCLAST DEVELOPMENT,0.20992,0.11907,0.071664,0,1
4,GO PLACENTA DEVELOPMENT,0.11002,0.11906,0.077568,0,1
4,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.092339,0.11836,0.117,0,1
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.065005,0.11818,0.10527,0,1
4,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.085497,0.11772,0.086108,0,1
4,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.060432,0.11429,0.10687,0,1
4,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.084763,0.11353,0.11728,0,1
4,GO PROTEIN PALMITOYLATION,0.063258,0.11283,0.095633,0,1
4,GO EXOCRINE SYSTEM DEVELOPMENT,0.14642,0.10856,0.10061,0,1
4,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.12721,0.10688,0.084322,0,1
4,GO LOCOMOTORY BEHAVIOR,0.10045,0.10652,0.089392,0,1
4,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.12322,0.10647,0.071638,0,1
4,GO SKIN EPIDERMIS DEVELOPMENT,0.08331,0.10418,0.074759,0,1
4,GO REGULATION OF FATTY ACID BETA OXIDATION,0.073043,0.10414,0.10036,0,1
4,GO ACTIN FILAMENT BASED PROCESS,0.079765,0.10392,0.075591,0,1
4,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.10646,0.10374,0.074706,0,1
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.67501,0.10364,0.043382,0,1
4,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.070488,0.10361,0.092168,0,1
4,GO VENTRICULAR SEPTUM DEVELOPMENT,0.15565,0.10358,0.077397,0,1
4,GO SCHWANN CELL DEVELOPMENT,0.10823,0.10204,0.077114,0,1
4,GO REGULATION OF PROTON TRANSPORT,0.18327,0.10193,0.084577,0,1
4,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.22503,0.10025,0.077377,0,1
4,GO NEUROINFLAMMATORY RESPONSE,0.10385,0.10014,0.066905,0,1
4,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.060988,0.099987,0.082768,0,1
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.14197,0.098734,0.048829,0,1
4,GO EMBRYONIC BODY MORPHOGENESIS,0.1653,0.097544,0.072095,0,1
4,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.2114,0.097292,0.11398,0,1
4,GO VAGINA DEVELOPMENT,0.19838,0.097095,0.06426,0,1
4,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.14642,0.096638,0.11901,0,1
4,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.19417,0.09654,0.048724,0,1
4,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.073694,0.095524,0.11993,0,1
4,GO REGULATION OF GTP BINDING,0.42133,0.09289,0.044196,0,1
4,GO RECEPTOR BIOSYNTHETIC PROCESS,0.095518,0.092487,0.078006,0,1
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.090782,0.091733,0.095372,0,1
4,GO REGULATION OF SYNAPSE ASSEMBLY,0.58864,0.091308,0.024015,0,1
4,GO INTERMEDIATE FILAMENT ORGANIZATION,0.065596,0.090725,0.090007,0,1
4,GO MORPHOGENESIS OF AN EPITHELIUM,0.11183,0.090412,0.058349,0,1
4,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.066192,0.09029,0.10194,0,1
4,GO EMBRYO IMPLANTATION,0.41899,0.090151,0.050148,0,1
4,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.091558,0.088123,0.09634,0,1
4,GO PSEUDOPODIUM ORGANIZATION,0.34213,0.088047,0.068641,0,1
4,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.10045,0.087853,0.075472,0,1
4,GO CELL RECOGNITION,0.32592,0.087136,0.036003,0,1
4,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,0.11933,0.087119,0.054412,0,1
4,GO LAMELLIPODIUM ORGANIZATION,0.18327,0.086137,0.066792,0,1
4,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,0.1262,0.085851,0.070492,0,1
4,GO REGULATION OF CIRCADIAN RHYTHM,0.073043,0.084971,0.065348,0,1
4,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.12822,0.08441,0.0663,0,1
4,GO TERPENOID BIOSYNTHETIC PROCESS,0.11275,0.084335,0.12437,0,1
4,GO POSITIVE REGULATION OF CYTOKINESIS,0.077698,0.08391,0.081107,0,1
4,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.096327,0.082688,0.069312,0,1
4,GO ERBB SIGNALING PATHWAY,0.16904,0.082681,0.060492,0,1
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.22042,0.082373,0.060474,0,1
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.10558,0.082341,0.096115,0,1
4,GO COENZYME A BIOSYNTHETIC PROCESS,0.12126,0.07958,0.099023,0,1
4,GO CARDIAC VENTRICLE DEVELOPMENT,0.18194,0.079109,0.064942,0,1
4,GO REGULATION OF ENDOCYTOSIS,0.17029,0.078655,0.06124,0,1
4,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.081168,0.078185,0.080773,0,1
4,GO REGULATION OF CELLULAR COMPONENT SIZE,0.1914,0.077375,0.054619,0,1
4,GO GMP METABOLIC PROCESS,0.16163,0.077223,0.071831,0,1
4,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.18461,0.077027,0.076019,0,1
4,GO GLIAL CELL ACTIVATION,0.1533,0.076563,0.063858,0,1
4,GO POSITIVE REGULATION OF BINDING,0.11742,0.075927,0.059789,0,1
4,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.33803,0.075785,0.048463,0,1
4,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.21889,0.075396,0.051373,0,1
4,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.10471,0.075117,0.068376,0,1
4,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.5314,0.0726,0.02743,0,1
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.081877,0.072561,0.065197,0,1
4,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.19979,0.071547,0.056777,0,1
4,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.1533,0.068704,0.051677,0,1
4,GO RETINA HOMEOSTASIS,0.16407,0.068232,0.032608,0,1
4,GO THYROID HORMONE METABOLIC PROCESS,0.51296,0.068071,0.034232,0,1
4,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.18461,0.067694,0.06501,0,1
4,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.067397,0.066936,0.088517,0,1
4,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.23128,0.066494,0.055906,0,1
4,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.079071,0.066038,0.071439,0,1
4,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.13979,0.065643,0.070336,0,1
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.09796,0.065581,0.062461,0,1
4,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.068006,0.064484,0.062283,0,1
4,GO PROTEIN K11 LINKED UBIQUITINATION,0.14197,0.064084,0.067782,0,1
4,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.086237,0.063091,0.062673,0,1
4,GO IN UTERO EMBRYONIC DEVELOPMENT,0.11183,0.062682,0.053591,0,1
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.10558,0.062459,0.060062,0,1
4,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.45238,0.061914,0.038721,0,1
4,GO REGULATION OF DNA CATABOLIC PROCESS,0.16407,0.06115,0.05846,0,1
4,GO REGULATION OF DEVELOPMENTAL GROWTH,0.47461,0.059216,0.028901,0,1
4,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.08331,0.059064,0.063283,0,1
4,GO HORMONE MEDIATED SIGNALING PATHWAY,0.15921,0.058791,0.054035,0,1
4,GO AUTOPHAGIC CELL DEATH,0.26614,0.058783,0.065977,0,1
4,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.22971,0.05846,0.042173,0,1
4,GO REGULATION OF CELL SHAPE,0.13979,0.058242,0.074072,0,1
4,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.35043,0.058224,0.038632,0,1
4,GO DNA MODIFICATION,0.14869,0.057753,0.044091,0,1
4,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.19278,0.057202,0.043989,0,1
4,GO REGULATION OF NUCLEASE ACTIVITY,0.10734,0.056814,0.065583,0,1
4,GO CELLULAR RESPONSE TO LIPID,0.071756,0.056556,0.071823,0,1
4,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.099614,0.056344,0.071586,0,1
4,GO MITOTIC CYTOKINESIS,0.33803,0.05507,0.038514,0,1
4,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.23445,0.054445,0.08504,0,1
4,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.11183,0.05264,0.066422,0,1
4,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.088486,0.052486,0.05581,0,1
4,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.39381,0.052463,0.0444,0,1
4,GO REGULATION OF CALCIUM ION TRANSPORT,0.071119,0.051465,0.062361,0,1
4,GO PROTEIN LOCALIZATION TO MEMBRANE,0.15921,0.051368,0.041701,0,1
4,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.073694,0.050944,0.098106,0,1
4,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.080464,0.049292,0.052025,0,1
4,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.178,0.049111,0.054776,0,1
4,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.33396,0.048472,0.038989,0,1
4,GO NUCLEAR ENVELOPE ORGANIZATION,0.16904,0.048304,0.052084,0,1
4,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.34213,0.048075,0.034977,0,1
4,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.5314,0.046953,0.020368,0,1
4,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.25753,0.046715,0.041793,0,1
4,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.086981,0.04567,0.054951,0,1
4,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.57752,0.042995,0.047811,0,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.084034,0.042355,0.04127,0,1
4,GO PROTEIN K63 LINKED UBIQUITINATION,0.084034,0.041533,0.060516,0,1
4,GO NADH METABOLIC PROCESS,0.30066,0.036198,0.06865,0,1
4,GO INTRACELLULAR PROTEIN TRANSPORT,0.079765,0.035113,0.043135,0,1
4,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.2458,0.032447,0.040145,0,1
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.16778,0.031704,0.034069,0,1
4,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.090782,0.030449,0.047544,0,1
4,GO MIDBRAIN DEVELOPMENT,0.50516,0.027988,0.030599,0,1
4,GO REFLEX,2.8814e-05,0.44617,0.38898,0,0
4,GO LIPOXYGENASE PATHWAY,0.0007901,0.35761,0.31178,0,0
4,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.00082553,0.34571,0.28928,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00019857,0.33346,0.39385,0,0
4,GO NEGATIVE REGULATION OF CELL KILLING,0.068006,0.32174,0.19407,0,0
4,GO HEART INDUCTION,0.0011668,0.28462,0.29565,0,0
4,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.0015038,0.27535,0.2571,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.00022208,0.26822,0.33318,0,0
4,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.15098,0.25264,0.10099,0,0
4,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.00013451,0.23768,0.27324,0,0
4,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.0040509,0.23577,0.19668,0,0
4,GO NEPHRIC DUCT MORPHOGENESIS,0.15921,0.234,0.1032,0,0
4,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.00073415,0.23354,0.25184,0,0
4,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00044781,0.23104,0.23564,0,0
4,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.0034243,0.22943,0.20777,0,0
4,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.001483,0.22615,0.23082,0,0
4,GO POSITIVE REGULATION OF HEART RATE,0.00013016,0.2237,0.24231,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.0016806,0.22155,0.2621,0,0
4,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,6.8888e-05,0.2197,0.28207,0,0
4,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.010895,0.21121,0.18633,0,0
4,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.063836,0.20869,0.14924,0,0
4,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.22348,0.20862,0.12685,0,0
4,GO POSITIVE REGULATION OF HEART CONTRACTION,1.2482e-05,0.20749,0.23549,0,0
4,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.0014624,0.20595,0.22219,0,0
4,GO KERATINOCYTE DEVELOPMENT,0.0055559,0.20235,0.2673,0,0
4,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0065235,0.19668,0.18485,0,0
4,GO HEART TRABECULA FORMATION,0.0076401,0.19011,0.21218,0,0
4,GO DEFENSE RESPONSE TO FUNGUS,0.00057029,0.18755,0.14881,0,0
4,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.10823,0.18641,0.13678,0,0
4,GO PEPTIDYL PROLINE HYDROXYLATION,0.014823,0.18583,0.17648,0,0
4,GO GAMMA DELTA T CELL DIFFERENTIATION,0.029754,0.18475,0.21313,0,0
4,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.049681,0.18345,0.21146,0,0
4,GO T CELL EXTRAVASATION,0.078382,0.18304,0.13347,0,0
4,GO NUCLEOTIDE TRANSPORT,3.0395e-05,0.17956,0.17393,0,0
4,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.014332,0.17895,0.14893,0,0
4,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.012798,0.17748,0.11871,0,0
4,GO PARTURITION,0.0074579,0.17408,0.18114,0,0
4,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.00043435,0.17022,0.20146,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.0020929,0.16994,0.21212,0,0
4,GO BLASTODERM SEGMENTATION,0.18595,0.16992,0.088548,0,0
4,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.1914,0.16965,0.12576,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.33396,0.16925,0.04016,0,0
4,GO PURINE NUCLEOTIDE TRANSPORT,6.545e-05,0.1675,0.18064,0,0
4,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.063836,0.16225,0.15913,0,0
4,GO THYMOCYTE APOPTOTIC PROCESS,0.091558,0.1599,0.10125,0,0
4,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.18194,0.15974,0.14273,0,0
4,GO NEUTRAL AMINO ACID TRANSPORT,0.010895,0.15958,0.14776,0,0
4,GO SKELETAL MUSCLE ADAPTATION,0.0023009,0.15792,0.17654,0,0
4,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0015463,0.15573,0.24737,0,0
4,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.062684,0.1554,0.13244,0,0
4,GO PITUITARY GLAND DEVELOPMENT,0.0062108,0.15504,0.22235,0,0
4,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.19838,0.15441,0.086194,0,0
4,GO NOREPINEPHRINE METABOLIC PROCESS,0.22042,0.15374,0.10073,0,0
4,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.0030839,0.15329,0.20451,0,0
4,GO CELLULAR RESPONSE TO LITHIUM ION,0.0013443,0.15253,0.18883,0,0
4,GO KETONE BODY METABOLIC PROCESS,0.03902,0.15234,0.13723,0,0
4,GO PROSTANOID METABOLIC PROCESS,0.077698,0.14895,0.12477,0,0
4,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.075674,0.14855,0.096508,0,0
4,GO NOTCH SIGNALING PATHWAY,3.628e-05,0.1449,0.1767,0,0
4,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.1873,0.1449,0.11557,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.10558,0.14457,0.12581,0,0
4,GO GLIAL CELL FATE COMMITMENT,0.062684,0.14399,0.20071,0,0
4,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.061549,0.14387,0.15322,0,0
4,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.24911,0.14374,0.075273,0,0
4,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.075009,0.14355,0.096366,0,0
4,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0012177,0.14259,0.26089,0,0
4,GO VASCULAR WOUND HEALING,0.001955,0.14234,0.2571,0,0
4,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,6.0079e-05,0.14205,0.15442,0,0
4,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.16778,0.14072,0.10575,0,0
4,GO TRIPARTITE REGIONAL SUBDIVISION,0.084034,0.14056,0.11481,0,0
4,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.14419,0.13898,0.093319,0,0
4,GO MACROPHAGE PROLIFERATION,0.1252,0.13872,0.12473,0,0
4,GO INTERLEUKIN 5 PRODUCTION,0.10558,0.13826,0.14441,0,0
4,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.071119,0.13762,0.10707,0,0
4,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.062114,0.137,0.13915,0,0
4,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.068619,0.13634,0.097268,0,0
4,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.14983,0.13613,0.091176,0,0
4,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.007921,0.13591,0.15958,0,0
4,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.11933,0.13571,0.1181,0,0
4,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.065596,0.13442,0.13232,0,0
4,GO RADIAL GLIAL CELL DIFFERENTIATION,0.10734,0.13439,0.12654,0,0
4,GO ETHANOL METABOLIC PROCESS,0.42367,0.13364,0.037857,0,0
4,GO CAMP METABOLIC PROCESS,0.088486,0.13171,0.10794,0,0
4,GO RENAL TUBULE DEVELOPMENT,0.074349,0.13082,0.082882,0,0
4,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.4355,0.13082,0.027862,0,0
4,GO REGULATION OF MEIOTIC CELL CYCLE,0.0047798,0.13059,0.10906,0,0
4,GO GANGLION DEVELOPMENT,0.24252,0.13047,0.15264,0,0
4,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.068006,0.12869,0.11095,0,0
4,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.09714,0.12865,0.16869,0,0
4,GO ETHER BIOSYNTHETIC PROCESS,0.09714,0.1282,0.069591,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.50776,0.12808,0.054931,0,0
4,GO BILE ACID BIOSYNTHETIC PROCESS,0.00076726,0.12747,0.16091,0,0
4,GO STARTLE RESPONSE,0.081877,0.12631,0.11198,0,0
4,GO STRIATED MUSCLE CONTRACTION,0.0024609,0.12539,0.12127,0,0
4,GO SECONDARY PALATE DEVELOPMENT,0.062114,0.12499,0.11297,0,0
4,GO CYCLOOXYGENASE PATHWAY,0.13444,0.12473,0.13956,0,0
4,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.12224,0.1246,0.11294,0,0
4,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.00012186,0.12422,0.14351,0,0
4,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.086237,0.12393,0.12822,0,0
4,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.072397,0.12388,0.10767,0,0
4,GO SYNAPTIC VESICLE DOCKING,0.1262,0.12324,0.17179,0,0
4,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.35043,0.12321,0.099122,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.024173,0.1231,0.15791,0,0
4,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.23286,0.12245,0.16559,0,0
4,GO REGULATION OF ANION TRANSPORT,0.00023667,0.12212,0.14868,0,0
4,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.11553,0.12199,0.12284,0,0
4,GO GLYCOPROTEIN CATABOLIC PROCESS,0.14869,0.12171,0.094539,0,0
4,GO INFLAMMATORY RESPONSE TO WOUNDING,0.28945,0.12147,0.10975,0,0
4,GO QUINONE METABOLIC PROCESS,0.017315,0.12112,0.19472,0,0
4,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.046474,0.12064,0.1218,0,0
4,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.44994,0.12056,0.034644,0,0
4,GO GAMMA DELTA T CELL ACTIVATION,0.11275,0.12019,0.12632,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.024173,0.12005,0.12266,0,0
4,GO ENDOTHELIAL CELL DEVELOPMENT,0.1453,0.11974,0.092747,0,0
4,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.026561,0.11971,0.13,0,0
4,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.42367,0.11854,0.10336,0,0
4,GO DIGESTIVE SYSTEM DEVELOPMENT,0.0085105,0.11831,0.12659,0,0
4,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.068006,0.11807,0.082032,0,0
4,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.073694,0.11761,0.098625,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0075485,0.11735,0.10785,0,0
4,GO SEGMENT SPECIFICATION,0.077018,0.11731,0.12989,0,0
4,GO BEHAVIORAL RESPONSE TO COCAINE,0.20265,0.11673,0.13354,0,0
4,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.45238,0.11664,0.066527,0,0
4,GO CELLULAR RESPONSE TO AMYLOID BETA,0.035336,0.11659,0.11855,0,0
4,GO KILLING OF CELLS OF OTHER ORGANISM,0.00012388,0.11634,0.15759,0,0
4,GO ETHANOL OXIDATION,0.10214,0.11627,0.14458,0,0
4,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.24416,0.11613,0.081626,0,0
4,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.066792,0.11596,0.11595,0,0
4,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.94993,0.1147,-0.018787,0,0
4,GO INACTIVATION OF MAPK ACTIVITY,0.11002,0.11452,0.10615,0,0
4,GO REGULATION OF TUBE SIZE,0.0026663,0.11438,0.11075,0,0
4,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.0078263,0.11402,0.10315,0,0
4,GO GLUTAMATE METABOLIC PROCESS,0.0043737,0.11296,0.11204,0,0
4,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.006444,0.11209,0.092613,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.0027381,0.11205,0.14532,0,0
4,GO OOCYTE DIFFERENTIATION,0.0087156,0.11123,0.10459,0,0
4,GO PROTEIN CONTAINING COMPLEX REMODELING,0.023419,0.11065,0.13174,0,0
4,GO LOCOMOTOR RHYTHM,0.070488,0.11043,0.10309,0,0
4,GO REGULATION OF ION TRANSPORT,0.0012886,0.11038,0.11119,0,0
4,GO TRABECULA MORPHOGENESIS,0.25583,0.11001,0.055262,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.090011,0.1098,0.12941,0,0
4,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.081877,0.1098,0.14307,0,0
4,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.066792,0.10977,0.10632,0,0
4,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.071119,0.10926,0.13064,0,0
4,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.077698,0.10916,0.15529,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.020828,0.10895,0.15975,0,0
4,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.047372,0.10874,0.097111,0,0
4,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.060988,0.10856,0.11642,0,0
4,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.1313,0.10844,0.12142,0,0
4,GO RESPONSE TO VITAMIN,0.26095,0.10832,0.060749,0,0
4,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.318,0.10822,0.12638,0,0
4,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.78451,0.10735,0.03361,0,0
4,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.11837,0.10687,0.081064,0,0
4,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.082591,0.10677,0.18642,0,0
4,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.24252,0.10649,0.21018,0,0
4,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.022686,0.10641,0.10288,0,0
4,GO GLYCOSIDE METABOLIC PROCESS,0.022686,0.10593,0.26887,0,0
4,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.13444,0.10585,0.11834,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.38047,0.10559,0.037429,0,0
4,GO SYNAPSE MATURATION,0.87926,0.1055,0.0020826,0,0
4,GO HORMONE METABOLIC PROCESS,0.0011021,0.10518,0.155,0,0
4,GO RESPONSE TO FUNGUS,0.0002117,0.10481,0.15087,0,0
4,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.20845,0.1046,0.063582,0,0
4,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.21889,0.10449,0.07335,0,0
4,GO LYMPHOCYTE HOMEOSTASIS,0.01829,0.10415,0.10151,0,0
4,GO POSITIVE REGULATION OF HEAT GENERATION,0.062684,0.10396,0.12988,0,0
4,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.22971,0.10356,0.21978,0,0
4,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.31997,0.10336,0.055302,0,0
4,GO REGULATION OF PROTEIN MATURATION,0.080464,0.10323,0.079491,0,0
4,GO BLEB ASSEMBLY,0.80326,0.10299,-0.032711,0,0
4,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.0092477,0.10287,0.12258,0,0
4,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.0058389,0.10267,0.12868,0,0
4,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.0081133,0.10223,0.10747,0,0
4,GO CHLORIDE TRANSPORT,0.00067188,0.10217,0.12124,0,0
4,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.19697,0.10199,0.10851,0,0
4,GO CALCIUM ION IMPORT INTO CYTOSOL,0.23445,0.10191,0.074965,0,0
4,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.13338,0.10172,0.10565,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.037139,0.10155,0.16451,0,0
4,GO BICARBONATE TRANSPORT,0.0058389,0.10144,0.12238,0,0
4,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.048746,0.10138,0.13809,0,0
4,GO SEROTONIN SECRETION,0.3739,0.10129,0.067877,0,0
4,GO POSITIVE REGULATION OF LIPID STORAGE,0.086981,0.10127,0.10886,0,0
4,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,0.16042,0.10086,0.083934,0,0
4,GO PURINE CONTAINING COMPOUND SALVAGE,0.32993,0.10086,0.053081,0,0
4,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,0.067397,0.10078,0.085987,0,0
4,GO ESTROUS CYCLE,0.21738,0.10049,0.085007,0,0
4,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.068006,0.10046,0.091595,0,0
4,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.24911,0.10001,0.058401,0,0
4,GO CELL JUNCTION ORGANIZATION,0.11092,0.09992,0.067618,0,0
4,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,7.0072e-05,0.099853,0.15481,0,0
4,GO BASIC AMINO ACID TRANSPORT,0.14983,0.099727,0.12409,0,0
4,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.082591,0.099611,0.082476,0,0
4,GO CELL MATURATION,0.0017277,0.09959,0.10814,0,0
4,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.03902,0.099567,0.09458,0,0
4,GO REGULATION OF HEAT GENERATION,0.06986,0.099358,0.12616,0,0
4,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.0033361,0.099281,0.10523,0,0
4,GO CARDIAC MUSCLE CONTRACTION,0.0096941,0.099244,0.10827,0,0
4,GO RENAL WATER HOMEOSTASIS,0.14755,0.099077,0.072598,0,0
4,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,0.16407,0.098621,0.088904,0,0
4,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.074349,0.098482,0.07273,0,0
4,GO GLYCINE TRANSPORT,0.5,0.098396,0.053851,0,0
4,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.061549,0.09838,0.10681,0,0
4,GO REGULATION OF RESPONSE TO FOOD,0.17156,0.098284,0.055156,0,0
4,GO PROTEIN AUTOPROCESSING,0.0056255,0.098239,0.12965,0,0
4,GO LIPID IMPORT INTO CELL,0.12421,0.097789,0.10088,0,0
4,GO REGULATION OF GLUTAMATE SECRETION,0.28213,0.097539,0.079766,0,0
4,GO UROGENITAL SYSTEM DEVELOPMENT,0.092339,0.097535,0.071376,0,0
4,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.40058,0.09729,0.080162,0,0
4,GO CELL SUBSTRATE ADHESION,0.1653,0.097081,0.074508,0,0
4,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.0070192,0.096977,0.094266,0,0
4,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.075009,0.096281,0.095434,0,0
4,GO INNER DYNEIN ARM ASSEMBLY,0.19417,0.096219,0.098044,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.042609,0.096179,0.1059,0,0
4,GO SKIN MORPHOGENESIS,0.70185,0.096178,0.010042,0,0
4,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.070488,0.095933,0.089835,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.22971,0.095508,0.060218,0,0
4,GO PROTEIN ACTIVATION CASCADE,0.36956,0.095363,0.04139,0,0
4,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.0065235,0.095222,0.10068,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.14642,0.095163,0.049972,0,0
4,GO MODIFIED AMINO ACID TRANSPORT,0.045155,0.094951,0.092541,0,0
4,GO POSITIVE REGULATION OF CELL AGING,0.15214,0.094484,0.084727,0,0
4,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.39606,0.094362,0.054286,0,0
4,GO PEROXISOMAL MEMBRANE TRANSPORT,0.044292,0.094338,0.086295,0,0
4,GO CELLULAR SODIUM ION HOMEOSTASIS,0.10129,0.093905,0.10056,0,0
4,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.092339,0.093718,0.16293,0,0
4,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.18062,0.093616,0.090358,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.22814,0.093394,0.036605,0,0
4,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.031953,0.093138,0.091043,0,0
4,GO DRUG METABOLIC PROCESS,0.0080166,0.092929,0.16872,0,0
4,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.5583,0.092892,0.039125,0,0
4,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.15214,0.092774,0.068844,0,0
4,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.045155,0.092667,0.10371,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.18866,0.092516,0.067435,0,0
4,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.078382,0.092237,0.081201,0,0
4,GO RENAL FILTRATION,0.35253,0.091805,0.1021,0,0
4,GO RESPIRATORY SYSTEM DEVELOPMENT,0.14755,0.091699,0.072373,0,0
4,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.015501,0.091513,0.087584,0,0
4,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.1914,0.091448,0.048432,0,0
4,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.30637,0.091143,0.041241,0,0
4,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.013546,0.091093,0.17291,0,0
4,GO CARDIAC CELL DEVELOPMENT,0.020385,0.090978,0.098863,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.084034,0.090914,0.099478,0,0
4,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.89205,0.090904,-0.05302,0,0
4,GO EPIBOLY,0.18062,0.090799,0.086509,0,0
4,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.5314,0.090761,0.020534,0,0
4,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,0.15447,0.090694,0.090551,0,0
4,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.071119,0.090376,0.12088,0,0
4,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.1262,0.090152,0.081192,0,0
4,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.39381,0.090142,0.029146,0,0
4,GO ENAMEL MINERALIZATION,0.51557,0.089962,0.072968,0,0
4,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.13763,0.089943,0.066442,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,0.36098,0.089934,0.073715,0,0
4,GO MIDGUT DEVELOPMENT,0.24252,0.089593,0.097663,0,0
4,GO LYMPH NODE DEVELOPMENT,0.017315,0.089564,0.11713,0,0
4,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.18595,0.089528,0.085687,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.007921,0.089207,0.12865,0,0
4,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.28213,0.088922,0.081866,0,0
4,GO SMOOTH MUSCLE CELL PROLIFERATION,0.14197,0.088757,0.075209,0,0
4,GO REGULATION OF BIOMINERALIZATION,0.10045,0.088204,0.08005,0,0
4,GO RESPONSE TO LEUCINE,0.10214,0.088198,0.11875,0,0
4,GO ENDOTHELIAL CELL MORPHOGENESIS,0.96284,0.088183,0.0054292,0,0
4,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.14197,0.087862,0.1301,0,0
4,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.26614,0.087806,0.03769,0,0
4,GO PROSTANOID BIOSYNTHETIC PROCESS,0.16042,0.087636,0.069095,0,0
4,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.080464,0.087582,0.10009,0,0
4,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.078382,0.087562,0.07139,0,0
4,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.28761,0.087497,0.044682,0,0
4,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.10646,0.087383,0.063305,0,0
4,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.3442,0.087275,0.097731,0,0
4,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.069238,0.087226,0.15163,0,0
4,GO NOSE DEVELOPMENT,0.63986,0.087218,0.11434,0,0
4,GO REGULATION OF CAMP MEDIATED SIGNALING,0.064418,0.087119,0.085305,0,0
4,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.10045,0.087069,0.070406,0,0
4,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,0.067397,0.086992,0.094181,0,0
4,GO RETINOIC ACID METABOLIC PROCESS,0.42133,0.086571,0.037188,0,0
4,GO RESPONSE TO UV B,0.82526,0.086529,0.0072134,0,0
4,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.31604,0.08633,0.053515,0,0
4,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.072397,0.085994,0.066812,0,0
4,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.073043,0.085847,0.089873,0,0
4,GO GANGLIOSIDE METABOLIC PROCESS,0.20845,0.085833,0.086055,0,0
4,GO INNERVATION,0.10471,0.085822,0.17712,0,0
4,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.49743,0.085809,0.043888,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.30066,0.08576,0.040494,0,0
4,GO GABAERGIC NEURON DIFFERENTIATION,0.34008,0.085622,0.15821,0,0
4,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.46713,0.085577,0.064371,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.066192,0.085535,0.16139,0,0
4,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.09714,0.085531,0.14036,0,0
4,GO RESPONSE TO AMPHETAMINE,0.027118,0.085496,0.151,0,0
4,GO MUSCLE CONTRACTION,0.017506,0.085017,0.077714,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.14419,0.084938,0.094165,0,0
4,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.093126,0.084903,0.097994,0,0
4,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.20409,0.084603,0.12667,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.46466,0.084524,0.055595,0,0
4,GO CGMP MEDIATED SIGNALING,0.25924,0.084497,0.068683,0,0
4,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.23605,0.084389,0.050952,0,0
4,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.050154,0.084346,0.080253,0,0
4,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.033608,0.083954,0.08126,0,0
4,GO PRO B CELL DIFFERENTIATION,0.096327,0.083953,0.10589,0,0
4,GO MYOTUBE CELL DEVELOPMENT,0.71693,0.083686,0.021559,0,0
4,GO GLUCOSE CATABOLIC PROCESS,0.12924,0.083588,0.10011,0,0
4,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.30829,0.083583,0.051518,0,0
4,GO ADULT BEHAVIOR,0.09714,0.083525,0.095631,0,0
4,GO BODY MORPHOGENESIS,0.37608,0.083511,0.056072,0,0
4,GO TISSUE MORPHOGENESIS,0.10045,0.083457,0.059176,0,0
4,GO MEMBRANE BIOGENESIS,0.318,0.083396,0.060275,0,0
4,GO REGULATION OF STEROL TRANSPORT,0.11002,0.083307,0.073972,0,0
4,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.22814,0.082968,0.058555,0,0
4,GO VITAMIN METABOLIC PROCESS,0.011678,0.082897,0.10718,0,0
4,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.16042,0.082728,0.074855,0,0
4,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.038637,0.082555,0.072777,0,0
4,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.10214,0.082509,0.075764,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.08331,0.082487,0.092649,0,0
4,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.68988,0.082388,-0.044083,0,0
4,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.15921,0.082285,0.08728,0,0
4,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.0030038,0.082269,0.14403,0,0
4,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.016205,0.082227,0.13932,0,0
4,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.0087156,0.08222,0.11404,0,0
4,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.20845,0.081964,0.063311,0,0
4,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,0.25583,0.081943,0.039173,0,0
4,GO REGULATION OF COLLATERAL SPROUTING,0.68094,0.08186,0.011861,0,0
4,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.073694,0.081552,0.088955,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.4355,0.081485,0.052206,0,0
4,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.1387,0.081356,0.085975,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.35463,0.081355,0.097974,0,0
4,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.016568,0.08135,0.094282,0,0
4,GO REGULATION OF CALCIUM ION IMPORT,0.2458,0.081253,0.058596,0,0
4,GO ASSOCIATIVE LEARNING,0.11933,0.081219,0.07229,0,0
4,GO REGULATION OF BONE DEVELOPMENT,0.084763,0.081159,0.091345,0,0
4,GO GLAND MORPHOGENESIS,0.14197,0.081068,0.084069,0,0
4,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.75048,0.0809,0.0087261,0,0
4,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.19003,0.0808,0.091812,0,0
4,GO CARDIAC MUSCLE CELL CONTRACTION,0.096327,0.08063,0.097439,0,0
4,GO VISUAL BEHAVIOR,0.026286,0.080622,0.09808,0,0
4,GO HYALURONAN CATABOLIC PROCESS,0.43312,0.080452,0.027296,0,0
4,GO STEROID CATABOLIC PROCESS,0.0072795,0.080404,0.19012,0,0
4,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.006444,0.080399,0.090443,0,0
4,GO CHAPERONE MEDIATED AUTOPHAGY,0.42838,0.080387,0.078585,0,0
4,GO GLIAL CELL MIGRATION,0.44752,0.080368,0.038769,0,0
4,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.065596,0.080344,0.10938,0,0
4,GO NEUROTRANSMITTER REUPTAKE,0.082591,0.080265,0.11475,0,0
4,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.071119,0.08023,0.077006,0,0
4,GO RESPONSE TO CATECHOLAMINE,0.041789,0.080076,0.096308,0,0
4,GO RESPONSE TO ZINC ION,0.040981,0.080025,0.14771,0,0
4,GO NEURAL TUBE DEVELOPMENT,0.37173,0.079845,0.031583,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.069238,0.079695,0.078727,0,0
4,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.077698,0.079635,0.077051,0,0
4,GO AMINE CATABOLIC PROCESS,0.067397,0.079617,0.10626,0,0
4,GO REGULATION OF CELL FATE COMMITMENT,0.21587,0.079342,0.055631,0,0
4,GO CARDIAC ATRIUM DEVELOPMENT,0.24252,0.079224,0.083336,0,0
4,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.11647,0.079183,0.08878,0,0
4,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.47963,0.079114,0.041303,0,0
4,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.13549,0.079112,0.061534,0,0
4,GO SUBPALLIUM DEVELOPMENT,0.094715,0.079048,0.14354,0,0
4,GO MACROPHAGE MIGRATION,0.11647,0.078962,0.058286,0,0
4,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.66616,0.078917,0.046026,0,0
4,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.21288,0.078878,0.05523,0,0
4,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.36526,0.078793,0.078487,0,0
4,GO TUBE DEVELOPMENT,0.062684,0.078679,0.072997,0,0
4,GO ACTIN MEDIATED CELL CONTRACTION,0.062684,0.078552,0.088389,0,0
4,GO RUFFLE ASSEMBLY,0.15683,0.07834,0.075048,0,0
4,GO TETRAPYRROLE METABOLIC PROCESS,0.21587,0.078331,0.068972,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.19838,0.078229,0.073914,0,0
4,GO AMINO ACID IMPORT,0.14869,0.078205,0.067256,0,0
4,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.13549,0.077895,0.063549,0,0
4,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.26267,0.077884,0.079533,0,0
4,GO PIGMENT CELL DIFFERENTIATION,0.20992,0.077854,0.066269,0,0
4,GO CONVERGENT EXTENSION,0.35674,0.077569,0.055188,0,0
4,GO REGULATION OF GROWTH HORMONE SECRETION,0.54208,0.077509,0.11086,0,0
4,GO RESPONSE TO GROWTH FACTOR,0.10045,0.077453,0.065346,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.10129,0.077328,0.12356,0,0
4,GO FIBROBLAST PROLIFERATION,0.1313,0.077214,0.07583,0,0
4,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.24089,0.077184,0.063694,0,0
4,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.26789,0.07706,0.086935,0,0
4,GO NEURAL TUBE FORMATION,0.1754,0.077003,0.057468,0,0
4,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.058787,0.076615,0.081736,0,0
4,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.065596,0.076561,0.062836,0,0
4,GO REPLICATIVE SENESCENCE,0.29502,0.076489,0.072698,0,0
4,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.071756,0.07645,0.069663,0,0
4,GO SKELETAL MUSCLE CONTRACTION,0.060432,0.076128,0.09091,0,0
4,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.15921,0.075764,0.060001,0,0
4,GO RESPONSE TO HYPEROXIA,0.79075,0.075733,0.011268,0,0
4,GO AXONEME ASSEMBLY,0.16285,0.07572,0.077418,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.41203,0.075702,0.069465,0,0
4,GO MALE MEIOTIC NUCLEAR DIVISION,0.16163,0.075554,0.094405,0,0
4,GO ORGAN INDUCTION,0.16285,0.075445,0.071206,0,0
4,GO MACROPHAGE DIFFERENTIATION,0.28395,0.075438,0.056787,0,0
4,GO COLLATERAL SPROUTING,0.46218,0.075336,0.034153,0,0
4,GO CHEMOSENSORY BEHAVIOR,0.1453,0.075264,0.040497,0,0
4,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.054582,0.075147,0.079694,0,0
4,GO POSITIVE REGULATION OF VESICLE FUSION,0.318,0.074975,0.11529,0,0
4,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.15921,0.074889,0.06841,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.066792,0.074818,0.098065,0,0
4,GO NOREPINEPHRINE TRANSPORT,0.2913,0.074738,0.075081,0,0
4,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.38488,0.074511,0.05126,0,0
4,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.067397,0.074505,0.1001,0,0
4,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.16778,0.07448,0.06901,0,0
4,GO RESPONSE TO MUSCLE ACTIVITY,0.68392,0.074416,0.029166,0,0
4,GO NEUROTRANSMITTER UPTAKE,0.1146,0.074374,0.09488,0,0
4,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.30637,0.074271,0.060014,0,0
4,GO GASTRULATION,0.2458,0.074128,0.057383,0,0
4,GO CARDIAC CHAMBER MORPHOGENESIS,0.30829,0.074092,0.052924,0,0
4,GO SEX DETERMINATION,0.42602,0.073964,0.032068,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.39156,0.073938,0.045744,0,0
4,GO GLUCOCORTICOID METABOLIC PROCESS,0.17669,0.073899,0.078247,0,0
4,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.092339,0.073821,0.077705,0,0
4,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.068006,0.073818,0.08957,0,0
4,GO CELLULAR RESPONSE TO IRON ION,0.63697,0.07381,0.023139,0,0
4,GO HEART FIELD SPECIFICATION,0.25414,0.073695,0.10793,0,0
4,GO OVARIAN FOLLICLE DEVELOPMENT,0.10912,0.07357,0.070118,0,0
4,GO POLYAMINE METABOLIC PROCESS,0.23286,0.073474,0.062371,0,0
4,GO SEMI LUNAR VALVE DEVELOPMENT,0.28945,0.073466,0.064487,0,0
4,GO KIDNEY EPITHELIUM DEVELOPMENT,0.032938,0.073446,0.10003,0,0
4,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.62832,0.073403,0.01991,0,0
4,GO PULMONARY VALVE MORPHOGENESIS,0.071756,0.073391,0.15905,0,0
4,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.32592,0.073292,0.045469,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.077018,0.073153,0.097666,0,0
4,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.22814,0.073129,0.055858,0,0
4,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.33396,0.073025,0.077038,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.075009,0.073018,0.072147,0,0
4,GO GLIAL CELL PROLIFERATION,0.14419,0.072868,0.079984,0,0
4,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.2644,0.072839,0.066776,0,0
4,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.37827,0.072693,0.062331,0,0
4,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.40743,0.072678,0.063985,0,0
4,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.22814,0.07265,0.069512,0,0
4,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.13027,0.072572,0.078412,0,0
4,GO UV DAMAGE EXCISION REPAIR,0.15921,0.072538,0.056231,0,0
4,GO REGULATION OF CHROMATIN BINDING,0.20699,0.072391,0.065434,0,0
4,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.13549,0.07239,0.096159,0,0
4,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.040981,0.072375,0.11953,0,0
4,GO SEGMENTATION,0.1387,0.072261,0.066001,0,0
4,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.11183,0.07222,0.10035,0,0
4,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.077698,0.072027,0.10162,0,0
4,GO I KAPPAB PHOSPHORYLATION,0.22195,0.071958,0.063445,0,0
4,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.25753,0.071512,0.084303,0,0
4,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.31604,0.071327,0.052184,0,0
4,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.44269,0.071296,0.047115,0,0
4,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.3442,0.071267,0.041333,0,0
4,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.099614,0.071257,0.052301,0,0
4,GO TUBE MORPHOGENESIS,0.178,0.071226,0.057454,0,0
4,GO CARDIAC SEPTUM MORPHOGENESIS,0.53406,0.071177,0.028889,0,0
4,GO PROTEIN REFOLDING,0.05063,0.070983,0.10768,0,0
4,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.13979,0.07088,0.057203,0,0
4,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.13656,0.070813,0.077944,0,0
4,GO DENDRITIC CELL CHEMOTAXIS,0.063836,0.070745,0.092401,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.30066,0.070651,0.077181,0,0
4,GO FOREBRAIN NEURON DIFFERENTIATION,0.26614,0.070642,0.11766,0,0
4,GO NEURONAL ION CHANNEL CLUSTERING,0.15683,0.070569,0.13536,0,0
4,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.077018,0.070528,0.086508,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.16654,0.070287,0.064111,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.46218,0.070124,0.062769,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.16904,0.069813,0.056824,0,0
4,GO REGULATION OF SYNAPSE MATURATION,0.91451,0.069783,-0.013234,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.54208,0.069748,0.068962,0,0
4,GO CARBOHYDRATE PHOSPHORYLATION,0.20554,0.069634,0.081255,0,0
4,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.071119,0.069535,0.092131,0,0
4,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.22195,0.069449,0.079978,0,0
4,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.090011,0.069278,0.068856,0,0
4,GO MAGNESIUM ION HOMEOSTASIS,0.84424,0.069258,0.0010283,0,0
4,GO PREPULSE INHIBITION,0.5583,0.069153,0.045493,0,0
4,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.043866,0.069056,0.11921,0,0
4,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.41203,0.068879,0.052671,0,0
4,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.1453,0.068799,0.094556,0,0
4,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.19417,0.068757,0.049219,0,0
4,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.18194,0.068448,0.065762,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.35886,0.068426,0.053101,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.089246,0.068313,0.089295,0,0
4,GO GLUTATHIONE METABOLIC PROCESS,0.21738,0.068262,0.077477,0,0
4,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.10912,0.068225,0.12854,0,0
4,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.11183,0.068166,0.099143,0,0
4,GO MATING BEHAVIOR,0.16904,0.068154,0.066878,0,0
4,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.18595,0.068139,0.056098,0,0
4,GO DEFINITIVE HEMOPOIESIS,0.20409,0.068138,0.066997,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.75972,0.06801,0.026937,0,0
4,GO RIG I SIGNALING PATHWAY,0.19697,0.067979,0.053351,0,0
4,GO FAT CELL PROLIFERATION,0.23766,0.067938,0.080441,0,0
4,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.21587,0.067922,0.06478,0,0
4,GO RNA INTERFERENCE,0.33803,0.067894,0.032436,0,0
4,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.54477,0.067801,0.043843,0,0
4,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.27317,0.067798,0.061403,0,0
4,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.49743,0.06737,0.043447,0,0
4,GO REGULATION OF CELL FATE SPECIFICATION,0.34213,0.067247,0.04808,0,0
4,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.14755,0.067224,0.05619,0,0
4,GO FEAR RESPONSE,0.076344,0.06721,0.077168,0,0
4,GO NEPHRON EPITHELIUM DEVELOPMENT,0.16285,0.067152,0.067859,0,0
4,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,0.2644,0.067079,0.037763,0,0
4,GO RETINAL GANGLION CELL AXON GUIDANCE,0.31997,0.066862,0.11391,0,0
4,GO WATER TRANSPORT,0.060988,0.066631,0.08534,0,0
4,GO CELLULAR EXTRAVASATION,0.36741,0.066576,0.048257,0,0
4,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.12421,0.066497,0.063076,0,0
4,GO NEGATIVE REGULATION OF ION TRANSPORT,0.16163,0.066449,0.043263,0,0
4,GO REGULATION OF VASCULATURE DEVELOPMENT,0.09796,0.066354,0.076564,0,0
4,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,0.41899,0.066227,0.036125,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.089246,0.066215,0.071157,0,0
4,GO CELL GROWTH,0.11002,0.066213,0.058484,0,0
4,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.18062,0.066165,0.05525,0,0
4,GO TUMOR NECROSIS FACTOR SECRETION,0.21437,0.065961,0.06262,0,0
4,GO METANEPHROS DEVELOPMENT,0.51819,0.065846,0.043984,0,0
4,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.061549,0.065824,0.088681,0,0
4,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.36956,0.065368,0.039122,0,0
4,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.14983,0.065328,0.063443,0,0
4,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.095518,0.065303,0.062121,0,0
4,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.23766,0.065245,0.038884,0,0
4,GO REGULATION OF REPRODUCTIVE PROCESS,0.027118,0.065128,0.067563,0,0
4,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.13444,0.065078,0.073321,0,0
4,GO EXCRETION,0.060432,0.065047,0.08411,0,0
4,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.070488,0.064859,0.077675,0,0
4,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.66616,0.064788,0.028523,0,0
4,GO REGULATION OF POTASSIUM ION TRANSPORT,0.40058,0.064654,0.040336,0,0
4,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.22042,0.064644,0.047603,0,0
4,GO PERICARDIUM DEVELOPMENT,0.5665,0.064483,0.028496,0,0
4,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.0021505,0.064437,0.088569,0,0
4,GO MELANOCYTE DIFFERENTIATION,0.15214,0.064256,0.082009,0,0
4,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.28213,0.064136,0.059301,0,0
4,GO INTERLEUKIN 4 PRODUCTION,0.099614,0.064056,0.10011,0,0
4,GO ACTIN CYTOSKELETON REORGANIZATION,0.19979,0.06401,0.05096,0,0
4,GO SYNAPSE ASSEMBLY,0.26964,0.063949,0.062279,0,0
4,GO POSITIVE REGULATION OF GROWTH,0.063258,0.063733,0.069737,0,0
4,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.19417,0.063623,0.043202,0,0
4,GO EPITHELIAL TUBE FORMATION,0.1313,0.06357,0.051009,0,0
4,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.20409,0.063497,0.068732,0,0
4,GO ADAPTATION OF SIGNALING PATHWAY,0.49231,0.063472,0.022084,0,0
4,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.54208,0.063465,0.027395,0,0
4,GO REGULATION OF METAL ION TRANSPORT,0.10299,0.063422,0.056735,0,0
4,GO T HELPER 2 CELL DIFFERENTIATION,0.89846,0.063312,-0.039799,0,0
4,GO REGULATION OF CHOLESTEROL EFFLUX,0.073043,0.063253,0.083258,0,0
4,GO SYNAPTIC TRANSMISSION GABAERGIC,0.89846,0.063226,-0.013773,0,0
4,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.77519,0.062986,0.022042,0,0
4,GO ENDODERMAL CELL FATE COMMITMENT,0.32792,0.062966,0.047706,0,0
4,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.41434,0.06291,0.061914,0,0
4,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.32393,0.062846,0.059268,0,0
4,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.081168,0.062794,0.074914,0,0
4,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.20845,0.062713,0.046088,0,0
4,GO EMBRYONIC AXIS SPECIFICATION,0.070488,0.06268,0.081463,0,0
4,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.31215,0.062537,0.045874,0,0
4,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.27495,0.062529,0.043941,0,0
4,GO STRIATUM DEVELOPMENT,0.15098,0.062518,0.078892,0,0
4,GO T CELL HOMEOSTASIS,0.12126,0.062489,0.058776,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.46466,0.062264,0.027452,0,0
4,GO EPITHELIAL CELL MATURATION,0.28761,0.062198,0.074184,0,0
4,GO PEPTIDE CROSS LINKING,0.23927,0.062196,0.061429,0,0
4,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.71996,0.062193,0.007867,0,0
4,GO LUNG MORPHOGENESIS,0.41434,0.062075,0.039885,0,0
4,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.17283,0.062048,0.057812,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY,0.61687,0.061999,0.028297,0,0
4,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.29502,0.061859,0.052118,0,0
4,GO EPITHELIAL TUBE MORPHOGENESIS,0.24911,0.061828,0.04547,0,0
4,GO ARTERY DEVELOPMENT,0.74435,0.06181,0.010273,0,0
4,GO OSTEOCLAST DIFFERENTIATION,0.21889,0.061635,0.059784,0,0
4,GO COBALAMIN METABOLIC PROCESS,0.095518,0.061606,0.095459,0,0
4,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.087731,0.061564,0.0706,0,0
4,GO VITAMIN CATABOLIC PROCESS,0.50776,0.061492,0.029281,0,0
4,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.41434,0.06142,0.044748,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.093918,0.061413,0.051263,0,0
4,GO NEUROTRANSMITTER SECRETION,0.48976,0.061399,0.074369,0,0
4,GO RRNA CATABOLIC PROCESS,0.10299,0.061355,0.088156,0,0
4,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.14642,0.061297,0.13921,0,0
4,GO ANIMAL ORGAN REGENERATION,0.075674,0.061279,0.075633,0,0
4,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.0027381,0.061211,0.097285,0,0
4,GO PROTEIN TRIMERIZATION,0.37827,0.061157,0.055639,0,0
4,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.41203,0.061132,0.055729,0,0
4,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.43075,0.061129,0.044039,0,0
4,GO NERVOUS SYSTEM PROCESS,0.090782,0.061125,0.058555,0,0
4,GO TRABECULA FORMATION,0.84107,0.061057,0.016466,0,0
4,GO MAST CELL MIGRATION,0.97899,0.060941,-0.00088167,0,0
4,GO MESENCHYMAL CELL DIFFERENTIATION,0.46466,0.060746,0.033887,0,0
4,GO CELL CELL SIGNALING,0.090011,0.060668,0.05839,0,0
4,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.43312,0.060666,0.039632,0,0
4,GO UTERUS DEVELOPMENT,0.94348,0.060504,-0.0093787,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.44028,0.060429,0.05195,0,0
4,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.30255,0.060358,0.065403,0,0
4,GO REGULATION OF VASOCONSTRICTION,0.084034,0.060337,0.073546,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.25924,0.060076,0.082629,0,0
4,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.30255,0.060058,0.045696,0,0
4,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.081877,0.060029,0.06812,0,0
4,GO ENDOCARDIAL CUSHION FORMATION,0.178,0.059956,0.090275,0,0
4,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,0.41434,0.059944,0.069063,0,0
4,GO REGULATION OF HAIR CYCLE,0.17156,0.059766,0.072745,0,0
4,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.017506,0.059717,0.10087,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,0.45238,0.059685,0.037984,0,0
4,GO MESENCHYME MORPHOGENESIS,0.43312,0.059596,0.036104,0,0
4,GO EMBRYONIC ORGAN DEVELOPMENT,0.50258,0.059257,0.028553,0,0
4,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.63408,0.059195,0.00095369,0,0
4,GO RHYTHMIC BEHAVIOR,0.14197,0.058996,0.089442,0,0
4,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.10734,0.058869,0.078247,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.30637,0.058807,0.041935,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.20699,0.058766,0.054451,0,0
4,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.25246,0.05869,0.05429,0,0
4,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.23286,0.058535,0.077648,0,0
4,GO TUBE FORMATION,0.23286,0.058522,0.038852,0,0
4,GO CARDIAC VENTRICLE MORPHOGENESIS,0.15921,0.058281,0.065513,0,0
4,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.50258,0.058199,0.034737,0,0
4,GO RESPONSE TO NICOTINE,0.31215,0.058182,0.053169,0,0
4,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.61687,0.057938,0.015798,0,0
4,GO RESPONSE TO AMYLOID BETA,0.20554,0.057889,0.077282,0,0
4,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.1313,0.057873,0.10338,0,0
4,GO RESPONSE TO RETINOIC ACID,0.37827,0.057866,0.051148,0,0
4,GO FACIAL NERVE MORPHOGENESIS,0.47211,0.057859,0.075106,0,0
4,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.18327,0.057827,0.064682,0,0
4,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.97576,0.057736,0.0033514,0,0
4,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.40743,0.057618,0.027359,0,0
4,GO GROWTH,0.20265,0.057587,0.048275,0,0
4,GO REGULATION OF KIDNEY DEVELOPMENT,0.36311,0.05747,0.053825,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.91451,0.057435,-0.011299,0,0
4,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.17283,0.0573,0.070814,0,0
4,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,0.22195,0.057194,0.036067,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.19417,0.057099,0.057573,0,0
4,GO AORTA MORPHOGENESIS,0.15447,0.057081,0.08401,0,0
4,GO REGULATION OF PROTEIN IMPORT,0.38267,0.057024,0.035868,0,0
4,GO REGULATION OF BONE MINERALIZATION,0.28945,0.057006,0.062166,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.45972,0.056942,0.028257,0,0
4,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.087731,0.056743,0.061694,0,0
4,GO NEUROTRANSMITTER TRANSPORT,0.30637,0.056452,0.082508,0,0
4,GO REGULATION OF GTPASE ACTIVITY,0.089246,0.056447,0.070081,0,0
4,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.068006,0.0562,0.07031,0,0
4,GO ALCOHOL CATABOLIC PROCESS,0.01849,0.056171,0.090475,0,0
4,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.78451,0.056148,-0.022249,0,0
4,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.31997,0.05612,0.066954,0,0
4,GO COMPLEMENT ACTIVATION,0.15447,0.056081,0.066611,0,0
4,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.08331,0.055898,0.11179,0,0
4,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.84741,0.055875,-0.033744,0,0
4,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.91772,0.055712,0.00042923,0,0
4,GO ALPHA AMINO ACID METABOLIC PROCESS,0.19557,0.055521,0.051218,0,0
4,GO POSTREPLICATION REPAIR,0.35886,0.055508,0.030991,0,0
4,GO ESTROGEN METABOLIC PROCESS,0.17283,0.055487,0.089799,0,0
4,GO AXIS SPECIFICATION,0.1914,0.05542,0.059958,0,0
4,GO KIDNEY MORPHOGENESIS,0.22971,0.055124,0.056948,0,0
4,GO REGULATION OF GASTRIC ACID SECRETION,0.22042,0.05502,0.073813,0,0
4,GO BEHAVIOR,0.25246,0.054997,0.05056,0,0
4,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.090011,0.054929,0.045662,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.1533,0.054831,0.085456,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.031631,0.054705,0.11837,0,0
4,GO SYNAPTIC VESICLE RECYCLING,0.08331,0.054676,0.095785,0,0
4,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.59705,0.054477,0.036413,0,0
4,GO GROWTH HORMONE SECRETION,0.44269,0.054396,0.097146,0,0
4,GO REGULATION OF TRANSFERASE ACTIVITY,0.074349,0.054372,0.064817,0,0
4,GO TRIGLYCERIDE CATABOLIC PROCESS,0.22503,0.054345,0.070832,0,0
4,GO LYMPHOCYTE CHEMOTAXIS,0.17283,0.054293,0.051605,0,0
4,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.56376,0.054274,0.02445,0,0
4,GO SYNAPTIC VESICLE PRIMING,0.25414,0.054223,0.12743,0,0
4,GO SYNAPTIC VESICLE EXOCYTOSIS,0.37608,0.054195,0.085895,0,0
4,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.12126,0.054088,0.072008,0,0
4,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.6691,0.05402,0.0050113,0,0
4,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.36741,0.053773,0.060816,0,0
4,GO CELLULAR COMPONENT MAINTENANCE,0.6055,0.05374,0.031586,0,0
4,GO MYELOID DENDRITIC CELL ACTIVATION,0.70486,0.053678,0.020962,0,0
4,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.11933,0.053619,0.0641,0,0
4,GO MUSCLE ORGAN MORPHOGENESIS,0.66321,0.053477,0.026304,0,0
4,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.079071,0.053459,0.083404,0,0
4,GO ATRIAL SEPTUM DEVELOPMENT,0.5665,0.05345,0.057659,0,0
4,GO RESPONSE TO ESTRADIOL,0.22503,0.053378,0.04529,0,0
4,GO EAR DEVELOPMENT,0.20992,0.053268,0.052017,0,0
4,GO FACE DEVELOPMENT,0.58029,0.05325,0.041694,0,0
4,GO NEGATIVE REGULATION OF CELL GROWTH,0.13338,0.053092,0.061369,0,0
4,GO NEGATIVE REGULATION OF BEHAVIOR,0.6055,0.052947,0.035282,0,0
4,GO HEPATOCYTE DIFFERENTIATION,0.17283,0.05294,0.071873,0,0
4,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,0.30066,0.052888,0.041868,0,0
4,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.93382,0.052739,0.0043863,0,0
4,GO HISTONE H2B UBIQUITINATION,0.11742,0.052691,0.067651,0,0
4,GO T CELL APOPTOTIC PROCESS,0.22814,0.052452,0.059542,0,0
4,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.71089,0.0524,0.013625,0,0
4,GO DEVELOPMENTAL CELL GROWTH,0.6312,0.052372,0.021179,0,0
4,GO REGULATION OF BINDING,0.071756,0.052356,0.066292,0,0
4,GO MAMMARY GLAND MORPHOGENESIS,0.049212,0.052351,0.12388,0,0
4,GO GLIOGENESIS,0.21738,0.052312,0.057369,0,0
4,GO REGULATION OF MICROTUBULE BINDING,0.61402,0.052266,0.032697,0,0
4,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.32592,0.052214,0.041628,0,0
4,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.67206,0.052148,0.02467,0,0
4,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.13549,0.052128,0.1119,0,0
4,GO MITOTIC DNA REPLICATION,0.61687,0.05206,0.035324,0,0
4,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.37608,0.051991,0.048413,0,0
4,GO NEGATIVE T CELL SELECTION,0.35674,0.051977,0.026945,0,0
4,GO CELLULAR RESPONSE TO NUTRIENT,0.30446,0.051906,0.064916,0,0
4,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.25246,0.051814,0.056482,0,0
4,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.42133,0.051709,0.03278,0,0
4,GO BASE EXCISION REPAIR AP SITE FORMATION,0.087731,0.051698,0.077594,0,0
4,GO HORMONE BIOSYNTHETIC PROCESS,0.16904,0.051607,0.077351,0,0
4,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.26789,0.051545,0.043138,0,0
4,GO RESPONSE TO ESTROGEN,0.61117,0.051504,0.028081,0,0
4,GO MUSCLE TISSUE DEVELOPMENT,0.42602,0.051368,0.034389,0,0
4,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.23286,0.051244,0.081727,0,0
4,GO CANONICAL WNT SIGNALING PATHWAY,0.61402,0.051191,0.028745,0,0
4,GO LENS FIBER CELL DEVELOPMENT,0.44752,0.051182,0.045667,0,0
4,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.15683,0.05109,0.065414,0,0
4,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.92738,0.050949,-0.025385,0,0
4,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.40286,0.050911,0.071473,0,0
4,GO REGULATION OF CELL DIFFERENTIATION,0.35043,0.050828,0.040835,0,0
4,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.096327,0.050707,0.099904,0,0
4,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.24745,0.050688,0.073836,0,0
4,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.13979,0.050679,0.046147,0,0
4,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.51035,0.050647,0.021595,0,0
4,GO CELLULAR RESPONSE TO CAMP,0.081168,0.05057,0.078437,0,0
4,GO PROTEIN AUTOPHOSPHORYLATION,0.12924,0.050499,0.069064,0,0
4,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.43312,0.050454,0.026217,0,0
4,GO RESPONSE TO AMINO ACID STARVATION,0.13763,0.050364,0.073369,0,0
4,GO IRON ION TRANSMEMBRANE TRANSPORT,0.19979,0.050333,0.076465,0,0
4,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.81896,0.050324,-0.014218,0,0
4,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.51035,0.050228,0.029418,0,0
4,GO ENDOTHELIAL CELL PROLIFERATION,0.13234,0.050205,0.07347,0,0
4,GO MUSCLE STRUCTURE DEVELOPMENT,0.17029,0.050128,0.051405,0,0
4,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.77829,0.050078,-0.0018547,0,0
4,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.13763,0.050029,0.094556,0,0
4,GO REGULATION OF SPINDLE ASSEMBLY,0.091558,0.049963,0.078402,0,0
4,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.94671,0.049933,-0.013912,0,0
4,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.72603,0.049897,0.048577,0,0
4,GO EMBRYONIC MORPHOGENESIS,0.31997,0.049872,0.04089,0,0
4,GO MEMORY,0.23128,0.049865,0.053785,0,0
4,GO ESTABLISHMENT OF CELL POLARITY,0.38267,0.049803,0.047899,0,0
4,GO BLOOD VESSEL MORPHOGENESIS,0.23927,0.049678,0.056112,0,0
4,GO REGULATION OF INTRACELLULAR TRANSPORT,0.16778,0.049671,0.048536,0,0
4,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.34008,0.049509,0.037425,0,0
4,GO POSITIVE REGULATION OF ERAD PATHWAY,0.31604,0.04931,0.057256,0,0
4,GO VASCULOGENESIS,0.89846,0.049176,-0.0041864,0,0
4,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.33396,0.049148,0.039904,0,0
4,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.31604,0.049059,0.061043,0,0
4,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.21288,0.049046,0.065799,0,0
4,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.24911,0.049035,0.085006,0,0
4,GO EXTRACELLULAR TRANSPORT,0.16654,0.049034,0.07334,0,0
4,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.318,0.049021,0.044881,0,0
4,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.19003,0.048663,0.055963,0,0
4,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.25414,0.048505,0.051323,0,0
4,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.16904,0.048401,0.10161,0,0
4,GO FOREBRAIN NEURON DEVELOPMENT,0.8379,0.04828,0.044427,0,0
4,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.21738,0.048251,0.051041,0,0
4,GO SERTOLI CELL DIFFERENTIATION,0.20699,0.048217,0.068312,0,0
4,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.29315,0.048045,0.051091,0,0
4,GO DERMATAN SULFATE METABOLIC PROCESS,0.9306,0.048038,-0.006816,0,0
4,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.1873,0.047939,0.071279,0,0
4,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.084034,0.04792,0.12569,0,0
4,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.44269,0.047916,0.11727,0,0
4,GO LEUKOCYTE HOMEOSTASIS,0.11183,0.047911,0.073899,0,0
4,GO MUSCLE CELL PROLIFERATION,0.18062,0.047789,0.060642,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.91451,0.047669,0.0076857,0,0
4,GO REGULATION OF TUBULIN DEACETYLATION,0.5314,0.047666,0.051938,0,0
4,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.29315,0.047623,0.067193,0,0
4,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.12421,0.047431,0.058095,0,0
4,GO FIBROBLAST MIGRATION,0.41899,0.047421,0.046788,0,0
4,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.16163,0.047373,0.056584,0,0
4,GO INTERFERON GAMMA PRODUCTION,0.086237,0.047325,0.079379,0,0
4,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.20409,0.047248,0.058327,0,0
4,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.067397,0.047118,0.065709,0,0
4,GO REGULATION OF ORGANELLE ORGANIZATION,0.19557,0.04707,0.038976,0,0
4,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.72907,0.04705,0.012407,0,0
4,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.58864,0.047048,0.039071,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.11092,0.04704,0.075972,0,0
4,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.18866,0.046933,0.072551,0,0
4,GO PROTEIN HETEROOLIGOMERIZATION,0.17411,0.046928,0.054186,0,0
4,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.3871,0.046916,0.039509,0,0
4,GO NEURON DEATH,0.14088,0.046859,0.053545,0,0
4,GO DETOXIFICATION,0.10823,0.046844,0.080308,0,0
4,GO REGIONALIZATION,0.15447,0.046839,0.064714,0,0
4,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.46713,0.04683,0.030621,0,0
4,GO PHOTOPERIODISM,0.22971,0.046764,0.066723,0,0
4,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.28033,0.046714,0.044476,0,0
4,GO CIRCULATORY SYSTEM DEVELOPMENT,0.318,0.046696,0.043802,0,0
4,GO VESICLE CYTOSKELETAL TRAFFICKING,0.29689,0.046613,0.053648,0,0
4,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.14755,0.046429,0.059539,0,0
4,GO HEAD MORPHOGENESIS,0.797,0.046428,0.017892,0,0
4,GO REGULATION OF ENDOCYTIC RECYCLING,0.68689,0.046292,0.038178,0,0
4,GO PROTEIN DEPHOSPHORYLATION,0.13027,0.046046,0.048579,0,0
4,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.20409,0.045996,0.059946,0,0
4,GO REGULATION OF PINOCYTOSIS,0.66616,0.045953,0.012018,0,0
4,GO EMBRYO DEVELOPMENT,0.3442,0.04589,0.034548,0,0
4,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.22195,0.045889,0.062222,0,0
4,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.19697,0.045872,0.077523,0,0
4,GO INTRA S DNA DAMAGE CHECKPOINT,0.43789,0.045871,0.031883,0,0
4,GO TAXIS,0.43075,0.045864,0.036834,0,0
4,GO AMINO SUGAR METABOLIC PROCESS,0.68094,0.045729,0.029416,0,0
4,GO RECEPTOR METABOLIC PROCESS,0.32195,0.045689,0.050388,0,0
4,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.13444,0.045592,0.060549,0,0
4,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.2913,0.045502,0.055607,0,0
4,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.34213,0.045469,0.051299,0,0
4,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.32792,0.04546,0.044879,0,0
4,GO CARDIAC CHAMBER DEVELOPMENT,0.5665,0.045389,0.03507,0,0
4,GO FORMATION OF PRIMARY GERM LAYER,0.29877,0.045135,0.0559,0,0
4,GO CARDIOLIPIN METABOLIC PROCESS,0.31997,0.045102,0.031277,0,0
4,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.066192,0.045078,0.122,0,0
4,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.15447,0.045051,0.056959,0,0
4,GO MULTICELLULAR ORGANISM REPRODUCTION,0.084034,0.045006,0.048017,0,0
4,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.69286,0.044838,0.016188,0,0
4,GO REGULATION OF METANEPHROS DEVELOPMENT,0.33803,0.044826,0.080872,0,0
4,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.27317,0.044779,0.022548,0,0
4,GO ENTRAINMENT OF CIRCADIAN CLOCK,0.11183,0.044757,0.0898,0,0
4,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.98869,0.044748,-0.0121,0,0
4,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.22195,0.044744,0.063779,0,0
4,GO NOREPINEPHRINE SECRETION,0.75356,0.044742,0.021064,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.44752,0.044736,0.041475,0,0
4,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.92094,0.044669,-0.00044501,0,0
4,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.1653,0.044637,0.061664,0,0
4,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.11837,0.044625,0.073422,0,0
4,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.24745,0.044578,0.082172,0,0
4,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.33599,0.044551,0.047564,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.38267,0.044518,0.040286,0,0
4,GO SULFATE TRANSPORT,0.21889,0.044428,0.068199,0,0
4,GO POST EMBRYONIC DEVELOPMENT,0.26267,0.044403,0.059451,0,0
4,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.079071,0.044397,0.074844,0,0
4,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,0.22042,0.044377,0.056294,0,0
4,GO REGULATION OF PROTEIN FOLDING,0.086981,0.044352,0.075156,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.94026,0.044337,-0.0016489,0,0
4,GO THYMIC T CELL SELECTION,0.1252,0.044307,0.056541,0,0
4,GO DRUG CATABOLIC PROCESS,0.15921,0.044291,0.10296,0,0
4,GO REGULATION OF CELL PROJECTION ORGANIZATION,0.797,0.04428,0.017715,0,0
4,GO SULFUR COMPOUND METABOLIC PROCESS,0.040981,0.044215,0.07744,0,0
4,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.16285,0.044195,0.050704,0,0
4,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.75048,0.044176,0.032363,0,0
4,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.20265,0.044159,0.044845,0,0
4,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.26267,0.044099,0.06085,0,0
4,GO MITOCHONDRIAL RNA PROCESSING,0.68689,0.044086,0.042056,0,0
4,GO TUBULIN DEACETYLATION,0.47963,0.04398,0.050354,0,0
4,GO WHITE FAT CELL DIFFERENTIATION,0.17669,0.043958,0.065617,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.069238,0.043935,0.06743,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.99515,0.043833,0.0056424,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.5314,0.043758,0.032063,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.29689,0.043666,0.069941,0,0
4,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.075009,0.043664,0.066523,0,0
4,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.86649,0.043641,-0.025517,0,0
4,GO SULFUR COMPOUND CATABOLIC PROCESS,0.36311,0.043573,0.033992,0,0
4,GO MEIOSIS I CELL CYCLE PROCESS,0.62545,0.043561,0.013747,0,0
4,GO REGULATION OF PROTEIN POLYMERIZATION,0.21288,0.04355,0.049231,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.62258,0.04354,0.036773,0,0
4,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,0.1793,0.043536,0.088625,0,0
4,GO EMBRYONIC DIGIT MORPHOGENESIS,0.44028,0.043469,0.043188,0,0
4,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.86649,0.043413,0.026052,0,0
4,GO SPINAL CORD PATTERNING,0.44269,0.043309,0.080917,0,0
4,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.26789,0.043236,0.034615,0,0
4,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.63697,0.043219,0.025267,0,0
4,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,0.99515,0.043175,0.010602,0,0
4,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.33194,0.043132,0.03333,0,0
4,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,0.73212,0.043103,0.028361,0,0
4,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.14642,0.043095,0.084217,0,0
4,GO MITOCHONDRION ORGANIZATION,0.029754,0.043025,0.060351,0,0
4,GO ACYLGLYCEROL HOMEOSTASIS,0.318,0.042988,0.050854,0,0
4,GO MITOCHONDRIAL TRANSPORT,0.084763,0.042983,0.048802,0,0
4,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.41203,0.042952,0.092067,0,0
4,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.57476,0.042923,0.025652,0,0
4,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.23605,0.042842,0.054476,0,0
4,GO REGULATION OF TRANSPORTER ACTIVITY,0.46218,0.042776,0.034844,0,0
4,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.31021,0.042769,0.045601,0,0
4,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.080464,0.042664,0.069571,0,0
4,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,0.13549,0.04258,0.061604,0,0
4,GO MYELOID CELL HOMEOSTASIS,0.060988,0.042518,0.086675,0,0
4,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.6055,0.042512,0.022513,0,0
4,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.97253,0.042496,-0.022432,0,0
4,GO PROTEIN OXIDATION,0.59144,0.042419,0.037218,0,0
4,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.62258,0.042327,0.024037,0,0
4,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.3442,0.042235,0.059563,0,0
4,GO SYNAPTIC SIGNALING,0.82211,0.042129,0.019475,0,0
4,GO MEIOTIC CELL CYCLE PROCESS,0.35674,0.041825,0.029033,0,0
4,GO SULFUR AMINO ACID METABOLIC PROCESS,0.23445,0.041811,0.047652,0,0
4,GO IRON ION HOMEOSTASIS,0.17029,0.041787,0.062735,0,0
4,GO ERK1 AND ERK2 CASCADE,0.36956,0.041634,0.049063,0,0
4,GO CELL JUNCTION DISASSEMBLY,0.38488,0.041477,0.047354,0,0
4,GO ESCRT COMPLEX DISASSEMBLY,0.63408,0.04146,0.033851,0,0
4,GO PIGMENT METABOLIC PROCESS,0.60834,0.04129,0.026724,0,0
4,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.15683,0.041284,0.090494,0,0
4,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.23286,0.041144,0.061767,0,0
4,GO RESPONSE TO INTERLEUKIN 7,0.20554,0.041102,0.069189,0,0
4,GO GENETIC IMPRINTING,0.41434,0.040967,0.055719,0,0
4,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.84107,0.040935,0.010507,0,0
4,GO REGENERATION,0.32592,0.040896,0.046235,0,0
4,GO RESPONSE TO AXON INJURY,0.37173,0.040809,0.053407,0,0
4,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.19979,0.040796,0.079087,0,0
4,GO ASTRAL MICROTUBULE ORGANIZATION,0.84107,0.040743,-0.0020883,0,0
4,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.53406,0.040675,0.034922,0,0
4,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.74435,0.040623,0.015903,0,0
4,GO PEPTIDYL PROLINE MODIFICATION,0.29502,0.040566,0.051981,0,0
4,GO TISSUE REGENERATION,0.1146,0.040506,0.078316,0,0
4,GO VASCULATURE DEVELOPMENT,0.35463,0.040455,0.045262,0,0
4,GO SMOOTH MUSCLE CONTRACTION,0.37608,0.040442,0.034517,0,0
4,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.28761,0.040392,0.064361,0,0
4,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.32792,0.040392,0.07239,0,0
4,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.79075,0.04035,0.023977,0,0
4,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.12421,0.040346,0.064849,0,0
4,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.30637,0.040302,0.055269,0,0
4,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.52082,0.040261,0.055058,0,0
4,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.5394,0.040255,0.03219,0,0
4,GO RESPONSE TO ORGANOPHOSPHORUS,0.16163,0.040245,0.054694,0,0
4,GO MESODERM MORPHOGENESIS,0.21288,0.040223,0.057604,0,0
4,GO ARGININE METABOLIC PROCESS,0.63408,0.040189,0.055977,0,0
4,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.22348,0.040103,0.044193,0,0
4,GO CELL CELL SIGNALING BY WNT,0.35674,0.040095,0.040312,0,0
4,GO NEGATIVE REGULATION OF GENE SILENCING,0.49743,0.040057,0.012251,0,0
4,GO LEFT RIGHT PATTERN FORMATION,0.48468,0.03994,0.047668,0,0
4,GO ORGANELLE LOCALIZATION,0.091558,0.03988,0.044596,0,0
4,GO REGULATION OF GLIAL CELL PROLIFERATION,0.16407,0.039802,0.090687,0,0
4,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.8379,0.039678,0.031989,0,0
4,GO DETECTION OF LIGHT STIMULUS,0.12421,0.039656,0.02723,0,0
4,GO CYTOSKELETON ORGANIZATION,0.44269,0.039612,0.03277,0,0
4,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.33599,0.039589,0.037734,0,0
4,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.47963,0.039453,0.033625,0,0
4,GO MACROPHAGE CHEMOTAXIS,0.22503,0.039395,0.04297,0,0
4,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.26267,0.03935,0.057017,0,0
4,GO CELL FATE DETERMINATION,0.24416,0.039304,0.077782,0,0
4,GO MULTICELLULAR ORGANISM GROWTH,0.5314,0.03928,0.036445,0,0
4,GO PROTEIN STABILIZATION,0.22971,0.039233,0.044279,0,0
4,GO ANIMAL ORGAN MORPHOGENESIS,0.36741,0.039118,0.040068,0,0
4,GO RESPONSE TO CAMP,0.1262,0.039087,0.067127,0,0
4,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.16654,0.038921,0.075379,0,0
4,GO REGULATION OF LYMPHOCYTE MIGRATION,0.070488,0.038874,0.10173,0,0
4,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.47963,0.038869,0.042929,0,0
4,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,0.45238,0.038844,0.033351,0,0
4,GO MYELOID CELL APOPTOTIC PROCESS,0.45972,0.038824,0.047703,0,0
4,GO MITOCHONDRION MORPHOGENESIS,0.99515,0.038789,-0.0045349,0,0
4,GO HETEROCHROMATIN ORGANIZATION,0.42133,0.038774,0.029298,0,0
4,GO PEPTIDYL AMINO ACID MODIFICATION,0.15565,0.038768,0.043407,0,0
4,GO HAIR FOLLICLE MATURATION,0.92094,0.038684,0.019867,0,0
4,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.32792,0.038658,0.054766,0,0
4,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.11742,0.038576,0.12661,0,0
4,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.41434,0.038541,0.037861,0,0
4,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.13444,0.038538,0.061285,0,0
4,GO SENSORY ORGAN MORPHOGENESIS,0.63986,0.038396,0.019539,0,0
4,GO POSITIVE THYMIC T CELL SELECTION,0.11367,0.038345,0.073381,0,0
4,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.34213,0.038286,0.062399,0,0
4,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.47461,0.038277,0.057765,0,0
4,GO AORTA DEVELOPMENT,0.92738,0.038251,-0.0096826,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.31604,0.038242,0.032816,0,0
4,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.86968,0.038088,-0.027119,0,0
4,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.33803,0.038035,0.041217,0,0
4,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.19838,0.037976,0.071326,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS,0.14983,0.037964,0.059122,0,0
4,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.42602,0.03794,0.047427,0,0
4,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.69586,0.037858,0.023424,0,0
4,GO NEGATIVE REGULATION OF JNK CASCADE,0.38267,0.037835,0.047365,0,0
4,GO PROTEIN INSERTION INTO MEMBRANE,0.2114,0.037703,0.044022,0,0
4,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.32195,0.037672,0.0684,0,0
4,GO NEURON PROJECTION EXTENSION,0.96284,0.037481,0.00074701,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.23927,0.037438,0.051062,0,0
4,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.87606,0.03741,0.0058284,0,0
4,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.72907,0.037323,0.022741,0,0
4,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.11183,0.037315,0.068927,0,0
4,GO INTERLEUKIN 17 PRODUCTION,0.090782,0.037275,0.10992,0,0
4,GO PINOCYTOSIS,0.36741,0.037132,0.033911,0,0
4,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.37173,0.03709,0.057113,0,0
4,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.47963,0.037052,0.039318,0,0
4,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.39832,0.036982,0.04761,0,0
4,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,0.81581,0.036806,0.0098338,0,0
4,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.4451,0.03669,0.023721,0,0
4,GO REGULATION OF CELLULAR EXTRAVASATION,0.32792,0.036675,0.074503,0,0
4,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,0.21738,0.036661,0.037264,0,0
4,GO SCHWANN CELL DIFFERENTIATION,0.50776,0.036635,0.033717,0,0
4,GO MITOCHONDRIAL FUSION,0.72603,0.036517,0.03457,0,0
4,GO EMBRYONIC ORGAN MORPHOGENESIS,0.94026,0.03634,0.0064204,0,0
4,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.32792,0.036299,0.070938,0,0
4,GO METENCEPHALON DEVELOPMENT,0.35463,0.036251,0.052856,0,0
4,GO RESPONSE TO FOOD,0.64276,0.036241,0.0123,0,0
4,GO NATURAL KILLER CELL DIFFERENTIATION,0.56376,0.036237,0.042097,0,0
4,GO MALE SEX DETERMINATION,0.32792,0.036236,0.060885,0,0
4,GO PROTEIN COMPLEX OLIGOMERIZATION,0.076344,0.036229,0.0623,0,0
4,GO NEUROMUSCULAR PROCESS,0.71693,0.036073,0.027132,0,0
4,GO GLIAL CELL DIFFERENTIATION,0.18866,0.035957,0.063872,0,0
4,GO GENITALIA DEVELOPMENT,0.11002,0.035833,0.070606,0,0
4,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.58307,0.035825,0.03279,0,0
4,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.18327,0.035654,0.036933,0,0
4,GO HISTONE H3 DEACETYLATION,0.53672,0.035641,0.03007,0,0
4,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.12322,0.035605,0.074123,0,0
4,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.33599,0.035597,0.045377,0,0
4,GO MODULATION BY VIRUS OF HOST PROCESS,0.17156,0.035529,0.065815,0,0
4,GO LONG TERM SYNAPTIC POTENTIATION,0.62258,0.035437,0.027074,0,0
4,GO DEVELOPMENTAL GROWTH,0.67501,0.03543,0.021371,0,0
4,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.57752,0.035163,0.036742,0,0
4,GO OVULATION CYCLE,0.66028,0.035121,0.023312,0,0
4,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.10299,0.034993,0.049089,0,0
4,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.318,0.034848,0.075379,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.15098,0.034811,0.051721,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.25078,0.03477,0.065875,0,0
4,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.83474,0.034583,0.011299,0,0
4,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.46713,0.034569,0.044374,0,0
4,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.63697,0.034519,0.039685,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.7814,0.034472,0.02123,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.71391,0.034371,-0.015402,0,0
4,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.48215,0.034348,0.064595,0,0
4,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.53406,0.034319,0.031515,0,0
4,GO REGULATION OF NERVOUS SYSTEM PROCESS,0.6312,0.034279,0.025547,0,0
4,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.39832,0.034265,0.053584,0,0
4,GO POSITIVE REGULATION OF CELL DIVISION,0.36098,0.034185,0.039336,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.59705,0.034164,0.033207,0,0
4,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,0.77519,0.034154,0.048864,0,0
4,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.41203,0.034051,0.051026,0,0
4,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.36741,0.033961,0.038101,0,0
4,GO INTERMEMBRANE LIPID TRANSFER,0.17411,0.033959,0.075561,0,0
4,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.70787,0.033921,-0.011458,0,0
4,GO BONE MATURATION,0.54208,0.033919,-0.029984,0,0
4,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.93382,0.033865,0.011684,0,0
4,GO T CELL DIFFERENTIATION IN THYMUS,0.99838,0.033805,0.0083676,0,0
4,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.62545,0.033683,0.026051,0,0
4,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.83158,0.033625,0.017075,0,0
4,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.17283,0.033613,0.043974,0,0
4,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.48215,0.033538,0.029586,0,0
4,GO CELLULAR IRON ION HOMEOSTASIS,0.28213,0.033387,0.055915,0,0
4,GO HEART FORMATION,0.67798,0.033303,0.037124,0,0
4,GO RETINA LAYER FORMATION,0.27495,0.03324,0.10667,0,0
4,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.10471,0.033207,0.1222,0,0
4,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.42133,0.033154,0.054713,0,0
4,GO REGULATION OF VIRAL TRANSCRIPTION,0.5583,0.033104,0.016806,0,0
4,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.37827,0.033062,0.04388,0,0
4,GO EAR MORPHOGENESIS,0.68094,0.033044,0.012917,0,0
4,GO SYNAPSE ORGANIZATION,0.64858,0.032918,-0.014019,0,0
4,GO APOPTOTIC CELL CLEARANCE,0.68988,0.032861,0.0061171,0,0
4,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.084034,0.032821,0.071015,0,0
4,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.22503,0.032714,0.067699,0,0
4,GO SALIVARY GLAND DEVELOPMENT,0.62545,0.032667,0.042597,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.30255,0.032632,0.038812,0,0
4,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.797,0.03261,-0.015551,0,0
4,GO MACROMOLECULE CATABOLIC PROCESS,0.085497,0.032538,0.04717,0,0
4,GO MALE GAMETE GENERATION,0.12421,0.032502,0.042375,0,0
4,GO ENDODERM DEVELOPMENT,0.58864,0.032475,0.027362,0,0
4,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.30637,0.032045,0.061354,0,0
4,GO PEPTIDE CATABOLIC PROCESS,0.29315,0.031923,0.068757,0,0
4,GO PYRUVATE METABOLIC PROCESS,0.24911,0.03189,0.056328,0,0
4,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.1754,0.031771,0.046197,0,0
4,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.19838,0.031752,0.060914,0,0
4,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.71089,0.031698,0.035289,0,0
4,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.87287,0.031492,-0.0075734,0,0
4,GO CELL VOLUME HOMEOSTASIS,0.34627,0.031469,0.049538,0,0
4,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.86012,0.031378,-0.0063429,0,0
4,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.60268,0.031281,0.034222,0,0
4,GO REGULATION OF CELL SIZE,0.86331,0.031237,0.0097592,0,0
4,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.71391,0.031178,0.015474,0,0
4,GO RESPONSE TO INTERLEUKIN 4,0.31409,0.031028,0.043617,0,0
4,GO HEMOGLOBIN METABOLIC PROCESS,0.14419,0.031006,0.062927,0,0
4,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.86331,0.030986,-0.017038,0,0
4,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.85694,0.030847,0.0051602,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.70486,0.030801,-0.012498,0,0
4,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.35043,0.03072,0.016651,0,0
4,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.66321,0.030552,0.017961,0,0
4,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.23128,0.030469,0.047576,0,0
4,GO LAMELLIPODIUM ASSEMBLY,0.52345,0.030441,0.041582,0,0
4,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.87606,0.030336,0.0016997,0,0
4,GO NAD METABOLIC PROCESS,0.45972,0.03029,0.051401,0,0
4,GO GERM CELL DEVELOPMENT,0.40743,0.030239,0.024856,0,0
4,GO PROTEIN TETRAMERIZATION,0.94348,0.030234,0.01417,0,0
4,GO FOREBRAIN GENERATION OF NEURONS,0.41203,0.030151,0.082105,0,0
4,GO DENSE CORE GRANULE TRANSPORT,0.49231,0.030082,0.091415,0,0
4,GO MEIOTIC CELL CYCLE,0.31021,0.030065,0.033681,0,0
4,GO OVULATION,0.64276,0.030035,0.023814,0,0
4,GO NEURON DEVELOPMENT,0.92416,0.029983,0.0033114,0,0
4,GO C4 DICARBOXYLATE TRANSPORT,0.21738,0.029845,0.056409,0,0
4,GO FEMALE SEX DIFFERENTIATION,0.40743,0.029732,0.039485,0,0
4,GO PROTEIN POLYMERIZATION,0.32993,0.029714,0.039636,0,0
4,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.90488,0.029598,0.00016424,0,0
4,GO RESPONSE TO FLUID SHEAR STRESS,0.35043,0.029533,0.065102,0,0
4,GO METANEPHRIC NEPHRON DEVELOPMENT,0.18461,0.029501,0.085737,0,0
4,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.49487,0.029403,0.045135,0,0
4,GO INNER EAR MORPHOGENESIS,0.70185,0.029376,0.018201,0,0
4,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.76281,0.029246,0.017252,0,0
4,GO SPROUTING ANGIOGENESIS,0.93382,0.029233,0.0046599,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.61687,0.029148,0.022223,0,0
4,GO REGULATION OF HEART MORPHOGENESIS,0.83158,0.029139,-0.016285,0,0
4,GO OOGENESIS,0.87926,0.029102,0.013126,0,0
4,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.29502,0.029073,0.031386,0,0
4,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.013856,0.029039,0.091036,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.70486,0.029014,0.032871,0,0
4,GO OUTFLOW TRACT MORPHOGENESIS,0.63986,0.02896,-0.020389,0,0
4,GO DEMETHYLATION,0.38047,0.028918,0.037033,0,0
4,GO GAMETE GENERATION,0.15447,0.028775,0.040218,0,0
4,GO EMBRYONIC PATTERN SPECIFICATION,0.58864,0.028698,0.028385,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.80953,0.028606,0.017679,0,0
4,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.86649,0.028588,0.032689,0,0
4,GO LACTATION,0.75356,0.028542,0.03143,0,0
4,GO SECONDARY HEART FIELD SPECIFICATION,0.51296,0.028324,0.090655,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,0.57476,0.028309,-0.018039,0,0
4,GO EYE MORPHOGENESIS,0.80012,0.028239,0.016881,0,0
4,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.64276,0.028218,0.03092,0,0
4,GO AMP METABOLIC PROCESS,0.95639,0.028109,-0.017951,0,0
4,GO HEART DEVELOPMENT,0.62832,0.027964,0.02605,0,0
4,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.70185,0.027828,0.022777,0,0
4,GO MICROTUBULE BUNDLE FORMATION,0.34213,0.027827,0.044408,0,0
4,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.1313,0.027767,0.093061,0,0
4,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.68689,0.027698,0.016342,0,0
4,GO OSTEOBLAST DIFFERENTIATION,0.80639,0.027602,0.018167,0,0
4,GO CELL PROJECTION ORGANIZATION,0.80639,0.027486,0.014611,0,0
4,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.92416,0.02718,0.0055108,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE,0.318,0.027164,0.03323,0,0
4,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,0.47461,0.027018,0.035513,0,0
4,GO REGULATION OF GOLGI ORGANIZATION,0.49231,0.027015,0.046831,0,0
4,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,0.22814,0.026966,0.038212,0,0
4,GO REGULATION OF CELL MORPHOGENESIS,0.94993,0.026914,0.0097859,0,0
4,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.29502,0.026841,0.046666,0,0
4,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,0.7814,0.026831,-0.0034565,0,0
4,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.26789,0.026816,0.070185,0,0
4,GO ASTROCYTE ACTIVATION,0.58029,0.026748,0.032297,0,0
4,GO CORTICAL CYTOSKELETON ORGANIZATION,0.66616,0.026734,0.036569,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.90167,0.026688,0.0047268,0,0
4,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.27673,0.026354,0.035192,0,0
4,GO AMINO ACID ACTIVATION,0.67206,0.0262,0.024868,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.41434,0.025991,0.040795,0,0
4,GO SENSORY ORGAN DEVELOPMENT,0.77829,0.025984,0.014491,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,0.25753,0.025979,0.041041,0,0
4,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.97899,0.025899,-0.014492,0,0
4,GO SPERM AXONEME ASSEMBLY,0.99838,0.025839,0.0088223,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1,0.025809,0.005873,0,0
4,GO ANION HOMEOSTASIS,0.40514,0.025699,0.049443,0,0
4,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.76899,0.02569,0.035503,0,0
4,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,0.91451,0.025619,0.014761,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.92416,0.025583,0.018619,0,0
4,GO TRNA 5 LEADER REMOVAL,0.4355,0.025409,0.036331,0,0
4,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.29502,0.025403,0.083691,0,0
4,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.99838,0.025188,-0.001037,0,0
4,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.18194,0.025112,0.048561,0,0
4,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.71089,0.025087,0.020216,0,0
4,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.23766,0.024933,0.07478,0,0
4,GO REGULATION OF PROTEIN SUMOYLATION,0.94993,0.024834,0.010885,0,0
4,GO REGULATION OF TRANS SYNAPTIC SIGNALING,0.98546,0.024819,0.0097509,0,0
4,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.6312,0.024815,0.029541,0,0
4,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.77829,0.024698,0.032459,0,0
4,GO TOXIN TRANSPORT,0.62258,0.024584,0.041369,0,0
4,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.28213,0.024522,0.067961,0,0
4,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.64567,0.024516,0.016251,0,0
4,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.60834,0.024516,0.035664,0,0
4,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.5665,0.024502,-0.019216,0,0
4,GO NEUROGENESIS,0.99192,0.024415,0.0070544,0,0
4,GO RESPONSE TO INTERLEUKIN 12,0.38267,0.024381,0.041443,0,0
4,GO SYNAPTIC VESICLE TRANSPORT,0.74741,0.024375,0.02062,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.797,0.024202,-0.026869,0,0
4,GO ACTIVATION OF MAPKKK ACTIVITY,0.95639,0.024168,0.033431,0,0
4,GO RESPONSE TO UV C,0.6055,0.024145,0.028697,0,0
4,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.3871,0.024086,0.05294,0,0
4,GO HISTONE MONOUBIQUITINATION,0.5583,0.024035,0.024266,0,0
4,GO NADPH REGENERATION,0.69885,0.023964,0.032711,0,0
4,GO CHONDROCYTE DIFFERENTIATION,0.65734,0.023922,0.03211,0,0
4,GO AMINO ACID TRANSPORT,0.084034,0.02386,0.084501,0,0
4,GO ONE CARBON METABOLIC PROCESS,0.99515,0.023831,-0.0054308,0,0
4,GO URONIC ACID METABOLIC PROCESS,0.57752,0.023798,0.021191,0,0
4,GO CELLULAR AMIDE METABOLIC PROCESS,0.51035,0.023686,0.027675,0,0
4,GO PROTEIN NITROSYLATION,0.81581,0.023682,-0.016229,0,0
4,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.75356,0.02367,0.013037,0,0
4,GO REGULATION OF CATION CHANNEL ACTIVITY,0.89205,0.023405,-0.0031023,0,0
4,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.35253,0.023401,0.045657,0,0
4,GO LACTATE METABOLIC PROCESS,0.64567,0.02324,0.027634,0,0
4,GO SYNAPTIC VESICLE BUDDING,0.51557,0.023239,0.049711,0,0
4,GO CARDIAC SEPTUM DEVELOPMENT,0.92416,0.023171,0.012511,0,0
4,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.99192,0.023158,-0.0058043,0,0
4,GO SEX DIFFERENTIATION,0.15447,0.023109,0.056385,0,0
4,GO CRANIAL NERVE MORPHOGENESIS,0.5394,0.023071,0.038802,0,0
4,GO DIACYLGLYCEROL METABOLIC PROCESS,0.48215,0.023031,0.041622,0,0
4,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.37173,0.022922,0.0443,0,0
4,GO ECTODERM DEVELOPMENT,0.20122,0.02285,0.055545,0,0
4,GO CYTOKINESIS,0.5394,0.022749,0.028651,0,0
4,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.98869,0.022739,0.01366,0,0
4,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.93704,0.022717,0.0019327,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.9113,0.022597,0.016156,0,0
4,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,0.41434,0.022583,0.051218,0,0
4,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.81896,0.022526,0.0013542,0,0
4,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.25246,0.022521,0.05178,0,0
4,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.40514,0.02251,0.030766,0,0
4,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.42602,0.022454,0.03172,0,0
4,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.68392,0.022443,0.024898,0,0
4,GO NEPHRON MORPHOGENESIS,0.59424,0.022441,0.023947,0,0
4,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.77829,0.022433,0.029629,0,0
4,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.37173,0.022244,0.043943,0,0
4,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.56925,0.02218,0.037336,0,0
4,GO NEUROTROPHIN SIGNALING PATHWAY,0.66028,0.02215,0.03123,0,0
4,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.71391,0.022127,0.0024638,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.98546,0.022121,0.0054072,0,0
4,GO MESENCHYME DEVELOPMENT,0.94993,0.022104,-0.0064574,0,0
4,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.90488,0.022103,-0.015386,0,0
4,GO NOTOCHORD DEVELOPMENT,0.96607,0.02205,-0.025896,0,0
4,GO PROTEASOME ASSEMBLY,0.96607,0.022033,0.0027258,0,0
4,GO CILIUM MOVEMENT,0.32195,0.021899,0.031425,0,0
4,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.2913,0.021807,0.065267,0,0
4,GO MODULATION BY HOST OF VIRAL PROCESS,0.5583,0.021758,0.02172,0,0
4,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.80953,0.021577,0.012555,0,0
4,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.56376,0.021555,0.047035,0,0
4,GO HEART GROWTH,0.81267,0.02132,0.017113,0,0
4,GO SKELETAL SYSTEM DEVELOPMENT,0.71391,0.021312,0.026007,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.572,0.021236,0.023794,0,0
4,GO RENAL SODIUM EXCRETION,0.2458,0.021197,0.059343,0,0
4,GO POSITIVE REGULATION OF CELL DEVELOPMENT,0.79387,0.02115,0.020433,0,0
4,GO REGULATION OF NUCLEAR DIVISION,0.34627,0.02101,0.035086,0,0
4,GO MEMBRANE DOCKING,0.35674,0.021008,0.037148,0,0
4,GO ADHERENS JUNCTION ASSEMBLY,0.36741,0.021004,0.079147,0,0
4,GO MITOCHONDRIAL FISSION,0.75356,0.020749,0.033276,0,0
4,GO MACROMOLECULE DEACYLATION,0.46962,0.020739,0.033063,0,0
4,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.71693,0.020677,0.011532,0,0
4,GO RESPONSE TO LIGHT STIMULUS,0.95316,0.02066,0.0061317,0,0
4,GO REGULATION OF CHROMATIN ORGANIZATION,0.46962,0.020621,0.025837,0,0
4,GO NEGATIVE REGULATION OF NEURON DEATH,0.47211,0.020597,0.032277,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.90488,0.020581,-0.0015439,0,0
4,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.42838,0.020559,0.03551,0,0
4,GO REGULATION OF HISTONE MODIFICATION,0.23605,0.020544,0.038036,0,0
4,GO RESPONSE TO SALT,0.40514,0.020499,0.043401,0,0
4,GO OVULATION CYCLE PROCESS,0.70787,0.020422,0.027718,0,0
4,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,0.46713,0.020393,0.028973,0,0
4,GO RESPONSE TO PROSTAGLANDIN,0.82842,0.020392,0.024219,0,0
4,GO ODONTOGENESIS,0.45482,0.020319,-0.035032,0,0
4,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,0.51296,0.020282,0.027421,0,0
4,GO REGULATION OF CELL DEVELOPMENT,0.9306,0.020145,0.0073632,0,0
4,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.88245,0.020106,0.01374,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.85694,0.020106,-0.010882,0,0
4,GO HINDBRAIN DEVELOPMENT,0.20409,0.019895,0.067977,0,0
4,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.65734,0.019852,0.006285,0,0
4,GO NUCLEOTIDE PHOSPHORYLATION,0.41434,0.019845,0.045536,0,0
4,GO REGULATION OF PHAGOCYTOSIS,0.28578,0.019843,0.057303,0,0
4,GO CHROMATIN SILENCING AT TELOMERE,0.318,0.01983,0.046584,0,0
4,GO IRON COORDINATION ENTITY TRANSPORT,0.91451,0.0198,0.018817,0,0
4,GO CARDIAC MYOFIBRIL ASSEMBLY,0.81267,0.019785,0.020957,0,0
4,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.7659,0.019708,-0.0053101,0,0
4,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.50776,0.019669,0.043742,0,0
4,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.41203,0.019601,0.029125,0,0
4,GO RESPONSE TO RADIATION,0.64567,0.019436,0.018358,0,0
4,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.89205,0.019374,-0.007298,0,0
4,GO VESICLE FUSION TO PLASMA MEMBRANE,0.22814,0.0193,0.14363,0,0
4,GO CELL PROJECTION ASSEMBLY,0.62258,0.019295,0.023971,0,0
4,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.29502,0.019237,0.085265,0,0
4,GO P38MAPK CASCADE,0.38047,0.019142,0.065808,0,0
4,GO HISTONE DEACETYLATION,0.64276,0.019131,0.028842,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.22195,0.019085,0.046,0,0
4,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.69885,0.019036,-0.020892,0,0
4,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.41899,0.018974,0.041017,0,0
4,GO PROTEIN LOCALIZATION TO NUCLEUS,0.97899,0.018913,0.01244,0,0
4,GO NEGATIVE REGULATION OF BINDING,0.2458,0.018617,0.052553,0,0
4,GO CAMERA TYPE EYE MORPHOGENESIS,0.58307,0.018439,0.03453,0,0
4,GO PATTERN SPECIFICATION PROCESS,0.59986,0.018385,0.028254,0,0
4,GO RESPONSE TO ANTIBIOTIC,0.42133,0.018335,0.036876,0,0
4,GO SPERMATID DIFFERENTIATION,0.5314,0.018282,0.023079,0,0
4,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.44752,0.018276,0.022397,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.47461,0.01826,0.043438,0,0
4,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.40514,0.018245,0.045383,0,0
4,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.84107,0.018211,0.0093693,0,0
4,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.73822,0.018209,-0.0036816,0,0
4,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,1,0.018148,0.0057741,0,0
4,GO ORGANELLE FISSION,0.87926,0.018098,0.0080512,0,0
4,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.84741,0.018051,-0.0086778,0,0
4,GO CARDIOCYTE DIFFERENTIATION,0.76899,0.018023,0.019361,0,0
4,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.7814,0.0179,-0.0078713,0,0
4,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,0.92416,0.017882,-0.0045233,0,0
4,GO GOLGI TO VACUOLE TRANSPORT,0.28945,0.0178,0.060922,0,0
4,GO CELL MORPHOGENESIS,0.99192,0.017772,0.0091027,0,0
4,GO RESPONSE TO NERVE GROWTH FACTOR,0.34213,0.017677,0.054558,0,0
4,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.97576,0.017615,0.0077661,0,0
4,GO TORC1 SIGNALING,0.26614,0.017606,0.058437,0,0
4,GO CELL AGGREGATION,0.75972,0.017589,0.0096125,0,0
4,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.75972,0.017426,0.018169,0,0
4,GO CELL AGING,0.79387,0.017346,0.013883,0,0
4,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.18062,0.017339,0.078429,0,0
4,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.32592,0.017306,0.071366,0,0
4,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.59144,0.017225,0.014794,0,0
4,GO NEGATIVE REGULATION OF GLIOGENESIS,0.36741,0.017162,0.070442,0,0
4,GO REGULATION OF BMP SIGNALING PATHWAY,0.94993,0.01711,0.016535,0,0
4,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.48722,0.017066,0.051753,0,0
4,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.98546,0.017051,0.019327,0,0
4,GO PROTEIN LOCALIZATION TO CELL JUNCTION,0.97253,0.016855,0.0097159,0,0
4,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.55558,0.016769,0.027032,0,0
4,GO REGULATION OF NEURON DIFFERENTIATION,0.68988,0.016756,-0.0048064,0,0
4,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.49487,0.016695,0.05161,0,0
4,GO THYROID GLAND DEVELOPMENT,0.61117,0.016661,-0.039529,0,0
4,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.46466,0.016551,0.028426,0,0
4,GO PLASMA MEMBRANE TUBULATION,0.91451,0.016394,0.021504,0,0
4,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.99515,0.016058,-0.024665,0,0
4,GO DE NOVO PROTEIN FOLDING,0.17029,0.015998,0.067902,0,0
4,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.67206,0.015822,0.039364,0,0
4,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.57752,0.015568,0.040276,0,0
4,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.88245,0.015492,0.0017519,0,0
4,GO REGULATION OF PHOSPHATASE ACTIVITY,0.26614,0.015407,0.049313,0,0
4,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.86331,0.015269,0.010045,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.48976,0.015254,0.021714,0,0
4,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.96284,0.015249,0.0062222,0,0
4,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.8379,0.015249,0.017113,0,0
4,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,0.56925,0.015243,0.022739,0,0
4,GO REGULATION OF MIRNA METABOLIC PROCESS,0.91772,0.015027,0.0014313,0,0
4,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.81267,0.014973,-0.062623,0,0
4,GO PEPTIDYL ARGININE METHYLATION,0.61687,0.014973,0.025664,0,0
4,GO RESPONSE TO GLUCAGON,0.75972,0.01496,0.016854,0,0
4,GO NODAL SIGNALING PATHWAY,0.68094,0.014938,0.043706,0,0
4,GO TROPHOBLAST CELL MIGRATION,0.87606,0.014822,0.0066577,0,0
4,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.98222,0.014785,0.015297,0,0
4,GO NEURON APOPTOTIC PROCESS,0.64276,0.014773,0.024855,0,0
4,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.50516,0.01474,0.033381,0,0
4,GO ALDITOL METABOLIC PROCESS,0.88245,0.014702,0.0007522,0,0
4,GO PROTEIN HOMOTETRAMERIZATION,0.572,0.01466,0.027539,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.94348,0.014594,-0.00033334,0,0
4,GO RESPONSE TO GAMMA RADIATION,0.56376,0.01457,0.01841,0,0
4,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.55287,0.014553,0.030106,0,0
4,GO REGULATION OF FEEDING BEHAVIOR,0.66616,0.014498,0.042898,0,0
4,GO VESICLE CARGO LOADING,0.9693,0.014494,0.0032243,0,0
4,GO CELLULAR COMPONENT MORPHOGENESIS,0.68988,0.014488,-0.01207,0,0
4,GO NEURON FATE SPECIFICATION,0.96284,0.014463,0.029334,0,0
4,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.52345,0.014352,0.030801,0,0
4,GO ASTROCYTE DEVELOPMENT,0.99838,0.014327,0.012739,0,0
4,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.86649,0.014313,0.02596,0,0
4,GO STEM CELL PROLIFERATION,0.87926,0.014266,0.0044351,0,0
4,GO CRISTAE FORMATION,0.26095,0.014252,0.067514,0,0
4,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,0.40973,0.0142,0.070196,0,0
4,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.92094,0.014151,0.0021289,0,0
4,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,0.82842,0.014122,0.010391,0,0
4,GO FEVER GENERATION,0.66028,0.014094,0.02289,0,0
4,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.89846,0.014076,0.015425,0,0
4,GO FATTY ACID HOMEOSTASIS,0.60834,0.014069,0.036804,0,0
4,GO THYMUS DEVELOPMENT,0.79387,0.014047,0.015405,0,0
4,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.49743,0.014023,0.030255,0,0
4,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.43789,0.013985,0.061766,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.77209,0.013845,0.016389,0,0
4,GO NCRNA CATABOLIC PROCESS,0.21587,0.01383,0.059423,0,0
4,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.23927,0.013827,0.054537,0,0
4,GO POSITIVE REGULATION OF GLIOGENESIS,0.10299,0.013786,0.078457,0,0
4,GO MOTOR NEURON AXON GUIDANCE,0.84741,0.0137,0.0015583,0,0
4,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,0.8379,0.013693,0.018058,0,0
4,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.9306,0.013533,0.014032,0,0
4,GO PROTEIN FOLDING,0.15565,0.013529,0.062257,0,0
4,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.37173,0.01341,0.048502,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.61402,0.013265,0.032527,0,0
4,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.86012,0.013174,0.010029,0,0
4,GO CELL PART MORPHOGENESIS,0.51035,0.013032,-0.026458,0,0
4,GO METHYLATION,0.797,0.012904,-0.0093817,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.35043,0.012864,0.040178,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.96607,0.012823,0.023522,0,0
4,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.83158,0.012739,0.012265,0,0
4,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.49743,0.012733,0.024167,0,0
4,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.91451,0.012601,-0.001595,0,0
4,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.35043,0.012571,-0.10425,0,0
4,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.5,0.01244,0.049477,0,0
4,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.94671,0.01241,0.0023947,0,0
4,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.52609,0.012406,-0.017343,0,0
4,GO MAINTENANCE OF PROTEIN LOCATION,0.49743,0.012366,0.032688,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.5583,0.01233,-0.020507,0,0
4,GO HEART MORPHOGENESIS,0.92416,0.012274,-0.0012462,0,0
4,GO LYSINE METABOLIC PROCESS,0.45727,0.011992,0.043652,0,0
4,GO NEURON DIFFERENTIATION,0.80953,0.011971,-0.0019536,0,0
4,GO HYPOTONIC RESPONSE,0.93704,0.011939,-0.021199,0,0
4,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.45972,0.011913,0.031258,0,0
4,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.70787,0.011888,-0.020637,0,0
4,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.89205,0.011516,-0.0003248,0,0
4,GO REGULATION OF DEPHOSPHORYLATION,0.36311,0.011473,0.041898,0,0
4,GO SENSORY SYSTEM DEVELOPMENT,0.95961,0.011405,0.0068158,0,0
4,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.99838,0.011349,-0.0012761,0,0
4,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,0.52609,0.011335,0.061308,0,0
4,GO MUSCLE FIBER DEVELOPMENT,0.84424,0.011294,-0.010146,0,0
4,GO HEAD DEVELOPMENT,0.65734,0.011154,0.024676,0,0
4,GO T CELL CHEMOTAXIS,0.68988,0.011141,0.018254,0,0
4,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.61117,0.010783,-0.013285,0,0
4,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.59705,0.01075,0.03674,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.95961,0.010744,0.0048111,0,0
4,GO CELL FATE COMMITMENT,0.99838,0.010723,0.010914,0,0
4,GO REGULATION OF MRNA CATABOLIC PROCESS,0.5,0.010681,-0.014029,0,0
4,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.46218,0.010655,0.070697,0,0
4,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.56103,0.010611,0.030698,0,0
4,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.75972,0.010506,-0.028902,0,0
4,GO LIPID PHOSPHORYLATION,0.36098,0.01036,0.056578,0,0
4,GO AXON DEVELOPMENT,0.26095,0.010273,-0.051814,0,0
4,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.50258,0.010243,0.064488,0,0
4,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.45972,0.010166,0.052461,0,0
4,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.68094,0.0097791,0.036048,0,0
4,GO PROTEIN TARGETING TO MITOCHONDRION,0.90809,0.009762,0.0095365,0,0
4,GO FIBRINOLYSIS,0.54208,0.0097181,0.020271,0,0
4,GO NUCLEOSIDE SALVAGE,0.6055,0.009601,0.016086,0,0
4,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.33194,0.0094965,0.048938,0,0
4,GO PROTEIN TARGETING,0.3739,0.0094117,0.025524,0,0
4,GO FOCAL ADHESION ASSEMBLY,0.47461,0.0093939,0.045651,0,0
4,GO REGULATION OF TORC1 SIGNALING,0.49743,0.0093794,0.05204,0,0
4,GO MITOTIC METAPHASE PLATE CONGRESSION,0.92094,0.0093759,0.020613,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.68689,0.0093459,0.0089071,0,0
4,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.5583,0.0092536,0.065222,0,0
4,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.97576,0.0092297,0.016201,0,0
4,GO HISTONE H4 ACETYLATION,0.65734,0.0091765,0.024455,0,0
4,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.86968,0.0091328,0.0066745,0,0
4,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.92416,0.009114,0.00052942,0,0
4,GO COGNITION,0.88565,0.0090793,5.5506e-05,0,0
4,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.49231,0.0089209,0.055831,0,0
4,GO ATP TRANSPORT,0.33194,0.008865,0.048636,0,0
4,GO FEMALE GAMETE GENERATION,0.87606,0.008812,0.0019321,0,0
4,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.82842,0.0087587,-0.010372,0,0
4,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.27673,0.0086648,-0.1016,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.87287,0.0085465,0.012132,0,0
4,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.66028,0.0083962,0.028045,0,0
4,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.68094,0.0083838,0.018368,0,0
4,GO PEPTIDE METABOLIC PROCESS,0.92738,0.0083501,0.00059172,0,0
4,GO ERYTHROCYTE DEVELOPMENT,0.96284,0.0083374,0.012319,0,0
4,GO CARTILAGE DEVELOPMENT,0.797,0.0083318,0.020512,0,0
4,GO INTERACTION WITH SYMBIONT,0.88565,0.0081789,-0.00085765,0,0
4,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.98869,0.0081217,0.0038506,0,0
4,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,0.63408,0.0080782,-0.0073393,0,0
4,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,0.75356,0.0080298,-0.022597,0,0
4,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.19417,0.0079562,0.089374,0,0
4,GO SEROTONIN TRANSPORT,0.75664,0.0078311,0.050507,0,0
4,GO DNA METHYLATION OR DEMETHYLATION,0.31021,0.0077514,0.042617,0,0
4,GO CENTROSOME SEPARATION,0.5,0.0077474,0.056617,0,0
4,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,0.71089,0.0076981,0.024158,0,0
4,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.98869,0.0075724,-0.0021247,0,0
4,GO CALCINEURIN MEDIATED SIGNALING,0.87287,0.0075031,0.00032691,0,0
4,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.7659,0.0074186,0.027182,0,0
4,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.43312,0.0074156,0.041915,0,0
4,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.98869,0.007359,0.010828,0,0
4,GO NUCLEAR ENVELOPE REASSEMBLY,0.86649,0.0072924,0.0087596,0,0
4,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.28395,0.0072501,0.053352,0,0
4,GO REGULATION OF CELL AGING,0.5314,0.0072362,-0.017562,0,0
4,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.86012,0.0071273,0.025757,0,0
4,GO REGULATION OF SENSORY PERCEPTION,0.90167,0.0071261,-0.010139,0,0
4,GO PROTEIN IMPORT,0.98546,0.0070483,0.012163,0,0
4,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,0.31409,0.006929,-0.048096,0,0
4,GO CELL FATE SPECIFICATION,0.52874,0.0068657,-0.022163,0,0
4,GO NUCLEUS LOCALIZATION,0.46962,0.0068648,-0.027888,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.61687,0.0067758,-0.02056,0,0
4,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.77209,0.0067075,0.016617,0,0
4,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.89205,0.0066088,0.0068438,0,0
4,GO MUSCLE FILAMENT SLIDING,0.38488,0.0065584,-0.051099,0,0
4,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.94993,0.0065503,-0.040131,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.45972,0.006547,0.051258,0,0
4,GO ACETYL COA METABOLIC PROCESS,0.44028,0.0064897,0.043413,0,0
4,GO CGMP METABOLIC PROCESS,0.99192,0.006482,-0.0045921,0,0
4,GO CELL CYCLE ARREST,0.68689,0.006477,0.024793,0,0
4,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.56925,0.0064615,0.034138,0,0
4,GO HISTONE H2A ACETYLATION,1,0.0063953,0.0047718,0,0
4,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.71996,0.0063923,-0.0020795,0,0
4,GO HISTONE H4 K5 ACETYLATION,0.99838,0.0063611,0.016222,0,0
4,GO ORGANELLE ASSEMBLY,0.75048,0.0063191,0.015209,0,0
4,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.71391,0.0062926,-0.0027595,0,0
4,GO RESPONSE TO ATP,0.49231,0.0061711,0.035953,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.68689,0.0061077,0.016287,0,0
4,GO SLEEP,0.25753,0.006033,0.068866,0,0
4,GO CELLULAR RESPONSE TO PH,0.47461,0.0059778,0.051969,0,0
4,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.41203,0.0058706,0.039701,0,0
4,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.1653,0.005741,0.086376,0,0
4,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,0.70787,0.0056892,-0.0024438,0,0
4,GO RESPONSE TO DOPAMINE,0.6515,0.0056643,0.03427,0,0
4,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.60268,0.0056169,-0.02709,0,0
4,GO NEURAL PRECURSOR CELL PROLIFERATION,0.9306,0.0055324,0.016732,0,0
4,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.86968,0.0054618,0.0030035,0,0
4,GO CELL CYCLE,0.70486,0.0053593,0.003737,0,0
4,GO REGULATION OF MITOCHONDRIAL FUSION,0.68094,0.005077,0.036238,0,0
4,GO LIMBIC SYSTEM DEVELOPMENT,0.97253,0.005063,0.0104,0,0
4,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.88565,0.0050427,-0.036725,0,0
4,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.62258,0.0049003,-0.020854,0,0
4,GO SPECIFICATION OF SYMMETRY,0.43312,0.0047791,-0.020531,0,0
4,GO CYTOLYSIS,0.57752,0.0047748,0.026479,0,0
4,GO SOMATIC STEM CELL DIVISION,0.3871,0.0047693,-0.069551,0,0
4,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.86968,0.0047293,0.02203,0,0
4,GO MOTILE CILIUM ASSEMBLY,0.88565,0.0047023,0.02109,0,0
4,GO TRNA 5 END PROCESSING,0.87926,0.0046405,0.008554,0,0
4,GO REGULATION OF CELL CYCLE,0.90167,0.0045685,0.011723,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.80326,0.0044823,0.0087667,0,0
4,GO GASTRIC ACID SECRETION,0.33396,0.0044142,0.051115,0,0
4,GO REGULATION OF MRNA BINDING,0.47712,0.0042205,-0.051201,0,0
4,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.9306,0.0041983,0.0079064,0,0
4,GO PRESYNAPSE ORGANIZATION,0.69885,0.0041079,0.025254,0,0
4,GO CARDIAC ATRIUM MORPHOGENESIS,0.99192,0.0040643,0.0068218,0,0
4,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.84741,0.0040594,0.0039718,0,0
4,GO GRANULOCYTE DIFFERENTIATION,0.82842,0.0040264,0.023789,0,0
4,GO INOSITOL LIPID MEDIATED SIGNALING,0.6515,0.0039106,0.029172,0,0
4,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.9113,0.0038316,-0.023259,0,0
4,GO MITOTIC CELL CYCLE ARREST,0.61687,0.0037831,0.0041287,0,0
4,GO REGULATION OF DNA METHYLATION,0.72907,0.0037807,0.02848,0,0
4,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.37827,0.0037791,0.038797,0,0
4,GO GONADOTROPIN SECRETION,0.32393,0.0037563,0.062106,0,0
4,GO RNA DESTABILIZATION,0.26614,0.0037163,-0.035387,0,0
4,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.57476,0.0036732,0.002149,0,0
4,GO CELLULAR SENESCENCE,0.94348,0.0036265,0.010369,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.8379,0.0036092,-0.0059067,0,0
4,GO REGULATION OF ORGANELLE ASSEMBLY,0.99515,0.0035966,0.0085944,0,0
4,GO DICARBOXYLIC ACID TRANSPORT,0.1914,0.0035349,0.073277,0,0
4,GO RESPONSE TO PROSTAGLANDIN E,0.6515,0.0031761,0.033221,0,0
4,GO COENZYME A METABOLIC PROCESS,0.33194,0.0031191,0.061292,0,0
4,GO RESPONSE TO IONIZING RADIATION,0.9693,0.0030193,0.0012451,0,0
4,GO RECEPTOR INTERNALIZATION,0.68094,0.0030031,-0.0040969,0,0
4,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.64858,0.0029514,0.043013,0,0
4,GO CAMERA TYPE EYE DEVELOPMENT,0.76899,0.0028379,-0.00048428,0,0
4,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.80012,0.0028101,0.013118,0,0
4,GO PROXIMAL DISTAL PATTERN FORMATION,0.36526,0.0027599,-0.070503,0,0
4,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.26614,0.0025482,-0.037963,0,0
4,GO IRON SULFUR CLUSTER ASSEMBLY,0.65734,0.0024631,0.028717,0,0
4,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.84107,0.0024402,-0.0067961,0,0
4,GO CELL JUNCTION MAINTENANCE,0.98222,0.0023687,0.012437,0,0
4,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.83158,0.0023125,0.0027065,0,0
4,GO RESPONSE TO NITRIC OXIDE,0.8379,0.0022835,0.017706,0,0
4,GO REGULATION OF CENTROSOME DUPLICATION,0.61972,0.0022304,0.028125,0,0
4,GO HEME METABOLIC PROCESS,0.9693,0.0021936,0.0074922,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.89526,0.002103,0.0060476,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE,0.94026,0.0019378,0.01003,0,0
4,GO L AMINO ACID TRANSPORT,0.47963,0.0017955,0.033558,0,0
4,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.97253,0.0017381,0.02315,0,0
4,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,0.73822,0.0017317,-0.0044838,0,0
4,GO MYOBLAST DIFFERENTIATION,0.80953,0.0016417,-0.010292,0,0
4,GO BLASTOCYST FORMATION,0.66321,0.0016262,0.026765,0,0
4,GO CELLULAR RESPONSE TO ATP,0.68392,0.0015908,0.030359,0,0
4,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,0.52082,0.001444,0.026119,0,0
4,GO REGULATION OF LIPASE ACTIVITY,0.80012,0.0013947,-0.0094501,0,0
4,GO PROTEOGLYCAN METABOLIC PROCESS,0.92416,0.0013574,0.010591,0,0
4,GO REGULATION OF HISTONE METHYLATION,0.70787,0.0013018,-0.001603,0,0
4,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.62258,0.0012911,0.019673,0,0
4,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.52082,0.0012502,0.034408,0,0
4,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.90809,0.0011868,0.014989,0,0
4,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.39381,0.0010994,0.039249,0,0
4,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.91451,0.0010936,0.0035571,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.83474,0.001077,0.018774,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,0.38933,0.0010721,-0.027471,0,0
4,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.88245,0.0010407,-0.0071982,0,0
4,GO BIOLOGICAL PHASE,0.7659,0.00096703,0.030583,0,0
4,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.97253,0.00087369,0.0065151,0,0
4,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.7659,0.00085792,-0.015195,0,0
4,GO SPERM MOTILITY,0.81267,0.0008335,0.016363,0,0
4,GO REGULATION OF GLIAL CELL MIGRATION,0.41434,0.00080587,0.041157,0,0
4,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.94671,0.00069837,0.0091746,0,0
4,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.83158,0.00062823,-0.0077025,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE,0.45238,0.00057179,0.071666,0,0
4,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.51296,0.00054593,-0.015269,0,0
4,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.54477,0.00049994,0.065406,0,0
4,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.69885,0.00047004,1.2382e-05,0,0
4,GO REGULATION OF SPROUTING ANGIOGENESIS,0.90809,0.00027003,0.014855,0,0
4,GO CEREBELLAR CORTEX DEVELOPMENT,0.99515,0.0002064,0.012786,0,0
4,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.64858,0.00012367,0.02481,0,0
4,GO REGULATION OF CYTOKINESIS,0.62258,-0.00029165,0.0022738,0,0
4,GO DIGESTIVE TRACT MORPHOGENESIS,0.90167,-0.00032436,0.0087556,0,0
4,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.96284,-0.0005194,-0.00090113,0,0
4,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.48976,-0.00062376,-0.012018,0,0
4,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.75972,-0.00063428,-0.016731,0,0
4,GO EXPLORATION BEHAVIOR,0.55016,-0.00066029,-0.060056,0,0
4,GO PROTEIN ACYLATION,0.74435,-0.00073588,0.0012507,0,0
4,GO AORTIC VALVE DEVELOPMENT,0.92094,-0.00075913,0.011096,0,0
4,GO THALAMUS DEVELOPMENT,0.5,-0.0009067,0.072751,0,0
4,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.68988,-0.00091295,0.028085,0,0
4,GO ERROR FREE TRANSLESION SYNTHESIS,0.46962,-0.00099067,-0.013488,0,0
4,GO NEGATIVE REGULATION OF TORC1 SIGNALING,0.5583,-0.0010557,-0.021096,0,0
4,GO CEREBELLAR CORTEX FORMATION,0.71996,-0.0010591,0.021732,0,0
4,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.67798,-0.0012144,0.035717,0,0
4,GO NEUTROPHIL HOMEOSTASIS,0.81581,-0.0013849,-0.032054,0,0
4,GO MICROTUBULE BASED TRANSPORT,0.59144,-0.0013855,-0.018714,0,0
4,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.94993,-0.0014854,0.03621,0,0
4,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.797,-0.0014917,-0.0054663,0,0
4,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.84424,-0.0015403,0.0085243,0,0
4,GO REGULATION OF SYNAPTIC VESICLE CYCLE,0.85376,-0.0017407,0.023933,0,0
4,GO PROTEIN LOCALIZATION TO ORGANELLE,0.99838,-0.0017518,0.012294,0,0
4,GO REGULATION OF EXTENT OF CELL GROWTH,0.40058,-0.0018418,-0.049324,0,0
4,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.76899,-0.0018667,0.002356,0,0
4,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.58864,-0.001987,-0.028775,0,0
4,GO RESPONSE TO MURAMYL DIPEPTIDE,0.42133,-0.0023988,-0.054651,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.92738,-0.0025377,0.018047,0,0
4,GO HEPARIN METABOLIC PROCESS,0.46218,-0.0027119,0.050314,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.71391,-0.0027594,-0.0039704,0,0
4,GO ACTIN CROSSLINK FORMATION,0.43075,-0.0027833,-0.047123,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.99838,-0.0028393,0.010323,0,0
4,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.98869,-0.0028921,0.00032219,0,0
4,GO POSITIVE REGULATION OF HISTONE METHYLATION,0.45727,-0.0030725,-0.020794,0,0
4,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.87926,-0.0033277,-0.00066753,0,0
4,GO NON RECOMBINATIONAL REPAIR,0.58585,-0.0035259,-0.0107,0,0
4,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.98869,-0.0035341,-0.00041828,0,0
4,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.84741,-0.0035383,0.00095987,0,0
4,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.48976,-0.0035739,-0.016332,0,0
4,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.92738,-0.003656,0.0015483,0,0
4,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.95316,-0.0036795,0.0091867,0,0
4,GO TRICARBOXYLIC ACID CYCLE,0.38267,-0.0038411,0.073257,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.28761,-0.0038632,-0.086549,0,0
4,GO CLATHRIN COAT ASSEMBLY,0.63408,-0.0039657,0.026862,0,0
4,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.49487,-0.004228,0.053489,0,0
4,GO POSITIVE REGULATION OF DNA REPLICATION,0.75664,-0.0042366,0.025389,0,0
4,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.78763,-0.0042994,0.002452,0,0
4,GO MICROTUBULE BASED MOVEMENT,0.87287,-0.0043841,-0.0012082,0,0
4,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,0.74435,-0.004408,0.0036748,0,0
4,GO CONNECTIVE TISSUE DEVELOPMENT,0.38047,-0.004529,0.044845,0,0
4,GO PHOTORECEPTOR CELL DEVELOPMENT,0.47963,-0.0045505,-0.029167,0,0
4,GO IMPORT INTO NUCLEUS,0.71996,-0.0045718,-0.0038962,0,0
4,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.81267,-0.0045963,0.0012018,0,0
4,GO REGULATION OF ANIMAL ORGAN FORMATION,0.95316,-0.0046335,0.0048458,0,0
4,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.63408,-0.0046782,0.039649,0,0
4,GO MESODERM DEVELOPMENT,0.75664,-0.0048582,-0.0080714,0,0
4,GO RESPONSE TO HYDROPEROXIDE,0.67206,-0.0048827,0.026025,0,0
4,GO REGULATION OF FIBROBLAST MIGRATION,0.6691,-0.0049875,-0.0069605,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.56103,-0.0049979,-0.026437,0,0
4,GO MITOCHONDRIAL TRANSCRIPTION,0.73517,-0.005112,-0.018522,0,0
4,GO REGULATION OF GLIOGENESIS,0.35463,-0.0052254,0.05119,0,0
4,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.29877,-0.0052411,-0.063956,0,0
4,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.81581,-0.0052478,0.023176,0,0
4,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.35886,-0.0052792,-0.084571,0,0
4,GO HINDBRAIN MORPHOGENESIS,0.83474,-0.0053013,0.014313,0,0
4,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.96284,-0.0054723,0.014164,0,0
4,GO MUSCLE ORGAN DEVELOPMENT,0.51296,-0.0054983,-0.0062712,0,0
4,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.75664,-0.0058738,0.024511,0,0
4,GO NUCLEAR MIGRATION,0.46218,-0.0059067,-0.032172,0,0
4,GO DOSAGE COMPENSATION,0.85059,-0.0059583,0.0018636,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.80639,-0.0059743,0.0076131,0,0
4,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.71089,-0.0059928,0.047164,0,0
4,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.38047,-0.0060705,-0.015962,0,0
4,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.97253,-0.0061306,0.001647,0,0
4,GO REGULATION OF LIPID KINASE ACTIVITY,0.61687,-0.0061507,-0.011664,0,0
4,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.84741,-0.006156,0.020974,0,0
4,GO ECTODERMAL PLACODE DEVELOPMENT,0.85059,-0.0062516,0.01149,0,0
4,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.97899,-0.0062576,0.010541,0,0
4,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.70185,-0.0064701,-0.0029017,0,0
4,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,0.5394,-0.0064961,-0.019058,0,0
4,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.64858,-0.0065099,-0.015894,0,0
4,GO ACTIVATION OF MAPKK ACTIVITY,0.85694,-0.0065179,0.021234,0,0
4,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.80326,-0.0065861,0.008077,0,0
4,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.64567,-0.0066101,0.026818,0,0
4,GO COCHLEA DEVELOPMENT,0.33803,-0.0066804,-0.060843,0,0
4,GO HISTONE H2A UBIQUITINATION,0.68689,-0.0067022,-0.014027,0,0
4,GO CYSTEINE METABOLIC PROCESS,0.51819,-0.0067705,-0.080469,0,0
4,GO STORE OPERATED CALCIUM ENTRY,0.61972,-0.0068282,-0.02198,0,0
4,GO LEARNING,0.6055,-0.0070792,-0.019681,0,0
4,GO MICROTUBULE DEPOLYMERIZATION,0.3871,-0.0071064,-0.052484,0,0
4,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.49487,-0.0071231,0.041522,0,0
4,GO PROTEIN MONOUBIQUITINATION,0.71089,-0.0071805,1.2065e-05,0,0
4,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.33599,-0.0073837,0.056727,0,0
4,GO RESPONSE TO LEAD ION,0.30446,-0.007471,-0.035251,0,0
4,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.9306,-0.007599,-0.0082938,0,0
4,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.55558,-0.0076264,0.044986,0,0
4,GO AROMATIC AMINO ACID TRANSPORT,0.96607,-0.0076584,0.00079004,0,0
4,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.318,-0.007672,-0.041885,0,0
4,GO REGULATION OF MITOTIC CELL CYCLE,0.65734,-0.0076983,0.019193,0,0
4,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.61972,-0.0077019,-0.030591,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,0.70486,-0.0077255,0.030811,0,0
4,GO SUBSTANTIA NIGRA DEVELOPMENT,0.797,-0.007841,0.0028894,0,0
4,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.96607,-0.007868,0.001012,0,0
4,GO MESENCHYMAL CELL PROLIFERATION,0.71391,-0.0078691,-0.029977,0,0
4,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.59144,-0.0079085,-0.020511,0,0
4,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.572,-0.0079606,-0.0047202,0,0
4,GO BASEMENT MEMBRANE ASSEMBLY,0.70486,-0.0082565,-0.028476,0,0
4,GO PIGMENT BIOSYNTHETIC PROCESS,0.65442,-0.0085919,-0.010317,0,0
4,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.87926,-0.0086222,0.014595,0,0
4,GO REGULATION OF EPITHELIAL TUBE FORMATION,0.49231,-0.0087091,-0.068658,0,0
4,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.21437,-0.0087184,-0.11556,0,0
4,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.72299,-0.0088393,-0.017514,0,0
4,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,0.21738,-0.0089455,-0.016233,0,0
4,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,0.24911,-0.009009,-0.0513,0,0
4,GO LENS FIBER CELL DIFFERENTIATION,0.71391,-0.0090879,0.033517,0,0
4,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.90167,-0.0090989,0.026036,0,0
4,GO POSITIVE REGULATION OF TORC1 SIGNALING,0.87606,-0.009102,0.034861,0,0
4,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.79075,-0.0091172,0.026928,0,0
4,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.58029,-0.0092167,-0.00016606,0,0
4,GO GENE SILENCING,0.6055,-0.0093174,-0.0076872,0,0
4,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.76899,-0.0094097,0.027893,0,0
4,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.96284,-0.0094473,0.023708,0,0
4,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.75664,-0.0095434,-0.0079007,0,0
4,GO REGULATION OF URINE VOLUME,0.57752,-0.0095536,-0.017577,0,0
4,GO HEART VALVE DEVELOPMENT,0.90809,-0.0095969,-8.4176e-05,0,0
4,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.84741,-0.0096635,-0.033623,0,0
4,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.68094,-0.0096687,0.028923,0,0
4,GO NCRNA 3 END PROCESSING,0.5665,-0.0098056,-0.033165,0,0
4,GO HYPEROSMOTIC RESPONSE,0.74435,-0.0098276,-0.0049946,0,0
4,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.86012,-0.0098392,0.022869,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.5665,-0.0098984,-0.014487,0,0
4,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,0.1873,-0.0099158,0.078357,0,0
4,GO DECIDUALIZATION,0.49231,-0.010006,-0.050328,0,0
4,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.57476,-0.01003,0.10488,0,0
4,GO AMIDE BIOSYNTHETIC PROCESS,0.72603,-0.010045,-0.0072197,0,0
4,GO AXONAL FASCICULATION,0.90809,-0.010047,0.0016607,0,0
4,GO NUCLEUS ORGANIZATION,0.7659,-0.010119,0.018942,0,0
4,GO CILIUM ORGANIZATION,0.75048,-0.010207,-0.0025594,0,0
4,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.6312,-0.010238,-0.014982,0,0
4,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.60268,-0.010272,-0.073202,0,0
4,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.3871,-0.010311,-0.02846,0,0
4,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.97899,-0.010319,-0.0032928,0,0
4,GO INTERLEUKIN 2 PRODUCTION,0.74128,-0.010341,-0.039452,0,0
4,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.85694,-0.010417,-0.017032,0,0
4,GO REGULATION OF CILIUM MOVEMENT,0.80012,-0.010487,0.011052,0,0
4,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.56376,-0.010624,-0.0041922,0,0
4,GO NEGATIVE CHEMOTAXIS,0.6055,-0.010634,-0.037241,0,0
4,GO NEURON RECOGNITION,0.76281,-0.010727,-0.023258,0,0
4,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.58864,-0.010917,0.036897,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.63986,-0.011117,-0.0016992,0,0
4,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.45238,-0.011199,-0.027192,0,0
4,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.77829,-0.011211,0.031587,0,0
4,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.38488,-0.011223,-0.039291,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,0.71089,-0.011305,0.032734,0,0
4,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.35043,-0.011456,-0.021581,0,0
4,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.93704,-0.011468,0.014945,0,0
4,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.87287,-0.011637,0.035276,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.77829,-0.011647,0.030918,0,0
4,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.74128,-0.01179,-0.013558,0,0
4,GO POLYSACCHARIDE CATABOLIC PROCESS,0.54746,-0.011846,0.039742,0,0
4,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.84107,-0.011864,-0.0064271,0,0
4,GO MONONUCLEAR CELL DIFFERENTIATION,0.86012,-0.011872,0.0027474,0,0
4,GO TRANSEPITHELIAL TRANSPORT,0.94348,-0.011903,0.00065151,0,0
4,GO ACIDIC AMINO ACID TRANSPORT,0.81267,-0.011966,0.040022,0,0
4,GO EXIT FROM MITOSIS,0.93704,-0.011978,0.016442,0,0
4,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.65734,-0.01203,-0.037745,0,0
4,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.22195,-0.012038,-0.040163,0,0
4,GO ENDODERM FORMATION,0.84424,-0.012228,-0.0010161,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,0.64858,-0.012265,-0.011623,0,0
4,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.90488,-0.012595,0.018529,0,0
4,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.79075,-0.012617,0.030076,0,0
4,GO NEURON MIGRATION,0.29877,-0.012823,-0.045111,0,0
4,GO GOLGI LOCALIZATION,0.86649,-0.013076,0.017625,0,0
4,GO REGULATION OF FILOPODIUM ASSEMBLY,0.91772,-0.013159,0.012762,0,0
4,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.12126,-0.013172,-0.063342,0,0
4,GO SMOOTHENED SIGNALING PATHWAY,0.36526,-0.013177,-0.02478,0,0
4,GO CELL DIVISION,0.2714,-0.013297,-0.016734,0,0
4,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.79075,-0.013498,0.024441,0,0
4,GO FILOPODIUM ASSEMBLY,0.61972,-0.013535,-0.0051464,0,0
4,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.73212,-0.013603,0.014488,0,0
4,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.72299,-0.013629,-0.014973,0,0
4,GO TOOTH MINERALIZATION,0.89846,-0.013671,0.018537,0,0
4,GO REGULATION OF PROTEIN ACETYLATION,0.54208,-0.013719,-0.0056521,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.86649,-0.013858,0.006643,0,0
4,GO NEURON PROJECTION REGENERATION,0.58307,-0.013875,-0.01246,0,0
4,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.77829,-0.013891,-0.022565,0,0
4,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.75664,-0.013921,0.028408,0,0
4,GO PROTEIN METHYLATION,0.9306,-0.013961,0.0027956,0,0
4,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,0.96607,-0.014016,0.0076222,0,0
4,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.58029,-0.014032,-0.024782,0,0
4,GO COPII COATED VESICLE CARGO LOADING,0.80639,-0.014039,-0.004453,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.98546,-0.014145,0.013029,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.77829,-0.014244,-0.0050691,0,0
4,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,0.39381,-0.014292,-0.04188,0,0
4,GO REGULATION OF CELL DIVISION,0.85059,-0.014361,0.0054423,0,0
4,GO REGULATION OF ATPASE ACTIVITY,0.33396,-0.014376,-0.014455,0,0
4,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.70486,-0.014412,-0.0194,0,0
4,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.82842,-0.01452,-0.0011446,0,0
4,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.62545,-0.014523,-0.043488,0,0
4,GO CELL CYCLE PROCESS,0.28213,-0.014773,-0.0099629,0,0
4,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.68689,-0.014785,-0.012709,0,0
4,GO MEIOTIC SPINDLE ORGANIZATION,0.47963,-0.014859,-0.027293,0,0
4,GO POSTSYNAPSE ORGANIZATION,0.12029,-0.014908,-0.084055,0,0
4,GO OXYGEN TRANSPORT,0.96607,-0.014915,-0.031713,0,0
4,GO CELL CYCLE CHECKPOINT,0.23766,-0.015187,-0.017149,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.80012,-0.015212,-9.9936e-05,0,0
4,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.80326,-0.015441,-0.012541,0,0
4,GO GLUTAMATE SECRETION,0.86012,-0.015551,0.027292,0,0
4,GO ORGAN GROWTH,0.58585,-0.015672,-0.013467,0,0
4,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.89205,-0.015845,0.01408,0,0
4,GO COVALENT CHROMATIN MODIFICATION,0.30637,-0.015863,-0.016737,0,0
4,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.78763,-0.015891,0.019276,0,0
4,GO RESPONSE TO POTASSIUM ION,0.46218,-0.015911,-0.050832,0,0
4,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.55016,-0.015995,-0.019588,0,0
4,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.71391,-0.016004,-0.021841,0,0
4,GO CHROMATIN ORGANIZATION,0.28395,-0.01604,-0.017338,0,0
4,GO VENTRICULAR SYSTEM DEVELOPMENT,0.13338,-0.01604,-0.074938,0,0
4,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.69586,-0.01606,0.032024,0,0
4,GO OLFACTORY LOBE DEVELOPMENT,0.87606,-0.016065,-0.001692,0,0
4,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.87606,-0.016146,0.012867,0,0
4,GO STRIATED MUSCLE CELL PROLIFERATION,0.33396,-0.0163,-0.046165,0,0
4,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.46466,-0.016378,-0.066133,0,0
4,GO MITOTIC CELL CYCLE,0.36311,-0.016421,-0.0075507,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,0.70486,-0.016488,0.0021345,0,0
4,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.42133,-0.016532,0.048932,0,0
4,GO HISTONE H3 K9 MODIFICATION,0.40058,-0.016553,-0.032957,0,0
4,GO METAPHASE PLATE CONGRESSION,0.56103,-0.016593,-0.0030946,0,0
4,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.88565,-0.016682,0.0057027,0,0
4,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.71693,-0.016777,-0.00885,0,0
4,GO DORSAL VENTRAL PATTERN FORMATION,0.62832,-0.016883,0.05033,0,0
4,GO ROOF OF MOUTH DEVELOPMENT,0.58864,-0.016933,-0.017844,0,0
4,GO PEPTIDYL LYSINE ACETYLATION,0.41666,-0.017005,-0.010305,0,0
4,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.48468,-0.017046,-0.015638,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE ARREST,0.61687,-0.017098,0.013219,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.97576,-0.0171,0.012969,0,0
4,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.23286,-0.017143,-0.031441,0,0
4,GO RESPONSE TO MANGANESE ION,0.90488,-0.017204,0.011591,0,0
4,GO PEPTIDYL LYSINE MODIFICATION,0.16042,-0.01722,-0.01866,0,0
4,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.94993,-0.017271,0.011121,0,0
4,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.43789,-0.017354,-0.054355,0,0
4,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.98546,-0.017508,0.012852,0,0
4,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.5,-0.017581,-0.018152,0,0
4,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.89846,-0.017594,0.011951,0,0
4,GO MEIOTIC CHROMOSOME SEGREGATION,0.47211,-0.017605,-0.02686,0,0
4,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,0.44028,-0.017787,-0.033267,0,0
4,GO SKELETAL MUSCLE CELL PROLIFERATION,0.67206,-0.017943,-0.036526,0,0
4,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,0.48722,-0.017946,-0.016893,0,0
4,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.52082,-0.018124,-0.041409,0,0
4,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.93382,-0.018316,-0.0054774,0,0
4,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.77519,-0.018518,0.019941,0,0
4,GO REGULATION OF DNA BINDING,0.64276,-0.01906,0.0052213,0,0
4,GO MITOTIC NUCLEAR DIVISION,0.46218,-0.019295,-0.0092518,0,0
4,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.66028,-0.019324,-0.027867,0,0
4,GO REGULATION OF RECEPTOR INTERNALIZATION,0.25246,-0.01938,-0.03367,0,0
4,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.42367,-0.019383,-0.025166,0,0
4,GO FIBROBLAST APOPTOTIC PROCESS,0.39606,-0.019415,-0.037948,0,0
4,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.99192,-0.019562,0.029806,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.69586,-0.019685,-0.0091454,0,0
4,GO REGULATION OF CELL CYCLE ARREST,0.50258,-0.019691,-0.00071841,0,0
4,GO PHOSPHATE ION TRANSPORT,0.50258,-0.019702,0.044412,0,0
4,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.6055,-0.019796,-0.017061,0,0
4,GO RESPONSE TO HEAT,0.70185,-0.019877,0.0087882,0,0
4,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.19838,-0.019964,-0.030206,0,0
4,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.48722,-0.020007,-0.0062918,0,0
4,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,0.99515,-0.020021,-2.0818e-05,0,0
4,GO MITOTIC DNA INTEGRITY CHECKPOINT,0.41203,-0.020048,-0.01169,0,0
4,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.21288,-0.020053,-0.060766,0,0
4,GO MRNA TRANSCRIPTION,0.62545,-0.020092,-0.0042289,0,0
4,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.72907,-0.020127,-0.0018065,0,0
4,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.66028,-0.020127,0.015635,0,0
4,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.10299,-0.020184,-0.069679,0,0
4,GO NEURON PROJECTION ARBORIZATION,0.94026,-0.020202,0.0077324,0,0
4,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.44269,-0.020217,-0.03353,0,0
4,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,0.28395,-0.020268,-0.059727,0,0
4,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.79387,-0.020305,-0.016951,0,0
4,GO CEREBRAL CORTEX DEVELOPMENT,0.86012,-0.020351,0.0080461,0,0
4,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,0.82526,-0.020374,0.020989,0,0
4,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,0.5665,-0.020381,-0.021906,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.95316,-0.020433,0.024147,0,0
4,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.58307,-0.020582,-0.035796,0,0
4,GO REGULATION OF AXONOGENESIS,0.43789,-0.020642,-0.04116,0,0
4,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.62832,-0.020678,-0.030396,0,0
4,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.70787,-0.020705,-0.00023219,0,0
4,GO PROTEIN ACETYLATION,0.21437,-0.020876,-0.014743,0,0
4,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.21738,-0.020925,-0.11511,0,0
4,GO MISMATCH REPAIR,0.49743,-0.020947,-0.013128,0,0
4,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.58585,-0.020995,-0.020238,0,0
4,GO FOREBRAIN DEVELOPMENT,0.70185,-0.021017,-0.0015944,0,0
4,GO MULTI ORGANISM LOCALIZATION,0.091558,-0.021101,-0.047797,0,0
4,GO SINGLE STRAND BREAK REPAIR,0.36098,-0.021193,-0.037164,0,0
4,GO ENDODERMAL CELL DIFFERENTIATION,0.80012,-0.021208,0.0044995,0,0
4,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.94671,-0.021208,0.0076427,0,0
4,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.2913,-0.021211,-0.019163,0,0
4,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.97576,-0.021288,0.01913,0,0
4,GO MITOTIC G1 S TRANSITION CHECKPOINT,0.84107,-0.021384,0.014404,0,0
4,GO REGULATION OF SPINDLE ORGANIZATION,0.83158,-0.021456,0.02546,0,0
4,GO STEM CELL DIFFERENTIATION,0.48976,-0.021456,-0.011157,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.86331,-0.021484,0.034202,0,0
4,GO BRONCHUS DEVELOPMENT,0.68689,-0.021548,-0.00661,0,0
4,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.31215,-0.021587,-0.081005,0,0
4,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.32592,-0.021647,-0.024932,0,0
4,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.45727,-0.021738,-0.040337,0,0
4,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.43075,-0.021958,-0.02717,0,0
4,GO RESPONSE TO VITAMIN D,0.49231,-0.022037,-0.054106,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.55287,-0.022067,-0.021178,0,0
4,GO HISTONE H4 DEACETYLATION,0.29877,-0.022211,-0.068017,0,0
4,GO HISTONE METHYLATION,0.60834,-0.022252,-0.011575,0,0
4,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.92738,-0.022299,0.0062502,0,0
4,GO GENITALIA MORPHOGENESIS,0.77209,-0.022329,-0.032827,0,0
4,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.88565,-0.022555,0.0012394,0,0
4,GO HISTONE H2A MONOUBIQUITINATION,0.3871,-0.022603,-0.030822,0,0
4,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.73212,-0.022609,-0.030776,0,0
4,GO EXTRACELLULAR MATRIX ASSEMBLY,0.73212,-0.022613,-0.024113,0,0
4,GO REGULATION OF TRANSLATIONAL ELONGATION,0.68094,-0.022614,-0.014497,0,0
4,GO NAD BIOSYNTHETIC PROCESS,0.797,-0.022655,-0.012804,0,0
4,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.93704,-0.022864,-0.020105,0,0
4,GO PROTEIN LOCALIZATION TO SYNAPSE,0.33194,-0.022949,-0.047509,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.39156,-0.023063,-0.017195,0,0
4,GO P BODY ASSEMBLY,0.30255,-0.023102,-0.026105,0,0
4,GO INHIBITORY SYNAPSE ASSEMBLY,0.61402,-0.023146,-0.02724,0,0
4,GO TRANSPORT ALONG MICROTUBULE,0.31409,-0.023215,-0.028227,0,0
4,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.89205,-0.023279,0.020924,0,0
4,GO NUCLEOSIDE METABOLIC PROCESS,0.95316,-0.02336,0.0047304,0,0
4,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,0.74128,-0.023365,-0.025919,0,0
4,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.69286,-0.023443,-0.013391,0,0
4,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.58029,-0.023477,-0.017751,0,0
4,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.5394,-0.023496,-0.017836,0,0
4,GO DNA METHYLATION,0.87926,-0.023517,0.006167,0,0
4,GO TELENCEPHALON DEVELOPMENT,0.36098,-0.023551,-0.022657,0,0
4,GO PROTEIN TARGETING TO MEMBRANE,0.46218,-0.023568,-0.026626,0,0
4,GO MICROTUBULE BASED PROCESS,0.33396,-0.023638,-0.01875,0,0
4,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.56103,-0.023652,-0.04448,0,0
4,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.57476,-0.023674,-0.028721,0,0
4,GO URETER DEVELOPMENT,0.50258,-0.024116,-0.061487,0,0
4,GO REGULATION OF EXIT FROM MITOSIS,0.61687,-0.024131,0.029498,0,0
4,GO DENDRITE DEVELOPMENT,0.47712,-0.024149,-0.023196,0,0
4,GO LYMPH VESSEL MORPHOGENESIS,0.47963,-0.02427,-0.042434,0,0
4,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.77829,-0.024284,0.0027762,0,0
4,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.1313,-0.024319,-0.048977,0,0
4,GO CELLULAR RESPONSE TO DRUG,0.74435,-0.02443,0.032799,0,0
4,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.39832,-0.024462,-0.044045,0,0
4,GO DETECTION OF VISIBLE LIGHT,0.572,-0.024701,-0.039116,0,0
4,GO EMBRYONIC HEART TUBE MORPHOGENESIS,0.23927,-0.024831,-0.03545,0,0
4,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.96284,-0.02485,0.0069151,0,0
4,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.6691,-0.025002,-0.0085882,0,0
4,GO SERTOLI CELL DEVELOPMENT,0.69586,-0.025052,-0.033513,0,0
4,GO POSITIVE REGULATION OF AXONOGENESIS,0.53406,-0.025152,-0.023546,0,0
4,GO LIPOPROTEIN LOCALIZATION,0.20699,-0.025231,-0.082659,0,0
4,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.90167,-0.025238,0.020612,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.22814,-0.025315,-0.065755,0,0
4,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.21587,-0.025428,-0.036575,0,0
4,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.90809,-0.025698,0.027241,0,0
4,GO MITOTIC CELL CYCLE CHECKPOINT,0.22658,-0.025902,-0.018889,0,0
4,GO CARDIAC MUSCLE CELL PROLIFERATION,0.19278,-0.026094,-0.07023,0,0
4,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.97576,-0.026191,0.016436,0,0
4,GO PEPTIDE BIOSYNTHETIC PROCESS,0.23128,-0.026277,-0.037105,0,0
4,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,0.21738,-0.026452,-0.062854,0,0
4,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.57476,-0.026469,-0.025592,0,0
4,GO PENILE ERECTION,0.46218,-0.026505,-0.054486,0,0
4,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.31215,-0.026661,-0.029232,0,0
4,GO DNA BIOSYNTHETIC PROCESS,0.075674,-0.026887,-0.026937,0,0
4,GO HISTONE H3 K9 METHYLATION,0.45727,-0.026925,-0.02731,0,0
4,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.92094,-0.02694,-0.0091875,0,0
4,GO SECRETORY GRANULE LOCALIZATION,0.68392,-0.02702,-0.024458,0,0
4,GO REGULATION OF GASTRULATION,0.94026,-0.027185,0.0055371,0,0
4,GO REGULATION OF HISTONE UBIQUITINATION,0.51035,-0.027212,-0.010018,0,0
4,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.60268,-0.027529,-0.040843,0,0
4,GO PROTEIN KINASE A SIGNALING,0.82842,-0.027571,-0.0034091,0,0
4,GO POSITIVE REGULATION OF URINE VOLUME,0.32195,-0.02763,-0.053808,0,0
4,GO DNA INTEGRITY CHECKPOINT,0.21587,-0.027657,-0.020307,0,0
4,GO PROTEIN DENEDDYLATION,0.61402,-0.027745,-0.022849,0,0
4,GO MICROTUBULE POLYMERIZATION,0.31409,-0.027909,-0.030202,0,0
4,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.26964,-0.02792,-0.039052,0,0
4,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.1793,-0.028144,-0.045637,0,0
4,GO REGULATION OF CENTROSOME CYCLE,0.52874,-0.028193,-0.0031757,0,0
4,GO CELL CYCLE G1 S PHASE TRANSITION,0.35886,-0.028207,-0.013001,0,0
4,GO SKELETAL SYSTEM MORPHOGENESIS,0.32592,-0.028443,-0.030845,0,0
4,GO ACTIVATION OF JNKK ACTIVITY,0.98546,-0.028472,0.023399,0,0
4,GO AXON EXTENSION,0.20699,-0.028622,-0.057032,0,0
4,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.76899,-0.028675,-0.00090533,0,0
4,GO APPENDAGE DEVELOPMENT,0.62832,-0.028682,-0.010192,0,0
4,GO REGULATION OF BEHAVIOR,0.78763,-0.028993,-0.0055253,0,0
4,GO TONGUE MORPHOGENESIS,0.20409,-0.029024,-0.13402,0,0
4,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.40286,-0.029104,-0.063262,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.84107,-0.029228,0.011481,0,0
4,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.59705,-0.029353,-0.025393,0,0
4,GO PALLIUM DEVELOPMENT,0.39832,-0.029441,-0.018399,0,0
4,GO VIRAL LATENCY,0.063258,-0.029572,-0.08687,0,0
4,GO RNA CATABOLIC PROCESS,0.25753,-0.029614,-0.032395,0,0
4,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,0.25924,-0.029696,-0.032801,0,0
4,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.89205,-0.0297,-0.00013763,0,0
4,GO RNA 5 END PROCESSING,0.71996,-0.029792,-0.0095575,0,0
4,GO POSITIVE REGULATION OF DNA BINDING,0.59986,-0.029948,-0.013601,0,0
4,GO MIRNA METABOLIC PROCESS,0.40286,-0.030146,-0.023378,0,0
4,GO APOPTOTIC DNA FRAGMENTATION,0.47211,-0.030556,-0.008943,0,0
4,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,0.86012,-0.030579,0.014313,0,0
4,GO MITOCHONDRIAL DNA REPLICATION,0.28033,-0.03075,-0.051816,0,0
4,GO REGULATION OF ORGAN GROWTH,0.23286,-0.030792,-0.034647,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,0.25583,-0.030965,-0.013052,0,0
4,GO REGULATION OF GENE SILENCING,0.077018,-0.031218,-0.04742,0,0
4,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.49231,-0.03126,-0.030259,0,0
4,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.78763,-0.031589,-0.0013107,0,0
4,GO POSITIVE REGULATION OF TRANSLATION,0.1754,-0.031911,-0.039793,0,0
4,GO REGULATION OF SYNAPTIC PLASTICITY,0.47712,-0.032021,-0.021481,0,0
4,GO HISTONE SERINE PHOSPHORYLATION,0.17669,-0.032186,-0.064109,0,0
4,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.58307,-0.032324,0.071805,0,0
4,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.49487,-0.032504,-0.015323,0,0
4,GO REGULATION OF ODONTOGENESIS,0.55016,-0.032545,-0.056248,0,0
4,GO REGULATION OF TRANSLATIONAL FIDELITY,0.77829,-0.032547,-0.0032278,0,0
4,GO GLUTAMINE METABOLIC PROCESS,0.28578,-0.032568,-0.054652,0,0
4,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.15214,-0.032704,-0.016489,0,0
4,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.77519,-0.03274,0.068077,0,0
4,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.92738,-0.032787,0.010515,0,0
4,GO HISTONE H3 K36 METHYLATION,0.55016,-0.032853,-0.038673,0,0
4,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.90167,-0.032882,-0.0038216,0,0
4,GO CELLULAR RESPONSE TO RADIATION,0.11183,-0.032962,-0.032031,0,0
4,GO APPENDAGE MORPHOGENESIS,0.43312,-0.033097,-0.026983,0,0
4,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.70787,-0.033157,-0.025213,0,0
4,GO MITOCHONDRIAL GENE EXPRESSION,0.54208,-0.033208,-0.022833,0,0
4,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.82842,-0.033362,0.0099138,0,0
4,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.3871,-0.033481,-0.010951,0,0
4,GO MICROTUBULE CYTOSKELETON ORGANIZATION,0.2114,-0.033491,-0.024935,0,0
4,GO REGULATION OF CHROMOSOME SEGREGATION,0.063258,-0.033557,-0.053751,0,0
4,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.44752,-0.033578,-0.019309,0,0
4,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.36098,-0.03376,-0.053282,0,0
4,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.41203,-0.033838,-0.054681,0,0
4,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.25753,-0.034207,-0.037773,0,0
4,GO NEURAL CREST CELL DIFFERENTIATION,0.24252,-0.034388,-0.051658,0,0
4,GO REGULATION OF OOGENESIS,0.59424,-0.034425,-0.007598,0,0
4,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.75972,-0.034624,0.021293,0,0
4,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.21889,-0.034811,-0.044007,0,0
4,GO FOLIC ACID METABOLIC PROCESS,0.43789,-0.034926,-0.057361,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.46713,-0.035088,-0.011556,0,0
4,GO MAINTENANCE OF CELL NUMBER,0.21288,-0.035127,-0.04369,0,0
4,GO T HELPER 1 CELL DIFFERENTIATION,0.60834,-0.035189,-0.063609,0,0
4,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.68094,-0.035322,-0.020205,0,0
4,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.16285,-0.035389,-0.036714,0,0
4,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.15098,-0.035499,-0.031881,0,0
4,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.34627,-0.035575,-0.026255,0,0
4,GO CELLULAR RESPONSE TO HEAT,0.16285,-0.03592,-0.025555,0,0
4,GO PROSTATIC BUD FORMATION,0.46218,-0.035936,-0.10164,0,0
4,GO NEGATIVE REGULATION OF DNA REPLICATION,0.55287,-0.035942,-0.017834,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.14642,-0.036074,-0.0249,0,0
4,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,0.24252,-0.036082,-0.037132,0,0
4,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.99192,-0.036109,0.031113,0,0
4,GO REGULATION OF TELOMERE CAPPING,0.34835,-0.036206,-0.016332,0,0
4,GO PEPTIDYL LYSINE METHYLATION,0.35886,-0.036246,-0.025768,0,0
4,GO ERBB2 SIGNALING PATHWAY,0.5583,-0.036303,-0.023296,0,0
4,GO OOCYTE MATURATION,0.82842,-0.036477,-0.0069294,0,0
4,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.36311,-0.036505,-0.030438,0,0
4,GO DENDRITE MORPHOGENESIS,0.1914,-0.036799,-0.057587,0,0
4,GO PROTEIN LOCALIZATION TO CYTOSKELETON,0.63408,-0.036893,0.002618,0,0
4,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.27673,-0.037114,-0.066269,0,0
4,GO DENDRITIC SPINE MAINTENANCE,1,-0.037135,0.029593,0,0
4,GO NUCLEAR TRANSPORT,0.095518,-0.037149,-0.031948,0,0
4,GO NEURON PROJECTION GUIDANCE,0.14419,-0.037156,-0.069934,0,0
4,GO BRANCHING MORPHOGENESIS OF A NERVE,0.6515,-0.03722,-0.03008,0,0
4,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.22658,-0.037272,-0.04853,0,0
4,GO MITOCHONDRIAL TRANSLATION,0.37827,-0.037315,-0.027314,0,0
4,GO POSITIVE REGULATION OF AXON EXTENSION,0.34213,-0.03733,-0.044741,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION,0.084763,-0.037631,-0.042834,0,0
4,GO REGULATION OF ERAD PATHWAY,0.91451,-0.037756,0.023941,0,0
4,GO L SERINE METABOLIC PROCESS,0.26095,-0.037912,-0.11053,0,0
4,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.21738,-0.037915,-0.048075,0,0
4,GO SPINDLE LOCALIZATION,0.20699,-0.037918,-0.031454,0,0
4,GO PHOTORECEPTOR CELL MAINTENANCE,0.67501,-0.038045,-0.028499,0,0
4,GO EMBRYONIC HEART TUBE DEVELOPMENT,0.27853,-0.038077,-0.033893,0,0
4,GO CELLULAR OXIDANT DETOXIFICATION,0.76899,-0.038218,0.033219,0,0
4,GO CELLULAR RESPONSE TO MANGANESE ION,0.71996,-0.038447,-0.010781,0,0
4,GO CELL CYCLE PHASE TRANSITION,0.13549,-0.038473,-0.018711,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.20265,-0.038488,-0.040825,0,0
4,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.33194,-0.03863,-0.0334,0,0
4,GO RESPONSE TO VITAMIN A,0.24089,-0.038764,-0.062706,0,0
4,GO PROTEIN HETEROTETRAMERIZATION,0.54746,-0.03877,-0.026196,0,0
4,GO REGULATION OF CELL CYCLE PROCESS,0.2458,-0.03878,-0.011637,0,0
4,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.12721,-0.038836,-0.060764,0,0
4,GO POSITIVE REGULATION OF RNA SPLICING,0.43789,-0.03889,-0.015018,0,0
4,GO AXO DENDRITIC TRANSPORT,0.22348,-0.038981,-0.033348,0,0
4,GO REGULATION OF RNA BINDING,0.17669,-0.039016,-0.061937,0,0
4,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.56376,-0.039083,-0.030881,0,0
4,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.84424,-0.039127,-0.0095199,0,0
4,GO REGULATION OF SISTER CHROMATID COHESION,0.23128,-0.03924,-0.043753,0,0
4,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.28033,-0.039298,-0.011992,0,0
4,GO MAINTENANCE OF ORGANELLE LOCATION,0.25583,-0.039346,-0.045441,0,0
4,GO NUCLEAR BODY ORGANIZATION,0.86968,-0.039924,0.030974,0,0
4,GO FIBROBLAST ACTIVATION,0.93704,-0.040077,0.013127,0,0
4,GO RNA POLYADENYLATION,0.068619,-0.040146,-0.059863,0,0
4,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.62832,-0.040172,-0.071906,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.59705,-0.040307,0.011982,0,0
4,GO TRANSLATIONAL ELONGATION,0.15565,-0.040389,-0.046665,0,0
4,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.25924,-0.040399,-0.025045,0,0
4,GO MICROTUBULE ANCHORING AT CENTROSOME,0.19417,-0.04044,-0.076213,0,0
4,GO PEPTIDYL ARGININE MODIFICATION,0.318,-0.040485,-0.036652,0,0
4,GO ASTROCYTE DIFFERENTIATION,0.82526,-0.040587,0.032161,0,0
4,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.38047,-0.040726,-0.050964,0,0
4,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.58585,-0.041024,-0.023083,0,0
4,GO CELLULAR RESPONSE TO RETINOIC ACID,0.5394,-0.041167,-0.021499,0,0
4,GO INTRACILIARY TRANSPORT,0.47461,-0.041175,-0.028915,0,0
4,GO CEREBELLAR CORTEX MORPHOGENESIS,0.45482,-0.041545,-0.038929,0,0
4,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,0.63408,-0.041713,-0.024297,0,0
4,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.11553,-0.04175,-0.050217,0,0
4,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.26095,-0.041762,-0.055171,0,0
4,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.77519,-0.041767,0.020279,0,0
4,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.19557,-0.041942,-0.023167,0,0
4,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.59986,-0.042144,-0.021545,0,0
4,GO ERROR PRONE TRANSLESION SYNTHESIS,0.38933,-0.042361,-0.020463,0,0
4,GO POST ANAL TAIL MORPHOGENESIS,0.73212,-0.042509,5.7014e-05,0,0
4,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.19838,-0.04251,-0.057432,0,0
4,GO NUCLEOTIDE EXCISION REPAIR,0.093918,-0.042886,-0.029231,0,0
4,GO NUCLEAR CHROMOSOME SEGREGATION,0.065596,-0.042916,-0.037648,0,0
4,GO SNRNA PROCESSING,0.11933,-0.042962,-0.068407,0,0
4,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.34627,-0.043007,-0.033283,0,0
4,GO MITOTIC SPINDLE ASSEMBLY,0.88565,-0.043179,0.006107,0,0
4,GO EMBRYONIC HEMOPOIESIS,0.35674,-0.043231,-0.03741,0,0
4,GO HISTONE UBIQUITINATION,0.34835,-0.04337,-0.017844,0,0
4,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.22195,-0.043374,-0.066734,0,0
4,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.47211,-0.043406,-0.039211,0,0
4,GO TELOMERE CAPPING,0.40514,-0.043438,-0.0092634,0,0
4,GO REGULATION OF MITOCHONDRIAL FISSION,0.90167,-0.043586,0.032187,0,0
4,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,0.38933,-0.043825,-0.044256,0,0
4,GO MICROTUBULE NUCLEATION,0.39606,-0.043936,-0.015501,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.1653,-0.043955,-0.049762,0,0
4,GO BONE DEVELOPMENT,0.25078,-0.043969,-0.035004,0,0
4,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.50776,-0.044045,-0.026181,0,0
4,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.45727,-0.044107,-0.028509,0,0
4,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.48468,-0.044136,-0.016813,0,0
4,GO HISTONE H3 ACETYLATION,0.10471,-0.044162,-0.036506,0,0
4,GO REGULATION OF STEM CELL DIVISION,0.71089,-0.04417,-0.014829,0,0
4,GO ATP DEPENDENT CHROMATIN REMODELING,0.080464,-0.04429,-0.058611,0,0
4,GO PRIMARY MIRNA PROCESSING,0.5665,-0.044393,-0.027089,0,0
4,GO FOREGUT MORPHOGENESIS,0.58029,-0.044394,-0.025157,0,0
4,GO SPINDLE ORGANIZATION,0.086981,-0.044517,-0.034545,0,0
4,GO CHROMOSOME ORGANIZATION,0.09796,-0.044612,-0.024992,0,0
4,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.081877,-0.044678,-0.070793,0,0
4,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.92416,-0.04484,0.024031,0,0
4,GO SNORNA METABOLIC PROCESS,0.26095,-0.044898,-0.0611,0,0
4,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,0.54477,-0.044902,-0.0299,0,0
4,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.13444,-0.045203,-0.050196,0,0
4,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.31604,-0.045215,-0.038088,0,0
4,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.20122,-0.045246,-0.11433,0,0
4,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,0.36526,-0.045311,-0.041589,0,0
4,GO RNA CAPPING,0.096327,-0.045434,-0.043451,0,0
4,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.40286,-0.045725,-0.049257,0,0
4,GO HISTONE H3 K4 METHYLATION,0.31604,-0.045757,-0.025962,0,0
4,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.20554,-0.046133,-0.097488,0,0
4,GO COLLAGEN METABOLIC PROCESS,0.82526,-0.046169,-0.0086616,0,0
4,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.5314,-0.046328,-0.024419,0,0
4,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,0.23605,-0.046342,-0.024452,0,0
4,GO ANTEROGRADE AXONAL TRANSPORT,0.5314,-0.046704,-0.0096378,0,0
4,GO REGULATION OF MICROTUBULE BASED PROCESS,0.14755,-0.046772,-0.031218,0,0
4,GO MICROTUBULE ANCHORING,0.31604,-0.046898,-0.034063,0,0
4,GO STEM CELL DIVISION,0.23605,-0.046932,-0.057528,0,0
4,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.2913,-0.047008,-0.044049,0,0
4,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.26267,-0.047228,-0.095725,0,0
4,GO RNA MODIFICATION,0.25583,-0.047395,-0.034325,0,0
4,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.43312,-0.047479,-0.060097,0,0
4,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,0.36098,-0.047546,-0.033352,0,0
4,GO REGULATION OF CHROMOSOME ORGANIZATION,0.11647,-0.047773,-0.02043,0,0
4,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.20554,-0.047802,-0.042399,0,0
4,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.49743,-0.048054,-0.014797,0,0
4,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.4451,-0.048178,-0.053423,0,0
4,GO G2 DNA DAMAGE CHECKPOINT,0.21587,-0.048527,-0.036096,0,0
4,GO CENTROSOME DUPLICATION,0.55558,-0.048605,-0.0069816,0,0
4,GO REGULATION OF DENDRITE DEVELOPMENT,0.37173,-0.049086,-0.031831,0,0
4,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,0.10823,-0.04915,-0.094971,0,0
4,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.19838,-0.049181,-0.036895,0,0
4,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.13027,-0.049368,-0.058796,0,0
4,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.052575,-0.049454,-0.045357,0,0
4,GO HISTONE H3 K14 ACETYLATION,0.2644,-0.049833,-0.029613,0,0
4,GO HISTONE PHOSPHORYLATION,0.20992,-0.049879,-0.03855,0,0
4,GO CORONARY VASCULATURE DEVELOPMENT,0.25246,-0.049984,-0.042559,0,0
4,GO PROSTATE GLAND DEVELOPMENT,0.20122,-0.049987,-0.094109,0,0
4,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.40973,-0.04999,-0.022142,0,0
4,GO CHROMOSOME LOCALIZATION,0.40514,-0.050306,-0.0065089,0,0
4,GO ACROSOME ASSEMBLY,0.11837,-0.050602,-0.085475,0,0
4,GO NUCLEOBASE METABOLIC PROCESS,0.30066,-0.050617,-0.036045,0,0
4,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.79075,-0.050656,-0.0010223,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.67501,-0.050691,-0.020015,0,0
4,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.61972,-0.050902,-0.037334,0,0
4,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.48468,-0.050924,-0.02255,0,0
4,GO WALKING BEHAVIOR,0.22814,-0.051044,-0.050784,0,0
4,GO REGULATION OF MICROTUBULE POLYMERIZATION,0.47461,-0.051079,-0.024434,0,0
4,GO RNA DECAPPING,0.091558,-0.051093,-0.048342,0,0
4,GO REPLACEMENT OSSIFICATION,0.33396,-0.051481,-0.046374,0,0
4,GO SKELETAL MUSCLE TISSUE REGENERATION,0.63697,-0.051534,-0.034812,0,0
4,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,0.1793,-0.051589,-0.070302,0,0
4,GO OSTEOBLAST DEVELOPMENT,0.45482,-0.051605,-0.0464,0,0
4,GO REGULATION OF STEM CELL DIFFERENTIATION,0.38047,-0.051664,-0.034114,0,0
4,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.18866,-0.05224,-0.056682,0,0
4,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.13338,-0.052288,-0.050665,0,0
4,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.48215,-0.052485,-0.019687,0,0
4,GO ANIMAL ORGAN FORMATION,0.36098,-0.052525,-0.03807,0,0
4,GO GAS TRANSPORT,0.63697,-0.052646,-0.050219,0,0
4,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.10385,-0.052789,-0.041188,0,0
4,GO POSITIVE REGULATION OF BEHAVIOR,0.41666,-0.052978,-0.053147,0,0
4,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,0.28033,-0.053254,-0.032087,0,0
4,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.35463,-0.053493,-0.030062,0,0
4,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.079765,-0.053517,-0.077487,0,0
4,GO REGULATION OF MRNA POLYADENYLATION,0.17156,-0.053603,-0.047756,0,0
4,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.34627,-0.053816,-0.07047,0,0
4,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.74435,-0.053916,0.061854,0,0
4,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.48722,-0.053977,-0.026124,0,0
4,GO SNRNA METABOLIC PROCESS,0.16654,-0.054154,-0.049299,0,0
4,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.22348,-0.054352,-0.047205,0,0
4,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.072397,-0.054697,-0.049541,0,0
4,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.20845,-0.054778,-0.09853,0,0
4,GO BRANCH ELONGATION OF AN EPITHELIUM,0.40973,-0.054988,-0.10052,0,0
4,GO TRANSLATIONAL TERMINATION,0.27853,-0.055126,-0.036738,0,0
4,GO CELLULAR RESPONSE TO ETHANOL,0.89846,-0.055375,0.0073615,0,0
4,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.48722,-0.055514,-0.051347,0,0
4,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.27317,-0.055579,-0.05343,0,0
4,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.22348,-0.055669,-0.029451,0,0
4,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.15565,-0.055816,-0.084477,0,0
4,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.075009,-0.055924,-0.086799,0,0
4,GO HOMOLOGOUS RECOMBINATION,0.11553,-0.056081,-0.05411,0,0
4,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,0.12029,-0.05642,-0.041324,0,0
4,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.2114,-0.056512,-0.070068,0,0
4,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,0.32393,-0.056548,-0.022031,0,0
4,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.2714,-0.056555,-0.04243,0,0
4,GO OXIDATIVE DEMETHYLATION,0.17411,-0.056636,-0.034818,0,0
4,GO HISTONE H3 K4 TRIMETHYLATION,0.13027,-0.056736,-0.061752,0,0
4,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.61972,-0.056792,-0.0081392,0,0
4,GO NCRNA METABOLIC PROCESS,0.089246,-0.056792,-0.06003,0,0
4,GO LYMPH VESSEL DEVELOPMENT,0.1387,-0.056837,-0.076088,0,0
4,GO SPINAL CORD DEVELOPMENT,0.41899,-0.056882,-0.035552,0,0
4,GO CEREBRAL CORTEX CELL MIGRATION,0.37827,-0.057041,-0.042627,0,0
4,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,0.13234,-0.057095,-0.030814,0,0
4,GO RESPONSE TO ACETYLCHOLINE,0.1873,-0.05729,-0.090653,0,0
4,GO REGULATION OF HELICASE ACTIVITY,0.43789,-0.057354,-0.032114,0,0
4,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.63697,-0.057511,-0.012824,0,0
4,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.42602,-0.058113,-0.027111,0,0
4,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.55287,-0.058198,-0.010107,0,0
4,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.32195,-0.058212,-0.020426,0,0
4,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.60268,-0.058306,0.011038,0,0
4,GO EMBRYONIC APPENDAGE MORPHOGENESIS,0.51557,-0.058359,-0.021127,0,0
4,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.66321,-0.058366,0.02577,0,0
4,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.10558,-0.058519,-0.039149,0,0
4,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.10912,-0.058519,-0.025927,0,0
4,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.36956,-0.058552,-0.038432,0,0
4,GO NEGATIVE REGULATION OF CELL DIVISION,0.32393,-0.058772,-0.03161,0,0
4,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.13979,-0.059117,-0.056365,0,0
4,GO SPINDLE ASSEMBLY,0.14197,-0.059353,-0.025836,0,0
4,GO SYNAPTIC VESICLE LOCALIZATION,0.32792,-0.059463,-0.035501,0,0
4,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.25078,-0.059669,-0.13817,0,0
4,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.80012,-0.059944,-0.0052673,0,0
4,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.17283,-0.060039,-0.053708,0,0
4,GO MITOCHONDRIAL GENOME MAINTENANCE,0.37173,-0.060084,-0.01931,0,0
4,GO HIPPOCAMPUS DEVELOPMENT,0.089246,-0.06009,-0.065933,0,0
4,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.22042,-0.060099,-0.069721,0,0
4,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.17156,-0.060187,-0.062718,0,0
4,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.081877,-0.060207,-0.078503,0,0
4,GO PRESYNAPTIC MEMBRANE ORGANIZATION,0.7814,-0.060258,-0.049624,0,0
4,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.27317,-0.060408,-0.088319,0,0
4,GO FOREBRAIN CELL MIGRATION,0.27673,-0.060559,-0.049031,0,0
4,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.318,-0.060576,-0.049037,0,0
4,GO LONG TERM MEMORY,0.30446,-0.060735,-0.046608,0,0
4,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.38047,-0.060791,-0.04173,0,0
4,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.90809,-0.06084,0.036372,0,0
4,GO NEURAL RETINA DEVELOPMENT,0.43312,-0.061362,-0.031242,0,0
4,GO PROTEIN POLYGLUTAMYLATION,0.36741,-0.061575,-0.023278,0,0
4,GO NEUROBLAST PROLIFERATION,0.15683,-0.061792,-0.052737,0,0
4,GO REGULATION OF DNA REPLICATION,0.12224,-0.061893,-0.0308,0,0
4,GO REGULATION OF PRESYNAPSE ORGANIZATION,0.82211,-0.06199,-0.019957,0,0
4,GO REGULATION OF MRNA 3 END PROCESSING,0.10045,-0.062154,-0.050955,0,0
4,GO HISTONE H4 K16 ACETYLATION,0.32592,-0.062322,-0.026883,0,0
4,GO NUCLEOSOME ASSEMBLY,0.13979,-0.06236,-0.053787,0,0
4,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.2114,-0.062383,-0.033497,0,0
4,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.41434,-0.062464,-0.032994,0,0
4,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,0.16285,-0.062497,-0.054338,0,0
4,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.16042,-0.06256,-0.072567,0,0
4,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,1,-0.062561,0.025397,0,0
4,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.14419,-0.062575,-0.09708,0,0
4,GO REGULATION OF CENTRIOLE REPLICATION,0.18327,-0.062751,-0.049706,0,0
4,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.27317,-0.062767,-0.048127,0,0
4,GO REGULATION OF EXCRETION,0.46962,-0.062849,-0.030631,0,0
4,GO PENTOSE METABOLIC PROCESS,0.5314,-0.062929,-0.030349,0,0
4,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,0.21738,-0.062931,-0.046299,0,0
4,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.94993,-0.063178,0.051371,0,0
4,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,0.087731,-0.063228,-0.061625,0,0
4,GO TRNA METABOLIC PROCESS,0.13763,-0.063302,-0.051035,0,0
4,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.13656,-0.063446,-0.0334,0,0
4,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.25414,-0.063514,-0.046373,0,0
4,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.16904,-0.06355,-0.067855,0,0
4,GO REGULATION OF AXON GUIDANCE,0.18595,-0.06369,-0.059043,0,0
4,GO CELLULAR RESPONSE TO VITAMIN D,0.29689,-0.063735,-0.08288,0,0
4,GO CHONDROCYTE DEVELOPMENT,0.64858,-0.063741,-0.027847,0,0
4,GO REGULATION OF STEM CELL PROLIFERATION,0.12822,-0.063768,-0.068232,0,0
4,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.20992,-0.063828,-0.032517,0,0
4,GO MIDDLE EAR MORPHOGENESIS,0.18866,-0.063917,-0.078719,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.19278,-0.064139,-0.072361,0,0
4,GO SNORNA 3 END PROCESSING,0.15802,-0.0642,-0.076898,0,0
4,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,0.072397,-0.06448,-0.038504,0,0
4,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,0.08331,-0.064498,-0.04217,0,0
4,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,0.086237,-0.06465,-0.084117,0,0
4,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.22814,-0.064911,-0.033219,0,0
4,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.23605,-0.065063,-0.024213,0,0
4,GO CELLULAR RESPONSE TO VITAMIN,0.66028,-0.065169,-0.026752,0,0
4,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.086237,-0.065588,-0.05096,0,0
4,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.22971,-0.0656,-0.084849,0,0
4,GO MITRAL VALVE DEVELOPMENT,0.21738,-0.065627,-0.088985,0,0
4,GO RIBOSOME ASSEMBLY,0.086981,-0.065748,-0.096912,0,0
4,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.34835,-0.066177,-0.067393,0,0
4,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.32195,-0.066482,-0.053496,0,0
4,GO SYNAPTIC MEMBRANE ADHESION,0.43312,-0.067084,-0.076105,0,0
4,GO 3 UTR MEDIATED MRNA STABILIZATION,0.50516,-0.067134,-0.0086101,0,0
4,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.34835,-0.067147,-0.09643,0,0
4,GO SEQUESTERING OF METAL ION,0.47461,-0.067273,-0.079235,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.074349,-0.067745,-0.085826,0,0
4,GO PEPTIDYL METHIONINE MODIFICATION,0.35253,-0.06781,-0.047299,0,0
4,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.13444,-0.068095,-0.04533,0,0
4,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.30829,-0.068371,-0.083623,0,0
4,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.32792,-0.068484,-0.041707,0,0
4,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.24416,-0.068548,-0.049315,0,0
4,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,0.76899,-0.06888,-0.023553,0,0
4,GO PORE COMPLEX ASSEMBLY,0.085497,-0.068981,-0.055258,0,0
4,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.15565,-0.068998,-0.050285,0,0
4,GO HISTONE EXCHANGE,0.084763,-0.069358,-0.060237,0,0
4,GO FOREBRAIN NEURON FATE COMMITMENT,0.77519,-0.070546,0.041308,0,0
4,GO NEURON FATE COMMITMENT,0.34213,-0.07074,-0.035355,0,0
4,GO AXONAL TRANSPORT,0.17029,-0.071022,-0.043962,0,0
4,GO VIRAL GENE EXPRESSION,0.086981,-0.071133,-0.069224,0,0
4,GO CELL MIGRATION IN HINDBRAIN,0.61402,-0.071336,-0.009407,0,0
4,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,0.084034,-0.071337,-0.10299,0,0
4,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.1793,-0.07161,-0.085554,0,0
4,GO RECEPTOR CLUSTERING,0.084034,-0.071679,-0.094711,0,0
4,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.09714,-0.071805,-0.057396,0,0
4,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.41203,-0.071926,-0.037564,0,0
4,GO CHROMATIN SILENCING,0.086981,-0.072389,-0.045047,0,0
4,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.3442,-0.072522,-0.033606,0,0
4,GO MATERNAL PLACENTA DEVELOPMENT,0.094715,-0.072953,-0.093774,0,0
4,GO COLLAGEN FIBRIL ORGANIZATION,0.53672,-0.073151,-0.043284,0,0
4,GO FORELIMB MORPHOGENESIS,0.10129,-0.073168,-0.10383,0,0
4,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.97576,-0.07325,0.019521,0,0
4,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.093918,-0.073466,-0.059787,0,0
4,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.10385,-0.073782,-0.10502,0,0
4,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,0.32195,-0.074275,-0.0089472,0,0
4,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.069238,-0.07442,-0.076944,0,0
4,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.073043,-0.074583,-0.068564,0,0
4,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.59424,-0.075456,-0.038046,0,0
4,GO REGULATION OF HISTONE H3 K9 METHYLATION,0.16285,-0.075465,-0.04959,0,0
4,GO NEGATIVE REGULATION OF AXON EXTENSION,0.12421,-0.075531,-0.084198,0,0
4,GO PROSTATE GLAND MORPHOGENESIS,0.39832,-0.075559,-0.099419,0,0
4,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.084034,-0.075586,-0.095564,0,0
4,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.56925,-0.075609,-0.034916,0,0
4,GO MESODERMAL CELL FATE COMMITMENT,0.093918,-0.075922,-0.083571,0,0
4,GO LEFT RIGHT AXIS SPECIFICATION,0.55287,-0.07611,-0.039036,0,0
4,GO RESPONSE TO X RAY,0.1146,-0.076549,-0.080492,0,0
4,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.099614,-0.07659,-0.06787,0,0
4,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.19278,-0.076893,-0.065723,0,0
4,GO SUCKLING BEHAVIOR,0.39156,-0.076971,-0.052721,0,0
4,GO CELL DIFFERENTIATION IN HINDBRAIN,0.15098,-0.077055,-0.089212,0,0
4,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.09796,-0.077089,-0.063378,0,0
4,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.18866,-0.07717,-0.069885,0,0
4,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,0.1533,-0.077323,-0.10028,0,0
4,GO MITOTIC SPINDLE ORGANIZATION,0.076344,-0.077572,-0.042341,0,0
4,GO SHORT TERM MEMORY,0.34835,-0.077642,-0.054054,0,0
4,GO ASYMMETRIC CELL DIVISION,0.62258,-0.078044,-0.015898,0,0
4,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.36741,-0.07823,-0.036069,0,0
4,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.12822,-0.078388,-0.066725,0,0
4,GO AXIS ELONGATION,0.47461,-0.078416,-0.060681,0,0
4,GO AXO DENDRITIC PROTEIN TRANSPORT,0.1533,-0.078606,-0.080205,0,0
4,GO REGULATION OF MYELINATION,0.08331,-0.078656,-0.058133,0,0
4,GO REGULATION OF MEMBRANE INVAGINATION,0.98546,-0.078675,0.014083,0,0
4,GO HISTONE H3 K27 METHYLATION,0.10734,-0.078978,-0.071124,0,0
4,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.26095,-0.079401,-0.051521,0,0
4,GO MEIOTIC CHROMOSOME SEPARATION,0.017506,-0.080082,-0.094131,0,0
4,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,0.4355,-0.080348,-0.053712,0,0
4,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.1533,-0.080813,-0.092201,0,0
4,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.67798,-0.081168,-0.0090732,0,0
4,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.40514,-0.081447,-0.026568,0,0
4,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.28578,-0.08165,-0.055071,0,0
4,GO REGULATION OF HEART GROWTH,0.25583,-0.08231,-0.043506,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.1653,-0.082486,-0.075542,0,0
4,GO REGULATION OF DENDRITE MORPHOGENESIS,0.077698,-0.082986,-0.079889,0,0
4,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.29689,-0.083379,-0.055248,0,0
4,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.79075,-0.083389,-0.049275,0,0
4,GO PSEUDOURIDINE SYNTHESIS,0.1262,-0.083527,-0.086098,0,0
4,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.49743,-0.083789,-0.029946,0,0
4,GO SISTER CHROMATID COHESION,0.13549,-0.083881,-0.047345,0,0
4,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.16285,-0.083958,-0.055858,0,0
4,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.039795,-0.084156,-0.13438,0,0
4,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.12822,-0.084284,-0.11634,0,0
4,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,0.29877,-0.08435,-0.11079,0,0
4,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.178,-0.084439,-0.098294,0,0
4,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.13979,-0.08481,-0.050902,0,0
4,GO REGULATION OF GONAD DEVELOPMENT,0.22971,-0.084862,-0.053155,0,0
4,GO COLLECTING DUCT DEVELOPMENT,0.48722,-0.084922,-0.041432,0,0
4,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.16285,-0.084942,-0.050385,0,0
4,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.1252,-0.085293,-0.075856,0,0
4,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.17156,-0.085397,-0.066335,0,0
4,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.10214,-0.08562,-0.11517,0,0
4,GO ANATOMICAL STRUCTURE REGRESSION,0.79075,-0.08639,-0.028941,0,0
4,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.071756,-0.086502,-0.10704,0,0
4,GO CHRONIC INFLAMMATORY RESPONSE,0.3871,-0.087107,-0.076238,0,0
4,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.29689,-0.08713,-0.045403,0,0
4,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.76281,-0.088099,-0.011323,0,0
4,GO TRACHEA MORPHOGENESIS,0.17669,-0.088653,-0.068789,0,0
4,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.073694,-0.088669,-0.12004,0,0
4,GO HISTONE H3 K9 TRIMETHYLATION,0.23766,-0.089372,-0.041152,0,0
4,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,0.065596,-0.089731,-0.14002,0,0
4,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.55558,-0.090376,-0.056816,0,0
4,GO LAYER FORMATION IN CEREBRAL CORTEX,0.19003,-0.090398,-0.085142,0,0
4,GO KIDNEY MESENCHYME DEVELOPMENT,0.2644,-0.090415,-0.062941,0,0
4,GO DENDRITIC TRANSPORT,0.11092,-0.090764,-0.096779,0,0
4,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.14308,-0.091124,-0.057333,0,0
4,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.61117,-0.091701,-0.030076,0,0
4,GO CELL CELL JUNCTION MAINTENANCE,0.42838,-0.091798,-0.059481,0,0
4,GO L GLUTAMATE IMPORT,0.077018,-0.092464,-0.089478,0,0
4,GO NEURON CELLULAR HOMEOSTASIS,0.15447,-0.092778,-0.11386,0,0
4,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.13027,-0.09293,-0.1212,0,0
4,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.16042,-0.09336,-0.13579,0,0
4,GO CORONARY VASCULATURE MORPHOGENESIS,0.087731,-0.09348,-0.10811,0,0
4,GO POSITIVE REGULATION OF HEART GROWTH,0.1873,-0.094042,-0.059707,0,0
4,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.71089,-0.094503,-0.036053,0,0
4,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.26614,-0.094562,-0.10376,0,0
4,GO NEGATIVE REGULATION OF CELL AGING,0.073694,-0.094575,-0.094389,0,0
4,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.13338,-0.094935,-0.09527,0,0
4,GO RNA METHYLATION,0.077018,-0.095665,-0.062375,0,0
4,GO REGULATION OF TRANSLATIONAL TERMINATION,0.17669,-0.096485,-0.067486,0,0
4,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.11002,-0.096527,-0.058394,0,0
4,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.10385,-0.096694,-0.10805,0,0
4,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.24416,-0.096798,-0.04995,0,0
4,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,0.11275,-0.097661,-0.038528,0,0
4,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.72299,-0.097829,0.0030795,0,0
4,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.74435,-0.098142,-0.015027,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.41203,-0.098394,-0.096363,0,0
4,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.1533,-0.09862,-0.08787,0,0
4,GO RESPONSE TO SALT STRESS,0.10646,-0.098824,-0.075067,0,0
4,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,0.10045,-0.099025,-0.11635,0,0
4,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.10214,-0.099052,-0.071264,0,0
4,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.21437,-0.099217,-0.10065,0,0
4,GO MITOCHONDRION DISTRIBUTION,0.073043,-0.099588,-0.069258,0,0
4,GO CELL DIFFERENTIATION IN SPINAL CORD,0.1313,-0.10051,-0.067889,0,0
4,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.08331,-0.10072,-0.090572,0,0
4,GO ETHANOL CATABOLIC PROCESS,0.10734,-0.101,-0.12325,0,0
4,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.16285,-0.10144,-0.085627,0,0
4,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.47461,-0.10189,-0.030366,0,0
4,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.19003,-0.1021,-0.060278,0,0
4,GO VOCALIZATION BEHAVIOR,0.34835,-0.10267,-0.10871,0,0
4,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.15921,-0.1031,-0.1269,0,0
4,GO RRNA 3 END PROCESSING,0.14308,-0.1032,-0.0601,0,0
4,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.15802,-0.10375,-0.074643,0,0
4,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.14419,-0.10379,-0.086457,0,0
4,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.12126,-0.10384,-0.096634,0,0
4,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.32592,-0.10413,-0.13199,0,0
4,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.36956,-0.10426,-0.07078,0,0
4,GO MITOCHONDRIAL PROTEIN PROCESSING,0.076344,-0.10447,-0.076193,0,0
4,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.28213,-0.10463,-0.051335,0,0
4,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.18194,-0.10475,-0.064305,0,0
4,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,0.13656,-0.10515,-0.11436,0,0
4,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.36526,-0.10536,-0.051686,0,0
4,GO RRNA METHYLATION,0.065005,-0.1076,-0.069137,0,0
4,GO FOREBRAIN REGIONALIZATION,0.081168,-0.10784,-0.10387,0,0
4,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,0.23286,-0.1087,-0.057763,0,0
4,GO RENAL VESICLE DEVELOPMENT,0.1262,-0.10942,-0.086197,0,0
4,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.32195,-0.10964,-0.064077,0,0
4,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.22814,-0.1118,-0.091178,0,0
4,GO VENTRAL SPINAL CORD DEVELOPMENT,0.062114,-0.11422,-0.087697,0,0
4,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.11275,-0.11503,-0.12783,0,0
4,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.089246,-0.11516,-0.10116,0,0
4,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.25753,-0.11576,-0.059424,0,0
4,GO CARDIAC CELL FATE COMMITMENT,0.14197,-0.11577,-0.12581,0,0
4,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.14197,-0.1188,-0.10291,0,0
4,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.14308,-0.11972,-0.10323,0,0
4,GO INNER CELL MASS CELL PROLIFERATION,0.0093576,-0.12004,-0.11973,0,0
4,GO TRANSCRIPTION BY RNA POLYMERASE I,0.088486,-0.12033,-0.047908,0,0
4,GO BLASTOCYST GROWTH,0.024947,-0.1206,-0.083258,0,0
4,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.57476,-0.12113,-0.082558,0,0
4,GO SIALYLATION,0.39381,-0.1216,-0.049248,0,0
4,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.10045,-0.12164,-0.059494,0,0
4,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.098784,-0.12343,-0.075717,0,0
4,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.067397,-0.12567,-0.08906,0,0
4,GO COLLAGEN BIOSYNTHETIC PROCESS,0.074349,-0.12837,-0.13814,0,0
4,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.27853,-0.12962,-0.079875,0,0
4,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.031953,-0.13123,-0.11137,0,0
4,GO RESPIRATORY SYSTEM PROCESS,0.0023321,-0.13239,-0.14063,0,0
4,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.48722,-0.13337,-0.057873,0,0
4,GO BONE TRABECULA MORPHOGENESIS,0.10471,-0.13482,-0.14452,0,0
4,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.20699,-0.13514,-0.081074,0,0
4,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.40743,-0.13674,-0.044781,0,0
4,GO IMP METABOLIC PROCESS,0.066792,-0.13925,-0.13292,0,0
4,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.10823,-0.13977,-0.13167,0,0
4,GO KINETOCHORE ASSEMBLY,0.1873,-0.14261,-0.066489,0,0
4,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.1313,-0.14455,-0.092117,0,0
4,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.064418,-0.1453,-0.12858,0,0
4,GO INTRACILIARY RETROGRADE TRANSPORT,0.22042,-0.14584,-0.081405,0,0
4,GO AXONAL TRANSPORT OF MITOCHONDRION,0.067397,-0.14681,-0.11682,0,0
4,GO DIVALENT METAL ION EXPORT,0.10129,-0.14891,-0.1369,0,0
4,GO CARTILAGE MORPHOGENESIS,0.010645,-0.1502,-0.21638,0,0
4,GO LEUKOCYTE AGGREGATION,0.32393,-0.15123,-0.11831,0,0
4,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,0.2644,-0.15207,-0.084966,0,0
4,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.21889,-0.15213,-0.062118,0,0
4,GO HOMOCYSTEINE METABOLIC PROCESS,0.06986,-0.15233,-0.13113,0,0
4,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.1793,-0.15375,-0.090984,0,0
4,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.0022396,-0.15489,-0.16332,0,0
4,GO KINETOCHORE ORGANIZATION,0.070488,-0.15671,-0.07809,0,0
4,GO GLYCINE METABOLIC PROCESS,0.086981,-0.15672,-0.094771,0,0
4,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.049681,-0.16378,-0.12563,0,0
4,GO RETINAL CONE CELL DIFFERENTIATION,0.060988,-0.16581,-0.11642,0,0
4,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.11275,-0.16599,-0.13248,0,0
4,GO ATRIAL SEPTUM MORPHOGENESIS,0.071119,-0.16907,-0.13863,0,0
4,GO DENTATE GYRUS DEVELOPMENT,0.078382,-0.18755,-0.1582,0,0
4,GO SYNAPTIC VESICLE MATURATION,0.14869,-0.193,-0.08015,0,0
4,GO OTIC VESICLE DEVELOPMENT,0.065596,-0.19344,-0.16023,0,0
4,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0075485,-0.20187,-0.20683,0,0
4,GO ELASTIC FIBER ASSEMBLY,0.06986,-0.25699,-0.16826,0,0
4,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,8.0256e-05,-0.29646,-0.29207,0,0
4,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.0037016,-0.36808,-0.31551,0,0
5,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.016752,0.21354,0.18193,1,1
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.022446,0.16968,0.1386,1,1
5,GO METHIONINE BIOSYNTHETIC PROCESS,0.047827,-0.028501,-0.14686,1,0
5,GO AMINO ACID ACTIVATION,0.019312,-0.040232,-0.16487,1,0
5,GO MEIOSIS I CELL CYCLE PROCESS,0.016938,-0.042576,-0.14311,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.051111,-0.046301,-0.13941,1,0
5,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.019104,-0.049073,-0.093435,1,0
5,GO REGULATION OF SPINDLE ASSEMBLY,0.0081133,-0.049797,-0.17973,1,0
5,GO TRNA PROCESSING,0.023419,-0.050405,-0.14202,1,0
5,GO SNORNA METABOLIC PROCESS,0.054074,-0.051642,-0.14504,1,0
5,GO METHIONINE METABOLIC PROCESS,0.027973,-0.05505,-0.14481,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.039795,-0.058048,-0.12682,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.02128,-0.05819,-0.11354,1,0
5,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,0.0066039,-0.05826,-0.15201,1,0
5,GO SNRNA PROCESSING,0.048746,-0.062211,-0.10234,1,0
5,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.048746,-0.062986,-0.12932,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.029754,-0.063725,-0.1393,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.032278,-0.063972,-0.16834,1,0
5,GO RNA 3 END PROCESSING,0.002702,-0.064151,-0.16897,1,0
5,GO UBIQUINONE METABOLIC PROCESS,0.0093576,-0.065059,-0.16338,1,0
5,GO NEGATIVE REGULATION OF MRNA PROCESSING,0.019104,-0.065579,-0.17505,1,0
5,GO ELECTRON TRANSPORT CHAIN,0.016752,-0.065601,-0.093065,1,0
5,GO SPERM AXONEME ASSEMBLY,0.056128,-0.067927,-0.13115,1,0
5,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.014823,-0.068165,-0.1044,1,0
5,GO TRNA METABOLIC PROCESS,0.010279,-0.068586,-0.15436,1,0
5,GO NCRNA PROCESSING,0.020385,-0.070129,-0.1438,1,0
5,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.0024281,-0.070171,-0.19254,1,0
5,GO NUCLEOSOME ASSEMBLY,0.03068,-0.071031,-0.12822,1,0
5,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.018898,-0.074522,-0.15733,1,0
5,GO RRNA METABOLIC PROCESS,0.022928,-0.075558,-0.14205,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.035336,-0.077047,-0.13999,1,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.011678,-0.077208,-0.22418,1,0
5,GO POSITIVE REGULATION OF MRNA PROCESSING,0.0098086,-0.077664,-0.16119,1,0
5,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.041789,-0.078466,-0.11484,1,0
5,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.058247,-0.078642,-0.17527,1,0
5,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.02128,-0.079185,-0.10921,1,0
5,GO VITAMIN CATABOLIC PROCESS,0.059879,-0.079871,-0.18651,1,0
5,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.023173,-0.080094,-0.15595,1,0
5,GO RNA SPLICING,0.00096848,-0.081198,-0.17556,1,0
5,GO REGULATION OF SPINDLE ORGANIZATION,0.0013633,-0.081777,-0.21266,1,0
5,GO SENSORY PERCEPTION OF BITTER TASTE,0.014172,-0.083104,-0.10849,1,0
5,GO CHROMATIN SILENCING,0.0040509,-0.083386,-0.17162,1,0
5,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.022928,-0.085787,-0.12866,1,0
5,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.043025,-0.088033,-0.14394,1,0
5,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,0.015674,-0.088628,-0.157,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.021509,-0.088718,-0.1393,1,0
5,GO RESPONSE TO LITHIUM ION,0.025475,-0.08914,-0.18399,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.00042777,-0.089468,-0.1584,1,0
5,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.017894,-0.089554,-0.17594,1,0
5,GO INTERSTRAND CROSS LINK REPAIR,0.0047198,-0.089702,-0.16877,1,0
5,GO BASE EXCISION REPAIR,0.0092477,-0.089705,-0.14201,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,0.052575,-0.089809,-0.21731,1,0
5,GO NCRNA METABOLIC PROCESS,0.0066851,-0.090032,-0.15493,1,0
5,GO NEGATIVE T CELL SELECTION,0.0021798,-0.090656,-0.22824,1,0
5,GO MIDBODY ABSCISSION,0.037139,-0.090666,-0.13585,1,0
5,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.0028492,-0.090878,-0.17805,1,0
5,GO TRNA MODIFICATION,0.0083098,-0.092405,-0.16987,1,0
5,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.020605,-0.092573,-0.17727,1,0
5,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.027401,-0.092687,-0.18335,1,0
5,GO NUCLEOTIDE EXCISION REPAIR,0.0051547,-0.093183,-0.15094,1,0
5,GO CHROMATIN SILENCING AT TELOMERE,0.023173,-0.094228,-0.11672,1,0
5,GO MRNA PROCESSING,0.00035024,-0.095162,-0.19125,1,0
5,GO IRON SULFUR CLUSTER ASSEMBLY,0.011949,-0.095231,-0.13185,1,0
5,GO PEPTIDE BIOSYNTHETIC PROCESS,9.03e-05,-0.095286,-0.14501,1,0
5,GO DETECTION OF VISIBLE LIGHT,0.000286,-0.09542,-0.18974,1,0
5,GO HISTONE H4 K16 ACETYLATION,0.019523,-0.096304,-0.17472,1,0
5,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.003607,-0.097339,-0.17807,1,0
5,GO NUCLEAR CHROMOSOME SEGREGATION,0.0016122,-0.097674,-0.17629,1,0
5,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.017506,-0.097836,-0.13542,1,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.027401,-0.098347,-0.13952,1,0
5,GO NUCLEOSOME ORGANIZATION,0.0012005,-0.098552,-0.16929,1,0
5,GO MITOTIC SPINDLE ASSEMBLY,0.0067673,-0.099082,-0.18282,1,0
5,GO POSITIVE REGULATION OF RNA SPLICING,6.1119e-05,-0.099084,-0.22771,1,0
5,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,0.040981,-0.09927,-0.16615,1,0
5,GO REGULATION OF MRNA BINDING,0.0065235,-0.099477,-0.18199,1,0
5,GO CELL CYCLE DNA REPLICATION,0.045155,-0.099532,-0.14138,1,0
5,GO MEIOTIC CELL CYCLE,9.6562e-05,-0.099533,-0.20321,1,0
5,GO HEPATOCYTE APOPTOTIC PROCESS,0.047372,-0.099786,-0.25334,1,0
5,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0019023,-0.099854,-0.21995,1,0
5,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.020605,-0.10051,-0.14504,1,0
5,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.0092477,-0.10089,-0.17475,1,0
5,GO CARDIOLIPIN METABOLIC PROCESS,0.000286,-0.10096,-0.22032,1,0
5,GO SPLICEOSOMAL COMPLEX ASSEMBLY,0.0089251,-0.101,-0.15503,1,0
5,GO CHROMOSOME SEGREGATION,0.0019023,-0.10181,-0.17747,1,0
5,GO URONIC ACID METABOLIC PROCESS,0.01128,-0.10183,-0.11364,1,0
5,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.0057669,-0.1023,-0.16118,1,0
5,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.01829,-0.10261,-0.1697,1,0
5,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.0013255,-0.10343,-0.19406,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.0055559,-0.10345,-0.18438,1,0
5,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.0044864,-0.10389,-0.16764,1,0
5,GO RNA PROCESSING,0.00035024,-0.10453,-0.18404,1,0
5,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.031631,-0.1046,-0.085271,1,0
5,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.001071,-0.10469,-0.20431,1,0
5,GO AEROBIC RESPIRATION,0.0019819,-0.10493,-0.15822,1,0
5,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.018091,-0.10494,-0.19225,1,0
5,GO MEIOTIC CHROMOSOME SEGREGATION,0.0010865,-0.10564,-0.16321,1,0
5,GO TRNA METHYLATION,0.0027747,-0.10567,-0.20447,1,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.011544,-0.10571,-0.12859,1,0
5,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.0081133,-0.10596,-0.1757,1,0
5,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.002631,-0.10612,-0.20117,1,0
5,GO CRISTAE FORMATION,0.0018764,-0.1062,-0.26971,1,0
5,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.001235,-0.1064,-0.17165,1,0
5,GO REGULATION OF RNA SPLICING,1.5014e-05,-0.10652,-0.2385,1,0
5,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.00021857,-0.1071,-0.14991,1,0
5,GO REGULATION OF TRANSLATIONAL ELONGATION,0.0065235,-0.10875,-0.16195,1,0
5,GO SISTER CHROMATID COHESION,0.0046018,-0.10899,-0.18157,1,0
5,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.00060545,-0.10906,-0.23745,1,0
5,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.010279,-0.10938,-0.10963,1,0
5,GO METAPHASE PLATE CONGRESSION,0.029754,-0.10949,-0.14428,1,0
5,GO RECOMBINATIONAL REPAIR,0.0020367,-0.10975,-0.20645,1,0
5,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.03006,-0.10981,-0.13569,1,0
5,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.033271,-0.10987,-0.17148,1,0
5,GO CENTROSOME DUPLICATION,0.0030038,-0.10999,-0.22123,1,0
5,GO RRNA MODIFICATION,0.013546,-0.11023,-0.16849,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.0032928,-0.11113,-0.16518,1,0
5,GO PSEUDOURIDINE SYNTHESIS,0.02521,-0.11122,-0.17573,1,0
5,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.044292,-0.11153,-0.12603,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0015038,-0.1117,-0.1709,1,0
5,GO MITOTIC SISTER CHROMATID SEGREGATION,0.012653,-0.11208,-0.15601,1,0
5,GO REGULATION OF HISTONE H3 K9 ACETYLATION,0.0044864,-0.1121,-0.18018,1,0
5,GO SNRNA TRANSCRIPTION,0.00054518,-0.11232,-0.17999,1,0
5,GO REGULATION OF SISTER CHROMATID COHESION,0.0081133,-0.11233,-0.20452,1,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.0005789,-0.1133,-0.18432,1,0
5,GO TRNA WOBBLE URIDINE MODIFICATION,0.0095807,-0.1135,-0.17045,1,0
5,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.0098086,-0.1135,-0.16576,1,0
5,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.00026858,-0.11352,-0.18546,1,0
5,GO RRNA METHYLATION,0.0094686,-0.11378,-0.17242,1,0
5,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.033948,-0.11398,-0.12171,1,0
5,GO ORGANELLE FISSION,6.545e-05,-0.1143,-0.2174,1,0
5,GO MATURATION OF SSU RRNA,0.026286,-0.11436,-0.16051,1,0
5,GO MITOTIC SPINDLE ORGANIZATION,0.00095459,-0.11454,-0.20977,1,0
5,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.0018764,-0.11474,-0.16836,1,0
5,GO PHOTOTRANSDUCTION,0.00016098,-0.11491,-0.20088,1,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.00031414,-0.11505,-0.30108,1,0
5,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,0.00029976,-0.11514,-0.17336,1,0
5,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.0069343,-0.11518,-0.14863,1,0
5,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00094089,-0.11532,-0.17877,1,0
5,GO CELLULAR RESPIRATION,0.012653,-0.11538,-0.11948,1,0
5,GO VIRAL BUDDING,0.00086244,-0.11547,-0.18639,1,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.0048405,-0.11564,-0.18452,1,0
5,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.0096941,-0.11617,-0.15586,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0012705,-0.11639,-0.17404,1,0
5,GO RNA MODIFICATION,0.00012388,-0.11701,-0.21345,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.0067673,-0.11741,-0.15711,1,0
5,GO SISTER CHROMATID SEGREGATION,0.0077327,-0.11752,-0.16552,1,0
5,GO MITOTIC RECOMBINATION,0.0011021,-0.1178,-0.23905,1,0
5,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,0.05357,-0.118,-0.17568,1,0
5,GO ATP DEPENDENT CHROMATIN REMODELING,0.0093576,-0.11825,-0.16198,1,0
5,GO MITOCHONDRION MORPHOGENESIS,0.00059648,-0.11846,-0.21953,1,0
5,GO SPINDLE ORGANIZATION,4.5558e-05,-0.1185,-0.23725,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0047798,-0.11852,-0.17025,1,0
5,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0061347,-0.11858,-0.16913,1,0
5,GO DNA PACKAGING,0.0019819,-0.11875,-0.18092,1,0
5,GO MRNA MODIFICATION,0.0018764,-0.11935,-0.22284,1,0
5,GO POSTREPLICATION REPAIR,0.00015331,-0.11946,-0.17527,1,0
5,GO VIRAL TRANSLATION,0.0070192,-0.11992,-0.19405,1,0
5,GO MULTIVESICULAR BODY ORGANIZATION,0.0034692,-0.11996,-0.17725,1,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,0.018091,-0.12007,-0.17599,1,0
5,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.0041031,-0.12043,-0.25295,1,0
5,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.0050904,-0.12044,-0.13497,1,0
5,GO MRNA METABOLIC PROCESS,4.6359e-05,-0.12058,-0.16497,1,0
5,GO SPERM EGG RECOGNITION,0.00072342,-0.12079,-0.15046,1,0
5,GO PROTEIN INSERTION INTO MEMBRANE,0.00055343,-0.12141,-0.18291,1,0
5,GO HISTONE H4 K5 ACETYLATION,0.0029645,-0.12171,-0.18812,1,0
5,GO RNA CATABOLIC PROCESS,8.7316e-05,-0.12176,-0.13644,1,0
5,GO AMIDE BIOSYNTHETIC PROCESS,3.2146e-06,-0.12212,-0.17669,1,0
5,GO MIDDLE EAR MORPHOGENESIS,0.0095807,-0.12227,-0.17775,1,0
5,GO REGULATION OF DNA METHYLATION,0.0011503,-0.12237,-0.28346,1,0
5,GO PROTEIN LOCALIZATION TO CHROMATIN,0.0041031,-0.12253,-0.1821,1,0
5,GO MRNA 3 END PROCESSING,0.00044103,-0.12255,-0.20404,1,0
5,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,0.010279,-0.12304,-0.18646,1,0
5,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.049212,-0.12328,-0.17059,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,1.3693e-05,-0.12336,-0.23062,1,0
5,GO MANNOSYLATION,0.00016361,-0.12337,-0.24846,1,0
5,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,4.7488e-06,-0.12348,-0.22327,1,0
5,GO REPLICATION FORK PROCESSING,0.0038977,-0.12349,-0.22236,1,0
5,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.028264,-0.12349,-0.14646,1,0
5,GO G0 TO G1 TRANSITION,0.00083767,-0.12357,-0.22454,1,0
5,GO DNA GEOMETRIC CHANGE,0.00070238,-0.1237,-0.20975,1,0
5,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,0.00036124,-0.12388,-0.21435,1,0
5,GO DNA REPAIR,0.00010852,-0.12389,-0.20879,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00072342,-0.12407,-0.18551,1,0
5,GO CYTOSKELETON DEPENDENT CYTOKINESIS,1.4741e-05,-0.12407,-0.25313,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,2.6981e-08,-0.12412,-0.26479,1,0
5,GO POSITIVE REGULATION OF ATPASE ACTIVITY,9.3381e-05,-0.12425,-0.17718,1,0
5,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,8.4424e-05,-0.12448,-0.20093,1,0
5,GO MRNA EXPORT FROM NUCLEUS,0.00094089,-0.12456,-0.19604,1,0
5,GO REGULATION OF LIGASE ACTIVITY,0.02945,-0.12471,-0.15426,1,0
5,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.026286,-0.12479,-0.11269,1,0
5,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,0.00012804,-0.12485,-0.21334,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0013069,-0.12497,-0.18674,1,0
5,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.0003557,-0.12499,-0.2331,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.0038478,-0.12515,-0.21467,1,0
5,GO MITOCHONDRIAL TRANSCRIPTION,0.001704,-0.12522,-0.18789,1,0
5,GO REGULATION OF MRNA PROCESSING,0.00013232,-0.12593,-0.23644,1,0
5,GO PEPTIDYL METHIONINE MODIFICATION,0.0096941,-0.12606,-0.19267,1,0
5,GO DNA METABOLIC PROCESS,3.3435e-06,-0.12617,-0.22504,1,0
5,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.014172,-0.12719,-0.18091,1,0
5,GO DNA CONFORMATION CHANGE,0.000662,-0.12762,-0.20396,1,0
5,GO CENTROSOME SEPARATION,0.0068504,-0.12769,-0.19522,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,0.0020646,-0.1285,-0.27663,1,0
5,GO PROTEIN MONOUBIQUITINATION,1.4741e-05,-0.129,-0.24741,1,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.0023009,-0.12914,-0.16718,1,0
5,GO RESPONSE TO ETHER,0.00024045,-0.1292,-0.20614,1,0
5,GO ANTIMICROBIAL HUMORAL RESPONSE,0.00082553,-0.12943,-0.18702,1,0
5,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,0.00070238,-0.12958,-0.29797,1,0
5,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,8.4424e-05,-0.13,-0.26758,1,0
5,GO REGULATION OF TRANSLATIONAL FIDELITY,0.0066039,-0.13012,-0.16559,1,0
5,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,0.00070238,-0.13028,-0.22429,1,0
5,GO RNA METHYLATION,0.00025617,-0.13041,-0.22074,1,0
5,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.0034243,-0.13056,-0.20933,1,0
5,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.020166,-0.13077,-0.14459,1,0
5,GO RESPONSE TO FOOD,0.030994,-0.13099,-0.11999,1,0
5,GO TRANSCRIPTION BY RNA POLYMERASE III,1.4207e-05,-0.13118,-0.19685,1,0
5,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.0071918,-0.13123,-0.21644,1,0
5,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.00029976,-0.13137,-0.18097,1,0
5,GO DNA REPLICATION CHECKPOINT,0.010041,-0.13144,-0.15716,1,0
5,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.0958e-05,-0.1318,-0.19712,1,0
5,GO APOPTOTIC MITOCHONDRIAL CHANGES,7.6446e-07,-0.13214,-0.2442,1,0
5,GO DNA MODIFICATION,9.5999e-07,-0.13223,-0.23312,1,0
5,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.484e-09,-0.13235,-0.27519,1,0
5,GO HISTONE H3 K9 ACETYLATION,7.8124e-06,-0.13254,-0.26687,1,0
5,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0037985,-0.13263,-0.20683,1,0
5,GO DNA METHYLATION OR DEMETHYLATION,1.7071e-05,-0.13278,-0.23891,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION,2.8271e-07,-0.13287,-0.25298,1,0
5,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.0027747,-0.13296,-0.13826,1,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.0011021,-0.13306,-0.17227,1,0
5,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,0.0032928,-0.13315,-0.18856,1,0
5,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.02945,-0.1332,-0.1601,1,0
5,GO CELL CYCLE G2 M PHASE TRANSITION,9.4959e-05,-0.13325,-0.20059,1,0
5,GO HISTONE H3 K27 METHYLATION,4.3236e-05,-0.13337,-0.27359,1,0
5,GO POLYAMINE BIOSYNTHETIC PROCESS,0.0025617,-0.1334,-0.1862,1,0
5,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.015674,-0.13393,-0.2296,1,0
5,GO REGULATION OF CENTROSOME DUPLICATION,0.00075607,-0.13422,-0.21529,1,0
5,GO MITOTIC CYTOKINETIC PROCESS,0.0029645,-0.13443,-0.18973,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00019541,-0.13457,-0.26855,1,0
5,GO RESPONSE TO OXYGEN RADICAL,0.00013899,-0.13462,-0.19713,1,0
5,GO OXIDATIVE DEMETHYLATION,0.0055559,-0.13466,-0.1545,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,1.7385e-05,-0.13484,-0.1346,1,0
5,GO IMP METABOLIC PROCESS,0.025743,-0.13504,-0.24467,1,0
5,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.01251,-0.13509,-0.1682,1,0
5,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,1.6418e-07,-0.13533,-0.17508,1,0
5,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,2.1543e-10,-0.13544,-0.29267,1,0
5,GO MITOCHONDRIAL PROTEIN PROCESSING,0.0016575,-0.13556,-0.16152,1,0
5,GO REGULATION OF MICROTUBULE BASED PROCESS,6.7411e-08,-0.13608,-0.29627,1,0
5,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.2505e-06,-0.13638,-0.24348,1,0
5,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,0.0037016,-0.13663,-0.2018,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,1.475e-06,-0.13663,-0.22948,1,0
5,GO NUCLEAR ENVELOPE REASSEMBLY,0.00098255,-0.13669,-0.23802,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,2.2775e-07,-0.13708,-0.25764,1,0
5,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,3.9941e-08,-0.13726,-0.26105,1,0
5,GO HISTONE MONOUBIQUITINATION,0.00053704,-0.13728,-0.23057,1,0
5,GO MITOTIC SISTER CHROMATID COHESION,0.019312,-0.13733,-0.16636,1,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00048316,-0.13754,-0.22205,1,0
5,GO METHYLATION,4.1552e-07,-0.13758,-0.24331,1,0
5,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,0.00019857,-0.13805,-0.2247,1,0
5,GO NEGATIVE REGULATION OF DNA REPAIR,1.5994e-06,-0.13829,-0.27529,1,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,3.4553e-09,-0.13857,-0.23256,1,0
5,GO DOUBLE STRAND BREAK REPAIR,0.00017457,-0.13879,-0.23077,1,0
5,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,0.0017517,-0.13939,-0.18085,1,0
5,GO GROOMING BEHAVIOR,0.0054192,-0.13962,-0.1936,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0029645,-0.13973,-0.15061,1,0
5,GO REGULATION OF LYSOSOMAL LUMEN PH,0.010645,-0.14024,-0.17332,1,0
5,GO PORE COMPLEX ASSEMBLY,9.9844e-05,-0.14047,-0.25814,1,0
5,GO TELOMERE CAPPING,3.8246e-05,-0.14057,-0.26648,1,0
5,GO RNA POLYADENYLATION,9.086e-06,-0.1406,-0.27783,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.0068504,-0.14076,-0.16455,1,0
5,GO HOMOLOGOUS RECOMBINATION,0.007921,-0.14094,-0.17645,1,0
5,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,7.8052e-07,-0.14119,-0.22949,1,0
5,GO GPI ANCHOR METABOLIC PROCESS,0.00018923,-0.14149,-0.21366,1,0
5,GO RNA INTERFERENCE,0.0024941,-0.14169,-0.1733,1,0
5,GO LIPID DIGESTION,0.010522,-0.14175,-0.25073,1,0
5,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0020929,-0.14183,-0.19978,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.0011503,-0.14234,-0.15748,1,0
5,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,1.2716e-05,-0.14269,-0.224,1,0
5,GO DETECTION OF LIGHT STIMULUS,4.9694e-05,-0.14329,-0.21051,1,0
5,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.00060545,-0.14336,-0.18169,1,0
5,GO REGULATION OF RNA BINDING,0.002631,-0.14342,-0.18661,1,0
5,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.00025617,-0.14354,-0.18193,1,0
5,GO HISTONE UBIQUITINATION,4.0314e-05,-0.14372,-0.24053,1,0
5,GO RNA STABILIZATION,0.00030449,-0.1441,-0.22136,1,0
5,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,7.2202e-11,-0.14426,-0.29712,1,0
5,GO CYTOKINESIS,2.8001e-06,-0.14451,-0.27424,1,0
5,GO CELLULAR AMINO ACID METABOLIC PROCESS,7.333e-07,-0.14472,-0.22267,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,2.2286e-07,-0.14481,-0.25442,1,0
5,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00090088,-0.14499,-0.30151,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.0005618,-0.14504,-0.29072,1,0
5,GO ORGANELLE INHERITANCE,5.8049e-05,-0.14541,-0.23073,1,0
5,GO GENE SILENCING,8.4805e-07,-0.14545,-0.2458,1,0
5,GO REGULATION OF ERAD PATHWAY,2.2505e-06,-0.14569,-0.32357,1,0
5,GO DNA DEPENDENT DNA REPLICATION,0.011813,-0.14583,-0.17153,1,0
5,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.00016629,-0.14584,-0.19474,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.002631,-0.14593,-0.20897,1,0
5,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.00036124,-0.1462,-0.17778,1,0
5,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.0028872,-0.14635,-0.23243,1,0
5,GO CYTOCHROME COMPLEX ASSEMBLY,0.00080175,-0.14647,-0.19453,1,0
5,GO PEPTIDE METABOLIC PROCESS,3.0156e-07,-0.14664,-0.18344,1,0
5,GO MRNA METHYLATION,0.0007901,-0.14671,-0.2682,1,0
5,GO AMINE METABOLIC PROCESS,4.3946e-06,-0.14677,-0.19561,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.0015249,-0.14693,-0.19414,1,0
5,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.00159,-0.14702,-0.25332,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.017894,-0.14709,-0.18602,1,0
5,GO REGULATION OF HISTONE H3 K4 METHYLATION,0.00059648,-0.14714,-0.20248,1,0
5,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.00026858,-0.14726,-0.17714,1,0
5,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.00012388,-0.14732,-0.20264,1,0
5,GO POLYAMINE METABOLIC PROCESS,0.00044781,-0.14781,-0.21991,1,0
5,GO RNA EXPORT FROM NUCLEUS,0.00090088,-0.14791,-0.19431,1,0
5,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.0060595,-0.14817,-0.17399,1,0
5,GO RNA LOCALIZATION,8.8796e-05,-0.1482,-0.21842,1,0
5,GO TRICARBOXYLIC ACID CYCLE,0.00044781,-0.14829,-0.23517,1,0
5,GO NON RECOMBINATIONAL REPAIR,8.5867e-06,-0.14862,-0.25341,1,0
5,GO CHROMOSOME ORGANIZATION,4.7488e-06,-0.14866,-0.24627,1,0
5,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.000662,-0.14869,-0.19295,1,0
5,GO NCRNA TRANSCRIPTION,0.00019857,-0.14875,-0.19544,1,0
5,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,8.7502e-06,-0.14882,-0.25666,1,0
5,GO MITOTIC NUCLEAR DIVISION,0.00047589,-0.14899,-0.21093,1,0
5,GO REGULATION OF CHROMOSOME SEGREGATION,0.00054518,-0.14899,-0.19655,1,0
5,GO MRNA SPLICE SITE SELECTION,0.0030839,-0.149,-0.20721,1,0
5,GO RDNA HETEROCHROMATIN ASSEMBLY,0.001568,-0.14918,-0.26143,1,0
5,GO PROTEIN ACYLATION,1.3351e-08,-0.1492,-0.29649,1,0
5,GO TRNA WOBBLE BASE MODIFICATION,0.0013069,-0.14929,-0.19672,1,0
5,GO POSITIVE REGULATION OF DNA REPLICATION,0.00010673,-0.14931,-0.24895,1,0
5,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0012177,-0.1497,-0.17338,1,0
5,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.014332,-0.14984,-0.15989,1,0
5,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,0.00040857,-0.14991,-0.20957,1,0
5,GO MULTI ORGANISM LOCALIZATION,3.5794e-07,-0.15002,-0.26032,1,0
5,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,6.1119e-05,-0.15015,-0.25975,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.0047198,-0.15025,-0.17146,1,0
5,GO TELOMERE ORGANIZATION,9.819e-05,-0.15064,-0.21236,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.03902,-0.15066,-0.118,1,0
5,GO PIGMENT GRANULE LOCALIZATION,0.0001179,-0.15109,-0.24533,1,0
5,GO REGULATION OF DNA REPAIR,5.5412e-06,-0.15138,-0.26,1,0
5,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,1.9393e-05,-0.15164,-0.18933,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,5.0766e-11,-0.15164,-0.29106,1,0
5,GO TRANSLESION SYNTHESIS,0.00012388,-0.15185,-0.19257,1,0
5,GO CHROMOSOME CONDENSATION,0.0052197,-0.15197,-0.17602,1,0
5,GO PROTEIN POLYGLUTAMYLATION,0.0026663,-0.15242,-0.22382,1,0
5,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.00068191,-0.15279,-0.20028,1,0
5,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,3.6877e-06,-0.15325,-0.2402,1,0
5,GO PROTEIN LOCALIZATION TO MITOCHONDRION,7.8124e-06,-0.15356,-0.20201,1,0
5,GO POSITIVE REGULATION OF FERTILIZATION,0.00061456,-0.15365,-0.26793,1,0
5,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,2.8886e-07,-0.15369,-0.30684,1,0
5,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00084997,-0.15375,-0.22769,1,0
5,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.00053704,-0.15401,-0.18562,1,0
5,GO REGULATION OF MESODERM DEVELOPMENT,0.0094686,-0.15407,-0.16557,1,0
5,GO DNA RECOMBINATION,0.00012594,-0.1542,-0.21827,1,0
5,GO PROTEIN TARGETING TO MITOCHONDRION,8.4424e-05,-0.15439,-0.17461,1,0
5,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,5.3562e-07,-0.15445,-0.26144,1,0
5,GO REGULATION OF CHROMOSOME SEPARATION,0.0013633,-0.15446,-0.1758,1,0
5,GO REPLICATIVE SENESCENCE,0.0014624,-0.15461,-0.25507,1,0
5,GO REGULATION OF CELL CYCLE CHECKPOINT,0.0071918,-0.15469,-0.14782,1,0
5,GO CHROMOSOME LOCALIZATION,0.013856,-0.15474,-0.1643,1,0
5,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.000286,-0.15504,-0.18433,1,0
5,GO PROTEIN LOCALIZATION TO KINETOCHORE,0.059331,-0.15526,-0.12423,1,0
5,GO PHOTORECEPTOR CELL DEVELOPMENT,0.00036686,-0.1553,-0.22989,1,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.0037985,-0.1555,-0.18751,1,0
5,GO REGULATION OF FERTILIZATION,0.00048316,-0.15594,-0.2003,1,0
5,GO SENSORY PERCEPTION OF TASTE,0.00064263,-0.15622,-0.15576,1,0
5,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.0066851,-0.15624,-0.22437,1,0
5,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,7.8911e-05,-0.15644,-0.23414,1,0
5,GO REGULATION OF NUCLEASE ACTIVITY,0.00016901,-0.15653,-0.20852,1,0
5,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.0030839,-0.15654,-0.17605,1,0
5,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,1.8032e-05,-0.15658,-0.20898,1,0
5,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.0013069,-0.15678,-0.18603,1,0
5,GO RESPONSE TO SALT,0.0013069,-0.15708,-0.19912,1,0
5,GO ORGANELLE LOCALIZATION,1.725e-09,-0.15736,-0.31308,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.00057029,-0.15739,-0.25747,1,0
5,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,5.332e-06,-0.15745,-0.22193,1,0
5,GO CHROMOSOME SEPARATION,0.00096848,-0.15787,-0.19043,1,0
5,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.00020178,-0.15788,-0.18137,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.014332,-0.15803,-0.15474,1,0
5,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,1.4207e-05,-0.15832,-0.2977,1,0
5,GO HISTONE H2A MONOUBIQUITINATION,0.0030038,-0.15842,-0.21053,1,0
5,GO MICROTUBULE CYTOSKELETON ORGANIZATION,1.0554e-07,-0.15861,-0.29241,1,0
5,GO NEGATIVE REGULATION OF DNA RECOMBINATION,3.9102e-06,-0.15864,-0.30007,1,0
5,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,3.094e-05,-0.15866,-0.21317,1,0
5,GO CENTRIOLE ASSEMBLY,0.00076726,-0.15876,-0.26004,1,0
5,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,1.9014e-08,-0.15877,-0.18687,1,0
5,GO CELLULAR AMIDE METABOLIC PROCESS,1.3671e-08,-0.15888,-0.21673,1,0
5,GO NUCLEAR EXPORT,5.6487e-06,-0.15915,-0.24664,1,0
5,GO MIRNA METABOLIC PROCESS,2.9332e-05,-0.15928,-0.25911,1,0
5,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.0024281,-0.15935,-0.18167,1,0
5,GO PEPTIDYL PROLINE MODIFICATION,1.3948e-05,-0.15949,-0.26542,1,0
5,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.00058763,-0.15949,-0.22918,1,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,4.5558e-05,-0.15969,-0.22393,1,0
5,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,2.1678e-11,-0.15983,-0.2918,1,0
5,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.00030449,-0.15987,-0.18517,1,0
5,GO REGULATION OF CYTOKINESIS,0.00010152,-0.15991,-0.26353,1,0
5,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,8.4262e-06,-0.15999,-0.2385,1,0
5,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.00044103,-0.16011,-0.25792,1,0
5,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,9.7998e-07,-0.16017,-0.29438,1,0
5,GO REGULATION OF CELL CYCLE PHASE TRANSITION,1.1316e-06,-0.16017,-0.23858,1,0
5,GO MITOTIC CYTOKINESIS,1.9749e-05,-0.16023,-0.257,1,0
5,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.00046872,-0.16029,-0.21677,1,0
5,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,4.5558e-05,-0.16049,-0.22905,1,0
5,GO CELLULAR PROTEIN CATABOLIC PROCESS,6.8695e-12,-0.16068,-0.31708,1,0
5,GO PEPTIDYL LYSINE MODIFICATION,1.9175e-06,-0.16073,-0.27725,1,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,4.7172e-05,-0.16082,-0.22707,1,0
5,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.00040235,-0.16084,-0.24434,1,0
5,GO EMBRYONIC BRAIN DEVELOPMENT,0.00025215,-0.16113,-0.22822,1,0
5,GO DNA TEMPLATED TRANSCRIPTION INITIATION,1.8594e-09,-0.16128,-0.2784,1,0
5,GO HISTONE H2B UBIQUITINATION,6.6066e-07,-0.16169,-0.28534,1,0
5,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,4.4787e-08,-0.16202,-0.25173,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,5.1446e-05,-0.16222,-0.2161,1,0
5,GO OTIC VESICLE DEVELOPMENT,0.055609,-0.16226,-0.15548,1,0
5,GO REGULATION OF PROTEIN FOLDING,9.4959e-05,-0.16234,-0.24332,1,0
5,GO ZINC ION TRANSPORT,5.1304e-06,-0.16259,-0.27139,1,0
5,GO MRNA CLEAVAGE,5.6085e-05,-0.16265,-0.23314,1,0
5,GO VIRION ASSEMBLY,4.7172e-05,-0.16275,-0.19579,1,0
5,GO PROTON TRANSMEMBRANE TRANSPORT,1.734e-06,-0.16297,-0.21013,1,0
5,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.5576e-05,-0.16328,-0.30175,1,0
5,GO NUCLEAR TRANSPORT,8.8282e-08,-0.16333,-0.26297,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,4.9694e-05,-0.16343,-0.22746,1,0
5,GO SINGLE STRAND BREAK REPAIR,0.016205,-0.16346,-0.19627,1,0
5,GO MULTIVESICULAR BODY SORTING PATHWAY,0.00018323,-0.16348,-0.226,1,0
5,GO POSITIVE REGULATION OF CENTROSOME CYCLE,0.011022,-0.16379,-0.22924,1,0
5,GO NUCLEUS ORGANIZATION,2.2286e-07,-0.16387,-0.28398,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00022927,-0.16388,-0.24257,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00015331,-0.16422,-0.27823,1,0
5,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,4.0314e-05,-0.16426,-0.20243,1,0
5,GO CELL CYCLE PHASE TRANSITION,1.8793e-06,-0.16429,-0.23694,1,0
5,GO ESTABLISHMENT OF RNA LOCALIZATION,2.6828e-05,-0.16489,-0.23319,1,0
5,GO SEXUAL REPRODUCTION,3.5427e-10,-0.16495,-0.26806,1,0
5,GO REGULATION OF DNA CATABOLIC PROCESS,0.00010673,-0.16523,-0.17602,1,0
5,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,1.5674e-06,-0.1653,-0.20846,1,0
5,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,5.1351e-07,-0.16542,-0.25463,1,0
5,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.00010673,-0.16544,-0.20343,1,0
5,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,7.6205e-11,-0.16552,-0.26388,1,0
5,GO REGULATION OF DNA REPLICATION,0.00013899,-0.16552,-0.24121,1,0
5,GO PEPTIDYL ARGININE METHYLATION,0.00092737,-0.16573,-0.22936,1,0
5,GO CIRCADIAN RHYTHM,4.9872e-09,-0.16586,-0.32319,1,0
5,GO REGULATION OF CILIUM MOVEMENT,0.0003557,-0.16592,-0.15113,1,0
5,GO REGULATION OF MRNA CATABOLIC PROCESS,1.0424e-06,-0.16617,-0.24462,1,0
5,GO REGULATION OF HISTONE H4 ACETYLATION,0.0072795,-0.16618,-0.21926,1,0
5,GO NUCLEAR ENVELOPE ORGANIZATION,9.7998e-07,-0.16643,-0.31592,1,0
5,GO PHAGOSOME ACIDIFICATION,8.0256e-05,-0.1665,-0.24152,1,0
5,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.00092737,-0.16668,-0.19731,1,0
5,GO PROTEIN ACETYLATION,1.0861e-06,-0.16671,-0.28057,1,0
5,GO CELL CYCLE PROCESS,9.028e-08,-0.16677,-0.26467,1,0
5,GO PROTEIN N LINKED GLYCOSYLATION,7.1819e-07,-0.16692,-0.2865,1,0
5,GO CELL CYCLE,7.1726e-09,-0.16705,-0.27404,1,0
5,GO CELL CYCLE CHECKPOINT,4.7488e-06,-0.16711,-0.25518,1,0
5,GO REGULATION OF TRANSLATIONAL TERMINATION,4.4771e-05,-0.16713,-0.29986,1,0
5,GO GAMETE GENERATION,2.004e-09,-0.16716,-0.26108,1,0
5,GO DETOXIFICATION,2.4091e-05,-0.16729,-0.21947,1,0
5,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,5.8262e-07,-0.16731,-0.25983,1,0
5,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00025215,-0.16734,-0.18689,1,0
5,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.00057029,-0.1676,-0.21241,1,0
5,GO MICROTUBULE BASED PROCESS,5.1356e-08,-0.1676,-0.28609,1,0
5,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,9.4959e-05,-0.16772,-0.22939,1,0
5,GO REGULATION OF CIRCADIAN RHYTHM,1.0424e-06,-0.16779,-0.28594,1,0
5,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00016098,-0.16785,-0.20757,1,0
5,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00033955,-0.16792,-0.25173,1,0
5,GO REGULATION OF MICROTUBULE BINDING,0.00082553,-0.168,-0.30976,1,0
5,GO REGULATION OF CELL CYCLE PROCESS,4.0678e-07,-0.16801,-0.25517,1,0
5,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0041031,-0.16819,-0.15896,1,0
5,GO ANTIBACTERIAL HUMORAL RESPONSE,0.0041031,-0.16855,-0.20969,1,0
5,GO KERATINIZATION,0.034984,-0.1688,-0.13885,1,0
5,GO REGULATION OF CELL CYCLE,1.0964e-09,-0.16896,-0.28499,1,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,1.2027e-05,-0.16909,-0.20447,1,0
5,GO SENSORY PERCEPTION OF SMELL,1.5865e-05,-0.16912,-0.22309,1,0
5,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.0067673,-0.16916,-0.15287,1,0
5,GO CELLULAR RESPONSE TO COPPER ION,0.027118,-0.16919,-0.29463,1,0
5,GO ATP METABOLIC PROCESS,2.0364e-06,-0.16928,-0.20708,1,0
5,GO DNA BIOSYNTHETIC PROCESS,3.7356e-07,-0.16931,-0.25481,1,0
5,GO REGULATION OF MITOTIC CELL CYCLE,6.4434e-08,-0.16947,-0.26331,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,4.5233e-07,-0.1697,-0.28219,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,3.5461e-06,-0.16976,-0.23881,1,0
5,GO HISTONE H4 ACETYLATION,0.00011033,-0.16985,-0.2571,1,0
5,GO MRNA TRANSPORT,7.1274e-05,-0.17006,-0.23371,1,0
5,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,3.1494e-05,-0.17035,-0.26853,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,4.3997e-05,-0.17065,-0.25948,1,0
5,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.00058763,-0.17082,-0.22587,1,0
5,GO DICARBOXYLIC ACID METABOLIC PROCESS,3.5794e-07,-0.17088,-0.26575,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE,5.6317e-09,-0.17095,-0.28286,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,3.5646e-05,-0.17095,-0.18406,1,0
5,GO MALE GAMETE GENERATION,7.1726e-09,-0.17097,-0.24812,1,0
5,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,2.0478e-05,-0.17111,-0.24752,1,0
5,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,6.8348e-09,-0.17146,-0.25664,1,0
5,GO PROTEIN FOLDING,8.6579e-07,-0.17155,-0.2631,1,0
5,GO REGULATION OF GLUTAMATE SECRETION,0.011151,-0.17171,-0.20754,1,0
5,GO SPINAL CORD PATTERNING,0.0060595,-0.17175,-0.27717,1,0
5,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,2.1621e-05,-0.1718,-0.20665,1,0
5,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.6828e-05,-0.17197,-0.28868,1,0
5,GO PROTEIN LOCALIZATION TO ORGANELLE,4.249e-10,-0.17199,-0.25042,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00012594,-0.17209,-0.22737,1,0
5,GO CELL CELL RECOGNITION,7.1819e-07,-0.17233,-0.23621,1,0
5,GO REGULATION OF CENTROSOME CYCLE,0.0035605,-0.17241,-0.20041,1,0
5,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,3.152e-06,-0.17273,-0.27717,1,0
5,GO INTRACILIARY TRANSPORT,0.00059648,-0.17291,-0.23472,1,0
5,GO REGULATION OF CENTRIOLE REPLICATION,0.00037835,-0.17302,-0.26112,1,0
5,GO DNA CATABOLIC PROCESS,4.7488e-06,-0.17312,-0.21878,1,0
5,GO HISTONE H3 ACETYLATION,1.0861e-06,-0.17348,-0.2813,1,0
5,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,9.6562e-05,-0.17359,-0.31959,1,0
5,GO NUCLEOSIDE METABOLIC PROCESS,1.9175e-06,-0.1736,-0.22138,1,0
5,GO TRNA TRANSPORT,0.00059648,-0.17368,-0.22547,1,0
5,GO POSITIVE REGULATION OF VIRAL PROCESS,1.2143e-08,-0.17376,-0.28496,1,0
5,GO REGULATION OF DNA METABOLIC PROCESS,3.0811e-07,-0.17387,-0.26743,1,0
5,GO CHROMATIN ORGANIZATION,3.0156e-07,-0.17395,-0.28118,1,0
5,GO REGULATION OF MICROTUBULE BASED MOVEMENT,2.0478e-05,-0.17402,-0.20189,1,0
5,GO PEPTIDYL LYSINE ACETYLATION,7.2414e-06,-0.17405,-0.27581,1,0
5,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.00015583,-0.17406,-0.21394,1,0
5,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,2.4972e-05,-0.1742,-0.23134,1,0
5,GO REGULATION OF NUCLEAR DIVISION,7.2414e-06,-0.17422,-0.22826,1,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.00021857,-0.17425,-0.29429,1,0
5,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,1.785e-11,-0.17428,-0.32907,1,0
5,GO REGULATION OF MRNA METABOLIC PROCESS,2.2958e-06,-0.17431,-0.23603,1,0
5,GO MITOTIC CELL CYCLE,6.8885e-07,-0.17468,-0.25664,1,0
5,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.001704,-0.17472,-0.17595,1,0
5,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,9.3381e-05,-0.17479,-0.21135,1,0
5,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,1.9175e-06,-0.17537,-0.29266,1,0
5,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,3.9872e-06,-0.17538,-0.27011,1,0
5,GO T HELPER CELL LINEAGE COMMITMENT,0.00044781,-0.17539,-0.22241,1,0
5,GO PROTEIN CATABOLIC PROCESS,4.1125e-12,-0.17544,-0.32545,1,0
5,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.00071283,-0.17555,-0.23556,1,0
5,GO ZINC ION HOMEOSTASIS,0.026561,-0.17557,-0.20102,1,0
5,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00010497,-0.1756,-0.22012,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.0030436,-0.17625,-0.23575,1,0
5,GO CELLULAR RESPONSE TO GAMMA RADIATION,3.094e-05,-0.1763,-0.29394,1,0
5,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,1.484e-09,-0.17647,-0.31451,1,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,1.3056e-06,-0.17663,-0.25391,1,0
5,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,9.5999e-07,-0.17676,-0.25384,1,0
5,GO ENDOSOMAL TRANSPORT,1.5604e-09,-0.17718,-0.33025,1,0
5,GO DNA INTEGRITY CHECKPOINT,1.4454e-06,-0.17722,-0.27403,1,0
5,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,5.3747e-08,-0.17728,-0.22984,1,0
5,GO RRNA TRANSCRIPTION,0.00082553,-0.17751,-0.2285,1,0
5,GO MACROMOLECULE CATABOLIC PROCESS,7.479e-12,-0.17762,-0.28795,1,0
5,GO NUCLEOSIDE SALVAGE,0.013394,-0.17789,-0.12846,1,0
5,GO TRANSFERRIN TRANSPORT,6.2046e-07,-0.17796,-0.29134,1,0
5,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.004964,-0.17819,-0.25964,1,0
5,GO PHOTORECEPTOR CELL MAINTENANCE,7.5001e-05,-0.17827,-0.21767,1,0
5,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,1.0519e-10,-0.17832,-0.31924,1,0
5,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,5.4184e-05,-0.17863,-0.26757,1,0
5,GO POSITIVE REGULATION OF HORMONE SECRETION,2.1624e-06,-0.17892,-0.26675,1,0
5,GO AXONEME ASSEMBLY,0.00014129,-0.17905,-0.24425,1,0
5,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.014172,-0.17951,-0.155,1,0
5,GO POSITIVE REGULATION OF HISTONE METHYLATION,4.1456e-06,-0.17967,-0.28656,1,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,9.086e-06,-0.17973,-0.30112,1,0
5,GO NEUROTRANSMITTER METABOLIC PROCESS,0.00010323,-0.17973,-0.28682,1,0
5,GO PROTEIN METHYLATION,5.5412e-06,-0.18006,-0.26567,1,0
5,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.00020178,-0.18016,-0.26089,1,0
5,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.00012186,-0.18019,-0.2155,1,0
5,GO DNA METHYLATION,8.5858e-05,-0.18024,-0.23735,1,0
5,GO NUCLEAR PORE ORGANIZATION,0.0071051,-0.18065,-0.22228,1,0
5,GO PHASIC SMOOTH MUSCLE CONTRACTION,0.0012886,-0.18076,-0.19624,1,0
5,GO CELL DIVISION,5.2445e-07,-0.18078,-0.2675,1,0
5,GO INTRACELLULAR TRANSPORT,2.559e-11,-0.181,-0.28482,1,0
5,GO CHROMATIN REMODELING,4.0314e-05,-0.18123,-0.23203,1,0
5,GO PROTEIN TARGETING,4.1552e-07,-0.18151,-0.16775,1,0
5,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.2027e-05,-0.18174,-0.21977,1,0
5,GO AMINE BIOSYNTHETIC PROCESS,0.00043435,-0.18184,-0.24162,1,0
5,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,0.0063654,-0.18198,-0.15521,1,0
5,GO POLYOL CATABOLIC PROCESS,1.6994e-06,-0.18201,-0.31099,1,0
5,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.0013069,-0.18246,-0.16553,1,0
5,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0049019,-0.1827,-0.18353,1,0
5,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,7.2414e-06,-0.18275,-0.26692,1,0
5,GO PHOTOPERIODISM,4.5684e-06,-0.18283,-0.26876,1,0
5,GO GOLGI LOCALIZATION,9.6129e-06,-0.18285,-0.29508,1,0
5,GO RESPONSE TO UV C,9.819e-05,-0.18287,-0.27903,1,0
5,GO DIGESTION,9.795e-06,-0.1829,-0.22513,1,0
5,GO MEMBRANE DOCKING,2.3784e-07,-0.18303,-0.29865,1,0
5,GO FAT CELL PROLIFERATION,0.0029256,-0.1834,-0.23898,1,0
5,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00019857,-0.18378,-0.21692,1,0
5,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,2.4861e-06,-0.18409,-0.254,1,0
5,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,1.6321e-06,-0.18478,-0.36125,1,0
5,GO COVALENT CHROMATIN MODIFICATION,2.6362e-08,-0.18491,-0.29941,1,0
5,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,0.00053704,-0.18498,-0.24279,1,0
5,GO EXIT FROM MITOSIS,4.8839e-05,-0.18499,-0.23515,1,0
5,GO BLASTOCYST DEVELOPMENT,1.3468e-07,-0.18507,-0.22948,1,0
5,GO MITOCHONDRION LOCALIZATION,1.9044e-05,-0.1851,-0.29514,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,8.1623e-05,-0.18516,-0.24617,1,0
5,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.016205,-0.18523,-0.14734,1,0
5,GO CELL FATE SPECIFICATION,0.00064263,-0.18532,-0.21589,1,0
5,GO CEREBELLAR CORTEX FORMATION,0.0013826,-0.18542,-0.26383,1,0
5,GO NEGATIVE REGULATION OF BEHAVIOR,0.001955,-0.18545,-0.18533,1,0
5,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,8.8282e-08,-0.18556,-0.25849,1,0
5,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,5.3617e-10,-0.18565,-0.25319,1,0
5,GO HISTONE H2A UBIQUITINATION,7.8911e-05,-0.18576,-0.24438,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE,1.1245e-09,-0.18587,-0.287,1,0
5,GO CELLULAR MACROMOLECULE LOCALIZATION,1.2417e-11,-0.18595,-0.30338,1,0
5,GO REGULATION OF MIRNA METABOLIC PROCESS,2.971e-06,-0.18618,-0.33069,1,0
5,GO ALDITOL METABOLIC PROCESS,0.00025617,-0.18619,-0.27444,1,0
5,GO DNA REPLICATION,0.00042128,-0.18619,-0.22105,1,0
5,GO ATP BIOSYNTHETIC PROCESS,0.00095459,-0.1862,-0.25755,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,1.5372e-07,-0.18623,-0.23889,1,0
5,GO PEPTIDYL ASPARAGINE MODIFICATION,5.2344e-05,-0.18625,-0.22447,1,0
5,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,7.2964e-10,-0.18629,-0.28712,1,0
5,GO ORGANELLE DISASSEMBLY,1.1307e-08,-0.18629,-0.28662,1,0
5,GO ACTIVATION OF INNATE IMMUNE RESPONSE,6.4592e-06,-0.18635,-0.2291,1,0
5,GO SULFUR AMINO ACID METABOLIC PROCESS,1.7706e-05,-0.18635,-0.23641,1,0
5,GO ALPHA AMINO ACID CATABOLIC PROCESS,2.2397e-08,-0.18646,-0.25001,1,0
5,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0023637,-0.18649,-0.16376,1,0
5,GO NCRNA EXPORT FROM NUCLEUS,9.4959e-05,-0.1865,-0.25219,1,0
5,GO REGULATION OF SPINDLE CHECKPOINT,0.0029256,-0.18655,-0.1612,1,0
5,GO REGULATION OF PROTEIN SUMOYLATION,1.5713e-07,-0.18669,-0.32287,1,0
5,GO REGULATION OF TELOMERE MAINTENANCE,1.2253e-05,-0.18672,-0.25564,1,0
5,GO PEPTIDYL ARGININE MODIFICATION,1.0361e-05,-0.18691,-0.23028,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO HEAT,3.2057e-05,-0.18704,-0.27612,1,0
5,GO CELLULAR RESPONSE TO ATP,1.2328e-07,-0.18709,-0.26488,1,0
5,GO ERAD PATHWAY,9.028e-08,-0.18729,-0.33946,1,0
5,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,3.9309e-10,-0.18729,-0.3165,1,0
5,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,3.8645e-11,-0.18753,-0.32546,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,6.8348e-09,-0.18771,-0.2055,1,0
5,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.7797e-11,-0.18774,-0.32054,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION,2.004e-09,-0.18782,-0.31781,1,0
5,GO REGULATION OF PROSTAGLANDIN SECRETION,5.6085e-05,-0.18814,-0.26001,1,0
5,GO CYTOKINETIC PROCESS,4.7172e-05,-0.18819,-0.26697,1,0
5,GO SEQUESTERING OF METAL ION,0.00013899,-0.18825,-0.22426,1,0
5,GO REGULATION OF CELL MATURATION,5.1351e-07,-0.18834,-0.25047,1,0
5,GO MAINTENANCE OF ORGANELLE LOCATION,3.2057e-05,-0.18875,-0.2895,1,0
5,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,1.8135e-09,-0.18889,-0.30907,1,0
5,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.00013899,-0.18903,-0.22903,1,0
5,GO NCRNA CATABOLIC PROCESS,6.6066e-07,-0.18932,-0.28902,1,0
5,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.00010852,-0.18938,-0.2194,1,0
5,GO ORGANELLE ASSEMBLY,2.3312e-10,-0.18962,-0.29309,1,0
5,GO RESPONSE TO ALKALOID,5.3562e-07,-0.18966,-0.27474,1,0
5,GO REGULATION OF MEMBRANE PERMEABILITY,1.8032e-05,-0.1897,-0.24558,1,0
5,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.0302e-06,-0.18971,-0.24447,1,0
5,GO REGULATION OF TELOMERASE ACTIVITY,8.5858e-05,-0.18983,-0.26427,1,0
5,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,3.4003e-08,-0.18983,-0.24808,1,0
5,GO REGULATION OF GENE SILENCING,1.3599e-06,-0.19015,-0.25837,1,0
5,GO ARACHIDONIC ACID SECRETION,6.7105e-06,-0.1902,-0.29134,1,0
5,GO PROTEIN HETEROOLIGOMERIZATION,2.5868e-06,-0.19046,-0.27412,1,0
5,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,0.0005618,-0.19052,-0.24831,1,0
5,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,6.3088e-12,-0.19052,-0.342,1,0
5,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,6.3249e-05,-0.19066,-0.28872,1,0
5,GO ANDROGEN METABOLIC PROCESS,0.001776,-0.19067,-0.21276,1,0
5,GO EXECUTION PHASE OF APOPTOSIS,5.2538e-08,-0.19074,-0.277,1,0
5,GO HEPATOCYTE DIFFERENTIATION,1.8701e-05,-0.19074,-0.29026,1,0
5,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,1.7154e-07,-0.19092,-0.27309,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,6.7105e-06,-0.19099,-0.21655,1,0
5,GO FOLIC ACID METABOLIC PROCESS,1.1165e-05,-0.19119,-0.28993,1,0
5,GO PEPTIDE HORMONE SECRETION,2.4837e-07,-0.19119,-0.31662,1,0
5,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,6.4341e-05,-0.19121,-0.2147,1,0
5,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,3.2631e-05,-0.19133,-0.21031,1,0
5,GO CILIUM ORGANIZATION,4.8198e-07,-0.1914,-0.29019,1,0
5,GO REGULATION OF CILIUM ASSEMBLY,4.2271e-06,-0.1915,-0.2826,1,0
5,GO ENTRAINMENT OF CIRCADIAN CLOCK,6.337e-06,-0.19165,-0.30174,1,0
5,GO DORSAL VENTRAL PATTERN FORMATION,3.3214e-05,-0.19173,-0.25494,1,0
5,GO EAR MORPHOGENESIS,2.1338e-07,-0.19174,-0.29267,1,0
5,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,9.0235e-07,-0.19207,-0.24356,1,0
5,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,1.9136e-07,-0.19209,-0.26985,1,0
5,GO MHC CLASS II BIOSYNTHETIC PROCESS,8.8282e-08,-0.19209,-0.25233,1,0
5,GO REGULATION OF PH,6.0979e-10,-0.19211,-0.28398,1,0
5,GO CELLULAR RESPONSE TO HEAT,3.9822e-07,-0.19215,-0.29255,1,0
5,GO REGULATION OF GENE EXPRESSION EPIGENETIC,2.5359e-06,-0.19221,-0.25092,1,0
5,GO PROTEIN POLYUBIQUITINATION,1.4112e-09,-0.19229,-0.29316,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,3.4773e-06,-0.19233,-0.24423,1,0
5,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.00096848,-0.1924,-0.26199,1,0
5,GO NUCLEOBASE METABOLIC PROCESS,0.00026858,-0.1926,-0.21251,1,0
5,GO REGULATION OF GASTRIC ACID SECRETION,0.00052901,-0.19263,-0.22082,1,0
5,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.00010852,-0.19273,-0.21051,1,0
5,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.0015463,-0.19278,-0.19567,1,0
5,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,1.0527e-08,-0.19282,-0.28955,1,0
5,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,1.1415e-11,-0.19318,-0.32745,1,0
5,GO POSITIVE REGULATION OF DNA REPAIR,6.8888e-05,-0.1934,-0.26702,1,0
5,GO POSITIVE REGULATION OF NUCLEAR DIVISION,1.0554e-07,-0.19432,-0.26279,1,0
5,GO TRANSPORT ALONG MICROTUBULE,2.5359e-06,-0.19444,-0.29907,1,0
5,GO MULTICELLULAR ORGANISM AGING,2.9332e-05,-0.1945,-0.25262,1,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0015038,-0.19466,-0.26833,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO STRESS,8.3747e-12,-0.19472,-0.34581,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.00020835,-0.19525,-0.25365,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,5.1356e-08,-0.19527,-0.3288,1,0
5,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,1.0791e-07,-0.19527,-0.26071,1,0
5,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.7452e-06,-0.19547,-0.25972,1,0
5,GO REGULATION OF VIRAL TRANSCRIPTION,3.8149e-08,-0.19556,-0.28045,1,0
5,GO CELLULAR AMINO ACID CATABOLIC PROCESS,8.6937e-09,-0.19564,-0.26553,1,0
5,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,4.3606e-10,-0.19569,-0.31369,1,0
5,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,4.31e-06,-0.19569,-0.30106,1,0
5,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,4.9403e-11,-0.19571,-0.32671,1,0
5,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,1.0756e-05,-0.19586,-0.24754,1,0
5,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.00059648,-0.19588,-0.27931,1,0
5,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,4.7999e-05,-0.19613,-0.27225,1,0
5,GO DNA DEALKYLATION,0.00010323,-0.19621,-0.23768,1,0
5,GO RETINA HOMEOSTASIS,1.3468e-07,-0.19626,-0.20346,1,0
5,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,2.801e-10,-0.19636,-0.31906,1,0
5,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.0049019,-0.19638,-0.19654,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,3.9102e-06,-0.19653,-0.23122,1,0
5,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.00074504,-0.19668,-0.24884,1,0
5,GO POSITIVE REGULATION OF CYTOKINESIS,0.00058763,-0.19678,-0.23785,1,0
5,GO OOGENESIS,6.8885e-07,-0.19692,-0.24296,1,0
5,GO DOPAMINE METABOLIC PROCESS,0.00015331,-0.19728,-0.27595,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.00073415,-0.19729,-0.19335,1,0
5,GO RESPONSE TO LIGHT STIMULUS,8.9487e-10,-0.19734,-0.29171,1,0
5,GO STEROL BIOSYNTHETIC PROCESS,0.00061456,-0.19758,-0.23159,1,0
5,GO GLYCINE METABOLIC PROCESS,0.0019285,-0.1976,-0.21608,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.6542e-10,-0.19778,-0.33441,1,0
5,GO SENSORY PERCEPTION,1.3085e-09,-0.19786,-0.26915,1,0
5,GO PURINE CONTAINING COMPOUND SALVAGE,0.0018508,-0.19793,-0.18217,1,0
5,GO RESPONSE TO RADIATION,2.457e-10,-0.19795,-0.29391,1,0
5,GO CELL DIFFERENTIATION IN SPINAL CORD,0.00053704,-0.19795,-0.24789,1,0
5,GO OUTER DYNEIN ARM ASSEMBLY,0.0003557,-0.19795,-0.25879,1,0
5,GO REGULATION OF CHROMOSOME ORGANIZATION,6.4699e-07,-0.19807,-0.26204,1,0
5,GO GLYCOSYL COMPOUND METABOLIC PROCESS,3.152e-06,-0.19814,-0.22159,1,0
5,GO PROTEIN K48 LINKED UBIQUITINATION,6.5125e-09,-0.19821,-0.29649,1,0
5,GO PIGMENT BIOSYNTHETIC PROCESS,1.6158e-05,-0.19824,-0.25824,1,0
5,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,6.4699e-07,-0.19826,-0.30148,1,0
5,GO HISTONE H2A ACETYLATION,0.012653,-0.19833,-0.15398,1,0
5,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,0.00032916,-0.19834,-0.27085,1,0
5,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,4.1026e-05,-0.19838,-0.2744,1,0
5,GO HISTONE H3 K9 TRIMETHYLATION,0.00025617,-0.19863,-0.27431,1,0
5,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,5.6245e-08,-0.19863,-0.29575,1,0
5,GO RESPONSE TO COCAINE,3.4409e-05,-0.19871,-0.28479,1,0
5,GO AXO DENDRITIC TRANSPORT,2.342e-06,-0.19875,-0.34061,1,0
5,GO MITOTIC CELL CYCLE CHECKPOINT,7.6657e-06,-0.19879,-0.2569,1,0
5,GO CELLULAR KETONE METABOLIC PROCESS,1.5753e-08,-0.19884,-0.26449,1,0
5,GO FEEDING BEHAVIOR,5.7582e-06,-0.19895,-0.25928,1,0
5,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0040509,-0.19901,-0.21128,1,0
5,GO NEGATIVE REGULATION OF ANION TRANSPORT,5.1351e-07,-0.19912,-0.34494,1,0
5,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,0.000286,-0.19919,-0.22231,1,0
5,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.011151,-0.19972,-0.1838,1,0
5,GO REGULATION OF MRNA POLYADENYLATION,7.9617e-06,-0.19976,-0.29627,1,0
5,GO GLYCOSYLATION,1.6407e-09,-0.19996,-0.33649,1,0
5,GO PROTEIN MANNOSYLATION,0.00015583,-0.20014,-0.27247,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.00013451,-0.20026,-0.25062,1,0
5,GO ORGANIC ACID TRANSPORT,1.2348e-10,-0.20029,-0.33478,1,0
5,GO NEUROPEPTIDE SIGNALING PATHWAY,0.001235,-0.20036,-0.18538,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,4.2271e-06,-0.20037,-0.23509,1,0
5,GO REGULATION OF ICOSANOID SECRETION,9.03e-05,-0.20037,-0.27514,1,0
5,GO MULTI ORGANISM PROCESS,5.0766e-11,-0.20039,-0.2947,1,0
5,GO MICROTUBULE NUCLEATION,0.000662,-0.20042,-0.32081,1,0
5,GO GERM CELL DEVELOPMENT,3.6435e-08,-0.20052,-0.2515,1,0
5,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,4.6202e-07,-0.2007,-0.28072,1,0
5,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.00011596,-0.20087,-0.24078,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,2.8886e-07,-0.20101,-0.27336,1,0
5,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.8389e-07,-0.20109,-0.31018,1,0
5,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.0019285,-0.20111,-0.20966,1,0
5,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,2.5884e-05,-0.20118,-0.21784,1,0
5,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,2.6914e-06,-0.20119,-0.25795,1,0
5,GO RNA DECAPPING,4.7488e-06,-0.20122,-0.29038,1,0
5,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.0011021,-0.20134,-0.26009,1,0
5,GO MICROTUBULE BASED MOVEMENT,1.439e-07,-0.20137,-0.28044,1,0
5,GO RESPONSE TO NITRIC OXIDE,3.7356e-07,-0.20155,-0.25435,1,0
5,GO DETECTION OF STIMULUS,6.4434e-08,-0.20156,-0.23535,1,0
5,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.8076e-11,-0.20157,-0.30868,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,7.3772e-08,-0.20168,-0.2286,1,0
5,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,0.0045438,-0.20186,-0.27975,1,0
5,GO SYNAPTIC VESICLE TRANSPORT,0.00010323,-0.20199,-0.2898,1,0
5,GO PROTEIN O LINKED GLYCOSYLATION,2.7078e-07,-0.202,-0.33345,1,0
5,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,5.0922e-10,-0.20201,-0.32477,1,0
5,GO INTERACTION WITH SYMBIONT,3.4003e-08,-0.20215,-0.28534,1,0
5,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,7.0522e-08,-0.20228,-0.26483,1,0
5,GO RESPONSE TO ATP,2.2139e-09,-0.20235,-0.29629,1,0
5,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,7.1121e-10,-0.2024,-0.30863,1,0
5,GO APOPTOTIC DNA FRAGMENTATION,2.4091e-05,-0.20253,-0.20131,1,0
5,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,5.4701e-07,-0.20256,-0.27413,1,0
5,GO SINGLE FERTILIZATION,1.1307e-08,-0.20261,-0.26306,1,0
5,GO HETEROCHROMATIN ORGANIZATION,5.6487e-06,-0.20272,-0.29461,1,0
5,GO SPERMATID DIFFERENTIATION,4.2444e-07,-0.20279,-0.23324,1,0
5,GO MACROMOLECULE DEACYLATION,1.3761e-09,-0.2028,-0.33821,1,0
5,GO REGULATION OF DNA BINDING,5.8856e-08,-0.20283,-0.26574,1,0
5,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,1.5027e-08,-0.20317,-0.26959,1,0
5,GO MULTICELLULAR ORGANISM REPRODUCTION,1.2023e-10,-0.20324,-0.28944,1,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.9514e-07,-0.20339,-0.30292,1,0
5,GO REGULATION OF ORGANELLE ORGANIZATION,1.887e-11,-0.2035,-0.33711,1,0
5,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,1.0212e-06,-0.20364,-0.28537,1,0
5,GO POSITIVE REGULATION OF TRANSLATION,1.9465e-08,-0.20371,-0.27034,1,0
5,GO VESICLE BUDDING FROM MEMBRANE,6.4192e-10,-0.20374,-0.33625,1,0
5,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,3.1729e-08,-0.20381,-0.28536,1,0
5,GO HISTONE METHYLATION,4.7488e-06,-0.20384,-0.27752,1,0
5,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,5.1304e-06,-0.20392,-0.26117,1,0
5,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,0.00042777,-0.20393,-0.25626,1,0
5,GO DNA DEMETHYLATION,0.00031414,-0.20394,-0.24227,1,0
5,GO ACETYL COA METABOLIC PROCESS,2.8886e-07,-0.20402,-0.3276,1,0
5,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,6.4699e-07,-0.2041,-0.3418,1,0
5,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00073415,-0.20419,-0.28982,1,0
5,GO MYOBLAST PROLIFERATION,8.5867e-06,-0.20435,-0.29965,1,0
5,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,5.3647e-09,-0.20451,-0.35545,1,0
5,GO CELLULAR RESPONSE TO NITRIC OXIDE,2.2286e-07,-0.20466,-0.30472,1,0
5,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,8.2543e-08,-0.20472,-0.35866,1,0
5,GO QUATERNARY AMMONIUM GROUP TRANSPORT,8.4805e-07,-0.20476,-0.28788,1,0
5,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,2.8305e-05,-0.20493,-0.2563,1,0
5,GO EPITHELIAL STRUCTURE MAINTENANCE,0.00013232,-0.20495,-0.18663,1,0
5,GO SENSORY PERCEPTION OF LIGHT STIMULUS,1.5604e-09,-0.20526,-0.28213,1,0
5,GO SYMBIOTIC PROCESS,3.8301e-10,-0.20528,-0.27238,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,6.3249e-05,-0.20557,-0.25741,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS,9.6431e-12,-0.20562,-0.34675,1,0
5,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.00026858,-0.20563,-0.23172,1,0
5,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,7.2414e-06,-0.20563,-0.26703,1,0
5,GO HISTONE H3 K4 METHYLATION,9.4959e-05,-0.20573,-0.22583,1,0
5,GO WALKING BEHAVIOR,0.00075607,-0.20575,-0.25168,1,0
5,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,0.001422,-0.20578,-0.31299,1,0
5,GO CELL REDOX HOMEOSTASIS,9.9844e-05,-0.20579,-0.19444,1,0
5,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.028e-08,-0.20583,-0.27569,1,0
5,GO P BODY ASSEMBLY,3.0811e-07,-0.20613,-0.31489,1,0
5,GO OXIDATION REDUCTION PROCESS,6.205e-09,-0.20636,-0.26583,1,0
5,GO EATING BEHAVIOR,1.0361e-05,-0.20655,-0.2322,1,0
5,GO SIGNAL RELEASE,1.2143e-08,-0.20655,-0.31813,1,0
5,GO FATTY ACID BETA OXIDATION,5.4982e-08,-0.20663,-0.31591,1,0
5,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0022701,-0.2067,-0.24139,1,0
5,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,2.7668e-07,-0.20676,-0.31702,1,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION,2.9514e-07,-0.20689,-0.28617,1,0
5,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,3.9102e-06,-0.20689,-0.28746,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,2.2926e-08,-0.20689,-0.28717,1,0
5,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.00044781,-0.2069,-0.29899,1,0
5,GO AXONAL TRANSPORT,6.9711e-06,-0.20699,-0.34327,1,0
5,GO CELLULAR RESPONSE TO CADMIUM ION,0.013546,-0.20704,-0.25435,1,0
5,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,3.5597e-11,-0.20719,-0.33077,1,0
5,GO REGULATION OF TRANSPORT,5.1691e-12,-0.20731,-0.35007,1,0
5,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,4.8198e-07,-0.20732,-0.28743,1,0
5,GO SPERM MOTILITY,1.6782e-07,-0.20738,-0.2365,1,0
5,GO O GLYCAN PROCESSING,9.9803e-06,-0.20767,-0.33827,1,0
5,GO RETINOIC ACID METABOLIC PROCESS,0.00029052,-0.20769,-0.21235,1,0
5,GO DENDRITE EXTENSION,0.0014624,-0.20771,-0.24623,1,0
5,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,3.8118e-09,-0.20778,-0.30984,1,0
5,GO HORMONE TRANSPORT,6.0205e-08,-0.20784,-0.31476,1,0
5,GO RESPONSE TO NITROSATIVE STRESS,0.0042095,-0.2081,-0.21257,1,0
5,GO GAMMA AMINOBUTYRIC ACID SECRETION,0.00074504,-0.2082,-0.27047,1,0
5,GO MODULATION BY HOST OF SYMBIONT PROCESS,1.5604e-09,-0.20838,-0.32606,1,0
5,GO HOMOCYSTEINE METABOLIC PROCESS,0.00011986,-0.20855,-0.28621,1,0
5,GO POSITIVE REGULATION OF DNA RECOMBINATION,1.1034e-07,-0.20868,-0.33728,1,0
5,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,2.6306e-11,-0.20885,-0.33711,1,0
5,GO SUBPALLIUM DEVELOPMENT,0.0040509,-0.20887,-0.29441,1,0
5,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,1.3671e-08,-0.20906,-0.32024,1,0
5,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,0.00020504,-0.2091,-0.25667,1,0
5,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,6.5125e-09,-0.20916,-0.2998,1,0
5,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,1.0424e-06,-0.20916,-0.30944,1,0
5,GO HYDROGEN PEROXIDE METABOLIC PROCESS,4.1815e-08,-0.20923,-0.24915,1,0
5,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,1.9465e-08,-0.2094,-0.31734,1,0
5,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0052854,-0.20952,-0.18709,1,0
5,GO PROTEIN TRANSPORT ALONG MICROTUBULE,0.0001179,-0.20958,-0.27696,1,0
5,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,9.03e-05,-0.20967,-0.21169,1,0
5,GO INTESTINAL LIPID ABSORPTION,0.0042095,-0.20969,-0.31195,1,0
5,GO NIK NF KAPPAB SIGNALING,1.9989e-07,-0.20986,-0.27259,1,0
5,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.00037835,-0.20998,-0.22789,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.0958e-05,-0.21018,-0.37005,1,0
5,GO IMPORT INTO NUCLEUS,2.9805e-09,-0.21033,-0.2941,1,0
5,GO HISTONE PHOSPHORYLATION,9.7991e-09,-0.21036,-0.28625,1,0
5,GO ONE CARBON METABOLIC PROCESS,5.0278e-07,-0.21039,-0.26965,1,0
5,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.00032916,-0.21051,-0.25373,1,0
5,GO REGULATION OF DNA RECOMBINATION,2.1338e-07,-0.2107,-0.29895,1,0
5,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,2.5424e-05,-0.21071,-0.44067,1,0
5,GO DOSAGE COMPENSATION,0.0001862,-0.21076,-0.27814,1,0
5,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.00041488,-0.2108,-0.23465,1,0
5,GO TRANSITION METAL ION TRANSPORT,2.2117e-10,-0.21083,-0.28271,1,0
5,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,2.9127e-12,-0.21085,-0.33003,1,0
5,GO PEPTIDYL LYSINE DIMETHYLATION,1.9749e-05,-0.21103,-0.24846,1,0
5,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.00025617,-0.21119,-0.24933,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,3.4296e-07,-0.21135,-0.29838,1,0
5,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,1.4207e-05,-0.2114,-0.27705,1,0
5,GO VACUOLAR ACIDIFICATION,3.2859e-07,-0.2116,-0.29611,1,0
5,GO PEPTIDYL LYSINE METHYLATION,3.2631e-05,-0.21168,-0.26518,1,0
5,GO NERVOUS SYSTEM PROCESS,4.8359e-10,-0.21182,-0.3122,1,0
5,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,6.6578e-05,-0.21184,-0.26485,1,0
5,GO PROTEIN K63 LINKED DEUBIQUITINATION,2.8262e-08,-0.21188,-0.33928,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.0026663,-0.2119,-0.32624,1,0
5,GO FEMALE GAMETE GENERATION,3.3713e-09,-0.2119,-0.27023,1,0
5,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,3.7356e-07,-0.21192,-0.27633,1,0
5,GO PROTEIN SUMOYLATION,2.5868e-06,-0.21197,-0.28385,1,0
5,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.00017176,-0.21201,-0.34577,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,2.1234e-05,-0.21212,-0.23978,1,0
5,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,4.7999e-05,-0.21214,-0.24952,1,0
5,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,9.086e-06,-0.21227,-0.26133,1,0
5,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,1.3196e-05,-0.21247,-0.30257,1,0
5,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,9.6562e-05,-0.21265,-0.30251,1,0
5,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,9.6562e-05,-0.21267,-0.26177,1,0
5,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,3.0302e-06,-0.21272,-0.20359,1,0
5,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1.0322e-07,-0.21274,-0.34523,1,0
5,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,2.2958e-06,-0.2128,-0.2624,1,0
5,GO VESICLE LOCALIZATION,1.0241e-10,-0.21282,-0.36271,1,0
5,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,9.2118e-07,-0.21292,-0.2754,1,0
5,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,7.6283e-05,-0.21293,-0.21513,1,0
5,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,1.4163e-06,-0.21303,-0.27469,1,0
5,GO RESPONSE TO GAMMA RADIATION,8.0712e-08,-0.21306,-0.3041,1,0
5,GO MITOTIC CHROMOSOME CONDENSATION,0.0055559,-0.21311,-0.22178,1,0
5,GO DENDRITE SELF AVOIDANCE,0.002702,-0.21325,-0.2404,1,0
5,GO HUMORAL IMMUNE RESPONSE,6.205e-09,-0.21357,-0.30246,1,0
5,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,9.2585e-06,-0.21377,-0.36368,1,0
5,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,1.2253e-05,-0.21381,-0.29245,1,0
5,GO REGULATION OF CGMP MEDIATED SIGNALING,3.7605e-06,-0.21399,-0.46219,1,0
5,GO REGULATION OF HISTONE UBIQUITINATION,1.064e-06,-0.21409,-0.2584,1,0
5,GO PROTEIN LOCALIZATION TO MEMBRANE,4.5526e-11,-0.21411,-0.28121,1,0
5,GO ORGANIC ACID METABOLIC PROCESS,1.4487e-10,-0.21429,-0.30029,1,0
5,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.0429e-07,-0.21452,-0.31571,1,0
5,GO DENSE CORE GRANULE TRANSPORT,0.0081133,-0.21469,-0.34661,1,0
5,GO PROTEIN HOMOTETRAMERIZATION,1.0161e-09,-0.21488,-0.30349,1,0
5,GO CELLULAR RESPONSE TO LIGHT STIMULUS,3.7356e-07,-0.21499,-0.26463,1,0
5,GO GLUTATHIONE METABOLIC PROCESS,8.7316e-05,-0.215,-0.24914,1,0
5,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,0.00023667,-0.21504,-0.25037,1,0
5,GO PIGMENT METABOLIC PROCESS,4.6202e-07,-0.21505,-0.29187,1,0
5,GO MICROTUBULE BUNDLE FORMATION,1.3599e-06,-0.21508,-0.27856,1,0
5,GO REGULATION OF HORMONE LEVELS,1.0279e-08,-0.21509,-0.30233,1,0
5,GO MITOTIC G2 M TRANSITION CHECKPOINT,6.7105e-06,-0.21511,-0.30336,1,0
5,GO STEROID BIOSYNTHETIC PROCESS,2.9514e-07,-0.21541,-0.28132,1,0
5,GO NEURON APOPTOTIC PROCESS,5.3647e-09,-0.21546,-0.32386,1,0
5,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.00036686,-0.21547,-0.27569,1,0
5,GO PEPTIDYL AMINO ACID MODIFICATION,1.8863e-12,-0.21587,-0.35065,1,0
5,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,8.1623e-05,-0.2159,-0.30671,1,0
5,GO CELL FATE COMMITMENT,9.028e-08,-0.21594,-0.29804,1,0
5,GO RHYTHMIC PROCESS,2.2707e-10,-0.21599,-0.3426,1,0
5,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,3.8924e-05,-0.21601,-0.25401,1,0
5,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,0.0063654,-0.21613,-0.30444,1,0
5,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,0.00063314,-0.21616,-0.24508,1,0
5,GO REGULATION OF ORGANIC ACID TRANSPORT,1.9558e-07,-0.2163,-0.32636,1,0
5,GO DIGESTIVE SYSTEM PROCESS,4.0678e-07,-0.21638,-0.25936,1,0
5,GO FATTY ACID DERIVATIVE TRANSPORT,3.6435e-08,-0.21651,-0.33328,1,0
5,GO CIRCADIAN REGULATION OF GENE EXPRESSION,1.4677e-08,-0.21654,-0.41507,1,0
5,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,6.6717e-09,-0.21658,-0.33908,1,0
5,GO HISTONE SERINE PHOSPHORYLATION,0.00022565,-0.21659,-0.22905,1,0
5,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.028556,-0.21666,-0.22622,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,1.2032e-06,-0.21672,-0.32529,1,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,5.2344e-05,-0.21679,-0.29852,1,0
5,GO DIOL BIOSYNTHETIC PROCESS,0.0005618,-0.21686,-0.26719,1,0
5,GO RESPONSE TO IMMOBILIZATION STRESS,4.6359e-05,-0.21702,-0.27957,1,0
5,GO RIBONUCLEOSIDE METABOLIC PROCESS,1.1034e-07,-0.21707,-0.26464,1,0
5,GO SPERM CAPACITATION,2.1621e-05,-0.21707,-0.22956,1,0
5,GO PROTEOLYSIS,6.6774e-12,-0.21711,-0.32711,1,0
5,GO PEPTIDYL LYSINE TRIMETHYLATION,1.734e-06,-0.21722,-0.30874,1,0
5,GO RETINOL METABOLIC PROCESS,3.2631e-05,-0.21728,-0.24018,1,0
5,GO SPINDLE MIDZONE ASSEMBLY,0.0028872,-0.21749,-0.21822,1,0
5,GO HEMOGLOBIN METABOLIC PROCESS,1.2792e-06,-0.21762,-0.34936,1,0
5,GO LYSINE METABOLIC PROCESS,0.0083098,-0.21763,-0.21394,1,0
5,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.0049019,-0.21776,-0.24982,1,0
5,GO PROTEIN IMPORT,2.0437e-10,-0.21776,-0.30673,1,0
5,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,2.856e-06,-0.21784,-0.33513,1,0
5,GO HISTONE H4 DEACETYLATION,4.4285e-07,-0.21784,-0.31441,1,0
5,GO HISTONE H3 K14 ACETYLATION,1.3442e-05,-0.21788,-0.2732,1,0
5,GO MACROAUTOPHAGY,1.9402e-11,-0.21791,-0.33979,1,0
5,GO MITOTIC DNA INTEGRITY CHECKPOINT,1.9563e-06,-0.21811,-0.28394,1,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,8.6937e-09,-0.21811,-0.33999,1,0
5,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.00043435,-0.21817,-0.25142,1,0
5,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,4.8673e-09,-0.21824,-0.2967,1,0
5,GO CELLULAR RESPONSE TO OXYGEN LEVELS,6.757e-10,-0.21831,-0.3023,1,0
5,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,1.3671e-08,-0.21838,-0.30629,1,0
5,GO MITOCHONDRIAL DNA REPLICATION,3.8246e-05,-0.21839,-0.24943,1,0
5,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,5.6317e-09,-0.21848,-0.34022,1,0
5,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,1.3196e-05,-0.21851,-0.26461,1,0
5,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,7.3739e-05,-0.21852,-0.20985,1,0
5,GO PROTEIN POLYMERIZATION,2.1085e-11,-0.21872,-0.36999,1,0
5,GO SMALL MOLECULE CATABOLIC PROCESS,1.3761e-09,-0.21882,-0.295,1,0
5,GO INTERLEUKIN 12 PRODUCTION,1.5674e-06,-0.21885,-0.30561,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,1.0958e-05,-0.21893,-0.26968,1,0
5,GO NADP METABOLIC PROCESS,1.2954e-05,-0.21896,-0.29697,1,0
5,GO MISMATCH REPAIR,1.4207e-05,-0.21899,-0.25233,1,0
5,GO MICROTUBULE SEVERING,6.6578e-05,-0.21908,-0.29193,1,0
5,GO CELLULAR COMPONENT DISASSEMBLY,7.0279e-11,-0.21908,-0.29909,1,0
5,GO EPIDERMAL CELL DIFFERENTIATION,1.0756e-05,-0.21912,-0.28608,1,0
5,GO MICROTUBULE BASED TRANSPORT,1.2281e-06,-0.21919,-0.30305,1,0
5,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,7.5001e-05,-0.21937,-0.23548,1,0
5,GO ENDOSOME ORGANIZATION,4.9069e-08,-0.21938,-0.30615,1,0
5,GO MAINTENANCE OF CELL NUMBER,4.6356e-09,-0.21955,-0.34394,1,0
5,GO POSITIVE REGULATION OF SECRETION,3.1098e-10,-0.21958,-0.33221,1,0
5,GO SULFATE TRANSPORT,4.7172e-05,-0.2196,-0.24661,1,0
5,GO ORGANIC ACID CATABOLIC PROCESS,9.1793e-10,-0.21967,-0.29789,1,0
5,GO RESPONSE TO XENOBIOTIC STIMULUS,2.3891e-06,-0.21975,-0.22222,1,0
5,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.0964e-09,-0.22003,-0.34417,1,0
5,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,9.2118e-07,-0.2201,-0.31472,1,0
5,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,3.0811e-07,-0.2202,-0.34896,1,0
5,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.00026858,-0.22024,-0.27106,1,0
5,GO TOR SIGNALING,8.8611e-12,-0.22027,-0.34977,1,0
5,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,2.4371e-06,-0.2203,-0.26745,1,0
5,GO CELLULAR HOMEOSTASIS,7.2702e-12,-0.2204,-0.32032,1,0
5,GO TRANSMEMBRANE TRANSPORT,1.1415e-11,-0.22047,-0.32253,1,0
5,GO VENTRAL SPINAL CORD DEVELOPMENT,0.00015331,-0.2205,-0.24964,1,0
5,GO SPERMATID NUCLEUS DIFFERENTIATION,5.1446e-05,-0.2205,-0.25126,1,0
5,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,1.7922e-07,-0.22057,-0.27592,1,0
5,GO HORMONE CATABOLIC PROCESS,0.0023321,-0.22061,-0.24147,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,7.0522e-08,-0.22062,-0.27662,1,0
5,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,1.2886e-07,-0.2208,-0.28224,1,0
5,GO RESPONSE TO ABIOTIC STIMULUS,1.1099e-11,-0.2208,-0.32775,1,0
5,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,3.2785e-11,-0.22091,-0.33766,1,0
5,GO REGULATION OF CATABOLIC PROCESS,2.521e-12,-0.22092,-0.33485,1,0
5,GO NEGATIVE REGULATION OF GENE SILENCING,2.5884e-05,-0.22113,-0.25415,1,0
5,GO TRANSPOSITION,0.0011836,-0.22123,-0.27132,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,5.3647e-09,-0.22138,-0.31764,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,2.4452e-09,-0.22144,-0.33858,1,0
5,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,1.8032e-05,-0.22159,-0.26806,1,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE,6.3569e-09,-0.22174,-0.29038,1,0
5,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,1.734e-06,-0.22195,-0.25479,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,1.8723e-07,-0.22207,-0.31537,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,1.6654e-06,-0.22213,-0.3315,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,1.996e-06,-0.22217,-0.32968,1,0
5,GO GOLGI ORGANIZATION,9.1793e-10,-0.22229,-0.36708,1,0
5,GO GLYCOLIPID BIOSYNTHETIC PROCESS,1.3056e-06,-0.2223,-0.29079,1,0
5,GO PROTEIN TETRAMERIZATION,5.3617e-10,-0.22231,-0.30084,1,0
5,GO REGULATION OF HORMONE SECRETION,3.1729e-08,-0.22238,-0.31161,1,0
5,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,5.2165e-11,-0.22251,-0.32678,1,0
5,GO EAR DEVELOPMENT,1.4334e-08,-0.22263,-0.32871,1,0
5,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,3.8149e-08,-0.22263,-0.31099,1,0
5,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,1.4334e-08,-0.22271,-0.2508,1,0
5,GO REGULATION OF PEPTIDE TRANSPORT,3.1032e-11,-0.22271,-0.33737,1,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,4.3355e-07,-0.22275,-0.35004,1,0
5,GO DETERMINATION OF ADULT LIFESPAN,0.00061456,-0.2228,-0.27235,1,0
5,GO GLIAL CELL FATE COMMITMENT,0.0092477,-0.22283,-0.26231,1,0
5,GO REGULATION OF HISTONE MODIFICATION,3.6293e-09,-0.22286,-0.31501,1,0
5,GO PROTEIN AUTOUBIQUITINATION,8.9558e-11,-0.22297,-0.32066,1,0
5,GO REGULATION OF HISTONE PHOSPHORYLATION,6.4699e-07,-0.22298,-0.30128,1,0
5,GO CELLULAR OXIDANT DETOXIFICATION,4.4285e-07,-0.22302,-0.2343,1,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,2.9859e-05,-0.22302,-0.259,1,0
5,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,6.2175e-05,-0.22321,-0.3101,1,0
5,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,3.6293e-09,-0.22338,-0.29636,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,2.9602e-08,-0.22353,-0.30348,1,0
5,GO REGULATION OF PROTEIN ACETYLATION,1.3599e-06,-0.22357,-0.27771,1,0
5,GO CELL CYCLE ARREST,1.3133e-11,-0.2238,-0.34193,1,0
5,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.00071283,-0.22382,-0.19024,1,0
5,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,4.1552e-07,-0.22385,-0.29174,1,0
5,GO ANION TRANSPORT,1.2074e-11,-0.22387,-0.34361,1,0
5,GO ENDODERMAL CELL FATE COMMITMENT,8.4424e-05,-0.22412,-0.24711,1,0
5,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,3.055e-09,-0.22425,-0.34612,1,0
5,GO RESPONSE TO HEAT,2.2926e-08,-0.22439,-0.30839,1,0
5,GO ADULT BEHAVIOR,1.6321e-06,-0.22442,-0.3194,1,0
5,GO AUTOPHAGY OF MITOCHONDRION,5.6451e-10,-0.22448,-0.32568,1,0
5,GO REGULATION OF CHROMATIN ORGANIZATION,1.8135e-09,-0.22464,-0.31345,1,0
5,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,6.337e-06,-0.22464,-0.32506,1,0
5,GO LEYDIG CELL DIFFERENTIATION,0.0016575,-0.22466,-0.3252,1,0
5,GO VACUOLAR TRANSPORT,6.3074e-11,-0.22468,-0.38062,1,0
5,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,3.6162e-06,-0.22469,-0.33273,1,0
5,GO HEME METABOLIC PROCESS,1.4741e-05,-0.22485,-0.3076,1,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,3.7605e-06,-0.22485,-0.28421,1,0
5,GO ORGANOPHOSPHATE METABOLIC PROCESS,3.5597e-11,-0.22489,-0.32523,1,0
5,GO REGULATION OF ORGANELLE ASSEMBLY,8.7184e-11,-0.22494,-0.35326,1,0
5,GO POST TRANSLATIONAL PROTEIN MODIFICATION,3.1032e-11,-0.22504,-0.34653,1,0
5,GO ANTEROGRADE AXONAL TRANSPORT,2.913e-06,-0.22508,-0.33975,1,0
5,GO FERTILIZATION,1.9064e-09,-0.22509,-0.26601,1,0
5,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.0019023,-0.22509,-0.23088,1,0
5,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.00040235,-0.2251,-0.28518,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,2.9371e-11,-0.22511,-0.34184,1,0
5,GO CELLULAR PIGMENTATION,1.5713e-07,-0.22513,-0.29767,1,0
5,GO T CELL APOPTOTIC PROCESS,4.2444e-07,-0.22517,-0.29338,1,0
5,GO SIGNAL PEPTIDE PROCESSING,0.010041,-0.2252,-0.17635,1,0
5,GO CYTOSOLIC TRANSPORT,1.2348e-10,-0.22521,-0.39892,1,0
5,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,6.757e-10,-0.22522,-0.34306,1,0
5,GO REGULATION OF VITAMIN METABOLIC PROCESS,2.5424e-05,-0.22533,-0.35005,1,0
5,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,4.6202e-07,-0.22537,-0.26241,1,0
5,GO HOMEOSTATIC PROCESS,3.6667e-12,-0.22546,-0.33122,1,0
5,GO PROTEIN O LINKED MANNOSYLATION,0.0010259,-0.2255,-0.26203,1,0
5,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,6.8348e-09,-0.22553,-0.33447,1,0
5,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,1.0958e-05,-0.2256,-0.28449,1,0
5,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,8.4871e-11,-0.22574,-0.33124,1,0
5,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,4.3606e-10,-0.22575,-0.37384,1,0
5,GO MACROPHAGE CHEMOTAXIS,5.2445e-07,-0.22577,-0.28524,1,0
5,GO CATECHOLAMINE METABOLIC PROCESS,4.4771e-05,-0.22586,-0.28079,1,0
5,GO REGULATION OF CYTOPLASMIC TRANSLATION,4.4807e-06,-0.22591,-0.29187,1,0
5,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.00073415,-0.22593,-0.26374,1,0
5,GO ISOTYPE SWITCHING TO IGG ISOTYPES,5.2303e-06,-0.22606,-0.25578,1,0
5,GO CD40 SIGNALING PATHWAY,3.3435e-06,-0.22612,-0.31403,1,0
5,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,1.6823e-09,-0.2265,-0.36159,1,0
5,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,7.8052e-07,-0.22651,-0.34349,1,0
5,GO HISTONE DEACETYLATION,1.1041e-08,-0.22654,-0.34746,1,0
5,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,4.4285e-07,-0.22656,-0.34963,1,0
5,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,1.0361e-05,-0.22659,-0.31782,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,7.1274e-05,-0.22659,-0.31687,1,0
5,GO REGULATION OF INSULIN SECRETION,1.1041e-08,-0.22668,-0.33544,1,0
5,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,9.1146e-12,-0.22669,-0.324,1,0
5,GO REGULATION OF CELLULAR CATABOLIC PROCESS,2.9127e-12,-0.22673,-0.34002,1,0
5,GO TRANSCYTOSIS,6.8396e-06,-0.22678,-0.33194,1,0
5,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.00024819,-0.22684,-0.28854,1,0
5,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.00019541,-0.22697,-0.25304,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.3351e-08,-0.22699,-0.36174,1,0
5,GO SOMATIC STEM CELL POPULATION MAINTENANCE,3.6567e-07,-0.22714,-0.33928,1,0
5,GO MONOSACCHARIDE CATABOLIC PROCESS,4.5684e-06,-0.22721,-0.29173,1,0
5,GO REGULATION OF MACROAUTOPHAGY,1.785e-11,-0.22723,-0.35841,1,0
5,GO REGULATION OF TOR SIGNALING,3.3697e-11,-0.22724,-0.36651,1,0
5,GO VIRAL RELEASE FROM HOST CELL,1.439e-07,-0.22748,-0.28856,1,0
5,GO REPRODUCTION,3.7602e-11,-0.22775,-0.3095,1,0
5,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,2.0478e-05,-0.22778,-0.30908,1,0
5,GO TETRAPYRROLE METABOLIC PROCESS,2.9514e-07,-0.22781,-0.28345,1,0
5,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,7.892e-08,-0.22785,-0.32695,1,0
5,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,2.3933e-10,-0.22799,-0.335,1,0
5,GO MACROPHAGE MIGRATION,1.0791e-07,-0.228,-0.31469,1,0
5,GO REGULATION OF GLUCOSE METABOLIC PROCESS,4.9624e-10,-0.22803,-0.37876,1,0
5,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,3.1004e-08,-0.22812,-0.30687,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,8.0712e-08,-0.22817,-0.32711,1,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,8.4415e-08,-0.22823,-0.30521,1,0
5,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,6.8396e-06,-0.22827,-0.30239,1,0
5,GO ECTODERM DEVELOPMENT,1.5037e-07,-0.22844,-0.28777,1,0
5,GO CELL AGING,5.9432e-10,-0.22855,-0.3143,1,0
5,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.009139,-0.22873,-0.17151,1,0
5,GO CELLULAR RESPONSE TO ALKALOID,2.206e-06,-0.22874,-0.25654,1,0
5,GO ANATOMICAL STRUCTURE HOMEOSTASIS,6.8406e-11,-0.2288,-0.3111,1,0
5,GO XENOBIOTIC CATABOLIC PROCESS,0.022686,-0.22881,-0.26484,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE ARREST,9.9803e-06,-0.22884,-0.27474,1,0
5,GO RESPONSE TO INTERLEUKIN 1,4.8673e-09,-0.22891,-0.27845,1,0
5,GO REGULATION OF STEM CELL DIFFERENTIATION,2.206e-06,-0.22897,-0.27961,1,0
5,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,8.0712e-08,-0.22897,-0.23385,1,0
5,GO PH REDUCTION,1.5713e-07,-0.22903,-0.25465,1,0
5,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,1.2604e-07,-0.22904,-0.29268,1,0
5,GO REGULATION OF ACROSOME REACTION,0.0012886,-0.2291,-0.26769,1,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,6.6578e-05,-0.22926,-0.25055,1,0
5,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.1032e-11,-0.22927,-0.36833,1,0
5,GO PROTEIN HOMOOLIGOMERIZATION,1.9402e-11,-0.22957,-0.32118,1,0
5,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,8.0712e-08,-0.22962,-0.3109,1,0
5,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,5.815e-11,-0.22969,-0.31861,1,0
5,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,8.2903e-10,-0.22974,-0.2875,1,0
5,GO CELL CELL SIGNALING,7.2202e-11,-0.22975,-0.3419,1,0
5,GO THIOESTER METABOLIC PROCESS,2.7668e-07,-0.23025,-0.28203,1,0
5,GO PHOTORECEPTOR CELL DIFFERENTIATION,0.00022565,-0.23026,-0.2438,1,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,7.6657e-06,-0.23026,-0.35683,1,0
5,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,9.2118e-07,-0.23029,-0.30958,1,0
5,GO CARBOHYDRATE TRANSPORT,5.3617e-10,-0.23031,-0.34865,1,0
5,GO RIG I SIGNALING PATHWAY,2.8271e-07,-0.23057,-0.31858,1,0
5,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.00058763,-0.23059,-0.25479,1,0
5,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,5.9748e-11,-0.23066,-0.36768,1,0
5,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,5.3256e-05,-0.23069,-0.28866,1,0
5,GO SENSORY ORGAN MORPHOGENESIS,1.1041e-08,-0.23073,-0.33544,1,0
5,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,7.0279e-11,-0.23081,-0.34718,1,0
5,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,3.7356e-07,-0.23105,-0.32357,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.536e-06,-0.23106,-0.39267,1,0
5,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,5.8698e-06,-0.23112,-0.34347,1,0
5,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,3.2057e-05,-0.23117,-0.25974,1,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,1.0202e-11,-0.23117,-0.36433,1,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,7.8286e-11,-0.2312,-0.3049,1,0
5,GO INNER EAR MORPHOGENESIS,1.8318e-07,-0.23129,-0.31193,1,0
5,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,8.7184e-11,-0.23136,-0.34907,1,0
5,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,1.0527e-08,-0.23137,-0.35176,1,0
5,GO INSULIN SECRETION,3.4796e-08,-0.23141,-0.33585,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.0098086,-0.23146,-0.24892,1,0
5,GO CELL CYCLE G1 S PHASE TRANSITION,1.0094e-07,-0.23148,-0.27603,1,0
5,GO RESPONSE TO IONIZING RADIATION,4.6356e-09,-0.23148,-0.31639,1,0
5,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,1.1034e-07,-0.23149,-0.34267,1,0
5,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,8.5867e-06,-0.23154,-0.29076,1,0
5,GO REGULATION OF CELLULAR PH,1.2131e-09,-0.23158,-0.29247,1,0
5,GO GLUTAMINE METABOLIC PROCESS,5.0278e-07,-0.23162,-0.30533,1,0
5,GO CARDIAC MUSCLE CELL DIFFERENTIATION,4.249e-10,-0.23184,-0.38094,1,0
5,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.7676e-09,-0.23185,-0.35051,1,0
5,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.00049053,-0.23188,-0.33281,1,0
5,GO RIBOSE PHOSPHATE METABOLIC PROCESS,7.8778e-10,-0.23211,-0.31227,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,1.0161e-09,-0.23215,-0.2936,1,0
5,GO CELLULAR RESPONSE TO PH,5.7051e-07,-0.23216,-0.2783,1,0
5,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,7.1121e-10,-0.23217,-0.29963,1,0
5,GO PEPTIDYL CYSTEINE MODIFICATION,6.2993e-08,-0.23218,-0.3053,1,0
5,GO GOLGI VESICLE TRANSPORT,1.642e-11,-0.23222,-0.35354,1,0
5,GO PEROXISOME ORGANIZATION,1.6782e-07,-0.23229,-0.26625,1,0
5,GO DNA DOUBLE STRAND BREAK PROCESSING,0.0023637,-0.23237,-0.20835,1,0
5,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.00028155,-0.23244,-0.22029,1,0
5,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,3.6877e-06,-0.23252,-0.2452,1,0
5,GO SEX DETERMINATION,3.6162e-06,-0.2326,-0.27361,1,0
5,GO LIVER REGENERATION,1.3039e-08,-0.23261,-0.30089,1,0
5,GO RESPONSE TO CHEMOKINE,3.9309e-10,-0.23265,-0.26722,1,0
5,GO LIPOPROTEIN METABOLIC PROCESS,8.0424e-11,-0.23267,-0.33204,1,0
5,GO CELLULAR DEFENSE RESPONSE,3.0156e-07,-0.23272,-0.31218,1,0
5,GO PEROXISOMAL TRANSPORT,2.8886e-07,-0.23273,-0.27257,1,0
5,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.8318e-07,-0.23277,-0.30534,1,0
5,GO DETECTION OF CALCIUM ION,0.01829,-0.2328,-0.21924,1,0
5,GO NUCLEAR BODY ORGANIZATION,9.6129e-06,-0.23286,-0.33691,1,0
5,GO ENDOMEMBRANE SYSTEM ORGANIZATION,1.785e-11,-0.23317,-0.3781,1,0
5,GO COPII COATED VESICLE BUDDING,2.7286e-10,-0.23325,-0.33311,1,0
5,GO REGULATION OF NEUROTRANSMITTER LEVELS,1.6654e-06,-0.23343,-0.32395,1,0
5,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,6.3569e-09,-0.23344,-0.3123,1,0
5,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,1.7687e-09,-0.23354,-0.30238,1,0
5,GO MUSCLE TISSUE DEVELOPMENT,1.0519e-10,-0.23357,-0.36502,1,0
5,GO T CELL RECEPTOR SIGNALING PATHWAY,1.3999e-08,-0.23387,-0.31187,1,0
5,GO PROTEIN LOCALIZATION TO NUCLEUS,2.1595e-09,-0.23394,-0.32227,1,0
5,GO REGULATION OF SECRETION,1.3737e-10,-0.23396,-0.3373,1,0
5,GO REGULATION OF CELL AGING,1.3419e-09,-0.23402,-0.33058,1,0
5,GO PURINE NUCLEOSIDE METABOLIC PROCESS,1.0322e-07,-0.23408,-0.24523,1,0
5,GO NEGATIVE REGULATION OF NEURON DEATH,3.3629e-10,-0.23413,-0.35057,1,0
5,GO MICROTUBULE POLYMERIZATION,8.3066e-07,-0.23417,-0.34638,1,0
5,GO AMINO ACID TRANSPORT,1.3671e-08,-0.23418,-0.34012,1,0
5,GO MODULATION OF PROCESS OF OTHER ORGANISM,3.5427e-10,-0.23419,-0.3252,1,0
5,GO RECEPTOR LOCALIZATION TO SYNAPSE,0.00029511,-0.2343,-0.31535,1,0
5,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.00013673,-0.23432,-0.31506,1,0
5,GO SPLEEN DEVELOPMENT,1.3999e-08,-0.23435,-0.31737,1,0
5,GO ANION TRANSMEMBRANE TRANSPORT,1.3133e-11,-0.23441,-0.35068,1,0
5,GO MEIOTIC SPINDLE ORGANIZATION,0.00029052,-0.23443,-0.2533,1,0
5,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,7.0279e-11,-0.23443,-0.36141,1,0
5,GO CELLULAR RESPONSE TO RADIATION,5.1356e-08,-0.23478,-0.28272,1,0
5,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,5.4356e-06,-0.23484,-0.32551,1,0
5,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,4.0868e-08,-0.23484,-0.2902,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,1.7309e-08,-0.23492,-0.32899,1,0
5,GO RESPONSE TO VIRUS,3.4796e-08,-0.23494,-0.3404,1,0
5,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.3693e-05,-0.23517,-0.26034,1,0
5,GO RESPONSE TO NITROGEN COMPOUND,2.1188e-12,-0.23533,-0.36419,1,0
5,GO ESTABLISHMENT OF TISSUE POLARITY,9.028e-08,-0.23545,-0.28345,1,0
5,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,1.5102e-11,-0.23547,-0.3637,1,0
5,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0005618,-0.2355,-0.26719,1,0
5,GO FEVER GENERATION,4.5233e-07,-0.23565,-0.22926,1,0
5,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,4.7488e-06,-0.23566,-0.35499,1,0
5,GO ION TRANSPORT,1.1099e-11,-0.23572,-0.33724,1,0
5,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,2.1595e-09,-0.23576,-0.35114,1,0
5,GO HINDBRAIN DEVELOPMENT,1.1034e-07,-0.23578,-0.33367,1,0
5,GO VESICLE CYTOSKELETAL TRAFFICKING,7.3772e-08,-0.23582,-0.36206,1,0
5,GO CATION TRANSPORT,3.8645e-11,-0.2359,-0.33356,1,0
5,GO CELLULAR RESPONSE TO UV,1.8318e-07,-0.23595,-0.30776,1,0
5,GO KERATINOCYTE DIFFERENTIATION,5.9056e-05,-0.23601,-0.27675,1,0
5,GO SODIUM ION HOMEOSTASIS,4.2444e-07,-0.23603,-0.28516,1,0
5,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,2.2707e-10,-0.23603,-0.34657,1,0
5,GO REGULATION OF HISTONE H3 K9 METHYLATION,1.1588e-05,-0.23604,-0.3252,1,0
5,GO INORGANIC ANION TRANSPORT,7.6205e-11,-0.23613,-0.32615,1,0
5,GO DIOL METABOLIC PROCESS,3.4409e-05,-0.23621,-0.30922,1,0
5,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,7.2414e-06,-0.2363,-0.27511,1,0
5,GO ER OVERLOAD RESPONSE,0.0011836,-0.2363,-0.24465,1,0
5,GO POSITIVE REGULATION OF TRANSPORT,6.8695e-12,-0.23633,-0.35991,1,0
5,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,7.2202e-11,-0.23637,-0.31038,1,0
5,GO PROTEIN LOCALIZATION TO CYTOSKELETON,1.2328e-07,-0.23643,-0.34659,1,0
5,GO LATERAL MESODERM DEVELOPMENT,0.00026858,-0.23648,-0.29799,1,0
5,GO NON MOTILE CILIUM ASSEMBLY,5.3256e-05,-0.23666,-0.25943,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,3.4098e-06,-0.23668,-0.31539,1,0
5,GO ACTIN NUCLEATION,1.3085e-09,-0.23677,-0.32899,1,0
5,GO GASTRIC ACID SECRETION,0.00023667,-0.23684,-0.20057,1,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,9.4341e-06,-0.23702,-0.34963,1,0
5,GO FC RECEPTOR SIGNALING PATHWAY,2.0546e-09,-0.23713,-0.32809,1,0
5,GO DEPHOSPHORYLATION,3.7602e-11,-0.23715,-0.34787,1,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,7.969e-07,-0.23726,-0.3535,1,0
5,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,3.8983e-07,-0.23735,-0.31349,1,0
5,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,1.7706e-05,-0.23736,-0.35871,1,0
5,GO REGULATION OF CELLULAR LOCALIZATION,1.4282e-11,-0.23767,-0.36194,1,0
5,GO AXONAL TRANSPORT OF MITOCHONDRION,0.00014362,-0.23767,-0.34038,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,2.4452e-09,-0.23771,-0.31122,1,0
5,GO REGULATION OF CYTOSKELETON ORGANIZATION,3.7602e-11,-0.23772,-0.38194,1,0
5,GO PROTEIN DEPHOSPHORYLATION,5.3602e-11,-0.23783,-0.34777,1,0
5,GO CHROMATIN DISASSEMBLY,7.2414e-06,-0.23785,-0.32345,1,0
5,GO IN UTERO EMBRYONIC DEVELOPMENT,6.1389e-11,-0.23796,-0.34269,1,0
5,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,0.00044781,-0.23804,-0.29192,1,0
5,GO GOLGI TO VACUOLE TRANSPORT,1.0169e-05,-0.23807,-0.34739,1,0
5,GO GOLGI VESICLE BUDDING,2.9515e-10,-0.23807,-0.34626,1,0
5,GO HISTONE DEUBIQUITINATION,7.2414e-06,-0.23829,-0.31752,1,0
5,GO T CELL LINEAGE COMMITMENT,0.00024045,-0.23843,-0.23188,1,0
5,GO REGULATION OF MULTI ORGANISM PROCESS,1.1041e-08,-0.2385,-0.2752,1,0
5,GO REGULATION OF PROTEIN STABILITY,1.1706e-10,-0.23854,-0.3127,1,0
5,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,8.9047e-09,-0.23871,-0.28995,1,0
5,GO BLASTOCYST FORMATION,5.6245e-08,-0.23872,-0.28374,1,0
5,GO DEFENSE RESPONSE TO BACTERIUM,5.8856e-08,-0.23872,-0.27707,1,0
5,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,1.0322e-07,-0.2388,-0.31862,1,0
5,GO PEPTIDE SECRETION,1.2682e-10,-0.23882,-0.35083,1,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.00016629,-0.23893,-0.30492,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,6.1321e-12,-0.23902,-0.37591,1,0
5,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,3.6435e-08,-0.23912,-0.35583,1,0
5,GO NEGATIVE REGULATION OF DNA REPLICATION,2.5884e-05,-0.23918,-0.29994,1,0
5,GO VESICLE ORGANIZATION,3.5597e-11,-0.2392,-0.37843,1,0
5,GO NEGATIVE REGULATION OF HISTONE METHYLATION,0.00010673,-0.2392,-0.29864,1,0
5,GO APOPTOTIC PROCESS,5.3186e-12,-0.2393,-0.34173,1,0
5,GO NEURAL RETINA DEVELOPMENT,7.105e-06,-0.2394,-0.31957,1,0
5,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,9.404e-07,-0.2394,-0.31895,1,0
5,GO ORGANIC ANION TRANSPORT,2.4214e-11,-0.23953,-0.34759,1,0
5,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,3.4796e-08,-0.23954,-0.31158,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,1.3948e-05,-0.23958,-0.31342,1,0
5,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.7125e-10,-0.23979,-0.31199,1,0
5,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,4.4807e-06,-0.23985,-0.30706,1,0
5,GO PATTERN SPECIFICATION PROCESS,2.3853e-09,-0.24019,-0.3396,1,0
5,GO MYELOID DENDRITIC CELL ACTIVATION,1.4207e-05,-0.2402,-0.27795,1,0
5,GO LONG CHAIN FATTY ACID TRANSPORT,2.8753e-10,-0.24025,-0.34035,1,0
5,GO PHOSPHOLIPID METABOLIC PROCESS,3.5629e-12,-0.24031,-0.36225,1,0
5,GO SULFUR COMPOUND TRANSPORT,1.7309e-08,-0.24036,-0.37073,1,0
5,GO GANGLION DEVELOPMENT,0.032607,-0.24042,-0.26752,1,0
5,GO NEUROTRANSMITTER SECRETION,1.7706e-05,-0.24046,-0.32277,1,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,8.4877e-09,-0.24052,-0.3099,1,0
5,GO PROTEIN LOCALIZATION TO SYNAPSE,2.011e-05,-0.24057,-0.3469,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,4.3774e-08,-0.24066,-0.33693,1,0
5,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,2.0429e-07,-0.2407,-0.33269,1,0
5,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,1.0241e-10,-0.24072,-0.32741,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,3.8833e-12,-0.2409,-0.38045,1,0
5,GO NEURON DEATH,1.5277e-10,-0.24095,-0.35682,1,0
5,GO MONOVALENT INORGANIC CATION TRANSPORT,2.1064e-09,-0.24101,-0.30945,1,0
5,GO ALCOHOL BIOSYNTHETIC PROCESS,2.5756e-08,-0.24105,-0.30923,1,0
5,GO ORGANOPHOSPHATE CATABOLIC PROCESS,1.1398e-10,-0.24106,-0.31326,1,0
5,GO REGULATION OF T CELL CHEMOTAXIS,1.0361e-05,-0.2411,-0.24924,1,0
5,GO ER NUCLEUS SIGNALING PATHWAY,4.5684e-06,-0.24116,-0.30419,1,0
5,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,5.9498e-07,-0.24129,-0.28957,1,0
5,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,1.6994e-06,-0.24133,-0.35508,1,0
5,GO MIDBRAIN DEVELOPMENT,6.586e-10,-0.24154,-0.31995,1,0
5,GO GLUCOSE METABOLIC PROCESS,7.8778e-10,-0.24173,-0.34884,1,0
5,GO NEGATIVE REGULATION OF BLOOD PRESSURE,2.2505e-06,-0.24185,-0.31392,1,0
5,GO PROTEIN DESTABILIZATION,9.7991e-09,-0.24187,-0.35033,1,0
5,GO REGULATION OF INNATE IMMUNE RESPONSE,5.02e-08,-0.24197,-0.30627,1,0
5,GO HEAD DEVELOPMENT,3.6293e-09,-0.24201,-0.3485,1,0
5,GO DETECTION OF ABIOTIC STIMULUS,3.2784e-06,-0.2422,-0.26592,1,0
5,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,4.0868e-08,-0.24223,-0.30443,1,0
5,GO CARBOHYDRATE PHOSPHORYLATION,2.5884e-05,-0.24224,-0.33762,1,0
5,GO GENETIC IMPRINTING,0.00011218,-0.24238,-0.27827,1,0
5,GO REGULATION OF PROTEIN MODIFICATION PROCESS,2.1812e-12,-0.24251,-0.36433,1,0
5,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,5.815e-11,-0.24252,-0.31618,1,0
5,GO LYTIC VACUOLE ORGANIZATION,5.3647e-09,-0.24256,-0.37073,1,0
5,GO VIRAL RNA GENOME REPLICATION,3.152e-06,-0.24262,-0.30923,1,0
5,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,4.6359e-05,-0.24268,-0.31297,1,0
5,GO REGULATION OF TRANSPOSITION,0.0019819,-0.24281,-0.28415,1,0
5,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.2434e-08,-0.24286,-0.3186,1,0
5,GO REGULATION OF MRNA 3 END PROCESSING,5.3562e-07,-0.24289,-0.31455,1,0
5,GO ION TRANSMEMBRANE TRANSPORT,1.9948e-11,-0.2429,-0.34278,1,0
5,GO INTERLEUKIN 10 PRODUCTION,7.0072e-05,-0.24292,-0.24924,1,0
5,GO DEFENSE RESPONSE TO VIRUS,6.2046e-07,-0.24297,-0.36011,1,0
5,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,2.0364e-06,-0.24298,-0.32957,1,0
5,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,6.2169e-06,-0.24299,-0.32206,1,0
5,GO PROTEIN NITROSYLATION,8.5867e-06,-0.24307,-0.26296,1,0
5,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,4.3355e-07,-0.24314,-0.37858,1,0
5,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,2.1624e-06,-0.24326,-0.27444,1,0
5,GO GLYCOPROTEIN METABOLIC PROCESS,1.4686e-11,-0.24332,-0.37845,1,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,1.1375e-05,-0.24349,-0.27334,1,0
5,GO IMMUNOGLOBULIN SECRETION,2.9514e-07,-0.24356,-0.32253,1,0
5,GO SECRETION,7.479e-12,-0.2436,-0.35634,1,0
5,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00017741,-0.24363,-0.27666,1,0
5,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.2162e-07,-0.2437,-0.32843,1,0
5,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,2.1624e-06,-0.2438,-0.35277,1,0
5,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,2.2926e-08,-0.24385,-0.3505,1,0
5,GO PRIMARY MIRNA PROCESSING,3.5794e-07,-0.24387,-0.32677,1,0
5,GO MONOCARBOXYLIC ACID TRANSPORT,7.8286e-11,-0.24391,-0.34755,1,0
5,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,4.8416e-06,-0.24397,-0.30049,1,0
5,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,8.7316e-05,-0.24404,-0.3116,1,0
5,GO FATTY ACID TRANSPORT,1.2348e-10,-0.24407,-0.35173,1,0
5,GO CEREBRAL CORTEX DEVELOPMENT,1.1794e-07,-0.24412,-0.35672,1,0
5,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.001422,-0.24413,-0.27306,1,0
5,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,6.4699e-07,-0.24417,-0.31337,1,0
5,GO METAL ION TRANSPORT,1.3133e-11,-0.24419,-0.34014,1,0
5,GO FATTY ACID CATABOLIC PROCESS,2.0398e-08,-0.24421,-0.3182,1,0
5,GO MUSCLE ORGAN DEVELOPMENT,4.6784e-11,-0.24422,-0.36992,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,8.5867e-06,-0.24423,-0.29213,1,0
5,GO REGULATION OF INTRACELLULAR TRANSPORT,1.6542e-10,-0.24457,-0.3336,1,0
5,GO LIPOSACCHARIDE METABOLIC PROCESS,1.7309e-08,-0.24459,-0.3413,1,0
5,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,6.895e-08,-0.24461,-0.31039,1,0
5,GO NEUTRAL LIPID METABOLIC PROCESS,8.4871e-11,-0.24462,-0.33611,1,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,1.3174e-07,-0.24473,-0.29488,1,0
5,GO CELLULAR RESPONSE TO DSRNA,3.1729e-08,-0.24474,-0.37991,1,0
5,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,3.2146e-06,-0.24479,-0.29901,1,0
5,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,3.3435e-06,-0.24486,-0.30279,1,0
5,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,1.6782e-07,-0.24488,-0.28682,1,0
5,GO SEGMENT SPECIFICATION,0.0016575,-0.24493,-0.25472,1,0
5,GO TROPHECTODERMAL CELL DIFFERENTIATION,1.6158e-05,-0.2451,-0.24527,1,0
5,GO REGULATION OF T CELL MEDIATED IMMUNITY,2.3891e-06,-0.24515,-0.30274,1,0
5,GO APICAL PROTEIN LOCALIZATION,0.00021857,-0.24515,-0.30732,1,0
5,GO VIRAL LIFE CYCLE,1.4471e-09,-0.24521,-0.34914,1,0
5,GO REGULATION OF HISTONE METHYLATION,1.1086e-06,-0.24521,-0.3013,1,0
5,GO L AMINO ACID TRANSPORT,1.4471e-09,-0.24525,-0.37899,1,0
5,GO CELLULAR RESPONSE TO IONIZING RADIATION,3.9035e-08,-0.24526,-0.31703,1,0
5,GO REGULATION OF MICROTUBULE POLYMERIZATION,1.0169e-05,-0.24528,-0.34541,1,0
5,GO LIPID EXPORT FROM CELL,1.1535e-07,-0.2453,-0.30636,1,0
5,GO REGULATION OF T CELL APOPTOTIC PROCESS,6.8396e-06,-0.24535,-0.30253,1,0
5,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,7.479e-12,-0.24537,-0.39172,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,3.7282e-08,-0.24538,-0.36093,1,0
5,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,7.2497e-05,-0.24539,-0.27778,1,0
5,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,2.6914e-06,-0.24541,-0.25669,1,0
5,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.1026e-05,-0.24546,-0.33364,1,0
5,GO NOSE DEVELOPMENT,0.044722,-0.24556,-0.21856,1,0
5,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,1.2534e-06,-0.24559,-0.27959,1,0
5,GO RESPONSE TO TEMPERATURE STIMULUS,3.2764e-10,-0.2456,-0.33263,1,0
5,GO HEAT GENERATION,1.8793e-06,-0.2456,-0.24588,1,0
5,GO MULTICELLULAR ORGANISM GROWTH,5.3617e-10,-0.24561,-0.38678,1,0
5,GO VESICLE FUSION TO PLASMA MEMBRANE,0.00063314,-0.24561,-0.32563,1,0
5,GO POSITIVE REGULATION OF ANION TRANSPORT,6.1583e-08,-0.24573,-0.29894,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,2.538e-07,-0.24585,-0.29731,1,0
5,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,3.0156e-07,-0.24588,-0.32359,1,0
5,GO MAGNESIUM ION HOMEOSTASIS,1.2027e-05,-0.24597,-0.31933,1,0
5,GO CHRONIC INFLAMMATORY RESPONSE,0.00014362,-0.246,-0.30529,1,0
5,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,1.5383e-12,-0.24609,-0.36606,1,0
5,GO RESPONSE TO TUMOR NECROSIS FACTOR,7.5266e-09,-0.24619,-0.31336,1,0
5,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,7.6283e-05,-0.24627,-0.30405,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,2.6581e-10,-0.24627,-0.33164,1,0
5,GO NEUTROPHIL CHEMOTAXIS,2.0879e-07,-0.24661,-0.28639,1,0
5,GO UV DAMAGE EXCISION REPAIR,3.2859e-07,-0.24663,-0.30259,1,0
5,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.00026024,-0.24664,-0.34115,1,0
5,GO ORGANELLE FUSION,9.7991e-09,-0.24672,-0.36205,1,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,3.9102e-06,-0.24683,-0.29328,1,0
5,GO REGULATION OF GLIAL CELL DIFFERENTIATION,1.4207e-05,-0.24684,-0.26855,1,0
5,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.0019023,-0.24688,-0.25248,1,0
5,GO RESPONSE TO COPPER ION,0.0020929,-0.24693,-0.27749,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,9.404e-07,-0.24701,-0.33436,1,0
5,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,9.1996e-11,-0.24703,-0.34111,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,1.0792e-11,-0.24704,-0.37724,1,0
5,GO PROTEIN DEPOLYMERIZATION,7.5266e-09,-0.24706,-0.39468,1,0
5,GO NAD BIOSYNTHETIC PROCESS,1.9749e-05,-0.24706,-0.30776,1,0
5,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,1.0279e-08,-0.24708,-0.3609,1,0
5,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.0025617,-0.24708,-0.2393,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION,1.2074e-11,-0.24715,-0.35113,1,0
5,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,1.0557e-05,-0.24722,-0.35392,1,0
5,GO EPIDERMIS DEVELOPMENT,1.6782e-07,-0.24724,-0.32547,1,0
5,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,1.0557e-05,-0.24739,-0.34542,1,0
5,GO CELL PROJECTION ASSEMBLY,3.9309e-10,-0.2474,-0.3563,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,1.0791e-07,-0.24765,-0.28443,1,0
5,GO SYNAPTIC VESICLE EXOCYTOSIS,7.105e-06,-0.24773,-0.34074,1,0
5,GO TUMOR NECROSIS FACTOR SECRETION,5.77e-09,-0.24791,-0.31873,1,0
5,GO MUSCLE CELL DIFFERENTIATION,1.0202e-11,-0.24794,-0.38831,1,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,1.5576e-05,-0.24796,-0.24985,1,0
5,GO CELLULAR SENESCENCE,6.8348e-09,-0.24799,-0.30812,1,0
5,GO REGIONALIZATION,5.1101e-09,-0.24803,-0.33844,1,0
5,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,2.3274e-07,-0.24808,-0.36326,1,0
5,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,1.3351e-08,-0.24809,-0.277,1,0
5,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0042636,-0.24815,-0.26728,1,0
5,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0011021,-0.24815,-0.29444,1,0
5,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,7.3739e-05,-0.24819,-0.35272,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,1.4112e-09,-0.24829,-0.34835,1,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0057669,-0.2483,-0.26226,1,0
5,GO REPRODUCTIVE BEHAVIOR,1.5037e-07,-0.24839,-0.33211,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,0.00061456,-0.24839,-0.24487,1,0
5,GO REGULATION OF MUSCLE SYSTEM PROCESS,2.1678e-11,-0.24849,-0.38032,1,0
5,GO NEURAL NUCLEUS DEVELOPMENT,3.2146e-06,-0.24851,-0.32138,1,0
5,GO RESPONSE TO TOXIC SUBSTANCE,2.3268e-09,-0.24863,-0.27887,1,0
5,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,2.1678e-11,-0.24876,-0.39787,1,0
5,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,5.8856e-08,-0.24877,-0.30543,1,0
5,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,7.7166e-08,-0.24878,-0.29795,1,0
5,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,2.634e-09,-0.24878,-0.32196,1,0
5,GO CARBOHYDRATE METABOLIC PROCESS,2.7041e-11,-0.24881,-0.34773,1,0
5,GO POSITIVE REGULATION OF T CELL PROLIFERATION,4.5233e-07,-0.24893,-0.32495,1,0
5,GO ICOSANOID METABOLIC PROCESS,1.3468e-07,-0.24923,-0.30176,1,0
5,GO CYTOSKELETON ORGANIZATION,3.7602e-11,-0.24927,-0.38263,1,0
5,GO HISTONE H3 K9 MODIFICATION,6.9711e-06,-0.24937,-0.31573,1,0
5,GO PROTEIN MATURATION,3.1098e-10,-0.24952,-0.32129,1,0
5,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,1.7385e-05,-0.24954,-0.33763,1,0
5,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,6.757e-10,-0.24962,-0.3561,1,0
5,GO RESPONSE TO INTERLEUKIN 7,3.4003e-08,-0.24967,-0.341,1,0
5,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0024609,-0.24985,-0.2727,1,0
5,GO NEGATIVE REGULATION OF DNA BINDING,3.152e-06,-0.24986,-0.2712,1,0
5,GO ISOPRENOID METABOLIC PROCESS,2.7668e-07,-0.24987,-0.27174,1,0
5,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,3.1729e-08,-0.25012,-0.35255,1,0
5,GO REGULATION OF RIBOSOME BIOGENESIS,1.4472e-05,-0.25027,-0.33229,1,0
5,GO ORGANIC ACID BIOSYNTHETIC PROCESS,4.8076e-11,-0.25036,-0.32354,1,0
5,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,2.188e-08,-0.25045,-0.30176,1,0
5,GO RESPONSE TO UV,1.6907e-08,-0.25052,-0.31476,1,0
5,GO ION HOMEOSTASIS,4.7449e-12,-0.2506,-0.33963,1,0
5,GO CHEMICAL HOMEOSTASIS,3.0856e-12,-0.25063,-0.34354,1,0
5,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,7.2702e-12,-0.25063,-0.35864,1,0
5,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,7.479e-12,-0.25074,-0.39046,1,0
5,GO ANATOMICAL STRUCTURE MATURATION,3.5427e-10,-0.25077,-0.33749,1,0
5,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,6.3088e-12,-0.25081,-0.39255,1,0
5,GO REGULATION OF REGULATED SECRETORY PATHWAY,3.9941e-08,-0.25082,-0.36174,1,0
5,GO NADH METABOLIC PROCESS,5.1446e-05,-0.25087,-0.31341,1,0
5,GO ECTODERMAL PLACODE DEVELOPMENT,0.00063314,-0.25091,-0.28449,1,0
5,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,1.2253e-05,-0.25097,-0.32592,1,0
5,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,1.8701e-05,-0.25099,-0.22931,1,0
5,GO UNSATURATED FATTY ACID METABOLIC PROCESS,3.1004e-08,-0.25102,-0.31399,1,0
5,GO CALCIUM MEDIATED SIGNALING,5.815e-11,-0.25115,-0.30434,1,0
5,GO CELLULAR ION HOMEOSTASIS,8.6145e-12,-0.25124,-0.32793,1,0
5,GO NEUTROPHIL MIGRATION,8.8282e-08,-0.25131,-0.29571,1,0
5,GO REGULATION OF NEURON MATURATION,1.0958e-05,-0.25132,-0.35517,1,0
5,GO FATTY ACYL COA METABOLIC PROCESS,6.2175e-05,-0.25139,-0.29088,1,0
5,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.00012388,-0.25141,-0.32451,1,0
5,GO REGULATION OF AMINO ACID TRANSPORT,3.5646e-05,-0.25143,-0.29725,1,0
5,GO REGULATION OF CELL CYCLE ARREST,1.4454e-06,-0.25144,-0.26863,1,0
5,GO LIPOPROTEIN CATABOLIC PROCESS,0.00015083,-0.2516,-0.28541,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,6.2046e-07,-0.25169,-0.37843,1,0
5,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,4.1948e-11,-0.25171,-0.36213,1,0
5,GO PROGESTERONE METABOLIC PROCESS,0.016205,-0.25175,-0.26469,1,0
5,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,5.0323e-06,-0.25178,-0.34336,1,0
5,GO T CELL SELECTION,7.105e-06,-0.25183,-0.25327,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,1.7309e-08,-0.25203,-0.32911,1,0
5,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,2.559e-11,-0.25214,-0.36509,1,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,1.2023e-10,-0.25222,-0.32929,1,0
5,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,4.1026e-05,-0.25228,-0.33875,1,0
5,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.5386e-08,-0.2523,-0.33846,1,0
5,GO CORNIFICATION,0.026561,-0.25233,-0.17986,1,0
5,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,8.3066e-07,-0.25234,-0.33694,1,0
5,GO POSITIVE REGULATION OF CATABOLIC PROCESS,1.6307e-12,-0.25237,-0.39861,1,0
5,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,1.2131e-09,-0.25239,-0.33273,1,0
5,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,2.0509e-11,-0.25247,-0.35384,1,0
5,GO NEPHRON TUBULE FORMATION,0.017894,-0.25249,-0.16642,1,0
5,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.007921,-0.25251,-0.36555,1,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.1034e-07,-0.25251,-0.33316,1,0
5,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,0.00010323,-0.25253,-0.30268,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.9014e-08,-0.25263,-0.32116,1,0
5,GO LIPID BIOSYNTHETIC PROCESS,5.815e-11,-0.25264,-0.33601,1,0
5,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.002702,-0.25272,-0.28571,1,0
5,GO GLYCEROL ETHER METABOLIC PROCESS,4.0657e-06,-0.2528,-0.29989,1,0
5,GO NEGATIVE REGULATION OF TRANSPORT,4.7449e-12,-0.25283,-0.33197,1,0
5,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.3085e-09,-0.25284,-0.36422,1,0
5,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,1.5713e-07,-0.25293,-0.32648,1,0
5,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00010673,-0.25298,-0.35511,1,0
5,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,5.3747e-08,-0.25302,-0.29056,1,0
5,GO HISTONE H3 K9 METHYLATION,7.7586e-05,-0.25315,-0.31881,1,0
5,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,8.0712e-08,-0.25319,-0.37798,1,0
5,GO INDOLALKYLAMINE METABOLIC PROCESS,0.00053704,-0.25321,-0.2292,1,0
5,GO CELLULAR HORMONE METABOLIC PROCESS,1.1086e-06,-0.25325,-0.26157,1,0
5,GO MUSCLE FIBER DEVELOPMENT,1.5217e-09,-0.25331,-0.34704,1,0
5,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,4.4807e-06,-0.25331,-0.31098,1,0
5,GO MALE SEX DETERMINATION,5.1446e-05,-0.25335,-0.27116,1,0
5,GO AMINO ACID TRANSMEMBRANE TRANSPORT,5.1101e-09,-0.25336,-0.3591,1,0
5,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,7.8124e-06,-0.25354,-0.29255,1,0
5,GO FOREBRAIN DEVELOPMENT,1.2604e-07,-0.25358,-0.33817,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.00029052,-0.25359,-0.26592,1,0
5,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,6.6774e-12,-0.25369,-0.35805,1,0
5,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,7.4177e-11,-0.254,-0.34222,1,0
5,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,2.5164e-08,-0.25403,-0.33998,1,0
5,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,5.5016e-10,-0.25405,-0.37221,1,0
5,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,8.0424e-11,-0.25408,-0.3331,1,0
5,GO TRIGLYCERIDE METABOLIC PROCESS,1.2759e-09,-0.25411,-0.3093,1,0
5,GO THYMUS DEVELOPMENT,1.1282e-07,-0.25414,-0.31155,1,0
5,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,1.2954e-05,-0.25415,-0.2572,1,0
5,GO RESPONSE TO INSULIN,2.8299e-12,-0.25417,-0.39213,1,0
5,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,4.4749e-10,-0.25427,-0.36952,1,0
5,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.00064263,-0.25428,-0.25587,1,0
5,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,3.9717e-11,-0.25431,-0.38608,1,0
5,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,7.2129e-08,-0.25447,-0.34599,1,0
5,GO RESPONSE TO UV B,1.9044e-05,-0.2545,-0.34113,1,0
5,GO CELL GROWTH,1.0493e-11,-0.25468,-0.40664,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,1.7385e-05,-0.25471,-0.32011,1,0
5,GO BILE ACID METABOLIC PROCESS,5.5864e-07,-0.25474,-0.30468,1,0
5,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,2.7797e-11,-0.25474,-0.35876,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,3.3806e-05,-0.2548,-0.23409,1,0
5,GO GRANULOCYTE MIGRATION,1.9014e-08,-0.2548,-0.32187,1,0
5,GO PROTEIN K63 LINKED UBIQUITINATION,7.8778e-10,-0.25482,-0.32609,1,0
5,GO REGULATION OF PRESYNAPSE ORGANIZATION,2.6828e-05,-0.25482,-0.34391,1,0
5,GO POSITIVE REGULATION OF TOR SIGNALING,5.793e-12,-0.25494,-0.37144,1,0
5,GO ERYTHROCYTE MATURATION,1.3468e-07,-0.25496,-0.38076,1,0
5,GO SPECIFICATION OF SYMMETRY,1.2759e-09,-0.25507,-0.33249,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,2.7614e-08,-0.25522,-0.31584,1,0
5,GO MITOCHONDRIAL DEPOLARIZATION,5.2303e-06,-0.25523,-0.32801,1,0
5,GO IRON ION TRANSPORT,4.3606e-10,-0.25529,-0.30905,1,0
5,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,6.2169e-06,-0.25532,-0.2703,1,0
5,GO POSITIVE REGULATION OF BLOOD PRESSURE,6.4434e-08,-0.25535,-0.29047,1,0
5,GO POSITIVE REGULATION OF CELL GROWTH,3.7319e-10,-0.25537,-0.36952,1,0
5,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.2434e-08,-0.25554,-0.34245,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,7.2497e-05,-0.25554,-0.33353,1,0
5,GO REGULATION OF NECROTIC CELL DEATH,9.7998e-07,-0.25565,-0.33578,1,0
5,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,1.0036e-08,-0.2557,-0.28232,1,0
5,GO RESPONSE TO MONOSACCHARIDE,5.5078e-11,-0.2557,-0.37334,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,1.9749e-05,-0.25583,-0.31305,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,5.3186e-12,-0.25589,-0.39711,1,0
5,GO RRNA CATABOLIC PROCESS,6.545e-05,-0.2559,-0.26449,1,0
5,GO STRIATED MUSCLE CELL DIFFERENTIATION,4.6784e-11,-0.25597,-0.38464,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,1.8353e-11,-0.25602,-0.35756,1,0
5,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,1.734e-06,-0.25616,-0.26644,1,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,3.152e-06,-0.2562,-0.3226,1,0
5,GO FATTY ACID BIOSYNTHETIC PROCESS,3.1098e-10,-0.25623,-0.32866,1,0
5,GO HISTONE H3 DEACETYLATION,3.0295e-08,-0.25624,-0.35126,1,0
5,GO INTERLEUKIN 2 PRODUCTION,3.5412e-09,-0.25625,-0.34232,1,0
5,GO POSITIVE REGULATION OF HEAT GENERATION,9.03e-05,-0.25626,-0.26289,1,0
5,GO POSITIVE REGULATION OF PROTEIN IMPORT,2.8925e-08,-0.25635,-0.37551,1,0
5,GO REGULATION OF GLUCOSE IMPORT,2.8369e-09,-0.25641,-0.34957,1,0
5,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0024281,-0.25661,-0.33277,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,7.6937e-12,-0.25664,-0.38092,1,0
5,GO MAGNESIUM ION TRANSPORT,8.3013e-05,-0.25679,-0.31535,1,0
5,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.0017277,-0.2568,-0.2251,1,0
5,GO NEUROTRANSMITTER TRANSPORT,4.6578e-06,-0.25719,-0.32645,1,0
5,GO CELLULAR RESPONSE TO HORMONE STIMULUS,1.7797e-12,-0.25723,-0.39693,1,0
5,GO ACTIN CROSSLINK FORMATION,4.6202e-07,-0.25726,-0.42858,1,0
5,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,8.9047e-09,-0.25737,-0.33118,1,0
5,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,4.5922e-10,-0.25744,-0.34941,1,0
5,GO INTERACTION WITH HOST,6.8406e-11,-0.25754,-0.39011,1,0
5,GO RESPONSE TO CARBOHYDRATE,1.2074e-11,-0.25769,-0.38361,1,0
5,GO REGULATION OF VESICLE MEDIATED TRANSPORT,2.9979e-12,-0.2577,-0.40431,1,0
5,GO RESPONSE TO DSRNA,2.8262e-08,-0.25771,-0.34305,1,0
5,GO REGULATION OF PROTEOLYSIS,1.5968e-11,-0.25778,-0.35974,1,0
5,GO CELL FATE DETERMINATION,1.8032e-05,-0.25793,-0.30907,1,0
5,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,4.4285e-07,-0.25795,-0.31438,1,0
5,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,8.6579e-07,-0.25797,-0.3252,1,0
5,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,2.7614e-08,-0.258,-0.3319,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.00076726,-0.25802,-0.33255,1,0
5,GO ETHANOL OXIDATION,0.00042777,-0.25805,-0.37103,1,0
5,GO RESPONSE TO STARVATION,4.3606e-10,-0.2581,-0.36513,1,0
5,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,2.2912e-11,-0.25818,-0.3542,1,0
5,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,2.634e-09,-0.2582,-0.30293,1,0
5,GO REGULATION OF CALCIUM MEDIATED SIGNALING,7.2202e-11,-0.25824,-0.32529,1,0
5,GO MESODERMAL CELL DIFFERENTIATION,9.3415e-09,-0.25825,-0.37501,1,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,7.1726e-09,-0.25828,-0.37963,1,0
5,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,2.2707e-10,-0.25828,-0.37379,1,0
5,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,5.2359e-09,-0.25828,-0.34241,1,0
5,GO RESPONSE TO CADMIUM ION,0.00019857,-0.2583,-0.27005,1,0
5,GO REGULATION OF CELL DEATH,6.1321e-12,-0.25839,-0.34979,1,0
5,GO PROSTANOID METABOLIC PROCESS,1.4472e-05,-0.25851,-0.30997,1,0
5,GO RESPONSE TO MANGANESE ION,1.2328e-07,-0.25859,-0.3385,1,0
5,GO CATION TRANSMEMBRANE TRANSPORT,2.7797e-11,-0.25866,-0.34769,1,0
5,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00159,-0.25875,-0.27583,1,0
5,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,9.8716e-08,-0.25905,-0.37969,1,0
5,GO REGULATION OF STEM CELL PROLIFERATION,1.7534e-07,-0.25907,-0.34067,1,0
5,GO REGULATION OF CELL DIVISION,3.3228e-08,-0.25913,-0.31922,1,0
5,GO SULFUR AMINO ACID CATABOLIC PROCESS,3.9613e-05,-0.25918,-0.26685,1,0
5,GO ACID SECRETION,7.333e-07,-0.25922,-0.24737,1,0
5,GO EXPLORATION BEHAVIOR,2.2824e-05,-0.25931,-0.3388,1,0
5,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,3.152e-06,-0.25942,-0.33566,1,0
5,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,2.0853e-05,-0.25945,-0.33213,1,0
5,GO RESPONSE TO LEPTIN,3.6162e-06,-0.25961,-0.32105,1,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,2.538e-07,-0.25962,-0.27465,1,0
5,GO HEXOSE CATABOLIC PROCESS,2.8001e-06,-0.25962,-0.32562,1,0
5,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,2.1621e-05,-0.25964,-0.33046,1,0
5,GO CELL DIFFERENTIATION IN HINDBRAIN,0.00029976,-0.2597,-0.27531,1,0
5,GO PROSTAGLANDIN SECRETION,2.1196e-06,-0.25972,-0.28534,1,0
5,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.00011986,-0.25976,-0.28145,1,0
5,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,7.2702e-12,-0.25993,-0.38183,1,0
5,GO INHIBITORY POSTSYNAPTIC POTENTIAL,0.001704,-0.25998,-0.31097,1,0
5,GO CHEMOSENSORY BEHAVIOR,7.0522e-08,-0.26,-0.27349,1,0
5,GO STEROID METABOLIC PROCESS,4.8673e-09,-0.26003,-0.31382,1,0
5,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,1.5838e-12,-0.2601,-0.37849,1,0
5,GO RESPONSE TO ORGANOPHOSPHORUS,9.9705e-11,-0.26011,-0.34312,1,0
5,GO AMINE CATABOLIC PROCESS,3.2162e-07,-0.26018,-0.33112,1,0
5,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,1.2032e-06,-0.26022,-0.28589,1,0
5,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,2.4491e-12,-0.26028,-0.3892,1,0
5,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,3.4634e-11,-0.26031,-0.42678,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.2482e-05,-0.26033,-0.3171,1,0
5,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,1.1282e-07,-0.26041,-0.28276,1,0
5,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,3.6361e-10,-0.26051,-0.32475,1,0
5,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,4.4812e-12,-0.26063,-0.35891,1,0
5,GO APOPTOTIC SIGNALING PATHWAY,6.8406e-11,-0.26067,-0.33841,1,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,2.6352e-05,-0.26073,-0.32753,1,0
5,GO GLUCOSE IMPORT,2.0437e-10,-0.26074,-0.36412,1,0
5,GO DIVALENT INORGANIC CATION TRANSPORT,8.1414e-12,-0.26075,-0.35998,1,0
5,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,4.3549e-12,-0.26084,-0.36801,1,0
5,GO REGULATION OF MEMBRANE POTENTIAL,4.5822e-08,-0.26085,-0.33883,1,0
5,GO REGULATION OF PEPTIDE SECRETION,1.6109e-10,-0.26089,-0.34624,1,0
5,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.4454e-06,-0.26096,-0.32246,1,0
5,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,7.0671e-12,-0.26101,-0.38598,1,0
5,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,2.8753e-10,-0.26105,-0.3814,1,0
5,GO DEVELOPMENTAL MATURATION,1.1533e-09,-0.26108,-0.35461,1,0
5,GO LYMPHOCYTE APOPTOTIC PROCESS,2.5756e-08,-0.26109,-0.32411,1,0
5,GO REGULATION OF T HELPER CELL DIFFERENTIATION,1.0322e-07,-0.26109,-0.3741,1,0
5,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,2.8001e-06,-0.26121,-0.29642,1,0
5,GO TERPENOID METABOLIC PROCESS,1.4076e-07,-0.26124,-0.29687,1,0
5,GO REGULATION OF ACTIN NUCLEATION,5.1351e-07,-0.26133,-0.32459,1,0
5,GO HORMONE MEDIATED SIGNALING PATHWAY,3.6586e-11,-0.26138,-0.36625,1,0
5,GO ACROSOME REACTION,4.31e-06,-0.26153,-0.32118,1,0
5,GO REGULATION OF LIPID TRANSPORT,9.9705e-11,-0.26153,-0.36077,1,0
5,GO RESPONSE TO METAL ION,7.1121e-10,-0.26154,-0.33569,1,0
5,GO GLUTAMATE SECRETION,4.1026e-05,-0.26155,-0.31415,1,0
5,GO SYNAPTIC VESICLE LOCALIZATION,3.8924e-05,-0.26164,-0.33156,1,0
5,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,2.4371e-06,-0.26174,-0.35719,1,0
5,GO PROTEIN K48 LINKED DEUBIQUITINATION,1.3039e-08,-0.2618,-0.36817,1,0
5,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,6.5837e-06,-0.26183,-0.2417,1,0
5,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,1.9948e-11,-0.26189,-0.38368,1,0
5,GO LIPID CATABOLIC PROCESS,7.0279e-11,-0.26193,-0.33924,1,0
5,GO POSITIVE REGULATION OF EXOCYTOSIS,6.0205e-08,-0.2621,-0.35497,1,0
5,GO RESPONSE TO OXIDATIVE STRESS,1.3888e-11,-0.26211,-0.35388,1,0
5,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.0020367,-0.26221,-0.31339,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,3.3435e-06,-0.26224,-0.31234,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION,3.247e-08,-0.26232,-0.33378,1,0
5,GO GLUCOSE CATABOLIC PROCESS,0.00020178,-0.26232,-0.32244,1,0
5,GO ALCOHOL METABOLIC PROCESS,1.2348e-10,-0.26242,-0.33663,1,0
5,GO V D J RECOMBINATION,0.014494,-0.26248,-0.19746,1,0
5,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,1.8142e-08,-0.26248,-0.32251,1,0
5,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,5.0323e-06,-0.2625,-0.25626,1,0
5,GO PLASMA MEMBRANE FUSION,3.758e-05,-0.26253,-0.3285,1,0
5,GO PIGMENTATION,2.3312e-10,-0.26255,-0.34973,1,0
5,GO NEGATIVE REGULATION OF ORGAN GROWTH,1.471e-07,-0.26255,-0.42592,1,0
5,GO ETHER METABOLIC PROCESS,3.5794e-07,-0.26265,-0.33501,1,0
5,GO ADULT HEART DEVELOPMENT,0.00032916,-0.26265,-0.30228,1,0
5,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,4.8359e-10,-0.26279,-0.34491,1,0
5,GO RESPONSE TO PEPTIDE HORMONE,1.5838e-12,-0.26282,-0.39078,1,0
5,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,0.00010852,-0.26285,-0.32895,1,0
5,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,3.6667e-12,-0.26293,-0.38883,1,0
5,GO TYPE B PANCREATIC CELL DEVELOPMENT,7.6657e-06,-0.26299,-0.36514,1,0
5,GO SECONDARY METABOLIC PROCESS,1.3442e-05,-0.26315,-0.26409,1,0
5,GO ACTIVATION OF MAPK ACTIVITY,9.9185e-12,-0.2632,-0.39533,1,0
5,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,9.9803e-06,-0.26333,-0.30552,1,0
5,GO SARCOMERE ORGANIZATION,1.4472e-05,-0.26334,-0.28048,1,0
5,GO NEURON RECOGNITION,3.2146e-06,-0.26339,-0.38515,1,0
5,GO REGULATION OF GLUCONEOGENESIS,1.1533e-09,-0.26349,-0.37309,1,0
5,GO MESONEPHRIC TUBULE MORPHOGENESIS,2.7614e-08,-0.26363,-0.35126,1,0
5,GO COGNITION,1.4471e-09,-0.26366,-0.35856,1,0
5,GO RESPONSE TO ENDOGENOUS STIMULUS,2.9127e-12,-0.26372,-0.38376,1,0
5,GO PROSTATE GLAND GROWTH,4.9694e-05,-0.26374,-0.31646,1,0
5,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,5.4701e-07,-0.26377,-0.34512,1,0
5,GO REGULATION OF ATP METABOLIC PROCESS,2.004e-09,-0.26389,-0.32795,1,0
5,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.00053704,-0.26391,-0.27529,1,0
5,GO RESPONSE TO EXTRACELLULAR STIMULUS,7.6205e-11,-0.2642,-0.34075,1,0
5,GO MONOSACCHARIDE METABOLIC PROCESS,4.4749e-10,-0.26424,-0.3464,1,0
5,GO EPITHELIUM DEVELOPMENT,2.2117e-10,-0.26424,-0.365,1,0
5,GO CELLULAR ALDEHYDE METABOLIC PROCESS,3.9872e-06,-0.26425,-0.28834,1,0
5,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,1.9993e-12,-0.26425,-0.37602,1,0
5,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,2.7676e-09,-0.26432,-0.36225,1,0
5,GO PALLIUM DEVELOPMENT,1.2534e-06,-0.26434,-0.31621,1,0
5,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,1.0958e-05,-0.26434,-0.24935,1,0
5,GO REGULATION OF MESONEPHROS DEVELOPMENT,3.8924e-05,-0.26461,-0.32885,1,0
5,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.0712e-08,-0.26465,-0.27293,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,8.8282e-08,-0.26467,-0.36867,1,0
5,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,8.1623e-05,-0.26474,-0.28124,1,0
5,GO CELLULAR LIPID METABOLIC PROCESS,1.2417e-11,-0.26476,-0.34138,1,0
5,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,1.3671e-08,-0.26476,-0.36458,1,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,4.4749e-10,-0.26482,-0.37411,1,0
5,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,2.2697e-09,-0.26488,-0.34601,1,0
5,GO POLYOL BIOSYNTHETIC PROCESS,4.7501e-09,-0.26492,-0.32928,1,0
5,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,3.8924e-05,-0.26503,-0.25019,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,3.0395e-05,-0.26508,-0.32703,1,0
5,GO REGULATION OF BINDING,5.9602e-12,-0.26509,-0.35922,1,0
5,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,6.3359e-07,-0.2651,-0.35751,1,0
5,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,4.9694e-05,-0.26519,-0.23391,1,0
5,GO ADAPTIVE THERMOGENESIS,4.9403e-11,-0.26523,-0.36491,1,0
5,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,3.8149e-08,-0.26527,-0.38704,1,0
5,GO TRICARBOXYLIC ACID METABOLIC PROCESS,5.5412e-06,-0.26529,-0.40153,1,0
5,GO METAL ION HOMEOSTASIS,8.8611e-12,-0.26535,-0.3388,1,0
5,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,1.0322e-07,-0.26546,-0.31299,1,0
5,GO ADULT LOCOMOTORY BEHAVIOR,2.8001e-06,-0.26546,-0.31433,1,0
5,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,1.1316e-06,-0.26553,-0.30599,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,2.7286e-10,-0.2656,-0.3473,1,0
5,GO MODULATION BY HOST OF VIRAL PROCESS,2.1064e-09,-0.26562,-0.35188,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,1.5372e-07,-0.26567,-0.32338,1,0
5,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,7.5451e-08,-0.2657,-0.35698,1,0
5,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,8.2543e-08,-0.26584,-0.33398,1,0
5,GO VESICLE TARGETING,6.0979e-10,-0.26587,-0.36288,1,0
5,GO REGULATION OF SYSTEM PROCESS,1.1415e-11,-0.2659,-0.3835,1,0
5,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,2.6828e-05,-0.26593,-0.3089,1,0
5,GO POSITIVE REGULATION OF SIGNALING,2.8299e-12,-0.26594,-0.36186,1,0
5,GO NEURAL TUBE PATTERNING,2.5756e-08,-0.26612,-0.34409,1,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,1.3351e-08,-0.26614,-0.31976,1,0
5,GO LIMBIC SYSTEM DEVELOPMENT,6.2046e-07,-0.26621,-0.32158,1,0
5,GO REGULATION OF CELL KILLING,2.856e-06,-0.26623,-0.31672,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,1.5037e-07,-0.26626,-0.34093,1,0
5,GO CERAMIDE METABOLIC PROCESS,1.6407e-09,-0.26633,-0.38012,1,0
5,GO MUSCLE STRUCTURE DEVELOPMENT,7.6937e-12,-0.26637,-0.39376,1,0
5,GO REGULATION OF PHOSPHATASE ACTIVITY,3.7319e-10,-0.26645,-0.36145,1,0
5,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,1.679e-12,-0.26646,-0.37198,1,0
5,GO RESPONSE TO L GLUTAMATE,0.001568,-0.26662,-0.26526,1,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,3.7602e-11,-0.26663,-0.35487,1,0
5,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,1.4487e-10,-0.26668,-0.39434,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,1.0519e-10,-0.26672,-0.35272,1,0
5,GO DEVELOPMENTAL INDUCTION,7.6446e-07,-0.26675,-0.31692,1,0
5,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,5.3617e-10,-0.2668,-0.39249,1,0
5,GO REGULATION OF AUTOPHAGY,5.9602e-12,-0.26695,-0.37325,1,0
5,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,1.0527e-08,-0.26696,-0.25876,1,0
5,GO REGULATION OF EXOCYTOSIS,3.9064e-09,-0.26697,-0.36855,1,0
5,GO RESPONSE TO PURINE CONTAINING COMPOUND,2.559e-11,-0.267,-0.3546,1,0
5,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,2.1624e-06,-0.26701,-0.29009,1,0
5,GO POSITIVE REGULATION OF TORC1 SIGNALING,2.0879e-07,-0.26702,-0.33017,1,0
5,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,1.7071e-05,-0.26706,-0.32812,1,0
5,GO MICROTUBULE DEPOLYMERIZATION,6.8396e-06,-0.26706,-0.35898,1,0
5,GO MEMBRANE ORGANIZATION,5.0237e-12,-0.26713,-0.37512,1,0
5,GO ORGANIC HYDROXY COMPOUND TRANSPORT,4.8359e-10,-0.26721,-0.35768,1,0
5,GO NEGATIVE REGULATION OF CELL DIVISION,0.00012594,-0.26728,-0.3125,1,0
5,GO LIPID METABOLIC PROCESS,7.6937e-12,-0.2673,-0.34611,1,0
5,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,2.3268e-09,-0.26733,-0.3359,1,0
5,GO NEURAL PRECURSOR CELL PROLIFERATION,2.2775e-07,-0.26739,-0.33959,1,0
5,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,1.3085e-09,-0.2674,-0.37052,1,0
5,GO RESPONSE TO PEPTIDE,9.6219e-13,-0.26752,-0.40214,1,0
5,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,2.9078e-09,-0.26764,-0.38251,1,0
5,GO RESPONSE TO NICOTINE,1.5865e-05,-0.26765,-0.27469,1,0
5,GO MANGANESE ION TRANSPORT,4.719e-07,-0.26773,-0.29096,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0017277,-0.26776,-0.27252,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,2.1234e-05,-0.26778,-0.27896,1,0
5,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,1.5753e-08,-0.26783,-0.38302,1,0
5,GO CELLULAR LIPID CATABOLIC PROCESS,1.8881e-10,-0.26788,-0.34144,1,0
5,GO CERAMIDE BIOSYNTHETIC PROCESS,3.2094e-09,-0.26796,-0.37759,1,0
5,GO REGULATION OF PROTEIN IMPORT,7.8778e-10,-0.26802,-0.37098,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.9078e-09,-0.26802,-0.32718,1,0
5,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,2.7041e-11,-0.26803,-0.36105,1,0
5,GO NEGATIVE REGULATION OF PROTEOLYSIS,5.3617e-10,-0.26805,-0.34291,1,0
5,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,5.4967e-09,-0.26809,-0.33462,1,0
5,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,2.8271e-07,-0.26809,-0.34233,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.8396e-06,-0.2681,-0.34168,1,0
5,GO FEAR RESPONSE,2.8925e-08,-0.26815,-0.30206,1,0
5,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,2.7e-09,-0.26821,-0.32147,1,0
5,GO PROTEIN PROCESSING,3.7319e-10,-0.26829,-0.3524,1,0
5,GO GROWTH,1.0792e-11,-0.2683,-0.38253,1,0
5,GO REGULATION OF NIK NF KAPPAB SIGNALING,1.1245e-09,-0.26836,-0.35937,1,0
5,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,4.8839e-05,-0.2684,-0.28549,1,0
5,GO MESODERM DEVELOPMENT,1.1706e-10,-0.26846,-0.34942,1,0
5,GO NEGATIVE REGULATION OF SIGNALING,2.2453e-12,-0.26868,-0.39114,1,0
5,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,2.4972e-05,-0.26869,-0.35649,1,0
5,GO AXIS SPECIFICATION,4.6881e-08,-0.2687,-0.30831,1,0
5,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,1.4741e-05,-0.2688,-0.27894,1,0
5,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,1.4487e-10,-0.26882,-0.36228,1,0
5,GO DEMETHYLATION,7.0522e-08,-0.26886,-0.3181,1,0
5,GO CIRCULATORY SYSTEM PROCESS,2.8299e-12,-0.26889,-0.39654,1,0
5,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,8.2864e-09,-0.26891,-0.3446,1,0
5,GO CARDIOBLAST DIFFERENTIATION,7.5001e-05,-0.26909,-0.32748,1,0
5,GO NUCLEOSIDE CATABOLIC PROCESS,0.00022565,-0.26913,-0.25335,1,0
5,GO OVARIAN FOLLICLE DEVELOPMENT,2.2775e-07,-0.26914,-0.31824,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,8.1138e-06,-0.26925,-0.35546,1,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,2.1595e-09,-0.26926,-0.33406,1,0
5,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,1.9387e-10,-0.26926,-0.38174,1,0
5,GO REGULATION OF MACROPHAGE MIGRATION,3.9941e-08,-0.26931,-0.32897,1,0
5,GO THIOESTER BIOSYNTHETIC PROCESS,1.9563e-06,-0.26935,-0.32947,1,0
5,GO EPITHELIAL CELL MATURATION,8.4262e-06,-0.26943,-0.29994,1,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,2.5884e-05,-0.26946,-0.34076,1,0
5,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,4.5526e-11,-0.26948,-0.35114,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,2.2286e-11,-0.26951,-0.37694,1,0
5,GO STEROL METABOLIC PROCESS,6.3569e-09,-0.26967,-0.33042,1,0
5,GO ALPHA BETA T CELL PROLIFERATION,2.9859e-05,-0.26983,-0.34138,1,0
5,GO RESPONSE TO INSECTICIDE,0.001955,-0.26983,-0.26692,1,0
5,GO SENSORY ORGAN DEVELOPMENT,3.6361e-10,-0.26984,-0.36984,1,0
5,GO ENERGY HOMEOSTASIS,8.2543e-08,-0.26985,-0.4004,1,0
5,GO FATTY ACID METABOLIC PROCESS,1.8389e-10,-0.27001,-0.3168,1,0
5,GO REGULATION OF CHROMATIN BINDING,3.2146e-06,-0.27019,-0.34469,1,0
5,GO REGULATION OF HYDROLASE ACTIVITY,8.1414e-12,-0.27022,-0.38157,1,0
5,GO POSITIVE REGULATION OF CHROMATIN BINDING,8.7502e-06,-0.27027,-0.34289,1,0
5,GO DORSAL SPINAL CORD DEVELOPMENT,0.00020835,-0.27029,-0.26825,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.8142e-08,-0.27036,-0.32715,1,0
5,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,9.7068e-11,-0.27046,-0.35341,1,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,9.6562e-05,-0.2705,-0.35918,1,0
5,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,8.4262e-06,-0.27055,-0.26542,1,0
5,GO REGULATION OF GROWTH,1.2074e-11,-0.27063,-0.3754,1,0
5,GO SECRETORY GRANULE ORGANIZATION,2.5934e-07,-0.27068,-0.3599,1,0
5,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,3.9613e-05,-0.27077,-0.30907,1,0
5,GO REGULATION OF EMBRYONIC DEVELOPMENT,2.3933e-10,-0.27084,-0.40258,1,0
5,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,3.8161e-07,-0.27091,-0.33784,1,0
5,GO MONOCYTE CHEMOTAXIS,1.2482e-05,-0.27097,-0.31225,1,0
5,GO CARBOHYDRATE DERIVATIVE TRANSPORT,4.0678e-07,-0.27102,-0.32134,1,0
5,GO POSITIVE REGULATION OF CELL KILLING,4.6359e-05,-0.27106,-0.30265,1,0
5,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,6.6717e-09,-0.27107,-0.33451,1,0
5,GO EMBRYO DEVELOPMENT,1.2074e-11,-0.2711,-0.37627,1,0
5,GO GRANULOCYTE CHEMOTAXIS,1.6129e-08,-0.27111,-0.3195,1,0
5,GO PROTEIN ACTIVATION CASCADE,6.5906e-08,-0.27129,-0.39877,1,0
5,GO SECRETORY GRANULE LOCALIZATION,0.00024819,-0.2713,-0.3941,1,0
5,GO PRIMARY ALCOHOL METABOLIC PROCESS,3.4003e-08,-0.27133,-0.30441,1,0
5,GO NEGATIVE REGULATION OF HORMONE SECRETION,6.0565e-09,-0.27134,-0.3191,1,0
5,GO ACROSOME ASSEMBLY,3.758e-05,-0.27135,-0.28847,1,0
5,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,5.2253e-10,-0.27136,-0.33025,1,0
5,GO CEREBELLAR CORTEX DEVELOPMENT,2.8305e-05,-0.27144,-0.30618,1,0
5,GO RESPONSE TO ISCHEMIA,3.7319e-10,-0.27152,-0.43106,1,0
5,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,4.1456e-06,-0.27162,-0.31125,1,0
5,GO LIPID OXIDATION,3.5427e-10,-0.2717,-0.33434,1,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,2.2958e-06,-0.27171,-0.29154,1,0
5,GO REGULATION OF RESPONSE TO TUMOR CELL,7.1819e-07,-0.27175,-0.33577,1,0
5,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.0322e-07,-0.27175,-0.36998,1,0
5,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.5038e-07,-0.27179,-0.31143,1,0
5,GO MITOCHONDRIAL GENOME MAINTENANCE,0.00058763,-0.27181,-0.26336,1,0
5,GO EMBRYONIC HEART TUBE DEVELOPMENT,1.1828e-09,-0.2719,-0.37564,1,0
5,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.00035024,-0.27191,-0.29764,1,0
5,GO MODULATION BY VIRUS OF HOST PROCESS,2.9805e-09,-0.27193,-0.35958,1,0
5,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,7.1274e-05,-0.27198,-0.28812,1,0
5,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,1.1099e-11,-0.27204,-0.33201,1,0
5,GO VESICLE DOCKING,5.4701e-07,-0.27212,-0.3602,1,0
5,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,7.2702e-12,-0.27233,-0.37552,1,0
5,GO POSITIVE REGULATION OF CELL DEVELOPMENT,5.2165e-11,-0.27237,-0.39682,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,4.4807e-06,-0.2724,-0.30902,1,0
5,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,7.4854e-10,-0.27247,-0.34341,1,0
5,GO REGULATION OF TRANSFERASE ACTIVITY,2.1812e-12,-0.27249,-0.37255,1,0
5,GO CARBOHYDRATE HOMEOSTASIS,2.5893e-10,-0.27255,-0.35164,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,2.5756e-08,-0.2726,-0.38065,1,0
5,GO INTERLEUKIN 4 PRODUCTION,5.5864e-07,-0.27267,-0.3009,1,0
5,GO NECROTIC CELL DEATH,3.8983e-07,-0.27268,-0.32039,1,0
5,GO RESPONSE TO ANTIBIOTIC,2.5066e-09,-0.27272,-0.31681,1,0
5,GO REGULATION OF SYMBIOTIC PROCESS,1.0791e-07,-0.27294,-0.33188,1,0
5,GO REGULATION OF PROTEIN TARGETING,1.6407e-09,-0.27295,-0.34199,1,0
5,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,7.2129e-08,-0.27296,-0.39617,1,0
5,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,8.0256e-05,-0.27301,-0.29269,1,0
5,GO PEPTIDYL SERINE MODIFICATION,5.1691e-12,-0.27312,-0.397,1,0
5,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,2.9805e-09,-0.27332,-0.45393,1,0
5,GO SYNAPTIC SIGNALING,7.892e-08,-0.27334,-0.34575,1,0
5,GO CELLULAR RESPONSE TO INSULIN STIMULUS,2.6711e-12,-0.27337,-0.39713,1,0
5,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,2.2707e-10,-0.2734,-0.36206,1,0
5,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,9.795e-06,-0.27345,-0.35152,1,0
5,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,4.3082e-09,-0.27351,-0.37565,1,0
5,GO REGULATION OF CELL PROJECTION ASSEMBLY,8.4871e-11,-0.27353,-0.39015,1,0
5,GO REGULATION OF PHOSPHORYLATION,1.6307e-12,-0.27353,-0.38271,1,0
5,GO EXOCYTIC PROCESS,3.152e-06,-0.27358,-0.33376,1,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,5.5078e-11,-0.27364,-0.37146,1,0
5,GO RESPONSE TO INORGANIC SUBSTANCE,6.4805e-11,-0.27366,-0.3379,1,0
5,GO SECOND MESSENGER MEDIATED SIGNALING,4.5526e-11,-0.27367,-0.33147,1,0
5,GO SEX DIFFERENTIATION,2.0437e-10,-0.27368,-0.33111,1,0
5,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,1.1478e-12,-0.27381,-0.37659,1,0
5,GO RESPONSE TO REDOX STATE,9.6562e-05,-0.27383,-0.31467,1,0
5,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,0.0013255,-0.27387,-0.24627,1,0
5,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,4.3082e-09,-0.27394,-0.34825,1,0
5,GO POSITIVE T CELL SELECTION,2.7312e-05,-0.27396,-0.25672,1,0
5,GO T HELPER 17 TYPE IMMUNE RESPONSE,6.5906e-08,-0.27404,-0.29194,1,0
5,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,8.6328e-08,-0.27415,-0.36346,1,0
5,GO RNA DESTABILIZATION,4.1552e-07,-0.27418,-0.36346,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,5.3747e-08,-0.27448,-0.32835,1,0
5,GO SKELETAL MUSCLE CELL DIFFERENTIATION,1.2733e-08,-0.27454,-0.32552,1,0
5,GO RESPONSE TO ETHANOL,1.5688e-10,-0.27455,-0.30672,1,0
5,GO REGULATION OF CELL DIFFERENTIATION,5.9602e-12,-0.27456,-0.39075,1,0
5,GO CELLULAR RESPONSE TO VIRUS,2.3784e-07,-0.27461,-0.31514,1,0
5,GO CYTOPLASM ORGANIZATION,1.2954e-05,-0.27464,-0.37206,1,0
5,GO HINDBRAIN MORPHOGENESIS,7.4873e-07,-0.27476,-0.3221,1,0
5,GO NUCLEOTIDE SALVAGE,8.8796e-05,-0.27478,-0.30351,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,8.5043e-10,-0.27478,-0.31902,1,0
5,GO BLOOD COAGULATION INTRINSIC PATHWAY,6.2046e-07,-0.27481,-0.29925,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.1307e-08,-0.2749,-0.38958,1,0
5,GO HEART DEVELOPMENT,1.1415e-11,-0.27501,-0.41597,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE,1.2534e-12,-0.27505,-0.40891,1,0
5,GO POST GOLGI VESICLE MEDIATED TRANSPORT,6.1389e-11,-0.27509,-0.40658,1,0
5,GO MEMBRANE LIPID METABOLIC PROCESS,1.4112e-09,-0.27511,-0.35063,1,0
5,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,1.0094e-07,-0.27513,-0.33123,1,0
5,GO LOCOMOTORY BEHAVIOR,2.6981e-08,-0.27518,-0.37032,1,0
5,GO LABYRINTHINE LAYER DEVELOPMENT,1.1086e-06,-0.2753,-0.37517,1,0
5,GO ACUTE PHASE RESPONSE,2.2286e-07,-0.27532,-0.28367,1,0
5,GO PROTEIN KINASE A SIGNALING,5.6451e-10,-0.27533,-0.34602,1,0
5,GO TELENCEPHALON DEVELOPMENT,1.2886e-07,-0.27534,-0.33825,1,0
5,GO MUSCLE FILAMENT SLIDING,1.6321e-06,-0.27535,-0.26875,1,0
5,GO CELLULAR IRON ION HOMEOSTASIS,5.5016e-10,-0.27537,-0.31091,1,0
5,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,1.1706e-10,-0.27541,-0.36689,1,0
5,GO RESPONSE TO MINERALOCORTICOID,1.1535e-07,-0.27541,-0.31625,1,0
5,GO SUCKLING BEHAVIOR,0.0016806,-0.27543,-0.30831,1,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,1.3599e-06,-0.27552,-0.3995,1,0
5,GO SODIUM ION TRANSPORT,1.9546e-09,-0.27554,-0.33371,1,0
5,GO T CELL MEDIATED IMMUNITY,7.8052e-07,-0.27564,-0.33955,1,0
5,GO REGULATION OF PEPTIDASE ACTIVITY,6.586e-10,-0.27568,-0.36959,1,0
5,GO ESTABLISHMENT OF SPINDLE ORIENTATION,3.2631e-05,-0.27572,-0.28888,1,0
5,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,2.521e-12,-0.27581,-0.38236,1,0
5,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,9.6431e-12,-0.27587,-0.36955,1,0
5,GO MODULATION BY SYMBIONT OF HOST PROCESS,2.2117e-10,-0.27592,-0.3721,1,0
5,GO ICOSANOID BIOSYNTHETIC PROCESS,1.4076e-07,-0.27599,-0.33597,1,0
5,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,5.6245e-08,-0.27603,-0.42231,1,0
5,GO TYPE I INTERFERON PRODUCTION,4.7963e-08,-0.27608,-0.36622,1,0
5,GO GLYCEROLIPID METABOLIC PROCESS,4.7449e-12,-0.27612,-0.35427,1,0
5,GO SPINDLE LOCALIZATION,3.0302e-06,-0.27613,-0.31775,1,0
5,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,4.3774e-08,-0.27616,-0.33483,1,0
5,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,7.5001e-05,-0.27626,-0.31341,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,9.819e-05,-0.2763,-0.31966,1,0
5,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,1.3693e-05,-0.27633,-0.32115,1,0
5,GO MRNA TRANSCRIPTION,4.1751e-05,-0.27639,-0.35573,1,0
5,GO RESPONSE TO X RAY,1.7922e-07,-0.27649,-0.34064,1,0
5,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,5.0323e-06,-0.27655,-0.3196,1,0
5,GO EXTRACELLULAR VESICLE BIOGENESIS,1.4076e-07,-0.27664,-0.34038,1,0
5,GO RESPONSE TO PEPTIDOGLYCAN,2.6362e-08,-0.27668,-0.31889,1,0
5,GO CELLULAR RESPONSE TO CHEMICAL STRESS,2.7797e-11,-0.27675,-0.35733,1,0
5,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,6.3088e-12,-0.27678,-0.40269,1,0
5,GO REGULATION OF RESPONSE TO STRESS,1.0493e-11,-0.27692,-0.3481,1,0
5,GO MAINTENANCE OF LOCATION,3.6667e-12,-0.27696,-0.36789,1,0
5,GO DIVALENT INORGANIC CATION HOMEOSTASIS,1.642e-11,-0.27701,-0.33492,1,0
5,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,1.2682e-10,-0.27707,-0.36891,1,0
5,GO ACTIVATED T CELL PROLIFERATION,6.4434e-08,-0.27712,-0.33674,1,0
5,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,2.4528e-05,-0.27715,-0.30804,1,0
5,GO REGULATION OF CHROMATIN ASSEMBLY,1.2733e-08,-0.27715,-0.35957,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,2.2926e-08,-0.27722,-0.35783,1,0
5,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,3.2162e-07,-0.27749,-0.32546,1,0
5,GO CATECHOLAMINE UPTAKE,0.00010323,-0.27751,-0.29334,1,0
5,GO G2 DNA DAMAGE CHECKPOINT,8.6579e-07,-0.27754,-0.32884,1,0
5,GO SKIN DEVELOPMENT,1.2328e-07,-0.27763,-0.34733,1,0
5,GO RESPONSE TO HORMONE,1.8323e-12,-0.27764,-0.38897,1,0
5,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,4.4812e-12,-0.27768,-0.34861,1,0
5,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,6.337e-06,-0.27772,-0.32885,1,0
5,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.00019857,-0.27774,-0.28254,1,0
5,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,7.9617e-06,-0.27776,-0.3117,1,0
5,GO HYPOTHALAMUS DEVELOPMENT,5.0323e-06,-0.27785,-0.33839,1,0
5,GO BEHAVIOR,1.6001e-09,-0.2779,-0.3591,1,0
5,GO REGULATION OF MACROPHAGE CHEMOTAXIS,1.5713e-07,-0.27806,-0.3156,1,0
5,GO TEMPERATURE HOMEOSTASIS,5.6594e-11,-0.27808,-0.36433,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,5.1351e-07,-0.27814,-0.32573,1,0
5,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,1.8142e-08,-0.27814,-0.3957,1,0
5,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.00013451,-0.27819,-0.24648,1,0
5,GO HIPPOCAMPUS DEVELOPMENT,1.9044e-05,-0.27824,-0.28857,1,0
5,GO TUBE FORMATION,4.249e-10,-0.2783,-0.38018,1,0
5,GO HEART GROWTH,3.1896e-11,-0.27833,-0.41833,1,0
5,GO REGULATION OF NEUTROPHIL MIGRATION,7.8124e-06,-0.27839,-0.32745,1,0
5,GO POLYSACCHARIDE METABOLIC PROCESS,3.2785e-11,-0.27854,-0.39137,1,0
5,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.00031907,-0.27855,-0.28855,1,0
5,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,9.404e-07,-0.27855,-0.31907,1,0
5,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,5.3617e-10,-0.27863,-0.32829,1,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00026024,-0.27866,-0.29112,1,0
5,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.0001803,-0.27871,-0.29333,1,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0020367,-0.27877,-0.26094,1,0
5,GO CELL KILLING,1.0861e-06,-0.27878,-0.28494,1,0
5,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,1.7534e-07,-0.27879,-0.33053,1,0
5,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,9.7068e-11,-0.27884,-0.35644,1,0
5,GO L SERINE METABOLIC PROCESS,0.0051547,-0.27888,-0.2421,1,0
5,GO MYOTUBE DIFFERENTIATION,4.6784e-11,-0.27891,-0.40047,1,0
5,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.6001e-09,-0.27899,-0.34003,1,0
5,GO ENDOCYTOSIS,1.3291e-12,-0.279,-0.4208,1,0
5,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.5838e-12,-0.27907,-0.3916,1,0
5,GO INSULIN RECEPTOR SIGNALING PATHWAY,2.0509e-11,-0.2791,-0.40587,1,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,7.8778e-10,-0.27919,-0.35645,1,0
5,GO REGULATION OF DEFENSE RESPONSE,3.5427e-10,-0.27926,-0.33173,1,0
5,GO EXTRACELLULAR TRANSPORT,2.2505e-06,-0.27927,-0.31123,1,0
5,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,5.5016e-10,-0.27937,-0.39365,1,0
5,GO SOMITE DEVELOPMENT,1.8723e-07,-0.27939,-0.325,1,0
5,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,2.9515e-10,-0.27944,-0.32888,1,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,1.1316e-06,-0.2795,-0.3905,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,2.0478e-05,-0.27962,-0.27631,1,0
5,GO PANCREATIC JUICE SECRETION,5.8856e-08,-0.27967,-0.32675,1,0
5,GO MAINTENANCE OF LOCATION IN CELL,1.5102e-11,-0.27977,-0.35761,1,0
5,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,8.4262e-06,-0.27999,-0.28644,1,0
5,GO BILE ACID AND BILE SALT TRANSPORT,0.00015331,-0.28,-0.32315,1,0
5,GO MUSCLE CELL DEVELOPMENT,8.4871e-11,-0.28001,-0.38206,1,0
5,GO CYTOKINE METABOLIC PROCESS,2.8753e-10,-0.28009,-0.38607,1,0
5,GO EXOCYTOSIS,1.736e-11,-0.2801,-0.37875,1,0
5,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,0.00076726,-0.2802,-0.3132,1,0
5,GO CALCIUM ION IMPORT,1.2131e-09,-0.28022,-0.36726,1,0
5,GO POSITIVE REGULATION OF PEPTIDE SECRETION,2.4452e-09,-0.28026,-0.32789,1,0
5,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00053704,-0.28029,-0.37238,1,0
5,GO ORGANOPHOSPHATE ESTER TRANSPORT,3.1098e-10,-0.28035,-0.3773,1,0
5,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,3.9963e-12,-0.28036,-0.39938,1,0
5,GO NEGATIVE REGULATION OF B CELL ACTIVATION,7.333e-07,-0.2805,-0.32901,1,0
5,GO SYNAPTIC VESICLE MATURATION,0.00057029,-0.28054,-0.36887,1,0
5,GO COPPER ION TRANSPORT,2.4305e-07,-0.28061,-0.31388,1,0
5,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.0047198,-0.28062,-0.26283,1,0
5,GO REGULATION OF HEAT GENERATION,2.0478e-05,-0.28069,-0.2718,1,0
5,GO MYOTUBE CELL DEVELOPMENT,2.65e-07,-0.2808,-0.29661,1,0
5,GO REGULATION OF CELL PROJECTION SIZE,0.00016098,-0.28082,-0.29546,1,0
5,GO EPITHELIAL TUBE FORMATION,1.7687e-09,-0.28085,-0.37058,1,0
5,GO REGULATION OF LYMPHOCYTE ACTIVATION,1.0241e-10,-0.28094,-0.36743,1,0
5,GO SYNAPTIC TRANSMISSION GABAERGIC,2.3853e-09,-0.28097,-0.34838,1,0
5,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,8.4877e-09,-0.28099,-0.28911,1,0
5,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.1282e-07,-0.28102,-0.3355,1,0
5,GO RESPONSE TO CORTICOSTERONE,6.2169e-06,-0.28105,-0.33039,1,0
5,GO T CELL CHEMOTAXIS,3.1004e-08,-0.28123,-0.31435,1,0
5,GO THALAMUS DEVELOPMENT,0.00094089,-0.28124,-0.27394,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.00080175,-0.28129,-0.31708,1,0
5,GO SOMITOGENESIS,1.2733e-08,-0.28137,-0.34688,1,0
5,GO ASSOCIATIVE LEARNING,2.2926e-08,-0.28142,-0.35577,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,9.5677e-09,-0.28146,-0.36942,1,0
5,GO SKIN EPIDERMIS DEVELOPMENT,2.8369e-09,-0.28149,-0.3882,1,0
5,GO NEGATIVE REGULATION OF CELL DEATH,1.9402e-11,-0.28155,-0.33799,1,0
5,GO REGULATION OF LYASE ACTIVITY,3.4003e-08,-0.28155,-0.32848,1,0
5,GO REGULATION OF ACTIN FILAMENT LENGTH,7.479e-12,-0.28165,-0.40247,1,0
5,GO REGULATION OF DEPHOSPHORYLATION,2.9515e-10,-0.2817,-0.36974,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,4.3082e-09,-0.28192,-0.37324,1,0
5,GO NEGATIVE REGULATION OF BINDING,5.9748e-11,-0.28195,-0.35373,1,0
5,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,2.8753e-10,-0.28199,-0.34422,1,0
5,GO MITOTIC G1 S TRANSITION CHECKPOINT,6.2169e-06,-0.282,-0.2741,1,0
5,GO RUFFLE ORGANIZATION,4.7963e-08,-0.28203,-0.35279,1,0
5,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,9.658e-10,-0.28233,-0.33596,1,0
5,GO NEURAL TUBE DEVELOPMENT,4.249e-10,-0.28234,-0.40243,1,0
5,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,7.892e-08,-0.28237,-0.31422,1,0
5,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,4.4771e-05,-0.28242,-0.30919,1,0
5,GO REGULATION OF CELL DEVELOPMENT,1.6109e-10,-0.28257,-0.39311,1,0
5,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,9.3415e-09,-0.28259,-0.31359,1,0
5,GO COCHLEA DEVELOPMENT,4.1815e-08,-0.28265,-0.35691,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,1.4487e-10,-0.2827,-0.38014,1,0
5,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,5.3562e-07,-0.28271,-0.36432,1,0
5,GO MUSCLE CELL FATE COMMITMENT,5.3562e-07,-0.28272,-0.33324,1,0
5,GO REGULATION OF PROTEIN KINASE ACTIVITY,2.9979e-12,-0.2829,-0.39037,1,0
5,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,8.4805e-07,-0.28292,-0.33694,1,0
5,GO REGULATION OF SYNAPTIC VESICLE CYCLE,1.5865e-05,-0.28292,-0.36161,1,0
5,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,7.969e-07,-0.28294,-0.3532,1,0
5,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.0016122,-0.28295,-0.22576,1,0
5,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.7309e-08,-0.28298,-0.37439,1,0
5,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.0017277,-0.28304,-0.29148,1,0
5,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,2.1338e-07,-0.28306,-0.38868,1,0
5,GO REGULATION OF MUSCLE CONTRACTION,5.5078e-11,-0.28308,-0.36272,1,0
5,GO AROMATIC AMINO ACID TRANSPORT,8.4424e-05,-0.28315,-0.43072,1,0
5,GO REGULATION OF T CELL CYTOKINE PRODUCTION,3.2162e-07,-0.28321,-0.33511,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,5.0278e-07,-0.28326,-0.35486,1,0
5,GO CARBOHYDRATE CATABOLIC PROCESS,2.8753e-10,-0.28329,-0.35557,1,0
5,GO ERYTHROCYTE DEVELOPMENT,1.3174e-07,-0.28331,-0.40956,1,0
5,GO ENDOCRINE SYSTEM DEVELOPMENT,2.0364e-06,-0.28331,-0.32149,1,0
5,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.00049053,-0.28334,-0.34256,1,0
5,GO CELLULAR GLUCOSE HOMEOSTASIS,2.801e-10,-0.2834,-0.37064,1,0
5,GO DOPAMINERGIC NEURON DIFFERENTIATION,3.3435e-06,-0.28346,-0.25055,1,0
5,GO THYROID HORMONE METABOLIC PROCESS,2.5868e-06,-0.28355,-0.27846,1,0
5,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,1.942e-12,-0.28359,-0.38139,1,0
5,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.001568,-0.28374,-0.31621,1,0
5,GO DIET INDUCED THERMOGENESIS,2.0879e-07,-0.28384,-0.30113,1,0
5,GO NEUROGENESIS,1.069e-09,-0.28387,-0.38015,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,5.7051e-07,-0.28397,-0.28793,1,0
5,GO CELLULAR RESPONSE TO STARVATION,3.6361e-10,-0.28397,-0.37756,1,0
5,GO IMMUNE SYSTEM DEVELOPMENT,1.5968e-11,-0.28398,-0.36452,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,9.1205e-09,-0.28402,-0.36564,1,0
5,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,3.8347e-06,-0.28406,-0.34652,1,0
5,GO HISTONE H3 K4 TRIMETHYLATION,9.2585e-06,-0.28407,-0.30066,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,2.0478e-05,-0.28408,-0.35561,1,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,9.4157e-10,-0.28411,-0.35217,1,0
5,GO IRON ION TRANSMEMBRANE TRANSPORT,2.5164e-08,-0.28417,-0.3362,1,0
5,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,4.1751e-05,-0.28434,-0.2739,1,0
5,GO RESPONSE TO BMP,3.192e-10,-0.28446,-0.4386,1,0
5,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,5.1356e-08,-0.2846,-0.33945,1,0
5,GO DOPAMINE BIOSYNTHETIC PROCESS,0.018693,-0.28463,-0.26739,1,0
5,GO FIBROBLAST ACTIVATION,1.064e-06,-0.28471,-0.35637,1,0
5,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,4.8416e-06,-0.28475,-0.33297,1,0
5,GO REGULATION OF MEMBRANE DEPOLARIZATION,8.0898e-09,-0.28486,-0.38496,1,0
5,GO MATING BEHAVIOR,4.1552e-07,-0.28501,-0.32602,1,0
5,GO NON CANONICAL WNT SIGNALING PATHWAY,4.7501e-09,-0.28501,-0.31728,1,0
5,GO EMBRYONIC HEART TUBE MORPHOGENESIS,8.5043e-10,-0.28502,-0.38915,1,0
5,GO MOLTING CYCLE,5.2253e-10,-0.28513,-0.37757,1,0
5,GO TRANSITION METAL ION HOMEOSTASIS,5.6317e-09,-0.28514,-0.31197,1,0
5,GO POSITIVE REGULATION OF HAIR CYCLE,3.5646e-05,-0.28517,-0.37293,1,0
5,GO RESPONSE TO AUDITORY STIMULUS,8.3013e-05,-0.28518,-0.35904,1,0
5,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,2.5893e-10,-0.28537,-0.43786,1,0
5,GO REGULATION OF SYNAPTIC PLASTICITY,6.2993e-08,-0.2854,-0.38268,1,0
5,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,1.5014e-05,-0.28543,-0.39912,1,0
5,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,3.8833e-12,-0.28548,-0.39323,1,0
5,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,1.9905e-10,-0.28553,-0.33975,1,0
5,GO LINOLEIC ACID METABOLIC PROCESS,5.7059e-05,-0.28559,-0.36538,1,0
5,GO EOSINOPHIL MIGRATION,0.00044103,-0.28563,-0.32201,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,1.1858e-08,-0.28564,-0.39581,1,0
5,GO CELL PROJECTION ORGANIZATION,9.4499e-11,-0.28565,-0.38943,1,0
5,GO AGING,1.9948e-11,-0.2857,-0.35055,1,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,1.174e-11,-0.28579,-0.40864,1,0
5,GO POSITIVE REGULATION OF CELL DIVISION,9.028e-08,-0.28588,-0.34476,1,0
5,GO INOSITOL METABOLIC PROCESS,6.1119e-05,-0.28591,-0.30752,1,0
5,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,9.6562e-05,-0.28594,-0.27659,1,0
5,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,1.3351e-08,-0.28595,-0.34025,1,0
5,GO GLAND DEVELOPMENT,2.2912e-11,-0.28616,-0.40096,1,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,6.3074e-11,-0.28616,-0.34088,1,0
5,GO REGULATION OF ISOTYPE SWITCHING,4.0033e-09,-0.28621,-0.40041,1,0
5,GO REGULATION OF IMMUNE EFFECTOR PROCESS,7.6792e-10,-0.28627,-0.36825,1,0
5,GO REGULATION OF VIRAL LIFE CYCLE,8.1361e-07,-0.28628,-0.36229,1,0
5,GO SUPRAMOLECULAR FIBER ORGANIZATION,1.0493e-11,-0.28632,-0.43533,1,0
5,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,1.7909e-10,-0.28643,-0.3786,1,0
5,GO STEM CELL DIFFERENTIATION,7.8778e-10,-0.28643,-0.33147,1,0
5,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,7.333e-07,-0.28645,-0.31161,1,0
5,GO REGULATION OF TORC1 SIGNALING,4.6356e-09,-0.28661,-0.41556,1,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,8.0256e-05,-0.28662,-0.28397,1,0
5,GO RESPONSE TO ALCOHOL,1.1415e-11,-0.28662,-0.35989,1,0
5,GO LEFT RIGHT PATTERN FORMATION,1.3325e-06,-0.28666,-0.34694,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,7.71e-09,-0.28671,-0.36673,1,0
5,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,3.9717e-11,-0.28676,-0.36818,1,0
5,GO ACTIVATION OF IMMUNE RESPONSE,4.0343e-10,-0.28677,-0.35016,1,0
5,GO THYMOCYTE APOPTOTIC PROCESS,6.5837e-06,-0.28693,-0.34847,1,0
5,GO RETINAL ROD CELL DIFFERENTIATION,0.0005211,-0.28699,-0.27826,1,0
5,GO DEFENSE RESPONSE TO OTHER ORGANISM,1.484e-09,-0.28705,-0.34176,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,4.0343e-10,-0.28705,-0.32214,1,0
5,GO MEMBRANE FUSION,1.0519e-10,-0.28706,-0.39175,1,0
5,GO TONGUE MORPHOGENESIS,0.013546,-0.2871,-0.19508,1,0
5,GO TISSUE REGENERATION,9.1205e-09,-0.28715,-0.35489,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,3.9941e-08,-0.28718,-0.44881,1,0
5,GO NEURON DIFFERENTIATION,2.3268e-09,-0.2872,-0.37986,1,0
5,GO REGULATION OF NEUROTRANSMITTER UPTAKE,2.6828e-05,-0.2872,-0.31783,1,0
5,GO REGULATION OF BLOOD PRESSURE,2.2117e-10,-0.28738,-0.36517,1,0
5,GO CAMERA TYPE EYE MORPHOGENESIS,3.8149e-08,-0.2875,-0.37206,1,0
5,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,3.9309e-10,-0.28752,-0.39269,1,0
5,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,1.2348e-10,-0.28759,-0.41543,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,3.1004e-08,-0.2876,-0.36981,1,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,2.3793e-12,-0.28771,-0.38371,1,0
5,GO TOXIN METABOLIC PROCESS,0.0003557,-0.28777,-0.29873,1,0
5,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,3.4003e-08,-0.2878,-0.43812,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,8.0815e-10,-0.28787,-0.32048,1,0
5,GO ANIMAL ORGAN MORPHOGENESIS,7.6937e-12,-0.28791,-0.40129,1,0
5,GO ALPHA BETA T CELL ACTIVATION,4.6356e-09,-0.28795,-0.36467,1,0
5,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,2.0776e-06,-0.28801,-0.33595,1,0
5,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,6.6717e-09,-0.28801,-0.38567,1,0
5,GO POSITIVE REGULATION OF PROTEOLYSIS,6.8695e-12,-0.28804,-0.38703,1,0
5,GO TONGUE DEVELOPMENT,0.00044103,-0.28819,-0.26312,1,0
5,GO REGULATION OF T CELL DIFFERENTIATION,1.5277e-10,-0.2882,-0.35625,1,0
5,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,5.2359e-09,-0.28828,-0.34286,1,0
5,GO LYSOSOMAL TRANSPORT,1.9402e-11,-0.28833,-0.43332,1,0
5,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,1.5604e-09,-0.28835,-0.38557,1,0
5,GO SMAD PROTEIN SIGNAL TRANSDUCTION,3.5427e-10,-0.28838,-0.43614,1,0
5,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,1.8573e-08,-0.28845,-0.39959,1,0
5,GO REGULATION OF CELLULAR RESPIRATION,4.0657e-06,-0.28848,-0.29891,1,0
5,GO PHAGOSOME MATURATION,2.0881e-08,-0.28857,-0.35891,1,0
5,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,6.895e-08,-0.28861,-0.32827,1,0
5,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,7.2702e-12,-0.28864,-0.40905,1,0
5,GO SUBSTANTIA NIGRA DEVELOPMENT,1.0527e-08,-0.28865,-0.31168,1,0
5,GO REGULATION OF FEEDING BEHAVIOR,7.105e-06,-0.28873,-0.27205,1,0
5,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,1.3948e-05,-0.28873,-0.32118,1,0
5,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,9.404e-07,-0.28879,-0.37504,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,8.6328e-08,-0.28882,-0.36682,1,0
5,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,2.4214e-11,-0.2889,-0.42941,1,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,3.8833e-12,-0.28895,-0.39909,1,0
5,GO LEUKOTRIENE METABOLIC PROCESS,3.1729e-08,-0.28905,-0.37659,1,0
5,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,3.7282e-08,-0.28919,-0.34186,1,0
5,GO DIENCEPHALON DEVELOPMENT,4.0314e-05,-0.28928,-0.30574,1,0
5,GO MOVEMENT IN HOST ENVIRONMENT,2.3933e-10,-0.28942,-0.41256,1,0
5,GO IMMUNOGLOBULIN PRODUCTION,6.757e-10,-0.28951,-0.31955,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,2.1807e-07,-0.28961,-0.35464,1,0
5,GO MUSCLE ORGAN MORPHOGENESIS,1.5217e-09,-0.28962,-0.40299,1,0
5,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,1.9064e-09,-0.28972,-0.37834,1,0
5,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,1.9465e-08,-0.28979,-0.39205,1,0
5,GO MYELOID LEUKOCYTE MIGRATION,3.1312e-09,-0.28981,-0.33956,1,0
5,GO EMBRYONIC FORELIMB MORPHOGENESIS,1.5052e-06,-0.28984,-0.35687,1,0
5,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,1.6823e-09,-0.28991,-0.40737,1,0
5,GO REGULATION OF RUFFLE ASSEMBLY,1.9558e-07,-0.29005,-0.38088,1,0
5,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,1.484e-09,-0.29005,-0.39556,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,2.2015e-05,-0.29018,-0.28509,1,0
5,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,1.7286e-12,-0.29022,-0.39824,1,0
5,GO REGULATION OF PROTEIN COMPLEX STABILITY,1.8032e-05,-0.29024,-0.33628,1,0
5,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,1.1165e-05,-0.29025,-0.3005,1,0
5,GO CELL VOLUME HOMEOSTASIS,1.8594e-09,-0.29025,-0.38435,1,0
5,GO METENCEPHALON DEVELOPMENT,2.5359e-06,-0.29031,-0.31301,1,0
5,GO POSITIVE REGULATION OF IMMUNE RESPONSE,5.3617e-10,-0.29043,-0.34327,1,0
5,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,3.7602e-11,-0.29052,-0.36129,1,0
5,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,2.4972e-05,-0.29054,-0.31508,1,0
5,GO HAIR CELL DIFFERENTIATION,2.856e-06,-0.29064,-0.36284,1,0
5,GO INTERLEUKIN 17 PRODUCTION,2.9514e-07,-0.29084,-0.36021,1,0
5,GO NEURAL TUBE FORMATION,7.5266e-09,-0.29091,-0.39107,1,0
5,GO PLASMA MEMBRANE TUBULATION,2.2397e-08,-0.29096,-0.45659,1,0
5,GO DENTATE GYRUS DEVELOPMENT,0.00036124,-0.29097,-0.30495,1,0
5,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,8.8796e-05,-0.29101,-0.31113,1,0
5,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,0.00016361,-0.29106,-0.31452,1,0
5,GO MAINTENANCE OF SYNAPSE STRUCTURE,0.00052901,-0.29106,-0.35261,1,0
5,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,5.9432e-10,-0.2911,-0.38511,1,0
5,GO CELL CELL SIGNALING BY WNT,2.559e-11,-0.29111,-0.38055,1,0
5,GO THYROID GLAND DEVELOPMENT,1.3878e-06,-0.29114,-0.36829,1,0
5,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,8.8389e-07,-0.29121,-0.35897,1,0
5,GO REGULATION OF LIPID METABOLIC PROCESS,1.5838e-12,-0.29127,-0.39304,1,0
5,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,1.5386e-08,-0.29128,-0.37107,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,4.8198e-07,-0.29136,-0.36994,1,0
5,GO REGULATION OF CYCLASE ACTIVITY,1.0791e-07,-0.29138,-0.33542,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,5.9432e-10,-0.2914,-0.36091,1,0
5,GO SPHINGOLIPID METABOLIC PROCESS,5.0922e-10,-0.29146,-0.38807,1,0
5,GO LYMPHOCYTE CHEMOTAXIS,2.8753e-10,-0.29151,-0.31969,1,0
5,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,4.719e-07,-0.29158,-0.40251,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.801e-10,-0.29163,-0.38092,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,6.586e-10,-0.29171,-0.38557,1,0
5,GO NEGATIVE REGULATION OF ION TRANSPORT,2.8753e-10,-0.29173,-0.34448,1,0
5,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,2.9078e-09,-0.29181,-0.33908,1,0
5,GO CELL MIGRATION IN HINDBRAIN,0.00023294,-0.29201,-0.37796,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.6884e-11,-0.29201,-0.44197,1,0
5,GO NEPHRON MORPHOGENESIS,1.2143e-08,-0.29204,-0.35253,1,0
5,GO TISSUE MORPHOGENESIS,1.3505e-11,-0.29208,-0.3987,1,0
5,GO NEURONAL ACTION POTENTIAL,0.00042777,-0.29213,-0.3071,1,0
5,GO LYMPHOCYTE COSTIMULATION,6.7411e-08,-0.29221,-0.35258,1,0
5,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,9.2118e-07,-0.29221,-0.41664,1,0
5,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,2.5893e-10,-0.29226,-0.38195,1,0
5,GO REGULATION OF IMMUNE RESPONSE,2.801e-10,-0.29228,-0.35427,1,0
5,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,8.2903e-10,-0.29231,-0.34059,1,0
5,GO VITAMIN TRANSPORT,1.2058e-07,-0.29243,-0.31841,1,0
5,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,9.9064e-10,-0.2925,-0.34823,1,0
5,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,0.00013232,-0.29252,-0.34343,1,0
5,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,3.8161e-07,-0.29255,-0.3676,1,0
5,GO BODY FLUID SECRETION,8.4871e-11,-0.29265,-0.3521,1,0
5,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,2.402e-08,-0.29267,-0.43002,1,0
5,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,9.3415e-09,-0.29272,-0.35498,1,0
5,GO MITOCHONDRION DISTRIBUTION,2.5868e-06,-0.29278,-0.34735,1,0
5,GO RESPONSE TO BIOTIC STIMULUS,1.8881e-10,-0.29287,-0.34247,1,0
5,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,1.3693e-05,-0.29296,-0.40689,1,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,9.5677e-09,-0.29297,-0.36526,1,0
5,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,3.8347e-06,-0.293,-0.44767,1,0
5,GO MUSCLE SYSTEM PROCESS,1.7286e-12,-0.29301,-0.40573,1,0
5,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,1.1533e-09,-0.29308,-0.33849,1,0
5,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.7687e-09,-0.2932,-0.34506,1,0
5,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,5.0237e-12,-0.29321,-0.38039,1,0
5,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,2.971e-06,-0.29332,-0.38973,1,0
5,GO CELLULAR RESPONSE TO X RAY,2.2505e-06,-0.29336,-0.32097,1,0
5,GO STARTLE RESPONSE,0.00081356,-0.29353,-0.28224,1,0
5,GO LIPID DROPLET ORGANIZATION,1.1307e-08,-0.29355,-0.34558,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,2.2453e-12,-0.29358,-0.39312,1,0
5,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,8.2903e-10,-0.29361,-0.36567,1,0
5,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.1729e-08,-0.29366,-0.43513,1,0
5,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,5.7051e-07,-0.29369,-0.31688,1,0
5,GO CARDIOCYTE DIFFERENTIATION,3.7319e-10,-0.29373,-0.40268,1,0
5,GO METANEPHRIC NEPHRON MORPHOGENESIS,7.892e-08,-0.29374,-0.40419,1,0
5,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,4.3549e-12,-0.29375,-0.41812,1,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,1.0169e-05,-0.2938,-0.34578,1,0
5,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,1.0094e-07,-0.29381,-0.40659,1,0
5,GO VACUOLE ORGANIZATION,6.3088e-12,-0.29386,-0.40315,1,0
5,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,9.1996e-11,-0.29396,-0.3951,1,0
5,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,2.7078e-07,-0.29408,-0.3538,1,0
5,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,2.7614e-08,-0.2941,-0.34506,1,0
5,GO REGULATION OF GLIAL CELL MIGRATION,2.8753e-10,-0.29412,-0.37154,1,0
5,GO POSITIVE REGULATION OF LIPASE ACTIVITY,1.4877e-10,-0.29419,-0.31871,1,0
5,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,5.9602e-12,-0.2942,-0.40211,1,0
5,GO REGULATION OF MUSCLE ADAPTATION,1.0161e-09,-0.29439,-0.42155,1,0
5,GO RESPONSE TO INTERLEUKIN 12,4.4807e-06,-0.29464,-0.27951,1,0
5,GO NEGATIVE REGULATION OF GLIOGENESIS,2.2824e-05,-0.2948,-0.27449,1,0
5,GO SMOOTHENED SIGNALING PATHWAY,3.055e-09,-0.2948,-0.35583,1,0
5,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,1.2143e-08,-0.29498,-0.38899,1,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,4.7449e-12,-0.29499,-0.40063,1,0
5,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,1.484e-09,-0.29502,-0.35555,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.5427e-10,-0.29502,-0.38108,1,0
5,GO STRESS GRANULE ASSEMBLY,1.0094e-07,-0.29511,-0.36464,1,0
5,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,8.4877e-09,-0.29522,-0.396,1,0
5,GO POSITIVE REGULATION OF ERAD PATHWAY,3.2146e-06,-0.29524,-0.38764,1,0
5,GO NATURAL KILLER CELL ACTIVATION,7.2129e-08,-0.29527,-0.33773,1,0
5,GO CHAPERONE MEDIATED PROTEIN FOLDING,7.5217e-06,-0.29529,-0.31058,1,0
5,GO MONONUCLEAR CELL MIGRATION,6.1583e-08,-0.29538,-0.33661,1,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.00023667,-0.29547,-0.3442,1,0
5,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,3.7282e-08,-0.29547,-0.40034,1,0
5,GO ACUTE INFLAMMATORY RESPONSE,1.0781e-08,-0.29553,-0.32471,1,0
5,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.00020178,-0.29554,-0.31706,1,0
5,GO CELLULAR SODIUM ION HOMEOSTASIS,7.2497e-05,-0.29567,-0.31375,1,0
5,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,2.7676e-09,-0.29579,-0.38756,1,0
5,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,3.2764e-10,-0.29587,-0.41258,1,0
5,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.00014839,-0.29588,-0.28305,1,0
5,GO REGULATION OF T CELL ACTIVATION,4.1403e-10,-0.29588,-0.36011,1,0
5,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.8053e-06,-0.29591,-0.28867,1,0
5,GO ENDOCARDIUM DEVELOPMENT,3.3806e-05,-0.29601,-0.31631,1,0
5,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,1.9546e-09,-0.29619,-0.42829,1,0
5,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,9.6538e-08,-0.29626,-0.35106,1,0
5,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,9.4499e-11,-0.29638,-0.35864,1,0
5,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.232e-12,-0.29639,-0.41659,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,5.6304e-12,-0.29644,-0.38801,1,0
5,GO PROTEIN HYDROXYLATION,8.5867e-06,-0.29647,-0.3822,1,0
5,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,7.2414e-06,-0.2965,-0.39324,1,0
5,GO NEGATIVE REGULATION OF CELL GROWTH,9.9185e-12,-0.2965,-0.42233,1,0
5,GO 3 UTR MEDIATED MRNA DESTABILIZATION,7.1819e-07,-0.29653,-0.39661,1,0
5,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,2.3312e-10,-0.29657,-0.37152,1,0
5,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,1.4112e-09,-0.29658,-0.40837,1,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,8.8389e-07,-0.29658,-0.3635,1,0
5,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,1.439e-07,-0.29662,-0.31835,1,0
5,GO REGULATION OF WNT SIGNALING PATHWAY,1.7442e-10,-0.29664,-0.3709,1,0
5,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.00017457,-0.29666,-0.33815,1,0
5,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,9.4407e-08,-0.29668,-0.34648,1,0
5,GO PEPTIDE CROSS LINKING,8.2543e-08,-0.29672,-0.43273,1,0
5,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,2.7312e-05,-0.29676,-0.34717,1,0
5,GO RECEPTOR RECYCLING,4.3606e-10,-0.29681,-0.37004,1,0
5,GO FLUID TRANSPORT,8.2903e-10,-0.29681,-0.345,1,0
5,GO SKELETAL MUSCLE TISSUE REGENERATION,3.7282e-08,-0.29684,-0.35672,1,0
5,GO ASTRAL MICROTUBULE ORGANIZATION,1.5994e-06,-0.29689,-0.37602,1,0
5,GO ENGULFMENT OF APOPTOTIC CELL,4.8673e-09,-0.29693,-0.39662,1,0
5,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,0.0019819,-0.29695,-0.26211,1,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,1.2759e-09,-0.29706,-0.39888,1,0
5,GO B CELL ACTIVATION,2.9515e-10,-0.29709,-0.38347,1,0
5,GO POSITIVE REGULATION OF AMINE TRANSPORT,6.7724e-05,-0.29718,-0.3105,1,0
5,GO ORGANELLE MEMBRANE FUSION,1.0964e-09,-0.29723,-0.40904,1,0
5,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,3.2894e-09,-0.29728,-0.39122,1,0
5,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,7.4873e-07,-0.29729,-0.37835,1,0
5,GO REGULATION OF ASTROCYTE DIFFERENTIATION,2.65e-07,-0.29732,-0.36245,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,8.3066e-07,-0.29733,-0.36554,1,0
5,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.0007786,-0.29733,-0.29681,1,0
5,GO REGULATION OF LIPID CATABOLIC PROCESS,9.9705e-11,-0.29736,-0.38962,1,0
5,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,3.2146e-06,-0.29745,-0.29972,1,0
5,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,7.0279e-11,-0.29747,-0.36034,1,0
5,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.0001803,-0.29747,-0.28485,1,0
5,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,2.5223e-10,-0.2975,-0.35626,1,0
5,GO SPINAL CORD DEVELOPMENT,1.4454e-06,-0.29751,-0.3245,1,0
5,GO RECEPTOR METABOLIC PROCESS,5.4724e-12,-0.29753,-0.40549,1,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.4967e-09,-0.29754,-0.38232,1,0
5,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,1.2534e-06,-0.29757,-0.34433,1,0
5,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.1125e-12,-0.29765,-0.4124,1,0
5,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,4.5822e-08,-0.29767,-0.3632,1,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS,2.7797e-11,-0.29772,-0.3843,1,0
5,GO REGULATION OF DENDRITE MORPHOGENESIS,5.1356e-08,-0.29773,-0.40148,1,0
5,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,1.1533e-09,-0.29778,-0.39502,1,0
5,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,4.9403e-11,-0.2978,-0.37902,1,0
5,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,8.3747e-12,-0.29782,-0.42174,1,0
5,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,3.9309e-10,-0.29784,-0.3535,1,0
5,GO BROWN FAT CELL DIFFERENTIATION,2.8925e-08,-0.29784,-0.3336,1,0
5,GO NATURAL KILLER CELL DIFFERENTIATION,8.6937e-09,-0.29786,-0.40662,1,0
5,GO DEVELOPMENTAL CELL GROWTH,3.4516e-10,-0.29787,-0.43134,1,0
5,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,1.3693e-05,-0.29792,-0.32673,1,0
5,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,7.892e-08,-0.29799,-0.35822,1,0
5,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.00010152,-0.298,-0.35848,1,0
5,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,5.7051e-07,-0.29808,-0.37734,1,0
5,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.0781e-08,-0.29815,-0.31681,1,0
5,GO REGULATION OF FATTY ACID METABOLIC PROCESS,4.3109e-11,-0.29819,-0.3801,1,0
5,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,8.7237e-10,-0.29822,-0.35559,1,0
5,GO RESPONSE TO PROTOZOAN,1.6418e-07,-0.29844,-0.38627,1,0
5,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,5.7923e-10,-0.29861,-0.41647,1,0
5,GO REGULATION OF HEMOPOIESIS,2.2286e-11,-0.29867,-0.36576,1,0
5,GO POTASSIUM ION TRANSPORT,6.8348e-09,-0.29871,-0.33773,1,0
5,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,4.3082e-09,-0.29872,-0.34452,1,0
5,GO INNATE IMMUNE RESPONSE,3.2094e-09,-0.29875,-0.35138,1,0
5,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.1274e-05,-0.29876,-0.358,1,0
5,GO RETINAL METABOLIC PROCESS,0.0054872,-0.29879,-0.28945,1,0
5,GO REGULATION OF DEVELOPMENTAL GROWTH,6.3074e-11,-0.29884,-0.3937,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,8.1414e-12,-0.2989,-0.4019,1,0
5,GO T HELPER 1 TYPE IMMUNE RESPONSE,1.6321e-06,-0.29907,-0.3762,1,0
5,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,2.2117e-10,-0.29922,-0.37956,1,0
5,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,9.4499e-11,-0.29928,-0.39938,1,0
5,GO ENDOCYTIC RECYCLING,8.0815e-10,-0.29929,-0.4226,1,0
5,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00086244,-0.29929,-0.35326,1,0
5,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,1.887e-11,-0.29936,-0.40801,1,0
5,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,1.2348e-10,-0.2994,-0.41146,1,0
5,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,2.6362e-08,-0.29941,-0.35532,1,0
5,GO PROSTANOID BIOSYNTHETIC PROCESS,3.8347e-06,-0.29943,-0.33822,1,0
5,GO CELL PROLIFERATION IN HINDBRAIN,5.5127e-05,-0.29946,-0.28812,1,0
5,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,0.00011033,-0.29951,-0.37228,1,0
5,GO CYTOKINE MEDIATED SIGNALING PATHWAY,1.3419e-09,-0.29961,-0.36296,1,0
5,GO ETHANOL CATABOLIC PROCESS,8.2686e-06,-0.29965,-0.3014,1,0
5,GO EMBRYONIC PLACENTA DEVELOPMENT,5.3747e-08,-0.29968,-0.39461,1,0
5,GO CELLULAR RESPONSE TO NITROGEN STARVATION,5.4356e-06,-0.29972,-0.26397,1,0
5,GO DEVELOPMENTAL GROWTH,2.4214e-11,-0.29973,-0.39967,1,0
5,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,1.2604e-07,-0.29976,-0.34674,1,0
5,GO POSITIVE REGULATION OF CYTOKINE SECRETION,1.6823e-09,-0.29981,-0.333,1,0
5,GO REGULATION OF PROTEIN DEPOLYMERIZATION,8.7237e-10,-0.29982,-0.41761,1,0
5,GO REGULATION OF PROTEIN BINDING,1.0205e-12,-0.29984,-0.42292,1,0
5,GO REGULATION OF CELL PROJECTION ORGANIZATION,4.0817e-11,-0.29987,-0.42834,1,0
5,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,3.192e-10,-0.29988,-0.33759,1,0
5,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,0.00045468,-0.2999,-0.39348,1,0
5,GO MALE SEX DIFFERENTIATION,5.2253e-10,-0.30004,-0.36292,1,0
5,GO BRAIN MORPHOGENESIS,9.5677e-09,-0.30016,-0.36548,1,0
5,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,2.3793e-12,-0.30019,-0.39399,1,0
5,GO MESODERM MORPHOGENESIS,3.192e-10,-0.30025,-0.40302,1,0
5,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,5.2165e-11,-0.30027,-0.37912,1,0
5,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,1.0527e-08,-0.30033,-0.34662,1,0
5,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,3.5597e-11,-0.30034,-0.40936,1,0
5,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,4.0678e-07,-0.30036,-0.33233,1,0
5,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,1.5383e-12,-0.30048,-0.39329,1,0
5,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,1.8793e-06,-0.30052,-0.29321,1,0
5,GO AMMONIUM ION METABOLIC PROCESS,0.0003557,-0.30064,-0.26745,1,0
5,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,2.457e-10,-0.30074,-0.3962,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,4.1751e-05,-0.30074,-0.3489,1,0
5,GO REGULATION OF CELL POPULATION PROLIFERATION,3.9963e-12,-0.30079,-0.37503,1,0
5,GO NAD METABOLIC PROCESS,4.9361e-06,-0.30102,-0.34815,1,0
5,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,3.1494e-05,-0.30107,-0.28923,1,0
5,GO RESPONSE TO CYTOKINE,1.3737e-10,-0.30114,-0.37251,1,0
5,GO POSITIVE REGULATION OF HEMOPOIESIS,1.0241e-10,-0.30116,-0.37981,1,0
5,GO PEPTIDYL THREONINE MODIFICATION,3.4516e-10,-0.30142,-0.38965,1,0
5,GO OLIGODENDROCYTE DIFFERENTIATION,8.6579e-07,-0.30147,-0.31966,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,1.1828e-09,-0.30157,-0.38871,1,0
5,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,4.9228e-07,-0.30157,-0.32704,1,0
5,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,4.9228e-07,-0.30159,-0.30365,1,0
5,GO RIBONUCLEOTIDE CATABOLIC PROCESS,6.205e-09,-0.30162,-0.35767,1,0
5,GO MEMBRANE FISSION,2.1196e-06,-0.30162,-0.38143,1,0
5,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,1.3133e-11,-0.30169,-0.36973,1,0
5,GO LYMPHOCYTE ACTIVATION,5.3602e-11,-0.30169,-0.37388,1,0
5,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,1.2281e-06,-0.30169,-0.36193,1,0
5,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,6.4592e-06,-0.3017,-0.32362,1,0
5,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,3.6435e-08,-0.30173,-0.37043,1,0
5,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,2.0983e-10,-0.30187,-0.39663,1,0
5,GO IMPORT INTO CELL,6.3074e-11,-0.30197,-0.38859,1,0
5,GO REGULATION OF ERBB SIGNALING PATHWAY,1.4107e-10,-0.30202,-0.42363,1,0
5,GO T CELL DIFFERENTIATION,1.0804e-10,-0.30204,-0.36616,1,0
5,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,1.4112e-09,-0.30212,-0.34207,1,0
5,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2759e-09,-0.30213,-0.36572,1,0
5,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.00054518,-0.30214,-0.29165,1,0
5,GO POTASSIUM ION HOMEOSTASIS,1.6514e-08,-0.30218,-0.35923,1,0
5,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.679e-12,-0.30221,-0.38809,1,0
5,GO MEGAKARYOCYTE DIFFERENTIATION,1.0527e-08,-0.30228,-0.37813,1,0
5,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,1.2434e-08,-0.30239,-0.38341,1,0
5,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,8.3026e-13,-0.30242,-0.39554,1,0
5,GO MICROTUBULE ANCHORING,7.892e-08,-0.30256,-0.38394,1,0
5,GO T CELL CYTOKINE PRODUCTION,3.0295e-08,-0.30257,-0.3253,1,0
5,GO MATING,5.9116e-09,-0.30276,-0.32361,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,8.5867e-06,-0.30281,-0.3329,1,0
5,GO OVULATION CYCLE PROCESS,8.0815e-10,-0.30281,-0.39672,1,0
5,GO APICAL JUNCTION ASSEMBLY,2.5934e-07,-0.30283,-0.39297,1,0
5,GO REGULATION OF HEART GROWTH,2.9515e-10,-0.30288,-0.39367,1,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,3.4516e-10,-0.30298,-0.32714,1,0
5,GO ACTIN FILAMENT BASED PROCESS,7.6937e-12,-0.30309,-0.44583,1,0
5,GO REGULATION OF MUSCLE HYPERTROPHY,5.5016e-10,-0.3031,-0.44081,1,0
5,GO POSITIVE REGULATION OF T CELL MIGRATION,8.9487e-10,-0.30312,-0.35521,1,0
5,GO GTP METABOLIC PROCESS,2.0364e-06,-0.30313,-0.30719,1,0
5,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,3.1896e-11,-0.30315,-0.35867,1,0
5,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,2.2707e-10,-0.30316,-0.40469,1,0
5,GO AMP METABOLIC PROCESS,7.2497e-05,-0.30319,-0.28043,1,0
5,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,1.734e-06,-0.30321,-0.34593,1,0
5,GO MEMBRANE DISASSEMBLY,5.4356e-06,-0.30321,-0.35524,1,0
5,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,9.028e-08,-0.30324,-0.31924,1,0
5,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,5.9498e-07,-0.30324,-0.44429,1,0
5,GO REGULATION OF CALCIUM ION IMPORT,8.4871e-11,-0.30332,-0.40849,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,1.8881e-10,-0.30335,-0.36095,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,1.6542e-10,-0.30336,-0.34146,1,0
5,GO LEUKOCYTE CELL CELL ADHESION,1.4877e-10,-0.30343,-0.38618,1,0
5,GO ACIDIC AMINO ACID TRANSPORT,7.0337e-07,-0.30349,-0.33461,1,0
5,GO JNK CASCADE,3.9963e-12,-0.30373,-0.41212,1,0
5,GO MITOPHAGY,1.5604e-09,-0.30373,-0.37331,1,0
5,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,1.3039e-08,-0.30376,-0.40278,1,0
5,GO MESONEPHROS DEVELOPMENT,1.6129e-08,-0.30382,-0.37571,1,0
5,GO WATER HOMEOSTASIS,6.1583e-08,-0.30387,-0.34679,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,3.1098e-10,-0.30395,-0.41668,1,0
5,GO ETHANOL METABOLIC PROCESS,5.4356e-06,-0.30399,-0.34173,1,0
5,GO L ASCORBIC ACID METABOLIC PROCESS,0.0011836,-0.30402,-0.25403,1,0
5,GO AMINO SUGAR CATABOLIC PROCESS,8.2543e-08,-0.30414,-0.33643,1,0
5,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,9.795e-06,-0.30423,-0.29908,1,0
5,GO REGULATION OF IMMUNE SYSTEM PROCESS,2.8573e-11,-0.30425,-0.37061,1,0
5,GO POSITIVE REGULATION OF ION TRANSPORT,2.9371e-11,-0.3043,-0.3444,1,0
5,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,2.2697e-09,-0.30431,-0.36036,1,0
5,GO REGULATION OF GTPASE ACTIVITY,9.3752e-12,-0.30433,-0.45015,1,0
5,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,3.7319e-10,-0.30436,-0.41955,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,2.2912e-11,-0.30438,-0.35932,1,0
5,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,7.0337e-07,-0.30447,-0.40513,1,0
5,GO POSITIVE REGULATION OF GROWTH,7.4177e-11,-0.3045,-0.38558,1,0
5,GO FUCOSE METABOLIC PROCESS,1.1034e-07,-0.30456,-0.35047,1,0
5,GO MYELOID LEUKOCYTE ACTIVATION,7.8778e-10,-0.30457,-0.36744,1,0
5,GO REGULATION OF HUMORAL IMMUNE RESPONSE,1.1828e-09,-0.30459,-0.4124,1,0
5,GO DENDRITIC CELL CHEMOTAXIS,2.8886e-07,-0.30468,-0.32834,1,0
5,GO NEURAL CREST FORMATION,0.00011406,-0.30473,-0.31478,1,0
5,GO REGULATION OF INTEGRIN ACTIVATION,6.2046e-07,-0.30475,-0.37274,1,0
5,GO ADRENAL GLAND DEVELOPMENT,0.00015083,-0.30477,-0.34584,1,0
5,GO TISSUE HOMEOSTASIS,1.7442e-10,-0.30481,-0.35389,1,0
5,GO REGULATION OF NEUROBLAST PROLIFERATION,1.3196e-05,-0.30482,-0.31848,1,0
5,GO LIPID LOCALIZATION,5.1691e-12,-0.30508,-0.38538,1,0
5,GO REGULATION OF T CELL MIGRATION,3.7319e-10,-0.30508,-0.36893,1,0
5,GO VASODILATION,1.9989e-07,-0.30509,-0.36447,1,0
5,GO MEMBRANE HYPERPOLARIZATION,5.2445e-07,-0.30521,-0.37084,1,0
5,GO POSITIVE REGULATION OF GTPASE ACTIVITY,8.6145e-12,-0.30524,-0.45359,1,0
5,GO ORGANIC CATION TRANSPORT,1.4471e-09,-0.30534,-0.3811,1,0
5,GO MICROTUBULE ANCHORING AT CENTROSOME,3.3435e-06,-0.3054,-0.38169,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,1.5753e-08,-0.30544,-0.35442,1,0
5,GO REGULATION OF FATTY ACID TRANSPORT,1.3039e-08,-0.30544,-0.37263,1,0
5,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,1.0004e-06,-0.30544,-0.38455,1,0
5,GO NEGATIVE REGULATION OF LYASE ACTIVITY,9.4341e-06,-0.30548,-0.3369,1,0
5,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,6.5125e-09,-0.30561,-0.31792,1,0
5,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,1.5277e-10,-0.30562,-0.37361,1,0
5,GO RESPONSE TO OSMOTIC STRESS,9.658e-10,-0.30578,-0.35686,1,0
5,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,5.7923e-10,-0.30578,-0.38294,1,0
5,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.6792e-10,-0.30579,-0.36199,1,0
5,GO NEGATIVE REGULATION OF PHOSPHORYLATION,7.479e-12,-0.3058,-0.41429,1,0
5,GO NEURON CELLULAR HOMEOSTASIS,1.4207e-05,-0.30591,-0.34797,1,0
5,GO LEUKOCYTE CHEMOTAXIS,1.5604e-09,-0.30591,-0.34721,1,0
5,GO RESPONSE TO ESTRADIOL,6.3074e-11,-0.30591,-0.37295,1,0
5,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,2.2697e-09,-0.30592,-0.3373,1,0
5,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,1.887e-11,-0.30593,-0.36481,1,0
5,GO LYMPHOCYTE DIFFERENTIATION,7.2202e-11,-0.30594,-0.37617,1,0
5,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,8.1138e-06,-0.30597,-0.27945,1,0
5,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.4098e-06,-0.30598,-0.33699,1,0
5,GO REGULATION OF WATER LOSS VIA SKIN,0.00036124,-0.30599,-0.31733,1,0
5,GO CYTOSOLIC CALCIUM ION TRANSPORT,1.3133e-11,-0.30601,-0.39362,1,0
5,GO OSTEOBLAST DEVELOPMENT,7.7166e-08,-0.30605,-0.35081,1,0
5,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,5.7582e-06,-0.30607,-0.28398,1,0
5,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,2.65e-07,-0.3062,-0.37433,1,0
5,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,4.4749e-10,-0.3062,-0.39808,1,0
5,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,4.6356e-09,-0.30641,-0.35435,1,0
5,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,4.3549e-12,-0.30645,-0.42961,1,0
5,GO L GLUTAMATE IMPORT,1.1245e-09,-0.30654,-0.37354,1,0
5,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,2.9078e-09,-0.30661,-0.36607,1,0
5,GO REGULATION OF MONOOXYGENASE ACTIVITY,1.2441e-09,-0.30661,-0.33446,1,0
5,GO PROTEIN LIPID COMPLEX ASSEMBLY,3.1004e-08,-0.30661,-0.38055,1,0
5,GO NEURON DEVELOPMENT,1.2441e-09,-0.30668,-0.39875,1,0
5,GO IRON ION HOMEOSTASIS,7.4177e-11,-0.30672,-0.35564,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,6.3249e-05,-0.30675,-0.3242,1,0
5,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,3.7319e-10,-0.30675,-0.36408,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.9905e-10,-0.30676,-0.40129,1,0
5,GO PROSTAGLANDIN TRANSPORT,4.3355e-07,-0.30677,-0.33343,1,0
5,GO NEUTRAL LIPID CATABOLIC PROCESS,1.4163e-06,-0.30678,-0.28844,1,0
5,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,3.9941e-08,-0.30691,-0.32737,1,0
5,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,5.2344e-05,-0.30701,-0.34766,1,0
5,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,1.8419e-06,-0.30708,-0.32346,1,0
5,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,5.9432e-10,-0.30709,-0.38499,1,0
5,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,2.9979e-12,-0.30716,-0.39593,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,1.1245e-09,-0.30718,-0.37527,1,0
5,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,5.3186e-12,-0.30739,-0.43849,1,0
5,GO REGULATION OF MONONUCLEAR CELL MIGRATION,2.1375e-08,-0.3074,-0.37033,1,0
5,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,4.3082e-09,-0.30743,-0.33096,1,0
5,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,2.6981e-08,-0.30748,-0.3804,1,0
5,GO RESPONSE TO OXYGEN LEVELS,1.5529e-11,-0.30754,-0.3571,1,0
5,GO TOXIN TRANSPORT,7.2964e-10,-0.30754,-0.39422,1,0
5,GO RESPONSE TO BACTERIUM,7.8286e-11,-0.30755,-0.34828,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,5.0766e-11,-0.30766,-0.40393,1,0
5,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,6.1119e-05,-0.30768,-0.30522,1,0
5,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,4.3549e-12,-0.30769,-0.38559,1,0
5,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.000286,-0.30771,-0.32326,1,0
5,GO CELL ACTIVATION,4.9403e-11,-0.30771,-0.37651,1,0
5,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.1041e-08,-0.30773,-0.31949,1,0
5,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,1.8053e-06,-0.30774,-0.38269,1,0
5,GO PROTEIN ADP RIBOSYLATION,1.5753e-08,-0.30782,-0.3803,1,0
5,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,9.0235e-07,-0.30788,-0.33101,1,0
5,GO NOREPINEPHRINE TRANSPORT,4.2271e-06,-0.30791,-0.35489,1,0
5,GO REGULATION OF BONE DEVELOPMENT,6.895e-08,-0.30794,-0.36802,1,0
5,GO NEGATIVE REGULATION OF CELL AGING,8.6937e-09,-0.30797,-0.40317,1,0
5,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.00015083,-0.30803,-0.34698,1,0
5,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,5.7059e-05,-0.30808,-0.36722,1,0
5,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,1.9402e-11,-0.30827,-0.45356,1,0
5,GO DEVELOPMENTAL PIGMENTATION,1.7687e-09,-0.30832,-0.35965,1,0
5,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,1.0004e-06,-0.30836,-0.41161,1,0
5,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,6.757e-10,-0.30838,-0.33313,1,0
5,GO RESPONSE TO MISFOLDED PROTEIN,3.7195e-09,-0.30842,-0.42742,1,0
5,GO CHEMOKINE BIOSYNTHETIC PROCESS,3.8347e-06,-0.30844,-0.38917,1,0
5,GO GENITALIA DEVELOPMENT,1.6823e-09,-0.30853,-0.36407,1,0
5,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.021509,-0.30857,-0.22762,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,1.2032e-06,-0.30868,-0.36672,1,0
5,GO REGULATION OF MYOBLAST DIFFERENTIATION,1.069e-09,-0.30881,-0.38844,1,0
5,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,3.5794e-07,-0.30899,-0.32325,1,0
5,GO RESPONSE TO CALCIUM ION,3.5427e-10,-0.30901,-0.38588,1,0
5,GO RESPONSE TO DIETARY EXCESS,1.4741e-05,-0.30912,-0.33577,1,0
5,GO POSITIVE REGULATION OF CELL DEATH,2.6711e-12,-0.30915,-0.39052,1,0
5,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,3.6586e-11,-0.30922,-0.37378,1,0
5,GO REGULATION OF B CELL DIFFERENTIATION,1.1789e-06,-0.30932,-0.38447,1,0
5,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0033799,-0.30936,-0.30741,1,0
5,GO DORSAL VENTRAL AXIS SPECIFICATION,0.00012186,-0.30942,-0.34821,1,0
5,GO REGULATION OF DENDRITE DEVELOPMENT,7.5266e-09,-0.30943,-0.40667,1,0
5,GO REGULATION OF MONOCYTE CHEMOTAXIS,2.2958e-06,-0.30946,-0.37163,1,0
5,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,8.7237e-10,-0.30964,-0.35882,1,0
5,GO NEGATIVE REGULATION OF PROTEIN BINDING,5.6594e-11,-0.30967,-0.39803,1,0
5,GO NEGATIVE REGULATION OF SECRETION,1.1415e-11,-0.30974,-0.33219,1,0
5,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,5.4724e-12,-0.30996,-0.44384,1,0
5,GO T CELL ACTIVATION,2.3312e-10,-0.3101,-0.37451,1,0
5,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,4.1125e-12,-0.31011,-0.42957,1,0
5,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,1.0791e-07,-0.31016,-0.4084,1,0
5,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,6.9323e-10,-0.31026,-0.32851,1,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,1.3468e-07,-0.31038,-0.38252,1,0
5,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,1.2328e-07,-0.31041,-0.31723,1,0
5,GO NEUROMUSCULAR PROCESS,6.0565e-09,-0.31042,-0.35138,1,0
5,GO MORPHOGENESIS OF AN EPITHELIUM,1.785e-11,-0.31043,-0.39721,1,0
5,GO SELECTIVE AUTOPHAGY,3.9717e-11,-0.3105,-0.38899,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,4.0033e-09,-0.31052,-0.36222,1,0
5,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,2.4528e-05,-0.31066,-0.33588,1,0
5,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,6.0079e-05,-0.31066,-0.37133,1,0
5,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,4.7999e-05,-0.3107,-0.28644,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,7.6792e-10,-0.31073,-0.39051,1,0
5,GO REGULATION OF PROTEIN DEUBIQUITINATION,5.2538e-08,-0.31083,-0.36725,1,0
5,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,2.2775e-07,-0.3109,-0.39695,1,0
5,GO POSITIVE REGULATION OF CELL ACTIVATION,4.249e-10,-0.31092,-0.36982,1,0
5,GO LUNG CELL DIFFERENTIATION,1.8701e-05,-0.31094,-0.3771,1,0
5,GO CHEMOKINE PRODUCTION,2.7e-09,-0.31111,-0.37659,1,0
5,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,9.5999e-07,-0.31118,-0.38257,1,0
5,GO KETONE BIOSYNTHETIC PROCESS,7.969e-07,-0.31123,-0.3319,1,0
5,GO SECONDARY HEART FIELD SPECIFICATION,0.00015583,-0.31123,-0.42248,1,0
5,GO CELLULAR RESPONSE TO DRUG,3.4516e-10,-0.3113,-0.37094,1,0
5,GO DEFENSE RESPONSE,2.0983e-10,-0.31138,-0.35009,1,0
5,GO B CELL PROLIFERATION,7.3476e-09,-0.31142,-0.36891,1,0
5,GO HYPEROSMOTIC SALINITY RESPONSE,1.475e-06,-0.31143,-0.33803,1,0
5,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,1.1398e-10,-0.31154,-0.36269,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,3.8149e-08,-0.31155,-0.38408,1,0
5,GO POLYOL METABOLIC PROCESS,1.6884e-11,-0.31162,-0.36875,1,0
5,GO T CELL PROLIFERATION,3.5412e-09,-0.31163,-0.35125,1,0
5,GO ORGAN GROWTH,1.9402e-11,-0.31167,-0.41608,1,0
5,GO ETHER BIOSYNTHETIC PROCESS,2.8271e-07,-0.3117,-0.42479,1,0
5,GO REGULATION OF MYOTUBE DIFFERENTIATION,7.4854e-10,-0.3118,-0.41319,1,0
5,GO RESPONSE TO REACTIVE OXYGEN SPECIES,5.0766e-11,-0.31189,-0.36143,1,0
5,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,2.5066e-09,-0.31192,-0.38213,1,0
5,GO KIDNEY MESENCHYME DEVELOPMENT,0.00016901,-0.31192,-0.32114,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.4516e-10,-0.31199,-0.37491,1,0
5,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,4.5233e-07,-0.31204,-0.39692,1,0
5,GO REGULATION OF PROTEIN DEACETYLATION,6.8348e-09,-0.3121,-0.38228,1,0
5,GO REGULATION OF ENDOCRINE PROCESS,1.5604e-09,-0.3121,-0.38239,1,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.00086244,-0.31219,-0.36016,1,0
5,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,1.1307e-08,-0.31237,-0.39863,1,0
5,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,3.1479e-07,-0.31238,-0.34549,1,0
5,GO POSITIVE REGULATION OF CELL CELL ADHESION,3.2764e-10,-0.31245,-0.38903,1,0
5,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,1.0241e-10,-0.31245,-0.35786,1,0
5,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,2.3274e-07,-0.31247,-0.372,1,0
5,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,4.8416e-06,-0.3125,-0.41794,1,0
5,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,4.0868e-08,-0.31251,-0.3926,1,0
5,GO PROTEIN LOCALIZATION TO CILIUM,1.0004e-06,-0.31271,-0.34355,1,0
5,GO RESPONSE TO LIPID,2.1188e-12,-0.31275,-0.3872,1,0
5,GO REGULATION OF EXOSOMAL SECRETION,1.7534e-07,-0.31276,-0.3901,1,0
5,GO PLACENTA BLOOD VESSEL DEVELOPMENT,7.71e-09,-0.31277,-0.45198,1,0
5,GO LEUKOCYTE MEDIATED CYTOTOXICITY,5.3562e-07,-0.3128,-0.32938,1,0
5,GO LIPID MODIFICATION,3.462e-12,-0.31284,-0.38428,1,0
5,GO CEREBELLAR CORTEX MORPHOGENESIS,3.758e-05,-0.31287,-0.3057,1,0
5,GO REGULATION OF CELLULAR COMPONENT SIZE,5.3186e-12,-0.31305,-0.41982,1,0
5,GO REGULATION OF PROTEIN KINASE A SIGNALING,3.2094e-09,-0.31322,-0.35093,1,0
5,GO LIPID PHOSPHORYLATION,1.887e-11,-0.31322,-0.4362,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,2.634e-09,-0.31323,-0.37592,1,0
5,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,1.5293e-05,-0.31326,-0.38504,1,0
5,GO PROTEIN LOCALIZATION TO VACUOLE,4.3109e-11,-0.31328,-0.4244,1,0
5,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,3.6435e-08,-0.31328,-0.42934,1,0
5,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,6.9323e-10,-0.31338,-0.38843,1,0
5,GO REGULATION OF LEUKOCYTE PROLIFERATION,1.1579e-08,-0.31341,-0.35282,1,0
5,GO CGMP METABOLIC PROCESS,3.0395e-05,-0.31341,-0.36919,1,0
5,GO SKELETAL SYSTEM DEVELOPMENT,4.6112e-12,-0.31343,-0.43092,1,0
5,GO REGULATION OF VIRAL GENOME REPLICATION,6.4592e-06,-0.31346,-0.35374,1,0
5,GO CELLULAR POTASSIUM ION HOMEOSTASIS,7.8052e-07,-0.3136,-0.33813,1,0
5,GO ADAPTATION OF SIGNALING PATHWAY,2.7614e-08,-0.31361,-0.34797,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,5.6451e-10,-0.31363,-0.44205,1,0
5,GO MAINTENANCE OF BLOOD BRAIN BARRIER,4.5233e-07,-0.31367,-0.45478,1,0
5,GO REGULATION OF TRANSMEMBRANE TRANSPORT,1.1415e-11,-0.31368,-0.36861,1,0
5,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,3.8161e-07,-0.31373,-0.36271,1,0
5,GO TRNA CATABOLIC PROCESS,0.00012804,-0.31373,-0.35525,1,0
5,GO EMBRYONIC ORGAN DEVELOPMENT,4.9403e-11,-0.31377,-0.38201,1,0
5,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,2.9371e-11,-0.31381,-0.35585,1,0
5,GO URETER DEVELOPMENT,3.7282e-08,-0.31382,-0.37384,1,0
5,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,6.0759e-07,-0.31401,-0.3506,1,0
5,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.2281e-06,-0.3141,-0.37595,1,0
5,GO RESPONSE TO WATER,5.2303e-06,-0.31412,-0.37255,1,0
5,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00011596,-0.31413,-0.36062,1,0
5,GO CELLULAR GLUCAN METABOLIC PROCESS,5.9748e-11,-0.31416,-0.40696,1,0
5,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,3.2785e-11,-0.31421,-0.38444,1,0
5,GO SEROTONIN SECRETION,0.00042777,-0.31421,-0.23639,1,0
5,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,2.3784e-07,-0.31424,-0.44656,1,0
5,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,4.7125e-10,-0.31452,-0.42805,1,0
5,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,8.1361e-07,-0.31456,-0.39444,1,0
5,GO RESPONSE TO NERVE GROWTH FACTOR,2.2775e-07,-0.31457,-0.35043,1,0
5,GO MYELOID CELL DIFFERENTIATION,8.3747e-12,-0.31463,-0.40571,1,0
5,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,1.3039e-08,-0.31463,-0.33267,1,0
5,GO REGULATION OF RECEPTOR INTERNALIZATION,1.3351e-08,-0.31465,-0.38946,1,0
5,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,5.9432e-10,-0.31471,-0.3749,1,0
5,GO REGULATION OF POTASSIUM ION TRANSPORT,6.5125e-09,-0.31473,-0.34569,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,6.3569e-09,-0.31478,-0.32332,1,0
5,GO REGULATION OF CELL ACTIVATION,5.9748e-11,-0.31485,-0.38024,1,0
5,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,9.6562e-05,-0.31499,-0.2938,1,0
5,GO NEUROTRANSMITTER UPTAKE,3.6567e-07,-0.31517,-0.32992,1,0
5,GO VIRAL GENOME REPLICATION,3.8983e-07,-0.31518,-0.35801,1,0
5,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,7.1726e-09,-0.31522,-0.38605,1,0
5,GO REGULATION OF BIOMINERALIZATION,1.9402e-11,-0.31527,-0.44861,1,0
5,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.0437e-10,-0.3154,-0.39371,1,0
5,GO REGULATION OF TRANS SYNAPTIC SIGNALING,9.6538e-08,-0.31541,-0.3742,1,0
5,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,1.4282e-11,-0.31546,-0.41025,1,0
5,GO REGULATION OF NEURON DIFFERENTIATION,8.2903e-10,-0.31554,-0.41069,1,0
5,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,5.6245e-08,-0.31566,-0.38482,1,0
5,GO IMMUNE EFFECTOR PROCESS,4.8359e-10,-0.3157,-0.37037,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,3.4516e-10,-0.31587,-0.38136,1,0
5,GO RESPONSE TO GROWTH FACTOR,1.0493e-11,-0.316,-0.42831,1,0
5,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,1.3761e-09,-0.31608,-0.44484,1,0
5,GO REGULATION OF B CELL ACTIVATION,1.2441e-09,-0.31618,-0.38081,1,0
5,GO FAT CELL DIFFERENTIATION,1.277e-11,-0.31619,-0.41288,1,0
5,GO REGULATION OF THE FORCE OF HEART CONTRACTION,1.0036e-08,-0.3162,-0.40371,1,0
5,GO ADIPOSE TISSUE DEVELOPMENT,7.8778e-10,-0.3162,-0.40173,1,0
5,GO REGULATION OF ORGAN GROWTH,6.4805e-11,-0.31622,-0.39136,1,0
5,GO PROTEIN LOCALIZATION TO CELL SURFACE,2.5893e-10,-0.31625,-0.41661,1,0
5,GO REPRODUCTIVE SYSTEM DEVELOPMENT,6.6581e-11,-0.31626,-0.3697,1,0
5,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,6.4699e-07,-0.31634,-0.40429,1,0
5,GO OSSIFICATION,4.0817e-11,-0.31635,-0.42286,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,2.9602e-08,-0.31635,-0.37167,1,0
5,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,3.4003e-08,-0.31641,-0.40108,1,0
5,GO CONNECTIVE TISSUE DEVELOPMENT,7.9144e-12,-0.31641,-0.46769,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,3.3629e-10,-0.31651,-0.37611,1,0
5,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,1.3039e-08,-0.31651,-0.36143,1,0
5,GO IRON COORDINATION ENTITY TRANSPORT,1.2792e-06,-0.31656,-0.35218,1,0
5,GO FORELIMB MORPHOGENESIS,1.0212e-06,-0.31659,-0.36271,1,0
5,GO REGULATION OF CELL FATE SPECIFICATION,9.9803e-06,-0.3166,-0.34912,1,0
5,GO POSITIVE REGULATION OF BINDING,1.0519e-10,-0.31661,-0.34833,1,0
5,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,8.4262e-06,-0.31664,-0.37907,1,0
5,GO REGULATION OF DENDRITE EXTENSION,0.0020092,-0.31678,-0.25196,1,0
5,GO ERBB2 SIGNALING PATHWAY,1.1041e-08,-0.3169,-0.40897,1,0
5,GO CANONICAL WNT SIGNALING PATHWAY,8.4871e-11,-0.31695,-0.38498,1,0
5,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,2.2707e-10,-0.31704,-0.37135,1,0
5,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,4.2487e-05,-0.31715,-0.4064,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,5.2359e-09,-0.31715,-0.3435,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION,2.2697e-09,-0.31745,-0.36429,1,0
5,GO ENSHEATHMENT OF NEURONS,9.9185e-12,-0.31745,-0.42135,1,0
5,GO REGULATION OF CALCIUM ION TRANSPORT,4.3549e-12,-0.31746,-0.38009,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,9.5999e-07,-0.31746,-0.37859,1,0
5,GO MAMMARY GLAND DEVELOPMENT,8.1414e-12,-0.31752,-0.45286,1,0
5,GO GLIAL CELL DIFFERENTIATION,1.2131e-09,-0.31762,-0.38662,1,0
5,GO POST ANAL TAIL MORPHOGENESIS,0.00013899,-0.31765,-0.30958,1,0
5,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,9.795e-06,-0.31767,-0.30371,1,0
5,GO ENTEROENDOCRINE CELL DIFFERENTIATION,3.357e-07,-0.31768,-0.36373,1,0
5,GO CLATHRIN COAT ASSEMBLY,9.6538e-08,-0.31776,-0.41604,1,0
5,GO LEUKOCYTE TETHERING OR ROLLING,1.8135e-09,-0.31778,-0.325,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,9.658e-10,-0.31783,-0.35244,1,0
5,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,3.5606e-08,-0.31788,-0.33056,1,0
5,GO SULFUR COMPOUND CATABOLIC PROCESS,4.5922e-10,-0.31788,-0.38739,1,0
5,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,6.205e-09,-0.31789,-0.42407,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,6.0759e-07,-0.31792,-0.40826,1,0
5,GO ENDOCRINE HORMONE SECRETION,8.5043e-10,-0.31793,-0.36826,1,0
5,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,1.3878e-06,-0.31795,-0.35173,1,0
5,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,1.0004e-06,-0.31802,-0.2875,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,5.7923e-10,-0.31805,-0.37817,1,0
5,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,2.2416e-05,-0.31805,-0.3407,1,0
5,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,2.3853e-09,-0.31807,-0.39847,1,0
5,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,5.2538e-08,-0.3181,-0.42031,1,0
5,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.6435e-08,-0.31814,-0.35693,1,0
5,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,0.00036686,-0.31814,-0.31742,1,0
5,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,9.2118e-07,-0.31828,-0.40457,1,0
5,GO AUTOPHAGOSOME MATURATION,5.5016e-10,-0.31833,-0.35658,1,0
5,GO LEUKOCYTE DIFFERENTIATION,3.8645e-11,-0.31844,-0.38946,1,0
5,GO REGULATION OF NOTCH SIGNALING PATHWAY,5.1101e-09,-0.31855,-0.45205,1,0
5,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,7.6205e-11,-0.31857,-0.43906,1,0
5,GO REGULATION OF HISTONE DEACETYLATION,3.2162e-07,-0.31864,-0.35685,1,0
5,GO IMPORT ACROSS PLASMA MEMBRANE,1.0202e-11,-0.31869,-0.40222,1,0
5,GO RETROGRADE AXONAL TRANSPORT,4.9694e-05,-0.31872,-0.39022,1,0
5,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,1.484e-09,-0.31887,-0.43558,1,0
5,GO REGULATION OF GASTRULATION,5.4967e-09,-0.3189,-0.43846,1,0
5,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,8.9558e-11,-0.31902,-0.38665,1,0
5,GO POSITIVE REGULATION OF B CELL ACTIVATION,2.004e-09,-0.31906,-0.3915,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,2.8886e-07,-0.31911,-0.35297,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,5.1101e-09,-0.31922,-0.3429,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,1.2027e-05,-0.31923,-0.3583,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.6306e-11,-0.31926,-0.4664,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,4.1025e-09,-0.31927,-0.4089,1,0
5,GO B CELL DIFFERENTIATION,2.5066e-09,-0.31936,-0.40028,1,0
5,GO CORTICAL CYTOSKELETON ORGANIZATION,1.1579e-08,-0.31939,-0.41054,1,0
5,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,7.4854e-10,-0.31945,-0.34076,1,0
5,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.00022565,-0.31949,-0.37587,1,0
5,GO LIPID HOMEOSTASIS,1.0202e-11,-0.31952,-0.38551,1,0
5,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,8.6328e-08,-0.31958,-0.32028,1,0
5,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,9.819e-05,-0.31969,-0.3474,1,0
5,GO LYSOSOME LOCALIZATION,1.0036e-08,-0.31972,-0.37353,1,0
5,GO LEUKOCYTE MEDIATED IMMUNITY,8.7237e-10,-0.31975,-0.3606,1,0
5,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.0004e-06,-0.3199,-0.38058,1,0
5,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,2.2286e-07,-0.31991,-0.37183,1,0
5,GO POSITIVE REGULATION OF PROTEIN BINDING,5.3186e-12,-0.31993,-0.43846,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,6.9323e-10,-0.31999,-0.37378,1,0
5,GO HEART MORPHOGENESIS,4.9403e-11,-0.32013,-0.42931,1,0
5,GO RESPONSE TO HYDROGEN PEROXIDE,1.2682e-10,-0.32017,-0.37551,1,0
5,GO REGULATION OF SENSORY PERCEPTION,2.0429e-07,-0.32023,-0.27362,1,0
5,GO REGULATION OF RNA EXPORT FROM NUCLEUS,2.1621e-05,-0.32026,-0.32383,1,0
5,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,4.249e-10,-0.3203,-0.40601,1,0
5,GO ENTRY INTO HOST,1.7442e-10,-0.32035,-0.45001,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,3.0856e-12,-0.32059,-0.38801,1,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,4.3109e-11,-0.32062,-0.3802,1,0
5,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,2.3274e-07,-0.32074,-0.34061,1,0
5,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,8.9047e-09,-0.32074,-0.38417,1,0
5,GO RESPONSE TO INTERLEUKIN 2,4.6202e-07,-0.32084,-0.38403,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,6.4192e-10,-0.32086,-0.35754,1,0
5,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,2.5893e-10,-0.32094,-0.3555,1,0
5,GO PHOSPHOLIPID TRANSPORT,2.0509e-11,-0.321,-0.42844,1,0
5,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,5.3602e-11,-0.32112,-0.41816,1,0
5,GO APPENDAGE DEVELOPMENT,3.2094e-09,-0.32119,-0.40614,1,0
5,GO SENSORY PERCEPTION OF PAIN,7.5266e-09,-0.32125,-0.3172,1,0
5,GO CATECHOLAMINE SECRETION,9.3381e-05,-0.32136,-0.31833,1,0
5,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,8.7502e-06,-0.32148,-0.33246,1,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.00010673,-0.32152,-0.3794,1,0
5,GO AMINE TRANSPORT,5.6085e-05,-0.32166,-0.28375,1,0
5,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,7.8124e-06,-0.32168,-0.37425,1,0
5,GO RECEPTOR BIOSYNTHETIC PROCESS,6.4192e-10,-0.32169,-0.4106,1,0
5,GO B CELL APOPTOTIC PROCESS,3.8347e-06,-0.32171,-0.36422,1,0
5,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.7676e-09,-0.32179,-0.38242,1,0
5,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,1.6418e-07,-0.32186,-0.39524,1,0
5,GO GLIOGENESIS,3.3629e-10,-0.32189,-0.38706,1,0
5,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,5.5412e-06,-0.32211,-0.3256,1,0
5,GO ERYTHROCYTE HOMEOSTASIS,5.815e-11,-0.32213,-0.40442,1,0
5,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,4.3606e-10,-0.32214,-0.41899,1,0
5,GO REGULATION OF LEUKOCYTE MIGRATION,3.9309e-10,-0.32215,-0.39192,1,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.0010113,-0.32218,-0.41002,1,0
5,GO MYOBLAST DIFFERENTIATION,2.1064e-09,-0.32222,-0.37405,1,0
5,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,2.9979e-12,-0.32229,-0.43168,1,0
5,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,1.6109e-10,-0.32241,-0.35142,1,0
5,GO REGULATION OF SODIUM ION TRANSPORT,3.5412e-09,-0.32247,-0.40083,1,0
5,GO REGULATION OF PINOCYTOSIS,3.5412e-09,-0.32247,-0.43026,1,0
5,GO REGULATION OF HORMONE METABOLIC PROCESS,2.7614e-08,-0.32248,-0.47107,1,0
5,GO INTERFERON GAMMA PRODUCTION,6.5906e-08,-0.32252,-0.32952,1,0
5,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,6.5125e-09,-0.32253,-0.38918,1,0
5,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,5.0323e-06,-0.32254,-0.30754,1,0
5,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,1.4207e-05,-0.32257,-0.39219,1,0
5,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,1.0964e-09,-0.32263,-0.33968,1,0
5,GO ACTIN FILAMENT ORGANIZATION,1.1099e-11,-0.32265,-0.43987,1,0
5,GO ANIMAL ORGAN FORMATION,5.6317e-09,-0.32271,-0.3554,1,0
5,GO HORMONE BIOSYNTHETIC PROCESS,1.5037e-07,-0.32271,-0.34565,1,0
5,GO SYNAPTIC TRANSMISSION CHOLINERGIC,4.5233e-07,-0.32278,-0.30085,1,0
5,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.9064e-09,-0.32278,-0.41685,1,0
5,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,1.7721e-08,-0.32282,-0.38821,1,0
5,GO BONE RESORPTION,8.4877e-09,-0.32306,-0.39482,1,0
5,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,1.475e-06,-0.32324,-0.37232,1,0
5,GO ADAPTIVE IMMUNE RESPONSE,1.9064e-09,-0.32329,-0.38737,1,0
5,GO ENERGY RESERVE METABOLIC PROCESS,3.9717e-11,-0.32338,-0.40008,1,0
5,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,3.1757e-12,-0.32344,-0.43059,1,0
5,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,8.2543e-08,-0.32349,-0.38233,1,0
5,GO REGULATION OF INFLAMMATORY RESPONSE,1.9387e-10,-0.32352,-0.3569,1,0
5,GO LEARNING,1.1579e-08,-0.32353,-0.37301,1,0
5,GO LEUKOCYTE PROLIFERATION,1.4112e-09,-0.32363,-0.3671,1,0
5,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,3.3629e-10,-0.3237,-0.44133,1,0
5,GO PROTEIN AUTOPHOSPHORYLATION,3.8833e-12,-0.32371,-0.45194,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,5.4982e-08,-0.32372,-0.34798,1,0
5,GO BRANCHED CHAIN AMINO ACID TRANSPORT,6.6066e-07,-0.32372,-0.50682,1,0
5,GO CELL CELL JUNCTION ASSEMBLY,1.5217e-09,-0.32376,-0.42034,1,0
5,GO GLYCEROLIPID CATABOLIC PROCESS,5.2359e-09,-0.32376,-0.32941,1,0
5,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00083767,-0.32387,-0.2857,1,0
5,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,8.2864e-09,-0.32393,-0.37006,1,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,1.1041e-08,-0.32397,-0.3095,1,0
5,GO COPII COATED VESICLE CARGO LOADING,7.892e-08,-0.32399,-0.3895,1,0
5,GO RESPONSE TO STEROID HORMONE,2.1188e-12,-0.32403,-0.40214,1,0
5,GO REGULATION OF CARDIAC CONDUCTION,2.9078e-09,-0.32412,-0.37758,1,0
5,GO RESPONSE TO VITAMIN A,8.8389e-07,-0.32424,-0.32504,1,0
5,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,8.1623e-05,-0.32424,-0.38153,1,0
5,GO GLUCOCORTICOID METABOLIC PROCESS,3.4796e-08,-0.32427,-0.40247,1,0
5,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.6514e-08,-0.32434,-0.38646,1,0
5,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,2.1375e-08,-0.32445,-0.44263,1,0
5,GO DENDRITIC TRANSPORT,0.00013899,-0.32448,-0.37493,1,0
5,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,0.0018764,-0.32462,-0.30824,1,0
5,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.0088198,-0.32476,-0.31246,1,0
5,GO LOCALIZATION WITHIN MEMBRANE,5.6317e-09,-0.32477,-0.40276,1,0
5,GO CELL JUNCTION ASSEMBLY,1.1415e-11,-0.32484,-0.4602,1,0
5,GO REGULATION OF NERVOUS SYSTEM PROCESS,7.0522e-08,-0.32484,-0.36159,1,0
5,GO REGULATION OF LIPASE ACTIVITY,1.3888e-11,-0.32496,-0.36679,1,0
5,GO REGULATION OF STEROID METABOLIC PROCESS,1.1858e-08,-0.32497,-0.35916,1,0
5,GO MYELOID DENDRITIC CELL DIFFERENTIATION,2.3891e-06,-0.32498,-0.33093,1,0
5,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,9.0235e-07,-0.325,-0.33069,1,0
5,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.000286,-0.32501,-0.30435,1,0
5,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,1.8353e-11,-0.32502,-0.35967,1,0
5,GO CELLULAR RESPONSE TO STEROL DEPLETION,3.0156e-07,-0.32507,-0.37972,1,0
5,GO REGULATION OF LIPID LOCALIZATION,1.887e-11,-0.32511,-0.37678,1,0
5,GO OPIOID RECEPTOR SIGNALING PATHWAY,9.404e-07,-0.32512,-0.40743,1,0
5,GO ACTIVATION OF GTPASE ACTIVITY,9.1996e-11,-0.32514,-0.44037,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,7.8052e-07,-0.32514,-0.37492,1,0
5,GO I KAPPAB PHOSPHORYLATION,1.9546e-09,-0.32522,-0.39942,1,0
5,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,7.8124e-06,-0.32534,-0.32932,1,0
5,GO BRANCH ELONGATION OF AN EPITHELIUM,1.2716e-05,-0.32544,-0.4003,1,0
5,GO NEGATIVE REGULATION OF KINASE ACTIVITY,6.4805e-11,-0.32556,-0.40239,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.00063314,-0.32556,-0.29871,1,0
5,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,1.484e-09,-0.32567,-0.33542,1,0
5,GO ALPHA BETA T CELL DIFFERENTIATION,6.0565e-09,-0.32568,-0.38554,1,0
5,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,4.7999e-05,-0.32573,-0.31167,1,0
5,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,5.6317e-09,-0.32574,-0.34317,1,0
5,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,5.7536e-08,-0.32577,-0.38179,1,0
5,GO INTERFERON ALPHA PRODUCTION,2.402e-08,-0.32581,-0.3813,1,0
5,GO REGULATION OF B CELL PROLIFERATION,2.2397e-08,-0.32594,-0.38566,1,0
5,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.026561,-0.32595,-0.18283,1,0
5,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00068191,-0.32596,-0.33348,1,0
5,GO CELLULAR COMPONENT MORPHOGENESIS,1.5217e-09,-0.326,-0.40978,1,0
5,GO STEROID HORMONE BIOSYNTHETIC PROCESS,5.7582e-06,-0.32606,-0.32991,1,0
5,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,7.1726e-09,-0.32607,-0.48852,1,0
5,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,5.3186e-12,-0.32636,-0.42619,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,4.0314e-05,-0.3265,-0.35868,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,1.1099e-11,-0.32655,-0.44033,1,0
5,GO KIDNEY MORPHOGENESIS,1.0279e-08,-0.32661,-0.36238,1,0
5,GO REGULATION OF CELL CELL ADHESION,3.1896e-11,-0.32665,-0.41022,1,0
5,GO REGULATION OF B CELL MEDIATED IMMUNITY,4.1403e-10,-0.32667,-0.38758,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.0241e-10,-0.32669,-0.4789,1,0
5,GO STEROID ESTERIFICATION,9.6538e-08,-0.32671,-0.43014,1,0
5,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,1.0557e-05,-0.32677,-0.39994,1,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,1.9993e-12,-0.32678,-0.41071,1,0
5,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,2.2397e-08,-0.3269,-0.36709,1,0
5,GO ANIMAL ORGAN REGENERATION,1.8594e-09,-0.32698,-0.34911,1,0
5,GO REGULATION OF MAPK CASCADE,2.1188e-12,-0.32698,-0.41656,1,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.7309e-08,-0.3271,-0.41734,1,0
5,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,1.7721e-08,-0.32711,-0.41968,1,0
5,GO REGULATION OF DOPAMINE SECRETION,0.00087508,-0.32711,-0.33123,1,0
5,GO RESPONSE TO PROSTAGLANDIN E,5.5078e-11,-0.32719,-0.39677,1,0
5,GO CELLULAR RESPONSE TO ANTIBIOTIC,6.8888e-05,-0.32722,-0.31809,1,0
5,GO BONE MATURATION,2.2286e-07,-0.32724,-0.39193,1,0
5,GO REGULATION OF MAP KINASE ACTIVITY,1.0202e-11,-0.32734,-0.43041,1,0
5,GO INNER EAR RECEPTOR CELL DEVELOPMENT,8.4415e-08,-0.32737,-0.37043,1,0
5,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.0032078,-0.32739,-0.40014,1,0
5,GO EMBRYONIC MORPHOGENESIS,2.7041e-11,-0.32743,-0.40542,1,0
5,GO I KAPPAB KINASE NF KAPPAB SIGNALING,6.8406e-11,-0.32744,-0.40537,1,0
5,GO OVULATION CYCLE,3.3629e-10,-0.32747,-0.40776,1,0
5,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,5.6304e-12,-0.32752,-0.42418,1,0
5,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,8.5043e-10,-0.32754,-0.3848,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,1.1375e-05,-0.32755,-0.29446,1,0
5,GO IMMUNOLOGICAL MEMORY PROCESS,9.6562e-05,-0.32757,-0.32524,1,0
5,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,4.232e-12,-0.32772,-0.41962,1,0
5,GO CYTOKINE SECRETION,2.5695e-09,-0.32782,-0.3273,1,0
5,GO REGULATION OF EPITHELIAL TUBE FORMATION,5.6085e-05,-0.32787,-0.34583,1,0
5,GO REGULATION OF URINE VOLUME,2.3312e-10,-0.32816,-0.37788,1,0
5,GO REGULATION OF STEM CELL DIVISION,3.5794e-07,-0.32817,-0.35995,1,0
5,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.00052901,-0.32817,-0.27617,1,0
5,GO INTERMEDIATE FILAMENT BASED PROCESS,2.1595e-09,-0.32822,-0.40108,1,0
5,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,2.8573e-11,-0.32832,-0.37711,1,0
5,GO NEGATIVE REGULATION OF VIRAL PROCESS,7.5217e-06,-0.32839,-0.39364,1,0
5,GO ALANINE TRANSPORT,3.5606e-08,-0.32846,-0.499,1,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS,3.8246e-05,-0.32855,-0.36596,1,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,1.4471e-09,-0.32865,-0.42544,1,0
5,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,3.462e-12,-0.32873,-0.43795,1,0
5,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,3.192e-10,-0.32876,-0.36724,1,0
5,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,3.7195e-09,-0.32881,-0.41851,1,0
5,GO RESPONSE TO ACTIVITY,1.2682e-10,-0.3289,-0.35578,1,0
5,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,2.5893e-10,-0.32899,-0.3676,1,0
5,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,5.1691e-12,-0.329,-0.39013,1,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,1.6654e-06,-0.32914,-0.37999,1,0
5,GO LONG TERM SYNAPTIC POTENTIATION,3.4516e-10,-0.32916,-0.4287,1,0
5,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.00024819,-0.32919,-0.29687,1,0
5,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,6.1119e-05,-0.32924,-0.42297,1,0
5,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,2.2117e-10,-0.32933,-0.45448,1,0
5,GO POSITIVE REGULATION OF MAPK CASCADE,1.3685e-12,-0.32943,-0.41643,1,0
5,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,4.8198e-07,-0.32943,-0.36041,1,0
5,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.9387e-10,-0.32947,-0.42247,1,0
5,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.00011218,-0.32952,-0.37497,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.6407e-09,-0.32957,-0.44593,1,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,1.5865e-05,-0.32966,-0.28661,1,0
5,GO REGULATION OF OSSIFICATION,7.4177e-11,-0.32969,-0.43411,1,0
5,GO ACTIN CYTOSKELETON REORGANIZATION,4.5922e-10,-0.32989,-0.42767,1,0
5,GO CYTOKINE PRODUCTION,1.3376e-10,-0.33003,-0.38065,1,0
5,GO MYOFIBRIL ASSEMBLY,2.4586e-08,-0.33005,-0.35871,1,0
5,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,1.8318e-07,-0.33008,-0.40932,1,0
5,GO REGENERATION,5.9748e-11,-0.33017,-0.37944,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,8.6328e-08,-0.33036,-0.38696,1,0
5,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.00029976,-0.33039,-0.30631,1,0
5,GO NEGATIVE REGULATION OF ENDOCYTOSIS,9.4499e-11,-0.33039,-0.40915,1,0
5,GO MONOAMINE TRANSPORT,3.5646e-05,-0.3304,-0.30828,1,0
5,GO REGULATION OF PROTEIN POLYUBIQUITINATION,3.4296e-07,-0.33044,-0.34616,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,1.2441e-09,-0.33048,-0.41343,1,0
5,GO INTERLEUKIN 8 PRODUCTION,3.7282e-08,-0.33051,-0.39463,1,0
5,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,4.4148e-09,-0.33057,-0.40317,1,0
5,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,2.0437e-10,-0.33076,-0.44164,1,0
5,GO PHOSPHOLIPID CATABOLIC PROCESS,2.004e-09,-0.33082,-0.40123,1,0
5,GO CARDIAC MYOFIBRIL ASSEMBLY,3.2146e-06,-0.3309,-0.37708,1,0
5,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.00011218,-0.33098,-0.33913,1,0
5,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,5.6245e-08,-0.33099,-0.34575,1,0
5,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,7.105e-06,-0.33112,-0.54363,1,0
5,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,3.7735e-12,-0.33114,-0.46495,1,0
5,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,6.2565e-10,-0.33124,-0.43467,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,1.3599e-06,-0.33125,-0.39153,1,0
5,GO NOREPINEPHRINE SECRETION,2.9332e-05,-0.33129,-0.33351,1,0
5,GO CAMERA TYPE EYE DEVELOPMENT,3.5427e-10,-0.33129,-0.39863,1,0
5,GO SUPEROXIDE METABOLIC PROCESS,1.7309e-08,-0.33132,-0.32604,1,0
5,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,3.9963e-12,-0.33148,-0.41832,1,0
5,GO GLIAL CELL PROLIFERATION,9.1793e-10,-0.33165,-0.38692,1,0
5,GO DIGESTIVE TRACT MORPHOGENESIS,3.6435e-08,-0.33178,-0.37521,1,0
5,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,8.7237e-10,-0.33188,-0.37952,1,0
5,GO REGULATION OF MITOPHAGY,2.9602e-08,-0.33189,-0.37934,1,0
5,GO MEMBRANE REPOLARIZATION,1.6514e-08,-0.33191,-0.41285,1,0
5,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,5.9056e-05,-0.33191,-0.3814,1,0
5,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,1.3999e-08,-0.33204,-0.51375,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,1.5383e-12,-0.33206,-0.4361,1,0
5,GO POSITIVE CHEMOTAXIS,5.9748e-11,-0.33211,-0.41976,1,0
5,GO CELL PROLIFERATION IN FOREBRAIN,2.4861e-06,-0.33215,-0.38643,1,0
5,GO INTRACELLULAR MRNA LOCALIZATION,2.2958e-06,-0.3322,-0.39031,1,0
5,GO RECEPTOR MEDIATED ENDOCYTOSIS,2.2453e-12,-0.33223,-0.4012,1,0
5,GO RESPONSE TO PARATHYROID HORMONE,3.9102e-06,-0.33236,-0.36693,1,0
5,GO DENDRITE DEVELOPMENT,1.2143e-08,-0.33236,-0.40405,1,0
5,GO SYNAPTIC VESICLE RECYCLING,6.5906e-08,-0.33237,-0.39765,1,0
5,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,8.2686e-06,-0.33243,-0.4018,1,0
5,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,8.9047e-09,-0.33255,-0.4105,1,0
5,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.8925e-08,-0.33277,-0.38866,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,1.064e-06,-0.33278,-0.40338,1,0
5,GO MYELOID CELL HOMEOSTASIS,8.2618e-11,-0.33283,-0.40717,1,0
5,GO REGULATION OF NEURON PROJECTION ARBORIZATION,2.9859e-05,-0.33286,-0.47651,1,0
5,GO ENDOCRINE PROCESS,1.7442e-10,-0.3329,-0.39549,1,0
5,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,6.0759e-07,-0.333,-0.39229,1,0
5,GO PROXIMAL DISTAL PATTERN FORMATION,0.00016901,-0.33306,-0.30774,1,0
5,GO LYMPHOCYTE MEDIATED IMMUNITY,7.1121e-10,-0.33309,-0.38366,1,0
5,GO TRANSMISSION OF NERVE IMPULSE,3.152e-06,-0.3331,-0.33988,1,0
5,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,3.1032e-11,-0.33322,-0.39046,1,0
5,GO SYNAPTIC VESICLE DOCKING,0.00076726,-0.33324,-0.36655,1,0
5,GO T HELPER 1 CELL DIFFERENTIATION,3.6877e-06,-0.33331,-0.46856,1,0
5,GO MACROPHAGE DIFFERENTIATION,5.5078e-11,-0.33336,-0.43311,1,0
5,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,0.0063654,-0.33337,-0.35336,1,0
5,GO ACYLGLYCEROL HOMEOSTASIS,4.9624e-10,-0.33342,-0.40095,1,0
5,GO REGULATION OF BLOOD CIRCULATION,3.6586e-11,-0.33377,-0.39581,1,0
5,GO CELL JUNCTION ORGANIZATION,6.8695e-12,-0.33382,-0.46473,1,0
5,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,0.00015838,-0.33394,-0.39109,1,0
5,GO EMBRYONIC ORGAN MORPHOGENESIS,2.457e-10,-0.33401,-0.38145,1,0
5,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,1.6782e-07,-0.33403,-0.3681,1,0
5,GO POSITIVE REGULATION OF JNK CASCADE,2.3113e-12,-0.33419,-0.44499,1,0
5,GO HEART PROCESS,4.1948e-11,-0.33426,-0.39174,1,0
5,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,1.7706e-05,-0.33426,-0.35704,1,0
5,GO EXCRETION,2.801e-10,-0.33429,-0.36969,1,0
5,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,3.2094e-09,-0.33439,-0.3664,1,0
5,GO PROTEIN LOCALIZATION TO PRESYNAPSE,6.1119e-05,-0.3344,-0.4313,1,0
5,GO MITOTIC CELL CYCLE ARREST,5.0278e-07,-0.33447,-0.36813,1,0
5,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,7.8286e-11,-0.3345,-0.40704,1,0
5,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,1.0161e-09,-0.3345,-0.40605,1,0
5,GO EPITHELIAL TUBE MORPHOGENESIS,4.9403e-11,-0.33451,-0.40394,1,0
5,GO STEROL HOMEOSTASIS,2.801e-10,-0.33472,-0.39681,1,0
5,GO SODIUM ION TRANSMEMBRANE TRANSPORT,1.484e-09,-0.3348,-0.36309,1,0
5,GO VESICLE CARGO LOADING,1.9989e-07,-0.3348,-0.38381,1,0
5,GO MALE GENITALIA DEVELOPMENT,3.4296e-07,-0.33507,-0.36534,1,0
5,GO SENSORY SYSTEM DEVELOPMENT,1.5688e-10,-0.3351,-0.40134,1,0
5,GO MICROVILLUS ORGANIZATION,1.3599e-06,-0.33511,-0.43496,1,0
5,GO SYNAPTIC VESICLE PRIMING,0.00017176,-0.33526,-0.3742,1,0
5,GO PROTEIN PALMITOYLATION,1.1034e-07,-0.33526,-0.37654,1,0
5,GO REGULATION OF SYNAPSE ASSEMBLY,4.3082e-09,-0.33536,-0.40614,1,0
5,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,9.4157e-10,-0.33538,-0.35663,1,0
5,GO CELLULAR HYPEROSMOTIC RESPONSE,8.0712e-08,-0.33541,-0.41836,1,0
5,GO METANEPHROS MORPHOGENESIS,5.7051e-07,-0.33545,-0.408,1,0
5,GO NEUROINFLAMMATORY RESPONSE,5.9748e-11,-0.33545,-0.38736,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,7.5266e-09,-0.33545,-0.398,1,0
5,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,5.2359e-09,-0.33566,-0.41444,1,0
5,GO POSITIVE REGULATION OF ACTIN NUCLEATION,1.3761e-09,-0.33576,-0.45412,1,0
5,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.00058763,-0.33581,-0.31268,1,0
5,GO EPITHELIAL CELL APOPTOTIC PROCESS,7.2202e-11,-0.33588,-0.43538,1,0
5,GO AMINO SUGAR BIOSYNTHETIC PROCESS,1.3468e-07,-0.33598,-0.37129,1,0
5,GO REGULATION OF RECEPTOR RECYCLING,1.5386e-08,-0.336,-0.37301,1,0
5,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,5.9116e-09,-0.33602,-0.42976,1,0
5,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,2.3467e-08,-0.33617,-0.46606,1,0
5,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,1.0212e-06,-0.33624,-0.37135,1,0
5,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,0.027401,-0.33639,-0.22602,1,0
5,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,2.7614e-08,-0.33644,-0.38785,1,0
5,GO DENDRITE MORPHOGENESIS,4.2784e-08,-0.33651,-0.41262,1,0
5,GO PROSTATE GLAND DEVELOPMENT,1.2131e-09,-0.33652,-0.45286,1,0
5,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,2.1375e-08,-0.33667,-0.36812,1,0
5,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,3.9822e-07,-0.33674,-0.3742,1,0
5,GO SECRETION BY TISSUE,1.4076e-07,-0.33689,-0.30332,1,0
5,GO AMINO ACID BETAINE METABOLIC PROCESS,2.8271e-07,-0.33707,-0.33301,1,0
5,GO PLACENTA DEVELOPMENT,2.2697e-09,-0.33722,-0.38897,1,0
5,GO FEMALE GENITALIA DEVELOPMENT,5.7051e-07,-0.33731,-0.32811,1,0
5,GO CELLULAR RESPONSE TO INTERFERON BETA,2.3661e-05,-0.33732,-0.37752,1,0
5,GO B CELL HOMEOSTASIS,1.5604e-09,-0.33746,-0.44751,1,0
5,GO SMOOTH MUSCLE CONTRACTION,5.3602e-11,-0.33757,-0.37817,1,0
5,GO WHITE FAT CELL DIFFERENTIATION,5.9432e-10,-0.33761,-0.38077,1,0
5,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.7687e-09,-0.3377,-0.37719,1,0
5,GO NEUROTROPHIN SIGNALING PATHWAY,3.3713e-09,-0.33773,-0.4348,1,0
5,GO CARDIAC MUSCLE CELL PROLIFERATION,1.9546e-09,-0.33777,-0.42456,1,0
5,GO C21 STEROID HORMONE METABOLIC PROCESS,1.7385e-05,-0.33779,-0.32404,1,0
5,GO AMINO SUGAR METABOLIC PROCESS,5.7923e-10,-0.33785,-0.36975,1,0
5,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,3.5794e-07,-0.33789,-0.33573,1,0
5,GO EMBRYONIC HEMOPOIESIS,2.8271e-07,-0.3379,-0.41138,1,0
5,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,3.2631e-05,-0.33791,-0.35882,1,0
5,GO NEGATIVE REGULATION OF TOR SIGNALING,2.5066e-09,-0.33801,-0.4098,1,0
5,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,6.2046e-07,-0.33807,-0.35493,1,0
5,GO RESPONSE TO ACIDIC PH,7.1819e-07,-0.3381,-0.41942,1,0
5,GO EOSINOPHIL CHEMOTAXIS,0.001776,-0.33814,-0.31039,1,0
5,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,6.4192e-10,-0.33819,-0.3923,1,0
5,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.0042095,-0.33841,-0.3211,1,0
5,GO INFLAMMATORY RESPONSE,1.0519e-10,-0.33842,-0.3711,1,0
5,GO RESPONSE TO FATTY ACID,3.2094e-09,-0.33842,-0.35579,1,0
5,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,5.5127e-05,-0.33859,-0.36213,1,0
5,GO REGULATION OF EPIDERMIS DEVELOPMENT,1.3174e-07,-0.3386,-0.40163,1,0
5,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,2.2139e-09,-0.33862,-0.45161,1,0
5,GO BONE MINERALIZATION,2.5223e-10,-0.33863,-0.42295,1,0
5,GO ZYMOGEN INHIBITION,7.4873e-07,-0.33868,-0.37983,1,0
5,GO CELLULAR RESPONSE TO IRON ION,1.0004e-06,-0.33874,-0.37939,1,0
5,GO EMBRYONIC DIGIT MORPHOGENESIS,5.7536e-08,-0.33875,-0.36122,1,0
5,GO SEQUESTERING OF CALCIUM ION,5.0766e-11,-0.33879,-0.39529,1,0
5,GO LEUKOCYTE APOPTOTIC PROCESS,1.0964e-09,-0.33889,-0.37525,1,0
5,GO LACTATION,2.3853e-09,-0.33893,-0.41334,1,0
5,GO MEMBRANE INVAGINATION,6.4805e-11,-0.33893,-0.4589,1,0
5,GO STRIATUM DEVELOPMENT,2.6362e-08,-0.33901,-0.41315,1,0
5,GO PROGRAMMED NECROTIC CELL DEATH,3.9941e-08,-0.33912,-0.36495,1,0
5,GO TUBE DEVELOPMENT,4.3549e-12,-0.33915,-0.44162,1,0
5,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.1533e-09,-0.33919,-0.36704,1,0
5,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,1.1398e-10,-0.33922,-0.40251,1,0
5,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,9.1996e-11,-0.33931,-0.42502,1,0
5,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,1.9175e-06,-0.33936,-0.39814,1,0
5,GO POSITIVE REGULATION OF NEURON DEATH,3.3713e-09,-0.33943,-0.40303,1,0
5,GO CAVEOLIN MEDIATED ENDOCYTOSIS,7.892e-08,-0.33954,-0.44759,1,0
5,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,5.1101e-09,-0.33971,-0.41687,1,0
5,GO PHAGOCYTOSIS RECOGNITION,1.9989e-07,-0.33984,-0.41339,1,0
5,GO RESPONSE TO DRUG,1.9402e-11,-0.33984,-0.38355,1,0
5,GO RECEPTOR INTERNALIZATION,5.3602e-11,-0.33987,-0.40088,1,0
5,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,2.801e-10,-0.33989,-0.41131,1,0
5,GO MUSCLE HYPERTROPHY,4.9403e-11,-0.33993,-0.45103,1,0
5,GO OSTEOBLAST DIFFERENTIATION,8.2618e-11,-0.33994,-0.42607,1,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,3.4003e-08,-0.34001,-0.37447,1,0
5,GO B CELL MEDIATED IMMUNITY,2.801e-10,-0.34017,-0.44017,1,0
5,GO PHOSPHOLIPID HOMEOSTASIS,4.3946e-06,-0.34019,-0.34557,1,0
5,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,7.1274e-05,-0.34019,-0.39551,1,0
5,GO CELL PART MORPHOGENESIS,4.6356e-09,-0.34027,-0.41202,1,0
5,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,7.5451e-08,-0.34029,-0.39134,1,0
5,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,3.9822e-07,-0.34034,-0.40717,1,0
5,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,2.8886e-07,-0.3404,-0.3857,1,0
5,GO REGULATION OF TOLERANCE INDUCTION,7.2414e-06,-0.34062,-0.39902,1,0
5,GO RESPONSE TO NUTRIENT,6.9323e-10,-0.34062,-0.37771,1,0
5,GO CELL CELL JUNCTION ORGANIZATION,2.2707e-10,-0.34077,-0.45898,1,0
5,GO PRESYNAPSE ORGANIZATION,2.1807e-07,-0.34077,-0.38274,1,0
5,GO CENTRIOLE CENTRIOLE COHESION,1.0212e-06,-0.34081,-0.40254,1,0
5,GO MYELOID LEUKOCYTE DIFFERENTIATION,4.0817e-11,-0.34083,-0.40795,1,0
5,GO POSITIVE REGULATION OF LIPID LOCALIZATION,5.3602e-11,-0.3409,-0.39044,1,0
5,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,8.2686e-06,-0.34095,-0.29424,1,0
5,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,5.77e-09,-0.34105,-0.37787,1,0
5,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,1.4282e-11,-0.34132,-0.44029,1,0
5,GO CELLULAR RESPONSE TO OSMOTIC STRESS,4.5239e-09,-0.34134,-0.39092,1,0
5,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,4.4787e-08,-0.34134,-0.4359,1,0
5,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,2.3853e-09,-0.34135,-0.3682,1,0
5,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,2.9979e-12,-0.34137,-0.419,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,1.3888e-11,-0.3415,-0.48211,1,0
5,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,4.0343e-10,-0.34157,-0.38865,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,3.6293e-09,-0.34163,-0.40081,1,0
5,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.2926e-08,-0.34166,-0.4093,1,0
5,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,4.2444e-07,-0.34171,-0.38654,1,0
5,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,2.6581e-10,-0.34172,-0.41408,1,0
5,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,1.0519e-10,-0.3418,-0.38885,1,0
5,GO REGULATION OF LIPID KINASE ACTIVITY,2.9979e-12,-0.34192,-0.44782,1,0
5,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,1.9558e-07,-0.34192,-0.40662,1,0
5,GO BIOMINERALIZATION,2.1085e-11,-0.34202,-0.44408,1,0
5,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,1.3999e-08,-0.34204,-0.40609,1,0
5,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,1.5372e-07,-0.34206,-0.40359,1,0
5,GO DENDRITIC CELL MIGRATION,3.0295e-08,-0.34214,-0.37666,1,0
5,GO RESPONSE TO ELECTRICAL STIMULUS,4.2444e-07,-0.34215,-0.33018,1,0
5,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,1.5372e-07,-0.34225,-0.42607,1,0
5,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,4.3236e-05,-0.34227,-0.43701,1,0
5,GO T CELL MEDIATED CYTOTOXICITY,0.00017457,-0.34227,-0.3916,1,0
5,GO RESPONSE TO STEROL DEPLETION,6.1583e-08,-0.34228,-0.41187,1,0
5,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,1.5102e-11,-0.34243,-0.40764,1,0
5,GO REGULATION OF COLLATERAL SPROUTING,3.7605e-06,-0.34271,-0.43856,1,0
5,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,1.7693e-06,-0.34275,-0.40858,1,0
5,GO CORTICOSTEROID HORMONE SECRETION,6.7105e-06,-0.3428,-0.3461,1,0
5,GO CARDIAC VENTRICLE MORPHOGENESIS,4.8359e-10,-0.34286,-0.43894,1,0
5,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,1.9387e-10,-0.34291,-0.39857,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,2.3467e-08,-0.34292,-0.39599,1,0
5,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,1.725e-09,-0.34299,-0.40512,1,0
5,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,8.6579e-07,-0.34302,-0.37673,1,0
5,GO GAS TRANSPORT,0.00014599,-0.34309,-0.30393,1,0
5,GO ANIMAL ORGAN MATURATION,1.5027e-08,-0.34311,-0.40688,1,0
5,GO FIBRINOLYSIS,1.5753e-08,-0.34317,-0.50538,1,0
5,GO CELL MOTILITY,3.3639e-12,-0.34317,-0.42839,1,0
5,GO COMPLEMENT ACTIVATION,1.7687e-09,-0.34328,-0.44438,1,0
5,GO UROGENITAL SYSTEM DEVELOPMENT,1.887e-11,-0.34336,-0.438,1,0
5,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,2.1595e-09,-0.3435,-0.44807,1,0
5,GO GROWTH HORMONE SECRETION,0.014332,-0.34361,-0.28674,1,0
5,GO EMBRYONIC APPENDAGE MORPHOGENESIS,2.5756e-08,-0.34369,-0.40594,1,0
5,GO RENAL TUBULE DEVELOPMENT,2.801e-10,-0.3437,-0.41986,1,0
5,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,4.8198e-07,-0.3437,-0.43997,1,0
5,GO PEPTIDYL SERINE DEPHOSPHORYLATION,2.0478e-05,-0.34375,-0.33918,1,0
5,GO PRO B CELL DIFFERENTIATION,2.3467e-08,-0.34378,-0.45079,1,0
5,GO REGULATION OF MYELOID CELL DIFFERENTIATION,6.8695e-12,-0.34382,-0.43091,1,0
5,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,2.8271e-07,-0.34398,-0.42282,1,0
5,GO CELLULAR RESPONSE TO LIPID,3.1757e-12,-0.34402,-0.39399,1,0
5,GO REGULATION OF FATTY ACID BETA OXIDATION,1.1041e-08,-0.34458,-0.42171,1,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,1.9393e-05,-0.34461,-0.40945,1,0
5,GO BONE CELL DEVELOPMENT,1.5713e-07,-0.34471,-0.44536,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,9.4499e-11,-0.34474,-0.45873,1,0
5,GO RESPONSE TO TESTOSTERONE,4.0678e-07,-0.34476,-0.33017,1,0
5,GO PREPULSE INHIBITION,0.00031414,-0.34477,-0.3853,1,0
5,GO RESPONSE TO COLD,6.5906e-08,-0.3449,-0.39989,1,0
5,GO TYPE 2 IMMUNE RESPONSE,1.6514e-08,-0.34494,-0.43351,1,0
5,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,1.4334e-08,-0.34498,-0.34677,1,0
5,GO POSITIVE REGULATION OF HEART GROWTH,1.7909e-10,-0.34504,-0.41215,1,0
5,GO EPITHELIAL CELL DEVELOPMENT,8.4871e-11,-0.34526,-0.466,1,0
5,GO FIBROBLAST APOPTOTIC PROCESS,3.8149e-08,-0.34546,-0.40317,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,1.277e-11,-0.34572,-0.4297,1,0
5,GO NEGATIVE REGULATION OF AUTOPHAGY,2.1812e-12,-0.34574,-0.41279,1,0
5,GO MUSCLE ADAPTATION,8.2618e-11,-0.34575,-0.43974,1,0
5,GO LEUKOCYTE HOMEOSTASIS,7.6792e-10,-0.34581,-0.39052,1,0
5,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00016361,-0.3459,-0.31746,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,6.205e-09,-0.34595,-0.36975,1,0
5,GO RESPONSE TO SALT STRESS,2.0429e-07,-0.34599,-0.34834,1,0
5,GO REGULATION OF LEUKOCYTE DEGRANULATION,4.4285e-07,-0.34605,-0.40162,1,0
5,GO ERBB SIGNALING PATHWAY,2.7797e-11,-0.34612,-0.42732,1,0
5,GO PARENTAL BEHAVIOR,6.1119e-05,-0.34627,-0.33393,1,0
5,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,1.0279e-08,-0.34636,-0.41185,1,0
5,GO BASE CONVERSION OR SUBSTITUTION EDITING,3.2784e-06,-0.34639,-0.42304,1,0
5,GO RESPONSE TO MECHANICAL STIMULUS,5.2253e-10,-0.34643,-0.41696,1,0
5,GO RESPONSE TO ESTROGEN,1.6823e-09,-0.34647,-0.39022,1,0
5,GO CIRCULATORY SYSTEM DEVELOPMENT,3.3639e-12,-0.3465,-0.4512,1,0
5,GO NEGATIVE REGULATION OF MAPK CASCADE,6.8695e-12,-0.34665,-0.46045,1,0
5,GO SYNAPSE ASSEMBLY,2.6362e-08,-0.34666,-0.40058,1,0
5,GO NEUROBLAST PROLIFERATION,7.1819e-07,-0.34669,-0.36469,1,0
5,GO EYE MORPHOGENESIS,2.2139e-09,-0.34674,-0.39719,1,0
5,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,1.0756e-05,-0.34674,-0.40768,1,0
5,GO SEMINIFEROUS TUBULE DEVELOPMENT,0.012087,-0.34682,-0.23468,1,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,2.538e-07,-0.34684,-0.40978,1,0
5,GO FEMALE SEX DIFFERENTIATION,3.3713e-09,-0.34687,-0.35579,1,0
5,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,1.6418e-07,-0.34692,-0.4996,1,0
5,GO CGMP MEDIATED SIGNALING,1.5604e-09,-0.34702,-0.40105,1,0
5,GO CARDIAC VENTRICLE FORMATION,0.00012186,-0.34703,-0.38778,1,0
5,GO GLYCOGEN BIOSYNTHETIC PROCESS,2.801e-10,-0.34709,-0.41858,1,0
5,GO CARDIAC VENTRICLE DEVELOPMENT,6.9323e-10,-0.3471,-0.43404,1,0
5,GO REGULATION OF OSTEOCLAST DEVELOPMENT,4.3355e-07,-0.34719,-0.37026,1,0
5,GO LEUKOCYTE MIGRATION,1.3737e-10,-0.34746,-0.40993,1,0
5,GO TELENCEPHALON GLIAL CELL MIGRATION,8.6579e-07,-0.34747,-0.41192,1,0
5,GO INTERLEUKIN 13 PRODUCTION,1.4163e-06,-0.34749,-0.41909,1,0
5,GO NEURON PROJECTION EXTENSION,2.634e-09,-0.34761,-0.43643,1,0
5,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,7.4854e-10,-0.34764,-0.39615,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,8.7184e-11,-0.34765,-0.35253,1,0
5,GO KERATINOCYTE MIGRATION,1.5529e-11,-0.34767,-0.43869,1,0
5,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,2.1375e-08,-0.34769,-0.38387,1,0
5,GO INTERLEUKIN 1 PRODUCTION,2.8262e-08,-0.34777,-0.40191,1,0
5,GO LYMPHOCYTE MIGRATION,2.2912e-11,-0.34781,-0.38612,1,0
5,GO FILOPODIUM ASSEMBLY,2.3268e-09,-0.34783,-0.46417,1,0
5,GO VENTRICULAR SYSTEM DEVELOPMENT,3.2894e-09,-0.34784,-0.41497,1,0
5,GO STORE OPERATED CALCIUM ENTRY,1.0781e-08,-0.34786,-0.43518,1,0
5,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,4.5922e-10,-0.34788,-0.35937,1,0
5,GO MEGAKARYOCYTE DEVELOPMENT,4.1751e-05,-0.34792,-0.4164,1,0
5,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,1.0756e-05,-0.34798,-0.3586,1,0
5,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,1.2027e-05,-0.34822,-0.33117,1,0
5,GO TORC1 SIGNALING,1.6823e-09,-0.34832,-0.40425,1,0
5,GO LONG TERM SYNAPTIC DEPRESSION,9.086e-06,-0.3484,-0.33706,1,0
5,GO ACTION POTENTIAL,2.1064e-09,-0.34842,-0.40002,1,0
5,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,1.5277e-10,-0.34846,-0.3813,1,0
5,GO REGULATION OF MAST CELL ACTIVATION,5.5864e-07,-0.34852,-0.37409,1,0
5,GO REGULATION OF CHEMOTAXIS,5.0766e-11,-0.34865,-0.40041,1,0
5,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,2.634e-09,-0.34891,-0.43788,1,0
5,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,4.1026e-05,-0.34893,-0.34946,1,0
5,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,6.1389e-11,-0.34915,-0.50343,1,0
5,GO NEGATIVE REGULATION OF HEART CONTRACTION,2.7676e-09,-0.34918,-0.37115,1,0
5,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,1.2886e-07,-0.34925,-0.36431,1,0
5,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,2.3467e-08,-0.34926,-0.426,1,0
5,GO CELL MORPHOGENESIS,1.0804e-10,-0.34928,-0.43375,1,0
5,GO OVULATION,1.5753e-08,-0.34934,-0.37669,1,0
5,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,7.2202e-11,-0.34935,-0.43223,1,0
5,GO REGULATORY T CELL DIFFERENTIATION,5.1351e-07,-0.34936,-0.39074,1,0
5,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,4.0678e-07,-0.34938,-0.43851,1,0
5,GO RESPONSE TO GONADOTROPIN,3.192e-10,-0.34948,-0.40344,1,0
5,GO T CELL MIGRATION,5.6451e-10,-0.34949,-0.41202,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,2.4452e-09,-0.34952,-0.47211,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,2.0983e-10,-0.34976,-0.36688,1,0
5,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,5.2359e-09,-0.34982,-0.40439,1,0
5,GO OXYGEN TRANSPORT,0.0011341,-0.34987,-0.3146,1,0
5,GO STEROL TRANSPORT,4.0817e-11,-0.34988,-0.43282,1,0
5,GO ENDOSOME TO LYSOSOME TRANSPORT,1.8389e-10,-0.34988,-0.39718,1,0
5,GO CELLULAR RESPONSE TO VITAMIN D,9.5999e-07,-0.34992,-0.43166,1,0
5,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,3.8301e-10,-0.35004,-0.3525,1,0
5,GO RAS PROTEIN SIGNAL TRANSDUCTION,1.6307e-12,-0.35015,-0.45869,1,0
5,GO REGULATION OF PHAGOCYTOSIS,1.3505e-11,-0.35036,-0.44504,1,0
5,GO REGULATION OF TRANSPORTER ACTIVITY,5.2165e-11,-0.35043,-0.38791,1,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,3.9941e-08,-0.35048,-0.43466,1,0
5,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,1.3085e-09,-0.35063,-0.41004,1,0
5,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,5.6317e-09,-0.35066,-0.44912,1,0
5,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,3.0395e-05,-0.35067,-0.36718,1,0
5,GO PRESYNAPTIC ENDOCYTOSIS,7.3772e-08,-0.35067,-0.39828,1,0
5,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,1.6514e-08,-0.35068,-0.48098,1,0
5,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,1.3737e-10,-0.35073,-0.44972,1,0
5,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,4.7125e-10,-0.35078,-0.43285,1,0
5,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.357e-07,-0.35089,-0.39824,1,0
5,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,1.2482e-05,-0.35091,-0.38568,1,0
5,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,0.00159,-0.35097,-0.24637,1,0
5,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.9558e-07,-0.35098,-0.36851,1,0
5,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,7.0671e-12,-0.35104,-0.39788,1,0
5,GO PANCREAS DEVELOPMENT,7.0522e-08,-0.35108,-0.37426,1,0
5,GO NEGATIVE REGULATION OF CELL CELL ADHESION,4.3109e-11,-0.35119,-0.44066,1,0
5,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0038478,-0.35133,-0.3125,1,0
5,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,4.4285e-07,-0.35137,-0.33455,1,0
5,GO SKELETAL SYSTEM MORPHOGENESIS,1.5968e-11,-0.35159,-0.43876,1,0
5,GO INTRACELLULAR LIPID TRANSPORT,1.3024e-10,-0.35164,-0.44579,1,0
5,GO RESPONSE TO ACID CHEMICAL,2.0509e-11,-0.35169,-0.40329,1,0
5,GO POSITIVE REGULATION OF GLUCONEOGENESIS,1.471e-07,-0.35173,-0.36141,1,0
5,GO LIPID IMPORT INTO CELL,1.3039e-08,-0.35175,-0.41855,1,0
5,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,5.77e-09,-0.3518,-0.4228,1,0
5,GO RESPONSE TO CAFFEINE,7.0522e-08,-0.3518,-0.35817,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,1.3351e-08,-0.35183,-0.43299,1,0
5,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,9.1205e-09,-0.35184,-0.37077,1,0
5,GO NEPHRON EPITHELIUM DEVELOPMENT,1.1706e-10,-0.35191,-0.42979,1,0
5,GO OSTEOCLAST DIFFERENTIATION,2.4893e-11,-0.35213,-0.41143,1,0
5,GO RESPONSE TO PH,5.7923e-10,-0.35215,-0.43295,1,0
5,GO OLIGODENDROCYTE DEVELOPMENT,2.3784e-07,-0.3522,-0.39791,1,0
5,GO NEGATIVE REGULATION OF LIPID TRANSPORT,8.7184e-11,-0.35226,-0.45963,1,0
5,GO HYPEROSMOTIC RESPONSE,1.1858e-08,-0.35226,-0.37187,1,0
5,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,5.3602e-11,-0.35228,-0.39753,1,0
5,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,2.6306e-11,-0.35231,-0.40853,1,0
5,GO PINOCYTOSIS,2.3467e-08,-0.35238,-0.43498,1,0
5,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,6.895e-08,-0.3524,-0.41667,1,0
5,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.6581e-10,-0.35241,-0.39143,1,0
5,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,3.3435e-06,-0.3525,-0.40187,1,0
5,GO ACETYL COA BIOSYNTHETIC PROCESS,7.7166e-08,-0.3526,-0.39861,1,0
5,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.0002117,-0.35262,-0.42269,1,0
5,GO PARAXIAL MESODERM MORPHOGENESIS,1.1588e-05,-0.35289,-0.38452,1,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,2.8925e-08,-0.35291,-0.41628,1,0
5,GO NEGATIVE REGULATION OF GROWTH,5.2165e-11,-0.35291,-0.40762,1,0
5,GO CELL CELL ADHESION,5.0237e-12,-0.35301,-0.42412,1,0
5,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.00017457,-0.35316,-0.37411,1,0
5,GO CARDIAC CONDUCTION,2.7286e-10,-0.3533,-0.40881,1,0
5,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,3.1896e-11,-0.35336,-0.47942,1,0
5,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,4.6784e-11,-0.35351,-0.42619,1,0
5,GO COPPER ION HOMEOSTASIS,4.0033e-09,-0.35354,-0.40365,1,0
5,GO RESPIRATORY BURST,1.9465e-08,-0.35356,-0.38616,1,0
5,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,4.2784e-08,-0.3536,-0.38592,1,0
5,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,3.9064e-09,-0.35374,-0.40582,1,0
5,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,3.2631e-05,-0.35381,-0.39322,1,0
5,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,4.4787e-08,-0.35388,-0.3977,1,0
5,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,9.5677e-09,-0.35401,-0.38598,1,0
5,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,1.0361e-05,-0.35401,-0.39714,1,0
5,GO NEGATIVE REGULATION OF CELL ACTIVATION,2.559e-11,-0.35403,-0.40951,1,0
5,GO RESPONSE TO VITAMIN D,1.5674e-06,-0.35413,-0.41247,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.0041031,-0.35439,-0.414,1,0
5,GO VITAMIN TRANSMEMBRANE TRANSPORT,2.5359e-06,-0.35444,-0.38398,1,0
5,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,2.1621e-05,-0.35448,-0.28067,1,0
5,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,2.2139e-09,-0.35448,-0.38691,1,0
5,GO NEURON MIGRATION,6.3359e-07,-0.35455,-0.3836,1,0
5,GO MULTICELLULAR ORGANISMAL SIGNALING,2.7e-09,-0.35457,-0.38164,1,0
5,GO REGULATION OF MICROVILLUS ORGANIZATION,0.00010152,-0.35472,-0.41846,1,0
5,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,3.2057e-05,-0.35481,-0.36768,1,0
5,GO HYALURONAN METABOLIC PROCESS,2.9371e-11,-0.35487,-0.4303,1,0
5,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,1.1478e-12,-0.35489,-0.41465,1,0
5,GO GMP METABOLIC PROCESS,7.0337e-07,-0.35493,-0.33555,1,0
5,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.00058763,-0.35498,-0.36885,1,0
5,GO CELLULAR RESPONSE TO RETINOIC ACID,9.9705e-11,-0.355,-0.46102,1,0
5,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,2.2505e-06,-0.35503,-0.40412,1,0
5,GO FOREGUT MORPHOGENESIS,9.7991e-09,-0.35512,-0.38236,1,0
5,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,7.892e-08,-0.35513,-0.37114,1,0
5,GO RESPONSE TO INACTIVITY,1.475e-06,-0.35532,-0.4416,1,0
5,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,2.9371e-11,-0.35532,-0.44439,1,0
5,GO AUTOPHAGY OF NUCLEUS,4.3109e-11,-0.35535,-0.42676,1,0
5,GO UTERUS DEVELOPMENT,5.8262e-07,-0.35545,-0.38642,1,0
5,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,5.1101e-09,-0.35545,-0.42015,1,0
5,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,3.5427e-10,-0.3555,-0.40895,1,0
5,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.0018508,-0.35552,-0.37991,1,0
5,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,3.1896e-11,-0.35565,-0.41779,1,0
5,GO HISTAMINE SECRETION,0.0040509,-0.3557,-0.27802,1,0
5,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,3.7605e-06,-0.35577,-0.39996,1,0
5,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,9.7991e-09,-0.35594,-0.48438,1,0
5,GO REGULATION OF RECEPTOR CLUSTERING,2.2416e-05,-0.35598,-0.44722,1,0
5,GO MYELOID CELL APOPTOTIC PROCESS,1.484e-09,-0.35602,-0.41787,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,1.3351e-08,-0.35609,-0.42183,1,0
5,GO SYNAPSE ORGANIZATION,9.658e-10,-0.35613,-0.43008,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,3.7282e-08,-0.3562,-0.42013,1,0
5,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.1098e-10,-0.35621,-0.43341,1,0
5,GO FOREBRAIN CELL MIGRATION,3.4003e-08,-0.35621,-0.38561,1,0
5,GO EPITHELIAL CELL FATE COMMITMENT,4.3997e-05,-0.35621,-0.3855,1,0
5,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,6.8348e-09,-0.35624,-0.40464,1,0
5,GO REGULATION OF STEROL TRANSPORT,2.7e-09,-0.35633,-0.37151,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,2.8573e-11,-0.35643,-0.48138,1,0
5,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,8.8282e-08,-0.35643,-0.41164,1,0
5,GO SPHINGOMYELIN METABOLIC PROCESS,9.404e-07,-0.35644,-0.43098,1,0
5,GO POSITIVE REGULATION OF MACROAUTOPHAGY,1.3133e-11,-0.35654,-0.42755,1,0
5,GO APPENDAGE MORPHOGENESIS,1.7309e-08,-0.35658,-0.41242,1,0
5,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,2.3312e-10,-0.35662,-0.41443,1,0
5,GO REGULATION OF BONE REMODELING,1.0322e-07,-0.35666,-0.40698,1,0
5,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,3.1896e-11,-0.35666,-0.46315,1,0
5,GO ESTABLISHMENT OF CELL POLARITY,1.6001e-09,-0.35667,-0.414,1,0
5,GO CARTILAGE DEVELOPMENT,1.9948e-11,-0.35675,-0.47124,1,0
5,GO CELLULAR EXTRAVASATION,2.5223e-10,-0.35691,-0.41425,1,0
5,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,2.8369e-09,-0.35694,-0.39957,1,0
5,GO DOPAMINE TRANSPORT,0.00047589,-0.35706,-0.30672,1,0
5,GO COCHLEA MORPHOGENESIS,2.0364e-06,-0.35708,-0.35137,1,0
5,GO MULTI MULTICELLULAR ORGANISM PROCESS,1.8389e-10,-0.35709,-0.39793,1,0
5,GO CALCINEURIN MEDIATED SIGNALING,4.4302e-11,-0.35722,-0.42367,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,1.4076e-07,-0.35723,-0.35743,1,0
5,GO DIACYLGLYCEROL METABOLIC PROCESS,5.7536e-08,-0.35729,-0.42596,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0001179,-0.35735,-0.33018,1,0
5,GO MYELOID CELL DEVELOPMENT,2.5756e-08,-0.35749,-0.41673,1,0
5,GO HISTONE H3 K36 METHYLATION,2.9514e-07,-0.35756,-0.38854,1,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,4.4749e-10,-0.35758,-0.44109,1,0
5,GO RECEPTOR CLUSTERING,2.0398e-08,-0.35776,-0.44332,1,0
5,GO INTERLEUKIN 6 PRODUCTION,7.1121e-10,-0.35779,-0.38577,1,0
5,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,9.7991e-09,-0.3578,-0.34141,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,1.2792e-06,-0.3579,-0.40004,1,0
5,GO MECHANORECEPTOR DIFFERENTIATION,5.6245e-08,-0.35799,-0.36298,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,5.3747e-08,-0.35809,-0.4084,1,0
5,GO CHOLESTEROL EFFLUX,1.5688e-10,-0.35819,-0.39573,1,0
5,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.00159,-0.35849,-0.31641,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,1.5604e-09,-0.35861,-0.42535,1,0
5,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,6.1389e-11,-0.35862,-0.43919,1,0
5,GO TAXIS,8.3747e-12,-0.35863,-0.40636,1,0
5,GO TRANSEPITHELIAL TRANSPORT,8.2618e-11,-0.35869,-0.38245,1,0
5,GO SEGMENTATION,4.8359e-10,-0.35874,-0.37918,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,1.2604e-07,-0.35889,-0.38401,1,0
5,GO ANOIKIS,7.892e-08,-0.35899,-0.44457,1,0
5,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,3.462e-12,-0.35901,-0.44592,1,0
5,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,1.471e-07,-0.35916,-0.39899,1,0
5,GO DENDRITIC CELL DIFFERENTIATION,1.2534e-06,-0.35931,-0.43541,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION,3.2785e-11,-0.35932,-0.43879,1,0
5,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,4.9069e-08,-0.35962,-0.42679,1,0
5,GO OLIGOSACCHARIDE METABOLIC PROCESS,7.2964e-10,-0.35971,-0.41667,1,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,1.4877e-10,-0.35971,-0.42224,1,0
5,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,2.2697e-09,-0.35973,-0.43307,1,0
5,GO POSITIVE REGULATION OF VASOCONSTRICTION,9.658e-10,-0.35974,-0.38486,1,0
5,GO ERK1 AND ERK2 CASCADE,5.9602e-12,-0.35991,-0.44039,1,0
5,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,1.174e-11,-0.35994,-0.47646,1,0
5,GO ACTIN FILAMENT DEPOLYMERIZATION,1.5217e-09,-0.36003,-0.4474,1,0
5,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,2.1064e-09,-0.36011,-0.44332,1,0
5,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,2.4837e-07,-0.36018,-0.50992,1,0
5,GO INTERLEUKIN 5 PRODUCTION,1.5994e-06,-0.36024,-0.41942,1,0
5,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,8.8389e-07,-0.36024,-0.38639,1,0
5,GO POSITIVE REGULATION OF MYELINATION,2.1595e-09,-0.36037,-0.38839,1,0
5,GO STEM CELL PROLIFERATION,1.6062e-07,-0.3605,-0.37313,1,0
5,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,3.3629e-10,-0.36054,-0.42329,1,0
5,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,7.5451e-08,-0.36072,-0.39915,1,0
5,GO PHAGOLYSOSOME ASSEMBLY,1.2534e-06,-0.36086,-0.45498,1,0
5,GO MAST CELL MIGRATION,3.8246e-05,-0.36091,-0.40906,1,0
5,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,5.5412e-06,-0.36093,-0.34641,1,0
5,GO REGULATION OF GONAD DEVELOPMENT,3.6293e-09,-0.36103,-0.38577,1,0
5,GO RESPONSE TO HYDROPEROXIDE,7.0337e-07,-0.36106,-0.38805,1,0
5,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,3.6567e-07,-0.36109,-0.48058,1,0
5,GO MUSCLE CELL APOPTOTIC PROCESS,3.3713e-09,-0.3613,-0.36881,1,0
5,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,6.0565e-09,-0.36134,-0.39313,1,0
5,GO NEGATIVE REGULATION OF NEURON MIGRATION,1.2328e-07,-0.36135,-0.37894,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,5.3617e-10,-0.36151,-0.40811,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,5.793e-12,-0.36156,-0.42388,1,0
5,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,3.5794e-07,-0.3616,-0.36482,1,0
5,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,2.9515e-10,-0.36165,-0.46194,1,0
5,GO REGULATION OF CELL MORPHOGENESIS,1.1398e-10,-0.3617,-0.44771,1,0
5,GO REGULATION OF BODY FLUID LEVELS,5.793e-12,-0.36216,-0.42737,1,0
5,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,2.3268e-09,-0.36227,-0.46787,1,0
5,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.0021215,-0.36232,-0.31967,1,0
5,GO FATTY ACID TRANSMEMBRANE TRANSPORT,8.9558e-11,-0.36263,-0.45516,1,0
5,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,9.9705e-11,-0.36266,-0.38513,1,0
5,GO MEMBRANE DEPOLARIZATION,1.3769e-07,-0.36272,-0.39576,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,3.3697e-11,-0.36276,-0.44574,1,0
5,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,2.559e-11,-0.36285,-0.46684,1,0
5,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,9.1205e-09,-0.36286,-0.38837,1,0
5,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,6.757e-10,-0.36295,-0.46284,1,0
5,GO REGULATION OF VASOCONSTRICTION,2.457e-10,-0.36304,-0.41536,1,0
5,GO RESPIRATORY SYSTEM DEVELOPMENT,1.4877e-10,-0.3631,-0.44762,1,0
5,GO ACTIN FILAMENT BUNDLE ORGANIZATION,1.8353e-11,-0.36312,-0.49058,1,0
5,GO AMYLOID BETA CLEARANCE,9.7068e-11,-0.3633,-0.44351,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,8.7237e-10,-0.36347,-0.47128,1,0
5,GO POSITIVE REGULATION OF LYASE ACTIVITY,5.7051e-07,-0.36356,-0.34438,1,0
5,GO IMMUNE RESPONSE TO TUMOR CELL,7.6446e-07,-0.36358,-0.44824,1,0
5,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,1.6823e-09,-0.3636,-0.41446,1,0
5,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,1.5277e-10,-0.36363,-0.4701,1,0
5,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,1.4487e-10,-0.3637,-0.37814,1,0
5,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,4.7963e-08,-0.36399,-0.40322,1,0
5,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,1.1099e-11,-0.36407,-0.45098,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,1.4076e-07,-0.36411,-0.43637,1,0
5,GO LIPOPROTEIN LOCALIZATION,3.2894e-09,-0.36412,-0.42959,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,4.9228e-07,-0.36427,-0.36054,1,0
5,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,3.2784e-06,-0.3644,-0.36355,1,0
5,GO MAINTENANCE OF CELL POLARITY,8.0712e-08,-0.36447,-0.37977,1,0
5,GO CARDIAC CHAMBER FORMATION,4.6359e-05,-0.36472,-0.37949,1,0
5,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,1.6514e-08,-0.36497,-0.39567,1,0
5,GO MULTICELLULAR ORGANISMAL MOVEMENT,2.4305e-07,-0.36536,-0.34813,1,0
5,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,7.2964e-10,-0.3654,-0.37117,1,0
5,GO PROTEIN TARGETING TO VACUOLE,2.4214e-11,-0.36553,-0.45793,1,0
5,GO LABYRINTHINE LAYER MORPHOGENESIS,0.0001803,-0.3656,-0.39374,1,0
5,GO REGULATION OF STRIATED MUSCLE CONTRACTION,2.2697e-09,-0.36564,-0.38101,1,0
5,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,4.7172e-05,-0.36589,-0.38683,1,0
5,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,1.1794e-07,-0.3659,-0.39205,1,0
5,GO CARDIAC CHAMBER DEVELOPMENT,1.9387e-10,-0.36591,-0.45864,1,0
5,GO CARNITINE SHUTTLE,1.1828e-09,-0.36608,-0.45612,1,0
5,GO EXPORT ACROSS PLASMA MEMBRANE,1.1245e-09,-0.3662,-0.41869,1,0
5,GO RESPONSE TO KETONE,8.8611e-12,-0.36631,-0.39485,1,0
5,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,8.6579e-07,-0.36632,-0.3829,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,6.8885e-07,-0.36635,-0.40404,1,0
5,GO RAC PROTEIN SIGNAL TRANSDUCTION,5.9116e-09,-0.36637,-0.40108,1,0
5,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,1.2143e-08,-0.36646,-0.43018,1,0
5,GO CELL AGGREGATION,9.028e-08,-0.36646,-0.38172,1,0
5,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.4771e-05,-0.36648,-0.34636,1,0
5,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,4.0657e-06,-0.36654,-0.37663,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,2.8886e-07,-0.36658,-0.35099,1,0
5,GO POSITIVE REGULATION OF TISSUE REMODELING,4.0314e-05,-0.36658,-0.34838,1,0
5,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,1.3948e-05,-0.36658,-0.35969,1,0
5,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,4.9624e-10,-0.36665,-0.41443,1,0
5,GO VITAMIN BIOSYNTHETIC PROCESS,4.0678e-07,-0.36669,-0.38391,1,0
5,GO XENOBIOTIC TRANSPORT,3.8645e-11,-0.36672,-0.45946,1,0
5,GO EMBRYONIC PATTERN SPECIFICATION,2.2397e-08,-0.36672,-0.34664,1,0
5,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.6761e-05,-0.36676,-0.30138,1,0
5,GO PROTEIN KINASE B SIGNALING,1.6884e-11,-0.36696,-0.40647,1,0
5,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,6.1583e-08,-0.36707,-0.42356,1,0
5,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,2.9371e-11,-0.36715,-0.41291,1,0
5,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,9.5677e-09,-0.36719,-0.50551,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS,4.4302e-11,-0.36734,-0.46036,1,0
5,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.00018923,-0.36739,-0.28653,1,0
5,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,6.6581e-11,-0.3674,-0.4202,1,0
5,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,2.0398e-08,-0.3674,-0.39641,1,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION,1.4107e-10,-0.36744,-0.46356,1,0
5,GO KERATAN SULFATE METABOLIC PROCESS,6.1389e-11,-0.36761,-0.47775,1,0
5,GO AUTOPHAGOSOME ORGANIZATION,8.8611e-12,-0.36775,-0.42943,1,0
5,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,2.1595e-09,-0.368,-0.40167,1,0
5,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,1.9064e-09,-0.36807,-0.47484,1,0
5,GO SPHINGOSINE BIOSYNTHETIC PROCESS,2.7614e-08,-0.3682,-0.43218,1,0
5,GO PEPTIDE CATABOLIC PROCESS,8.7237e-10,-0.36827,-0.45839,1,0
5,GO POSITIVE REGULATION OF AUTOPHAGY,5.1691e-12,-0.36831,-0.44293,1,0
5,GO CARDIAC ATRIUM DEVELOPMENT,5.2538e-08,-0.36835,-0.43286,1,0
5,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.00070238,-0.36844,-0.35848,1,0
5,GO POSITIVE REGULATION OF CHEMOTAXIS,1.4112e-09,-0.36877,-0.37068,1,0
5,GO CELL JUNCTION MAINTENANCE,6.7461e-07,-0.36879,-0.42304,1,0
5,GO MODIFICATION OF SYNAPTIC STRUCTURE,4.4148e-09,-0.36894,-0.47791,1,0
5,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,7.0337e-07,-0.36899,-0.35632,1,0
5,GO VAGINA DEVELOPMENT,4.8198e-07,-0.3691,-0.37373,1,0
5,GO REGULATION OF JUN KINASE ACTIVITY,1.2682e-10,-0.3691,-0.43781,1,0
5,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0016575,-0.36911,-0.27653,1,0
5,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,1.642e-11,-0.36916,-0.43776,1,0
5,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,8.9047e-09,-0.36926,-0.44753,1,0
5,GO INTERMEMBRANE LIPID TRANSFER,8.6145e-12,-0.36927,-0.46382,1,0
5,GO AMINOGLYCAN METABOLIC PROCESS,1.736e-11,-0.36928,-0.43999,1,0
5,GO FUCOSYLATION,7.7166e-08,-0.36953,-0.3972,1,0
5,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0005789,-0.3696,-0.36667,1,0
5,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,1.6782e-07,-0.36967,-0.43482,1,0
5,GO LUNG MORPHOGENESIS,3.1098e-10,-0.36969,-0.47645,1,0
5,GO CELL CHEMOTAXIS,1.8389e-10,-0.36991,-0.3884,1,0
5,GO CERAMIDE TRANSPORT,2.1064e-09,-0.37,-0.43098,1,0
5,GO NOTCH RECEPTOR PROCESSING,0.00020504,-0.37011,-0.35531,1,0
5,GO REGULATION OF VASCULAR PERMEABILITY,2.4893e-11,-0.37011,-0.50793,1,0
5,GO POSITIVE REGULATION OF OSSIFICATION,2.5893e-10,-0.37025,-0.44629,1,0
5,GO SHORT TERM MEMORY,0.00010152,-0.37026,-0.34782,1,0
5,GO TUBE MORPHOGENESIS,4.232e-12,-0.37031,-0.45828,1,0
5,GO AXON DEVELOPMENT,3.4553e-09,-0.37034,-0.42078,1,0
5,GO BIOLOGICAL ADHESION,2.3113e-12,-0.37038,-0.45603,1,0
5,GO HYPOTONIC RESPONSE,1.1041e-08,-0.37043,-0.43028,1,0
5,GO RENAL VESICLE DEVELOPMENT,1.9175e-06,-0.37062,-0.37682,1,0
5,GO REGULATION OF VESICLE FUSION,3.9872e-06,-0.37064,-0.42924,1,0
5,GO INFLAMMATORY CELL APOPTOTIC PROCESS,1.0791e-07,-0.37068,-0.3897,1,0
5,GO POSITIVE REGULATION OF BIOMINERALIZATION,1.6907e-08,-0.37078,-0.41806,1,0
5,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,3.3639e-12,-0.3708,-0.48682,1,0
5,GO NEGATIVE REGULATION OF HEMOPOIESIS,1.0792e-11,-0.37092,-0.45896,1,0
5,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,3.8301e-10,-0.37101,-0.43132,1,0
5,GO REGULATION OF BONE MINERALIZATION,1.9905e-10,-0.37128,-0.45387,1,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,2.0478e-05,-0.37132,-0.44402,1,0
5,GO PLASMINOGEN ACTIVATION,1.5372e-07,-0.37149,-0.4583,1,0
5,GO REGULATION OF FAT CELL DIFFERENTIATION,3.7602e-11,-0.37154,-0.45397,1,0
5,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,2.4861e-06,-0.37161,-0.51136,1,0
5,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,0.0071918,-0.3718,-0.30253,1,0
5,GO CELLULAR COPPER ION HOMEOSTASIS,6.0565e-09,-0.37187,-0.43953,1,0
5,GO HISTAMINE TRANSPORT,0.00057029,-0.37195,-0.30663,1,0
5,GO ACTIVATION OF MAPKKK ACTIVITY,8.6328e-08,-0.37204,-0.48639,1,0
5,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,2.5223e-10,-0.37207,-0.3916,1,0
5,GO NATURAL KILLER CELL MEDIATED IMMUNITY,1.8723e-07,-0.37242,-0.38579,1,0
5,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,3.5461e-06,-0.37245,-0.38926,1,0
5,GO REGULATION OF HAIR CYCLE,2.8925e-08,-0.37247,-0.38095,1,0
5,GO INTEGRIN ACTIVATION,9.3415e-09,-0.37248,-0.44527,1,0
5,GO PROSTATE GLAND MORPHOGENESIS,4.2784e-08,-0.3725,-0.51097,1,0
5,GO REGULATION OF POSTSYNAPSE ORGANIZATION,1.7721e-08,-0.37253,-0.4105,1,0
5,GO HETEROTYPIC CELL CELL ADHESION,6.5906e-08,-0.37263,-0.40148,1,0
5,GO CARDIAC ATRIUM MORPHOGENESIS,7.892e-08,-0.37268,-0.44487,1,0
5,GO AMINO ACID IMPORT,3.7195e-09,-0.3728,-0.4261,1,0
5,GO REGULATION OF CYTOPLASMIC TRANSPORT,8.8282e-08,-0.37285,-0.43935,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL BUD,8.0712e-08,-0.3729,-0.4655,1,0
5,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,1.3999e-08,-0.3729,-0.43133,1,0
5,GO ASYMMETRIC CELL DIVISION,1.7721e-08,-0.37292,-0.41445,1,0
5,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,2.65e-07,-0.37322,-0.50151,1,0
5,GO HINDLIMB MORPHOGENESIS,4.9069e-08,-0.37329,-0.41136,1,0
5,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00094089,-0.37335,-0.3982,1,0
5,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,3.8983e-07,-0.37345,-0.33795,1,0
5,GO SUPEROXIDE ANION GENERATION,7.969e-07,-0.37362,-0.38046,1,0
5,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,1.8573e-08,-0.37369,-0.47032,1,0
5,GO STRIATED MUSCLE ADAPTATION,3.2764e-10,-0.37371,-0.44825,1,0
5,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0005618,-0.37373,-0.32975,1,0
5,GO SPHINGOID METABOLIC PROCESS,2.4452e-09,-0.37384,-0.45597,1,0
5,GO REGULATION OF CARTILAGE DEVELOPMENT,8.0424e-11,-0.37385,-0.48578,1,0
5,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.1098e-10,-0.37403,-0.48576,1,0
5,GO RESPONSE TO CORTICOSTEROID,5.0766e-11,-0.37419,-0.38844,1,0
5,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,5.4967e-09,-0.37431,-0.42123,1,0
5,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,8.7237e-10,-0.37435,-0.42777,1,0
5,GO T CELL DIFFERENTIATION IN THYMUS,1.6109e-10,-0.37457,-0.38048,1,0
5,GO SMAD PROTEIN COMPLEX ASSEMBLY,5.6317e-09,-0.37464,-0.45414,1,0
5,GO LAYER FORMATION IN CEREBRAL CORTEX,5.0278e-07,-0.37471,-0.40293,1,0
5,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,8.8611e-12,-0.37473,-0.45365,1,0
5,GO POSITIVE REGULATION OF B CELL PROLIFERATION,9.5677e-09,-0.37474,-0.41698,1,0
5,GO DETECTION OF MECHANICAL STIMULUS,2.971e-06,-0.37478,-0.36279,1,0
5,GO NEGATIVE REGULATION OF OSSIFICATION,3.9064e-09,-0.37482,-0.44126,1,0
5,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,5.3617e-10,-0.37489,-0.45809,1,0
5,GO REGULATION OF CELL SIZE,1.642e-11,-0.37502,-0.45179,1,0
5,GO MECHANOSENSORY BEHAVIOR,0.00024045,-0.37529,-0.41906,1,0
5,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,8.2618e-11,-0.37531,-0.48866,1,0
5,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,1.0094e-07,-0.37535,-0.39529,1,0
5,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,3.9822e-07,-0.37538,-0.40372,1,0
5,GO CARNITINE METABOLIC PROCESS,3.2146e-06,-0.37541,-0.32821,1,0
5,GO NEUROTRANSMITTER REUPTAKE,2.2958e-06,-0.37544,-0.341,1,0
5,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.9175e-06,-0.37554,-0.33471,1,0
5,GO ENDOCRINE PANCREAS DEVELOPMENT,9.2321e-08,-0.37564,-0.36518,1,0
5,GO CYSTEINE METABOLIC PROCESS,6.545e-05,-0.37585,-0.35748,1,0
5,GO REGULATION OF CATION CHANNEL ACTIVITY,2.457e-10,-0.37592,-0.38762,1,0
5,GO REGULATION OF MEMBRANE REPOLARIZATION,3.247e-08,-0.37593,-0.4269,1,0
5,GO RESPONSE TO TUMOR CELL,2.1375e-08,-0.37604,-0.45325,1,0
5,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,5.1101e-09,-0.37622,-0.4255,1,0
5,GO SYNCYTIUM FORMATION,5.6304e-12,-0.37626,-0.48868,1,0
5,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,1.2441e-09,-0.37626,-0.42221,1,0
5,GO RESPONSE TO INCREASED OXYGEN LEVELS,4.6784e-11,-0.37627,-0.41735,1,0
5,GO SIALYLATION,2.342e-06,-0.37627,-0.47767,1,0
5,GO POSITIVE REGULATION OF ORGAN GROWTH,4.9403e-11,-0.37649,-0.41911,1,0
5,GO GLIAL CELL MIGRATION,2.9515e-10,-0.37655,-0.46001,1,0
5,GO GDP METABOLIC PROCESS,1.8032e-05,-0.37661,-0.3418,1,0
5,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,2.7286e-10,-0.37679,-0.49171,1,0
5,GO INTERFERON BETA PRODUCTION,5.0922e-10,-0.37692,-0.43306,1,0
5,GO PIGMENT ACCUMULATION,2.8886e-07,-0.37749,-0.41427,1,0
5,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,1.0004e-06,-0.3776,-0.43567,1,0
5,GO MESENCHYME DEVELOPMENT,1.785e-11,-0.37766,-0.43785,1,0
5,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,1.1398e-10,-0.37769,-0.44496,1,0
5,GO VITAMIN D METABOLIC PROCESS,1.7154e-07,-0.37771,-0.42448,1,0
5,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,1.484e-09,-0.37773,-0.42306,1,0
5,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.0055559,-0.3778,-0.36448,1,0
5,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,2.9371e-11,-0.37782,-0.41015,1,0
5,GO REGULATION OF CAMP MEDIATED SIGNALING,9.658e-10,-0.37792,-0.41132,1,0
5,GO GOLGI RIBBON FORMATION,1.5604e-09,-0.37797,-0.48122,1,0
5,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,8.6937e-09,-0.378,-0.41853,1,0
5,GO ANION HOMEOSTASIS,6.8406e-11,-0.37807,-0.41931,1,0
5,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,0.00092737,-0.37807,-0.33515,1,0
5,GO INTERLEUKIN 1 BETA PRODUCTION,3.247e-08,-0.37829,-0.40898,1,0
5,GO BONE MORPHOGENESIS,2.5223e-10,-0.3783,-0.4601,1,0
5,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.7125e-10,-0.3784,-0.44929,1,0
5,GO COPULATION,1.4207e-05,-0.37841,-0.30901,1,0
5,GO REGULATION OF PROTEIN MATURATION,1.4471e-09,-0.37847,-0.40637,1,0
5,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,2.7041e-11,-0.37857,-0.4322,1,0
5,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.1479e-07,-0.37864,-0.41814,1,0
5,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,4.1403e-10,-0.37882,-0.43602,1,0
5,GO COAGULATION,9.6431e-12,-0.3789,-0.45605,1,0
5,GO RECEPTOR SIGNALING PATHWAY VIA STAT,9.4499e-11,-0.37903,-0.39844,1,0
5,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,1.3878e-06,-0.37915,-0.40617,1,0
5,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,4.4807e-06,-0.3792,-0.42342,1,0
5,GO ACTIN FILAMENT SEVERING,9.5999e-07,-0.37934,-0.47604,1,0
5,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,2.634e-09,-0.37935,-0.40303,1,0
5,GO PLATELET DEGRANULATION,2.0437e-10,-0.37948,-0.48836,1,0
5,GO ARACHIDONIC ACID METABOLIC PROCESS,7.8976e-09,-0.37953,-0.3644,1,0
5,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,1.1858e-08,-0.37963,-0.44449,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,5.9834e-06,-0.37973,-0.46063,1,0
5,GO INTESTINAL ABSORPTION,4.9694e-05,-0.37998,-0.36789,1,0
5,GO REGULATION OF TISSUE REMODELING,8.6937e-09,-0.38002,-0.44255,1,0
5,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.2434e-08,-0.38007,-0.45996,1,0
5,GO GRANULOCYTE DIFFERENTIATION,2.65e-07,-0.38026,-0.38426,1,0
5,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,1.2023e-10,-0.38031,-0.44921,1,0
5,GO LIPID STORAGE,8.8611e-12,-0.3804,-0.42178,1,0
5,GO POSITIVE REGULATION OF URINE VOLUME,1.7721e-08,-0.38045,-0.37089,1,0
5,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.00070238,-0.38049,-0.34944,1,0
5,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,3.4553e-09,-0.38052,-0.43261,1,0
5,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,2.8262e-08,-0.38056,-0.41098,1,0
5,GO PROTEIN TRIMERIZATION,1.5753e-08,-0.38067,-0.35767,1,0
5,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,4.2784e-08,-0.38076,-0.44842,1,0
5,GO PROTEIN DEMETHYLATION,1.4076e-07,-0.38087,-0.40826,1,0
5,GO REGULATION OF POSITIVE CHEMOTAXIS,3.2162e-07,-0.38106,-0.37827,1,0
5,GO INOSITOL LIPID MEDIATED SIGNALING,2.9979e-12,-0.38116,-0.46312,1,0
5,GO CELLULAR RESPONSE TO FATTY ACID,1.3174e-07,-0.38126,-0.36769,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,3.2785e-11,-0.38141,-0.464,1,0
5,GO LIPID TRANSLOCATION,4.3082e-09,-0.38144,-0.471,1,0
5,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,1.1307e-08,-0.38145,-0.38585,1,0
5,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,2.9078e-09,-0.38146,-0.40123,1,0
5,GO FRUCTOSE METABOLIC PROCESS,0.0010865,-0.38148,-0.37766,1,0
5,GO STRIATED MUSCLE CELL PROLIFERATION,1.0422e-09,-0.38154,-0.40487,1,0
5,GO PIGMENT CELL DIFFERENTIATION,2.8369e-09,-0.38156,-0.3925,1,0
5,GO INTERMEDIATE FILAMENT ORGANIZATION,7.8052e-07,-0.38169,-0.3411,1,0
5,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,3.0156e-07,-0.3818,-0.38549,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,9.4157e-10,-0.38191,-0.42612,1,0
5,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,4.0868e-08,-0.38197,-0.41719,1,0
5,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,6.2565e-10,-0.38203,-0.43241,1,0
5,GO SKELETAL MUSCLE CELL PROLIFERATION,2.3891e-06,-0.38208,-0.34125,1,0
5,GO PSEUDOPODIUM ORGANIZATION,4.3997e-05,-0.3821,-0.38846,1,0
5,GO REGULATION OF CELL ADHESION,6.8695e-12,-0.38242,-0.46142,1,0
5,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,1.1789e-06,-0.38246,-0.39151,1,0
5,GO POSITIVE REGULATION OF BLOOD CIRCULATION,3.2094e-09,-0.38247,-0.35405,1,0
5,GO RESPONSE TO RETINOIC ACID,9.7068e-11,-0.3827,-0.42981,1,0
5,GO TRIPARTITE REGIONAL SUBDIVISION,1.6457e-05,-0.38276,-0.36961,1,0
5,GO REGULATION OF SYNAPSE MATURATION,7.0337e-07,-0.38287,-0.46651,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,5.1356e-08,-0.38294,-0.45565,1,0
5,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,1.7534e-07,-0.38313,-0.56071,1,0
5,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,3.6293e-09,-0.38317,-0.46669,1,0
5,GO PHAGOCYTOSIS,1.2074e-11,-0.38318,-0.45294,1,0
5,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,4.0033e-09,-0.38323,-0.46386,1,0
5,GO BONE DEVELOPMENT,9.1996e-11,-0.38329,-0.45367,1,0
5,GO SCHWANN CELL DEVELOPMENT,3.1098e-10,-0.38354,-0.47123,1,0
5,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,2.7452e-06,-0.38359,-0.4627,1,0
5,GO REGULATION OF FEMALE GONAD DEVELOPMENT,1.4163e-06,-0.3837,-0.36492,1,0
5,GO ARGININE METABOLIC PROCESS,6.205e-09,-0.38401,-0.445,1,0
5,GO RESPONSE TO TYPE I INTERFERON,3.6924e-05,-0.38405,-0.49178,1,0
5,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,9.9705e-11,-0.38451,-0.37797,1,0
5,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,4.4148e-09,-0.38456,-0.42064,1,0
5,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,5.1356e-08,-0.38462,-0.44368,1,0
5,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,1.0756e-05,-0.38472,-0.3543,1,0
5,GO RESPONSE TO ANGIOTENSIN,3.192e-10,-0.38481,-0.4699,1,0
5,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,5.4982e-08,-0.38571,-0.4659,1,0
5,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,2.634e-09,-0.38573,-0.52041,1,0
5,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,2.595e-12,-0.38574,-0.48949,1,0
5,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,7.2414e-06,-0.38577,-0.50499,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.3376e-10,-0.38587,-0.43153,1,0
5,GO LAMELLIPODIUM ASSEMBLY,1.1099e-11,-0.38612,-0.45782,1,0
5,GO MUSCLE CELL PROLIFERATION,1.174e-11,-0.38617,-0.43882,1,0
5,GO LONG TERM MEMORY,1.2023e-10,-0.38623,-0.4696,1,0
5,GO GASTRULATION,3.5597e-11,-0.3865,-0.46764,1,0
5,GO PLASMA MEMBRANE ORGANIZATION,9.6431e-12,-0.38668,-0.521,1,0
5,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,1.1535e-07,-0.38669,-0.42174,1,0
5,GO RESPONSE TO ACETYLCHOLINE,4.2271e-06,-0.38701,-0.38072,1,0
5,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,3.4773e-06,-0.38707,-0.44854,1,0
5,GO RECEPTOR CATABOLIC PROCESS,4.5922e-10,-0.38716,-0.48828,1,0
5,GO REGULATION OF LYMPHOCYTE MIGRATION,2.0437e-10,-0.38728,-0.41407,1,0
5,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,3.5427e-10,-0.38736,-0.51323,1,0
5,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,1.8389e-10,-0.38737,-0.43903,1,0
5,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,1.3196e-05,-0.38751,-0.35714,1,0
5,GO REGULATION OF RESPIRATORY BURST,3.6567e-07,-0.38761,-0.3736,1,0
5,GO ASTROCYTE DIFFERENTIATION,2.5893e-10,-0.38765,-0.4184,1,0
5,GO OSTEOCLAST DEVELOPMENT,1.9014e-08,-0.38766,-0.47111,1,0
5,GO PROTEIN OXIDATION,3.6877e-06,-0.38778,-0.41991,1,0
5,GO MICROVILLUS ASSEMBLY,1.1579e-08,-0.3878,-0.52727,1,0
5,GO RESPONSE TO INTERLEUKIN 15,7.5266e-09,-0.38789,-0.45064,1,0
5,GO GLIAL CELL ACTIVATION,1.4487e-10,-0.38797,-0.41033,1,0
5,GO BETA CATENIN TCF COMPLEX ASSEMBLY,1.2434e-08,-0.38818,-0.50514,1,0
5,GO CELL JUNCTION DISASSEMBLY,1.0804e-10,-0.3883,-0.47842,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,1.2604e-07,-0.38875,-0.47894,1,0
5,GO NEURON MATURATION,6.0759e-07,-0.38902,-0.35903,1,0
5,GO EMBRYONIC PLACENTA MORPHOGENESIS,2.1234e-05,-0.38918,-0.43117,1,0
5,GO COLLATERAL SPROUTING,5.1356e-08,-0.38923,-0.48226,1,0
5,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,6.3569e-09,-0.38926,-0.45678,1,0
5,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,1.8135e-09,-0.38938,-0.41533,1,0
5,GO FORMATION OF PRIMARY GERM LAYER,1.6884e-11,-0.38944,-0.50903,1,0
5,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.00020178,-0.3896,-0.43514,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.1706e-10,-0.39005,-0.43191,1,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,5.3647e-09,-0.39023,-0.40581,1,0
5,GO ACTIVATION OF JUN KINASE ACTIVITY,8.9558e-11,-0.39029,-0.47404,1,0
5,GO ACTIVATION OF MAPKK ACTIVITY,9.4499e-11,-0.39034,-0.47621,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,5.9748e-11,-0.39052,-0.44376,1,0
5,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.00016629,-0.39067,-0.36806,1,0
5,GO CYTOLYSIS,6.6578e-05,-0.39085,-0.36915,1,0
5,GO RESPONSE TO INTERLEUKIN 6,2.6981e-08,-0.39096,-0.41524,1,0
5,GO FATTY ACID HOMEOSTASIS,1.6514e-08,-0.39102,-0.42815,1,0
5,GO REGULATION OF CELL JUNCTION ASSEMBLY,1.277e-11,-0.39103,-0.49583,1,0
5,GO CHLORIDE ION HOMEOSTASIS,8.9047e-09,-0.3911,-0.47032,1,0
5,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,2.3793e-12,-0.39128,-0.4581,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,8.8611e-12,-0.39136,-0.4678,1,0
5,GO ENDOCHONDRAL BONE MORPHOGENESIS,6.2565e-10,-0.39146,-0.47428,1,0
5,GO REGULATION OF TUBULIN DEACETYLATION,1.9136e-07,-0.39159,-0.43605,1,0
5,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,1.7534e-07,-0.39166,-0.40373,1,0
5,GO POSITIVE REGULATION OF ENDOCYTOSIS,9.9185e-12,-0.39173,-0.47658,1,0
5,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,2.8305e-05,-0.39174,-0.44832,1,0
5,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,1.5753e-08,-0.39184,-0.47248,1,0
5,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,3.9064e-09,-0.39192,-0.52203,1,0
5,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,1.6884e-11,-0.39199,-0.47153,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,3.4796e-08,-0.39199,-0.35048,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.00052901,-0.392,-0.39258,1,0
5,GO SCHWANN CELL DIFFERENTIATION,1.0161e-09,-0.39205,-0.44129,1,0
5,GO REGULATION OF FATTY ACID OXIDATION,4.5922e-10,-0.39211,-0.41688,1,0
5,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,7.6792e-10,-0.39249,-0.4438,1,0
5,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,8.7237e-10,-0.39249,-0.43477,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,4.0033e-09,-0.39258,-0.44988,1,0
5,GO STEROID HORMONE SECRETION,1.471e-07,-0.39265,-0.37663,1,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.0546e-09,-0.39267,-0.43753,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,1.9402e-11,-0.39273,-0.52198,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,4.8359e-10,-0.39273,-0.45687,1,0
5,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,7.5451e-08,-0.39281,-0.43751,1,0
5,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,3.9963e-12,-0.39291,-0.49951,1,0
5,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,1.1398e-10,-0.39304,-0.4422,1,0
5,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,3.357e-07,-0.39304,-0.40907,1,0
5,GO DIVALENT METAL ION EXPORT,4.4787e-08,-0.39307,-0.42922,1,0
5,GO MYOBLAST FUSION,3.5597e-11,-0.39309,-0.52703,1,0
5,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,5.7923e-10,-0.39321,-0.45256,1,0
5,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,1.3599e-06,-0.39329,-0.51258,1,0
5,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,1.6823e-09,-0.39336,-0.41576,1,0
5,GO NEGATIVE REGULATION OF PROTEIN MATURATION,5.2538e-08,-0.39337,-0.43016,1,0
5,GO GOLGI TO ENDOSOME TRANSPORT,7.4177e-11,-0.39358,-0.49814,1,0
5,GO MACROPHAGE ACTIVATION,1.1398e-10,-0.39358,-0.42236,1,0
5,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,8.3747e-12,-0.39393,-0.49096,1,0
5,GO PARAXIAL MESODERM DEVELOPMENT,1.996e-06,-0.39402,-0.37413,1,0
5,GO ARTERY MORPHOGENESIS,5.2253e-10,-0.39407,-0.46151,1,0
5,GO GENITALIA MORPHOGENESIS,7.5451e-08,-0.39417,-0.44855,1,0
5,GO REGULATION OF AXONOGENESIS,3.055e-09,-0.39421,-0.46645,1,0
5,GO OPTIC NERVE DEVELOPMENT,1.155e-06,-0.39428,-0.43084,1,0
5,GO PLATELET MORPHOGENESIS,1.6001e-09,-0.39431,-0.5149,1,0
5,GO BONE REMODELING,1.6823e-09,-0.39443,-0.44977,1,0
5,GO SMOOTH MUSCLE CELL DIFFERENTIATION,6.4805e-11,-0.39481,-0.44334,1,0
5,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,7.6792e-10,-0.39507,-0.44208,1,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.0161e-09,-0.39518,-0.41095,1,0
5,GO ATRIAL SEPTUM MORPHOGENESIS,5.8049e-05,-0.39526,-0.41777,1,0
5,GO SYNAPTIC MEMBRANE ADHESION,7.5217e-06,-0.39551,-0.45986,1,0
5,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,3.4773e-06,-0.3957,-0.41121,1,0
5,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,3.2859e-07,-0.39571,-0.36894,1,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,5.2359e-09,-0.39584,-0.40019,1,0
5,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,3.0811e-07,-0.39587,-0.47207,1,0
5,GO PEPTIDYL TYROSINE MODIFICATION,1.7797e-12,-0.39592,-0.46084,1,0
5,GO FIBROBLAST MIGRATION,6.2565e-10,-0.39602,-0.46731,1,0
5,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,4.9228e-07,-0.39612,-0.36319,1,0
5,GO CONVERGENT EXTENSION,8.4805e-07,-0.39645,-0.38538,1,0
5,GO APOPTOTIC CELL CLEARANCE,8.4871e-11,-0.39645,-0.49895,1,0
5,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,8.5043e-10,-0.39663,-0.43256,1,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.5052e-06,-0.39668,-0.38409,1,0
5,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,4.719e-07,-0.39669,-0.4691,1,0
5,GO EXCITATORY SYNAPSE ASSEMBLY,4.1552e-07,-0.3967,-0.45377,1,0
5,GO REGULATION OF LIPID STORAGE,1.3888e-11,-0.3968,-0.43795,1,0
5,GO CALCIUM ION IMPORT INTO CYTOSOL,1.4454e-06,-0.39716,-0.39688,1,0
5,GO REGULATION OF MICROGLIAL CELL ACTIVATION,2.9078e-09,-0.39731,-0.40245,1,0
5,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,3.3713e-09,-0.39738,-0.40432,1,0
5,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,3.1098e-10,-0.39757,-0.53044,1,0
5,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,8.2903e-10,-0.39764,-0.47079,1,0
5,GO REGULATION OF VACUOLE ORGANIZATION,4.7125e-10,-0.39764,-0.42405,1,0
5,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,9.9705e-11,-0.39771,-0.38939,1,0
5,GO LAMELLIPODIUM ORGANIZATION,9.3752e-12,-0.39788,-0.46955,1,0
5,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,3.9822e-07,-0.39798,-0.37533,1,0
5,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,4.2271e-06,-0.3981,-0.40936,1,0
5,GO RESPONSE TO WOUNDING,7.9144e-12,-0.3982,-0.4685,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.9602e-12,-0.39828,-0.52901,1,0
5,GO RESPONSE TO PAIN,6.4434e-08,-0.39846,-0.38852,1,0
5,GO REGULATION OF PROTEIN GLYCOSYLATION,1.1535e-07,-0.39854,-0.41619,1,0
5,GO ENDOCARDIAL CUSHION MORPHOGENESIS,3.4296e-07,-0.39857,-0.43535,1,0
5,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,4.5239e-09,-0.3987,-0.51582,1,0
5,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.4452e-09,-0.3988,-0.55906,1,0
5,GO RAP PROTEIN SIGNAL TRANSDUCTION,5.2445e-07,-0.39885,-0.49589,1,0
5,GO REGULATION OF HEPATOCYTE PROLIFERATION,9.795e-06,-0.39915,-0.43186,1,0
5,GO REGULATION OF SULFUR METABOLIC PROCESS,7.5217e-06,-0.3993,-0.41481,1,0
5,GO NEPHRIC DUCT DEVELOPMENT,9.404e-07,-0.39936,-0.43854,1,0
5,GO STEM CELL DIVISION,1.3737e-10,-0.39961,-0.48988,1,0
5,GO BLOOD VESSEL MORPHOGENESIS,4.4812e-12,-0.39962,-0.49465,1,0
5,GO REGULATION OF KERATINOCYTE PROLIFERATION,1.7534e-07,-0.39968,-0.47994,1,0
5,GO PIGMENT GRANULE ORGANIZATION,9.8716e-08,-0.39968,-0.36552,1,0
5,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,1.1858e-08,-0.3997,-0.41301,1,0
5,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,0.0011341,-0.40014,-0.39941,1,0
5,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,4.6784e-11,-0.40017,-0.48339,1,0
5,GO RESPONSE TO INTERFERON BETA,0.00032916,-0.40021,-0.45562,1,0
5,GO NEPHRON DEVELOPMENT,3.4634e-11,-0.40024,-0.48465,1,0
5,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,3.0811e-07,-0.4006,-0.41103,1,0
5,GO ENDOTHELIAL CELL PROLIFERATION,5.6304e-12,-0.40063,-0.51099,1,0
5,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,3.5427e-10,-0.40071,-0.46931,1,0
5,GO RESPONSE TO DEXAMETHASONE,1.7687e-09,-0.40074,-0.41464,1,0
5,GO POSITIVE REGULATION OF COAGULATION,6.4192e-10,-0.40078,-0.46383,1,0
5,GO MESENCHYMAL TO EPITHELIAL TRANSITION,4.6578e-06,-0.40079,-0.37865,1,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,1.1579e-08,-0.40102,-0.40656,1,0
5,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,5.0922e-10,-0.40107,-0.47862,1,0
5,GO RELAXATION OF MUSCLE,2.8925e-08,-0.40119,-0.40534,1,0
5,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,6.6581e-11,-0.40125,-0.50819,1,0
5,GO POSTSYNAPSE ORGANIZATION,7.6792e-10,-0.40141,-0.43973,1,0
5,GO MUCUS SECRETION,0.0073682,-0.4017,-0.32315,1,0
5,GO GLYCINE TRANSPORT,2.7312e-05,-0.40186,-0.44114,1,0
5,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,5.3562e-07,-0.40194,-0.41477,1,0
5,GO RESPONSE TO FLUID SHEAR STRESS,6.3074e-11,-0.40204,-0.55653,1,0
5,GO SULFATION,2.8262e-08,-0.40204,-0.37064,1,0
5,GO CHONDROCYTE DEVELOPMENT,1.9064e-09,-0.40233,-0.52552,1,0
5,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,8.2618e-11,-0.40234,-0.45698,1,0
5,GO OSTEOBLAST PROLIFERATION,6.4434e-08,-0.40259,-0.45651,1,0
5,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,7.4177e-11,-0.40264,-0.4442,1,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,1.2792e-06,-0.40267,-0.39084,1,0
5,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,4.9069e-08,-0.40272,-0.45823,1,0
5,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,2.1624e-06,-0.4032,-0.34289,1,0
5,GO CELLULAR RESPONSE TO CALCIUM ION,3.247e-08,-0.40332,-0.39086,1,0
5,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,5.3256e-05,-0.40333,-0.4462,1,0
5,GO RESPONSE TO THYROID HORMONE,3.247e-08,-0.4034,-0.45361,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,1.9465e-08,-0.4034,-0.4951,1,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,2.5756e-08,-0.40342,-0.41387,1,0
5,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,1.9044e-05,-0.40346,-0.36523,1,0
5,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,9.0235e-07,-0.40349,-0.37408,1,0
5,GO REPLACEMENT OSSIFICATION,5.3617e-10,-0.40377,-0.5108,1,0
5,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,3.4634e-11,-0.404,-0.46452,1,0
5,GO LUNG EPITHELIUM DEVELOPMENT,8.4415e-08,-0.40407,-0.41864,1,0
5,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,2.9514e-07,-0.40407,-0.48032,1,0
5,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,3.9035e-08,-0.40412,-0.49727,1,0
5,GO TOLERANCE INDUCTION,3.6924e-05,-0.40438,-0.47057,1,0
5,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,4.0343e-10,-0.40441,-0.46933,1,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.8363e-05,-0.40446,-0.40233,1,0
5,GO VITAMIN D BIOSYNTHETIC PROCESS,4.1456e-06,-0.4048,-0.46506,1,0
5,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.00081356,-0.40482,-0.31125,1,0
5,GO CARDIAC CHAMBER MORPHOGENESIS,2.8753e-10,-0.40513,-0.46662,1,0
5,GO CYCLOOXYGENASE PATHWAY,1.536e-06,-0.40513,-0.43414,1,0
5,GO POSITIVE REGULATION OF CELL MATURATION,1.064e-06,-0.40517,-0.41895,1,0
5,GO ACTIVATION OF JNKK ACTIVITY,1.5604e-09,-0.40518,-0.49546,1,0
5,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,1.6994e-06,-0.4054,-0.53833,1,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,1.0791e-07,-0.40552,-0.4448,1,0
5,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,7.333e-07,-0.40569,-0.42132,1,0
5,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,3.7195e-09,-0.40572,-0.50985,1,0
5,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,7.6446e-07,-0.40577,-0.40742,1,0
5,GO ENDOCARDIAL CUSHION DEVELOPMENT,2.1807e-07,-0.40596,-0.43574,1,0
5,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,3.8645e-11,-0.40607,-0.48716,1,0
5,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,6.757e-10,-0.40611,-0.40984,1,0
5,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,3.8149e-08,-0.4063,-0.45959,1,0
5,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,4.7449e-12,-0.40636,-0.47741,1,0
5,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,8.4877e-09,-0.40664,-0.42531,1,0
5,GO ESTROUS CYCLE,1.4472e-05,-0.40682,-0.33985,1,0
5,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,3.8833e-12,-0.40688,-0.47564,1,0
5,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,3.2162e-07,-0.40704,-0.43488,1,0
5,GO ENDOTHELIUM DEVELOPMENT,8.9558e-11,-0.40713,-0.50576,1,0
5,GO HISTONE H3 K9 DEMETHYLATION,6.1583e-08,-0.40734,-0.45292,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.5102e-11,-0.40752,-0.47328,1,0
5,GO ASTROCYTE ACTIVATION,8.4415e-08,-0.40776,-0.40484,1,0
5,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,1.4677e-08,-0.40777,-0.45355,1,0
5,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,6.8695e-12,-0.40793,-0.47397,1,0
5,GO PROTEOGLYCAN METABOLIC PROCESS,4.5922e-10,-0.4082,-0.44823,1,0
5,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,1.0004e-06,-0.40831,-0.42615,1,0
5,GO LEUKOCYTE AGGREGATION,1.6761e-05,-0.40831,-0.4497,1,0
5,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,5.0278e-07,-0.40844,-0.42631,1,0
5,GO VASCULATURE DEVELOPMENT,2.9979e-12,-0.40861,-0.4917,1,0
5,GO PROTEIN AUTO ADP RIBOSYLATION,5.1356e-08,-0.40863,-0.48594,1,0
5,GO ANATOMICAL STRUCTURE REGRESSION,7.5451e-08,-0.40917,-0.53842,1,0
5,GO MONOACYLGLYCEROL METABOLIC PROCESS,7.6446e-07,-0.40956,-0.39415,1,0
5,GO REGULATION OF SPROUTING ANGIOGENESIS,5.793e-12,-0.40957,-0.51668,1,0
5,GO MITRAL VALVE DEVELOPMENT,3.5794e-07,-0.4097,-0.43867,1,0
5,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,5.9498e-07,-0.40973,-0.45476,1,0
5,GO REGULATION OF ANOIKIS,6.4699e-07,-0.40986,-0.48858,1,0
5,GO EPITHELIAL CELL PROLIFERATION,1.2074e-11,-0.40987,-0.44435,1,0
5,GO REGULATION OF MACROPHAGE ACTIVATION,2.3312e-10,-0.40989,-0.45792,1,0
5,GO DENDRITIC SPINE DEVELOPMENT,2.5223e-10,-0.41023,-0.45886,1,0
5,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,5.4982e-08,-0.4105,-0.42595,1,0
5,GO REGULATION OF VASCULATURE DEVELOPMENT,8.3747e-12,-0.41059,-0.48091,1,0
5,GO REGULATION OF B CELL APOPTOTIC PROCESS,1.536e-06,-0.41116,-0.40131,1,0
5,GO KERATINOCYTE PROLIFERATION,1.3174e-07,-0.41127,-0.43716,1,0
5,GO TYPE B PANCREATIC CELL PROLIFERATION,3.4296e-07,-0.41132,-0.51408,1,0
5,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,0.00014599,-0.41138,-0.37842,1,0
5,GO AMEBOIDAL TYPE CELL MIGRATION,2.7494e-12,-0.41139,-0.5008,1,0
5,GO MUSCLE CELL CELLULAR HOMEOSTASIS,1.2143e-08,-0.41146,-0.45387,1,0
5,GO TRABECULA FORMATION,1.0422e-09,-0.41147,-0.50843,1,0
5,GO MYELIN ASSEMBLY,1.0422e-09,-0.41149,-0.53517,1,0
5,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,6.5837e-06,-0.4115,-0.38169,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.4302e-11,-0.41191,-0.46357,1,0
5,GO NERVE DEVELOPMENT,1.9465e-08,-0.41196,-0.46604,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,4.5233e-07,-0.41212,-0.49669,1,0
5,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,3.7319e-10,-0.41226,-0.45143,1,0
5,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,2.3554e-11,-0.41239,-0.48716,1,0
5,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,5.9116e-09,-0.41243,-0.41811,1,0
5,GO CELL CELL ADHESION MEDIATED BY CADHERIN,3.2162e-07,-0.41243,-0.506,1,0
5,GO RESPONSE TO MAGNESIUM ION,9.2118e-07,-0.41254,-0.48924,1,0
5,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,2.3467e-08,-0.41255,-0.45964,1,0
5,GO REGULATION OF CHOLESTEROL EFFLUX,2.6581e-10,-0.41256,-0.40478,1,0
5,GO MEMBRANE PROTEIN PROTEOLYSIS,7.4177e-11,-0.41264,-0.5072,1,0
5,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.00029976,-0.41268,-0.40022,1,0
5,GO MESENCHYME MORPHOGENESIS,5.4967e-09,-0.41287,-0.44545,1,0
5,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,1.8389e-10,-0.41306,-0.46441,1,0
5,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.4487e-10,-0.41306,-0.52483,1,0
5,GO RHO PROTEIN SIGNAL TRANSDUCTION,1.0824e-12,-0.4131,-0.50928,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,2.3467e-08,-0.4133,-0.47126,1,0
5,GO CELLULAR RESPONSE TO VITAMIN,5.6317e-09,-0.41332,-0.51394,1,0
5,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,1.9558e-07,-0.41333,-0.54992,1,0
5,GO MESENCHYMAL CELL DIFFERENTIATION,1.5968e-11,-0.41341,-0.47099,1,0
5,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,7.8286e-11,-0.41375,-0.50894,1,0
5,GO MUSCLE CELL MIGRATION,3.1312e-09,-0.41381,-0.47565,1,0
5,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,2.3853e-09,-0.4139,-0.4201,1,0
5,GO RESPONSE TO IRON ION,3.5412e-09,-0.41393,-0.42464,1,0
5,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,1.8594e-09,-0.41425,-0.50142,1,0
5,GO EMBRYONIC HINDLIMB MORPHOGENESIS,2.0879e-07,-0.41426,-0.41788,1,0
5,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,2.0546e-09,-0.41427,-0.40482,1,0
5,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,1.6823e-09,-0.41456,-0.50091,1,0
5,GO NEGATIVE REGULATION OF CELL ADHESION,5.1691e-12,-0.41468,-0.4898,1,0
5,GO RESPONSE TO VITAMIN,4.5239e-09,-0.41471,-0.43682,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,2.7286e-10,-0.41476,-0.46909,1,0
5,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,1.3376e-10,-0.41494,-0.52252,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,9.3415e-09,-0.41517,-0.44148,1,0
5,GO ADHERENS JUNCTION ORGANIZATION,8.0815e-10,-0.41521,-0.50683,1,0
5,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,1.2348e-10,-0.41569,-0.49795,1,0
5,GO REGULATION OF EXTENT OF CELL GROWTH,8.9487e-10,-0.41569,-0.46585,1,0
5,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,9.1205e-09,-0.41575,-0.43213,1,0
5,GO LIVER MORPHOGENESIS,3.7356e-07,-0.41594,-0.39876,1,0
5,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,3.357e-07,-0.41614,-0.5062,1,0
5,GO REGULATION OF NEURON MIGRATION,1.6418e-07,-0.41638,-0.45488,1,0
5,GO HEART VALVE FORMATION,3.6567e-07,-0.41667,-0.4841,1,0
5,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,3.7605e-06,-0.41673,-0.46662,1,0
5,GO GLIAL CELL DEVELOPMENT,1.6109e-10,-0.41676,-0.43566,1,0
5,GO IMMUNOLOGICAL SYNAPSE FORMATION,2.4371e-06,-0.41678,-0.47512,1,0
5,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,8.9047e-09,-0.41678,-0.43345,1,0
5,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,1.3671e-08,-0.41678,-0.46118,1,0
5,GO DETECTION OF TEMPERATURE STIMULUS,0.00011218,-0.41683,-0.36482,1,0
5,GO ACTOMYOSIN STRUCTURE ORGANIZATION,1.0493e-11,-0.41704,-0.50093,1,0
5,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,5.6245e-08,-0.41704,-0.42663,1,0
5,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,2.3784e-07,-0.4172,-0.4862,1,0
5,GO SNARE COMPLEX ASSEMBLY,3.6293e-09,-0.41739,-0.44207,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,1.8135e-09,-0.41747,-0.53457,1,0
5,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,2.0879e-07,-0.41753,-0.46093,1,0
5,GO PROTEIN LOCALIZATION TO LYSOSOME,1.3376e-10,-0.41763,-0.48011,1,0
5,GO REGULATION OF AUTOPHAGOSOME MATURATION,8.8282e-08,-0.41764,-0.44546,1,0
5,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,8.9487e-10,-0.41788,-0.5395,1,0
5,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,4.2784e-08,-0.41797,-0.42185,1,0
5,GO REGULATION OF FIBROBLAST MIGRATION,3.8118e-09,-0.41803,-0.47135,1,0
5,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,2.3853e-09,-0.41807,-0.48179,1,0
5,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,1.1398e-10,-0.41809,-0.4794,1,0
5,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,9.1205e-09,-0.41817,-0.44484,1,0
5,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,5.3617e-10,-0.41852,-0.47422,1,0
5,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,6.586e-10,-0.41856,-0.55478,1,0
5,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,9.3415e-09,-0.41877,-0.49225,1,0
5,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,1.7534e-07,-0.4188,-0.44171,1,0
5,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,3.5412e-09,-0.41926,-0.49413,1,0
5,GO REGULATION OF ACTION POTENTIAL,1.6109e-10,-0.41947,-0.48155,1,0
5,GO REGULATION OF FIBRINOLYSIS,2.5223e-10,-0.41985,-0.4956,1,0
5,GO REGULATION OF HEART RATE,8.4877e-09,-0.41998,-0.38848,1,0
5,GO GALACTOSE METABOLIC PROCESS,2.2286e-07,-0.42009,-0.47268,1,0
5,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,6.1389e-11,-0.42031,-0.499,1,0
5,GO RESPONSE TO INTERFERON GAMMA,2.6981e-08,-0.42054,-0.46041,1,0
5,GO NEURON PROJECTION REGENERATION,5.1101e-09,-0.42075,-0.46742,1,0
5,GO INHIBITORY SYNAPSE ASSEMBLY,1.0958e-05,-0.42104,-0.42902,1,0
5,GO ENDODERM DEVELOPMENT,7.0671e-12,-0.42112,-0.57934,1,0
5,GO AXIS ELONGATION,3.4296e-07,-0.42149,-0.3976,1,0
5,GO NEURONAL ION CHANNEL CLUSTERING,0.00047589,-0.42156,-0.40281,1,0
5,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,5.9432e-10,-0.42179,-0.50815,1,0
5,GO LENS FIBER CELL DIFFERENTIATION,7.6205e-11,-0.42195,-0.48581,1,0
5,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,1.642e-11,-0.42197,-0.48076,1,0
5,GO TISSUE REMODELING,2.5893e-10,-0.42204,-0.4913,1,0
5,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,2.4091e-05,-0.42215,-0.43265,1,0
5,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,3.4553e-09,-0.42219,-0.44338,1,0
5,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,1.3442e-05,-0.4222,-0.42001,1,0
5,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,4.5233e-07,-0.42233,-0.41403,1,0
5,GO VENTRICULAR SEPTUM DEVELOPMENT,4.7125e-10,-0.42237,-0.48469,1,0
5,GO REGULATION OF AMPA RECEPTOR ACTIVITY,1.8032e-05,-0.42248,-0.41007,1,0
5,GO REGULATION OF HIPPO SIGNALING,4.4787e-08,-0.42268,-0.51389,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,3.9941e-08,-0.42284,-0.44879,1,0
5,GO SPROUTING ANGIOGENESIS,1.2417e-11,-0.42323,-0.51541,1,0
5,GO CELLULAR RESPONSE TO ALCOHOL,9.1996e-11,-0.42324,-0.44038,1,0
5,GO NEGATIVE REGULATION OF LIPID STORAGE,2.9371e-11,-0.42336,-0.47884,1,0
5,GO NEURON REMODELING,5.6245e-08,-0.42344,-0.40516,1,0
5,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,1.5027e-08,-0.42355,-0.45262,1,0
5,GO RESPONSE TO GROWTH HORMONE,5.4967e-09,-0.42367,-0.471,1,0
5,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.0037985,-0.42379,-0.28214,1,0
5,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,2.0881e-08,-0.42388,-0.40662,1,0
5,GO NEURON PROJECTION GUIDANCE,5.6317e-09,-0.42394,-0.44081,1,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,1.6109e-10,-0.42402,-0.4979,1,0
5,GO POST EMBRYONIC DEVELOPMENT,5.3617e-10,-0.42406,-0.44785,1,0
5,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,4.4148e-09,-0.42411,-0.47086,1,0
5,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,1.2058e-07,-0.42448,-0.48595,1,0
5,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,8.7184e-11,-0.42462,-0.47591,1,0
5,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,5.1356e-08,-0.42488,-0.47102,1,0
5,GO REGULATION OF ENDOCYTIC RECYCLING,4.5822e-08,-0.42515,-0.46189,1,0
5,GO CELLULAR COMPONENT MAINTENANCE,3.7319e-10,-0.4252,-0.45382,1,0
5,GO REGULATION OF SECONDARY METABOLIC PROCESS,2.342e-06,-0.42523,-0.45909,1,0
5,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,2.7804e-05,-0.42536,-0.34416,1,0
5,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,3.8161e-07,-0.42551,-0.44005,1,0
5,GO REGULATION OF KIDNEY DEVELOPMENT,3.192e-10,-0.42554,-0.45896,1,0
5,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,1.0804e-10,-0.42581,-0.52983,1,0
5,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,8.2618e-11,-0.42593,-0.4693,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,9.4407e-08,-0.42594,-0.46129,1,0
5,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,1.5217e-09,-0.42605,-0.42707,1,0
5,GO STRESS FIBER ASSEMBLY,3.9963e-12,-0.42605,-0.54687,1,0
5,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,3.0296e-10,-0.42618,-0.44727,1,0
5,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.0001803,-0.42641,-0.58988,1,0
5,GO MAST CELL MEDIATED IMMUNITY,3.1479e-07,-0.42645,-0.39927,1,0
5,GO PLATELET ACTIVATION,1.4686e-11,-0.42705,-0.50013,1,0
5,GO CRANIOFACIAL SUTURE MORPHOGENESIS,4.7501e-09,-0.42716,-0.56661,1,0
5,GO ARF PROTEIN SIGNAL TRANSDUCTION,7.0279e-11,-0.42733,-0.50136,1,0
5,GO P38MAPK CASCADE,8.7237e-10,-0.42769,-0.48701,1,0
5,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.00010852,-0.42805,-0.33365,1,0
5,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,1.5277e-10,-0.42809,-0.51403,1,0
5,GO INCLUSION BODY ASSEMBLY,2.342e-06,-0.42818,-0.4447,1,0
5,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,6.757e-10,-0.42834,-0.51815,1,0
5,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,3.9309e-10,-0.42873,-0.49919,1,0
5,GO LENS FIBER CELL DEVELOPMENT,2.6581e-10,-0.42884,-0.51032,1,0
5,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,2.634e-09,-0.42887,-0.42727,1,0
5,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,3.6361e-10,-0.42902,-0.47363,1,0
5,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,2.2926e-08,-0.42913,-0.5185,1,0
5,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,3.0811e-07,-0.42944,-0.47446,1,0
5,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,3.8645e-11,-0.42971,-0.56971,1,0
5,GO WOUND HEALING,8.8611e-12,-0.42976,-0.48807,1,0
5,GO DENDRITIC SPINE MORPHOGENESIS,8.4877e-09,-0.43013,-0.44471,1,0
5,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,2.3554e-11,-0.43052,-0.45526,1,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,2.9514e-07,-0.43065,-0.3847,1,0
5,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,6.586e-10,-0.4311,-0.47899,1,0
5,GO METANEPHRIC NEPHRON DEVELOPMENT,1.3039e-08,-0.43118,-0.47529,1,0
5,GO REGULATION OF CELL SHAPE,1.5688e-10,-0.43125,-0.47764,1,0
5,GO PROTEIN DEGLYCOSYLATION,1.0241e-10,-0.43155,-0.52234,1,0
5,GO PODOSOME ASSEMBLY,1.0279e-08,-0.43164,-0.56851,1,0
5,GO HEMATOPOIETIC STEM CELL PROLIFERATION,5.1351e-07,-0.43211,-0.39889,1,0
5,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,2.0546e-09,-0.43218,-0.50991,1,0
5,GO ARTERY DEVELOPMENT,5.6594e-11,-0.43237,-0.50313,1,0
5,GO METANEPHRIC EPITHELIUM DEVELOPMENT,1.8135e-09,-0.43253,-0.53988,1,0
5,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,6.2993e-08,-0.43279,-0.43332,1,0
5,GO MATERNAL PLACENTA DEVELOPMENT,6.7461e-07,-0.43311,-0.42028,1,0
5,GO ACTIN FILAMENT BASED MOVEMENT,1.5529e-11,-0.43312,-0.45844,1,0
5,GO SERTOLI CELL DIFFERENTIATION,2.4452e-09,-0.43317,-0.45437,1,0
5,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,1.3769e-07,-0.43326,-0.40518,1,0
5,GO CELLULAR RESPONSE TO ACID CHEMICAL,9.6431e-12,-0.43354,-0.52396,1,0
5,GO GLIAL CELL APOPTOTIC PROCESS,4.8198e-07,-0.43384,-0.47933,1,0
5,GO AMINOGLYCAN CATABOLIC PROCESS,1.5688e-10,-0.434,-0.48233,1,0
5,GO AXON EXTENSION,1.0422e-09,-0.43431,-0.47608,1,0
5,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,4.4302e-11,-0.43451,-0.48193,1,0
5,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,1.277e-11,-0.43463,-0.4978,1,0
5,GO HEPARIN METABOLIC PROCESS,9.2321e-08,-0.43473,-0.46368,1,0
5,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,6.895e-08,-0.43476,-0.4742,1,0
5,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,3.3214e-05,-0.43485,-0.34785,1,0
5,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,0.00025215,-0.43497,-0.44366,1,0
5,GO RESPONSE TO FORSKOLIN,1.5994e-06,-0.43499,-0.45397,1,0
5,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,6.0565e-09,-0.43507,-0.54485,1,0
5,GO MAST CELL ACTIVATION,1.0554e-07,-0.43514,-0.39124,1,0
5,GO REGULATION OF NEURON PROJECTION REGENERATION,1.9989e-07,-0.43532,-0.43774,1,0
5,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,2.5164e-08,-0.43569,-0.48558,1,0
5,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,9.5677e-09,-0.4357,-0.50107,1,0
5,GO AORTA DEVELOPMENT,8.2903e-10,-0.4357,-0.53092,1,0
5,GO COLLAGEN METABOLIC PROCESS,1.642e-11,-0.43571,-0.57452,1,0
5,GO RENAL SYSTEM PROCESS,2.595e-12,-0.43576,-0.50608,1,0
5,GO RESPONSE TO AMYLOID BETA,4.8824e-12,-0.43577,-0.51433,1,0
5,GO NOTOCHORD DEVELOPMENT,7.7166e-08,-0.43593,-0.49661,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,9.9064e-10,-0.43603,-0.44047,1,0
5,GO TRABECULA MORPHOGENESIS,8.2903e-10,-0.43634,-0.5138,1,0
5,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,7.8976e-09,-0.4364,-0.45405,1,0
5,GO POSITIVE REGULATION OF BONE RESORPTION,0.00013451,-0.43642,-0.36043,1,0
5,GO REGULATION OF KERATINOCYTE MIGRATION,4.7449e-12,-0.43685,-0.50835,1,0
5,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,2.2453e-12,-0.43749,-0.50904,1,0
5,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,7.8911e-05,-0.43768,-0.43932,1,0
5,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,4.0033e-09,-0.43785,-0.52514,1,0
5,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,1.9064e-09,-0.43811,-0.51425,1,0
5,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,7.2202e-11,-0.43816,-0.46375,1,0
5,GO BARBED END ACTIN FILAMENT CAPPING,2.6914e-06,-0.43819,-0.43298,1,0
5,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,2.2775e-07,-0.43855,-0.43689,1,0
5,GO ASTROCYTE DEVELOPMENT,1.6986e-10,-0.43882,-0.48162,1,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,3.357e-07,-0.43897,-0.43571,1,0
5,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,2.2775e-07,-0.43934,-0.51636,1,0
5,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,7.0017e-09,-0.43936,-0.46551,1,0
5,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,5.3562e-07,-0.43966,-0.48647,1,0
5,GO HYALURONAN BIOSYNTHETIC PROCESS,8.0815e-10,-0.4397,-0.50958,1,0
5,GO POSITIVE REGULATION OF AXONOGENESIS,2.6981e-08,-0.43974,-0.4748,1,0
5,GO RELAXATION OF CARDIAC MUSCLE,1.5713e-07,-0.43985,-0.47955,1,0
5,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,1.3174e-07,-0.4399,-0.40338,1,0
5,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,1.1588e-05,-0.43991,-0.42145,1,0
5,GO CELLULAR RESPONSE TO KETONE,4.1403e-10,-0.44005,-0.41498,1,0
5,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,1.9014e-08,-0.44017,-0.48466,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,3.1896e-11,-0.44018,-0.5165,1,0
5,GO ENDODERM FORMATION,1.3505e-11,-0.4403,-0.60426,1,0
5,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,3.4516e-10,-0.44038,-0.51344,1,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,2.6581e-10,-0.44041,-0.48326,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,1.0964e-09,-0.44047,-0.47456,1,0
5,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,1.2733e-08,-0.44058,-0.4482,1,0
5,GO NETRIN ACTIVATED SIGNALING PATHWAY,0.00016361,-0.44083,-0.38291,1,0
5,GO NEGATIVE REGULATION OF AXON EXTENSION,5.5016e-10,-0.44089,-0.50161,1,0
5,GO POSITIVE REGULATION OF STEROL TRANSPORT,7.1726e-09,-0.44093,-0.43968,1,0
5,GO REGULATION OF MEMBRANE INVAGINATION,9.1205e-09,-0.44104,-0.50457,1,0
5,GO LUNG ALVEOLUS DEVELOPMENT,2.6581e-10,-0.44107,-0.5317,1,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,2.0853e-05,-0.44109,-0.38942,1,0
5,GO CELLULAR RESPONSE TO NUTRIENT,9.4157e-10,-0.44133,-0.49865,1,0
5,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,2.65e-07,-0.44146,-0.48811,1,0
5,GO GAP JUNCTION ASSEMBLY,4.7963e-08,-0.44179,-0.5308,1,0
5,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,1.471e-07,-0.44209,-0.44344,1,0
5,GO POSITIVE REGULATION OF PROTEIN MATURATION,3.5606e-08,-0.44211,-0.44276,1,0
5,GO DETECTION OF BIOTIC STIMULUS,6.0205e-08,-0.44219,-0.473,1,0
5,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,2.9602e-08,-0.44223,-0.43155,1,0
5,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,2.9805e-09,-0.44224,-0.44714,1,0
5,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,8.1361e-07,-0.44352,-0.54782,1,0
5,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,1.7071e-05,-0.44394,-0.44031,1,0
5,GO SMOOTH MUSCLE CELL PROLIFERATION,1.642e-11,-0.44399,-0.47186,1,0
5,GO POSTSYNAPSE ASSEMBLY,5.332e-06,-0.4441,-0.47942,1,0
5,GO REGULATION OF MACROPHAGE DIFFERENTIATION,7.3476e-09,-0.44426,-0.51681,1,0
5,GO NEURONAL STEM CELL POPULATION MAINTENANCE,1.4334e-08,-0.44432,-0.49216,1,0
5,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,1.5217e-09,-0.44437,-0.45624,1,0
5,GO REGULATION OF MYOBLAST FUSION,8.4415e-08,-0.44446,-0.45754,1,0
5,GO SUBSTRATE DEPENDENT CELL MIGRATION,4.9624e-10,-0.44466,-0.52954,1,0
5,GO TISSUE MIGRATION,3.462e-12,-0.44477,-0.52976,1,0
5,GO RESPONSE TO PROGESTERONE,1.9387e-10,-0.44484,-0.4593,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,4.7172e-05,-0.44503,-0.36919,1,0
5,GO MAMMARY GLAND DUCT MORPHOGENESIS,6.3569e-09,-0.44504,-0.48499,1,0
5,GO REGULATION OF COAGULATION,4.5922e-10,-0.44514,-0.50579,1,0
5,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,2.4305e-07,-0.4456,-0.54128,1,0
5,GO EPITHELIAL CELL MORPHOGENESIS,7.4873e-07,-0.44566,-0.51578,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,1.3737e-10,-0.44569,-0.51695,1,0
5,GO PROTEIN LOCALIZATION TO AXON,4.5558e-05,-0.4458,-0.47266,1,0
5,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,3.8161e-07,-0.44582,-0.5052,1,0
5,GO INTRACELLULAR STEROL TRANSPORT,5.1101e-09,-0.44609,-0.45425,1,0
5,GO SMOOTH MUSCLE CELL MIGRATION,6.586e-10,-0.44686,-0.53757,1,0
5,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,4.4302e-11,-0.44691,-0.45307,1,0
5,GO ODONTOGENESIS,1.0804e-10,-0.44698,-0.4735,1,0
5,GO ACTIN FILAMENT NETWORK FORMATION,0.00049802,-0.44714,-0.41808,1,0
5,GO POSITIVE REGULATION OF AXON EXTENSION,1.0964e-09,-0.44718,-0.50526,1,0
5,GO CELL SUBSTRATE ADHESION,5.6304e-12,-0.44718,-0.55331,1,0
5,GO ENDOTHELIAL CELL MIGRATION,3.7735e-12,-0.44727,-0.54348,1,0
5,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.001118,-0.44762,-0.37779,1,0
5,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.174e-11,-0.44767,-0.50642,1,0
5,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,1.1034e-07,-0.44771,-0.48344,1,0
5,GO GLOMERULAR EPITHELIUM DEVELOPMENT,3.4516e-10,-0.44773,-0.5809,1,0
5,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,2.8262e-08,-0.44782,-0.43174,1,0
5,GO CRANIAL NERVE DEVELOPMENT,1.2058e-07,-0.44787,-0.42544,1,0
5,GO LEFT RIGHT AXIS SPECIFICATION,1.734e-06,-0.44795,-0.4378,1,0
5,GO KERATAN SULFATE CATABOLIC PROCESS,3.055e-09,-0.44823,-0.52131,1,0
5,GO ADHERENS JUNCTION ASSEMBLY,2.9514e-07,-0.44902,-0.50433,1,0
5,GO NEURON CELL CELL ADHESION,9.9844e-05,-0.44904,-0.42755,1,0
5,GO HEART VALVE DEVELOPMENT,3.1032e-11,-0.44926,-0.56688,1,0
5,GO MATURE B CELL DIFFERENTIATION,3.1479e-07,-0.44931,-0.49585,1,0
5,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,2.7797e-11,-0.44941,-0.49184,1,0
5,GO NEURON PROJECTION ORGANIZATION,2.1543e-10,-0.44949,-0.48119,1,0
5,GO POSITIVE REGULATION OF P38MAPK CASCADE,1.3761e-09,-0.44996,-0.47189,1,0
5,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,1.1307e-08,-0.45011,-0.50314,1,0
5,GO RESPONSE TO INTERFERON ALPHA,2.6352e-05,-0.45015,-0.58686,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,5.6451e-10,-0.45022,-0.51517,1,0
5,GO PROTEIN TARGETING TO LYSOSOME,4.0343e-10,-0.45022,-0.54078,1,0
5,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,5.2253e-10,-0.45045,-0.47091,1,0
5,GO COLLAGEN CATABOLIC PROCESS,1.0241e-10,-0.45094,-0.50844,1,0
5,GO RENAL ABSORPTION,1.1789e-06,-0.45112,-0.5129,1,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,1.5102e-11,-0.45129,-0.58843,1,0
5,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,2.7452e-06,-0.45164,-0.42405,1,0
5,GO HYALURONAN CATABOLIC PROCESS,9.658e-10,-0.45185,-0.54322,1,0
5,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,1.0212e-06,-0.45189,-0.43903,1,0
5,GO ATRIAL SEPTUM DEVELOPMENT,2.6914e-06,-0.45189,-0.43125,1,0
5,GO REGULATION OF DEACETYLASE ACTIVITY,2.6386e-06,-0.45195,-0.44545,1,0
5,GO DORSAL AORTA DEVELOPMENT,4.8416e-06,-0.45197,-0.47798,1,0
5,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,8.6937e-09,-0.45199,-0.46327,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,1.8881e-10,-0.45224,-0.49806,1,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,4.3355e-07,-0.45323,-0.42661,1,0
5,GO SYNAPSE MATURATION,3.2784e-06,-0.4535,-0.47316,1,0
5,GO DECIDUALIZATION,6.8396e-06,-0.4536,-0.42602,1,0
5,GO CELLULAR RESPONSE TO SALT STRESS,5.6245e-08,-0.45387,-0.47781,1,0
5,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,1.5277e-10,-0.45408,-0.5081,1,0
5,GO HOMOTYPIC CELL CELL ADHESION,8.7237e-10,-0.45417,-0.51237,1,0
5,GO GLYCOPROTEIN CATABOLIC PROCESS,6.5125e-09,-0.45446,-0.55351,1,0
5,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,3.1479e-07,-0.45485,-0.55168,1,0
5,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,2.1375e-08,-0.45562,-0.47974,1,0
5,GO GROWTH PLATE CARTILAGE DEVELOPMENT,2.7078e-07,-0.45564,-0.43692,1,0
5,GO UV PROTECTION,4.8198e-07,-0.45571,-0.42115,1,0
5,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,7.0522e-08,-0.45599,-0.41802,1,0
5,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,4.4302e-11,-0.45606,-0.56968,1,0
5,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,9.8716e-08,-0.45613,-0.45452,1,0
5,GO VENOUS BLOOD VESSEL DEVELOPMENT,5.3747e-08,-0.45659,-0.51214,1,0
5,GO NEGATIVE REGULATION OF WOUND HEALING,1.6884e-11,-0.4566,-0.51388,1,0
5,GO BLOOD VESSEL REMODELING,1.5968e-11,-0.4566,-0.58446,1,0
5,GO REGULATION OF RESPONSE TO WOUNDING,1.1398e-10,-0.45675,-0.46592,1,0
5,GO NEGATIVE REGULATION OF COAGULATION,5.9432e-10,-0.45697,-0.53973,1,0
5,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,1.8142e-08,-0.4571,-0.48124,1,0
5,GO MEMBRANE BIOGENESIS,4.7125e-10,-0.45724,-0.50842,1,0
5,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,8.5043e-10,-0.45726,-0.48982,1,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,1.3351e-08,-0.45729,-0.43592,1,0
5,GO REGULATION OF BMP SIGNALING PATHWAY,1.2682e-10,-0.45729,-0.48323,1,0
5,GO VENTRICULAR SEPTUM MORPHOGENESIS,1.7687e-09,-0.45731,-0.51193,1,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,2.7041e-11,-0.4574,-0.51823,1,0
5,GO REGULATION OF WOUND HEALING,1.3024e-10,-0.45743,-0.48818,1,0
5,GO POSITIVE REGULATION OF LIPID STORAGE,1.0804e-10,-0.4575,-0.47854,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,3.6435e-08,-0.45804,-0.44979,1,0
5,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,2.004e-09,-0.45829,-0.43122,1,0
5,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,4.31e-06,-0.45843,-0.47986,1,0
5,GO B CELL RECEPTOR SIGNALING PATHWAY,1.1794e-07,-0.4587,-0.45597,1,0
5,GO ACTIN FILAMENT BASED TRANSPORT,1.996e-06,-0.45891,-0.41697,1,0
5,GO NEGATIVE REGULATION OF TISSUE REMODELING,4.7963e-08,-0.45893,-0.49454,1,0
5,GO HAIR FOLLICLE MATURATION,1.3174e-07,-0.459,-0.45314,1,0
5,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,1.1099e-11,-0.45957,-0.50057,1,0
5,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,1.642e-11,-0.45983,-0.52202,1,0
5,GO MULTI ORGANISM CELLULAR PROCESS,6.8695e-12,-0.45983,-0.55027,1,0
5,GO DEFINITIVE HEMOPOIESIS,1.6542e-10,-0.45998,-0.53594,1,0
5,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,2.7e-09,-0.4602,-0.56706,1,0
5,GO INTEGRIN MEDIATED SIGNALING PATHWAY,1.7909e-10,-0.4608,-0.53383,1,0
5,GO REGULATION OF CELLULAR EXTRAVASATION,2.2697e-09,-0.46098,-0.4571,1,0
5,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,2.5756e-08,-0.46109,-0.44029,1,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,7.71e-09,-0.46119,-0.54353,1,0
5,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,1.0791e-07,-0.46119,-0.47431,1,0
5,GO FOAM CELL DIFFERENTIATION,6.6581e-11,-0.46198,-0.48392,1,0
5,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.00028155,-0.46233,-0.39782,1,0
5,GO POSITIVE REGULATION OF MITOPHAGY,4.4148e-09,-0.46245,-0.45258,1,0
5,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.457e-10,-0.46304,-0.48106,1,0
5,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,6.5906e-08,-0.46307,-0.503,1,0
5,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,3.0296e-10,-0.46355,-0.60088,1,0
5,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,4.0868e-08,-0.46401,-0.45553,1,0
5,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,7.0522e-08,-0.46466,-0.53689,1,0
5,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,3.0856e-12,-0.46502,-0.55204,1,0
5,GO REGULATION OF EPITHELIAL CELL MIGRATION,1.942e-12,-0.46505,-0.54858,1,0
5,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,8.9047e-09,-0.46522,-0.51368,1,0
5,GO EMBRYO IMPLANTATION,1.1307e-08,-0.46587,-0.45962,1,0
5,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,7.0337e-07,-0.46591,-0.46653,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,1.9546e-09,-0.46597,-0.4793,1,0
5,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,2.6981e-08,-0.46647,-0.44392,1,0
5,GO REGULATION OF SUPEROXIDE ANION GENERATION,6.5837e-06,-0.46668,-0.43536,1,0
5,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,1.6884e-11,-0.46671,-0.49419,1,0
5,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,1.0094e-07,-0.46696,-0.46,1,0
5,GO EXTRACELLULAR MATRIX DISASSEMBLY,2.1678e-11,-0.46752,-0.55424,1,0
5,GO CARDIAC SEPTUM DEVELOPMENT,4.249e-10,-0.46759,-0.51124,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,1.4677e-08,-0.46768,-0.51864,1,0
5,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,4.2271e-06,-0.46788,-0.45944,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,2.7494e-12,-0.46813,-0.57228,1,0
5,GO SECONDARY PALATE DEVELOPMENT,4.9872e-09,-0.46816,-0.48658,1,0
5,GO NEGATIVE REGULATION OF EXOCYTOSIS,6.0979e-10,-0.46841,-0.46832,1,0
5,GO CHONDROCYTE DIFFERENTIATION,4.5526e-11,-0.46905,-0.5172,1,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,3.8301e-10,-0.46978,-0.49755,1,0
5,GO CHONDROITIN SULFATE CATABOLIC PROCESS,8.6937e-09,-0.47027,-0.52362,1,0
5,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,1.0519e-10,-0.47034,-0.50839,1,0
5,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,6.205e-09,-0.47042,-0.50784,1,0
5,GO RESPONSE TO MUSCLE STRETCH,1.1165e-05,-0.47058,-0.44916,1,0
5,GO REGULATION OF CELL SUBSTRATE ADHESION,2.4214e-11,-0.47098,-0.5556,1,0
5,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,3.0811e-07,-0.47119,-0.50445,1,0
5,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,5.2253e-10,-0.47146,-0.48819,1,0
5,GO ENDOTHELIAL CELL DEVELOPMENT,3.2764e-10,-0.4715,-0.56266,1,0
5,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,8.4871e-11,-0.47188,-0.46835,1,0
5,GO GASTRULATION WITH MOUTH FORMING SECOND,4.9228e-07,-0.47221,-0.44558,1,0
5,GO GLAND MORPHOGENESIS,9.7068e-11,-0.47229,-0.53446,1,0
5,GO POSITIVE REGULATION OF WOUND HEALING,2.5066e-09,-0.4726,-0.47973,1,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,8.6328e-08,-0.47263,-0.55552,1,0
5,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,4.5526e-11,-0.4727,-0.53699,1,0
5,GO VASCULOGENESIS,1.1097e-10,-0.4727,-0.51935,1,0
5,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,1.7721e-08,-0.47278,-0.62388,1,0
5,GO LYMPH VESSEL MORPHOGENESIS,1.2682e-10,-0.47295,-0.5255,1,0
5,GO ADHESION OF SYMBIONT TO HOST,1.0322e-07,-0.47311,-0.48973,1,0
5,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,2.188e-08,-0.47328,-0.46686,1,0
5,GO MESENCHYMAL CELL PROLIFERATION,1.2143e-08,-0.47379,-0.50072,1,0
5,GO CARDIAC SEPTUM MORPHOGENESIS,1.1533e-09,-0.47385,-0.50926,1,0
5,GO ENDODERMAL CELL DIFFERENTIATION,4.9403e-11,-0.47397,-0.6426,1,0
5,GO SOMATIC STEM CELL DIVISION,1.064e-06,-0.47421,-0.54024,1,0
5,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,3.6293e-09,-0.47422,-0.53615,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,1.0791e-07,-0.4743,-0.46769,1,0
5,GO NEGATIVE REGULATION OF BONE REMODELING,1.536e-06,-0.47439,-0.43693,1,0
5,GO HIPPO SIGNALING,1.3174e-07,-0.47449,-0.52742,1,0
5,GO ZYMOGEN ACTIVATION,1.4334e-08,-0.47487,-0.50536,1,0
5,GO TRACHEA DEVELOPMENT,1.484e-09,-0.47507,-0.50528,1,0
5,GO PROTEIN DEMANNOSYLATION,4.8359e-10,-0.47544,-0.51651,1,0
5,GO NUCLEAR MIGRATION,6.4434e-08,-0.47557,-0.49557,1,0
5,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,7.6792e-10,-0.47587,-0.49918,1,0
5,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,2.3274e-07,-0.47589,-0.43313,1,0
5,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,4.1403e-10,-0.47645,-0.52517,1,0
5,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,2.5934e-07,-0.47654,-0.43805,1,0
5,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,3.6435e-08,-0.47658,-0.50781,1,0
5,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,3.8301e-10,-0.47694,-0.5612,1,0
5,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1.6986e-10,-0.47696,-0.5345,1,0
5,GO AMYLOID BETA METABOLIC PROCESS,6.8406e-11,-0.47728,-0.47872,1,0
5,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,8.7237e-10,-0.47738,-0.48161,1,0
5,GO DISACCHARIDE METABOLIC PROCESS,1.7721e-08,-0.47741,-0.44934,1,0
5,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,2.538e-07,-0.4781,-0.4796,1,0
5,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,1.3085e-09,-0.47836,-0.5061,1,0
5,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,3.9941e-08,-0.47852,-0.46126,1,0
5,GO PLATELET AGGREGATION,4.249e-10,-0.47882,-0.50916,1,0
5,GO ANATOMICAL STRUCTURE ARRANGEMENT,6.5125e-09,-0.47889,-0.56521,1,0
5,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.1691e-12,-0.47917,-0.57149,1,0
5,GO T CELL EXTRAVASATION,3.7356e-07,-0.47926,-0.48632,1,0
5,GO ALDEHYDE BIOSYNTHETIC PROCESS,9.7991e-09,-0.47937,-0.57349,1,0
5,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,2.0853e-05,-0.4799,-0.4257,1,0
5,GO NEGATIVE REGULATION OF CHEMOTAXIS,7.6205e-11,-0.48011,-0.52704,1,0
5,GO MEMBRANE LIPID CATABOLIC PROCESS,2.8262e-08,-0.48041,-0.47426,1,0
5,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,4.8673e-09,-0.48049,-0.44501,1,0
5,GO NEGATIVE REGULATION OF TORC1 SIGNALING,3.0811e-07,-0.48053,-0.50171,1,0
5,GO NEGATIVE REGULATION OF ANOIKIS,1.6321e-06,-0.48069,-0.54091,1,0
5,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,3.1098e-10,-0.481,-0.49629,1,0
5,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,1.9558e-07,-0.48115,-0.53987,1,0
5,GO BIOLOGICAL PHASE,7.3803e-06,-0.48259,-0.44112,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,2.1196e-06,-0.48281,-0.47578,1,0
5,GO ELASTIC FIBER ASSEMBLY,2.6362e-08,-0.48327,-0.6879,1,0
5,GO TRACHEA MORPHOGENESIS,4.2042e-09,-0.48334,-0.49353,1,0
5,GO CELL MATRIX ADHESION,1.3505e-11,-0.48335,-0.55854,1,0
5,GO BODY MORPHOGENESIS,1.1097e-10,-0.48337,-0.53062,1,0
5,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,1.2604e-07,-0.48346,-0.44091,1,0
5,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00096848,-0.48348,-0.39651,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,2.7494e-12,-0.48356,-0.56775,1,0
5,GO CELL SUBSTRATE JUNCTION ORGANIZATION,1.887e-11,-0.48374,-0.60841,1,0
5,GO CHAPERONE MEDIATED AUTOPHAGY,6.6717e-09,-0.48389,-0.51932,1,0
5,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,8.2543e-08,-0.48417,-0.49714,1,0
5,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,7.5451e-08,-0.48421,-0.5356,1,0
5,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,2.5893e-10,-0.48422,-0.47063,1,0
5,GO N GLYCAN PROCESSING,5.5016e-10,-0.48431,-0.55925,1,0
5,GO REVERSE CHOLESTEROL TRANSPORT,1.1858e-08,-0.48448,-0.55542,1,0
5,GO CELLULAR RESPONSE TO STEROL,1.4487e-10,-0.48459,-0.51213,1,0
5,GO AMELOGENESIS,6.0979e-10,-0.48492,-0.50225,1,0
5,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,7.1274e-05,-0.48496,-0.44444,1,0
5,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,2.1338e-07,-0.48515,-0.45542,1,0
5,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,3.2631e-05,-0.48529,-0.39087,1,0
5,GO EMBRYONIC BODY MORPHOGENESIS,1.2759e-09,-0.48544,-0.51721,1,0
5,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,1.3769e-07,-0.48605,-0.50951,1,0
5,GO REGULATION OF COLLAGEN METABOLIC PROCESS,3.8645e-11,-0.48639,-0.59287,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,5.3747e-08,-0.48647,-0.51109,1,0
5,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,6.586e-10,-0.48653,-0.46994,1,0
5,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,2.3891e-06,-0.48657,-0.50668,1,0
5,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,1.0554e-07,-0.4868,-0.49344,1,0
5,GO NEGATIVE REGULATION OF CELL KILLING,2.4528e-05,-0.48805,-0.52283,1,0
5,GO RESPONSE TO POTASSIUM ION,6.545e-05,-0.48821,-0.36685,1,0
5,GO REGULATION OF PODOSOME ASSEMBLY,6.5906e-08,-0.48823,-0.58156,1,0
5,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,4.249e-10,-0.48906,-0.5108,1,0
5,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,1.1828e-09,-0.48913,-0.57145,1,0
5,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,6.0979e-10,-0.48958,-0.51565,1,0
5,GO AMYLOID BETA FORMATION,1.642e-11,-0.48959,-0.49113,1,0
5,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,5.1351e-07,-0.49026,-0.53533,1,0
5,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,1.6907e-08,-0.49066,-0.55662,1,0
5,GO RESPONSE TO LEUCINE,5.4982e-08,-0.4909,-0.47022,1,0
5,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,1.5968e-11,-0.49164,-0.56889,1,0
5,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,4.7963e-08,-0.49182,-0.58461,1,0
5,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,7.5451e-08,-0.49214,-0.47676,1,0
5,GO ENDOCARDIAL CUSHION FORMATION,9.7991e-09,-0.49253,-0.5285,1,0
5,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,2.8573e-11,-0.49267,-0.46896,1,0
5,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,1.0493e-11,-0.4927,-0.5175,1,0
5,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,3.6924e-05,-0.49351,-0.3693,1,0
5,GO NUCLEUS LOCALIZATION,4.7501e-09,-0.49357,-0.49542,1,0
5,GO COMMISSURAL NEURON AXON GUIDANCE,7.8124e-06,-0.49393,-0.51322,1,0
5,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,3.3713e-09,-0.49408,-0.54108,1,0
5,GO INNERVATION,5.7051e-07,-0.49418,-0.5687,1,0
5,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,3.3629e-10,-0.49445,-0.59847,1,0
5,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,1.7442e-10,-0.49464,-0.5335,1,0
5,GO EXTRACELLULAR STRUCTURE ORGANIZATION,2.7494e-12,-0.49487,-0.57598,1,0
5,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,3.7605e-06,-0.49535,-0.44299,1,0
5,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,2.4893e-11,-0.4958,-0.48703,1,0
5,GO NEGATIVE REGULATION OF AXONOGENESIS,1.2759e-09,-0.49643,-0.51817,1,0
5,GO ENTRY OF BACTERIUM INTO HOST CELL,7.5266e-09,-0.49647,-0.59399,1,0
5,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,9.9064e-10,-0.49672,-0.52444,1,0
5,GO NEURON PROJECTION ARBORIZATION,5.8262e-07,-0.4974,-0.49903,1,0
5,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,2.6352e-05,-0.49762,-0.48259,1,0
5,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,8.5043e-10,-0.49764,-0.54256,1,0
5,GO LYMPHANGIOGENESIS,4.4787e-08,-0.49806,-0.47429,1,0
5,GO CORONARY VASCULATURE DEVELOPMENT,2.801e-10,-0.49822,-0.5121,1,0
5,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,5.6451e-10,-0.4994,-0.49529,1,0
5,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,2.8753e-10,-0.4994,-0.48578,1,0
5,GO RESPONSE TO INTERLEUKIN 18,4.719e-07,-0.49968,-0.58023,1,0
5,GO PROTEIN KINASE C SIGNALING,1.7687e-09,-0.50067,-0.52226,1,0
5,GO NEURAL CREST CELL DIFFERENTIATION,1.7909e-10,-0.5013,-0.47469,1,0
5,GO EPITHELIAL CELL CELL ADHESION,3.0156e-07,-0.50145,-0.58554,1,0
5,GO GERMINAL CENTER FORMATION,1.1579e-08,-0.5015,-0.55526,1,0
5,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,1.4076e-07,-0.502,-0.471,1,0
5,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,6.757e-10,-0.50349,-0.62789,1,0
5,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,1.9926e-08,-0.5035,-0.5374,1,0
5,GO REGULATION OF RENAL SYSTEM PROCESS,4.0817e-11,-0.50399,-0.5262,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,2.7e-09,-0.50405,-0.50287,1,0
5,GO VOCALIZATION BEHAVIOR,2.8814e-05,-0.50414,-0.46783,1,0
5,GO REGULATION OF INCLUSION BODY ASSEMBLY,5.4356e-06,-0.5048,-0.46617,1,0
5,GO NEGATIVE REGULATION OF BONE MINERALIZATION,1.2886e-07,-0.50512,-0.45779,1,0
5,GO CELLULAR RESPONSE TO CHOLESTEROL,8.4871e-11,-0.50544,-0.53683,1,0
5,GO AORTIC VALVE DEVELOPMENT,2.3554e-11,-0.50576,-0.61795,1,0
5,GO RESPONSE TO EPINEPHRINE,2.3891e-06,-0.50608,-0.42865,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,2.5893e-10,-0.5061,-0.61483,1,0
5,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,1.0322e-07,-0.50626,-0.47721,1,0
5,GO DETECTION OF OTHER ORGANISM,2.2958e-06,-0.50633,-0.49817,1,0
5,GO LAMELLIPODIUM MORPHOGENESIS,6.6717e-09,-0.50634,-0.53379,1,0
5,GO FOCAL ADHESION ASSEMBLY,5.6594e-11,-0.50668,-0.58263,1,0
5,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,3.1032e-11,-0.50669,-0.50098,1,0
5,GO PROSTATIC BUD FORMATION,9.0235e-07,-0.50693,-0.51542,1,0
5,GO GAMMA DELTA T CELL ACTIVATION,8.4262e-06,-0.50699,-0.39005,1,0
5,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,1.3196e-05,-0.50805,-0.41659,1,0
5,GO AXONAL FASCICULATION,1.0036e-08,-0.50806,-0.52295,1,0
5,GO NEUROBLAST DIVISION,4.3082e-09,-0.50828,-0.56182,1,0
5,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,1.2441e-09,-0.50828,-0.47896,1,0
5,GO HEART TRABECULA MORPHOGENESIS,2.4586e-08,-0.50832,-0.46727,1,0
5,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,1.6129e-08,-0.50901,-0.49539,1,0
5,GO NEGATIVE REGULATION OF HIPPO SIGNALING,5.2359e-09,-0.5091,-0.64298,1,0
5,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,9.3415e-09,-0.50937,-0.55209,1,0
5,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,1.2281e-06,-0.5099,-0.50064,1,0
5,GO N ACETYLNEURAMINATE METABOLIC PROCESS,5.8262e-07,-0.51004,-0.45436,1,0
5,GO T HELPER 2 CELL DIFFERENTIATION,2.6362e-08,-0.51006,-0.54139,1,0
5,GO CELL ADHESION MEDIATED BY INTEGRIN,8.4871e-11,-0.51033,-0.56963,1,0
5,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,6.8406e-11,-0.51045,-0.60102,1,0
5,GO MACROPHAGE PROLIFERATION,1.725e-09,-0.51072,-0.55909,1,0
5,GO COLLAGEN BIOSYNTHETIC PROCESS,2.9515e-10,-0.51106,-0.64454,1,0
5,GO REGULATION OF GTP BINDING,9.7991e-09,-0.5123,-0.47574,1,0
5,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,2.2286e-11,-0.51259,-0.59325,1,0
5,GO REGULATION OF AMYLOID BETA CLEARANCE,4.8076e-11,-0.51273,-0.52687,1,0
5,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,6.4805e-11,-0.51462,-0.55828,1,0
5,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,8.0815e-10,-0.5152,-0.48063,1,0
5,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,4.3774e-08,-0.5159,-0.55736,1,0
5,GO MONONUCLEAR CELL DIFFERENTIATION,5.2359e-09,-0.51626,-0.5858,1,0
5,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,5.3747e-08,-0.51653,-0.46942,1,0
5,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,6.1389e-11,-0.51656,-0.50847,1,0
5,GO PRESYNAPTIC MEMBRANE ORGANIZATION,1.4472e-05,-0.51663,-0.46379,1,0
5,GO PERICARDIUM DEVELOPMENT,1.2604e-07,-0.51717,-0.50252,1,0
5,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,5.3647e-09,-0.51727,-0.51034,1,0
5,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,1.3325e-06,-0.51802,-0.52757,1,0
5,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,5.3602e-11,-0.51868,-0.5199,1,0
5,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,8.4871e-11,-0.51884,-0.61393,1,0
5,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,2.1595e-09,-0.51886,-0.50944,1,0
5,GO SERTOLI CELL DEVELOPMENT,7.1726e-09,-0.51906,-0.49504,1,0
5,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,5.3747e-08,-0.51931,-0.50656,1,0
5,GO CHOLESTEROL STORAGE,6.3074e-11,-0.51931,-0.54908,1,0
5,GO SYNAPTIC VESICLE CLUSTERING,0.00015838,-0.51962,-0.46748,1,0
5,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,2.9805e-09,-0.52035,-0.5687,1,0
5,GO POSITIVE REGULATION OF VESICLE FUSION,6.0759e-07,-0.52087,-0.50617,1,0
5,GO SEMI LUNAR VALVE DEVELOPMENT,4.8076e-11,-0.52162,-0.60898,1,0
5,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,2.913e-06,-0.52166,-0.5907,1,0
5,GO RESPONSE TO STEROL,1.0202e-11,-0.5219,-0.54383,1,0
5,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,7.8976e-09,-0.52258,-0.59476,1,0
5,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,1.0361e-05,-0.52357,-0.47721,1,0
5,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,1.7385e-05,-0.52361,-0.55883,1,0
5,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,3.5427e-10,-0.52414,-0.5733,1,0
5,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,2.0398e-08,-0.52421,-0.50347,1,0
5,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,2.8271e-07,-0.52422,-0.58362,1,0
5,GO CERAMIDE CATABOLIC PROCESS,1.5037e-07,-0.52505,-0.50614,1,0
5,GO POSITIVE REGULATION OF VASCULOGENESIS,7.2129e-08,-0.52526,-0.49345,1,0
5,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,9.2321e-08,-0.52527,-0.51407,1,0
5,GO CHONDROCYTE PROLIFERATION,1.3599e-06,-0.52685,-0.46514,1,0
5,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,1.1794e-07,-0.52853,-0.49668,1,0
5,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,1.2131e-09,-0.52864,-0.57046,1,0
5,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,4.7501e-09,-0.52882,-0.4944,1,0
5,GO FACE DEVELOPMENT,4.4749e-10,-0.52949,-0.54619,1,0
5,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.9926e-08,-0.53013,-0.51086,1,0
5,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.00018923,-0.53106,-0.40885,1,0
5,GO CELLULAR RESPONSE TO ETHANOL,1.9064e-09,-0.53144,-0.47945,1,0
5,GO RESPONSE TO HYPEROXIA,4.1948e-11,-0.53177,-0.51757,1,0
5,GO COLLAGEN FIBRIL ORGANIZATION,1.3419e-09,-0.53188,-0.62774,1,0
5,GO NEURAL CREST CELL MIGRATION,1.9387e-10,-0.53213,-0.53035,1,0
5,GO LIMB BUD FORMATION,1.9393e-05,-0.53228,-0.48884,1,0
5,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,1.0322e-07,-0.53236,-0.6595,1,0
5,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,1.8594e-09,-0.53287,-0.53884,1,0
5,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,7.8976e-09,-0.53293,-0.5634,1,0
5,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,4.4787e-08,-0.53321,-0.55982,1,0
5,GO REGULATION OF AXON GUIDANCE,5.6451e-10,-0.53445,-0.53487,1,0
5,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.00069207,-0.53499,-0.60426,1,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,2.2707e-10,-0.53583,-0.52411,1,0
5,GO OLIGOPEPTIDE TRANSPORT,1.0791e-07,-0.53584,-0.47592,1,0
5,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,5.9432e-10,-0.53645,-0.51775,1,0
5,GO EPIBOLY,2.2912e-11,-0.53676,-0.61057,1,0
5,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,3.2162e-07,-0.53768,-0.63412,1,0
5,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,1.7721e-08,-0.53844,-0.50953,1,0
5,GO NEGATIVE CHEMOTAXIS,4.4749e-10,-0.53855,-0.56639,1,0
5,GO LYMPH VESSEL DEVELOPMENT,1.4471e-09,-0.53914,-0.56999,1,0
5,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,6.4192e-10,-0.53952,-0.54479,1,0
5,GO DENDRITIC CELL APOPTOTIC PROCESS,1.5027e-08,-0.53969,-0.61868,1,0
5,GO REGULATION OF CELL MATRIX ADHESION,4.6784e-11,-0.54,-0.58336,1,0
5,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,2.8753e-10,-0.54042,-0.59864,1,0
5,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,1.4877e-10,-0.541,-0.57887,1,0
5,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,1.8881e-10,-0.54127,-0.57988,1,0
5,GO BEHAVIORAL RESPONSE TO PAIN,6.8348e-09,-0.54232,-0.52642,1,0
5,GO NEUTROPHIL HOMEOSTASIS,1.3761e-09,-0.54232,-0.62691,1,0
5,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,3.1098e-10,-0.54239,-0.5907,1,0
5,GO REGULATION OF RECEPTOR BINDING,9.9064e-10,-0.54258,-0.59174,1,0
5,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,6.3569e-09,-0.5427,-0.5829,1,0
5,GO SEQUESTERING OF TRIGLYCERIDE,2.004e-09,-0.54508,-0.46986,1,0
5,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,9.7068e-11,-0.54517,-0.53133,1,0
5,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,3.4634e-11,-0.5454,-0.54334,1,0
5,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,2.0881e-08,-0.54541,-0.67901,1,0
5,GO REGULATION OF AMYLOID BETA FORMATION,3.019e-11,-0.54568,-0.52827,1,0
5,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,6.2565e-10,-0.54654,-0.59399,1,0
5,GO NEGATIVE REGULATION OF BIOMINERALIZATION,3.2764e-10,-0.54664,-0.56126,1,0
5,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,2.0546e-09,-0.54713,-0.57393,1,0
5,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,5.3747e-08,-0.54716,-0.54121,1,0
5,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,2.5934e-07,-0.54808,-0.49324,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.001071,-0.54812,-0.61889,1,0
5,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,7.71e-09,-0.54844,-0.48888,1,0
5,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,5.1356e-08,-0.54986,-0.4981,1,0
5,GO MEMBRANE RAFT ORGANIZATION,2.0429e-07,-0.55035,-0.56124,1,0
5,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,1.9014e-08,-0.55292,-0.64002,1,0
5,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,3.055e-09,-0.5533,-0.52329,1,0
5,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,6.5125e-09,-0.55429,-0.53064,1,0
5,GO RESPONSE TO MURAMYL DIPEPTIDE,9.7068e-11,-0.55456,-0.61233,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,5.6304e-12,-0.55478,-0.66146,1,0
5,GO PROTEIN LOCALIZATION TO ENDOSOME,4.8198e-07,-0.55543,-0.55112,1,0
5,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,5.3647e-09,-0.55593,-0.53495,1,0
5,GO EMBRYONIC EYE MORPHOGENESIS,1.6907e-08,-0.55846,-0.48862,1,0
5,GO REGULATION OF VASCULOGENESIS,8.0712e-08,-0.55896,-0.54729,1,0
5,GO BONE GROWTH,2.3853e-09,-0.55916,-0.55136,1,0
5,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,1.6542e-10,-0.55925,-0.55796,1,0
5,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,8.4805e-07,-0.55956,-0.54428,1,0
5,GO DERMATAN SULFATE METABOLIC PROCESS,2.9078e-09,-0.56,-0.60213,1,0
5,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,3.2146e-06,-0.56082,-0.56491,1,0
5,GO OLIGOSACCHARIDE CATABOLIC PROCESS,8.0898e-09,-0.56096,-0.58171,1,0
5,GO METANEPHRIC GLOMERULUS DEVELOPMENT,7.3476e-09,-0.56111,-0.64302,1,0
5,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,7.6205e-11,-0.56147,-0.60547,1,0
5,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,3.1004e-08,-0.56151,-0.55214,1,0
5,GO BONE TRABECULA MORPHOGENESIS,3.5412e-09,-0.56201,-0.64673,1,0
5,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,5.2253e-10,-0.56288,-0.67122,1,0
5,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,5.77e-09,-0.56321,-0.55792,1,0
5,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,3.1729e-08,-0.56365,-0.55901,1,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,3.8149e-08,-0.56762,-0.51876,1,0
5,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,2.6362e-08,-0.56775,-0.59796,1,0
5,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,5.2359e-09,-0.57047,-0.53114,1,0
5,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,9.028e-08,-0.57054,-0.50992,1,0
5,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.00013673,-0.57095,-0.4233,1,0
5,GO CORONARY VASCULATURE MORPHOGENESIS,3.7195e-09,-0.57108,-0.57627,1,0
5,GO EXOCRINE SYSTEM DEVELOPMENT,7.9144e-12,-0.57142,-0.61186,1,0
5,GO FACIAL NERVE MORPHOGENESIS,1.5027e-08,-0.5717,-0.67574,1,0
5,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,7.5266e-09,-0.57206,-0.59906,1,0
5,GO CORPUS CALLOSUM DEVELOPMENT,1.3671e-08,-0.57215,-0.54532,1,0
5,GO REGULATION OF PROTEIN KINASE C SIGNALING,2.4586e-08,-0.57223,-0.63349,1,0
5,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,3.3713e-09,-0.57226,-0.60059,1,0
5,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,1.2434e-08,-0.57276,-0.59749,1,0
5,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,5.0237e-12,-0.57321,-0.69441,1,0
5,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,1.3039e-08,-0.57506,-0.55147,1,0
5,GO CRANIAL NERVE MORPHOGENESIS,4.8359e-10,-0.57581,-0.57929,1,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,1.1706e-10,-0.57621,-0.62466,1,0
5,GO REGULATION OF GLOMERULUS DEVELOPMENT,5.02e-08,-0.5773,-0.6548,1,0
5,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,6.3359e-07,-0.57766,-0.57737,1,0
5,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,3.5427e-10,-0.57769,-0.58504,1,0
5,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,4.9624e-10,-0.57832,-0.60508,1,0
5,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,1.3505e-11,-0.57861,-0.63962,1,0
5,GO MACROPHAGE CYTOKINE PRODUCTION,7.2202e-11,-0.57959,-0.66909,1,0
5,GO REGULATION OF PLATELET AGGREGATION,3.0295e-08,-0.57997,-0.58189,1,0
5,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,2.188e-08,-0.58006,-0.57761,1,0
5,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,1.5052e-06,-0.58051,-0.54534,1,0
5,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,6.9323e-10,-0.58234,-0.60277,1,0
5,GO REGULATION OF METANEPHROS DEVELOPMENT,3.1098e-10,-0.58307,-0.66726,1,0
5,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,4.4302e-11,-0.58417,-0.56775,1,0
5,GO LATERAL VENTRICLE DEVELOPMENT,3.6435e-08,-0.58647,-0.54609,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,7.2202e-11,-0.58694,-0.61042,1,0
5,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,3.094e-05,-0.59092,-0.60771,1,0
5,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,4.5922e-10,-0.59095,-0.66066,1,0
5,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,1.8419e-06,-0.59251,-0.43983,1,0
5,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,3.6293e-09,-0.59264,-0.68935,1,0
5,GO BLASTODERM SEGMENTATION,2.5756e-08,-0.59501,-0.53869,1,0
5,GO DENDRITIC SPINE MAINTENANCE,1.785e-11,-0.59526,-0.59423,1,0
5,GO GLYCOLIPID CATABOLIC PROCESS,1.3174e-07,-0.59591,-0.54866,1,0
5,GO INFLAMMATORY RESPONSE TO WOUNDING,1.0791e-07,-0.59929,-0.62211,1,0
5,GO POSITIVE REGULATION OF NEURON MIGRATION,6.205e-09,-0.5998,-0.61074,1,0
5,GO REGULATION OF PLATELET ACTIVATION,4.7125e-10,-0.60052,-0.58633,1,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,4.5922e-10,-0.60152,-0.61298,1,0
5,GO SKIN MORPHOGENESIS,1.4112e-09,-0.60198,-0.7464,1,0
5,GO TOOTH MINERALIZATION,1.2682e-10,-0.60407,-0.62798,1,0
5,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,1.6129e-08,-0.60496,-0.61803,1,0
5,GO BASEMENT MEMBRANE ORGANIZATION,3.9963e-12,-0.60531,-0.7235,1,0
5,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,6.205e-09,-0.60697,-0.51118,1,0
5,GO CELL CELL JUNCTION MAINTENANCE,3.5038e-07,-0.60776,-0.54441,1,0
5,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,7.3772e-08,-0.60783,-0.61309,1,0
5,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,6.9323e-10,-0.60848,-0.57442,1,0
5,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,2.4452e-09,-0.609,-0.69204,1,0
5,GO REGULATION OF MONOCYTE DIFFERENTIATION,1.6823e-09,-0.60964,-0.72698,1,0
5,GO SALIVARY GLAND DEVELOPMENT,2.1085e-11,-0.61058,-0.62825,1,0
5,GO ENDOTHELIAL CELL CHEMOTAXIS,4.3606e-10,-0.6123,-0.56564,1,0
5,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,3.5597e-11,-0.61268,-0.6076,1,0
5,GO EXTRACELLULAR MATRIX ASSEMBLY,2.3113e-12,-0.61396,-0.76843,1,0
5,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,4.4771e-05,-0.61396,-0.54333,1,0
5,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,2.188e-08,-0.61401,-0.66237,1,0
5,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,7.2202e-11,-0.61449,-0.61674,1,0
5,GO NEGATIVE REGULATION OF AXON GUIDANCE,1.3737e-10,-0.6187,-0.63301,1,0
5,GO LATERAL SPROUTING FROM AN EPITHELIUM,8.8389e-07,-0.61976,-0.54871,1,0
5,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,2.5695e-09,-0.62393,-0.73811,1,0
5,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,5.0766e-11,-0.62506,-0.69411,1,0
5,GO AMYLOID FIBRIL FORMATION,1.2759e-09,-0.62756,-0.59706,1,0
5,GO GLOMERULUS DEVELOPMENT,5.793e-12,-0.63129,-0.6743,1,0
5,GO HEMIDESMOSOME ASSEMBLY,3.7605e-06,-0.63235,-0.65246,1,0
5,GO PULMONARY VALVE DEVELOPMENT,3.6293e-09,-0.63738,-0.62863,1,0
5,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,6.1389e-11,-0.63971,-0.67005,1,0
5,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,6.8348e-09,-0.65034,-0.65842,1,0
5,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.0016347,-0.65197,-0.70339,1,0
5,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,2.5934e-07,-0.65502,-0.58535,1,0
5,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,6.3569e-09,-0.65547,-0.75713,1,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,6.3074e-11,-0.65571,-0.66812,1,0
5,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,9.1996e-11,-0.66214,-0.71526,1,0
5,GO GLOMERULAR MESANGIUM DEVELOPMENT,9.8716e-08,-0.66352,-0.63549,1,0
5,GO PULMONARY VALVE MORPHOGENESIS,3.055e-09,-0.67331,-0.67118,1,0
5,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,3.6361e-10,-0.67538,-0.65159,1,0
5,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,1.9387e-10,-0.6766,-0.66129,1,0
5,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,7.5266e-09,-0.67825,-0.75319,1,0
5,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,1.3761e-09,-0.67833,-0.62902,1,0
5,GO BLEB ASSEMBLY,2.3274e-07,-0.67845,-0.7084,1,0
5,GO MYELIN MAINTENANCE,2.5066e-09,-0.68053,-0.6246,1,0
5,GO ENDOTHELIAL CELL MORPHOGENESIS,7.8052e-07,-0.68857,-0.68432,1,0
5,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,1.4107e-10,-0.68904,-0.70743,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,1.2074e-11,-0.69359,-0.78763,1,0
5,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,6.8406e-11,-0.69487,-0.82994,1,0
5,GO ENAMEL MINERALIZATION,5.3617e-10,-0.70806,-0.67601,1,0
5,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,4.6784e-11,-0.73389,-0.7603,1,0
5,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,4.0817e-11,-0.73544,-0.8046,1,0
5,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,3.055e-09,-0.78671,-0.77825,1,0
5,GO RENAL FILTRATION,2.1085e-11,-0.85641,-0.85433,1,0
5,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,2.004e-09,-0.86145,-0.80726,1,0
5,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,1.3085e-09,-0.88876,-0.8355,1,0
5,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,3.1312e-09,-0.92305,-0.91119,1,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.09714,0.11418,0.0941,0,1
5,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.11367,0.084633,0.057421,0,1
5,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.15802,0.075156,0.050945,0,1
5,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.1453,0.070989,0.054574,0,1
5,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.9693,0.069651,-0.040248,0,1
5,GO FOREBRAIN NEURON FATE COMMITMENT,0.9693,0.18587,-0.079851,0,0
5,GO DETOXIFICATION OF INORGANIC COMPOUND,0.86331,0.10288,-0.1198,0,0
5,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.15802,0.082908,0.045622,0,0
5,GO MALE MEIOSIS I,0.73212,0.08278,-0.10159,0,0
5,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.070488,0.077187,0.051292,0,0
5,GO PROTEIN NEDDYLATION,0.31021,0.075934,0.027414,0,0
5,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.43312,0.073185,0.013162,0,0
5,GO TRANSLATIONAL TERMINATION,0.30066,0.059028,0.018987,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.19417,0.05742,0.047035,0,0
5,GO AEROBIC ELECTRON TRANSPORT CHAIN,0.14642,0.056568,0.059937,0,0
5,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.86331,0.052027,-0.0085823,0,0
5,GO MATURATION OF LSU RRNA,0.40286,0.051181,-0.069886,0,0
5,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.81267,0.047002,-0.046954,0,0
5,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.41434,0.045509,0.026307,0,0
5,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.58864,0.043846,0.028663,0,0
5,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.36526,0.042856,0.044283,0,0
5,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.2114,0.039833,0.041882,0,0
5,GO MITOCHONDRIAL TRANSLATION,0.61117,0.038344,-0.012502,0,0
5,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.39156,0.037917,-0.087699,0,0
5,GO PROTEASOME ASSEMBLY,0.17411,0.035351,0.027496,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.797,0.034345,-0.05347,0,0
5,GO NEURON FATE SPECIFICATION,0.95639,0.032936,-0.019971,0,0
5,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.51035,0.030715,0.013049,0,0
5,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.83158,0.024701,-0.084169,0,0
5,GO CHROMATIN REMODELING AT CENTROMERE,0.56103,0.021156,0.019555,0,0
5,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.46466,0.01954,-0.080617,0,0
5,GO MITOCHONDRIAL GENE EXPRESSION,0.97253,0.019435,-0.03813,0,0
5,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.98546,0.017523,-0.037069,0,0
5,GO RIBOSOME ASSEMBLY,0.82842,0.016971,-0.011764,0,0
5,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.51296,0.015027,-0.061135,0,0
5,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.89205,0.014623,-0.017348,0,0
5,GO TRNA 5 LEADER REMOVAL,0.99515,0.0090195,-0.021076,0,0
5,GO LACTATE METABOLIC PROCESS,0.22814,0.0081228,-0.11605,0,0
5,GO TRANSLATIONAL ELONGATION,0.8379,0.0044539,-0.021291,0,0
5,GO KINETOCHORE ORGANIZATION,0.35043,0.0019082,-0.074589,0,0
5,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.82842,0.0012665,-0.012546,0,0
5,GO NEGATIVE REGULATION OF RNA SPLICING,0.26267,-0.0032955,-0.091122,0,0
5,GO REGULATION OF APPETITE,0.49743,-0.003461,-0.04866,0,0
5,GO CYTOPLASMIC TRANSLATION,0.45972,-0.0037295,-0.040404,0,0
5,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.86649,-0.0054167,-0.027569,0,0
5,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.38047,-0.007076,-0.071858,0,0
5,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.36098,-0.011094,-0.071505,0,0
5,GO PROTEIN DENEDDYLATION,0.46466,-0.011974,-0.056159,0,0
5,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,0.28578,-0.01251,-0.10571,0,0
5,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.13656,-0.013536,-0.093492,0,0
5,GO ERROR FREE TRANSLESION SYNTHESIS,0.18866,-0.014333,-0.085694,0,0
5,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.36741,-0.015588,-0.06218,0,0
5,GO TRANSLATIONAL INITIATION,0.9693,-0.015838,-0.0049897,0,0
5,GO HISTONE EXCHANGE,0.40743,-0.016294,-0.050183,0,0
5,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.59424,-0.021036,-0.043801,0,0
5,GO PROTEIN TARGETING TO MEMBRANE,0.43312,-0.021757,-0.03862,0,0
5,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.12721,-0.022235,-0.11822,0,0
5,GO SNORNA 3 END PROCESSING,0.26789,-0.022589,-0.089417,0,0
5,GO MRNA CIS SPLICING VIA SPLICEOSOME,0.085497,-0.023943,-0.12089,0,0
5,GO TRNA 5 END PROCESSING,0.63697,-0.024586,-0.05234,0,0
5,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.20992,-0.024598,-0.079184,0,0
5,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.61117,-0.025161,-0.026048,0,0
5,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,0.24089,-0.026859,-0.15136,0,0
5,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.089246,-0.031679,-0.13736,0,0
5,GO ERROR PRONE TRANSLESION SYNTHESIS,0.088486,-0.033831,-0.091382,0,0
5,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.29315,-0.034036,-0.056982,0,0
5,GO CENTROMERE COMPLEX ASSEMBLY,0.572,-0.036308,-0.049944,0,0
5,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.74435,-0.037051,-0.041501,0,0
5,GO MALE MEIOTIC NUCLEAR DIVISION,0.065596,-0.038476,-0.16987,0,0
5,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.11183,-0.04077,-0.083368,0,0
5,GO ALDEHYDE CATABOLIC PROCESS,0.40514,-0.041915,-0.048725,0,0
5,GO MITOCHONDRIAL RNA PROCESSING,0.18062,-0.041966,-0.16138,0,0
5,GO TETRAHYDROFOLATE INTERCONVERSION,0.21889,-0.042674,-0.10562,0,0
5,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.10385,-0.045185,-0.084186,0,0
5,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.17283,-0.045328,-0.10204,0,0
5,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.59705,-0.045393,-0.048304,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.23128,-0.045622,-0.091965,0,0
5,GO KINETOCHORE ASSEMBLY,0.2644,-0.046254,-0.08001,0,0
5,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.30255,-0.047607,-0.1122,0,0
5,GO OXIDATIVE PHOSPHORYLATION,0.63697,-0.047939,-0.032702,0,0
5,GO RNA 5 END PROCESSING,0.089246,-0.048031,-0.12179,0,0
5,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,0.27317,-0.048582,-0.076947,0,0
5,GO VIRAL LATENCY,0.44269,-0.049219,-0.061552,0,0
5,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.1262,-0.051004,-0.080568,0,0
5,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.17029,-0.054934,-0.11852,0,0
5,GO HISTONE MRNA METABOLIC PROCESS,0.076344,-0.055652,-0.10434,0,0
5,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.36311,-0.056746,-0.076785,0,0
5,GO VIRAL GENE EXPRESSION,0.2913,-0.056776,-0.042295,0,0
5,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,0.22195,-0.057219,-0.15026,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.32993,-0.058474,-0.031538,0,0
5,GO RNA SURVEILLANCE,0.10385,-0.060197,-0.1041,0,0
5,GO REGULATION OF RESPONSE TO FOOD,0.12224,-0.060922,-0.078197,0,0
5,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.13444,-0.061293,-0.12722,0,0
5,GO QUINONE METABOLIC PROCESS,0.046474,-0.062827,-0.13876,0,0
5,GO RIBOSOME BIOGENESIS,0.062684,-0.063332,-0.11929,0,0
5,GO RRNA 3 END PROCESSING,0.34835,-0.06339,-0.054944,0,0
5,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.12322,-0.063586,-0.06041,0,0
5,GO MESODERMAL CELL FATE COMMITMENT,0.026013,-0.064994,-0.16887,0,0
5,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,0.18327,-0.065262,-0.18794,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.25414,-0.065476,-0.090234,0,0
5,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.035336,-0.067145,-0.11109,0,0
5,GO PIRNA METABOLIC PROCESS,0.26614,-0.067434,-0.094644,0,0
5,GO MEIOTIC CELL CYCLE PROCESS,0.00067188,-0.068347,-0.18416,0,0
5,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.084034,-0.068873,-0.11289,0,0
5,GO MESODERMAL CELL FATE SPECIFICATION,0.13027,-0.068889,-0.12588,0,0
5,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.26789,-0.069981,-0.084001,0,0
5,GO NCRNA 3 END PROCESSING,0.10734,-0.07021,-0.081905,0,0
5,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.20699,-0.072149,-0.21987,0,0
5,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.06986,-0.072581,-0.087616,0,0
5,GO DNA LIGATION,0.25753,-0.072586,-0.077411,0,0
5,GO MITOTIC DNA REPLICATION,0.080464,-0.073039,-0.17037,0,0
5,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.084763,-0.075665,-0.20618,0,0
5,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.16904,-0.076725,-0.088656,0,0
5,GO TELOMERASE RNA LOCALIZATION,0.15802,-0.078026,-0.10913,0,0
5,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.14983,-0.079491,-0.11367,0,0
5,GO MACROMOLECULE DEPALMITOYLATION,0.14869,-0.079976,-0.075589,0,0
5,GO MITOTIC METAPHASE PLATE CONGRESSION,0.31215,-0.081018,-0.09317,0,0
5,GO MATURATION OF 5 8S RRNA,0.070488,-0.081371,-0.13211,0,0
5,GO NEURON FATE COMMITMENT,0.38267,-0.082111,-0.10951,0,0
5,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.074349,-0.082755,-0.13468,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.21437,-0.083207,-0.068328,0,0
5,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.086981,-0.08395,-0.068055,0,0
5,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0089251,-0.084257,-0.16584,0,0
5,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,0.087731,-0.084316,-0.12064,0,0
5,GO PENTOSE METABOLIC PROCESS,0.061549,-0.084408,-0.13987,0,0
5,GO SEQUESTERING OF ACTIN MONOMERS,0.50516,-0.085179,-0.020471,0,0
5,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.041789,-0.085264,-0.19399,0,0
5,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.063836,-0.085621,-0.11301,0,0
5,GO SNRNA METABOLIC PROCESS,0.031631,-0.087259,-0.11372,0,0
5,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.099614,-0.087394,-0.1458,0,0
5,GO CARDIAC CELL FATE COMMITMENT,0.13656,-0.087629,-0.12379,0,0
5,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.11183,-0.090645,-0.10419,0,0
5,GO DNA REPLICATION INITIATION,0.1262,-0.093095,-0.097437,0,0
5,GO SPINDLE ASSEMBLY,0.00031414,-0.094546,-0.216,0,0
5,GO KILLING OF CELLS OF OTHER ORGANISM,0.0047198,-0.095354,-0.12078,0,0
5,GO CELLULAR RESPONSE TO LITHIUM ION,0.026561,-0.10347,-0.14628,0,0
5,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.0089251,-0.10611,-0.16691,0,0
5,GO MITOCHONDRIAL FUSION,0.015674,-0.10647,-0.20986,0,0
5,GO CELLULAR RESPONSE TO ZINC ION,0.14197,-0.1072,-0.19664,0,0
5,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.068006,-0.10723,-0.087671,0,0
5,GO ESCRT COMPLEX DISASSEMBLY,0.045591,-0.10757,-0.13706,0,0
5,GO RNA CAPPING,0.01585,-0.10804,-0.12153,0,0
5,GO TRANSCRIPTION BY RNA POLYMERASE I,0.001483,-0.10885,-0.21024,0,0
5,GO GABAERGIC NEURON DIFFERENTIATION,0.36956,-0.10888,-0.20805,0,0
5,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.0016806,-0.11125,-0.19328,0,0
5,GO TELENCEPHALON REGIONALIZATION,0.27495,-0.11147,-0.1133,0,0
5,GO DEFENSE RESPONSE TO FUNGUS,0.0039481,-0.11574,-0.15528,0,0
5,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.093126,-0.1171,-0.10446,0,0
5,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.0024609,-0.1172,-0.18485,0,0
5,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.042609,-0.12048,-0.18897,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.14983,-0.12242,-0.14138,0,0
5,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.14642,-0.12253,-0.085466,0,0
5,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.27853,-0.12339,-0.10221,0,0
5,GO OLFACTORY LOBE DEVELOPMENT,0.011678,-0.12423,-0.24324,0,0
5,GO BASE EXCISION REPAIR AP SITE FORMATION,0.019104,-0.12477,-0.13806,0,0
5,GO DNA STRAND ELONGATION,0.096327,-0.12594,-0.11622,0,0
5,GO POSITIVE REGULATION OF BEHAVIOR,0.060988,-0.12776,-0.19484,0,0
5,GO REGULATION OF ATPASE ACTIVITY,4.7172e-05,-0.12811,-0.19717,0,0
5,GO REGULATION OF TELOMERE CAPPING,2.2416e-05,-0.12885,-0.2776,0,0
5,GO MEIOTIC CHROMOSOME SEPARATION,0.0018006,-0.12889,-0.1813,0,0
5,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.00042128,-0.13088,-0.20815,0,0
5,GO PROTEIN TRANSMEMBRANE TRANSPORT,4.6578e-06,-0.13134,-0.19183,0,0
5,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.0086125,-0.13194,-0.20565,0,0
5,GO PROTEIN K11 LINKED UBIQUITINATION,0.0027747,-0.13354,-0.15881,0,0
5,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,2.5424e-05,-0.13528,-0.20837,0,0
5,GO MYOBLAST MIGRATION,0.11183,-0.13743,-0.16605,0,0
5,GO OOCYTE MATURATION,0.0010408,-0.14114,-0.18838,0,0
5,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.24252,-0.14121,-0.085505,0,0
5,GO REGULATION OF EXIT FROM MITOSIS,0.0015249,-0.14233,-0.19342,0,0
5,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,4.5558e-05,-0.14238,-0.23364,0,0
5,GO FOREBRAIN GENERATION OF NEURONS,0.001071,-0.14238,-0.28291,0,0
5,GO PROTEIN HETEROTETRAMERIZATION,0.00072342,-0.14299,-0.19468,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.012227,-0.14489,-0.20885,0,0
5,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.32792,-0.14547,-0.079554,0,0
5,GO POSITIVE REGULATION OF CELL AGING,0.00042128,-0.14553,-0.1893,0,0
5,GO MITOCHONDRIAL TRANSPORT,6.6066e-07,-0.14693,-0.22387,0,0
5,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,9.6562e-05,-0.14775,-0.19777,0,0
5,GO NADPH REGENERATION,0.0013826,-0.14795,-0.24753,0,0
5,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.27317,-0.14829,-0.080042,0,0
5,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,2.2958e-06,-0.15019,-0.2238,0,0
5,GO REGULATION OF HELICASE ACTIVITY,0.090782,-0.15083,-0.10751,0,0
5,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.0021798,-0.15173,-0.21414,0,0
5,GO INNER CELL MASS CELL PROLIFERATION,0.00099681,-0.15252,-0.2519,0,0
5,GO FOREBRAIN REGIONALIZATION,0.060988,-0.15329,-0.15187,0,0
5,GO DRUG CATABOLIC PROCESS,0.00011986,-0.15486,-0.21135,0,0
5,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.00075607,-0.15564,-0.16181,0,0
5,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,1.8793e-06,-0.15714,-0.25366,0,0
5,GO MITOCHONDRION ORGANIZATION,8.4415e-08,-0.15728,-0.22411,0,0
5,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,5.2165e-11,-0.15869,-0.26535,0,0
5,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,0.090011,-0.15917,-0.17349,0,0
5,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,4.7488e-06,-0.1594,-0.28504,0,0
5,GO COBALAMIN METABOLIC PROCESS,3.6924e-05,-0.16015,-0.24938,0,0
5,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.0010408,-0.16019,-0.20757,0,0
5,GO FOREBRAIN NEURON DIFFERENTIATION,0.0043184,-0.16192,-0.27866,0,0
5,GO CIRCADIAN SLEEP WAKE CYCLE,0.002631,-0.16192,-0.22236,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.0038977,-0.16488,-0.25223,0,0
5,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.015329,-0.16698,-0.2411,0,0
5,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.00023667,-0.16804,-0.1603,0,0
5,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.0033799,-0.16863,-0.30725,0,0
5,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.027401,-0.16877,-0.14077,0,0
5,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.00065224,-0.17075,-0.28023,0,0
5,GO REGULATION OF MITOCHONDRIAL FUSION,0.014658,-0.17374,-0.25889,0,0
5,GO POSITIVE REGULATION OF DNA BINDING,6.337e-06,-0.17394,-0.24396,0,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,1.0554e-07,-0.17465,-0.26479,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.00086244,-0.17491,-0.25972,0,0
5,GO PROTEIN AUTOPROCESSING,0.0021798,-0.17505,-0.18797,0,0
5,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.00044781,-0.17538,-0.26231,0,0
5,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,2.2775e-07,-0.17661,-0.29452,0,0
5,GO POSITIVE THYMIC T CELL SELECTION,3.5646e-05,-0.17769,-0.26352,0,0
5,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.001422,-0.17868,-0.19781,0,0
5,GO SLEEP,0.00062378,-0.17941,-0.20898,0,0
5,GO BEHAVIORAL RESPONSE TO COCAINE,0.007921,-0.1804,-0.30152,0,0
5,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.00030449,-0.182,-0.25037,0,0
5,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,6.2993e-08,-0.18296,-0.23754,0,0
5,GO NODAL SIGNALING PATHWAY,0.001568,-0.18448,-0.17185,0,0
5,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,2.9332e-05,-0.18559,-0.32671,0,0
5,GO INTRACELLULAR PROTEIN TRANSPORT,1.7442e-10,-0.18615,-0.26013,0,0
5,GO ALPHA AMINO ACID METABOLIC PROCESS,8.6328e-08,-0.1863,-0.25117,0,0
5,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.0030038,-0.18681,-0.19449,0,0
5,GO RESPONSE TO DOPAMINE,7.3803e-06,-0.18821,-0.28493,0,0
5,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00012594,-0.18999,-0.28806,0,0
5,GO CELLULAR RESPONSE TO MANGANESE ION,1.9749e-05,-0.19077,-0.27244,0,0
5,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,4.1026e-05,-0.19143,-0.309,0,0
5,GO GLYCOSIDE METABOLIC PROCESS,0.026013,-0.19173,-0.22282,0,0
5,GO RESPONSE TO ISOQUINOLINE ALKALOID,5.9834e-06,-0.19193,-0.26375,0,0
5,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,0.10299,-0.19195,-0.20863,0,0
5,GO BLASTOCYST GROWTH,0.0001862,-0.19226,-0.25707,0,0
5,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,1.6823e-09,-0.19308,-0.28738,0,0
5,GO TERPENOID BIOSYNTHETIC PROCESS,0.001071,-0.19361,-0.21055,0,0
5,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,0.00054518,-0.1941,-0.20936,0,0
5,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.00037835,-0.19733,-0.23717,0,0
5,GO CILIUM MOVEMENT,1.5372e-07,-0.19771,-0.2421,0,0
5,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.032607,-0.19966,-0.19973,0,0
5,GO RESPONSE TO FUNGUS,2.9859e-05,-0.19993,-0.21985,0,0
5,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.00058763,-0.19996,-0.26102,0,0
5,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.014332,-0.20157,-0.14274,0,0
5,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,4.5684e-06,-0.20346,-0.24723,0,0
5,GO REGULATION OF PROTON TRANSPORT,0.00031907,-0.20579,-0.23778,0,0
5,GO REGULATION OF MEIOTIC CELL CYCLE,1.0958e-05,-0.20812,-0.24803,0,0
5,GO OOCYTE DIFFERENTIATION,2.5424e-05,-0.20823,-0.23016,0,0
5,GO REGULATION OF MITOCHONDRION ORGANIZATION,9.1793e-10,-0.20852,-0.31544,0,0
5,GO AUDITORY RECEPTOR CELL DEVELOPMENT,2.8305e-05,-0.20937,-0.33384,0,0
5,GO MITOCHONDRIAL FISSION,1.3769e-07,-0.21023,-0.36008,0,0
5,GO PROTEIN LOCALIZATION TO CELL JUNCTION,1.5994e-06,-0.2108,-0.36851,0,0
5,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,3.6162e-06,-0.21086,-0.30717,0,0
5,GO LIPOXYGENASE PATHWAY,0.03006,-0.21178,-0.18768,0,0
5,GO REGULATION OF OOGENESIS,1.1165e-05,-0.21182,-0.23996,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,6.5837e-06,-0.21336,-0.38451,0,0
5,GO 3 UTR MEDIATED MRNA STABILIZATION,0.011022,-0.21429,-0.22739,0,0
5,GO HEART FIELD SPECIFICATION,0.00020504,-0.21512,-0.34866,0,0
5,GO GLUTAMATE METABOLIC PROCESS,1.7693e-06,-0.21586,-0.26386,0,0
5,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,4.9069e-08,-0.21599,-0.257,0,0
5,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.00011033,-0.21689,-0.28141,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,3.2057e-05,-0.21798,-0.31141,0,0
5,GO PHOSPHATE ION TRANSPORT,3.357e-07,-0.21835,-0.29081,0,0
5,GO ORGAN INDUCTION,3.9102e-06,-0.21885,-0.29031,0,0
5,GO ENDOPLASMIC RETICULUM ORGANIZATION,4.3606e-10,-0.21941,-0.33319,0,0
5,GO DNA DEAMINATION,0.065005,-0.22006,-0.22433,0,0
5,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,3.8161e-07,-0.22234,-0.28601,0,0
5,GO NEUTRAL AMINO ACID TRANSPORT,1.0004e-06,-0.22251,-0.37197,0,0
5,GO REGULATION OF CELL FATE COMMITMENT,2.7312e-05,-0.22268,-0.26273,0,0
5,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,2.457e-10,-0.22397,-0.29943,0,0
5,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,1.8793e-06,-0.22404,-0.32155,0,0
5,GO DE NOVO PROTEIN FOLDING,0.00018923,-0.22593,-0.25897,0,0
5,GO NUCLEOTIDE TRANSPORT,1.996e-06,-0.22638,-0.3063,0,0
5,GO PROTEIN REFOLDING,0.0020929,-0.22695,-0.21477,0,0
5,GO CELL MATURATION,2.634e-09,-0.2276,-0.31138,0,0
5,GO VISUAL BEHAVIOR,1.9989e-07,-0.22776,-0.32592,0,0
5,GO VITAMIN METABOLIC PROCESS,1.2733e-08,-0.22855,-0.29171,0,0
5,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,2.2958e-06,-0.22913,-0.40467,0,0
5,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,2.0879e-07,-0.23074,-0.32772,0,0
5,GO INTRA S DNA DAMAGE CHECKPOINT,2.971e-06,-0.23076,-0.30064,0,0
5,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,6.6578e-05,-0.23142,-0.23298,0,0
5,GO REGULATION OF GLIOGENESIS,1.5037e-07,-0.23149,-0.29547,0,0
5,GO ALCOHOL CATABOLIC PROCESS,3.055e-09,-0.23261,-0.31999,0,0
5,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,2.5066e-09,-0.2327,-0.33498,0,0
5,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0042636,-0.23276,-0.19133,0,0
5,GO PROTEIN STABILIZATION,2.457e-10,-0.23492,-0.30395,0,0
5,GO VESICLE TRANSPORT ALONG MICROTUBULE,1.8723e-07,-0.23528,-0.34671,0,0
5,GO RESPONSE TO ZINC ION,0.00014129,-0.23579,-0.24283,0,0
5,GO DRUG METABOLIC PROCESS,1.3056e-06,-0.23595,-0.26534,0,0
5,GO COENZYME A BIOSYNTHETIC PROCESS,0.003654,-0.23601,-0.21361,0,0
5,GO KETONE BODY METABOLIC PROCESS,0.0012527,-0.23641,-0.21113,0,0
5,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.00011033,-0.23655,-0.27212,0,0
5,GO RETINAL CONE CELL DIFFERENTIATION,0.00159,-0.2373,-0.24351,0,0
5,GO PYRUVATE METABOLIC PROCESS,4.7501e-09,-0.23735,-0.34754,0,0
5,GO THYMIC T CELL SELECTION,4.1456e-06,-0.23867,-0.24938,0,0
5,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,2.538e-07,-0.23905,-0.33048,0,0
5,GO REGULATION OF ODONTOGENESIS,2.6386e-06,-0.23906,-0.33655,0,0
5,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,1.1245e-09,-0.23924,-0.30004,0,0
5,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,1.0964e-09,-0.24066,-0.3303,0,0
5,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.00018323,-0.24168,-0.29647,0,0
5,GO RESPONSE TO CATECHOLAMINE,8.8389e-07,-0.24214,-0.31044,0,0
5,GO DICARBOXYLIC ACID TRANSPORT,5.1351e-07,-0.24239,-0.3031,0,0
5,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,2.188e-08,-0.24258,-0.34206,0,0
5,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,6.6578e-05,-0.24323,-0.29026,0,0
5,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,7.1274e-05,-0.24333,-0.29205,0,0
5,GO HORMONE METABOLIC PROCESS,5.2538e-08,-0.24397,-0.27975,0,0
5,GO STEROID CATABOLIC PROCESS,5.9056e-05,-0.24398,-0.30813,0,0
5,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,1.0493e-11,-0.24458,-0.32572,0,0
5,GO RHYTHMIC BEHAVIOR,4.9069e-08,-0.2447,-0.34896,0,0
5,GO C4 DICARBOXYLATE TRANSPORT,1.9393e-05,-0.24473,-0.29376,0,0
5,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.00091404,-0.2452,-0.26807,0,0
5,GO PROTEIN CONTAINING COMPLEX REMODELING,2.7668e-07,-0.2454,-0.31603,0,0
5,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,3.8118e-09,-0.24568,-0.32078,0,0
5,GO T CELL HOMEOSTASIS,3.5038e-07,-0.24736,-0.28635,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,1.3878e-06,-0.24745,-0.31798,0,0
5,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0066851,-0.24764,-0.16591,0,0
5,GO AUTOPHAGIC CELL DEATH,2.1621e-05,-0.24797,-0.30584,0,0
5,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,1.1165e-05,-0.24824,-0.29406,0,0
5,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,4.5558e-05,-0.24833,-0.30421,0,0
5,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.00011406,-0.24852,-0.24842,0,0
5,GO PURINE NUCLEOTIDE TRANSPORT,5.7582e-06,-0.2496,-0.3157,0,0
5,GO REGULATION OF GOLGI ORGANIZATION,2.1338e-07,-0.24978,-0.37383,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,4.0343e-10,-0.25141,-0.35852,0,0
5,GO ATP TRANSPORT,4.719e-07,-0.25235,-0.32374,0,0
5,GO REGULATION OF PROTEIN POLYMERIZATION,3.5597e-11,-0.2531,-0.38529,0,0
5,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,3.7605e-06,-0.2531,-0.34798,0,0
5,GO PROTEIN COMPLEX OLIGOMERIZATION,1.887e-11,-0.2558,-0.33063,0,0
5,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,6.1119e-05,-0.25672,-0.27017,0,0
5,GO POSITIVE REGULATION OF GLIOGENESIS,5.6245e-08,-0.25679,-0.29756,0,0
5,GO PENILE ERECTION,4.1026e-05,-0.25767,-0.28189,0,0
5,GO SULFUR COMPOUND METABOLIC PROCESS,4.4749e-10,-0.25775,-0.30716,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.5865e-05,-0.25858,-0.32295,0,0
5,GO CELL RECOGNITION,1.6407e-09,-0.26258,-0.32415,0,0
5,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,3.0156e-07,-0.26276,-0.30835,0,0
5,GO RUFFLE ASSEMBLY,2.8886e-07,-0.26301,-0.35037,0,0
5,GO REGULATION OF ANION TRANSPORT,3.1098e-10,-0.2632,-0.3418,0,0
5,GO AXO DENDRITIC PROTEIN TRANSPORT,1.7706e-05,-0.26355,-0.41143,0,0
5,GO REGULATION OF REPRODUCTIVE PROCESS,2.6306e-11,-0.26359,-0.30645,0,0
5,GO NUCLEOTIDE PHOSPHORYLATION,3.3713e-09,-0.26443,-0.34266,0,0
5,GO RESPONSE TO INTERLEUKIN 4,3.4003e-08,-0.26481,-0.31836,0,0
5,GO PEROXISOMAL MEMBRANE TRANSPORT,7.0337e-07,-0.26533,-0.30077,0,0
5,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,3.8347e-06,-0.26591,-0.26966,0,0
5,GO EMBRYONIC AXIS SPECIFICATION,1.0557e-05,-0.26755,-0.25989,0,0
5,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.0085105,-0.26777,-0.25406,0,0
5,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.00045468,-0.26796,-0.26327,0,0
5,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.001442,-0.2689,-0.25978,0,0
5,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,1.064e-06,-0.26939,-0.28349,0,0
5,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.00031414,-0.27078,-0.32796,0,0
5,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,1.3419e-09,-0.27108,-0.32576,0,0
5,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,1.9136e-07,-0.2718,-0.30049,0,0
5,GO RESPONSE TO LEAD ION,3.7605e-06,-0.27235,-0.34505,0,0
5,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,3.0811e-07,-0.27238,-0.34548,0,0
5,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.402e-08,-0.27249,-0.33757,0,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,1.887e-11,-0.27303,-0.35796,0,0
5,GO FOREBRAIN NEURON DEVELOPMENT,0.00013451,-0.27303,-0.39564,0,0
5,GO CLATHRIN DEPENDENT ENDOCYTOSIS,5.77e-09,-0.27306,-0.42643,0,0
5,GO SEROTONIN TRANSPORT,2.9332e-05,-0.2737,-0.32728,0,0
5,GO HEART FORMATION,1.8363e-05,-0.27453,-0.32531,0,0
5,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,1.8594e-09,-0.27515,-0.34043,0,0
5,GO RESPONSE TO GLUCAGON,4.7963e-08,-0.2761,-0.36869,0,0
5,GO CHLORIDE TRANSPORT,9.1996e-11,-0.27649,-0.342,0,0
5,GO MODIFIED AMINO ACID TRANSPORT,4.8673e-09,-0.27681,-0.37315,0,0
5,GO NOTCH SIGNALING PATHWAY,2.1543e-10,-0.27709,-0.41531,0,0
5,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,5.7051e-07,-0.27762,-0.33964,0,0
5,GO ESTROGEN METABOLIC PROCESS,7.0337e-07,-0.27815,-0.26734,0,0
5,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,8.9558e-11,-0.27847,-0.40924,0,0
5,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,5.332e-06,-0.27923,-0.33561,0,0
5,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,1.9905e-10,-0.27979,-0.35457,0,0
5,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,3.9064e-09,-0.28037,-0.30748,0,0
5,GO BILE ACID BIOSYNTHETIC PROCESS,5.3747e-08,-0.28057,-0.3154,0,0
5,GO BICARBONATE TRANSPORT,2.402e-08,-0.28088,-0.31288,0,0
5,GO COENZYME A METABOLIC PROCESS,0.00017741,-0.2811,-0.25901,0,0
5,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,7.892e-08,-0.28152,-0.35995,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,8.6328e-08,-0.28156,-0.31902,0,0
5,GO REGULATION OF METAL ION TRANSPORT,7.9144e-12,-0.28239,-0.37194,0,0
5,GO MOTILE CILIUM ASSEMBLY,5.4184e-05,-0.28262,-0.33177,0,0
5,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,1.0036e-08,-0.28267,-0.29674,0,0
5,GO REGULATION OF MITOCHONDRIAL FISSION,1.8723e-07,-0.28324,-0.35742,0,0
5,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,1.2682e-10,-0.28426,-0.35152,0,0
5,GO COLLECTING DUCT DEVELOPMENT,1.5674e-06,-0.28456,-0.4662,0,0
5,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,3.7195e-09,-0.2866,-0.4287,0,0
5,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.00029511,-0.28677,-0.37552,0,0
5,GO WATER TRANSPORT,1.5372e-07,-0.28694,-0.31401,0,0
5,GO SKELETAL MUSCLE ADAPTATION,4.4771e-05,-0.28942,-0.28901,0,0
5,GO POSITIVE REGULATION OF LIPID TRANSPORT,2.801e-10,-0.28942,-0.35237,0,0
5,GO MUSCLE CONTRACTION,2.521e-12,-0.28955,-0.39678,0,0
5,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,1.1706e-10,-0.2902,-0.42197,0,0
5,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.05063,-0.29116,-0.19154,0,0
5,GO REGULATION OF GROWTH HORMONE SECRETION,0.08331,-0.29158,-0.21573,0,0
5,GO RESPONSE TO MUSCLE ACTIVITY,9.404e-07,-0.29164,-0.34429,0,0
5,GO RESPONSE TO AMINO ACID STARVATION,1.471e-07,-0.29184,-0.34824,0,0
5,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,2.2958e-06,-0.29184,-0.37794,0,0
5,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,1.8142e-08,-0.29276,-0.34673,0,0
5,GO LYMPHOCYTE HOMEOSTASIS,7.8976e-09,-0.29292,-0.35582,0,0
5,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,4.0678e-07,-0.29516,-0.38047,0,0
5,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,1.642e-11,-0.29649,-0.37846,0,0
5,GO RESPONSE TO CAMP,2.3933e-10,-0.29741,-0.37527,0,0
5,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,2.7668e-07,-0.29795,-0.35834,0,0
5,GO MEMORY,1.3376e-10,-0.29913,-0.39896,0,0
5,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.00032916,-0.29915,-0.3129,0,0
5,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0013826,-0.29991,-0.34285,0,0
5,GO REGULATION OF TUBE SIZE,1.2348e-10,-0.30037,-0.35362,0,0
5,GO INTRACILIARY RETROGRADE TRANSPORT,0.0010113,-0.30097,-0.24928,0,0
5,GO REGULATION OF BEHAVIOR,4.2444e-07,-0.30099,-0.30992,0,0
5,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.0012527,-0.30107,-0.35699,0,0
5,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0031247,-0.30131,-0.31504,0,0
5,GO DIGESTIVE SYSTEM DEVELOPMENT,1.2131e-09,-0.30181,-0.39395,0,0
5,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,1.8389e-10,-0.30211,-0.37253,0,0
5,GO RESPONSE TO AMPHETAMINE,1.8032e-05,-0.30287,-0.29149,0,0
5,GO REGULATION OF ION TRANSPORT,4.5526e-11,-0.30465,-0.35247,0,0
5,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,6.0991e-06,-0.30618,-0.44636,0,0
5,GO REGULATION OF ANIMAL ORGAN FORMATION,3.3214e-05,-0.30628,-0.29833,0,0
5,GO PHOSPHATIDIC ACID METABOLIC PROCESS,2.3312e-10,-0.3066,-0.3944,0,0
5,GO MORPHOGENESIS OF AN ENDOTHELIUM,3.0295e-08,-0.30739,-0.39429,0,0
5,GO SYNAPTIC VESICLE BUDDING,1.0004e-06,-0.30771,-0.37243,0,0
5,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.00037835,-0.30787,-0.29131,0,0
5,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,7.1819e-07,-0.30813,-0.36834,0,0
5,GO RENAL SODIUM EXCRETION,4.8673e-09,-0.30829,-0.35539,0,0
5,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,1.4472e-05,-0.30903,-0.36928,0,0
5,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,5.6245e-08,-0.30952,-0.38459,0,0
5,GO REGULATION OF GLIAL CELL PROLIFERATION,2.7668e-07,-0.3099,-0.35711,0,0
5,GO CARDIAC CELL DEVELOPMENT,1.2759e-09,-0.31017,-0.39105,0,0
5,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,3.019e-11,-0.31021,-0.35934,0,0
5,GO POLYSACCHARIDE CATABOLIC PROCESS,5.77e-09,-0.31238,-0.36303,0,0
5,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,5.0563e-05,-0.31301,-0.29147,0,0
5,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,1.4471e-09,-0.31326,-0.31371,0,0
5,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,2.1338e-07,-0.31397,-0.3771,0,0
5,GO NEUROTRANSMITTER CATABOLIC PROCESS,7.7586e-05,-0.31415,-0.30279,0,0
5,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,4.1815e-08,-0.31441,-0.35665,0,0
5,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,5.815e-11,-0.31454,-0.3494,0,0
5,GO PROTEIN LOCALIZATION TO MICROTUBULE,5.2445e-07,-0.31456,-0.40483,0,0
5,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,2.3554e-11,-0.31548,-0.44247,0,0
5,GO REGULATION OF EXCRETION,1.0791e-07,-0.3163,-0.35817,0,0
5,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,4.0817e-11,-0.3166,-0.3941,0,0
5,GO RESPONSE TO AMINE,2.2775e-07,-0.31705,-0.31153,0,0
5,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.00030928,-0.31722,-0.40677,0,0
5,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,8.2864e-09,-0.31853,-0.40518,0,0
5,GO RETINA LAYER FORMATION,0.0016122,-0.31907,-0.30967,0,0
5,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,7.2414e-06,-0.32033,-0.44261,0,0
5,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0010408,-0.32118,-0.27188,0,0
5,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.00090088,-0.32153,-0.29901,0,0
5,GO PITUITARY GLAND DEVELOPMENT,0.0053519,-0.32194,-0.25485,0,0
5,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,1.4076e-07,-0.3232,-0.35175,0,0
5,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,4.9624e-10,-0.3236,-0.3591,0,0
5,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.00030449,-0.3242,-0.33582,0,0
5,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,1.7721e-08,-0.32436,-0.36596,0,0
5,GO NOREPINEPHRINE METABOLIC PROCESS,2.2824e-05,-0.32468,-0.42786,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,1.6823e-09,-0.32578,-0.38199,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,1.9136e-07,-0.32821,-0.31809,0,0
5,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,3.7605e-06,-0.32848,-0.33195,0,0
5,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,5.332e-06,-0.32878,-0.38479,0,0
5,GO LOCOMOTORY EXPLORATION BEHAVIOR,2.3239e-05,-0.33006,-0.34395,0,0
5,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,1.0322e-07,-0.33077,-0.41719,0,0
5,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,2.0983e-10,-0.33088,-0.38377,0,0
5,GO TUBULIN DEACETYLATION,2.5934e-07,-0.33303,-0.43629,0,0
5,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,1.5529e-11,-0.33354,-0.38615,0,0
5,GO BASIC AMINO ACID TRANSPORT,8.2543e-08,-0.33359,-0.48427,0,0
5,GO CEREBRAL CORTEX CELL MIGRATION,3.9822e-07,-0.33469,-0.39059,0,0
5,GO SKELETAL MUSCLE CONTRACTION,4.3355e-07,-0.33498,-0.32226,0,0
5,GO REFLEX,0.00096848,-0.33558,-0.37391,0,0
5,GO REGULATION OF ENDOCYTOSIS,1.1478e-12,-0.33671,-0.43819,0,0
5,GO RESPIRATORY SYSTEM PROCESS,2.1196e-06,-0.33937,-0.37597,0,0
5,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,2.9371e-11,-0.33945,-0.37285,0,0
5,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,1.1535e-07,-0.3398,-0.33075,0,0
5,GO CELLULAR RESPONSE TO CAMP,8.9558e-11,-0.33993,-0.38488,0,0
5,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,3.0295e-08,-0.34008,-0.4395,0,0
5,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,1.0791e-07,-0.34021,-0.37867,0,0
5,GO INOSITOL PHOSPHATE METABOLIC PROCESS,1.4092e-12,-0.34098,-0.40598,0,0
5,GO PARTURITION,1.6418e-07,-0.34181,-0.35166,0,0
5,GO TRIGLYCERIDE CATABOLIC PROCESS,3.6924e-05,-0.34191,-0.25883,0,0
5,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,1.6514e-08,-0.34231,-0.42,0,0
5,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,4.0314e-05,-0.34293,-0.40017,0,0
5,GO RESPONSE TO PROSTAGLANDIN,8.2864e-09,-0.34307,-0.36854,0,0
5,GO LYMPH NODE DEVELOPMENT,4.7125e-10,-0.34475,-0.41392,0,0
5,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,5.9432e-10,-0.34542,-0.34775,0,0
5,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,1.642e-11,-0.34645,-0.49171,0,0
5,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,8.2864e-09,-0.34939,-0.3746,0,0
5,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,1.0361e-05,-0.35134,-0.37972,0,0
5,GO EPIDERMIS MORPHOGENESIS,1.6418e-07,-0.35364,-0.43416,0,0
5,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,2.4371e-06,-0.35408,-0.37341,0,0
5,GO NEGATIVE REGULATION OF PROTEIN IMPORT,2.4305e-07,-0.35722,-0.37359,0,0
5,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,6.3569e-09,-0.35761,-0.39331,0,0
5,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,5.2253e-10,-0.35768,-0.40647,0,0
5,GO CARTILAGE MORPHOGENESIS,3.152e-06,-0.3578,-0.48707,0,0
5,GO PEPTIDYL PROLINE HYDROXYLATION,6.7724e-05,-0.35793,-0.36497,0,0
5,GO NEGATIVE REGULATION OF JNK CASCADE,3.9941e-08,-0.35944,-0.40234,0,0
5,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,9.6538e-08,-0.35999,-0.39192,0,0
5,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,3.1494e-05,-0.36027,-0.40262,0,0
5,GO STRIATED MUSCLE CONTRACTION,7.6205e-11,-0.36117,-0.39913,0,0
5,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,7.8052e-07,-0.36155,-0.41792,0,0
5,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,1.0964e-09,-0.3617,-0.42831,0,0
5,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,1.7154e-07,-0.36256,-0.42095,0,0
5,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,2.5223e-10,-0.36316,-0.37698,0,0
5,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,3.5412e-09,-0.36352,-0.43922,0,0
5,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,7.2129e-08,-0.36368,-0.42081,0,0
5,GO RENAL WATER HOMEOSTASIS,3.6293e-09,-0.3656,-0.42522,0,0
5,GO RETINAL GANGLION CELL AXON GUIDANCE,0.00039622,-0.36589,-0.38677,0,0
5,GO KIDNEY EPITHELIUM DEVELOPMENT,3.7319e-10,-0.36671,-0.4412,0,0
5,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,2.8001e-06,-0.36706,-0.41474,0,0
5,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,3.2146e-06,-0.36789,-0.39617,0,0
5,GO RESPONSE TO AXON INJURY,4.1025e-09,-0.37446,-0.40601,0,0
5,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,1.5027e-08,-0.37527,-0.4035,0,0
5,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,3.7356e-07,-0.37555,-0.37892,0,0
5,GO HEART INDUCTION,0.00071283,-0.37783,-0.33657,0,0
5,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,1.1307e-08,-0.37797,-0.50597,0,0
5,GO MELANOCYTE DIFFERENTIATION,6.1583e-08,-0.37885,-0.38171,0,0
5,GO FIBROBLAST PROLIFERATION,1.5277e-10,-0.3793,-0.44442,0,0
5,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,3.7282e-08,-0.38245,-0.38682,0,0
5,GO GONADOTROPIN SECRETION,5.5412e-06,-0.3827,-0.35729,0,0
5,GO HEART TRABECULA FORMATION,2.8814e-05,-0.38343,-0.36743,0,0
5,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,8.2543e-08,-0.38586,-0.36067,0,0
5,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,4.4787e-08,-0.38615,-0.36922,0,0
5,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,1.2886e-07,-0.38641,-0.40817,0,0
5,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,5.1101e-09,-0.38702,-0.43536,0,0
5,GO REGULATION OF FILOPODIUM ASSEMBLY,5.4967e-09,-0.3877,-0.49603,0,0
5,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,2.5893e-10,-0.38918,-0.40727,0,0
5,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,3.9822e-07,-0.38966,-0.45366,0,0
5,GO CARDIAC MUSCLE CONTRACTION,1.3376e-10,-0.39159,-0.41549,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,1.6542e-10,-0.39352,-0.46442,0,0
5,GO PHOSPHOLIPID DEPHOSPHORYLATION,5.3602e-11,-0.39426,-0.44113,0,0
5,GO MOTOR NEURON AXON GUIDANCE,1.1086e-06,-0.39775,-0.38806,0,0
5,GO REGULATION OF HEART MORPHOGENESIS,2.8886e-07,-0.39846,-0.39817,0,0
5,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,1.725e-09,-0.39858,-0.38969,0,0
5,GO REGULATION OF MYELINATION,6.205e-09,-0.39876,-0.37003,0,0
5,GO REGULATION OF NMDA RECEPTOR ACTIVITY,1.6907e-08,-0.40086,-0.46921,0,0
5,GO EPHRIN RECEPTOR SIGNALING PATHWAY,6.4805e-11,-0.40139,-0.43136,0,0
5,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,8.6328e-08,-0.40574,-0.41278,0,0
5,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,2.1196e-06,-0.40769,-0.47254,0,0
5,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,9.404e-07,-0.40888,-0.41272,0,0
5,GO POSITIVE REGULATION OF BONE MINERALIZATION,2.402e-08,-0.40898,-0.46293,0,0
5,GO NEPHRIC DUCT MORPHOGENESIS,2.4972e-05,-0.409,-0.39935,0,0
5,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,7.5451e-08,-0.40909,-0.46683,0,0
5,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,3.2146e-06,-0.40928,-0.45337,0,0
5,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,8.6145e-12,-0.41007,-0.46687,0,0
5,GO GANGLIOSIDE METABOLIC PROCESS,1.3769e-07,-0.41404,-0.43663,0,0
5,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,4.2042e-09,-0.41499,-0.44409,0,0
5,GO INNER DYNEIN ARM ASSEMBLY,5.1446e-05,-0.41566,-0.37403,0,0
5,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,5.8856e-08,-0.41594,-0.42405,0,0
5,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,1.3376e-10,-0.42487,-0.43462,0,0
5,GO METANEPHROS DEVELOPMENT,2.2697e-09,-0.42547,-0.41629,0,0
5,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,7.7166e-08,-0.42559,-0.45724,0,0
5,GO ROOF OF MOUTH DEVELOPMENT,9.5677e-09,-0.42582,-0.4231,0,0
5,GO CELLULAR RESPONSE TO AMYLOID BETA,3.019e-11,-0.42774,-0.52787,0,0
5,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.7586e-05,-0.42972,-0.45121,0,0
5,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,2.004e-09,-0.43618,-0.52586,0,0
5,GO AORTA MORPHOGENESIS,5.2538e-08,-0.44007,-0.46738,0,0
5,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,9.2321e-08,-0.44392,-0.40276,0,0
5,GO LOCOMOTOR RHYTHM,4.9069e-08,-0.44488,-0.50718,0,0
5,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,4.7963e-08,-0.44761,-0.4678,0,0
5,GO POSITIVE REGULATION OF HEART RATE,2.9332e-05,-0.45005,-0.33356,0,0
5,GO KERATINOCYTE DEVELOPMENT,0.0011836,-0.45174,-0.31727,0,0
5,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.0089251,-0.4525,-0.28067,0,0
5,GO OUTFLOW TRACT MORPHOGENESIS,5.3617e-10,-0.45273,-0.51261,0,0
5,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,2.7e-09,-0.45438,-0.45769,0,0
5,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,9.7998e-07,-0.45559,-0.42508,0,0
5,GO MIDGUT DEVELOPMENT,8.3066e-07,-0.4569,-0.45377,0,0
5,GO CARDIAC MUSCLE CELL CONTRACTION,2.7797e-11,-0.45707,-0.5011,0,0
5,GO POSITIVE REGULATION OF HEART CONTRACTION,4.8416e-06,-0.45763,-0.33599,0,0
5,GO CAMP METABOLIC PROCESS,1.9402e-11,-0.45791,-0.53546,0,0
5,GO MAMMARY GLAND MORPHOGENESIS,7.2964e-10,-0.45809,-0.51637,0,0
5,GO RADIAL GLIAL CELL DIFFERENTIATION,2.8262e-08,-0.45834,-0.47981,0,0
5,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,1.3948e-05,-0.45866,-0.45747,0,0
5,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,2.2775e-07,-0.46259,-0.49164,0,0
5,GO TROPHOBLAST CELL MIGRATION,3.0302e-06,-0.4656,-0.42643,0,0
5,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,1.725e-09,-0.4709,-0.57052,0,0
5,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,2.9371e-11,-0.48158,-0.48719,0,0
5,GO ACTIN MEDIATED CELL CONTRACTION,2.0509e-11,-0.48492,-0.45118,0,0
5,GO BRONCHUS DEVELOPMENT,3.2162e-07,-0.48715,-0.51442,0,0
5,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,5.02e-08,-0.5055,-0.46676,0,0
5,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,3.9822e-07,-0.51007,-0.4492,0,0
5,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,7.0522e-08,-0.51417,-0.51762,0,0
5,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.00014599,-0.51744,-0.43283,0,0
5,GO NEGATIVE REGULATION OF RECEPTOR BINDING,3.0811e-07,-0.52307,-0.51235,0,0
5,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,2.559e-11,-0.52643,-0.55452,0,0
5,GO INACTIVATION OF MAPK ACTIVITY,3.1729e-08,-0.52758,-0.49293,0,0
5,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,2.6981e-08,-0.52864,-0.6803,0,0
5,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,7.3476e-09,-0.53359,-0.46634,0,0
5,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,1.6407e-09,-0.54002,-0.59783,0,0
5,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,1.6823e-09,-0.54573,-0.5236,0,0
5,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,3.2785e-11,-0.54888,-0.58835,0,0
5,GO GAMMA DELTA T CELL DIFFERENTIATION,8.5858e-05,-0.55291,-0.4345,0,0
5,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,2.0881e-08,-0.55321,-0.54689,0,0
5,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,1.0422e-09,-0.56116,-0.57434,0,0
5,GO VASCULAR WOUND HEALING,6.7411e-08,-0.5764,-0.4942,0,0
5,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.00010852,-0.58525,-0.40778,0,0
5,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,5.8262e-07,-0.58572,-0.56592,0,0
5,GO HEAD MORPHOGENESIS,3.8118e-09,-0.60363,-0.53884,0,0
5,GO BASEMENT MEMBRANE ASSEMBLY,3.7602e-11,-0.70796,-0.82127,0,0
5,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,3.4634e-11,-0.71379,-0.73466,0,0
5,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,1.5688e-10,-0.76382,-0.75733,0,0
5,GO REGULATION OF GLOMERULAR FILTRATION,4.9624e-10,-0.80192,-0.80314,0,0
6,GO POSTSYNAPTIC MEMBRANE ASSEMBLY,1.3351e-08,0.68229,0.69335,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR ACTIVITY,6.0205e-08,0.60011,0.63879,1,1
6,GO SPINAL CORD MOTOR NEURON CELL FATE SPECIFICATION,9.028e-08,0.58956,0.57491,1,1
6,GO NEGATIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,4.2042e-09,0.58914,0.57125,1,1
6,GO PREPULSE INHIBITION,3.6567e-07,0.58051,0.52909,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ASSEMBLY,2.4371e-06,0.57101,0.54442,1,1
6,GO REGULATION OF POSTSYNAPTIC SPECIALIZATION ASSEMBLY,1.8363e-05,0.56806,0.52539,1,1
6,GO VOCALIZATION BEHAVIOR,2.188e-08,0.56696,0.61147,1,1
6,GO COMMISSURAL NEURON AXON GUIDANCE,5.1356e-08,0.56212,0.5886,1,1
6,GO POSTSYNAPTIC SPECIALIZATION ORGANIZATION,4.3774e-08,0.55514,0.5407,1,1
6,GO REGULATION OF SYNAPSE MATURATION,3.2784e-06,0.53615,0.50132,1,1
6,GO CELL FATE SPECIFICATION INVOLVED IN PATTERN SPECIFICATION,1.6407e-09,0.531,0.5613,1,1
6,GO SYNAPTIC MEMBRANE ADHESION,3.8347e-06,0.52321,0.44592,1,1
6,GO FOREBRAIN NEURON FATE COMMITMENT,0.0017277,0.52161,0.4759,1,1
6,GO CEREBELLAR GRANULAR LAYER DEVELOPMENT,1.5386e-08,0.51765,0.4827,1,1
6,GO PRESYNAPTIC MEMBRANE ORGANIZATION,9.0235e-07,0.51214,0.5195,1,1
6,GO SYNAPSE MATURATION,4.7999e-05,0.51163,0.42694,1,1
6,GO CARDIAC VENTRICLE FORMATION,1.5994e-06,0.50483,0.47286,1,1
6,GO POSTSYNAPSE ASSEMBLY,7.3772e-08,0.50113,0.50858,1,1
6,GO RETINAL ROD CELL DIFFERENTIATION,3.9102e-06,0.49829,0.40531,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE ORGANIZATION,2.3891e-06,0.49605,0.3685,1,1
6,GO NEURON CELL CELL ADHESION,2.5756e-08,0.49465,0.58635,1,1
6,GO ANATOMICAL STRUCTURE REGRESSION,0.00032916,0.49413,0.36322,1,1
6,GO PERIPHERAL NERVOUS SYSTEM NEURON DIFFERENTIATION,1.536e-06,0.4909,0.53335,1,1
6,GO NETRIN ACTIVATED SIGNALING PATHWAY,5.1351e-07,0.48405,0.47228,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER FORMATION,1.1086e-06,0.4811,0.41011,1,1
6,GO REGULATION OF LONG TERM SYNAPTIC DEPRESSION,3.0302e-06,0.47813,0.4882,1,1
6,GO VENTRAL SPINAL CORD INTERNEURON DIFFERENTIATION,7.5451e-08,0.46618,0.50764,1,1
6,GO NOSE DEVELOPMENT,7.892e-08,0.45447,0.51303,1,1
6,GO MAINTENANCE OF SYNAPSE STRUCTURE,1.3769e-07,0.44894,0.4659,1,1
6,GO SYNAPTIC VESICLE CLUSTERING,1.6654e-06,0.44753,0.53101,1,1
6,GO SPINAL CORD PATTERNING,4.1025e-09,0.44584,0.48644,1,1
6,GO NEGATIVE REGULATION OF STEM CELL PROLIFERATION,0.00013899,0.44573,0.40244,1,1
6,GO REGULATION OF EPITHELIAL TUBE FORMATION,1.9563e-06,0.44132,0.39852,1,1
6,GO CELL PROLIFERATION INVOLVED IN HEART MORPHOGENESIS,4.0678e-07,0.43995,0.47729,1,1
6,GO NEURON FATE SPECIFICATION,2.6981e-08,0.43731,0.50141,1,1
6,GO POSITIVE REGULATION OF MESONEPHROS DEVELOPMENT,3.628e-05,0.43609,0.3772,1,1
6,GO POSITIVE REGULATION OF NEURON MIGRATION,8.5858e-05,0.42935,0.36587,1,1
6,GO NEURONAL ION CHANNEL CLUSTERING,5.4356e-06,0.42926,0.42653,1,1
6,GO LIMB BUD FORMATION,6.7105e-06,0.42874,0.42597,1,1
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.0868e-08,0.42711,0.38963,1,1
6,GO POSTSYNAPTIC MEMBRANE ORGANIZATION,1.8318e-07,0.42682,0.40258,1,1
6,GO HINDBRAIN RADIAL GLIA GUIDED CELL MIGRATION,2.8001e-06,0.42474,0.41963,1,1
6,GO REGULATION OF DOPAMINE RECEPTOR SIGNALING PATHWAY,5.4184e-05,0.42473,0.35421,1,1
6,GO REGULATION OF POSTSYNAPTIC DENSITY ORGANIZATION,8.6579e-07,0.42083,0.49582,1,1
6,GO CARDIAC CHAMBER FORMATION,3.3435e-06,0.41817,0.41246,1,1
6,GO THALAMUS DEVELOPMENT,6.0205e-08,0.41726,0.40993,1,1
6,GO FACIAL NERVE MORPHOGENESIS,0.00018923,0.41717,0.3747,1,1
6,GO MICROTUBULE DEPOLYMERIZATION,2.0776e-06,0.41616,0.33391,1,1
6,GO SKELETAL MUSCLE ACETYLCHOLINE GATED CHANNEL CLUSTERING,9.1829e-05,0.41569,0.36721,1,1
6,GO REGULATION OF NEUROBLAST PROLIFERATION,6.205e-09,0.41163,0.39898,1,1
6,GO CEREBELLAR CORTEX MORPHOGENESIS,7.6792e-10,0.41085,0.37229,1,1
6,GO INTRASPECIES INTERACTION BETWEEN ORGANISMS,1.484e-09,0.41051,0.42396,1,1
6,GO SPINAL CORD ASSOCIATION NEURON DIFFERENTIATION,5.7536e-08,0.40801,0.44904,1,1
6,GO OTIC VESICLE DEVELOPMENT,9.2585e-06,0.40728,0.36445,1,1
6,GO NEURON FATE COMMITMENT,8.4877e-09,0.40581,0.42221,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC PLASTICITY,1.9749e-05,0.40245,0.4586,1,1
6,GO INHIBITORY POSTSYNAPTIC POTENTIAL,1.2032e-06,0.4019,0.41594,1,1
6,GO SMOOTHENED SIGNALING PATHWAY INVOLVED IN DORSAL VENTRAL NEURAL TUBE PATTERNING,9.8716e-08,0.40151,0.35032,1,1
6,GO POSITIVE REGULATION OF CIRCADIAN RHYTHM,4.5822e-08,0.40076,0.49538,1,1
6,GO MALE SEX DETERMINATION,6.6066e-07,0.40015,0.37603,1,1
6,GO NEUROMUSCULAR SYNAPTIC TRANSMISSION,5.9834e-06,0.39801,0.32423,1,1
6,GO REGULATION OF NEURON MIGRATION,3.9035e-08,0.39788,0.40332,1,1
6,GO NEGATIVE REGULATION OF SYNAPSE ORGANIZATION,1.3878e-06,0.39024,0.4048,1,1
6,GO REGULATION OF POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0003557,0.38333,0.29353,1,1
6,GO NEGATIVE REGULATION OF MEMBRANE POTENTIAL,3.0302e-06,0.38286,0.34908,1,1
6,GO AXON ENSHEATHMENT IN CENTRAL NERVOUS SYSTEM,8.6579e-07,0.38183,0.36318,1,1
6,GO INNERVATION,2.3661e-05,0.38041,0.43516,1,1
6,GO REGULATION OF MICROTUBULE DEPOLYMERIZATION,2.6828e-05,0.38029,0.29971,1,1
6,GO MICROTUBULE ANCHORING AT CENTROSOME,1.0322e-07,0.37834,0.3371,1,1
6,GO PARENTAL BEHAVIOR,2.0853e-05,0.37753,0.41576,1,1
6,GO CEREBELLAR CORTEX FORMATION,6.3569e-09,0.37712,0.36735,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER MORPHOGENESIS,7.0337e-07,0.3767,0.38133,1,1
6,GO POSITIVE REGULATION OF CILIUM ASSEMBLY,4.0678e-07,0.37506,0.33901,1,1
6,GO TONGUE MORPHOGENESIS,0.00012804,0.3741,0.3422,1,1
6,GO SEMINIFEROUS TUBULE DEVELOPMENT,5.1356e-08,0.37394,0.45003,1,1
6,GO DORSAL VENTRAL NEURAL TUBE PATTERNING,1.6062e-07,0.37147,0.34513,1,1
6,GO REGULATION OF EXCITATORY SYNAPSE ASSEMBLY,5.332e-06,0.36517,0.39186,1,1
6,GO LENS MORPHOGENESIS IN CAMERA TYPE EYE,9.1205e-09,0.36485,0.41837,1,1
6,GO NEGATIVE REGULATION OF ADENYLATE CYCLASE ACTIVITY,2.856e-06,0.3634,0.3719,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE MORPHOGENESIS,3.9941e-08,0.36318,0.42458,1,1
6,GO SYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,5.6487e-06,0.36308,0.36057,1,1
6,GO REGULATION OF RECEPTOR CLUSTERING,0.00052901,0.36186,0.30628,1,1
6,GO NEGATIVE REGULATION OF CATECHOLAMINE SECRETION,2.5359e-06,0.36131,0.47703,1,1
6,GO HISTONE H3 K9 DEMETHYLATION,6.4699e-07,0.36071,0.3359,1,1
6,GO CELL DIFFERENTIATION IN HINDBRAIN,1.3671e-08,0.35788,0.3669,1,1
6,GO CENTRAL NERVOUS SYSTEM PROJECTION NEURON AXONOGENESIS,2.7804e-05,0.3563,0.34281,1,1
6,GO REGULATION OF PRESYNAPSE ORGANIZATION,4.4771e-05,0.35546,0.30837,1,1
6,GO ATRIAL SEPTUM MORPHOGENESIS,2.5424e-05,0.3548,0.39021,1,1
6,GO CENTRIOLE CENTRIOLE COHESION,2.9078e-09,0.35382,0.37125,1,1
6,GO EMBRYONIC BRAIN DEVELOPMENT,2.1624e-06,0.35213,0.26603,1,1
6,GO HISTONE H3 K27 METHYLATION,1.6062e-07,0.3498,0.28356,1,1
6,GO REGULATION OF TRANSMISSION OF NERVE IMPULSE,2.0364e-06,0.34932,0.32084,1,1
6,GO PHASIC SMOOTH MUSCLE CONTRACTION,1.9393e-05,0.34861,0.29963,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,9.028e-08,0.34803,0.45034,1,1
6,GO GAMMA AMINOBUTYRIC ACID SECRETION,8.4424e-05,0.34651,0.29433,1,1
6,GO FOREBRAIN REGIONALIZATION,9.4407e-08,0.34644,0.40639,1,1
6,GO SOMATIC STEM CELL DIVISION,0.00026024,0.34552,0.34053,1,1
6,GO REGULATION OF MESONEPHROS DEVELOPMENT,0.00023294,0.34538,0.28937,1,1
6,GO POSITIVE REGULATION OF NEUROBLAST PROLIFERATION,5.2445e-07,0.34499,0.34282,1,1
6,GO SPINAL CORD DEVELOPMENT,1.4877e-10,0.34477,0.36818,1,1
6,GO NEGATIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.031311,0.34408,0.19407,1,1
6,GO RESPONSE TO ACETYLCHOLINE,5.0278e-07,0.34347,0.34357,1,1
6,GO NEGATIVE REGULATION OF GLIAL CELL PROLIFERATION,0.00022208,0.33923,0.37604,1,1
6,GO FORELIMB MORPHOGENESIS,7.892e-08,0.33866,0.36254,1,1
6,GO NEGATIVE REGULATION OF LYASE ACTIVITY,3.9872e-06,0.33619,0.36849,1,1
6,GO PROSTATE GLAND MORPHOGENESIS,0.0019819,0.33555,0.28564,1,1
6,GO G PROTEIN COUPLED GLUTAMATE RECEPTOR SIGNALING PATHWAY,2.0478e-05,0.33492,0.49168,1,1
6,GO NEUROTRANSMITTER RECEPTOR LOCALIZATION TO POSTSYNAPTIC SPECIALIZATION MEMBRANE,2.1234e-05,0.33452,0.29494,1,1
6,GO POSITIVE REGULATION OF BROWN FAT CELL DIFFERENTIATION,0.00018323,0.33442,0.33026,1,1
6,GO LATERAL SPROUTING FROM AN EPITHELIUM,0.0025961,0.33392,0.31542,1,1
6,GO POSITIVE REGULATION OF CREB TRANSCRIPTION FACTOR ACTIVITY,1.8363e-05,0.33386,0.32997,1,1
6,GO RESPONSE TO L GLUTAMATE,4.1026e-05,0.33364,0.31084,1,1
6,GO RESPONSE TO AUDITORY STIMULUS,4.0314e-05,0.33192,0.36859,1,1
6,GO RECEPTOR CLUSTERING,1.0424e-06,0.33044,0.29158,1,1
6,GO NEUROTRANSMITTER GATED ION CHANNEL CLUSTERING,0.0021215,0.33,0.29117,1,1
6,GO MRNA SPLICE SITE SELECTION,8.0424e-11,0.32981,0.39362,1,1
6,GO GAMMA AMINOBUTYRIC ACID SIGNALING PATHWAY,9.6562e-05,0.32908,0.28442,1,1
6,GO POSITIVE REGULATION OF AMINO ACID TRANSPORT,9.9844e-05,0.32885,0.30059,1,1
6,GO HISTONE H3 K9 METHYLATION,9.658e-10,0.32848,0.33499,1,1
6,GO ECTODERMAL PLACODE DEVELOPMENT,4.31e-06,0.32816,0.3881,1,1
6,GO TELENCEPHALON REGIONALIZATION,8.4262e-06,0.32752,0.39166,1,1
6,GO CELL PROLIFERATION IN HINDBRAIN,2.913e-06,0.32572,0.34668,1,1
6,GO POSITIVE REGULATION OF STEM CELL PROLIFERATION,4.2042e-09,0.32489,0.29648,1,1
6,GO NEGATIVE REGULATION OF MACROPHAGE ACTIVATION,9.795e-06,0.32439,0.31222,1,1
6,GO CORONARY VASCULATURE MORPHOGENESIS,0.00094089,0.32429,0.27455,1,1
6,GO REGULATION OF LONG TERM NEURONAL SYNAPTIC PLASTICITY,0.0003557,0.32354,0.2737,1,1
6,GO RECEPTOR LOCALIZATION TO SYNAPSE,8.6579e-07,0.32259,0.33557,1,1
6,GO CELL JUNCTION MAINTENANCE,3.8983e-07,0.32197,0.33845,1,1
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN LUNG MORPHOGENESIS,0.0020929,0.32169,0.25059,1,1
6,GO HISTONE H3 K36 METHYLATION,6.6717e-09,0.32148,0.35443,1,1
6,GO LONG TERM SYNAPTIC DEPRESSION,1.996e-06,0.32089,0.32266,1,1
6,GO CEREBRAL CORTEX NEURON DIFFERENTIATION,3.2859e-07,0.32088,0.43852,1,1
6,GO MODIFICATION OF POSTSYNAPTIC ACTIN CYTOSKELETON,3.758e-05,0.31975,0.30089,1,1
6,GO NEGATIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,3.5794e-07,0.31903,0.30634,1,1
6,GO GANGLION DEVELOPMENT,0.00014362,0.31862,0.33301,1,1
6,GO EMBRYONIC FORELIMB MORPHOGENESIS,2.342e-06,0.31774,0.3002,1,1
6,GO CELL DIFFERENTIATION IN SPINAL CORD,1.0964e-09,0.31744,0.35836,1,1
6,GO ATRIAL SEPTUM DEVELOPMENT,0.00017457,0.31502,0.28239,1,1
6,GO DORSAL SPINAL CORD DEVELOPMENT,2.8886e-07,0.31441,0.39242,1,1
6,GO INHIBITORY SYNAPSE ASSEMBLY,1.8032e-05,0.3141,0.39963,1,1
6,GO TELENCEPHALON GLIAL CELL MIGRATION,3.6924e-05,0.31333,0.27302,1,1
6,GO NEURAL TUBE PATTERNING,1.3769e-07,0.3128,0.28053,1,1
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY INVOLVED IN NEURON PROJECTION GUIDANCE,0.00037835,0.3121,0.36727,1,1
6,GO PARASYMPATHETIC NERVOUS SYSTEM DEVELOPMENT,0.0024281,0.31192,0.24714,1,1
6,GO PROTEIN LOCALIZATION TO POSTSYNAPSE,5.0323e-06,0.31157,0.28897,1,1
6,GO PROTEIN LOCALIZATION TO NON MOTILE CILIUM,3.3806e-05,0.31083,0.30245,1,1
6,GO NEUROBLAST PROLIFERATION,2.188e-08,0.31017,0.32654,1,1
6,GO CELL FATE SPECIFICATION,2.8262e-08,0.30964,0.30318,1,1
6,GO PROTEIN LOCALIZATION TO CILIARY MEMBRANE,6.0079e-05,0.3096,0.30163,1,1
6,GO STABILIZATION OF MEMBRANE POTENTIAL,0.0068504,0.30916,0.27627,1,1
6,GO GLIAL CELL FATE COMMITMENT,0.00094089,0.30835,0.31821,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,6.2169e-06,0.30797,0.34386,1,1
6,GO BRAIN MORPHOGENESIS,8.8282e-08,0.30754,0.29467,1,1
6,GO DORSAL VENTRAL AXIS SPECIFICATION,7.7586e-05,0.30749,0.29519,1,1
6,GO REGULATION OF SKELETAL MUSCLE CELL DIFFERENTIATION,1.0756e-05,0.30697,0.3164,1,1
6,GO LEFT RIGHT AXIS SPECIFICATION,0.00084997,0.30676,0.23212,1,1
6,GO CEREBELLAR CORTEX DEVELOPMENT,2.8369e-09,0.30667,0.34151,1,1
6,GO EPITHELIAL CELL MATURATION,6.0759e-07,0.30654,0.31686,1,1
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM PROCESS,1.6907e-08,0.30619,0.32662,1,1
6,GO NERVE DEVELOPMENT,3.3214e-05,0.30596,0.30186,1,1
6,GO THYROID GLAND DEVELOPMENT,5.8698e-06,0.30591,0.29249,1,1
6,GO STARTLE RESPONSE,8.1138e-06,0.30545,0.33909,1,1
6,GO GANGLIOSIDE BIOSYNTHETIC PROCESS,4.5558e-05,0.30464,0.30069,1,1
6,GO ACTIN FILAMENT BASED TRANSPORT,3.3214e-05,0.30401,0.26591,1,1
6,GO EMBRYONIC SKELETAL SYSTEM MORPHOGENESIS,1.3196e-05,0.30361,0.2711,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON DEVELOPMENT,2.1196e-06,0.30332,0.28267,1,1
6,GO REGULATION OF COLLATERAL SPROUTING,0.00034485,0.30279,0.26915,1,1
6,GO NEURON MIGRATION,2.3467e-08,0.3026,0.34172,1,1
6,GO NEGATIVE REGULATION OF DENDRITE DEVELOPMENT,9.1829e-05,0.30238,0.25917,1,1
6,GO NEGATIVE REGULATION OF FATTY ACID OXIDATION,0.00095459,0.30231,0.26613,1,1
6,GO GROWTH HORMONE SECRETION,5.5412e-06,0.30191,0.40869,1,1
6,GO PROTEIN LOCALIZATION TO AXON,0.00058763,0.30168,0.35389,1,1
6,GO NEURON PROJECTION GUIDANCE,7.1819e-07,0.29993,0.27618,1,1
6,GO CELL PROLIFERATION IN FOREBRAIN,1.2716e-05,0.2999,0.29685,1,1
6,GO NEGATIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,8.1623e-05,0.29834,0.31033,1,1
6,GO CHROMATIN MEDIATED MAINTENANCE OF TRANSCRIPTION,1.6321e-06,0.29782,0.2801,1,1
6,GO ESTABLISHMENT OF PLANAR POLARITY INVOLVED IN NEURAL TUBE CLOSURE,0.0011503,0.2975,0.2534,1,1
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION,0.011949,0.29715,0.2641,1,1
6,GO ESTABLISHMENT OF PLANAR POLARITY OF EMBRYONIC EPITHELIUM,0.001442,0.29697,0.23088,1,1
6,GO METENCEPHALON DEVELOPMENT,2.5066e-09,0.29662,0.33079,1,1
6,GO NEGATIVE REGULATION OF RECEPTOR INTERNALIZATION,1.2027e-05,0.2966,0.29414,1,1
6,GO RESPONSE TO POTASSIUM ION,4.2487e-05,0.2954,0.31556,1,1
6,GO MYOBLAST MIGRATION,0.0050904,0.29499,0.23538,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON AXONOGENESIS,1.8701e-05,0.29458,0.26194,1,1
6,GO SYNAPTIC VESICLE DOCKING,0.0032928,0.29453,0.27788,1,1
6,GO RETROGRADE AXONAL TRANSPORT,2.2505e-06,0.29358,0.3045,1,1
6,GO NEGATIVE REGULATION OF PEPTIDE HORMONE SECRETION,3.6162e-06,0.29339,0.27223,1,1
6,GO HINDBRAIN DEVELOPMENT,3.3713e-09,0.29336,0.28733,1,1
6,GO NEURON RECOGNITION,2.9332e-05,0.29304,0.27572,1,1
6,GO SYNAPTIC VESICLE MATURATION,0.0007786,0.29191,0.31496,1,1
6,GO MICROTUBULE NUCLEATION BY MICROTUBULE ORGANIZING CENTER,8.4805e-07,0.29146,0.31875,1,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,0.0024941,0.29143,0.19223,1,1
6,GO ACROSOME ASSEMBLY,8.2543e-08,0.29139,0.32542,1,1
6,GO NEGATIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,7.2497e-05,0.29125,0.26639,1,1
6,GO SEX DETERMINATION,2.7452e-06,0.29093,0.29426,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO POSTSYNAPTIC MEMBRANE,6.0991e-06,0.29061,0.34119,1,1
6,GO AXONEMAL DYNEIN COMPLEX ASSEMBLY,0.00019229,0.29023,0.28412,1,1
6,GO NEGATIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.01499,0.29008,0.21959,1,1
6,GO CENTRAL NERVOUS SYSTEM NEURON DIFFERENTIATION,9.7991e-09,0.28983,0.30208,1,1
6,GO HEART VALVE FORMATION,7.2497e-05,0.28958,0.40424,1,1
6,GO NEURAL RETINA DEVELOPMENT,5.4701e-07,0.28954,0.29602,1,1
6,GO PROXIMAL DISTAL PATTERN FORMATION,6.8888e-05,0.28954,0.26659,1,1
6,GO HISTONE H3 K9 MODIFICATION,4.1403e-10,0.28946,0.30959,1,1
6,GO MYELIN MAINTENANCE,0.016027,0.28921,0.21723,1,1
6,GO POSTSYNAPSE ORGANIZATION,7.892e-08,0.28908,0.30917,1,1
6,GO VENTRAL SPINAL CORD DEVELOPMENT,2.188e-08,0.28875,0.31009,1,1
6,GO REGULATION OF MICROTUBULE BINDING,0.00010323,0.28864,0.26812,1,1
6,GO POSITIVE REGULATION OF CAMP MEDIATED SIGNALING,0.00086244,0.28849,0.25208,1,1
6,GO MODULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,3.7605e-06,0.28844,0.36419,1,1
6,GO COCHLEA MORPHOGENESIS,0.0005789,0.2884,0.23725,1,1
6,GO HIPPO SIGNALING,0.00010852,0.28816,0.24584,1,1
6,GO CRANIAL NERVE MORPHOGENESIS,0.00018323,0.28798,0.28246,1,1
6,GO NOREPINEPHRINE SECRETION,0.00013899,0.28785,0.25824,1,1
6,GO NUCLEUS LOCALIZATION,2.5424e-05,0.28783,0.25579,1,1
6,GO REGULATION OF ADENYLATE CYCLASE ACTIVITY,6.0079e-05,0.28777,0.27355,1,1
6,GO NEPHRON TUBULE FORMATION,9.3381e-05,0.28706,0.28621,1,1
6,GO DIVALENT METAL ION EXPORT,7.8911e-05,0.28672,0.30411,1,1
6,GO REGULATION OF CENTRIOLE REPLICATION,2.5868e-06,0.28526,0.27217,1,1
6,GO NON MOTILE CILIUM ASSEMBLY,1.2281e-06,0.2851,0.25386,1,1
6,GO REGULATION OF HISTONE H3 K9 METHYLATION,1.725e-09,0.28467,0.32527,1,1
6,GO REGULATION OF SYNAPTIC TRANSMISSION GLUTAMATERGIC,2.4371e-06,0.28392,0.3156,1,1
6,GO NUCLEAR MIGRATION,2.8814e-05,0.28337,0.26419,1,1
6,GO REGULATION OF INCLUSION BODY ASSEMBLY,0.0037498,0.28281,0.24766,1,1
6,GO REGULATION OF POSTSYNAPSE ORGANIZATION,4.1552e-07,0.28277,0.31075,1,1
6,GO PROSTATE GLANDULAR ACINUS DEVELOPMENT,0.0029256,0.28189,0.28776,1,1
6,GO NEURON PROJECTION ARBORIZATION,1.5994e-06,0.28179,0.33704,1,1
6,GO POSITIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.00029976,0.28172,0.25472,1,1
6,GO PHOTORECEPTOR CELL MAINTENANCE,3.9035e-08,0.28169,0.26225,1,1
6,GO EMBRYONIC CAMERA TYPE EYE FORMATION,0.0007901,0.28143,0.28014,1,1
6,GO POSITIVE REGULATION OF GLYCOGEN METABOLIC PROCESS,4.9361e-06,0.28133,0.30033,1,1
6,GO GLUTAMATE RECEPTOR SIGNALING PATHWAY,3.6877e-06,0.28101,0.30245,1,1
6,GO DNA DEPENDENT DNA REPLICATION MAINTENANCE OF FIDELITY,1.5713e-07,0.28089,0.2771,1,1
6,GO EXCITATORY SYNAPSE ASSEMBLY,7.5217e-06,0.2799,0.34821,1,1
6,GO REGULATION OF CILIUM ASSEMBLY,9.028e-08,0.27962,0.25415,1,1
6,GO SPINAL CORD MOTOR NEURON DIFFERENTIATION,4.2784e-08,0.27912,0.29499,1,1
6,GO PROTEIN DEMETHYLATION,2.0879e-07,0.27873,0.27732,1,1
6,GO NEGATIVE REGULATION OF VASCULAR PERMEABILITY,0.0011836,0.2786,0.23999,1,1
6,GO PROTEIN LOCALIZATION TO MICROTUBULE ORGANIZING CENTER,3.8983e-07,0.27852,0.24496,1,1
6,GO ACTIN CROSSLINK FORMATION,8.4805e-07,0.27842,0.34174,1,1
6,GO POSITIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,4.7963e-08,0.2781,0.28853,1,1
6,GO NEGATIVE REGULATION OF DNA RECOMBINATION,7.105e-06,0.27741,0.23424,1,1
6,GO SYNAPSE ORGANIZATION,2.206e-06,0.27705,0.25485,1,1
6,GO AXON DEVELOPMENT,1.0861e-06,0.27677,0.2525,1,1
6,GO MICROTUBULE ANCHORING AT MICROTUBULE ORGANIZING CENTER,9.404e-07,0.27664,0.2868,1,1
6,GO REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.2534e-06,0.27631,0.27936,1,1
6,GO EMBRYONIC CAMERA TYPE EYE MORPHOGENESIS,7.6446e-07,0.27615,0.30323,1,1
6,GO PROTEIN LOCALIZATION TO CILIUM,8.8282e-08,0.27499,0.29874,1,1
6,GO REGULATION OF AMPA RECEPTOR ACTIVITY,0.00023294,0.2748,0.31766,1,1
6,GO RESPONSE TO NICOTINE,1.1282e-07,0.27401,0.30262,1,1
6,GO NEGATIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,0.00076726,0.27381,0.30286,1,1
6,GO PANCREAS DEVELOPMENT,1.3056e-06,0.27266,0.29059,1,1
6,GO CELL MORPHOGENESIS INVOLVED IN NEURON DIFFERENTIATION,4.9228e-07,0.27209,0.25641,1,1
6,GO SYNAPSE ASSEMBLY,1.4454e-06,0.27205,0.28574,1,1
6,GO ASTRAL MICROTUBULE ORGANIZATION,1.8573e-08,0.27194,0.34086,1,1
6,GO SIALYLATION,5.1446e-05,0.27175,0.30117,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE NEUROTRANSMITTER RECEPTOR LEVELS,1.2534e-06,0.27169,0.2643,1,1
6,GO NEUROTRANSMITTER RECEPTOR TRANSPORT,3.3435e-06,0.27162,0.29685,1,1
6,GO OLIGODENDROCYTE DEVELOPMENT,0.00045468,0.27082,0.20372,1,1
6,GO DENTATE GYRUS DEVELOPMENT,0.00058763,0.27041,0.31398,1,1
6,GO POSTSYNAPTIC SIGNAL TRANSDUCTION,1.3878e-06,0.27017,0.27747,1,1
6,GO ALTERNATIVE MRNA SPLICING VIA SPLICEOSOME,4.0343e-10,0.26979,0.29166,1,1
6,GO NEGATIVE REGULATION OF AXONOGENESIS,0.0002443,0.26897,0.23261,1,1
6,GO REGULATION OF STEM CELL PROLIFERATION,1.6782e-07,0.26882,0.27122,1,1
6,GO NEGATIVE REGULATION OF HISTONE H3 K9 METHYLATION,1.0791e-07,0.26834,0.31242,1,1
6,GO EMBRYONIC DIGESTIVE TRACT MORPHOGENESIS,1.1588e-05,0.26801,0.26005,1,1
6,GO GAMMA AMINOBUTYRIC ACID TRANSPORT,0.00042777,0.26718,0.23126,1,1
6,GO LYSINE METABOLIC PROCESS,0.0032501,0.2662,0.2036,1,1
6,GO PHOTORECEPTOR CELL DIFFERENTIATION,1.1794e-07,0.26566,0.2746,1,1
6,GO REGULATION OF SYNAPSE STRUCTURE OR ACTIVITY,6.8885e-07,0.26527,0.26587,1,1
6,GO REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,2.0478e-05,0.26498,0.23195,1,1
6,GO REGULATION OF AXONOGENESIS,2.5868e-06,0.26455,0.26591,1,1
6,GO KINETOCHORE ORGANIZATION,2.5424e-05,0.26446,0.24956,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,5.9498e-07,0.26381,0.27404,1,1
6,GO TONGUE DEVELOPMENT,0.00032408,0.26375,0.2719,1,1
6,GO POSITIVE REGULATION OF STEM CELL DIFFERENTIATION,0.0029256,0.26372,0.23009,1,1
6,GO SPERMATID NUCLEUS DIFFERENTIATION,8.6328e-08,0.26344,0.27852,1,1
6,GO LEARNING,4.8198e-07,0.26336,0.26697,1,1
6,GO DENDRITE SELF AVOIDANCE,0.0023637,0.26334,0.19907,1,1
6,GO NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.00014362,0.26317,0.2419,1,1
6,GO CARDIAC MYOFIBRIL ASSEMBLY,0.00018923,0.26276,0.23821,1,1
6,GO REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.6514e-08,0.26205,0.28451,1,1
6,GO POSITIVE REGULATION OF DENDRITE MORPHOGENESIS,6.895e-08,0.262,0.29599,1,1
6,GO HISTONE H3 K9 TRIMETHYLATION,3.3713e-09,0.26151,0.28946,1,1
6,GO NEURAL CREST FORMATION,0.00065224,0.26106,0.25005,1,1
6,GO MAMMARY GLAND DUCT MORPHOGENESIS,0.0085105,0.26104,0.17175,1,1
6,GO CELLULAR POTASSIUM ION HOMEOSTASIS,0.00014599,0.26048,0.23115,1,1
6,GO REGULATION OF SYNAPSE ASSEMBLY,3.8246e-05,0.26041,0.24962,1,1
6,GO NEGATIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,0.00030449,0.25934,0.20341,1,1
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN CELL FATE COMMITMENT,0.00063314,0.25915,0.24998,1,1
6,GO AXONAL FASCICULATION,0.00071283,0.25911,0.25656,1,1
6,GO REGULATION OF SMOOTHENED SIGNALING PATHWAY,1.1165e-05,0.25881,0.22592,1,1
6,GO GENETIC IMPRINTING,3.9872e-06,0.25863,0.25082,1,1
6,GO NEGATIVE REGULATION OF NEURAL PRECURSOR CELL PROLIFERATION,1.2954e-05,0.25832,0.28293,1,1
6,GO CEREBELLAR PURKINJE CELL LAYER DEVELOPMENT,6.9711e-06,0.25799,0.30536,1,1
6,GO POSITIVE REGULATION OF CHROMATIN BINDING,1.8053e-06,0.25797,0.30198,1,1
6,GO REGULATION OF BROWN FAT CELL DIFFERENTIATION,4.7488e-06,0.25719,0.29524,1,1
6,GO CELL PART MORPHOGENESIS,5.4701e-07,0.25711,0.24477,1,1
6,GO MAST CELL MIGRATION,0.0023321,0.25702,0.32355,1,1
6,GO ADULT HEART DEVELOPMENT,0.0025617,0.25664,0.18612,1,1
6,GO PROTEIN TRANSPORT ALONG MICROTUBULE,8.4415e-08,0.25631,0.28968,1,1
6,GO CELL MIGRATION IN HINDBRAIN,5.3256e-05,0.25619,0.29177,1,1
6,GO REGULATION OF CHROMATIN BINDING,1.8318e-07,0.25595,0.29888,1,1
6,GO SYNAPTIC TRANSMISSION GLUTAMATERGIC,3.2146e-06,0.25559,0.30006,1,1
6,GO EMBRYONIC SKELETAL SYSTEM DEVELOPMENT,3.5022e-05,0.25551,0.23293,1,1
6,GO DENDRITE MORPHOGENESIS,8.2543e-08,0.25506,0.30021,1,1
6,GO REGULATION OF DENDRITIC SPINE MORPHOGENESIS,5.7051e-07,0.25484,0.31668,1,1
6,GO METANEPHROS MORPHOGENESIS,0.00039018,0.25478,0.23245,1,1
6,GO EMBRYONIC BODY MORPHOGENESIS,6.3249e-05,0.25476,0.27251,1,1
6,GO MODIFICATION OF POSTSYNAPTIC STRUCTURE,0.00020504,0.25427,0.26316,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA NONHOMOLOGOUS END JOINING,8.8796e-05,0.2541,0.19839,1,1
6,GO REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,3.4098e-06,0.25398,0.23275,1,1
6,GO HISTONE H2A MONOUBIQUITINATION,1.5386e-08,0.25347,0.27321,1,1
6,GO UTERINE SMOOTH MUSCLE CONTRACTION,0.00095459,0.2534,0.22915,1,1
6,GO SECONDARY HEART FIELD SPECIFICATION,0.0045438,0.25335,0.28358,1,1
6,GO POSITIVE REGULATION OF COLLATERAL SPROUTING,0.0005133,0.25329,0.29334,1,1
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM PROCESS,6.8396e-06,0.25321,0.27477,1,1
6,GO CYTOPLASMIC MICROTUBULE ORGANIZATION,3.4796e-08,0.25217,0.27254,1,1
6,GO RESPONSE TO LEUCINE,0.00010323,0.25204,0.27624,1,1
6,GO REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,6.4592e-06,0.25197,0.24784,1,1
6,GO RESPONSE TO PLATELET DERIVED GROWTH FACTOR,9.795e-06,0.25179,0.27189,1,1
6,GO PHARYNGEAL SYSTEM DEVELOPMENT,0.001235,0.2516,0.24358,1,1
6,GO PROTEIN POLYGLUTAMYLATION,6.9711e-06,0.25136,0.27089,1,1
6,GO REGULATION OF HEPATOCYTE PROLIFERATION,0.0024941,0.2512,0.23795,1,1
6,GO REGULATION OF NERVOUS SYSTEM PROCESS,1.9989e-07,0.25047,0.28638,1,1
6,GO ATRIOVENTRICULAR VALVE DEVELOPMENT,5.7059e-05,0.25044,0.29344,1,1
6,GO NEGATIVE REGULATION OF GLIOGENESIS,1.6321e-06,0.25003,0.29369,1,1
6,GO APICAL PROTEIN LOCALIZATION,7.3803e-06,0.24996,0.28049,1,1
6,GO POSITIVE REGULATION OF DENDRITIC SPINE DEVELOPMENT,1.8723e-07,0.24972,0.31331,1,1
6,GO NEURON PROJECTION ORGANIZATION,1.3442e-05,0.24922,0.24563,1,1
6,GO ADENYLATE CYCLASE INHIBITING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,9.9803e-06,0.24911,0.23329,1,1
6,GO RESPONSE TO FORSKOLIN,0.002631,0.24911,0.25478,1,1
6,GO POSITIVE REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,2.8001e-06,0.2487,0.22834,1,1
6,GO DENDRITIC SPINE MORPHOGENESIS,1.536e-06,0.24825,0.2955,1,1
6,GO SYNAPTIC VESICLE LOCALIZATION,2.3239e-05,0.24765,0.25903,1,1
6,GO NEGATIVE REGULATION OF TORC1 SIGNALING,3.3806e-05,0.24737,0.28285,1,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,1.4472e-05,0.24737,0.23298,1,1
6,GO OVARIAN FOLLICLE DEVELOPMENT,1.9749e-05,0.24716,0.25498,1,1
6,GO CHLORIDE ION HOMEOSTASIS,0.0035146,0.24714,0.21656,1,1
6,GO NEGATIVE REGULATION OF ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0037016,0.24708,0.24983,1,1
6,GO POSITIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.00019229,0.24658,0.22452,1,1
6,GO COLLATERAL SPROUTING,0.00013899,0.24648,0.24265,1,1
6,GO CRANIOFACIAL SUTURE MORPHOGENESIS,0.030994,0.24637,0.20424,1,1
6,GO SOMITE DEVELOPMENT,2.342e-06,0.2462,0.21579,1,1
6,GO REGULATION OF NEUROTRANSMITTER RECEPTOR ACTIVITY,1.0958e-05,0.24616,0.29702,1,1
6,GO G0 TO G1 TRANSITION,1.069e-09,0.24595,0.28288,1,1
6,GO CHEMICAL SYNAPTIC TRANSMISSION POSTSYNAPTIC,4.1456e-06,0.2459,0.28067,1,1
6,GO CILIARY BASAL BODY PLASMA MEMBRANE DOCKING,4.7963e-08,0.24581,0.24205,1,1
6,GO INTRACILIARY TRANSPORT,4.9228e-07,0.24563,0.30151,1,1
6,GO REGULATION OF RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.00022208,0.24539,0.3342,1,1
6,GO REGULATION OF MORPHOGENESIS OF A BRANCHING STRUCTURE,0.00024045,0.24528,0.22212,1,1
6,GO IRON COORDINATION ENTITY TRANSPORT,8.7316e-05,0.24471,0.24589,1,1
6,GO L GLUTAMATE TRANSMEMBRANE TRANSPORT,0.00074504,0.24466,0.16541,1,1
6,GO CELLULAR COMPONENT MORPHOGENESIS,9.0235e-07,0.24458,0.22797,1,1
6,GO METANEPHRIC NEPHRON MORPHOGENESIS,0.0059852,0.24433,0.15411,1,1
6,GO AUTONOMIC NERVOUS SYSTEM DEVELOPMENT,3.0395e-05,0.24427,0.26593,1,1
6,GO REGULATION OF HISTONE H3 K9 ACETYLATION,5.2445e-07,0.24384,0.25441,1,1
6,GO MICROTUBULE ANCHORING,4.31e-06,0.2434,0.2351,1,1
6,GO POSITIVE REGULATION OF NEURON DIFFERENTIATION,7.333e-07,0.24309,0.23263,1,1
6,GO PEPTIDYL LYSINE TRIMETHYLATION,1.439e-07,0.24309,0.22292,1,1
6,GO SPLICEOSOMAL COMPLEX ASSEMBLY,9.1205e-09,0.24238,0.25493,1,1
6,GO PROTEIN LOCALIZATION TO KINETOCHORE,4.6578e-06,0.24231,0.24215,1,1
6,GO NEURON CELLULAR HOMEOSTASIS,0.00098255,0.24212,0.2384,1,1
6,GO POSITIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.6761e-05,0.24211,0.26825,1,1
6,GO DETECTION OF TEMPERATURE STIMULUS,0.00061456,0.24206,0.31095,1,1
6,GO PEPTIDYL LYSINE DIMETHYLATION,1.7922e-07,0.2419,0.24777,1,1
6,GO DENDRITIC SPINE DEVELOPMENT,2.856e-06,0.24185,0.25881,1,1
6,GO URETER DEVELOPMENT,0.0053519,0.24179,0.30209,1,1
6,GO DORSAL VENTRAL PATTERN FORMATION,2.1595e-09,0.24172,0.29351,1,1
6,GO POSITIVE REGULATION OF SYNAPSE ASSEMBLY,0.00030928,0.24172,0.23243,1,1
6,GO NEURAL PRECURSOR CELL PROLIFERATION,1.0279e-08,0.24115,0.26667,1,1
6,GO HISTONE H4 K16 ACETYLATION,9.2118e-07,0.24111,0.22419,1,1
6,GO POSTSYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0023009,0.24098,0.23569,1,1
6,GO APPENDAGE MORPHOGENESIS,9.795e-06,0.24067,0.22441,1,1
6,GO REGULATION OF DENDRITE DEVELOPMENT,1.8318e-07,0.24022,0.2625,1,1
6,GO HINDBRAIN MORPHOGENESIS,3.5606e-08,0.23989,0.26321,1,1
6,GO MICROTUBULE ORGANIZING CENTER LOCALIZATION,2.2286e-07,0.23982,0.27033,1,1
6,GO REGULATION OF EXTENT OF CELL GROWTH,9.6129e-06,0.2397,0.24805,1,1
6,GO REGULATION OF SYNAPTIC VESICLE CYCLE,1.9044e-05,0.23951,0.28157,1,1
6,GO NEGATIVE REGULATION OF SYNAPTIC TRANSMISSION,1.0169e-05,0.23926,0.2515,1,1
6,GO REGULATION OF NEURON PROJECTION DEVELOPMENT,8.9166e-06,0.239,0.2138,1,1
6,GO MORPHOGENESIS OF EMBRYONIC EPITHELIUM,3.8924e-05,0.23872,0.18674,1,1
6,GO PROTEIN INSERTION INTO MITOCHONDRIAL MEMBRANE INVOLVED IN APOPTOTIC SIGNALING PATHWAY,2.4861e-06,0.23863,0.2366,1,1
6,GO REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.0279e-08,0.23831,0.24101,1,1
6,GO FOREBRAIN DEVELOPMENT,3.8149e-08,0.23805,0.24568,1,1
6,GO CARDIAC ATRIUM MORPHOGENESIS,6.545e-05,0.23787,0.26629,1,1
6,GO INTRACILIARY TRANSPORT INVOLVED IN CILIUM ASSEMBLY,1.0212e-06,0.23758,0.29404,1,1
6,GO NEGATIVE REGULATION OF HISTONE METHYLATION,2.1375e-08,0.23757,0.29286,1,1
6,GO SEGMENT SPECIFICATION,0.00015583,0.23708,0.28664,1,1
6,GO NEURON MATURATION,1.2027e-05,0.23687,0.25114,1,1
6,GO CRANIAL NERVE DEVELOPMENT,0.00020178,0.23676,0.25527,1,1
6,GO CENTRIOLE ASSEMBLY,5.3562e-07,0.23668,0.26462,1,1
6,GO POSITIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00070238,0.23663,0.28704,1,1
6,GO PERIPHERAL NERVOUS SYSTEM DEVELOPMENT,4.0314e-05,0.23658,0.20037,1,1
6,GO REPRODUCTIVE BEHAVIOR,7.2414e-06,0.23649,0.24797,1,1
6,GO LOCALIZATION WITHIN MEMBRANE,8.9166e-06,0.23646,0.22018,1,1
6,GO GABAERGIC NEURON DIFFERENTIATION,0.0083098,0.23623,0.31938,1,1
6,GO SYNAPTIC TRANSMISSION CHOLINERGIC,0.00043435,0.23603,0.18414,1,1
6,GO CARDIAC ATRIUM DEVELOPMENT,0.00010152,0.23564,0.23953,1,1
6,GO DENDRITE DEVELOPMENT,1.1794e-07,0.23559,0.26615,1,1
6,GO EMBRYONIC APPENDAGE MORPHOGENESIS,3.5646e-05,0.23523,0.20761,1,1
6,GO PROTECTION FROM NON HOMOLOGOUS END JOINING AT TELOMERE,6.7105e-06,0.23522,0.22166,1,1
6,GO NEGATIVE REGULATION OF AXON EXTENSION,0.0002443,0.23515,0.22206,1,1
6,GO STEM CELL PROLIFERATION,2.2505e-06,0.23515,0.22523,1,1
6,GO VESICLE MEDIATED TRANSPORT IN SYNAPSE,2.342e-06,0.23486,0.27254,1,1
6,GO REGULATION OF NERVOUS SYSTEM DEVELOPMENT,5.9498e-07,0.23458,0.21676,1,1
6,GO VENTRICULAR SYSTEM DEVELOPMENT,1.471e-07,0.23417,0.26042,1,1
6,GO REGULATION OF NEURON DIFFERENTIATION,6.4699e-07,0.23398,0.23002,1,1
6,GO REGULATION OF DENDRITE MORPHOGENESIS,1.3468e-07,0.23341,0.28495,1,1
6,GO EXPLORATION BEHAVIOR,0.0094686,0.23303,0.17374,1,1
6,GO KINETOCHORE ASSEMBLY,0.00016901,0.23293,0.22331,1,1
6,GO CEREBRAL CORTEX RADIALLY ORIENTED CELL MIGRATION,1.7071e-05,0.23281,0.25356,1,1
6,GO REGULATION OF PROTEIN KINASE C SIGNALING,0.026286,0.23281,0.22239,1,1
6,GO PROGRAMMED CELL DEATH INVOLVED IN CELL DEVELOPMENT,5.3256e-05,0.23271,0.31868,1,1
6,GO MITOCHONDRION DISTRIBUTION,1.3693e-05,0.23271,0.23969,1,1
6,GO CELLULAR RESPONSE TO VITAMIN D,0.00042777,0.23261,0.26429,1,1
6,GO REGULATION OF INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,6.4592e-06,0.23246,0.2415,1,1
6,GO REGULATION OF HISTONE H3 K9 TRIMETHYLATION,4.4787e-08,0.23226,0.2612,1,1
6,GO CELLULAR COMPONENT MAINTENANCE,1.0004e-06,0.23224,0.26021,1,1
6,GO TUBE FORMATION,6.0991e-06,0.23224,0.19867,1,1
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION OF PAIN,0.00057029,0.23207,0.2769,1,1
6,GO POSITIVE REGULATION OF DENDRITE DEVELOPMENT,2.2926e-08,0.232,0.28453,1,1
6,GO INTRACELLULAR ESTROGEN RECEPTOR SIGNALING PATHWAY,1.2534e-06,0.23171,0.22317,1,1
6,GO NEGATIVE REGULATION OF DNA REPLICATION,4.3236e-05,0.2317,0.21379,1,1
6,GO NEGATIVE REGULATION OF NEURON MIGRATION,0.00029052,0.23149,0.19362,1,1
6,GO HIPPOCAMPUS DEVELOPMENT,2.0364e-06,0.23125,0.22744,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY COMPETITIVE PROMOTER BINDING,0.0072795,0.23096,0.17593,1,1
6,GO REGULATION OF DOPAMINERGIC NEURON DIFFERENTIATION,3.9872e-06,0.23092,0.26035,1,1
6,GO REGULATION OF NUCLEAR CELL CYCLE DNA REPLICATION,0.00034485,0.23081,0.22487,1,1
6,GO EMBRYONIC DIGIT MORPHOGENESIS,0.00021857,0.23074,0.17928,1,1
6,GO FAT CELL PROLIFERATION,0.020605,0.23063,0.14465,1,1
6,GO AXONEME ASSEMBLY,3.0905e-06,0.23057,0.28646,1,1
6,GO OUTER DYNEIN ARM ASSEMBLY,0.0020367,0.23011,0.2311,1,1
6,GO MICROTUBULE SEVERING,1.7154e-07,0.22979,0.29227,1,1
6,GO POSITIVE REGULATION OF GLUTAMATE SECRETION,0.02945,0.2295,0.22722,1,1
6,GO POTASSIUM ION HOMEOSTASIS,6.8888e-05,0.22937,0.21918,1,1
6,GO REGULATION OF SYNAPTIC PLASTICITY,1.2482e-05,0.22926,0.24263,1,1
6,GO HINDLIMB MORPHOGENESIS,0.0028118,0.22903,0.18603,1,1
6,GO POSITIVE REGULATION OF HISTONE METHYLATION,1.2733e-08,0.22833,0.25566,1,1
6,GO NEURON DEVELOPMENT,7.6446e-07,0.22778,0.22129,1,1
6,GO METANEPHRIC RENAL VESICLE MORPHOGENESIS,0.0044864,0.22754,0.19585,1,1
6,GO POSITIVE REGULATION OF DNA REPAIR,1.8723e-07,0.22747,0.20672,1,1
6,GO PRESYNAPSE ORGANIZATION,2.011e-05,0.22728,0.26907,1,1
6,GO MODIFICATION OF SYNAPTIC STRUCTURE,0.00063314,0.22692,0.2099,1,1
6,GO ESTROUS CYCLE,0.00020178,0.22668,0.24207,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME CENTROMERIC REGION,3.0905e-06,0.22654,0.24453,1,1
6,GO DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,2.2958e-06,0.22649,0.23177,1,1
6,GO CHONDROCYTE DIFFERENTIATION INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00052901,0.226,0.29185,1,1
6,GO NEURAL TUBE DEVELOPMENT,1.1588e-05,0.22549,0.19324,1,1
6,GO REGULATION OF HIPPO SIGNALING,0.0093576,0.22549,0.17523,1,1
6,GO RESPONSE TO VITAMIN A,0.0023637,0.22544,0.20711,1,1
6,GO REPLICATION FORK PROCESSING,1.9044e-05,0.22541,0.2357,1,1
6,GO VENTRICULAR SEPTUM MORPHOGENESIS,0.011678,0.22506,0.16994,1,1
6,GO SINGLE STRAND BREAK REPAIR,7.6657e-06,0.22504,0.23258,1,1
6,GO STRIATUM DEVELOPMENT,0.0007786,0.22503,0.21333,1,1
6,GO NEURON DIFFERENTIATION,1.9558e-07,0.22499,0.22554,1,1
6,GO EMBRYONIC EYE MORPHOGENESIS,2.011e-05,0.22494,0.25082,1,1
6,GO REGULATION OF TRANSCRIPTION INVOLVED IN G1 S TRANSITION OF MITOTIC CELL CYCLE,2.8814e-05,0.22492,0.22873,1,1
6,GO REGULATION OF TUBULIN DEACETYLATION,0.0022095,0.2246,0.20904,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF MONOPOLAR CELL POLARITY,0.0016575,0.22448,0.1982,1,1
6,GO REGULATION OF SHORT TERM NEURONAL SYNAPTIC PLASTICITY,0.020605,0.22446,0.25984,1,1
6,GO APPENDAGE DEVELOPMENT,3.6924e-05,0.22409,0.19145,1,1
6,GO SMOOTHENED SIGNALING PATHWAY,1.3174e-07,0.22399,0.23606,1,1
6,GO NEGATIVE REGULATION OF CILIUM ASSEMBLY,2.7452e-06,0.22395,0.26187,1,1
6,GO REGULATION OF GENE EXPRESSION BY GENETIC IMPRINTING,1.7706e-05,0.22391,0.24604,1,1
6,GO SMAD PROTEIN COMPLEX ASSEMBLY,0.0001803,0.22352,0.21422,1,1
6,GO REGULATION OF CYCLASE ACTIVITY,8.5858e-05,0.22329,0.21642,1,1
6,GO REGULATION OF POSTSYNAPTIC MEMBRANE POTENTIAL,9.795e-06,0.22322,0.27993,1,1
6,GO NEGATIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.012945,0.22303,0.25358,1,1
6,GO REGULATION OF HEAT GENERATION,8.3013e-05,0.22256,0.27,1,1
6,GO CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,2.342e-06,0.2225,0.21671,1,1
6,GO MESONEPHRIC TUBULE MORPHOGENESIS,0.001483,0.22241,0.17241,1,1
6,GO REGULATION OF TRANS SYNAPTIC SIGNALING,3.7356e-07,0.22173,0.26628,1,1
6,GO POSITIVE REGULATION OF GLYCOLYTIC PROCESS,7.6657e-06,0.22146,0.34876,1,1
6,GO MICROTUBULE POLYMERIZATION,2.2015e-05,0.22141,0.22405,1,1
6,GO NEUROGENESIS,6.0759e-07,0.2214,0.20944,1,1
6,GO LACTATE METABOLIC PROCESS,0.0023637,0.22138,0.16707,1,1
6,GO DOSAGE COMPENSATION,4.5684e-06,0.22137,0.21771,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION OF NOTCH RECEPTOR TARGET,0.00096848,0.22136,0.21794,1,1
6,GO NEGATIVE REGULATION OF DNA BINDING,1.3878e-06,0.22124,0.21815,1,1
6,GO PHOTORECEPTOR CELL DEVELOPMENT,1.1789e-06,0.22116,0.22159,1,1
6,GO BRANCHING MORPHOGENESIS OF A NERVE,0.0018764,0.2211,0.27831,1,1
6,GO POSITIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.00021511,0.22109,0.22179,1,1
6,GO HEAD DEVELOPMENT,8.4415e-08,0.22074,0.21646,1,1
6,GO POLY A PLUS MRNA EXPORT FROM NUCLEUS,1.2604e-07,0.22051,0.26934,1,1
6,GO ANATOMICAL STRUCTURE ARRANGEMENT,0.013856,0.22043,0.18357,1,1
6,GO RAB PROTEIN SIGNAL TRANSDUCTION,0.00043435,0.21992,0.24259,1,1
6,GO CGMP METABOLIC PROCESS,0.012653,0.2196,0.19724,1,1
6,GO ADULT BEHAVIOR,6.8885e-07,0.21946,0.27072,1,1
6,GO SUBSTANTIA NIGRA DEVELOPMENT,1.1375e-05,0.21924,0.2055,1,1
6,GO TELOMERE MAINTENANCE VIA RECOMBINATION,0.0013826,0.21912,0.17149,1,1
6,GO LONG TERM SYNAPTIC POTENTIATION,0.00037835,0.21896,0.20728,1,1
6,GO REGULATION OF NEURON PROJECTION ARBORIZATION,0.00068191,0.21819,0.22904,1,1
6,GO MITOTIC SISTER CHROMATID COHESION,1.0169e-05,0.21819,0.23836,1,1
6,GO SKELETAL SYSTEM MORPHOGENESIS,8.5858e-05,0.21818,0.18082,1,1
6,GO MICROTUBULE BUNDLE FORMATION,1.9989e-07,0.21814,0.25908,1,1
6,GO CENTROMERE COMPLEX ASSEMBLY,0.0001862,0.2181,0.20851,1,1
6,GO HISTONE H2A UBIQUITINATION,3.8983e-07,0.21808,0.22694,1,1
6,GO HISTONE H4 K5 ACETYLATION,1.0861e-06,0.21786,0.22277,1,1
6,GO REGULATION OF CLATHRIN DEPENDENT ENDOCYTOSIS,2.0478e-05,0.21785,0.24394,1,1
6,GO MYOTUBE CELL DEVELOPMENT,4.8839e-05,0.21749,0.20376,1,1
6,GO MITOTIC G2 DNA DAMAGE CHECKPOINT,3.3806e-05,0.21747,0.217,1,1
6,GO MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,1.3325e-06,0.21743,0.24067,1,1
6,GO ATTACHMENT OF MITOTIC SPINDLE MICROTUBULES TO KINETOCHORE,0.00023667,0.21743,0.19281,1,1
6,GO GASTRO INTESTINAL SYSTEM SMOOTH MUSCLE CONTRACTION,0.0045438,0.21734,0.23432,1,1
6,GO POSITIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,1.475e-06,0.21715,0.20751,1,1
6,GO COCHLEA DEVELOPMENT,1.8053e-06,0.21709,0.27754,1,1
6,GO ACTIVATION OF PROTEIN KINASE A ACTIVITY,4.0314e-05,0.2169,0.26317,1,1
6,GO MAMMARY GLAND EPITHELIAL CELL DIFFERENTIATION,2.8305e-05,0.21682,0.26087,1,1
6,GO REGULATION OF APPETITE,4.7172e-05,0.2168,0.16899,1,1
6,GO SENSORY PERCEPTION OF TEMPERATURE STIMULUS,0.00057029,0.21678,0.27331,1,1
6,GO COPULATION,0.00055343,0.21611,0.21472,1,1
6,GO REGULATION OF DNA METHYLATION DEPENDENT HETEROCHROMATIN ASSEMBLY,6.8888e-05,0.21583,0.20414,1,1
6,GO POSITIVE REGULATION OF DEVELOPMENTAL GROWTH,3.2784e-06,0.21536,0.20439,1,1
6,GO CELLULAR RESPONSE TO X RAY,0.0002443,0.2153,0.16138,1,1
6,GO DENDRITIC TRANSPORT,1.1375e-05,0.21514,0.31524,1,1
6,GO POSITIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,8.1138e-06,0.21461,0.18562,1,1
6,GO SEROTONIN SECRETION,0.0065235,0.2145,0.20551,1,1
6,GO POSITIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,8.9166e-06,0.21438,0.21664,1,1
6,GO EPITHELIAL TUBE FORMATION,1.2716e-05,0.21421,0.1869,1,1
6,GO ERYTHROCYTE MATURATION,0.00017741,0.21399,0.19175,1,1
6,GO SUBPALLIUM DEVELOPMENT,0.0024941,0.21364,0.22695,1,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR,4.9694e-05,0.21359,0.19542,1,1
6,GO CELLULAR SODIUM ION HOMEOSTASIS,0.0023321,0.21359,0.1909,1,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION INVOLVED IN METANEPHROS MORPHOGENESIS,0.016205,0.21351,0.16613,1,1
6,GO STEM CELL DIVISION,0.0037498,0.21336,0.17153,1,1
6,GO CENTRAL NERVOUS SYSTEM DEVELOPMENT,1.6418e-07,0.21332,0.21474,1,1
6,GO NEGATIVE REGULATION OF GENE EXPRESSION EPIGENETIC,6.8348e-09,0.21304,0.24393,1,1
6,GO POSITIVE REGULATION OF ORGANELLE ASSEMBLY,7.333e-07,0.21291,0.223,1,1
6,GO MATING BEHAVIOR,0.00020504,0.21288,0.21794,1,1
6,GO REGULATION OF HISTONE METHYLATION,4.3082e-09,0.21241,0.24031,1,1
6,GO POSITIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,9.3381e-05,0.21231,0.17224,1,1
6,GO CORPUS CALLOSUM DEVELOPMENT,0.0016806,0.21171,0.24353,1,1
6,GO MITOTIC RECOMBINATION,0.0012886,0.21171,0.19031,1,1
6,GO TYPE B PANCREATIC CELL DEVELOPMENT,0.0010259,0.21147,0.22397,1,1
6,GO SEGMENTATION,5.6085e-05,0.21139,0.1827,1,1
6,GO MITOCHONDRIAL DNA METABOLIC PROCESS,0.0086125,0.21106,0.16364,1,1
6,GO NATURAL KILLER CELL DIFFERENTIATION,0.00022927,0.21096,0.20632,1,1
6,GO LYMPHOID PROGENITOR CELL DIFFERENTIATION,0.00034485,0.21074,0.22757,1,1
6,GO REGULATION OF DEVELOPMENTAL GROWTH,1.1806e-05,0.2106,0.17873,1,1
6,GO CEREBRAL CORTEX DEVELOPMENT,5.7536e-08,0.21052,0.25447,1,1
6,GO SULFATION,0.0020092,0.20979,0.17624,1,1
6,GO RETINA DEVELOPMENT IN CAMERA TYPE EYE,1.5037e-07,0.20969,0.2455,1,1
6,GO DIENCEPHALON DEVELOPMENT,9.6562e-05,0.20965,0.23225,1,1
6,GO REGULATION OF POSTSYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0037498,0.20938,0.28494,1,1
6,GO DETERMINATION OF ADULT LIFESPAN,0.026561,0.20934,0.11814,1,1
6,GO CILIUM ORGANIZATION,1.7721e-08,0.20904,0.24134,1,1
6,GO CELLULAR RESPONSE TO GLUCOSE STARVATION,6.8396e-06,0.20881,0.20784,1,1
6,GO CARDIOBLAST DIFFERENTIATION,0.013243,0.20872,0.17493,1,1
6,GO NOREPINEPHRINE TRANSPORT,0.0014022,0.20813,0.21412,1,1
6,GO REGULATION OF GLUTAMATE SECRETION,0.0038478,0.2081,0.2642,1,1
6,GO FOREBRAIN CELL MIGRATION,3.2057e-05,0.2081,0.2318,1,1
6,GO POST ANAL TAIL MORPHOGENESIS,3.5022e-05,0.2078,0.24838,1,1
6,GO NEGATIVE REGULATION OF TELOMERASE ACTIVITY,0.00020178,0.20771,0.20681,1,1
6,GO CARDIAC MUSCLE CELL MYOBLAST DIFFERENTIATION,0.0039992,0.20747,0.27034,1,1
6,GO REGULATION OF HELICASE ACTIVITY,0.00081356,0.20731,0.18469,1,1
6,GO DEVELOPMENTAL GROWTH INVOLVED IN MORPHOGENESIS,1.5576e-05,0.2072,0.21087,1,1
6,GO BRANCHING MORPHOGENESIS OF AN EPITHELIAL TUBE,0.0021798,0.20717,0.15508,1,1
6,GO SYNAPTIC SIGNALING,1.6994e-06,0.20695,0.24135,1,1
6,GO NEGATIVE REGULATION OF NERVOUS SYSTEM DEVELOPMENT,6.9711e-06,0.20689,0.20844,1,1
6,GO ENDOCRINE PANCREAS DEVELOPMENT,0.00017457,0.2064,0.21343,1,1
6,GO POSITIVE REGULATION OF CENTROSOME CYCLE,6.5837e-06,0.20622,0.26942,1,1
6,GO RESPONSE TO FOOD,4.3997e-05,0.20615,0.17921,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER INVOLVED IN CELLULAR RESPONSE TO CHEMICAL STIMULUS,2.5424e-05,0.20602,0.29058,1,1
6,GO PEPTIDYL L CYSTEINE S PALMITOYLATION,6.3249e-05,0.20596,0.23919,1,1
6,GO NEURAL NUCLEUS DEVELOPMENT,1.5674e-06,0.20559,0.27555,1,1
6,GO NEUROTRANSMITTER SECRETION,5.6085e-05,0.20549,0.25144,1,1
6,GO REGULATION OF CELL DEVELOPMENT,3.6877e-06,0.20539,0.18848,1,1
6,GO NEGATIVE REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.01849,0.20502,0.13692,1,1
6,GO EYE PHOTORECEPTOR CELL DIFFERENTIATION,1.7706e-05,0.20424,0.20496,1,1
6,GO POLARIZED EPITHELIAL CELL DIFFERENTIATION,0.00044781,0.20421,0.22085,1,1
6,GO REGULATION OF CELL MORPHOGENESIS,3.4409e-05,0.20415,0.185,1,1
6,GO POSITIVE REGULATION OF PROTEIN ACETYLATION,8.9047e-09,0.20408,0.23602,1,1
6,GO REGULATION OF NEUROTRANSMITTER TRANSPORT,6.1119e-05,0.20401,0.24556,1,1
6,GO DOPAMINE RECEPTOR SIGNALING PATHWAY,0.00012388,0.20401,0.20392,1,1
6,GO REGULATION OF CHROMATIN ASSEMBLY OR DISASSEMBLY,6.5906e-08,0.20397,0.24065,1,1
6,GO POSTSYNAPTIC NEUROTRANSMITTER RECEPTOR INTERNALIZATION,0.0051547,0.20384,0.17091,1,1
6,GO DIGESTIVE TRACT MORPHOGENESIS,0.00014839,0.20371,0.21742,1,1
6,GO CAMERA TYPE EYE PHOTORECEPTOR CELL DIFFERENTIATION,0.00053704,0.20364,0.22281,1,1
6,GO UTERUS DEVELOPMENT,0.0020929,0.20353,0.20832,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION,2.011e-05,0.2034,0.23779,1,1
6,GO REGULATION OF DNA DEPENDENT DNA REPLICATION,3.1479e-07,0.20327,0.22639,1,1
6,GO ECTODERM DEVELOPMENT,6.8888e-05,0.20305,0.17645,1,1
6,GO NEGATIVE REGULATION OF CELL DEVELOPMENT,3.3214e-05,0.2026,0.18553,1,1
6,GO REGULATION OF CHROMATIN ASSEMBLY,6.7105e-06,0.20218,0.20744,1,1
6,GO TELENCEPHALON DEVELOPMENT,1.1535e-07,0.20215,0.23382,1,1
6,GO PRO B CELL DIFFERENTIATION,0.00058763,0.20197,0.23235,1,1
6,GO LABYRINTHINE LAYER BLOOD VESSEL DEVELOPMENT,0.0047798,0.20183,0.17313,1,1
6,GO REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,2.2416e-05,0.20167,0.21312,1,1
6,GO HISTONE H3 K14 ACETYLATION,5.9498e-07,0.20165,0.222,1,1
6,GO PROTEIN LOCALIZATION TO CYTOSKELETON,1.0169e-05,0.20119,0.19929,1,1
6,GO NEGATIVE REGULATION OF SMOOTHENED SIGNALING PATHWAY,0.0013633,0.20118,0.1763,1,1
6,GO EPITHELIAL CELL FATE COMMITMENT,0.007921,0.2008,0.25942,1,1
6,GO REGULATION OF MICROTUBULE POLYMERIZATION,6.2175e-05,0.20075,0.23771,1,1
6,GO SPERM AXONEME ASSEMBLY,0.00010673,0.20073,0.22644,1,1
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,5.2303e-06,0.20048,0.21092,1,1
6,GO REGULATION OF GLUCAN BIOSYNTHETIC PROCESS,1.7706e-05,0.20013,0.22287,1,1
6,GO ENDOCRINE SYSTEM DEVELOPMENT,3.628e-05,0.19987,0.21337,1,1
6,GO CELL FATE DETERMINATION,0.01128,0.19956,0.14483,1,1
6,GO N TERMINAL PROTEIN AMINO ACID ACETYLATION,0.00049802,0.19939,0.19328,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE,1.5576e-05,0.19831,0.19944,1,1
6,GO LATERAL VENTRICLE DEVELOPMENT,0.0013255,0.19824,0.24011,1,1
6,GO DETECTION OF LIGHT STIMULUS INVOLVED IN SENSORY PERCEPTION,5.4184e-05,0.19805,0.18407,1,1
6,GO TELOMERE MAINTENANCE IN RESPONSE TO DNA DAMAGE,7.6657e-06,0.19803,0.21731,1,1
6,GO REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.0021505,0.19778,0.237,1,1
6,GO POSITIVE REGULATION OF CHROMATIN ORGANIZATION,4.3774e-08,0.19768,0.20321,1,1
6,GO NON RECOMBINATIONAL REPAIR,8.5858e-05,0.19745,0.15794,1,1
6,GO REGULATION OF RAC PROTEIN SIGNAL TRANSDUCTION,6.2175e-05,0.19719,0.20156,1,1
6,GO SYNAPTIC TRANSMISSION GABAERGIC,0.00038422,0.19716,0.19399,1,1
6,GO ATP DEPENDENT CHROMATIN REMODELING,1.8053e-06,0.19712,0.21291,1,1
6,GO REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.022446,0.19711,0.15245,1,1
6,GO DOUBLE STRAND BREAK REPAIR VIA BREAK INDUCED REPLICATION,0.00022208,0.19693,0.20807,1,1
6,GO POSITIVE REGULATION OF AXONOGENESIS,9.9803e-06,0.19691,0.25531,1,1
6,GO REGULATION OF RECEPTOR INTERNALIZATION,4.1456e-06,0.1969,0.21131,1,1
6,GO EMBRYONIC ORGAN MORPHOGENESIS,5.9834e-06,0.19683,0.20389,1,1
6,GO NEUROMUSCULAR PROCESS CONTROLLING POSTURE,0.0067673,0.1966,0.18828,1,1
6,GO CENTROSOME DUPLICATION,2.206e-06,0.19643,0.22355,1,1
6,GO HISTONE H3 K4 METHYLATION,7.1726e-09,0.1963,0.24578,1,1
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.0012005,0.19625,0.22523,1,1
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.0060595,0.196,0.16946,1,1
6,GO L GLUTAMATE IMPORT,0.028264,0.19595,0.1235,1,1
6,GO REGULATION OF ORGANELLE ASSEMBLY,1.064e-06,0.19594,0.1799,1,1
6,GO POSITIVE REGULATION OF TORC1 SIGNALING,3.152e-06,0.19586,0.25711,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,3.9102e-06,0.19576,0.21572,1,1
6,GO DNA DOUBLE STRAND BREAK PROCESSING,6.4341e-05,0.19569,0.22428,1,1
6,GO ORGANIC CATION TRANSPORT,0.008211,0.19558,0.1448,1,1
6,GO MESENCHYMAL CELL PROLIFERATION,0.0032928,0.19547,0.20638,1,1
6,GO RENAL VESICLE DEVELOPMENT,0.0071051,0.19531,0.1865,1,1
6,GO REGULATION OF SISTER CHROMATID COHESION,1.3878e-06,0.19463,0.24163,1,1
6,GO PROTEIN ACETYLATION,2.634e-09,0.19459,0.19825,1,1
6,GO REGULATION OF MODIFICATION OF SYNAPTIC STRUCTURE,0.0011836,0.19451,0.18121,1,1
6,GO EMBRYONIC CAMERA TYPE EYE DEVELOPMENT,6.2169e-06,0.1945,0.23979,1,1
6,GO CHROMATIN ASSEMBLY OR DISASSEMBLY,1.0527e-08,0.1945,0.22153,1,1
6,GO FUCOSYLATION,0.02945,0.19438,0.12945,1,1
6,GO PATTERN SPECIFICATION PROCESS,4.1552e-07,0.1942,0.21169,1,1
6,GO CELL MORPHOGENESIS,1.0756e-05,0.19411,0.18849,1,1
6,GO REGULATION OF MICROTUBULE BASED PROCESS,4.9228e-07,0.19407,0.20466,1,1
6,GO POSITIVE REGULATION OF AXON EXTENSION,0.00030928,0.19398,0.21333,1,1
6,GO DEVELOPMENT OF PRIMARY FEMALE SEXUAL CHARACTERISTICS,3.2631e-05,0.19359,0.19315,1,1
6,GO INTESTINAL EPITHELIAL CELL DEVELOPMENT,0.016205,0.1934,0.17409,1,1
6,GO MICROTUBULE ORGANIZING CENTER ORGANIZATION,2.2958e-06,0.19334,0.20227,1,1
6,GO POSITIVE REGULATION OF ORGANIC ACID TRANSPORT,0.0032078,0.19328,0.15353,1,1
6,GO RECOMBINATIONAL REPAIR,3.2784e-06,0.19321,0.19798,1,1
6,GO P BODY ASSEMBLY,1.0212e-06,0.19308,0.20449,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,1.0958e-05,0.19302,0.20002,1,1
6,GO REGULATION OF MRNA PROCESSING,1.6514e-08,0.19294,0.21993,1,1
6,GO SOMITE ROSTRAL CAUDAL AXIS SPECIFICATION,0.0007901,0.19274,0.23479,1,1
6,GO CAMERA TYPE EYE MORPHOGENESIS,2.913e-06,0.1927,0.2099,1,1
6,GO DEVELOPMENT OF PRIMARY SEXUAL CHARACTERISTICS,1.3693e-05,0.19267,0.16647,1,1
6,GO SOMITOGENESIS,0.00014362,0.19262,0.15989,1,1
6,GO NEGATIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.00032408,0.19255,0.19824,1,1
6,GO KIDNEY MORPHOGENESIS,4.1026e-05,0.19253,0.19985,1,1
6,GO RETINA MORPHOGENESIS IN CAMERA TYPE EYE,2.3661e-05,0.19227,0.22702,1,1
6,GO ORGANISM EMERGENCE FROM PROTECTIVE STRUCTURE,3.5022e-05,0.19208,0.18023,1,1
6,GO NUCLEOSOME ASSEMBLY,2.6914e-06,0.19183,0.2259,1,1
6,GO CHROMATIN REMODELING AT CENTROMERE,0.00073415,0.19179,0.19302,1,1
6,GO INNER EAR MORPHOGENESIS,1.7385e-05,0.19173,0.21084,1,1
6,GO EMBRYONIC HEART TUBE MORPHOGENESIS,5.0563e-05,0.19168,0.18281,1,1
6,GO DNA STRAND ELONGATION INVOLVED IN DNA REPLICATION,0.00014129,0.19128,0.21356,1,1
6,GO REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00020178,0.19115,0.20698,1,1
6,GO NEUROMUSCULAR JUNCTION DEVELOPMENT,0.0019023,0.1911,0.18208,1,1
6,GO NEGATIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,0.00010323,0.19108,0.21783,1,1
6,GO MESENCHYMAL TO EPITHELIAL TRANSITION,0.016568,0.19097,0.16228,1,1
6,GO NEGATIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.6418e-07,0.19083,0.21534,1,1
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.00083767,0.19074,0.18438,1,1
6,GO GROOMING BEHAVIOR,0.00074504,0.19063,0.23595,1,1
6,GO MITOCHONDRION LOCALIZATION,3.2057e-05,0.19062,0.1903,1,1
6,GO INTRACELLULAR MRNA LOCALIZATION,0.0007901,0.1906,0.19194,1,1
6,GO RESPONSE TO ELECTRICAL STIMULUS,0.00022208,0.19047,0.22894,1,1
6,GO EPITHELIAL TUBE MORPHOGENESIS,0.00042128,0.19047,0.1515,1,1
6,GO SENSORY ORGAN MORPHOGENESIS,1.0557e-05,0.1903,0.18078,1,1
6,GO REGULATION OF TORC1 SIGNALING,1.8419e-06,0.19006,0.22444,1,1
6,GO REGULATION OF CAMP MEDIATED SIGNALING,0.002702,0.18974,0.15232,1,1
6,GO EMBRYONIC HEMOPOIESIS,0.00020835,0.18944,0.23215,1,1
6,GO REGULATION OF PEPTIDE HORMONE SECRETION,2.4528e-05,0.18936,0.19219,1,1
6,GO PROTEIN LOCALIZATION TO CHROMATIN,6.5837e-06,0.18932,0.18034,1,1
6,GO NEGATIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.4787e-08,0.18903,0.18487,1,1
6,GO POST EMBRYONIC ANIMAL MORPHOGENESIS,0.00052901,0.18874,0.22504,1,1
6,GO ENDOCARDIUM DEVELOPMENT,0.00054518,0.18869,0.22342,1,1
6,GO BRANCHING INVOLVED IN MAMMARY GLAND DUCT MORPHOGENESIS,0.02174,0.18865,0.15001,1,1
6,GO CRANIAL SKELETAL SYSTEM DEVELOPMENT,0.00036686,0.18855,0.19263,1,1
6,GO CARTILAGE DEVELOPMENT INVOLVED IN ENDOCHONDRAL BONE MORPHOGENESIS,0.00044781,0.18852,0.21662,1,1
6,GO POSITIVE REGULATION OF HISTONE H3 K4 METHYLATION,7.8052e-07,0.18851,0.25747,1,1
6,GO INOSITOL METABOLIC PROCESS,0.003654,0.18836,0.18446,1,1
6,GO REGULATION OF NEURONAL SYNAPTIC PLASTICITY,0.0032928,0.18824,0.1998,1,1
6,GO REGULATION OF NEUROTRANSMITTER LEVELS,0.00022208,0.18819,0.20654,1,1
6,GO POSITIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,3.357e-07,0.18805,0.22554,1,1
6,GO PROTEIN CONTAINING COMPLEX LOCALIZATION,1.6129e-08,0.18801,0.19879,1,1
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.019104,0.18794,0.14769,1,1
6,GO REGULATION OF CELL CYCLE ARREST,1.7922e-07,0.18781,0.19219,1,1
6,GO AXON EXTENSION,3.5022e-05,0.18764,0.22565,1,1
6,GO REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.00013232,0.18749,0.1693,1,1
6,GO DNA REPLICATION INDEPENDENT NUCLEOSOME ORGANIZATION,0.00042777,0.18748,0.19494,1,1
6,GO HETEROCHROMATIN ORGANIZATION,1.9563e-06,0.18743,0.19249,1,1
6,GO NEUROMUSCULAR PROCESS CONTROLLING BALANCE,8.5858e-05,0.18741,0.19946,1,1
6,GO PALLIUM DEVELOPMENT,1.8318e-07,0.18715,0.22966,1,1
6,GO POSITIVE REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.2792e-06,0.18702,0.20129,1,1
6,GO NEGATIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,2.7614e-08,0.18699,0.17935,1,1
6,GO ENERGY HOMEOSTASIS,0.0058389,0.18694,0.1621,1,1
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DIFFERENTIATION,0.00070238,0.18676,0.17409,1,1
6,GO SYNAPTIC VESICLE EXOCYTOSIS,9.9844e-05,0.18664,0.25165,1,1
6,GO REGULATION OF CIRCADIAN RHYTHM,6.0565e-09,0.18664,0.22443,1,1
6,GO PROTEIN AUTO ADP RIBOSYLATION,0.0076401,0.18662,0.2004,1,1
6,GO SEMAPHORIN PLEXIN SIGNALING PATHWAY,0.0065235,0.1866,0.2079,1,1
6,GO DEVELOPMENTAL CELL GROWTH,7.7586e-05,0.18658,0.18994,1,1
6,GO AXONAL TRANSPORT OF MITOCHONDRION,0.0015038,0.18648,0.21469,1,1
6,GO NEGATIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.1034e-07,0.18617,0.18306,1,1
6,GO POSITIVE REGULATION OF CELL DEVELOPMENT,5.7582e-06,0.18595,0.18034,1,1
6,GO NEUROTRANSMITTER TRANSPORT,0.00017741,0.18572,0.22746,1,1
6,GO PROTEIN PALMITOYLATION,4.0314e-05,0.18568,0.22721,1,1
6,GO CONVERGENT EXTENSION,0.0034692,0.18554,0.17583,1,1
6,GO ENTEROENDOCRINE CELL DIFFERENTIATION,0.0047798,0.18554,0.19646,1,1
6,GO REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.0104,0.18539,0.15647,1,1
6,GO HISTONE H4 ACETYLATION,1.3174e-07,0.18509,0.20226,1,1
6,GO MITOTIC G2 M TRANSITION CHECKPOINT,1.9044e-05,0.18498,0.20167,1,1
6,GO PRESYNAPTIC ENDOCYTOSIS,6.8888e-05,0.18492,0.21399,1,1
6,GO NEGATIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00022565,0.18483,0.24272,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF BIPOLAR CELL POLARITY,1.9393e-05,0.18448,0.21534,1,1
6,GO REGULATION OF CARBOHYDRATE CATABOLIC PROCESS,0.00072342,0.18445,0.14641,1,1
6,GO NEGATIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0015249,0.18418,0.18784,1,1
6,GO LUNG CELL DIFFERENTIATION,0.0022396,0.18394,0.26539,1,1
6,GO GLANDULAR EPITHELIAL CELL DEVELOPMENT,0.0016347,0.18393,0.19339,1,1
6,GO GLANDULAR EPITHELIAL CELL DIFFERENTIATION,0.0019285,0.1839,0.18297,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO CENTROSOME,6.6578e-05,0.1838,0.23139,1,1
6,GO NEURON PROJECTION EXTENSION,3.0395e-05,0.18378,0.21909,1,1
6,GO REGULATION OF TRANSPOSITION,0.0056958,0.18375,0.19753,1,1
6,GO PEPTIDYL LYSINE ACETYLATION,2.1064e-09,0.18369,0.20762,1,1
6,GO NEGATIVE REGULATION OF CENTROSOME CYCLE,0.00022565,0.18368,0.16951,1,1
6,GO CELL JUNCTION ORGANIZATION,0.00014362,0.18353,0.17323,1,1
6,GO REGULATION OF EMBRYONIC DEVELOPMENT,0.0013255,0.18353,0.13965,1,1
6,GO SPLICEOSOMAL TRI SNRNP COMPLEX ASSEMBLY,5.2344e-05,0.18309,0.19654,1,1
6,GO POSITIVE REGULATION OF PROTEIN EXPORT FROM NUCLEUS,2.4528e-05,0.18297,0.23775,1,1
6,GO NEURAL TUBE FORMATION,9.819e-05,0.18296,0.17109,1,1
6,GO EYE MORPHOGENESIS,4.8416e-06,0.18293,0.19996,1,1
6,GO NEGATIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERASE,1.9044e-05,0.18286,0.20204,1,1
6,GO NEGATIVE REGULATION OF MRNA PROCESSING,3.7282e-08,0.18284,0.21385,1,1
6,GO HISTONE H4 DEACETYLATION,0.00070238,0.18275,0.17525,1,1
6,GO REGULATION OF MICROTUBULE CYTOSKELETON ORGANIZATION,7.6446e-07,0.18256,0.21394,1,1
6,GO DETECTION OF TEMPERATURE STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0013069,0.18252,0.27477,1,1
6,GO REGULATION OF RESPONSE TO FOOD,0.00092737,0.1825,0.16092,1,1
6,GO MEMBRANE DISASSEMBLY,0.03902,0.18244,0.13023,1,1
6,GO MAMMARY GLAND DEVELOPMENT,0.015329,0.18238,0.11658,1,1
6,GO NEGATIVE REGULATION OF HORMONE SECRETION,0.00039622,0.18222,0.15062,1,1
6,GO NEGATIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.0005618,0.18217,0.19878,1,1
6,GO CHROMATIN SILENCING,3.0295e-08,0.18216,0.21985,1,1
6,GO PROTEIN ACYLATION,3.1312e-09,0.18181,0.20095,1,1
6,GO GAMETE GENERATION,3.4796e-08,0.18179,0.18315,1,1
6,GO POSITIVE REGULATION OF AMINE TRANSPORT,0.00038422,0.18176,0.25423,1,1
6,GO SYNAPTIC VESICLE RECYCLING,9.1829e-05,0.18175,0.20554,1,1
6,GO TRACHEA DEVELOPMENT,0.046031,0.18155,0.14871,1,1
6,GO MORPHOGENESIS OF A BRANCHING STRUCTURE,0.0047198,0.18155,0.13578,1,1
6,GO DEMETHYLATION,7.333e-07,0.18143,0.18621,1,1
6,GO ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,6.9711e-06,0.18138,0.20545,1,1
6,GO REGIONALIZATION,3.0302e-06,0.1812,0.20414,1,1
6,GO INCLUSION BODY ASSEMBLY,0.0071918,0.1811,0.1925,1,1
6,GO REGULATION OF MICROTUBULE BASED MOVEMENT,2.971e-06,0.1811,0.20084,1,1
6,GO POSITIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.00013016,0.18092,0.18731,1,1
6,GO NEURONAL STEM CELL POPULATION MAINTENANCE,0.0067673,0.18076,0.1779,1,1
6,GO CAMERA TYPE EYE DEVELOPMENT,5.332e-06,0.18066,0.19086,1,1
6,GO RESPONSE TO STEROL,0.0033361,0.18055,0.15884,1,1
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN CELL CELL SIGNALING,5.8049e-05,0.18051,0.15114,1,1
6,GO DNA REPLICATION CHECKPOINT,4.2487e-05,0.18044,0.20718,1,1
6,GO LOCOMOTORY BEHAVIOR,1.6761e-05,0.18025,0.23114,1,1
6,GO REGULATION OF ORGANELLE TRANSPORT ALONG MICROTUBULE,0.015159,0.18024,0.17062,1,1
6,GO HISTONE H2A ACETYLATION,3.6924e-05,0.18019,0.18766,1,1
6,GO SECONDARY PALATE DEVELOPMENT,0.0029256,0.17977,0.21068,1,1
6,GO MRNA CIS SPLICING VIA SPLICEOSOME,1.6158e-05,0.17977,0.18722,1,1
6,GO MAINTENANCE OF ORGANELLE LOCATION,0.00016629,0.17977,0.1927,1,1
6,GO EMBRYONIC HEART TUBE DEVELOPMENT,3.628e-05,0.17971,0.18032,1,1
6,GO CELLULAR PROCESS INVOLVED IN REPRODUCTION IN MULTICELLULAR ORGANISM,4.3355e-07,0.17959,0.17362,1,1
6,GO SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.001442,0.17955,0.1352,1,1
6,GO TRANSPORT ALONG MICROTUBULE,3.5794e-07,0.17951,0.2045,1,1
6,GO POSITIVE REGULATION OF CELL PROJECTION ORGANIZATION,1.5576e-05,0.17909,0.19117,1,1
6,GO PERICARDIUM DEVELOPMENT,0.032607,0.17909,0.1389,1,1
6,GO HISTONE H3 K4 TRIMETHYLATION,9.4959e-05,0.17903,0.18852,1,1
6,GO POST EMBRYONIC DEVELOPMENT,0.00053704,0.17889,0.16879,1,1
6,GO REGULATION OF CELL PROJECTION ORGANIZATION,2.0853e-05,0.17875,0.18319,1,1
6,GO PEPTIDYL LYSINE METHYLATION,9.658e-10,0.17874,0.24421,1,1
6,GO CELL CELL ADHESION MEDIATED BY CADHERIN,0.0096941,0.17864,0.19159,1,1
6,GO REGULATION OF GLYCOGEN METABOLIC PROCESS,0.0007786,0.17842,0.18261,1,1
6,GO POST EMBRYONIC ANIMAL ORGAN DEVELOPMENT,0.018693,0.17833,0.16995,1,1
6,GO MICROTUBULE BASED TRANSPORT,7.333e-07,0.17823,0.20383,1,1
6,GO CELL PROJECTION ASSEMBLY,6.337e-06,0.17817,0.16835,1,1
6,GO REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.0010408,0.17815,0.15092,1,1
6,GO REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.00075607,0.1778,0.13736,1,1
6,GO MEIOTIC CHROMOSOME SEGREGATION,2.9332e-05,0.17774,0.1924,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,5.8049e-05,0.17771,0.1846,1,1
6,GO OVULATION CYCLE PROCESS,0.0012886,0.1776,0.15691,1,1
6,GO DEVELOPMENTAL GROWTH,0.00011218,0.17753,0.15437,1,1
6,GO FEMALE SEX DIFFERENTIATION,0.00012804,0.17725,0.17012,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME SEGREGATION,0.00053704,0.17717,0.14809,1,1
6,GO SPECIFICATION OF SYMMETRY,2.5359e-06,0.177,0.16659,1,1
6,GO G2 DNA DAMAGE CHECKPOINT,2.9859e-05,0.177,0.20083,1,1
6,GO SEX DIFFERENTIATION,2.6828e-05,0.17686,0.15926,1,1
6,GO REGULATION OF FEEDING BEHAVIOR,0.00098255,0.17639,0.18312,1,1
6,GO MALE GAMETE GENERATION,5.02e-08,0.17619,0.17776,1,1
6,GO MATING,0.00012804,0.1761,0.17474,1,1
6,GO AXONAL TRANSPORT,6.7724e-05,0.17608,0.20127,1,1
6,GO TRIPARTITE REGIONAL SUBDIVISION,0.048746,0.17604,0.13591,1,1
6,GO OLIGODENDROCYTE DIFFERENTIATION,2.7804e-05,0.17596,0.21655,1,1
6,GO PHOSPHATIDYLINOSITOL 3 PHOSPHATE BIOSYNTHETIC PROCESS,0.001071,0.17569,0.1896,1,1
6,GO REGULATION OF CILIUM MOVEMENT,7.3739e-05,0.17567,0.1932,1,1
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,4.6578e-06,0.17554,0.19748,1,1
6,GO NEGATIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,5.4184e-05,0.17526,0.18178,1,1
6,GO MITOTIC CHROMOSOME CONDENSATION,5.0563e-05,0.17526,0.24991,1,1
6,GO CELLULAR RESPONSE TO ESTRADIOL STIMULUS,0.00043435,0.17525,0.20401,1,1
6,GO MALE SEX DIFFERENTIATION,0.00094089,0.17518,0.1362,1,1
6,GO ACTIVATION OF ADENYLATE CYCLASE ACTIVITY,0.029754,0.1749,0.13678,1,1
6,GO NEGATIVE REGULATION OF BIOSYNTHETIC PROCESS,4.2444e-07,0.1747,0.16071,1,1
6,GO CELL CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00044103,0.17463,0.1846,1,1
6,GO MULTICELLULAR ORGANISM GROWTH,2.9332e-05,0.17458,0.16469,1,1
6,GO MAINTENANCE OF CELL NUMBER,6.545e-05,0.17431,0.14907,1,1
6,GO GERM CELL DEVELOPMENT,6.2993e-08,0.17418,0.1958,1,1
6,GO ENDOCARDIAL CUSHION MORPHOGENESIS,0.0087156,0.17407,0.15401,1,1
6,GO POSITIVE REGULATION OF GLUCOSE METABOLIC PROCESS,3.2631e-05,0.17395,0.19084,1,1
6,GO ENDOTHELIAL CELL DEVELOPMENT,0.054582,0.17393,0.11471,1,1
6,GO PEPTIDE HORMONE SECRETION,3.8924e-05,0.17389,0.18357,1,1
6,GO EMBRYONIC PATTERN SPECIFICATION,3.3806e-05,0.17379,0.189,1,1
6,GO MICROTUBULE BASED MOVEMENT,2.0429e-07,0.17368,0.20323,1,1
6,GO NUCLEOSOME ORGANIZATION,7.1819e-07,0.17367,0.20263,1,1
6,GO HISTONE EXCHANGE,0.00036124,0.17362,0.16599,1,1
6,GO ENSHEATHMENT OF NEURONS,0.0017277,0.17339,0.14038,1,1
6,GO ESTABLISHMENT OF MITOCHONDRION LOCALIZATION,0.00046872,0.17324,0.21233,1,1
6,GO BEHAVIOR,3.2784e-06,0.17323,0.20362,1,1
6,GO CHROMATIN SILENCING AT TELOMERE,4.1751e-05,0.17307,0.18531,1,1
6,GO REGULATION OF DEVELOPMENTAL PIGMENTATION,0.0042636,0.17302,0.16068,1,1
6,GO BETA CATENIN TCF COMPLEX ASSEMBLY,0.017506,0.17289,0.15184,1,1
6,GO DNA PACKAGING,7.6446e-07,0.17262,0.20026,1,1
6,GO CELL PROJECTION ORGANIZATION,9.404e-07,0.17246,0.19023,1,1
6,GO DNA REPLICATION,3.0905e-06,0.17238,0.18707,1,1
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0060595,0.17237,0.20972,1,1
6,GO NEGATIVE REGULATION OF CHROMOSOME ORGANIZATION,2.4837e-07,0.17223,0.19907,1,1
6,GO NEGATIVE REGULATION OF NEURON PROJECTION DEVELOPMENT,0.0042095,0.17214,0.15685,1,1
6,GO SEXUAL REPRODUCTION,8.8282e-08,0.17197,0.17038,1,1
6,GO AXIS ELONGATION,0.0059852,0.17196,0.17323,1,1
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION,2.6362e-08,0.17192,0.21338,1,1
6,GO SISTER CHROMATID COHESION,1.9563e-06,0.17147,0.20982,1,1
6,GO RESPONSE TO NERVE GROWTH FACTOR,6.2175e-05,0.17144,0.20029,1,1
6,GO MISMATCH REPAIR,1.2716e-05,0.17132,0.17543,1,1
6,GO DNA RECOMBINATION,2.8305e-05,0.17129,0.15859,1,1
6,GO SENSORY SYSTEM DEVELOPMENT,3.0905e-06,0.17128,0.18864,1,1
6,GO EMBRYONIC ORGAN DEVELOPMENT,4.7999e-05,0.17128,0.17336,1,1
6,GO CHROMATIN ORGANIZATION INVOLVED IN REGULATION OF TRANSCRIPTION,3.9064e-09,0.17126,0.2233,1,1
6,GO STEROID HORMONE MEDIATED SIGNALING PATHWAY,0.00020835,0.17125,0.14174,1,1
6,GO GLIAL CELL PROLIFERATION,0.0043184,0.17114,0.15817,1,1
6,GO MULTICELLULAR ORGANISM REPRODUCTION,6.3359e-07,0.17095,0.15488,1,1
6,GO INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,1.8701e-05,0.17066,0.16508,1,1
6,GO CELLULAR RESPONSE TO STEROL,0.0011341,0.17059,0.19142,1,1
6,GO PROTEIN LOCALIZATION TO ENDOSOME,0.0012527,0.17055,0.2392,1,1
6,GO HORMONE MEDIATED SIGNALING PATHWAY,0.00022565,0.17031,0.14096,1,1
6,GO ACTIVATION OF GTPASE ACTIVITY,0.0022396,0.17025,0.1272,1,1
6,GO ENDOCARDIAL CUSHION DEVELOPMENT,0.0035605,0.17023,0.16607,1,1
6,GO POSITIVE REGULATION OF NEURON APOPTOTIC PROCESS,0.00025215,0.17008,0.15435,1,1
6,GO MICROTUBULE NUCLEATION,0.00013232,0.17007,0.19859,1,1
6,GO INNER EAR RECEPTOR CELL STEREOCILIUM ORGANIZATION,0.033271,0.17003,0.10857,1,1
6,GO SERTOLI CELL DEVELOPMENT,0.027686,0.17001,0.14691,1,1
6,GO MEMBRANE DOCKING,9.795e-06,0.16992,0.17125,1,1
6,GO HISTONE METHYLATION,4.5239e-09,0.16963,0.23128,1,1
6,GO HISTONE H3 K9 ACETYLATION,1.9175e-06,0.16947,0.21284,1,1
6,GO NEGATIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.0089251,0.16933,0.19772,1,1
6,GO REGULATION OF PROTEIN DEACETYLATION,0.0017277,0.16896,0.139,1,1
6,GO ADHERENS JUNCTION ASSEMBLY,0.012087,0.16892,0.17034,1,1
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE BY NERVOUS SYSTEM PROCESS,0.0029256,0.16868,0.17984,1,1
6,GO CYTOSKELETON DEPENDENT INTRACELLULAR TRANSPORT,4.9228e-07,0.16863,0.20451,1,1
6,GO FOREGUT MORPHOGENESIS,0.00042777,0.16862,0.21333,1,1
6,GO REGULATION OF MRNA POLYADENYLATION,5.0563e-05,0.16861,0.17883,1,1
6,GO REGULATION OF SPINDLE CHECKPOINT,5.8049e-05,0.16845,0.22653,1,1
6,GO MESONEPHROS DEVELOPMENT,0.0020367,0.16825,0.16362,1,1
6,GO POSITIVE REGULATION OF FAT CELL DIFFERENTIATION,0.030368,0.16804,0.12195,1,1
6,GO SCHWANN CELL DEVELOPMENT,0.0061347,0.16802,0.15793,1,1
6,GO NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.00086244,0.16793,0.19438,1,1
6,GO PEPTIDYL GLUTAMIC ACID MODIFICATION,3.4773e-06,0.16788,0.19479,1,1
6,GO REGULATION OF NEURON MATURATION,0.017125,0.16756,0.15965,1,1
6,GO REGULATION OF DOUBLE STRAND BREAK REPAIR,1.2482e-05,0.16741,0.17069,1,1
6,GO HISTONE UBIQUITINATION,1.1086e-06,0.16716,0.17949,1,1
6,GO ADIPOSE TISSUE DEVELOPMENT,0.00037835,0.16692,0.18444,1,1
6,GO HOMOLOGOUS CHROMOSOME PAIRING AT MEIOSIS,0.00057029,0.16677,0.17997,1,1
6,GO DETECTION OF MECHANICAL STIMULUS,0.0024609,0.16671,0.17844,1,1
6,GO NEPHRON MORPHOGENESIS,0.00020835,0.16659,0.1818,1,1
6,GO EXTRACELLULAR TRANSPORT,0.0044864,0.1664,0.17948,1,1
6,GO MONOAMINE TRANSPORT,0.001071,0.16635,0.2309,1,1
6,GO CELLULAR RESPONSE TO ESTROGEN STIMULUS,0.001955,0.16632,0.21148,1,1
6,GO SIGNAL TRANSDUCTION IN ABSENCE OF LIGAND,0.00022927,0.16626,0.1517,1,1
6,GO POSITIVE REGULATION OF MRNA SPLICING VIA SPLICEOSOME,1.0169e-05,0.1662,0.19811,1,1
6,GO GLAND DEVELOPMENT,0.0023637,0.16586,0.12585,1,1
6,GO NEGATIVE REGULATION OF CHROMATIN ORGANIZATION,7.969e-07,0.16579,0.18455,1,1
6,GO POSITIVE REGULATION OF CELL MORPHOGENESIS INVOLVED IN DIFFERENTIATION,4.3236e-05,0.16565,0.19738,1,1
6,GO NOTCH RECEPTOR PROCESSING,0.036409,0.1656,0.13183,1,1
6,GO MEIOSIS I CELL CYCLE PROCESS,1.6457e-05,0.16558,0.18611,1,1
6,GO BONE MORPHOGENESIS,0.011678,0.16547,0.14343,1,1
6,GO RNA DESTABILIZATION,0.00014599,0.16506,0.16177,1,1
6,GO DOUBLE STRAND BREAK REPAIR,1.4741e-05,0.16501,0.17045,1,1
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION RESULTING IN TRANSCRIPTION,0.00019541,0.16475,0.17904,1,1
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION ELONGATION,2.5884e-05,0.16462,0.18799,1,1
6,GO NEUROMUSCULAR PROCESS,4.2487e-05,0.1646,0.20226,1,1
6,GO RESPONSE TO LEUKEMIA INHIBITORY FACTOR,0.00015583,0.16434,0.14792,1,1
6,GO FORMATION OF EXTRACHROMOSOMAL CIRCULAR DNA,0.0034243,0.16429,0.17729,1,1
6,GO ASSOCIATIVE LEARNING,0.00025215,0.16425,0.16988,1,1
6,GO REGULATION OF JUN KINASE ACTIVITY,0.0056255,0.1642,0.11855,1,1
6,GO PROSTATIC BUD FORMATION,0.050154,0.16418,0.19023,1,1
6,GO RAS PROTEIN SIGNAL TRANSDUCTION,0.0054872,0.16418,0.11523,1,1
6,GO POSITIVE REGULATION OF MRNA CATABOLIC PROCESS,3.2146e-06,0.16358,0.19125,1,1
6,GO SIGNAL TRANSDUCTION INVOLVED IN G2 DNA DAMAGE CHECKPOINT,0.0027747,0.16351,0.16989,1,1
6,GO RESPONSE TO COCAINE,5.6085e-05,0.16332,0.22179,1,1
6,GO MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.011544,0.16317,0.13148,1,1
6,GO LOCOMOTION INVOLVED IN LOCOMOTORY BEHAVIOR,0.0030436,0.16315,0.20989,1,1
6,GO REGULATION OF DNA DAMAGE CHECKPOINT,0.00026024,0.16308,0.18014,1,1
6,GO ENTRAINMENT OF CIRCADIAN CLOCK,2.5884e-05,0.16306,0.19006,1,1
6,GO NEGATIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.039406,0.16239,0.11345,1,1
6,GO CYTOKINESIS,0.00024819,0.16233,0.13886,1,1
6,GO REGULATION OF PHOSPHATASE ACTIVITY,2.4528e-05,0.16225,0.1636,1,1
6,GO CHONDROCYTE DEVELOPMENT,0.0059116,0.1622,0.17402,1,1
6,GO REGULATION OF WNT SIGNALING PATHWAY,0.0022701,0.16212,0.11909,1,1
6,GO VENTRICULAR SEPTUM DEVELOPMENT,0.0058389,0.16178,0.14491,1,1
6,GO REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,6.6578e-05,0.16168,0.15396,1,1
6,GO REGULATION OF DNA REPAIR,3.5038e-07,0.16162,0.1867,1,1
6,GO MITOTIC DNA INTEGRITY CHECKPOINT,2.7078e-07,0.1616,0.19303,1,1
6,GO POSITIVE REGULATION OF MRNA PROCESSING,4.3236e-05,0.16152,0.16908,1,1
6,GO REGULATION OF MUSCLE ORGAN DEVELOPMENT,0.0020646,0.16141,0.12545,1,1
6,GO POSITIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.0062108,0.16085,0.17542,1,1
6,GO HEART MORPHOGENESIS,0.00083767,0.16069,0.15129,1,1
6,GO OVULATION CYCLE,0.0012177,0.16061,0.15392,1,1
6,GO NEGATIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00033432,0.16057,0.15969,1,1
6,GO CENTROSOME SEPARATION,0.0007901,0.1601,0.16864,1,1
6,GO MUSCLE FIBER DEVELOPMENT,0.00022565,0.15976,0.1762,1,1
6,GO PHOSPHORYLATION OF RNA POLYMERASE II C TERMINAL DOMAIN,0.0013255,0.15973,0.14692,1,1
6,GO CELL CELL SIGNALING,6.0079e-05,0.15962,0.14618,1,1
6,GO COGNITION,1.2716e-05,0.15958,0.18579,1,1
6,GO SKIN EPIDERMIS DEVELOPMENT,0.0047798,0.15933,0.1265,1,1
6,GO ARF PROTEIN SIGNAL TRANSDUCTION,0.0018764,0.15921,0.16991,1,1
6,GO LEFT RIGHT PATTERN FORMATION,0.009139,0.15912,0.15131,1,1
6,GO LIMBIC SYSTEM DEVELOPMENT,1.6761e-05,0.15912,0.18911,1,1
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.045591,0.15908,0.11507,1,1
6,GO PROTEIN METHYLATION,2.5164e-08,0.15906,0.20706,1,1
6,GO NEGATIVE REGULATION OF NEURON APOPTOTIC PROCESS,1.9749e-05,0.15898,0.16427,1,1
6,GO AXO DENDRITIC TRANSPORT,7.8911e-05,0.1588,0.18906,1,1
6,GO NEGATIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.015159,0.15875,0.1814,1,1
6,GO ACTIVATION OF MAPKKK ACTIVITY,0.026286,0.15854,0.16076,1,1
6,GO RHO PROTEIN SIGNAL TRANSDUCTION,0.059331,0.15851,0.10081,1,1
6,GO DEVELOPMENTAL PROCESS INVOLVED IN REPRODUCTION,2.8814e-05,0.15851,0.14249,1,1
6,GO NEGATIVE REGULATION OF DEPHOSPHORYLATION,2.3239e-05,0.15845,0.16119,1,1
6,GO PLACENTA BLOOD VESSEL DEVELOPMENT,0.021053,0.15841,0.12823,1,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL DIFFERENTIATION,0.0046604,0.15827,0.18594,1,1
6,GO REGULATION OF CHROMOSOME SEGREGATION,6.8888e-05,0.15811,0.17568,1,1
6,GO ADRENERGIC RECEPTOR SIGNALING PATHWAY,0.0027747,0.15797,0.1601,1,1
6,GO MOLTING CYCLE,0.0038478,0.15794,0.12203,1,1
6,GO MICROTUBULE BASED PROCESS,6.7411e-08,0.15775,0.20006,1,1
6,GO REGULATION OF CILIUM DEPENDENT CELL MOTILITY,0.0043737,0.15762,0.11151,1,1
6,GO NEGATIVE REGULATION OF CELL PROJECTION ORGANIZATION,0.0022095,0.15738,0.15474,1,1
6,GO PROTEIN DEPOLYMERIZATION,0.00017741,0.15721,0.17147,1,1
6,GO ANTEROGRADE AXONAL TRANSPORT,0.0005618,0.15717,0.16726,1,1
6,GO SENSORY PERCEPTION OF MECHANICAL STIMULUS,0.0002443,0.15704,0.14834,1,1
6,GO RHODOPSIN MEDIATED SIGNALING PATHWAY,0.0010113,0.15694,0.095657,1,1
6,GO HISTONE DEACETYLATION,0.00014362,0.15671,0.16618,1,1
6,GO OPTIC NERVE DEVELOPMENT,0.0078263,0.15665,0.25435,1,1
6,GO EMBRYONIC DIGESTIVE TRACT DEVELOPMENT,0.041789,0.15646,0.10593,1,1
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL GROWTH,0.0066851,0.15643,0.12658,1,1
6,GO DETECTION OF MECHANICAL STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0019023,0.15641,0.19352,1,1
6,GO CELL FATE COMMITMENT,5.5864e-07,0.15637,0.20355,1,1
6,GO POSITIVE REGULATION OF HEAT GENERATION,0.0020092,0.15636,0.2381,1,1
6,GO REGULATION OF CELL SIZE,8.3013e-05,0.15625,0.18257,1,1
6,GO EAR MORPHOGENESIS,6.8888e-05,0.15613,0.17922,1,1
6,GO REGULATION OF MITOPHAGY,0.0016575,0.15601,0.1478,1,1
6,GO INTRACELLULAR RECEPTOR SIGNALING PATHWAY,0.0033799,0.15598,0.11411,1,1
6,GO NEGATIVE REGULATION OF HISTONE MODIFICATION,1.8793e-06,0.15586,0.18028,1,1
6,GO REGULATION OF RNA SPLICING,2.8262e-08,0.15584,0.19796,1,1
6,GO MITOTIC SPINDLE ORGANIZATION,8.3013e-05,0.15575,0.17153,1,1
6,GO SYNAPTIC TRANSMISSION DOPAMINERGIC,0.0037016,0.15573,0.16303,1,1
6,GO POSITIVE REGULATION OF ATP METABOLIC PROCESS,0.0020646,0.15563,0.16883,1,1
6,GO DNA INTEGRITY CHECKPOINT,9.7998e-07,0.15561,0.18547,1,1
6,GO REGULATION OF HISTONE PHOSPHORYLATION,0.0038977,0.15552,0.14178,1,1
6,GO INTERSTRAND CROSS LINK REPAIR,6.2169e-06,0.15552,0.19535,1,1
6,GO SECRETORY GRANULE ORGANIZATION,0.0013255,0.15539,0.16149,1,1
6,GO RNA SPLICING VIA TRANSESTERIFICATION REACTIONS,2.1234e-05,0.15532,0.15499,1,1
6,GO POSITIVE REGULATION OF RECEPTOR INTERNALIZATION,0.0059852,0.1553,0.15504,1,1
6,GO NEGATIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.012653,0.15526,0.13486,1,1
6,GO POSITIVE REGULATION OF JUN KINASE ACTIVITY,0.0095807,0.15518,0.12194,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.0098086,0.15513,0.13888,1,1
6,GO MITOTIC DNA REPLICATION,0.032938,0.15495,0.13244,1,1
6,GO INNER EAR RECEPTOR CELL DEVELOPMENT,0.009139,0.15495,0.14442,1,1
6,GO POSITIVE REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,4.6359e-05,0.15486,0.16859,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME SEPARATION,0.0041031,0.15459,0.13423,1,1
6,GO REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.00081356,0.15446,0.15387,1,1
6,GO REGULATION OF CYTOKINESIS,6.8888e-05,0.15446,0.17127,1,1
6,GO POSITIVE REGULATION OF FIBROBLAST MIGRATION,0.01251,0.15444,0.20902,1,1
6,GO REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.0015463,0.15404,0.13676,1,1
6,GO MRNA EXPORT FROM NUCLEUS,7.7586e-05,0.15398,0.1521,1,1
6,GO POLYOL CATABOLIC PROCESS,0.017125,0.15379,0.11925,1,1
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0022701,0.15373,0.19366,1,1
6,GO HISTONE DEUBIQUITINATION,7.5001e-05,0.15371,0.181,1,1
6,GO HOMOLOGOUS CHROMOSOME SEGREGATION,0.00014362,0.15366,0.19132,1,1
6,GO LIPID TRANSLOCATION,0.024173,0.15339,0.1367,1,1
6,GO MITRAL VALVE DEVELOPMENT,0.0056255,0.15318,0.18051,1,1
6,GO MECHANORECEPTOR DIFFERENTIATION,0.0013069,0.15304,0.17752,1,1
6,GO ANDROGEN RECEPTOR SIGNALING PATHWAY,0.0011503,0.15296,0.14547,1,1
6,GO SPERMATID DIFFERENTIATION,2.2958e-06,0.15294,0.18066,1,1
6,GO MEIOTIC SPINDLE ORGANIZATION,0.00049053,0.15293,0.19576,1,1
6,GO SCHWANN CELL DIFFERENTIATION,0.0028872,0.15283,0.15257,1,1
6,GO COVALENT CHROMATIN MODIFICATION,8.2903e-10,0.15264,0.2055,1,1
6,GO CHROMOSOME LOCALIZATION,0.0001803,0.15263,0.14184,1,1
6,GO REGULATION OF MRNA 3 END PROCESSING,0.00010852,0.15262,0.1626,1,1
6,GO REGULATION OF LYASE ACTIVITY,0.0018508,0.15254,0.16237,1,1
6,GO KIDNEY MESENCHYME DEVELOPMENT,0.049681,0.15253,0.16982,1,1
6,GO MICROTUBULE CYTOSKELETON ORGANIZATION INVOLVED IN MITOSIS,0.00015838,0.15194,0.15797,1,1
6,GO REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,7.7586e-05,0.15185,0.16182,1,1
6,GO NEGATIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.048285,0.1515,0.15215,1,1
6,GO REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.0043737,0.15137,0.11206,1,1
6,GO GLIAL CELL DIFFERENTIATION,0.00052901,0.15121,0.16203,1,1
6,GO REGULATION OF CELL DIFFERENTIATION,0.00026438,0.15119,0.13296,1,1
6,GO ENDOPLASMIC RETICULUM TUBULAR NETWORK ORGANIZATION,0.016386,0.15116,0.15098,1,1
6,GO SENSORY ORGAN DEVELOPMENT,4.7488e-06,0.1511,0.18348,1,1
6,GO HEPARAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.0075485,0.15097,0.15369,1,1
6,GO EMBRYONIC MORPHOGENESIS,0.00019857,0.15074,0.14885,1,1
6,GO CHONDROCYTE PROLIFERATION,0.026838,0.15068,0.15569,1,1
6,GO REGULATION OF DNA BINDING,1.3948e-05,0.15041,0.15406,1,1
6,GO N TERMINAL PROTEIN AMINO ACID MODIFICATION,0.003607,0.15034,0.15906,1,1
6,GO REPRODUCTION,5.0563e-05,0.15029,0.13133,1,1
6,GO EMBRYO DEVELOPMENT ENDING IN BIRTH OR EGG HATCHING,2.8814e-05,0.15024,0.15085,1,1
6,GO REGULATION OF AXON GUIDANCE,0.0034243,0.15009,0.17049,1,1
6,GO REGULATION OF CYCLIN DEPENDENT PROTEIN KINASE ACTIVITY,1.2716e-05,0.14998,0.17651,1,1
6,GO DENDRITE EXTENSION,0.00055343,0.14996,0.22995,1,1
6,GO NEGATIVE REGULATION OF DNA METABOLIC PROCESS,5.0323e-06,0.14995,0.17662,1,1
6,GO REGULATION OF RNA EXPORT FROM NUCLEUS,0.00032408,0.14994,0.1864,1,1
6,GO STRESS GRANULE ASSEMBLY,0.001442,0.14977,0.17271,1,1
6,GO SYNAPTIC VESICLE TRANSPORT,0.0035146,0.14974,0.15886,1,1
6,GO REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.0012527,0.14952,0.14864,1,1
6,GO REGULATION OF NOTCH SIGNALING PATHWAY,0.0039992,0.14939,0.15567,1,1
6,GO REGULATION OF CHROMATIN ORGANIZATION,1.9465e-08,0.14929,0.1874,1,1
6,GO SKELETAL MUSCLE CELL PROLIFERATION,0.024947,0.14919,0.14849,1,1
6,GO POSITIVE REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.00076726,0.14913,0.178,1,1
6,GO ADENYLATE CYCLASE ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00084997,0.14908,0.16894,1,1
6,GO REGULATION OF PSEUDOPODIUM ASSEMBLY,0.02174,0.14893,0.16692,1,1
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE III,0.00018923,0.14892,0.14074,1,1
6,GO REGULATION OF MEMBRANE PERMEABILITY,0.00040857,0.14883,0.13441,1,1
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY COUPLED TO CYCLIC NUCLEOTIDE SECOND MESSENGER,0.00046165,0.14879,0.15717,1,1
6,GO REGULATION OF GLUCOSE METABOLIC PROCESS,0.0019023,0.14867,0.13515,1,1
6,GO ORGANELLE LOCALIZATION,0.00020504,0.14816,0.12862,1,1
6,GO AXIS SPECIFICATION,8.1623e-05,0.14806,0.17373,1,1
6,GO EXIT FROM MITOSIS,0.00099681,0.14788,0.13699,1,1
6,GO GLUTAMINE FAMILY AMINO ACID CATABOLIC PROCESS,0.012798,0.14787,0.12057,1,1
6,GO INSULIN SECRETION,0.00024819,0.14783,0.1696,1,1
6,GO RRNA CATABOLIC PROCESS,0.003654,0.14759,0.14424,1,1
6,GO POSITIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.016205,0.14749,0.11262,1,1
6,GO SPINDLE ORGANIZATION,2.6828e-05,0.14738,0.17177,1,1
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0065235,0.14732,0.19978,1,1
6,GO THYMUS DEVELOPMENT,2.1234e-05,0.14719,0.19621,1,1
6,GO CILIUM OR FLAGELLUM DEPENDENT CELL MOTILITY,3.152e-06,0.14718,0.17599,1,1
6,GO REGULATION OF SISTER CHROMATID SEGREGATION,0.00013232,0.14712,0.17442,1,1
6,GO EAR DEVELOPMENT,0.0001179,0.14702,0.16932,1,1
6,GO SIGNAL TRANSDUCTION INVOLVED IN CELL CYCLE CHECKPOINT,3.152e-06,0.14701,0.20614,1,1
6,GO CLATHRIN COAT ASSEMBLY,0.026286,0.14699,0.13139,1,1
6,GO GLYCOGEN BIOSYNTHETIC PROCESS,0.0076401,0.14671,0.13413,1,1
6,GO DNA GEOMETRIC CHANGE,0.00013451,0.14662,0.15679,1,1
6,GO REGULATION OF HISTONE MODIFICATION,6.5906e-08,0.1465,0.18108,1,1
6,GO CELL CELL SIGNALING BY WNT,0.0017277,0.1463,0.12087,1,1
6,GO REGULATION OF MEMBRANE POTENTIAL,0.0010558,0.1463,0.15859,1,1
6,GO REGULATION OF ATTACHMENT OF SPINDLE MICROTUBULES TO KINETOCHORE,0.0019023,0.14599,0.15724,1,1
6,GO CIRCADIAN RHYTHM,2.2824e-05,0.14597,0.15317,1,1
6,GO REGULATION OF NEURON PROJECTION REGENERATION,0.02174,0.14586,0.15921,1,1
6,GO TRANSPOSITION,0.0088198,0.14576,0.17977,1,1
6,GO OOGENESIS,2.971e-06,0.14576,0.1825,1,1
6,GO REGULATION OF DNA RECOMBINATION,0.00025215,0.14572,0.14834,1,1
6,GO POSITIVE REGULATION OF CELL CYCLE ARREST,8.8282e-08,0.1457,0.2127,1,1
6,GO GOLGI RIBBON FORMATION,0.002702,0.1457,0.17913,1,1
6,GO REGULATION OF ASTROCYTE DIFFERENTIATION,0.02915,0.14555,0.14105,1,1
6,GO SYNAPTONEMAL COMPLEX ORGANIZATION,0.028264,0.14512,0.13484,1,1
6,GO MITOTIC SPINDLE ASSEMBLY,0.00087508,0.14509,0.14446,1,1
6,GO RENAL TUBULE DEVELOPMENT,0.014823,0.14488,0.12533,1,1
6,GO REGULATION OF DNA REPLICATION,6.0991e-06,0.14454,0.17214,1,1
6,GO SPECIFICATION OF ANIMAL ORGAN IDENTITY,0.0071918,0.14442,0.16858,1,1
6,GO NEURON PROJECTION REGENERATION,0.0021215,0.14423,0.17469,1,1
6,GO NUCLEAR CHROMOSOME SEGREGATION,3.4098e-06,0.14421,0.17444,1,1
6,GO VESICLE DOCKING INVOLVED IN EXOCYTOSIS,0.011678,0.14419,0.14526,1,1
6,GO HEART VALVE DEVELOPMENT,0.041383,0.14411,0.11704,1,1
6,GO REGULATION OF FATTY ACID BETA OXIDATION,0.018091,0.14401,0.13791,1,1
6,GO HORMONE TRANSPORT,0.00045468,0.14395,0.14703,1,1
6,GO NUCLEAR BODY ORGANIZATION,0.00030449,0.14387,0.16896,1,1
6,GO CYTOSKELETON ORGANIZATION,0.00020178,0.14384,0.13619,1,1
6,GO PROTEIN KINASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0051547,0.14334,0.13894,1,1
6,GO REGULATION OF SENSORY PERCEPTION,0.001483,0.14325,0.12572,1,1
6,GO REGULATION OF CENTROSOME CYCLE,5.6085e-05,0.14321,0.17574,1,1
6,GO REGULATION OF GTPASE ACTIVITY,0.0052854,0.14321,0.1122,1,1
6,GO POSITIVE REGULATION OF MEMBRANE PERMEABILITY,0.00011218,0.1432,0.14264,1,1
6,GO FEAR RESPONSE,0.00057029,0.14314,0.16773,1,1
6,GO RESPONSE TO UV C,0.03006,0.14312,0.10425,1,1
6,GO NEGATIVE REGULATION OF RNA SPLICING,4.2271e-06,0.14294,0.17327,1,1
6,GO NEGATIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.0056958,0.14281,0.11353,1,1
6,GO METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.0022095,0.14267,0.14866,1,1
6,GO REGULATION OF CELL JUNCTION ASSEMBLY,0.0093576,0.14255,0.12693,1,1
6,GO POSITIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,5.1446e-05,0.14255,0.14595,1,1
6,GO CATECHOLAMINE SECRETION,0.0014624,0.1425,0.26201,1,1
6,GO SMOOTH MUSCLE CONTRACTION,0.022209,0.14249,0.098188,1,1
6,GO NEGATIVE REGULATION OF MRNA METABOLIC PROCESS,2.2505e-06,0.14243,0.16626,1,1
6,GO CELL CYCLE ARREST,0.00016901,0.14203,0.13762,1,1
6,GO DNA DEPENDENT DNA REPLICATION,3.6877e-06,0.14192,0.19146,1,1
6,GO MRNA METHYLATION,0.0039992,0.14184,0.15286,1,1
6,GO CHROMATIN REMODELING,4.2444e-07,0.14128,0.19201,1,1
6,GO PROTEIN AUTOUBIQUITINATION,0.00027284,0.1412,0.14142,1,1
6,GO DETECTION OF VISIBLE LIGHT,2.0478e-05,0.14119,0.12308,1,1
6,GO REGULATION OF MULTICELLULAR ORGANISM GROWTH,4.6359e-05,0.14109,0.18165,1,1
6,GO ESTABLISHMENT OF CELL POLARITY,0.00013016,0.14107,0.15872,1,1
6,GO CELLULAR RESPONSE TO UV,0.00036686,0.14068,0.13955,1,1
6,GO CHROMOSOME SEGREGATION,4.9361e-06,0.14065,0.17527,1,1
6,GO REGULATION OF CHROMOSOME SEPARATION,0.0012005,0.14042,0.15187,1,1
6,GO C TERMINAL PROTEIN AMINO ACID MODIFICATION,0.00068191,0.1403,0.15921,1,1
6,GO REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.0016806,0.1403,0.24817,1,1
6,GO LUNG MORPHOGENESIS,0.053071,0.14029,0.10604,1,1
6,GO TORC1 SIGNALING,2.1621e-05,0.14028,0.18626,1,1
6,GO REGULATION OF TYPE B PANCREATIC CELL PROLIFERATION,0.033608,0.14028,0.182,1,1
6,GO CHROMOSOME SEPARATION,0.00032916,0.14024,0.16709,1,1
6,GO CANONICAL WNT SIGNALING PATHWAY,0.0087156,0.14012,0.10893,1,1
6,GO RNA SPLICING,4.2487e-05,0.14009,0.14403,1,1
6,GO MORPHOGENESIS OF AN EPITHELIUM,0.0061347,0.13996,0.10959,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF TRANSMEMBRANE ELECTROCHEMICAL GRADIENT,0.0053519,0.13981,0.1556,1,1
6,GO MULTI ORGANISM PROCESS,1.5293e-05,0.13972,0.13555,1,1
6,GO MITOTIC SISTER CHROMATID SEGREGATION,0.00015083,0.13972,0.15334,1,1
6,GO GLIAL CELL DEVELOPMENT,0.0068504,0.1397,0.13307,1,1
6,GO SISTER CHROMATID SEGREGATION,3.3214e-05,0.13957,0.16651,1,1
6,GO MIDBRAIN DEVELOPMENT,6.1119e-05,0.1395,0.14642,1,1
6,GO GENITALIA MORPHOGENESIS,0.059879,0.13948,0.19385,1,1
6,GO REGULATION OF HORMONE SECRETION,0.00037835,0.13946,0.15051,1,1
6,GO METAPHASE PLATE CONGRESSION,0.00070238,0.13928,0.12853,1,1
6,GO HEAT GENERATION,0.00076726,0.13916,0.18497,1,1
6,GO REGULATION OF SPINDLE ASSEMBLY,0.0024609,0.13904,0.13403,1,1
6,GO ER OVERLOAD RESPONSE,0.058247,0.13896,0.11132,1,1
6,GO POSITIVE REGULATION OF DNA REPLICATION,9.9844e-05,0.13895,0.14885,1,1
6,GO NEGATIVE REGULATION OF CELL MATRIX ADHESION,0.031311,0.13891,0.13135,1,1
6,GO MITOTIC CELL CYCLE CHECKPOINT,8.1361e-07,0.13852,0.18328,1,1
6,GO PROTEIN KINASE C SIGNALING,0.012798,0.1385,0.17027,1,1
6,GO REGULATION OF CELL DIVISION,7.3739e-05,0.13849,0.1499,1,1
6,GO CELL CYCLE DNA REPLICATION,1.4741e-05,0.13847,0.19044,1,1
6,GO MRNA TRANSPORT,0.00010852,0.13846,0.14046,1,1
6,GO POSITIVE REGULATION OF PROTEIN SUMOYLATION,0.00024819,0.13834,0.15902,1,1
6,GO NEGATIVE REGULATION OF CHROMOSOME SEGREGATION,3.3214e-05,0.13831,0.20522,1,1
6,GO REGULATION OF CHROMOSOME ORGANIZATION,1.6321e-06,0.13827,0.15618,1,1
6,GO WNT SIGNALING PATHWAY INVOLVED IN MIDBRAIN DOPAMINERGIC NEURON DIFFERENTIATION,0.017506,0.13823,0.14027,1,1
6,GO POSITIVE REGULATION OF DNA DEPENDENT DNA REPLICATION,0.00073415,0.13821,0.18088,1,1
6,GO NEPHRON EPITHELIUM DEVELOPMENT,0.0072795,0.13807,0.14204,1,1
6,GO CHROMATIN ORGANIZATION,1.1533e-09,0.13801,0.20664,1,1
6,GO POSITIVE REGULATION OF RNA SPLICING,4.6359e-05,0.13776,0.16701,1,1
6,GO ACIDIC AMINO ACID TRANSPORT,0.0014624,0.13753,0.16965,1,1
6,GO POSITIVE REGULATION OF CELL DIFFERENTIATION,0.0005211,0.13738,0.13489,1,1
6,GO POSITIVE REGULATION OF CHROMOSOME ORGANIZATION,2.913e-06,0.13724,0.14683,1,1
6,GO CELLULAR RESPONSE TO LIGHT STIMULUS,1.8032e-05,0.13723,0.13407,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS VIA SOMATIC MUTATION,0.0023009,0.13722,0.14373,1,1
6,GO POTASSIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.00032916,0.13688,0.19528,1,1
6,GO PHOTOTRANSDUCTION VISIBLE LIGHT,0.00048316,0.13687,0.092697,1,1
6,GO POSITIVE REGULATION OF MRNA METABOLIC PROCESS,6.2046e-07,0.13668,0.17786,1,1
6,GO REGULATION OF GONAD DEVELOPMENT,0.01849,0.13645,0.14251,1,1
6,GO REGULATION OF GLIAL CELL DIFFERENTIATION,0.00040235,0.13641,0.17506,1,1
6,GO HISTONE H3 ACETYLATION,1.2032e-06,0.13637,0.17171,1,1
6,GO PROTEIN DNA COMPLEX SUBUNIT ORGANIZATION,7.6657e-06,0.13634,0.15976,1,1
6,GO REGULATION OF PROTEIN ACETYLATION,3.7356e-07,0.13631,0.17654,1,1
6,GO POSITIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.0043737,0.13606,0.11642,1,1
6,GO POSITIVE REGULATION OF CELL DIVISION,0.0005618,0.13598,0.15407,1,1
6,GO SPERM MOTILITY,7.2414e-06,0.13592,0.16974,1,1
6,GO CHROMOSOME ORGANIZATION INVOLVED IN MEIOTIC CELL CYCLE,0.00024819,0.13582,0.17848,1,1
6,GO CELL CYCLE CHECKPOINT,8.8389e-07,0.1357,0.18501,1,1
6,GO ADULT LOCOMOTORY BEHAVIOR,0.0035605,0.13567,0.16153,1,1
6,GO REGULATION OF INSULIN SECRETION,0.00017457,0.13553,0.16968,1,1
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.014494,0.13546,0.11947,1,1
6,GO POSITIVE REGULATION OF RNA BIOSYNTHETIC PROCESS,4.8416e-06,0.13527,0.14782,1,1
6,GO REGULATION OF GLUCOSE IMPORT,0.0052197,0.13518,0.12276,1,1
6,GO DETECTION OF LIGHT STIMULUS,0.00016361,0.13505,0.096981,1,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNE RECEPTORS,0.0088198,0.13499,0.10969,1,1
6,GO NEURAL CREST CELL DIFFERENTIATION,0.0092477,0.13484,0.14641,1,1
6,GO REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,7.3739e-05,0.13484,0.13657,1,1
6,GO EPITHELIAL CELL DEVELOPMENT,0.012653,0.13474,0.12631,1,1
6,GO POSITIVE REGULATION OF NUCLEOBASE CONTAINING COMPOUND METABOLIC PROCESS,2.4861e-06,0.1347,0.14564,1,1
6,GO POSITIVE REGULATION OF HEART GROWTH,0.02915,0.13461,0.10674,1,1
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE PERMEABILITY INVOLVED IN APOPTOTIC PROCESS,0.00029511,0.13459,0.13503,1,1
6,GO SMOOTH MUSCLE TISSUE DEVELOPMENT,0.0023321,0.13459,0.17551,1,1
6,GO CELLULAR COMPONENT ASSEMBLY INVOLVED IN MORPHOGENESIS,0.017506,0.13442,0.10322,1,1
6,GO POSITIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.013093,0.13438,0.19461,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE,6.3249e-05,0.13428,0.12763,1,1
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX STABILIZATION,0.028264,0.13407,0.090692,1,1
6,GO SINGLE FERTILIZATION,0.00019229,0.13407,0.13585,1,1
6,GO OXIDATIVE DEMETHYLATION,0.0045438,0.13402,0.10685,1,1
6,GO TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,3.628e-05,0.13399,0.13477,1,1
6,GO MITOCHONDRIAL GENOME MAINTENANCE,0.00054518,0.13391,0.15959,1,1
6,GO VIRAL RNA GENOME REPLICATION,0.018091,0.13378,0.10917,1,1
6,GO CYTOPLASMIC SEQUESTERING OF PROTEIN,3.3806e-05,0.13376,0.17896,1,1
6,GO POSITIVE REGULATION OF GTPASE ACTIVITY,0.0094686,0.1337,0.10501,1,1
6,GO SKELETAL MUSCLE CELL DIFFERENTIATION,0.00043435,0.13368,0.149,1,1
6,GO POSITIVE REGULATION OF MITOTIC SISTER CHROMATID SEGREGATION,0.0037016,0.13348,0.13437,1,1
6,GO MULTICELLULAR ORGANISM AGING,0.01016,0.13331,0.11586,1,1
6,GO REGULATION OF SYNAPTIC VESICLE ENDOCYTOSIS,0.0021798,0.13329,0.18334,1,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME,0.00013232,0.13317,0.14593,1,1
6,GO CELL CYCLE G2 M PHASE TRANSITION,0.00017457,0.13313,0.12992,1,1
6,GO DNA STRAND ELONGATION,0.00013451,0.13309,0.18175,1,1
6,GO DEVELOPMENTAL MATURATION,9.3381e-05,0.13306,0.15901,1,1
6,GO NEGATIVE REGULATION OF METAPHASE ANAPHASE TRANSITION OF CELL CYCLE,0.00010852,0.13286,0.19834,1,1
6,GO REGULATION OF POTASSIUM ION TRANSPORT,0.00075607,0.13278,0.14924,1,1
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.00073415,0.13273,0.13944,1,1
6,GO REGULATION OF CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.0076401,0.13272,0.11495,1,1
6,GO SMOOTH MUSCLE CELL DIFFERENTIATION,0.0065235,0.13271,0.15786,1,1
6,GO NEGATIVE REGULATION OF CAMP MEDIATED SIGNALING,0.017125,0.1326,0.13619,1,1
6,GO DNA CONFORMATION CHANGE,6.337e-06,0.13259,0.17629,1,1
6,GO NEURON APOPTOTIC PROCESS,4.3997e-05,0.13247,0.14292,1,1
6,GO FERTILIZATION,7.0072e-05,0.13246,0.14307,1,1
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSLATION,0.0088198,0.13244,0.12609,1,1
6,GO CHROMOSOME CONDENSATION,0.00065224,0.13227,0.16814,1,1
6,GO REPRODUCTIVE SYSTEM DEVELOPMENT,0.0046018,0.13226,0.11242,1,1
6,GO NEUROTROPHIN SIGNALING PATHWAY,0.0013443,0.13224,0.16467,1,1
6,GO REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,2.4528e-05,0.13196,0.13989,1,1
6,GO REGULATION OF RAS PROTEIN SIGNAL TRANSDUCTION,0.011022,0.13184,0.11413,1,1
6,GO NEGATIVE REGULATION OF DNA REPAIR,0.0025617,0.13179,0.12724,1,1
6,GO NEGATIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.014172,0.13173,0.12678,1,1
6,GO RETINOIC ACID METABOLIC PROCESS,0.004156,0.13171,0.19795,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE PROCESS,0.00027284,0.13169,0.11679,1,1
6,GO ACTIVIN RECEPTOR SIGNALING PATHWAY,0.0019285,0.13169,0.16768,1,1
6,GO CELLULAR RESPONSE TO CHOLESTEROL,0.020385,0.1314,0.13558,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE II,1.1588e-05,0.13121,0.14531,1,1
6,GO NEUROTRANSMITTER UPTAKE,0.035691,0.13116,0.11552,1,1
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00013899,0.13109,0.13416,1,1
6,GO CARDIAC LEFT VENTRICLE MORPHOGENESIS,0.0013826,0.13097,0.20082,1,1
6,GO EMBRYO DEVELOPMENT,6.2175e-05,0.13095,0.1418,1,1
6,GO POSITIVE REGULATION OF CYTOKINESIS,0.0011668,0.1308,0.15489,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO VACUOLE,0.040187,0.13077,0.10239,1,1
6,GO DNA CATABOLIC PROCESS ENDONUCLEOLYTIC,3.152e-06,0.13076,0.16535,1,1
6,GO PROTEIN MONOUBIQUITINATION,0.00021511,0.13072,0.14127,1,1
6,GO FUCOSE METABOLIC PROCESS,0.031953,0.13063,0.1307,1,1
6,GO VESICLE DOCKING,0.024428,0.1306,0.11137,1,1
6,GO GASTRULATION WITH MOUTH FORMING SECOND,0.0099244,0.13046,0.17727,1,1
6,GO CELLULAR RESPONSE TO STEROID HORMONE STIMULUS,0.016027,0.13039,0.099047,1,1
6,GO CYTOSKELETON DEPENDENT CYTOKINESIS,0.001442,0.13024,0.12518,1,1
6,GO NEGATIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.00011033,0.13006,0.16939,1,1
6,GO ORGANELLE FISSION,1.8701e-05,0.12982,0.1442,1,1
6,GO EATING BEHAVIOR,0.00048316,0.12966,0.14855,1,1
6,GO RHYTHMIC PROCESS,8.5867e-06,0.12952,0.15891,1,1
6,GO HYPEROSMOTIC RESPONSE,0.00049802,0.12941,0.17352,1,1
6,GO WNT SIGNALING PATHWAY CALCIUM MODULATING PATHWAY,0.0041031,0.1292,0.17188,1,1
6,GO TELOMERE CAPPING,0.00096848,0.12908,0.12856,1,1
6,GO SYNAPTIC VESICLE CYTOSKELETAL TRANSPORT,0.0084096,0.12893,0.1396,1,1
6,GO REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.00070238,0.12888,0.12083,1,1
6,GO REGULATION OF CYTOPLASMIC TRANSLATION,0.021973,0.12884,0.10365,1,1
6,GO CALCIUM ION REGULATED EXOCYTOSIS,0.0088198,0.12878,0.21754,1,1
6,GO REGULATION OF DEPHOSPHORYLATION,6.6578e-05,0.12873,0.14406,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.0024281,0.12868,0.13898,1,1
6,GO POSITIVE REGULATION OF PEPTIDE HORMONE SECRETION,0.00043435,0.12821,0.16805,1,1
6,GO REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.00076726,0.12805,0.14046,1,1
6,GO REGULATION OF ENDOCYTIC RECYCLING,0.037139,0.12772,0.14784,1,1
6,GO TISSUE MORPHOGENESIS,0.0062108,0.12758,0.10601,1,1
6,GO ANTERIOR POSTERIOR PATTERN SPECIFICATION,0.00035024,0.12736,0.17339,1,1
6,GO LENS DEVELOPMENT IN CAMERA TYPE EYE,0.00042777,0.12729,0.17735,1,1
6,GO MRNA PROCESSING,4.7172e-05,0.12722,0.14508,1,1
6,GO REGULATION OF CENTROSOME DUPLICATION,0.00027716,0.12712,0.16775,1,1
6,GO NEGATIVE REGULATION OF ORGANELLE ORGANIZATION,8.5858e-05,0.12708,0.13398,1,1
6,GO RESPIRATORY SYSTEM DEVELOPMENT,0.012367,0.12698,0.13216,1,1
6,GO JNK CASCADE,0.058247,0.12665,0.077156,1,1
6,GO REGULATION OF CELL CYCLE PROCESS,4.6578e-06,0.12655,0.14254,1,1
6,GO CYCLIC NUCLEOTIDE METABOLIC PROCESS,0.019312,0.12651,0.13311,1,1
6,GO MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION,0.00016361,0.1265,0.14243,1,1
6,GO POSITIVE REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.0015249,0.12646,0.15111,1,1
6,GO NEGATIVE REGULATION OF CELL DIFFERENTIATION,0.0017517,0.12636,0.1263,1,1
6,GO GROWTH,0.0011341,0.12635,0.11811,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.01016,0.12635,0.1048,1,1
6,GO DEVELOPMENTAL INDUCTION,0.0035146,0.12628,0.16541,1,1
6,GO LENS FIBER CELL DIFFERENTIATION,0.036048,0.12597,0.1205,1,1
6,GO NEGATIVE REGULATION OF ORGANELLE ASSEMBLY,0.0003557,0.12585,0.12934,1,1
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.0001862,0.12581,0.12887,1,1
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.007921,0.12576,0.13985,1,1
6,GO REGULATION OF CELL CYCLE,2.6914e-06,0.1257,0.14047,1,1
6,GO SKELETAL MUSCLE ORGAN DEVELOPMENT,0.00027284,0.12562,0.1437,1,1
6,GO MITOTIC G1 S TRANSITION CHECKPOINT,4.7172e-05,0.12529,0.17316,1,1
6,GO REGULATION OF MRNA METABOLIC PROCESS,0.00076726,0.12517,0.11095,1,1
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRIAL MEMBRANE,0.0028118,0.12507,0.11124,1,1
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR PRODUCTION,0.0098086,0.12505,0.15497,1,1
6,GO DEFINITIVE HEMOPOIESIS,0.011411,0.12484,0.17386,1,1
6,GO POSITIVE REGULATION OF CYTOPLASMIC TRANSPORT,0.027118,0.12481,0.20428,1,1
6,GO WHITE FAT CELL DIFFERENTIATION,0.001071,0.12475,0.18232,1,1
6,GO REGULATION OF GENE EXPRESSION EPIGENETIC,1.9989e-07,0.12468,0.16982,1,1
6,GO REGULATION OF FATTY ACID OXIDATION,0.034636,0.12455,0.12002,1,1
6,GO REGULATION OF HISTONE H4 ACETYLATION,0.010645,0.12447,0.12786,1,1
6,GO HISTONE H3 DEACETYLATION,8.7316e-05,0.12445,0.18904,1,1
6,GO NLS BEARING PROTEIN IMPORT INTO NUCLEUS,0.021973,0.12444,0.15037,1,1
6,GO FILOPODIUM ASSEMBLY,0.0054192,0.12439,0.16049,1,1
6,GO SKELETAL SYSTEM DEVELOPMENT,0.0092477,0.12439,0.10311,1,1
6,GO RESPIRATORY GASEOUS EXCHANGE BY RESPIRATORY SYSTEM,0.0093576,0.12435,0.11464,1,1
6,GO REGULATION OF SPINDLE ORGANIZATION,0.00076726,0.12424,0.14188,1,1
6,GO NEGATIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.0034692,0.12418,0.16966,1,1
6,GO REGULATION OF SYSTEM PROCESS,0.0021505,0.12397,0.1282,1,1
6,GO NEGATIVE REGULATION OF TOR SIGNALING,0.00022927,0.12382,0.16885,1,1
6,GO ENDOSOME TO LYSOSOME TRANSPORT,0.00098255,0.12381,0.12434,1,1
6,GO POSITIVE REGULATION OF ORGAN GROWTH,0.0094686,0.12291,0.13661,1,1
6,GO VENTRICULAR TRABECULA MYOCARDIUM MORPHOGENESIS,0.022928,0.12285,0.17014,1,1
6,GO MEMBRANE BIOGENESIS,0.003166,0.1228,0.19811,1,1
6,GO ANIMAL ORGAN MATURATION,0.008211,0.12251,0.14361,1,1
6,GO DNA REPLICATION INITIATION,0.00033955,0.12242,0.16847,1,1
6,GO NEGATIVE REGULATION OF JUN KINASE ACTIVITY,0.034984,0.12234,0.11356,1,1
6,GO ORGANELLE ASSEMBLY,9.086e-06,0.12227,0.14026,1,1
6,GO ERYTHROCYTE DEVELOPMENT,0.020828,0.12225,0.10832,1,1
6,GO PROTEIN K48 LINKED UBIQUITINATION,0.0060595,0.1222,0.10899,1,1
6,GO CHROMOSOME ORGANIZATION,4.2784e-08,0.12199,0.17452,1,1
6,GO VESICLE CYTOSKELETAL TRAFFICKING,0.0020929,0.12188,0.14252,1,1
6,GO NERVOUS SYSTEM PROCESS,3.5646e-05,0.12162,0.14744,1,1
6,GO POSITIVE REGULATION OF GROWTH,0.00030449,0.12156,0.13871,1,1
6,GO MITOTIC CELL CYCLE,0.0001862,0.12153,0.1254,1,1
6,GO COLUMNAR CUBOIDAL EPITHELIAL CELL DEVELOPMENT,0.0059852,0.12145,0.14184,1,1
6,GO GLIOGENESIS,0.00075607,0.12113,0.14709,1,1
6,GO ERROR PRONE TRANSLESION SYNTHESIS,1.7385e-05,0.12111,0.17649,1,1
6,GO POSITIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0014624,0.12108,0.14222,1,1
6,GO PROTEIN DEPHOSPHORYLATION,0.0007786,0.12107,0.11252,1,1
6,GO CELL DIVISION,2.4528e-05,0.121,0.14939,1,1
6,GO REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.037882,0.12089,0.10937,1,1
6,GO EXCRETION,0.014013,0.12083,0.10864,1,1
6,GO POSITIVE REGULATION OF MRNA 3 END PROCESSING,0.03429,0.1207,0.1096,1,1
6,GO CELLULAR COMPONENT DISASSEMBLY INVOLVED IN EXECUTION PHASE OF APOPTOSIS,9.9803e-06,0.12041,0.13893,1,1
6,GO POSITIVE REGULATION OF CELLULAR BIOSYNTHETIC PROCESS,6.1119e-05,0.12027,0.12028,1,1
6,GO REGULATION OF NUCLEOTIDE METABOLIC PROCESS,0.0011836,0.12017,0.13564,1,1
6,GO NEGATIVE REGULATION OF GTPASE ACTIVITY,0.0013633,0.11965,0.13379,1,1
6,GO MESENCHYME DEVELOPMENT,0.014013,0.11962,0.11716,1,1
6,GO FEMALE GAMETE GENERATION,2.7312e-05,0.11953,0.14124,1,1
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.0010865,0.11941,0.1017,1,1
6,GO SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,3.0395e-05,0.1194,0.13438,1,1
6,GO NUCLEOTIDE EXCISION REPAIR,0.02174,0.11931,0.077834,1,1
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0015463,0.11928,0.11879,1,1
6,GO NEGATIVE REGULATION OF NUCLEAR DIVISION,0.00059648,0.11927,0.152,1,1
6,GO REGULATION OF MITOTIC CELL CYCLE,6.7724e-05,0.11921,0.12085,1,1
6,GO REGULATION OF GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.013546,0.11917,0.092326,1,1
6,GO NEGATIVE REGULATION OF NEURON DEATH,0.00039622,0.11915,0.12947,1,1
6,GO CARDIAC SEPTUM DEVELOPMENT,0.01585,0.11911,0.13711,1,1
6,GO HEART DEVELOPMENT,0.0037985,0.11904,0.11473,1,1
6,GO EMBRYONIC SKELETAL JOINT DEVELOPMENT,0.017699,0.11882,0.20274,1,1
6,GO CARDIAC VENTRICLE DEVELOPMENT,0.0083098,0.11881,0.11662,1,1
6,GO POSITIVE REGULATION OF CYCLASE ACTIVITY,0.01849,0.11875,0.13632,1,1
6,GO MODULATION BY SYMBIONT OF HOST PROCESS,0.004964,0.1187,0.11481,1,1
6,GO RESPONSE TO IRON ION,0.024947,0.11866,0.12138,1,1
6,GO SODIUM ION HOMEOSTASIS,0.0088198,0.11843,0.11875,1,1
6,GO POSITIVE REGULATION OF NUCLEAR DIVISION,5.3256e-05,0.11817,0.13097,1,1
6,GO TRANSMISSION OF NERVE IMPULSE,0.0029645,0.11816,0.19623,1,1
6,GO MITOTIC CYTOKINESIS,0.013546,0.11816,0.10152,1,1
6,GO EMBRYONIC CRANIAL SKELETON MORPHOGENESIS,0.0023321,0.11815,0.1784,1,1
6,GO ENTERIC NERVOUS SYSTEM DEVELOPMENT,0.030368,0.1181,0.11714,1,1
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.0015038,0.11807,0.12769,1,1
6,GO POSITIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0017517,0.11805,0.11943,1,1
6,GO HISTONE MONOUBIQUITINATION,4.0314e-05,0.11804,0.16462,1,1
6,GO CELLULAR GLUCAN METABOLIC PROCESS,0.033608,0.11796,0.097114,1,1
6,GO POSITIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.043444,0.11786,0.11484,1,1
6,GO INORGANIC ION IMPORT ACROSS PLASMA MEMBRANE,0.0047798,0.11778,0.13494,1,1
6,GO REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.031311,0.11775,0.07867,1,1
6,GO REGULATION OF CELL CYCLE CHECKPOINT,1.5576e-05,0.11763,0.20774,1,1
6,GO FEEDING BEHAVIOR,0.001118,0.1175,0.15553,1,1
6,GO REGULATION OF PROTEIN DEPHOSPHORYLATION,0.00046165,0.11738,0.12776,1,1
6,GO POSITIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.004964,0.11737,0.13197,1,1
6,GO MITOTIC NUCLEAR DIVISION,7.3739e-05,0.11718,0.15071,1,1
6,GO RESPONSE TO UV,0.00029976,0.11706,0.1327,1,1
6,GO REGULATION OF CELL CYCLE PHASE TRANSITION,0.00026858,0.11703,0.11425,1,1
6,GO PEPTIDYL TYROSINE DEPHOSPHORYLATION,0.003607,0.11694,0.12017,1,1
6,GO POSITIVE REGULATION OF CELL CYCLE,6.8885e-07,0.11683,0.14549,1,1
6,GO ESTABLISHMENT OF ORGANELLE LOCALIZATION,0.012945,0.11679,0.088341,1,1
6,GO CARDIAC VENTRICLE MORPHOGENESIS,0.0043184,0.11666,0.13667,1,1
6,GO POSITIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.043025,0.11655,0.10849,1,1
6,GO CELLULAR RESPONSE TO HORMONE STIMULUS,0.036409,0.11654,0.083109,1,1
6,GO CELL CYCLE,9.6129e-06,0.11649,0.13688,1,1
6,GO MULTICELLULAR ORGANISMAL MOVEMENT,0.016027,0.11619,0.10996,1,1
6,GO VIRAL LATENCY,0.022928,0.1161,0.1124,1,1
6,GO CELL CYCLE PROCESS,1.7385e-05,0.11609,0.14004,1,1
6,GO REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.0021215,0.11585,0.16812,1,1
6,GO NEGATIVE REGULATION OF EPITHELIAL TO MESENCHYMAL TRANSITION,0.048285,0.11581,0.11856,1,1
6,GO REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,4.1026e-05,0.11573,0.13536,1,1
6,GO POSITIVE REGULATION OF CELL CYCLE PROCESS,1.8419e-06,0.1157,0.15062,1,1
6,GO HOMOLOGOUS RECOMBINATION,0.00054518,0.11546,0.18331,1,1
6,GO MEIOTIC CELL CYCLE,1.3693e-05,0.11533,0.16532,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION,0.00096848,0.11531,0.10142,1,1
6,GO NEGATIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.0033361,0.11524,0.10632,1,1
6,GO REGULATION OF CELLULAR COMPONENT SIZE,0.0025277,0.11511,0.12734,1,1
6,GO RAC PROTEIN SIGNAL TRANSDUCTION,0.001422,0.11507,0.14272,1,1
6,GO REGULATION OF HISTONE DEACETYLATION,0.037509,0.11506,0.10671,1,1
6,GO NEGATIVE REGULATION OF MITOTIC CELL CYCLE,0.00084997,0.11495,0.1107,1,1
6,GO DENDRITIC SPINE MAINTENANCE,0.031311,0.11475,0.14995,1,1
6,GO ACROSOME REACTION,0.0054872,0.11471,0.15515,1,1
6,GO ENDOTHELIUM DEVELOPMENT,0.014172,0.11459,0.13726,1,1
6,GO NEGATIVE REGULATION OF TRANSPORTER ACTIVITY,0.033948,0.11452,0.084347,1,1
6,GO RESPONSE TO LIGHT STIMULUS,9.9844e-05,0.11407,0.12061,1,1
6,GO PROTEIN MANNOSYLATION,0.030368,0.1139,0.11314,1,1
6,GO DETECTION OF ABIOTIC STIMULUS,4.1026e-05,0.11382,0.14506,1,1
6,GO REGULATION OF ANATOMICAL STRUCTURE MORPHOGENESIS,0.010645,0.1137,0.10055,1,1
6,GO DNA DEALKYLATION,0.0080166,0.11351,0.12241,1,1
6,GO ACTIVATION OF JUN KINASE ACTIVITY,0.021053,0.11342,0.10895,1,1
6,GO REGULATION OF EXOCYTOSIS,0.00076726,0.11332,0.15527,1,1
6,GO REGULATION OF REGULATED SECRETORY PATHWAY,0.00014839,0.11328,0.1892,1,1
6,GO POSITIVE REGULATION OF HISTONE DEACETYLATION,0.039406,0.11326,0.1592,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.00061456,0.11314,0.10499,1,1
6,GO DNA REPAIR,4.5558e-05,0.11297,0.14193,1,1
6,GO POSITIVE REGULATION OF MITOPHAGY,0.035691,0.11283,0.098483,1,1
6,GO CELLULAR MACROMOLECULE LOCALIZATION,0.0049019,0.11278,0.089004,1,1
6,GO PROTEIN LOCALIZATION TO GOLGI APPARATUS,0.032607,0.11269,0.092458,1,1
6,GO REGULATION OF NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.0081133,0.11266,0.15061,1,1
6,GO LIPOPROTEIN BIOSYNTHETIC PROCESS,0.0087156,0.11266,0.10289,1,1
6,GO RETINA HOMEOSTASIS,0.00029511,0.11265,0.12179,1,1
6,GO NEGATIVE REGULATION OF CATION CHANNEL ACTIVITY,0.0033361,0.1126,0.12528,1,1
6,GO REGULATION OF PEPTIDYL LYSINE ACETYLATION,1.2716e-05,0.11256,0.1581,1,1
6,GO HISTONE PHOSPHORYLATION,0.0073682,0.11246,0.10956,1,1
6,GO RNA EXPORT FROM NUCLEUS,0.0021798,0.11239,0.12065,1,1
6,GO PEPTIDYL LYSINE MODIFICATION,2.8262e-08,0.11216,0.17593,1,1
6,GO SENSORY PERCEPTION OF PAIN,0.0016347,0.11214,0.13391,1,1
6,GO RNA POLYADENYLATION,0.017506,0.11208,0.11007,1,1
6,GO GOLGI ORGANIZATION,0.051595,0.11158,0.075417,1,1
6,GO DEPHOSPHORYLATION,0.0012886,0.11123,0.10736,1,1
6,GO POSITIVE REGULATION OF BMP SIGNALING PATHWAY,0.0039481,0.11118,0.19687,1,1
6,GO STRIATED MUSCLE CELL PROLIFERATION,0.010279,0.111,0.10935,1,1
6,GO PROTEIN INSERTION INTO MEMBRANE,0.0023009,0.11089,0.10732,1,1
6,GO SODIUM ION TRANSMEMBRANE TRANSPORT,0.043444,0.11068,0.086617,1,1
6,GO REGULATION OF PHOSPHORYLATION,0.057711,0.11056,0.071099,1,1
6,GO MODIFICATION DEPENDENT MACROMOLECULE CATABOLIC PROCESS,0.011022,0.11044,0.086006,1,1
6,GO REGULATION OF CELL MATURATION,0.02128,0.11043,0.087102,1,1
6,GO REGULATION OF ORGANELLE ORGANIZATION,0.00081356,0.11041,0.1113,1,1
6,GO POSITIVE REGULATION OF ORGANELLE ORGANIZATION,0.0030038,0.10989,0.097369,1,1
6,GO PHOTOPERIODISM,0.00031907,0.10952,0.16427,1,1
6,GO MEMBRANE HYPERPOLARIZATION,0.011544,0.10945,0.19543,1,1
6,GO PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.022209,0.10935,0.086658,1,1
6,GO LIPID PHOSPHORYLATION,0.001422,0.10919,0.13075,1,1
6,GO CYCLIC NUCLEOTIDE MEDIATED SIGNALING,0.0024281,0.10908,0.13526,1,1
6,GO ENERGY RESERVE METABOLIC PROCESS,0.057711,0.1084,0.084765,1,1
6,GO REGULATION OF HISTONE H3 K4 METHYLATION,5.5127e-05,0.10835,0.17544,1,1
6,GO TERMINATION OF RNA POLYMERASE II TRANSCRIPTION,0.0026663,0.10822,0.11741,1,1
6,GO MODULATION BY VIRUS OF HOST PROCESS,0.003654,0.10805,0.12327,1,1
6,GO RESPONSE TO TRANSFORMING GROWTH FACTOR BETA,0.02174,0.10792,0.10455,1,1
6,GO REGULATION OF VESICLE MEDIATED TRANSPORT,0.014823,0.10783,0.098407,1,1
6,GO CYTOSOLIC TRANSPORT,0.01849,0.10781,0.099956,1,1
6,GO DNA DEMETHYLATION,0.0035146,0.10777,0.14746,1,1
6,GO CELLULAR RESPONSE TO STARVATION,0.01016,0.10775,0.10546,1,1
6,GO CALCINEURIN MEDIATED SIGNALING,0.00084997,0.10763,0.16517,1,1
6,GO REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00019541,0.10746,0.16608,1,1
6,GO REGULATION OF GROWTH,0.002631,0.10734,0.10873,1,1
6,GO MESODERM DEVELOPMENT,0.0072795,0.10724,0.10021,1,1
6,GO POSITIVE REGULATION OF GLIAL CELL DIFFERENTIATION,0.00013899,0.10722,0.21429,1,1
6,GO RESPONSE TO STARVATION,0.01128,0.10711,0.10322,1,1
6,GO DNA METHYLATION OR DEMETHYLATION,6.1119e-05,0.10709,0.13293,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.0043737,0.10704,0.096472,1,1
6,GO CELLULAR RESPONSE TO DNA DAMAGE STIMULUS,5.4184e-05,0.10692,0.12633,1,1
6,GO POSITIVE REGULATION OF REPRODUCTIVE PROCESS,0.0054872,0.10688,0.097585,1,1
6,GO POSTREPLICATION REPAIR,0.0051547,0.1068,0.090792,1,1
6,GO POSITIVE REGULATION OF DNA RECOMBINATION,0.012653,0.10651,0.09606,1,1
6,GO ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.0010865,0.10594,0.13035,1,1
6,GO DIACYLGLYCEROL METABOLIC PROCESS,0.03068,0.10585,0.13654,1,1
6,GO MUSCLE TISSUE DEVELOPMENT,0.0052197,0.10579,0.095891,1,1
6,GO PROTEIN LOCALIZATION TO LYSOSOME,0.036048,0.10577,0.12103,1,1
6,GO RNA POLYMERASE II PREINITIATION COMPLEX ASSEMBLY,0.00025215,0.10572,0.11847,1,1
6,GO IN UTERO EMBRYONIC DEVELOPMENT,0.003166,0.10556,0.098024,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO GROWTH FACTOR STIMULUS,0.024428,0.10553,0.11167,1,1
6,GO CELL CYCLE PHASE TRANSITION,0.00055343,0.10528,0.11225,1,1
6,GO MIRNA MEDIATED INHIBITION OF TRANSLATION,0.011813,0.10519,0.13933,1,1
6,GO NUCLEUS ORGANIZATION,0.0020092,0.1051,0.10905,1,1
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT ORGANIZATION,0.00091404,0.10499,0.11334,1,1
6,GO PROTEIN K63 LINKED DEUBIQUITINATION,0.0042636,0.10489,0.12305,1,1
6,GO REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.020385,0.10489,0.098279,1,1
6,GO VESICLE MEDIATED TRANSPORT TO THE PLASMA MEMBRANE,0.023668,0.10449,0.086982,1,1
6,GO SIGNAL RELEASE,0.00049802,0.10442,0.13847,1,1
6,GO MITOTIC CELL CYCLE ARREST,0.019312,0.10441,0.14664,1,1
6,GO EYE PHOTORECEPTOR CELL DEVELOPMENT,0.0074579,0.10435,0.099803,1,1
6,GO NEUROPEPTIDE SIGNALING PATHWAY,0.0030839,0.10428,0.15642,1,1
6,GO CELL VOLUME HOMEOSTASIS,0.018898,0.104,0.11571,1,1
6,GO REGULATION OF PROTEIN LOCALIZATION,0.007921,0.10398,0.091268,1,1
6,GO NEGATIVE REGULATION OF WNT SIGNALING PATHWAY,0.024428,0.10381,0.092327,1,1
6,GO MUSCLE ORGAN MORPHOGENESIS,0.014013,0.1038,0.11341,1,1
6,GO POSITIVE REGULATION OF SYNAPTIC TRANSMISSION GABAERGIC,0.046031,0.10363,0.1082,1,1
6,GO MUSCLE ORGAN DEVELOPMENT,0.0033799,0.10362,0.10376,1,1
6,GO RECEPTOR INTERNALIZATION,0.013394,0.1036,0.10986,1,1
6,GO PEPTIDYL AMINO ACID MODIFICATION,0.0028872,0.10359,0.095245,1,1
6,GO NEGATIVE REGULATION OF SIGNALING,0.016752,0.10358,0.085706,1,1
6,GO POSITIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.00072342,0.10354,0.14161,1,1
6,GO REGULATION OF MUSCLE CELL DIFFERENTIATION,0.0011503,0.10337,0.13003,1,1
6,GO MAMMARY GLAND EPITHELIUM DEVELOPMENT,0.055093,0.10323,0.096834,1,1
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT BIOGENESIS,0.0038478,0.10301,0.10625,1,1
6,GO CELLULAR RESPONSE TO ORGANIC CYCLIC COMPOUND,0.027118,0.10298,0.083388,1,1
6,GO APOPTOTIC DNA FRAGMENTATION,0.00010497,0.1029,0.13673,1,1
6,GO POSITIVE REGULATION OF MITOTIC NUCLEAR DIVISION,4.4771e-05,0.10284,0.14231,1,1
6,GO REGULATION OF PROTEIN SUMOYLATION,0.0025617,0.10282,0.1243,1,1
6,GO REGULATION OF TRANSPORTER ACTIVITY,0.026013,0.10255,0.096502,1,1
6,GO ANATOMICAL STRUCTURE MATURATION,0.00071283,0.10232,0.12864,1,1
6,GO POSITIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.00072342,0.10172,0.15585,1,1
6,GO PEPTIDYL THREONINE MODIFICATION,0.0013255,0.10154,0.11837,1,1
6,GO MITOTIC METAPHASE PLATE CONGRESSION,0.0059116,0.10147,0.096197,1,1
6,GO RNA STABILIZATION,0.0035146,0.10145,0.13085,1,1
6,GO POSITIVE REGULATION OF CELL GROWTH,0.0030839,0.1014,0.11999,1,1
6,GO REGULATION OF PROTEIN MODIFICATION PROCESS,0.023668,0.10128,0.079983,1,1
6,GO PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.049681,0.10117,0.069149,1,1
6,GO NEGATIVE REGULATION OF DEVELOPMENTAL PROCESS,0.0045438,0.10099,0.10606,1,1
6,GO POSITIVE REGULATION OF WNT SIGNALING PATHWAY,0.046474,0.10059,0.075058,1,1
6,GO NUCLEAR ENVELOPE ORGANIZATION,0.051595,0.10025,0.083944,1,1
6,GO PROTEIN POLYUBIQUITINATION,0.0076401,0.10022,0.086274,1,1
6,GO RESPONSE TO ETHER,0.016938,0.10011,0.11598,1,1
6,GO TROPHOBLAST GIANT CELL DIFFERENTIATION,0.059331,0.1001,0.11892,1,1
6,GO ACTIVATION OF PROTEIN KINASE ACTIVITY,0.03429,0.10003,0.088903,1,1
6,GO ESTABLISHMENT OF RNA LOCALIZATION,0.0080166,0.099848,0.097091,1,1
6,GO MACROMOLECULE DEACYLATION,0.0003557,0.099842,0.14003,1,1
6,GO REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.022446,0.099798,0.097496,1,1
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0019023,0.099788,0.13845,1,1
6,GO NUCLEAR PORE ORGANIZATION,0.057711,0.099697,0.12342,1,1
6,GO REGULATION OF BINDING,0.022209,0.099577,0.085785,1,1
6,GO PROTEIN K48 LINKED DEUBIQUITINATION,0.00023294,0.099465,0.16248,1,1
6,GO REGULATION OF HISTONE UBIQUITINATION,0.015159,0.099436,0.098608,1,1
6,GO REGULATION OF ANATOMICAL STRUCTURE SIZE,0.0090315,0.099254,0.10583,1,1
6,GO POLYSACCHARIDE BIOSYNTHETIC PROCESS,0.045591,0.099207,0.088699,1,1
6,GO RNA LOCALIZATION,0.0137,0.099117,0.087718,1,1
6,GO PROTEIN MODIFICATION BY SMALL PROTEIN REMOVAL,0.03006,0.098988,0.071719,1,1
6,GO REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.0083098,0.098631,0.11766,1,1
6,GO NEURON DEATH,0.0014022,0.098567,0.11532,1,1
6,GO POSITIVE REGULATION OF MOLECULAR FUNCTION,0.051111,0.098325,0.071628,1,1
6,GO INTRA GOLGI VESICLE MEDIATED TRANSPORT,0.016205,0.0983,0.10188,1,1
6,GO PROTEIN LOCALIZATION TO MEMBRANE,0.0042636,0.098257,0.073232,1,1
6,GO TRANSFORMING GROWTH FACTOR BETA RECEPTOR SIGNALING PATHWAY,0.018091,0.098141,0.10763,1,1
6,GO REGULATION OF SECRETION,0.0054872,0.097908,0.10373,1,1
6,GO MRNA 3 END PROCESSING,0.00031414,0.09782,0.1445,1,1
6,GO REGULATION OF SODIUM ION TRANSPORT,0.029754,0.097667,0.10683,1,1
6,GO NEGATIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.0061347,0.09763,0.11923,1,1
6,GO PROTEIN LOCALIZATION TO CELL PERIPHERY,0.016568,0.097617,0.10425,1,1
6,GO CELLULAR RESPONSE TO ENDOGENOUS STIMULUS,0.017315,0.097449,0.087938,1,1
6,GO DNA TEMPLATED TRANSCRIPTION ELONGATION,0.0054872,0.09736,0.10052,1,1
6,GO DNA METHYLATION,0.00067188,0.097303,0.12982,1,1
6,GO INORGANIC ANION TRANSMEMBRANE TRANSPORT,0.0044864,0.097184,0.12421,1,1
6,GO PHOTOTRANSDUCTION,0.0029645,0.097126,0.073262,1,1
6,GO REGULATION OF DIGESTIVE SYSTEM PROCESS,0.031631,0.096812,0.084409,1,1
6,GO NEGATIVE REGULATION OF ION TRANSPORT,0.0085105,0.096462,0.094663,1,1
6,GO LIPOPROTEIN METABOLIC PROCESS,0.059879,0.095742,0.070012,1,1
6,GO VESICLE LOCALIZATION,0.020166,0.095654,0.09126,1,1
6,GO RETROGRADE TRANSPORT ENDOSOME TO GOLGI,0.00095459,0.095497,0.12413,1,1
6,GO DNA METABOLIC PROCESS,7.2497e-05,0.095473,0.12237,1,1
6,GO POSITIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.011022,0.095348,0.13882,1,1
6,GO NUCLEOTIDE EXCISION REPAIR DNA GAP FILLING,0.0137,0.095023,0.088123,1,1
6,GO NEGATIVE REGULATION OF CALCIUM ION TRANSPORT,0.0033799,0.095008,0.11969,1,1
6,GO SENSORY PERCEPTION,0.0024941,0.094928,0.095559,1,1
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,9.6562e-05,0.094628,0.12503,1,1
6,GO RESPONSE TO MONOSACCHARIDE,0.027401,0.094607,0.086396,1,1
6,GO REGULATION OF HAIR CYCLE,0.040981,0.094328,0.10225,1,1
6,GO REGULATION OF RNA POLYMERASE II REGULATORY REGION SEQUENCE SPECIFIC DNA BINDING,0.052083,0.094297,0.10116,1,1
6,GO SNRNA TRANSCRIPTION,0.0032501,0.094238,0.098293,1,1
6,GO POSITIVE REGULATION OF TOR SIGNALING,0.0005056,0.093945,0.14844,1,1
6,GO LYSOSOMAL TRANSPORT,0.019312,0.093593,0.10168,1,1
6,GO ENDOSOMAL TRANSPORT,0.031631,0.093539,0.081472,1,1
6,GO RESPONSE TO CARBOHYDRATE,0.055609,0.093349,0.074148,1,1
6,GO SODIUM ION TRANSPORT,0.013856,0.093326,0.10096,1,1
6,GO REGULATION OF MITOCHONDRIAL OUTER MEMBRANE PERMEABILIZATION INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.013394,0.093147,0.095619,1,1
6,GO PROTEIN LOCALIZATION TO NUCLEUS,0.013546,0.093085,0.090551,1,1
6,GO REGULATION OF INTRACELLULAR TRANSPORT,0.01128,0.092801,0.084854,1,1
6,GO ENZYME LINKED RECEPTOR PROTEIN SIGNALING PATHWAY,0.036048,0.092477,0.087705,1,1
6,GO DNA SYNTHESIS INVOLVED IN DNA REPAIR,0.0075485,0.092419,0.099908,1,1
6,GO REGULATION OF HORMONE LEVELS,0.012653,0.092347,0.095798,1,1
6,GO EPITHELIAL STRUCTURE MAINTENANCE,0.032938,0.092257,0.11226,1,1
6,GO QUATERNARY AMMONIUM GROUP TRANSPORT,0.036772,0.091765,0.13678,1,1
6,GO SENSORY PERCEPTION OF LIGHT STIMULUS,0.001955,0.091595,0.087342,1,1
6,GO ORGAN GROWTH,0.015501,0.091501,0.09515,1,1
6,GO NEGATIVE REGULATION OF CELL GROWTH,0.036772,0.091465,0.08504,1,1
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0068504,0.091413,0.095103,1,1
6,GO CELLULAR RESPONSE TO RADIATION,0.00081356,0.091327,0.098127,1,1
6,GO PEPTIDYL SERINE MODIFICATION,0.0018006,0.091232,0.11461,1,1
6,GO REGULATION OF TRANSFERASE ACTIVITY,0.048285,0.091194,0.07384,1,1
6,GO REGULATION OF DNA METABOLIC PROCESS,3.3214e-05,0.090949,0.12783,1,1
6,GO REGULATION OF CELL PROJECTION ASSEMBLY,0.0048405,0.090949,0.12264,1,1
6,GO CELL GROWTH,0.0056958,0.090795,0.11038,1,1
6,GO IMPORT INTO NUCLEUS,0.0104,0.090741,0.092449,1,1
6,GO REGULATION OF PEPTIDE TRANSPORT,0.012798,0.090675,0.084055,1,1
6,GO PEPTIDE SECRETION,0.027973,0.090289,0.083569,1,1
6,GO POSITIVE REGULATION OF ATPASE ACTIVITY,0.0094686,0.090041,0.08062,1,1
6,GO VACUOLAR TRANSPORT,0.03902,0.089818,0.081709,1,1
6,GO REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.046031,0.089815,0.083012,1,1
6,GO CELLULAR RESPONSE TO NITROGEN COMPOUND,0.043025,0.089745,0.08001,1,1
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.0019285,0.089668,0.11101,1,1
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO MITOCHONDRION,0.0016347,0.08954,0.11305,1,1
6,GO NEGATIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.000662,0.08927,0.14435,1,1
6,GO DETECTION OF STIMULUS INVOLVED IN SENSORY PERCEPTION,0.0070192,0.089259,0.099155,1,1
6,GO REGULATION OF TOR SIGNALING,0.00090088,0.088831,0.13215,1,1
6,GO POSITIVE REGULATION OF CATABOLIC PROCESS,0.051111,0.088497,0.075323,1,1
6,GO PROTEIN SUMOYLATION,0.0001862,0.08803,0.1391,1,1
6,GO REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.0080166,0.087812,0.10595,1,1
6,GO REGULATION OF NUCLEAR DIVISION,0.00015331,0.087812,0.12811,1,1
6,GO REGULATION OF PEPTIDE SECRETION,0.02945,0.08769,0.084353,1,1
6,GO POSITIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.024687,0.087372,0.086464,1,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSPORT,0.02945,0.086953,0.13787,1,1
6,GO REGULATION OF TRANSPORT,0.015674,0.086911,0.08402,1,1
6,GO NUCLEAR EXPORT,0.0020929,0.08675,0.11516,1,1
6,GO POSITIVE REGULATION OF TRANSCRIPTION INITIATION FROM RNA POLYMERASE II PROMOTER,0.00044103,0.086642,0.10889,1,1
6,GO ACTIVATION OF JNKK ACTIVITY,0.026286,0.086431,0.13469,1,1
6,GO PROTEOGLYCAN METABOLIC PROCESS,0.037509,0.086365,0.10193,1,1
6,GO NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.0057669,0.086048,0.11991,1,1
6,GO DNA MODIFICATION,0.0005211,0.085731,0.10345,1,1
6,GO REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.0067673,0.085592,0.092824,1,1
6,GO CELLULAR RESPONSE TO PEPTIDE HORMONE STIMULUS,0.058247,0.085489,0.07562,1,1
6,GO METHYLATION,0.00081356,0.085443,0.12006,1,1
6,GO POSITIVE REGULATION OF NEURON DEATH,0.035336,0.085357,0.096872,1,1
6,GO NCRNA TRANSCRIPTION,0.0071918,0.084936,0.094243,1,1
6,GO MITOCHONDRIAL MEMBRANE ORGANIZATION,0.042197,0.084608,0.067495,1,1
6,GO MUSCLE CELL DIFFERENTIATION,0.012798,0.084554,0.09997,1,1
6,GO SODIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.0063654,0.084466,0.16047,1,1
6,GO REGULATION OF CELLULAR LOCALIZATION,0.0057669,0.084339,0.094699,1,1
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.029754,0.083894,0.081263,1,1
6,GO POSITIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.048746,0.083709,0.074221,1,1
6,GO NEGATIVE REGULATION OF BINDING,0.0086125,0.083664,0.10138,1,1
6,GO INSULIN RECEPTOR SIGNALING PATHWAY,0.0032928,0.08345,0.11475,1,1
6,GO GENE SILENCING,0.00020504,0.082995,0.12257,1,1
6,GO DNA TEMPLATED TRANSCRIPTION INITIATION,0.0020092,0.082764,0.095315,1,1
6,GO REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,1.3196e-05,0.082763,0.13495,1,1
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.010645,0.082758,0.087103,1,1
6,GO RESPONSE TO PROSTAGLANDIN E,0.032607,0.082614,0.10899,1,1
6,GO SECOND MESSENGER MEDIATED SIGNALING,0.02945,0.082344,0.085031,1,1
6,GO DNA CATABOLIC PROCESS,7.6283e-05,0.081431,0.1307,1,1
6,GO CYTOPLASMIC SEQUESTERING OF TRANSCRIPTION FACTOR,0.014172,0.081221,0.12183,1,1
6,GO RESPONSE TO RADIATION,0.0012886,0.080964,0.098477,1,1
6,GO EXECUTION PHASE OF APOPTOSIS,0.0086125,0.080362,0.089118,1,1
6,GO PEPTIDYL CYSTEINE MODIFICATION,0.017894,0.079631,0.097036,1,1
6,GO POSITIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.010279,0.079159,0.087691,1,1
6,GO ACTIVATION OF MAPKK ACTIVITY,0.038258,0.079094,0.10814,1,1
6,GO POSITIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.010522,0.078463,0.088945,1,1
6,GO FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.046031,0.078355,0.074891,1,1
6,GO THYROID HORMONE METABOLIC PROCESS,0.051111,0.078074,0.13736,1,1
6,GO POSITIVE REGULATION OF DNA TEMPLATED TRANSCRIPTION INITIATION,0.00099681,0.078072,0.1028,1,1
6,GO RESPONSE TO ESTRADIOL,0.035691,0.077756,0.089399,1,1
6,GO MUSCLE STRUCTURE DEVELOPMENT,0.023668,0.07758,0.085487,1,1
6,GO RNA DECAPPING,0.026838,0.077426,0.090465,1,1
6,GO HOMEOSTASIS OF NUMBER OF CELLS WITHIN A TISSUE,0.036409,0.077188,0.11529,1,1
6,GO REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.02915,0.077007,0.13512,1,1
6,GO NEGATIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.052083,0.07683,0.08334,1,1
6,GO CELLULAR RESPONSE TO ALCOHOL,0.034636,0.07656,0.099805,1,1
6,GO REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.033948,0.076366,0.085627,1,1
6,GO METAL ION TRANSPORT,0.047827,0.076264,0.075458,1,1
6,GO REGULATION OF CYTOSKELETON ORGANIZATION,0.013856,0.076093,0.096747,1,1
6,GO BASE EXCISION REPAIR,0.011151,0.075612,0.091393,1,1
6,GO NEGATIVE REGULATION OF RESPONSE TO DNA DAMAGE STIMULUS,0.0030436,0.074719,0.10262,1,1
6,GO PROTEIN LOCALIZATION TO ORGANELLE,0.034636,0.074432,0.063515,1,1
6,GO PROTEIN K63 LINKED UBIQUITINATION,0.03006,0.074416,0.079689,1,1
6,GO DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.00086244,0.074279,0.12494,1,1
6,GO STEM CELL DIFFERENTIATION,0.0054192,0.074271,0.095981,1,1
6,GO CATION TRANSPORT,0.043444,0.074005,0.078483,1,1
6,GO NUCLEAR TRANSPORT,0.0021215,0.073951,0.10814,1,1
6,GO POSITIVE REGULATION OF DOUBLE STRAND BREAK REPAIR VIA HOMOLOGOUS RECOMBINATION,0.012945,0.073463,0.12925,1,1
6,GO CELLULAR PROTEIN CONTAINING COMPLEX ASSEMBLY,0.021509,0.073429,0.071804,1,1
6,GO APOPTOTIC MITOCHONDRIAL CHANGES,0.017506,0.073241,0.079165,1,1
6,GO ION TRANSMEMBRANE TRANSPORT,0.043866,0.073082,0.078958,1,1
6,GO RESPONSE TO ACTIVITY,0.052575,0.073014,0.077859,1,1
6,GO DNA DAMAGE RESPONSE DETECTION OF DNA DAMAGE,0.040981,0.072602,0.066464,1,1
6,GO REGULATION OF ATP METABOLIC PROCESS,0.058787,0.072154,0.077385,1,1
6,GO PROTEIN HOMOOLIGOMERIZATION,0.058787,0.07179,0.0669,1,1
6,GO MONOVALENT INORGANIC CATION TRANSPORT,0.021053,0.071399,0.097403,1,1
6,GO SIGNAL TRANSDUCTION IN RESPONSE TO DNA DAMAGE,0.00029511,0.071121,0.13088,1,1
6,GO RNA 3 END PROCESSING,0.027686,0.070129,0.085384,1,1
6,GO REGULATION OF GLIAL CELL MIGRATION,0.033608,0.069658,0.092763,1,1
6,GO POSITIVE REGULATION OF DNA METABOLIC PROCESS,0.0016347,0.069553,0.096434,1,1
6,GO REGULATION OF CELLULAR RESPONSE TO STRESS,0.018693,0.068807,0.077179,1,1
6,GO MRNA METABOLIC PROCESS,0.016568,0.068631,0.076356,1,1
6,GO POSITIVE REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.05357,0.068306,0.079351,1,1
6,GO TRANSCRIPTION BY RNA POLYMERASE III,0.026013,0.068026,0.06998,1,1
6,GO TRANSLESION SYNTHESIS,0.020605,0.06775,0.08659,1,1
6,GO POSITIVE REGULATION OF INTRACELLULAR TRANSPORT,0.015674,0.067416,0.085352,1,1
6,GO REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.015329,0.06725,0.079351,1,1
6,GO MITOPHAGY,0.019104,0.067174,0.10496,1,1
6,GO REGULATION OF MACROAUTOPHAGY,0.052083,0.06671,0.06988,1,1
6,GO MORPHOGENESIS OF A POLARIZED EPITHELIUM,0.022446,0.066585,0.097393,1,1
6,GO POSITIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.014172,0.066153,0.089721,1,1
6,GO CELLULAR GLUCOSE HOMEOSTASIS,0.039406,0.065469,0.093972,1,1
6,GO REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.023919,0.064688,0.083105,1,1
6,GO TOR SIGNALING,0.0040509,0.063786,0.10784,1,1
6,GO CATION TRANSMEMBRANE TRANSPORT,0.043866,0.06377,0.080224,1,1
6,GO ERROR FREE TRANSLESION SYNTHESIS,0.026286,0.062302,0.07718,1,1
6,GO INORGANIC ION TRANSMEMBRANE TRANSPORT,0.044292,0.062225,0.079298,1,1
6,GO POSITIVE REGULATION OF BINDING,0.051111,0.062023,0.07104,1,1
6,GO CELLULAR RESPONSE TO IONIZING RADIATION,0.054582,0.062021,0.05989,1,1
6,GO CELLULAR SENESCENCE,0.032607,0.061317,0.091106,1,1
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.027401,0.061291,0.074901,1,1
6,GO REGULATION OF CYTOPLASMIC TRANSPORT,0.026286,0.060975,0.13526,1,1
6,GO REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.040582,0.060315,0.073808,1,1
6,GO CELL CYCLE G1 S PHASE TRANSITION,0.018091,0.058042,0.090864,1,1
6,GO PROTEIN POLYMERIZATION,0.015159,0.057435,0.10167,1,1
6,GO NUCLEIC ACID PHOSPHODIESTER BOND HYDROLYSIS,0.049212,0.0545,0.068959,1,1
6,GO ANATOMICAL STRUCTURE HOMEOSTASIS,0.028264,0.052507,0.0693,1,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS DEADENYLATION DEPENDENT DECAY,0.012653,0.049696,0.087874,1,1
6,GO HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.051595,0.038765,0.070138,1,1
6,GO CATECHOLAMINE UPTAKE INVOLVED IN SYNAPTIC TRANSMISSION,0.0047798,0.30818,0.22307,1,0
6,GO MECHANOSENSORY BEHAVIOR,0.0056958,0.29518,0.33492,1,0
6,GO PROTEIN LOCALIZATION TO SYNAPSE,6.9711e-06,0.24624,0.28093,1,0
6,GO NEGATIVE REGULATION OF NEURON PROJECTION REGENERATION,0.006444,0.234,0.23426,1,0
6,GO REGULATION OF DEVELOPMENT HETEROCHRONIC,0.0027381,0.23366,0.27868,1,0
6,GO LATERAL MESODERM DEVELOPMENT,0.001118,0.22929,0.25107,1,0
6,GO CELLULAR RESPONSE TO BRAIN DERIVED NEUROTROPHIC FACTOR STIMULUS,0.0012886,0.22737,0.27047,1,0
6,GO POSITIVE REGULATION OF EXCITATORY POSTSYNAPTIC POTENTIAL,0.00012388,0.22538,0.30952,1,0
6,GO LAYER FORMATION IN CEREBRAL CORTEX,0.00069207,0.21332,0.23745,1,0
6,GO HOMOPHILIC CELL ADHESION VIA PLASMA MEMBRANE ADHESION MOLECULES,0.00028155,0.20378,0.22804,1,0
6,GO REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,8.0256e-05,0.20177,0.2712,1,0
6,GO SUCKLING BEHAVIOR,0.010279,0.19911,0.20088,1,0
6,GO NOTOCHORD DEVELOPMENT,0.042609,0.19874,0.16282,1,0
6,GO PROTEIN LOCALIZATION TO PRESYNAPSE,0.0062108,0.19806,0.21876,1,0
6,GO POSITIVE REGULATION OF SIGNALING RECEPTOR ACTIVITY,0.00022208,0.19643,0.21643,1,0
6,GO V D J RECOMBINATION,8.4424e-05,0.19564,0.26363,1,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.020605,0.19455,0.14122,1,0
6,GO CATECHOLAMINE UPTAKE,0.0043737,0.18858,0.20014,1,0
6,GO CELLULAR RESPONSE TO VITAMIN,0.0030839,0.18767,0.20328,1,0
6,GO REGULATION OF NEUROTRANSMITTER UPTAKE,0.0089251,0.17778,0.15747,1,0
6,GO IONOTROPIC GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.012945,0.17313,0.21457,1,0
6,GO PROSTATE GLAND GROWTH,0.049681,0.16995,0.13767,1,0
6,GO LONG TERM MEMORY,0.0055559,0.16862,0.16418,1,0
6,GO CHROMATIN DISASSEMBLY,0.00020835,0.16505,0.19365,1,0
6,GO RDNA HETEROCHROMATIN ASSEMBLY,0.00020504,0.16285,0.19473,1,0
6,GO NEUROTRANSMITTER REUPTAKE,0.01995,0.15957,0.14962,1,0
6,GO RESPONSE TO INSECTICIDE,0.046474,0.1539,0.1718,1,0
6,GO EPITHELIAL CELL MORPHOGENESIS,0.046031,0.15335,0.19102,1,0
6,GO REGULATION OF FEMALE GONAD DEVELOPMENT,0.0104,0.15236,0.1981,1,0
6,GO N GLYCAN PROCESSING,0.012087,0.1507,0.19184,1,0
6,GO CALCIUM ION REGULATED EXOCYTOSIS OF NEUROTRANSMITTER,0.003166,0.14976,0.3332,1,0
6,GO REGULATION OF STEM CELL DIVISION,0.0053519,0.14961,0.16651,1,0
6,GO LABYRINTHINE LAYER DEVELOPMENT,0.049681,0.1427,0.12495,1,0
6,GO REGULATION OF BMP SIGNALING PATHWAY,0.010895,0.14244,0.1536,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION ELONGATION FROM RNA POLYMERASE II PROMOTER,0.0080166,0.14172,0.13929,1,0
6,GO RESPONSE TO BMP,0.0084096,0.14144,0.13187,1,0
6,GO DNA LIGATION,0.030368,0.1401,0.10689,1,0
6,GO NEGATIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.046474,0.13942,0.15092,1,0
6,GO CARDIAC CONDUCTION SYSTEM DEVELOPMENT,0.008211,0.1391,0.18923,1,0
6,GO ENDOCHONDRAL BONE MORPHOGENESIS,0.02128,0.13794,0.1317,1,0
6,GO MEMBRANE FISSION,0.0067673,0.13779,0.16611,1,0
6,GO MALE MEIOSIS I,0.017506,0.1374,0.17405,1,0
6,GO CARDIAC MUSCLE CELL PROLIFERATION,0.031953,0.13537,0.099645,1,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER TRANSPORT,0.0035605,0.13504,0.26755,1,0
6,GO REGULATION OF NON MOTILE CILIUM ASSEMBLY,0.0038478,0.13496,0.15399,1,0
6,GO CALCIUM ION IMPORT INTO CYTOSOL,0.0086125,0.13495,0.19023,1,0
6,GO POSITIVE REGULATION OF SYNAPTIC VESICLE EXOCYTOSIS,0.018898,0.1344,0.27266,1,0
6,GO ACTIVATION OF PROTEIN KINASE B ACTIVITY,0.0024281,0.13377,0.16639,1,0
6,GO ADHERENS JUNCTION ORGANIZATION,0.0069343,0.13324,0.16251,1,0
6,GO CORTICOSTEROID RECEPTOR SIGNALING PATHWAY,0.012798,0.13264,0.17092,1,0
6,GO VASCULOGENESIS,0.042609,0.13208,0.12941,1,0
6,GO NEGATIVE REGULATION OF DENDRITE MORPHOGENESIS,0.033608,0.13177,0.14672,1,0
6,GO SPINDLE LOCALIZATION,0.00159,0.13034,0.14072,1,0
6,GO NEGATIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.027401,0.12864,0.1276,1,0
6,GO CELLULAR RESPONSE TO NUTRIENT,0.01251,0.1272,0.15578,1,0
6,GO BONE MATURATION,0.0083098,0.12697,0.15501,1,0
6,GO GDP METABOLIC PROCESS,0.033608,0.1266,0.14212,1,0
6,GO POTASSIUM ION TRANSPORT,0.00080175,0.12623,0.1638,1,0
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.039795,0.12528,0.11429,1,0
6,GO NEUROEPITHELIAL CELL DIFFERENTIATION,0.006444,0.12453,0.20523,1,0
6,GO ANIMAL ORGAN MORPHOGENESIS,0.0010408,0.1243,0.13022,1,0
6,GO CELL AGGREGATION,0.022928,0.12422,0.11941,1,0
6,GO BONE DEVELOPMENT,0.032607,0.12387,0.096139,1,0
6,GO NEURAL CREST CELL MIGRATION,0.0071051,0.12289,0.18077,1,0
6,GO CIRCADIAN REGULATION OF GENE EXPRESSION,0.0027747,0.12267,0.15847,1,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION,0.049212,0.12172,0.1018,1,0
6,GO UROGENITAL SYSTEM DEVELOPMENT,0.027118,0.12157,0.097887,1,0
6,GO REGULATION OF STEM CELL POPULATION MAINTENANCE,0.0066039,0.12126,0.16062,1,0
6,GO DOPAMINE TRANSPORT,0.017699,0.12063,0.23085,1,0
6,GO MRNA CLEAVAGE INVOLVED IN MRNA PROCESSING,0.02128,0.11983,0.10828,1,0
6,GO AMINE TRANSPORT,0.0052197,0.11717,0.20364,1,0
6,GO CELL JUNCTION ASSEMBLY,0.003166,0.11651,0.14467,1,0
6,GO RETINOIC ACID RECEPTOR SIGNALING PATHWAY,0.013394,0.1163,0.17694,1,0
6,GO FIBROBLAST APOPTOTIC PROCESS,0.038637,0.11586,0.11643,1,0
6,GO NEPHRON DEVELOPMENT,0.033608,0.11555,0.11164,1,0
6,GO TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.010522,0.11522,0.11784,1,0
6,GO CELL CELL JUNCTION MAINTENANCE,0.045591,0.11425,0.17198,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTRACELLULAR STIMULUS,0.013394,0.11392,0.12042,1,0
6,GO CARDIAC CHAMBER DEVELOPMENT,0.028852,0.11375,0.10074,1,0
6,GO CARDIAC SEPTUM MORPHOGENESIS,0.0096941,0.11344,0.17576,1,0
6,GO REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.037139,0.11315,0.11065,1,0
6,GO HAIR CELL DIFFERENTIATION,0.036772,0.11312,0.13063,1,0
6,GO REGULATION OF CELL AGING,0.02915,0.11284,0.1074,1,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE ADHESION,0.031311,0.11204,0.1434,1,0
6,GO LUNG EPITHELIUM DEVELOPMENT,0.0104,0.11035,0.19464,1,0
6,GO GLUCOSE IMPORT,0.032278,0.11009,0.089803,1,0
6,GO BETA CATENIN DESTRUCTION COMPLEX DISASSEMBLY,0.0057669,0.10991,0.13744,1,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL APICAL BASAL POLARITY,0.037882,0.10926,0.15895,1,0
6,GO POSITIVE REGULATION OF NEUROTRANSMITTER SECRETION,0.013093,0.10557,0.2377,1,0
6,GO REGULATION OF POLYSACCHARIDE METABOLIC PROCESS,0.014494,0.10546,0.13065,1,0
6,GO RESPONSE TO X RAY,0.026013,0.1052,0.090345,1,0
6,GO MESENCHYMAL CELL DIFFERENTIATION,0.042609,0.10276,0.10508,1,0
6,GO CDP DIACYLGLYCEROL METABOLIC PROCESS,0.0043184,0.10102,0.15537,1,0
6,GO UV DAMAGE EXCISION REPAIR,0.0092477,0.1009,0.12749,1,0
6,GO CARDIAC CHAMBER MORPHOGENESIS,0.034984,0.099976,0.11305,1,0
6,GO EMBRYONIC SKELETAL JOINT MORPHOGENESIS,0.05063,0.099829,0.19474,1,0
6,GO REGULATION OF FIBROBLAST MIGRATION,0.022686,0.098919,0.11365,1,0
6,GO RENAL SYSTEM PROCESS,0.025475,0.098754,0.12296,1,0
6,GO REGULATION OF RECEPTOR LOCALIZATION TO SYNAPSE,0.039795,0.098725,0.11495,1,0
6,GO POSITIVE REGULATION OF PROTEIN MATURATION,0.027973,0.098709,0.15245,1,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO TRANSFORMING GROWTH FACTOR BETA STIMULUS,0.017699,0.098505,0.11154,1,0
6,GO UV PROTECTION,0.031311,0.098356,0.13825,1,0
6,GO INOSITOL PHOSPHATE CATABOLIC PROCESS,0.047827,0.098194,0.11525,1,0
6,GO REGULATION OF CATECHOLAMINE METABOLIC PROCESS,0.055093,0.09709,0.087712,1,0
6,GO REGULATION OF FAT CELL DIFFERENTIATION,0.046474,0.096932,0.10231,1,0
6,GO DOPAMINERGIC NEURON DIFFERENTIATION,0.010645,0.09691,0.11738,1,0
6,GO NERVE GROWTH FACTOR SIGNALING PATHWAY,0.053071,0.096606,0.13362,1,0
6,GO NEGATIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.014332,0.096198,0.12191,1,0
6,GO GROWTH PLATE CARTILAGE DEVELOPMENT,0.043444,0.095335,0.14987,1,0
6,GO EPITHELIUM DEVELOPMENT,0.030368,0.093124,0.088291,1,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.014013,0.092306,0.1187,1,0
6,GO RESPONSE TO SALT STRESS,0.056128,0.091968,0.098131,1,0
6,GO NEGATIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.0026663,0.091586,0.13894,1,0
6,GO REGULATION OF SULFUR METABOLIC PROCESS,0.046474,0.090539,0.15818,1,0
6,GO POSITIVE REGULATION OF MUSCLE HYPERTROPHY,0.018693,0.090511,0.1378,1,0
6,GO REGULATION OF DOPAMINE SECRETION,0.028852,0.088992,0.24545,1,0
6,GO REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.047372,0.087412,0.12133,1,0
6,GO POSITIVE REGULATION OF HORMONE SECRETION,0.0054192,0.086323,0.11907,1,0
6,GO SOMATIC STEM CELL POPULATION MAINTENANCE,0.03068,0.086273,0.098687,1,0
6,GO MULTICELLULAR ORGANISMAL SIGNALING,0.0099244,0.086127,0.14098,1,0
6,GO HETEROPHILIC CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.049212,0.086043,0.15228,1,0
6,GO POSITIVE REGULATION OF ANION TRANSPORT,0.052083,0.085675,0.077986,1,0
6,GO REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.031631,0.08485,0.061843,1,0
6,GO NEGATIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.026013,0.081078,0.096072,1,0
6,GO TUBE MORPHOGENESIS,0.058247,0.080692,0.08453,1,0
6,GO VENTRICULAR CARDIAC MUSCLE TISSUE DEVELOPMENT,0.023419,0.080539,0.10114,1,0
6,GO GLYCOSPHINGOLIPID BIOSYNTHETIC PROCESS,0.05357,0.080042,0.13178,1,0
6,GO HYPEROSMOTIC SALINITY RESPONSE,0.015674,0.079998,0.18015,1,0
6,GO SPLEEN DEVELOPMENT,0.05063,0.079845,0.091473,1,0
6,GO REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.055609,0.079514,0.089227,1,0
6,GO RESPONSE TO ALKALOID,0.018693,0.079209,0.09474,1,0
6,GO REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.0084096,0.078916,0.10792,1,0
6,GO PEPTIDYL SERINE DEPHOSPHORYLATION,0.037882,0.078228,0.12767,1,0
6,GO REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.048285,0.078064,0.078623,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.02521,0.077886,0.076954,1,0
6,GO SENSORY PERCEPTION OF SMELL,0.035336,0.077817,0.078227,1,0
6,GO CARDIAC MUSCLE TISSUE DEVELOPMENT,0.036772,0.077632,0.070255,1,0
6,GO LIPID DROPLET ORGANIZATION,0.054582,0.07734,0.09727,1,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION,0.0059116,0.077057,0.12907,1,0
6,GO MRNA TRANSCRIPTION,0.036048,0.076766,0.11046,1,0
6,GO MYOBLAST DIFFERENTIATION,0.055093,0.075168,0.07671,1,0
6,GO TAXIS,0.026013,0.074723,0.095156,1,0
6,GO CARDIAC CONDUCTION,0.030368,0.074584,0.12319,1,0
6,GO REGULATION OF VASOCONSTRICTION,0.017894,0.07432,0.11179,1,0
6,GO NEGATIVE REGULATION OF RNA CATABOLIC PROCESS,0.022446,0.072837,0.10351,1,0
6,GO REGULATION OF CARBOHYDRATE BIOSYNTHETIC PROCESS,0.025743,0.072597,0.091795,1,0
6,GO BROWN FAT CELL DIFFERENTIATION,0.05063,0.072587,0.11287,1,0
6,GO T CELL DIFFERENTIATION IN THYMUS,0.022209,0.072344,0.099101,1,0
6,GO RESPONSE TO GROWTH FACTOR,0.055093,0.071296,0.07995,1,0
6,GO POSITIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.014823,0.071203,0.17311,1,0
6,GO TUBE DEVELOPMENT,0.047827,0.070686,0.087172,1,0
6,GO POSITIVE REGULATION OF CELL CYCLE PHASE TRANSITION,0.01829,0.070603,0.083448,1,0
6,GO PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.046474,0.070051,0.10388,1,0
6,GO INOSITOL PHOSPHATE MEDIATED SIGNALING,0.050154,0.069919,0.09642,1,0
6,GO REGULATION OF TRANSMEMBRANE TRANSPORT,0.045591,0.069902,0.08206,1,0
6,GO REGULATION OF ESTABLISHMENT OR MAINTENANCE OF CELL POLARITY,0.049681,0.069491,0.11242,1,0
6,GO NEGATIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.045155,0.06942,0.15147,1,0
6,GO REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.049681,0.068738,0.07371,1,0
6,GO ANIMAL ORGAN FORMATION,0.015159,0.06856,0.12737,1,0
6,GO REGULATION OF PROTEIN DEPOLYMERIZATION,0.033608,0.067321,0.1129,1,0
6,GO REGULATION OF DENDRITE EXTENSION,0.055093,0.066633,0.186,1,0
6,GO REGULATION OF PROTEIN KINASE A SIGNALING,0.028556,0.06551,0.11403,1,0
6,GO CARNITINE SHUTTLE,0.049681,0.06266,0.13856,1,0
6,GO WALKING BEHAVIOR,0.024687,0.06008,0.12804,1,0
6,GO POSITIVE REGULATION OF MITOTIC CELL CYCLE,0.0018006,0.059746,0.099948,1,0
6,GO POSITIVE REGULATION OF DIGESTIVE SYSTEM PROCESS,0.054074,0.058875,0.081595,1,0
6,GO ESTABLISHMENT OF SPINDLE ORIENTATION,0.03068,0.058267,0.09655,1,0
6,GO REGULATION OF CATION CHANNEL ACTIVITY,0.023919,0.05308,0.10749,1,0
6,GO REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.042609,0.052939,0.12099,1,0
6,GO REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.056128,0.052061,0.080174,1,0
6,GO REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.032278,0.050637,0.12859,1,0
6,GO TELOMERE MAINTENANCE VIA SEMI CONSERVATIVE REPLICATION,0.020828,0.050469,0.095537,1,0
6,GO REGULATION OF ORGAN GROWTH,0.047372,0.04729,0.084001,1,0
6,GO NEGATIVE REGULATION OF PROTEIN POLYMERIZATION,0.049212,0.044,0.11663,1,0
6,GO ESTABLISHMENT OF MITOTIC SPINDLE LOCALIZATION,0.0094686,0.042307,0.11985,1,0
6,GO POSITIVE REGULATION OF ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.057179,0.039854,0.1122,1,0
6,GO INTERLEUKIN 1 MEDIATED SIGNALING PATHWAY,0.03068,-0.041857,-0.085218,1,0
6,GO RESPONSE TO XENOBIOTIC STIMULUS,0.033271,-0.046442,-0.09231,1,0
6,GO VIRAL GENE EXPRESSION,0.058787,-0.046457,-0.099056,1,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.059879,-0.046858,-0.11146,1,0
6,GO POSITIVE REGULATION OF TELOMERASE RNA LOCALIZATION TO CAJAL BODY,0.048746,-0.048402,-0.12566,1,0
6,GO PIGMENT BIOSYNTHETIC PROCESS,0.051595,-0.051176,-0.086464,1,0
6,GO REGULATION OF MULTI ORGANISM PROCESS,0.057179,-0.055132,-0.058385,1,0
6,GO WATER SOLUBLE VITAMIN METABOLIC PROCESS,0.038637,-0.056301,-0.069539,1,0
6,GO GLYCOSYL COMPOUND BIOSYNTHETIC PROCESS,0.059331,-0.057101,-0.090219,1,0
6,GO T CELL RECEPTOR SIGNALING PATHWAY,0.049212,-0.05742,-0.070058,1,0
6,GO TETRAPYRROLE METABOLIC PROCESS,0.032938,-0.057932,-0.092163,1,0
6,GO REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.024687,-0.059238,-0.12112,1,0
6,GO CELLULAR RESPONSE TO BIOTIC STIMULUS,0.022928,-0.059685,-0.094145,1,0
6,GO NEGATIVE T CELL SELECTION,0.027118,-0.060381,-0.12861,1,0
6,GO TRANSLATIONAL INITIATION,0.046921,-0.060722,-0.1134,1,0
6,GO PIGMENT METABOLIC PROCESS,0.047827,-0.061222,-0.084545,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.054582,-0.062302,-0.15438,1,0
6,GO TETRAPYRROLE BIOSYNTHETIC PROCESS,0.0056958,-0.062691,-0.1575,1,0
6,GO RESPIRATORY CHAIN COMPLEX IV ASSEMBLY,0.019523,-0.063221,-0.11334,1,0
6,GO RESPONSE TO MANGANESE ION,0.025475,-0.063571,-0.0946,1,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL TRANSLATION,0.043444,-0.063719,-0.14629,1,0
6,GO PHOSPHATIDYLCHOLINE ACYL CHAIN REMODELING,0.046921,-0.067161,-0.079036,1,0
6,GO ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.056128,-0.067508,-0.067875,1,0
6,GO TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.05357,-0.06793,-0.08454,1,0
6,GO RESPONSE TO BACTERIUM,0.017315,-0.068292,-0.090954,1,0
6,GO MYD88 INDEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.049212,-0.068425,-0.11049,1,0
6,GO NEUTROPHIL CHEMOTAXIS,0.0104,-0.068477,-0.095472,1,0
6,GO REGULATION OF NEUTROPHIL MIGRATION,0.040981,-0.068561,-0.097144,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 4 PRODUCTION,0.033948,-0.068635,-0.11289,1,0
6,GO REGULATION OF INFLAMMATORY RESPONSE,0.046031,-0.069531,-0.072735,1,0
6,GO ICOSANOID METABOLIC PROCESS,0.054074,-0.06968,-0.10492,1,0
6,GO AMINO ACID ACTIVATION,0.048746,-0.069736,-0.12074,1,0
6,GO NEUTROPHIL MIGRATION,0.014658,-0.070198,-0.099952,1,0
6,GO MYELOID LEUKOCYTE MIGRATION,0.023173,-0.070244,-0.087982,1,0
6,GO RESPONSE TO INTERLEUKIN 7,0.03429,-0.071015,-0.081091,1,0
6,GO POSITIVE REGULATION OF GRANULOCYTE CHEMOTAXIS,0.040187,-0.072015,-0.12307,1,0
6,GO CYTOKINE METABOLIC PROCESS,0.020605,-0.072267,-0.11188,1,0
6,GO IRON SULFUR CLUSTER ASSEMBLY,0.054074,-0.073315,-0.10475,1,0
6,GO MITOCHONDRIAL CYTOCHROME C OXIDASE ASSEMBLY,0.017506,-0.073607,-0.1081,1,0
6,GO DEOXYRIBOSE PHOSPHATE CATABOLIC PROCESS,0.018091,-0.074592,-0.09139,1,0
6,GO NEUTRAL LIPID BIOSYNTHETIC PROCESS,0.022928,-0.074604,-0.10891,1,0
6,GO CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.022209,-0.075831,-0.1002,1,0
6,GO PHAGOCYTOSIS,0.058247,-0.076984,-0.069872,1,0
6,GO PSEUDOURIDINE SYNTHESIS,0.052083,-0.077351,-0.1491,1,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.03429,-0.077452,-0.078837,1,0
6,GO ACUTE INFLAMMATORY RESPONSE,0.046031,-0.078166,-0.10011,1,0
6,GO CELLULAR MODIFIED AMINO ACID BIOSYNTHETIC PROCESS,0.059879,-0.07944,-0.083405,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION,0.030368,-0.079787,-0.10106,1,0
6,GO INTERLEUKIN 2 PRODUCTION,0.03902,-0.079794,-0.096095,1,0
6,GO REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.049681,-0.080489,-0.091116,1,0
6,GO AROMATIC AMINO ACID FAMILY METABOLIC PROCESS,0.030994,-0.080492,-0.081517,1,0
6,GO CELLULAR DEFENSE RESPONSE,0.018898,-0.08119,-0.13874,1,0
6,GO POSITIVE REGULATION OF B CELL PROLIFERATION,0.049212,-0.0816,-0.11078,1,0
6,GO RESPONSE TO HYDROGEN PEROXIDE,0.055093,-0.082259,-0.063034,1,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.02128,-0.0823,-0.14542,1,0
6,GO MITOCHONDRIAL RESPIRATORY CHAIN COMPLEX ASSEMBLY,0.0050904,-0.082741,-0.12888,1,0
6,GO REGULATION OF TRANSLATIONAL ELONGATION,0.047372,-0.083298,-0.078134,1,0
6,GO PROSTANOID METABOLIC PROCESS,0.02174,-0.08339,-0.16844,1,0
6,GO PEPTIDYL PROLINE MODIFICATION,0.0080166,-0.083679,-0.11888,1,0
6,GO RNA 5 END PROCESSING,0.0065235,-0.083737,-0.16153,1,0
6,GO RESPONSE TO INTERLEUKIN 12,0.046474,-0.08375,-0.1051,1,0
6,GO NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.01995,-0.084384,-0.12595,1,0
6,GO LEUKOCYTE MEDIATED CYTOTOXICITY,0.032938,-0.08494,-0.11898,1,0
6,GO POSITIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.043866,-0.0856,-0.11306,1,0
6,GO REGULATION OF PLASMA LIPOPROTEIN PARTICLE LEVELS,0.020828,-0.086256,-0.096763,1,0
6,GO TRANSLATIONAL ELONGATION,0.0089251,-0.086614,-0.12439,1,0
6,GO ADAPTIVE IMMUNE RESPONSE,0.043444,-0.086967,-0.10466,1,0
6,GO POSITIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.043444,-0.087852,-0.087199,1,0
6,GO COMPLEMENT ACTIVATION,0.03429,-0.088012,-0.12802,1,0
6,GO MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.0095807,-0.088536,-0.115,1,0
6,GO REGULATION OF HUMORAL IMMUNE RESPONSE,0.024947,-0.088902,-0.1456,1,0
6,GO MYELOID LEUKOCYTE ACTIVATION,0.014494,-0.090206,-0.10426,1,0
6,GO TROPHECTODERMAL CELL DIFFERENTIATION,0.011411,-0.09096,-0.11114,1,0
6,GO STEROID HORMONE BIOSYNTHETIC PROCESS,0.010279,-0.09125,-0.12915,1,0
6,GO MITOCHONDRIAL GENE EXPRESSION,0.0067673,-0.091548,-0.14757,1,0
6,GO NEGATIVE REGULATION OF IMMUNE EFFECTOR PROCESS,0.057711,-0.091892,-0.10841,1,0
6,GO NEGATIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.047827,-0.091912,-0.12458,1,0
6,GO KERATAN SULFATE METABOLIC PROCESS,0.052083,-0.09198,-0.095163,1,0
6,GO LEUKOCYTE MEDIATED IMMUNITY,0.027973,-0.092234,-0.097386,1,0
6,GO POSITIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.045155,-0.093222,-0.092594,1,0
6,GO SULFUR COMPOUND CATABOLIC PROCESS,0.011544,-0.09377,-0.10752,1,0
6,GO LEUKOCYTE CHEMOTAXIS,0.05063,-0.094183,-0.071214,1,0
6,GO GRANULOCYTE MIGRATION,0.0041031,-0.094188,-0.12012,1,0
6,GO REGULATION OF FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.032938,-0.094575,-0.16697,1,0
6,GO MYELOID DENDRITIC CELL ACTIVATION,0.031311,-0.094603,-0.10129,1,0
6,GO RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0051547,-0.094928,-0.11407,1,0
6,GO IRON ION TRANSMEMBRANE TRANSPORT,0.010041,-0.095194,-0.11053,1,0
6,GO CD40 SIGNALING PATHWAY,0.039795,-0.095377,-0.11228,1,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MIGRATION,0.010895,-0.095436,-0.097759,1,0
6,GO RESPONSE TO INTERLEUKIN 15,0.024687,-0.097361,-0.11905,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.0104,-0.097707,-0.12646,1,0
6,GO URONIC ACID METABOLIC PROCESS,0.0066851,-0.099332,-0.10338,1,0
6,GO FATTY ACID DERIVATIVE BIOSYNTHETIC PROCESS,0.022928,-0.099457,-0.095696,1,0
6,GO REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.022209,-0.0998,-0.11567,1,0
6,GO PROTEIN TRIMERIZATION,0.052575,-0.099869,-0.095574,1,0
6,GO PROTEIN HYDROXYLATION,0.03006,-0.10006,-0.15869,1,0
6,GO LYTIC VACUOLE ORGANIZATION,0.037509,-0.10009,-0.072898,1,0
6,GO REGULATION OF NEUTROPHIL CHEMOTAXIS,0.050154,-0.10065,-0.096577,1,0
6,GO REGULATION OF OXIDATIVE PHOSPHORYLATION,0.037882,-0.10115,-0.096757,1,0
6,GO CELLULAR RESPONSE TO MOLECULE OF BACTERIAL ORIGIN,0.0042636,-0.10127,-0.12892,1,0
6,GO NEGATIVE REGULATION OF IMMUNE RESPONSE,0.035691,-0.10243,-0.11329,1,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.056128,-0.10264,-0.083204,1,0
6,GO CELLULAR RESPIRATION,0.014823,-0.10347,-0.10205,1,0
6,GO PHAGOSOME MATURATION,0.050154,-0.10364,-0.077344,1,0
6,GO T CELL MEDIATED IMMUNITY,0.012367,-0.10442,-0.15338,1,0
6,GO MITOCHONDRIAL TRANSLATION,0.0022396,-0.10475,-0.162,1,0
6,GO BRANCHED CHAIN AMINO ACID METABOLIC PROCESS,0.033608,-0.10483,-0.097636,1,0
6,GO RIBOSOMAL SMALL SUBUNIT ASSEMBLY,0.0046604,-0.10483,-0.16648,1,0
6,GO GLYCEROL ETHER METABOLIC PROCESS,0.020605,-0.10557,-0.11516,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION,0.035691,-0.10601,-0.098166,1,0
6,GO POSITIVE REGULATION OF MONOCYTE CHEMOTAXIS,0.02915,-0.10666,-0.086792,1,0
6,GO POSITIVE REGULATION OF CALCIUM ION IMPORT,0.033608,-0.10697,-0.10337,1,0
6,GO CHEMOKINE PRODUCTION,0.055609,-0.10746,-0.095252,1,0
6,GO REGULATION OF T CELL APOPTOTIC PROCESS,0.033271,-0.10767,-0.13275,1,0
6,GO PLATELET AGGREGATION,0.056652,-0.1077,-0.092902,1,0
6,GO REGULATION OF CELL KILLING,0.042197,-0.10773,-0.11359,1,0
6,GO NEGATIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.008211,-0.10804,-0.14724,1,0
6,GO PROSTAGLANDIN SECRETION,0.011813,-0.10845,-0.12245,1,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.017506,-0.10885,-0.1417,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN,0.032938,-0.10901,-0.1017,1,0
6,GO NEGATIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.02128,-0.10934,-0.15536,1,0
6,GO UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.016205,-0.10936,-0.13786,1,0
6,GO REGULATION OF LEUKOCYTE PROLIFERATION,0.027118,-0.10937,-0.10199,1,0
6,GO GRANULOCYTE CHEMOTAXIS,0.0034243,-0.10978,-0.11767,1,0
6,GO PROTEIN TRANSMEMBRANE IMPORT INTO INTRACELLULAR ORGANELLE,0.012087,-0.11012,-0.096419,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.011544,-0.11026,-0.13955,1,0
6,GO POSITIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.030368,-0.11057,-0.13117,1,0
6,GO RESPONSE TO GROWTH HORMONE,0.043025,-0.11093,-0.094985,1,0
6,GO B CELL HOMEOSTASIS,0.040981,-0.1114,-0.09823,1,0
6,GO BLOOD COAGULATION INTRINSIC PATHWAY,0.0088198,-0.11158,-0.11547,1,0
6,GO COPPER ION HOMEOSTASIS,0.023919,-0.11177,-0.10089,1,0
6,GO REGULATION OF T CELL MIGRATION,0.026013,-0.11228,-0.08977,1,0
6,GO GLYCEROPHOSPHOLIPID CATABOLIC PROCESS,0.010041,-0.11256,-0.1149,1,0
6,GO CELLULAR RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0026663,-0.11301,-0.13459,1,0
6,GO TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.054074,-0.11389,-0.10921,1,0
6,GO PLASMA MEMBRANE FUSION,0.049681,-0.11393,-0.17105,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.031311,-0.11396,-0.096303,1,0
6,GO NADH DEHYDROGENASE COMPLEX ASSEMBLY,0.0042636,-0.11414,-0.14015,1,0
6,GO PURINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0051547,-0.11421,-0.089528,1,0
6,GO PROTEASOME ASSEMBLY,0.01128,-0.11423,-0.11056,1,0
6,GO REGULATION OF TRANSLATIONAL TERMINATION,0.037139,-0.11585,-0.10593,1,0
6,GO PENTOSE METABOLIC PROCESS,0.051595,-0.11593,-0.095348,1,0
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.028264,-0.11593,-0.11547,1,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 17 PRODUCTION,0.0061347,-0.11652,-0.17299,1,0
6,GO PHOSPHOLIPID CATABOLIC PROCESS,0.011544,-0.11736,-0.11984,1,0
6,GO SECRETION BY TISSUE,0.020166,-0.11759,-0.11373,1,0
6,GO REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.02945,-0.11767,-0.095181,1,0
6,GO REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.03068,-0.1178,-0.11325,1,0
6,GO CELL KILLING,0.015674,-0.11792,-0.10875,1,0
6,GO TRANSLATIONAL TERMINATION,0.00061456,-0.11846,-0.1814,1,0
6,GO DEFENSE RESPONSE TO GRAM POSITIVE BACTERIUM,0.017315,-0.11859,-0.10929,1,0
6,GO B CELL PROLIFERATION,0.011022,-0.11932,-0.12307,1,0
6,GO REGULATION OF LIPOPROTEIN LIPASE ACTIVITY,0.038258,-0.12042,-0.11007,1,0
6,GO RELAXATION OF MUSCLE,0.043025,-0.12058,-0.10752,1,0
6,GO NEGATIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.012087,-0.12067,-0.16377,1,0
6,GO PROTEIN IMPORT INTO MITOCHONDRIAL MATRIX,0.01128,-0.12147,-0.13368,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.031953,-0.12249,-0.1218,1,0
6,GO RIBOSOMAL LARGE SUBUNIT ASSEMBLY,0.0055559,-0.1228,-0.19101,1,0
6,GO ETHER METABOLIC PROCESS,0.033271,-0.12346,-0.11928,1,0
6,GO PEPTIDE CROSS LINKING,0.0063654,-0.12387,-0.19632,1,0
6,GO RIBOSOMAL LARGE SUBUNIT BIOGENESIS,0.0094686,-0.12426,-0.1819,1,0
6,GO REGULATION OF GRANULOCYTE CHEMOTAXIS,0.015674,-0.12433,-0.095076,1,0
6,GO PROTEIN ACTIVATION CASCADE,0.056128,-0.12466,-0.11199,1,0
6,GO POSITIVE REGULATION OF OSTEOCLAST DIFFERENTIATION,0.011544,-0.12471,-0.10106,1,0
6,GO HEME METABOLIC PROCESS,0.0029645,-0.1259,-0.17793,1,0
6,GO CELLULAR RESPONSE TO INTERFERON BETA,0.026286,-0.12614,-0.15859,1,0
6,GO RESPONSE TO DSRNA,0.016386,-0.12626,-0.093844,1,0
6,GO PORPHYRIN CONTAINING COMPOUND METABOLIC PROCESS,0.0037498,-0.12657,-0.16393,1,0
6,GO NEGATIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.024173,-0.12716,-0.12157,1,0
6,GO CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0038478,-0.12783,-0.1391,1,0
6,GO TOLL LIKE RECEPTOR 3 SIGNALING PATHWAY,0.05063,-0.12918,-0.13371,1,0
6,GO AEROBIC RESPIRATION,0.0034243,-0.12988,-0.1213,1,0
6,GO RESPONSE TO ARSENIC CONTAINING SUBSTANCE,0.0053519,-0.13023,-0.13585,1,0
6,GO MACROPHAGE CHEMOTAXIS,0.058247,-0.13026,-0.090006,1,0
6,GO PURINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.0052197,-0.13038,-0.16176,1,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY REGULATION OF THE RELEASE OF SEQUESTERED CALCIUM ION,0.014172,-0.13042,-0.14204,1,0
6,GO RESPONSE TO INTERFERON GAMMA,0.017699,-0.13124,-0.16856,1,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.019523,-0.13157,-0.11793,1,0
6,GO T HELPER 1 TYPE IMMUNE RESPONSE,0.0015249,-0.13166,-0.20483,1,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE,0.0078263,-0.13197,-0.12629,1,0
6,GO RIBOSOME ASSEMBLY,0.0030436,-0.13235,-0.17874,1,0
6,GO PTERIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.036772,-0.13236,-0.14821,1,0
6,GO PHOSPHATIDYLINOSITOL ACYL CHAIN REMODELING,0.017506,-0.13239,-0.12269,1,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT UBIQUINOL TO CYTOCHROME C,0.0032501,-0.13273,-0.15276,1,0
6,GO REGULATION OF OSTEOCLAST DEVELOPMENT,0.00049802,-0.13298,-0.17613,1,0
6,GO CARBOHYDRATE DERIVATIVE TRANSPORT,0.0044298,-0.13321,-0.11121,1,0
6,GO REGULATION OF MONONUCLEAR CELL MIGRATION,0.0092477,-0.13327,-0.13842,1,0
6,GO ATF6 MEDIATED UNFOLDED PROTEIN RESPONSE,0.052575,-0.13333,-0.1276,1,0
6,GO INTERLEUKIN 8 PRODUCTION,0.0044864,-0.13338,-0.15656,1,0
6,GO RETINOL METABOLIC PROCESS,0.05063,-0.13356,-0.11384,1,0
6,GO MATURATION OF LSU RRNA,0.041383,-0.13358,-0.15214,1,0
6,GO MYELOID DENDRITIC CELL DIFFERENTIATION,0.051595,-0.13478,-0.10887,1,0
6,GO INTEGRIN ACTIVATION,0.054582,-0.13484,-0.094101,1,0
6,GO DICARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.0032928,-0.13561,-0.16573,1,0
6,GO CELLULAR COPPER ION HOMEOSTASIS,0.010895,-0.13592,-0.13474,1,0
6,GO INTERLEUKIN 10 PRODUCTION,0.014823,-0.13708,-0.12944,1,0
6,GO ICOSANOID BIOSYNTHETIC PROCESS,0.0054872,-0.13763,-0.15611,1,0
6,GO SPHINGOMYELIN METABOLIC PROCESS,0.059879,-0.1401,-0.1066,1,0
6,GO PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.0083098,-0.14021,-0.15927,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE RECEPTOR CATABOLIC PROCESS,0.0042095,-0.14076,-0.1813,1,0
6,GO NEGATIVE REGULATION OF B CELL APOPTOTIC PROCESS,0.026013,-0.14089,-0.13636,1,0
6,GO ELECTRON TRANSPORT CHAIN,0.00058763,-0.14139,-0.1248,1,0
6,GO MYD88 DEPENDENT TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.0028872,-0.1417,-0.14231,1,0
6,GO EXTRACELLULAR MATRIX DISASSEMBLY,0.05063,-0.14251,-0.10436,1,0
6,GO CD4 POSITIVE ALPHA BETA T CELL CYTOKINE PRODUCTION,0.001483,-0.14268,-0.17087,1,0
6,GO REGULATION OF MONOCYTE CHEMOTAXIS,0.013394,-0.14319,-0.14535,1,0
6,GO POSITIVE REGULATION BY HOST OF VIRAL PROCESS,0.0086125,-0.14322,-0.14733,1,0
6,GO POSITIVE REGULATION OF T CELL PROLIFERATION,0.0061347,-0.14457,-0.14107,1,0
6,GO L ASCORBIC ACID METABOLIC PROCESS,0.0056255,-0.14554,-0.19635,1,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.0055559,-0.14777,-0.14515,1,0
6,GO MONONUCLEAR CELL DIFFERENTIATION,0.046474,-0.14802,-0.13443,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.046474,-0.14818,-0.11995,1,0
6,GO AMINO SUGAR CATABOLIC PROCESS,0.0014624,-0.14875,-0.16303,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.009139,-0.14902,-0.18278,1,0
6,GO NEGATIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.035336,-0.14959,-0.13615,1,0
6,GO MACROMOLECULE DEPALMITOYLATION,0.0042095,-0.1496,-0.14159,1,0
6,GO IMMUNE RESPONSE TO TUMOR CELL,0.016938,-0.14965,-0.18759,1,0
6,GO B CELL APOPTOTIC PROCESS,0.017506,-0.15,-0.11969,1,0
6,GO ATP SYNTHESIS COUPLED ELECTRON TRANSPORT,0.000286,-0.15006,-0.15845,1,0
6,GO AROMATIC AMINO ACID FAMILY CATABOLIC PROCESS,0.0007901,-0.15007,-0.13963,1,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.040981,-0.15019,-0.12388,1,0
6,GO INTERFERON GAMMA PRODUCTION,0.0048405,-0.15057,-0.12586,1,0
6,GO POSITIVE REGULATION OF T CELL MIGRATION,0.0037016,-0.15058,-0.12926,1,0
6,GO MITOCHONDRIAL TRANSLATIONAL TERMINATION,0.00042777,-0.15063,-0.19234,1,0
6,GO RESPIRATORY ELECTRON TRANSPORT CHAIN,0.001776,-0.15084,-0.13861,1,0
6,GO PROSTANOID BIOSYNTHETIC PROCESS,0.0094686,-0.15088,-0.20778,1,0
6,GO CELL ADHESION MEDIATED BY INTEGRIN,0.0056958,-0.15098,-0.18506,1,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.023419,-0.15344,-0.1477,1,0
6,GO MONONUCLEAR CELL MIGRATION,0.0011021,-0.15359,-0.16293,1,0
6,GO T HELPER 2 CELL CYTOKINE PRODUCTION,0.010769,-0.15372,-0.13357,1,0
6,GO REGULATION OF SYNCYTIUM FORMATION BY PLASMA MEMBRANE FUSION,0.0033361,-0.15375,-0.17556,1,0
6,GO POSITIVE REGULATION OF INTERFERON GAMMA PRODUCTION,0.0044298,-0.15387,-0.12945,1,0
6,GO NEGATIVE REGULATION OF PROTEIN MATURATION,0.01499,-0.1542,-0.14133,1,0
6,GO OXIDATIVE PHOSPHORYLATION,0.00016629,-0.15445,-0.1443,1,0
6,GO DEFENSE RESPONSE TO BACTERIUM,0.0098086,-0.1545,-0.10604,1,0
6,GO NUCLEOTIDE SUGAR BIOSYNTHETIC PROCESS,0.001442,-0.15469,-0.16641,1,0
6,GO PIGMENT ACCUMULATION,0.056652,-0.15717,-0.11725,1,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR INVOLVED IN INFLAMMATORY RESPONSE,0.00049053,-0.15781,-0.18289,1,0
6,GO GLYCOSYLCERAMIDE METABOLIC PROCESS,0.015329,-0.15787,-0.11712,1,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.0048405,-0.15789,-0.13638,1,0
6,GO REGULATION OF PHOSPHOLIPASE A2 ACTIVITY,0.033271,-0.15798,-0.17615,1,0
6,GO PURINE NUCLEOBASE BIOSYNTHETIC PROCESS,0.0071918,-0.15829,-0.21757,1,0
6,GO RELAXATION OF CARDIAC MUSCLE,0.017699,-0.15963,-0.15803,1,0
6,GO PLATELET DEGRANULATION,0.013243,-0.16014,-0.13098,1,0
6,GO POSITIVE REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.039795,-0.16056,-0.11652,1,0
6,GO REGULATION OF BONE DEVELOPMENT,0.00038422,-0.16081,-0.15842,1,0
6,GO NEGATIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.052575,-0.16087,-0.13877,1,0
6,GO LOW DENSITY LIPOPROTEIN RECEPTOR PARTICLE METABOLIC PROCESS,0.0031247,-0.16199,-0.15137,1,0
6,GO POSITIVE REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.019312,-0.16324,-0.10084,1,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,0.003166,-0.16327,-0.17639,1,0
6,GO MATURE B CELL DIFFERENTIATION,0.014332,-0.16393,-0.17827,1,0
6,GO BENZENE CONTAINING COMPOUND METABOLIC PROCESS,0.012367,-0.16457,-0.1531,1,0
6,GO MITOCHONDRIAL ELECTRON TRANSPORT NADH TO UBIQUINONE,0.00080175,-0.16463,-0.1547,1,0
6,GO GERMINAL CENTER FORMATION,0.036048,-0.16499,-0.18496,1,0
6,GO PROTEIN OXIDATION,0.021053,-0.16555,-0.17719,1,0
6,GO PURINE NUCLEOBASE METABOLIC PROCESS,0.0020367,-0.16646,-0.18147,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY HORMONE,0.027686,-0.16692,-0.14098,1,0
6,GO REGULATION OF B CELL PROLIFERATION,0.0052854,-0.167,-0.14299,1,0
6,GO COPPER ION TRANSPORT,0.0022095,-0.16726,-0.1639,1,0
6,GO REGULATION OF LIPOPROTEIN PARTICLE CLEARANCE,0.038258,-0.16769,-0.15485,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE MEDIATED BY A CHEMICAL SIGNAL,0.011022,-0.16794,-0.14486,1,0
6,GO REGULATION OF ANTIGEN PROCESSING AND PRESENTATION,0.0010259,-0.1682,-0.21258,1,0
6,GO NEGATIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.045591,-0.16829,-0.20169,1,0
6,GO REGULATION OF LEUKOCYTE DEGRANULATION,0.037882,-0.16834,-0.099671,1,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA OXIDASE,0.0070192,-0.16894,-0.1736,1,0
6,GO POSITIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.0075485,-0.16943,-0.20857,1,0
6,GO ACTIN FILAMENT SEVERING,0.023919,-0.1696,-0.16366,1,0
6,GO CELLULAR RESPONSE TO GROWTH HORMONE STIMULUS,0.034636,-0.16989,-0.14054,1,0
6,GO FORMATION OF CYTOPLASMIC TRANSLATION INITIATION COMPLEX,0.019523,-0.17118,-0.18567,1,0
6,GO AMP METABOLIC PROCESS,0.0069343,-0.17253,-0.19207,1,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.047372,-0.17258,-0.11559,1,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS ENGULFMENT,0.033271,-0.17418,-0.1833,1,0
6,GO PURINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.0047198,-0.17847,-0.17355,1,0
6,GO INTERLEUKIN 13 PRODUCTION,0.014172,-0.18049,-0.19276,1,0
6,GO REGULATION OF TYPE 2 IMMUNE RESPONSE,0.042609,-0.18153,-0.15812,1,0
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISM GROWTH,0.0072795,-0.18222,-0.19474,1,0
6,GO HISTAMINE TRANSPORT,0.024173,-0.18291,-0.16856,1,0
6,GO REGULATION OF COAGULATION,0.017699,-0.18314,-0.14264,1,0
6,GO POSITIVE REGULATION OF MONONUCLEAR CELL MIGRATION,0.01016,-0.18325,-0.12833,1,0
6,GO NEGATIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN INFLAMMATORY RESPONSE,0.036048,-0.18334,-0.14808,1,0
6,GO POSITIVE REGULATION OF CHEMOKINE BIOSYNTHETIC PROCESS,0.0017517,-0.18433,-0.24236,1,0
6,GO CHEMOKINE C X C MOTIF LIGAND 2 PRODUCTION,0.0053519,-0.18593,-0.1851,1,0
6,GO DENDRITIC CELL DIFFERENTIATION,0.01995,-0.18621,-0.16754,1,0
6,GO RESPONSE TO PROTOZOAN,0.0010408,-0.18626,-0.20162,1,0
6,GO CELL REDOX HOMEOSTASIS,0.00046165,-0.18655,-0.15563,1,0
6,GO NEGATIVE REGULATION OF STEROID METABOLIC PROCESS,0.0020646,-0.18947,-0.16893,1,0
6,GO CHEMOKINE BIOSYNTHETIC PROCESS,0.00029976,-0.18953,-0.25347,1,0
6,GO RESPONSE TO INTERFERON ALPHA,0.03902,-0.19153,-0.25481,1,0
6,GO ZYMOGEN ACTIVATION,0.0092477,-0.19309,-0.18467,1,0
6,GO LIPID IMPORT INTO CELL,0.014658,-0.19315,-0.11115,1,0
6,GO MEMBRANE LIPID CATABOLIC PROCESS,0.0038478,-0.19395,-0.15881,1,0
6,GO COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE,0.022928,-0.19429,-0.19524,1,0
6,GO DETECTION OF MOLECULE OF BACTERIAL ORIGIN,0.00014129,-0.19452,-0.31627,1,0
6,GO GALACTOSE METABOLIC PROCESS,0.0044864,-0.1946,-0.20939,1,0
6,GO DETECTION OF BIOTIC STIMULUS,0.012087,-0.19579,-0.1729,1,0
6,GO ARACHIDONIC ACID METABOLIC PROCESS,0.021053,-0.19602,-0.13569,1,0
6,GO LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00081356,-0.19632,-0.19211,1,0
6,GO POSITIVE REGULATION OF TYPE 2 IMMUNE RESPONSE,0.002702,-0.19702,-0.18659,1,0
6,GO FIBRINOLYSIS,0.0028118,-0.19727,-0.23754,1,0
6,GO CYTOCHROME COMPLEX ASSEMBLY,0.0017517,-0.19758,-0.14967,1,0
6,GO PLASMA LIPOPROTEIN PARTICLE CLEARANCE,0.00038422,-0.19774,-0.19473,1,0
6,GO REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.003654,-0.19803,-0.19281,1,0
6,GO RESPONSE TO EPINEPHRINE,0.044292,-0.19828,-0.1536,1,0
6,GO REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,7.5001e-05,-0.19856,-0.27778,1,0
6,GO NUCLEOTIDE SALVAGE,0.0024609,-0.19933,-0.21323,1,0
6,GO REGULATION OF B CELL APOPTOTIC PROCESS,0.0019819,-0.19989,-0.16954,1,0
6,GO RESPONSE TO PEPTIDOGLYCAN,0.00072342,-0.20005,-0.1796,1,0
6,GO REGULATION OF PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.0076401,-0.20204,-0.18013,1,0
6,GO RESPONSE TO MUSCLE STRETCH,0.054074,-0.20284,-0.11858,1,0
6,GO C21 STEROID HORMONE BIOSYNTHETIC PROCESS,0.022686,-0.20538,-0.1533,1,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE CLEARANCE,0.0011668,-0.20555,-0.20077,1,0
6,GO REGULATION OF MYOBLAST FUSION,0.0027381,-0.20654,-0.19368,1,0
6,GO TYPE 2 IMMUNE RESPONSE,0.0094686,-0.2085,-0.18419,1,0
6,GO LEUKOTRIENE BIOSYNTHETIC PROCESS,0.027973,-0.20851,-0.1311,1,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ENDOPLASMIC RETICULUM,0.010279,-0.20895,-0.19297,1,0
6,GO NEGATIVE REGULATION OF COAGULATION,0.0085105,-0.21175,-0.19408,1,0
6,GO INTERLEUKIN 5 PRODUCTION,0.010895,-0.21204,-0.21888,1,0
6,GO GUANOSINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.0021215,-0.21282,-0.18327,1,0
6,GO AEROBIC ELECTRON TRANSPORT CHAIN,1.3693e-05,-0.21408,-0.21723,1,0
6,GO REGULATION OF FIBRINOLYSIS,0.00075607,-0.2144,-0.23319,1,0
6,GO CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.004964,-0.21458,-0.19535,1,0
6,GO T CELL MEDIATED CYTOTOXICITY,0.0038977,-0.21462,-0.26686,1,0
6,GO GROWTH HORMONE RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.032278,-0.21591,-0.17769,1,0
6,GO NEGATIVE REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.0013255,-0.21604,-0.18226,1,0
6,GO VITAMIN D METABOLIC PROCESS,0.0027381,-0.21637,-0.19215,1,0
6,GO TOLERANCE INDUCTION,0.028264,-0.21666,-0.21332,1,0
6,GO REGULATION OF VIRAL ENTRY INTO HOST CELL,0.002702,-0.21748,-0.30082,1,0
6,GO ETHANOL METABOLIC PROCESS,0.0059116,-0.21827,-0.18942,1,0
6,GO DETECTION OF OTHER ORGANISM,0.020828,-0.21838,-0.19849,1,0
6,GO REGULATION OF VITAMIN METABOLIC PROCESS,0.0035605,-0.21851,-0.22064,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE ANTIGEN VIA MHC CLASS I,0.0087156,-0.21918,-0.20922,1,0
6,GO BEHAVIORAL RESPONSE TO PAIN,0.0074579,-0.21931,-0.21654,1,0
6,GO VITAMIN TRANSMEMBRANE TRANSPORT,0.012945,-0.21985,-0.16356,1,0
6,GO REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.022686,-0.22037,-0.11625,1,0
6,GO POSITIVE REGULATION OF T HELPER 1 TYPE IMMUNE RESPONSE,4.8839e-05,-0.22214,-0.29879,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 1 BETA PRODUCTION,0.0095807,-0.22301,-0.20899,1,0
6,GO GLYCOLIPID CATABOLIC PROCESS,0.0020092,-0.2232,-0.24963,1,0
6,GO POSITIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.024947,-0.22345,-0.17673,1,0
6,GO LIPOPROTEIN CATABOLIC PROCESS,0.00087508,-0.22534,-0.21072,1,0
6,GO GLUTATHIONE METABOLIC PROCESS,0.00070238,-0.22545,-0.18446,1,0
6,GO INTERLEUKIN 17 PRODUCTION,9.4959e-05,-0.22927,-0.22751,1,0
6,GO MONOCYTE CHEMOTAXIS,0.00044781,-0.22952,-0.20399,1,0
6,GO VASODILATION,0.001422,-0.23036,-0.17806,1,0
6,GO PHAGOLYSOSOME ASSEMBLY,0.020605,-0.23321,-0.14119,1,0
6,GO POSITIVE REGULATION OF OSTEOBLAST PROLIFERATION,0.022446,-0.23534,-0.15471,1,0
6,GO MEMBRANE RAFT ORGANIZATION,0.043025,-0.23614,-0.19211,1,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.003166,-0.23859,-0.20148,1,0
6,GO MODULATION BY SYMBIONT OF ENTRY INTO HOST,0.0023637,-0.24248,-0.29554,1,0
6,GO HISTAMINE SECRETION,0.0051547,-0.24286,-0.23832,1,0
6,GO CELL PROLIFERATION INVOLVED IN METANEPHROS DEVELOPMENT,0.011678,-0.24362,-0.24935,1,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL PROLIFERATION,0.004156,-0.24423,-0.21665,1,0
6,GO TRAIL ACTIVATED APOPTOTIC SIGNALING PATHWAY,0.037139,-0.24424,-0.18799,1,0
6,GO NEGATIVE REGULATION OF B CELL PROLIFERATION,0.00059648,-0.2444,-0.21219,1,0
6,GO REGULATION OF MICROVILLUS ORGANIZATION,0.054074,-0.24471,-0.1661,1,0
6,GO REGULATION OF LYSOSOMAL LUMEN PH,0.0005133,-0.24474,-0.19571,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,2.2416e-05,-0.24611,-0.23751,1,0
6,GO CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00026024,-0.24762,-0.28762,1,0
6,GO CHRONIC INFLAMMATORY RESPONSE,4.3997e-05,-0.24884,-0.28893,1,0
6,GO PHOSPHATIDYLCHOLINE CATABOLIC PROCESS,0.00074504,-0.24955,-0.24809,1,0
6,GO NEGATIVE REGULATION OF MULTI ORGANISM PROCESS,1.9563e-06,-0.25154,-0.28771,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION VIA MHC CLASS IB,0.028264,-0.2524,-0.30015,1,0
6,GO PURINE NUCLEOSIDE MONOPHOSPHATE BIOSYNTHETIC PROCESS,9.6562e-05,-0.25271,-0.25083,1,0
6,GO BRANCHED CHAIN AMINO ACID TRANSPORT,0.011813,-0.25426,-0.18451,1,0
6,GO CERAMIDE CATABOLIC PROCESS,0.0030038,-0.25527,-0.19272,1,0
6,GO KERATAN SULFATE CATABOLIC PROCESS,0.001118,-0.25605,-0.23383,1,0
6,GO NEGATIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.003654,-0.25737,-0.20155,1,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,1.6457e-05,-0.2575,-0.36302,1,0
6,GO VITAMIN BIOSYNTHETIC PROCESS,8.4424e-05,-0.25864,-0.20489,1,0
6,GO REGULATION OF LIPOPOLYSACCHARIDE MEDIATED SIGNALING PATHWAY,0.00061456,-0.25937,-0.21629,1,0
6,GO CELLULAR RESPONSE TO EPINEPHRINE STIMULUS,0.001442,-0.26018,-0.23345,1,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CONTRACTION,0.011151,-0.26045,-0.2091,1,0
6,GO OLIGOSACCHARIDE CATABOLIC PROCESS,0.0005618,-0.26122,-0.28972,1,0
6,GO SIGNAL PEPTIDE PROCESSING,0.00016629,-0.26326,-0.21105,1,0
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY INTEGRIN,0.00014362,-0.26369,-0.31166,1,0
6,GO GLYCINE TRANSPORT,0.0053519,-0.26678,-0.22292,1,0
6,GO VITAMIN D BIOSYNTHETIC PROCESS,0.0031247,-0.26872,-0.21233,1,0
6,GO REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.018898,-0.26914,-0.22783,1,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF EXOGENOUS PEPTIDE ANTIGEN VIA MHC CLASS I,0.0062108,-0.27073,-0.22994,1,0
6,GO TOLL LIKE RECEPTOR 2 SIGNALING PATHWAY,0.0023637,-0.2765,-0.27184,1,0
6,GO INFLAMMATORY RESPONSE TO WOUNDING,0.020385,-0.2918,-0.22602,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY CIRCULATORY RENIN ANGIOTENSIN,0.0018006,-0.29264,-0.26126,1,0
6,GO DENDRITIC CELL APOPTOTIC PROCESS,0.0039481,-0.29469,-0.25091,1,0
6,GO PLASMINOGEN ACTIVATION,0.00036124,-0.29512,-0.2547,1,0
6,GO TRANSFORMING GROWTH FACTOR BETA1 PRODUCTION,2.6828e-05,-0.29774,-0.29068,1,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE BY RENIN ANGIOTENSIN,0.001071,-0.30653,-0.29562,1,0
6,GO REGULATION OF CELL PROLIFERATION INVOLVED IN KIDNEY DEVELOPMENT,0.0050269,-0.30776,-0.26438,1,0
6,GO DETECTION OF EXTERNAL BIOTIC STIMULUS,0.0015463,-0.30792,-0.25999,1,0
6,GO MATURE B CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.00019857,-0.30845,-0.31915,1,0
6,GO CYCLOOXYGENASE PATHWAY,0.0014624,-0.30919,-0.27498,1,0
6,GO REGULATION OF ASPARTIC TYPE PEPTIDASE ACTIVITY,0.0035605,-0.32051,-0.25451,1,0
6,GO NEGATIVE REGULATION OF ANION TRANSMEMBRANE TRANSPORT,0.00035024,-0.32155,-0.2365,1,0
6,GO XENOBIOTIC CATABOLIC PROCESS,0.0089251,-0.32278,-0.25023,1,0
6,GO GLUTATHIONE DERIVATIVE METABOLIC PROCESS,0.0026663,-0.3283,-0.29406,1,0
6,GO POSITIVE REGULATION OF MACROPHAGE ACTIVATION,2.6828e-05,-0.32934,-0.3249,1,0
6,GO RESPONSE TO INTERFERON BETA,0.00021511,-0.33506,-0.37284,1,0
6,GO ETHANOL OXIDATION,0.00012388,-0.33575,-0.36428,1,0
6,GO FRUCTOSE METABOLIC PROCESS,0.01499,-0.33586,-0.20618,1,0
6,GO NEGATIVE REGULATION OF LIPASE ACTIVITY,0.00013673,-0.33945,-0.31192,1,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED CYTOTOXICITY,0.013243,-0.33965,-0.28148,1,0
6,GO EOSINOPHIL MIGRATION,0.0005789,-0.36419,-0.25216,1,0
6,GO POSITIVE REGULATION BY SYMBIONT OF ENTRY INTO HOST,0.00029511,-0.3757,-0.45471,1,0
6,GO EOSINOPHIL CHEMOTAXIS,0.00091404,-0.38544,-0.26168,1,0
6,GO POSITIVE REGULATION OF VESICLE FUSION,0.025743,-0.42172,-0.25176,1,0
6,GO MUCUS SECRETION,1.2027e-05,-0.5652,-0.52948,1,0
6,GO NEGATIVE REGULATION OF GLYCOLYTIC PROCESS,0.30446,0.21165,0.09171,0,1
6,GO DENSE CORE GRANULE TRANSPORT,0.089246,0.20456,0.15278,0,1
6,GO NITRIC OXIDE MEDIATED SIGNAL TRANSDUCTION,0.14419,0.18898,0.088313,0,1
6,GO ESTABLISHMENT OF BLOOD BRAIN BARRIER,0.13234,0.18765,0.13704,0,1
6,GO DERMATAN SULFATE METABOLIC PROCESS,0.080464,0.18343,0.13756,0,1
6,GO REGULATION OF NEUROTROPHIN TRK RECEPTOR SIGNALING PATHWAY,0.10471,0.17635,0.13436,0,1
6,GO REGULATION OF WNT SIGNALING PATHWAY PLANAR CELL POLARITY PATHWAY,0.066792,0.17339,0.13226,0,1
6,GO LYMPH VESSEL MORPHOGENESIS,0.12924,0.16972,0.11253,0,1
6,GO NEURON PROJECTION EXTENSION INVOLVED IN NEURON PROJECTION GUIDANCE,0.065596,0.15996,0.13291,0,1
6,GO POSITIVE REGULATION OF NON CANONICAL WNT SIGNALING PATHWAY,0.11742,0.15806,0.13484,0,1
6,GO REGULATION OF CELL CELL ADHESION MEDIATED BY CADHERIN,0.11553,0.15531,0.12626,0,1
6,GO DERMATAN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.15565,0.15317,0.094436,0,1
6,GO NEGATIVE CHEMOTAXIS,0.12029,0.15291,0.11292,0,1
6,GO REFLEX,0.59705,0.14715,0.03843,0,1
6,GO REGULATION OF VASCULOGENESIS,0.38047,0.14377,0.068095,0,1
6,GO EPIDERMIS MORPHOGENESIS,0.19417,0.14094,0.076333,0,1
6,GO NEGATIVE REGULATION OF OSSIFICATION,0.13444,0.13966,0.078899,0,1
6,GO ACTOMYOSIN STRUCTURE ORGANIZATION,0.072397,0.13802,0.091974,0,1
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.10471,0.13783,0.11874,0,1
6,GO REGULATION OF DNA METHYLATION,0.060988,0.13745,0.083744,0,1
6,GO CELLULAR RESPONSE TO STEROL DEPLETION,0.23927,0.13601,0.061003,0,1
6,GO PROSTATE GLAND DEVELOPMENT,0.068619,0.1355,0.10453,0,1
6,GO ESTABLISHMENT OF ENDOTHELIAL BARRIER,0.093126,0.13356,0.10535,0,1
6,GO GOLGI LOCALIZATION,0.074349,0.13352,0.071426,0,1
6,GO CELLULAR CARBOHYDRATE BIOSYNTHETIC PROCESS,0.075674,0.13227,0.082895,0,1
6,GO MIDGUT DEVELOPMENT,0.065596,0.13035,0.14041,0,1
6,GO RNA SURVEILLANCE,0.36311,0.12906,0.033092,0,1
6,GO ACTIVATION OF TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE ACTIVITY,0.087731,0.12874,0.12278,0,1
6,GO POSITIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.1313,0.12774,0.10174,0,1
6,GO ANOIKIS,0.066792,0.1244,0.11013,0,1
6,GO BASIC AMINO ACID TRANSPORT,0.1453,0.1242,0.095945,0,1
6,GO NEGATIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.13444,0.12417,0.10839,0,1
6,GO MANNOSYLATION,0.1754,0.12314,0.067558,0,1
6,GO NEURON DEATH IN RESPONSE TO OXIDATIVE STRESS,0.21889,0.12242,0.057565,0,1
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.084763,0.1224,0.13306,0,1
6,GO TOLL LIKE RECEPTOR 9 SIGNALING PATHWAY,0.20265,0.12107,0.062214,0,1
6,GO NEGATIVE REGULATION OF BMP SIGNALING PATHWAY,0.066192,0.12012,0.10808,0,1
6,GO SPERM CAPACITATION,0.066792,0.11987,0.10242,0,1
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSPORT,0.14642,0.11829,0.096407,0,1
6,GO CDC42 PROTEIN SIGNAL TRANSDUCTION,0.23128,0.11756,0.090628,0,1
6,GO REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.1313,0.11754,0.062928,0,1
6,GO COLLAGEN ACTIVATED SIGNALING PATHWAY,0.24252,0.11699,0.13087,0,1
6,GO NEGATIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.23445,0.11673,0.059624,0,1
6,GO REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.090782,0.1165,0.065073,0,1
6,GO SOMATIC RECOMBINATION OF IMMUNOGLOBULIN GENE SEGMENTS,0.10214,0.11585,0.069015,0,1
6,GO INTRACELLULAR LIPID TRANSPORT,0.16904,0.11584,0.075819,0,1
6,GO MAGNESIUM ION TRANSPORT,0.14642,0.11537,0.07252,0,1
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.30829,0.11507,0.049978,0,1
6,GO MYELIN ASSEMBLY,0.16285,0.11461,0.10426,0,1
6,GO NEGATIVE REGULATION OF PHAGOCYTOSIS,0.10471,0.11375,0.076362,0,1
6,GO SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.086237,0.1122,0.12522,0,1
6,GO ACTIN FILAMENT BUNDLE ORGANIZATION,0.077698,0.11218,0.090323,0,1
6,GO PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.36311,0.11216,0.06698,0,1
6,GO ACTIN FILAMENT ORGANIZATION,0.15098,0.11147,0.074513,0,1
6,GO CELLULAR CARBOHYDRATE METABOLIC PROCESS,0.08331,0.11121,0.072738,0,1
6,GO REGULATION OF KERATINOCYTE PROLIFERATION,0.39381,0.10989,0.047946,0,1
6,GO REGULATION OF MYOBLAST DIFFERENTIATION,0.11553,0.10987,0.061967,0,1
6,GO EMBRYONIC HINDLIMB MORPHOGENESIS,0.23128,0.10946,0.086548,0,1
6,GO G PROTEIN COUPLED RECEPTOR INTERNALIZATION,0.09714,0.10898,0.098947,0,1
6,GO POSITIVE REGULATION OF B CELL DIFFERENTIATION,0.11837,0.10858,0.10866,0,1
6,GO POSITIVE REGULATION OF HYDROLASE ACTIVITY,0.17283,0.10778,0.057043,0,1
6,GO PSEUDOPODIUM ORGANIZATION,0.095518,0.10723,0.14303,0,1
6,GO STRESS FIBER ASSEMBLY,0.20122,0.10672,0.077104,0,1
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC,0.093918,0.10599,0.049788,0,1
6,GO MAMMARY GLAND MORPHOGENESIS,0.1453,0.10572,0.091091,0,1
6,GO EPITHELIAL TUBE BRANCHING INVOLVED IN LUNG MORPHOGENESIS,0.21587,0.10551,0.074212,0,1
6,GO POLYSACCHARIDE METABOLIC PROCESS,0.091558,0.10527,0.075912,0,1
6,GO ACTIN FILAMENT BASED PROCESS,0.063836,0.10526,0.085387,0,1
6,GO CHEMOSENSORY BEHAVIOR,0.060988,0.10514,0.091051,0,1
6,GO C4 DICARBOXYLATE TRANSPORT,0.20554,0.10456,0.066567,0,1
6,GO METANEPHRIC NEPHRON DEVELOPMENT,0.13656,0.10441,0.099527,0,1
6,GO CHAPERONE MEDIATED PROTEIN TRANSPORT,0.25583,0.10417,0.075938,0,1
6,GO REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.075009,0.10398,0.068692,0,1
6,GO SHORT TERM MEMORY,0.071119,0.10395,0.11367,0,1
6,GO CARDIAC CELL DEVELOPMENT,0.11933,0.10287,0.077889,0,1
6,GO REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.11367,0.10053,0.076356,0,1
6,GO NUCLEOLAR LARGE RRNA TRANSCRIPTION BY RNA POLYMERASE I,0.18866,0.10045,0.0718,0,1
6,GO MITOTIC NUCLEAR ENVELOPE DISASSEMBLY,0.11367,0.10013,0.11767,0,1
6,GO INTRACELLULAR STEROL TRANSPORT,0.36956,0.099841,0.050359,0,1
6,GO NEUROBLAST DIVISION,0.25246,0.0991,0.07952,0,1
6,GO REGULATION OF ENDOCYTOSIS,0.098784,0.098914,0.074333,0,1
6,GO ENDOCYTIC RECYCLING,0.061549,0.098615,0.09366,0,1
6,GO MELANOCYTE DIFFERENTIATION,0.086981,0.098005,0.097526,0,1
6,GO HEPARAN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.15683,0.097765,0.079735,0,1
6,GO MODULATION BY VIRUS OF HOST CELLULAR PROCESS,0.074349,0.097681,0.056718,0,1
6,GO MODULATION BY SYMBIONT OF HOST CELLULAR PROCESS,0.079765,0.097559,0.062076,0,1
6,GO POSITIVE REGULATION OF CATALYTIC ACTIVITY,0.11647,0.09669,0.062822,0,1
6,GO SOMATIC DIVERSIFICATION OF IMMUNOGLOBULINS,0.070488,0.096682,0.07131,0,1
6,GO IMIDAZOLE CONTAINING COMPOUND METABOLIC PROCESS,0.079765,0.096598,0.068575,0,1
6,GO TRANSCRIPTION ELONGATION FROM RNA POLYMERASE I PROMOTER,0.59705,0.096065,0.0089179,0,1
6,GO REGULATION OF EPIDERMIS DEVELOPMENT,0.19003,0.095445,0.067517,0,1
6,GO STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.2714,0.095397,0.050981,0,1
6,GO REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.093918,0.095335,0.079356,0,1
6,GO REGULATION OF ANDROGEN RECEPTOR SIGNALING PATHWAY,0.1387,0.094846,0.072433,0,1
6,GO POSITIVE REGULATION OF TRANSFERASE ACTIVITY,0.060988,0.094327,0.075654,0,1
6,GO NEGATIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.25246,0.093867,0.058049,0,1
6,GO LACTATION,0.079071,0.093458,0.090754,0,1
6,GO RESPONSE TO WATER,0.34627,0.093294,0.062064,0,1
6,GO PROTEIN AUTOPHOSPHORYLATION,0.1313,0.093286,0.070391,0,1
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.82211,0.09263,0.023612,0,1
6,GO REGULATION OF HYDROLASE ACTIVITY,0.24911,0.092555,0.051238,0,1
6,GO ASPARTATE FAMILY AMINO ACID CATABOLIC PROCESS,0.074349,0.091813,0.080014,0,1
6,GO POSITIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.12322,0.09139,0.064266,0,1
6,GO MULTICELLULAR ORGANISMAL HOMEOSTASIS,0.082591,0.0909,0.072332,0,1
6,GO POSITIVE REGULATION OF MAP KINASE ACTIVITY,0.27853,0.090272,0.052399,0,1
6,GO PROTEIN ADP RIBOSYLATION,0.068619,0.09005,0.099163,0,1
6,GO HEART PROCESS,0.15214,0.08895,0.074178,0,1
6,GO POSITIVE REGULATION OF JNK CASCADE,0.20554,0.088332,0.065009,0,1
6,GO NEGATIVE REGULATION OF MOLECULAR FUNCTION,0.098784,0.08751,0.0647,0,1
6,GO CELLULAR PROTEIN CATABOLIC PROCESS,0.081168,0.087394,0.060418,0,1
6,GO REGULATION OF HAIR FOLLICLE DEVELOPMENT,0.14308,0.087275,0.078681,0,1
6,GO 2 OXOGLUTARATE METABOLIC PROCESS,0.13656,0.086412,0.065022,0,1
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.12721,0.086179,0.07558,0,1
6,GO POSITIVE REGULATION OF EXOCYTOSIS,0.082591,0.085771,0.09247,0,1
6,GO REGULATION OF HEART GROWTH,0.15447,0.085543,0.07136,0,1
6,GO PROTEIN CATABOLIC PROCESS,0.10385,0.085526,0.058609,0,1
6,GO RESPONSE TO EXTRACELLULAR STIMULUS,0.10385,0.085392,0.058219,0,1
6,GO PIRNA METABOLIC PROCESS,0.10385,0.084687,0.085024,0,1
6,GO ENDOMEMBRANE SYSTEM ORGANIZATION,0.062684,0.084641,0.07545,0,1
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION PROCESS,0.063258,0.08426,0.068881,0,1
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.13763,0.084129,0.061284,0,1
6,GO NEGATIVE REGULATION OF RESPONSE TO STIMULUS,0.12029,0.083938,0.063636,0,1
6,GO POSITIVE REGULATION OF SIGNALING,0.079765,0.083832,0.066765,0,1
6,GO RECEPTOR METABOLIC PROCESS,0.079765,0.083402,0.078302,0,1
6,GO ADAPTATION OF SIGNALING PATHWAY,0.1387,0.083382,0.073676,0,1
6,GO TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR,0.16042,0.082869,0.045084,0,1
6,GO PROTEIN K11 LINKED UBIQUITINATION,0.35043,0.082565,0.029047,0,1
6,GO REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.1873,0.082161,0.05787,0,1
6,GO INOSITOL PHOSPHATE METABOLIC PROCESS,0.084034,0.082007,0.094009,0,1
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.14983,0.081932,0.057489,0,1
6,GO TRANSMEMBRANE RECEPTOR PROTEIN TYROSINE KINASE SIGNALING PATHWAY,0.20845,0.081876,0.062232,0,1
6,GO EPITHELIAL CELL PROLIFERATION,0.15098,0.081516,0.070564,0,1
6,GO DNA UNWINDING INVOLVED IN DNA REPLICATION,0.14308,0.081362,0.082885,0,1
6,GO RNA PROCESSING,0.095518,0.081351,0.061279,0,1
6,GO POSITIVE REGULATION OF KIDNEY DEVELOPMENT,0.20122,0.0813,0.075648,0,1
6,GO REGULATION OF ACTION POTENTIAL,0.12421,0.081057,0.097068,0,1
6,GO CELLULAR HYPEROSMOTIC RESPONSE,0.060988,0.081015,0.10559,0,1
6,GO PRIMARY MIRNA PROCESSING,0.071756,0.080518,0.087993,0,1
6,GO INTRACELLULAR TRANSPORT,0.074349,0.080261,0.062109,0,1
6,GO NUCLEOSIDE DIPHOSPHATE METABOLIC PROCESS,0.084034,0.08024,0.07843,0,1
6,GO RESPONSE TO ENDOGENOUS STIMULUS,0.09714,0.079951,0.064869,0,1
6,GO ACTIN CYTOSKELETON REORGANIZATION,0.094715,0.079945,0.076096,0,1
6,GO NUCLEOTIDE EXCISION REPAIR DNA INCISION,0.10129,0.079622,0.057196,0,1
6,GO POSITIVE REGULATION OF PEPTIDE SECRETION,0.073694,0.079572,0.070713,0,1
6,GO REGULATION OF PROTEIN KINASE ACTIVITY,0.081877,0.079305,0.068358,0,1
6,GO PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.093918,0.078864,0.078798,0,1
6,GO CARBOHYDRATE HOMEOSTASIS,0.063836,0.078744,0.077848,0,1
6,GO REGULATION OF TELOMERE MAINTENANCE,0.070488,0.078554,0.075613,0,1
6,GO REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.066792,0.078389,0.073817,0,1
6,GO SUPRAMOLECULAR FIBER ORGANIZATION,0.062684,0.078256,0.082743,0,1
6,GO MITOCHONDRIAL CALCIUM ION HOMEOSTASIS,0.86968,0.078164,-0.011173,0,1
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSPORT,0.071756,0.078106,0.072948,0,1
6,GO CELLULAR RESPONSE TO PEPTIDE,0.13338,0.077739,0.065193,0,1
6,GO POSITIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.15921,0.077729,0.061154,0,1
6,GO POSITIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.072397,0.077558,0.077694,0,1
6,GO POSITIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.31021,0.07738,0.054888,0,1
6,GO POSITIVE REGULATION OF PROTEIN KINASE ACTIVITY,0.092339,0.077026,0.071418,0,1
6,GO NEGATIVE REGULATION OF JNK CASCADE,0.071119,0.076867,0.095067,0,1
6,GO REGULATION OF BLOOD CIRCULATION,0.079765,0.076085,0.086621,0,1
6,GO POSITIVE REGULATION OF TRANSPORT,0.10734,0.075766,0.064526,0,1
6,GO TUMOR NECROSIS FACTOR SECRETION,0.29877,0.075176,0.044666,0,1
6,GO NEGATIVE REGULATION OF PHOSPHORUS METABOLIC PROCESS,0.067397,0.075093,0.072949,0,1
6,GO MUSCLE CELL DEVELOPMENT,0.10646,0.074637,0.069956,0,1
6,GO NEGATIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.1873,0.074022,0.054783,0,1
6,GO POSITIVE REGULATION OF CELL AGING,0.30829,0.073802,0.047568,0,1
6,GO REGULATION OF MITOCHONDRIAL FISSION,0.073043,0.073373,0.079998,0,1
6,GO POSITIVE REGULATION OF PROTEIN MODIFICATION BY SMALL PROTEIN CONJUGATION OR REMOVAL,0.11837,0.073177,0.047668,0,1
6,GO VESICLE ORGANIZATION,0.54746,0.073098,0.033139,0,1
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.20699,0.072797,0.0712,0,1
6,GO RNA INTERFERENCE,0.23128,0.072711,0.063723,0,1
6,GO RESPONSE TO ORGANIC CYCLIC COMPOUND,0.16163,0.072358,0.055733,0,1
6,GO TELOMERE ORGANIZATION,0.075009,0.072297,0.07381,0,1
6,GO REGULATION OF CELL SHAPE,0.060988,0.072173,0.09572,0,1
6,GO ONE CARBON METABOLIC PROCESS,0.3739,0.072032,0.041963,0,1
6,GO NEGATIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.13763,0.071768,0.11076,0,1
6,GO POSITIVE REGULATION OF P38MAPK CASCADE,0.24089,0.071505,0.094183,0,1
6,GO REGULATION OF CELL POPULATION PROLIFERATION,0.20992,0.071377,0.053692,0,1
6,GO POSITIVE REGULATION OF GENE EXPRESSION EPIGENETIC,0.061549,0.071275,0.082821,0,1
6,GO PREASSEMBLY OF GPI ANCHOR IN ER MEMBRANE,0.063836,0.071005,0.07301,0,1
6,GO ESTABLISHMENT OF PIGMENT GRANULE LOCALIZATION,0.25753,0.070435,0.052191,0,1
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CONTRACTION,0.41666,0.069744,0.043377,0,1
6,GO CELLULAR RESPONSE TO CARBOHYDRATE STIMULUS,0.084763,0.069246,0.076443,0,1
6,GO REGULATION OF MAP KINASE ACTIVITY,0.55558,0.068772,0.034367,0,1
6,GO ENDOSOME ORGANIZATION,0.28761,0.068501,0.044261,0,1
6,GO REGULATION OF PROTEIN POLYUBIQUITINATION,0.08331,0.068407,0.084975,0,1
6,GO POSITIVE REGULATION OF SEQUESTERING OF CALCIUM ION,0.45238,0.068038,0.043514,0,1
6,GO BILE ACID BIOSYNTHETIC PROCESS,0.19838,0.067814,0.050566,0,1
6,GO AORTA DEVELOPMENT,0.42602,0.067265,0.048939,0,1
6,GO ION TRANSPORT,0.10385,0.067203,0.062973,0,1
6,GO NEGATIVE REGULATION OF PROTEIN ACETYLATION,0.076344,0.067022,0.071112,0,1
6,GO REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.084034,0.066977,0.063321,0,1
6,GO PROTEIN CONTAINING COMPLEX SUBUNIT ORGANIZATION,0.092339,0.066928,0.055953,0,1
6,GO REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.16407,0.066719,0.0715,0,1
6,GO REGULATION OF CELL DEATH,0.34213,0.066416,0.040252,0,1
6,GO NEGATIVE REGULATION OF MITOCHONDRION ORGANIZATION,0.19417,0.066346,0.051919,0,1
6,GO ENDOCYTOSIS,0.41434,0.066331,0.045989,0,1
6,GO CELLULAR RESPONSE TO INSULIN STIMULUS,0.13444,0.065611,0.065639,0,1
6,GO TISSUE HOMEOSTASIS,0.17411,0.065026,0.053754,0,1
6,GO RESPONSE TO ACID CHEMICAL,0.11647,0.064918,0.068098,0,1
6,GO INTRACELLULAR PROTEIN TRANSPORT,0.12822,0.06448,0.051405,0,1
6,GO NEGATIVE REGULATION OF PEPTIDYL LYSINE ACETYLATION,0.19557,0.064353,0.058584,0,1
6,GO DNA TEMPLATED TRANSCRIPTION TERMINATION,0.074349,0.064107,0.063183,0,1
6,GO NUCLEOBASE CONTAINING COMPOUND TRANSPORT,0.072397,0.063979,0.068812,0,1
6,GO HOMEOSTATIC PROCESS,0.20699,0.063958,0.046835,0,1
6,GO ACTIN FILAMENT BASED MOVEMENT,0.26789,0.063711,0.057342,0,1
6,GO CARBOHYDRATE BIOSYNTHETIC PROCESS,0.56376,0.063709,0.027511,0,1
6,GO CELLULAR RESPONSE TO EXTRACELLULAR STIMULUS,0.10558,0.063304,0.069307,0,1
6,GO RESPONSE TO FATTY ACID,0.33599,0.06295,0.04399,0,1
6,GO RESPONSE TO TEMPERATURE STIMULUS,0.20265,0.062926,0.050493,0,1
6,GO POSITIVE REGULATION OF SECRETION,0.075674,0.062675,0.070434,0,1
6,GO APOPTOTIC PROCESS,0.28578,0.06214,0.043064,0,1
6,GO POSITIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.45972,0.062105,0.024562,0,1
6,GO CELLULAR RESPONSE TO CALCIUM ION,0.15802,0.061885,0.078572,0,1
6,GO MITOCHONDRIAL FISSION,0.22348,0.061768,0.05172,0,1
6,GO TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.11553,0.061499,0.062566,0,1
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.086981,0.061126,0.07046,0,1
6,GO PIGMENT GRANULE LOCALIZATION,0.3442,0.060999,0.043939,0,1
6,GO POSITIVE REGULATION OF CELL DEATH,0.22042,0.060569,0.05522,0,1
6,GO RESPONSE TO SALT,0.45238,0.06054,0.031252,0,1
6,GO GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR,0.081168,0.06027,0.063311,0,1
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT,0.084763,0.060231,0.073993,0,1
6,GO REGULATION OF MUSCLE SYSTEM PROCESS,0.32195,0.060135,0.047275,0,1
6,GO CELLULAR RESPONSE TO FATTY ACID,0.318,0.060066,0.05339,0,1
6,GO FEVER GENERATION,0.36741,0.059909,0.05402,0,1
6,GO RESPONSE TO HORMONE,0.39832,0.059358,0.040754,0,1
6,GO MIDDLE EAR MORPHOGENESIS,0.24089,0.059235,0.0567,0,1
6,GO T CELL LINEAGE COMMITMENT,0.099614,0.059136,0.08983,0,1
6,GO RNA DEPENDENT DNA BIOSYNTHETIC PROCESS,0.21738,0.058235,0.049128,0,1
6,GO POSITIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.20992,0.058108,0.055169,0,1
6,GO ESTABLISHMENT OF TISSUE POLARITY,0.093918,0.058014,0.06863,0,1
6,GO NEGATIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.32993,0.057725,0.047261,0,1
6,GO PHOSPHATIDYLINOSITOL PHOSPHORYLATION,0.10823,0.056301,0.080619,0,1
6,GO CELLULAR RESPONSE TO OXYGEN CONTAINING COMPOUND,0.2458,0.056177,0.049259,0,1
6,GO REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.15447,0.055198,0.051449,0,1
6,GO REGULATION OF MAPK CASCADE,0.43075,0.054926,0.037104,0,1
6,GO PROTEIN COMPLEX OLIGOMERIZATION,0.13234,0.054882,0.053758,0,1
6,GO RESPONSE TO NITROGEN COMPOUND,0.2114,0.0548,0.050665,0,1
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL PROLIFERATION,0.55016,0.054758,0.047202,0,1
6,GO MEMBRANE ORGANIZATION,0.1252,0.054513,0.063521,0,1
6,GO RESPONSE TO PEPTIDE HORMONE,0.35886,0.054133,0.045794,0,1
6,GO MACROAUTOPHAGY,0.10734,0.05411,0.059063,0,1
6,GO DETECTION OF STIMULUS,0.070488,0.053877,0.056546,0,1
6,GO CARBOHYDRATE PHOSPHORYLATION,0.11837,0.053786,0.086229,0,1
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.37173,0.05366,0.04501,0,1
6,GO NEGATIVE REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.20845,0.053111,0.056251,0,1
6,GO NEGATIVE REGULATION OF CATALYTIC ACTIVITY,0.35463,0.052975,0.044691,0,1
6,GO PROCESS UTILIZING AUTOPHAGIC MECHANISM,0.23128,0.052961,0.044882,0,1
6,GO NEGATIVE REGULATION OF PHOSPHORYLATION,0.25753,0.05267,0.052388,0,1
6,GO REGULATION OF MITOCHONDRION ORGANIZATION,0.084763,0.052665,0.06354,0,1
6,GO NEGATIVE REGULATION OF BLOOD CIRCULATION,0.43312,0.052076,0.045529,0,1
6,GO MAINTENANCE OF BLOOD BRAIN BARRIER,0.26614,0.051705,0.090346,0,1
6,GO NON CANONICAL WNT SIGNALING PATHWAY,0.077018,0.051693,0.070644,0,1
6,GO ACTIVATION OF MAPK ACTIVITY,0.1914,0.050789,0.057028,0,1
6,GO REGULATION OF SMALL MOLECULE METABOLIC PROCESS,0.3739,0.050192,0.036894,0,1
6,GO NEGATIVE REGULATION OF CATABOLIC PROCESS,0.11553,0.050149,0.050995,0,1
6,GO PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.095518,0.050129,0.072097,0,1
6,GO RESPONSE TO PEPTIDE,0.3739,0.050063,0.044551,0,1
6,GO POLYOL METABOLIC PROCESS,0.55016,0.048632,0.03918,0,1
6,GO NEGATIVE REGULATION OF PROTEASOMAL PROTEIN CATABOLIC PROCESS,0.23605,0.048406,0.049728,0,1
6,GO ANION TRANSMEMBRANE TRANSPORT,0.14755,0.04816,0.05995,0,1
6,GO MUSCLE CONTRACTION,0.46218,0.047555,0.036283,0,1
6,GO REGULATION OF AUTOPHAGY,0.22503,0.045742,0.048482,0,1
6,GO REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.081168,0.045438,0.081649,0,1
6,GO RESPONSE TO INSULIN,0.27673,0.045287,0.052188,0,1
6,GO REGULATION OF PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.081877,0.044729,0.065992,0,1
6,GO GENITALIA DEVELOPMENT,0.41666,0.04471,0.041475,0,1
6,GO DIVALENT INORGANIC CATION TRANSPORT,0.31021,0.044373,0.046603,0,1
6,GO INORGANIC ANION TRANSPORT,0.1914,0.042947,0.054593,0,1
6,GO NEGATIVE REGULATION OF MULTICELLULAR ORGANISMAL PROCESS,0.22971,0.04256,0.053391,0,1
6,GO NEGATIVE REGULATION OF CANONICAL WNT SIGNALING PATHWAY,0.16654,0.041886,0.062013,0,1
6,GO RESPONSE TO OXYGEN CONTAINING COMPOUND,0.38933,0.041817,0.04039,0,1
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE ACTIVITY,0.66321,0.03997,0.02294,0,1
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE BIOSYNTHETIC PROCESS,0.97253,0.039662,-0.0021986,0,1
6,GO RESPONSE TO PROSTAGLANDIN,0.14755,0.038542,0.079513,0,1
6,GO CELLULAR HOMEOSTASIS,0.4355,0.038212,0.032475,0,1
6,GO NEGATIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION,0.11933,0.034788,0.057697,0,1
6,GO REGULATION OF PROTEIN TARGETING,0.19979,0.032174,0.056578,0,1
6,GO POSITIVE REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,0.00021857,0.47055,0.42136,0,0
6,GO REGULATION OF GROWTH HORMONE SECRETION,2.6386e-06,0.38499,0.53173,0,0
6,GO RETINAL GANGLION CELL AXON GUIDANCE,0.0013069,0.32697,0.30724,0,0
6,GO CEREBRAL CORTEX GABAERGIC INTERNEURON DIFFERENTIATION,0.0032928,0.30433,0.41256,0,0
6,GO NEGATIVE REGULATION OF MICROTUBULE POLYMERIZATION OR DEPOLYMERIZATION,0.00024045,0.29035,0.26343,0,0
6,GO COLLECTING DUCT DEVELOPMENT,1.5293e-05,0.29033,0.32603,0,0
6,GO CARDIAC RIGHT VENTRICLE MORPHOGENESIS,0.0010113,0.28762,0.27242,0,0
6,GO BEHAVIORAL RESPONSE TO COCAINE,0.0005789,0.2793,0.33105,0,0
6,GO RETINA LAYER FORMATION,0.00026438,0.27295,0.29422,0,0
6,GO PENILE ERECTION,0.00064263,0.27268,0.25633,0,0
6,GO INNER DYNEIN ARM ASSEMBLY,0.001071,0.27102,0.33283,0,0
6,GO PHOTORECEPTOR CELL OUTER SEGMENT ORGANIZATION,0.00016901,0.2594,0.3246,0,0
6,GO REGULATION OF GLUTAMATE RECEPTOR SIGNALING PATHWAY,7.3739e-05,0.25586,0.27687,0,0
6,GO PRESYNAPTIC MODULATION OF CHEMICAL SYNAPTIC TRANSMISSION,0.0023321,0.25231,0.26731,0,0
6,GO POSITIVE REGULATION OF BEHAVIOR,0.003654,0.24755,0.19896,0,0
6,GO BRANCHING INVOLVED IN PROSTATE GLAND MORPHOGENESIS,0.0024281,0.24651,0.27602,0,0
6,GO POSITIVE REGULATION OF GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.001483,0.24376,0.29878,0,0
6,GO REGULATION OF PRESYNAPTIC CYTOSOLIC CALCIUM ION CONCENTRATION,0.0020929,0.23858,0.30239,0,0
6,GO FOREBRAIN NEURON DEVELOPMENT,0.0010408,0.22715,0.26505,0,0
6,GO POSITIVE REGULATION OF VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.0018256,0.22619,0.22825,0,0
6,GO AXO DENDRITIC PROTEIN TRANSPORT,0.00096848,0.22607,0.23306,0,0
6,GO SEROTONIN TRANSPORT,0.0060595,0.21617,0.18734,0,0
6,GO REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.0010259,0.21273,0.19201,0,0
6,GO G PROTEIN COUPLED ACETYLCHOLINE RECEPTOR SIGNALING PATHWAY,0.0010408,0.21117,0.2209,0,0
6,GO POSITIVE REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.00013673,0.211,0.2328,0,0
6,GO RESOLUTION OF MEIOTIC RECOMBINATION INTERMEDIATES,1.3693e-05,0.21085,0.23659,0,0
6,GO MOTILE CILIUM ASSEMBLY,0.0029645,0.20836,0.23636,0,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ASSEMBLY,0.089246,0.20644,0.12887,0,0
6,GO NEGATIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.0042095,0.20535,0.25538,0,0
6,GO SIGNAL TRANSDUCTION INVOLVED IN REGULATION OF GENE EXPRESSION,0.0059852,0.20535,0.17199,0,0
6,GO PROTEIN LOCALIZATION TO CELL JUNCTION,4.7488e-06,0.20312,0.24596,0,0
6,GO REGULATION OF SYNAPTIC VESICLE FUSION TO PRESYNAPTIC ACTIVE ZONE MEMBRANE,0.088486,0.20277,0.27384,0,0
6,GO FOREBRAIN NEURON DIFFERENTIATION,0.00030449,0.20272,0.25853,0,0
6,GO CARDIAC CELL FATE COMMITMENT,0.0028872,0.20104,0.26348,0,0
6,GO INTRACILIARY RETROGRADE TRANSPORT,2.2015e-05,0.19722,0.31443,0,0
6,GO NEGATIVE REGULATION OF INCLUSION BODY ASSEMBLY,0.090782,0.19241,0.17655,0,0
6,GO POSITIVE REGULATION OF FILOPODIUM ASSEMBLY,0.0084096,0.19019,0.17812,0,0
6,GO MEIOTIC CHROMOSOME SEPARATION,3.7605e-06,0.1889,0.23227,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO SYNAPSE,0.0024941,0.18808,0.16386,0,0
6,GO MESENCHYMAL CELL APOPTOTIC PROCESS,0.079765,0.18473,0.13995,0,0
6,GO TUBULIN DEACETYLATION,0.0018508,0.18361,0.19511,0,0
6,GO REGULATION OF RESPIRATORY SYSTEM PROCESS,0.00090088,0.18315,0.18567,0,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL DIFFERENTIATION,0.01995,0.18209,0.20079,0,0
6,GO NEGATIVE REGULATION OF NEURON DIFFERENTIATION,0.00017741,0.18187,0.18373,0,0
6,GO PITUITARY GLAND DEVELOPMENT,0.0017517,0.1793,0.24893,0,0
6,GO ESCRT COMPLEX DISASSEMBLY,0.0030038,0.17914,0.15104,0,0
6,GO RETINA VASCULATURE MORPHOGENESIS IN CAMERA TYPE EYE,0.10646,0.17912,0.13788,0,0
6,GO MALE MEIOTIC NUCLEAR DIVISION,0.00029052,0.17861,0.20667,0,0
6,GO GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR PRODUCTION,0.003607,0.17439,0.23214,0,0
6,GO SPONTANEOUS SYNAPTIC TRANSMISSION,0.012945,0.17385,0.21858,0,0
6,GO REGULATION OF GLIAL CELL PROLIFERATION,0.0010558,0.17276,0.20399,0,0
6,GO FOREBRAIN GENERATION OF NEURONS,0.0010259,0.16997,0.20656,0,0
6,GO COLLAGEN ACTIVATED TYROSINE KINASE RECEPTOR SIGNALING PATHWAY,0.20554,0.16994,0.17491,0,0
6,GO CELLULAR RESPONSE TO GLUCAGON STIMULUS,0.00037257,0.16975,0.20157,0,0
6,GO REGULATION OF NMDA RECEPTOR ACTIVITY,0.0015038,0.16916,0.20795,0,0
6,GO REGULATION OF BEHAVIOR,7.1274e-05,0.16727,0.18852,0,0
6,GO BASIC AMINO ACID TRANSMEMBRANE TRANSPORT,0.12029,0.16585,0.1213,0,0
6,GO CELL MIGRATION INVOLVED IN HEART DEVELOPMENT,0.11742,0.16288,0.14286,0,0
6,GO OLFACTORY BULB INTERNEURON DIFFERENTIATION,0.19003,0.16168,0.13777,0,0
6,GO INTESTINAL EPITHELIAL CELL DIFFERENTIATION,0.018091,0.16147,0.13596,0,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.13338,0.16136,0.1058,0,0
6,GO EYELID DEVELOPMENT IN CAMERA TYPE EYE,0.0045438,0.16055,0.22067,0,0
6,GO REGULATION OF SKELETAL MUSCLE ADAPTATION,0.065596,0.15916,0.16521,0,0
6,GO HEART FORMATION,0.0073682,0.15831,0.18023,0,0
6,GO 3 UTR MEDIATED MRNA STABILIZATION,0.00024819,0.158,0.22793,0,0
6,GO EPITHELIAL CELL CELL ADHESION,0.11647,0.15789,0.14537,0,0
6,GO KERATINOCYTE DEVELOPMENT,0.086981,0.15771,0.18397,0,0
6,GO RETROGRADE TRANSPORT ENDOSOME TO PLASMA MEMBRANE,0.00013232,0.15619,0.18111,0,0
6,GO SECRETORY GRANULE LOCALIZATION,0.11183,0.15545,0.12771,0,0
6,GO TRNA CATABOLIC PROCESS,0.063836,0.15455,0.15503,0,0
6,GO CEREBRAL CORTEX CELL MIGRATION,0.00025617,0.15436,0.21213,0,0
6,GO REGULATION OF KERATINOCYTE DIFFERENTIATION,0.52874,0.15308,0.030567,0,0
6,GO POSITIVE REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.10385,0.15299,0.10011,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE,0.014013,0.15073,0.16842,0,0
6,GO REGULATION OF HEART MORPHOGENESIS,0.019104,0.15018,0.14972,0,0
6,GO REGULATION OF MYELINATION,0.0020367,0.14821,0.14484,0,0
6,GO REGULATION OF ANIMAL ORGAN FORMATION,0.0104,0.14663,0.16614,0,0
6,GO NEGATIVE REGULATION OF NEUROINFLAMMATORY RESPONSE,0.024947,0.14518,0.12798,0,0
6,GO ORGANELLE TRANSPORT ALONG MICROTUBULE,0.00014839,0.14172,0.16479,0,0
6,GO ENDOTHELIAL CELL MORPHOGENESIS,0.076344,0.1407,0.19375,0,0
6,GO CELLULAR PROTEIN CONTAINING COMPLEX LOCALIZATION,0.0039992,0.13901,0.16271,0,0
6,GO POSITIVE REGULATION OF CELL JUNCTION ASSEMBLY,0.0065235,0.13838,0.15721,0,0
6,GO VISUAL BEHAVIOR,0.0011668,0.13828,0.13335,0,0
6,GO RENAL WATER HOMEOSTASIS,0.001483,0.1382,0.18865,0,0
6,GO MOTOR NEURON AXON GUIDANCE,0.044292,0.13791,0.12064,0,0
6,GO SYNAPTIC VESICLE PRIMING,0.17669,0.13749,0.13534,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.16285,0.13678,0.096035,0,0
6,GO BONE TRABECULA MORPHOGENESIS,0.36311,0.13655,0.080989,0,0
6,GO POSTSYNAPTIC CYTOSKELETON ORGANIZATION,0.0072795,0.13616,0.17222,0,0
6,GO REPLACEMENT OSSIFICATION,0.14642,0.13609,0.079722,0,0
6,GO POSITIVE REGULATION OF VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.13549,0.13517,0.14341,0,0
6,GO NEGATIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.10646,0.13482,0.093472,0,0
6,GO RESPONSE TO GLUCAGON,0.00071283,0.1344,0.16636,0,0
6,GO SEQUESTERING OF ACTIN MONOMERS,0.085497,0.13329,0.1712,0,0
6,GO RESPONSE TO DOPAMINE,8.4424e-05,0.13218,0.17897,0,0
6,GO EMBRYONIC AXIS SPECIFICATION,1.0958e-05,0.13214,0.21618,0,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN E STIMULUS,0.0038478,0.13187,0.16276,0,0
6,GO NEUROTRANSMITTER BIOSYNTHETIC PROCESS,0.0023009,0.13084,0.21296,0,0
6,GO EMBRYONIC PLACENTA DEVELOPMENT,0.068619,0.13069,0.10886,0,0
6,GO NEUROTRANSMITTER METABOLIC PROCESS,0.093126,0.13062,0.10089,0,0
6,GO MEMORY,0.00025617,0.13042,0.16655,0,0
6,GO GLOMERULAR BASEMENT MEMBRANE DEVELOPMENT,0.19838,0.13035,0.10374,0,0
6,GO NOREPINEPHRINE METABOLIC PROCESS,0.008211,0.13025,0.23937,0,0
6,GO NEGATIVE REGULATION OF EMBRYONIC DEVELOPMENT,0.08331,0.12865,0.10822,0,0
6,GO REGULATION OF FILOPODIUM ASSEMBLY,0.013394,0.12763,0.15842,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR STEROID HORMONE RECEPTOR SIGNALING PATHWAY,0.0075485,0.12688,0.23052,0,0
6,GO FEMALE MEIOTIC NUCLEAR DIVISION,0.0017277,0.12678,0.15644,0,0
6,GO REGULATION OF VASCULAR PERMEABILITY,0.1453,0.12653,0.078347,0,0
6,GO 3 UTR MEDIATED MRNA DESTABILIZATION,0.065596,0.12619,0.11245,0,0
6,GO POSITIVE REGULATION OF RECEPTOR RECYCLING,0.56376,0.12601,0.026411,0,0
6,GO REGULATION OF SYNAPTIC VESICLE RECYCLING,0.023919,0.1258,0.15501,0,0
6,GO ROOF OF MOUTH DEVELOPMENT,0.00063314,0.12505,0.17122,0,0
6,GO REGULATION OF OOGENESIS,0.0051547,0.12478,0.1059,0,0
6,GO NEGATIVE REGULATION OF LIPID CATABOLIC PROCESS,0.11553,0.12332,0.082984,0,0
6,GO CILIUM MOVEMENT,2.2416e-05,0.12308,0.17373,0,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED NEURON DEATH,0.17156,0.1222,0.086732,0,0
6,GO MEGAKARYOCYTE DEVELOPMENT,0.096327,0.12209,0.13618,0,0
6,GO CELLULAR RESPONSE TO CORTICOSTEROID STIMULUS,0.16654,0.122,0.068755,0,0
6,GO ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.13656,0.12137,0.088343,0,0
6,GO CALCIUM INDEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.13763,0.12136,0.14236,0,0
6,GO RETINA VASCULATURE DEVELOPMENT IN CAMERA TYPE EYE,0.078382,0.12009,0.12086,0,0
6,GO REGULATION OF CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.09714,0.11945,0.12041,0,0
6,GO REGULATION OF CGMP MEDIATED SIGNALING,0.40973,0.11913,0.047478,0,0
6,GO SKIN MORPHOGENESIS,0.38267,0.11876,0.069626,0,0
6,GO DIGESTIVE SYSTEM DEVELOPMENT,0.00039018,0.11859,0.17644,0,0
6,GO PARTURITION,0.16407,0.11826,0.075035,0,0
6,GO POSITIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.11553,0.11823,0.078033,0,0
6,GO METANEPHRIC NEPHRON EPITHELIUM DEVELOPMENT,0.52609,0.11762,0.055064,0,0
6,GO SPHINGOLIPID MEDIATED SIGNALING PATHWAY,0.01016,0.1176,0.17981,0,0
6,GO REGULATION OF GLIOGENESIS,0.00027284,0.11642,0.16249,0,0
6,GO NEGATIVE REGULATION OF FIBROBLAST PROLIFERATION,0.13444,0.11638,0.10017,0,0
6,GO REGULATION OF RESPIRATORY GASEOUS EXCHANGE,0.0037498,0.11623,0.14568,0,0
6,GO INTRA S DNA DAMAGE CHECKPOINT,0.0023957,0.11604,0.15704,0,0
6,GO RESPONSE TO AMINO ACID STARVATION,0.019523,0.11538,0.11564,0,0
6,GO NEGATIVE REGULATION OF STEM CELL DIFFERENTIATION,0.68689,0.1152,0.010255,0,0
6,GO METANEPHROS DEVELOPMENT,0.062114,0.11489,0.097924,0,0
6,GO PROTEIN TARGETING TO VACUOLE,0.10299,0.11478,0.090784,0,0
6,GO KIDNEY EPITHELIUM DEVELOPMENT,0.011151,0.11418,0.13335,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.037509,0.11386,0.11771,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.13234,0.11373,0.123,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEACETYLATION,0.022928,0.11349,0.15074,0,0
6,GO VESICLE FUSION TO PLASMA MEMBRANE,0.1754,0.11336,0.16043,0,0
6,GO ALANINE TRANSPORT,0.42133,0.11228,0.060823,0,0
6,GO RESPONSE TO CATECHOLAMINE,0.0062108,0.11157,0.12685,0,0
6,GO VENOUS BLOOD VESSEL DEVELOPMENT,0.30255,0.11149,0.075774,0,0
6,GO REGULATION OF OLIGODENDROCYTE DIFFERENTIATION,0.0050904,0.11091,0.17342,0,0
6,GO POSITIVE REGULATION OF CELL MATURATION,0.19557,0.1108,0.095547,0,0
6,GO GAMMA DELTA T CELL ACTIVATION,0.063258,0.11079,0.153,0,0
6,GO RESPIRATORY SYSTEM PROCESS,0.0104,0.11062,0.14306,0,0
6,GO ASYMMETRIC CELL DIVISION,0.093918,0.10977,0.12548,0,0
6,GO OLFACTORY LOBE DEVELOPMENT,0.02945,0.10896,0.15172,0,0
6,GO VESICLE TRANSPORT ALONG MICROTUBULE,0.0052197,0.10855,0.13138,0,0
6,GO MORPHOGENESIS OF AN EPITHELIAL SHEET,0.22971,0.10842,0.074369,0,0
6,GO REGULATION OF ACTOMYOSIN STRUCTURE ORGANIZATION,0.20992,0.10743,0.072569,0,0
6,GO RESPONSE TO UV B,0.10299,0.10726,0.11592,0,0
6,GO BUNDLE OF HIS CELL TO PURKINJE MYOCYTE COMMUNICATION,0.44994,0.10711,0.090431,0,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.28395,0.10683,0.061499,0,0
6,GO ARTERY MORPHOGENESIS,0.2458,0.10648,0.065184,0,0
6,GO REGULATION OF EARLY ENDOSOME TO LATE ENDOSOME TRANSPORT,0.11367,0.1062,0.11489,0,0
6,GO NEGATIVE REGULATION OF NOTCH SIGNALING PATHWAY,0.36956,0.10606,0.060916,0,0
6,GO POSITIVE REGULATION OF CATECHOLAMINE SECRETION,0.19838,0.10494,0.11998,0,0
6,GO NEGATIVE REGULATION OF SINGLE STRANDED VIRAL RNA REPLICATION VIA DOUBLE STRANDED DNA INTERMEDIATE,0.31997,0.10484,0.077653,0,0
6,GO CALCIUM DEPENDENT CELL CELL ADHESION VIA PLASMA MEMBRANE CELL ADHESION MOLECULES,0.016027,0.10481,0.15522,0,0
6,GO PROTEIN LOCALIZATION TO MICROTUBULE,0.015674,0.10479,0.14573,0,0
6,GO REGULATION OF PROTEIN GLYCOSYLATION,0.09714,0.10469,0.12886,0,0
6,GO BASE CONVERSION OR SUBSTITUTION EDITING,0.58864,0.10466,0.031636,0,0
6,GO POSITIVE REGULATION OF PROTEIN IMPORT,0.32592,0.1046,0.038214,0,0
6,GO BLASTODERM SEGMENTATION,0.080464,0.10439,0.13087,0,0
6,GO CLATHRIN DEPENDENT ENDOCYTOSIS,0.0023009,0.10418,0.15402,0,0
6,GO NEGATIVE REGULATION OF AXON GUIDANCE,0.060432,0.10396,0.14654,0,0
6,GO MEIOTIC CELL CYCLE PROCESS,5.2344e-05,0.10387,0.15948,0,0
6,GO NEGATIVE REGULATION OF CELL AGING,0.11742,0.10244,0.098546,0,0
6,GO CELL CELL JUNCTION ORGANIZATION,0.090011,0.10226,0.096294,0,0
6,GO NEGATIVE REGULATION OF LONG TERM SYNAPTIC POTENTIATION,0.18062,0.10222,0.10475,0,0
6,GO REGULATION OF PROTEIN K63 LINKED UBIQUITINATION,0.1914,0.10221,0.072109,0,0
6,GO GMP METABOLIC PROCESS,0.066192,0.1022,0.079651,0,0
6,GO SPINDLE ASSEMBLY,0.00016901,0.10182,0.1508,0,0
6,GO EPHRIN RECEPTOR SIGNALING PATHWAY,0.0028118,0.10179,0.14635,0,0
6,GO GLIAL CELL MIGRATION,0.22503,0.10149,0.066829,0,0
6,GO CORONARY VASCULATURE DEVELOPMENT,0.15683,0.10147,0.087282,0,0
6,GO REGULATION OF EXIT FROM MITOSIS,0.021973,0.1011,0.13178,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE,0.03006,0.10094,0.10854,0,0
6,GO MORPHOGENESIS OF AN EPITHELIAL BUD,0.13234,0.10069,0.11042,0,0
6,GO ENAMEL MINERALIZATION,0.40743,0.10041,0.05855,0,0
6,GO PHOSPHATIDYLINOSITOL DEPHOSPHORYLATION,0.0095807,0.099913,0.12987,0,0
6,GO CYCLIC NUCLEOTIDE BIOSYNTHETIC PROCESS,0.041383,0.099694,0.15687,0,0
6,GO NEGATIVE REGULATION OF HIPPO SIGNALING,0.56103,0.099562,0.0062993,0,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.10646,0.099332,0.086268,0,0
6,GO REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.13234,0.099071,0.060242,0,0
6,GO REGULATION OF MITOTIC SPINDLE ASSEMBLY,0.14197,0.099049,0.075344,0,0
6,GO REGULATION OF AMINO ACID TRANSPORT,0.09796,0.099004,0.10361,0,0
6,GO POSITIVE REGULATION OF POTASSIUM ION TRANSPORT,0.020385,0.098632,0.1142,0,0
6,GO GLAND MORPHOGENESIS,0.094715,0.098437,0.10625,0,0
6,GO RETROGRADE VESICLE MEDIATED TRANSPORT GOLGI TO ENDOPLASMIC RETICULUM,0.20699,0.098051,0.058765,0,0
6,GO BODY MORPHOGENESIS,0.12224,0.097955,0.087202,0,0
6,GO INTERLEUKIN 6 MEDIATED SIGNALING PATHWAY,0.16654,0.097437,0.10625,0,0
6,GO PLACENTA DEVELOPMENT,0.11933,0.097035,0.07513,0,0
6,GO RHYTHMIC BEHAVIOR,0.015329,0.096857,0.1138,0,0
6,GO REGULATION OF TELOMERE CAPPING,0.02915,0.095808,0.095911,0,0
6,GO OOCYTE MATURATION,0.046921,0.095765,0.1238,0,0
6,GO AUTOPHAGY OF NUCLEUS,0.86331,0.095706,0.018043,0,0
6,GO RESPONSE TO INACTIVITY,0.21738,0.095692,0.082646,0,0
6,GO NEGATIVE REGULATION OF LIPID STORAGE,0.38047,0.095619,0.05459,0,0
6,GO BRONCHUS DEVELOPMENT,0.084763,0.095515,0.17336,0,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO OXIDATIVE STRESS,0.32592,0.095229,0.070453,0,0
6,GO NEGATIVE REGULATION OF PLASMA MEMBRANE BOUNDED CELL PROJECTION ASSEMBLY,0.012227,0.09488,0.15338,0,0
6,GO ODONTOGENESIS,0.19838,0.094821,0.080392,0,0
6,GO VITAMIN CATABOLIC PROCESS,0.060988,0.094771,0.21514,0,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.068619,0.094277,0.23405,0,0
6,GO HEART FIELD SPECIFICATION,0.15098,0.093968,0.14582,0,0
6,GO CELLULAR RESPONSE TO ABIOTIC STIMULUS,0.13979,0.09364,0.053197,0,0
6,GO CELLULAR RESPONSE TO ANTIBIOTIC,0.48976,0.093585,0.053317,0,0
6,GO DORSAL AORTA DEVELOPMENT,0.1533,0.093523,0.11921,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MIGRATION,0.21889,0.092687,0.13212,0,0
6,GO CELL MATURATION,0.00029052,0.092338,0.14434,0,0
6,GO LIPOPROTEIN LOCALIZATION,0.079765,0.092264,0.087833,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION REGULATORY REGION DNA BINDING,0.40286,0.091965,0.059443,0,0
6,GO NEGATIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.25078,0.091805,0.05563,0,0
6,GO MULTICELLULAR ORGANISMAL RESPONSE TO STRESS,0.074349,0.091507,0.077386,0,0
6,GO RRNA TRANSCRIPTION,0.25583,0.091431,0.044978,0,0
6,GO POSITIVE REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.16285,0.091118,0.075284,0,0
6,GO GANGLIOSIDE METABOLIC PROCESS,0.02521,0.091032,0.13393,0,0
6,GO GAMMA DELTA T CELL DIFFERENTIATION,0.06986,0.090751,0.20225,0,0
6,GO NEGATIVE REGULATION OF CELLULAR SENESCENCE,0.10912,0.090594,0.10787,0,0
6,GO REGULATION OF ENDOTHELIAL CELL DIFFERENTIATION,0.085497,0.090514,0.10628,0,0
6,GO CARDIAC MUSCLE CELL DIFFERENTIATION,0.065005,0.090484,0.076147,0,0
6,GO RESPONSE TO VITAMIN D,0.090782,0.090349,0.11539,0,0
6,GO OSTEOBLAST DEVELOPMENT,0.20122,0.090061,0.060431,0,0
6,GO ARTERY DEVELOPMENT,0.318,0.089925,0.054189,0,0
6,GO REGULATION OF NATURAL KILLER CELL ACTIVATION,0.35253,0.089453,0.046476,0,0
6,GO CHONDROCYTE DIFFERENTIATION,0.088486,0.089345,0.086882,0,0
6,GO NEGATIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.26789,0.089216,0.044269,0,0
6,GO HOMEOSTASIS OF NUMBER OF CELLS,0.17669,0.089182,0.054749,0,0
6,GO INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.013856,0.089082,0.11984,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEPOLYMERIZATION,0.36741,0.088436,0.057601,0,0
6,GO ORGANIC HYDROXY COMPOUND TRANSPORT,0.16042,0.08843,0.065881,0,0
6,GO REGULATION OF MEIOTIC CELL CYCLE,0.016568,0.087827,0.10414,0,0
6,GO NEGATIVE REGULATION OF CELL DIVISION,0.37608,0.087388,0.070324,0,0
6,GO REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.18194,0.087242,0.074617,0,0
6,GO POSITIVE REGULATION OF MACROAUTOPHAGY,0.063258,0.08707,0.076482,0,0
6,GO NEGATIVE REGULATION OF ENDOCYTOSIS,0.25246,0.086996,0.068384,0,0
6,GO REGULATION OF PROTEIN IMPORT,0.3739,0.086949,0.030776,0,0
6,GO NEGATIVE REGULATION OF MUSCLE TISSUE DEVELOPMENT,0.068006,0.086907,0.10134,0,0
6,GO REGULATION OF CAMP DEPENDENT PROTEIN KINASE ACTIVITY,0.068619,0.086747,0.10175,0,0
6,GO REGULATION OF MEMBRANE LIPID DISTRIBUTION,0.074349,0.086704,0.091706,0,0
6,GO REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.30829,0.086615,0.04669,0,0
6,GO INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.10129,0.086453,0.1012,0,0
6,GO BONE GROWTH,0.10646,0.086273,0.12025,0,0
6,GO LIPID HOMEOSTASIS,0.59424,0.086246,0.027787,0,0
6,GO POSITIVE REGULATION OF KERATINOCYTE DIFFERENTIATION,0.59986,0.086015,0.014801,0,0
6,GO OUTFLOW TRACT MORPHOGENESIS,0.063836,0.085967,0.12656,0,0
6,GO BRANCH ELONGATION OF AN EPITHELIUM,0.26789,0.085879,0.074822,0,0
6,GO INNER EAR AUDITORY RECEPTOR CELL DIFFERENTIATION,0.11837,0.085809,0.10514,0,0
6,GO SEROTONIN RECEPTOR SIGNALING PATHWAY,0.0046018,0.084874,0.12724,0,0
6,GO POSITIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.18595,0.084692,0.059195,0,0
6,GO CHLORIDE TRANSPORT,0.023919,0.084522,0.0993,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN METANEPHROS DEVELOPMENT,0.34835,0.084305,0.059608,0,0
6,GO RESPONSE TO COLD,0.26964,0.084157,0.056284,0,0
6,GO NEURONAL ACTION POTENTIAL,0.29315,0.084096,0.084182,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL ACTIVATION,0.19838,0.084012,0.081068,0,0
6,GO PRIMARY AMINO COMPOUND METABOLIC PROCESS,0.19979,0.08396,0.12141,0,0
6,GO KERATINOCYTE PROLIFERATION,0.41899,0.083535,0.046459,0,0
6,GO POSITIVE REGULATION OF CARTILAGE DEVELOPMENT,0.25753,0.083483,0.052304,0,0
6,GO CD4 POSITIVE OR CD8 POSITIVE ALPHA BETA T CELL LINEAGE COMMITMENT,0.084034,0.083425,0.10474,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.10734,0.083399,0.082048,0,0
6,GO POSITIVE REGULATION OF PROTEIN POLYUBIQUITINATION,0.065005,0.083169,0.098221,0,0
6,GO POSITIVE REGULATION OF MESENCHYMAL CELL PROLIFERATION,0.17156,0.083133,0.11827,0,0
6,GO FIBROBLAST MIGRATION,0.16285,0.082981,0.06933,0,0
6,GO POSITIVE REGULATION OF MYELINATION,0.14642,0.082752,0.071977,0,0
6,GO ESTABLISHMENT OF EPITHELIAL CELL POLARITY,0.15683,0.082529,0.08442,0,0
6,GO INOSITOL LIPID MEDIATED SIGNALING,0.17411,0.082376,0.069214,0,0
6,GO REGULATION OF CARTILAGE DEVELOPMENT,0.14983,0.082293,0.07706,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL PROLIFERATION,0.25246,0.082272,0.070349,0,0
6,GO ENDOCRINE HORMONE SECRETION,0.14642,0.082203,0.057572,0,0
6,GO LYMPHANGIOGENESIS,0.099614,0.081709,0.10769,0,0
6,GO NEGATIVE REGULATION OF CARBOHYDRATE METABOLIC PROCESS,0.10912,0.081608,0.099556,0,0
6,GO TRANSCRIPTION INITIATION FROM RNA POLYMERASE I PROMOTER,0.42133,0.081405,0.024829,0,0
6,GO GLUTAMATE SECRETION,0.061549,0.081328,0.14621,0,0
6,GO STRIATED MUSCLE ADAPTATION,0.16904,0.081245,0.076227,0,0
6,GO POSITIVE REGULATION OF DNA BINDING,0.0052854,0.080921,0.11496,0,0
6,GO RECEPTOR SIGNALING PATHWAY VIA STAT,0.38267,0.080764,0.04234,0,0
6,GO FAT CELL DIFFERENTIATION,0.080464,0.080721,0.080463,0,0
6,GO ASTROCYTE DIFFERENTIATION,0.085497,0.080374,0.089806,0,0
6,GO RENAL FILTRATION,0.061549,0.080344,0.22444,0,0
6,GO MUSCLE CELL MIGRATION,0.29502,0.08005,0.058351,0,0
6,GO REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.31409,0.080049,0.065501,0,0
6,GO MAMMARY GLAND ALVEOLUS DEVELOPMENT,0.21288,0.079348,0.090877,0,0
6,GO RESPONSE TO AXON INJURY,0.063836,0.079174,0.09282,0,0
6,GO REVERSE CHOLESTEROL TRANSPORT,0.085497,0.079128,0.13549,0,0
6,GO POSITIVE REGULATION OF LYASE ACTIVITY,0.1873,0.079067,0.065259,0,0
6,GO TRANSCRIPTION BY RNA POLYMERASE I,0.49487,0.078985,0.020177,0,0
6,GO TRANSCYTOSIS,0.66321,0.078862,0.028782,0,0
6,GO PHENOL CONTAINING COMPOUND METABOLIC PROCESS,0.066192,0.078829,0.087507,0,0
6,GO REGULATION OF DEACETYLASE ACTIVITY,0.34627,0.078537,0.063867,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.038637,0.078535,0.068899,0,0
6,GO MORPHOGENESIS OF AN EPITHELIAL FOLD,0.063258,0.078262,0.10365,0,0
6,GO RESPONSE TO LEAD ION,0.092339,0.078169,0.095834,0,0
6,GO CORTICOSTEROID HORMONE SECRETION,0.35674,0.078099,0.062048,0,0
6,GO ANTERIOR POSTERIOR AXIS SPECIFICATION,0.1262,0.077705,0.082188,0,0
6,GO MYELOID CELL HOMEOSTASIS,0.35253,0.077218,0.052249,0,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN LOCALIZATION,0.10299,0.077027,0.063855,0,0
6,GO MAINTENANCE OF CELL POLARITY,0.088486,0.07701,0.11956,0,0
6,GO OSTEOBLAST DIFFERENTIATION,0.48215,0.076906,0.03243,0,0
6,GO PHOSPHOLIPID TRANSPORT,0.53406,0.076341,0.033421,0,0
6,GO POSITIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.24252,0.076256,0.11621,0,0
6,GO METANEPHRIC MESENCHYME DEVELOPMENT,0.077018,0.07618,0.18064,0,0
6,GO MAINTENANCE OF APICAL BASAL CELL POLARITY,0.18595,0.076113,0.12622,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE ARREST,0.14088,0.076063,0.07599,0,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.38933,0.075891,0.062261,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.38933,0.075813,0.061233,0,0
6,GO POSITIVE REGULATION OF VASOCONSTRICTION,0.18866,0.075641,0.060871,0,0
6,GO HISTONE MRNA METABOLIC PROCESS,0.2114,0.075533,0.038993,0,0
6,GO MRNA TRANSCRIPTION BY RNA POLYMERASE II,0.064418,0.075041,0.095753,0,0
6,GO CARDIOCYTE DIFFERENTIATION,0.15214,0.07495,0.064396,0,0
6,GO POSITIVE REGULATION OF MEIOTIC NUCLEAR DIVISION,0.30829,0.074818,0.082514,0,0
6,GO AUTOPHAGOSOME ORGANIZATION,0.14755,0.0747,0.064316,0,0
6,GO REGULATION OF PROTEIN TARGETING TO MEMBRANE,0.091558,0.074673,0.09145,0,0
6,GO REGULATION OF KIDNEY DEVELOPMENT,0.1146,0.074241,0.080981,0,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL DIAMETER,0.0048405,0.074152,0.10836,0,0
6,GO LIPID OXIDATION,0.69286,0.074098,0.020054,0,0
6,GO SMAD PROTEIN SIGNAL TRANSDUCTION,0.11837,0.074078,0.076259,0,0
6,GO CELL SUBSTRATE JUNCTION ORGANIZATION,0.44269,0.073819,0.049834,0,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE RECEPTOR PROTEIN SERINE THREONINE KINASE SIGNALING PATHWAY,0.030368,0.073793,0.098665,0,0
6,GO NEGATIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.09796,0.073696,0.13438,0,0
6,GO NEGATIVE REGULATION OF VASCULATURE DEVELOPMENT,0.18062,0.073246,0.072652,0,0
6,GO LENS FIBER CELL DEVELOPMENT,0.13234,0.07323,0.10383,0,0
6,GO PIGMENTATION,0.34213,0.073013,0.043343,0,0
6,GO PEPTIDYL THREONINE DEPHOSPHORYLATION,0.13444,0.073011,0.096449,0,0
6,GO REGULATION OF GRANULOCYTE DIFFERENTIATION,0.93382,0.073004,-0.012947,0,0
6,GO IMMUNOGLOBULIN PRODUCTION INVOLVED IN IMMUNOGLOBULIN MEDIATED IMMUNE RESPONSE,0.39606,0.072887,0.043041,0,0
6,GO REGULATION OF PROTEIN EXPORT FROM NUCLEUS,0.0092477,0.072605,0.11396,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS EXONUCLEOLYTIC,0.093918,0.07231,0.064077,0,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION IN RESPONSE TO MITOCHONDRIAL DEPOLARIZATION,0.24252,0.072296,0.069535,0,0
6,GO REGULATION OF AUTOPHAGY OF MITOCHONDRION,0.318,0.072271,0.044488,0,0
6,GO PROTEIN NEDDYLATION,0.84107,0.071997,-0.0088416,0,0
6,GO LEPTIN MEDIATED SIGNALING PATHWAY,0.17283,0.071957,0.089729,0,0
6,GO PROTEIN DNA COMPLEX DISASSEMBLY,0.40514,0.071825,0.029912,0,0
6,GO NEGATIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.46713,0.071799,0.044111,0,0
6,GO CONNECTIVE TISSUE DEVELOPMENT,0.09714,0.071684,0.074663,0,0
6,GO GOLGI TO VACUOLE TRANSPORT,0.33194,0.071646,0.052358,0,0
6,GO PLASMA MEMBRANE TUBULATION,0.25753,0.071638,0.071944,0,0
6,GO REGULATION OF LAMELLIPODIUM ASSEMBLY,0.33599,0.071443,0.051991,0,0
6,GO CHEMICAL HOMEOSTASIS,0.38047,0.071381,0.040007,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL PROLIFERATION,0.38267,0.071355,0.040813,0,0
6,GO NEGATIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.29689,0.071307,0.05532,0,0
6,GO PROTEIN LOCALIZATION TO VACUOLE,0.060432,0.071304,0.089445,0,0
6,GO REGULATION OF CATION TRANSMEMBRANE TRANSPORT,0.082591,0.071236,0.07841,0,0
6,GO POSITIVE REGULATION OF PODOSOME ASSEMBLY,0.16654,0.071209,0.15256,0,0
6,GO POSITIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.12721,0.071152,0.072723,0,0
6,GO POSITIVE REGULATION OF RECEPTOR MEDIATED ENDOCYTOSIS,0.44752,0.071101,0.053414,0,0
6,GO ANATOMICAL STRUCTURE FORMATION INVOLVED IN MORPHOGENESIS,0.060432,0.071061,0.079889,0,0
6,GO NEGATIVE REGULATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.1754,0.071049,0.082643,0,0
6,GO GRANULOCYTE DIFFERENTIATION,0.25414,0.070962,0.065655,0,0
6,GO EPIDERMIS DEVELOPMENT,0.30446,0.070955,0.042037,0,0
6,GO ADAPTIVE THERMOGENESIS,0.20845,0.070827,0.055173,0,0
6,GO RADIAL GLIAL CELL DIFFERENTIATION,0.3739,0.070635,0.076822,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.18194,0.070453,0.056018,0,0
6,GO POSITIVE REGULATION OF MEIOTIC CELL CYCLE,0.066192,0.07043,0.12877,0,0
6,GO NEGATIVE REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.22348,0.070345,0.073607,0,0
6,GO PORE COMPLEX ASSEMBLY,0.22042,0.070028,0.049346,0,0
6,GO GONADOTROPIN SECRETION,0.33396,0.069975,0.074695,0,0
6,GO REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.5314,0.06972,0.042833,0,0
6,GO CELLULAR RESPONSE TO LIPID,0.44994,0.069386,0.034685,0,0
6,GO RRNA 3 END PROCESSING,0.61402,0.069341,0.0095079,0,0
6,GO LAMELLIPODIUM ORGANIZATION,0.72603,0.069334,0.027091,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.38267,0.069262,0.075581,0,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS INVOLVED IN CELLULAR PROTEIN CATABOLIC PROCESS,0.086237,0.069252,0.063909,0,0
6,GO RESPONSE TO IONIZING RADIATION,0.14419,0.069211,0.052688,0,0
6,GO NOTCH SIGNALING PATHWAY,0.044722,0.069136,0.094316,0,0
6,GO CYCLIC NUCLEOTIDE CATABOLIC PROCESS,0.1754,0.069036,0.099838,0,0
6,GO POSITIVE REGULATION OF FATTY ACID OXIDATION,0.75356,0.068982,0.02627,0,0
6,GO CATECHOLAMINE BIOSYNTHETIC PROCESS,0.5665,0.068977,0.074998,0,0
6,GO REGULATION OF VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.70787,0.068904,0.033207,0,0
6,GO MULTI ORGANISM CELLULAR PROCESS,0.082591,0.068849,0.1068,0,0
6,GO ENDOPLASMIC RETICULUM MANNOSE TRIMMING,0.3871,0.068653,0.035403,0,0
6,GO REGULATION OF PLATELET AGGREGATION,0.6691,0.068564,0.030356,0,0
6,GO N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.22814,0.068514,0.066826,0,0
6,GO NEGATIVE REGULATION OF TRANSLATIONAL INITIATION,0.43789,0.068438,0.029852,0,0
6,GO POSITIVE T CELL SELECTION,0.19697,0.068437,0.054432,0,0
6,GO METANEPHRIC EPITHELIUM DEVELOPMENT,0.65734,0.068185,0.037533,0,0
6,GO SKIN DEVELOPMENT,0.31604,0.068162,0.043994,0,0
6,GO RIBONUCLEOTIDE CATABOLIC PROCESS,0.1653,0.068147,0.06192,0,0
6,GO SERTOLI CELL DIFFERENTIATION,0.17411,0.068113,0.084524,0,0
6,GO NEGATIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.18595,0.068079,0.098794,0,0
6,GO INTERMEDIATE FILAMENT BASED PROCESS,0.37827,0.067975,0.050457,0,0
6,GO POSITIVE REGULATION OF MULTI ORGANISM PROCESS,0.15802,0.067966,0.059651,0,0
6,GO CIRCULATORY SYSTEM DEVELOPMENT,0.072397,0.067901,0.076763,0,0
6,GO EPIBOLY,0.85059,0.067827,-0.015407,0,0
6,GO CARTILAGE DEVELOPMENT,0.22503,0.067661,0.05827,0,0
6,GO CAMP METABOLIC PROCESS,0.14983,0.067514,0.09333,0,0
6,GO EPITHELIAL CELL DIFFERENTIATION,0.085497,0.067175,0.081871,0,0
6,GO TOOTH MINERALIZATION,0.24089,0.067144,0.093435,0,0
6,GO CELL MOTILITY,0.15683,0.066994,0.066324,0,0
6,GO POSITIVE REGULATION OF VIRAL GENOME REPLICATION,0.35674,0.066616,0.025179,0,0
6,GO PROTEIN TARGETING TO LYSOSOME,0.28213,0.066507,0.083765,0,0
6,GO NEGATIVE REGULATION OF SKELETAL MUSCLE TISSUE DEVELOPMENT,0.17283,0.066207,0.079749,0,0
6,GO STEROL HOMEOSTASIS,0.66321,0.066102,0.01477,0,0
6,GO REGULATION OF ENDOTHELIAL CELL CHEMOTAXIS,0.93704,0.06607,0.0013918,0,0
6,GO CARNITINE METABOLIC PROCESS,0.34627,0.065926,0.063727,0,0
6,GO NEGATIVE REGULATION OF MYELOID CELL APOPTOTIC PROCESS,0.11742,0.065834,0.119,0,0
6,GO ACTIVATION OF NF KAPPAB INDUCING KINASE ACTIVITY,0.51035,0.065829,0.039143,0,0
6,GO EXOCRINE SYSTEM DEVELOPMENT,0.10912,0.065493,0.11456,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA JAK STAT,0.3739,0.065455,0.056202,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.15098,0.065434,0.074319,0,0
6,GO MULTI ORGANISM LOCALIZATION,0.12822,0.065393,0.051872,0,0
6,GO RESPONSE TO FIBROBLAST GROWTH FACTOR,0.2114,0.065342,0.050007,0,0
6,GO RESPONSE TO ISOQUINOLINE ALKALOID,0.071119,0.065293,0.09309,0,0
6,GO MYOBLAST PROLIFERATION,0.42838,0.065093,0.0262,0,0
6,GO EXOCYTIC PROCESS,0.19979,0.065057,0.08201,0,0
6,GO REGULATION OF SYNAPTIC TRANSMISSION DOPAMINERGIC,0.11002,0.064533,0.12617,0,0
6,GO NEGATIVE REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.22042,0.06449,0.11539,0,0
6,GO RESPONSE TO STEROID HORMONE,0.38933,0.06443,0.039723,0,0
6,GO REGULATION OF DELAYED RECTIFIER POTASSIUM CHANNEL ACTIVITY,0.1453,0.064413,0.058909,0,0
6,GO EPIDERMAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.39381,0.064397,0.04785,0,0
6,GO GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.4451,0.064251,0.030432,0,0
6,GO HISTONE SERINE PHOSPHORYLATION,0.24252,0.064111,0.058126,0,0
6,GO CELLULAR RESPONSE TO ACID CHEMICAL,0.13656,0.063885,0.088348,0,0
6,GO POSITIVE REGULATION OF GLUCONEOGENESIS,0.30637,0.06366,0.046263,0,0
6,GO EMBRYONIC PLACENTA MORPHOGENESIS,0.081877,0.063523,0.19232,0,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE ASSEMBLY,0.20699,0.063326,0.080401,0,0
6,GO VASCULAR ENDOTHELIAL CELL PROLIFERATION,0.17156,0.063295,0.084876,0,0
6,GO CHAPERONE COFACTOR DEPENDENT PROTEIN REFOLDING,0.318,0.063156,0.054169,0,0
6,GO REGULATION OF STEM CELL DIFFERENTIATION,0.28033,0.063053,0.044088,0,0
6,GO MITOCHONDRIAL DNA REPLICATION,0.86649,0.062743,0.0021791,0,0
6,GO NUCLEOTIDE EXCISION REPAIR PREINCISION COMPLEX ASSEMBLY,0.16778,0.062697,0.049914,0,0
6,GO SIGNAL TRANSDUCTION BY PROTEIN PHOSPHORYLATION,0.38047,0.062673,0.039826,0,0
6,GO LIVER REGENERATION,0.48722,0.062562,0.01876,0,0
6,GO POSITIVE REGULATION OF PROTEIN METABOLIC PROCESS,0.27673,0.062515,0.047312,0,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ASSEMBLY,0.10471,0.062323,0.07042,0,0
6,GO TERPENOID BIOSYNTHETIC PROCESS,0.2458,0.062317,0.070589,0,0
6,GO REGULATION OF LIPID STORAGE,0.67501,0.062311,0.016823,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL DIFFERENTIATION,0.093918,0.06228,0.092985,0,0
6,GO REGULATION OF GTP BINDING,0.14088,0.062071,0.11505,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.6312,0.062047,0.034131,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR TRANSPORT,0.30446,0.062004,0.038777,0,0
6,GO RETINAL CONE CELL DIFFERENTIATION,0.67206,0.061948,0.042184,0,0
6,GO CYTOPLASM ORGANIZATION,0.44269,0.061811,0.05936,0,0
6,GO MODULATION OF PROCESS OF OTHER ORGANISM,0.42602,0.061704,0.027046,0,0
6,GO ERBB SIGNALING PATHWAY,0.42367,0.061648,0.040193,0,0
6,GO TERMINATION OF RNA POLYMERASE I TRANSCRIPTION,0.59705,0.061601,-0.00035928,0,0
6,GO PHOSPHATIDYLINOSITOL BIOSYNTHETIC PROCESS,0.11837,0.061464,0.063433,0,0
6,GO NATURAL KILLER CELL ACTIVATION,0.42133,0.061384,0.028905,0,0
6,GO BIOLOGICAL ADHESION,0.36098,0.061194,0.052783,0,0
6,GO SPINDLE MIDZONE ASSEMBLY,0.077698,0.061149,0.10636,0,0
6,GO TRACHEA MORPHOGENESIS,0.1252,0.06108,0.10126,0,0
6,GO RESPONSE TO EPIDERMAL GROWTH FACTOR,0.49743,0.061058,0.053766,0,0
6,GO PROTEIN LOCALIZATION TO PHAGOPHORE ASSEMBLY SITE,0.15802,0.06062,0.083869,0,0
6,GO REGULATION OF ICOSANOID SECRETION,0.41666,0.060263,0.053651,0,0
6,GO ASTROCYTE DEVELOPMENT,0.56103,0.060094,0.040097,0,0
6,GO DOPAMINE METABOLIC PROCESS,0.15921,0.060012,0.11321,0,0
6,GO NEGATIVE REGULATION OF CELL POPULATION PROLIFERATION,0.11275,0.059915,0.067995,0,0
6,GO DICARBOXYLIC ACID TRANSPORT,0.030368,0.05967,0.11457,0,0
6,GO REGULATORY T CELL DIFFERENTIATION,0.24416,0.05957,0.073932,0,0
6,GO POSITIVE REGULATION OF GLIOGENESIS,0.011678,0.059492,0.12821,0,0
6,GO REGULATION OF OXIDOREDUCTASE ACTIVITY,0.95316,0.059458,0.0023289,0,0
6,GO CARBOHYDRATE TRANSMEMBRANE TRANSPORT,0.21738,0.059249,0.053805,0,0
6,GO NCRNA EXPORT FROM NUCLEUS,0.076344,0.059211,0.088379,0,0
6,GO PROTEIN LOCALIZATION TO CELL CELL JUNCTION,0.2714,0.059068,0.1156,0,0
6,GO NEUROTRANSMITTER CATABOLIC PROCESS,0.39156,0.05879,0.039195,0,0
6,GO NEGATIVE REGULATION OF CELL DEATH,0.40973,0.058783,0.03445,0,0
6,GO SKELETAL MUSCLE ADAPTATION,0.13027,0.058689,0.10045,0,0
6,GO CARDIAC MUSCLE TISSUE MORPHOGENESIS,0.057179,0.058433,0.094566,0,0
6,GO FOCAL ADHESION ASSEMBLY,0.15802,0.058116,0.07548,0,0
6,GO SNARE COMPLEX ASSEMBLY,0.90809,0.058099,0.013091,0,0
6,GO MESENCHYME MORPHOGENESIS,0.50776,0.058088,0.03754,0,0
6,GO MESODERMAL CELL FATE SPECIFICATION,0.40286,0.058071,0.053645,0,0
6,GO REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.076344,0.058069,0.080382,0,0
6,GO BRANCHING INVOLVED IN BLOOD VESSEL MORPHOGENESIS,0.25414,0.058053,0.064979,0,0
6,GO REGULATION OF ION TRANSPORT,0.051111,0.058035,0.082586,0,0
6,GO REGULATION OF ACTIN FILAMENT ORGANIZATION,0.38933,0.057665,0.048744,0,0
6,GO RIBONUCLEOPROTEIN COMPLEX SUBUNIT ORGANIZATION,0.46962,0.057477,0.025242,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.49743,0.057392,0.027249,0,0
6,GO NEGATIVE REGULATION OF BEHAVIOR,0.12721,0.057312,0.097241,0,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.11647,0.057214,0.090862,0,0
6,GO CELL CELL ADHESION,0.28761,0.057166,0.055049,0,0
6,GO PHOSPHOLIPID DEPHOSPHORYLATION,0.020166,0.057033,0.12274,0,0
6,GO REGULATION OF FATTY ACID TRANSPORT,0.46218,0.056965,0.033122,0,0
6,GO POSITIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.25753,0.056924,0.075382,0,0
6,GO REGULATION OF RECEPTOR RECYCLING,0.89526,0.056706,0.0064643,0,0
6,GO NEGATIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.1533,0.056646,0.08016,0,0
6,GO CARBOHYDRATE CATABOLIC PROCESS,0.45972,0.056475,0.033044,0,0
6,GO IMPORT INTO CELL,0.095518,0.056472,0.08492,0,0
6,GO NEGATIVE REGULATION OF STRESS ACTIVATED PROTEIN KINASE SIGNALING CASCADE,0.24416,0.056456,0.06415,0,0
6,GO CIRCADIAN SLEEP WAKE CYCLE SLEEP,0.15802,0.056366,0.091006,0,0
6,GO GOLGI VESICLE TRANSPORT,0.42367,0.056176,0.03507,0,0
6,GO REGULATION OF PROTEIN POLYMERIZATION,0.0083098,0.056123,0.11467,0,0
6,GO AMINO ACID TRANSMEMBRANE TRANSPORT,0.28213,0.056091,0.046178,0,0
6,GO AORTIC VALVE DEVELOPMENT,0.99515,0.055797,-0.0017524,0,0
6,GO REGULATION OF ORGANIC ACID TRANSPORT,0.14642,0.05576,0.065595,0,0
6,GO ERYTHROCYTE HOMEOSTASIS,0.25753,0.055736,0.057236,0,0
6,GO SPLICEOSOMAL SNRNP ASSEMBLY,0.39156,0.055714,0.03337,0,0
6,GO TYPE B PANCREATIC CELL PROLIFERATION,0.42602,0.055653,0.07815,0,0
6,GO RESPONSE TO OSMOTIC STRESS,0.32792,0.055452,0.047467,0,0
6,GO NEGATIVE REGULATION OF PEPTIDE SECRETION,0.032607,0.055414,0.086541,0,0
6,GO VESICLE MEDIATED TRANSPORT BETWEEN ENDOSOMAL COMPARTMENTS,0.18595,0.055299,0.079587,0,0
6,GO REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.36311,0.055205,0.040745,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CELL DIFFERENTIATION,0.30066,0.055118,0.057638,0,0
6,GO REGULATION OF NUCLEAR TRANSCRIBED MRNA POLY A TAIL SHORTENING,0.14869,0.055071,0.092139,0,0
6,GO MONOCARBOXYLIC ACID CATABOLIC PROCESS,0.46218,0.05505,0.028135,0,0
6,GO OOCYTE DIFFERENTIATION,0.094715,0.05497,0.078759,0,0
6,GO RNA METHYLATION,0.59144,0.054964,0.028742,0,0
6,GO NEGATIVE REGULATION OF GROWTH,0.2114,0.054889,0.057027,0,0
6,GO EPITHELIAL CELL DIFFERENTIATION INVOLVED IN KIDNEY DEVELOPMENT,0.32592,0.054848,0.068663,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CELL MIGRATION,0.55016,0.054809,0.039864,0,0
6,GO REGULATION OF TRANSCRIPTION OF NUCLEOLAR LARGE RRNA BY RNA POLYMERASE I,0.11553,0.054715,0.074582,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DEVELOPMENT,0.69286,0.054652,0.032066,0,0
6,GO REGULATION OF MRNA CATABOLIC PROCESS,0.24745,0.054609,0.041846,0,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX ASSEMBLY,0.13979,0.054537,0.063598,0,0
6,GO REGULATION OF GENE SILENCING,0.069238,0.054497,0.07075,0,0
6,GO INTERMEMBRANE LIPID TRANSFER,0.30637,0.054409,0.062707,0,0
6,GO PYRIMIDINE NUCLEOBASE METABOLIC PROCESS,0.62832,0.054343,0.027649,0,0
6,GO GLUCOSE CATABOLIC PROCESS,0.45238,0.054339,0.046461,0,0
6,GO CHEMOKINE C C MOTIF LIGAND 5 PRODUCTION,0.068619,0.054192,0.13338,0,0
6,GO REGULATION OF RETROGRADE PROTEIN TRANSPORT ER TO CYTOSOL,0.5394,0.05411,0.032665,0,0
6,GO RESPONSE TO ABIOTIC STIMULUS,0.20699,0.054078,0.045958,0,0
6,GO CELLULAR RESPONSE TO PROSTAGLANDIN STIMULUS,0.10558,0.054008,0.11065,0,0
6,GO TEMPERATURE HOMEOSTASIS,0.13656,0.054008,0.063898,0,0
6,GO MONOVALENT INORGANIC ANION HOMEOSTASIS,0.178,0.053984,0.088032,0,0
6,GO POSITIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.1387,0.053978,0.062285,0,0
6,GO POSITIVE REGULATION OF GONAD DEVELOPMENT,0.37173,0.053823,0.056853,0,0
6,GO ERBB2 SIGNALING PATHWAY,0.28761,0.053759,0.050079,0,0
6,GO CELLULAR MACROMOLECULE CATABOLIC PROCESS,0.11092,0.053615,0.048204,0,0
6,GO WATER TRANSPORT,0.20122,0.053334,0.11445,0,0
6,GO INNER CELL MASS CELL PROLIFERATION,0.31997,0.053225,0.049014,0,0
6,GO MATERNAL PLACENTA DEVELOPMENT,0.51819,0.053196,0.056992,0,0
6,GO LIPID MODIFICATION,0.20409,0.052403,0.05643,0,0
6,GO ION HOMEOSTASIS,0.6055,0.052382,0.02679,0,0
6,GO NEGATIVE REGULATION OF CELL FATE COMMITMENT,0.28578,0.052257,0.07294,0,0
6,GO COMPLEMENT ACTIVATION LECTIN PATHWAY,0.33803,0.052154,0.090685,0,0
6,GO POSITIVE REGULATION OF SMALL GTPASE MEDIATED SIGNAL TRANSDUCTION,0.26614,0.052062,0.064117,0,0
6,GO TRNA WOBBLE BASE MODIFICATION,0.3871,0.052018,0.033526,0,0
6,GO OSSIFICATION,0.36311,0.051968,0.041943,0,0
6,GO PEPTIDYL METHIONINE MODIFICATION,0.44269,0.051961,0.038088,0,0
6,GO MUSCLE SYSTEM PROCESS,0.50776,0.051938,0.035778,0,0
6,GO NEGATIVE REGULATION OF PLATELET AGGREGATION,0.39832,0.051898,0.082339,0,0
6,GO NEGATIVE REGULATION OF AUTOPHAGY,0.5314,0.051799,0.036976,0,0
6,GO SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.45238,0.051796,0.044464,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.86012,0.051774,0.022871,0,0
6,GO METAL ION HOMEOSTASIS,0.58864,0.051489,0.030728,0,0
6,GO REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.47461,0.051456,0.045817,0,0
6,GO REGULATION OF CATABOLIC PROCESS,0.178,0.051375,0.047426,0,0
6,GO PHOSPHATIDYLSERINE ACYL CHAIN REMODELING,0.94026,0.051307,-0.0060144,0,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.24911,0.050829,0.076571,0,0
6,GO REGULATION OF MEIOTIC NUCLEAR DIVISION,0.22814,0.050673,0.05373,0,0
6,GO LEUKOCYTE MIGRATION INVOLVED IN INFLAMMATORY RESPONSE,0.33396,0.050658,0.090548,0,0
6,GO REGULATION OF RESPONSE TO STRESS,0.54746,0.050638,0.029745,0,0
6,GO HEAD MORPHOGENESIS,0.50776,0.05058,0.049387,0,0
6,GO EXTRACELLULAR MATRIX ASSEMBLY,0.20122,0.050514,0.085466,0,0
6,GO GASTRULATION,0.38267,0.050413,0.044363,0,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.62545,0.050409,0.022818,0,0
6,GO FATTY ACID TRANSMEMBRANE TRANSPORT,0.18461,0.050163,0.080276,0,0
6,GO EXPORT ACROSS PLASMA MEMBRANE,0.1313,0.05016,0.085503,0,0
6,GO CIRCULATORY SYSTEM PROCESS,0.19979,0.050158,0.057894,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS,0.76899,0.050131,0.012615,0,0
6,GO EPITHELIAL CELL PROLIFERATION INVOLVED IN PROSTATE GLAND DEVELOPMENT,0.076344,0.050081,0.15239,0,0
6,GO MYELOID CELL DIFFERENTIATION,0.52609,0.050051,0.027441,0,0
6,GO UBIQUINONE METABOLIC PROCESS,0.85694,0.049999,0.0025372,0,0
6,GO REGULATION OF CELLULAR COMPONENT MOVEMENT,0.31604,0.049964,0.052267,0,0
6,GO COBALAMIN METABOLIC PROCESS,0.25753,0.049953,0.051362,0,0
6,GO RESPONSE TO MITOCHONDRIAL DEPOLARISATION,0.24252,0.049932,0.067109,0,0
6,GO STEROL METABOLIC PROCESS,0.99838,0.049864,-0.00051253,0,0
6,GO REGULATION OF CELL FATE SPECIFICATION,0.30637,0.049847,0.082784,0,0
6,GO CELLULAR RESPONSE TO VIRUS,0.58029,0.049787,0.019877,0,0
6,GO REGULATION OF LIPID METABOLIC PROCESS,0.79075,0.049693,-0.0009875,0,0
6,GO ASTROCYTE ACTIVATION,0.10823,0.049691,0.090934,0,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.12224,0.04963,0.08559,0,0
6,GO POSITIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.12322,0.049615,0.067457,0,0
6,GO REGULATION OF PROTEIN BINDING,0.44028,0.049452,0.045725,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE BY P53 CLASS MEDIATOR,0.40514,0.049383,0.044733,0,0
6,GO MYELOID CELL DEVELOPMENT,0.28761,0.049331,0.055011,0,0
6,GO NEGATIVE REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.36098,0.049293,0.069377,0,0
6,GO REGULATION OF EXOSOMAL SECRETION,0.48722,0.049253,0.036365,0,0
6,GO REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.48468,0.049152,0.032624,0,0
6,GO BONE CELL DEVELOPMENT,0.85059,0.048987,0.019374,0,0
6,GO REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.13444,0.048983,0.058277,0,0
6,GO COPII COATED VESICLE CARGO LOADING,0.46218,0.048813,0.048803,0,0
6,GO NEGATIVE REGULATION OF BIOMINERALIZATION,0.26964,0.048809,0.086462,0,0
6,GO LYMPHOCYTE DIFFERENTIATION,0.2913,0.048797,0.038515,0,0
6,GO REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.67501,0.048793,0.029234,0,0
6,GO CELL RECOGNITION,0.03902,0.048695,0.088728,0,0
6,GO BLASTOCYST DEVELOPMENT,0.21587,0.048673,0.040554,0,0
6,GO POSITIVE REGULATION OF STRESS FIBER ASSEMBLY,0.55287,0.048655,0.03977,0,0
6,GO MRNA CLEAVAGE,0.096327,0.048539,0.085639,0,0
6,GO CELLULAR RESPONSE TO ETHANOL,0.92094,0.048471,0.0099482,0,0
6,GO NEGATIVE REGULATION OF LIPID LOCALIZATION,0.71693,0.048465,0.016456,0,0
6,GO REGULATION OF GAMMA DELTA T CELL ACTIVATION,0.11553,0.048465,0.18031,0,0
6,GO NEGATIVE REGULATION OF CALCIUM MEDIATED SIGNALING,0.13549,0.048447,0.079328,0,0
6,GO POSITIVE REGULATION OF INTRACELLULAR SIGNAL TRANSDUCTION,0.5,0.048428,0.032996,0,0
6,GO BILE ACID METABOLIC PROCESS,0.19838,0.048381,0.060579,0,0
6,GO STEROID HORMONE SECRETION,0.30829,0.048316,0.055522,0,0
6,GO LYMPH VESSEL DEVELOPMENT,0.25583,0.048312,0.087234,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.6055,0.04824,0.024812,0,0
6,GO GLOMERULUS DEVELOPMENT,0.94026,0.048168,0.024971,0,0
6,GO RESPONSE TO MUSCLE ACTIVITY,0.56925,0.048106,0.026222,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.22814,0.047963,0.072854,0,0
6,GO PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.33599,0.04794,0.053979,0,0
6,GO CELL CELL JUNCTION ASSEMBLY,0.30255,0.047933,0.061724,0,0
6,GO NEGATIVE REGULATION OF CELL CYCLE G2 M PHASE TRANSITION,0.5394,0.047891,0.021161,0,0
6,GO RESPONSE TO MISFOLDED PROTEIN,0.67206,0.047884,0.041872,0,0
6,GO REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.41899,0.047749,0.043641,0,0
6,GO REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.2644,0.047632,0.05565,0,0
6,GO CELL MATRIX ADHESION,0.6515,0.047525,0.033623,0,0
6,GO DNA DEALKYLATION INVOLVED IN DNA REPAIR,0.58029,0.047497,0.024056,0,0
6,GO NEGATIVE REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.02128,0.047458,0.11264,0,0
6,GO TRNA METHYLATION,0.69286,0.047384,0.0077578,0,0
6,GO POSITIVE REGULATION OF VIRAL TRANSCRIPTION,0.049212,0.047314,0.061024,0,0
6,GO PROTEIN REFOLDING,0.47963,0.046994,0.047073,0,0
6,GO REGULATION OF PLASMA MEMBRANE ORGANIZATION,0.27673,0.046799,0.11296,0,0
6,GO P38MAPK CASCADE,0.28213,0.046647,0.077727,0,0
6,GO PHENOL CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.56103,0.046625,0.049484,0,0
6,GO QUINONE METABOLIC PROCESS,0.75048,0.046594,0.020271,0,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY IN RESPONSE TO VIRUS,0.9693,0.046575,3.1613e-05,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.57752,0.046561,0.0228,0,0
6,GO T CELL SELECTION,0.32195,0.046543,0.044932,0,0
6,GO ORGANONITROGEN COMPOUND CATABOLIC PROCESS,0.4355,0.046513,0.034764,0,0
6,GO GLYCOPROTEIN METABOLIC PROCESS,0.57476,0.046436,0.026578,0,0
6,GO NEGATIVE REGULATION OF UBIQUITIN PROTEIN TRANSFERASE ACTIVITY,0.080464,0.046392,0.072005,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.13444,0.046277,0.095893,0,0
6,GO TRANSMEMBRANE TRANSPORT,0.20409,0.046241,0.051826,0,0
6,GO SPHINGOLIPID BIOSYNTHETIC PROCESS,0.21587,0.046187,0.058636,0,0
6,GO AROMATIC AMINO ACID TRANSPORT,0.33194,0.046106,0.084215,0,0
6,GO DNA BIOSYNTHETIC PROCESS,0.065005,0.046099,0.059404,0,0
6,GO NEGATIVE REGULATION OF G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.47461,0.046083,0.055347,0,0
6,GO REGULATION OF RNA BINDING,0.51296,0.046055,0.026222,0,0
6,GO IMMUNE SYSTEM DEVELOPMENT,0.33599,0.045884,0.038796,0,0
6,GO TRNA WOBBLE URIDINE MODIFICATION,0.68094,0.045875,0.0073324,0,0
6,GO CELLULAR RESPONSE TO MANGANESE ION,0.45238,0.045811,0.041459,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS,0.2644,0.045773,0.038919,0,0
6,GO GLYCOLIPID BIOSYNTHETIC PROCESS,0.1533,0.045701,0.0632,0,0
6,GO LIVER MORPHOGENESIS,0.22814,0.045647,0.068771,0,0
6,GO RNA MODIFICATION,0.91772,0.045509,-0.0037438,0,0
6,GO MAINTENANCE OF PROTEIN LOCATION,0.27673,0.045502,0.048398,0,0
6,GO NADH METABOLIC PROCESS,0.32592,0.045395,0.050958,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION,0.29877,0.045293,0.040417,0,0
6,GO CELLULAR RESPONSE TO RETINOIC ACID,0.34627,0.045207,0.053531,0,0
6,GO POSITIVE REGULATION OF CYTOKINE SECRETION,0.71996,0.045201,0.023872,0,0
6,GO AMMONIUM ION METABOLIC PROCESS,0.178,0.045186,0.090573,0,0
6,GO NEGATIVE REGULATION OF SECRETION,0.093918,0.045094,0.063236,0,0
6,GO AUTOPHAGIC CELL DEATH,0.23445,0.044907,0.076845,0,0
6,GO ACTION POTENTIAL,0.24745,0.044896,0.074385,0,0
6,GO MYOFIBRIL ASSEMBLY,0.44028,0.044837,0.044863,0,0
6,GO REGULATION OF KILLING OF CELLS OF OTHER ORGANISM,0.42602,0.044796,0.052553,0,0
6,GO PLASMA MEMBRANE PHOSPHOLIPID SCRAMBLING,0.69286,0.044751,0.013226,0,0
6,GO GOLGI TO ENDOSOME TRANSPORT,0.88245,0.044698,0.010232,0,0
6,GO DNA METHYLATION INVOLVED IN GAMETE GENERATION,0.11553,0.044547,0.062493,0,0
6,GO AMINO ACID BETAINE METABOLIC PROCESS,0.21738,0.044455,0.075636,0,0
6,GO B CELL DIFFERENTIATION,0.3739,0.044395,0.040268,0,0
6,GO T CELL DIFFERENTIATION,0.2913,0.044276,0.03842,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL DIFFERENTIATION,0.97253,0.044222,0.010015,0,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS,0.1653,0.044131,0.049724,0,0
6,GO RECEPTOR MEDIATED ENDOCYTOSIS,0.34008,0.04412,0.051815,0,0
6,GO REGULATION OF CELLULAR CATABOLIC PROCESS,0.30066,0.044116,0.040082,0,0
6,GO POSITIVE REGULATION OF CYTOSKELETON ORGANIZATION,0.30255,0.044002,0.053582,0,0
6,GO REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.75972,0.043809,-0.031586,0,0
6,GO REGULATION OF VIRAL INDUCED CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.77829,0.043789,0.013782,0,0
6,GO NEGATIVE REGULATION OF DNA BINDING TRANSCRIPTION FACTOR ACTIVITY,0.16163,0.043729,0.05578,0,0
6,GO CD8 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.67206,0.043653,0.058406,0,0
6,GO REGULATION OF OSTEOBLAST DIFFERENTIATION,0.57752,0.043471,0.034082,0,0
6,GO AMELOGENESIS,0.6515,0.043423,0.031437,0,0
6,GO MAGNESIUM ION HOMEOSTASIS,0.3871,0.043422,0.077742,0,0
6,GO PYRIMIDINE NUCLEOTIDE METABOLIC PROCESS,0.73212,0.043308,0.017129,0,0
6,GO PYRUVATE METABOLIC PROCESS,0.20845,0.0433,0.058329,0,0
6,GO NEGATIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.28945,0.043298,0.045455,0,0
6,GO PHOSPHATIDYLETHANOLAMINE METABOLIC PROCESS,0.15921,0.043265,0.067067,0,0
6,GO RESPONSE TO METAL ION,0.5665,0.043181,0.031134,0,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF BLOOD VOLUME,0.28578,0.043111,0.13988,0,0
6,GO WOUND HEALING SPREADING OF EPIDERMAL CELLS,0.95639,0.043083,-0.015275,0,0
6,GO POSITIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.47461,0.042922,0.045735,0,0
6,GO NEGATIVE REGULATION OF CELLULAR CATABOLIC PROCESS,0.28033,0.042848,0.037387,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.19417,0.042845,0.081803,0,0
6,GO NEGATIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.01849,0.042771,0.12191,0,0
6,GO PURINE CONTAINING COMPOUND METABOLIC PROCESS,0.51557,0.042644,0.024602,0,0
6,GO REGULATION OF CELL MATRIX ADHESION,0.70185,0.042603,0.037158,0,0
6,GO MAINTENANCE OF GASTROINTESTINAL EPITHELIUM,0.33194,0.042445,0.065961,0,0
6,GO REGULATION OF B CELL DIFFERENTIATION,0.25753,0.042315,0.059269,0,0
6,GO PODOSOME ASSEMBLY,0.24252,0.042172,0.10224,0,0
6,GO REGULATION OF CELL PROJECTION SIZE,0.45972,0.042141,0.06349,0,0
6,GO RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.081877,0.04211,0.074988,0,0
6,GO POSITIVE REGULATION OF BLOOD PRESSURE,0.22503,0.041893,0.064824,0,0
6,GO APICAL JUNCTION ASSEMBLY,0.38047,0.041881,0.070241,0,0
6,GO REGULATION OF SMOOTH MUSCLE CONTRACTION,0.21288,0.041879,0.058082,0,0
6,GO RESPONSE TO MECHANICAL STIMULUS,0.74128,0.04183,0.028384,0,0
6,GO POSITIVE REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.21437,0.041745,0.063477,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.41434,0.041745,0.030562,0,0
6,GO NEGATIVE REGULATION OF PROTEIN BINDING,0.53406,0.041533,0.041159,0,0
6,GO RESPONSE TO OXYGEN LEVELS,0.99515,0.041526,0.011593,0,0
6,GO POSITIVE REGULATION OF PROTEIN BINDING,0.73517,0.041463,0.026344,0,0
6,GO VIRAL GENOME REPLICATION,0.66028,0.041446,0.008994,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE,0.32195,0.041429,0.042041,0,0
6,GO REGULATION OF ERAD PATHWAY,0.34008,0.041422,0.043008,0,0
6,GO REGULATION OF CHONDROCYTE DIFFERENTIATION,0.10299,0.041358,0.094591,0,0
6,GO REGULATION OF ENDOCRINE PROCESS,0.43075,0.041305,0.038393,0,0
6,GO NEGATIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.41899,0.041226,0.040859,0,0
6,GO REGULATION OF HYDROGEN PEROXIDE METABOLIC PROCESS,0.057179,0.041205,0.10262,0,0
6,GO REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.2458,0.040975,0.041766,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE DIFFERENTIATION,0.51819,0.040919,0.02432,0,0
6,GO CORTICAL ACTIN CYTOSKELETON ORGANIZATION,0.23605,0.040909,0.06927,0,0
6,GO ER NUCLEUS SIGNALING PATHWAY,0.68689,0.040894,0.023341,0,0
6,GO CELLULAR RESPONSE TO CHEMICAL STRESS,0.69586,0.040877,-0.0047808,0,0
6,GO NEGATIVE REGULATION OF ERBB SIGNALING PATHWAY,0.66616,0.040788,0.01712,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.73822,0.040785,0.021629,0,0
6,GO GOLGI TO PLASMA MEMBRANE TRANSPORT,0.80953,0.040758,0.010452,0,0
6,GO SUBSTRATE DEPENDENT CELL MIGRATION,0.86012,0.040737,0.0059666,0,0
6,GO REGULATION OF REPRODUCTIVE PROCESS,0.23766,0.040647,0.041593,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.19557,0.040585,0.095611,0,0
6,GO PHOSPHATIDIC ACID METABOLIC PROCESS,0.12721,0.040564,0.068847,0,0
6,GO STRIATED MUSCLE CELL DIFFERENTIATION,0.12126,0.040428,0.063963,0,0
6,GO MACROMOLECULE CATABOLIC PROCESS,0.16778,0.040354,0.043021,0,0
6,GO G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART PROCESS,0.82526,0.040295,0.017053,0,0
6,GO REGULATION OF MONOOXYGENASE ACTIVITY,0.41899,0.040291,0.02726,0,0
6,GO CELLULAR MONOVALENT INORGANIC CATION HOMEOSTASIS,0.26789,0.040147,0.042832,0,0
6,GO POSITIVE REGULATION OF CELL POPULATION PROLIFERATION,0.48215,0.040099,0.034634,0,0
6,GO PROTEIN IMPORT,0.17156,0.040077,0.055016,0,0
6,GO LAMELLIPODIUM ASSEMBLY,0.40743,0.03998,0.050012,0,0
6,GO REGULATION OF URINE VOLUME,0.10823,0.03997,0.075978,0,0
6,GO POSITIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.15921,0.039854,0.10523,0,0
6,GO SARCOMERE ORGANIZATION,0.59424,0.03976,0.03646,0,0
6,GO MACROPHAGE DIFFERENTIATION,0.87606,0.039708,0.0036845,0,0
6,GO REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.48976,0.039586,0.046216,0,0
6,GO POSITIVE REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.80326,0.039451,-0.038274,0,0
6,GO CELLULAR ION HOMEOSTASIS,0.71996,0.03945,0.027095,0,0
6,GO NEGATIVE REGULATION OF SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.26267,0.039088,0.061224,0,0
6,GO POSTTRANSCRIPTIONAL REGULATION OF GENE EXPRESSION,0.33803,0.038939,0.038037,0,0
6,GO REGULATION OF T CELL DIFFERENTIATION,0.35886,0.038783,0.032218,0,0
6,GO RESPONSE TO CALCIUM ION,0.55287,0.038707,0.034157,0,0
6,GO NEGATIVE REGULATION OF HEART CONTRACTION,0.92094,0.038691,-0.013511,0,0
6,GO NEGATIVE REGULATION OF TRANSFERASE ACTIVITY,0.21889,0.038591,0.054311,0,0
6,GO CALCIUM ION IMPORT,0.10299,0.038557,0.081058,0,0
6,GO CATECHOLAMINE METABOLIC PROCESS,0.17669,0.038466,0.10915,0,0
6,GO REGULATION OF ISOTYPE SWITCHING,0.35043,0.038437,0.044161,0,0
6,GO REGULATION OF OSSIFICATION,0.53672,0.038427,0.034508,0,0
6,GO POSITIVE REGULATION OF FATTY ACID BETA OXIDATION,0.64276,0.038354,0.052809,0,0
6,GO CELLULAR CARBOHYDRATE CATABOLIC PROCESS,0.47461,0.038135,0.030068,0,0
6,GO PROTEIN STABILIZATION,0.16407,0.038098,0.05155,0,0
6,GO NEGATIVE REGULATION OF MACROAUTOPHAGY,0.36311,0.038054,0.059324,0,0
6,GO HEPATICOBILIARY SYSTEM DEVELOPMENT,0.13979,0.038023,0.065021,0,0
6,GO POSITIVE REGULATION OF AUTOPHAGY,0.38488,0.037965,0.050813,0,0
6,GO PROTEIN KINASE A SIGNALING,0.22042,0.03782,0.066041,0,0
6,GO ACTIVATION OF JANUS KINASE ACTIVITY,0.84107,0.037787,-0.037961,0,0
6,GO CELLULAR RESPONSE TO KETONE,0.22814,0.037736,0.058789,0,0
6,GO NEGATIVE REGULATION OF BLOOD PRESSURE,0.23605,0.037514,0.063983,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HEAT,0.23128,0.037385,0.061978,0,0
6,GO REGULATION OF HEMOPOIESIS,0.56925,0.037385,0.024505,0,0
6,GO PROTEIN LOCALIZATION TO CELL SURFACE,0.51819,0.037345,0.030544,0,0
6,GO REGULATION OF GLIAL CELL APOPTOTIC PROCESS,0.32393,0.037249,0.12758,0,0
6,GO CELL SUBSTRATE ADHESION,0.76281,0.037108,0.027712,0,0
6,GO RESPONSE TO LIPID,0.73822,0.037043,0.02142,0,0
6,GO WNT SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.16163,0.037004,0.082628,0,0
6,GO LIPID METABOLIC PROCESS,0.98546,0.036904,0.0097814,0,0
6,GO ORGANOPHOSPHATE ESTER TRANSPORT,0.53672,0.036834,0.034713,0,0
6,GO MEMBRANE LIPID BIOSYNTHETIC PROCESS,0.25078,0.036833,0.046783,0,0
6,GO REGULATION OF HEMATOPOIETIC PROGENITOR CELL DIFFERENTIATION,0.52874,0.03683,0.0213,0,0
6,GO ASPARTATE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.93382,0.036811,-0.0092582,0,0
6,GO NUCLEOTIDE TRANSPORT,0.6515,0.036785,0.034924,0,0
6,GO MYOTUBE DIFFERENTIATION,0.37827,0.036762,0.048396,0,0
6,GO RESPONSE TO ALCOHOL,0.29502,0.036644,0.046891,0,0
6,GO SECRETION,0.83158,0.036615,0.018256,0,0
6,GO MITOCHONDRION MORPHOGENESIS,0.29315,0.036552,0.044143,0,0
6,GO PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.88565,0.036519,0.012391,0,0
6,GO EPIDERMAL CELL DIFFERENTIATION,0.797,0.036419,0.0085677,0,0
6,GO NEGATIVE REGULATION OF CIRCADIAN RHYTHM,0.42367,0.036391,0.031732,0,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.085497,0.036339,0.069927,0,0
6,GO REGULATION OF NIK NF KAPPAB SIGNALING,0.94671,0.036332,0.0012717,0,0
6,GO REGULATION OF FATTY ACID METABOLIC PROCESS,0.62545,0.036184,0.029269,0,0
6,GO MONOVALENT INORGANIC CATION HOMEOSTASIS,0.14983,0.036154,0.05071,0,0
6,GO REGULATION OF RENAL SYSTEM PROCESS,0.3442,0.036087,0.083379,0,0
6,GO POSITIVE REGULATION OF MYOBLAST DIFFERENTIATION,0.1653,0.035863,0.083237,0,0
6,GO POSITIVE REGULATION OF TRANSPORTER ACTIVITY,0.10385,0.035844,0.080633,0,0
6,GO SYMBIOTIC PROCESS,0.63986,0.035818,-0.010805,0,0
6,GO NODAL SIGNALING PATHWAY,0.18194,0.035804,0.10821,0,0
6,GO HISTONE H2B UBIQUITINATION,0.45482,0.035697,0.04237,0,0
6,GO VASCULAR PROCESS IN CIRCULATORY SYSTEM,0.35886,0.035596,0.043419,0,0
6,GO NEGATIVE REGULATION OF KINASE ACTIVITY,0.36098,0.035367,0.048595,0,0
6,GO POSITIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.42838,0.035338,0.04972,0,0
6,GO POSITIVE REGULATION OF ION TRANSPORT,0.31021,0.035247,0.048529,0,0
6,GO STRIATED MUSCLE CONTRACTION,0.65734,0.035236,0.035687,0,0
6,GO GLIAL CELL APOPTOTIC PROCESS,0.33396,0.035168,0.086264,0,0
6,GO POSITIVE REGULATION OF RECEPTOR BIOSYNTHETIC PROCESS,0.10912,0.035165,0.073166,0,0
6,GO MODULATION BY HOST OF SYMBIONT PROCESS,0.88245,0.035123,-0.018875,0,0
6,GO NEGATIVE REGULATION OF HISTONE ACETYLATION,0.52082,0.035029,0.031882,0,0
6,GO CELLULAR RESPONSE TO EXTERNAL STIMULUS,0.70787,0.035006,0.026705,0,0
6,GO NEGATIVE REGULATION OF LIPID METABOLIC PROCESS,0.9306,0.034954,0.0022846,0,0
6,GO NEURON REMODELING,0.86968,0.034878,0.019005,0,0
6,GO GLUTAMINE FAMILY AMINO ACID METABOLIC PROCESS,0.58864,0.034853,0.027939,0,0
6,GO POSITIVE REGULATION OF PHOSPHOPROTEIN PHOSPHATASE ACTIVITY,0.65734,0.034824,0.027228,0,0
6,GO REGULATION OF ATPASE ACTIVITY,0.059879,0.034739,0.062495,0,0
6,GO NEGATIVE REGULATION OF PROTEIN TYROSINE KINASE ACTIVITY,0.94026,0.034716,0.014821,0,0
6,GO CELLULAR RESPONSE TO CAMP,0.51296,0.034551,0.036141,0,0
6,GO TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.797,0.034538,0.011873,0,0
6,GO REGULATION OF CHOLESTEROL METABOLIC PROCESS,0.97576,0.034472,-0.0039939,0,0
6,GO NEGATIVE REGULATION OF ERAD PATHWAY,0.5583,0.034451,0.034264,0,0
6,GO OLIGOSACCHARIDE LIPID INTERMEDIATE BIOSYNTHETIC PROCESS,0.98869,0.034402,-0.0051668,0,0
6,GO POSITIVE REGULATION OF PROTEIN POLYMERIZATION,0.2458,0.034396,0.057414,0,0
6,GO POSITIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.80953,0.03437,0.0075063,0,0
6,GO NEGATIVE REGULATION OF TRANSPORT,0.29877,0.034245,0.040283,0,0
6,GO MUSCLE CELL APOPTOTIC PROCESS,0.38933,0.034235,0.043112,0,0
6,GO MONOCARBOXYLIC ACID METABOLIC PROCESS,0.79075,0.034159,0.014917,0,0
6,GO OSTEOBLAST PROLIFERATION,0.72299,0.03411,0.038065,0,0
6,GO AORTA MORPHOGENESIS,0.23286,0.034105,0.079106,0,0
6,GO REGULATION OF INTEGRIN ACTIVATION,0.98869,0.034095,0.0069584,0,0
6,GO NEGATIVE REGULATION OF PHOSPHATIDYLINOSITOL 3 KINASE SIGNALING,0.91772,0.034013,0.01206,0,0
6,GO LIPID STORAGE,0.92738,0.033943,0.011802,0,0
6,GO SNRNA METABOLIC PROCESS,0.64858,0.033931,-0.0029133,0,0
6,GO NCRNA CATABOLIC PROCESS,0.24252,0.033919,0.047571,0,0
6,GO REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.2913,0.033911,0.043916,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.66616,0.033821,0.023873,0,0
6,GO ERAD PATHWAY,0.80326,0.033819,0.0011834,0,0
6,GO REGULATION OF CARDIAC CONDUCTION,0.25078,0.033731,0.066333,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DUPLEX UNWINDING,0.19979,0.033662,0.043267,0,0
6,GO REGULATION OF ACTIN FILAMENT BASED PROCESS,0.67206,0.033621,0.031879,0,0
6,GO RESPONSE TO NUTRIENT,0.74435,0.03361,0.021858,0,0
6,GO GLOMERULAR EPITHELIUM DEVELOPMENT,0.68988,0.033605,0.046059,0,0
6,GO POSITIVE REGULATION OF MAPK CASCADE,0.55016,0.033594,0.032474,0,0
6,GO ENDOPLASMIC RETICULUM ORGANIZATION,0.28033,0.03356,0.058605,0,0
6,GO RESPONSE TO DRUG,0.72603,0.033549,0.020967,0,0
6,GO ORGANIC HYDROXY COMPOUND METABOLIC PROCESS,0.92738,0.033512,0.0098001,0,0
6,GO FATTY ACID CATABOLIC PROCESS,0.70486,0.033392,0.021096,0,0
6,GO POSITIVE REGULATION OF ACTIN NUCLEATION,0.35886,0.033294,0.059946,0,0
6,GO ANION TRANSPORT,0.5,0.033259,0.03423,0,0
6,GO IMMUNOLOGICAL MEMORY PROCESS,0.76899,0.033203,0.033712,0,0
6,GO NEGATIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.82842,0.033199,-0.00077794,0,0
6,GO MICROVILLUS ASSEMBLY,0.94026,0.033107,0.021587,0,0
6,GO DIVALENT INORGANIC CATION HOMEOSTASIS,0.64276,0.033083,0.02972,0,0
6,GO RESPONSE TO ETHANOL,0.56925,0.032964,0.028879,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR SIGNALING PATHWAY VIA STAT,0.14983,0.032577,0.095377,0,0
6,GO NEGATIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.85376,0.032474,0.056397,0,0
6,GO NUCLEOTIDE PHOSPHORYLATION,0.14308,0.032374,0.068668,0,0
6,GO REGULATION OF MUSCLE CONTRACTION,0.50776,0.03236,0.03415,0,0
6,GO INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.58029,0.032322,0.040097,0,0
6,GO PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED RECEPTOR SIGNALING PATHWAY,0.36956,0.032229,0.031631,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO OXIDATIVE STRESS,0.48976,0.03213,0.037335,0,0
6,GO WATER HOMEOSTASIS,0.086237,0.032076,0.10245,0,0
6,GO SKELETAL MUSCLE CONTRACTION,0.20265,0.032038,0.065244,0,0
6,GO NEGATIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.74435,0.032029,-0.011215,0,0
6,GO CHOLESTEROL STORAGE,0.92416,0.032016,-0.0041776,0,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN BIOSYNTHETIC PROCESS,0.66321,0.032011,0.024887,0,0
6,GO GLUCOSE METABOLIC PROCESS,0.4355,0.031978,0.04192,0,0
6,GO POSITIVE REGULATION OF EPIDERMAL CELL DIFFERENTIATION,0.79075,0.03195,0.021736,0,0
6,GO MEMBRANE LIPID METABOLIC PROCESS,0.80326,0.031886,0.013287,0,0
6,GO REGULATION OF LAMELLIPODIUM ORGANIZATION,0.83158,0.031791,0.019633,0,0
6,GO MATERNAL PROCESS INVOLVED IN FEMALE PREGNANCY,0.31409,0.031709,0.07029,0,0
6,GO REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.5314,0.031708,0.025972,0,0
6,GO REGULATION OF EXTRACELLULAR MATRIX ORGANIZATION,0.6312,0.031703,0.029177,0,0
6,GO REGULATION OF UBIQUITIN PROTEIN LIGASE ACTIVITY,0.30446,0.031556,0.038249,0,0
6,GO NEGATIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.67501,0.031418,0.033916,0,0
6,GO STEROL TRANSPORT,0.97576,0.031417,0.0037728,0,0
6,GO REGULATION OF PODOSOME ASSEMBLY,0.31997,0.03129,0.099415,0,0
6,GO NEGATIVE REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.073043,0.031239,0.093727,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL TYROSINE PHOSPHORYLATION,0.44269,0.031213,0.051435,0,0
6,GO NEGATIVE REGULATION OF MACROPHAGE MIGRATION,0.82842,0.031205,0.0077625,0,0
6,GO RESPONSE TO KETONE,0.38488,0.031143,0.040589,0,0
6,GO RAP PROTEIN SIGNAL TRANSDUCTION,0.50516,0.030808,0.054654,0,0
6,GO REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.18866,0.030781,0.085571,0,0
6,GO LUNG ALVEOLUS DEVELOPMENT,0.35674,0.030646,0.072692,0,0
6,GO NEGATIVE REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.64276,0.030559,0.020495,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY BY P53 CLASS MEDIATOR,0.30829,0.03039,0.046215,0,0
6,GO SODIUM INDEPENDENT ORGANIC ANION TRANSPORT,0.1146,0.030196,0.12025,0,0
6,GO NEGATIVE REGULATION OF UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.066792,0.030136,0.066785,0,0
6,GO DETECTION OF CHEMICAL STIMULUS INVOLVED IN SENSORY PERCEPTION OF TASTE,0.61402,0.030124,-0.049022,0,0
6,GO RNA CATABOLIC PROCESS,0.92738,0.030107,-0.0035335,0,0
6,GO NEGATIVE REGULATION OF ANIMAL ORGAN MORPHOGENESIS,0.41899,0.030065,0.04583,0,0
6,GO TRIGLYCERIDE CATABOLIC PROCESS,0.39832,0.030035,0.051085,0,0
6,GO REPLICATIVE SENESCENCE,0.73517,0.029966,0.0085194,0,0
6,GO POSITIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.58307,0.02995,0.037419,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.74128,0.029926,0.012131,0,0
6,GO T CELL HOMEOSTASIS,0.53672,0.029779,0.042185,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO NUCLEUS,0.25583,0.029715,0.055461,0,0
6,GO TRNA TRANSPORT,0.1754,0.029587,0.067756,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.53672,0.029515,0.03359,0,0
6,GO NEGATIVE REGULATION OF MORPHOGENESIS OF AN EPITHELIUM,0.2458,0.029503,0.085,0,0
6,GO RESPONSE TO INORGANIC SUBSTANCE,0.95961,0.029459,0.013576,0,0
6,GO REGULATION OF CHOLESTEROL EFFLUX,0.71996,0.029454,0.030068,0,0
6,GO POSITIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.86649,0.02937,-0.020134,0,0
6,GO NEGATIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.72603,0.029322,0.020408,0,0
6,GO POSITIVE REGULATION OF URINE VOLUME,0.48215,0.029117,0.029744,0,0
6,GO CELL AGING,0.17283,0.02905,0.053774,0,0
6,GO NEGATIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.26095,0.028941,0.077514,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORTER ACTIVITY,0.51296,0.028794,0.04011,0,0
6,GO RESPONSE TO CAFFEINE,0.797,0.028677,0.010461,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO MEMBRANE,0.66321,0.0286,0.00077626,0,0
6,GO CELLULAR RESPONSE TO OXYGEN LEVELS,0.66028,0.028555,0.02248,0,0
6,GO REGULATION OF GOLGI ORGANIZATION,0.39606,0.028541,0.049624,0,0
6,GO SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.72603,0.028499,0.022682,0,0
6,GO REGULATION OF CELLULAR PROTEIN CATABOLIC PROCESS,0.29877,0.028449,0.040486,0,0
6,GO CELLULAR RESPONSE TO ALKALOID,0.098784,0.028446,0.075418,0,0
6,GO NEGATIVE REGULATION OF INTERFERON BETA PRODUCTION,0.48215,0.028356,0.044368,0,0
6,GO LIPOSACCHARIDE METABOLIC PROCESS,0.77519,0.028289,0.01382,0,0
6,GO ACTIN POLYMERIZATION OR DEPOLYMERIZATION,0.24911,0.028229,0.054626,0,0
6,GO LOCOMOTOR RHYTHM,0.92416,0.028226,0.042868,0,0
6,GO AMEBOIDAL TYPE CELL MIGRATION,0.9306,0.028207,0.015048,0,0
6,GO PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.14983,0.028109,0.089337,0,0
6,GO SNRNA PROCESSING,0.94671,0.028103,-0.038154,0,0
6,GO RESPONSE TO TESTOSTERONE,0.63986,0.028101,0.029373,0,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS FROM PYRUVATE,0.42838,0.028051,0.065907,0,0
6,GO IMPORT ACROSS PLASMA MEMBRANE,0.28213,0.028039,0.06216,0,0
6,GO MORPHOGENESIS OF AN ENDOTHELIUM,0.36098,0.027932,0.073541,0,0
6,GO POSITIVE REGULATION OF CATION CHANNEL ACTIVITY,0.079071,0.027918,0.093052,0,0
6,GO NCRNA 3 END PROCESSING,0.69286,0.027799,-0.039735,0,0
6,GO CELLULAR LIPID METABOLIC PROCESS,0.9693,0.027667,0.0075616,0,0
6,GO MESODERMAL CELL DIFFERENTIATION,0.51296,0.027619,0.023699,0,0
6,GO POST GOLGI VESICLE MEDIATED TRANSPORT,0.98869,0.027585,0.0043851,0,0
6,GO PROTEIN O LINKED MANNOSYLATION,0.6515,0.027555,0.025858,0,0
6,GO POSITIVE REGULATION OF RNA POLYMERASE II TRANSCRIPTION PREINITIATION COMPLEX ASSEMBLY,0.13549,0.027539,0.065465,0,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.91772,0.027426,0.01606,0,0
6,GO CELL DEATH IN RESPONSE TO OXIDATIVE STRESS,0.63986,0.027231,0.025425,0,0
6,GO MUSCLE HYPERTROPHY IN RESPONSE TO STRESS,0.42133,0.027206,0.066669,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.30255,0.027174,0.059938,0,0
6,GO CALCIUM ION TRANSMEMBRANE TRANSPORT VIA HIGH VOLTAGE GATED CALCIUM CHANNEL,0.30829,0.027143,0.082961,0,0
6,GO REGULATION OF ACTIN FILAMENT LENGTH,0.28213,0.027131,0.055997,0,0
6,GO BLOOD VESSEL MORPHOGENESIS,0.4355,0.027081,0.042542,0,0
6,GO NEGATIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.37608,0.027038,0.062922,0,0
6,GO POLYSACCHARIDE CATABOLIC PROCESS,0.79387,0.027022,0.011696,0,0
6,GO REGULATION OF METAL ION TRANSPORT,0.2114,0.026914,0.052247,0,0
6,GO NEGATIVE REGULATION OF HYDROLASE ACTIVITY,0.75048,0.026876,0.023288,0,0
6,GO ENDOTHELIAL CELL PROLIFERATION,0.80953,0.026813,0.026428,0,0
6,GO POSITIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.93704,0.026702,0.011971,0,0
6,GO MESODERM MORPHOGENESIS,0.48215,0.026647,0.027898,0,0
6,GO PEPTIDYL TYROSINE MODIFICATION,0.70185,0.026626,0.029951,0,0
6,GO NEGATIVE REGULATION OF CARTILAGE DEVELOPMENT,0.45238,0.02654,0.066116,0,0
6,GO REGULATION OF TUBE SIZE,0.50776,0.02652,0.035279,0,0
6,GO RUFFLE ASSEMBLY,0.36526,0.026515,0.057963,0,0
6,GO PHOSPHORYLATED CARBOHYDRATE DEPHOSPHORYLATION,0.081877,0.026444,0.094874,0,0
6,GO HEART GROWTH,0.17411,0.026374,0.066947,0,0
6,GO DICHOTOMOUS SUBDIVISION OF AN EPITHELIAL TERMINAL UNIT,0.57476,0.026195,0.073418,0,0
6,GO STEROL BIOSYNTHETIC PROCESS,0.78763,0.026105,0.016495,0,0
6,GO REGULATION OF CHOLESTEROL BIOSYNTHETIC PROCESS,0.97253,0.025997,0.01062,0,0
6,GO SMOOTH MUSCLE CELL MIGRATION,0.7659,0.025949,0.022946,0,0
6,GO INDUCTION OF POSITIVE CHEMOTAXIS,0.72603,0.025933,0.047835,0,0
6,GO POSITIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.53406,0.025883,-0.023766,0,0
6,GO GLUCOSAMINE CONTAINING COMPOUND METABOLIC PROCESS,0.73212,0.025863,0.021657,0,0
6,GO DETECTION OF CALCIUM ION,0.22658,0.02583,0.10653,0,0
6,GO I KAPPAB KINASE NF KAPPAB SIGNALING,0.49487,0.025822,-0.033616,0,0
6,GO NEGATIVE REGULATION OF BONE MINERALIZATION,0.72907,0.025738,0.030024,0,0
6,GO SPHINGOLIPID METABOLIC PROCESS,0.75356,0.025738,0.019907,0,0
6,GO REGULATION OF MEMBRANE REPOLARIZATION,0.80012,0.025384,0.029551,0,0
6,GO TRABECULA MORPHOGENESIS,0.70185,0.025276,0.022745,0,0
6,GO SYNAPTIC VESICLE BUDDING,0.40286,0.025221,0.057794,0,0
6,GO CELLULAR POLYSACCHARIDE CATABOLIC PROCESS,0.84107,0.025107,0.011556,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOPLASM,0.81581,0.025044,-0.027804,0,0
6,GO NEGATIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.53406,0.024713,0.055453,0,0
6,GO MULTIVESICULAR BODY ORGANIZATION,0.60834,0.024699,0.027322,0,0
6,GO PROTEIN DEMANNOSYLATION,0.89526,0.024678,-0.00098854,0,0
6,GO PROTEOLYSIS,0.37827,0.024653,0.03379,0,0
6,GO ORGANOPHOSPHATE METABOLIC PROCESS,0.68988,0.024475,0.01831,0,0
6,GO REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.73517,0.024457,0.023276,0,0
6,GO ISOPRENOID METABOLIC PROCESS,0.83474,0.02437,-0.0053129,0,0
6,GO LABYRINTHINE LAYER MORPHOGENESIS,0.48976,0.024338,0.089376,0,0
6,GO POSITIVE REGULATION OF FATTY ACID TRANSPORT,0.77519,0.024313,-0.017635,0,0
6,GO NEGATIVE REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.39606,0.024257,0.037106,0,0
6,GO TETRAHYDROFOLATE INTERCONVERSION,0.58585,0.02423,-0.039794,0,0
6,GO TETRAHYDROFOLATE METABOLIC PROCESS,0.95316,0.024189,-0.011524,0,0
6,GO MUSCLE HYPERTROPHY,0.72299,0.024135,0.024556,0,0
6,GO BRANCHING INVOLVED IN LABYRINTHINE LAYER MORPHOGENESIS,0.94993,0.024117,0.032228,0,0
6,GO REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.34008,0.024093,0.043842,0,0
6,GO LEUKOCYTE DIFFERENTIATION,0.82211,0.023913,0.011758,0,0
6,GO POSITIVE REGULATION OF PROTEOLYSIS,0.84741,0.023888,0.0028683,0,0
6,GO CELLULAR RESPONSE TO LEPTIN STIMULUS,0.18327,0.023793,0.091906,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SECRETION,0.99192,0.023734,0.00018488,0,0
6,GO ALPHA BETA T CELL DIFFERENTIATION,0.89205,0.023594,0.0022626,0,0
6,GO BLASTOCYST GROWTH,0.61402,0.023507,0.023715,0,0
6,GO CELLULAR RESPONSE TO IRON ION,0.51557,0.023489,0.045465,0,0
6,GO REGULATION OF VASCULATURE DEVELOPMENT,0.69586,0.02339,0.02715,0,0
6,GO CELLULAR RESPONSE TO PH,0.29689,0.023389,0.039636,0,0
6,GO REGULATION OF MYELOID CELL DIFFERENTIATION,0.66028,0.023265,0.025231,0,0
6,GO DNA DEAMINATION,0.91772,0.023197,-0.017139,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO ORGANELLE,0.95961,0.023078,0.0011242,0,0
6,GO ARP2 3 COMPLEX MEDIATED ACTIN NUCLEATION,0.55558,0.023061,0.023912,0,0
6,GO T HELPER 17 TYPE IMMUNE RESPONSE,0.71089,0.023046,0.01775,0,0
6,GO REGULATION OF LIPID KINASE ACTIVITY,0.35463,0.022995,0.051608,0,0
6,GO ENDOCARDIAL CUSHION FORMATION,0.5394,0.022811,0.039573,0,0
6,GO REGULATION OF MEMBRANE DEPOLARIZATION,0.5,0.022698,-0.026014,0,0
6,GO ORGANELLE INHERITANCE,0.59986,0.022443,0.023089,0,0
6,GO REGULATION OF PH,0.59705,0.022436,0.023346,0,0
6,GO BIOMINERALIZATION,0.9306,0.022324,0.021959,0,0
6,GO SCF DEPENDENT PROTEASOMAL UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS,0.59424,0.0223,-0.024779,0,0
6,GO AMINO ACID TRANSPORT,0.14755,0.022294,0.076859,0,0
6,GO NEGATIVE REGULATION OF CELLULAR COMPONENT MOVEMENT,0.71996,0.022287,0.030126,0,0
6,GO RENAL SODIUM EXCRETION,0.34008,0.022186,0.066541,0,0
6,GO RNA PHOSPHODIESTER BOND HYDROLYSIS ENDONUCLEOLYTIC,0.46962,0.022178,0.024638,0,0
6,GO VASCULATURE DEVELOPMENT,0.36741,0.022174,0.043999,0,0
6,GO HEMATOPOIETIC STEM CELL PROLIFERATION,0.2458,0.02216,0.076818,0,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.86331,0.022155,-0.0023735,0,0
6,GO RIBOSE PHOSPHATE METABOLIC PROCESS,0.59424,0.022082,0.024492,0,0
6,GO ORGANIC ANION TRANSPORT,0.85376,0.021868,0.018612,0,0
6,GO ADRENAL GLAND DEVELOPMENT,0.61117,0.021814,0.047765,0,0
6,GO CARBOHYDRATE METABOLIC PROCESS,0.84107,0.021698,0.017671,0,0
6,GO REGULATION OF PINOCYTOSIS,0.84424,0.021539,0.0076384,0,0
6,GO REGULATION OF MUSCLE HYPERTROPHY,0.62832,0.021109,0.033234,0,0
6,GO REGULATION OF MRNA BINDING,0.86012,0.021101,-0.02209,0,0
6,GO POSITIVE REGULATION OF LAMELLIPODIUM ORGANIZATION,0.76281,0.020938,0.019549,0,0
6,GO REGULATION OF PROTEOLYSIS,0.68689,0.020936,-0.0098391,0,0
6,GO REGULATION OF CELL SUBSTRATE JUNCTION ORGANIZATION,0.63408,0.020869,0.03601,0,0
6,GO POSITIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.92738,0.020802,0.0091598,0,0
6,GO PLASMA MEMBRANE ORGANIZATION,0.49743,0.020753,0.058803,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEAR BODY,0.67501,0.020735,-0.04144,0,0
6,GO ORGAN INDUCTION,0.42838,0.020669,0.070328,0,0
6,GO REGULATION OF EPIDERMAL GROWTH FACTOR ACTIVATED RECEPTOR ACTIVITY,0.318,0.020651,0.061191,0,0
6,GO ANION HOMEOSTASIS,0.58864,0.020568,0.038222,0,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPASE ACTIVITY,0.54208,0.020565,0.033427,0,0
6,GO BONE MINERALIZATION,0.77519,0.020401,0.022285,0,0
6,GO POSITIVE REGULATION OF SMAD PROTEIN SIGNAL TRANSDUCTION,0.74128,0.020377,0.027537,0,0
6,GO REGULATION OF MUSCLE ADAPTATION,0.51557,0.02037,0.041379,0,0
6,GO VIRAL LIFE CYCLE,0.69586,0.020268,-0.019583,0,0
6,GO OSTEOCLAST DIFFERENTIATION,0.80012,0.020262,0.02584,0,0
6,GO RESPONSE TO INTERLEUKIN 6,0.78451,0.020229,0.031174,0,0
6,GO GLUTAMATE METABOLIC PROCESS,0.34213,0.020079,0.056589,0,0
6,GO LIPID BIOSYNTHETIC PROCESS,0.89526,0.020076,0.010086,0,0
6,GO FIBROBLAST PROLIFERATION,0.86012,0.020031,0.0082019,0,0
6,GO NCRNA METABOLIC PROCESS,0.48722,0.020028,-0.039591,0,0
6,GO CELLULAR NITROGEN COMPOUND CATABOLIC PROCESS,0.89526,0.019975,0.0016386,0,0
6,GO PHOSPHATIDYLINOSITOL METABOLIC PROCESS,0.23927,0.01996,0.050089,0,0
6,GO RENAL ABSORPTION,0.83474,0.019945,0.019491,0,0
6,GO POSITIVE REGULATION OF ISOTYPE SWITCHING,0.88245,0.019874,0.0074274,0,0
6,GO NEGATIVE REGULATION OF TRANSMEMBRANE TRANSPORT,0.27317,0.019584,0.048017,0,0
6,GO POSITIVE REGULATION OF T CELL DIFFERENTIATION IN THYMUS,0.92416,0.019539,-0.0013414,0,0
6,GO POSITIVE REGULATION OF OSSIFICATION,0.8379,0.019467,0.018786,0,0
6,GO ISOPRENOID BIOSYNTHETIC PROCESS,0.48976,0.019457,0.036231,0,0
6,GO VESICLE TARGETING,0.95639,0.019352,0.0080991,0,0
6,GO CELLULAR RESPONSE TO INORGANIC SUBSTANCE,0.39156,0.019349,0.043579,0,0
6,GO GOLGI VESICLE BUDDING,0.67206,0.019332,-0.010882,0,0
6,GO POSITIVE REGULATION OF ION TRANSMEMBRANE TRANSPORT,0.28395,0.019321,0.054291,0,0
6,GO POSITIVE REGULATION OF ASTROCYTE DIFFERENTIATION,0.5,0.019227,0.07826,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE TISSUE DEVELOPMENT,0.5,0.0192,0.03352,0,0
6,GO POSITIVE REGULATION OF TYROSINE PHOSPHORYLATION OF STAT PROTEIN,0.86649,0.019199,-0.0013852,0,0
6,GO REGULATION OF DNA BIOSYNTHETIC PROCESS,0.14197,0.019181,0.061284,0,0
6,GO RESPONSE TO DIETARY EXCESS,0.82842,0.019163,-0.0096543,0,0
6,GO REGULATION OF PRODUCTION OF SMALL RNA INVOLVED IN GENE SILENCING BY RNA,0.82211,0.018918,0.0034014,0,0
6,GO NEGATIVE REGULATION OF PROTEIN SERINE THREONINE KINASE ACTIVITY,0.75664,0.018727,0.026787,0,0
6,GO REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.6691,0.018726,0.022272,0,0
6,GO ORGANIC CYCLIC COMPOUND CATABOLIC PROCESS,0.99515,0.018567,-0.0015915,0,0
6,GO NEGATIVE REGULATION OF POTASSIUM ION TRANSMEMBRANE TRANSPORT,0.59986,0.018537,0.024944,0,0
6,GO CELL CELL SIGNALING INVOLVED IN CARDIAC CONDUCTION,0.44752,0.018525,0.060191,0,0
6,GO PLATELET DERIVED GROWTH FACTOR RECEPTOR BETA SIGNALING PATHWAY,0.74435,0.018504,-0.013723,0,0
6,GO REGULATION OF CARDIOCYTE DIFFERENTIATION,0.79387,0.018325,0.015163,0,0
6,GO RESPONSE TO ANTIBIOTIC,0.56376,0.018044,0.036011,0,0
6,GO NEGATIVE REGULATION OF CHEMOTAXIS,0.63986,0.017937,-0.01549,0,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY IN ABSENCE OF LIGAND,0.78763,0.017807,0.030098,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO BACTERIUM,0.82211,0.017798,0.034386,0,0
6,GO LIPID LOCALIZATION,0.75356,0.01767,-0.0032876,0,0
6,GO IRON ION HOMEOSTASIS,0.42133,0.017611,-0.022663,0,0
6,GO REGULATION OF SPROUTING ANGIOGENESIS,0.8379,0.017545,0.022563,0,0
6,GO NEGATIVE REGULATION OF INTRACELLULAR PROTEIN TRANSPORT,0.89205,0.017428,0.0049687,0,0
6,GO NEGATIVE REGULATION BY HOST OF VIRAL TRANSCRIPTION,0.83158,0.017402,-0.038599,0,0
6,GO GLYCOSYLATION,0.69586,0.017307,0.015867,0,0
6,GO HEPATOCYTE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.99515,0.017171,-0.0012991,0,0
6,GO NEGATIVE REGULATION OF NF KAPPAB TRANSCRIPTION FACTOR ACTIVITY,0.21738,0.017037,0.046595,0,0
6,GO NEGATIVE REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.86649,0.016986,0.017667,0,0
6,GO NUCLEOSIDE BISPHOSPHATE METABOLIC PROCESS,0.67206,0.016942,-0.023792,0,0
6,GO CYTOPLASMIC PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.86649,0.016922,0.0021484,0,0
6,GO SERINE FAMILY AMINO ACID CATABOLIC PROCESS,0.99192,0.016904,-0.028242,0,0
6,GO MYELOID LEUKOCYTE DIFFERENTIATION,0.75356,0.016679,-0.010764,0,0
6,GO REGULATION OF ANION TRANSPORT,0.48976,0.016616,0.031865,0,0
6,GO DEVELOPMENTAL PIGMENTATION,0.86331,0.016516,0.018444,0,0
6,GO POSITIVE REGULATION OF ERYTHROCYTE DIFFERENTIATION,0.19278,0.016471,0.081453,0,0
6,GO RNA CAPPING,0.3739,0.016052,0.028361,0,0
6,GO POSITIVE REGULATION OF OSTEOBLAST DIFFERENTIATION,0.88885,0.016012,0.0035485,0,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT BUNDLE ASSEMBLY,0.73822,0.015993,-0.010577,0,0
6,GO POSITIVE REGULATION OF MITOCHONDRIAL FISSION,0.61687,0.015965,0.024847,0,0
6,GO REGULATION OF T HELPER CELL DIFFERENTIATION,0.82211,0.015819,-0.028985,0,0
6,GO PROTEIN TETRAMERIZATION,0.60834,0.015809,0.021453,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE METABOLIC PROCESS,0.7659,0.015768,0.013785,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE SECRETION,0.86331,0.015766,0.008064,0,0
6,GO CARBOHYDRATE TRANSPORT,0.797,0.015745,0.021025,0,0
6,GO PURINE NUCLEOTIDE TRANSPORT,0.73212,0.015699,0.035183,0,0
6,GO POSITIVE REGULATION OF FERTILIZATION,0.50776,0.015524,0.045738,0,0
6,GO VASCULAR WOUND HEALING,0.48722,0.015336,0.091949,0,0
6,GO TRNA MODIFICATION,0.95639,0.015308,-0.016329,0,0
6,GO REGULATION OF BICELLULAR TIGHT JUNCTION ASSEMBLY,0.77209,0.015162,0.0077636,0,0
6,GO ENDOPLASMIC RETICULUM TO GOLGI VESICLE MEDIATED TRANSPORT,0.68094,0.015105,-0.0059927,0,0
6,GO POSITIVE REGULATION OF BIOMINERALIZATION,0.81267,0.014868,0.024255,0,0
6,GO CARTILAGE MORPHOGENESIS,0.44994,0.01485,0.070813,0,0
6,GO REGULATION OF CELL ADHESION,0.88885,0.014747,0.007428,0,0
6,GO REGULATION OF ACROSOME REACTION,0.79387,0.014647,-0.003775,0,0
6,GO REGULATION OF KERATINOCYTE MIGRATION,0.84424,0.01461,0.0061381,0,0
6,GO IMMUNOGLOBULIN PRODUCTION,0.8379,0.014476,-0.00522,0,0
6,GO ATP METABOLIC PROCESS,0.56925,0.01447,-0.016097,0,0
6,GO CELLULAR PROTEIN COMPLEX DISASSEMBLY,0.97253,0.014372,-0.0036266,0,0
6,GO PROTEIN LIPID COMPLEX ASSEMBLY,0.64567,0.014357,-0.016557,0,0
6,GO THYMIC T CELL SELECTION,0.9113,0.01433,-0.0093505,0,0
6,GO MITOCHONDRIAL FUSION,0.81896,0.014326,0.028331,0,0
6,GO EXTRACELLULAR VESICLE BIOGENESIS,0.7814,0.014325,0.02297,0,0
6,GO PROGRAMMED CELL DEATH IN RESPONSE TO REACTIVE OXYGEN SPECIES,0.53672,0.014212,0.035604,0,0
6,GO REGULATION OF RYANODINE SENSITIVE CALCIUM RELEASE CHANNEL ACTIVITY,0.70185,0.014191,0.007683,0,0
6,GO FATTY ACID BETA OXIDATION USING ACYL COA DEHYDROGENASE,0.89205,0.014163,0.0044769,0,0
6,GO MEGAKARYOCYTE DIFFERENTIATION,0.18062,0.014004,0.063787,0,0
6,GO RESPONSE TO AMYLOID BETA,0.54477,0.013935,0.052852,0,0
6,GO PYRIMIDINE NUCLEOTIDE BIOSYNTHETIC PROCESS,0.95316,0.013874,0.01141,0,0
6,GO INDOLE CONTAINING COMPOUND METABOLIC PROCESS,0.54477,0.013621,0.047504,0,0
6,GO REGULATION OF GLUCONEOGENESIS,0.2114,0.013606,0.071139,0,0
6,GO PROTEIN AUTOPROCESSING,0.72299,0.013587,0.018666,0,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL DIAMETER,0.5583,0.013569,-0.033889,0,0
6,GO POSITIVE REGULATION OF TELOMERE CAPPING,0.28395,0.013515,0.070378,0,0
6,GO REGULATION OF ANOIKIS,0.85059,0.013392,0.015472,0,0
6,GO NEGATIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.89846,0.013384,-0.026173,0,0
6,GO REGULATION OF DNA TEMPLATED TRANSCRIPTION IN RESPONSE TO STRESS,0.32393,0.013335,-0.035469,0,0
6,GO NEGATIVE REGULATION OF NUCLEOCYTOPLASMIC TRANSPORT,0.5583,0.013304,-0.032395,0,0
6,GO PARAXIAL MESODERM DEVELOPMENT,0.3871,0.013301,0.061573,0,0
6,GO REGULATION OF NUCLEASE ACTIVITY,0.99515,0.01322,0.0031282,0,0
6,GO PROTEIN KINASE B SIGNALING,0.5583,0.013206,0.034988,0,0
6,GO CARBOHYDRATE DERIVATIVE METABOLIC PROCESS,0.88565,0.013169,0.0063883,0,0
6,GO NEGATIVE REGULATION OF GENE SILENCING,0.45727,0.01309,0.032696,0,0
6,GO ANAPHASE PROMOTING COMPLEX DEPENDENT CATABOLIC PROCESS,0.20265,0.012947,-0.06375,0,0
6,GO REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.59144,0.012888,-0.0090541,0,0
6,GO REGULATION OF TRANSCRIPTION BY RNA POLYMERASE I,0.99515,0.012887,-0.0046905,0,0
6,GO REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO HYPOXIA,0.69286,0.012745,-0.023545,0,0
6,GO POSITIVE REGULATION OF HORMONE METABOLIC PROCESS,0.28213,0.012738,-0.12506,0,0
6,GO G PROTEIN COUPLED PURINERGIC RECEPTOR SIGNALING PATHWAY,0.45972,0.012736,0.07175,0,0
6,GO REGULATION OF CALCIUM MEDIATED SIGNALING,0.20554,0.01271,0.048196,0,0
6,GO DE NOVO PROTEIN FOLDING,0.68392,0.012637,0.021732,0,0
6,GO NEGATIVE REGULATION OF MEIOTIC CELL CYCLE,0.35253,0.012622,0.054895,0,0
6,GO NEGATIVE REGULATION OF FAT CELL DIFFERENTIATION,0.39606,0.012562,0.058465,0,0
6,GO DIET INDUCED THERMOGENESIS,0.97899,0.012543,-0.0055858,0,0
6,GO PHOSPHOLIPID METABOLIC PROCESS,0.75664,0.012339,0.022085,0,0
6,GO POSITIVE THYMIC T CELL SELECTION,0.77519,0.012318,-0.024981,0,0
6,GO MATURATION OF 5 8S RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.24252,0.012244,-0.090963,0,0
6,GO POSITIVE REGULATION OF TRANSLATIONAL INITIATION,0.49487,0.012105,0.033162,0,0
6,GO POST TRANSLATIONAL PROTEIN MODIFICATION,0.88245,0.011917,0.003201,0,0
6,GO POSITIVE REGULATION OF NUCLEOTIDE BIOSYNTHETIC PROCESS,0.81267,0.01184,-0.0028073,0,0
6,GO OUTFLOW TRACT SEPTUM MORPHOGENESIS,0.37608,0.011834,0.075326,0,0
6,GO ELASTIC FIBER ASSEMBLY,0.96607,0.011712,-0.029259,0,0
6,GO CELLULAR RESPONSE TO REACTIVE OXYGEN SPECIES,0.49487,0.011579,-0.012243,0,0
6,GO NUCLEAR ENVELOPE REASSEMBLY,0.73517,0.011463,0.02702,0,0
6,GO PROTEIN DESTABILIZATION,0.75048,0.011383,0.023275,0,0
6,GO PROTEIN CONTAINING COMPLEX REMODELING,0.88245,0.011305,0.0032222,0,0
6,GO HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.63697,0.0113,0.021246,0,0
6,GO GLYCOSPHINGOLIPID METABOLIC PROCESS,0.99515,0.011176,0.0086826,0,0
6,GO CELLULAR EXTRAVASATION,0.64858,0.011114,-0.015945,0,0
6,GO ORGAN OR TISSUE SPECIFIC IMMUNE RESPONSE,0.65734,0.011042,-0.029098,0,0
6,GO REGULATION OF CELL FATE COMMITMENT,0.19979,0.011008,0.098559,0,0
6,GO RIBONUCLEOPROTEIN COMPLEX BIOGENESIS,0.62258,0.010972,-0.033036,0,0
6,GO TERPENOID METABOLIC PROCESS,0.99838,0.010958,0.003851,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.58307,0.010928,0.025647,0,0
6,GO HIGH DENSITY LIPOPROTEIN PARTICLE REMODELING,0.7814,0.010855,0.017726,0,0
6,GO REGULATION OF PROTEIN STABILITY,0.59705,0.010814,0.029636,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSMEMBRANE TRANSPORT,0.68392,0.010813,0.024851,0,0
6,GO AGING,0.39606,0.01073,0.034993,0,0
6,GO NEGATIVE REGULATION OF ANION TRANSPORT,0.59424,0.01067,-0.0070402,0,0
6,GO ENGULFMENT OF APOPTOTIC CELL,0.83474,0.010659,0.012559,0,0
6,GO POSITIVE REGULATION OF DEPHOSPHORYLATION,0.79075,0.010641,0.024579,0,0
6,GO HEPARIN METABOLIC PROCESS,0.54746,0.010612,-0.060783,0,0
6,GO RESPONSE TO ESTROGEN,0.70185,0.010359,-0.011765,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.94348,0.010277,0.010884,0,0
6,GO RESPONSE TO STEROL DEPLETION,0.71089,0.010183,-0.026203,0,0
6,GO BICARBONATE TRANSPORT,0.97253,0.010159,0.0038747,0,0
6,GO SPROUTING ANGIOGENESIS,0.59705,0.010103,0.033584,0,0
6,GO CLEAVAGE INVOLVED IN RRNA PROCESSING,0.33194,0.010086,-0.075435,0,0
6,GO MALE GENITALIA DEVELOPMENT,0.63986,0.010069,0.016979,0,0
6,GO NEGATIVE REGULATION OF ATPASE ACTIVITY,0.68094,0.0098601,0.028888,0,0
6,GO REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.43312,0.0097872,0.046032,0,0
6,GO MIRNA METABOLIC PROCESS,0.82526,0.0097582,0.0056059,0,0
6,GO CORTICAL CYTOSKELETON ORGANIZATION,0.74128,0.0097354,0.030578,0,0
6,GO HORMONE CATABOLIC PROCESS,0.6515,0.0096432,0.027647,0,0
6,GO BODY FLUID SECRETION,0.82842,0.0096056,-0.010862,0,0
6,GO ALCOHOL METABOLIC PROCESS,0.66616,0.009602,-0.014272,0,0
6,GO CELLULAR RESPONSE TO GAMMA RADIATION,0.85376,0.0094805,0.0092397,0,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL INVOLVED IN CONTRACTION,0.93704,0.0094717,0.039004,0,0
6,GO N ACETYLNEURAMINATE METABOLIC PROCESS,0.99515,0.009403,0.0070011,0,0
6,GO POSITIVE REGULATION OF RELEASE OF CYTOCHROME C FROM MITOCHONDRIA,0.27317,0.0093524,0.072418,0,0
6,GO POSITIVE REGULATION OF ENDOCYTOSIS,0.77519,0.0093256,0.0035581,0,0
6,GO NEGATIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.74741,0.0093073,0.045899,0,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.58864,0.0092565,0.042813,0,0
6,GO GLUTAMINE METABOLIC PROCESS,0.70185,0.0092175,-0.017382,0,0
6,GO ATP TRANSPORT,0.38047,0.0091699,0.065379,0,0
6,GO REGULATION OF APOPTOTIC SIGNALING PATHWAY,0.76899,0.0091588,0.0042538,0,0
6,GO POSITIVE REGULATION OF BONE MINERALIZATION,0.66321,0.009136,0.032586,0,0
6,GO CELLULAR RESPONSE TO SALT STRESS,0.59144,0.0089947,0.037075,0,0
6,GO FACE DEVELOPMENT,0.6312,0.0089914,0.039847,0,0
6,GO NEGATIVE REGULATION OF MAPK CASCADE,0.80012,0.0089067,0.019322,0,0
6,GO NEGATIVE REGULATION OF CARDIAC MUSCLE TISSUE GROWTH,0.35463,0.0088438,0.056937,0,0
6,GO POSITIVE REGULATION OF SPROUTING ANGIOGENESIS,0.94348,0.0088247,0.0046596,0,0
6,GO RESPONSE TO LITHIUM ION,0.28033,0.0088089,0.12468,0,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN BIOSYNTHETIC PROCESS,0.51296,0.0087642,0.052296,0,0
6,GO POSITIVE REGULATION OF TELOMERE MAINTENANCE VIA TELOMERE LENGTHENING,0.61402,0.0085723,0.030127,0,0
6,GO RECEPTOR RECYCLING,0.58029,0.008523,0.027327,0,0
6,GO CELLULAR COMPONENT DISASSEMBLY,0.80639,0.0084942,0.009319,0,0
6,GO REGULATION OF OSTEOCLAST DIFFERENTIATION,0.52874,0.0084748,0.036451,0,0
6,GO RESPONSE TO GAMMA RADIATION,0.87287,0.0084305,-0.0006045,0,0
6,GO NEGATIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.81581,0.0082515,-0.019164,0,0
6,GO FORMATION OF PRIMARY GERM LAYER,0.68689,0.0082282,-0.0097019,0,0
6,GO REGULATION OF CELLULAR KETONE METABOLIC PROCESS,0.51296,0.0082068,-0.019082,0,0
6,GO NEGATIVE REGULATION OF COLD INDUCED THERMOGENESIS,0.90167,0.0081929,0.018388,0,0
6,GO ESTROGEN METABOLIC PROCESS,0.31604,0.0081318,-0.046149,0,0
6,GO POSITIVE REGULATION OF CALCIUM MEDIATED SIGNALING,1,0.0080649,0.002743,0,0
6,GO PHOSPHATIDYLCHOLINE BIOSYNTHETIC PROCESS,0.86012,0.0080262,0.0046743,0,0
6,GO NEGATIVE REGULATION OF HEMOPOIESIS,0.92416,0.0080183,0.012484,0,0
6,GO ALPHA AMINO ACID CATABOLIC PROCESS,0.84424,0.0078666,0.01131,0,0
6,GO REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION,0.38047,0.0075538,0.042953,0,0
6,GO NEGATIVE REGULATION OF CELL ADHESION,0.44028,0.0075427,0.048398,0,0
6,GO NEGATIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.75048,0.0075238,-0.013775,0,0
6,GO REGULATION OF MYOTUBE DIFFERENTIATION,0.85376,0.0074381,0.024142,0,0
6,GO NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR SIGNALING PATHWAY,0.78763,0.0074177,-0.0097427,0,0
6,GO HETEROTYPIC CELL CELL ADHESION,0.92094,0.0074122,0.01894,0,0
6,GO FATTY ACID BETA OXIDATION,0.78763,0.007343,0.015368,0,0
6,GO SECONDARY METABOLIC PROCESS,0.43312,0.0072488,0.055403,0,0
6,GO PHOSPHATIDYLSERINE METABOLIC PROCESS,0.98546,0.0072466,0.012032,0,0
6,GO T HELPER 17 CELL LINEAGE COMMITMENT,0.90488,0.0071925,0.007541,0,0
6,GO RESPONSE TO PURINE CONTAINING COMPOUND,0.86012,0.0071583,0.010542,0,0
6,GO PHOSPHOLIPID BIOSYNTHETIC PROCESS,0.62545,0.0071559,0.02605,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.65734,0.0071459,-0.011086,0,0
6,GO NEGATIVE REGULATION OF CELLULAR RESPONSE TO INSULIN STIMULUS,0.62545,0.0071346,0.04002,0,0
6,GO T HELPER CELL LINEAGE COMMITMENT,0.80953,0.007126,-0.00081612,0,0
6,GO REGENERATION,0.65442,0.0071226,0.020629,0,0
6,GO STORE OPERATED CALCIUM ENTRY,0.59705,0.0070633,0.031553,0,0
6,GO MONOSACCHARIDE METABOLIC PROCESS,0.81267,0.0070216,0.0026797,0,0
6,GO DIGESTIVE SYSTEM PROCESS,0.80012,0.0069946,0.017239,0,0
6,GO RECEPTOR BIOSYNTHETIC PROCESS,0.98222,0.0068924,0.0037401,0,0
6,GO STEROID METABOLIC PROCESS,0.6312,0.0068713,-0.020712,0,0
6,GO APOPTOTIC SIGNALING PATHWAY,0.67206,0.0068459,-0.001093,0,0
6,GO L ASPARTATE TRANSMEMBRANE TRANSPORT,0.89846,0.0068289,-0.0127,0,0
6,GO AMINO SUGAR BIOSYNTHETIC PROCESS,0.99515,0.0067833,0.0044148,0,0
6,GO CELLULAR RESPONSE TO ATP,0.38047,0.0067221,0.046186,0,0
6,GO REGULATION OF VIRAL GENOME REPLICATION,0.85694,0.0066117,-0.024589,0,0
6,GO STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.6055,0.0065128,0.034062,0,0
6,GO NEGATIVE REGULATION OF PROTEIN IMPORT,0.95961,0.0063802,-0.0061815,0,0
6,GO NEGATIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.68094,0.0061164,-0.013158,0,0
6,GO LEUKOCYTE TETHERING OR ROLLING,0.84741,0.0060438,0.0059267,0,0
6,GO PEPTIDYL ARGININE METHYLATION,0.92738,0.0060198,0.010491,0,0
6,GO POSITIVE REGULATION OF NIK NF KAPPAB SIGNALING,0.64858,0.0059137,-0.022736,0,0
6,GO POSITIVE REGULATION OF PROTEIN CONTAINING COMPLEX DISASSEMBLY,0.68094,0.0057965,0.032291,0,0
6,GO LYMPHOCYTE COSTIMULATION,0.55287,0.0057429,-0.020771,0,0
6,GO MODULATION BY HOST OF VIRAL PROCESS,0.36741,0.0056796,-0.053768,0,0
6,GO ESTABLISHMENT OF PROTEIN LOCALIZATION TO PLASMA MEMBRANE,0.75664,0.0055893,-0.00087739,0,0
6,GO POSITIVE REGULATION OF SUPRAMOLECULAR FIBER ORGANIZATION,0.6515,0.0055304,0.037273,0,0
6,GO POSITIVE REGULATION OF HEMOPOIESIS,0.41434,0.0054539,0.033701,0,0
6,GO INTERLEUKIN 27 MEDIATED SIGNALING PATHWAY,0.53406,0.0054318,-0.066004,0,0
6,GO ACTIN FILAMENT DEPOLYMERIZATION,0.69885,0.0053901,0.036607,0,0
6,GO GLYCEROLIPID METABOLIC PROCESS,0.74741,0.0053273,0.025489,0,0
6,GO NEGATIVE REGULATION OF POSTTRANSCRIPTIONAL GENE SILENCING,0.98869,0.0052361,0.0037851,0,0
6,GO UBIQUITIN DEPENDENT ERAD PATHWAY,1,0.0051703,0.0039409,0,0
6,GO THIOESTER METABOLIC PROCESS,0.66616,0.0051606,-0.028624,0,0
6,GO NEGATIVE REGULATION OF AMYLOID BETA FORMATION,0.86331,0.0050436,0.06001,0,0
6,GO RESPONSE TO OXIDATIVE STRESS,0.47963,0.0050201,-0.014372,0,0
6,GO REGULATION OF SEQUESTERING OF TRIGLYCERIDE,0.98869,0.0049829,0.0083763,0,0
6,GO RESPONSE TO HEAT,0.63408,0.004942,0.029186,0,0
6,GO MUSCLE ADAPTATION,0.98222,0.0049149,0.0093383,0,0
6,GO PIGMENT GRANULE ORGANIZATION,0.35463,0.004833,-0.053096,0,0
6,GO REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.62832,0.0047769,-0.016402,0,0
6,GO MEMBRANE REPOLARIZATION,0.86012,0.0047584,0.017548,0,0
6,GO CELLULAR IRON ION HOMEOSTASIS,0.50776,0.0047426,-0.015263,0,0
6,GO LYMPHOCYTE ACTIVATION,0.9306,0.0047081,-0.0013031,0,0
6,GO ORGANIC ACID TRANSMEMBRANE TRANSPORT,0.79387,0.0045799,0.020215,0,0
6,GO VESICLE TARGETING TO FROM OR WITHIN GOLGI,0.48468,0.0045518,-0.021928,0,0
6,GO LEUKOCYTE AGGREGATION,0.94026,0.004427,0.010965,0,0
6,GO LAMELLIPODIUM MORPHOGENESIS,0.96284,0.0043896,0.010934,0,0
6,GO REGULATION OF TRIGLYCERIDE CATABOLIC PROCESS,0.82842,0.0042962,0.0075067,0,0
6,GO MYELOID CELL APOPTOTIC PROCESS,0.67798,0.0042741,0.031644,0,0
6,GO REGULATION OF LIPID CATABOLIC PROCESS,0.58029,0.0042347,-0.010102,0,0
6,GO REGULATION OF IMMUNE SYSTEM PROCESS,0.63986,0.0041932,-0.01011,0,0
6,GO CELLULAR KETONE METABOLIC PROCESS,0.65734,0.0041712,-0.0092601,0,0
6,GO NEGATIVE REGULATION OF PEPTIDYL SERINE PHOSPHORYLATION,0.76281,0.0039287,0.023251,0,0
6,GO POSITIVE REGULATION OF DNA DAMAGE RESPONSE SIGNAL TRANSDUCTION BY P53 CLASS MEDIATOR,0.67798,0.0038736,0.0248,0,0
6,GO SODIUM ION IMPORT ACROSS PLASMA MEMBRANE,0.34627,0.0038675,0.079451,0,0
6,GO FATTY ACID METABOLIC PROCESS,0.56376,0.0038582,-0.020338,0,0
6,GO REGULATION OF CELL SUBSTRATE ADHESION,0.85059,0.003856,0.026008,0,0
6,GO REGULATION OF BODY FLUID LEVELS,0.73517,0.0038553,0.003184,0,0
6,GO CELLULAR LIPID CATABOLIC PROCESS,0.44028,0.0038039,-0.022661,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.55016,0.0037934,0.039039,0,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN CELL,0.99192,0.0037794,0.013251,0,0
6,GO PROTEIN HETEROTETRAMERIZATION,0.6515,0.0037126,0.02459,0,0
6,GO LOCOMOTORY EXPLORATION BEHAVIOR,0.33396,0.0036983,0.072526,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO WOUNDING,0.52082,0.0036684,0.052736,0,0
6,GO NEGATIVE REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.61402,0.0035367,-0.037622,0,0
6,GO RESPONSE TO RETINOIC ACID,0.77829,0.0035315,0.026465,0,0
6,GO ORGANELLE MEMBRANE FUSION,0.7814,0.0034794,0.0027056,0,0
6,GO S ADENOSYLMETHIONINE METABOLIC PROCESS,0.84741,0.0033495,0.022437,0,0
6,GO METHIONINE BIOSYNTHETIC PROCESS,0.97253,0.0032661,0.014736,0,0
6,GO VIRAL RELEASE FROM HOST CELL,0.82842,0.003171,0.001177,0,0
6,GO ORGANELLE DISASSEMBLY,0.62832,0.0030506,0.02973,0,0
6,GO POSITIVE REGULATION OF VASCULATURE DEVELOPMENT,0.95316,0.0030312,0.0050269,0,0
6,GO MAINTENANCE OF LOCATION,0.92416,0.0030298,0.010441,0,0
6,GO INTERMEDIATE FILAMENT ORGANIZATION,0.91772,0.0029527,0.0033486,0,0
6,GO REGULATION OF VIRAL TRANSCRIPTION,0.6312,0.0029267,-0.017638,0,0
6,GO RIBONUCLEOSIDE METABOLIC PROCESS,0.57476,0.0029214,-0.018676,0,0
6,GO OPIOID RECEPTOR SIGNALING PATHWAY,0.96607,0.0027408,0.021661,0,0
6,GO MULTI MULTICELLULAR ORGANISM PROCESS,0.6312,0.0027205,0.033449,0,0
6,GO FATTY ACID BIOSYNTHETIC PROCESS,0.1873,0.002666,-0.052552,0,0
6,GO CELLULAR RESPONSE TO NITRIC OXIDE,0.59424,0.0026508,0.038342,0,0
6,GO NEGATIVE REGULATION OF T CELL DIFFERENTIATION,0.67206,0.0026425,0.0092591,0,0
6,GO REGULATION OF INSULIN LIKE GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.42838,0.0026139,0.082946,0,0
6,GO ENDODERM DEVELOPMENT,0.6691,0.0026087,0.027314,0,0
6,GO NEGATIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.80953,0.0025619,0.017778,0,0
6,GO AUDITORY RECEPTOR CELL DEVELOPMENT,0.75972,0.0025297,0.041992,0,0
6,GO COPII COATED VESICLE BUDDING,0.66028,0.0025087,-0.011647,0,0
6,GO RESPONSE TO INTERLEUKIN 2,0.41434,0.0024947,0.072901,0,0
6,GO SNORNA METABOLIC PROCESS,0.84107,0.0023883,-0.019943,0,0
6,GO FLUID TRANSPORT,0.85059,0.0023779,0.032556,0,0
6,GO PYRIMIDINE CONTAINING COMPOUND CATABOLIC PROCESS,0.83474,0.0023131,0.010478,0,0
6,GO REGULATION OF POSITIVE CHEMOTAXIS,0.55016,0.002288,0.056883,0,0
6,GO AMINO ACID IMPORT,0.59144,0.002275,-0.024011,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS EXONUCLEOLYTIC 3 5,0.2114,0.002231,-0.089408,0,0
6,GO MANGANESE ION TRANSPORT,0.6691,0.0022289,0.022857,0,0
6,GO RESPONSE TO LEPTIN,0.62545,0.0022124,0.040256,0,0
6,GO ENDOTHELIAL CELL CHEMOTAXIS,0.99192,0.002095,0.0043811,0,0
6,GO POSITIVE REGULATION OF ERAD PATHWAY,0.85694,0.0020619,-0.010342,0,0
6,GO PROTEIN HOMOTETRAMERIZATION,0.99838,0.0020421,0.010108,0,0
6,GO POSTTRANSLATIONAL PROTEIN TARGETING TO ENDOPLASMIC RETICULUM MEMBRANE,0.62832,0.0018932,0.033827,0,0
6,GO POSITIVE REGULATION OF VACUOLE ORGANIZATION,0.41899,0.0018847,-0.058035,0,0
6,GO NUCLEOSIDE BISPHOSPHATE BIOSYNTHETIC PROCESS,0.67206,0.0018426,-0.020628,0,0
6,GO REGULATION OF PROGRAMMED NECROTIC CELL DEATH,0.65442,0.0018115,-0.014453,0,0
6,GO REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.44994,0.0017837,0.041122,0,0
6,GO PROGESTERONE METABOLIC PROCESS,0.86968,0.0017455,0.015561,0,0
6,GO AUTOPHAGY OF MITOCHONDRION,0.57752,0.0014957,0.035418,0,0
6,GO DEFENSE RESPONSE TO VIRUS,0.58029,0.0013751,-0.034802,0,0
6,GO REGULATION OF MITOCHONDRIAL MEMBRANE POTENTIAL,0.5583,0.0013565,-0.014521,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL APOPTOTIC PROCESS,0.9693,0.0013538,0.0015719,0,0
6,GO CYTOSOLIC CALCIUM ION TRANSPORT,0.99515,0.0012928,0.016116,0,0
6,GO NEGATIVE REGULATION OF PLATELET DERIVED GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.48468,0.001222,0.059384,0,0
6,GO ALPHA LINOLENIC ACID METABOLIC PROCESS,0.85059,0.0010309,0.0019519,0,0
6,GO NAD METABOLIC PROCESS,0.70486,0.001001,0.016305,0,0
6,GO EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.71693,0.00098678,-0.013285,0,0
6,GO REGULATION OF RESPIRATORY BURST,0.41666,0.00094403,0.058198,0,0
6,GO REGULATION OF PROTEIN FOLDING,0.96284,0.00078907,0.015972,0,0
6,GO SALIVARY GLAND DEVELOPMENT,0.80953,0.00069794,0.028533,0,0
6,GO REGULATION OF ER TO GOLGI VESICLE MEDIATED TRANSPORT,0.71996,0.00053298,0.021125,0,0
6,GO PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.70486,0.00041823,-0.0055777,0,0
6,GO HORMONE BIOSYNTHETIC PROCESS,0.33396,0.00028313,-0.042874,0,0
6,GO LIPID CATABOLIC PROCESS,0.48722,0.0002279,-0.019632,0,0
6,GO AMIDE BIOSYNTHETIC PROCESS,0.28761,0.00017717,-0.03885,0,0
6,GO POSITIVE REGULATION OF PROTEIN DEPHOSPHORYLATION,0.84424,0.0001683,0.028196,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.89205,7.9621e-05,0.010701,0,0
6,GO SLEEP,0.64858,3.4808e-05,0.029119,0,0
6,GO REGULATION OF FIBROBLAST GROWTH FACTOR RECEPTOR SIGNALING PATHWAY,0.55558,-1.169e-05,0.046562,0,0
6,GO OLIGOSACCHARIDE METABOLIC PROCESS,0.96284,-7.5362e-05,0.0094101,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 12 PRODUCTION,0.73822,-0.00011179,-0.016369,0,0
6,GO POSITIVE REGULATION OF LIPID KINASE ACTIVITY,0.64567,-0.00039933,0.031602,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.87287,-0.00056565,0.019063,0,0
6,GO REGULATION OF LEUKOCYTE DIFFERENTIATION,0.87287,-0.00059675,0.0093171,0,0
6,GO NEGATIVE REGULATION OF AMINE TRANSPORT,0.33599,-0.00060616,0.13652,0,0
6,GO CYTOKINETIC PROCESS,0.92094,-0.000633,0.0098418,0,0
6,GO PH REDUCTION,0.70185,-0.00080175,0.02012,0,0
6,GO NEUROINFLAMMATORY RESPONSE,0.9306,-0.00083053,-0.0007837,0,0
6,GO POSITIVE REGULATION OF LIPID CATABOLIC PROCESS,0.67206,-0.00095824,-0.012447,0,0
6,GO CELL FATE COMMITMENT INVOLVED IN FORMATION OF PRIMARY GERM LAYER,0.79387,-0.00096666,-0.0049945,0,0
6,GO POSITIVE REGULATION OF PROTEIN EXIT FROM ENDOPLASMIC RETICULUM,0.31604,-0.0010073,-0.075136,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.74741,-0.0011172,-0.015697,0,0
6,GO REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.71089,-0.0012224,0.030915,0,0
6,GO CALCIUM MEDIATED SIGNALING USING INTRACELLULAR CALCIUM SOURCE,0.87926,-0.0013034,0.011963,0,0
6,GO RESPONSE TO PROGESTERONE,0.58029,-0.0013293,0.036913,0,0
6,GO REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO CHROMOSOME,0.51035,-0.0013416,-0.04766,0,0
6,GO NEGATIVE REGULATION OF PROTEOLYSIS,0.31409,-0.001508,-0.035952,0,0
6,GO MHC CLASS II BIOSYNTHETIC PROCESS,0.86012,-0.0015606,-0.00028942,0,0
6,GO POSITIVE REGULATION OF CARDIAC MUSCLE CELL DIFFERENTIATION,0.48215,-0.0015851,-0.026544,0,0
6,GO ALCOHOL CATABOLIC PROCESS,0.79387,-0.0015938,0.029191,0,0
6,GO INTERACTION WITH HOST,0.46713,-0.0015958,-0.032566,0,0
6,GO BASE EXCISION REPAIR AP SITE FORMATION,0.77829,-0.0016369,0.021864,0,0
6,GO REGULATION OF LIGASE ACTIVITY,0.95316,-0.001696,-0.0006072,0,0
6,GO VACUOLE ORGANIZATION,0.97899,-0.0017289,0.012763,0,0
6,GO REGULATION OF CELLULAR PH,0.9113,-0.0018286,0.0048967,0,0
6,GO NUCLEOSIDE PHOSPHATE CATABOLIC PROCESS,0.56376,-0.0019225,0.025001,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.96607,-0.0019279,0.0033407,0,0
6,GO REGULATION OF GLOMERULAR FILTRATION,0.49743,-0.0020368,0.11999,0,0
6,GO REGULATION OF ENDOTHELIAL CELL DEVELOPMENT,0.87287,-0.0021047,0.0090563,0,0
6,GO EXOCYTOSIS,0.30066,-0.0021216,-0.026776,0,0
6,GO KETONE BODY METABOLIC PROCESS,0.68689,-0.0021806,-0.034393,0,0
6,GO REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.9113,-0.0023725,0.01078,0,0
6,GO PROTEIN LOCALIZATION TO MITOCHONDRION,0.56376,-0.0024195,0.025584,0,0
6,GO NEGATIVE REGULATION OF REGULATED SECRETORY PATHWAY,0.40514,-0.0024765,0.051728,0,0
6,GO HYALURONAN BIOSYNTHETIC PROCESS,0.8379,-0.0024859,-0.0032874,0,0
6,GO STEROID BIOSYNTHETIC PROCESS,0.3739,-0.0024963,-0.029992,0,0
6,GO PHOSPHATIDYLETHANOLAMINE BIOSYNTHETIC PROCESS,0.33396,-0.0024987,0.054301,0,0
6,GO PROTEIN TARGETING,0.48976,-0.0026259,-0.032562,0,0
6,GO PEPTIDYL TYROSINE AUTOPHOSPHORYLATION,0.96284,-0.0026355,0.023247,0,0
6,GO POSITIVE REGULATION OF VIRAL LIFE CYCLE,0.31997,-0.0026798,-0.053077,0,0
6,GO ERK1 AND ERK2 CASCADE,0.83158,-0.002707,6.3073e-05,0,0
6,GO ALPHA BETA T CELL ACTIVATION,0.74128,-0.0027454,-0.021688,0,0
6,GO POSITIVE REGULATION OF RUFFLE ASSEMBLY,0.96284,-0.0027683,0.010176,0,0
6,GO REGULATION OF NEUROINFLAMMATORY RESPONSE,0.40286,-0.002817,-0.045706,0,0
6,GO POLYOL BIOSYNTHETIC PROCESS,0.6055,-0.0028421,-0.0015728,0,0
6,GO CELLULAR RESPONSE TO HEAT,0.65442,-0.0028555,0.029967,0,0
6,GO FATTY ACYL COA METABOLIC PROCESS,0.45238,-0.0030158,-0.042971,0,0
6,GO GLYCEROPHOSPHOLIPID METABOLIC PROCESS,0.74435,-0.0031384,0.025688,0,0
6,GO RESPONSE TO PARATHYROID HORMONE,0.45238,-0.0031408,0.045562,0,0
6,GO ORGANELLE FUSION,0.87926,-0.0032193,0.0094449,0,0
6,GO ALPHA BETA T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.81581,-0.0032221,-0.022664,0,0
6,GO RESPONSE TO CADMIUM ION,0.70486,-0.0033179,-0.023404,0,0
6,GO REGULATION OF TELOMERASE ACTIVITY,1,-0.0034771,0.011013,0,0
6,GO NEGATIVE REGULATION OF ORGAN GROWTH,0.6055,-0.0036876,0.041635,0,0
6,GO REGULATION OF DEFENSE RESPONSE,0.25414,-0.0036959,-0.041527,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE METABOLIC PROCESS,0.99515,-0.0038737,-0.0087149,0,0
6,GO AMINOGLYCAN METABOLIC PROCESS,0.68689,-0.0038757,-0.0073764,0,0
6,GO CELL DIFFERENTIATION INVOLVED IN EMBRYONIC PLACENTA DEVELOPMENT,0.99192,-0.003935,0.042723,0,0
6,GO AUDITORY RECEPTOR CELL MORPHOGENESIS,0.45972,-0.0039665,0.073621,0,0
6,GO VIRAL BUDDING,0.87606,-0.0039851,0.021111,0,0
6,GO B CELL ACTIVATION,0.69885,-0.0041769,-0.01512,0,0
6,GO GLYCOSYL COMPOUND METABOLIC PROCESS,0.44028,-0.0041877,-0.018077,0,0
6,GO POSITIVE REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.82526,-0.0042248,0.027101,0,0
6,GO POLY N ACETYLLACTOSAMINE METABOLIC PROCESS,0.68689,-0.0044046,0.021695,0,0
6,GO NEGATIVE REGULATION OF GLUCOSE TRANSMEMBRANE TRANSPORT,0.82842,-0.0044956,0.028088,0,0
6,GO GLOMERULAR EPITHELIAL CELL DIFFERENTIATION,0.71089,-0.0045674,0.051272,0,0
6,GO REGULATION OF MACROPHAGE DIFFERENTIATION,0.35674,-0.004585,-0.075884,0,0
6,GO NEGATIVE REGULATION OF PROTEIN CATABOLIC PROCESS,0.98222,-0.004615,0.014995,0,0
6,GO REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.31409,-0.0046424,-0.053776,0,0
6,GO MONOCARBOXYLIC ACID BIOSYNTHETIC PROCESS,0.63697,-0.0046512,-0.010073,0,0
6,GO DIGESTION,0.81581,-0.0047143,0.010171,0,0
6,GO MITOCHONDRION ORGANIZATION,0.85694,-0.0047551,0.0060144,0,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MIRNAS INVOLVED IN GENE SILENCING BY MIRNA,0.44994,-0.0048095,0.054127,0,0
6,GO ASPARTATE FAMILY AMINO ACID METABOLIC PROCESS,0.52345,-0.0048135,0.033144,0,0
6,GO PEPTIDYL ARGININE MODIFICATION,0.94993,-0.0049211,0.010348,0,0
6,GO PYRIMIDINE RIBONUCLEOTIDE METABOLIC PROCESS,0.76899,-0.0050119,-0.003995,0,0
6,GO REGULATION OF MEGAKARYOCYTE DIFFERENTIATION,0.69586,-0.005066,0.021182,0,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.65734,-0.0052673,-0.01542,0,0
6,GO HEXOSE CATABOLIC PROCESS,0.67501,-0.0052723,-0.027314,0,0
6,GO PROTEIN N LINKED GLYCOSYLATION,0.32993,-0.0052812,-0.032944,0,0
6,GO REGULATION OF INOSITOL PHOSPHATE BIOSYNTHETIC PROCESS,0.85376,-0.0053054,-0.00059931,0,0
6,GO GPI ANCHOR METABOLIC PROCESS,0.62832,-0.0054831,0.021032,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING INVOLVED IN CARDIAC CONDUCTION,0.61402,-0.0055332,-0.028614,0,0
6,GO SENSORY PERCEPTION OF CHEMICAL STIMULUS,0.51035,-0.0056268,0.020976,0,0
6,GO PROTEIN QUALITY CONTROL FOR MISFOLDED OR INCOMPLETELY SYNTHESIZED PROTEINS,0.81267,-0.0057557,-0.00098099,0,0
6,GO RESPONSE TO CORTICOSTEROID,0.90809,-0.0057689,-0.0016075,0,0
6,GO MITOCHONDRIAL TRANSPORT,0.78763,-0.0058321,0.017767,0,0
6,GO INTERLEUKIN 7 MEDIATED SIGNALING PATHWAY,0.82526,-0.0059521,0.02579,0,0
6,GO SMALL MOLECULE CATABOLIC PROCESS,0.90167,-0.0060203,0.00087671,0,0
6,GO ROSTROCAUDAL NEURAL TUBE PATTERNING,0.23766,-0.0060226,0.061654,0,0
6,GO UDP N ACETYLGLUCOSAMINE METABOLIC PROCESS,0.55016,-0.0060442,-0.02762,0,0
6,GO INTERFERON ALPHA PRODUCTION,0.72907,-0.0060582,-0.0059654,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.23128,-0.0060847,-0.067205,0,0
6,GO FOAM CELL DIFFERENTIATION,0.42602,-0.0061127,-0.05646,0,0
6,GO POSITIVE REGULATION OF CHONDROCYTE DIFFERENTIATION,0.88565,-0.0063005,0.01429,0,0
6,GO POSITIVE REGULATION OF OXIDATIVE STRESS INDUCED CELL DEATH,0.66321,-0.0063978,-0.020455,0,0
6,GO REGULATION OF ERBB SIGNALING PATHWAY,0.95639,-0.0063989,0.014871,0,0
6,GO POSITIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.60834,-0.0064525,-0.03365,0,0
6,GO PHOSPHOLIPID HOMEOSTASIS,0.6691,-0.006478,0.024447,0,0
6,GO CELL COMMUNICATION INVOLVED IN CARDIAC CONDUCTION,0.77209,-0.0064864,0.030701,0,0
6,GO REGULATION OF B CELL MEDIATED IMMUNITY,0.8379,-0.0065753,-0.0093837,0,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.96607,-0.0066347,-0.014475,0,0
6,GO POSITIVE REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.77829,-0.0067822,0.020677,0,0
6,GO VESICLE CARGO LOADING,0.91772,-0.0068263,0.0010936,0,0
6,GO REGULATION OF DNA CATABOLIC PROCESS,0.59144,-0.0068799,0.038908,0,0
6,GO ALCOHOL BIOSYNTHETIC PROCESS,0.74128,-0.0069028,-0.0016306,0,0
6,GO DICARBOXYLIC ACID CATABOLIC PROCESS,0.8379,-0.0069031,-0.0055924,0,0
6,GO ZINC ION TRANSPORT,0.79387,-0.0069353,-0.00052252,0,0
6,GO ACTIVATION OF INNATE IMMUNE RESPONSE,0.59705,-0.0070187,-0.025346,0,0
6,GO NCRNA PROCESSING,0.36098,-0.0070534,-0.055062,0,0
6,GO NEGATIVE REGULATION OF VIRAL LIFE CYCLE,0.57752,-0.0072107,-0.050743,0,0
6,GO POSITIVE REGULATION OF PHOSPHATASE ACTIVITY,0.85694,-0.007253,-0.0022151,0,0
6,GO SPHINGOID METABOLIC PROCESS,0.99192,-0.0074561,0.010446,0,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.67206,-0.007496,-0.0088574,0,0
6,GO RESPONSE TO MURAMYL DIPEPTIDE,0.61687,-0.0075838,0.034012,0,0
6,GO ORGANOPHOSPHATE CATABOLIC PROCESS,0.60268,-0.0076525,-0.0043163,0,0
6,GO ORGANOPHOSPHATE BIOSYNTHETIC PROCESS,0.7814,-0.0077264,0.0013109,0,0
6,GO PHOSPHATIDYLGLYCEROL METABOLIC PROCESS,0.98869,-0.0077394,0.015046,0,0
6,GO CELLULAR RESPONSE TO LIPOPROTEIN PARTICLE STIMULUS,0.44269,-0.0078377,-0.044106,0,0
6,GO CALCIUM MEDIATED SIGNALING,0.26964,-0.0079702,0.038918,0,0
6,GO RESPONSE TO VITAMIN,0.64567,-0.0080067,0.037435,0,0
6,GO CELLULAR RESPONSE TO OSMOTIC STRESS,0.74435,-0.0080298,0.0024564,0,0
6,GO UBIQUITIN DEPENDENT PROTEIN CATABOLIC PROCESS VIA THE MULTIVESICULAR BODY SORTING PATHWAY,0.28945,-0.0080417,0.053341,0,0
6,GO TELOMERASE RNA LOCALIZATION,0.45727,-0.0080475,-0.056537,0,0
6,GO NEUTRAL LIPID METABOLIC PROCESS,0.63697,-0.0080744,-0.0096293,0,0
6,GO POSITIVE REGULATION OF VIRAL PROCESS,0.44994,-0.0081044,-0.02387,0,0
6,GO REGULATION OF AMYLOID BETA CLEARANCE,0.96284,-0.0081482,-0.0072504,0,0
6,GO RESPONSE TO OXYGEN RADICAL,0.49487,-0.0082188,0.036513,0,0
6,GO POSITIVE REGULATION OF CHOLESTEROL EFFLUX,0.87606,-0.0082425,0.024416,0,0
6,GO NEGATIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.56376,-0.0082845,-0.03434,0,0
6,GO PROTEIN LIPID COMPLEX SUBUNIT ORGANIZATION,0.99838,-0.0083071,0.0037106,0,0
6,GO PARAXIAL MESODERM MORPHOGENESIS,0.88565,-0.0083108,0.016461,0,0
6,GO POSITIVE REGULATION OF LIPASE ACTIVITY,0.91451,-0.0083486,0.013707,0,0
6,GO MRNA MODIFICATION,0.36956,-0.0083668,0.046446,0,0
6,GO POSITIVE REGULATION OF PEPTIDYL THREONINE PHOSPHORYLATION,0.9113,-0.0084018,0.025475,0,0
6,GO ACTIN NUCLEATION,0.61687,-0.0085441,-0.007715,0,0
6,GO REGULATION OF ATP BIOSYNTHETIC PROCESS,0.69586,-0.0086332,0.040412,0,0
6,GO REGULATION OF MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.88885,-0.0086559,-0.0052313,0,0
6,GO REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.39381,-0.0087737,-0.040864,0,0
6,GO LYSOSOME LOCALIZATION,0.93704,-0.0087985,0.018709,0,0
6,GO REGULATION OF HIGH VOLTAGE GATED CALCIUM CHANNEL ACTIVITY,0.36741,-0.0088609,0.075335,0,0
6,GO EMBRYONIC VISCEROCRANIUM MORPHOGENESIS,0.83158,-0.0088747,0.046348,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE PHOSPHORYLATION,0.40286,-0.0091272,0.08759,0,0
6,GO T CELL ACTIVATION,0.73822,-0.0093159,-0.01463,0,0
6,GO COENZYME A BIOSYNTHETIC PROCESS,0.69586,-0.0093874,-0.0021276,0,0
6,GO POSITIVE REGULATION OF TRANSCRIPTION FROM RNA POLYMERASE II PROMOTER IN RESPONSE TO STRESS,0.52345,-0.0094301,0.061499,0,0
6,GO AMYLOID PRECURSOR PROTEIN METABOLIC PROCESS,1,-0.0094631,0.023124,0,0
6,GO RRNA MODIFICATION,0.22971,-0.0095017,-0.076447,0,0
6,GO CAVEOLIN MEDIATED ENDOCYTOSIS,0.6691,-0.009687,0.058329,0,0
6,GO TRANSFERRIN TRANSPORT,0.84424,-0.0097418,0.0038224,0,0
6,GO POSITIVE REGULATION OF DNA BIOSYNTHETIC PROCESS,0.84424,-0.0098641,0.021503,0,0
6,GO TOXIN TRANSPORT,0.26789,-0.0098944,0.065743,0,0
6,GO NEGATIVE REGULATION OF VIRAL PROCESS,0.52874,-0.0099267,-0.055415,0,0
6,GO REGULATION OF PROTON TRANSPORT,0.92416,-0.010028,0.023235,0,0
6,GO REGULATION OF PROTEIN DEUBIQUITINATION,0.88245,-0.010122,-0.0031939,0,0
6,GO REGULATION OF CHEMOKINE MEDIATED SIGNALING PATHWAY,0.94348,-0.010247,0.01016,0,0
6,GO TRNA PROCESSING,0.63697,-0.01035,-0.029582,0,0
6,GO ORGANIC ACID CATABOLIC PROCESS,0.92738,-0.01046,-0.0011536,0,0
6,GO CARDIAC MUSCLE CELL ACTION POTENTIAL,0.8379,-0.010551,0.016995,0,0
6,GO TRANSITION METAL ION TRANSPORT,0.69885,-0.010667,4.0614e-05,0,0
6,GO CARDIOLIPIN METABOLIC PROCESS,0.40743,-0.010792,-0.045412,0,0
6,GO RESPONSE TO OXYGEN GLUCOSE DEPRIVATION,0.69885,-0.01085,-0.017839,0,0
6,GO RRNA METHYLATION,0.35253,-0.010859,-0.056611,0,0
6,GO LIPID EXPORT FROM CELL,0.56376,-0.010948,-0.028322,0,0
6,GO REGULATION OF BLOOD PRESSURE,0.67798,-0.010948,0.028718,0,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ENDOPLASMIC RETICULUM,0.94348,-0.01095,0.010847,0,0
6,GO REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.28761,-0.010963,-0.061362,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE DIFFERENTIATION,0.6055,-0.011011,-0.022201,0,0
6,GO RESPONSE TO WOUNDING,0.9306,-0.011022,0.010869,0,0
6,GO AMINO SUGAR METABOLIC PROCESS,0.65734,-0.011024,-0.01152,0,0
6,GO SENSORY PERCEPTION OF BITTER TASTE,0.85376,-0.01116,-0.027208,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS,0.48215,-0.011179,-0.039102,0,0
6,GO TRIGLYCERIDE METABOLIC PROCESS,0.37827,-0.011293,-0.02945,0,0
6,GO REGULATION OF HEMATOPOIETIC STEM CELL DIFFERENTIATION,0.56925,-0.011527,-0.02538,0,0
6,GO DRUG CATABOLIC PROCESS,0.69286,-0.011546,-0.025915,0,0
6,GO MONOSACCHARIDE BIOSYNTHETIC PROCESS,0.4451,-0.011557,-0.016095,0,0
6,GO CELLULAR AMIDE METABOLIC PROCESS,0.21587,-0.01169,-0.038157,0,0
6,GO MUCOPOLYSACCHARIDE METABOLIC PROCESS,0.66321,-0.011915,-0.010472,0,0
6,GO THIOESTER BIOSYNTHETIC PROCESS,0.59705,-0.012081,-0.027212,0,0
6,GO SARCOPLASMIC RETICULUM CALCIUM ION TRANSPORT,0.26267,-0.012115,-0.053665,0,0
6,GO POSITIVE REGULATION OF RENAL SODIUM EXCRETION,0.85376,-0.012184,0.0041838,0,0
6,GO CELLULAR RESPONSE TO FLUID SHEAR STRESS,0.99515,-0.012252,0.029078,0,0
6,GO REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.6691,-0.012355,-0.012665,0,0
6,GO RESPONSE TO VIRUS,0.62545,-0.012361,-0.02929,0,0
6,GO NEUTRAL LIPID CATABOLIC PROCESS,0.63986,-0.012531,0.033784,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION,0.78451,-0.012533,0.0205,0,0
6,GO KERATINOCYTE MIGRATION,0.47211,-0.012622,-0.02788,0,0
6,GO CARBOHYDRATE DERIVATIVE BIOSYNTHETIC PROCESS,0.71996,-0.012693,0.00020502,0,0
6,GO NEGATIVE REGULATION OF EXOCYTOSIS,0.78763,-0.012746,-0.015342,0,0
6,GO CARDIAC MUSCLE CONTRACTION,0.80953,-0.012823,0.015687,0,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.95316,-0.012962,0.0069714,0,0
6,GO INACTIVATION OF MAPK ACTIVITY,0.55016,-0.013298,-0.014284,0,0
6,GO REGULATION OF HOMOTYPIC CELL CELL ADHESION,0.63697,-0.013449,-0.029408,0,0
6,GO NEGATIVE REGULATION OF ANOIKIS,0.72603,-0.013463,0.035087,0,0
6,GO NEGATIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.58864,-0.013522,-0.022529,0,0
6,GO MONOCARBOXYLIC ACID TRANSPORT,0.54746,-0.013612,-0.013928,0,0
6,GO REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY VIA DEATH DOMAIN RECEPTORS,0.66028,-0.013972,-0.030086,0,0
6,GO CELLULAR RESPONSE TO AMYLOID BETA,0.46713,-0.014246,0.058316,0,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.36311,-0.014301,-0.026357,0,0
6,GO REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.77209,-0.014448,0.016067,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.58029,-0.014448,-0.0090093,0,0
6,GO ESTABLISHMENT OF LYMPHOCYTE POLARITY,0.90488,-0.014599,0.0040747,0,0
6,GO RESPONSE TO HEPATOCYTE GROWTH FACTOR,0.49743,-0.014621,-0.043639,0,0
6,GO REGULATION OF MESODERM DEVELOPMENT,0.71996,-0.014639,0.028131,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.92738,-0.014676,0.0069005,0,0
6,GO MEDIUM CHAIN FATTY ACID METABOLIC PROCESS,0.64567,-0.014832,-0.029374,0,0
6,GO RESPONSE TO FUNGUS,0.71996,-0.014978,0.0076347,0,0
6,GO CERAMIDE METABOLIC PROCESS,0.89205,-0.015066,0.011413,0,0
6,GO MULTIVESICULAR BODY SORTING PATHWAY,0.87606,-0.015067,0.01887,0,0
6,GO PHOSPHATE ION TRANSMEMBRANE TRANSPORT,0.89846,-0.015413,0.025151,0,0
6,GO DECIDUALIZATION,0.94026,-0.015415,-0.0033113,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION IN RESPONSE TO STRESS,0.60268,-0.015429,-0.020258,0,0
6,GO REGULATION OF LIPOPROTEIN METABOLIC PROCESS,0.99192,-0.01559,0.00084445,0,0
6,GO ORGANIC HYDROXY COMPOUND BIOSYNTHETIC PROCESS,0.6691,-0.015838,0.0033036,0,0
6,GO ORGANIC ACID METABOLIC PROCESS,0.52082,-0.015945,-0.014161,0,0
6,GO REGULATION OF LIPID TRANSPORT,0.68094,-0.016122,-0.012024,0,0
6,GO RESPONSE TO DEXAMETHASONE,0.54208,-0.01619,-0.033474,0,0
6,GO AMYLOID BETA FORMATION,0.99192,-0.016346,0.026491,0,0
6,GO CHONDROITIN SULFATE PROTEOGLYCAN METABOLIC PROCESS,0.98546,-0.016364,0.020742,0,0
6,GO INTERFERON BETA PRODUCTION,0.97253,-0.016495,0.011139,0,0
6,GO POSITIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.97899,-0.016585,0.0054539,0,0
6,GO OXIDATION REDUCTION PROCESS,0.24252,-0.016735,-0.035173,0,0
6,GO BRANCHING INVOLVED IN SALIVARY GLAND MORPHOGENESIS,0.51819,-0.016798,-0.043638,0,0
6,GO POSITIVE REGULATION OF PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.46713,-0.016842,-0.025479,0,0
6,GO POSITIVE REGULATION OF TRANSLATION,0.17156,-0.016916,-0.04141,0,0
6,GO POSITIVE REGULATION OF PROTEIN TARGETING TO MITOCHONDRION,0.48976,-0.016926,0.045155,0,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION,0.38933,-0.016927,-0.030357,0,0
6,GO OVULATION,0.85059,-0.01697,-0.0085822,0,0
6,GO SEQUESTERING OF TRIGLYCERIDE,0.69586,-0.016972,-0.019678,0,0
6,GO MONOSACCHARIDE CATABOLIC PROCESS,0.48976,-0.016994,-0.031927,0,0
6,GO BLASTOCYST FORMATION,0.39156,-0.017034,-0.017726,0,0
6,GO REGULATION OF RESPONSE TO INTERFERON GAMMA,0.45482,-0.017052,-0.057484,0,0
6,GO NEGATIVE REGULATION OF STRIATED MUSCLE CELL DIFFERENTIATION,0.86012,-0.017109,0.0053893,0,0
6,GO PANCREATIC JUICE SECRETION,0.87287,-0.017153,-0.0045783,0,0
6,GO MIDBODY ABSCISSION,0.74128,-0.017189,0.0072315,0,0
6,GO CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.83158,-0.017191,-0.011623,0,0
6,GO PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.29315,-0.017263,-0.037405,0,0
6,GO ACTIN MEDIATED CELL CONTRACTION,0.80012,-0.01728,2.4038e-05,0,0
6,GO HEART TRABECULA MORPHOGENESIS,0.84424,-0.0173,0.024796,0,0
6,GO REGULATION OF TISSUE REMODELING,0.42838,-0.017368,-0.040199,0,0
6,GO RESPONSE TO REACTIVE OXYGEN SPECIES,0.34213,-0.017399,-0.021831,0,0
6,GO REGULATION OF CALCIUM ION IMPORT,0.67798,-0.017567,-0.014369,0,0
6,GO REGULATION OF EXCRETION,0.4451,-0.017588,0.063496,0,0
6,GO REGULATION OF PHAGOCYTOSIS,0.30637,-0.017628,-0.047075,0,0
6,GO INTERLEUKIN 6 PRODUCTION,0.5583,-0.017634,-0.01717,0,0
6,GO REGULATION OF REMOVAL OF SUPEROXIDE RADICALS,0.66028,-0.017641,0.033742,0,0
6,GO NEGATIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.74435,-0.017689,-0.038105,0,0
6,GO PEPTIDE BIOSYNTHETIC PROCESS,0.22814,-0.017778,-0.046493,0,0
6,GO HORMONE METABOLIC PROCESS,0.9113,-0.017805,0.0021502,0,0
6,GO SMALL NUCLEOLAR RIBONUCLEOPROTEIN COMPLEX ASSEMBLY,0.75972,-0.01782,-0.024835,0,0
6,GO POSITIVE REGULATION OF PROTEIN KINASE B SIGNALING,0.75048,-0.018238,0.022328,0,0
6,GO ENDOPLASMIC RETICULUM TO CYTOSOL TRANSPORT,0.39381,-0.01825,-0.036049,0,0
6,GO REGULATION OF BONE REMODELING,0.54208,-0.018268,-0.030126,0,0
6,GO REGULATION OF LIPID LOCALIZATION,0.81267,-0.018316,-0.0060827,0,0
6,GO REGULATION OF SECONDARY METABOLIC PROCESS,0.9113,-0.018334,-0.0017566,0,0
6,GO BINDING OF SPERM TO ZONA PELLUCIDA,0.40743,-0.018376,-0.021862,0,0
6,GO CELLULAR RESPONSE TO INCREASED OXYGEN LEVELS,0.61402,-0.018433,-0.018373,0,0
6,GO B CELL MEDIATED IMMUNITY,0.20699,-0.018516,-0.071699,0,0
6,GO NEGATIVE REGULATION OF NECROTIC CELL DEATH,0.7814,-0.018717,-0.0040351,0,0
6,GO PYRIMIDINE NUCLEOSIDE BIOSYNTHETIC PROCESS,0.60268,-0.018762,-0.017139,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.9306,-0.0189,0.009207,0,0
6,GO NAD BIOSYNTHETIC PROCESS,0.6055,-0.018933,-0.035483,0,0
6,GO GENERATION OF PRECURSOR METABOLITES AND ENERGY,0.23445,-0.018955,-0.029705,0,0
6,GO MODIFIED AMINO ACID TRANSPORT,0.27853,-0.018974,-0.039161,0,0
6,GO IRON ION TRANSPORT,0.75664,-0.0191,0.0014918,0,0
6,GO PULMONARY VALVE MORPHOGENESIS,0.70787,-0.019183,-0.056569,0,0
6,GO REGULATION OF BONE MINERALIZATION,0.83474,-0.019331,-7.0565e-05,0,0
6,GO FEMALE GENITALIA DEVELOPMENT,0.83158,-0.019454,-0.010925,0,0
6,GO CELLULAR RESPONSE TO TESTOSTERONE STIMULUS,0.67206,-0.019483,0.072324,0,0
6,GO DEOXYRIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.84741,-0.019504,0.019096,0,0
6,GO KERATINOCYTE DIFFERENTIATION,0.80012,-0.019521,-0.021357,0,0
6,GO SELECTIVE AUTOPHAGY,0.97253,-0.019592,0.010618,0,0
6,GO REGULATION OF LYMPHOCYTE ACTIVATION,0.5583,-0.0196,-0.021042,0,0
6,GO PYRIMIDINE RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.43789,-0.019623,-0.047638,0,0
6,GO LYSOSOMAL PROTEIN CATABOLIC PROCESS,0.22658,-0.019627,-0.045722,0,0
6,GO SNORNA 3 END PROCESSING,0.78763,-0.019633,-0.022477,0,0
6,GO PULMONARY VALVE DEVELOPMENT,0.62832,-0.019751,-0.054004,0,0
6,GO POSITIVE REGULATION OF LIPID METABOLIC PROCESS,0.46466,-0.01979,-0.018691,0,0
6,GO ISOTYPE SWITCHING TO IGG ISOTYPES,0.92094,-0.019939,-0.012118,0,0
6,GO TRNA METABOLIC PROCESS,0.59705,-0.019939,-0.026565,0,0
6,GO NIK NF KAPPAB SIGNALING,0.31997,-0.020037,-0.043379,0,0
6,GO LOW DENSITY LIPOPROTEIN PARTICLE REMODELING,0.98546,-0.020058,-0.0095114,0,0
6,GO PEPTIDE METABOLIC PROCESS,0.12822,-0.020125,-0.048791,0,0
6,GO DEFENSE RESPONSE,0.18595,-0.020168,-0.047573,0,0
6,GO I KAPPAB PHOSPHORYLATION,0.30637,-0.020219,-0.052275,0,0
6,GO MESODERMAL CELL FATE COMMITMENT,0.94026,-0.020244,-0.0036045,0,0
6,GO POSITIVE REGULATION OF AMYLOID BETA FORMATION,0.77209,-0.020258,-0.00099699,0,0
6,GO ANIMAL ORGAN REGENERATION,0.5394,-0.020316,-0.024943,0,0
6,GO POSITIVE CHEMOTAXIS,0.84107,-0.020353,-0.002524,0,0
6,GO POSITIVE REGULATION OF WOUND HEALING,0.87606,-0.020747,0.003449,0,0
6,GO EPITHELIAL TO MESENCHYMAL TRANSITION INVOLVED IN ENDOCARDIAL CUSHION FORMATION,0.88565,-0.0209,-0.0060345,0,0
6,GO TRANSEPITHELIAL TRANSPORT,0.62258,-0.020931,-0.013454,0,0
6,GO MAST CELL ACTIVATION,0.66028,-0.020991,-0.015272,0,0
6,GO REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.41434,-0.021032,-0.0080678,0,0
6,GO REGULATION OF SECONDARY METABOLITE BIOSYNTHETIC PROCESS,0.54477,-0.021092,-0.029091,0,0
6,GO REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.35253,-0.021241,-0.039223,0,0
6,GO REGULATION OF STEROID METABOLIC PROCESS,0.36956,-0.021329,-0.04186,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE CATABOLIC PROCESS,0.52082,-0.021401,-0.022689,0,0
6,GO NLRP3 INFLAMMASOME COMPLEX ASSEMBLY,0.48976,-0.021419,-0.032831,0,0
6,GO MODULATION BY HOST OF VIRAL GENOME REPLICATION,0.34008,-0.021538,-0.06694,0,0
6,GO TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.11367,-0.021587,-0.081636,0,0
6,GO REGULATION OF REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.38488,-0.021712,-0.027507,0,0
6,GO INNATE IMMUNE RESPONSE ACTIVATING SIGNAL TRANSDUCTION,0.39606,-0.021973,-0.033244,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO OXIDATIVE STRESS,0.75048,-0.02201,-0.0096007,0,0
6,GO GLYCEROLIPID BIOSYNTHETIC PROCESS,0.96284,-0.022127,0.010685,0,0
6,GO POSITIVE REGULATION OF MYELOID CELL DIFFERENTIATION,0.61687,-0.022198,-0.0091424,0,0
6,GO ORGANIC ACID TRANSPORT,0.94348,-0.022237,0.009983,0,0
6,GO PYRIMIDINE NUCLEOTIDE CATABOLIC PROCESS,0.74128,-0.022385,-0.0046163,0,0
6,GO PATTERN RECOGNITION RECEPTOR SIGNALING PATHWAY,0.18461,-0.022404,-0.055392,0,0
6,GO POSITIVE REGULATION OF I KAPPAB KINASE NF KAPPAB SIGNALING,0.39832,-0.022531,-0.043957,0,0
6,GO POSITIVE REGULATION OF ACTIN FILAMENT POLYMERIZATION,0.37173,-0.022576,-0.023619,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.63986,-0.022613,0.0076627,0,0
6,GO REGULATION OF T HELPER 2 CELL DIFFERENTIATION,0.72907,-0.02263,-0.058002,0,0
6,GO BONE REMODELING,0.49487,-0.022659,-0.028754,0,0
6,GO MATURATION OF 5 8S RRNA,0.12721,-0.022771,-0.11408,0,0
6,GO REGULATION OF BIOMINERALIZATION,0.79387,-0.022962,0.022398,0,0
6,GO PROTEIN HETEROOLIGOMERIZATION,0.87926,-0.023101,0.019498,0,0
6,GO EXTRACELLULAR REGULATION OF SIGNAL TRANSDUCTION,0.48722,-0.023115,-0.059249,0,0
6,GO BASEMENT MEMBRANE ASSEMBLY,0.95639,-0.023118,0.014066,0,0
6,GO CELL MIGRATION INVOLVED IN GASTRULATION,0.95961,-0.023218,0.0079813,0,0
6,GO PIGMENT CELL DIFFERENTIATION,0.98546,-0.023246,0.01236,0,0
6,GO PEPTIDYL ASPARAGINE MODIFICATION,0.36311,-0.023262,-0.047077,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO MEMBRANE,0.69586,-0.023728,-0.0063148,0,0
6,GO MUSCLE CELL FATE COMMITMENT,0.27495,-0.023768,-0.086869,0,0
6,GO AMYLOID PRECURSOR PROTEIN BIOSYNTHETIC PROCESS,0.92738,-0.023776,0.017547,0,0
6,GO MITOCHONDRIAL PROTEIN PROCESSING,0.43312,-0.023793,-0.043848,0,0
6,GO CELLULAR RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.34213,-0.024024,-0.017219,0,0
6,GO REGULATION OF CELL CELL ADHESION,0.55287,-0.024066,-0.019198,0,0
6,GO POSITIVE REGULATION OF FATTY ACID METABOLIC PROCESS,0.84107,-0.024117,0.014114,0,0
6,GO T CELL DIFFERENTIATION INVOLVED IN IMMUNE RESPONSE,0.72299,-0.024137,-0.025052,0,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE,0.37827,-0.024185,-0.032182,0,0
6,GO PROTEIN DEGLYCOSYLATION,0.40973,-0.024232,-0.050804,0,0
6,GO CHONDROITIN SULFATE BIOSYNTHETIC PROCESS,1,-0.024233,0.0068202,0,0
6,GO REGULATION OF DEFENSE RESPONSE TO VIRUS BY VIRUS,0.91772,-0.02428,-0.0023176,0,0
6,GO REGULATION OF ACTIN NUCLEATION,0.75048,-0.024351,0.0013927,0,0
6,GO RESPONSE TO IMMOBILIZATION STRESS,0.86331,-0.024418,-0.019672,0,0
6,GO LEUKOCYTE APOPTOTIC PROCESS,0.19003,-0.024524,-0.059141,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.62258,-0.024666,0.0027653,0,0
6,GO HAIR FOLLICLE MATURATION,0.88885,-0.024679,-0.012985,0,0
6,GO CELL COMMUNICATION BY ELECTRICAL COUPLING,0.81267,-0.0247,-0.0017864,0,0
6,GO POSITIVE REGULATION OF MONOOXYGENASE ACTIVITY,0.90488,-0.024753,0.0076877,0,0
6,GO RUFFLE ORGANIZATION,0.90809,-0.024913,0.028494,0,0
6,GO REGULATION OF PHOSPHOLIPASE ACTIVITY,0.28213,-0.024956,-0.036822,0,0
6,GO NEGATIVE REGULATION OF SPROUTING ANGIOGENESIS,0.94348,-0.025001,0.011673,0,0
6,GO REGULATION OF EPITHELIAL CELL MIGRATION,0.46466,-0.025426,-0.020932,0,0
6,GO AUTOPHAGOSOME MATURATION,0.59424,-0.025439,-0.012456,0,0
6,GO TRICARBOXYLIC ACID CYCLE,0.10299,-0.025443,-0.089261,0,0
6,GO POSITIVE REGULATION OF CELL CYCLE G1 S PHASE TRANSITION,0.48722,-0.025614,-0.02194,0,0
6,GO POSITIVE REGULATION OF B CELL ACTIVATION,0.36311,-0.025641,-0.035501,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.39832,-0.025699,-0.030875,0,0
6,GO ORGANIC ACID BIOSYNTHETIC PROCESS,0.32195,-0.025774,-0.023267,0,0
6,GO SIGNALING RECEPTOR LIGAND PRECURSOR PROCESSING,0.96284,-0.025843,0.0024777,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.3871,-0.025975,-0.051039,0,0
6,GO GUANOSINE CONTAINING COMPOUND METABOLIC PROCESS,0.90809,-0.026217,0.0045708,0,0
6,GO PHOSPHATIDYLCHOLINE METABOLIC PROCESS,0.30255,-0.026224,-0.036486,0,0
6,GO POSITIVE REGULATION OF CELL MATRIX ADHESION,0.51296,-0.026238,-0.035231,0,0
6,GO SULFATE TRANSPORT,0.69286,-0.026332,-0.010178,0,0
6,GO POSITIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.21587,-0.026339,-0.039283,0,0
6,GO MEMBRANE DEPOLARIZATION,0.62832,-0.026346,0.047514,0,0
6,GO VASCULAR ASSOCIATED SMOOTH MUSCLE CONTRACTION,0.91451,-0.026369,0.0070772,0,0
6,GO VERY LONG CHAIN FATTY ACID METABOLIC PROCESS,0.94026,-0.026546,0.0042082,0,0
6,GO PYRIMIDINE DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.65442,-0.026569,0.028893,0,0
6,GO CERAMIDE BIOSYNTHETIC PROCESS,0.90167,-0.026571,0.013954,0,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE DIFFERENTIATION,0.20845,-0.026599,-0.067553,0,0
6,GO POSITIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.45727,-0.026671,-0.029019,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.97253,-0.026684,0.0068248,0,0
6,GO REGULATION OF RESPONSE TO REACTIVE OXYGEN SPECIES,0.52874,-0.026741,-0.010745,0,0
6,GO DEOXYRIBONUCLEOTIDE BIOSYNTHETIC PROCESS,0.95961,-0.026914,0.0093111,0,0
6,GO CHOLESTEROL EFFLUX,0.61402,-0.0271,-0.014641,0,0
6,GO RESPONSE TO CAMP,0.81267,-0.027105,0.011879,0,0
6,GO NUCLEOSIDE SALVAGE,0.58307,-0.027223,-0.019182,0,0
6,GO NEGATIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.33194,-0.027517,-0.071704,0,0
6,GO CELL ACTIVATION,0.25583,-0.027517,-0.03558,0,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.87606,-0.027574,-0.029073,0,0
6,GO POSITIVE REGULATION OF INTERFERON BETA PRODUCTION,0.76281,-0.027645,-0.008926,0,0
6,GO POSITIVE REGULATION OF T CELL APOPTOTIC PROCESS,0.67501,-0.027871,-0.017462,0,0
6,GO RESPONSE TO AMINE,0.55287,-0.027909,-0.02209,0,0
6,GO REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.40058,-0.027959,-0.025119,0,0
6,GO PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.48976,-0.027987,-0.020401,0,0
6,GO POSITIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.40743,-0.028025,-0.026335,0,0
6,GO PEROXISOMAL MEMBRANE TRANSPORT,0.74741,-0.02828,0.029376,0,0
6,GO REGULATION OF TRANSLATIONAL INITIATION BY EIF2 ALPHA PHOSPHORYLATION,0.60834,-0.028311,-0.034447,0,0
6,GO POSITIVE REGULATION OF ATP BIOSYNTHETIC PROCESS,0.89846,-0.028392,0.0071178,0,0
6,GO ATP BIOSYNTHETIC PROCESS,0.18595,-0.028504,-0.057698,0,0
6,GO REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.30829,-0.028665,-0.051467,0,0
6,GO SEMI LUNAR VALVE DEVELOPMENT,0.50258,-0.028682,-0.042531,0,0
6,GO REGULATION OF PROTEIN MATURATION,0.61972,-0.028684,-0.011539,0,0
6,GO MAINTENANCE OF PROTEIN LOCATION IN NUCLEUS,0.43075,-0.028797,-0.023444,0,0
6,GO RIG I SIGNALING PATHWAY,0.25924,-0.028798,-0.056055,0,0
6,GO SMALL MOLECULE BIOSYNTHETIC PROCESS,0.3739,-0.02891,-0.017362,0,0
6,GO REGULATION OF RIBOSOME BIOGENESIS,0.39606,-0.028956,-0.060146,0,0
6,GO MEMBRANE FUSION,0.70486,-0.028966,0.0074958,0,0
6,GO POSITIVE REGULATION OF SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.65734,-0.029168,-0.026455,0,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE METABOLIC PROCESS,0.84741,-0.029174,-0.0051335,0,0
6,GO CELLULAR AMINO ACID BIOSYNTHETIC PROCESS,0.58307,-0.029182,-0.024308,0,0
6,GO POSITIVE REGULATION OF STEROL TRANSPORT,0.61972,-0.029361,-0.019091,0,0
6,GO PYRIMIDINE NUCLEOSIDE CATABOLIC PROCESS,0.39156,-0.029448,-0.062158,0,0
6,GO NEGATIVE REGULATION OF DEFENSE RESPONSE TO VIRUS,0.64567,-0.029533,-0.012502,0,0
6,GO HYPOTHALAMUS DEVELOPMENT,0.77209,-0.029667,0.034814,0,0
6,GO PROTEIN TARGETING TO MEMBRANE,0.33803,-0.029725,-0.056878,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.69286,-0.029797,-0.01037,0,0
6,GO POSITIVE REGULATION OF ERBB SIGNALING PATHWAY,0.70787,-0.029884,0.056082,0,0
6,GO PURINE NUCLEOSIDE METABOLIC PROCESS,0.62258,-0.029904,-0.012479,0,0
6,GO FC EPSILON RECEPTOR SIGNALING PATHWAY,0.54477,-0.029971,-0.016944,0,0
6,GO TISSUE MIGRATION,0.64567,-0.030008,-0.01301,0,0
6,GO GLIAL CELL ACTIVATION,0.49487,-0.030029,-0.025044,0,0
6,GO TRNA THREONYLCARBAMOYLADENOSINE METABOLIC PROCESS,0.35674,-0.030064,-0.086828,0,0
6,GO REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.66321,-0.030317,-0.0054399,0,0
6,GO KETONE BIOSYNTHETIC PROCESS,0.39832,-0.030367,-0.039233,0,0
6,GO RESPONSE TO ATP,0.84107,-0.030388,1.4046e-05,0,0
6,GO ACID SECRETION,0.41203,-0.030653,0.06845,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT,0.65734,-0.030689,-0.016239,0,0
6,GO VIRAL TRANSLATION,0.18194,-0.030913,-0.089071,0,0
6,GO RESPONSE TO CYTOKINE,0.13763,-0.031131,-0.054422,0,0
6,GO NEGATIVE REGULATION OF MUSCLE HYPERTROPHY,0.60268,-0.031151,-0.025515,0,0
6,GO L AMINO ACID TRANSPORT,0.76899,-0.031163,0.01839,0,0
6,GO NEGATIVE REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.4451,-0.031182,-0.03659,0,0
6,GO CELLULAR BIOGENIC AMINE METABOLIC PROCESS,0.94026,-0.031354,0.0056385,0,0
6,GO RRNA METABOLIC PROCESS,0.27317,-0.031535,-0.067145,0,0
6,GO POSITIVE REGULATION OF VASCULAR PERMEABILITY,0.46713,-0.031552,-0.042869,0,0
6,GO REGULATION OF PROTEIN COMPLEX STABILITY,0.36526,-0.031578,-0.04569,0,0
6,GO NEGATIVE REGULATION OF ATP METABOLIC PROCESS,0.48215,-0.031792,-0.036793,0,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL PROLIFERATION INVOLVED IN SPROUTING ANGIOGENESIS,0.91772,-0.031886,0.0047776,0,0
6,GO REGULATION OF CALCIUM ION TRANSPORT INTO CYTOSOL,0.55016,-0.031907,-0.011769,0,0
6,GO CELL JUNCTION DISASSEMBLY,0.29689,-0.031914,-0.051736,0,0
6,GO TISSUE REMODELING,0.36741,-0.031939,-0.035856,0,0
6,GO ACTIVATED T CELL PROLIFERATION,0.94671,-0.031997,0.026675,0,0
6,GO GLUCOCORTICOID METABOLIC PROCESS,0.86968,-0.032026,-0.0020792,0,0
6,GO MAINTENANCE OF PROTEIN LOCALIZATION IN ORGANELLE,0.2644,-0.032076,-0.027435,0,0
6,GO CARDIAC MUSCLE CELL CONTRACTION,0.72603,-0.032121,0.011552,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.67798,-0.032127,-0.0076321,0,0
6,GO REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.4355,-0.032164,-0.023391,0,0
6,GO REGULATION OF IMMUNE RESPONSE,0.14642,-0.032197,-0.051936,0,0
6,GO RESPONSE TO ORGANOPHOSPHORUS,0.81581,-0.032199,0.0038477,0,0
6,GO SUPEROXIDE METABOLIC PROCESS,0.87926,-0.032223,-0.003055,0,0
6,GO CYTOKINE PRODUCTION,0.20845,-0.032232,-0.050676,0,0
6,GO SUBSTRATE ADHESION DEPENDENT CELL SPREADING,0.80639,-0.032233,-0.0091942,0,0
6,GO ALPHA AMINO ACID METABOLIC PROCESS,0.62545,-0.032248,-0.012241,0,0
6,GO NEGATIVE REGULATION OF LIPID TRANSPORT,0.30446,-0.032336,-0.057762,0,0
6,GO CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.69286,-0.032375,-0.02279,0,0
6,GO MACROPHAGE PROLIFERATION,0.96607,-0.032507,0.013197,0,0
6,GO FOLIC ACID CONTAINING COMPOUND METABOLIC PROCESS,0.28395,-0.03276,-0.039667,0,0
6,GO RESPONSE TO TOPOLOGICALLY INCORRECT PROTEIN,0.28945,-0.032877,-0.023756,0,0
6,GO SULFUR COMPOUND METABOLIC PROCESS,0.11183,-0.032947,-0.052003,0,0
6,GO L ALPHA AMINO ACID TRANSMEMBRANE TRANSPORT,0.91772,-0.033091,0.0082013,0,0
6,GO MEMBRANE PROTEIN INTRACELLULAR DOMAIN PROTEOLYSIS,0.61687,-0.033139,-0.031388,0,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.45972,-0.033259,0.091435,0,0
6,GO NUCLEOTIDE EXCISION REPAIR DNA DAMAGE RECOGNITION,0.87287,-0.033273,0.0044633,0,0
6,GO LYMPHOCYTE APOPTOTIC PROCESS,0.074349,-0.033273,-0.081719,0,0
6,GO PROTEIN MATURATION,0.39606,-0.033274,-0.016844,0,0
6,GO HUMORAL IMMUNE RESPONSE MEDIATED BY CIRCULATING IMMUNOGLOBULIN,0.11647,-0.033298,-0.13063,0,0
6,GO RESPONSE TO PH,0.37608,-0.033301,-0.034316,0,0
6,GO REGULATION OF VESICLE FUSION,0.52874,-0.033573,-0.041463,0,0
6,GO CALCIUM ION TRANSMEMBRANE IMPORT INTO CYTOSOL,0.70486,-0.033674,-0.00099734,0,0
6,GO RNA SPLICING VIA ENDONUCLEOLYTIC CLEAVAGE AND LIGATION,0.57476,-0.033746,-0.020532,0,0
6,GO RESPONSE TO ACIDIC PH,0.21738,-0.033815,-0.083732,0,0
6,GO POSITIVE REGULATION OF INNATE IMMUNE RESPONSE,0.4355,-0.033847,-0.032193,0,0
6,GO NUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.31604,-0.033862,-0.032672,0,0
6,GO WOUND HEALING,0.63697,-0.0339,-0.0095415,0,0
6,GO POSITIVE REGULATION OF ALPHA BETA T CELL DIFFERENTIATION,0.13234,-0.033953,-0.088992,0,0
6,GO LEUKOTRIENE METABOLIC PROCESS,0.28945,-0.033983,-0.059625,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL MIGRATION,0.3739,-0.034055,-0.037917,0,0
6,GO NEGATIVE REGULATION OF VIRAL TRANSCRIPTION,0.15802,-0.034224,-0.094197,0,0
6,GO NEGATIVE REGULATION OF CELL CELL ADHESION,0.80639,-0.034233,-0.008358,0,0
6,GO CYTOKINE SECRETION,0.52609,-0.03431,-0.022081,0,0
6,GO RESPONSE TO TUMOR NECROSIS FACTOR,0.14088,-0.034321,-0.061018,0,0
6,GO POSITIVE REGULATION OF TELOMERASE ACTIVITY,0.27495,-0.034342,-0.032088,0,0
6,GO GASTRIC ACID SECRETION,0.88245,-0.034407,0.019569,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO BIOTIC STIMULUS,0.28033,-0.034626,-0.044532,0,0
6,GO CELLULAR RESPONSE TO GONADOTROPIN STIMULUS,0.70185,-0.034674,-0.024507,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF PEPTIDE OR POLYSACCHARIDE ANTIGEN VIA MHC CLASS II,0.69586,-0.034733,-0.0037936,0,0
6,GO REGULATION OF GASTRIC ACID SECRETION,0.86968,-0.034767,0.00086035,0,0
6,GO EPITHELIAL CELL APOPTOTIC PROCESS,0.99515,-0.034835,0.012881,0,0
6,GO PROTEIN O LINKED GLYCOSYLATION,0.29877,-0.034935,-0.050533,0,0
6,GO RESPONSE TO INCREASED OXYGEN LEVELS,0.78451,-0.034945,-0.00063187,0,0
6,GO RESPONSE TO FOLLICLE STIMULATING HORMONE,0.57752,-0.03512,-0.031802,0,0
6,GO PROGRAMMED NECROTIC CELL DEATH,0.23927,-0.035145,-0.053504,0,0
6,GO PURINE CONTAINING COMPOUND CATABOLIC PROCESS,0.58029,-0.035197,-0.017377,0,0
6,GO ORGANONITROGEN COMPOUND BIOSYNTHETIC PROCESS,0.39606,-0.035213,-0.020369,0,0
6,GO REGULATION OF ODONTOGENESIS,0.66616,-0.035296,-0.034628,0,0
6,GO CELLULAR PIGMENTATION,0.77519,-0.035389,-0.0079661,0,0
6,GO VIRAL BUDDING VIA HOST ESCRT COMPLEX,0.85059,-0.035447,0.0093805,0,0
6,GO LEUKOCYTE HOMEOSTASIS,0.20265,-0.03546,-0.04257,0,0
6,GO INTERACTION WITH SYMBIONT,0.1252,-0.03551,-0.056724,0,0
6,GO RESPONSE TO NITROSATIVE STRESS,0.72603,-0.035531,-0.03344,0,0
6,GO REGULATION OF METANEPHROS DEVELOPMENT,0.52082,-0.035553,-0.053941,0,0
6,GO HOMOTYPIC CELL CELL ADHESION,0.3442,-0.03558,-0.048508,0,0
6,GO RESPONSE TO TOXIC SUBSTANCE,0.74435,-0.035605,-0.0021782,0,0
6,GO CELL SURFACE RECEPTOR SIGNALING PATHWAY INVOLVED IN HEART DEVELOPMENT,0.45972,-0.035655,-0.039303,0,0
6,GO NEGATIVE REGULATION OF IMMUNE SYSTEM PROCESS,0.43075,-0.035674,-0.024919,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.28395,-0.035774,-0.059464,0,0
6,GO POSITIVE REGULATION OF T CELL CYTOKINE PRODUCTION,0.25924,-0.035814,-0.061371,0,0
6,GO CELLULAR RESPONSE TO LITHIUM ION,0.76281,-0.035893,0.042799,0,0
6,GO MEMBRANE INVAGINATION,0.28395,-0.035941,-0.040653,0,0
6,GO POSITIVE REGULATION OF ESTABLISHMENT OF PROTEIN LOCALIZATION TO TELOMERE,0.35253,-0.035961,-0.075103,0,0
6,GO NEGATIVE REGULATION OF B CELL ACTIVATION,0.40743,-0.036004,-0.052943,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 6 PRODUCTION,0.47712,-0.036055,-0.034981,0,0
6,GO REGULATION OF ENDOTHELIAL CELL MIGRATION,0.38047,-0.036155,-0.029589,0,0
6,GO REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.20122,-0.036158,-0.052169,0,0
6,GO NUCLEOSIDE METABOLIC PROCESS,0.58029,-0.036295,-0.015222,0,0
6,GO PHOSPHATIDYLGLYCEROL ACYL CHAIN REMODELING,0.60268,-0.036305,-0.009419,0,0
6,GO ACETYL COA METABOLIC PROCESS,0.92416,-0.03658,0.0095981,0,0
6,GO NEGATIVE REGULATION OF VIRAL RELEASE FROM HOST CELL,0.7659,-0.036597,0.025407,0,0
6,GO PYRIMIDINE NUCLEOSIDE METABOLIC PROCESS,0.53406,-0.036735,-0.024653,0,0
6,GO REGULATION OF CELL ACTIVATION,0.46218,-0.036742,-0.024223,0,0
6,GO AMINOGLYCAN BIOSYNTHETIC PROCESS,0.572,-0.036774,-0.016959,0,0
6,GO POSITIVE REGULATION OF VASCULOGENESIS,0.9693,-0.036863,0.01043,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE APOPTOTIC PROCESS,0.80953,-0.03688,-0.010588,0,0
6,GO LYMPHOCYTE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.29689,-0.037014,-0.057031,0,0
6,GO REGULATION OF VACUOLE ORGANIZATION,0.62258,-0.037113,-0.007442,0,0
6,GO MITOCHONDRIAL RNA PROCESSING,0.31604,-0.037116,-0.087126,0,0
6,GO AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.66616,-0.037245,0.0044988,0,0
6,GO NEGATIVE REGULATION OF INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO DNA DAMAGE,0.58585,-0.03735,-0.011945,0,0
6,GO O GLYCAN PROCESSING,0.10214,-0.037363,-0.11076,0,0
6,GO BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.27673,-0.037449,-0.043779,0,0
6,GO MUSCLE CELL PROLIFERATION,0.60268,-0.03756,-0.010558,0,0
6,GO INFLAMMATORY RESPONSE,0.095518,-0.037632,-0.059251,0,0
6,GO MEMBRANE DEPOLARIZATION DURING ACTION POTENTIAL,0.76281,-0.037966,-0.0023896,0,0
6,GO LONG CHAIN FATTY ACID TRANSPORT,0.12421,-0.038224,-0.047697,0,0
6,GO DEOXYRIBONUCLEOTIDE METABOLIC PROCESS,0.1754,-0.038227,-0.035579,0,0
6,GO LONG CHAIN FATTY ACYL COA METABOLIC PROCESS,0.69586,-0.038278,-0.033165,0,0
6,GO MAST CELL MEDIATED IMMUNITY,0.52345,-0.038303,-0.024162,0,0
6,GO PEROXISOME ORGANIZATION,0.1793,-0.03834,-0.052529,0,0
6,GO FATTY ACID TRANSPORT,0.14088,-0.038495,-0.043774,0,0
6,GO REGULATION OF PHOSPHOLIPASE C ACTIVITY,0.59424,-0.038536,-0.0076725,0,0
6,GO ACTIVATION OF PHOSPHOLIPASE C ACTIVITY,0.41666,-0.038742,-0.027038,0,0
6,GO KILLING OF CELLS IN OTHER ORGANISM INVOLVED IN SYMBIOTIC INTERACTION,0.30255,-0.038765,-0.043486,0,0
6,GO CELLULAR AMINO ACID CATABOLIC PROCESS,0.98222,-0.03882,-0.0013223,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 1 PRODUCTION,0.80012,-0.038908,-0.0094179,0,0
6,GO DEFENSE RESPONSE TO FUNGUS,0.24911,-0.039001,-0.048348,0,0
6,GO REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.39832,-0.039046,-0.020998,0,0
6,GO REGULATION OF T CELL ACTIVATION,0.39381,-0.039078,-0.031819,0,0
6,GO REGULATION OF GASTRULATION,0.80639,-0.039196,-0.0051799,0,0
6,GO SPHINGOSINE BIOSYNTHETIC PROCESS,0.46713,-0.039511,-0.020598,0,0
6,GO L SERINE METABOLIC PROCESS,0.54477,-0.039551,-0.024477,0,0
6,GO POSITIVE REGULATION OF GLIAL CELL PROLIFERATION,0.32393,-0.039613,-0.065668,0,0
6,GO TOXIN METABOLIC PROCESS,0.63408,-0.039642,0.046353,0,0
6,GO POSITIVE REGULATION OF RESPONSE TO EXTERNAL STIMULUS,0.12421,-0.039986,-0.052217,0,0
6,GO REGULATION OF TOLL LIKE RECEPTOR 4 SIGNALING PATHWAY,0.80326,-0.040045,-0.018835,0,0
6,GO PROTON TRANSMEMBRANE TRANSPORT,0.43312,-0.040088,-0.012172,0,0
6,GO PROTEIN PROCESSING,0.17411,-0.04014,-0.038709,0,0
6,GO POSITIVE REGULATION OF LIPID TRANSPORT,0.45727,-0.040352,-0.019683,0,0
6,GO CELLULAR RESPONSE TO DEXAMETHASONE STIMULUS,0.72299,-0.040358,-0.022906,0,0
6,GO METHIONINE METABOLIC PROCESS,0.69586,-0.040462,0.002581,0,0
6,GO DENDRITIC CELL MIGRATION,0.67798,-0.040526,-0.020972,0,0
6,GO CELLULAR RESPONSE TO OXYGEN RADICAL,0.89205,-0.040526,0.015216,0,0
6,GO NEGATIVE REGULATION OF VOLTAGE GATED POTASSIUM CHANNEL ACTIVITY,0.96284,-0.040616,0.029763,0,0
6,GO POSITIVE REGULATION OF IMMUNE RESPONSE,0.074349,-0.040619,-0.062996,0,0
6,GO REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.10471,-0.040773,-0.08695,0,0
6,GO CELLULAR RESPONSE TO LOW DENSITY LIPOPROTEIN PARTICLE STIMULUS,0.30066,-0.041011,-0.066439,0,0
6,GO CYTOPLASMIC TRANSLATION,0.088486,-0.041152,-0.10018,0,0
6,GO CARDIAC EPITHELIAL TO MESENCHYMAL TRANSITION,0.62545,-0.041164,-0.030667,0,0
6,GO REGULATION OF CELLULAR EXTRAVASATION,0.29315,-0.041229,-0.051149,0,0
6,GO REGULATION OF CELL GROWTH INVOLVED IN CARDIAC MUSCLE CELL DEVELOPMENT,0.51296,-0.041293,-0.009348,0,0
6,GO IRES DEPENDENT VIRAL TRANSLATIONAL INITIATION,0.12421,-0.041302,-0.084578,0,0
6,GO POSITIVE REGULATION OF CARDIOCYTE DIFFERENTIATION,0.62545,-0.041502,-0.019135,0,0
6,GO RESPONSE TO ANGIOTENSIN,0.14197,-0.04151,-0.077266,0,0
6,GO POSITIVE REGULATION OF CELL ADHESION,0.24745,-0.041757,-0.045232,0,0
6,GO POSITIVE REGULATION OF CELLULAR AMIDE METABOLIC PROCESS,0.16904,-0.041796,-0.035144,0,0
6,GO REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.25924,-0.041883,-0.048318,0,0
6,GO RESPONSE TO NITRIC OXIDE,0.71089,-0.042151,-0.0033476,0,0
6,GO RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.1754,-0.042165,-0.031249,0,0
6,GO CGMP MEDIATED SIGNALING,0.35043,-0.042289,-0.042561,0,0
6,GO NEGATIVE REGULATION OF KIDNEY DEVELOPMENT,0.77519,-0.042354,0.027835,0,0
6,GO DICARBOXYLIC ACID METABOLIC PROCESS,0.31215,-0.042428,-0.03331,0,0
6,GO REGULATION OF AUTOPHAGOSOME MATURATION,0.67206,-0.042432,-0.0083467,0,0
6,GO CHAPERONE MEDIATED PROTEIN COMPLEX ASSEMBLY,0.53672,-0.042505,-0.033343,0,0
6,GO RESPONSE TO BIOTIC STIMULUS,0.12924,-0.042632,-0.055762,0,0
6,GO FC RECEPTOR SIGNALING PATHWAY,0.62832,-0.042686,-0.0090757,0,0
6,GO PURINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.49743,-0.042927,-0.023333,0,0
6,GO POSITIVE REGULATION OF MEMBRANE POTENTIAL,0.12322,-0.042956,-0.094557,0,0
6,GO VASCULAR ENDOTHELIAL GROWTH FACTOR SIGNALING PATHWAY,0.68392,-0.04317,-0.019149,0,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.24416,-0.04319,-0.032669,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.22195,-0.043233,-0.053981,0,0
6,GO NEGATIVE REGULATION OF INFLAMMATORY RESPONSE,0.26789,-0.043277,-0.038052,0,0
6,GO NUCLEOSIDE PHOSPHATE BIOSYNTHETIC PROCESS,0.35674,-0.043446,-0.023268,0,0
6,GO MITOTIC CYTOKINETIC PROCESS,0.88565,-0.043465,0.0089757,0,0
6,GO RESPONSE TO HYPEROXIA,0.71089,-0.043524,-0.016013,0,0
6,GO ORGANIC HYDROXY COMPOUND CATABOLIC PROCESS,1,-0.043587,0.020949,0,0
6,GO T CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.38488,-0.043824,-0.062336,0,0
6,GO MYELOID LEUKOCYTE CYTOKINE PRODUCTION,0.65442,-0.043907,-0.012488,0,0
6,GO NEGATIVE REGULATION OF GLUCONEOGENESIS,0.22971,-0.043981,0.11286,0,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC PROCESS,0.1453,-0.044288,-0.050341,0,0
6,GO VESICLE BUDDING FROM MEMBRANE,0.41434,-0.044299,-0.021964,0,0
6,GO RESPONSE TO REDOX STATE,0.58029,-0.044353,-0.021341,0,0
6,GO NEPHRIC DUCT MORPHOGENESIS,0.71089,-0.044367,-0.037372,0,0
6,GO AMYLOID BETA CLEARANCE,0.35674,-0.044769,-0.051208,0,0
6,GO POSITIVE REGULATION OF G1 S TRANSITION OF MITOTIC CELL CYCLE,0.25078,-0.045003,-0.044199,0,0
6,GO REGULATION OF T CELL CYTOKINE PRODUCTION,0.1873,-0.045194,-0.074382,0,0
6,GO PHOSPHATE ION TRANSPORT,0.30446,-0.045277,-0.022745,0,0
6,GO PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.98869,-0.045314,0.017839,0,0
6,GO REGULATION OF CALCIUM ION TRANSPORT,0.80326,-0.04533,0.0055244,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.1453,-0.045336,-0.051265,0,0
6,GO LYMPH NODE DEVELOPMENT,0.6055,-0.045363,-0.011636,0,0
6,GO REGULATION OF PROTEIN LOCALIZATION TO CHROMOSOME TELOMERIC REGION,0.35253,-0.045367,-0.06344,0,0
6,GO REGULATION OF ALPHA BETA T CELL ACTIVATION,0.19697,-0.045399,-0.066162,0,0
6,GO PROTEIN PEPTIDYL PROLYL ISOMERIZATION,0.063258,-0.045476,-0.091018,0,0
6,GO LEUKOCYTE CELL CELL ADHESION,0.1873,-0.045638,-0.056589,0,0
6,GO RESPONSE TO INTERLEUKIN 1,0.078382,-0.045745,-0.067994,0,0
6,GO CELLULAR AMINO ACID METABOLIC PROCESS,0.18062,-0.045921,-0.043804,0,0
6,GO REGULATION OF MITOCHONDRIAL FUSION,0.3739,-0.046005,-0.044314,0,0
6,GO TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.18327,-0.046021,-0.049618,0,0
6,GO REGULATION OF WATER LOSS VIA SKIN,0.98222,-0.046148,0.0060255,0,0
6,GO POTASSIUM ION EXPORT ACROSS PLASMA MEMBRANE,0.88245,-0.046188,-0.011812,0,0
6,GO ETHANOL CATABOLIC PROCESS,0.48976,-0.046228,-0.034447,0,0
6,GO PROTEIN LOCALIZATION TO NUCLEOLUS,0.16407,-0.046477,-0.076179,0,0
6,GO RECEPTOR CATABOLIC PROCESS,0.38933,-0.046484,-0.034426,0,0
6,GO REGULATION OF RECEPTOR BINDING,0.43789,-0.046522,-0.031619,0,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE TO VIRUS BY HOST,0.87606,-0.046548,0.026201,0,0
6,GO LATE ENDOSOME TO VACUOLE TRANSPORT VIA MULTIVESICULAR BODY SORTING PATHWAY,0.19838,-0.046562,-0.047893,0,0
6,GO AMINE BIOSYNTHETIC PROCESS,0.53406,-0.046626,-0.020406,0,0
6,GO CELLULAR MODIFIED AMINO ACID METABOLIC PROCESS,0.3442,-0.046728,-0.023751,0,0
6,GO LYMPHOCYTE MEDIATED IMMUNITY,0.13444,-0.046736,-0.080124,0,0
6,GO HEMOGLOBIN METABOLIC PROCESS,0.10646,-0.046737,-0.053676,0,0
6,GO POSITIVE REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.9693,-0.046757,-0.0199,0,0
6,GO CELLULAR RESPONSE TO NITROGEN STARVATION,0.37173,-0.046866,-0.028171,0,0
6,GO SULFUR COMPOUND BIOSYNTHETIC PROCESS,0.17411,-0.046921,-0.054299,0,0
6,GO REGULATION OF LEUKOCYTE CHEMOTAXIS,0.12822,-0.046929,-0.054575,0,0
6,GO REGULATION OF HORMONE METABOLIC PROCESS,0.30066,-0.046934,-0.058934,0,0
6,GO IMMUNE RESPONSE REGULATING SIGNALING PATHWAY,0.12822,-0.046936,-0.047915,0,0
6,GO SULFUR AMINO ACID BIOSYNTHETIC PROCESS,0.8379,-0.046972,0.0053141,0,0
6,GO REGULATION OF CHEMOTAXIS,0.50516,-0.047158,-0.01179,0,0
6,GO HYDROGEN PEROXIDE BIOSYNTHETIC PROCESS,0.9306,-0.047209,0.015699,0,0
6,GO PROTEIN FOLDING,0.60834,-0.047274,-0.016137,0,0
6,GO MAINTENANCE OF LOCATION IN CELL,0.37173,-0.047359,-0.015332,0,0
6,GO REGULATION OF IMMUNOGLOBULIN PRODUCTION,0.25924,-0.047365,-0.049596,0,0
6,GO CELLULAR MODIFIED AMINO ACID CATABOLIC PROCESS,0.85694,-0.047434,0.03183,0,0
6,GO NADPH REGENERATION,0.21437,-0.04745,-0.072544,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.44752,-0.047452,-0.044212,0,0
6,GO REGULATION OF NITRIC OXIDE BIOSYNTHETIC PROCESS,0.33803,-0.047499,-0.04375,0,0
6,GO RESPONSE TO ISCHEMIA,0.87287,-0.047575,0.012115,0,0
6,GO AMINE CATABOLIC PROCESS,0.14869,-0.047606,-0.094074,0,0
6,GO CELLULAR OXIDANT DETOXIFICATION,0.10385,-0.047648,-0.072516,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO CYTOKINE STIMULUS,0.23286,-0.047824,-0.035929,0,0
6,GO AMYLOID BETA METABOLIC PROCESS,0.44028,-0.048263,-0.017372,0,0
6,GO POSITIVE REGULATION OF EPIDERMIS DEVELOPMENT,0.62545,-0.048337,-0.033133,0,0
6,GO HYPOTONIC RESPONSE,0.97899,-0.048415,0.034902,0,0
6,GO ENDOTHELIAL CELL MIGRATION,0.32592,-0.048425,-0.030976,0,0
6,GO POSITIVE REGULATION OF CELL ACTIVATION,0.20992,-0.048477,-0.047477,0,0
6,GO GLYCOLYTIC PROCESS THROUGH FRUCTOSE 6 PHOSPHATE,0.62832,-0.048482,-0.050205,0,0
6,GO PROTOPORPHYRINOGEN IX METABOLIC PROCESS,0.32393,-0.04858,-0.04528,0,0
6,GO NEGATIVE REGULATION OF ALPHA BETA T CELL ACTIVATION,0.79075,-0.048608,-0.012437,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE APOPTOTIC PROCESS,0.28213,-0.048871,-0.061954,0,0
6,GO MITOCHONDRIAL RNA METABOLIC PROCESS,0.13763,-0.048919,-0.095832,0,0
6,GO INNATE IMMUNE RESPONSE,0.077018,-0.048919,-0.080548,0,0
6,GO DEFENSE RESPONSE TO OTHER ORGANISM,0.080464,-0.049011,-0.071865,0,0
6,GO CARBOHYDRATE DERIVATIVE CATABOLIC PROCESS,0.10214,-0.049243,-0.060289,0,0
6,GO COAGULATION,0.33599,-0.049245,-0.027926,0,0
6,GO NEGATIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.5394,-0.049272,-0.0092207,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.34213,-0.049286,-0.050072,0,0
6,GO REGULATION OF PEPTIDASE ACTIVITY,0.12421,-0.049299,-0.058523,0,0
6,GO ACTIVATION OF IMMUNE RESPONSE,0.073043,-0.049349,-0.06067,0,0
6,GO BILE ACID AND BILE SALT TRANSPORT,0.30829,-0.049392,-0.084036,0,0
6,GO TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.31997,-0.049541,-0.065214,0,0
6,GO CELLULAR RESPONSE TO HYDROGEN PEROXIDE,0.1313,-0.049606,-0.051105,0,0
6,GO RIBOSOME BIOGENESIS,0.17283,-0.049608,-0.090121,0,0
6,GO GLOMERULAR EPITHELIAL CELL DEVELOPMENT,0.63986,-0.049648,-0.041259,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE ACTIVATION,0.32993,-0.049674,-0.040067,0,0
6,GO REGULATION OF TAU PROTEIN KINASE ACTIVITY,0.66028,-0.049998,-0.065116,0,0
6,GO GOLGI TO PLASMA MEMBRANE PROTEIN TRANSPORT,0.088486,-0.050037,-0.073638,0,0
6,GO VIRION ASSEMBLY,0.32393,-0.050168,-0.022692,0,0
6,GO KILLING OF CELLS OF OTHER ORGANISM,0.40286,-0.050223,-0.019647,0,0
6,GO REGULATION OF SYMBIOTIC PROCESS,0.40058,-0.050235,-0.043727,0,0
6,GO POSITIVE REGULATION OF OXIDOREDUCTASE ACTIVITY,0.29315,-0.050275,-0.039619,0,0
6,GO POSITIVE REGULATION OF DEFENSE RESPONSE,0.079071,-0.050318,-0.068339,0,0
6,GO REGULATION OF FATTY ACID BIOSYNTHETIC PROCESS,0.47211,-0.050339,-0.027915,0,0
6,GO REACTIVE OXYGEN SPECIES BIOSYNTHETIC PROCESS,0.22971,-0.050424,-0.047675,0,0
6,GO PROTEIN NITROSYLATION,0.10646,-0.050599,-0.11042,0,0
6,GO POSITIVE REGULATION OF INSULIN SECRETION INVOLVED IN CELLULAR RESPONSE TO GLUCOSE STIMULUS,0.61402,-0.050655,0.012478,0,0
6,GO FRUCTOSE 6 PHOSPHATE METABOLIC PROCESS,0.55287,-0.050693,-0.039589,0,0
6,GO POSITIVE REGULATION OF T HELPER CELL DIFFERENTIATION,0.14642,-0.050938,-0.1012,0,0
6,GO POSITIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.38933,-0.050959,-0.038356,0,0
6,GO REGULATION OF LYMPHOCYTE MIGRATION,0.34835,-0.051035,-0.032788,0,0
6,GO REGULATION OF MITOCHONDRIAL GENE EXPRESSION,0.061549,-0.051243,-0.11651,0,0
6,GO CRISTAE FORMATION,0.30446,-0.051365,-0.047431,0,0
6,GO REGULATION OF IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.38047,-0.051444,-0.046544,0,0
6,GO T CELL EXTRAVASATION,0.48215,-0.051698,-0.065889,0,0
6,GO INTEGRIN MEDIATED SIGNALING PATHWAY,0.52609,-0.051767,-0.030404,0,0
6,GO B CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.24911,-0.051942,-0.051853,0,0
6,GO CELLULAR TRANSITION METAL ION HOMEOSTASIS,0.071756,-0.052014,-0.054091,0,0
6,GO REGULATION OF HEART RATE,0.63986,-0.052164,-0.0057822,0,0
6,GO REGULATION OF AMYLOID BETA FORMATION,0.54746,-0.052168,-0.001709,0,0
6,GO PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.42602,-0.052624,-0.043658,0,0
6,GO REGULATION OF INNATE IMMUNE RESPONSE,0.26095,-0.052646,-0.046293,0,0
6,GO CELLULAR METABOLIC COMPOUND SALVAGE,0.14642,-0.052803,-0.075726,0,0
6,GO REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.12029,-0.052891,-0.069468,0,0
6,GO POSITIVE REGULATION OF MUSCLE CONTRACTION,0.15447,-0.052944,-0.046054,0,0
6,GO TERTIARY ALCOHOL METABOLIC PROCESS,0.71996,-0.05296,-0.015489,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL MIGRATION,0.40286,-0.053033,-0.047224,0,0
6,GO REGULATION OF RUFFLE ASSEMBLY,0.52345,-0.053078,-0.010113,0,0
6,GO OXYGEN TRANSPORT,0.52082,-0.053251,-0.071632,0,0
6,GO REGULATION OF VIRAL LIFE CYCLE,0.36741,-0.053263,-0.057345,0,0
6,GO POSITIVE REGULATION OF CHEMOTAXIS,0.5394,-0.053365,-0.0096006,0,0
6,GO ALPHA AMINO ACID BIOSYNTHETIC PROCESS,0.13656,-0.053521,-0.074515,0,0
6,GO POSITIVE REGULATION OF PRODUCTION OF MOLECULAR MEDIATOR OF IMMUNE RESPONSE,0.067397,-0.053681,-0.08794,0,0
6,GO MUSCLE CELL CELLULAR HOMEOSTASIS,0.30066,-0.053731,-0.07742,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL MIGRATION,0.30446,-0.053761,-0.029798,0,0
6,GO RENAL SYSTEM PROCESS INVOLVED IN REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.39381,-0.053919,-0.042191,0,0
6,GO POSITIVE REGULATION OF EXECUTION PHASE OF APOPTOSIS,0.076344,-0.05416,-0.075051,0,0
6,GO ANTIMICROBIAL HUMORAL IMMUNE RESPONSE MEDIATED BY ANTIMICROBIAL PEPTIDE,0.14983,-0.054225,-0.043789,0,0
6,GO ZYMOGEN INHIBITION,0.22348,-0.054279,-0.095691,0,0
6,GO CELLULAR RESPONSE TO DSRNA,0.23286,-0.054371,-0.062124,0,0
6,GO PEROXISOMAL TRANSPORT,0.10912,-0.054602,-0.064585,0,0
6,GO ENERGY DERIVATION BY OXIDATION OF ORGANIC COMPOUNDS,0.16163,-0.054632,-0.039489,0,0
6,GO NEGATIVE REGULATION OF PEPTIDASE ACTIVITY,0.14088,-0.05468,-0.064233,0,0
6,GO POSITIVE REGULATION OF PHAGOCYTOSIS,0.2913,-0.054802,-0.060817,0,0
6,GO TRANSITION METAL ION HOMEOSTASIS,0.085497,-0.055497,-0.051528,0,0
6,GO TISSUE REGENERATION,0.85694,-0.055527,-0.0024941,0,0
6,GO POSITIVE REGULATION OF INTERFERON ALPHA PRODUCTION,0.32393,-0.055744,-0.063871,0,0
6,GO POSITIVE REGULATION OF EXTRINSIC APOPTOTIC SIGNALING PATHWAY,0.18866,-0.055811,-0.065471,0,0
6,GO ACYLGLYCEROL HOMEOSTASIS,0.54208,-0.05582,-0.032427,0,0
6,GO POSITIVE REGULATION OF LIPID LOCALIZATION,0.27673,-0.055857,-0.04321,0,0
6,GO REGULATION OF THE FORCE OF HEART CONTRACTION,0.32792,-0.055894,-0.065919,0,0
6,GO POSITIVE REGULATION OF PEPTIDASE ACTIVITY,0.14197,-0.055908,-0.047281,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE MIGRATION,0.85694,-0.055908,-0.010563,0,0
6,GO REGULATION OF STEROL TRANSPORT,0.1387,-0.056128,-0.079922,0,0
6,GO ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.22503,-0.056152,-0.03115,0,0
6,GO POSITIVE REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.22195,-0.056529,-0.06891,0,0
6,GO UDP N ACETYLGLUCOSAMINE BIOSYNTHETIC PROCESS,0.26614,-0.056621,-0.05146,0,0
6,GO LYMPHOCYTE CHEMOTAXIS,0.22042,-0.056722,-0.046424,0,0
6,GO PHYSIOLOGICAL CARDIAC MUSCLE HYPERTROPHY,0.41899,-0.056926,-0.027709,0,0
6,GO FATTY ACID HOMEOSTASIS,0.37827,-0.056926,-0.057115,0,0
6,GO PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.30829,-0.057066,-0.05924,0,0
6,GO ENDOPLASMIC RETICULUM CALCIUM ION HOMEOSTASIS,0.093918,-0.057092,-0.055061,0,0
6,GO POSITIVE REGULATION OF B CELL MEDIATED IMMUNITY,0.41666,-0.057101,-0.042542,0,0
6,GO REGULATION OF TRANSLATION IN RESPONSE TO STRESS,0.32592,-0.057224,-0.032703,0,0
6,GO DOPAMINE BIOSYNTHETIC PROCESS,0.97899,-0.057234,0.015496,0,0
6,GO T CELL CYTOKINE PRODUCTION,0.11183,-0.057415,-0.082975,0,0
6,GO REGULATION OF RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL,0.2913,-0.057426,-0.030302,0,0
6,GO PROTEIN TARGETING TO MITOCHONDRION,0.1533,-0.0575,-0.052168,0,0
6,GO LONG CHAIN FATTY ACYL COA BIOSYNTHETIC PROCESS,0.56925,-0.057651,-0.039226,0,0
6,GO SYNCYTIUM FORMATION,0.36526,-0.057662,-0.048361,0,0
6,GO REGULATION OF LIPASE ACTIVITY,0.088486,-0.058141,-0.057319,0,0
6,GO CELL CHEMOTAXIS,0.12224,-0.058309,-0.054823,0,0
6,GO THYMOCYTE APOPTOTIC PROCESS,0.22503,-0.058417,-0.080232,0,0
6,GO ARACHIDONIC ACID SECRETION,0.1653,-0.058479,-0.044221,0,0
6,GO RESPONSE TO CHEMOKINE,0.070488,-0.058682,-0.05944,0,0
6,GO FC RECEPTOR MEDIATED STIMULATORY SIGNALING PATHWAY,0.25924,-0.058776,-0.034979,0,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID TRANSPORT,0.64276,-0.058854,-0.016977,0,0
6,GO REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.19417,-0.058883,-0.045115,0,0
6,GO MEMBRANE REPOLARIZATION DURING ACTION POTENTIAL,0.37608,-0.059109,-0.026488,0,0
6,GO REGULATION OF MACROPHAGE ACTIVATION,0.095518,-0.059185,-0.07994,0,0
6,GO GLUCOCORTICOID BIOSYNTHETIC PROCESS,0.70486,-0.059304,-0.014751,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION TRANSPORT,0.26789,-0.05931,-0.0261,0,0
6,GO FORMATION OF TRANSLATION PREINITIATION COMPLEX,0.49487,-0.059407,-0.047522,0,0
6,GO POSITIVE REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.38267,-0.059409,-0.043814,0,0
6,GO REGULATION OF MIRNA METABOLIC PROCESS,0.178,-0.059439,-0.072642,0,0
6,GO HYALURONAN METABOLIC PROCESS,0.35253,-0.05947,-0.037695,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE MIGRATION,0.26095,-0.059484,-0.03711,0,0
6,GO NEGATIVE REGULATION OF PROTEIN LOCALIZATION TO CELL PERIPHERY,0.35043,-0.059662,-0.050175,0,0
6,GO SERINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.44752,-0.05968,-0.047105,0,0
6,GO EXTRACELLULAR STRUCTURE ORGANIZATION,0.72299,-0.059702,-0.012733,0,0
6,GO POSITIVE REGULATION OF PATHWAY RESTRICTED SMAD PROTEIN PHOSPHORYLATION,0.5,-0.060042,-0.021943,0,0
6,GO NEGATIVE REGULATION OF ACTIN FILAMENT DEPOLYMERIZATION,0.78763,-0.060068,0.002199,0,0
6,GO RESPONSE TO AMPHETAMINE,0.78763,-0.060162,0.0060279,0,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM STRESS INDUCED INTRINSIC APOPTOTIC SIGNALING PATHWAY,0.34835,-0.060308,-0.020139,0,0
6,GO CELLULAR HORMONE METABOLIC PROCESS,0.3871,-0.060316,-0.038406,0,0
6,GO LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.071119,-0.060339,-0.082657,0,0
6,GO POSITIVE REGULATION OF HUMORAL IMMUNE RESPONSE,0.10471,-0.06053,-0.054348,0,0
6,GO CHAPERONE MEDIATED PROTEIN FOLDING,0.37827,-0.060536,-0.031759,0,0
6,GO LEYDIG CELL DIFFERENTIATION,0.56925,-0.060567,0.068361,0,0
6,GO RESPONSE TO MINERALOCORTICOID,0.15214,-0.060666,-0.066535,0,0
6,GO NEGATIVE REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.50258,-0.060815,-0.024392,0,0
6,GO INNER MITOCHONDRIAL MEMBRANE ORGANIZATION,0.14983,-0.060893,-0.062979,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE CHEMOTAXIS,0.33396,-0.06105,-0.055482,0,0
6,GO POSITIVE REGULATION OF RHO PROTEIN SIGNAL TRANSDUCTION,0.21288,-0.061051,-0.051248,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.3739,-0.061056,-0.048286,0,0
6,GO IMMUNE EFFECTOR PROCESS,0.069238,-0.061089,-0.071437,0,0
6,GO NEGATIVE REGULATION OF MYOTUBE DIFFERENTIATION,0.178,-0.061096,-0.091441,0,0
6,GO ACETYL COA BIOSYNTHETIC PROCESS,0.58864,-0.061165,-0.026448,0,0
6,GO MITOCHONDRIAL CALCIUM ION TRANSMEMBRANE TRANSPORT,0.16285,-0.06117,-0.07028,0,0
6,GO VITAMIN METABOLIC PROCESS,0.10385,-0.061179,-0.046254,0,0
6,GO FAT SOLUBLE VITAMIN METABOLIC PROCESS,0.85059,-0.06135,0.0045477,0,0
6,GO RESPONSE TO ZINC ION,0.48215,-0.061789,-0.045565,0,0
6,GO CELLULAR RESPONSE TO TOXIC SUBSTANCE,0.27673,-0.061855,-0.040648,0,0
6,GO POSITIVE REGULATION OF CELL CELL ADHESION,0.20699,-0.061887,-0.048443,0,0
6,GO CELLULAR RESPONSE TO DRUG,0.22042,-0.061961,-0.023057,0,0
6,GO RESPONSE TO PAIN,0.32195,-0.061967,-0.075764,0,0
6,GO REGULATION OF NECROTIC CELL DEATH,0.14088,-0.062027,-0.069046,0,0
6,GO REGULATION OF CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.31409,-0.062068,-0.068141,0,0
6,GO ENDODERMAL CELL FATE COMMITMENT,0.18062,-0.062102,-0.047272,0,0
6,GO MEMBRANE DEPOLARIZATION DURING CARDIAC MUSCLE CELL ACTION POTENTIAL,0.59144,-0.062154,0.052663,0,0
6,GO POSITIVE REGULATION OF MONOCYTE DIFFERENTIATION,0.27317,-0.062157,-0.12789,0,0
6,GO CELL CELL RECOGNITION,0.075009,-0.062166,-0.061359,0,0
6,GO IMMUNOLOGICAL SYNAPSE FORMATION,0.41434,-0.062546,-0.064554,0,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.25924,-0.062552,-0.060406,0,0
6,GO GAP JUNCTION ASSEMBLY,0.23605,-0.062558,-0.073847,0,0
6,GO CELLULAR RESPONSE TO EXOGENOUS DSRNA,0.40743,-0.062882,-0.050111,0,0
6,GO REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.13338,-0.062952,-0.077815,0,0
6,GO PYRIMIDINE NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.58864,-0.062971,-0.0090408,0,0
6,GO SEQUESTERING OF CALCIUM ION,0.19979,-0.063331,-0.037293,0,0
6,GO REGULATION OF STEROID BIOSYNTHETIC PROCESS,0.10214,-0.063556,-0.059365,0,0
6,GO PROSTAGLANDIN TRANSPORT,0.10299,-0.063561,-0.080593,0,0
6,GO PURINE CONTAINING COMPOUND SALVAGE,0.14088,-0.063636,-0.09536,0,0
6,GO POSITIVE REGULATION OF BONE RESORPTION,0.11837,-0.063766,-0.0878,0,0
6,GO REGULATION OF CELLULAR RESPIRATION,0.32195,-0.06385,-0.057221,0,0
6,GO MOVEMENT IN HOST ENVIRONMENT,0.13979,-0.063964,-0.077926,0,0
6,GO REGULATION OF CARDIAC MUSCLE CELL ACTION POTENTIAL,0.572,-0.064017,-0.034272,0,0
6,GO SHORT CHAIN FATTY ACID METABOLIC PROCESS,0.42602,-0.064186,-0.072924,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 2 PRODUCTION,0.44269,-0.064217,-0.03817,0,0
6,GO STEROID ESTERIFICATION,0.15098,-0.064237,-0.1168,0,0
6,GO POSITIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.33396,-0.064449,-0.047406,0,0
6,GO SENSORY PERCEPTION OF TASTE,0.63408,-0.064553,-0.036884,0,0
6,GO POSITIVE REGULATION OF CALCIUM ION DEPENDENT EXOCYTOSIS,0.94026,-0.064646,0.1122,0,0
6,GO REGULATION OF RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.24416,-0.064655,-0.024815,0,0
6,GO FIBROBLAST ACTIVATION,0.46218,-0.064677,-0.029684,0,0
6,GO REACTIVE NITROGEN SPECIES METABOLIC PROCESS,0.1313,-0.064854,-0.065776,0,0
6,GO REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.29877,-0.065001,-0.063984,0,0
6,GO NEUTROPHIL HOMEOSTASIS,0.25583,-0.065147,-0.090694,0,0
6,GO KERATINIZATION,0.49231,-0.065208,-0.053499,0,0
6,GO EMBRYO IMPLANTATION,0.178,-0.065494,-0.062219,0,0
6,GO NEGATIVE REGULATION OF MAP KINASE ACTIVITY,0.24745,-0.065673,-0.051496,0,0
6,GO REGULATION OF T CELL MEDIATED IMMUNITY,0.080464,-0.06576,-0.10668,0,0
6,GO ER ASSOCIATED MISFOLDED PROTEIN CATABOLIC PROCESS,0.30066,-0.065964,-0.042341,0,0
6,GO PYRIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.34627,-0.066037,-0.038778,0,0
6,GO REGULATION OF IMMUNE EFFECTOR PROCESS,0.09796,-0.066217,-0.076858,0,0
6,GO AMYLOID FIBRIL FORMATION,0.78763,-0.06626,-0.0010127,0,0
6,GO PTERIDINE CONTAINING COMPOUND METABOLIC PROCESS,0.090011,-0.066338,-0.072204,0,0
6,GO POSITIVE REGULATION OF ERK1 AND ERK2 CASCADE,0.2458,-0.06648,-0.034677,0,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE METABOLIC PROCESS,0.14308,-0.066507,-0.069908,0,0
6,GO HYDROGEN PEROXIDE METABOLIC PROCESS,0.48215,-0.066578,-0.016313,0,0
6,GO REGULATION OF RESPONSE TO WOUNDING,0.74435,-0.066665,-0.00089647,0,0
6,GO NEGATIVE REGULATION OF BONE REMODELING,0.23927,-0.066826,-0.077802,0,0
6,GO BONE RESORPTION,0.12721,-0.066846,-0.067938,0,0
6,GO RESPONSE TO THYROID HORMONE,0.14419,-0.066968,-0.098584,0,0
6,GO SEQUESTERING OF METAL ION,0.19003,-0.066996,-0.073646,0,0
6,GO CELLULAR RESPONSE TO THYROID HORMONE STIMULUS,0.51035,-0.067053,-0.051439,0,0
6,GO NUCLEOBASE CONTAINING SMALL MOLECULE INTERCONVERSION,0.12126,-0.067151,-0.084887,0,0
6,GO OSTEOCLAST DEVELOPMENT,0.075009,-0.067242,-0.08445,0,0
6,GO INTERLEUKIN 4 PRODUCTION,0.14088,-0.067448,-0.075188,0,0
6,GO NEGATIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL ACTIVATION,0.79075,-0.067564,-0.010762,0,0
6,GO MITOTIC NUCLEAR ENVELOPE REASSEMBLY,0.38488,-0.067886,-0.039969,0,0
6,GO POSITIVE REGULATION OF MUSCLE CELL APOPTOTIC PROCESS,0.21288,-0.068028,-0.07917,0,0
6,GO POSITIVE REGULATION OF ALCOHOL BIOSYNTHETIC PROCESS,0.44269,-0.068156,-0.029193,0,0
6,GO PHENOL CONTAINING COMPOUND CATABOLIC PROCESS,0.74128,-0.068223,-0.0039795,0,0
6,GO RESPONSE TO GONADOTROPIN,0.20699,-0.068307,-0.061893,0,0
6,GO MUSCLE FILAMENT SLIDING,0.24745,-0.068442,-0.049503,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR SUPERFAMILY CYTOKINE PRODUCTION,0.67206,-0.068487,-0.0257,0,0
6,GO INTESTINAL ABSORPTION,0.35043,-0.068634,-0.057695,0,0
6,GO PHOSPHATIDYLETHANOLAMINE ACYL CHAIN REMODELING,0.22814,-0.068693,-0.056041,0,0
6,GO T CELL APOPTOTIC PROCESS,0.16163,-0.068811,-0.06925,0,0
6,GO ACTIN FILAMENT NETWORK FORMATION,0.69885,-0.068843,-0.00090388,0,0
6,GO CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.4355,-0.068884,-0.044993,0,0
6,GO CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.48215,-0.068913,-0.024779,0,0
6,GO POSITIVE REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.16778,-0.068934,-0.11254,0,0
6,GO RELEASE OF SEQUESTERED CALCIUM ION INTO CYTOSOL BY ENDOPLASMIC RETICULUM,0.1653,-0.06912,-0.06761,0,0
6,GO AMINE METABOLIC PROCESS,0.18062,-0.069144,-0.036042,0,0
6,GO INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.24252,-0.069229,-0.03924,0,0
6,GO NEPHRIC DUCT DEVELOPMENT,0.98869,-0.069399,0.00069718,0,0
6,GO PROTEIN IMPORT INTO PEROXISOME MATRIX,0.66028,-0.069405,0.0021016,0,0
6,GO PROTEIN TRANSMEMBRANE TRANSPORT,0.045155,-0.069414,-0.062435,0,0
6,GO PROTEIN DENEDDYLATION,0.09714,-0.069418,-0.072174,0,0
6,GO POSITIVE REGULATION OF CHEMOKINE PRODUCTION,0.15565,-0.069547,-0.077048,0,0
6,GO DIOL BIOSYNTHETIC PROCESS,0.20122,-0.06957,-0.052382,0,0
6,GO RIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.29502,-0.06962,-0.033798,0,0
6,GO SMOOTH MUSCLE CELL PROLIFERATION,0.16163,-0.069976,-0.053354,0,0
6,GO ALDEHYDE CATABOLIC PROCESS,0.20409,-0.070045,-0.049413,0,0
6,GO GTP METABOLIC PROCESS,0.16904,-0.070049,-0.065204,0,0
6,GO POSITIVE REGULATION OF CELL SUBSTRATE ADHESION,0.45972,-0.070065,-0.036755,0,0
6,GO REGULATION OF B CELL ACTIVATION,0.20265,-0.070099,-0.05562,0,0
6,GO NEGATIVE REGULATION OF T CELL PROLIFERATION,0.21738,-0.070118,-0.060582,0,0
6,GO LYMPHOCYTE HOMEOSTASIS,0.13234,-0.070255,-0.050999,0,0
6,GO NEGATIVE REGULATION OF SODIUM ION TRANSMEMBRANE TRANSPORT,0.67798,-0.070262,-0.043779,0,0
6,GO MONOACYLGLYCEROL METABOLIC PROCESS,0.36311,-0.070268,-0.059387,0,0
6,GO REGULATION OF T HELPER 17 TYPE IMMUNE RESPONSE,0.65442,-0.0703,-0.014488,0,0
6,GO PRIMARY ALCOHOL CATABOLIC PROCESS,0.3739,-0.07042,-0.029253,0,0
6,GO PLATELET ACTIVATION,0.36741,-0.07046,-0.022806,0,0
6,GO HEPATOCYTE APOPTOTIC PROCESS,0.32592,-0.070754,-0.018377,0,0
6,GO PYRIDINE CONTAINING COMPOUND BIOSYNTHETIC PROCESS,0.1653,-0.070774,-0.070325,0,0
6,GO LEUKOCYTE MIGRATION,0.1262,-0.070952,-0.053286,0,0
6,GO DENDRITIC CELL CHEMOTAXIS,0.75356,-0.071009,-0.0082909,0,0
6,GO SULFUR AMINO ACID CATABOLIC PROCESS,0.54477,-0.071147,-0.029195,0,0
6,GO PRIMARY ALCOHOL METABOLIC PROCESS,0.16904,-0.07119,-0.06872,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE BIOSYNTHETIC PROCESS,0.23286,-0.071216,-0.032887,0,0
6,GO TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.10646,-0.071234,-0.070906,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 8 PRODUCTION,0.12421,-0.071461,-0.078078,0,0
6,GO NEGATIVE REGULATION OF INNATE IMMUNE RESPONSE,0.14419,-0.071557,-0.10439,0,0
6,GO HYDROGEN PEROXIDE CATABOLIC PROCESS,0.29689,-0.07166,-0.041655,0,0
6,GO CYTOKINE MEDIATED SIGNALING PATHWAY,0.060988,-0.071764,-0.083461,0,0
6,GO GLYCEROLIPID CATABOLIC PROCESS,0.318,-0.071835,-0.040925,0,0
6,GO CELLULAR RESPONSE TO MECHANICAL STIMULUS,0.077698,-0.071853,-0.10845,0,0
6,GO NECROTIC CELL DEATH,0.1262,-0.072314,-0.073474,0,0
6,GO DEFENSE RESPONSE TO GRAM NEGATIVE BACTERIUM,0.14419,-0.072366,-0.053486,0,0
6,GO POSITIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.10646,-0.072537,-0.065723,0,0
6,GO POSITIVE REGULATION OF KERATINOCYTE PROLIFERATION,0.27317,-0.072595,-0.090067,0,0
6,GO PINOCYTOSIS,0.11275,-0.072611,-0.075919,0,0
6,GO HUMORAL IMMUNE RESPONSE,0.078382,-0.072697,-0.076046,0,0
6,GO REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.3739,-0.072782,-0.032816,0,0
6,GO LONG CHAIN FATTY ACID METABOLIC PROCESS,0.1146,-0.072798,-0.062809,0,0
6,GO ENDOCRINE PROCESS,0.42133,-0.072879,-0.024922,0,0
6,GO UNSATURATED FATTY ACID METABOLIC PROCESS,0.064418,-0.073284,-0.086862,0,0
6,GO NUCLEOTIDE SUGAR METABOLIC PROCESS,0.095518,-0.073355,-0.08182,0,0
6,GO POSITIVE REGULATION OF PHOSPHOLIPID METABOLIC PROCESS,0.21738,-0.073452,-0.056777,0,0
6,GO REGULATION OF FERTILIZATION,0.47963,-0.073608,-0.015625,0,0
6,GO FOLIC ACID METABOLIC PROCESS,0.11092,-0.07392,-0.067784,0,0
6,GO RESPONSE TO MACROPHAGE COLONY STIMULATING FACTOR,0.15921,-0.074041,-0.082181,0,0
6,GO TUMOR NECROSIS FACTOR BIOSYNTHETIC PROCESS,0.15098,-0.074044,-0.074744,0,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON PRODUCTION,0.093126,-0.074107,-0.062677,0,0
6,GO NEGATIVE REGULATION OF GLYCOPROTEIN METABOLIC PROCESS,0.61402,-0.074276,-0.042569,0,0
6,GO CELLULAR RESPONSE TO PURINE CONTAINING COMPOUND,0.38488,-0.074322,-0.060348,0,0
6,GO PHAGOSOME ACIDIFICATION,0.23128,-0.074731,-0.050707,0,0
6,GO POSITIVE REGULATION OF PROTEIN LOCALIZATION TO CELL SURFACE,0.099614,-0.074734,-0.061711,0,0
6,GO REGULATION OF ADAPTIVE IMMUNE RESPONSE,0.060432,-0.074744,-0.097469,0,0
6,GO SULFUR COMPOUND TRANSPORT,0.27495,-0.075089,-0.027026,0,0
6,GO DEOXYRIBOSE PHOSPHATE BIOSYNTHETIC PROCESS,0.99515,-0.07511,0.017746,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE CELL CELL ADHESION,0.1146,-0.0752,-0.068977,0,0
6,GO POSITIVE REGULATION OF REACTIVE OXYGEN SPECIES METABOLIC PROCESS,0.32993,-0.075215,-0.044871,0,0
6,GO LEUKOCYTE PROLIFERATION,0.081877,-0.075252,-0.069277,0,0
6,GO REGULATION OF AMYLOID PRECURSOR PROTEIN CATABOLIC PROCESS,0.49743,-0.075433,-0.0068281,0,0
6,GO REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.11837,-0.075441,-0.059861,0,0
6,GO REGULATION OF STRIATED MUSCLE CONTRACTION,0.2644,-0.075568,-0.027842,0,0
6,GO ACUTE PHASE RESPONSE,0.11367,-0.07589,-0.068375,0,0
6,GO POSITIVE REGULATION OF PRI MIRNA TRANSCRIPTION BY RNA POLYMERASE II,0.55558,-0.075953,-0.026266,0,0
6,GO REGULATION OF MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.088486,-0.076004,-0.13415,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO HYPOXIA,0.32195,-0.07606,-0.021503,0,0
6,GO FATTY ACID DERIVATIVE TRANSPORT,0.178,-0.076156,-0.044471,0,0
6,GO INTERFERON GAMMA MEDIATED SIGNALING PATHWAY,0.070488,-0.076273,-0.17589,0,0
6,GO POSITIVE REGULATION OF CALCINEURIN MEDIATED SIGNALING,0.19979,-0.076749,-0.054697,0,0
6,GO G PROTEIN COUPLED PURINERGIC NUCLEOTIDE RECEPTOR SIGNALING PATHWAY,0.007921,-0.07685,-0.11854,0,0
6,GO POLYAMINE BIOSYNTHETIC PROCESS,0.066192,-0.077163,-0.074421,0,0
6,GO ETHER BIOSYNTHETIC PROCESS,0.069238,-0.077799,-0.16298,0,0
6,GO NUCLEOTIDE SUGAR TRANSMEMBRANE TRANSPORT,0.17411,-0.077916,-0.10863,0,0
6,GO REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.11837,-0.077919,-0.084583,0,0
6,GO MAMMARY GLAND EPITHELIAL CELL PROLIFERATION,0.072397,-0.077986,-0.080118,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED CYTOTOXICITY,0.34835,-0.07799,-0.04945,0,0
6,GO REGULATION OF MEMBRANE INVAGINATION,0.14642,-0.078076,-0.10423,0,0
6,GO POSITIVE REGULATION OF TOLL LIKE RECEPTOR SIGNALING PATHWAY,0.10823,-0.078099,-0.081728,0,0
6,GO MEMBRANE PROTEIN PROTEOLYSIS,0.19557,-0.078107,-0.068871,0,0
6,GO NEGATIVE REGULATION OF BLOOD VESSEL ENDOTHELIAL CELL MIGRATION,0.18327,-0.078214,-0.059758,0,0
6,GO DENDRITIC CELL CYTOKINE PRODUCTION,0.24745,-0.078278,-0.093113,0,0
6,GO NEGATIVE REGULATION OF CELL ACTIVATION,0.60834,-0.0785,-0.024401,0,0
6,GO POSITIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.19979,-0.078544,-0.062636,0,0
6,GO AMINOGLYCAN CATABOLIC PROCESS,0.23605,-0.078655,-0.060123,0,0
6,GO POSITIVE REGULATION OF TISSUE REMODELING,0.067397,-0.078908,-0.08366,0,0
6,GO REGULATION OF MACROPHAGE MIGRATION,0.23128,-0.078973,-0.042147,0,0
6,GO APOPTOTIC PROCESS INVOLVED IN MORPHOGENESIS,0.5665,-0.079323,-0.026745,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.077698,-0.079427,-0.043569,0,0
6,GO KERATAN SULFATE BIOSYNTHETIC PROCESS,0.11367,-0.079935,-0.066553,0,0
6,GO INDOLALKYLAMINE METABOLIC PROCESS,0.81581,-0.079966,-0.0040428,0,0
6,GO POSITIVE REGULATION OF CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.065596,-0.080023,-0.10067,0,0
6,GO REGULATION OF CELLULAR AMINE METABOLIC PROCESS,0.24252,-0.080188,-0.041813,0,0
6,GO REGULATION OF LEUKOCYTE MIGRATION,0.09714,-0.0806,-0.05876,0,0
6,GO NEGATIVE REGULATION OF TISSUE REMODELING,0.24745,-0.080692,-0.076852,0,0
6,GO THROMBIN ACTIVATED RECEPTOR SIGNALING PATHWAY,0.30066,-0.08087,-0.073912,0,0
6,GO NUCLEOSIDE DIPHOSPHATE BIOSYNTHETIC PROCESS,0.3871,-0.08129,-0.033777,0,0
6,GO METANEPHRIC GLOMERULUS DEVELOPMENT,0.79387,-0.081419,-0.018683,0,0
6,GO TYPE I INTERFERON PRODUCTION,0.20122,-0.081711,-0.050466,0,0
6,GO TRICARBOXYLIC ACID METABOLIC PROCESS,0.24416,-0.08195,-0.060978,0,0
6,GO IMMUNOGLOBULIN SECRETION,0.16163,-0.082162,-0.070917,0,0
6,GO RESPONSE TO FLUID SHEAR STRESS,0.48976,-0.082239,-0.014803,0,0
6,GO NEGATIVE REGULATION OF LIPID BIOSYNTHETIC PROCESS,0.088486,-0.082325,-0.077039,0,0
6,GO GLUCOSE 6 PHOSPHATE METABOLIC PROCESS,0.12421,-0.082345,-0.050414,0,0
6,GO VACUOLAR ACIDIFICATION,0.11002,-0.082364,-0.06891,0,0
6,GO REGULATION OF ACUTE INFLAMMATORY RESPONSE,0.24911,-0.082376,-0.052857,0,0
6,GO T HELPER 1 CELL DIFFERENTIATION,0.11933,-0.082377,-0.16124,0,0
6,GO GLYCOSYL COMPOUND CATABOLIC PROCESS,0.06986,-0.082398,-0.096759,0,0
6,GO DETOXIFICATION,0.060432,-0.082655,-0.083018,0,0
6,GO C21 STEROID HORMONE METABOLIC PROCESS,0.18062,-0.083059,-0.071733,0,0
6,GO ANTIMICROBIAL HUMORAL RESPONSE,0.11183,-0.08314,-0.062317,0,0
6,GO INTERLEUKIN 1 PRODUCTION,0.075674,-0.083154,-0.094334,0,0
6,GO POSITIVE REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.084763,-0.083494,-0.081855,0,0
6,GO CORNIFICATION,0.318,-0.083528,-0.085011,0,0
6,GO ENTRY INTO HOST,0.094715,-0.083586,-0.10131,0,0
6,GO POSITIVE REGULATION OF CELLULAR EXTRAVASATION,0.26789,-0.083593,-0.069509,0,0
6,GO LINOLEIC ACID METABOLIC PROCESS,0.24252,-0.083773,-0.10372,0,0
6,GO POSITIVE REGULATION OF NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.35253,-0.083881,-0.067148,0,0
6,GO RESPONSE TO CORTICOSTERONE,0.35043,-0.083937,-0.041457,0,0
6,GO IRE1 MEDIATED UNFOLDED PROTEIN RESPONSE,0.068006,-0.084042,-0.067027,0,0
6,GO NUCLEOSIDE CATABOLIC PROCESS,0.1146,-0.084059,-0.081306,0,0
6,GO REGULATION OF EPITHELIAL CELL APOPTOTIC PROCESS,0.63986,-0.084144,-0.014988,0,0
6,GO PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.10129,-0.084186,-0.068272,0,0
6,GO T CELL CHEMOTAXIS,0.074349,-0.08439,-0.071558,0,0
6,GO ANDROGEN METABOLIC PROCESS,0.13027,-0.084428,-0.09087,0,0
6,GO XENOBIOTIC TRANSPORT,0.57476,-0.084487,-0.0095049,0,0
6,GO NEGATIVE REGULATION OF ANTIGEN RECEPTOR MEDIATED SIGNALING PATHWAY,0.13763,-0.084521,-0.079708,0,0
6,GO ADAPTIVE IMMUNE RESPONSE BASED ON SOMATIC RECOMBINATION OF IMMUNE RECEPTORS BUILT FROM IMMUNOGLOBULIN SUPERFAMILY DOMAINS,0.088486,-0.084644,-0.094877,0,0
6,GO REGULATION OF PROSTAGLANDIN SECRETION,0.15447,-0.084861,-0.069936,0,0
6,GO REGULATION OF ENDOPLASMIC RETICULUM UNFOLDED PROTEIN RESPONSE,0.19697,-0.08488,-0.043936,0,0
6,GO RRNA CONTAINING RIBONUCLEOPROTEIN COMPLEX EXPORT FROM NUCLEUS,0.079071,-0.084924,-0.12651,0,0
6,GO POSITIVE REGULATION OF TYPE I INTERFERON MEDIATED SIGNALING PATHWAY,0.25414,-0.084937,-0.079174,0,0
6,GO CELL MIGRATION INVOLVED IN SPROUTING ANGIOGENESIS,0.39381,-0.085167,-0.050743,0,0
6,GO POSITIVE REGULATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY INVOLVED IN APOPTOTIC SIGNALING PATHWAY,0.5394,-0.085241,-0.029806,0,0
6,GO ENDODERMAL CELL DIFFERENTIATION,0.19838,-0.085443,-0.090367,0,0
6,GO REGULATION OF ACTIN FILAMENT BASED MOVEMENT,0.25753,-0.085563,-0.057752,0,0
6,GO REGULATION OF LEUKOCYTE ADHESION TO VASCULAR ENDOTHELIAL CELL,0.062114,-0.086127,-0.10419,0,0
6,GO POSITIVE REGULATION OF MAST CELL ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.48215,-0.086147,0.00053917,0,0
6,GO VITAMIN TRANSPORT,0.080464,-0.086335,-0.071125,0,0
6,GO REGULATION OF B CELL RECEPTOR SIGNALING PATHWAY,0.20122,-0.086336,-0.060315,0,0
6,GO INTERLEUKIN 12 PRODUCTION,0.071756,-0.086444,-0.087489,0,0
6,GO ENDOTHELIAL CELL APOPTOTIC PROCESS,0.37608,-0.086903,-0.034805,0,0
6,GO REGULATION OF SPHINGOLIPID BIOSYNTHETIC PROCESS,0.23766,-0.087048,-0.049484,0,0
6,GO RIBOSOMAL SMALL SUBUNIT BIOGENESIS,0.12126,-0.087291,-0.10395,0,0
6,GO NEPHRON TUBULE EPITHELIAL CELL DIFFERENTIATION,0.37173,-0.087303,-0.074933,0,0
6,GO DISACCHARIDE METABOLIC PROCESS,0.50516,-0.087403,-0.029437,0,0
6,GO MEMBRANE PROTEIN ECTODOMAIN PROTEOLYSIS,0.22658,-0.087462,-0.078201,0,0
6,GO POSITIVE REGULATION OF TRANSFORMING GROWTH FACTOR BETA PRODUCTION,0.20845,-0.087503,-0.059681,0,0
6,GO NEGATIVE REGULATION OF CYTOKINE BIOSYNTHETIC PROCESS,0.1262,-0.087619,-0.087056,0,0
6,GO ZINC ION HOMEOSTASIS,0.12322,-0.087734,-0.1201,0,0
6,GO POSITIVE REGULATION OF NEUTROPHIL MIGRATION,0.11002,-0.087741,-0.082675,0,0
6,GO CYTOPLASMIC TRANSLATIONAL INITIATION,0.12224,-0.087968,-0.098686,0,0
6,GO NEGATIVE REGULATION OF RESPONSE TO WOUNDING,0.47712,-0.088091,-0.023831,0,0
6,GO POLYAMINE METABOLIC PROCESS,0.06986,-0.088298,-0.058514,0,0
6,GO INTERLEUKIN 1 BETA PRODUCTION,0.087731,-0.08836,-0.091107,0,0
6,GO NATURAL KILLER CELL MEDIATED IMMUNITY,0.18461,-0.088406,-0.07614,0,0
6,GO RESPONSE TO INTERLEUKIN 18,0.13338,-0.088476,-0.15221,0,0
6,GO ATRIAL CARDIAC MUSCLE CELL TO AV NODE CELL SIGNALING,0.25246,-0.088525,-0.077441,0,0
6,GO REGULATION OF HEART RATE BY CARDIAC CONDUCTION,0.62258,-0.088593,-0.004392,0,0
6,GO POSITIVE REGULATION OF MYELOID LEUKOCYTE MEDIATED IMMUNITY,0.072397,-0.088686,-0.066326,0,0
6,GO NUCLEOBASE BIOSYNTHETIC PROCESS,0.1313,-0.088686,-0.10513,0,0
6,GO RIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.08331,-0.088716,-0.049193,0,0
6,GO ARGININE METABOLIC PROCESS,0.60834,-0.088944,-0.027368,0,0
6,GO CELL DEATH IN RESPONSE TO HYDROGEN PEROXIDE,0.090782,-0.089204,-0.064511,0,0
6,GO PHAGOCYTOSIS RECOGNITION,0.72299,-0.089277,0.028703,0,0
6,GO REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.32792,-0.089351,-0.034623,0,0
6,GO REGULATION OF HORMONE BIOSYNTHETIC PROCESS,0.40973,-0.089486,-0.037841,0,0
6,GO REGULATION OF PROTEIN CATABOLIC PROCESS IN THE VACUOLE,0.076344,-0.089576,-0.079793,0,0
6,GO NADP METABOLIC PROCESS,0.22971,-0.08967,-0.051286,0,0
6,GO RIBONUCLEOSIDE CATABOLIC PROCESS,0.3442,-0.089807,-0.077682,0,0
6,GO T CELL PROLIFERATION,0.073043,-0.090127,-0.074281,0,0
6,GO REGULATION OF LYMPHOCYTE CHEMOTAXIS,0.17669,-0.090226,-0.07164,0,0
6,GO REGULATION OF KETONE BIOSYNTHETIC PROCESS,0.33194,-0.090492,-0.056756,0,0
6,GO CHEMICAL HOMEOSTASIS WITHIN A TISSUE,0.2913,-0.090706,-0.084936,0,0
6,GO POSITIVE REGULATION OF FIBROBLAST PROLIFERATION,0.12322,-0.090881,-0.097713,0,0
6,GO RESPONSE TO TUMOR CELL,0.088486,-0.091614,-0.11603,0,0
6,GO MACROPHAGE ACTIVATION,0.079071,-0.091868,-0.065962,0,0
6,GO COENZYME A METABOLIC PROCESS,0.80639,-0.091984,0.012932,0,0
6,GO ANGIOGENESIS INVOLVED IN WOUND HEALING,0.35886,-0.092083,-0.025462,0,0
6,GO CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.10734,-0.092365,-0.075253,0,0
6,GO REGULATION OF MACROPHAGE CHEMOTAXIS,0.098784,-0.092385,-0.071126,0,0
6,GO CELLULAR RESPONSE TO CADMIUM ION,0.44269,-0.092513,-0.068585,0,0
6,GO REGULATION OF INTEGRIN MEDIATED SIGNALING PATHWAY,0.13549,-0.092904,-0.11044,0,0
6,GO BASEMENT MEMBRANE ORGANIZATION,0.73517,-0.092924,-0.015483,0,0
6,GO SPERM EGG RECOGNITION,0.068006,-0.093074,-0.059921,0,0
6,GO POSITIVE REGULATION OF CD4 POSITIVE ALPHA BETA T CELL DIFFERENTIATION,0.096327,-0.093107,-0.11044,0,0
6,GO REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.060432,-0.093196,-0.11787,0,0
6,GO T HELPER 2 CELL DIFFERENTIATION,0.20992,-0.093216,-0.13463,0,0
6,GO SERINE FAMILY AMINO ACID METABOLIC PROCESS,0.35674,-0.093298,-0.040026,0,0
6,GO MITOCHONDRIAL DEPOLARIZATION,0.13656,-0.093418,-0.079856,0,0
6,GO CYTOKINE PRODUCTION INVOLVED IN IMMUNE RESPONSE,0.090011,-0.09357,-0.079373,0,0
6,GO REGULATION OF METALLOPEPTIDASE ACTIVITY,0.8379,-0.093676,0.033322,0,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION,0.18595,-0.09369,-0.036988,0,0
6,GO REGULATION OF T CELL CHEMOTAXIS,0.096327,-0.094018,-0.072052,0,0
6,GO RESPONSE TO HYDROPEROXIDE,0.24089,-0.09478,-0.091917,0,0
6,GO REGULATION OF CELLULAR RESPONSE TO VASCULAR ENDOTHELIAL GROWTH FACTOR STIMULUS,0.12126,-0.094887,-0.10299,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE DIFFERENTIATION,0.13234,-0.096034,-0.12524,0,0
6,GO GAS TRANSPORT,0.29502,-0.096054,-0.081847,0,0
6,GO INTRINSIC APOPTOTIC SIGNALING PATHWAY IN RESPONSE TO ENDOPLASMIC RETICULUM STRESS,0.14983,-0.096098,-0.046229,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE PROLIFERATION,0.14983,-0.09611,-0.07158,0,0
6,GO RESPONSE TO INTERLEUKIN 4,0.033271,-0.096156,-0.076179,0,0
6,GO POSITIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.071756,-0.096201,-0.12414,0,0
6,GO POSITIVE REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.16407,-0.096381,-0.061657,0,0
6,GO POSITIVE REGULATION OF TRIGLYCERIDE BIOSYNTHETIC PROCESS,0.080464,-0.096409,-0.11244,0,0
6,GO FATTY ACID DERIVATIVE METABOLIC PROCESS,0.062114,-0.096711,-0.07905,0,0
6,GO DIOL METABOLIC PROCESS,0.33803,-0.09725,-0.032433,0,0
6,GO REGULATION OF CARDIAC MUSCLE CONTRACTION BY CALCIUM ION SIGNALING,0.087731,-0.098233,-0.083879,0,0
6,GO ENDONUCLEOLYTIC CLEAVAGE INVOLVED IN RRNA PROCESSING,0.085497,-0.098269,-0.12087,0,0
6,GO NEGATIVE REGULATION OF MUSCLE CONTRACTION,0.073043,-0.098391,-0.085758,0,0
6,GO LEUKOCYTE ACTIVATION INVOLVED IN INFLAMMATORY RESPONSE,0.092339,-0.098437,-0.065209,0,0
6,GO NUCLEOBASE METABOLIC PROCESS,0.099614,-0.098883,-0.068578,0,0
6,GO INFLAMMATORY CELL APOPTOTIC PROCESS,0.15565,-0.098895,-0.079249,0,0
6,GO POSITIVE REGULATION OF LEUKOCYTE DEGRANULATION,0.25924,-0.098948,-0.027098,0,0
6,GO CELLULAR RESPONSE TO REACTIVE NITROGEN SPECIES,0.69286,-0.099272,-0.00072762,0,0
6,GO MATURATION OF SSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.066792,-0.099283,-0.11272,0,0
6,GO FATTY ACID DERIVATIVE CATABOLIC PROCESS,0.075009,-0.099444,-0.13022,0,0
6,GO POSITIVE REGULATION OF HAIR CYCLE,0.1914,-0.099741,-0.09147,0,0
6,GO POSITIVE REGULATION OF LIPID STORAGE,0.071756,-0.10048,-0.10018,0,0
6,GO GLUTAMINE FAMILY AMINO ACID BIOSYNTHETIC PROCESS,0.11742,-0.10083,-0.098984,0,0
6,GO FATTY ACYL COA BIOSYNTHETIC PROCESS,0.29502,-0.10125,-0.058993,0,0
6,GO POSITIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.40286,-0.10135,-0.067823,0,0
6,GO POSITIVE REGULATION OF CYTOSOLIC CALCIUM ION CONCENTRATION INVOLVED IN PHOSPHOLIPASE C ACTIVATING G PROTEIN COUPLED SIGNALING PATHWAY,0.12721,-0.10136,-0.073628,0,0
6,GO MATURATION OF LSU RRNA FROM TRICISTRONIC RRNA TRANSCRIPT SSU RRNA 5 8S RRNA LSU RRNA,0.11183,-0.10195,-0.12175,0,0
6,GO GLYCOSIDE METABOLIC PROCESS,0.44269,-0.10199,-0.046726,0,0
6,GO NITRIC OXIDE SYNTHASE BIOSYNTHETIC PROCESS,0.10823,-0.10237,-0.11324,0,0
6,GO MITOCHONDRIAL TRANSMEMBRANE TRANSPORT,0.15683,-0.10239,-0.056535,0,0
6,GO BARBED END ACTIN FILAMENT CAPPING,0.14983,-0.10243,-0.091737,0,0
6,GO POSITIVE REGULATION OF TUMOR NECROSIS FACTOR MEDIATED SIGNALING PATHWAY,0.10734,-0.10334,-0.12199,0,0
6,GO ENDODERM FORMATION,0.36098,-0.10353,-0.055553,0,0
6,GO REGULATION OF ACTIN CYTOSKELETON REORGANIZATION,0.15683,-0.10419,-0.061324,0,0
6,GO ENTRY OF BACTERIUM INTO HOST CELL,0.64276,-0.10421,-0.034791,0,0
6,GO RESPONSE TO MAGNESIUM ION,0.072397,-0.10448,-0.14073,0,0
6,GO HEMIDESMOSOME ASSEMBLY,0.5314,-0.1046,-0.043076,0,0
6,GO CELLULAR ALDEHYDE METABOLIC PROCESS,0.072397,-0.10462,-0.084479,0,0
6,GO MACROPHAGE CYTOKINE PRODUCTION,0.13234,-0.10469,-0.11375,0,0
6,GO NONRIBOSOMAL PEPTIDE BIOSYNTHETIC PROCESS,0.062114,-0.10476,-0.11815,0,0
6,GO ALPHA BETA T CELL PROLIFERATION,0.062114,-0.10566,-0.11563,0,0
6,GO DRUG METABOLIC PROCESS,0.061549,-0.10567,-0.099666,0,0
6,GO CELLULAR RESPONSE TO ZINC ION,0.28578,-0.10575,-0.1302,0,0
6,GO INTERLEUKIN 35 MEDIATED SIGNALING PATHWAY,0.47461,-0.10586,-0.040612,0,0
6,GO CERAMIDE TRANSPORT,0.1262,-0.10596,-0.078891,0,0
6,GO REGULATION OF RECEPTOR CATABOLIC PROCESS,0.077698,-0.10611,-0.15349,0,0
6,GO REGULATION OF WOUND HEALING,0.29315,-0.10638,-0.044734,0,0
6,GO B CELL RECEPTOR SIGNALING PATHWAY,0.075009,-0.10644,-0.094984,0,0
6,GO REGULATION OF PERK MEDIATED UNFOLDED PROTEIN RESPONSE,0.15565,-0.10671,-0.082651,0,0
6,GO PROTEASOMAL UBIQUITIN INDEPENDENT PROTEIN CATABOLIC PROCESS,0.13979,-0.107,-0.11264,0,0
6,GO ALDEHYDE BIOSYNTHETIC PROCESS,0.2114,-0.10717,-0.10265,0,0
6,GO MACROPHAGE MIGRATION,0.11553,-0.10724,-0.062675,0,0
6,GO REGULATION OF MICROGLIAL CELL ACTIVATION,0.12721,-0.10765,-0.079056,0,0
6,GO MATURATION OF SSU RRNA,0.17029,-0.10772,-0.092937,0,0
6,GO LYMPHOCYTE MIGRATION,0.20845,-0.10774,-0.038074,0,0
6,GO VAGINA DEVELOPMENT,0.32592,-0.10814,-0.041297,0,0
6,GO NEGATIVE REGULATION OF VIRAL GENOME REPLICATION,0.32993,-0.10837,-0.093633,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.10646,-0.10848,-0.079307,0,0
6,GO STEROID CATABOLIC PROCESS,0.2114,-0.10882,-0.063244,0,0
6,GO HOMOCYSTEINE METABOLIC PROCESS,0.086237,-0.10885,-0.12011,0,0
6,GO LIPOXYGENASE PATHWAY,0.032938,-0.10886,-0.21426,0,0
6,GO NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN CONTAINING 2 SIGNALING PATHWAY,0.19979,-0.11044,-0.093134,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.35674,-0.1109,-0.036405,0,0
6,GO NEGATIVE REGULATION OF WOUND HEALING,0.1387,-0.11127,-0.084875,0,0
6,GO NEGATIVE REGULATION OF CELL ADHESION MEDIATED BY INTEGRIN,0.36526,-0.11156,-0.037591,0,0
6,GO MYOBLAST FUSION,0.093918,-0.11218,-0.096858,0,0
6,GO PRIMARY ALCOHOL BIOSYNTHETIC PROCESS,0.21288,-0.11285,-0.087826,0,0
6,GO REGULATION OF RESPONSE TO TUMOR CELL,0.1754,-0.11298,-0.092332,0,0
6,GO RIBONUCLEOSIDE MONOPHOSPHATE METABOLIC PROCESS,0.071756,-0.11312,-0.084069,0,0
6,GO REGULATION OF TOLERANCE INDUCTION,0.32792,-0.11318,-0.094106,0,0
6,GO COLLAGEN FIBRIL ORGANIZATION,0.29877,-0.11336,-0.082695,0,0
6,GO CHONDROITIN SULFATE CATABOLIC PROCESS,0.29877,-0.11353,-0.074726,0,0
6,GO 3 PHOSPHOADENOSINE 5 PHOSPHOSULFATE METABOLIC PROCESS,0.10646,-0.11374,-0.075022,0,0
6,GO NEGATIVE REGULATION OF RECEPTOR BINDING,0.60268,-0.11416,-0.02141,0,0
6,GO BIOLOGICAL PHASE,0.36098,-0.11431,-0.097291,0,0
6,GO PEPTIDE CATABOLIC PROCESS,0.13444,-0.11463,-0.065727,0,0
6,GO SULFUR AMINO ACID METABOLIC PROCESS,0.14088,-0.11507,-0.064495,0,0
6,GO REGULATION OF THYMOCYTE APOPTOTIC PROCESS,0.077018,-0.11548,-0.15573,0,0
6,GO RESPIRATORY BURST,0.063258,-0.1155,-0.096802,0,0
6,GO SKELETAL MUSCLE TISSUE REGENERATION,0.084034,-0.11584,-0.094489,0,0
6,GO NEGATIVE REGULATION OF REPRODUCTIVE PROCESS,0.00098255,-0.116,-0.12179,0,0
6,GO GLYCINE METABOLIC PROCESS,0.11183,-0.11641,-0.10853,0,0
6,GO APOPTOTIC CELL CLEARANCE,0.090011,-0.11649,-0.10631,0,0
6,GO RETINAL METABOLIC PROCESS,0.44028,-0.11664,-0.060921,0,0
6,GO POSITIVE REGULATION OF COAGULATION,0.16654,-0.11703,-0.074527,0,0
6,GO REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.19838,-0.1177,-0.05315,0,0
6,GO ACUTE INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.81581,-0.11779,-0.00057595,0,0
6,GO MICROVILLUS ORGANIZATION,0.19979,-0.11797,-0.081913,0,0
6,GO LIPID DIGESTION,0.11647,-0.11798,-0.14203,0,0
6,GO REGULATION OF VASCULAR ASSOCIATED SMOOTH MUSCLE CELL PROLIFERATION,0.081168,-0.11824,-0.085082,0,0
6,GO REGULATION OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR SIGNALING PATHWAY,0.48976,-0.11845,-0.041972,0,0
6,GO T CELL MIGRATION,0.069238,-0.11873,-0.080551,0,0
6,GO POSITIVE REGULATION OF MACROPHAGE DERIVED FOAM CELL DIFFERENTIATION,0.17669,-0.11881,-0.11018,0,0
6,GO REGULATION OF CELLULAR AMINO ACID METABOLIC PROCESS,0.073043,-0.11883,-0.089071,0,0
6,GO NEGATIVE REGULATION OF ORGANIC ACID TRANSPORT,0.21738,-0.11896,-0.041439,0,0
6,GO REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.16285,-0.11939,-0.10267,0,0
6,GO COLLAGEN CATABOLIC PROCESS,0.15921,-0.11941,-0.069365,0,0
6,GO POSITIVE REGULATION OF CELL KILLING,0.11742,-0.11963,-0.098023,0,0
6,GO REGULATION OF TRANSLATIONAL FIDELITY,0.1252,-0.12082,-0.090903,0,0
6,GO NEGATIVE REGULATION OF LYMPHOCYTE MEDIATED IMMUNITY,0.25753,-0.12082,-0.081527,0,0
6,GO POSITIVE REGULATION OF BLOOD CIRCULATION,0.093918,-0.12161,-0.041081,0,0
6,GO TRABECULA FORMATION,0.23286,-0.1219,-0.080043,0,0
6,GO POSITIVE REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.15921,-0.12318,-0.092876,0,0
6,GO NEGATIVE REGULATION OF ENDOTHELIAL CELL APOPTOTIC PROCESS,0.074349,-0.12342,-0.067974,0,0
6,GO POSITIVE REGULATION OF PROTEIN AUTOPHOSPHORYLATION,0.33194,-0.12469,-0.048731,0,0
6,GO ALDITOL METABOLIC PROCESS,0.099614,-0.12501,-0.082928,0,0
6,GO HEART TRABECULA FORMATION,0.10129,-0.12525,-0.11597,0,0
6,GO NEGATIVE REGULATION OF AUTOPHAGOSOME ASSEMBLY,0.15098,-0.12571,-0.087916,0,0
6,GO BLOOD VESSEL REMODELING,0.18461,-0.12577,-0.060658,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED CYTOTOXICITY,0.1914,-0.1263,-0.1669,0,0
6,GO CELL CELL ADHESION INVOLVED IN GASTRULATION,0.096327,-0.12662,-0.076774,0,0
6,GO REGULATION OF CELL COMMUNICATION BY ELECTRICAL COUPLING,0.014172,-0.1268,-0.15692,0,0
6,GO POSITIVE REGULATION OF ACTIVATED T CELL PROLIFERATION,0.2114,-0.12899,-0.055297,0,0
6,GO HEPATOCYTE DIFFERENTIATION,0.060432,-0.13106,-0.11482,0,0
6,GO POSITIVE REGULATION OF STEROID METABOLIC PROCESS,0.062114,-0.13126,-0.15447,0,0
6,GO NEGATIVE REGULATION OF CHEMOKINE PRODUCTION,0.075674,-0.13142,-0.12875,0,0
6,GO CHAPERONE MEDIATED AUTOPHAGY,0.44269,-0.13152,-0.055868,0,0
6,GO NUCLEAR TRANSCRIBED MRNA CATABOLIC PROCESS NONSENSE MEDIATED DECAY,0.070488,-0.13182,-0.12129,0,0
6,GO VENTRICULAR CARDIAC MUSCLE CELL MEMBRANE REPOLARIZATION,0.28213,-0.13183,-0.055887,0,0
6,GO POSITIVE REGULATION OF HEART CONTRACTION,0.011022,-0.13383,-0.11612,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MEDIATED IMMUNITY,0.086981,-0.13398,-0.11266,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE CHEMOTAXIS,0.071756,-0.1343,-0.11835,0,0
6,GO GLYCOPROTEIN CATABOLIC PROCESS,0.08331,-0.13439,-0.11982,0,0
6,GO OLIGOPEPTIDE TRANSPORT,0.19979,-0.13461,-0.082188,0,0
6,GO CELLULAR RESPONSE TO COPPER ION,0.22971,-0.13493,-0.12522,0,0
6,GO PLATELET MORPHOGENESIS,0.079071,-0.13497,-0.062354,0,0
6,GO TRNA 5 END PROCESSING,0.00088789,-0.13645,-0.17243,0,0
6,GO ANTIBACTERIAL HUMORAL RESPONSE,0.35253,-0.13704,-0.032545,0,0
6,GO CYTOLYSIS,0.075674,-0.13853,-0.13691,0,0
6,GO REGULATION OF LAMELLIPODIUM MORPHOGENESIS,0.43789,-0.13872,-0.077441,0,0
6,GO NEGATIVE REGULATION OF T CELL MEDIATED IMMUNITY,0.10299,-0.13875,-0.092054,0,0
6,GO OLIGOSACCHARIDE BIOSYNTHETIC PROCESS,0.40286,-0.1405,-0.051142,0,0
6,GO NEGATIVE REGULATION OF VIRAL ENTRY INTO HOST CELL,0.10385,-0.14142,-0.20745,0,0
6,GO NEGATIVE REGULATION OF LEUKOCYTE MIGRATION,0.062684,-0.14216,-0.087398,0,0
6,GO POSITIVE REGULATION OF STRIATED MUSCLE CELL APOPTOTIC PROCESS,0.13234,-0.14303,-0.17606,0,0
6,GO DEOXYRIBONUCLEOSIDE TRIPHOSPHATE METABOLIC PROCESS,0.0016347,-0.14324,-0.13016,0,0
6,GO REGULATION OF ODONTOGENESIS OF DENTIN CONTAINING TOOTH,0.073694,-0.1436,-0.16209,0,0
6,GO LONG CHAIN FATTY ACID BIOSYNTHETIC PROCESS,0.10129,-0.14424,-0.1103,0,0
6,GO ADHESION OF SYMBIONT TO HOST,0.085497,-0.14455,-0.12087,0,0
6,GO NEGATIVE REGULATION OF MUSCLE ADAPTATION,0.18595,-0.14477,-0.11086,0,0
6,GO REGULATION OF MAST CELL ACTIVATION,0.10045,-0.14536,-0.077549,0,0
6,GO REGULATION OF MONOCYTE DIFFERENTIATION,0.1873,-0.14681,-0.11161,0,0
6,GO MONOCYTE CHEMOTACTIC PROTEIN 1 PRODUCTION,0.28033,-0.14792,-0.09219,0,0
6,GO REGULATION OF SUPEROXIDE METABOLIC PROCESS,0.098784,-0.14808,-0.09219,0,0
6,GO IMP METABOLIC PROCESS,0.11933,-0.14895,-0.11738,0,0
6,GO NEGATIVE REGULATION OF CELL KILLING,0.10734,-0.1506,-0.1888,0,0
6,GO DETOXIFICATION OF INORGANIC COMPOUND,0.52874,-0.15267,-0.17794,0,0
6,GO INTESTINAL LIPID ABSORPTION,0.1313,-0.15279,-0.1502,0,0
6,GO NEUTRAL AMINO ACID TRANSPORT,0.00080175,-0.15299,-0.15454,0,0
6,GO NEGATIVE REGULATION OF INTERLEUKIN 10 PRODUCTION,0.065005,-0.15349,-0.11666,0,0
6,GO REGULATION OF STEROID HORMONE BIOSYNTHETIC PROCESS,0.11837,-0.15359,-0.10952,0,0
6,GO NEGATIVE REGULATION OF SMOOTH MUSCLE CELL PROLIFERATION,0.09714,-0.15387,-0.082388,0,0
6,GO NEGATIVE REGULATION OF NATURAL KILLER CELL MEDIATED IMMUNITY,0.14419,-0.1551,-0.20942,0,0
6,GO MITOCHONDRIAL TRANSCRIPTION,0.14419,-0.15513,-0.09086,0,0
6,GO HYALURONAN CATABOLIC PROCESS,0.11933,-0.15527,-0.12879,0,0
6,GO POSITIVE REGULATION OF INTERLEUKIN 13 PRODUCTION,0.070488,-0.15582,-0.15999,0,0
6,GO CYSTEINE METABOLIC PROCESS,0.23766,-0.1564,-0.099956,0,0
6,GO NAD BIOSYNTHESIS VIA NICOTINAMIDE RIBOSIDE SALVAGE PATHWAY,0.11647,-0.15643,-0.13502,0,0
6,GO REGULATION OF COLLAGEN METABOLIC PROCESS,0.18194,-0.15693,-0.093419,0,0
6,GO COLLAGEN METABOLIC PROCESS,0.30066,-0.16379,-0.049197,0,0
6,GO CD4 POSITIVE ALPHA BETA T CELL PROLIFERATION,0.086981,-0.16399,-0.087324,0,0
6,GO SUPEROXIDE ANION GENERATION,0.11002,-0.1646,-0.11252,0,0
6,GO HEART INDUCTION,0.178,-0.16601,-0.093942,0,0
6,GO POSITIVE REGULATION OF HEART RATE,0.0062877,-0.16653,-0.15012,0,0
6,GO REGULATION OF GLOMERULUS DEVELOPMENT,0.16042,-0.1677,-0.12069,0,0
6,GO RESPONSE TO COPPER ION,0.11183,-0.16814,-0.11562,0,0
6,GO REGULATION OF APOPTOTIC PROCESS INVOLVED IN DEVELOPMENT,0.39156,-0.16913,-0.091592,0,0
6,GO POSITIVE REGULATION OF INFLAMMATORY RESPONSE TO ANTIGENIC STIMULUS,0.18461,-0.16948,-0.07842,0,0
6,GO REGULATION OF PLATELET ACTIVATION,0.077698,-0.17059,-0.12843,0,0
6,GO REGULATION OF HETEROTYPIC CELL CELL ADHESION,0.14869,-0.17135,-0.080493,0,0
6,GO NEGATIVE REGULATION OF PLATELET ACTIVATION,0.25753,-0.17164,-0.092097,0,0
6,GO TRNA 5 LEADER REMOVAL,0.00065224,-0.17358,-0.17877,0,0
6,GO POSITIVE REGULATION OF COLLAGEN METABOLIC PROCESS,0.15214,-0.17379,-0.12097,0,0
6,GO REGULATION OF GLUCOCORTICOID METABOLIC PROCESS,0.18461,-0.17605,-0.11733,0,0
6,GO REGULATION OF EXTRACELLULAR MATRIX DISASSEMBLY,0.22042,-0.17688,-0.074842,0,0
6,GO RESPONSE TO TYPE I INTERFERON,0.063836,-0.17702,-0.18309,0,0
6,GO POSITIVE REGULATION OF T CELL RECEPTOR SIGNALING PATHWAY,0.076344,-0.17705,-0.09937,0,0
6,GO RESPONSE TO LAMINAR FLUID SHEAR STRESS,0.22814,-0.17753,-0.066602,0,0
6,GO NUCLEOSIDE TRIPHOSPHATE CATABOLIC PROCESS,0.0007786,-0.17871,-0.14643,0,0
6,GO NEGATIVE REGULATION OF SYSTEMIC ARTERIAL BLOOD PRESSURE,0.060432,-0.17887,-0.10212,0,0
6,GO MACROPHAGE ACTIVATION INVOLVED IN IMMUNE RESPONSE,0.10045,-0.17958,-0.1103,0,0
6,GO REGULATION OF UNSATURATED FATTY ACID BIOSYNTHETIC PROCESS,0.19417,-0.18581,-0.1163,0,0
6,GO REGULATION OF CD8 POSITIVE ALPHA BETA T CELL ACTIVATION,0.067397,-0.18678,-0.15897,0,0
6,GO GLOMERULAR MESANGIUM DEVELOPMENT,0.23445,-0.18713,-0.090656,0,0
6,GO ACTIVATION OF CYSTEINE TYPE ENDOPEPTIDASE ACTIVITY,0.065596,-0.1933,-0.14454,0,0
6,GO COLLAGEN BIOSYNTHETIC PROCESS,0.12126,-0.19748,-0.11989,0,0
6,GO REGULATION OF RESPONSE TO OSMOTIC STRESS,0.066192,-0.19849,-0.0796,0,0
6,GO POSITIVE REGULATION OF METANEPHROS DEVELOPMENT,0.093918,-0.2021,-0.15255,0,0
6,GO NEGATIVE REGULATION OF AMINO ACID TRANSPORT,0.11002,-0.20326,-0.067645,0,0
6,GO BLEB ASSEMBLY,0.38933,-0.20382,-0.13056,0,0
6,GO PEPTIDYL PROLINE HYDROXYLATION,0.012798,-0.20829,-0.20754,0,0
6,GO RENAL SYSTEM VASCULATURE DEVELOPMENT,0.11742,-0.21259,-0.13156,0,0
6,GO FAT SOLUBLE VITAMIN BIOSYNTHETIC PROCESS,0.0019285,-0.2156,-0.19497,0,0
6,GO REGULATION OF DENDRITIC CELL DIFFERENTIATION,0.071756,-0.22162,-0.2525,0,0
6,GO NOTCH SIGNALING INVOLVED IN HEART DEVELOPMENT,0.17156,-0.22337,-0.12319,0,0
6,GO CARDIAC NEURAL CREST CELL DIFFERENTIATION INVOLVED IN HEART DEVELOPMENT,0.21437,-0.22448,-0.13347,0,0
6,GO MEMBRANE REPOLARIZATION DURING VENTRICULAR CARDIAC MUSCLE CELL ACTION POTENTIAL,0.032607,-0.23149,-0.13457,0,0
6,GO TROPHOBLAST CELL MIGRATION,0.00076726,-0.24755,-0.22727,0,0
6,GO REGULATION OF SUPEROXIDE ANION GENERATION,0.071119,-0.25062,-0.15965,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS ANTIGEN,0.094715,-0.27299,-0.31124,0,0
6,GO REGULATION OF AMINO ACID IMPORT ACROSS PLASMA MEMBRANE,0.0018256,-0.27351,-0.25961,0,0
6,GO ANTIGEN PROCESSING AND PRESENTATION OF ENDOGENOUS PEPTIDE ANTIGEN,0.11183,-0.2939,-0.3436,0,0
